PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shimizu, H; Tosaki, A; Ohsawa, N; Ishizuka-Katsura, Y; Shoji, S; Miyazaki, H; Oyama, F; Terada, T; Shirouzu, M; Sekine, S; Nukina, N; Yokoyama, S				Shimizu, Hideaki; Tosaki, Asako; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Miyazaki, Haruko; Oyama, Fumitaka; Terada, Takaho; Shirouzu, Mikako; Sekine, Shun-ichi; Nukina, Nobuyuki; Yokoyama, Shigeyuki			Parallel homodimer structures of the extracellular domains of the voltage-gated sodium channel beta 4 subunit explain its role in cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATION; CRYSTALLOGRAPHY; PIPELINE; SPRING-8; SYSTEM; ALPHA	Voltage-gated sodium channels (VGSCs) are transmembrane proteins required for the generation of action potentials in excitable cells and essential for propagating electrical impulses along nerve cells. VGSCs are complexes of a pore-forming alpha subunit and auxiliary beta subunits, designated as beta 1/beta 1B-beta 4 (encoded by SCN1B-4B, respectively), which also function in cell-cell adhesion. We previously reported the structural basis for the trans homophilic interaction of the beta 4 subunit, which contributes to its adhesive function. Here, using crystallo-graphic and biochemical analyses, we show that the beta 4 extracellular domains directly interact with each other in a parallel manner that involves an intermolecular disulfide bond between the unpaired Cys residues (Cys(58)) in the loop connecting strands B and C and intermolecular hydrophobic and hydrogen-bonding interactions of the N-terminal segments (Ser(30)-Val(35)). Under reducing conditions, an N-terminally deleted beta 4 mutant exhibited decreased cell adhesion compared with the wild type, indicating that the beta 4 cis dimer contributes to the trans homophilic interaction of beta 4 in cell- cell adhesion. Furthermore, this mutant exhibited increased association with the alpha subunit, indicating that the cis dimerization of beta 4 affects alpha-beta 4 complex formation. These observations provide the structural basis for the parallel dimer formation of beta 4 in VGSCs and reveal its mechanism in cell-cell adhesion.	[Shimizu, Hideaki; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Terada, Takaho; Shirouzu, Mikako; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Hideaki; Ohsawa, Noboru; Ishizuka-Katsura, Yoshiko; Shoji, Shisako; Shirouzu, Mikako; Sekine, Shun-ichi] RIKEN, Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Hideaki; Tosaki, Asako; Miyazaki, Haruko; Oyama, Fumitaka; Nukina, Nobuyuki] RIKEN, Lab Struct Neuropathol, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Miyazaki, Haruko; Nukina, Nobuyuki] Juntendo Univ, Dept Neurosci Neurodegenerat Disorders, Grad Sch Med, Tokyo 1138421, Japan; [Miyazaki, Haruko; Nukina, Nobuyuki] Doshisha Univ, Grad Sch Brain Sci, Lab Struct Neuropathol, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100394, Japan; [Oyama, Fumitaka] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan; [Terada, Takaho; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN; Juntendo University; Doshisha University; Kogakuin University; RIKEN	Yokoyama, S (corresponding author), RIKEN, Struct Biol Lab, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp	Yokoyama, Shigeyuki/N-6911-2015; Nukina, Nobuyuki/GPP-6265-2022; Oyama, Fumitaka/Q-4268-2019; Shimizu, Hideaki/C-4142-2017; Shoji, Shisako/AAJ-2654-2020; Sekine, Shun-ichi/N-5450-2015; Shirouzu, Mikako/A-6521-2016; Shoji, Shisako/C-3690-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Oyama, Fumitaka/0000-0002-1095-8306; Shimizu, Hideaki/0000-0003-0174-5947; Shoji, Shisako/0000-0001-8787-2159; Sekine, Shun-ichi/0000-0001-8174-8704; Shoji, Shisako/0000-0001-8787-2159	Japan Society for the Promotion of Science [24770195, 17H01564, 16K07005]; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED); AMED [Yugo-Nou 17dm0107140h0002]; CREST from the Japan Science and Technology Agency;  [22240037];  [16H01345]; Grants-in-Aid for Scientific Research [16H01345] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED; CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) 24770195 (to H. S.), for Scientific Research (A) 17H01564 (to N. N.), and for Scientific Research (C) 16K07005 (to H. M.) from the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research on Innovative Areas 22240037 and 16H01345 (to N. N.), the Targeted Proteins Research Program (to S. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) (to S. Y.) from MEXT and the Japan Agency for Medical Research and Development (AMED); Yugo-Nou 17dm0107140h0002 (to N. N.) from AMED; and CREST (to N. N.) from the Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baroni D, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00108; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2009, NEUROSCI LETT, V462, P272, DOI 10.1016/j.neulet.2009.07.020; Meadows LS, 2002, J NEUROSCI, V22, P10699; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Miyazaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6525; Namadurai S, 2014, J BIOL CHEM, V289, P10797, DOI 10.1074/jbc.M113.527994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Shimizu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26618; Sugahara Michihiro, 2008, Journal of Structural and Functional Genomics, V9, P21, DOI 10.1007/s10969-008-9042-y; Tan BH, 2010, HEART RHYTHM, V7, P771, DOI 10.1016/j.hrthm.2010.01.032; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yu FH, 2003, J NEUROSCI, V23, P7577	34	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13428	13440		10.1074/jbc.M117.786509	http://dx.doi.org/10.1074/jbc.M117.786509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655765	Green Published, hybrid			2022-12-26	WOS:000407465300028
J	Lin, KY; Cheng, CY; Li, CW; Yang, CJ; Tsai, MS; Liu, CE; Lee, YT; Tang, HJ; Wang, NC; Lin, TY; Lee, YC; Lin, SP; Huang, YS; Zhang, JY; Ko, WC; Cheng, SH; Hung, CC				Lin, Kuan-Yin; Cheng, Chien-Yu; Li, Chia-Wen; Yang, Chia-Jui; Tsai, Mao-Song; Liu, Chun-Eng; Lee, Yuan-Ti; Tang, Hung-Jen; Wang, Ning-Chi; Lin, Te-Yu; Lee, Yi-Chien; Lin, Shih-Ping; Huang, Yu-Shan; Zhang, Jun-Yu; Ko, Wen-Chien; Cheng, Shu-Hsing; Hung, Chien-Ching		Taiwan HIV Study Grp	Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; HEPATITIS-B-VIRUS; TREATMENT RESPONSE; CELL COUNT; INFECTION; PREVALENCE; ADULTS; CARE	Objectives The international and national HIV treatment guidelines in 2016 have focused on scaling up access to combination antiretroviral therapy (cART). We aimed to assess the trends and treatment outcomes of late cART initiation in Taiwan. Methods Between June 2012 and May 2016, we retrospectively included antiretroviral-naive HIV-positive adults who initiated cART. Late initiation was defined as when cART was initiated in patients with a CD4 count <200 cells/mm(3) or having experienced AIDS-defining illnesses. The treatment outcomes were assessed up to 6 months after starting cART. Results We included 3655 HIV-positive patients, and the majority of the patients were male (95.4%) with a median age of 31 years and initiated non-nucleoside reverse-transcriptase inhibitor-containing regimens (87.0%). The median CD4 count at cART initiation increased from 207 cells/mm 3 in 2012 to 298 cells/mm 3 in 2016, and the overall proportion of late cART initiation decreased from 49.1% in 2012 to 29.0% in 2016 (P for trend <0.001). Late cART initiation mainly resulted from late presentation for HIV care and was associated with older age (per 1-year increase, adjusted odds ratio [AOR], 1.05; 95% CI, 1.04-1.06), HBsAg seropositivity (AOR, 1.31; 95% CI, 1.04-1.64), HIV care in central and southern Taiwan, initiating cART in earlier year, non-intravenous drug users (AOR, 1.96; 95% CI, 1.33-2.86), and negative hepatitis C serostatus (AOR, 1.47; 95% CI, 1.04-2.08). Compared with non-late initiators, late initiators had a higher rate of all-cause mortality (1.7% vs. 0.3%) and regimen modification due to virological failure (7.1% vs. 2.6%). The predicting factors of all-cause mortality were late cART initiation (adjusted hazard ratio [AHR], 5.40; 95% CI, 2.14-13.65) and older age (AHR, 1.06; 95% CI, 1.03-1.10). Conclusions While the proportion of late cART initiation decreased over time in Taiwan, late initiation remained in a substantial proportion of HIV-positive patients. The late initiators had higher risk for poor outcomes. The need for strategies to earlier detection of HIV infection and expediting cART initiation should be highlighted, especially among the older population.	[Lin, Kuan-Yin] Natl Taiwan Univ Hosp, Dept Med, Jin Shan Branch, New Taipei, Taiwan; [Cheng, Chien-Yu; Cheng, Shu-Hsing] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Taoyuan, Taiwan; [Cheng, Chien-Yu] Natl Yang Ming Univ, Sch Publ Hlth, Taipei, Taiwan; [Li, Chia-Wen; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Li, Chia-Wen; Ko, Wen-Chien] Natl Cheng Kung Univ, Dept Med, Med Coll, Tainan, Taiwan; [Yang, Chia-Jui; Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Yang, Chia-Jui] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Chun-Eng] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Wang, Ning-Chi; Lin, Te-Yu] Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Wang, Ning-Chi; Lin, Te-Yu] Natl Def Med Ctr, Taipei, Taiwan; [Lee, Yi-Chien] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Lin, Shih-Ping] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Yu-Shan] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Zhang, Jun-Yu] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Cheng, Shu-Hsing] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Tri-Service General Hospital; National Defense Medical Center; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Cheng, SH (corresponding author), Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Internal Med, Taoyuan, Taiwan.; Cheng, SH (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Hung, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei, Taiwan.; Hung, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Hung, CC (corresponding author), China Med Univ, Taichung, Taiwan.	shuhsingcheng@gmail.com; hcc0401@ntu.edu.tw	cheng, chien-yu/M-1108-2019; Wang, Ning-Chi/GLT-7544-2022; Lee, Yuan-Ti/ABH-7837-2020; Ko, Wen-Chien/ABG-4316-2020	cheng, chien-yu/0000-0002-1886-0370; Lee, Yuan-Ti/0000-0003-4577-4379; Ko, Wen-Chien/0000-0001-7497-149X; Lin, Kuan-Yin/0000-0001-6877-5345; Huang, Yu-Shan/0000-0002-9047-5709	Taiwan Centers for Disease Control [MOHW103-CDC-C-114-000405]	Taiwan Centers for Disease Control	The authors would like to thank Taiwan Centers for Disease Control for research grant support (grant number MOHW103-CDC-C-114-000405 to C.-C. H.). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication. The authors also thank all study members participating in the Taiwan HIV Study Group: Hsin-Yun Sun, Sui-Yuan Chang, Pei-Ying Wu, Jun-Yu Zhang, Hsi-Yen Chang, Wen-Chun Liu, Yi-Ching Su, and Chien-Ching Hung , National Taiwan University Hospital, Taipei; Ning-Chi Wang and Te-Yu Lin, Tri-Service General Hospital and National Defense Medical Center, Taipei; Kuan-Yin Lin, National Taiwan University Hospital Jin-Shan Branch, New Taipei City; Chia-Jui Yang, and Mao-Song Tsai, Far Eastern Memorial Hospital, New Taipei City; Yi-Chieh Lee, Lotung Poh-Ai Hospital, Lo-Hsu Foundation, I-Lan; Chien-Yu Cheng and Shu-Hsing Cheng, Tao-Yuan General Hospital, Ministry of Health and Welfare, Tao-Yuan; Yu-Shan Huang, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu; Yuan-Ti Lee and Chia-Chun Lin, Chung Shan Medical University Hospital, Taichung; Shih-Ping Lin, Chia-Yin Hsieh, and Hsiu-Wen Wang, Taichung Veterans General Hospital, Taichung; Mao-Wang Ho, China Medical University Hospital, Taichung; Chun-Eng Liu and Yu-Lin Lee, Changhua Christian Hospital, Changhua; Yi-Chien Lee, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi; Hung-Jen Tang and Huei-Chun Ku, Chi Mei Medical Center, Tainan; Chia-Wen Li, Nan-Yao Lee, and Wen-Chien Ko, National Cheng Kung University Hospital, Tainan; Po-Liang Lu and Yen-Hsu Chen, Kaohsiung Medical University Hospital, Kaohsiung; Hsi-Hsun Lin, E-Da Hospital, Kaohsiung; Wen-Chi Huang and Chen-Hsiang Lee, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung; Tun-Chieh Chen, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung.; The authors would like to thank Taiwan Centers for Disease Control for research grant support (grant number MOHW103-CDC-C-114-000405 to C.-C. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control, 2013, GUID DIAGN TREATM HI; Centers for Disease Control R. O. C. (Taiwan), 2014, STAT COMM DIS SURV R; Chang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep35779; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Edwards JK, 2015, CLIN INFECT DIS, V61, P1189, DOI 10.1093/cid/civ463; Ford N, 2015, CLIN INFECT DIS, V60, P1128, DOI 10.1093/cid/ciu1138; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Harwood RH, 2014, AGE AGEING, V43, P308, DOI 10.1093/ageing/afu016; Huang SM, 2016, INT J STD AIDS, V27, P890, DOI 10.1177/0956462415600570; Kiertiburanakul S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18804; Lahuerta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037125; Lai CC, 2016, J ANTIMICROB CHEMOTH, V71, P226, DOI 10.1093/jac/dkv284; Lai CC, 2012, J ANTIMICROB CHEMOTH, V67, P1254, DOI 10.1093/jac/dkr601; Lesko CR, 2013, CLIN INFECT DIS, V57, P1027, DOI 10.1093/cid/cit421; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lourenco L, 2015, HIV MED, V16, P337, DOI 10.1111/hiv.12212; Ministry of Health and Welfare R. O. C. (Taiwan), 2008, DENS MED RES TAIW; Ministry of the Interior R. O. C. (Taiwan), 2016, ED LEV TABL TAIW; Mutimura E, 2015, AIDS, V29, P67, DOI 10.1097/QAD.0000000000000520; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Perez-Molina JA, 2012, J ANTIMICROB CHEMOTH, V67, P312, DOI 10.1093/jac/dkr478; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Tsai MS, 2013, J INFECT DIS, V208, P1184, DOI 10.1093/infdis/jit299; UNAIDS/WHO, 2013, REP GLOB AIDS EP; UNAIDS/WHO, 2016, GLOB AIDS UPD; UNAIDS/WHO, 2016, CONGUID UANT DRU; UNAIDS/ WHO, 2013, HIV AS PAC; UNAIDS/ WHO, 2014, 90 90 90 AMB TREATM; UNAIDS/ WHO, 2013, CONGUID UANT DRU; UNAIDS/ WHO, 2010, ANT THER HIV INF AD; World Bank, 2016, COUNTR LEND GROUPS; Wright ST, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19463; Wu PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171596	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179870	10.1371/journal.pone.0179870	http://dx.doi.org/10.1371/journal.pone.0179870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665938	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700042
J	Rudolf, G; Tul, N; Verdenik, I; Volk, M; Brezigar, A; Vokac, NK; Jersin, N; Prosenc, B; Srsen, TP; Peterlin, B				Rudolf, Gorazd; Tul, Natasa; Verdenik, Ivan; Volk, Marija; Brezigar, Anamarija; Vokac, Nadja Kokalj; Jersin, Natasa; Prosenc, Bernarda; Srsen, Tanja Premru; Peterlin, Borut			Impact of prenatal screening on the prevalence of Down syndrome in Slovenia	PLOS ONE			English	Article							MATERNAL AGE; TRENDS	Objectives To evaluate the impact of prenatal screening and genetic testing for trisomy 21 (T21) on the prevalence of T21 in Slovenia. Design and setting Data about all prenatally and postnatally confirmed cases of T21 in Slovenia between 1981 and 2012 were collected retrospectively from all genetic laboratories in Slovenia. The expected number of babies with T21 according to maternal age was calculated. Main outcome measures The primary outcomes measures were number of fetuses and newborn infants with T21 diagnosed prenatally and postnatally and the impact of advances in screening and genetic diagnostics on the prevalence of newborns with T21 in Slovenia. Results Despite a significantly increased mean maternal age from 25.4 years in year 1981 to 30.3 years in year 2012 the prevalence of newborn infants with T21 was 0.51 per 1000 births compared to 0.55 per 1000 births, respectively. The prevalence of prenatally diagnosed cases increased from 0.03 per 1000 births to 2.06 per 1000. The detection rate of T21 in year 2012 was 78,9%. The total number of prenatal invasive procedures (chorionic villous sampling and amniocenteses) carried out during that period was rising until 2002, since when it is stable at around 7%. Conclusion The advancement and implementation of screening tests and prenatal diagnostic procedures in Slovenia caused an important improvement in the efficiency of the prenatal detection of T21.	[Rudolf, Gorazd; Volk, Marija; Prosenc, Bernarda; Peterlin, Borut] Univ Med Ctr Ljubljana, CIMG, Ljubljana, Slovenia; [Tul, Natasa; Verdenik, Ivan; Jersin, Natasa; Srsen, Tanja Premru] Univ Med Ctr Ljubljana, Div Gynaecol & Obstet, Dept Perinatol, Ljubljana, Slovenia; [Brezigar, Anamarija] Medgen, Outpatient Clin Med Genet, Ljubljana, Slovenia; [Vokac, Nadja Kokalj] Univ Med Ctr Maribor, Lab Med Genet, Maribor, Slovenia	University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Maribor	Rudolf, G (corresponding author), Univ Med Ctr Ljubljana, CIMG, Ljubljana, Slovenia.	gorazd.img@gmail.com	Verdenik, Ivan/G-9618-2012; Premru-Srsen, Tanja/AGK-8909-2022	Premru-Srsen, Tanja/0000-0003-2597-0188				Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Cocchi G, 2010, BIRTH DEFECTS RES A, V88, P474, DOI 10.1002/bdra.20666; Crombag NMTH, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-437; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Gidiri M, 2007, BJOG-INT J OBSTET GY, V114, P458, DOI 10.1111/j.1471-0528.2007.01266.x; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Merilainen A, 2014, CLIN MED INSIGHTS-RE, V8, P45, DOI 10.4137/CMRH.S14958; Metneki J, 2005, EUR J EPIDEMIOL, V20, P525, DOI 10.1007/s10654-005-4261-z; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Morris JK, 2009, BMJ-BRIT MED J, V339, pb3794, DOI DOI 10.1136/BMJ.B3794; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033	11	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180348	10.1371/journal.pone.0180348	http://dx.doi.org/10.1371/journal.pone.0180348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665986	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700002
J	Shin, S; Kim, J; Kim-Wanner, SZ; Bonig, H; Cho, SR; Kim, S; Choi, JR; Lee, KA				Shin, Saeam; Kim, Juwon; Kim-Wanner, Soo-Zin; Boenig, Halvard; Cho, Sung Ran; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A			A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BLOOD PROGENITOR CELLS; ACUTE HEART-FAILURE; PERIPHERAL-BLOOD; HEALTHY DONORS; VOLUNTEER DONORS; CONTROLLED-TRIAL; POPULATION; COUNT; TRANSPLANTATION	Mobilization of hematopoietic stem cells (HSCs) from the bone marrow to the peripheral blood is a complex mechanism that involves adhesive and chemotactic interactions of HSCs as well as their bone marrow microenvironment. In addition to a number of non-genetic factors, genetic susceptibilities also contribute to the mobilization outcome. Identification of genetic factors associated with HSC yield is important to better understand the mechanism behind HSC mobilization. In the present study, we enrolled 148 Korean participants (56 healthy donors and 92 patients) undergoing HSC mobilization for allogeneic or autologous HSC transplantation. Among a total of 53 polymorphisms in 33 candidate genes, one polymorphism (rs11264422) in relaxin/insulin-like family peptide receptor 4 (RXFP4) gene was significantly associated with a higher HSC yield after mobilization in Koreans. However, in a set of 101 Europeans, no association was found between circulating CD34+ cell counts and rs11264422 genotype. Therefore, we suggest that the ethnic differences in subjects' genetic background may be related to HSC mobilization. In conclusion, the relaxin-relaxin receptor axis may play an important role in HSC mobilization. We believe that the results of the current study could provide new insights for therapies that use relaxin and HSC populations, as well as a better understanding of HSC regulation and mobilization at the molecular level.	[Shin, Saeam; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Shin, Saeam] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Juwon] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea; [Kim-Wanner, Soo-Zin; Boenig, Halvard] German Red Cross Blood Serv BaWuHe, Frankfurt, Germany; [Boenig, Halvard] Johann Wolfgang Goethe Med Univ, Inst Transfus Med & Immune Hematol, Frankfurt, Germany; [Boenig, Halvard] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Cho, Sung Ran] Ajou Univ, Sch Med, Dept Lab Med, Suwon, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Yonsei University; University of Washington; University of Washington Seattle; Ajou University	Lee, KA (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	KAL1119@yuhs.ac	Cho, Sung-Ran/AAK-9950-2021; Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Kim, Sinyoung/0000-0002-2609-8945; Shin, Saeam/0000-0003-1501-3923; Lee, Kyung-A/0000-0001-5320-6705	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120030]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120030, http://www.htdream.kr/, KAL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2011, PLOS GENET, V7; Ameen RM, 2008, CLIN LYMPHOMA MYELOM, V8, P106, DOI 10.3816/CLM.2008.n.012; Ben Nasr M, 2011, TRANSPL P, V43, P635, DOI 10.1016/j.transproceed.2011.01.016; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bitto A, 2013, CLIN SCI, V125, P575, DOI 10.1042/CS20130105; Boels K, 2003, BRIT J PHARMACOL, V140, P932, DOI 10.1038/sj.bjp.0705521; Bogunia-Kubik K, 2009, BONE MARROW TRANSPL, V44, P273, DOI 10.1038/bmt.2009.30; Cohen KS, 2013, BLOOD; Cottler-Fox M, 2006, BLOOD REV, V20, P43, DOI 10.1016/j.blre.2005.06.001; De La Rubia J, 2002, J HEMATOTH STEM CELL, V11, P705, DOI 10.1089/15258160260194857; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gupta R, 2011, CIRC-CARDIOVASC INTE, V4, P2, DOI 10.1161/CIRCINTERVENTIONS.110.960716; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Koenigsmann M, 2004, TRANSFUSION, V44, P777, DOI 10.1111/j.0041-1132.2004.03321.x; Komeno Y, 2006, BIOL BLOOD MARROW TR, V12, P408, DOI 10.1016/j.bbmt.2005.11.007; Kong M, 2013, INT J IMMUNOGENET, V40, P120, DOI 10.1111/j.1744-313X.2012.01141.x; Lenk J, 2013, BIOL BLOOD MARROW TR, V19, P1517, DOI 10.1016/j.bbmt.2013.07.018; Lentner C, 1982, GEIGY SCI TABLES; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Martin-Antonio B, 2011, HAEMATOL-HEMATOL J, V96, P102, DOI 10.3324/haematol.2010.026401; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Okada Y, 2012, J HUM GENET, V57, P161, DOI 10.1038/jhg.2012.2; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Pavone V, 2006, BONE MARROW TRANSPL, V37, P719, DOI 10.1038/sj.bmt.1705298; Platzbecker U, 2005, TRANSFUSION, V45, P11, DOI 10.1111/j.1537-2995.2005.04107.x; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Schulz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121859; Segal MS, 2012, BLOOD, V119, P629, DOI 10.1182/blood-2011-04-346007; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Szmigielska-Kaplon A, 2014, BIOL BLOOD MARROW TR, V20, P986, DOI 10.1016/j.bbmt.2014.03.019; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teipel R, 2015, TRANSFUSION, V55, P2855, DOI 10.1111/trf.13239; Tietjens J, 2016, HEART, V102, P95, DOI 10.1136/heartjnl-2014-306786; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasu S, 2008, BLOOD, V112, P2092, DOI 10.1182/blood-2008-03-143677; Wang TF, 2008, BIOL BLOOD MARROW TR, V14, P1305, DOI 10.1016/j.bbmt.2008.09.002; Wang XL, 2015, STEM CELL RES, V15, P14, DOI 10.1016/j.scr.2015.04.004; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	44	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179986	10.1371/journal.pone.0179986	http://dx.doi.org/10.1371/journal.pone.0179986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666004	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700049
J	Agostinete, RR; Duarte, JP; Valente-dos-Santos, J; Coelho-e-Silva, MJ; Tavares, OM; Conde, JM; Fontes-Ribeiro, CA; Condello, G; Capranica, L; Caires, SU; Fernandes, RAMA				Agostinete, Ricardo R.; Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Tavares, Oscar M.; Conde, Jorge M.; Fontes-Ribeiro, Carlos A.; Condello, Giancarlo; Capranica, Laura; Caires, Suziane U.; Fernandes, Ro A. Mulo A.			Bone tissue, blood lipids and inflammatory profiles in adolescent male athletes from sports contrasting in mechanical load	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MINERAL DENSITY; RESISTANCE EXERCISE; ADIPOSE-TISSUE; CALCIUM INTAKE; CHILDREN; IMPACT; RISK; PARTICIPATION; FITNESS	Exploring the effect of non-impact and impact sports is particular relevant to understand the interaction between skeletal muscle and bone health during growth. The current study aimed to compare total and regional bone and soft-tissue composition, in parallel to measurements of blood lipid and inflammatory profiles between adolescent athletes and non-athletes. Anthropometry, biological maturity, dual energy X-ray absorptiometry (DXA) scans, training load and lipid and inflammatory profiles were assessed in a cross-sectional sample of 53 male adolescents (20 non-athletes, 15 swimmers and 18 basketball players) aged 12-19 years. Multiple comparisons between groups were performed using analysis of variance, covariance and magnitude effects (ES-r and Cohen's d). The comparisons of controls with other groups were very large for high-sensitivity C-reactive protein (d range: 2.17-2.92). The differences between sports disciplines, regarding tissue outputs obtained from DXA scan were moderate for all variables except fat tissue (d = 0.4). It was possible to determine small differences (ES-r = 0.17) between controls and swimmers for bone area at the lower limbs (13.0%). In parallel, between swimmers and basketball players, the gradient of the differences was small (ES-r range: 0.15-0.23) for bone mineral content (24.6%), bone area (11.3%) and bone mineral density (11.1%) at the lower limbs, favoring the basketball players. These observations highlight that youth male athletes presented better blood and soft tissues profiles with respect to controls. Furthermore, sport-specific differences emerged for the lower limbs, with basketball players presenting higher bone mineral content, area and density than swimmers.	[Agostinete, Ricardo R.; Caires, Suziane U.; Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Dept Phys Educ, Lab Invest Exercise LIVE, Sao Paulo, Brazil; [Agostinete, Ricardo R.; Caires, Suziane U.; Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Dept Phys Therapy, Postgrad Program Phys Therapy, Sao Paulo, Brazil; [Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.] Univ Coimbra, CIDAF UID DTP 04213 2016, Fac Sport Sci & Phys Educ, Coimbra, Portugal; [Duarte, Joao P.] Portuguese Fdn Sci & Technol SFRH BD 101083 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao] Portuguese Fdn Sci & Technol SFRH BPD 100470 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao; Fontes-Ribeiro, Carlos A.] Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Valente-dos-Santos, Joao] Lusofona Univ Humanities & Technol, Fac Phys Educ & Sport, Lisbon, Portugal; [Tavares, Oscar M.] Inst Politecn Coimbra, Sch Hlth & Technol, Dept Med Imaging & Radiat Therapy, Coimbra, Portugal; [Conde, Jorge M.] Inst Politecn Coimbra, Coimbra, Portugal; [Fontes-Ribeiro, Carlos A.] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, Coimbra, Portugal; [Condello, Giancarlo; Capranica, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Fernandes, Ro A. Mulo A.] Sao Paulo State Univ UNESP, Inst Biosci, Postgrad Program Kinesiol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Coimbra; Universidade de Coimbra; Lusofona University; Instituto Politecnico de Coimbra (IPC); Instituto Politecnico de Coimbra (IPC); Universidade de Coimbra; Foro Italico University of Rome; Universidade Estadual Paulista	Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, CIDAF UID DTP 04213 2016, Fac Sport Sci & Phys Educ, Coimbra, Portugal.	mjcesilva@hotmail.com	Condello, Giancarlo/AAC-8365-2020; Ribeiro, Carlos A Fontes/B-7729-2018; Coelho-e-Silva, Manuel J/V-1645-2017; Silva, Manuel Coelho E/O-2604-2019; Agostinete, Ricardo/N-7874-2016; Laura, Capranica/AFW-3460-2022; Valente-dos-Santos, Joao/ABE-3220-2020; Fernandes, Rômulo A/G-3114-2012	Condello, Giancarlo/0000-0001-5092-3258; Ribeiro, Carlos A Fontes/0000-0002-9707-4895; Coelho-e-Silva, Manuel J/0000-0003-4512-7331; Silva, Manuel Coelho E/0000-0003-4512-7331; Agostinete, Ricardo/0000-0001-8420-7225; Valente-dos-Santos, Joao/0000-0003-0980-0269; Fernandes, Rômulo A/0000-0003-1576-8090; Capranica, Laura/0000-0003-3073-7655; Marques Duarte, Joao Pedro/0000-0002-7536-9780; Tavares, Oscar/0000-0002-1437-0307; Conde, Jorge/0000-0002-2225-8569	Sao Paulo Research Foundation (FAPESP) [2013/06963-5, 2015/13543-8, 2016/06920-2]; JPD [SFRH/BD/101083/2014]; JVdS [SFRH/ BPD/100470/2014]; Portuguese Foundation for Science and Technology; Portuguese Foundation for Science and Technology [uid/dtp/04213/2016]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); JPD; JVdS; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This study was supported by the Sao Paulo Research Foundation (FAPESP,Process 2013/06963-5,2015/13543-8 and 2016/06920-2). JPD (SFRH/BD/101083/2014) and JVdS(SFRH/ BPD/100470/2014) were partially supported by the Portuguese Foundation for Science and Technology. CIDAF is registered in Portuguese Foundation for Science and Technology: uid/dtp/04213/2016. No other current funding sources for this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio M, 2002, SCAND J MED SCI SPOR, V12, P179, DOI 10.1034/j.1600-0838.2002.00250.x; Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; Agostinete RR, 2016, J CLIN DENSITOM, V19, P375, DOI 10.1016/j.jocd.2016.04.006; American Heart Association, 2014, CHILDR CHOL; Bellew James W, 2006, Pediatr Phys Ther, V18, P19, DOI 10.1097/01.pep.0000200952.63544.16; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J, 1988, STAT POWER ANAL SOCI, V2nd; Quiterio ALD, 2011, J STRENGTH COND RES, V25, P3439, DOI 10.1519/JSC.0b013e318216003b; Dollman J, 2005, BRIT J SPORT MED, V39, P892, DOI 10.1136/bjsm.2004.016675; Ducher G, 2006, J BONE MINER METAB, V24, P484, DOI 10.1007/s00774-006-0710-3; Dyson K, 1997, MED SCI SPORT EXER, V29, P443, DOI 10.1097/00005768-199704000-00004; European Commission, 2008, EU PHYS ACT GUID REC; European Commission Expert Group on Health-enhancing Physical Activity, 2015, EXP GROUP HLTH ENH P; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gillam G., 1985, NSCA J, V6, P44; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Horowitz JF, 2003, TRENDS ENDOCRIN MET, V14, P386, DOI 10.1016/S1043-2760(03)00143-7; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Katzmarzyk PT, 1998, PEDIATR EXERC SCI, V10, P378, DOI 10.1123/pes.10.4.378; Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Lipnowski S, 2012, PAED CHILD HEALT-CAN, V17, P209, DOI 10.1093/pch/17.4.209; McGuigan MR, 2008, PEDIATR EXERC SCI, V20, P333, DOI 10.1123/pes.20.3.333; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Molgaard C, 2001, OSTEOPOROSIS INT, V12, P887, DOI 10.1007/s001980170042; Naghii MR, 2011, INT J OCCUP MED ENV, V24, P380, DOI 10.2478/s13382-011-0044-9; Nemet D, 2002, PEDIATRICS, V110, P681, DOI 10.1542/peds.110.4.681; Nordstrom A, 2005, J BONE MINER RES, V20, P202, DOI 10.1359/JBMR.041012; Nordstrom P, 1998, J BONE MINER RES, V13, P1141, DOI 10.1359/jbmr.1998.13.7.1141; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pfeiffer KA, 2006, J ADOLESCENT HEALTH, V39, P523, DOI 10.1016/j.jadohealth.2006.03.005; Pyne DB, 2014, INT J SPORT NUTR EXE, V24, P351, DOI 10.1123/ijsnem.2014-0047; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; RUIZ JC, 1995, J BONE MINER RES, V10, P675; Seabra A, 2016, J SPORT SCI, V34, P1822, DOI 10.1080/02640414.2016.1140219; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Tanaka H, 2009, SPORTS MED, V39, P377, DOI 10.2165/00007256-200939050-00004; Tenforde AS, 2011, PM&R, V3, P861, DOI 10.1016/j.pmrj.2011.05.019; Trost SG, 1997, PREV MED, V26, P257, DOI 10.1006/pmed.1996.0137; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Wiebe PN, 2002, PEDIATR EXERC SCI, V14, P345, DOI 10.1123/pes.14.4.345; Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang PF, 2011, J MUSCULOSKEL NEURON, V11, P8; Zribi A, 2014, J CLIN DENSITOM, V17, P156, DOI 10.1016/j.jocd.2013.04.001	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180357	10.1371/journal.pone.0180357	http://dx.doi.org/10.1371/journal.pone.0180357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662190	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300144
J	Kralik, I; Stefanic, M; Brkic, H; Saric, G; Tezak, S; Ivankovic, SG; Griotto, N; Stimac, D; Rubin, O; Salha, T; Ivanisevic, Z; Jurkovic, S; Faj, D				Kralik, Ivana; Stefanic, Mario; Brkic, Hrvoje; Saric, Gordan; Tezak, Stanko; Ivankovic, Svjetlana Grbac; Griotto, Neva; Stimac, Damir; Rubin, Otmar; Salha, Tamer; Ivanisevic, Zrinka; Jurkovic, Slaven; Faj, Dario			Estimated collective effective dose to the population from nuclear medicine diagnostic procedures in Croatia: A comparison of 2010 and 2015	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; FEBRILE INFANTS; UTI	Objective This study presents national surveys of patient exposure from nuclear medicine (NM) diagnostic procedures in 2010 and 2015 in the Republic of Croatia. Methods The survey was performed according to the European Commission Dose DataMed (DDM) project methodology. 28 most frequent NM diagnostic procedures were identified. Data about frequencies of procedures and average administered activities of radioisotopes used in those procedures were collected. Average administered activities were converted to effective doses according to the dose conversion coefficients. Then the collective effective dose to the population and an effective dose per capita were calculated based on the number of the most frequent NM diagnostic procedures and the average effective dose per procedure. Results In 2010, 41200 NM diagnostic procedures led to 146.7 manSv collective effective dose to the population and in 2015, 42000 NM diagnostic procedures led to 146.8 manSv collective effective dose to the population. The frequencies of NM diagnostic procedures were 9.7 and 9.8 annually per 1000 population with 34.1 pSv and 34.2 pSv effective dose per capita for 2010 and 2015, respectively. The main contributors to the annual collective dose from NM in Croatia are examinations of the bone, heart, thyroid and PET/CT tumour diagnostic. Average administered activities have not changed considerably from 2010 to 2015. Nevertheless, within the frequency of some of the procedures, significant changes were found in fiveyear period. Conclusions Frequencies, average administered activities and collective effective dose to the population from NM diagnostic procedures in Croatia are comparable to the values reported by other European surveys. Changes were found between 2010 and 2015 and we intend to perform this study periodically to identify possible trends, but also to raise awareness about the potential dose optimization.	[Kralik, Ivana] State Off Radiol & Nucl Safety, Zagreb, Croatia; [Stefanic, Mario; Brkic, Hrvoje; Saric, Gordan; Stimac, Damir; Rubin, Otmar; Salha, Tamer; Ivanisevic, Zrinka; Faj, Dario] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia; [Stefanic, Mario; Saric, Gordan; Stimac, Damir; Rubin, Otmar; Salha, Tamer] Univ Hosp Ctr Osijek, Osijek, Croatia; [Tezak, Stanko] Univ Hosp Ctr Zagreb, Zahreb, Croatia; [Ivankovic, Svjetlana Grbac; Griotto, Neva; Jurkovic, Slaven] Univ Hosp Ctr Rijeka, Rijeka, Croatia; [Ivankovic, Svjetlana Grbac; Griotto, Neva; Jurkovic, Slaven] Univ Rijeka, Fac Med, Rijeka, Croatia	University of JJ Strossmayer Osijek; University of Zagreb; University of Rijeka; University of Rijeka	Faj, D (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia.	dariofaj@mefos.hr	Stimac, Davor/S-7420-2018; Brkić, Hrvoje/B-8477-2013; Štimac, Davor/ABF-7086-2020	Stimac, Davor/0000-0001-8243-2453; Brkić, Hrvoje/0000-0001-6692-6875; IVANISEVIC, ZRINKA/0000-0002-2952-0574; Kralik, Ivana/0000-0002-2912-3472; Faj, Dario/0000-0002-4111-5459; Stefanic, Mario/0000-0001-8995-6137				Andrea C, PRISTUP DJETETU S PR; Balat D, 2014, WORKSH EUR POP DOS M, P26; Clement C. H., 2008, Annals of the ICRP, V38, P1, DOI 10.1016/j.icrp.2008.08.003; European Commision, 2008, EUR GUID EST POP DOS; European Commision. Medical Radiation Exposure of the European Population, 2014, RAD PROTECTION; ICRP, 1988, ANN ICRP, V18; ICRP International commission for radiation protection (ICRP), 1998, ANN ICRP, V28, P1; Kusic Z, 2005, COLLEGIUM ANTROPOL, V29, P9; Kusie Z, 2008, LIJECNICKI VJESNIK, V131, P328; La Scola C, 2013, PEDIATRICS, V131, pE665, DOI 10.1542/peds.2012-0164; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Montini G, 2009, PEDIATRICS, V123, pE239, DOI 10.1542/peds.2008-1003; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; Nichols M, 2014, EUROPEAN HEART J; Prlie I, 2010, ARHIV HIGIJENU RADA, V61, P69; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Shrimpton P, 2008, FREQUENCY COLLECTIVE; Skrk D, 2013, RADIOL ONCOL, V47, P304, DOI 10.2478/raon-2013-0048; Teles P, 2013, RADIAT PROT DOSIM, V154, P446, DOI 10.1093/rpd/ncs258; Tsapaki V, 2009, AM J ROENTGENOL, V193, P559, DOI 10.2214/AJR.08.2115; Yeh DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165526	21	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180057	10.1371/journal.pone.0180057	http://dx.doi.org/10.1371/journal.pone.0180057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662092	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300094
J	Ma, Y; Wang, YH; Xu, ZH; Wang, YJ; Fallon, JK; Liu, F				Ma, Yan; Wang, Yuhua; Xu, Zhenghong; Wang, Yongjun; Fallon, John K.; Liu, Feng			Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; CHEMOTHERAPY; GLYCOPROTEIN; CELLS; INHIBITION; SECRETION; EFFICACY; IMPROVES	We conducted a prospective, meaningful study of extreme low dose of 5-fluorouracil (5FU) as a metronomic agent targeting cancer associated fibroblasts (CAFs) to reverse Multidrug resistance (MDR) by sensitizing cancer associated fibroblasts and down-regulating P-glycoprotein (P-gp). The combination of 5FU and Taxol inhibited resistant KB-8-5 tumor growth by 79% and H460/Tax-R tumor growth by 55%. The inhibition was significant for both tumor types compared with Taxol treatment alone (p<0.001 and p = 0.0067, respectively). Nevertheless, the low -dose 5FU (2.2 mg/kg compared to the therapeutic dose of 50-150 mg/kg) showed negligible tumor inhibitory effect. The tumor growth inhibition study on resistant tumors demonstrated that the continuous administration of low dose 5FU with Taxol significantly inhibited the tumor growth. The treatment overcomes drug resistance in tumors by down -regulating multi -drug resistance transporter protein (P-gp), and more importantly, by eliminating CAFs recruited by resistant tumors. Compared with traditional metronomic chemotherapy, 5FU as metronomic agent targeting CAFs can avoid the disadvantages resulted from the concomitant administration of antiangiogenetic drug. The approach has good translational potential for clinical trials when treating stroma-rich drug resistant tumors.	[Ma, Yan; Wang, Yuhua; Xu, Zhenghong; Wang, Yongjun; Fallon, John K.; Liu, Feng] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Ma, Yan] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China; [Wang, Yongjun] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Guangzhou University of Chinese Medicine; Shenyang Pharmaceutical University	Ma, Y; Wang, YH (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA.; Ma, Y (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China.	mygzhtcm@163.com; yhw_albert@163.com		Fallon, John/0000-0003-1848-0121	National Cancer Institute National Institutes of Health [5R01CA149387]; National Nature Science Foundation of China [81403109]; Science and Technology Planning Project of Guangdong Province [2014A020210021]; NATIONAL CANCER INSTITUTE [R01CA149387] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1. National Cancer Institute National Institutes of Health (5R01CA149387), Feng Liu; 2. National Nature Science Foundation of China (81403109), Yan Ma; 3. Science and Technology Planning Project of Guangdong Province (2014A020210021), Yan Ma.	Benasso M, 1997, SEMIN ONCOL, V24, pS46; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; Brenda PN, 2000, CLIN BREAST CANCER, V1, P136; Browder T, 2000, CANCER RES, V60, P1878; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Cristiane CD, 2000, FOOD CHEM TOXICOL, V48, P3120; Cruz JJ, 2008, CANCER TREAT REV, V34, P268, DOI 10.1016/j.ctrv.2007.12.004; Han EKH, 2000, EUR J CANCER, V36, P1565, DOI 10.1016/S0959-8049(00)00145-3; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Johnson LM, 2013, CANCER BIOL THER, V14, P90, DOI 10.4161/cbt.22636; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; PIWNICAWORMS D, 1993, CANCER RES, V53, P977; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Yan M, 2014, MOL PHARM, V11, P2623	19	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180023	10.1371/journal.pone.0180023	http://dx.doi.org/10.1371/journal.pone.0180023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662182	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300089
J	Ruis, C; Roy, S; Brown, JR; Allen, DJ; Goldstein, RA; Breuer, J				Ruis, Christopher; Roy, Sunando; Brown, Julianne R.; Allen, David J.; Goldstein, Richard A.; Breuer, Judith			The emerging GII.P16-GII.4 Sydney 2012 norovirus lineage is circulating worldwide, arose by late-2014 and contains polymerase changes that may increase virus transmission	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TOOL	Noroviruses are a leading cause of human gastroenteritis worldwide. The norovirus genotype GII.4 is the most prevalent genotype in the human population and has caused six pandemics since 1995. A novel norovirus lineage containing the GII.P16 polymerase and pandemic GII.4 Sydney 2012 capsid was recently detected in Asia and Germany. We demonstrate that this lineage is also circulating within the UK and USA and has been circulating since October 2014 or earlier. While the lineage does not contain unique substitutions in the capsid, it does contain polymerase substitutions close to positions known to influence polymerase function and virus transmission. These polymerase substitutions are shared with a GII.P16-GII.2 virus that dominated outbreaks in Germany in Winter 2016. We suggest that the substitutions in the polymerase may have resulted in a more transmissible virus and the combination of this polymerase and the pandemic GII.4 capsid may result in a highly transmissible virus. Further surveillance efforts will be required to determine whether the GII.P16-GII.4 Sydney 2012 lineage increases in frequency over the coming months.	[Ruis, Christopher; Roy, Sunando; Goldstein, Richard A.; Breuer, Judith] UCL, Div Infect & Immun, London, England; [Brown, Julianne R.; Breuer, Judith] Great Ormond St Hosp Sick Children, Dept Microbiol Virol & Infect Control, London, England; [Allen, David J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London, England; [Allen, David J.] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England; [Allen, David J.] NIHR Hlth Protect Res Unit Gastrointestinal Infec, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Public Health England	Ruis, C (corresponding author), UCL, Div Infect & Immun, London, England.	christopher.ruis.10@ucl.ac.uk		Brown, Julianne/0000-0002-4681-9586; Breuer, Judith/0000-0001-8246-0534; Goldstein, Richard/0000-0001-5148-4672	UCL CoMPLEX; Wellcome Trust [203268/Z/16/Z]; National Institute for Health Research (NIHR) [NIHRHCS-D12-03-15]; Medical Research Council (UK) [MC_U117573805]; UCL/UCLHNIHR Biomedical Resource Centre; Engineering and Physical Sciences Research Council [1206225, 1488410] Funding Source: researchfish; Medical Research Council [MC_PC_13056, 1241875] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-15] Funding Source: researchfish; MRC [MC_PC_13056] Funding Source: UKRI	UCL CoMPLEX; Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLHNIHR Biomedical Resource Centre; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CR is funded by a studentship form UCL CoMPLEX. SR is funded by the Wellcome Trust grant 203268/Z/16/Z (websitehttps://wellcome.ac.uk/). JRB is funded by a National Institute for Health Research (NIHR) doctoral fellowship (NIHRHCS-D12-03-15, websitehttp://www.nihr.ac.uk/). DJA is affiliated to the National Institute for Health Research Health Protection Research Unit (NIHRHPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with University of East Anglia, University of Oxford and the Institute of Food Research. DJA is based at London School of Hygiene & Tropical Medicine and Public Health England. RAG is funded by the Medical Research Council (UK) grant MC_U117573805 (websitehttps://www.mrc.ac.uk/) .JB receives funding from the UCL/UCLHNIHR Biomedical Resource Centre (websitehttps://www.uclh.nhs.uk/Research/BRC/Pages/Home.aspx).	Arias A, 2016, MSPHERE, P1; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Choi YS, 2017, FOOD ENV VIROL; de Graaf M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/nrmicro.2016.48; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Matsushima Y, 2016, GENOME ANNOUNC, P4; Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	15	53	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179572	10.1371/journal.pone.0179572	http://dx.doi.org/10.1371/journal.pone.0179572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662035	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000404608300034
J	Agunos, A; Leger, DF; Carson, CA; Gow, SP; Bosman, A; Irwin, RJ; Reid-Smith, RJ				Agunos, Agnes; Leger, David F.; Carson, Carolee A.; Gow, Sheryl P.; Bosman, Angelina; Irwin, Rebecca J.; Reid-Smith, Richard J.			Antimicrobial use surveillance in broiler chicken flocks in Canada, 2013-2015	PLOS ONE			English	Article							USAGE	There is a paucity of data on the reason for and the quantity of antimicrobials used in broiler chickens in Canada. To address this, the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) implemented surveillance of antimicrobial use (AMU) and antimicrobial resistance (AMR) in broiler chicken flocks in 2013. Shortly after this (2014), the poultry industry banned the preventive use of ceftiofur in broiler chickens. The objectives of this analysis were to describe antimicrobial use (AMU) in Canadian broiler chickens between 2013 and 2015 (n = 378 flocks), compare these results to other animal species in Canada, to highlight the utility of farm surveillance data to evaluate the impact of a policy change, and to explore how different antimicrobial use metrics might affect data interpretation and communication. The surveillance data indicated that the poultry industry policy resulted in lower antimicrobial use and resistance, and they successfully captured information on when, where, why, and how much antimicrobials were being used. The majority of antimicrobials were administered via the feed (95%). The relative frequency of antimicrobial classes used in broiler chickens differed from those used in swine or in food animal production in general. Coccidiostats were the most frequently used antimicrobial classes (53% of total kg). Excluding coccidiostats, the top three most frequently used antimicrobial classes were bacitracin (53% of flocks), virginiamycin (25%) and avilamycin (21%), mainly used for the prevention of necrotic enteritis. Depending on the AMU metric utilized, the relative rankings of the top antimicrobials changed; hence the choice of the AMU metric is an important consideration for any AMU reporting. When using milligrams/Population Correction Unit (mg/PCU) the top three antimicrobial classes used were bacitracins (76 mg/PCU), trimethoprim-sulfonamides (24 mg/PCU), and penicillins (15 mg/PCU), whereas when using a number of Defined Daily Doses in animals using Canadian standards/1,000 chicken-days at risk (nDDDvetCA/1,000 CD) the ranking was bacitracins (223nDDDvetCA/1,000 CD), streptogramins (118 nDDDvetCA/1,000 CD), and trimethoprim-sulfonamides (87 nDDDvetCA/1,000 CD). The median animal treatment days in feed for one cycle (ATD/cycle) during the three-year study were 34 ATD/cycle; this was equal to the mean age of the flocks at pre-harvest sampling day (days at risk), indicating that the studied flocks except those that were raised without antibiotics and organic, were fed with medicated rations throughout the observation period. Overall, more than half (59%) of antimicrobials used in broiler chickens were in classes not used in human medicine, such as ionophores and chemical coccidiostats aimed to prevent coccidiosis. Compared to grower-finisher pigs and in production animal species (national sales data), the mg/PCU of antimicrobials used in broiler chickens was relatively lower. The findings of this paper highlighted the importance of farm-level AMU surveillance in measuring the impact of interventions to reduce antimicrobials in poultry.	[Agunos, Agnes; Leger, David F.; Carson, Carolee A.; Bosman, Angelina; Irwin, Rebecca J.; Reid-Smith, Richard J.] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Gow, Sheryl P.] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Saskatoon, SK, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Agunos, A (corresponding author), Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	agnes.agunos@phac-aspc.gc.ca		Bosman, Angelina/0000-0003-1815-4537; Agunos, Agnes/0000-0003-2357-3509	Public Health Agency of Canada; Saskatchewan Agriculture; Alberta Agriculture and Forestry	Public Health Agency of Canada; Saskatchewan Agriculture; Alberta Agriculture and Forestry	The CIPARS farm surveillance program is funded by the Public Health Agency of Canada. In 2013-2015, the Saskatchewan Agriculture and Alberta Agriculture and Forestry provided partial funding.There was no additional external funding received during the study period.	AgriMedia Inc, 2013, CAN CHICK FARM PLAN; Apley MD, 2012, FOODBORNE PATHOG DIS, V9, P272, DOI 10.1089/fpd.2011.0983; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Boulianne M, 2016, CAN J VET RES, V80, P49; Canadian Animal Health Institute, 2016, COMP VET PROD; Canadian Food Inspection Agency, 2016, COMP MED INGR BROCH; Carrique-Mas JJ, 2015, ZOONOSES PUBLIC HLTH, V62, P70, DOI 10.1111/zph.12165; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Chauvin C, 2008, J VET PHARMACOL THER, V31, P301, DOI 10.1111/j.1365-2885.2008.00960.x; Chicken Farmers of Canada, 2017, ALL CAL 2016 2017, P1; Chicken Farmers of Canada, 2016, RESP ANT US CAN CHIC; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Collineau L, 2016, ZOONOSES PUBLIC HLTH; DANMAP, 2016, DANMAP 2015 US ANT A, P144; European Medicines Agency, 2017, GUID PROV D IN PRESS, P36; European Medicines Agency, 2016, 6 ESVAC EUR MED AG, P176; European Medicines Agency, 2015, PRINC ASS DEF DAIL D, P68; European Medicines Agency, 2016, DEF DAIL DOS AN DDDV, P29; Government of Canada, 2017, FOOD DRUGS ACT REG A, V151; Government of Canada, 2015, FED ACT PLAN ANT RES; Health Canada, 2009, VET DRUGS DIR CAT AN; Health Canada, 2014, NOT STAK COLL EFF PR; Lanckriet A, 2010, AVIAN PATHOL, V39, P63, DOI 10.1080/03079450903505771; MARAN, 2015, MON ANT RES ANT US A, P190; McDougald LR, 2013, DIS POULTRY, V13th, P1148; Nilsson O, 2016, VET MICROBIOL, V184, P80, DOI 10.1016/j.vetmic.2016.01.012; Nolan LK., 2020, DIS POULTRY, P770, DOI 10.1002/9781119421481.ch18; OIE, 2018, TERR ANIM HLTH CODE, V1, P1; Ontario Animal Health Network Poultry Network, 2016, ONT AN HLTH NETW Q R; Persoons D, 2012, PREV VET MED; PHAC, 2015, CAN INT PROGR ANT RE, P1; Public Health Agency of Canada, 2016, PUBL HLTH AG CAN SUR; Public Health Agency of Canada, 2016, CAN ANT RES SURV SYS; Slavic D, 2011, CAN J VET RES, V75, P89; VKM, 2015, RISK DEV ANT RES US, V30, P1; World Health Organization (WHO), 2016, WHO GLOB ACT PLAN AN, P28	36	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179384	10.1371/journal.pone.0179384	http://dx.doi.org/10.1371/journal.pone.0179384			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658278	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900023
J	Mitsopoulos, P; Lapohos, O; Weraarpachai, W; Antonicka, H; Chang, YH; Madrenas, J				Mitsopoulos, Panagiotis; Lapohos, Orsolya; Weraarpachai, Woranontee; Antonicka, Hana; Chang, Yu-Han; Madrenas, Joaquin			Stomatin-like protein 2 deficiency results in impaired mitochondrial translation	PLOS ONE			English	Article							DNA; ACTIVATION; RIBOSOMES	Mitochondria translate the RNAs for 13 core polypeptides of respiratory chain and ATP synthase complexes that are essential for the assembly and function of these complexes. This process occurs in close proximity to the mitochondrial inner membrane. However, the mechanisms and molecular machinery involved in mitochondrial translation are not fully understood, and defects in this process can result in severe diseases. Stomatin-like protein (SLP)-2 is a mainly mitochondrial protein that forms cardiolipin- and prohibitin-enriched microdomains in the mitochondrial inner membrane that are important for the formation of respiratory supercomplexes and their function. Given this regulatory role of SLP-2 in processes closely associated with the mitochondrial inner membrane, we hypothesized that the function of SLP-2 would have an impact on mitochondrial translation. 35 S-Methionine/cysteine pulse labeling of resting or activated T cells from T cell-specific Slp-2 knockout mice showed a significant impairment in the production of several mitochondrial DNA-encoded polypeptides following T cell activation, including Cytb, COXI, COXII, COXIII, and ATP6. Measurement of mitochondrial DNA stability and mitochondrial transcription revealed that this impairment was at the post-transcriptional level. Examination of mitochondrial ribosome assembly showed that SLP-2 migrated in sucrose-density gradients similarly to the large ribosomal subunit but that its deletion at the genetic level did not affect mitochondrial ribosome assembly. Functionally, the impairment in mitochondrial translation correlated with decreased interleukin-2 production in activated T cells. Altogether, these data show that SLP-2 acts as a general regulator of mitochondrial translation.	[Mitsopoulos, Panagiotis; Lapohos, Orsolya; Chang, Yu-Han; Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Mitsopoulos, Panagiotis; Lapohos, Orsolya; Chang, Yu-Han; Madrenas, Joaquin] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Weraarpachai, Woranontee; Antonicka, Hana] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Weraarpachai, Woranontee; Antonicka, Hana] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Weraarpachai, Woranontee] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai, Thailand	McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; McGill University; McGill University; Chiang Mai University	Madrenas, J (corresponding author), McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada.; Madrenas, J (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	joaquin.madrenas@labiomed.org	Madrenas, Quim/P-5008-2019	Antonicka, Hana/0000-0002-2525-2867	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research.	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Christie DA, 2012, J IMMUNOL, V189, P4349, DOI 10.4049/jimmunol.1103829; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Mitsopoulos P, 2013, METHOD CELL BIOL, V117, P411, DOI 10.1016/B978-0-12-408143-7.00022-0; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; SPITHILL TW, 1978, MOL GEN GENET, V164, P155, DOI 10.1007/BF00267380; VANDERKLEI IJ, 1994, MICROSC RES TECHNIQ, V27, P284, DOI 10.1002/jemt.1070270404; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340	29	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179967	10.1371/journal.pone.0179967	http://dx.doi.org/10.1371/journal.pone.0179967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654702	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500042
J	Blazevic, S; Horvaticek, M; Kesic, M; Zill, P; Hranilovic, D; Ivanisevic, M; Desoye, G; Stefulj, J				Blazevic, Sofia; Horvaticek, Marina; Kesic, Maja; Zill, Peter; Hranilovic, Dubravka; Ivanisevic, Marina; Desoye, Gernot; Stefulj, Jasminka			Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitus	PLOS ONE			English	Article							DNA METHYLATION; HOUSEKEEPING GENES; FETAL-GROWTH; EXPRESSION; SYSTEM; ASSOCIATION; PROMOTER; HEALTH; PCR; POLYMORPHISMS	We tested the hypothesis that gestational diabetes mellitus (GDM) alters the DNA methylation pattern of the fetal serotonin transporter gene (SLC6A4), and examined the functional relevance of DNA methylation for regulation of the SLC6A4 expression in the human placenta. The study included 50 mother-infant pairs. Eighteen mothers were diagnosed with GDM and 32 had normal glucose tolerance (NGT). All neonates were of normal birth weight and born at term by planned Cesarean section. DNA and RNA were isolated from samples of tissue collected from the fetal side of the placenta immediately after delivery. DNA methylation was quantified at 7 CpG sites within the SLC6A4 distal promoter region using PCR amplification of bisulfite treated DNA and subsequent DNA sequencing. SLC6A4 mRNA levels were measured by reverse transcription D quantitative PCR (RT-qPCR). Functional SLC6A4 polymorphisms (5HTTLPR, STin2, rs25531) were genotyped using standard PCRbased procedures. Average DNA methylation across the 7 analyzed loci was decreased in the GDM as compared to the NGT group (by 27.1%, p = 0.037) and negatively correlated, before and after adjustment for potential confounder/s, with maternal plasma glucose levels at the 24th to 28th week of gestation (p<0.05). Placental SLC6A4 mRNA levels were inversely correlated with average DNA methylation (p = 0.010) while no statistically significant association was found with the SLC6A4 genotypes (p>0.05). The results suggest that DNA methylation of the fetal SLC6A4 gene is sensitive to the maternal metabolic state in pregnancy. They also indicate a predominant role of epigenetic over genetic mechanisms in the regulation of SLC6A4 expression in the human placenta. Longitudinal studies in larger cohorts are needed to verify these results and determine to which degree placental SLC6A4 changes may contribute to long-term outcomes of infants exposed to GDM.	[Blazevic, Sofia; Hranilovic, Dubravka] Univ Zagreb, Fac Sci, Dept Biol, Zagreb, Croatia; [Horvaticek, Marina; Ivanisevic, Marina] Clin Hosp Ctr Zagreb, Dept Obstet & Gynecol, Zagreb, Croatia; [Kesic, Maja; Stefulj, Jasminka] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Zill, Peter] Ludwig Maximilian Univ Munich, Dept Psychiat, Munich, Germany; [Desoye, Gernot] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Stefulj, Jasminka] Catholic Univ Croatia, Dept Psychol, Zagreb, Croatia	University of Zagreb; University of Zagreb; Rudjer Boskovic Institute; University of Munich; Medical University of Graz	Stefulj, J (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia.; Stefulj, J (corresponding author), Catholic Univ Croatia, Dept Psychol, Zagreb, Croatia.	jasminka.stefulj@irb.hr	Stefulj, Jasminka/A-1267-2011; Blazevic, Sofia A/I-3516-2012	Blazevic, Sofia A/0000-0003-2895-4853; Desoye, Gernot/0000-0002-5715-3230	German Academic Exchange Service and Croatian Ministry of Science, Education and Sport; Catholic University of Croatia	German Academic Exchange Service and Croatian Ministry of Science, Education and Sport; Catholic University of Croatia	The study was supported by the bilateral mobility grant of the German Academic Exchange Service and Croatian Ministry of Science, Education and Sport (to JS and PZ), and by the grant of Catholic University of Croatia (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaari JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045813; Allard C, 2015, EPIGENETICS-US, V10, P342, DOI 10.1080/15592294.2015.1029700; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Booij L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119061; Booij L, 2015, J PSYCHIATR NEUROSCI, V40, P5, DOI 10.1503/jpn.140099; Cleal JK, 2009, PLACENTA, V30, P1002, DOI 10.1016/j.placenta.2009.09.002; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Crume TL, 2011, J PEDIATR-US, V158, P941, DOI 10.1016/j.jpeds.2010.12.007; Desgagne V, 2014, EPIGENOMICS-UK, V6, P193, DOI 10.2217/epi.14.3; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Domschke K, 2014, INT J NEUROPSYCHOPH, V17, P1167, DOI 10.1017/S146114571400039X; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilbert WM, 1999, OBSTET GYNECOL, V93, P536, DOI 10.1016/S0029-7844(98)00484-0; Holbrook JD, 2016, EPIGENOMICS-UK, V8, P1173, DOI 10.2217/epi-2016-0079; Homberg JR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00212; Houde AA, 2015, EPIGENOMICS-UK, V7, P1111, DOI 10.2217/epi.15.72; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Hranilovic D, 2003, BIOL PSYCHIAT, V54, P884, DOI 10.1016/S0006-3223(03)00179-3; Hranilovic D, 2016, AUTISM RES, V9, P204, DOI 10.1002/aur.1519; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang HJ, 2013, PROG NEURO-PSYCHOPH, V44, P23, DOI 10.1016/j.pnpbp.2013.01.006; Kinast K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00072; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Li YC, 2016, J BIOL CHEM, V291, P9657, DOI 10.1074/jbc.M116.713693; Li YC, 2014, P NATL ACAD SCI USA, V111, pE5697, DOI 10.1073/pnas.1416675112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovrencic MV, 2013, BIOCHEM MEDICA, V23, P7, DOI 10.11613/BM.2013.002; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Montirosso R, 2016, EPIGENOMICS-UK, V8, P895, DOI 10.2217/epi-2016-0010; Muller CL, 2016, NEUROSCIENCE, V321, P24, DOI 10.1016/j.neuroscience.2015.11.010; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007; Nikolova YS, 2014, NAT NEUROSCI, V17, P1153, DOI 10.1038/nn.3778; Odgerel Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.80; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Provenzi L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00099; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Sacks KN, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.030; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Unal R, 2007, J NEUROCHEM, V101, P937, DOI 10.1111/j.1471-4159.2007.04469.x; Van Lelyveld N, 2007, NEUROGASTROENT MOTIL, V19, P342, DOI 10.1111/j.1365-2982.2006.00891.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Viau M, 2009, REPROD BIOMED ONLINE, V19, P207, DOI 10.1016/S1472-6483(10)60074-0; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; Watanabe H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147143; Xiang AH, 2015, JAMA-J AM MED ASSOC, V313, P1425, DOI 10.1001/jama.2015.2707; Ye JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100192; Zill P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040479	63	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179934	10.1371/journal.pone.0179934	http://dx.doi.org/10.1371/journal.pone.0179934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650965	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300031
J	Hu, W; Li, WJ; Chen, H; Liu, J; Wang, SY; Chen, JH				Hu, Wei; Li, Wenjian; Chen, Hao; Liu, Jing; Wang, Shuyang; Chen, Jihong			Changes in transcript levels of starch hydrolysis genes and raising citric acid production via carbon ion irradiation mutagenesis of Aspergillus niger	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BEAM IRRADIATION; MUTANT STRAIN; AMYLASE GENES; AMYR; OPTIMIZATION; ACTIVATOR; RICE; ACCUMULATION; BIOREACTOR	The filamentous ascomycete Aspergillus niger is well known for its ability to accumulate citric acid for the hydrolysis of starchy materials. To improve citric acid productivity, heavy ion beam mutagenesis was utilized to produce mutant A. niger strains with enhanced production of citric acid in this work. It was demonstrated that a mutant HW2 with high concentration of citric acid was isolated after carbon ion irradiation with the energy of 80Mev/mu, which was obvious increase higher than the original strain from liquefied corn starch as a feedstock. More importantly, with the evidence from the expression profiles of key genes and enzyme activity involved in the starch hydrolysis process between original strain and various phenotype mutants, our results confirmed that different transcript levels of key genes involving in starch hydrolysis process between original strain and mutants could be a significant contributor to different citric acid concentration in A. niger, such as, amyR and glaA, which therefore opened a new avenue for constructing genetically engineered A. niger mutants for high-yield citric acid accumulation in the future. As such, this work demonstrated that heavy ion beam mutagenesis presented an efficient alternative strategy to be developed to generate various phenotype microbe species mutants for functional genes research.	[Hu, Wei; Li, Wenjian; Liu, Jing; Wang, Shuyang; Chen, Jihong] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China; [Chen, Hao] Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Gansu Agricultural University	Hu, W; Chen, JH (corresponding author), Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China.	hudongli007@impcas.ac.cn; chjh@impcas.ac.cn		Hu, Wei/0000-0002-6678-9468	National Natural Science Foundation of China [11605259]; western talents program of the Chinese Academy of Sciences [Y706030XB0]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); western talents program of the Chinese Academy of Sciences	This work was supported financially by National Natural Science Foundation of China (No.11605259) and the western talents program of the Chinese Academy of Sciences (Y706030XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON L L, 1972, Journal of Bacteriology, V111, P771; Betiku E, 2013, BIOMASS BIOENERG, V55, P350, DOI 10.1016/j.biombioe.2013.02.034; Bizukojc M, 2010, WORLD J MICROB BIOT, V26, P41, DOI 10.1007/s11274-009-0140-1; Bohle K, 2007, J BIOTECHNOL, V132, P353, DOI 10.1016/j.jbiotec.2007.08.005; Carlsen M, 2001, APPL MICROBIOL BIOT, V57, P346, DOI 10.1007/s002530100772; Chen QF, 2014, GENET MOL RES, V13, P7029, DOI 10.4238/2014.March.26.9; Chen Y, 2016, CURR OPIN BIOTECH, V37, P165, DOI 10.1016/j.copbio.2015.11.004; Dhillon GS, 2013, IND CROP PROD, V41, P78, DOI 10.1016/j.indcrop.2012.04.001; Du Y, 2014, MUTAT RES-GEN TOX EN, V759, P28, DOI 10.1016/j.mrgentox.2013.07.018; Gomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P816, DOI 10.1271/bbb.64.816; Guo JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25949; Henriksen ALS, 1999, MICROBIOL-SGM, V145, P729, DOI 10.1099/13500872-145-3-729; Hirano T, 2012, MUTAT RES-FUND MOL M, V735, P19, DOI 10.1016/j.mrfmmm.2012.04.010; Hu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060700; Hu W, 2016, J ZHEJIANG UNIV-SC B, V17, P262, DOI 10.1631/jzus.B1500120; Hu W, 2014, J ZHEJIANG UNIV-SC B, V15, P1006, DOI 10.1631/jzus.B1400132; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Jiang BL, 2017, NUCL SCI TECH, V28, DOI 10.1007/s41365-016-0157-8; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Kazama Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-161; Krull R, 2013, J BIOTECHNOL, V163, P112, DOI 10.1016/j.jbiotec.2012.06.024; Lesniak W, 2002, BIOTECHNOL LETT, V24, P1065, DOI 10.1023/A:1016030513270; Li SW, 2011, APPL BIOCHEM BIOTECH, V165, P913, DOI 10.1007/s12010-011-9308-x; Li ZL, 2016, OXID MED CELL LONGEV, V2016, P12, DOI DOI 10.1007/S10529-016-2066-7; Liu JH, 2016, APPL SPECTROSC, V70, P1639, DOI 10.1177/0003702816645605; Lofty WA, 2007, BIORESOURCE TECHNOL, V98, P3470, DOI 10.1016/j.biortech.2006.11.032; Lotfy WA, 2007, BIORESOURCE TECHNOL, V98, P3464, DOI 10.1016/j.biortech.2006.11.007; Lu D, 2010, PLASMA SCI TECHNOL, V12, P753, DOI 10.1088/1009-0630/12/6/21; Murai K, 2013, NUCL INSTRUM METH B, V314, P59, DOI 10.1016/j.nimb.2013.05.026; PAPAGIANNI M, 1994, BIOTECHNOL LETT, V16, P929, DOI 10.1007/BF00128627; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Sarangbin S, 1999, CARBOHYD POLYM, V38, P219, DOI 10.1016/S0144-8617(98)00094-0; Show PL, 2015, FRONT LIFE SCI, V8, P271, DOI 10.1080/21553769.2015.1033653; Soccol CR, 2006, FOOD TECHNOL BIOTECH, V44, P141; Suzuki A, 1996, J FERMENT BIOENG, V81, P320, DOI 10.1016/0922-338X(96)80584-8; Takano N, 2013, J RADIAT RES, V54, P637, DOI 10.1093/jrr/rrt007; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; vanKuyk PA, 2012, APPL MICROBIOL BIOT, V93, P285, DOI 10.1007/s00253-011-3550-6; Vendruscolo F, 2008, CRIT REV BIOTECHNOL, V28, P1, DOI [10.1080/07388550801913840, 10.1080/07388550801913840 ]; Wang BS, 2017, BIOPROC BIOSYST ENG, V40, P45, DOI 10.1007/s00449-016-1673-y; Wang L, 2016, APPL MICROBIOL BIOT, V100, P5791, DOI 10.1007/s00253-016-7324-z; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26327; Yang L, 2017, FUNGAL BIOL REV, V31, P33, DOI 10.1016/j.fbr.2016.11.001; Yang Y., 2013, CHINA BREWING, V32, P22; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zhang H, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0463-1	46	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180120	10.1371/journal.pone.0180120	http://dx.doi.org/10.1371/journal.pone.0180120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650980	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300040
J	Radli, M; Veprintsev, DB; Rudiger, SGD				Radli, Martina; Veprintsev, Dmitry B.; Rudiger, Stefan G. D.			Production and purification of human Hsp90 beta in Escherichia coli	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ATPASE ACTIVITY; EUKARYOTIC HSP90; PROTEIN; REVEALS; PROTEOSTASIS; HYDROLYSIS; COMPLEX; BINDING; DOMAIN	The molecular chaperone Hsp90 is an essential member of the cellular proteostasis system. It plays an important role in the stabilisation and activation of a large number of client proteins and is involved in fatal disease processes, e.g. Alzheimer disease, cancer and cystic fibrosis. This makes Hsp90 a crucial protein to study. Mechanistic studies require large amounts of protein but the production and purification of recombinant human Hsp90 in Escherichia coli is challenging and laborious. Here we identified conditions that influence Hsp90 production, and optimised a fast and efficient purification protocol. We found that the nutrient value of the culturing medium and the length of induction had significant effect on Hsp90 production in Escherichia coli. Our fast, single-day purification protocol resulted in a stable, well-folded and pure sample that was resistant to degradation in a reproducible manner. We anticipate that our results provide a useful tool to produce higher amount of pure, well-folded and stable recombinant human Hsp90 beta in Escherichia coli in an efficient way.	[Radli, Martina; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Padualaan 8, Utrecht, Netherlands; [Radli, Martina; Rudiger, Stefan G. D.] Univ Utrecht, Sci Life, Utrecht, Netherlands; [Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	Utrecht University; Utrecht University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rudiger, SGD (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Padualaan 8, Utrecht, Netherlands.; Rudiger, SGD (corresponding author), Univ Utrecht, Sci Life, Utrecht, Netherlands.	s.g.d.rudiger@uu.nl	Veprintsev, Dmitry B/H-2228-2012; Rüdiger, Stefan GD/G-4906-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; Rüdiger, Stefan GD/0000-0002-1807-2972	Internationale Stichting Alzheimer Onderzoek (ISAO) [14542]; FP7 ITN-IDP "ManiFold" [317371]; FP7 ITN "WntsApp" [608180]; Netherlands Organisation for Health Research and Development (ZonMW) [91215084]	Internationale Stichting Alzheimer Onderzoek (ISAO); FP7 ITN-IDP "ManiFold"; FP7 ITN "WntsApp"; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO), grant No. 14542, (https://www.alzheimernederland.nl), FP7 ITN-IDP "ManiFold", grant No. 317371, Marie Curie Actions, Europeans Commission, (https://ec.europa.eu/research/ mariecurieactions/), FP7 ITN "WntsApp", grant No. 608180, Marie Curie Actions, Europeans Commission, (https://ec.eurona.eu/research/ mariecurieactions/) and The Netherlands Organisation for Health Research and Development (ZonMW), Grant No. 91215084 (https //www zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Buchner J, 1998, METHOD ENZYMOL, V290, P409, DOI 10.1016/S0076-6879(98)90034-9; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hipp M. S., 2014, TRENDS CELL BIOL; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lepyrier E, 2015, BBA-PROTEINS PROTEOM, V1854, P1412, DOI 10.1016/j.bbapap.2015.07.003; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Moullintraffort L, 2010, FEBS J, V277, P292; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180047	10.1371/journal.pone.0180047	http://dx.doi.org/10.1371/journal.pone.0180047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651008	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300038
J	McCreight, JC; Schneider, SE; Wilburn, DB; Swanson, WJ				McCreight, Jennifer C.; Schneider, Sean E.; Wilburn, Damien B.; Swanson, Willie J.			Evolution of microRNA in primates	PLOS ONE			English	Article							DEEP-SEQUENCING DATA; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTION FACTORS; TARGET INTERACTIONS; GENETIC-VARIATION; RAPID EVOLUTION; NONCODING RNAS; STEM-CELLS; MIRNA; EXPRESSION	MicroRNA play an important role in post-transcriptional regulation of most transcripts in the human genome, but their evolution across the primate lineage is largely uncharacterized. A particular miRNA can have one to thousands of messenger RNA targets, establishing the potential for a small change in sequence or overall miRNA structure to have profound phenotypic effects. However, the majority of non-human primate miRNA is predicted solely by homology to the human genome and lacks experimental validation. In the present study, we sequenced thirteen species representing a wide range of the primate phylogeny. Hundreds of miRNA were validated, and the number of species with experimentally validated miRNA was tripled. These species include a sister taxon to humans (bonobo) and basal primates (aye-aye, mouse lemur, galago). Consistent with previous studies, we found the seed region and mature miRNA to be highly conserved across primates, with overall structural conservation of the pre-miRNA hairpin. However, there were a number of interesting exceptions, including a seed shift due to structural changes in miR-501. We also identified an increase in the number of miR-320 paralogs throughout primate evolution. Many of these non-conserved miRNA appear to regulate neuronal processes, illustrating the importance of investigating miRNA to learn more about human evolution.	[McCreight, Jennifer C.; Schneider, Sean E.; Wilburn, Damien B.; Swanson, Willie J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schneider, Sean E.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	McCreight, JC (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jcmccreight@gmail.com		Swanson, Willie/0000-0002-6553-0921	National Institutes of Health/National Human Genome Research Institute Genome Training Grant [HG000035]; National Science Foundation Graduate Research Fellowship; National Institutes of Health [HD076862]; UW Royalty Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute Genome Training Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Royalty Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by a National Institutes of Health/National Human Genome Research Institute Genome Training Grant, Grant number HG000035, https://www.genome.gov/ 14514710/training-and-career-development-institutional-training-grants-t32/; National Science Foundation Graduate Research Fellowship awarded to JCM, no grant number, https://www.nsfgrfp.org/; UW Royalty Research Fund Grant, no grant number, https.//www.washington.edu/research/or/?page=rrf; and National Institutes of Health, Grant number HD076862, https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank past and present members of the Swanson and Thomas labs for their assistance, especially R. George for her preliminary miRNA data. Sequencing was performed in collaboration with the lab of Debbie Nickerson, with special thanks to A. Gordon for programming assistance and comments, C. Frazar for library preparation help, and T. Shaffer for quality control on raw reads. Thanks to C. Cassady for programming assistance. We also thank committee members J. Akey, D. Nickerson, C. Quietsch, and W. L. Ruzzo for their feedback. J.C. McCreight was supported by a National Institutes of Health/National Human Genome Research Institute Genome Training Grant (grant number HG000035) and a National Science Foundation Graduate Research Fellowship. This research was funded by a UW Royalty Research Fund Grant and the National Institutes of Health (grant number HD076862).	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Baev V, 2009, COMPUT BIOL CHEM, V33, P62, DOI 10.1016/j.compbiolchem.2008.07.024; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Chang CB, 1998, J NEUROBIOL, V36, P128, DOI 10.1002/(SICI)1097-4695(199808)36:2<128::AID-NEU3>3.0.CO;2-3; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Dannemann M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-116; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fang ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054215; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallego A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154194; Gao ZL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00067; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; George RD, 2011, GENOME RES, V21, P1686, DOI 10.1101/gr.121327.111; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Gruber AR, 2009, PAC S BIOCOMPUT, P69; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hansen TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010961; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Iwagami Y, 2013, BRIT J CANCER, V109, P502, DOI 10.1038/bjc.2013.320; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Manier DH, 2000, J AFFECT DISORDERS, V61, P51, DOI 10.1016/S0165-0327(99)00190-1; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; The Chimpanzee Sequencing and Analysis Consortium, 2004, NATURE, V437, P69; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Ukai T, 2012, J ORTHOP RES, V30, P1915, DOI 10.1002/jor.22157; Vachev TI, 2016, INT J CURR MICROBIOL, V5, P221, DOI DOI 10.20546/ijcmas.2016.501.020; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0069-6; Washietl S., 2011, RNAZ 2 1 USER MANUAL; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Yang S, 2011, BIOINFORMATICS, V27, P2972, DOI 10.1093/bioinformatics/btr503; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	72	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0176596	10.1371/journal.pone.0176596	http://dx.doi.org/10.1371/journal.pone.0176596			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640911	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800002
J	Petrov, PI; Mandija, S; Sommer, IEC; van den Berg, CAT; Neggers, SFW				Petrov, Petar I.; Mandija, Stefano; Sommer, Iris E. C.; van den Berg, Cornelis A. T.; Neggers, Sebastiaan F. W.			How much detail is needed in modeling a transcranial magnetic stimulation figure-8 coil: Measurements and brain simulations	PLOS ONE			English	Article							INDUCED ELECTRIC-FIELD; TMS; FMRI	Background Despite TMS wide adoption, its spatial and temporal patterns of neuronal effects are not well understood. Although progress has been made in predicting induced currents in the brain using realistic finite element models (FEM), there is little consensus on how a magnetic field of a typical TMS coil should be modeled. Empirical validation of such models is limited and subject to several limitations. Methods We evaluate and empirically validate models of a figure-of-eight TMS coil that are commonly used in published modeling studies, of increasing complexity: simple circular coil model; coil with in-plane spiral winding turns; and finally one with stacked spiral winding turns. We will assess the electric fields induced by all 3 coil models in the motor cortex using a computer FEM model. Biot-Savart models of discretized wires were used to approximate the 3 coil models of increasing complexity. We use a tailored MR based phase mapping technique to get a full 3D validation of the incident magnetic field induced in a cylindrical phantom by our TMS coil. FEM based simulations on a meshed 3D brain model consisting of five tissues types were performed, using two orthogonal coil orientations. Results Substantial differences in the induced currents are observed, both theoretically and empirically, between highly idealized coils and coils with correctly modeled spiral winding turns. Thickness of the coil winding turns affect minimally the induced electric field, and it does not influence the predicted activation. Conclusion TMS coil models used in FEM simulations should include in-plane coil geometry in order to make reliable predictions of the incident field. Modeling the in-plane coil geometry is important to correctly simulate the induced electric field and to correctly make reliable predictions of neuronal activation.	[Petrov, Petar I.; Sommer, Iris E. C.; Neggers, Sebastiaan F. W.] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Mandija, Stefano; van den Berg, Cornelis A. T.] Univ Med Ctr Utrecht, Ctr Image Sci, Utrecht, Netherlands; [van den Berg, Cornelis A. T.] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Petrov, PI (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	P.I.Petrov-2@umcutrecht.nl	Mandija, Stefano/AAN-4050-2021; sommer, iris/D-1190-2014	sommer, iris/0000-0002-2682-5313; Sommer, Iris/0000-0001-5597-3262; Petrov, Petar/0000-0002-7504-6615; van den Berg, Cornelis/0000-0002-5565-6889	DeNeCor project [ENIAC131003]	DeNeCor project	This work was supported by the DeNeCor project being part of the ENIAC Joint Undertaking, Project number ENIAC131003, http://eniac.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the DeNeCor project being part of the ENIAC Joint Undertaking.	Bohning DE, 1997, NEUROREPORT, V8, P2535, DOI 10.1097/00001756-199707280-00023; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; de Berker AO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00613; De Geeter N, 2015, PHYS MED BIOL, V60, P453, DOI 10.1088/0031-9155/60/2/453; De Geeter N, 2011, IEEE T BIO-MED ENG, V58, P310, DOI 10.1109/TBME.2010.2087758; de Weijer AD, 2014, J CLIN NEUROPHYSIOL, V31, P474, DOI 10.1097/WNP.0000000000000075; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Hernandez-Garcia L, 2007, NEUROIMAGE, V36, P1171, DOI 10.1016/j.neuroimage.2007.03.064; Janssen AM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0036-2; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krieg TD, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046014; Krieg TD, 2013, BRAIN STIMUL, V6, P898, DOI 10.1016/j.brs.2013.05.007; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Madsen KH, 2015, BRAIN STIMUL, V8, P1205, DOI 10.1016/j.brs.2015.07.035; Mandija S, 2016, NMR BIOMED, P1; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Neggers SFW, 2015, PROG BRAIN RES, P1; Nieminen JO, 2015, BRAIN STIMUL, V8, P582, DOI 10.1016/j.brs.2015.01.004; Nummenmaa A, 2014, BRAIN STIMUL, V7, P80, DOI 10.1016/j.brs.2013.10.001; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Peres A. S. C., 2009, World Congress on Medical Physics and Biomedical Engineering. World Congress 2009. Diagnostic and Therapeutic Instrumentation, Clinical Engineering, P571, DOI 10.1007/978-3-642-03885-3_159; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P1; Pu LN, 2010, J X-RAY SCI TECHNOL, V18, P57, DOI 10.3233/XST-2010-0241; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; Ravazzani P, 1996, ANN BIOMED ENG, V24, P606, DOI 10.1007/BF02684229; Salinas FS, 2007, PHYS MED BIOL, V52, P2879, DOI 10.1088/0031-9155/52/10/016; Salinas FS, 2009, PHYS MED BIOL, V54, P3631, DOI 10.1088/0031-9155/54/12/002; Schutter DJLG, 2006, J ECT, V22, P176, DOI 10.1097/01.yct.0000235924.60364.27; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2002, NEUROIMAGE, V17, P1117, DOI 10.1006/nimg.2002.1282; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479	37	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178952	10.1371/journal.pone.0178952	http://dx.doi.org/10.1371/journal.pone.0178952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640923	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800014
J	Littler, DR; Ang, SY; Moriel, DG; Kocan, M; Kleifeld, O; Johnson, MD; Tran, MT; Paton, AW; Paton, JC; Summers, RJ; Schembri, MA; Rossjohn, J; Beddoe, T				Littler, Dene R.; Ang, Sheng Y.; Moriel, Danilo G.; Kocan, Martina; Kleifeld, Oded; Johnson, Matthew D.; Tran, Mai T.; Paton, Adrienne W.; Paton, James C.; Summers, Roger J.; Schembri, Mark A.; Rossjohn, Jamie; Beddoe, Travis			Structure-function analyses of a pertussis-like toxin from pathogenic Escherichia coli reveal a distinct mechanism of inhibition of trimeric G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYZED ADP-RIBOSYLATION; ISLET-ACTIVATING PROTEIN; CRYSTAL-STRUCTURE; CHOLERA-TOXIN; IDENTIFICATION; BINDING; FAMILY; MUTATIONS; VIRULENCE; SUBUNIT	Pertussis-like toxins are secreted by several bacterial pathogens during infection. They belong to the AB(5) virulence factors, which bind to glycans on host cell membranes for internalization. Host cell recognition and internalization are mediated by toxin B subunits sharing a unique pentameric ring-like assembly. Although the role of pertussis toxin in whooping cough is well-established, pertussis-like toxins produced by other bacteria are less studied, and their mechanisms of action are unclear. Here, we report that some extra-intestinal Escherichia coli pathogens (i.e. those that reside in the gut but can spread to other bodily locations) encode a pertussis-like toxin that inhibits mammalian cell growth in vitro. We found that this protein, EcPlt, is related to toxins produced by both nontyphoidal and typhoidal Salmonella serovars. Pertussis-like toxins are secreted as disulfide-bonded heterohexamers in which the catalytic ADP-ribosyltransferase subunit is activated when exposed to the reducing environment in mammalian cells. We found here that the reduced EcPlt exhibits large structural rearrangements associated with its activation. We noted that inhibitory residues tethered within the NAD(+)-binding site by an intramolecular disulfide in the oxidized state dissociate upon the reduction and enable loop restructuring to form the nucleotide-binding site. Surprisingly, although pertussis toxin targets a cysteine residue within the alpha subunit of inhibitory trimeric G-proteins, we observed that activated EcPlt toxin modifies a proximal lysine/asparagine residue instead. In conclusion, our results reveal the molecular mechanism underpinning activation of pertussis-like toxins, and we also identified differences in host target specificity.	[Littler, Dene R.; Johnson, Matthew D.; Tran, Mai T.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Littler, Dene R.; Johnson, Matthew D.; Tran, Mai T.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Ang, Sheng Y.; Kocan, Martina; Summers, Roger J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Moriel, Danilo G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Kleifeld, Oded] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Beddoe, Travis] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic 3086, Australia; [Beddoe, Travis] La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic 3086, Australia	Monash University; Monash University; Monash University; University of Queensland; Technion Israel Institute of Technology; University of Adelaide; Cardiff University; Monash University; La Trobe University; La Trobe University	Beddoe, T (corresponding author), La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic 3086, Australia.; Beddoe, T (corresponding author), La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic 3086, Australia.	jamie.rossjohn@monash.edu.au; t.beddoe@latrobe.edu.au	Summers, Roger J/F-6351-2011; Rossjohn, Jamie/F-9032-2013; Schembri, Mark A/C-7262-2009; Beddoe, Travis/F-3415-2014	Summers, Roger J/0000-0002-8367-4056; Rossjohn, Jamie/0000-0002-2020-7522; Schembri, Mark A/0000-0003-4863-9260; Beddoe, Travis/0000-0003-4550-2277; Kocan, Martina/0000-0003-3468-6197	National Institutes of Health [GM62116, GM98791 NIGMS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R24GM098791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of beamline MX2 at the Australian Synchrotron for assistance with X-ray data collection. We acknowledge the Consortium for Functional Glycomics funded by National Institutes of Health Grants GM62116 and GM98791 NIGMS for services provided by the Glycan Array Synthesis Core (The Scripps Research Institute, La Jolla, CA) that produced the mammalian glycan microarray and the Protein-Glycan Interaction Core (Emory University School of Medicine, Atlanta, GA) that assisted with analysis of samples on the array. We thank Natasha Ng for initially cloning EcPltAB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANTOINE R, 1993, J BIOL CHEM, V268, P24149; AVIGAN J, 1992, BIOCHEMISTRY-US, V31, P7736, DOI 10.1021/bi00148a039; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cummings MD, 1998, PROTEINS, V31, P282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; GRAF R, 1992, MOL PHARMACOL, V42, P760; Hausman SZ, 1996, INFECT IMMUN, V64, P4020, DOI 10.1128/IAI.64.10.4020-4026.1996; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; HEWLETT EL, 1983, INFECT IMMUN, V40, P1198, DOI 10.1128/IAI.40.3.1198-1203.1983; HOSHINO S, 1990, FEBS LETT, V276, P227, DOI 10.1016/0014-5793(90)80548-W; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Jobling MG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw001; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KASLOW HR, 1987, BIOCHEMISTRY-US, V26, P123, DOI 10.1021/bi00375a018; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; LOCHT C, 1990, J BIOL CHEM, V265, P4552; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Moriel DG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00326-16; Ng N, 2013, ACTA CRYSTALLOGR F, V69, P912, DOI 10.1107/S1744309113018927; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; Nichols KB, 2016, J BACTERIOL, V198, P1487, DOI 10.1128/JB.00791-15; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; O'Neal CJ, 2004, BIOCHEMISTRY-US, V43, P3772, DOI 10.1021/bi0360152; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Samson AL, 2014, J BIOL CHEM, V289, P26922, DOI 10.1074/jbc.M114.570275; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Uchida I, 2009, MICROBIOL-SGM, V155, P3710, DOI 10.1099/mic.0.028399-0; Wang H, 2013, INFECT IMMUN, V81, P673, DOI 10.1128/IAI.01043-12; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; XU YR, 1994, J BIOL CHEM, V269, P9993; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	56	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15143	15158		10.1074/jbc.M117.796094	http://dx.doi.org/10.1074/jbc.M117.796094			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28663369	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000409902100036
J	Almarzouki, AF; Brown, CA; Brown, RJ; Leung, MHK; Jones, AKP				Almarzouki, Abeer F.; Brown, Christopher A.; Brown, Richard J.; Leung, Matthew H. K.; Jones, Anthony K. P.			Negative expectations interfere with the analgesic effect of safety cues on pain perception by priming the cortical representation of pain in the midcingulate cortex	PLOS ONE			English	Article							PLACEBO ANALGESIA; PATIENT EXPECTATIONS; ATTENTIONAL BIASES; QUESTIONNAIRE-III; EVOKED-POTENTIALS; FEAR-AVOIDANCE; MODULATION; PERSPECTIVE; LOCALIZATION; EXPERIENCE	It is well known that the efficacy of treatment effects, including those of placebos, is heavily dependent on positive expectations regarding treatment outcomes. For example, positive expectations about pain treatments are essential for pain reduction. Such positive expectations not only depend on the properties of the treatment itself, but also on the context in which the treatment is presented. However, it is not clear how the preceding threat of pain will bias positive expectancy effects. One hypothesis is that threatening contexts trigger fearful and catastrophic thinking, reducing the pain-relieving effects of positive expectancy. In this study, we investigated the disruptive influence of threatening contexts on positive expectancy effects while 41 healthy volunteers experienced laser-induced heat pain. A threatening context was induced using pain-threatening cues that preceded the induction of positive expectancies via subsequent pain-safety cues. We also utilised electroencephalography (EEG) to investigate potential neural mechanisms underlying these effects. Lastly, we used the Fear of Pain Questionnaire to address whether the disruptive effect of negative contexts on cued pain relief was related to the degree of fear of pain. As predicted, participants responded less to pain-safety cues (i.e., experienced more pain) when these were preceded by pain-threatening cues. In this threatening context, an enhancement of the N2 component of the laser-evoked potential was detected, which was more pronounced in fearful individuals. This effect was localised to the midcingulate cortex, an area thought to integrate negative affect with pain experience to enable adaptive behaviour in aversive situations. These results suggest that threatening contexts disrupt the effect of pain relief cues via an aversive priming mechanism that enhances neural responses in the early stages of sensory processing.	[Almarzouki, Abeer F.] King Abdulaziz Univ, Dept Physiol, Fac Med, Jeddah, Saudi Arabia; [Brown, Christopher A.] Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England; [Brown, Richard J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Leung, Matthew H. K.] Royal Bolton NHS Fdn Trust, Bolton, England; [Jones, Anthony K. P.] Univ Manchester, Salford Royal NHS Fdn Trust, Div Neurosci & Cognit Psychol, Human Pain Res Grp, Salford, Lancs, England	King Abdulaziz University; University of Liverpool; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester	Almarzouki, AF (corresponding author), King Abdulaziz Univ, Dept Physiol, Fac Med, Jeddah, Saudi Arabia.	Afmalmarzouki@kau.edu.sa		Almarzouki, Abeer F/0000-0001-8090-5341; Brown, Christopher/0000-0003-1414-2635; Jones, Anthony/0000-0001-6944-9365; Brown, Richard/0000-0003-3961-2023	King Abdul-Aziz University scholarship scheme	King Abdul-Aziz University scholarship scheme	The study has been funded by King Abdul-Aziz University scholarship scheme.	Asmundson GJG, 2007, J PAIN, V8, P11, DOI 10.1016/j.jpain.2006.05.008; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bentley DE, 2004, CLIN NEUROPHYSIOL, V115, P1846, DOI 10.1016/j.clinph.2004.03.010; Bialosky JE, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-19; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Brown CA, 2008, PAIN, V139, P324, DOI 10.1016/j.pain.2008.04.028; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Brown CA, 2010, PAIN, V150, P428, DOI 10.1016/j.pain.2010.04.017; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Clark JA, 2008, CLIN NEUROPHYSIOL, V119, P2870, DOI 10.1016/j.clinph.2008.09.022; Crombez G, 1999, J PSYCHOSOM RES, V47, P403, DOI 10.1016/S0022-3999(99)00046-X; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Gandhi R, 2009, J ARTHROPLASTY, V24, P716, DOI 10.1016/j.arth.2008.05.016; Huneke NTM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078278; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Iles R, EXTRACRANIAL LOCALIZ; Jones A, 2013, PLACEBO AND PAIN: FROM BENCH TO BEDSIDE, P37, DOI 10.1016/B978-0-12-397928-5.00005-2; Judge A, 2011, OSTEOARTHR CARTILAGE, V19, P659, DOI 10.1016/j.joca.2011.03.009; Keogh E, 2003, PAIN, V104, P85, DOI 10.1016/S0304-3959(02)00468-2; Keogh E, 2001, J ANXIETY DISORD, V15, P299, DOI 10.1016/S0887-6185(01)00065-2; Lantz G, 1997, ELECTROEN CLIN NEURO, V102, P414, DOI 10.1016/S0921-884X(96)96551-0; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; Martini M, 2015, EUR J NEUROSCI, V41, P498, DOI 10.1111/ejn.12807; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Ohara S, 2004, PAIN, V110, P318, DOI 10.1016/j.pain.2004.04.009; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Pagnoni G, 2014, PHYS LIFE REV, V11, P555, DOI 10.1016/j.plrev.2014.05.006; Petersen GL, 2014, PAIN, V155, P1426, DOI 10.1016/j.pain.2014.04.016; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Smeets RJEM, 2008, CLIN J PAIN, V24, P305, DOI 10.1097/AJP.0b013e318164aa75; Stancak A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00552; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Wager TD, 2005, PAIN, V115, P225, DOI 10.1016/j.pain.2005.03.018; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180006	10.1371/journal.pone.0180006	http://dx.doi.org/10.1371/journal.pone.0180006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665973	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700051
J	Hanes, MS; Moremen, KW; Cummings, RD				Hanes, Melinda S.; Moremen, Kelley W.; Cummings, Richard D.			Biochemical characterization of functional domains of the chaperone Cosmc	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ENDOPLASMIC-RETICULUM; T-SYNTHASE; O-GLYCOSYLATION; BINDING-SITES; IN-VITRO; PROTEIN; O-FUCOSYL-TRANSFERASE-1; GLYCOSYLTRANSFERASES; IDENTIFICATION	Cosmc is an endoplasmic reticulum chaperone necessary for normal protein O-GalNAc glycosylation through regulation of T-synthase, its single client. Loss-of-function of Cosmc results in expression of the Tn antigen, which is associated with multiple human diseases including cancer. Despite intense interest in dysregulated expression of the Tn antigen, little is known about the structure and function of Cosmc, including domain organization, secondary structure, oligomerization, and co-factors. Limited proteolysis experiments show that Cosmc contains a structured N-terminal domain (Cosmc Delta 256), and biochemical characterization of Cosmc Delta 256 reveals wild type chaperone activity. Interestingly, CosmcE152K, which shows loss of function in vivo, exhibits wild type-like activity in vitro. Cosmc and CosmcE152K heterogeneously oligomerize and form monomeric, dimeric, trimeric, and tetrameric species, while Cosmc Delta 256 is predominantly monomeric as characterized by chemical crosslinking and blue native page electrophoresis. Additionally, Cosmc selectively binds divalent cations in thermal shift assays and metal binding is abrogated by the Cosmc Delta 256 truncation, and perturbed by the E152K mutation. Therefore, the N-terminal domain of Cosmc mediates T-synthase binding and chaperone function, whereas the C-terminal domain is necessary for oligomerization and metal binding. Our results provide new structure-function insight to Cosmc, indicate that Cosmc behaves as a modular protein and suggests points of modulation or regulation of in vivo chaperone function.	[Hanes, Melinda S.; Cummings, Richard D.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Georgia; University of Georgia	Cummings, RD (corresponding author), Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	rcummin1@bidmc.harvard.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health Grants: National Institute of General Medical Sciences [GM068559]; National Cancer Institute [CA183215]; National Institute of General Medical Sciences [P41GM103390, P01GM107012]; National Institutes of Health Grants [GM068559, CA183215, P41GM103390, P01GM107012]; NATIONAL CANCER INSTITUTE [F32CA183215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, P41GM103390, R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health Grants: National Institute of General Medical Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants: National Institute of General Medical Sciences (www.nigms.nih.gov) GM068559 (to R. D. C.), National Cancer Institute (www.cancer.gov) CA183215 (to M. S. H.), and National Institute of General Medical Sciences P41GM103390 and P01GM107012 (to K.W.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate members of the Cummings laboratory for critical discussions. This work was supported, in whole or in part, by National Institutes of Health Grants GM068559 (to R. D. C.), CA183215 (to M. S. H.), P41GM103390 and P01GM107012 (to K.W.M.).	Arakawa T, 2010, J PHARM SCI-US, V99, P1674, DOI 10.1002/jps.21974; Aryal RP, 2014, J BIOL CHEM, V289, P11630, DOI 10.1074/jbc.M114.555870; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Babor M, 2005, PROTEINS, V59, P221, DOI 10.1002/prot.20431; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Breton C, 2002, BIOCHEM SOC SYMP, V69, P23; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fontana Angelo, 2012, Methods Mol Biol, V896, P297, DOI 10.1007/978-1-4614-3704-8_20; Formosa T., 2013, BIOCHIM BIOPHYS ACTA, V1819, P247; Gloster TM, 2014, CURR OPIN STRUC BIOL, V28, P131, DOI 10.1016/j.sbi.2014.08.012; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju Tongzhong, 2013, Methods Mol Biol, V1022, P15, DOI 10.1007/978-1-62703-465-4_2; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KAO PN, 1986, J BIOL CHEM, V261, P8085; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Kudelka MR, 2016, P NATL ACAD SCI USA, V113, P14787, DOI 10.1073/pnas.1612158114; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Mallett TC, 1998, BIOCHEMISTRY-US, V37, P8790, DOI 10.1021/bi9803630; MOSCKOVITZ R, 1988, J BIOL CHEM, V263, P1017; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Park C, 2001, PROTEIN ENG, V14, P939, DOI 10.1093/protein/14.11.939; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Subedi GP, 2015, HIGH YIELD EXPRESSIO; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Won HS, 2004, J MOL BIOL, V341, P893, DOI 10.1016/j.jmb.2004.06.046	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180242	10.1371/journal.pone.0180242	http://dx.doi.org/10.1371/journal.pone.0180242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665962	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700076
J	Bellettiere, J; Winkler, EAH; Chastin, SFM; Kerr, J; Owen, N; Dunstan, DW; Healy, GN				Bellettiere, John; Winkler, Elisabeth A. H.; Chastin, Sebastien F. M.; Kerr, Jacqueline; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.			Associations of sitting accumulation patterns with cardio-metabolic risk biomarkers in Australian adults	PLOS ONE			English	Article							MEASURED SEDENTARY TIME; PHYSICAL-ACTIVITY; CARDIOMETABOLIC BIOMARKERS; BREAKS; BEHAVIOR; ADJUSTMENT; DISEASE	Background High amounts of time spent sitting can increase cardiovascular disease risk and are deleteriously associated cardio-metabolic risk biomarkers. Though evidence suggests that accruing sitting time in prolonged periods may convey additional risk, verification using high-quality measures is needed. We examined this issue in adults from the Australian Diabetes, Obesity and Lifestyle Study, using accurate measures of sitting accumulation. Methods In 2011/12, 739 adults aged 36 to 89 years (mean +/- SD 58 +/- 10 years) wore activPAL3 (TM) monitors (which provide accurate objective measures of sitting); 678 provided >= 4 valid days of monitor data and complete cardio-metabolic biomarker and confounder data. Multivariable linear regression models examined associations of sitting time, sitting time accrued in >= 30 minute bouts (prolonged sitting time), and three measures of sitting accumulation patterns with cardio-metabolic risk markers: body mass index (BMI), waist circumference, blood pressure, high- and low- density lipoprotein (HDL and LDL) cholesterol, triglycerides, glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and 2-hour post-load glucose (PLG). Interactions tests examined whether associations of sitting time with biomarkers varied by usual sitting bout duration. Results Adjusted for potential confounders, greater amounts of sitting time and prolonged sitting time were significantly (p<0.05) deleteriously associated with BMI, waist circumference, HDL cholesterol, and triglycerides. Total sitting time was also significantly associated with higher PLG. Sitting accumulation patterns of frequently interrupted sitting (compared to patterns with relatively more prolonged sitting) were significantly beneficially associated with BMI, waist circumference, HDL cholesterol, triglycerides, PLG, and with FPG. Effect sizes were typically larger for accumulation patterns than for sitting time. Significant interactions (p<0.05) showed that associations of sitting time with HDL, triglycerides and PLG became more deleterious the longer at a time sitting was usually accumulated. Conclusions Adding to previous evidence reliant on low-quality measures, our study showed that accumulating sitting in patterns where sitting was most frequently interrupted had significant beneficial associations with several cardio-metabolic biomarkers and that sitting for prolonged periods at a time may exacerbate some of the effects of sitting time. The findings support sedentary behavior guidelines that promote reducing and regularly interrupting sitting.	[Bellettiere, John] Joint Doctoral Program Publ Hlth Epidemiol, San Diego, CA USA; [Bellettiere, John] San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA; [Winkler, Elisabeth A. H.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Chastin, Sebastien F. M.; Dunstan, David W.; Healy, Genevieve N.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Chastin, Sebastien F. M.] Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, Ghent, East Flanders, Belgium; [Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Swinburne Univ Technol, Melbourne, Vic, Australia; [Dunstan, David W.] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA, Australia	California State University System; San Diego State University; University of Queensland; Glasgow Caledonian University; Ghent University; University of California System; University of California San Diego; Baker Heart and Diabetes Institute; Swinburne University of Technology; Australian Catholic University; Curtin University	Bellettiere, J (corresponding author), Joint Doctoral Program Publ Hlth Epidemiol, San Diego, CA USA.; Bellettiere, J (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA.	jbellettiere@ucsd.edu	Bellettiere, John/AAC-6092-2020; Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Chastin, Sebastien/ABF-1455-2020; Healy, Genevieve/A-7408-2008	Bellettiere, John/0000-0002-7167-3048; Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Chastin, Sebastien/0000-0003-1421-9348; Healy, Genevieve/0000-0001-7093-7892	National Health and Medical Research Council of Australia [566940, 1000986, 1003960, 1078360, 108029]; Victorian Government's OIS Program; Victorian Government's OIS Programme; National Health and Medical Research Council [NHMRC] [233200]; Australian Government Department of Health and Ageing; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca; Bristol-Myers Squibb; City Health Centre-Diabetes Service Canberra; Department of Health and Community Services Northern Territory; Department of Health and Human Services Tasmania; Department of Health New South Wales; Department of Health Western Australia; Department of Health South Australia; Department of Human Services Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital; Sydney; Sanofi Aventis and Sanofi Synthelabo	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; Victorian Government's OIS Programme; National Health and Medical Research Council [NHMRC](National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); City Health Centre-Diabetes Service Canberra; Department of Health and Community Services Northern Territory; Department of Health and Human Services Tasmania; Department of Health New South Wales; Department of Health Western Australia; Department of Health South Australia; Department of Human Services Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia(Eli Lilly); Estate of the Late Edward Wilson; GlaxoSmithKline(GlaxoSmithKline); Jack Brockhoff Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharmaceuticals(Novo Nordisk); Pfizer Pty Ltd(Pfizer); Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital; Sydney; Sanofi Aventis and Sanofi Synthelabo	This work was supported by: National Health and Medical Research Council of Australia [Program Grant #566940 to NO; Centre of Research Excellence Grant #1000986 to GNH, NO, DWD with salary support to EW; Senior Principal Research Fellowship #1003960 to NO; Senior Research Fellowship #1078360 to DWD; Career Development Fellowship #108029 to GNH]; and, the Victorian Government's OIS Program (to NO and DWD). The Australian Diabetes, Obesity and Lifestyle study (AusDiab), co-coordinated by the Baker IDI Heart and Diabetes Institute, was supported in part by the Victorian Government's OIS Programme, and gratefully acknowledges the generous support given by the National Health and Medical Research Council [NHMRC grant #233200], Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service Canberra, Department of Health and Community Services Northern Territory, Department of Health and Human Services Tasmania, Department of Health New South Wales, Department of Health Western Australia, Department of Health South Australia, Department of Human Services Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis and Sanofi Synthelabo. The funders of this study had no role in the data analysis or interpretation of the results.	Australian Government, 2014, AUSTR PHYS ACT SED B; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Barr E. L. M., 2005, AUSDIAB 2005 AUSTR D; Barreira TV, 2015, GAIT POSTURE, V42, P70, DOI 10.1016/j.gaitpost.2015.04.008; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chastin SFM, 2015, MEAS PHYS EDUC EXERC, V19, P138, DOI 10.1080/1091367X.2015.1050592; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Chastin SF, 2015, MEASUREMENT PHYS ED; Chief Medical Officers of England, 2011, REP PHYS ACT HLTH 4; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Dempsey P., 2015, HEAR LUNG CIRC, V24, pS127, DOI [DOI 10.1016/J.HLC.2015.06.033, 10.1016/j.hlc.2015.06.033]; Dempsey PC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0797-4; Dempsey PC, 2016, DIABETOLOGIA DIABETO; Dunstan D., 2016, SEDENTARY BEHAV HLTH; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Falconer CL, 2015, MED SCI SPORT EXERC, V1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giles GG, 1996, DIETARY QUESTIONNAIR; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119140; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Healy GN, 2015, EUR HEART J; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Henson J, 2015, DIABETES CA IN PRESS; Keadle SK, 2017, AM J PREV MED, V52, P541, DOI 10.1016/j.amepre.2016.11.010; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Larsen RN, 2014, NUTR METAB CARDIOVAS, V24, P976, DOI 10.1016/j.numecd.2014.04.011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Page A, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0032-9; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Qi QB, 2015, CIRCULATION, V132, P1560, DOI 10.1161/CIRCULATIONAHA.115.016938; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Tanamas SK, 2013, AUSDIAB 2012 AUSTR D, P1; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van der Berg JD, 2016, DIABETOLOGIA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	47	90	91	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180119	10.1371/journal.pone.0180119	http://dx.doi.org/10.1371/journal.pone.0180119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662164	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300106
J	Chun, N; Haddadin, AS; Liu, JY; Hou, YF; Wong, KA; Lee, D; Rushbrook, JI; Gulaya, K; Hines, R; Hollis, T; Nuno, BN; Mangi, AA; Hashim, S; Pekna, M; Catalfamo, A; Chin, HY; Patel, F; Rayala, S; Shevde, K; Heeger, PS; Zhang, M				Chun, Nicholas; Haddadin, Ala S.; Liu, Junying; Hou, Yunfang; Wong, Karen A.; Lee, Daniel; Rushbrook, Julie I.; Gulaya, Karan; Hines, Roberta; Hollis, Tamika; Nuno, Beatriz Nistal; Mangi, Abeel A.; Hashim, Sabet; Pekna, Marcela; Catalfamo, Amy; Chin, Hsiao-ying; Patel, Foramben; Rayala, Sravani; Shevde, Ketan; Heeger, Peter S.; Zhang, Ming			Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MANNOSE-BINDING LECTIN; BYPASS GRAFT-SURGERY; OPEN-HEART-SURGERY; PERCUTANEOUS CORONARY INTERVENTION; ALTERNATIVE PATHWAY COMPLEMENT; CARDIAC TROPONIN-I; C-REACTIVE PROTEIN; NF-KAPPA-B; CARDIOPULMONARY BYPASS	The pathophysiology of myocardial injury that results from cardiac ischemia and reperfusion (I/R) is incompletely understood. Experimental evidence from murine models indicates that innate immune mechanisms including complement activation via the classical and lectin pathways are crucial. Whether factor B (f B), a component of the alternative complement pathway required for amplification of complement cascade activation, participates in the pathophysiology of myocardial I/R injury has not been addressed. We induced regional myocardial I/R injury by transient coronary ligation in WT C57BL/6 mice, a manipulation that resulted in marked myocardial necrosis associated with activation of fB protein and myocardial deposition of C3 activation products. In contrast, in f13(-/-) mice, the same procedure resulted in significantly reduced myocardial necrosis (% ventricular tissue necrotic; fB(-/-) mice, 20 4%; WT mice, 45 3%; P< 0.05) and diminished deposition of C3 activation products in the myocardial tissue (fB(-/-) mice, 0 0%; WT mice, 31 6%; P<0.05). Reconstitution of fB(-/-) mice with WT serum followed by cardiac I/R restored the myocardial necrosis and activated C3 deposition in the myocardium. In translational human studies we measured levels of activated fB (Bb) in intracoronary blood samples obtained during cardio-pulmonary bypass surgery before and after aortic cross clamping (AXCL), during which global heart ischemia was induced. Intracoronary Bb increased immediately after AXCL, and the levels were directly correlated with peripheral blood levels of cardiac troponin I, an established biomarker of myocardial necrosis (Spearman coefficient = 0.465, P < 0.01). Taken together, our results support the conclusion that circulating fB is a crucial pathophysiological	[Chun, Nicholas; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Chun, Nicholas; Heeger, Peter S.] Icahn Sch Med Mt Sinai, Translat Transplant Res Ctr, New York, NY 10029 USA; [Haddadin, Ala S.; Hines, Roberta; Hollis, Tamika; Nuno, Beatriz Nistal] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Liu, Junying; Hou, Yunfang; Wong, Karen A.; Rushbrook, Julie I.; Gulaya, Karan; Catalfamo, Amy; Chin, Hsiao-ying; Shevde, Ketan; Zhang, Ming] Suny Downstate Med Ctr, Coll Med, Dept Anesthesiol, Brooklyn, NY 11203 USA; [Lee, Daniel] Suny Downstate Med Ctr, Coll Med, Dept Surg, Brooklyn, NY 11203 USA; [Mangi, Abeel A.; Hashim, Sabet] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Pekna, Marcela] Gothenburg Univ, Dept Med Chem & Cell Biol, Gothenburg, Sweden; [Patel, Foramben; Rayala, Sravani] Long Isl Univ, Dept Biomed Sci, Brookville, NY USA; [Zhang, Ming] Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; University of Gothenburg; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhang, M (corresponding author), Suny Downstate Med Ctr, Coll Med, Dept Anesthesiol, Brooklyn, NY 11203 USA.; Zhang, M (corresponding author), Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA.	ming.zhang@downstate.edu	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021; Nistal-Nuno, Beatriz/AFS-7236-2022	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Nistal-Nuno, Beatriz/0000-0003-2210-0726	NIH [1R21HL088527, 1 R21A1117695-01]; ECRIP Award from New York State Department of Health;  [T32 (5T32DK007757)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117695, T32AI078892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECRIP Award from New York State Department of Health; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was funded in part by NIH grant 1R21HL088527 (MZ) and 1 R21A1117695-01 (PSH and MZ) and an ECRIP Award from New York State Department of Health (KS and MZ). Dr. Yunfang Hou is an ECRIP fellow. NC is supported by T32 (5T32DK007757).; The authors would like to thank Dr. James Cottrell for his continued support, Drs. Anita Mehrotra, Jeremy Weedon and Feng Dai for helpful advice on biostatistical analyses, and the CT ICU staff members of University Hospital SUNY Downstate and Yale-New Haven Hospital for their valuable assistance. The research was funded in part by NIH grant 1R21HL088527 (MZ) and 1R21AI117695-01 (PSH and MZ) and an ECRIP Award from New York State Department of Health (KS and MZ). Dr. Yunfang Hou is an ECRIP fellow. NC is supported by T32 (5T32DK007757).	Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Alam MR, 2014, J MOL CELLULAR CARDI; Alcock RF, 2012, HEART, V98, P792, DOI 10.1136/heartjnl-2011-301577; Arcasoy SM, 2005, J HEART LUNG TRANSPL, V24, P1483, DOI 10.1016/j.healun.2004.11.314; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Atkinson C, 2010, J IMMUNOL, V185, P7007, DOI 10.4049/jimmunol.1001504; Banda NK, 2008, ARTHRITIS RHEUM-US, V58, P3081, DOI 10.1002/art.23865; Barratt-Due A, 2012, IMMUNOBIOLOGY, V217, P1047, DOI 10.1016/j.imbio.2012.07.019; Bay JT, 2013, KIDNEY INT, V83, P264, DOI 10.1038/ki.2012.373; Bell JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00096; Berger SP, 2005, AM J TRANSPLANT, V5, P1361, DOI 10.1111/j.1600-6143.2005.00841.x; Berger SP, 2007, J AM SOC NEPHROL, V18, P2416, DOI 10.1681/ASN.2007030262; Bernink FJP, 2014, INT J CARDIOL, V170, P261, DOI 10.1016/j.ijcard.2013.11.007; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; Brown DI, 2015, CIRC RES, V116, P531, DOI 10.1161/CIRCRESAHA.116.303584; Bruins P, 1997, CIRCULATION, V96, P3542; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cabrera-Fuentes HA, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0586-x; Calo L, 2013, CURR PHARM DESIGN, V19, P6848, DOI 10.2174/138161281939131127110701; Charlagorla P, 2013, MOL IMMUNOL, V56, P507, DOI 10.1016/j.molimm.2013.05.001; Chen J, 2011, J SURG RES, V167, pE131, DOI 10.1016/j.jss.2009.05.041; Cravedi P, 2014, J CLIN INVEST, V124, P2348, DOI 10.1172/JCI72273; Crespo M, 2013, TRANSPL IMMUNOL, V29, P28, DOI 10.1016/j.trim.2013.07.002; Csencsits K, 2008, AM J TRANSPLANT, V8, P1622, DOI 10.1111/j.1600-6143.2008.02295.x; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Damman J, 2013, KIDNEY INT, V83, P191, DOI 10.1038/ki.2012.397; Das S, 2012, BBA-BIOMEMBRANES, V1818, P1451, DOI 10.1016/j.bbamem.2011.11.008; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Erbel R, 2014, EUR HEART J, V35, P313, DOI 10.1093/eurheartj/eht550; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fiane AE, 2005, EUR HEART J, V26, P1660, DOI 10.1093/eurheartj/ehi198; Fildes JE, 2008, J HEART LUNG TRANSPL, V27, P1353, DOI 10.1016/j.healun.2008.08.011; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fleming SD, 2006, AUTOIMMUN REV, V5, P89, DOI 10.1016/j.autrev.2005.09.006; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Gollop ND, 2013, INTERACT CARDIOV TH, V17, P867, DOI 10.1093/icvts/ivt303; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gottlieb RA, 2011, J CARDIOVASC PHARM T, V16, P233, DOI 10.1177/1074248411409581; Greenson N, 2001, AM HEART J, V141, P447, DOI 10.1067/mhj.2001.113071; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Halestrap AP, 2014, J MOL CELLULAR CARDI; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hoedemaekers C, 2010, ANN THORAC SURG, V89, P710, DOI 10.1016/j.athoracsur.2009.11.049; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; HOLT GD, 1990, J BIOL CHEM, V265, P2852; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Ibernon M, 2014, TRANSPLANT REV-ORLAN, V28, P21, DOI 10.1016/j.trre.2013.10.006; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Ito WD, 1997, J MOL CELL CARDIOL, V29, P2169, DOI 10.1006/jmcc.1997.0456; Jane-wit D, 2015, P NATL ACAD SCI USA, V112, P9686, DOI 10.1073/pnas.1503535112; Januzzi JL, 2011, MINERVA ANESTESIOL, V77, P334; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Koolen BB, 2013, INTERACT CARDIOV TH, V17, P608, DOI 10.1093/icvts/ivt259; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuhn-Regnier F, 1999, EUR J CARDIO-THORAC, V15, P67, DOI 10.1016/S1010-7940(98)00289-9; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Lee H, 2010, MOL IMMUNOL, V47, P972, DOI 10.1016/j.molimm.2009.11.022; Lee JC, 2011, CLIN CHEST MED, V32, P279, DOI 10.1016/j.ccm.2011.02.007; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Magro CM, 2003, AM J TRANSPLANT, V3, P1143, DOI 10.1034/j.1600-6143.2003.00152.x; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Marcheix B, 2008, ANN THORAC SURG, V85, P530, DOI 10.1016/j.athoracsur.2007.08.050; MERI S, 1985, CLIN EXP IMMUNOL, V60, P597; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Millington TM, 2010, KIDNEY INT, V78, pS18, DOI 10.1038/ki.2010.417; Mitchell Rita G, 2002, Am Heart J, V144, pE9, DOI 10.1067/mhj.2002.126114; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Morciano G, 2014, J MOL CELLULAR CARDI; Muller AL, 2013, INT J CARDIOL, V164, P39, DOI 10.1016/j.ijcard.2012.01.103; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Neuhof C, 2014, WORLD J CARDIOL, V6, P638, DOI 10.4330/wjc.v6.i7.638; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pavlov VI, 2015, AM J PATHOL, V185, P347, DOI 10.1016/j.ajpath.2014.10.015; PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404; Pekna M, 1998, SCAND J IMMUNOL, V47, P375; Pickard JMJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0453-6; Przyklenk K, 2012, CARDIOVASC RES, V94, P197, DOI 10.1093/cvr/cvr358; Raedler H, 2011, AM J TRANSPLANT, V11, P1397, DOI 10.1111/j.1600-6143.2011.03561.x; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Rassaf T, 2014, CARDIOVASC RES, V102, P321, DOI 10.1093/cvr/cvu071; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, AM J PATHOL, V162, P363, DOI 10.1016/S0002-9440(10)63830-8; Roberts BW, 2013, SHOCK, V39, P229, DOI 10.1097/SHK.0b013e31827f565b; Robinson E, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0476-7; Rodriguez ER, 2005, AM J TRANSPLANT, V5, P2778, DOI 10.1111/j.1600-6143.2005.01074.x; RUBIN B, 1989, MICROCIRC ENDOTH LYM, V5, P207; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Schoos MM, 2013, MOL IMMUNOL, V54, P408, DOI 10.1016/j.molimm.2013.01.008; Schouten O, 2006, CORONARY ARTERY DIS, V17, P173, DOI 10.1097/00019501-200603000-00012; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; SEGHAYE MC, 1993, J THORAC CARDIOV SUR, V106, P978, DOI 10.1016/S0022-5223(19)33968-6; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Smith PK, 2011, J THORAC CARDIOV SUR, V142, P89, DOI 10.1016/j.jtcvs.2010.08.035; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Stahl GL, 2012, ANESTH ANALG, V115, P759, DOI 10.1213/ANE.0b013e3182652b7d; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Tsokos GC, 2015, CIRCULATION, V131, P1153, DOI 10.1161/CIRCULATIONAHA.115.015613; Vermes E, 2000, ANN THORAC SURG, V70, P2087, DOI 10.1016/S0003-4975(00)02152-4; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Wang Y, 2010, SHOCK, V34, P548, DOI 10.1097/SHK.0b013e3181e686f5; Wolff RA, 2000, J MOL CELL CARDIOL, V32, P225, DOI 10.1006/jmcc.1999.1074; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhang M, 2007, EXPERT OPIN BIOL TH, V7, P1575, DOI 10.1517/14712598.7.10.1575; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zhang M, 2006, J MOL CELL CARDIOL, V41, P62, DOI 10.1016/j.yjmcc.2006.02.006; Zhang M, 2013, INT J CARDIOL, V166, P499, DOI 10.1016/j.ijcard.2011.11.032; Zhong CY, 2004, ANESTHESIOLOGY, V100, P540, DOI 10.1097/00000542-200403000-00012	138	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179450	10.1371/journal.pone.0179450	http://dx.doi.org/10.1371/journal.pone.0179450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662037	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300022
J	Spangler, GL; Rosen, BD; Ilori, MB; Hanotte, O; Kim, ES; Sonstegard, TS; Burke, JM; Morgan, JLM; Notter, DR; Van Tassell, CP				Spangler, Gordon L.; Rosen, Benjamin D.; Ilori, Moses Babatunde; Hanotte, Olivier; Kim, Eui-Soo; Sonstegard, Tad S.; Burke, Joan M.; Morgan, James L. M.; Notter, David R.; Van Tassell, Curtis P.			Whole genome structural analysis of Caribbean hair sheep reveals quantitative link to West African ancestry	PLOS ONE			English	Article							WIDE ASSOCIATION REVEALS; HAEMONCHUS-CONTORTUS; RESISTANCE; QTL; HISTORY; ORIGIN; GROWTH; BREEDS	Hair sheep of Caribbean origin have become an important part of the U.S. sheep industry. Their lack of wool eliminates a number of health concerns and drastically reduces the cost of production. More importantly, Caribbean hair sheep demonstrate robust production performance even in the presence of drug-resistant gastrointestinal nematodes, a rising concern to the industry. Despite the growing importance of hair sheep in the Americas their genetic origins have remained speculative. Prior to this report no genetic studies were able to identify a unique geographical origin of hair sheep in the New World. Our study clarifies the African and European ancestry of Caribbean hair sheep. Whole-genome structural analysis was conducted on four established breeds of hair sheep from the Caribbean region. Using breeds representing Africa and Europe we establish an objective measure indicating Caribbean hair sheep are derived from Iberian and West African origins. Caribbean hair sheep result from West African introgression into established ecotypes of Iberian descent. Genotypes from 47,750 autosomal single nucleotide polymorphism markers scored in 290 animals were used to characterize the population structure of the St. Croix, Barbados Black-belly, Morada Nova, and Santa Ines. Principal components, admixture, and phylogenetic analyses results correlate with historical patterns of colonization and trade. These patterns support co-migration of these sheep with humans.	[Spangler, Gordon L.; Rosen, Benjamin D.; Van Tassell, Curtis P.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA; [Ilori, Moses Babatunde; Hanotte, Olivier] Univ Nottingham, Sch Life Sci, Nottingham, England; [Kim, Eui-Soo; Sonstegard, Tad S.] Acceligen Recombinetics Inc, St Paul, MN USA; [Burke, Joan M.] ARS, Dale Bumpers Small Farms Res Stn, USDA, Booneville, AR USA; [Morgan, James L. M.] Katahdin Hair Sheep Int, Fayetteville, AR USA; [Notter, David R.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA USA	United States Department of Agriculture (USDA); University of Nottingham; United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University	Rosen, BD (corresponding author), ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA.	ben.rosen@ars.usda.gov	Burke, Joan M/GLU-6395-2022; Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Hanotte, Olivier/0000-0002-2877-4767; Ilori, Babatunde/0000-0002-5316-1495				Alvarez I, 2013, ANIM GENET, V44, P344, DOI 10.1111/j.1365-2052.2012.02398.x; Alvarez I, 2012, SMALL RUMINANT RES, V104, P89, DOI 10.1016/j.smallrumres.2011.10.025; Amarante AFT, 2004, VET PARASITOL, V120, P91, DOI 10.1016/j.vetpar.2003.12.004; Aumont G, 2003, VET PARASITOL, V116, P139, DOI 10.1016/S0304-4017(03)00259-0; Benavides MV, 2016, TRENDS PARASITOL, V32, P470, DOI 10.1016/j.pt.2016.03.007; Blackburn HD, GENETIC STRUCTURE DI; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Bryc, GEN WID PATT POP STR; Burke JM, 2002, VET PARASITOL, V109, P265, DOI 10.1016/S0304-4017(02)00272-8; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Ciani E, 2014, ANIM GENET, V45, P256, DOI 10.1111/age.12106; Ciani E, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0139-z; Delgado J.V., 2000, ANIM GENET RESOUR IN, V28, P27, DOI [10.1017/S1014233900001334, DOI 10.1017/S1014233900001334]; Fariello MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103813; Galloway J. H., 2005, SUGAR CANE IND HIST; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Henzell T, 2007, AUSTRALIAN AGRICULTURE: ITS HISTORY AND CHALLENGES, P1; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Jones K., MARKETING COULD BOOS; Kijas J, 2017, ANIM GENET, V48, P237, DOI [10.1111/age.12513, 10.1111/age.12409]; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Lee T-H, 2014, BMC GENOMICS, P15; Legarra A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0087-7; Lv F-H, 2014, MOL BIOL EVOL; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; Major RH, 1870, SELECT LETT CHRISTOP; Malhado CHM, 2009, SMALL RUMINANT RES, V84, P16, DOI 10.1016/j.smallrumres.2009.04.006; Mariante A. da S., 1999, Animal Genetic Resources Information, P107; Matika O, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0191-3; McManus Concepta, 2010, R. Bras. Zootec., V39, P236, DOI 10.1590/S1516-35982010001300026; Milne C, 2000, SMALL RUMINANT RES, V36, P99, DOI 10.1016/S0921-4488(99)00154-6; Morris ST, 2009, SMALL RUMINANT RES, V86, P59, DOI 10.1016/j.smallrumres.2009.09.019; Muigai AWT, 2013, AFR ARCHAEOL REV, V30, P39, DOI 10.1007/s10437-013-9129-0; Muigai AWT, GENETIC DIVERSITY RE; Notter DR, 2003, SMALL RUMINANT RES, V47, P221, DOI 10.1016/S0921-4488(02)00279-1; Paiva SR, 2011, J HERED, V102, P697, DOI 10.1093/jhered/esr101; Paiva SR, 2005, PESQUI AGROPECU BRAS, V40, P887, DOI 10.1590/S0100-204X2005000900008; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; WATSON AM, 1974, J ECON HIST, V34, P8, DOI 10.1017/S0022050700079602; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Zygoyiannis D, 2006, SMALL RUMINANT RES, V62, P143, DOI 10.1016/j.smallrumres.2005.07.043	50	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179021	10.1371/journal.pone.0179021	http://dx.doi.org/10.1371/journal.pone.0179021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662044	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300013
J	Croft, S; Chauvenet, ALM; Smith, GC				Croft, Simon; Chauvenet, Alienor L. M.; Smith, Graham C.			A systematic approach to estimate the distribution and total abundance of British mammals	PLOS ONE			English	Article							DEER	Robust policy decisions regarding the protection and management of terrestrial mammals require knowledge of where species are and in what numbers. The last comprehensive review, presenting absolute estimates at a national scale, was published nearly 20 years ago and was largely based on expert opinion. We investigated and propose a systematic data driven approach combing publically available occurrence data with published density estimates to predict species distribution maps and derive total abundance figures for all terrestrial mammals inhabiting Britain. Our findings suggest that the methodology has potential; generally producing plausible predictions consistent with existing information. However, inconsistencies in the availability and recording of data impact the certainty of this output limiting its current application for policy. Restrictions on access and use of occurrence data at a local level produces "data deserts" for which models cannot compensate. This leads to gaps in spatial distribution of species and consequently underestimates abundance. For many species the limited number of geo-referenced densities hampered the extrapolation from habitat suitability to absolute abundance. Even for well-studied species, further density estimates are required. Many density estimates used were pre-1995 and therefore the derived abundance should not be considered a current estimate. To maximise a systematic approach in the future we make the following recommendations: 1. To mitigate the attitudes of a minority of local data providers occurrence records must be submitted to national surveys such as the Mammal Society's Mammal Tracker. 2. Studies are required to estimate density for common species and in areas of low or no abundance. 3. To ensure such studies can be collated and used efficiently we propose a standardised approach reporting density estimates based on the 1km resolution British National Grid, or habitat representative of the 1km square, with digital maps to accompany publications.	[Croft, Simon; Chauvenet, Alienor L. M.; Smith, Graham C.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [Chauvenet, Alienor L. M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Animal & Plant Health Agency UK; University of Queensland	Smith, GC (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	graham.smith@apha.gsi.gov.uk	Chauvenet, Alienor/L-9135-2015; Smith, Graham C/J-2593-2013	Chauvenet, Alienor/0000-0002-3743-7375; Smith, Graham C/0000-0002-9897-6794	Department for Environment, Food Rural Affairs [SE0430]	Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food & Rural Affairs (https://www.gov.uk/government/organisations/department-for-environment-food-rural-afairs) under project SE0430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, DIVERS DISTRIB, V16, P515, DOI 10.1111/j.1472-4642.2010.00662.x; Aebischer NJ., 2011, NATL GAMEBAG CENSUS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Association of Local Environmental Records Centres, LRC ACCR GUID HDB LR; Bates D, IME4 LINEAR MIXED EF; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burham KP, 2002, MODEL SLECTION MULTI; Calcagno V, GLMULTI MODEL SELECT; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Harris S. J., 2015, 673 BTO; Harris SJ, 1995, JOINT NATURE CONSERV; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2015, R CRAN PROJ INTERNET; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Mazerolle MJ, ALCCMODAVG MODEL SEL; Moore NP, 2003, NEW ZEAL J ZOOL, V30, P443, DOI 10.1080/03014223.2003.9518351; Morton D., 2011, 1107 COUNTR SURV CTR; Naimi B, 2016, ECOGRAPHY; National Biodiversity Network, 2015, STRAT 2015 2020 1 DR; National Records of Scotland, 2011, CENS AGG DAT SCOTLAN; Norbury G, 2015, MAMMAL REV, V45, P79, DOI 10.1111/mam.12034; Office for National Statistics, 2015, 2011 CENS AGGR DAT E; Putman RJ, 1998, MAMMAL REV, V28, P141, DOI 10.1046/j.1365-2907.1998.00031.x; Robertson PA, 2015, MAMMAL REV, V45, P128, DOI 10.1111/mam.12038; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Sandfort R, 2015, MAMMAL REV, V45, P191, DOI 10.1111/mam.12039; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Smith GC, 2007, VET J, V173, P302, DOI 10.1016/j.tvjl.2005.11.017; Smith G. C., 2009, MANAGEMENT DIS WILD; Uhrin M, 2016, MAMMAL REV, V46, P1, DOI 10.1111/mam.12050; Venables WN., 2002, MODERN APPL STAT S 4; Webbon CC, 2004, J APPL ECOL, V41, P768, DOI 10.1111/j.0021-8901.2004.00930.x; Yarnell RW, 2014, MAMMAL REV, V44, P234, DOI 10.1111/mam.12026; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]	39	28	29	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0176339	10.1371/journal.pone.0176339	http://dx.doi.org/10.1371/journal.pone.0176339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658248	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900002
J	Jerszurki, D; Souza, JLM; Silva, LCR				Jerszurki, Daniela; Souza, Jorge L. M.; Silva, Lucas C. R.			Expanding the geography of evapotranspiration: An improved method to quantify land-to-air water fluxes in tropical and subtropical regions	PLOS ONE			English	Article							LIMITED WEATHER DATA; PENMAN-MONTEITH; TRANSPIRATION RATE; MODELS; HARGREAVES; EVAPORATION; EQUATION; FORMULA; STATE	The development of new reference evapotranspiration (ETo) methods hold significant promise for improving our quantitative understanding of climatic impacts on water loss from the land to the atmosphere. To address the challenge of estimating ETo in tropical and subtropical regions where direct measurements are scarce we tested a new method based on geographical patterns of extraterrestrial radiation (Ra) and atmospheric water potential (psi(air)). Our approach consisted of generating daily estimates of ETo across several climate zones in Brazil as a model system which we compared with standard ETOPM (Penman-Monteith) estimates. In contrast with ETOPM, the simplified method (ETMJS) relies solely on (psi(air) calculated from widely available air temperature (degrees C) and relative humidity (%) data, which combined with Ra data resulted in reliable estimates of equivalent evaporation (Ee) and ETo. We used regression analyses of psi(air) vs ETOPM and Ee vs ETo(PM) to calibrate the ETMJS (psi(air)) and ETows estimates from 2004 to 2014 and between seasons and climatic zone. Finally, we evaluated the performance of the new method based on the coefficient of determination (Fe) and correlation (R), index of agreement "d', mean absolute error (MAE) and mean reason (MR). This evaluation confirmed the suitability of the ETMJS method for application in tropical and subtropical regions, where the climatic information needed for the standard ETOPM calculation is absent.	[Jerszurki, Daniela] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Wyler Dept Dryland Agr, Sede Boqer, Israel; [Souza, Jorge L. M.] Univ Fed Parana, Soil & Environm Studies Program, Curitiba, Parana, Brazil; [Silva, Lucas C. R.] Univ Oregon, Environm Studies Program, Eugene, OR 97403 USA; [Silva, Lucas C. R.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA	Ben Gurion University; Universidade Federal do Parana; University of Oregon; University of Oregon	Jerszurki, D (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Wyler Dept Dryland Agr, Sede Boqer, Israel.	danijerszurki@gmail.com	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X; 	Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil); Araucaria Foundation	Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil); Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	DJ was supported by Coordination for the Improvement of Higher Education Personnel (CAPES/PDSE, Brazil) (https://www.capes.gov.br) and Araucaria Foundation (http://www.fappr.pr.gov.br).	Alexandris S, 2006, AGR WATER MANAGE, V82, P371, DOI 10.1016/j.agwat.2005.08.001; Alexandris S, 2003, AGR WATER MANAGE, V60, P157, DOI 10.1016/S0378-3774(02)00172-5; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2005, 078440805X ENV WAT R; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 1963, J IRR DRAIN DIV-ASCE, DOI [10.1061/JRCEA4.0000287, DOI 10.1061/JRCEA4.0000287]; Benevides JG, 1970, AGRONOMIA TROPICAL, V20, P335; Berti A, 2014, AGR WATER MANAGE, V140, P20, DOI 10.1016/j.agwat.2014.03.015; Blaney H., 1950, DETERMINING WATER RE; Borges Alisson C., 2007, Rev. bras. eng. agríc. ambient., V11, P293, DOI 10.1590/S1415-43662007000300008; Borges JCF, 2012, REV BRAS ENG AGR AMB, V16, P380, DOI 10.1590/S1415-43662012000400008; Borges VP, 2010, REV BRAS ENG AGR AMB, V14, P74, DOI 10.1590/S1415-43662010000100010; Budiko M. I., 1974, CLIMATE LIFE; CAMARGO A. P., 1997, REV BRASILEIRA AGROM, V5, P89, DOI DOI 10.13083/1414-3984.V20N02A08; Campbell S., 1977, INTRO ENV BIOPHYSICS; Chagas RM, 2013, IRRIGA; Couvreur V, 2016, AGR FOREST METEOROL, V221, P71, DOI 10.1016/j.agrformet.2016.02.008; da Cunha FF, 2017, ENG AGR-JABOTICABAL, V37, P173, DOI [10.1590/1809-4430-eng.agric.v37n1p173-184/2017, 10.1590/1809-4430-Eng.Agric.v37n1p173-184/2017]; de Araraquara SP, 2005, ENGENHARIA AGRICOLA, V25, P713; Carvalho Luiz Gonsaga de, 2011, Pesqui. Agropecu. Trop., V41, P456, DOI 10.5216/pat.v41i3.12760; de Lacerda ZC, 2015, ENG AGR-JABOTICABAL, V35, P27, DOI 10.1590/1809-4430-Eng.Agric.v35n1p27-38/2015; de Melo GL, 2012, ENG AGR-JABOTICABAL, V32, P874, DOI 10.1590/S0100-69162012000500007; Djaman K, 2015, J HYDROL-REG STUD, V3, P139, DOI 10.1016/j.ejrh.2015.02.002; Duursma RA, 2008, TREE PHYSIOL, V28, P265, DOI 10.1093/treephys/28.2.265; George B.A., 2012, J INDIAN WATER RESOU, V32, P15; Gharun M, 2015, AGR FOREST METEOROL, V200, P249, DOI 10.1016/j.agrformet.2014.09.027; Gocic M, 2010, COMPUT ELECTRON AGR, V71, P158, DOI 10.1016/j.compag.2010.01.003; Gong L, 2006, J HYDROL, V329, P3; Hamon W. R., 1961, J HYDRAUL DIV, V87, P107, DOI [10.1061/JYCEAJ.0000599, DOI 10.1061/JYCEAJ.0000599]; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Hillel D., 1971, SOIL WATER PHYS PRIN; Hupet F, 2001, J HYDROL, V243, P192, DOI 10.1016/S0022-1694(00)00413-3; Irmak S, 2006, J IRRIG DRAIN ENG, V132, P564, DOI 10.1061/(ASCE)0733-9437(2006)132:6(564); Jensen M.E., 1990, EVAPOTRANSPIRATION I; Kampfer N., 2013, MONITORING ATMOSPHER; Lemos LCD, 2010, REV BRAS ENG AGR AMB, V14, P165, DOI 10.1590/S1415-43662010000200007; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; Makkink G.F., 1957, J I WATER ENG, V11, P277; Martinez CJ, 2010, J IRRIG DRAIN ENG, V136, P494, DOI 10.1061/(ASCE)IR.1943-4774.0000214; MEDEIROS A. T., 2002, THESIS, P103; Mendonça José C., 2003, Rev. bras. eng. agríc. ambient., V7, P275, DOI 10.1590/S1415-43662003000200015; Mohawesh OE, 2011, PLANT SOIL ENVIRON, V57, P145, DOI 10.17221/240/2010-PSE; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Novak V, 2013, EVAPOTRANSPIRATION S; Oliveira Rubens A., 2008, Rev. bras. eng. agríc. ambient., V12, P166, DOI 10.1590/S1415-43662008000200009; Pandey PK, 2016, INT SOIL WATER CONSE, V4, P52, DOI 10.1016/j.iswcr.2016.02.003; PENMAN H. L., 1963, VEGETATION HYDROLOGY; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Philip JR, 1964, J APPL METEOROL, V3, P390; Pilau FG, 2012, CIENC RURAL, V42, P283, DOI 10.1590/S0103-84782012000200016; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rana G, 1998, THEOR APPL CLIMATOL, V60, P141, DOI 10.1007/s007040050039; Ravazzani G, 2012, J IRRIG DRAIN ENG, V138, P592, DOI 10.1061/(ASCE)IR.1943-4774.0000453; REICHARDT K., 2012, SOLO PLANTA ATMOSFER; Cunha Paulo César Ribeiro da, 2013, Pesqui. Agropecu. Trop., V43, P114, DOI 10.1590/S1983-40632013000200005; Rojas JP, 2013, J IRRIG DRAIN ENG, V139, P285, DOI 10.1061/(ASCE)IR.1943-4774.0000523; Romanenko V.A., 1961, P UKR HYDR RES I KIE; Sabziparvar AA, 2010, J IRRIG DRAIN ENG, V136, P724, DOI 10.1061/(ASCE)IR.1943-4774.0000242; Schendel U, 1967, VEGETATIONS WASSERVE; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Silva AO, 2011, REV CAATINGA; Silva KO, REV BRASILEIRA ENGEN; Silva LCR, 2015, GEOCHEM PERSPECT LET, V1, P33, DOI 10.7185/geochemlet.1504; Silva LCR, 2015, TRENDS PLANT SCI, V20, P399, DOI 10.1016/j.tplants.2015.05.007; Slayter RO, 1967, PLANT WATER RELATION; Syperreck VLG, ACTA SCI AGRONOMY; Tanaka AA, 2016, PESQUI AGROPECU BRAS, V51, P91, DOI 10.1590/S0100-204X2016000200001; Thornthwaite C, 1944, T AM GEOPHYS UNION, V25, P686; Todorovic M, 2013, J HYDROL, V481, P166, DOI 10.1016/j.jhydrol.2012.12.034; Trabert W., 1896, METEOROL Z, V13, P261; Trajkovic S, 2007, J IRRIG DRAIN ENG, V133, P38, DOI 10.1061/(ASCE)0733-9437(2007)133:1(38); Trajkovic S, 2009, WATER RESOUR MANAG, V23, P3057, DOI 10.1007/s11269-009-9423-4; TURC L., 1961, Annales Agronomiques, V12, P13; Valiantzas JD, 2013, J HYDROL, V505, P13, DOI 10.1016/j.jhydrol.2013.09.005; Vescove Humberto V., 2005, Eng. Agríc., V25, P713, DOI 10.1590/S0100-69162005000300017; Weiss A, 2001, AGRON J, V93, P1321, DOI 10.2134/agronj2001.1321; Wilks D.S., 2011, STAT METHODS ATMOSPH; WILLMOTT CJ, 1985, J GEOPHYS RES-OCEANS, V90, P8995, DOI 10.1029/JC090iC05p08995; Wright J.L., 1972, J IRRIGATION DRAINAG, V98, P193, DOI DOI 10.1061/JRCEA4.0013020; Xavier AC, 2016, INT J CLIMATOL, V36, P2644, DOI 10.1002/joc.4518; Xu CY, 2005, J HYDROL, V308, P105, DOI 10.1016/j.jhydrol.2004.10.024; Yan H, 2012, REMOTE SENS ENVIRON, V124, P581, DOI 10.1016/j.rse.2012.06.004; Yoder RE, 2005, APPL ENG AGRIC, V21, P197	84	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180055	10.1371/journal.pone.0180055	http://dx.doi.org/10.1371/journal.pone.0180055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658324	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900054
J	Albers-Wolthers, CHJ; de Gier, J; Walen, M; van Kooten, PJS; Lambalk, CB; Leegwater, PAJ; Roelen, BAJ; Schaefers-Okkens, AC; Rutten, VPMG; Millar, RPM; Kooistra, HS				Albers-Wolthers, C. H. J.; de Gier, J.; Walen, M.; van Kooten, P. J. S.; Lambalk, C. B.; Leegwater, P. A. J.; Roelen, B. A. J.; Schaefers-Okkens, A. C.; Rutten, V. P. M. G.; Millar, R. P. M.; Kooistra, H. S.			In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation	PLOS ONE			English	Article							CENTRAL PRECOCIOUS PUBERTY; GONADOTROPIN-SECRETION; ESTROUS-CYCLE; LUTEINIZING-HORMONE; SEXUAL-BEHAVIOR; RECEPTOR GPR54; CORPUS-LUTEUM; LIFE-SPAN; BITCH; GENE	Kisspeptins (KPs) and their receptor (GPR54 or KiSS1R) play a key-role in regulation of the hypothalamic-pituitary-gonadal axis and are therefore interesting targets for therapeutic interventions in the field of reproductive endocrinology. As dogs show a rapid and robust LH response after the administration of KP10, they can serve as a good animal model for research concerning KP signaling. The aims of the present study were to test the antagonistic properties of KP analogs p234, p271, p354, and p356 in vitro, by determining the intracellular Ca2+ response of CHEM1 cells that stably express human GPR54, and to study the in vivo effects of these peptides on basal plasma LH concentration and the KP10-induced LH response in female dogs. Exposure of the CHEM1 cells to KP-10 resulted in a clear Ca2+ response. P234, p271, p354, and p356 did not prevent or lower the KP10-induced Ca2+ response. Moreover, the in vivo studies in the dogs showed that none of these supposed antagonists lowered the basal plasma LH concentration and none of the peptides lowered the KP10-induced LH response. In conclusion, p234, p271, p354, and p356 had no antagonistic effects in vitro nor any effect on basal and kisspeptin- stimulated plasma LH concentration in female dogs.	[Albers-Wolthers, C. H. J.; de Gier, J.; Walen, M.; Leegwater, P. A. J.; Schaefers-Okkens, A. C.; Kooistra, H. S.] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [van Kooten, P. J. S.; Rutten, V. P. M. G.] Univ Utrecht, Div Immunol, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Lambalk, C. B.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet Gynecol & Reprod Med, Amsterdam, Netherlands; [Roelen, B. A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Rutten, V. P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Millar, R. P. M.] Univ Pretoria, Ctr Neuroendocrinol, Pretoria, South Africa; [Millar, R. P. M.] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Millar, R. P. M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Millar, R. P. M.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University; Vrije Universiteit Amsterdam; Utrecht University; University of Pretoria; University of Pretoria; University of Pretoria; University of Cape Town; University of Edinburgh	Albers-Wolthers, CHJ (corresponding author), Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands.	c.h.j.albers-wolthers@uu.nl	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Leegwater, Peter/0000-0002-4100-015X; Lambalk, Cornelis/0000-0003-3947-5129				Albers-Wolthers CHJ, 2016, THERIOGENOLOGY, V86, P589, DOI 10.1016/j.theriogenology.2016.02.009; Albers-Wolthers KHJ, 2014, NEUROENDOCRINOLOGY, V99, P178, DOI 10.1159/000364877; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Colledge W. H., 2008, V46, P117, DOI 10.1007/400_2007_050; CONCANNON P, 1977, BIOL REPROD, V17, P604, DOI 10.1095/biolreprod17.4.604; d'Anglemont de Tassigny X, 2010, J NEUROSCI, V30, P8581, DOI DOI 10.1523/JNEUR; De Bond JAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057972; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dedes I, 2012, SYST BIOL REPROD MED, V58, P121, DOI 10.3109/19396368.2011.651555; Dhillo WS, 2007, J CLIN ENDOCR METAB, V92, P3958, DOI 10.1210/jc.2007-1116; George JT, 2012, HUM REPROD, V27, P3552, DOI 10.1093/humrep/des326; Goodman RL, 2012, ENDOCRINOLOGY, V153, P5918, DOI 10.1210/en.2012-1611; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; Guerriero KA, 2012, ENDOCRINOLOGY, V153, P825, DOI 10.1210/en.2011-1565; Hashizume T, 2010, ANIM REPROD SCI, V118, P37, DOI 10.1016/j.anireprosci.2009.05.017; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kooistra HS, 1999, BIOL REPROD, V60, P65, DOI 10.1095/biolreprod60.1.65; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liu XH, 2011, J NEUROSCI, V31, P2421, DOI 10.1523/JNEUROSCI.5759-10.2011; Mazaheri A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.156839; Mikkelsen JD, 2009, REGUL PEPTIDES, V152, P95, DOI 10.1016/j.regpep.2008.10.001; Millar RP, 2010, BRAIN RES, V1364, P81, DOI 10.1016/j.brainres.2010.09.044; NETT TM, 1975, P SOC EXP BIOL MED, V148, P134, DOI 10.3181/00379727-148-38491; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; OKKENS AC, 1986, J REPROD FERTIL, V77, P187, DOI 10.1530/jrf.0.0770187; OKKENS AC, 1985, VET QUART, V7, P173, DOI 10.1080/01652176.1985.9693979; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Reece JF, 2006, VET REC, V159, P379, DOI 10.1136/vr.159.12.379; Rhie YJ, 2014, J KOREAN MED SCI, V29, P1120, DOI 10.3346/jkms.2014.29.8.1120; Rhodes L, 2013, E BOOK CONTRACEPTION; Richardson CC, 2006, DIABETOLOGIA, V49, P2131; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Roseweir AK, 2009, HUM REPROD UPDATE, V15, P203, DOI 10.1093/humupd/dmn058; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Roseweir AK, 2013, ADV EXP MED BIOL, V784, P159, DOI 10.1007/978-1-4614-6199-9_8; Schaefers-Okkens A. C., 2010, Clinical endocrinology of dogs and cats: an illustrated text, P203; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225; Smith JT, 2009, NEUROENDOCRINOLOGY, V90, P283, DOI 10.1159/000227806; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Verma S, 2014, NEUROENDOCRINOLOGY, V99, P190, DOI 10.1159/000365419; WILDT DE, 1979, BIOL REPROD, V20, P648, DOI 10.1095/biolreprod20.3.648; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Zmora N, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131870	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179156	10.1371/journal.pone.0179156	http://dx.doi.org/10.1371/journal.pone.0179156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650956	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300049
J	Francis, S; Saavedra-Rodriguez, K; Perera, R; Paine, M; Black, WC; Delgoda, R				Francis, Sheena; Saavedra-Rodriguez, Karla; Perera, Rushika; Paine, Mark; Black, William C.; Delgoda, Rupika			Insecticide resistance to permethrin and malathion and associated mechanisms in Aedes aegypti mosquitoes from St. Andrew Jamaica	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; FRENCH-WEST-INDIES; PYRETHROID RESISTANCE; POPULATIONS; MUTATION; MEXICO	The emergence of novel diseases spread by the Aedes aegypti mosquito in Jamaica and the Caribbean, has prompted studies on insecticide resistance towards effective management of the vector. Though Jamaica has been using the organophosphate insecticide malathion in its vector control program for more than 30 years, resistance to the pesticide has not been tested in over a decade. We analyzed resistance to malathion and the pyrethroid insecticide, permethrin on mosquitoes collected across St. Andrew, Jamaica, and analyzed the molecular basis of resistance. The Center for Disease Control (CDC) bioassay revealed that Ae. aegypti mosquitoes from St. Andrew, Jamaica were resistant to permethrin (15 mu g/bottle) with mortalities at 0-8% at 30 minute exposure time, while contact with malathion (50 mu g/bottle) revealed <= 50% mortality at 15 minutes, which increased to 100% at 45 minutes. The standard susceptible New Orleans (NO) strain exhibited 100% mortality within15 minutes. The activities of multifunction oxidases and p-nitro phenyl-acetate esterases were significantly greater in most Jamaican populations in comparison to the NO strain, while activities of glutathione-S-transferase, acetylcholinesterase, a-esterase and beta-esterase activity were relatively equal, or lower than that of the control strain. The frequency of knockdown resistance mutations in the voltage dependent sodium channel gene were measured. All collections were fixed for Cys1,534 while 56% of mosquitoes were Ile1,016/Val1,016 heterozygotes, and 33% were Ile1,016 homozygotes. Aedes aegypti from St. Andrew Jamaica are resistant to permethrin with variations in the mode of mechanism, and possibly developing resistance to malathion. Continued monitoring of resistance is critically important to manage the spread of the vector in the country.	[Francis, Sheena; Delgoda, Rupika] Univ West Indies, Fac Sci & Technol, Nat Prod Inst, Mona, Jamaica; [Saavedra-Rodriguez, Karla; Perera, Rushika; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Paine, Mark] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University West Indies Mona Jamaica; Colorado State University; Liverpool School of Tropical Medicine	Delgoda, R (corresponding author), Univ West Indies, Fac Sci & Technol, Nat Prod Inst, Mona, Jamaica.; Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	William.Black@ColoState.edu; thejani.delgoda@uwimona.edu.jm	Paine, Mark John Ingraham/O-7450-2019; Francis, Sheena/AAA-9461-2019	Paine, Mark John Ingraham/0000-0003-2061-7713; Saavedra-Rodriguez, Karla/0000-0001-8511-3327; Delgoda, Rupika/0000-0002-6100-481X; Francis, Sheena/0000-0002-2240-8627	University of the West Indies, Mona; New Initiative Grant	University of the West Indies, Mona; New Initiative Grant	This work was supported by the University of the West Indies, Mona, Principal's New Initiative Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254; Barrett JR, 2006, ENVIRON HEALTH PERSP, V114, pA544, DOI 10.1289/ehp.114-a544a; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BIGLEY WS, 1962, J INSECT PHYSIOL, V8, P545, DOI 10.1016/0022-1910(62)90065-3; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Brogdon W, 2010, GUIDELINE EVALUATING; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Castle T, 1999, JAMAICA REV PANAM SA, V5, P100; Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88; Flores AE, 2006, J AM MOSQUITO CONTR, V22, P672, DOI 10.2987/8756-971X(2006)22[672:MOIRIF]2.0.CO;2; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; MOH, 2016, ZIK VIR OUTBR CONT S; PAHO, 2014, EP AL; Pan American Health Organization (PAHO), 2014, NUMB REP CAS DENG SE; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59; Rawlins SC., 1998, REV PANAMERICANA SAL, V4; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; The Gleaner, 2014, THE GLEANER; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Valle D, 2006, QUANTIFICATION METHO; Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263; WHO, 2017, SIT REP ZIK VIR MICR; WHO, 2013, TEST PROC INS RES MA; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008; ZWICK R. W., 1964, MOSQUITO NEWS, V24, P202	34	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179673	10.1371/journal.pone.0179673	http://dx.doi.org/10.1371/journal.pone.0179673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650966	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000404537300013
J	Iino, C; Shimoyama, T; Igarashi, T; Aihara, T; Ishii, K; Sakamoto, J; Tono, H; Fukuda, S				Iino, Chikara; Shimoyama, Tadashi; Igarashi, Takasato; Aihara, Tomoyuki; Ishii, Kentaro; Sakamoto, Juichi; Tono, Hiroshi; Fukuda, Shinsaku			Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer	PLOS ONE			English	Article							CHEMOTHERAPY; GEMCITABINE; SURVIVAL; SITE; S-1	Objective To assess the influence of biliary drainage to cholangitis on modified Glasgow Prognostic Score (mGPS) in patients with pancreatic cancer. Methods mGPS was calculated before and after biliary drainage in 47 consecutive patients with inoperable pancreatic cancer who were receiving chemotherapy. Biliary drainage was indicated for malignant obstructive jaundice that prevented the administration of chemotherapy. To elucidate mGPS values, serum levels of CRP and albumin were measured at the time of diagnosis (before biliary drainage). Overall survival was evaluated and risk factors, which contribute to overall survival, were examined. Results Biliary drainage was performed in 15 patients. Using values obtained before biliary drainage, there were no significant differences in median survival time between patients with a mGPS of 0 and those with a mGPS of 1 or 2 (10.7 vs. 9.4 months; p = 0.757). However, using values obtained after biliary drainage, median survival time was significantly higher in patients with a mGPS of 0 than in those with a mGPS of 1 or 2 (11.4 vs. 4.7 months; p = 0.002). Multivariate analysis revealed that a mGPS of 1 or 2 (HR: 3.38; 95% CI: 1.35-8.46, p = 0.009), a carbohydrate antigen 19-9 >1000 U/mL (2.52; 1.22-5.23, p = 0.013), a performance status of 2 (7.68; 2.72-21.28, p = 0.001), carcinoembryonic antigen level >10 ng/mL (2.29; 1.134.61, p = 0.021) were independently associated with overall survival. Conclusion mGPS values obtained after biliary drainage appear to be a more reliable indicator of overall survival in patients with inoperable pancreatic cancer.	[Iino, Chikara; Igarashi, Takasato; Aihara, Tomoyuki; Ishii, Kentaro; Sakamoto, Juichi; Tono, Hiroshi] Hirosaki Municipal Hosp, Dept Internal Med, Hirosaki, Aomori, Japan; [Iino, Chikara; Shimoyama, Tadashi; Igarashi, Takasato; Fukuda, Shinsaku] Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan	Hirosaki University	Iino, C (corresponding author), Hirosaki Municipal Hosp, Dept Internal Med, Hirosaki, Aomori, Japan.; Iino, C (corresponding author), Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan.	chikaran0601@yahoo.co.jp	Iino, Chikara/I-8730-2019	Iino, Chikara/0000-0001-6844-4415				Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; Ishizuka M, 2009, ANN SURG, V250, P268, DOI 10.1097/SLA.0b013e3181b16e24; Kasuga A, 2015, CANCER CHEMOTH PHARM, V75, P457, DOI 10.1007/s00280-014-2665-8; Martin HL, 2014, INTERN MED J, V44, P676, DOI 10.1111/imj.12453; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Shimoda M, 2010, CHEMOTHERAPY, V56, P501, DOI 10.1159/000321014; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680	10	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178777	10.1371/journal.pone.0178777	http://dx.doi.org/10.1371/journal.pone.0178777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644836	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100008
J	Sorensen, ML; Dahl, P; Sams, T				Sorensen, Mikkel Lindstrom; Dahl, Peter; Sams, Thomas			How fast is a collective bacterial state established?	PLOS ONE			English	Article							LUXR-LUXI FAMILY; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; AUTOINDUCER-BINDING; ASSOCIATION RATES; DNA-BINDING; QUORUM; PROTEIN; SPECIFICITY; EXPRESSION	Bacteria in a biofilm colony have the capacity to monitor the size and growth conditions for the colony and modify their phenotypical behaviour to optimise attacks, defence, migration, etc. The quorum sensing systems controlling this involve production and sensing of diffusive signal molecules. Frequently, quorum sensing systems carry a positive feedback loop which produces a switch at a threshold size of the colony. This all-or-none switch can be beneficial to create a sudden attack, leaving a host little time to establish a defence. The reaction-diffusion system describing a basal quorum sensing loop involves production of signal molecules, diffusion of signal molecules, and detection of signal molecules. We study the ignition process in a numerical solution for a basal quorum sensor and demonstrate that even in a large colony the ignition travels through the whole colony in a less than a minute. The ignition of the positive feedback loop was examined in different approximations. As expected, in the exact calculation the ignition was found to be delayed compared to a calculation where the binding of signal molecules was quasistatic. The buffering of signal molecules is found to have little effect on the ignition process. Contrary to expectation, we find that the ignition does not start when the threshold is reached at the center-instead it allows for the threshold to be approached in the whole colony followed by an almost simultaneous ignition of the whole biofilm aggregate.	[Sorensen, Mikkel Lindstrom; Dahl, Peter; Sams, Thomas] Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark; [Sorensen, Mikkel Lindstrom; Dahl, Peter] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Sams, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark.	tsams@dtu.dk	Sams, Thomas/A-9781-2014	Sams, Thomas/0000-0002-6316-2539				Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; [Anonymous], 2016, MATLAB VERS 9 1 0 44; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; Claussen A, 2013, INT J MOL SCI, V14, P13360, DOI 10.3390/ijms140713360; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; Fagerlind MG, 2005, BIOSYSTEMS, V80, P201, DOI 10.1016/j.biosystems.2004.11.008; Fagerlind MG, 2003, J MOL MICROB BIOTECH, V6, P88, DOI 10.1159/000076739; Ferkinghoff-Borg J, 2014, MOL BIOSYST, V10, P103, DOI 10.1039/c3mb70230h; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Garde C, 2015, SENSORS-BASEL, V15, P4229, DOI 10.3390/s150204229; Garde C, 2010, J MOL BIOL, V396, P849, DOI 10.1016/j.jmb.2010.01.002; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Kirke DF, 2004, FEMS MICROBIOL LETT, V241, P109, DOI 10.1016/j.femsle.2004.10.011; Lynch MJ, 2002, ENVIRON MICROBIOL, V4, P18, DOI 10.1046/j.1462-2920.2002.00264.x; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Pai A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.43; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Sams T., 2017, UNPUB; Sappington KJ, 2011, MBIO, V2, DOI 10.1128/mBio.00011-11; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schlosshauer M, 2002, J PHYS CHEM B, V106, P12079, DOI 10.1021/jp025894j; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; STEWART PS, 1993, APPL ENVIRON MICROB, V59, P327, DOI 10.1128/AEM.59.1.327-329.1993; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Trovato A, 2014, FEMS MICROBIOL LETT, V352, P198, DOI 10.1111/1574-6968.12394; Ventre I, 2003, MOL MICROBIOL, V48, P187, DOI 10.1046/j.1365-2958.2003.03422.x; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; Welch M, 2013, BIOCHEMISTRY-US, V52, P4433, DOI 10.1021/bi400315s; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180199	10.1371/journal.pone.0180199	http://dx.doi.org/10.1371/journal.pone.0180199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644896	gold, Green Submitted, Green Published			2022-12-26	WOS:000404145100065
J	Hindriksen, S; Bramer, AJ; Truong, MA; Vromans, MJM; Post, JB; Verlaan-Klink, I; Snippert, HJ; Lens, SMA; Hadders, MA				Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.			Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; MAMMALIAN-CELLS; GENE-EXPRESSION; HISTONE H3; HOMOLOGOUS RECOMBINATION; MULTIPROTEIN COMPLEXES; SPINDLE CHECKPOINT; VERTEBRATE CELLS; STEM-CELLS	The CRISPR/Cas9 system is a highly effective tool for genome editing. Key to robust genome editing is the efficient delivery of the CRISPR/Cas9 machinery. Viral delivery systems are efficient vehicles for the transduction of foreign genes but commonly used viral vectors suffer from a limited capacity in the genetic information they can carry. Baculovirus however is capable of carrying large exogenous DNA fragments. Here we investigate the use of baculoviral vectors as a delivery vehicle for CRISPR/Cas9 based genome-editing tools. We demonstrate transduction of a panel of cell lines with Cas9 and an sgRNA sequence, which results in efficient knockout of all four targeted subunits of the chromosomal passenger complex (CPC). We further show that introduction of a homology directed repair template into the same CRISPR/Cas9 baculovirus facilitates introduction of specific point mutations and endogenous gene tags. Tagging of the CPC recruitment factor Haspin with the fluorescent reporter YFP allowed us to study its native localization as well as recruitment to the cohesin subunit Pds5B.	[Hindriksen, Sanne; Bramer, Arne J.; My Anh Truong; Vromans, Martijn J. M.; Post, Jasmin B.; Verlaan-Klink, Ingrid; Snippert, Hugo J.; Lens, Susanne M. A.; Hadders, Michael A.] Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Lens, SMA; Hadders, MA (corresponding author), Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands.	S.M.A.Lens@umcutrecht.nl; M.A.Hadders@umcutrecht.nl		Truong, My Anh/0000-0002-9450-1978	Dutch Cancer Society, KWF Kankerbestrijding [UU2011-5134]; Netherlands Organization for Scientific Research [NWO-Vici 918.12.610, NWO-Veni 722.013.003]	Dutch Cancer Society, KWF Kankerbestrijding(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by The Dutch Cancer Society, KWF Kankerbestrijding (UU2011-5134 to S.M.A.L.) and The Netherlands Organization for Scientific Research (NWO-Vici 918.12.610 to S.M.A.L. and NWO-Veni 722.013.003 to M.A.H.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; Airenne KJ, 2011, METHODS MOL BIOL, V737, P279, DOI 10.1007/978-1-61779-095-9_12; Barsoum J, 1997, HUM GENE THER, V8, P2011, DOI 10.1089/hum.1997.8.17-2011; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cheshenko N, 2001, GENE THER, V8, P846, DOI 10.1038/sj.gt.3301459; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couturier AM, 2016, NUCLEIC ACIDS RES, V44, P10879, DOI 10.1093/nar/gkw921; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Edgerton H, 2016, J CELL BIOL, V213, P651, DOI 10.1083/jcb.201511080; Elkins JM, 2012, J MED CHEM, V55, P7841, DOI 10.1021/jm3008954; Fine EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10777; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Lei YN, 2011, MOL THER, V19, P942, DOI 10.1038/mt.2011.12; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mahonen AJ, 2007, J BIOTECHNOL, V131, P1, DOI 10.1016/j.jbiotec.2007.05.022; Mahonen AJ, 2010, J BIOTECHNOL, V145, P111, DOI 10.1016/j.jbiotec.2009.11.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; O'Flynn NMJ, 2013, BIOSCIENCE REP, V33, P23, DOI 10.1042/BSR20120093; Ohta S, 2016, MOL CELL PROTEOMICS, V15, P2802, DOI 10.1074/mcp.M116.057885; Pan YF, 2009, J GENE MED, V11, P1030, DOI 10.1002/jgm.1390; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shoji I, 1997, J GEN VIROL, V78, P2657, DOI 10.1099/0022-1317-78-10-2657; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Song SU, 2003, J GEN VIROL, V84, P697, DOI 10.1099/vir.0.18772-0; SOULE HD, 1990, CANCER RES, V50, P6075; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; TJIA ST, 1983, VIROLOGY, V125, P107; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoshida MM, 2016, J CELL BIOL, V213, P665, DOI 10.1083/jcb.201511079; Zhu HB, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt721	76	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179514	10.1371/journal.pone.0179514	http://dx.doi.org/10.1371/journal.pone.0179514			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640891	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800036
J	Lin, SF; Chien, JY; Kapupara, K; Huang, CYF; Huang, SP				Lin, Shu-Fang; Chien, Jia-Ying; Kapupara, Kishan; Huang, Chi-Ying F.; Huang, Shun-Ping			Oroxylin A promotes retinal ganglion cell survival in a rat optic nerve crush model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR G-CSF; MICROGLIAL ACTIVATION; AXONAL DEGENERATION; MEMORY IMPAIRMENT; ADULT-RAT; INJURY; EXPRESSION; DEATH; INHIBITION	Purpose To investigate the effect of oroxylin A on the survival of retinal ganglion cells (RGC) and the activation of microglial cells in a rat optic nerve (ON) crush model. Methods Oroxylin A (15mg/Kg in 0.2ml phosphate-buffered saline) or phosphate-buffered saline (PBS control) was immediately administered after ON crush once by subcutaneous injection. Rats were euthanized at 2 weeks after the crush injury. The density of RGC was counted by retrograde labeling with FluoroGold and immunostaining of retina flat mounts for Brn3a. Electrophysiological visual function was assessed by flash visual evoked potentials (FVEP). TUNEL assay, immunoblotting analysis of glial fibrillary acidic protein (GFAP), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in the retinas, and immunohistochemistry of GFAP in the retinas and ED1 in the ON were evaluated. Results Two weeks after the insult, the oroxylin A-treated group had significantly higher FG labeled cells and Brn3a+ cells suggesting preserved RGC density in the central and mid-peripheral retinas compared with those of the PBS-treated group. FVEP measurements showed a significantly better preserved latency of the P1 wave in the ON-crushed, oroxylin A-treated rats than the ON-crushed, PBS treated rats. TUNEL assays showed fewer TUNEL positive cells in the ON-crushed, oroxylin A-treated rats. The number of ED1 positive cells was reduced at the lesion site of the optic nerve in the ON-crushed, oroxylin A-treated group. Increased GFAP expression in the retina was reduced greatly in ON-crushed, oroxylin A-treated group. Furthermore, administration of oroxylin A significantly attenuated ON crush insult-induced iNOS and COX-2 expression in the retinas. Conclusions These results demonstrated that oroxylin A hasss neuroprotective effects on RGC survival with preserved visual function and a decrease in microglial infiltration in the ONs after ON crush injury.	[Lin, Shu-Fang; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chien, Jia-Ying; Kapupara, Kishan; Huang, Shun-Ping] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chien, Jia-Ying] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Tzu Chi University; National Tsing Hua University; National Yang Ming Chiao Tung University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Huang, SP (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.	cyhuang5@ym.edu.tw; sphophdoc1688@gms.tcu.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Kapupara, Kishan/0000-0002-0463-9050; Chien, Jia-Ying/0000-0002-3438-9435	Ministry of Science and Technology, R.O.C [MOST 105-2628-B-320-002-MY3]; Yang Ming University collaboration project [YM106C024]	Ministry of Science and Technology, R.O.C; Yang Ming University collaboration project	This work was supported by The Ministry of Science and Technology, R.O.C (grant nos. MOST 105-2628-B-320-002-MY3) and the Yang Ming University collaboration project (YM106C024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Ministry of Science and Technology, R.O.C (grant nos. MOST 105-2628-B-320-002-MY3) and the Yang-Ming University collaboration project (YM106C024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors sincerely thank Miss Su Zen Chen for her excellent assistance with figures.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brust AK, 2008, BIOMARK INSIGHTS, V3, P387; Chang CH, 2014, EXP EYE RES, V118, P109, DOI 10.1016/j.exer.2013.11.012; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Chien JY, 2016, EXP EYE RES, V143, P148, DOI 10.1016/j.exer.2015.10.004; Dietz GPH, 2005, MOL BRAIN RES, V136, P118, DOI 10.1016/j.molbrainres.2005.01.011; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Hanke J, 2004, ACT NEUR S, V89, P75; Heiduschka P, 2008, GRAEF ARCH CLIN EXP, V246, P1559, DOI 10.1007/s00417-008-0895-3; Huang TL, 2014, OPHTHALMIC RES, V51, P173, DOI 10.1159/000357736; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Kaufman PL, 1999, P NATL ACAD SCI USA, V96, P9455, DOI 10.1073/pnas.96.17.9455; Kim DH, 2008, NEUROPHARMACOLOGY, V55, P639, DOI 10.1016/j.neuropharm.2008.05.019; Kim DH, 2006, PHARMACOL BIOCHEM BE, V85, P658, DOI 10.1016/j.pbb.2006.10.025; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Koeberle PD, 1999, EXP NEUROL, V158, P366, DOI 10.1006/exnr.1999.7113; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; PELLEGRINO RG, 1984, PROC R SOC SER B-BIO, V222, P155, DOI 10.1098/rspb.1984.0056; Pham TAN, 2012, BIOORG MED CHEM LETT, V22, P2534, DOI 10.1016/j.bmcl.2012.01.135; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Rohatgi T, 2003, J NEUROSCI RES, V73, P246, DOI 10.1002/jnr.10643; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Tual-Chalot S, 2013, VIVO; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu N, 2014, LIFE SCI, V94, P17, DOI 10.1016/j.lfs.2013.10.034; Wu N, 2009, OPHTHALMIC RES, V42, P21, DOI 10.1159/000219681; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178584	10.1371/journal.pone.0178584	http://dx.doi.org/10.1371/journal.pone.0178584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640893	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800007
J	Piening, BC; Geffers, C; Gastmeier, P; Schwab, F				Piening, Brar C.; Geffers, Christine; Gastmeier, Petra; Schwab, Frank			Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection	PLOS ONE			English	Article							LATE-ONSET SEPSIS; OUTCOMES	Objective Mortality in very low birth weight infants following microbiology confirmed primary bloodstream infections varies with the type of causative pathogen. Given evidence from other studies that infections with gram negative bacteria and fungi cause a higher case fatality risk. We tried to confirm this in a nation-wide multi-center trial. Methods A cohort of 55,465 very low birth weight infants from 242 neonatal departments participating in the German national neonatal infection surveillance system NEO-KISS was used to investigate differences in the case fatality risk of microbiology confirmed primary blood-stream infections according to individual pathogens. Cox proportional hazard regression analyses were performed with the outcomes death and time from microbiology confirmed primary bloodstream infections. The results were adjusted to the recorded risk factors and hospital and department characteristics. Results A total of 4 094 very low birth weight infants with microbiology confirmed primary bloodstream infections were included in the analysis. The crude case fatality risk was 5.7%. The Cox proportional hazard regression analysis with adjustment for available risk factors revealed that microbiology confirmed primary bloodstream infections caused by Klebsiella spp. (HR 3.17 CI95 1.69-5.95), Enterobacter spp. (HR 3.42 CI95 1.86-6.27), Escherichia coli (HR 3.32 CI95 1.84-6.00) and Serratia spp. (HR 3.30 CI95 1.44-7.57) were associated with significantly higher case fatality risk compared to Staphylococcus aureus. After adjusting, case fatality risk of Candida albicans causing microbiology confirmed primary bloodstream infections was not higher than that of S. aureus. Conclusion In very low birth weight infants, bloodstream infections caused by gram negative pathogens have an increased case fatality risk compared to bloodstream infections caused by gram positive pathogens. This should be considered for prevention and therapy. Further research should address the specific risk factors for case fatality of C. albicans bloodstream infections.	[Piening, Brar C.; Geffers, Christine; Gastmeier, Petra; Schwab, Frank] Charite Univ Med Ctr, Inst Hyg & Environm Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Piening, BC (corresponding author), Charite Univ Med Ctr, Inst Hyg & Environm Med, Berlin, Germany.	brar.piening@charite.de	Piening, Brar/E-2622-2014	Piening, Brar/0000-0002-4478-5597; Gastmeier, Petra/0000-0001-5520-4287; Geffers, Christine/0000-0003-3047-6416	governmental Robert-Koch-Institut	governmental Robert-Koch-Institut	The authors are members of the German national reference center for surveillance of nosocomial infections which is funded by the governmental Robert-Koch-Institut (http://www.rki. de/DE/Content/Infekt/NRZ/nrz_node.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However besides the general funding of the national reference center which enables it to serve its mission of promoting surveillance of nosocomial infections in German hospitals the authors received no specific funding for this work.	Benzouina Soukayna, 2016, Pan Afr Med J, V23, P197, DOI 10.11604/pamj.2016.23.197.7401; Cleminson J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003850.pub5; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Gastmeier P, 2004, J HOSP INFECT, V57, P126, DOI 10.1016/j.jhin.2003.12.038; Geffers C, 2008, J HOSP INFECT; Hohlagschwandtner M., 2001, Archives of Gynecology and Obstetrics, V265, P113, DOI 10.1007/s004040100197; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Kaneko M, 2015, J OBSTET GYNAECOL RE, V41, P1056, DOI 10.1111/jog.12686; Leister R, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-11; Levit O, 2014, PEDIATR INFECT DIS J, V33, P143, DOI 10.1097/INF.0000000000000024; Prieto CL, 2013, AM J PERINAT, V30, P353, DOI 10.1055/s-0032-1324701; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; MODANLOU HD, 1980, AM J OBSTET GYNECOL, V138, P1157, DOI 10.1016/S0002-9378(16)32784-3; Roy P, 2014, J TROP PEDIATRICS, V60, P480, DOI 10.1093/tropej/fmu042; Schwab F, 2015, PEDIATR INFECT DIS J, V34, P235, DOI 10.1097/INF.0000000000000532; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Stoll BJ, 2003, SEMIN PERINATOL, V27, P293, DOI 10.1016/S0146-0005(03)00046-6; Suwal A, 2013, J NEPAL MED ASSOC, V52, P563; Townsel CD, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00006; Tsai MH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.024; Tsai MH, 2016, AM J INFECT CONTROL, V44, P146, DOI 10.1016/j.ajic.2015.09.009; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283	24	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0180134	10.1371/journal.pone.0180134	http://dx.doi.org/10.1371/journal.pone.0180134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640920	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800092
J	Prats-Sanchez, L; Martinez-Domeno, A; Camps-Renom, P; Delgado-Mederos, R; Guisado-Alonso, D; Marin, R; Dorado, L; Rudilosso, S; Gomez-Gonzalez, A; Purroy, F; Gomez-Choco, M; Canovas, D; Cocho, D; Garces, M; Abilleira, S; Martin-Fabregas, J				Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Delgado-Mederos, Raquel; Guisado-Alonso, Daniel; Marin, Rebeca; Dorado, Laura; Rudilosso, Salvatore; Gomez-Gonzalez, Alejandra; Purroy, Francisco; Gomez-Choco, Manuel; Canovas, David; Cocho, Dolores; Garces, Moises; Abilleira, Sonia; Martin-Fabregas, Joan			Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; WHITE-MATTER LESIONS; INTRACEREBRAL HEMORRHAGE; CEREBRAL MICROBLEEDS; SAFE IMPLEMENTATION; THERAPY; CLASSIFICATION; PATHOGENESIS	Background and purpose Remote parenchymal haemorrhage (rPH) after intravenous thrombolysis is defined as hemorrhages that appear in brain regions without visible ischemic damage, remote from the area of ischemia causing the initial stroke symptom. The pathophysiology of rPH is not clear and may be explained by different underlying mechanisms. We hypothesized that rPH may have different risk factors according to the bleeding location. We report the variables that we found associated with deep and lobar rPH after intravenous thrombolysis. Methods This is a descriptive study of patients with ischemic stroke who were treated with intravenous thrombolysis. These patients were included in a multicenter prospective registry. We collected demographic, clinical and radiological data. We evaluated the number and distribution of cerebral microbleeds (CMB) from Magnetic Resonance Imaging. We excluded patients treated endovascularly, patients with parenchymal hemorrhage without concomitant rPH and stroke mimics. We compared the variables from patients with deep or lobar rPH with those with no intracranial hemorrhage. Results We studied 934 patients (mean age 73.9 +/- 12.6 years) and 52.8% were men. We observed rPH in 34 patients (3.6%); 9 (0.9%) were deep and 25 (2.7%) lobar. No hemorrhage was observed in 900 (96.6%) patients. Deep rPH were associated with hypertensive episodes within first 24 hours after intravenous thrombolysis (77.7% vs 23.3%, p<0.001). Lobar rPH were associated with the presence of CMB (53.8% vs 7.9%, p<0.001), multiple (>1) CMB (30.7% vs 4.4%, p = 0.003), lobar CMB (53.8% vs 3.0%, p<0.001) and severe leukoaraiosis (76.9% vs 42%, p = 0.02). Conclusions A high blood pressure within the first 24 hours after intravenous thrombolysis is associated with deep rPH, whereas lobar rPH are associated with imaging markers of amyloid deposition. Thus, our results suggest that deep and lobar rPH after intravenous thrombolysis may have different mechanisms.	[Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Delgado-Mederos, Raquel; Guisado-Alonso, Daniel; Marin, Rebeca; Martin-Fabregas, Joan] Hosp Santa Creu & Sant Pau, Serv Neurol, Biomed Res Inst, IIB St Pau, Barcelona, Spain; [Dorado, Laura] Hosp Badalona Germans Trias & Pujol, Dept Neurol, Badalona, Spain; [Rudilosso, Salvatore] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain; [Gomez-Gonzalez, Alejandra] Hosp del Mar, Dept Neurol, Barcelona, Spain; [Purroy, Francisco] Hosp Arnau Vilanova, Dept Neurol, Lleida, Spain; [Gomez-Choco, Manuel] Hosp Moises Broggi, Dept Neurol, St Joan Desp, Spain; [Canovas, David] Hosp Univ Sabadell Corp Sanitaria Parc Taul, Dept Neurol, Sabadell, Spain; [Cocho, Dolores] Univ Granollers, Hosp Gen, Dept Neurol, Granollers, Spain; [Garces, Moises] Hosp Verge de la Cinta, Dept Neurol, Tortosa, Spain; [Abilleira, Sonia] Stroke Programme Agcy Hlth Qual & Assessment Cata, Barcelona, Spain; [Martin-Fabregas, Joan] Univ Autonoma Barcelona, Med Dept, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University Hospital Arnau de Vilanova; Autonomous University of Barcelona	Prats-Sanchez, L (corresponding author), Hosp Santa Creu & Sant Pau, Serv Neurol, Biomed Res Inst, IIB St Pau, Barcelona, Spain.	lpratss@santpau.cat	Purroy, Francisco/D-4538-2009; Gomez-Choco, Manuel/AAA-1958-2021; Rudilosso, Salvatore/B-9265-2018; Guisado-Alonso, Daniel/F-3399-2018	Purroy, Francisco/0000-0002-1808-5968; Gomez-Choco, Manuel/0000-0002-4191-7574; Rudilosso, Salvatore/0000-0002-8775-6884; Martinez-Domeno, Alejandro/0000-0002-9933-3192; Marti-Fabregas, Joan/0000-0001-9229-8649; Cocho, Dolores/0000-0003-2151-6068; Prats Sanchez, Luis Antonio/0000-0002-3192-4631; Abilleira, Sonia/0000-0002-5587-128X; Guisado-Alonso, Daniel/0000-0002-5799-3184; CAMPS-RENOM, POL/0000-0001-6587-6271; GARCES REDONDO, MOISES/0000-0002-1756-5492	Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS [RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by Ministery of Health-Institute de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS RD012/0014, FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, STROKE, V40, P2442, DOI 10.1161/STROKEAHA.109.548602; Charidimou A, 2015, NEUROLOGY, V85, P927, DOI 10.1212/WNL.0000000000001923; Charidimou A, 2015, BRAIN, V138, P2126, DOI 10.1093/brain/awv162; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Craig SAA, ENHANCED CONTROL HYP; Curtze S, 2016, ANN NEUROL, V80, P593, DOI 10.1002/ana.24760; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kidwell CS, 2002, STROKE, V33, P95, DOI 10.1161/hs0102.101792; Kimura K, 2013, STROKE, V44, P2776, DOI 10.1161/STROKEAHA.113.001778; Ly JV, 2010, ANN NEUROL, V68, P959, DOI 10.1002/ana.22072; Marti-Fabregas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156992; Matosevic B, 2013, NEUROLOGY, V80, P1216, DOI 10.1212/WNL.0b013e3182897015; Mazya MV, 2014, STROKE, V45, P1657, DOI 10.1161/STROKEAHA.114.004923; Meretoja A, 2012, STROKE, V43, P2592, DOI 10.1161/STROKEAHA.112.661603; Pantoni L, 2014, CEREBROVASC DIS, V37, P5, DOI 10.1159/000356796; Prats-Sanchez L, 2016, STROKE, V47, P2003, DOI 10.1161/STROKEAHA.116.013952; Ruecker M, 2012, NEUROLOGY, V79, P31, DOI 10.1212/WNL.0b013e31825dcdf0; Shoamanesh A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00203; SLOAN MA, 1995, NEUROLOGY, V45, P649, DOI 10.1212/WNL.45.4.649; Trouillas P, 2006, STROKE, V37, P556, DOI 10.1161/01.STR.0000196942.84707.71; Tsivgoulis G, 2016, JAMA NEUROL, V73, P675, DOI 10.1001/jamaneurol.2016.0292	24	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178284	10.1371/journal.pone.0178284	http://dx.doi.org/10.1371/journal.pone.0178284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640874	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800004
J	Yagi, S; Koh, Y; Akamatsu, H; Kanai, K; Hayata, A; Tokudome, N; Akamatsu, K; Endo, K; Nakamura, S; Higuchi, M; Kanbara, H; Nakanishi, M; Ueda, H; Yamamoto, N				Yagi, Satomi; Koh, Yasuhiro; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Endo, Katsuya; Nakamura, Seita; Higuchi, Masayuki; Kanbara, Hisashige; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki			Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients	PLOS ONE			English	Article							BREAST-CANCER; MICROCAVITY ARRAY; BLOOD; EXPRESSION; SURVIVAL	Circulating tumor cells (CTCs), defined as tumor cells circulating in the peripheral blood of patients with solid tumors, are relatively rare. Diagnosis using CTCs is expected to help in the decision-making for precision cancer medicine. We have developed an automated microcavity array (MCA) system to detect CTCs based on the differences in size and deformability between tumor cells and normal blood cells. Herein, we evaluated the system using blood samples from non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) patients. To evaluate the recovery of CTCs, preclinical experiments were performed by spiking NSCLC cell lines (NCI-H820, A549, NCI-H23 and NCI-H441) into peripheral whole blood samples from healthy volunteers. The recovery rates were 70% or more in all cell lines. For clinical evaluation, 6 mL of peripheral blood was collected from 50 patients with advanced lung cancer and from 10 healthy donors. Cells recovered on the filter were stained. We defined CTCs as DAPI-positive, cytokeratin-positive, and CD45-negative cells under the fluorescence microscope. The 50 lung cancer patients had a median age of 72 years (range, 48-85 years); 76% had NSCLC and 20% had SCLC, and 14% were at stage III disease whereas 86% were at stage IV. One or more CTCs were detected in 80% of the lung cancer patients (median 2.5). A comparison of the CellSearch system with our MCA system, using the samples from NSCLC patients, confirmed the superiority of our system (median CTC count, 0 versus 11 for CellSearch versus MCA; p = 0.0001, n = 17). The study results suggest that our MCA system has good clinical potential for diagnosing CTCs in lung cancer.	[Yagi, Satomi; Endo, Katsuya; Nakamura, Seita; Higuchi, Masayuki; Kanbara, Hisashige] Hitachi Chem Co Ltd, Med Business Unit, Ibaraki, Japan; [Yagi, Satomi; Koh, Yasuhiro; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Hitachi Limited; Wakayama Medical University	Koh, Y (corresponding author), Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan.	ykoh@wakayama-med.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED; Hitachi Chemical Co., Ltd.	Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Hitachi Chemical Co., Ltd.	This clinical study was supported by the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) and the Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development, AMED. Hitachi Chemical Co., Ltd. provided support in the form of salaries for authors [SY, KE, SN, MH and HK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33488; Adams DL, 2016, CANCER EPIDEM BIOMAR, V25, P1037, DOI 10.1158/1055-9965.EPI-15-1221; Bednarz-Knoll N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2940; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Koh Y, 2016, EUR J CANCER, V69, pS14, DOI 10.1016/S0959-8049(16)32629-6; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Souza E, 2016, ONCOTARGETS THER, V9, P7503; Stebbing J, 2009, LANCET ONCOL, V10, P1138, DOI 10.1016/S1470-2045(09)70260-8; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; WHO, 2015, CANCER	28	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179744	10.1371/journal.pone.0179744	http://dx.doi.org/10.1371/journal.pone.0179744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640869	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800059
J	Ko, WK; Lee, SH; Kim, SJ; Jo, MJ; Kumar, H; Han, IB; Sohn, S				Ko, Wan-Kyu; Lee, Soo-Hong; Kim, Sung Jun; Jo, Min-Jae; Kumar, Hemant; Han, In-Bo; Sohn, Seil			Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages	PLOS ONE			English	Article							NF-KAPPA-B; CELL VIABILITY; NITRIC-OXIDE; PATHWAYS; KINASE	Purpose The aim of this study was to investigate the anti-inflammatory effects of Ursodeoxycholic acid (UDCA) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Methods We induced an inflammatory process in RAW 264.7 macrophages using LPS. The anti-inflammatory effects of UDCA on LPS-stimulated RAW 264.7 macrophages were analyzed using nitric oxide (NO). Pro-inflammatory and anti-inflammatory cytokines were analyzed by quantitative real time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA). The phosphorylations of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 in mitogen-activated protein kinase (MAPK) signaling pathways and nuclear factor kappa-light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B alpha) signaling pathways were evaluated by western blot assays. Results UDCA decreased the LPS-stimulated release of the inflammatory mediator NO. UDCA also decreased the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin 1-alpha (IL-1 alpha), interleukin 1-beta (IL-1 beta), and interleukin 6 (IL-6) in mRNA and protein levels. In addition, UDCA increased an anti-inflammatory cytokine interleukin 10 (IL-10) in the LPS-stimulated RAW 264.7 macrophages. UDCA inhibited the expression of inflammatory transcription factor nuclear factor kappa B (NF-kappa B) in LPS-stimulated RAW 264.7 macrophages. Furthermore, UDCA suppressed the phosphorylation of ERK, JNK, and p38 signals related to inflammatory pathways. In addition, the phosphorylation of I kappa B alpha, the inhibitor of NF-kappa B, also inhibited by UDCA. Conclusion UDCA inhibits the pro-inflammatory responses by LPS in RAW 264.7 macrophages. UDCA also suppresses the phosphorylation by LPS on ERK, JNK, and p38 in MAPKs and NF-kappa B pathway. These results suggest that UDCA can serve as a useful anti-inflammatory drug.	[Ko, Wan-Kyu; Kim, Sung Jun; Jo, Min-Jae; Kumar, Hemant; Han, In-Bo; Sohn, Seil] CHA Univ, Dept Neurosurg, CHA Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Lee, Soo-Hong] CHA Univ, Dept Biomed Sci, Seongnam Si, Gyeonggi Do, South Korea	Pochon Cha University; Pochon Cha University	Han, IB; Sohn, S (corresponding author), CHA Univ, Dept Neurosurg, CHA Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea.	hanib@cha.ac.kr; sisohn@cha.ac.kr	Kumar, Hemant/G-4576-2018	Kumar, Hemant/0000-0002-6434-0245	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and future Planning [NRF-2016M3A9E8941668]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and future Planning	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/index) funded by the Ministry of Science, Information & Communication Technology (ICT) and future Planning (NRF-2016M3A9E8941668). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aupperle KR, 1999, J IMMUNOL, V163, P427; BACHRACH WH, 1982, DIGEST DIS SCI, V27, P737, DOI 10.1007/BF01393771; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Chen HG, 2013, INT J SURG, V11, P1060, DOI 10.1016/j.ijsu.2013.10.007; Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gomez-Zorrilla S, 2016, MICROB DRUG RESIST; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Iwasawa A, 2013, REGUL TOXICOL PHARM, V66, P177, DOI 10.1016/j.yrtph.2013.03.014; Joo SS, 2003, ARCH PHARM RES, V26, P1067, DOI 10.1007/BF02994760; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kim HR, 2015, MOL IMMUNOL, V63, P355, DOI 10.1016/j.molimm.2014.09.003; Kullmann F, 1997, Z GASTROENTEROL, V35, P171; Lee CJ, 2010, SHOCK, V33, P93, DOI 10.1097/SHK.0b013e3181a6eaf5; LEUSCHNER U, 1989, GASTROENTEROLOGY, V97, P1268, DOI 10.1016/0016-5085(89)91698-3; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ma CH, 2015, J ETHNOPHARMACOL, V168, P349, DOI 10.1016/j.jep.2015.03.068; Manzi S, 2000, ANN RHEUM DIS, V59, P321, DOI 10.1136/ard.59.5.321; Newton K., 2012, COLD SPRING HARB PER, V4; Parameswaran N., 2010, CRITICAL REV EUKARYO, V20; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; RYAN GB, 1977, AM J PATHOL, V86, P183; Salhanick MA, 2016, SHOCK, V46, P144, DOI 10.1097/SHK.0000000000000609; Shi KQ, 2012, MOL BIOL REP, V39, P9715, DOI 10.1007/s11033-012-1836-0; Sorensen NS, 2011, VET IMMUNOL IMMUNOP, V139, P296, DOI 10.1016/j.vetimm.2010.10.016; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Xu ZY, 2008, BIOCHEM ENG J, V41, P280, DOI 10.1016/j.bej.2008.05.019	32	57	60	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180673	10.1371/journal.pone.0180673	http://dx.doi.org/10.1371/journal.pone.0180673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665991	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700023
J	Yamamoto, K; Kawai-Toyooka, H; Hamaji, T; Tsuchikane, Y; Mori, T; Takahashi, F; Sekimoto, H; Ferris, PJ; Nozaki, H				Yamamoto, Kayoko; Kawai-Toyooka, Hiroko; Hamaji, Takashi; Tsuchikane, Yuki; Mori, Toshiyuki; Takahashi, Fumio; Sekimoto, Hiroyuki; Ferris, Patrick J.; Nozaki, Hisayoshi			Molecular evolutionary analysis of a gender-limited MID ortholog from the homothallic species Volvox africanus with male and monoecious spheroids	PLOS ONE			English	Article							MATING-TYPE LOCUS; PHYLOGENETIC ANALYSIS; CHLAMYDOMONAS; CHLOROPHYTA; VOLVOCALES	Volvox is a very interesting oogamous organism that exhibits various types of sexuality and/or sexual spheroids depending upon species or strains. However, molecular bases of such sexual reproduction characteristics have not been studied in this genus. In the model species V. carteri, an ortholog of the minus mating type-determining or minus dominance gene (MID) of isogamous Chlamydomonas reinhardtii is male-specific and determines the sperm formation. Male and female genders are genetically determined (heterothallism) in V. carteri, whereas in several other species of Volvox both male and female gametes (sperm and eggs) are formed within the same clonal culture (homothallism). To resolve the molecular basis of the evolution of Volvox species with monoecious spheroids, we here describe a MID ortholog in the homothallic species V. africanus that produces both monoecious and male spheroids within a single clonal culture. Comparison of synonymous and nonsynonymous nucleotide substitutions in MID genes between V. africanus and heterothallic volvocacean species suggests that the MID gene of V. africanus evolved under the same degree of functional constraint as those of the heterothallic species. Based on semi quantitative reverse transcription polymerase chain reaction analyses using the asexual, male and monoecious spheroids isolated from a sexually induced V. africanus culture, the MID mRNA level was significantly upregulated in the male spheroids, but suppressed in the monoecious spheroids. These results suggest that the monoecious spheroid-specific down regulation of gene expression of the MID homolog correlates with the formation of both eggs and sperm in the same spheroid in V. africanus.	[Yamamoto, Kayoko; Kawai-Toyooka, Hiroko; Hamaji, Takashi; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Tsuchikane, Yuki; Sekimoto, Hiroyuki] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo, Japan; [Mori, Toshiyuki] Juntendo Univ, Sch Med, Dept Trop Med & Parasitol, Bunkyo Ku, Tokyo, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Ferris, Patrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	University of Tokyo; Japan Womens University; Juntendo University; Ritsumeikan University; University of Arizona	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Mori, Toshiyuki/F-8488-2013	Sekimoto, Hiroyuki/0000-0002-7362-2324; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498; Tsuchikane, Yuki/0000-0002-2316-1574	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [15K14590, 16H02518]; National Aeronautics and Space Administration [NNX13AH41G]; National Science Foundation [MCB-1412395]; Grants-in-Aid for Scientific Research [15H05237] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TH and HN were supported by Grants-in-Aid for Scientific Research (grant numbers 16H06734, 15K14590 and 16H02518) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/). PJF was supported by the National Aeronautics and Space Administration (https://www.usa.gov/federal-agencies/national-aeronautics-and-space-administration; grant number NNX13AH41G) and the National Science Foundation (https://www.nsf.gov/;; grant number MCB-1412395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Coleman AW, 1999, P NATL ACAD SCI USA, V96, P13892, DOI 10.1073/pnas.96.24.13892; EBERSOLD WT, 1967, SCIENCE, V157, P447, DOI 10.1126/science.157.3787.447; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 1997, GENETICS, V146, P859; FERRIS PJ, 1994, CELL, V76, P1135, DOI 10.1016/0092-8674(94)90389-1; Geng S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001904; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2016, G3-GENES GENOM GENET, V6, P1179, DOI 10.1534/g3.115.026229; Hamaji T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064385; Hiraide R, 2013, MOL BIOL EVOL, V30, P1038, DOI 10.1093/molbev/mst018; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kianianmomeni A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1117; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Nakada T, 2007, EUR J PHYCOL, V42, P177, DOI 10.1080/09670260601145816; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Nozaki H, 1997, J PHYCOL, V33, P864, DOI 10.1111/j.0022-3646.1997.00864.x; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; NOZAKI H, 1983, BOT MAG TOKYO, V96, P103, DOI 10.1007/BF02491095; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142632; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Starr RC, 1971, SEXUAL REPROD VOLVOX, P59; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180313	10.1371/journal.pone.0180313	http://dx.doi.org/10.1371/journal.pone.0180313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665990	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700083
J	Hartmann, AM; Pisella, LI; Medina, I; Nothwang, HG				Hartmann, Anna-Maria; Pisella, Lucie I.; Medina, Igor; Nothwang, Hans Gerd			Molecular cloning and biochemical characterization of two cation chloride cotransporter subfamily members of Hydra vulgaris	PLOS ONE			English	Article							K-CL COTRANSPORTER; FUNCTIONAL EXPRESSION; INTRACELLULAR CHLORIDE; SEQUENCE ALIGNMENT; TRANSPORT ACTIVITY; KCC2; IDENTIFICATION; MUTATIONS; TOPOLOGY; BINDING	Cation Chloride Cotransporters (CCCs) comprise secondary active membrane proteins mainly mediating the symport of cations (Na+, K+) coupled with chloride (CI-). They are divided into K+-CI- outward transporters (KCCs), the Natr-Cl- (NKCCs) and Na+Cl-(NCCs) inward transporters, the cation chloride cotransporter interacting protein CIP1, and the polyamine transporter CCC9. KCCs and N(K)CCs are established in the genome since eukaryotes and metazoans, respectively. Most of the physiological and functional data were obtained from vertebrate species. To get insights into the basal functional properties of KCCs and N(K)CCs in the metazoan lineage, we cloned and characterized KCC and N(K) CC from the cnidarian Hydra vulgaris. HvKCC is composed of 1,032 amino-acid residues. Functional analyses revealed that hvKCC mediates a Natindependent, Cl- and K+ (TI+) dependent cotransport. The classification of hvKCC as a functional K-CI cotransporter is furthermore supported by phylogenetic analyses and a similar structural organization. Interestingly, recently obtained physiological analyses indicate a role of cnidarian KCCs in hyposmotic volume regulation of nematocytes. HvN(K)CC is composed of 965 amino-acid residues. Phylogenetic analyses and structural organization suggest that hvN(K)CC is a member of the N(K)CC subfamily. However, no inorganic ion cotransport function could be detected using different buffer conditions. Thus, hvN(K)CC is a N(K)CC subfamily member without a detectable inorganic ion cotransporter function. Taken together, the data identify two non-bilaterian solute carrier 12 (SLC12) gene family members, thereby paving the way for a better understanding of the evolutionary paths of this important cotransporter family.	[Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Oldenburg, Germany; [Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, Oldenburg, Germany; [Pisella, Lucie I.; Medina, Igor] INSERM, Unite 901, INMED, Marseille, France; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4All, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Oldenburg, Germany.; Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, Oldenburg, Germany.	anna.maria.hartmann@uol.de	; Medina, Igor/O-5532-2016	Nothwang, Hans Gerd/0000-0001-7695-6437; Medina, Igor/0000-0001-6839-5414	Deutsche Forschungsgemeinschaft [HA 6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge the excellent technical support by M. Reents. We thank Daniel Drees for his help in initial experiments. This work was supported by the Deutsche Forschungsgemeinschaft (grant HA 6338/2-1 to AMH), httpligepris.dfg.deigeprisiprotekt/222358325.	Antrobus SP, 2012, AM J PHYSIOL-CELL PH, V303, pC1180, DOI 10.1152/ajpcell.00274.2012; Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Arosio D, 2010, NAT METHODS, V7, P516, DOI [10.1038/nmeth.1471, 10.1038/NMETH.1471]; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Carmosino M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-16; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Doding A, 2012, BIOCHEM BIOPH RES CO, V420, P492, DOI 10.1016/j.bbrc.2012.02.147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedel P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00007; Gagnon E, 2005, AM J PHYSIOL-CELL PH, V290, P134; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gerelsaikhan T, 2006, BIOCHEMISTRY-US, V45, P12060, DOI 10.1021/bi061126x; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann A-M, 2014, MOL BIOL EVOLUTION; Hartmann A-M, 2014, FRONTIERS CELLULAR N, V8; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Holtzman EJ, 1998, AM J PHYSIOL-RENAL, V275, pF550, DOI 10.1152/ajprenal.1998.275.4.F550; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2014, EMBO REPORTS; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2014, EMBO REPORTS; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Lauf PK, 2006, EXP EYE RES, V82, P55, DOI 10.1016/j.exer.2005.05.002; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lemonnier E, 2010, ACTA PAEDIATR, V99, P1885, DOI 10.1111/j.1651-2227.2010.01933.x; Lichtarge O, 2002, CURR OPIN STRUC BIOL, V12, P21, DOI 10.1016/S0959-440X(02)00284-1; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Marino A, 2010, CELL PHYSIOL BIOCHEM, V26, P209, DOI 10.1159/000320529; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Payne JA, 1997, AJP CELL PHYSL, V273; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Puskarjov M, 2014, NEUROPHARMACOLOGY; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Raimondo JV, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00202; Rambaut A, 2009, FIGTREE V1 3 1 COMPU; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Sun QF, 2010, AM J PHYSIOL-CELL PH, V298, pC26, DOI 10.1152/ajpcell.00376.2009; Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Warmuth S, 2009, STRUCTURE, V17, P538, DOI 10.1016/j.str.2009.02.009; Weber M, 2014, J BIOL CHEM; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	86	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179968	10.1371/journal.pone.0179968	http://dx.doi.org/10.1371/journal.pone.0179968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662098	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000404608300081
J	Jin, LQ; Ling, MZ; Yue, WQ				Jin, Li-Qiang; Ling, Mingze; Yue, Weiqiang			Tire-road friction estimation and traction control strategy for motorized electric vehicle	PLOS ONE			English	Review							LITHIUM-ION BATTERY; ULTRACAPACITOR; SYSTEM	In this paper, an optimal longitudinal slip ratio system for real-time identification of electric vehicle (EV) with motored wheels is proposed based on the adhesion between tire and road surface. First and foremost, the optimal longitudinal slip rate torque control can be identified in real time by calculating the derivative and slip rate of the adhesion coefficient. Secondly, the vehicle speed estimation method is also brought. Thirdly, an ideal vehicle simulation model is proposed to verify the algorithm with simulation, and we find that the slip ratio corresponds to the detection of the adhesion limit in real time. Finally, the proposed strategy is applied to traction control system (TCS). The results showed that the method can effectively identify the state of wheel and calculate the optimal slip ratio without wheel speed sensor; in the meantime, it can improve the accelerated stability of electric vehicle with traction control system (TCS).	[Jin, Li-Qiang; Ling, Mingze; Yue, Weiqiang] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China	Jilin University	Jin, LQ (corresponding author), Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China.	jinlq@jlu.edu.cn			China Postdoctoral Science Foundation [2013M540248]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Professor Li-Qiang Jin received support from China Postdoctoral Science Foundation (2013M540248). The funder had a role in study design, analysis and decision to publish the manuscript.	Astrom KJ, 2001, CONTROL ENG PRACT, V9, P1163, DOI 10.1016/S0967-0661(01)00062-4; Boyraz P, 2013, IEEE INT VEH SYM, P1330; Cirovic V, 2013, MECHATRONICS, V23, P135, DOI 10.1016/j.mechatronics.2012.11.007; Gustafsson F, 1998, IEEE CONTR SYST MAG, V18, P42, DOI 10.1109/37.710877; Hu X., 2015, IEEE T IND ELECTRON, V62, P1; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2011, P AMER CONTR CONF, P935; Kataoka H, 2001, ELECTR ENG JPN, V135, P56, DOI 10.1002/eej.1033; Khatun P, 2003, IEEE T VEH TECHNOL, V52, P1356, DOI 10.1109/TVT.2003.815922; Li HZ, 2012, CHIN J MECH ENG-EN, V25, P1130, DOI 10.3901/CJME.2012.06.1130; Li L, 2015, MECH SYST SIGNAL PR, V56-57, P259, DOI 10.1016/j.ymssp.2014.10.006; Li Lianbing, 2004, ANTISLIP CONTROL EV; Okano Takahiro, 2002, P PCC OSAKA 2002 OSA, V4, P2; Ono Eiichi, DENSO TECHNICAL REV, V9; Sawada Mamoru, DENSO TECHNICAL REV, V9; Student C. L., VEHICLE SYSTEM DY S1, V25, P413; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Svendenius Jacob, 2003, REV WHEEL MODELING F, P16; Umeno T., SAE 2002 WORLD C EXH; Umeno T., ESTIMATION TIRE ROAD; Umeno Takaji, R D REV TOYOTA CRDL, V37; VanZanten Anton T., 1996, 3 INT S ADV VEH CONT, P573; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204	25	7	8	14	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179526	10.1371/journal.pone.0179526	http://dx.doi.org/10.1371/journal.pone.0179526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662053	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300029
J	Kanamori, H; Nakade, Y; Yamauchi, T; Sakamoto, K; Inoue, T; Yamamoto, T; Kobayashi, Y; Ishii, N; Ohashi, T; Ito, K; Sumida, Y; Nakao, H; Fukuzawa, Y; Yoneda, M				Kanamori, Hiroyuki; Nakade, Yukiomi; Yamauchi, Taeko; Sakamoto, Kazumasa; Inoue, Tadahisa; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Ito, Kiyoaki; Sumida, Yoshio; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Yoneda, Masashi			Influence of nicotine on choline-deficient, L amino acid-defined diet-induced non-alcoholic steatohepatitis in rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BODY-WEIGHT; EXPRESSION; OBESITY; MICE; CONSUMPTION; PROTEIN-1; APOPTOSIS	Nicotine, a major compound in cigarette smoke, decreases food intake and body weight gain in mammals; however, the influence of nicotine on the progression of non-alcoholic steatohepatitis (NASH) remains controversial. This study aimed to investigate the effect of nicotine on NASH in rat models. Male Wistar rats were fed choline-deficient, L-amino acid defined (CDAA) diet and treated with nicotine or saline. Food intake, body weight gain, presence of hepatic steatosis, inflammation, and fibrosis were assessed 6 weeks after the rats were fed CDAA diet. Hepatic branch vagotomy was performed to elucidate the mechanism through which nicotine affected steatohepatitis. CDAA diet induced hepatic steatosis, inflammation, and fibrosis, as well as increased the expression of inflammation-related genes. Conversely, nicotine significantly attenuated food intake, body weight gain, and inhibited the CDAA-diet-induced hepatic steatosis, inflammation, and fibrosis, together with increased expression of inflammation-related genes. Hepatic branch vagotomy by itself decreased food intake, body weight gain, and attenuated the CDAA-diet-induced hepatic steatosis, but not inflammation. However, nicotine did not change the food intake, body weight gain, and CDAA diet-induced hepatic steatosis and inflammation in vagotomized rats. These results suggest that nicotine attenuates the CDAA-diet-induced hepatic steatosis and inflammation through the hepatic branch of the vagus nerve in rats.	[Kanamori, Hiroyuki; Nakade, Yukiomi; Yamauchi, Taeko; Sakamoto, Kazumasa; Inoue, Tadahisa; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Ito, Kiyoaki; Sumida, Yoshio; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan	Aichi Medical University	Nakade, Y (corresponding author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan.	ynakade@aichi-med-u.ac.jp	Inoue, Tadahisa/AFK-7576-2022; Sumida, Yoshio/AAL-6723-2020	Inoue, Tadahisa/0000-0003-0718-9099; 	Smoking Research Foundation (Japan); Program for the Strategic Research Foundation at Private Universities [S1101027]	Smoking Research Foundation (Japan); Program for the Strategic Research Foundation at Private Universities	This work was supported by the Smoking Research Foundation (Japan), and by the Program for the Strategic Research Foundation at Private Universities (S1101027) to MY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, AM J PHYSIOL-ENDOC M, V280, pE867, DOI 10.1152/ajpendo.2001.280.6.E867; BARTER PJ, 1973, METABOLISM, V22, P779, DOI 10.1016/0026-0495(73)90048-6; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Friedman TC, 2012, ENDOCRINOLOGY, V153, P5809, DOI 10.1210/en.2012-1750; GHOSHAL AK, 1983, AM J PATHOL, V113, P309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GRUNBERG NE, 1984, PSYCHOPHARMACOLOGY, V83, P93, DOI 10.1007/BF00427430; Hashimoto T, 2004, TOXICOL APPL PHARM, V196, P1, DOI 10.1016/j.taap.2003.09.004; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; LEVIN ED, 1987, PHYSIOL BEHAV, V39, P441, DOI 10.1016/0031-9384(87)90370-2; Liu RH, 2003, EUR J PHARMACOL, V458, P227, DOI 10.1016/S0014-2999(02)02726-7; Mangubat M, 2012, J ENDOCRINOL, V212, P317, DOI 10.1530/JOE-11-0350; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Nakae D, 1999, PATHOL INT, V49, P1028, DOI 10.1046/j.1440-1827.1999.00990.x; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; NIIJIMA A, 1983, AM J PHYSIOL, V244, pR611, DOI 10.1152/ajpregu.1983.244.5.R611; Niijima A, 2001, AUTON NEUROSCI-BASIC, V93, P48, DOI 10.1016/S1566-0702(01)00328-9; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Seoane-Collazo P, 2014, ENDOCRINOLOGY, V155, P1679, DOI 10.1210/en.2013-1839; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wasada T, 2008, METABOLISM, V57, P980, DOI 10.1016/j.metabol.2008.02.015; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yoneda M, 2001, J GASTROENTEROL, V36, P361, DOI 10.1007/s005350170079; YUEN ST, 1995, PHARMACOL TOXICOL, V77, P225, DOI 10.1111/j.1600-0773.1995.tb01017.x	34	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180475	10.1371/journal.pone.0180475	http://dx.doi.org/10.1371/journal.pone.0180475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662136	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300160
J	Nygaard, UC; Li, ZG; Palys, T; Jackson, B; Subbiah, M; Malipatlolla, M; Sampath, V; Maecker, H; Karagas, MR; Nadeau, KC				Nygaard, Unni C.; Li, Zhigang; Palys, Thomas; Jackson, Brian; Subbiah, Melanie; Malipatlolla, Meena; Sampath, Vanitha; Maecker, Holden; Karagas, Margaret R.; Nadeau, Kari C.			Cord blood T cell subpopulations and associations with maternal cadmium and arsenic exposures	PLOS ONE			English	Article							OXIDATIVE STRESS; IMMUNE; POPULATION; EXPRESSION; INFECTION	Background Arsenic and cadmium are environmental pollutants, and although the evidence for adverse immune effects after prenatal arsenic and cadmium exposures is increasing, little is known about the underlying immunological mechanisms. Methods We investigated the relationship between prenatal arsenic and cadmium exposures and a variety of T cell subpopulations measured in cord blood for 63 participants in the New Hampshire Birth Cohort Study. Post-partum toenail concentrations of arsenic and cadmium were used as an estimate of maternal exposure during pregnancy. The characteristics of cord blood proportions of T lymphocytes and subpopulations (expression of markers for Th1, Th2, Th17, Th1Th17, induced and natural regulatory T cells and NKTs) are presented. Results In regression analyses, maternal arsenic exposure levels were inversely associated with cord blood T helper memory cells (-21%, 95% CI: -36%, -3%) and the association was found to be stronger in females. They were also inversely associated with activated T helper memory cells, particularly in males (-26%, 95% CI: -43%, -3%). Similarly, inverse associations were observed between cadmium exposure levels and activated T helper memory cells (-16%, 95% CI: -30%, -1%) and also for T helper memory cells in females (-20%, 95% CI: -35%, -3%). Conclusion The results suggest that prenatal exposures to relatively low levels of arsenic and cadmium may contribute to altered distribution of T cell populations at birth. These changes in theory, could have contributed to the previously reported immunosuppressive effects observed later in infancy/childhood.	[Nygaard, Unni C.; Sampath, Vanitha; Nadeau, Kari C.] Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA; [Nygaard, Unni C.; Sampath, Vanitha; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA; [Nygaard, Unni C.] Norwegian Inst Publ Hlth, Dept Toxicol & Risk Assessment, Oslo, Norway; [Li, Zhigang; Palys, Thomas; Jackson, Brian; Subbiah, Melanie; Karagas, Margaret R.] Childrens Environm Hlth & Dis Prevent Res Ctr Dar, Lebanon, NH USA; [Malipatlolla, Meena; Maecker, Holden] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA	Stanford University; Stanford University; Norwegian Institute of Public Health (NIPH); Stanford University	Nadeau, KC (corresponding author), Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA.; Nadeau, KC (corresponding author), Stanford Univ, Dept Pediat, Sean N Parker Ctr Allergy & Asthma Res,Sch Med, Div Pulm & Crit Care,Div Immunol Allergy & Rheuma, Stanford, CA 94305 USA.	knadeau@stanford.edu			National Institute of Environmental Health Sciences (NIEHS) [P01ES022832, R21ES020936]; US National Institutes of Health (NIH); US Environmental Protection Agency (EPA) [RD83544201]; National Center for Research Resources (NCRR) [P20GM104416]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants P01ES022832 and R21ES020936 by the National Institute of Environmental Health Sciences (NIEHS), US National Institutes of Health (NIH) and RD83544201 from the US Environmental Protection Agency (EPA). Additional laboratory support was provided by the Center of Molecular Epidemiology through grant P20GM104416 from National Center for Research Resources (NCRR), Centers of Biomedical Research Excellence (COBRE) program	Abdul KSM, 2015, ENVIRON TOXICOL PHAR, V40, P828, DOI 10.1016/j.etap.2015.09.016; Agency for Toxic Substances and Disease Registry, 2016, PRIOR LIST HAX SUBST; Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Cottingham KL, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-149; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; Davis MA, 2014, J EXPO SCI ENV EPID, V24, P467, DOI 10.1038/jes.2014.38; Duan XX, 2015, INT IMMUNOPHARMACOL, V28, P1059, DOI 10.1016/j.intimp.2015.08.025; Fabrigar L. R., 2012, EXPLORATORY FACTOR A; Farzan SF, 2016, ENVIRON HEALTH PERSP, V124, P840, DOI 10.1289/ehp.1409282; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Ferrario Daniele, 2016, Curr Environ Health Rep, V3, P1, DOI 10.1007/s40572-016-0082-3; Ferrario D, 2009, TOXICOLOGY, V260, P132, DOI 10.1016/j.tox.2009.03.019; Fragiadakis GK, 2016, J IMMUNOL, V197, P4482, DOI 10.4049/jimmunol.1601195; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Hall BM, 2015, CLIN J AM SOC NEPHRO, V10, P2050, DOI 10.2215/CJN.06620714; Hanson ML, 2010, TOXICOL APPL PHARM, V242, P136, DOI 10.1016/j.taap.2009.09.023; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Karagas MR, 2000, AM J EPIDEMIOL, V152, P84, DOI 10.1093/aje/152.1.84; Lappalainen M, 2009, PEDIAT ALLERG IMM-UK, V20, P714, DOI 10.1111/j.1399-3038.2009.00865.x; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pillet S, 2005, TOXICOLOGY, V209, P289, DOI 10.1016/j.tox.2004.12.007; Pillet S, 2006, TOXICOL SCI, V92, P423, DOI 10.1093/toxsci/kfl005; Rager JE, 2014, ENVIRON MOL MUTAGEN, V55, P196, DOI 10.1002/em.21842; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Ritz B, 1998, ARCH ENVIRON HEALTH, V53, P272, DOI 10.1080/00039899809605708; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; SIMONET M, 1984, IMMUNOLOGY, V53, P155; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; WHO, 2011, GUID DRINK WAT QUAL; Wienecke J, 2012, PLACENTA, V33, P39, DOI 10.1016/j.placenta.2011.10.014	38	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179606	10.1371/journal.pone.0179606	http://dx.doi.org/10.1371/journal.pone.0179606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662050	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000404608300037
J	Wasenius, NS; Grattan, KP; Harvey, ALJ; Barrowman, N; Goldfield, GS; Adamo, KB				Wasenius, Niko S.; Grattan, Kimberly P.; Harvey, Alysha L. J.; Barrowman, Nick; Goldfield, Gary S.; Adamo, Kristi B.			Maternal gestational weight gain and objectively measured physical activity among offspring	PLOS ONE			English	Article							BODY-MASS INDEX; SEDENTARY BEHAVIOR; BIRTH-WEIGHT; INSULIN-RESISTANCE; DIET QUALITY; PREGNANCY; OBESITY; CHILDREN; LEPTIN; LIFE	Objective Animal studies have suggested that maternal weight-related factors during pregnancy can program offspring physical activity in a sex-dependent manner. However, there is limited evidence in humans. The purpose of this study was to investigate the association between maternal gestational weight gain (GWG) and offspring total physical activity (TPA) level and to determine whether these associations are moderated by sex of offspring or maternal pre-pregnancy weight status. Method We studied 56 boys (mean age = 3.7 years, standard deviation (SD) 0.5) and 57 girls (mean age = 3.5 +/- 0.5 years) enrolled in licensed childcare centers. TPA was objectively measured using Actical (R) accelerometers. Information on pre-pregnancy body mass index (BMI), GWG, and other maternal factors were collected with a maternal health questionnaire. Associations between GWG, as a continuous variable or categorically (inadequate, adequate, and excessive), and offspring TPA were analysed using linear mixed models to take into account the intraclass correlation between the clusters (childcare centers). Models were adjusted for gestational age, accelerometer weartime, socioeconomic status, and pre-pregnancy BMI status. Results We found a significant sex interaction (P-value = 0.009). In boys, greater GWG was associated with decreased offspring TPA (beta = -3.2 counts.1000(-1)/d, 95% confidence intervals (CI) = -6.4-0.02, P-value = 0.049). In girls born to mothers categorized as overweight or obese, the association between the GWG and TPA followed an inverted U-shape curve (beta for GWG squared = -0.1 counts.1000(-1)/d, 95% CI = (-0.2 --0.04), P-value = 0.005). In contrast, a U-shaped curve was found in girls born to mothers classified as lean (pre-pregnancy BMI<25 kg/m(2)) (beta for GWG squared = 0.7 counts.1000(-1)/d, 95% CI = 0.2-1.2, P-value = 0.011). In boys, TPA in offspring was higher among women with inadequate GWG compared to adequate GWG (P-value = 0.0137), whereas no significant differences were found in girls (P-value = 0.107). Conclusion Maternal GWG can be an important biological marker of offspring TPA. These findings support the sex-dependent early developmental programming influence of GWG on TPA.	[Wasenius, Niko S.; Grattan, Kimberly P.; Harvey, Alysha L. J.; Adamo, Kristi B.] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada; [Wasenius, Niko S.] Folkhalsan Res Ctr, Helsinki, Finland; [Barrowman, Nick] CHEO RI, Clin Res Unit, Ottawa, ON, Canada; [Goldfield, Gary S.; Adamo, Kristi B.] Hlth Act Living & Obes HALO Res Grp, Ottawa, ON, Canada	University of Ottawa; Folkhalsan Research Center; University of Ottawa; Children's Hospital of Eastern Ontario	Adamo, KB (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.; Adamo, KB (corresponding author), Hlth Act Living & Obes HALO Res Grp, Ottawa, ON, Canada.	kadamo@uottawa.ca	Wasenius, Niko/AAE-8927-2020; Barrowman, Nick/AAL-3166-2020	Wasenius, Niko/0000-0002-9007-6660; Barrowman, Nick/0000-0002-4704-9595; Adamo, Kristi/0000-0001-7925-1889; Goldfield, Gary/0000-0001-6216-7824	Canadian Institutes of Health Research [CIHR-MOP123326]; Yrjo Jahnsson Foundation; Institute of Human Development, Child and Youth Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Yrjo Jahnsson Foundation; Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR))	This study was financially supported by the Canadian Institutes of Health Research (CIHR-MOP123326) (http://www.cihr-irsc.gc.ca/e/193. html). Dr. Wasenius was supported as a postdoctoral fellow by the Yrjo Jahnsson Foundation (http://www.yjs.fi/en/) and Dr.Adamo was supported by a CIHR New Investigator Award from the Institute of Human Development, Child and Youth Health (http://www.cihr-irsc.gc.ca/e/ 8688.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adamo KB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-305; AL Rayyan N, 2014, MOL CELL ENDOCRINOL, V384, P134, DOI 10.1016/j.mce.2014.01.017; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Bacchi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166254; Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012; Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Biro F M, 1999, J Pediatr Adolesc Gynecol, V12, P31, DOI 10.1016/S1083-3188(00)86618-8; Breton C, 2013, J ENDOCRINOL, V216, pR19, DOI 10.1530/JOE-12-0157; Brett KE, 2016, J MATERN-FETAL NEO M, V29, P1399, DOI 10.3109/14767058.2015.1049522; Canadian Society for Exercise Physiology, 2013, CAN SOC EX PHYSL PHY; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colley R., 2012, ACTICAL ACCELEROMETE; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Colley RC, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-54; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Diemert A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1012-y; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; Eclarinal JD, 2016, FASEB J, V30, P2541, DOI 10.1096/fj.201500018R; Eriksson JG, 2014, ANN MED, V46, P434, DOI 10.3109/07853890.2014.919728; Ferraro ZM, 2012, J MATERN-FETAL NEO M, V25, P538, DOI 10.3109/14767058.2011.638953; Forno E, 2014, PEDIATRICS, V134, pE535, DOI 10.1542/peds.2014-0439; Garland T, 2017, PHYSIOL BIOCHEM ZOOL, V90, P1, DOI 10.1086/689775; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gohlke BC, 2006, J PEDIATR ENDOCR MET, V19, P3; Goldfield GS, 2016, AM J PREV MED, V51, P225, DOI 10.1016/j.amepre.2016.03.024; Good DJ, 2015, EXERC SPORT SCI REV, V43, P231, DOI 10.1249/JES.0000000000000057; Guinhouya BC, 2011, INT J PEDIATR OBES, V6, P361, DOI 10.3109/17477166.2011.605896; Hrolfsdottir L, 2015, INT J OBESITY, V39, P671, DOI 10.1038/ijo.2014.179; Institute of Medicine, 2009, COMMITTEE REEXAMINE; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Johnson SA, 2017, J DEV ORIG HLTH DIS, V8, P75, DOI 10.1017/S2040174416000490; Kehoe SH, 2012, J DEV ORIG HLTH DIS, V3, P245, DOI 10.1017/S2040174412000189; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kuzik N, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0642-6; Lagiou P, 2004, EUR J CLIN NUTR, V58, P231, DOI 10.1038/sj.ejcn.1601771; Laraia BA, 2007, PUBLIC HEALTH NUTR, V10, P920, DOI 10.1017/S1368980007657991; Lesseur C, 2014, PSYCHONEUROENDOCRINO, V40, P1, DOI 10.1016/j.psyneuen.2013.10.012; Logan CA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41847; Mamun AA, 2014, OBES REV, V15, P338, DOI 10.1111/obr.12132; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; McClure CK, 2011, OBESITY, V19, P1047, DOI 10.1038/oby.2010.300; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Plagemann A, 2008, J MATERN-FETAL NEO M, V21, P143, DOI 10.1080/14767050801929869; Ridgway CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016125; Shin D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030162; Tikanmaki M, 2017, PEDIAT RES; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Tremblay Mark, 2007, Health Rep, V18 Suppl, P7; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P357, DOI [10.1139/h2012-026, 10.1139/H2012-026, 10.1139/H2012-018, 10.1139/h2012-018]; Tsigga M, 2011, PUBLIC HEALTH NUTR, V14, P290, DOI 10.1017/S1368980010001989; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Wang H, 2015, J NEUROENDOCRINOL, V27, P600, DOI 10.1111/jne.12281; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	57	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180249	10.1371/journal.pone.0180249	http://dx.doi.org/10.1371/journal.pone.0180249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662129	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300131
J	Zhang, T; Bai, YX; Hong, XL; Sun, LW; Liu, YJ				Zhang, Tong; Bai, Yuxuan; Hong, Xiuling; Sun, Liwei; Liu, Yujun			Particulate matter and heavy metal deposition on the leaves of Euonymus japonicus during the East Asian monsoon in Beijing, China	PLOS ONE			English	Article							ATMOSPHERIC PARTICLES; TRACE-ELEMENTS; POLLUTION; AREA; VEGETATION; TREES; PM10; SOIL; ACCUMULATION; INDICATORS	Plants can be effectively used as bio-monitors of environmental pollution. However, how the particulate matter (PM) and heavy metal retention ability of plants changes in different areas with human disturbance along with monsoon has not yet been investigated in urban ecosystems. In this study, we measured the amount of PM and heavy metals such as Ni, Cr, Cu, Pb, and Zn accumulated by the leaves of Euonymus japonicus during the East Asian monsoon from different functional units in Beijing, China. A rinse-and-weigh method developed in our laboratory was used to determine the mass of the PM, and electro-thermal atomic absorption spectrometry was used for heavy metal analysis. We found that the types of functional units had little influence, whereas the monsoon had a significant effect on the deposition of PM: northwest areas during the monsoon had the lowest effect (with 0.005, 0.453, 0.643, and 1.569 g/m(2) fine, coarse, large, and total PM, respectively), and the southeast areas during the monsoon had the highest effect (0.015, 2.687, 1.941, and 4.228 g/m(2) for fine, coarse, large, and total PM, respectively). Notable, we found considerable variations in heavy metal accumulation across the functional units analyzed, that is, the accumulation level was higher in communities than in parks (P < 0.0001 for all heavy metals). Moreover, a positive relationship was found between PM retention and heavy metal accumulation by the leaves of E. japonicus. Taken together, our results suggested that the PM and heavy metal retention ability of E. japonicus was sensitive to human disturbance and monsoon in Beijing. Since E. japonicus is a widely distributed tree and has the ability of to purify the atmosphere, it is an ideal plant for mitigating urban environmental pollution.	[Zhang, Tong; Hong, Xiuling; Sun, Liwei; Liu, Yujun] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Bai, Yuxuan] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, LW; Liu, YJ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China.	lsun2013@bjfu.edu.cn; yjliubio@bjfu.edu.cn	Liu, Yujun/H-3661-2015; Bai, Yuxuan/ABB-6460-2020	Liu, Yujun/0000-0001-6588-3359; 	China Special Fund for Forestry Research [201304301]	China Special Fund for Forestry Research	This research was supported by the China Special Fund for Forestry Research in the Public Interest (Grant No. 201304301).	BAIDOURELA A, 2015, NAT ENVIRON POLLUT T, V14, P53; Chang Y, 2015, CHINESE LANDSCAPE AR, V1; [程念亮 Cheng Nianliang], 2015, [环境科学研究, Research of Environmental Sciences], V28, P163; [戴斯迪 Dai Sidi], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P154; Dao Xu, 2015, Huanjing Huaxue-Environmental Chemistry, V34, P60, DOI 10.7524/j.issn.0254-6108.2015.01.2014032603; DMUCHOWSKI W, 1995, ENVIRON POLLUT, V87, P87, DOI 10.1016/S0269-7491(99)80012-8; Dreher KL, 1997, J TOXICOL ENV HEALTH, V50, P285, DOI 10.1080/009841097160492; Espinosa AJF, 2006, CHEMOSPHERE, V62, P1665, DOI 10.1016/j.chemosphere.2005.06.038; Gratani L, 2008, ATMOS ENVIRON, V42, P8273, DOI 10.1016/j.atmosenv.2008.07.032; Hong XiuLing, 2015, Journal of Beijing Forestry University, V37, P147; Jamil S, 2009, LANDSCAPE URBAN PLAN, V92, P136, DOI 10.1016/j.landurbplan.2009.04.002; Ji DS, 2012, ATMOS ENVIRON, V50, P338, DOI 10.1016/j.atmosenv.2011.11.053; Kabata-Pendias A., 2011, TRACE ELEMENTS SOILS, DOI [10.1201/9781420039900, 10.1201/b10158-25, DOI 10.1201/B10158-25]; KIM ND, 1994, ENVIRON POLLUT, V86, P89, DOI 10.1016/0269-7491(94)90010-8; Kozlov MV, 2000, ENVIRON POLLUT, V107, P413, DOI 10.1016/S0269-7491(99)00159-1; Kulizhskiy S, 2014, PROCED EARTH PLAN SC, V10, P399, DOI 10.1016/j.proeps.2014.08.071; Li Q, 2015, INT J CLIMATOL; Li Q, 2016, INT J CLIMATOL, V36, P346, DOI 10.1002/joc.4350; [李永杰 LI Yong-jie], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P257; Liang S, 2011, J NW FORESTRY U, V3; Liu DM, 2005, GEOSCIENCE, V4; Liu Ling, 2013, Huanjing Kexue, V34, P2361; Lorenzini G, 2006, ATMOS ENVIRON, V40, P4025, DOI 10.1016/j.atmosenv.2006.03.032; Maisto G, 2004, GEODERMA, V122, P269, DOI 10.1016/j.geoderma.2004.01.013; Martinez-Lopez S, 2014, J SOIL SEDIMENT, V14, P794, DOI 10.1007/s11368-013-0836-6; Monaci F, 2000, ENVIRON POLLUT, V107, P321, DOI 10.1016/S0269-7491(99)00175-X; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2013, ENVIRON POLLUT, V178, P395, DOI 10.1016/j.envpol.2013.03.050; Pacyna JM., 2001, ENV REV, V9, P269, DOI [10.1139/er-9-4-269, DOI 10.1139/ER-9-4-269, 10.1139/a01-012]; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Przybysz A, 2014, SCI TOTAL ENVIRON, V481, P360, DOI 10.1016/j.scitotenv.2014.02.072; Qiu Y, 2009, CHEMOSPHERE, V75, P447, DOI 10.1016/j.chemosphere.2008.12.061; Rossini Oliva S, 2004, COMMUN SOIL SCI PLAN, V35, P1543, DOI 10.1081/CSS-120038553; Samara C, 2003, ATMOS ENVIRON, V37, P41, DOI 10.1016/S1352-2310(02)00772-0; Samecka-Cymerman A, 2009, TREES-STRUCT FUNCT, V23, P923, DOI 10.1007/s00468-009-0334-z; Sawidis T, 2011, ENVIRON POLLUT, V159, P3560, DOI 10.1016/j.envpol.2011.08.008; Serbula SM, 2012, ECOTOX ENVIRON SAFE, V76, P209, DOI 10.1016/j.ecoenv.2011.10.009; Shi HW, 2010, NO HORTICULTURE; Simon E, 2006, ENVIRON POLLUT, V159, P1229; Song YS, 2015, ATMOS ENVIRON, V105, P53, DOI 10.1016/j.atmosenv.2015.01.032; Speak AF, 2012, ATMOS ENVIRON, V61, P283, DOI 10.1016/j.atmosenv.2012.07.043; Tomasevic M, 2005, CHEMOSPHERE, V61, P753, DOI 10.1016/j.chemosphere.2005.03.077; Tomasevic M., 2010, FU PHYS CHEM TECH, V8, P1, DOI [DOI 10.2298/FUPCT1001001T, 10.2298/FUPCT1001001T]; Vesper DJ, 2003, J HYDROL, V276, P20, DOI 10.1016/S0022-1694(03)00023-4; Voutsa D, 1996, ENVIRON POLLUT, V94, P325, DOI 10.1016/S0269-7491(96)00088-7; Wang LL, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/685971; Wang L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008054; [王晓磊 Wang Xiaolei], 2014, [生态学报, Acta Ecologica Sinica], V34, P1910; Wang Y, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4126-6; [王赞红 Wang Zanhong], 2006, [生态环境, Ecology and Environment], V15, P327; Wannaz ED, 2006, SCI TOTAL ENVIRON, V361, P267, DOI 10.1016/j.scitotenv.2005.11.005; Wei Wang, 2008, J LIAONING NORMAL U, V31, p1~4; Wu GX, 2016, SCI CHINA EARTH SCI, V59, P1, DOI 10.1007/s11430-015-5198-z; Wu Z, 2009, J GEOPHYS RES-ATMOS, V114, P85; Xiong Y, 2004, J CHINESE LANDSCAPE, V4; Zhang L., 2010, J GEOPHYS RES, V115, P2232; Zhang XX, 1997, J BEIJING FORESTRY U, V19, P12; Zhang Y. Y., 2009, TROP GEOGRAPHY, V29, P324; Zhao ST, 2016, J NW FORESTRY U; Zhao XJ, 2013, ATMOS CHEM PHYS, V13, P5685, DOI 10.5194/acp-13-5685-2013; Zhong C, 2008, J AGR U HEBEI, V5; Zhou Z., 2001, ACTA ECOL SIN, V22, P2036	63	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179840	10.1371/journal.pone.0179840	http://dx.doi.org/10.1371/journal.pone.0179840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662081	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300056
J	Amara, S; Majors, C; Roy, B; Hill, S; Rose, KL; Myles, EL; Tiriveedhi, V				Amara, Suneetha; Majors, Ciera; Roy, Bipradas; Hill, Salisha; Rose, Kristie L.; Myles, Elbert L.; Tiriveedhi, Venkataswarup			Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation	PLOS ONE			English	Article							INDUCIBLE KINASE 3; CARDIOVASCULAR-DISEASE; COLLAGEN-V; INFLAMMATION; IDENTIFICATION; ACTIVATION; INHIBITION; EXPRESSION; INDUCTION; PATHWAY	Chronic inflammation is a well-known precursor for cancer development and proliferation. We have recently demonstrated that high salt (NaCI) synergizes with sub-effective interleukin (IL)-17 to induce breast cancer cell proliferation. However, the exact molecular mechanisms mediating this effect are unclear. In our current study, we adopted a phosphoproteomic-based approach to identify salt modulated kinase-proteome specific molecular targets. The phosphoprotemics based binary comparison between heavy labelled MCF-7 cells treated with high salt (Delta 0.05 M NaCI) and light labelled MCF-7 cells cultured under basal conditions demonstrated an enhanced phosphorylation of Serine-493 of SIK3 protein. The mRNA transcript and protein expression analysis of SIK3 in MCF-7 cells demonstrated a synergistic enhancement following co-treatment with high salt and sub-effective IL-17 (0.1 ng/mL), as compared to either treatments alone. A similar increase in SIK3 expression was observed in other breast cancer cell lines, MDA-MB-231, BT20, and AU565, while nonmalignant breast epithelial cell line, MCF10A, did not induce SIK3 expression under similar conditions. Biochemical studies revealed mTORC2 acted as upstream mediator of SIK3 phosphorylation. Importantly, cell cycle analysis by flow cytometry demonstrated SIK3 induced GO/G1-phase release mediated cell proliferation, while SIK3 silencing abolished this effect. Also, SIK3 induced pro-inflammatory arginine metabolism, as evidenced by upregulation of the enzymes iNOS and ASS-1, along with downregulation of anti-inflammatory enzymes, arginase-1 and ornithine decarboxylase. Furthermore, gelatin zymography analysis has demonstrated that SIK3 induced expression of tumor metastatic CXCR4 through MMP-9 activation. Taken together, our data suggests a critical role of SIK3 in mediating three important hallmarks of cancer namely, cell proliferation, inflammation and metastasis. These studies provide a mechanistic basis for the future utilization of SIK3 as a key drug discovery target to improve breast cancer therapy.	[Amara, Suneetha] St Thomas Midtown, Dept Med, Nashville, TN USA; [Majors, Ciera; Roy, Bipradas; Myles, Elbert L.; Tiriveedhi, Venkataswarup] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Hill, Salisha; Rose, Kristie L.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Rose, Kristie L.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Tiriveedhi, Venkataswarup] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA	Tennessee State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Tiriveedhi, V (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.; Tiriveedhi, V (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	vtirivee@tnstate.edu	Roy, Bipradas/AAY-7908-2020	Roy, Bipradas/0000-0001-6472-951X; Tiriveedhi, Venkataswarup/0000-0003-4708-5905	NIH [2U54-CA163066-06-6611]; NATIONAL CANCER INSTITUTE [U54CA163066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant 2U54-CA163066-06-6611 (VT). The funding organization has no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Amara S, 2016, CELL BIOCHEM BIOPHYS, V74, P427, DOI 10.1007/s12013-016-0736-7; Amara S, 2016, ONCOL LETT, V12, P933, DOI 10.3892/ol.2016.4713; Amara S, 2016, CELL IMMUNOL, V302, P1, DOI 10.1016/j.cellimm.2015.12.007; Amara S, 2015, MOL IMMUNOL, V64, P26, DOI 10.1016/j.molimm.2014.10.021; Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Baldo MP, 2015, HEART FAIL REV, V20, P461, DOI 10.1007/s10741-015-9478-7; Berggreen C, 2012, CELL SIGNAL, V24, P1863, DOI 10.1016/j.cellsig.2012.05.001; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; Brocker Chad, 2012, Biomol Concepts, V3, P345; Charoenfuprasert S, 2011, ONCOGENE, V30, P3570, DOI 10.1038/onc.2011.77; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chen H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.154; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; D'Elia L, 2014, CANCER TREAT RES, V159, P83, DOI 10.1007/978-3-642-38007-5_6; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dirajlal-Fargo S, 2017, AIDS, V31, P533, DOI 10.1097/QAD.0000000000001363; Du WQ, 2016, EXPERT OPIN THER TAR, V20, P477, DOI 10.1517/14728222.2016.1101452; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Itoh Y, 2015, J BIOL CHEM, V290, P17879, DOI 10.1074/jbc.M115.640821; Kim SY, 2013, MOL ENDOCRINOL, V27, P1958, DOI 10.1210/me.2013-1240; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Liu Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.83; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Masui K, 2014, CELL CYCLE, V13, P1053, DOI 10.4161/cc.28377; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Ouwerkerk R, 2007, BREAST CANCER RES TR, V106, P151, DOI 10.1007/s10549-006-9485-4; Platt D, 2014, BIOCHEM BIOPH RES CO, V455, P107, DOI 10.1016/j.bbrc.2014.10.124; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Sarma NJ, 2014, J VIROL, V88, P3733, DOI 10.1128/JVI.03060-13; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Tiriveedhi V, 2012, AM J TRANSPLANT, V12, P2663, DOI 10.1111/j.1600-6143.2012.04191.x; Tiriveedhi V, 2012, CLIN EXP IMMUNOL, V167, P158, DOI 10.1111/j.1365-2249.2011.04486.x; Tiriveedhi V, 2014, CLIN CANCER RES, V20, P5964, DOI 10.1158/1078-0432.CCR-14-0059; Tiriveedhi V, 2014, TRANSPL IMMUNOL, V30, P93, DOI 10.1016/j.trim.2013.12.003; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P807, DOI 10.1016/j.healun.2013.06.003; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P714, DOI 10.1016/j.healun.2013.04.006; Tiriveedhi V, 2012, CELL IMMUNOL, V273, P59, DOI 10.1016/j.cellimm.2011.11.006; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Weng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38894; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Zaric O, 2016, RADIOLOGY, V280, P39, DOI 10.1148/radiol.2016151304	49	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180097	10.1371/journal.pone.0180097	http://dx.doi.org/10.1371/journal.pone.0180097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658303	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900058
J	Heiskanen, K; Ahonen, R; Kanerva, R; Karttunen, P; Timonen, J				Heiskanen, Kati; Ahonen, Riitta; Kanerva, Risto; Karttunen, Pekka; Timonen, Johanna			The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland	PLOS ONE			English	Article							DRUG SHORTAGES; IMPACT	The aim of this study was to explore the reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. The study took the form of semi-structured interviews. Forty-one pharmaceutical companies and pharmaceutical wholesalers were invited to participate in the study. The pharmaceutical companies were the member organizations of Pharma Industry Finland (PIF) (N = 30) and the Finnish Generic Pharmaceutical Association (FGPA) (N = 7). One company which is a central player in the pharmaceutical market in Finland but does not belong to PIF or FGPA was also invited. The pharmaceutical wholesalers were those with a nationwide distribution network (N = 3). A total of 30 interviews were conducted between March and June 2016. The data were subjected to qualitative thematic analysis. The most common reasons behind medicine shortages in Finland were the small size of the pharmaceutical market (29/30), sudden or fluctuating demand (28/30), small stock sizes (25/30), long delivery time (23/30) and a long or complex production chain (23/30). The reasons for the medicine shortages were supply-related more often than demand-related. However, the reasons were often complex and there was more than one reason behind a shortage. Supply-related reasons behind shortages commonly interfaced with the country-specific characteristics of Finland, whereas demand-related reasons were commonly associated with the predictability and attractiveness of the market. Some reasons, such as raw material shortages, were considered global and thus had similar effects on other countries.	[Heiskanen, Kati; Ahonen, Riitta; Timonen, Johanna] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm Social Pharm, Kuopio Campus, Kuopio, Finland; [Kanerva, Risto] Espoo I Tapiola Pharm, Espoo, Finland; [Karttunen, Pekka] Siilinjarvi I Pharm, Siilinjarvi, Finland	University of Eastern Finland	Heiskanen, K (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Sch Pharm Social Pharm, Kuopio Campus, Kuopio, Finland.	kati.heiskanen@uef.fi	Sarnola, Kati/AAR-5493-2021	Sarnola, Kati/0000-0003-1300-7482	Association of Finnish Pharmacies	Association of Finnish Pharmacies	Association of Finnish Pharmacies : The funder provided support in the form of research grant for author[KH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	[Anonymous], 2008, TENDERING PHARM EU M; Association of Finnish Pharmacies, 2015, ANN REV; Baumer AM, 2004, AM J HEALTH-SYST PH, V61, P2015, DOI 10.1093/ajhp/61.19.2015; Becker DJ, 2013, J ONCOL PRACT, V9, pE122, DOI 10.1200/JOP.2012.000799; Besancon L, 2013, INT PHARM FEDERATION; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Canadian Pharmacists Association, 2010, CAN DRUG SHORT SURV; Claus B., 2015, J PHARM BELG, V1, P24; Creese A, WHOEDMPAR20045; De Weerdt E, 2015, REGUL TOXICOL PHARM, V71, P251, DOI 10.1016/j.yrtph.2015.01.005; Dylst P, 2011, HEALTH POLICY, V101, P146, DOI 10.1016/j.healthpol.2011.03.004; EAHP, EAHP POL BRIEF MED S; EFPIA, 2016, PHARM IND FIG; Erginel E, 2014, EUROPEAN COMMISSION; European Federation of Pharmaceutical Industries and Associations, 2014, EFPIA GOOD PRACT REV; European Healthcare Distribution Association (GIRP), MED SHORT EUR THEIR; European Medicines Agency, EUR MED REG NETW; European Medicines Agency, SHORT CAT; Finnish Medicines Agency, SAAT; Finnish Medicines Agency, REP QUANT BE STOCK M; Finnish Medicines Agency and Social Insurance Institution, 2015, FINN STAT MED STAT P, P56; Gloor C, EVALUATION MED SHORT; Guest G., 2012, APPL THEMATIC ANAL, P11; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Heiskanen K, 2015, HEALTH POLICY, V119, P232, DOI 10.1016/j.healthpol.2014.11.001; Hennink M, 2016, QUAL HEALTH RES, V27, P1; Hunnisett-Dritz D, 2012, AM J HEALTH-SYST PH, V69, P1416, DOI 10.2146/ajhp120113; Institute for Safe Medication Practices [ISMP], 2010, ISMP MED SAFETY ALER, V15, P4; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; McLaughlin M, 2013, J MANAGE CARE PHARM, V19, P783, DOI 10.18553/jmcp.2013.19.9.783; Ministry of Social Affairs and Health, REF PRIC SYST; Ministry social Affairs and Health, SOC WELF HLTH CAR SY; Morrison A, 2011, DRUG SUPPLY DISRUPTI, P17; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Pelkonen E., 2010, LAAKKEISTA TERVEYTTA, P28; Pharma Industry Finland, OUR ACT; Pharma Industry Finland, MED CAR HOSP MED; Pharma Industry Finland, PHARM MAN FINL; Pharma Industry Finland, 2015, PHARM SAL FINL 2015; Rinnakkaislaaketeollisuusry, RINN TIET SIV; Silverman D, 2013, DOING QUALITATIVE RE, P297; Smith F, COMMUNICATION, V1; Tan YX, 2016, INT J CLIN PHARM-NET, V38, P1133, DOI 10.1007/s11096-016-0342-1; Timonen J, 2013, J PHARM HEALTH SERV, V4, P165, DOI 10.1111/jphs.12021; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Wiedenmayer K., 2004, ACCESS MED MED SUPPL	46	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179479	10.1371/journal.pone.0179479	http://dx.doi.org/10.1371/journal.pone.0179479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658307	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900027
J	Nayyar, S; Sharma, BK; Kaur, A; Kalia, A; Sanghera, GS; Thind, KS; Yadav, IS; Sandhu, JS				Nayyar, Shivani; Sharma, Bipen Kumar; Kaur, Ajinder; Kalia, Anu; Sanghera, Gulzar Singh; Thind, Karanjit Singh; Yadav, Inderjit Singh; Sandhu, Jagdeep Singh			Red rot resistant transgenic sugarcane developed through expression of beta-1,3-glucanase gene	PLOS ONE			English	Article							COLLETOTRICHUM-FALCATUM; TRICHODERMA-HARZIANUM; SUCROSE ACCUMULATION; PATHOGEN; BGN13.1; ENZYMES	Sugarcane (Saccharum spp.) is a commercially important crop, vulnerable to fungal disease red rot caused by Colletotrichum falcatum Went. The pathogen attacks sucrose accumulating parenchyma cells of cane stalk leading to severe losses in cane yield and sugar recovery. We report development of red rot resistant transgenic sugarcane through expression of beta-1,3-glucanase gene from Trichoderma spp. The transgene integration and its expression were confirmed by quantitative reverse transcription-PCR in first clonal generation raised from T0 plants revealing up to 4.4-fold higher expression, in comparison to non-transgenic sugarcane. Bioassay of transgenic plants with two virulent C. falcatum pathotypes, Cf 08 and Cf 09 causing red rot disease demonstrated that some plants were resistant to Cf 08 and moderately resistant to Cf 09. The electron micrographs of sucrose storing stalk parenchyma cells from these plants displayed characteristic sucrose-filled cells inhibiting Cf 08 hyphae and lysis of Cf 09 hyphae; in contrast, the cells of susceptible plants were sucrose depleted and prone to both the pathotypes. The transgene expression was up-regulated (up to 2.0-fold in leaves and 5.0-fold in roots) after infection, as compared to before infection in resistant plants. The transgene was successfully transmitted to second clonal generation raised from resistant transgenic plants. beta-1,3-glucanase protein structural model revealed that active sites Glutamate 628 and Aspartate 569 of the catalytic domain acted as proton donor and nucleophile having role in cleaving beta-1,3-glycosidic bonds and pathogen hyphal lysis.	[Nayyar, Shivani; Kaur, Ajinder; Yadav, Inderjit Singh; Sandhu, Jagdeep Singh] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India; [Sharma, Bipen Kumar; Sanghera, Gulzar Singh] Punjab Agr Univ, Reg Res Stn, Kapurthala, India; [Kalia, Anu] Punjab Agr Univ, Electron Microscopy & Nanosci Lab, Ludhiana, Punjab, India; [Thind, Karanjit Singh] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India	Punjab Agricultural University; Punjab Agricultural University; Punjab Agricultural University; Punjab Agricultural University	Sandhu, JS (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India.	js_sandhu@pau.edu	Sanghera, Gulzar S/J-7301-2019; Yadav, Inderjit/AAG-6336-2020; Kalia, Anu/M-5833-2019	yadav, inderjit/0000-0001-9988-945X; Kalia, Anu/0000-0001-8367-1923	School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana	School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana	This research was supported by in-house financial support provided by School of Agricultural Biotechnology, Punjab Agricultural University, Ludhiana. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri VP., 1990, DIS SUGARCANE SUGAR; ALBERSHEIM P, 1974, PLANT PHYSIOL, V53, P684, DOI 10.1104/pp.53.5.684; BOZZOLA J, 1999, ELECT MICROSCOPY; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; El-Katatny Momein H. A., 2008, Archives of Phytopathology and Plant Protection, V41, P175, DOI 10.1080/03235400600679818; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Gupta V, 2010, FUNCT INTEGR GENOMIC, V10, P207, DOI 10.1007/s10142-009-0144-9; Kheiri H-R., 2014, J CROP PROT, V3, P31; Kumar A, 2002, SUGARCANE CROP MANAG, P109; Kumar N, 2011, J PHYTOPATHOL, V159, P260, DOI 10.1111/j.1439-0434.2010.01759.x; Lam E, 2009, GCB BIOENERGY, V1, P251, DOI 10.1111/j.1757-1707.2009.01016.x; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu Mei, 2004, J Zhejiang Univ Sci, V5, P133, DOI 10.1631/jzus.2004.0133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercado JA, 2015, TRANSGENIC RES, V24, P979, DOI 10.1007/s11248-015-9895-3; Ming R, 2006, PL BRED RE, V27, P15; MOORE PH, 1995, AUST J PLANT PHYSIOL, V22, P661, DOI 10.1071/PP9950661; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; O'Kennedy MM, 2011, S AFR J BOT, V77, P335, DOI 10.1016/j.sajb.2010.09.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prapagdee B, 2008, INT J BIOL SCI, V4, P330; Prathima PT, 2013, APPL BIOCHEM BIOTECH, V171, P488, DOI 10.1007/s12010-013-0346-4; Rott P., 2000, GUIDE SUGARCANE DIS; Saksena P, 2013, J PLANT PROT RES, P53; Satyavir, 2003, INDIAN PHYTOPATHOL, V56, P245; Sharma R, 2015, J PLANT PATHOL MIC S, V1, P3; Singh D., 2012, 10 PATH WORKSH NANN, P9; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Singh PP, 1999, PHYTOPATHOLOGY, V89, P92, DOI 10.1094/PHYTO.1999.89.1.92; Singh RK, 2016, MOL GENET GENOMICS, V291, P1363, DOI 10.1007/s00438-016-1190-3; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SRINIVASAN K. V., 1961, J INDIAN BOT SOC, V40, P566; Sun H, 2006, BIOTECHNOL LETT, V28, P131, DOI 10.1007/s10529-005-5132-0; Sundar AR., 2012, FUNCTIONAL PLANT SCI, P51; Uys L, 2007, PHYTOCHEMISTRY, V68, P2375, DOI 10.1016/j.phytochem.2007.04.023; Vijai Singh, 2008, Sugar Tech, V10, P158, DOI 10.1007/s12355-008-0028-7; Vijai Singh, 2008, Indian Phytopathology, V61, P486; Viswanathan R, 2003, WORLD J MICROB BIOT, V19, P953, DOI 10.1023/B:WIBI.0000007329.68910.e5; Viswanathan R., 1999, Sugar Cane, P9; Viswanathan R., 2013, RECENT ACHIEVEMENTS; Viswanathan R., 2010, PLANT DIS RED ROT SU; Wang JP, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00201; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	46	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179723	10.1371/journal.pone.0179723	http://dx.doi.org/10.1371/journal.pone.0179723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658312	gold, Green Submitted, Green Published			2022-12-26	WOS:000404607900041
J	Squarcina, L; Bellani, M; Rossetti, MG; Perlini, C; Delvecchio, G; Dusi, N; Barillari, M; Ruggeri, M; Altamura, CA; Bertoldo, A; Brambilla, P				Squarcina, Letizia; Bellani, Marcella; Rossetti, Maria Gloria; Perlini, Cinzia; Delvecchio, Giuseppe; Dusi, Nicola; Barillari, Marco; Ruggeri, Mirella; Altamura, Carlo A.; Bertoldo, Alessandra; Brambilla, Paolo			Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics study	PLOS ONE			English	Article							DIFFUSION-TENSOR; CORPUS-CALLOSUM; RADIAL DIFFUSIVITY; INTERMEDIATE PHENOTYPES; FRACTIONAL ANISOTROPY; I DISORDER; ABNORMALITIES; INTEGRITY; DYSCONNECTIVITY; MICROSTRUCTURE	Several strands of evidence reported a significant overlapping, in terms of clinical symptoms, epidemiology and treatment response, between the two major psychotic disorders-Schizophrenia (SCZ) and Bipolar Disorder (BD). Nevertheless, the shared neurobiological correlates of these two disorders are far from conclusive. This study aims toward a better understanding of possible common microstructural brain alterations in SCZ and BD. Magnetic Resonance Diffusion data of 33 patients with BD, 19 with SCZ and 35 healthy controls were acquired. Diffusion indexes were calculated, then analyzed using Tract-Based Spatial Statistics (TBSS). We tested correlations with clinical and psychological variables. In both patient groups mean diffusion (MD), volume ratio (VR) and radial diffusivity (RD) showed a significant increase, while fractional anisotropy (FA) and mode (MO) decreased compared to the healthy group. Changes in diffusion were located, for both diseases, in the fronto-temporal and callosal networks. Finally, no significant differences were identified between patient groups, and a significant correlations between length of disease and FA and VR within the corpus callosum, corona radiata and thalamic radiation were observed in bipolar disorder. To our knowledge, this is the first study applying TBSS on all the DTI indexes at the same time in both patient groups showing that they share similar impairments in microstructural connectivity, with particular regards to fronto-temporal and callosal communication, which are likely to worsen over time. Such features may represent neural common underpinnings characterizing major psychoses and confirm the central role of white matter pathology in schizophrenia and bipolar disorder.	[Squarcina, Letizia] IRCCS E Medea Sci Inst, Bosisio Parini, Lecco, Italy; [Bellani, Marcella; Dusi, Nicola; Ruggeri, Mirella] AOUI Verona, Sect Psychiat, Verona, Italy; [Rossetti, Maria Gloria] Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Perlini, Cinzia] Dept Neurosci Biomed & Movement Sci, Sect Clin Psychol, Verona, Italy; [Delvecchio, Giuseppe; Barillari, Marco] Univ Verona, Dept Radiol, Verona, Italy; [Altamura, Carlo A.; Brambilla, Paolo] Univ Milan, Dept Neurosci & Mental Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy; [Brambilla, Paolo] UTHouston Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	IRCCS Eugenio Medea; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; Baylor College of Medicine	Brambilla, P (corresponding author), Univ Milan, Dept Neurosci & Mental Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.; Brambilla, P (corresponding author), UTHouston Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	paolo.brambilla1@unimi.it	rossetti, maria gloria/AFF-6265-2022; Dusi, Nicola/J-9431-2016; Perlini, Cinzia/F-8492-2010; Delvecchio, Giuseppe/J-7721-2016; Squarcina, Letizia/J-9869-2016; brambilla, paolo/B-4184-2010; Rossetti, Maria Gloria/AAB-9797-2019; Bellani, Marcella/F-3929-2010	Dusi, Nicola/0000-0003-2204-0030; Perlini, Cinzia/0000-0002-4281-0920; Delvecchio, Giuseppe/0000-0003-4750-1980; Squarcina, Letizia/0000-0001-6209-4629; brambilla, paolo/0000-0002-4021-8456; Bellani, Marcella/0000-0003-1727-5396; Barillari, Marco/0000-0002-2820-0229; Rossetti, Maria Gloria/0000-0001-7843-8721	Ministry of Health [GR-20102 316745, GR-2010-2316745, GR-2010-2319022]	Ministry of Health	This study was partly supported by grants from the Ministry of Health (GR-20102 316745) to Paolo Brambilla (GR-2010-2316745) and to Marcella Bellani (GR-2010-2319022).	Altinbas K, 2014, PSYCHIAT DANUB, V26, P200; Anderson D, 2013, BIPOLAR DISORD, V15, P680, DOI 10.1111/bdi.12096; Andersson J. L., 2008, ORG HUM BRAIN MAPP; Ashtari M, 2007, ARCH GEN PSYCHIAT, V64, P1270, DOI 10.1001/archpsyc.64.11.1270; Barnea-Goraly N, 2009, BIOL PSYCHIAT, V66, P238, DOI 10.1016/j.biopsych.2009.02.025; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bauer IE, 2015, J PSYCHIATR RES, V62, P115, DOI 10.1016/j.jpsychires.2015.01.008; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bellani M, 2012, FUNCT NEUROL, V27, P29; Bellani M, 2010, EXP BRAIN RES, V201, P339, DOI 10.1007/s00221-009-2021-0; Bellani M, 2009, BIOCHEM SOC T, V37, P1096, DOI 10.1042/BST0371096; Benedetti F, 2011, BIOL PSYCHIAT, V69, P309, DOI 10.1016/j.biopsych.2010.07.028; Beyer JL, 2005, NEUROPSYCHOPHARMACOL, V30, P2225, DOI 10.1038/sj.npp.1300802; Brambilla P, 2004, J NEUROL NEUROSUR PS, V75, P221; Brambilla P, 2003, BIOL PSYCHIAT, V54, P1294, DOI 10.1016/S0006-3223(03)00070-2; Brambilla P, 2007, INT REV PSYCHIATR, V19, P459, DOI 10.1080/09540260701500975; Brambilla P, 2011, PROG NEURO-PSYCHOPH, V35, P1093, DOI 10.1016/j.pnpbp.2011.03.007; Brambilla P, 2009, INT REV PSYCHIATR, V21, P380, DOI 10.1080/09540260902962172; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Cosgrove VE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-127; Cui LQ, 2011, PSYCHIAT RES-NEUROIM, V194, P347, DOI 10.1016/j.pscychresns.2011.03.010; Cui LQ, 2011, NEUROSCI LETT, V489, P94, DOI 10.1016/j.neulet.2010.11.073; Domen PAE, 2013, SCHIZOPHR RES, V146, P291, DOI 10.1016/j.schres.2013.03.002; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Emsell L, 2013, BIOL PSYCHIAT, V73, P194, DOI 10.1016/j.biopsych.2012.09.023; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Florio V, 2013, EXP BRAIN RES, V230, P175, DOI 10.1007/s00221-013-3642-x; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Gupta CN, 2015, SCHIZOPHRENIA BULL, V41, P1133, DOI 10.1093/schbul/sbu177; Haller S, 2011, J PSYCHIATR NEUROSCI, V36, P391, DOI 10.1503/jpn.100140; Heckers S, 2008, SCHIZOPHRENIA BULL, V34, P591, DOI 10.1093/schbul/sbn046; Ivleva EI, 2010, NEUROSCI BIOBEHAV R, V34, P897, DOI 10.1016/j.neubiorev.2009.11.022; Karbasforoushan H, 2015, PSYCHOL MED, V45, P109, DOI 10.1017/S0033291714001111; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Knochel C, 2016, SCHIZOPHR RES, V172, P78, DOI 10.1016/j.schres.2016.02.007; Koch K, 2011, BRIT J PSYCHIAT, V198, P223, DOI 10.1192/bjp.bp.110.081836; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Kumar J, 2015, PSYCHOL MED, V45, P759, DOI 10.1017/S0033291714001810; Kuswanto C. N., 2015, NEUROPSYCHOPHARMACOL, V17; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Levitt JJ, 2012, SCHIZOPHR RES, V136, P55, DOI 10.1016/j.schres.2011.09.009; Li J, 2014, PSYCHIAT RES-NEUROIM, V221, P58, DOI 10.1016/j.pscychresns.2013.10.007; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu XY, 2013, BEHAV BRAIN RES, V252, P157, DOI 10.1016/j.bbr.2013.05.061; Lu LH, 2011, BIPOLAR DISORD, V13, P604, DOI 10.1111/j.1399-5618.2011.00958.x; Macritchie KAN, 2013, J AFFECT DISORDERS, V148, P249, DOI 10.1016/j.jad.2012.12.002; Maggioni E, 2017, EPIDEMIOLOG IN PRESS; Maggioni E., 2016, EPIDEMIOL PSYCH SCI, P1; Magioncalda P, 2016, J AFFECT DISORDERS, V193, P39, DOI 10.1016/j.jad.2015.12.050; Maller JJ, 2014, J AFFECT DISORDERS, V169, P118, DOI 10.1016/j.jad.2014.08.016; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Molina V, 2011, EUR ARCH PSY CLIN N, V261, P313, DOI 10.1007/s00406-010-0183-1; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; Oertel-Knochel V, 2014, J AFFECT DISORDERS, V155, P223, DOI 10.1016/j.jad.2013.11.004; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P363, DOI 10.1111/j.1600-0447.2012.01864.x; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Reid MA, 2016, SCHIZOPHR RES, V170, P341, DOI 10.1016/j.schres.2015.12.003; Roalf DR, 2013, SCHIZOPHR RES, V143, P172, DOI 10.1016/j.schres.2012.10.014; Roybal DJ, 2015, PSYCHIAT RES-NEUROIM, V232, P184, DOI 10.1016/j.pscychresns.2015.02.007; Scheel M, 2013, BRAIN STRUCT FUNCT, V218, P151, DOI 10.1007/s00429-012-0389-2; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Skudlarski P, 2013, AM J PSYCHIAT, V170, P886, DOI 10.1176/appi.ajp.2013.12111448; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Tamminga CA, 2013, AM J PSYCHIAT, V170, P1263, DOI 10.1176/appi.ajp.2013.12101339; Tansella M, 2003, BRIT J PSYCHIAT, V183, P167, DOI 10.1192/bjp.183.2.167; Tomasino B, 2011, PSYCHOL MED, V41, P301, DOI 10.1017/S0033291710000875; Torgerson CM, 2013, BRAIN IMAGING BEHAV, V7, P129, DOI 10.1007/s11682-012-9202-3; Vai B, 2014, EXPERT REV NEUROTHER, V14, P631, DOI 10.1586/14737175.2014.915744; Versace A, 2014, MOL PSYCHIATR, V19, P200, DOI 10.1038/mp.2012.188; Wagner G, 2015, CORTEX, V66, P35, DOI 10.1016/j.cortex.2015.02.004; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189; Zhou Y, 2015, NEUROSCI BULL, V31, P207, DOI 10.1007/s12264-014-1502-8	88	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178089	10.1371/journal.pone.0178089	http://dx.doi.org/10.1371/journal.pone.0178089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658249	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900003
J	Nakamura, R; Okura, T; Fujioka, Y; Sumi, K; Matsuzawa, K; Izawa, S; Ueta, E; Kato, M; Taniguchi, S; Yamamoto, K				Nakamura, Risa; Okura, Tsuyoshi; Fujioka, Yohei; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Ueta, Etsuko; Kato, Masahiko; Taniguchi, Shin-ichi; Yamamoto, Kazuhiro			Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study	PLOS ONE			English	Article							GLUCOSE-UPTAKE; IN-VIVO; SENSITIVITY; OBESITY; ADIPONECTIN; SECRETION; OXIDATION; BIOMARKER; HUMANS; IRISIN	Type 2 diabetes mellitus (T2DM) is caused by insulin resistance and beta cell dysfunction. In recent studies reported that several markers associated with insulin sensitivity in skeletal muscle, Adiponectin and other parameters, such as fatty acid-binding protein (FABP4), have been reported to regulate insulin resistance, but it remains unclear which factor mostly affects insulin resistance in T2DM. In this cross-sectional study, we evaluated the relationships between several kinds of biomarkers and insulin resistance, and insulin secretion in T2DM and healthy controls. We recruited 30 participants (12 T2DM and 18 non-diabetic healthy controls). Participants underwent a meal tolerance test during which plasma glucose, insulin and serum C-peptide immunoreactivity were measured. We performed a hyperinsulinemic-euglycemic clamp and measured the glucose-disposal rate (GDR). The fasting serum levels of adiponectin, insulin-like growth factor-1, irisin, autotaxin, FABP4 and interleukin-6 were measured by ELISA. We found a strong negative correlation between FABP4 concentration and GDR in T2DM (r = -0.657, p = 0.020). FABP4 also was positively correlated with insulin secretion during the meal tolerance test in T2DM (IRI (120): r = 0.604, p = 0.038) and was positively related to the insulinogenic index in non-DM subjects (r = 0.536, p = 0.022). Autotaxin was also related to GDR. However, there was no relationship with insulin secretion. We found that serum FABP4 concentration were associated with insulin resistance and secretion in T2DM. This suggests that FABP4 may play an important role in glucose homeostasis.	[Nakamura, Risa; Okura, Tsuyoshi; Fujioka, Yohei; Sumi, Keisuke; Izawa, Shoichiro; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan; [Matsuzawa, Kazuhiko; Taniguchi, Shin-ichi] Tottori Univ, Dept Reg Med, Fac Med, Yonago, Tottori, Japan; [Ueta, Etsuko] Tottori Univ, Sch Hlth Sci, Fac Med, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University	Okura, T (corresponding author), Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan.	ohkura@med.tottori-u.ac.jp			JSPS KAKENHI [26870373, 16K08935]; Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; MSD	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; MSD	This work was supported by a JSPS KAKENHI Grant-in-Aid for Young Scientists (B) grant number 26870373 (2014-2015), JSPS KAKENHI Grant-in-Aid for Scientific Research (C) grant number 16K08935 (2016-), the Japan Diabetes Foundation (2013), grants for young researchers from the Japan Association for Diabetes Education and Care (2013, 2014). This work also supported by the MSD research grant (2013, 2015).	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; Greco EA, 2013, WORLD J DIABETES, V4, P31, DOI 10.4239/wjd.v4.i2.31; Hamrick Mark W, 2017, J Bone Metab, V24, P1, DOI 10.11005/jbm.2017.24.1.1; Hideki Ota, 2012, AM J HYPERTENTION; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hsu WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028311; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Kawamori R, 1998, DIABETES RES CLIN PR, V41, P35, DOI 10.1016/S0168-8227(98)00056-4; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Perakakis N, 2017, NAT REV ENDOCRINOL; Reeves VL, 2015, OBESITY, V23, P2371, DOI 10.1002/oby.21232; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Sirbu A, 2013, GROWTH HORM IGF RES, V23, P2, DOI 10.1016/j.ghir.2012.10.001; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Tomoaki Morioka, 2017, J DIABETES INVESTIG; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yoshino Gen, 2006, Journal of the Japan Diabetes Society, V49, P361; Zhang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146605	39	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179737	10.1371/journal.pone.0179737	http://dx.doi.org/10.1371/journal.pone.0179737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654680	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500029
J	Wu, Q; Sun, RY; Ni, M; Yu, J; Li, YQ; Yu, CJ; Dou, K; Ren, JH; Chen, J				Wu, Qiong; Sun, Ruiyan; Ni, Mi; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Ren, Jianhong; Chen, Jie			Identification of a novel fungus, Trichoderma asperellum GDFS1009, and comprehensive evaluation of its biocontrol efficacy	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; ANTIFUNGAL ACTIVITY; PLANT; MYCOPARASITISM; PEPTAIBOLS; DIVERSITY; VIRENS; ACID; BIODIVERSITY; INDUCTION	Due to its efficient broad-spectrum antimicrobial activity, Trichoderma has been established as an internationally recognized biocontrol fungus. In this study, we found and identified a novel strain of Trichoderma asperellum, named GDFS1009. The mycelium of T. asperellum GDFS1009 exhibits a high growth rate, high sporulation capacity, and strong inhibitory effects against pathogens that cause cucumber fusarium wilt and corn stalk rot. T. asperellum GDFS1009 secretes chitinase, glucanase, and protease, which can degrade the cell walls of fungi and contribute to mycoparasitism. The secreted xylanases are good candidates for inducing plant resistance and enhancing plant immunity against pathogens. RNA sequencing (RNA-seq) and gas chromatography-mass spectrometry (GC-MS) showed that T. asperellum GDFS1009 produces primary metabolites that are precursors of antimicrobial compounds; it also produces a variety of antimicrobial secondary metabolites, including polyketides and alkanes. In addition, this study speculated the presence of six antimicrobial peptides via ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-QTOF-MS/ MS). Future studies should focus on these antimicrobial metabolites for facilitating widespread application in the field of agricultural bio-control.	[Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Environm & Resource, Shanghai, Peoples R China; [Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Wu, Qiong; Sun, Ruiyan; Yu, Jia; Li, Yaqian; Yu, Chuanjin; Dou, Kai; Chen, Jie] Minist Agr, Key Lab Urban South Agr, Shanghai, Peoples R China; [Ni, Mi] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Ni, Mi] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ren, Jianhong] Suzhou BioNovoGene Metabol Platform, Suzhou, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Environm & Resource, Shanghai, Peoples R China.; Chen, J (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Chen, J (corresponding author), Minist Agr, Key Lab Urban South Agr, Shanghai, Peoples R China.	jiechen59@sjtu.edu.cn		Ni, Mi/0000-0002-8930-6887; Dou, Kai/0000-0003-2665-0231	National Special Project of Basic Work Project for Science and Technology [2014FY120900]; National Natural Science Foundation of China [31270155]; Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality [12JC1404600]; China Agriculture Research System [CARS-02]	National Special Project of Basic Work Project for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality; China Agriculture Research System	This work was supported by National Special Project of Basic Work Project for Science and Technology (2014FY120900), National Natural Science Foundation of China (31270155), Key Project for Basic Science Research, Science and Technology Commission of Shanghai Municipality (12JC1404600) and China Agriculture Research System (no. CARS-02).	Bailey BA, 2008, BIOL CONTROL, V46, P24, DOI 10.1016/j.biocontrol.2008.01.003; Blaszczyk L, 2011, J APPL GENET, V52, P233, DOI 10.1007/s13353-011-0039-z; Chen LL, 2009, FEMS MICROBIOL LETT, V299, P135, DOI 10.1111/j.1574-6968.2009.01746.x; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; DEAN JFD, 1991, PLANT PHYSIOL, V95, P316, DOI 10.1104/pp.95.1.316; Degenkolb T, 2008, CHEM BIODIVERS, V5, P671, DOI 10.1002/cbdv.200890064; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Devi G. I., 2013, International Research Journal of Biological Sciences, V2, P16; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; GEREMIA RA, 1993, MOL MICROBIOL, V8, P603, DOI 10.1111/j.1365-2958.1993.tb01604.x; GRAHAM AF, 1986, J APPL BACTERIOL, V61, P39, DOI 10.1111/j.1365-2672.1986.tb03756.x; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hollink E, 2005, TETRAHEDRON LETT, V46, P2005, DOI 10.1016/j.tetlet.2005.01.150; Horace GC, 1986, AGR BIOL CHEM TOKYO, V50, P2943, DOI DOI 10.1080/00021369.1986.10867860; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Jayaraj J, 2010, J PLANT INTERACT, V5, P147, DOI 10.1080/17429140903291012; Kadu S, 2016, WORLD J PHARM LIFE S, V2, P222; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kerroum F, 2015, INT J SCI NAT, V6, P141; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Krause C, 2006, AMINO ACIDS, V30, P435, DOI 10.1007/s00726-005-0275-9; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kulkarni A, 2009, EUR J MED CHEM, V44, P2904, DOI 10.1016/j.ejmech.2008.12.012; Leelavathi M. S., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P96; Limon MC, 1999, PHYTOPATHOLOGY, V89, P254, DOI 10.1094/PHYTO.1999.89.3.254; Lin J, 2006, ENVIRON SCI TECHNOL, V29, P82; Liu Y, 2013, J MOL MICROB BIOTECH, V23, P431, DOI 10.1159/000346830; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Metcalf DA, 2004, PLANT DIS, V88, P287, DOI 10.1094/PDIS.2004.88.3.287; Mohamed-Benkada M, 2006, RAPID COMMUN MASS SP, V20, P1176, DOI 10.1002/rcm.2430; Nawrocka J, 2013, BIOL CONTROL, V67, P149, DOI 10.1016/j.biocontrol.2013.07.005; Nielsen KF, 2005, J AGR FOOD CHEM, V53, P8190, DOI 10.1021/jf051279b; NORMAN BH, 1992, TETRAHEDRON LETT, V33, P6803, DOI 10.1016/S0040-4039(00)61780-X; R Core Team, 2021, R LANGUAGE ENV STAT; Ruiz N, 2007, PEPTIDES, V28, P1351, DOI 10.1016/j.peptides.2007.05.012; Sadfi-Zouaoui N, 2009, CAN J MICROBIOL, V55, P154, DOI [10.1139/W08-101, 10.1139/w08-101]; Selvaraj K., 2011, INT J APPL BIOL PHAR, V2, P179; Sharon E, 2007, EUR J PLANT PATHOL, V118, P247, DOI 10.1007/s10658-007-9140-x; Shoresh M, 2004, J ZHEJIANG U AGR LIF, V30, P385; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Sumayo M, 2013, PLANT PATHOLOGY J, V29, P174, DOI 10.5423/PPJ.SI.09.2012.0143; Sun HY, 2006, BIOTECHNOL LETT, V28, P1719, DOI [10.1007/s10529-006-9151-2, 10.1007/s10529-005-5132-0]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vazquez-Garciduenas S, 1998, APPL ENVIRON MICROB, V64, P1442; Vinale F, 2008, PHYSIOL MOL PLANT P, V72, P80, DOI 10.1016/j.pmpp.2008.05.005; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Viterbo A, 2001, FEMS MICROBIOL LETT, V200, P169, DOI 10.1111/j.1574-6968.2001.tb10710.x; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Weindling R, 1932, PHYTOPATHOLOGY, V22, P837; Wolf GA, 1996, J MICROBIOL METH, V25, P337, DOI 10.1016/0167-7012(96)00005-X; Wu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073729; Yang HJ, 2002, J LIQ CHROMATOGR R T, V25, P2709, DOI 10.1081/JLC-120014387; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yedidia I, 2000, PLANT PHYSIOL BIOCH, V38, P863, DOI 10.1016/S0981-9428(00)01198-0; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Yue HR, 2012, CHEM SOC REV, V41, P4218, DOI 10.1039/c2cs15359a; Zakrzewski J, 2011, BIOORG MED CHEM LETT, V21, P514, DOI 10.1016/j.bmcl.2010.10.092	66	55	63	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179957	10.1371/journal.pone.0179957	http://dx.doi.org/10.1371/journal.pone.0179957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644879	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100053
J	Shi, PF; Fan, XN; Ni, JJ; Khan, Z; Li, M				Shi, Pengfei; Fan, Xinnan; Ni, Jianjun; Khan, Zubair; Li, Min			A novel underwater dam crack detection and classification approach based on sonar images	PLOS ONE			English	Article							EARTHQUAKE	Underwater dam crack detection and classification based on sonar images is a challenging task because underwater environments are complex and because cracks are quite random and diverse in nature. Furthermore, obtainable sonar images are of low resolution. To address these problems, a novel underwater dam crack detection and classification approach based on sonar imagery is proposed. First, the sonar images are divided into image blocks. Second, a clustering analysis of a 3-D feature space is used to obtain the crack fragments. Third, the crack fragments are connected using an improved tensor voting method. Fourth, a minimum spanning tree is used to obtain the crack curve. Finally, an improved evidence theory combined with fuzzy rule reasoning is proposed to classify the cracks. Experimental results show that the proposed approach is able to detect underwater dam cracks and classify them accurately and effectively under complex underwater environments.	[Shi, Pengfei; Fan, Xinnan; Ni, Jianjun; Khan, Zubair; Li, Min] Hohai Univ, Coll IOT Engn, Changzhou, Jiangsu, Peoples R China	Hohai University	Shi, PF (corresponding author), Hohai Univ, Coll IOT Engn, Changzhou, Jiangsu, Peoples R China.	flyshn@hotmail.com	Khan, Zubair/X-7459-2019; Khan, Zubair/O-8169-2018	Khan, Zubair/0000-0002-9651-5767; Khan, Zubair/0000-0002-9651-5767	National Natural Science Foundation of China [61573128, 61203365]; Fundamental Research Funds for the Central Universities [2017B02914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (grant numbers 61573128, 61203365), and the Fundamental Research Funds for the Central Universities (grant number 2017B02914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant numbers 61573128, 61203365), and the Fundamental Research Funds for the Central Universities (grant number 2017B02914). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay B, 2015, SIGNAL IMAGE VIDEO P, V9, P967, DOI 10.1007/s11760-015-0758-4; Andalo FA, 2010, PATTERN RECOGN, V43, P26, DOI 10.1016/j.patcog.2009.06.012; Bernstone C, 2009, MEASUREMENT, V42, P878, DOI 10.1016/j.measurement.2009.01.007; Bouchette G, 2014, IEEE T GEOSCI REMOTE, V52, P1407, DOI 10.1109/TGRS.2013.2250982; Chen CP, 2012, APPL MECH MATER, V220-223, P1315, DOI 10.4028/www.scientific.net/AMM.220-223.1315; Cong-ping Chen, 2012, 2012 International Conference on Systems and Informatics (ICSAI 2012), P1825, DOI 10.1109/ICSAI.2012.6223399; Dou J, 2015, REMOTE SENS-BASEL, V7, P4318, DOI 10.3390/rs70404318; Ghamisi P, 2015, IEEE T GEOSCI REMOTE, V53, P2335, DOI 10.1109/TGRS.2014.2358934; Glisic B, 2012, STRUCT HEALTH MONIT, V11, P161, DOI 10.1177/1475921711414233; Grote AB, 2014, CAN J FISH AQUAT SCI, V71, P545, DOI 10.1139/cjfas-2013-0308; Guan HY, 2015, IEEE T INTELL TRANSP, V16, P2457, DOI 10.1109/TITS.2015.2409192; Kabir S, 2009, CONSTR BUILD MATER, V23, P3166, DOI 10.1016/j.conbuildmat.2009.06.013; Koch C, 2015, ADV ENG INFORM, V29, P196, DOI 10.1016/j.aei.2015.01.008; Lai SL, 2014, J CHIN INST ENG, V37, P428, DOI 10.1080/02533839.2013.799949; Martinez J, 2014, INT J MINER PROCESS, V133, P67, DOI 10.1016/j.minpro.2014.09.008; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Murphy RR, 2009, 2009 IEEE INT WORKSH, P1, DOI DOI 10.1109/SSRR.2009.5424144; Oliveira H, 2013, IEEE T INTELL TRANSP, V14, P155, DOI 10.1109/TITS.2012.2208630; Rashwan HA, 2013, IEEE T IMAGE PROCESS, V22, P2589, DOI 10.1109/TIP.2013.2253481; Rezaiee-Pajand M, 2015, P I CIVIL ENG-STR B, V168, P192, DOI 10.1680/stbu.12.00078; SHAFER G, 1981, PHILOS SCI, V48, P337, DOI 10.1086/289004; Stephan T, 2013, SPIE OPTICAL METROLO; Su HZ, 2013, IEEE SENS J, V13, P1403, DOI 10.1109/JSEN.2012.2227468; Wickramarathne TL, 2013, IEEE T CYBERNETICS, V43, P712, DOI 10.1109/TSMCB.2012.2214771; Williams S., 2008, OCEANS, P1; Xu XY, 2011, PATTERN RECOGN LETT, V32, P956, DOI 10.1016/j.patrec.2011.01.021; Xu XJ, 2013, J CENT SOUTH UNIV, V20, P2605, DOI 10.1007/s11771-013-1775-5; Xue XH, 2014, COMPUT CONCRETE, V13, P633, DOI 10.12989/cac.2014.13.5.633; Ye XW, 2016, J SENSORS, V2016, DOI 10.1155/2016/7103039; Zalama E, 2014, COMPUT-AIDED CIV INF, V29, P342, DOI 10.1111/mice.12042; Zou Q, 2012, PATTERN RECOGN LETT, V33, P227, DOI 10.1016/j.patrec.2011.11.004	31	11	11	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179627	10.1371/journal.pone.0179627	http://dx.doi.org/10.1371/journal.pone.0179627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640925	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800046
J	Kaundun, SS; Hutchings, SJ; Dale, RP; Howell, A; Morris, JA; Kramer, VC; Shivrain, VK; Mcindoe, E				Kaundun, Shiv S.; Hutchings, Sarah-Jane; Dale, Richard P.; Howell, Anushka; Morris, James A.; Kramer, Vance C.; Shivrain, Vinod K.; Mcindoe, Eddie			Mechanism of resistance to mesotrione in an Amaranthus tuberculatus population from Nebraska, USA	PLOS ONE			English	Article							HPPD-INHIBITING HERBICIDES; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; GLYPHOSATE RESISTANCE; CRYSTAL-STRUCTURES; WATERHEMP; ATRAZINE; PLANTS; SELECTIVITY; RESPONSES; TRIAZINE	Amaranthus tuberculatus is a troublesome weed in corn and soybean production systems in Midwestern USA, due in part to its ability to evolve multiple resistance to key herbicides including 4-hydroxyphenylpyruvate dioxygenase (HPPD). Here we have investigated the mechanism of resistance to mesotrione, an important chemical for managing broadleaf weeds in corn, in a multiple herbicide resistant population (NEB) from Nebraska. NEB showed a 2.4-fold and 45-fold resistance increase to mesotrione compared to a standard sensitive population (SEN) in pre-emergence and post-emergence dose-response pot tests, respectively. Sequencing of the whole HPPD gene from 12 each of sensitive and resistant plants did not detect any target-site mutations that could be associated with post emergence resistance to mesotrione in NEB. Resistance was not due to HPPD gene duplication or over-expression before or after herbicide treatment, as revealed by qPCR. Additionally, no difference in mesotrione uptake was detected between NEB and SEN. In contrast, higher levels of mesotrione metabolism via 4-hydroxylation of the dione ring were observed in NEB compared to the sensitive population. Overall, the NEB population was characterised by lower levels of parent mesotrione exported to other parts of the plant, either as a consequence of metabolism in the treated leaves and/or impaired translocation of the herbicide. This study demonstrates another case of non-target-site based resistance to an important class of herbicides in an A. tuberculatus population. The knowledge generated here will help design strategies for managing multiple herbicide resistance in this problematic weed species.	[Kaundun, Shiv S.; Hutchings, Sarah-Jane; Dale, Richard P.; Howell, Anushka; Morris, James A.; Mcindoe, Eddie] Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell, Berks, England; [Kramer, Vance C.] Syngenta, Res Triangle Pk, NC USA; [Shivrain, Vinod K.] Syngenta, Vero Beach Res Ctr, Vero Beach, FL USA	Syngenta; Syngenta; Syngenta	Kaundun, SS (corresponding author), Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com			Syngenta	Syngenta(Syngenta)	The study was commercially funded by Syngenta, which provided support in the form of salary for SSK, S-JH, RPD, AH, JAM, VCK, VKS, EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abendroth JA, 2006, WEED TECHNOL, V20, P267, DOI 10.1614/WT-05-020R.1; Almsick A. van, 2009, Outlooks on Pest Management, V20, P27, DOI 10.1564/20feb09; [Anonymous], 2016, AGRISERVICE; Beaudegnies R, 2009, BIOORGAN MED CHEM, V17, P4134, DOI 10.1016/j.bmc.2009.03.015; Bell MS, 2013, WEED SCI, V61, P460, DOI 10.1614/WS-D-12-00166.1; Betha S, 2016, INCREASED HPPD GENE; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; Duke SO, 2015, PEST MANAG SCI, V71, P652, DOI 10.1002/ps.3863; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; Evans C., 2016, THESIS; Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030; Foes MJ, 1998, WEED SCI, V46, P514, DOI 10.1017/S0043174500091013; Fritze IM, 2004, PLANT PHYSIOL, V134, P1388, DOI 10.1104/pp.103.034082; Goggin DE, 2016, J EXP BOT, V67, P3223, DOI 10.1093/jxb/erw120; Goodwin B, 1972, BIOCH PHYSIOL CLINC, P1; Green JM, 2011, J AGR FOOD CHEM, V59, P5819, DOI 10.1021/jf101286h; Gressel J, 2009, PEST MANAG SCI, V65, P1164, DOI 10.1002/ps.1842; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; Hamprecht G, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P197; Hausman NE, 2016, WEED TECHNOL, V30, P106, DOI 10.1614/WT-D-15-00098.1; Hausman NE, 2011, PEST MANAG SCI, V67, P258, DOI 10.1002/ps.2100; Hawkes T, 2010, US Patent Application, Patent No. [2010/01975032010, 01975032010]; Hawkes TR, 2014, PEST MANAG SCI, V70, P1316, DOI 10.1002/ps.3699; Heap I, 2016, INT SURVEY HERBICIDE; Hirai K, 2002, HERBICIDE CLASSES IN DEVELOPMENT, P179; Huffman J, 2015, WEED SCI, V63, P799, DOI 10.1614/WS-D-15-00055.1; Hugie JA, 2008, WEED SCI, V56, P265, DOI 10.1614/WS-07-128.1; JEFFORD CW, 1981, EXPERIENTIA, V37, P1134, DOI 10.1007/BF01989880; Jhala AJ, 2014, WEED TECHNOL, V28, P28, DOI 10.1614/WT-D-13-00090.1; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Ma R, 2016, AGRON J, V108, P1196, DOI 10.2134/agronj2015.0571; Ma R, 2013, PLANT PHYSIOL, V163, P363, DOI 10.1104/pp.113.223156; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Matringe M, 2005, PEST MANAG SCI, V61, P269, DOI 10.1002/ps.997; McMullan PM, 2011, WEED TECHNOL, V25, P514, DOI 10.1614/WT-D-10-00150.1; Michel A, 2012, JULIUS KUHN ARCH, V30, P103; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nandula VK, 2013, WEED SCI, V61, P374, DOI 10.1614/WS-D-12-00155.1; Pallett K. E., 1997, Pesticide Science, V50, P83, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;83::AID-PS554&gt;3.0.CO;2-S; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; Peterson D., 2012, CHARACTERIZATION HPP; Ruiz-Sola M, 2012, ARABIDOPSIS BOOK, P1; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schultz JL, 2015, WEED SCI, V63, P336, DOI 10.1614/WS-D-14-00102.1; SECOR J, 1994, PLANT PHYSIOL, V106, P1429, DOI 10.1104/pp.106.4.1429; Siehl DL, 2014, PLANT PHYSIOL, V166, P1162, DOI 10.1104/pp.114.247205; STREIBIG JC, 1988, WEED RES, V28, P479, DOI 10.1111/j.1365-3180.1988.tb00831.x; Tan S, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P423, DOI 10.1079/9781780640853.0423; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tranel PJ, 2011, J AGR FOOD CHEM, V59, P5808, DOI 10.1021/jf103797n; Viviani E, 1998, PESTIC BIOCHEM PHYS, V62, P125, DOI 10.1006/pest.1998.2375; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Williams MM, 2008, WEED SCI, V56, P364, DOI 10.1614/WS-07-149.1; Woodworth A.R., 1996, PLANT PHYSIOL, V111, P1353; Woodyard AJ, 2009, WEED SCI, V57, P369, DOI 10.1614/WS-08-175.1; Wuerffel RJ, 2015, WEED SCI, V63, P511, DOI 10.1614/WS-D-14-00108.1; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3	59	29	29	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180095	10.1371/journal.pone.0180095	http://dx.doi.org/10.1371/journal.pone.0180095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662111	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300103
J	Coutinho, E; Schuller, B				Coutinho, Eduardo; Schuller, Bjorn			Shared acoustic codes underlie emotional communication in music and speech-Evidence from deep transfer learning	PLOS ONE			English	Article							RECOGNITION; EXPRESSION	Music and speech exhibit striking similarities in the communication of emotions in the acoustic domain, in such a way that the communication of specific emotions is achieved, at least to a certain extent, by means of shared acoustic patterns. From an Affective Sciences points of view, determining the degree of overlap between both domains is fundamental to understand the shared mechanisms underlying such phenomenon. From a Machine learning perspective, the overlap between acoustic codes for emotional expression in music and speech opens new possibilities to enlarge the amount of data available to develop music and speech emotion recognition systems. In this article, we investigate time-continuous predictions of emotion (Arousal and Valence) in music and speech, and the Transfer Learning between these domains. We establish a comparative framework including intra- (i.e., models trained and tested on the same modality, either music or speech) and cross-domain experiments (i.e., models trained in one modality and tested on the other). In the cross domain context, we evaluated two strategies the direct transfer between domains, and the contribution of Transfer Learning techniques (feature-representation-transfer based on Denoising Auto Encoders) for reducing the gap in the feature space distributions. Our results demonstrate an excellent cross-domain generalisation performance with and without feature representation transfer in both directions. In the case of music, cross-domain approaches outperformed intra-domain models for Valence estimation, whereas for Speech intra-domain models achieve the best performance. This is the first demonstration of shared acoustic codes for emotional expression in music and speech in the time-continuous domain.	[Coutinho, Eduardo] Univ Liverpool, Dept Mus, Liverpool, Merseyside, England; [Coutinho, Eduardo; Schuller, Bjorn] Imperial Coll London, Dept Comp, London, England	University of Liverpool; Imperial College London	Coutinho, E (corresponding author), Univ Liverpool, Dept Mus, Liverpool, Merseyside, England.; Coutinho, E (corresponding author), Imperial Coll London, Dept Comp, London, England.	e.coutinho@liverpool.ac.uk	Coutinho, Eduardo/K-1391-2019	Coutinho, Eduardo/0000-0001-5234-1497; Schuller, Bjorn/0000-0002-6478-8699	European Union [645378]	European Union(European Commission)	This work was partially funded by European Union's Horizon 2020 (blipe:/ec.europa.eu/programmestorizon2020/) research and innovation programme under grant agreement No. 645378 (ARIA-VALUSPA) awarded to Bjorn Schuller.	Alain G, 2014, J MACH LEARN RES, V15, P3563; Aljanaki A, 2014, WORK NOT P MED 2014, V1263; Aljanaki A, 2015, WORK NOT P MED 2015, V1436; Arnold A., 2007, PROC 7 IEEE INT C DA, P77, DOI DOI 10.1109/ICDMW.2007.109; Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Bengio, 2011, P ICML, DOI DOI 10.1177/1753193411430810; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918; Brown S, 2000, ORIGINS OF MUSIC, P271; Coutinho E, 2014, MEDIAEVAL WORKSH, V1263, P5; Coutinho E, 2017, MUSIC PERCEPT, V34, P371, DOI 10.1525/MP.2017.34.4.371; Coutinho E, 2014, IEEE IJCNN, P3592, DOI 10.1109/IJCNN.2014.6889814; Coutinho E, 2013, COGNITION EMOTION, V27, P658, DOI 10.1080/02699931.2012.732559; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Coutinho E, 2009, MUSIC PERCEPT, V27, P1, DOI 10.1525/MP.2009.27.1.1; Deng J, 2013, INT CONF AFFECT, P511, DOI 10.1109/ACII.2013.90; Douglas-Cowie E, 2007, LECT NOTES COMPUT SC, V4738, P488; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Feng Y., 2003, P 26 ANN INT ACM SIG, P375, DOI [DOI 10.1145/860500.860508, 10.1145/860435.860508]; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Gabrielsson Alf, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0014; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Ilie G, 2011, MUSIC PERCEPT, V28, P247, DOI 10.1525/MP.2011.28.3.247; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kawakami A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00311; KIVY P, 1980, PHILOS STUD, V38, P351, DOI 10.1007/BF00419335; Korhonen M, 2004, MODELING CONTINUOUS; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lin YC, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037683; McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Ranzato M.A., 2007, ADV NEURAL INF PROCE, P1137, DOI DOI 10.7551/mitpress/7503.003.0147; Ringeval F., 2013, AUT FAC GEST REC FG, P1, DOI [DOI 10.1109/FG.2013.6553805, 10.1109/FG.2013.6553805]; Ringeval F, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1335, DOI 10.1145/2733373.2806408; Ringeval F, 2015, PATTERN RECOGN LETT, V66, P22, DOI 10.1016/j.patrec.2014.11.007; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Scherer Klaus R, 2013, EMOTIONAL POWER MUSI, V2013, P121, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0010; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; Schuller B, 2011, 2 LECT NOT COMP SCI, V6975; Schuller B, 2013, INTERSPEECH, P148; Schuller B, 2010, IEEE T AFFECT COMPUT, V1, P119, DOI 10.1109/T-AFFC.2010.8; Schuller B, 2014, INTERSPEECH, P427; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Vincent P., 2008, P 25 INT C MACHINE L, P1096, DOI 10.1145/1390156.1390294; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Weninger F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00292; Wollmer M, 2010, IEEE J-STSP, V4, P867, DOI 10.1109/JSTSP.2010.2057200; Wollmer M, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P597; Wollmer M, 2011, ACM T SPEECH LANGUAG, V7, P12; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	63	13	13	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179289	10.1371/journal.pone.0179289	http://dx.doi.org/10.1371/journal.pone.0179289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EZ3JT	28658285	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900019
J	Duffy-Anderson, JT; Stabeno, PJ; Siddon, EC; Andrews, AG; Cooper, DW; Eisner, LB; Farley, EV; Harpold, CE; Heintz, RA; Kimmel, DG; Sewall, FF; Spear, AH; Yasumishii, EC				Duffy-Anderson, Janet T.; Stabeno, Phyllis J.; Siddon, Elizabeth C.; Andrews, Alex G.; Cooper, Daniel W.; Eisner, Lisa B.; Farley, Edward V.; Harpold, Colleen E.; Heintz, Ron A.; Kimmel, David G.; Sewall, Fletcher F.; Spear, Adam H.; Yasumishii, Ellen C.			Return of warm conditions in the southeastern Bering Sea: Phytoplankton - Fish	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; WALLEYE POLLOCK; SHELF; ZOOPLANKTON; AGE-0; ABUNDANCE; NORTHERN; IMPACTS; BIOMASS; GROWTH	In 2014, the Bering Sea shifted back to warmer ocean temperatures (+2 degrees C above average), bringing concern for the potential for a new warm stanza and broad biological and ecological cascading effects. In 2015 and 2016 dedicated surveys were executed to study the progression of ocean heating and ecosystem response. We describe ecosystem response to multiple, consecutive years of ocean warming and offer perspective on the broader impacts. Ecosystem changes observed include reduced spring phytoplankton biomass over the southeast Bering Sea shelf relative to the north, lower abundances of large-bodied crustacean zooplankton taxa, and degraded feeding and body condition of age-0 walleye pollock. This suggests poor ecosystem conditions for young pollock production and the risk of significant decline in the number of pollock available to the pollock fishery in 2-3 years. However, we also noted that high quality prey, large copepods and euphausiids, and lower temperatures in the north may have provided a refuge from poor conditions over the southern shelf, potentially buffering the impact of a sequential-year warm stanza on the Bering Sea pollock population. We offer the hypothesis that juvenile (age-0, age-1) pollock may buffer deleterious warm stanza effects by either utilizing high productivity waters associated with the strong, northerly Cold Pool, as a refuge from the warm, low production areas of the southern shelf, or by exploiting alternative prey over the southern shelf. We show that in 2015, the ocean waters influenced by spring sea ice (the Cold Pool) supported robust phytoplankton biomass (spring) comprised of centric diatom chains, a crustacean copepod community comprised of large-bodied taxa (spring, summer), and a large aggregation of midwater fishes, potentially young pollock. In this manner, the Cold Pool may have acted as a trophic refuge in that year. The few age-0 pollock occurring over the southeast shelf consumed high numbers of euphausiids which may have provided a high quality alternate prey. In 2016 a retracted Cold Pool precluded significant refuging in the north, though pollock foraging on available euphausiids over the southern shelf may have mitigated the effect of warm waters and reduced large availability of large copepods. This work presents the hypothesis that, in the short term, juvenile pollock can mitigate the drastic impacts of sustained warming. This short-term buffering, combined with recent observations (2017) of renewed sea ice presence over southeast Bering Sea shelf and a potential return to average or at least cooler ecosystem conditions, suggests that recent warm year stanza (2014-2016) effects to the pollock population and fishery may be mitigated.	[Duffy-Anderson, Janet T.; Cooper, Daniel W.; Harpold, Colleen E.; Kimmel, David G.; Spear, Adam H.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Stabeno, Phyllis J.] Pacific Marine Environm Lab, Seattle, WA USA; [Siddon, Elizabeth C.; Andrews, Alex G.; Eisner, Lisa B.; Farley, Edward V.; Heintz, Ron A.; Sewall, Fletcher F.; Yasumishii, Ellen C.] NOAA, Alaska Fisheries Sci Ctr, Auke Bay Labs, Natl Marine Fisheries Serv, Juneau, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Duffy-Anderson, JT (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Janet.Duffy-Anderson@noaa.gov	Farley, E/HHM-4227-2022; Kimmel, David/AFM-9673-2022; Kimmel, David G./N-1148-2019	Kimmel, David/0000-0001-7232-7801; 	National Oceanic and Atmospheric Administration; National Marine Fisheries Service, Office of Science and Technology; North Pacific Climate Regimes and Ecosystem Productivity Program	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Marine Fisheries Service, Office of Science and Technology; North Pacific Climate Regimes and Ecosystem Productivity Program	This work was supported by the National Oceanic and Atmospheric Administration. Support was also provided by the National Marine Fisheries Service, Office of Science and Technology and by the North Pacific Climate Regimes and Ecosystem Productivity Program.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], [No title captured]; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Boldt JL, 2012, FISH B-NOAA, V110, P293; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2008, DEEP-SEA RES PT II, V55, P1775, DOI 10.1016/j.dsr2.2008.04.029; Coyle KO, 2002, PROG OCEANOGR, V55, P177, DOI 10.1016/S0079-6611(02)00077-0; Dalsgaard J, 2013, ADV MAR BIOL, V46, P225; DeRobertis A, 2014, NMFS AFSC 272; Duffy-Anderson JT, 2016, DEEP-SEA RES PT II, V134, P283, DOI 10.1016/j.dsr2.2015.02.001; Eisner LB, 2016, DEEP-SEA RES PT II, V134, P100, DOI 10.1016/j.dsr2.2015.07.012; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; Farley Edward V. Jr, 2005, Alaska Fishery Research Bulletin, V11, P15; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; HINCKLEY S, 1987, FISH B-NOAA, V85, P481; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hunsicker ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066025; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hurst TP, 2007, CAN J FISH AQUAT SCI, V64, P449, DOI 10.1139/F07-025; Kotwicki S., 2016, STOCK ASSESSMENT FIS, P55; Ladd C, 2016, ECOSYSTEM CONSIDERAT, P87; Laney SR, 2014, DEEP-SEA RES PT II, V105, P30, DOI 10.1016/j.dsr2.2014.03.012; Lomas MW, 2012, DEEP-SEA RES PT II, V65-70, P126, DOI 10.1016/j.dsr2.2012.02.010; Moss JH, 2009, T AM FISH SOC, V138, P497, DOI 10.1577/T08-126.1; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; PETERSON W, 2015, WARM BLOB CONTINUES, V23, P44; Peterson W., 2015, WARM BLOB CONTINUES, V23, P36; Petrik CM, 2016, ICES J MAR SCI, V73, P1890, DOI 10.1093/icesjms/fsw004; Siddon EC, 2013, DEEP-SEA RES PT II, V94, P140, DOI 10.1016/j.dsr2.2012.12.007; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sigler MF, 2016, DEEP-SEA RES PT II, V134, P223, DOI 10.1016/j.dsr2.2016.01.003; Sogard SM, 2000, J FISH BIOL, V56, P1; Sogard SM, 1996, MAR ECOL PROG SER, V133, P43, DOI 10.3354/meps133043; Stabeno PJ, 2016, DEEP-SEA RES PT II, V134, P13, DOI 10.1016/j.dsr2.2016.05.010; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P14, DOI 10.1016/j.dsr2.2012.02.019; Stabeno PJ, 1999, UASGCP REP, V99, P1; Thorson JT, 2015, ICES J MAR SCI, V72, P1297, DOI 10.1093/icesjms/fsu243; VIDAL J, 1986, DEEP-SEA RES, V33, P523, DOI 10.1016/0198-0149(86)90129-9; Wang SX, 2014, LECT NOTES COMPUT SC, V8388, P175, DOI 10.1007/978-3-319-06826-8_14; Wyllie Echeverria Tina, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P131; Wyllie-Echeverria T, 1998, FISH OCEANOGR, V7, P159, DOI 10.1046/j.1365-2419.1998.00058.x	44	50	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178955	10.1371/journal.pone.0178955	http://dx.doi.org/10.1371/journal.pone.0178955			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658253	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900010
J	Banni, M; Sforzini, S; Arlt, VM; Barranger, A; Dallas, LJ; Oliveri, C; Aminot, Y; Pacchioni, B; Millino, C; Lanfranchi, G; Readman, JW; Moore, MN; Viarengo, A; Jha, AN				Banni, Mohamed; Sforzini, Susanna; Arlt, Volker M.; Barranger, Audrey; Dallas, Lorna J.; Oliveri, Caterina; Aminot, Yann; Pacchioni, Beniamina; Millino, Caterina; Lanfranchi, Gerolamo; Readman, James W.; Moore, Michael N.; Viarengo, Aldo; Jha, Awadhesh N.			Assessing the impact of Benzo[a]pyrene on Marine Mussels: Application of a novel targeted low density microarray complementing classical biomarker responses	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TISSUE-SPECIFIC EXPRESSION; OXIDATIVE DNA-DAMAGE; HEAT-SHOCK-PROTEIN; MYTILUS-EDULIS-L; IN-VIVO; DIGESTIVE GLAND; METABOLIC-ACTIVATION; ACTIN CYTOSKELETON; GENE-EXPRESSION	Despite the increasing use of mussels in environmental monitoring and ecotoxicological studies, their genomes and gene functions have not been thoroughly explored. Several cDNA microarrays were recently proposed for Mytilus spp., but putatively identified partial transcripts have rendered the generation of robust transcriptional responses difficult in terms of pathway identification. We developed a new low density oligonucleotide microarray with 465 probes covering the same number of genes. Target genes were selected to cover most of the well-known biological processes in the stress response documented over the last decade in bivalve species at the cellular and tissue levels. Our new 'STressREsponse Microarray' (STREM) platform consists of eight sub-arrays with three replicates for each target in each sub-array. To assess the potential use of the new array, we tested the effect of the ubiquitous environmental pollutant benzo[a] pyrene (B[a] P) at 5, 50, and 100 mu g/L on two target tissues, the gills and digestive gland, of Mytilus galloprovincialis exposed invivo for three days. Bioaccumulation of B[a] P was also determined demonstrating exposure in both tissues. In addition to the well-known effects of B[a] P on DNA metabolism and oxidative stress, the new array data provided clues about the implication of other biological processes, such as cytoskeleton, immune response, adhesion to substrate, and mitochondrial activities. Transcriptional data were confirmed using qRT-PCR. We further investigated cellular functions and possible alterations related to biological processes highlighted by the microarray data using oxidative stress biomarkers ( Lipofuscin content) and the assessment of genotoxicity. DNA damage, as measured by the alkaline comet assay, increased as a function of dose. DNA adducts measurements using 32 P-postlabeling method also showed the presence of bulky DNA adducts (i.e. dG-N-2-BPDE). Lipofiscin content increased significantly in B[a] P exposed mussels. Immunohistochemical analysis of tubulin and actin showed changes in cytoskeleton organisation. Our results adopting an integrated approach confirmed that the combination of newly developed transcriptomic approcah, classical biomarkers along with chemical analysis of water and tissue samples should be considered for environmental bioimonitoring and ecotoxicological studies to obtain holistic information to assess the impact of contaminants on the biota.	[Banni, Mohamed; Sforzini, Susanna; Oliveri, Caterina; Viarengo, Aldo] Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Alessandria, Italy; [Banni, Mohamed] Sousse Univ, ISA Chott Mariem, Lab Biochem & Environm Toxicol, Sousse, Tunisia; [Arlt, Volker M.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Analyt & Environm Sci Div, London, England; [Arlt, Volker M.] Kings Coll London, Publ Hlth England, NIHR Hlth Protect Res Unit Hlth Impact Environm H, London, England; [Barranger, Audrey; Dallas, Lorna J.; Moore, Michael N.; Jha, Awadhesh N.] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England; [Aminot, Yann; Readman, James W.] Univ Plymouth, Ctr Chem Sci, Plymouth, Devon, England; [Pacchioni, Beniamina; Millino, Caterina; Lanfranchi, Gerolamo] Univ Padua, Padua, Italy; [Readman, James W.; Moore, Michael N.] Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England; [Moore, Michael N.] Univ Exeter, Med Sch, Knowledge Spa, ECEHH,Royal Cornwall Hosp, Truro, Cornwall, England	University of Eastern Piedmont Amedeo Avogadro; Universite de Sousse; University of London; King's College London; Public Health England; University of London; King's College London; University of Plymouth; University of Plymouth; University of Padua; Plymouth Marine Laboratory; Royal Cornwall Hospital; University of Exeter	Banni, M (corresponding author), Univ Piemonte Orientale, Dept Sci & Technol Innovat DiSIT, Alessandria, Italy.; Banni, M (corresponding author), Sousse Univ, ISA Chott Mariem, Lab Biochem & Environm Toxicol, Sousse, Tunisia.; Jha, AN (corresponding author), Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England.	m_banni@yahoo.fr; a.jha@plymouth.ac.uk	Barranger, Audrey/AAJ-8271-2020; Banni, Mohamed/M-2144-2014	Sforzini, Susanna/0000-0002-7310-7605; Banni, Mohamed/0000-0001-9764-0343; Jha, Awadhesh/0000-0001-9660-4308; Aminot, Yann/0000-0002-6507-9261; Arlt, Volker Manfred/0000-0003-4314-9318; Viarengo, Aldo/0000-0002-1557-6526; Barranger, Audrey/0000-0002-2947-6921	Natural Environment Research Council (NERC), UK [NE/L006782/1]; Cancer Research UK [C313/A14329]; Wellcome Trust [101126/Z/13/Z, 101126/B/13/Z]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU); Public Health England (PHE); NERC [NE/L006782/1] Funding Source: UKRI; Natural Environment Research Council [NE/L006782/1] Funding Source: researchfish	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Health Protection Research Unit (NIHR HPRU); Public Health England (PHE); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is supported by Natural Environment Research Council (NERC), UK (Grant No.NE/L006782/1; PI: ANJ). Work at King's College London is further supported by Cancer Research UK (Grant C313/A14329), the Wellcome Trust (Grants 101126/Z/13/Z and 101126/B/13/Z) and in part by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King's College London in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health or PHE.	Akcha F, 2000, MAR ECOL PROG SER, V205, P195, DOI 10.3354/meps205195; Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Al-Subiai SN, 2012, MUTAT RES-GEN TOX EN, V745, P92, DOI 10.1016/j.mrgentox.2011.12.019; Altenburger R, 2003, BIOMARKERS PAH PROSP, P147; Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036; Arlt VM, 2008, CARCINOGENESIS, V29, P656, DOI 10.1093/carcin/bgn002; Attig H, 2010, ECOTOX ENVIRON SAFE, V73, P1712, DOI 10.1016/j.ecoenv.2010.08.007; Banan A, 2001, AM J PHYSIOL-GASTR L, V280, pG1234, DOI 10.1152/ajpgi.2001.280.6.G1234; Banni M, 2005, BIOMARKERS, V10, P105, DOI 10.1080/13547500500107497; Banni M, 2010, ECOTOX ENVIRON SAFE, V73, P842, DOI 10.1016/j.ecoenv.2009.12.032; Banni M, 2009, CHEMOSPHERE, V77, P902, DOI 10.1016/j.chemosphere.2009.08.041; Banni M, 2016, ENVIRON RES, V145, P135, DOI 10.1016/j.envres.2015.12.003; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Banni M, 2009, COMP BIOCHEM PHYS C, V149, P414, DOI 10.1016/j.cbpc.2008.09.017; Bayne B.L., 1976, MARINE MUSSELS THEIR; Bignell JP, 2011, MAR ENVIRON RES, V72, P25, DOI 10.1016/j.marenvres.2011.05.004; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Canova S, 1998, MUTAT RES-FUND MOL M, V399, P17, DOI 10.1016/S0027-5107(97)00263-7; Carlson EA, 2002, AQUAT TOXICOL, V56, P289, DOI 10.1016/S0166-445X(01)00223-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P10, DOI 10.1016/S0955-0674(89)80030-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connelly H, 2010, INT J TOXICOL, V29, P532, DOI 10.1177/1091581810377518; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; D'Agata A, 2014, NANOTOXICOLOGY, V8, P549, DOI 10.3109/17435390.2013.807446; Dallas LJ, 2013, MUTAT RES-GEN TOX EN, V754, P22, DOI 10.1016/j.mrgentox.2013.03.009; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Devier MH, 2005, J ENVIRON MONITOR, V7, P224, DOI 10.1039/b409577d; Di Y, 2017, MUTAGENESIS, V32, P77, DOI 10.1093/mutage/gew049; Di YA, 2011, ENVIRON SCI TECHNOL, V45, P8974, DOI 10.1021/es201547x; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Farkas J, 2015, SCI TOTAL ENVIRON, V511, P469, DOI 10.1016/j.scitotenv.2014.12.084; Gomez-Mendikute A, 2003, TOXICOL IN VITRO, V17, P539, DOI 10.1016/S0887-2333(03)00093-6; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Jerina D M, 1991, Adv Exp Med Biol, V283, P533; Jha AN, 1996, MUTAT RES-ENVIR MUTA, V359, P141, DOI 10.1016/S0165-1161(96)90260-5; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; Kelley ML, 2001, ONCOGENE, V20, P748, DOI 10.1038/sj.onc.1204144; Krais AM, 2016, ARCH TOXICOL, V90, P839, DOI 10.1007/s00204-015-1531-8; Kucab JE, 2015, MUTAT RES-FUND MOL M, V773, P48, DOI 10.1016/j.mrfmmm.2015.01.013; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Liu T, 2015, GENE, V555, P108, DOI 10.1016/j.gene.2014.10.051; LIVINGSTONE DR, 1984, SCI TOTAL ENVIRON, V39, P209, DOI 10.1016/0048-9697(84)90080-9; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Long AS, 2016, TOXICOL APPL PHARM, V290, P31, DOI 10.1016/j.taap.2015.11.010; Maria VL, 2013, AQUAT TOXICOL, V144, P284, DOI 10.1016/j.aquatox.2013.10.009; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MARTINEZ PG, 1995, TOXICOL APPL PHARM, V131, P332, DOI 10.1006/taap.1995.1076; Matocq MD, 2009, MOL ECOL, V18, P2310, DOI 10.1111/j.1365-294X.2009.04172.x; McGarry MA, 2002, BIOCHEM BIOPH RES CO, V294, P101, DOI 10.1016/S0006-291X(02)00437-0; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MOORE MN, 1988, MAR ECOL PROG SER, V46, P81, DOI 10.3354/meps046081; Negri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066802; Pearse A. G. E., 1985, HISTOCHEMISTRY THEOR, V2, P441; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phillips DH, 2014, METHODS MOL BIOL, V1105, P127, DOI 10.1007/978-1-62703-739-6_10; Riva C, 2011, AQUAT TOXICOL, V104, P14, DOI 10.1016/j.aquatox.2011.03.008; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sogbanmu TO, 2016, ENVIRON SCI POLLUT R, V23, P14489, DOI 10.1007/s11356-016-6490-y; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Telli-Karakoc F, 2002, MAR ENVIRON RES, V54, P511, DOI 10.1016/S0141-1136(02)00192-7; Tian SM, 2013, AQUAT TOXICOL, V144, P162, DOI 10.1016/j.aquatox.2013.09.031; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wessel N, 2007, AQUAT TOXICOL, V85, P133, DOI 10.1016/j.aquatox.2007.08.007; Widdows J, 2002, MAR ENVIRON RES, V53, P327, DOI 10.1016/S0141-1136(01)00120-9; Yakovleva L, 2006, BIOCHEMISTRY-US, V45, P7644, DOI 10.1021/bi060158h	69	41	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178460	10.1371/journal.pone.0178460	http://dx.doi.org/10.1371/journal.pone.0178460			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651000	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000404537300046
J	Alexander, PM; Caudell, DL; Kucera, GL; Pladna, KM; Pardee, TS				Alexander, Peter M.; Caudell, David L.; Kucera, Gregory L.; Pladna, Kristin M.; Pardee, Timothy S.			The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PROTEIN-KINASE-C; ACUTE MYELOID-LEUKEMIA; BCR-ABL; ADULT; CHEMOTHERAPY; IMATINIB; CELLS; RESISTANCE; DASATINIB	Philadelphia chromosome positive B cell acute lymphoblastic leukemia (Ph+ ALL) is an aggressive cancer of the bone marrow. The addition of tyrosine kinase inhibitors (TKIs) has improved outcomes but many patients still suffer relapse and novel therapeutic agents are needed. KPC34 is an orally available, novel phospholipid conjugate of gemcitabine, rationally designed to overcome multiple mechanisms of resistance, inhibit the classical and novel isoforms of protein kinase C, is able to cross the blood brain barrier and is orally bio-available. KPC34 had an IC50 in the nanomolar range against multiple ALL cell lines tested but was lowest for Ph+ lines. In mice bearing either naive or resistant Ph+ ALL, KPC34 treatment resulted in significantly improved survival compared to cytarabine and gemcitabine. Treatment with KPC34 and doxorubicin was more effective than doxorubicin and cytarabine. Mice with recurrence of their ALL after initial treatment with cytarabine and doxorubicin saw dramatic improvements in hind limb paralysis after treatment with KPC34 demonstrating activity against established CNS disease. Consistent with this KPC34 was better than gemcitabine at reducing CNS leukemic burden. These promising pre-clinical results justify the continued development of KPC34 for the treatment of Ph+ALL.	[Alexander, Peter M.; Kucera, Gregory L.; Pladna, Kristin M.; Pardee, Timothy S.] Wake Forest Baptist Hlth, Sect Hematol & Oncol, Internal Med, Winston Salem, NC 27157 USA; [Caudell, David L.] Wake Forest Baptist Hlth, Pathol Comparat Med, Winston Salem, NC USA; [Kucera, Gregory L.; Pardee, Timothy S.] Wake Forest Univ, Ctr Comprehens Canc, Canc Biol, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Baptist Hlth, Sect Hematol & Oncol, Internal Med, Winston Salem, NC 27157 USA.; Pardee, TS (corresponding author), Wake Forest Univ, Ctr Comprehens Canc, Canc Biol, Winston Salem, NC 27109 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP); National Cancer Institute [T32CA079448-09, 1K08CA169809-01, P30CA012197]; NCI Cancer Center [P30CA012197]; NATIONAL CANCER INSTITUTE [K08CA169809, P30CA012197, T32CA079448] Funding Source: NIH RePORTER	Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Doug Coley Foundation for Leukemia Research, Wake Forest Innovations (SPARK award, TSP), and the National Cancer Institute (T32CA079448-09, PMA, 1K08CA169809-01, TSP, P30CA012197, GLK).The Cell virus and vector laboratory and flow to me try core are supported by NCI Cancer Center Support Grant (CCSG) P30CA012197.	Annino L, 2002, BLOOD, V99, P863, DOI 10.1182/blood.V99.3.863; Boulos N, 2011, BLOOD, V117, P3585, DOI 10.1182/blood-2010-08-301267; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Fielding Adele K, 2015, Am Soc Clin Oncol Educ Book, pe352, DOI 10.14694/EdBook_AM.2015.35.e352; Fielding AK, 2014, BLOOD, V123, P843, DOI 10.1182/blood-2013-09-529008; Foa R, 2011, BLOOD, V118, P6521, DOI 10.1182/blood-2011-05-351403; Galmarini CM, 2003, BRIT J HAEMATOL, V122, P53, DOI 10.1046/j.1365-2141.2003.04386.x; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Goncalves RP, 2005, LEUKEMIA RES, V29, P955, DOI 10.1016/j.leukres.2005.01.013; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Jabbour E, 2010, CANCER-AM CANCER SOC, V116, P2290, DOI 10.1002/cncr.25008; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Kim DY, 2015, BLOOD, V126, P746, DOI 10.1182/blood-2015-03-636548; Kuang P, 2016, LEUKEMIA LYMPHOMA, V57, P2321, DOI 10.3109/10428194.2016.1144882; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Lilly MB, 2010, AM J HEMATOL, V85, P164, DOI 10.1002/ajh.21615; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Marks DI, 2010, HEMATOL-AM SOC HEMAT, P13, DOI 10.1182/asheducation-2010.1.13; Moschovi M, 2004, J PEDIAT HEMATOL ONC, V26, P289, DOI 10.1097/00043426-200405000-00006; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Nowak G, 2003, J PHARMACOL EXP THER, V306, P157, DOI 10.1124/jpet.103.050336; Ottmann OG, 2013, LEUKEMIA, V27, P1411, DOI 10.1038/leu.2012.324; Ottmann Oliver G, 2009, Hematology Am Soc Hematol Educ Program, P371, DOI 10.1182/asheducation-2009.1.371; Pickin KA, 2009, J DRUG DELIV SCI TEC, V19, P31, DOI 10.1016/S1773-2247(09)50004-4; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Reman O, 2008, LEUKEMIA RES, V32, P1741, DOI 10.1016/j.leukres.2008.04.011; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Roy M, 2015, CHEM-BIOL INTERACT, V242, P195, DOI 10.1016/j.cbi.2015.10.004; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Todd RF, 2015, TUMOR BOARD REV GUID; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179798	10.1371/journal.pone.0179798	http://dx.doi.org/10.1371/journal.pone.0179798			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644853	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100038
J	Kang, YM; Jung, CH; Cho, YK; Jang, JE; Hwang, JY; Kim, EH; Lee, WJ; Park, JY; Kim, HK				Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Jang, Jung Eun; Hwang, Jenie Yoonoo; Kim, Eun Hee; Lee, Woo Je; Park, Joong-Yeol; Kim, Hong-Kyu			Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; INSULIN-RESISTANCE; FAT DISTRIBUTION; INFLAMMATION; MORTALITY; ASSOCIATION; OVERWEIGHT	Objective Some individuals with metabolically healthy obesity (MHO) convert to metabolically unhealthy obesity (MUO) phenotype, and visceral adiposity is one of proposed mechanisms underlying such conversion. Visceral adipose index (VAI) is a novel mathematical model which estimates visceral adiposity based on anthropometric and lipid profiles. We aimed to determine the association of VAI-estimated visceral adiposity with the MHO-to-MUO conversion and the predictive value of VAI in estimating such unfavorable outcomes. Methods A total of 2,204 Korean subjects with the MHO phenotype were enrolled and stratified by body mass index and metabolic health state according to Wildman criteria at baseline and last follow-up examinations. VAI was calculated at baseline. Results Over a median follow-up period of 41.1 months, 46.0% of subjects converted to MUO phenotype. Higher VAI quartiles were associated with a greater proportion of subjects who underwent MHO-to-MUO conversion, and also with increased odds ratios for such conversion even after multivariate analyses. The optimal VAI cut off value was around 1.00, and VAI had a greater power in the prediction of MHO-to MUO conversion than waist circumference in both genders. Conclusion MHO phenotypes with high VAI values are associated with poor future metabolic outcomes. VAI-estimated visceral adiposity is well correlated with the prognosis of MHO subjects, and VAI has a good predictive value in determining the MHO-to-MUO conversion.	[Kang, Yu Mi; Jung, Chang Hee; Cho, Yun Kyung; Jang, Jung Eun; Lee, Woo Je; Park, Joong-Yeol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Hwang, Jenie Yoonoo; Kim, Eun Hee; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jung, CH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.; Kim, HK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea.	chjung0204@gmail.com; hkkim0801@amc.seoul.kr	Kang, Yu Mi/AAW-2935-2020; Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396				Al-Daghri NM, 2014, PEDIATR RES, V75, P459, DOI 10.1038/pr.2013.229; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Jung CH, 2014, OBESITY, V22, P2613, DOI 10.1002/oby.20883; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Mangge H, 2013, OBESITY, V21, pE71, DOI 10.1002/oby.20061; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Oh JY, 2013, OBESITY, V21, P1690, DOI 10.1002/oby.20096; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Park YW, 2002, INT J OBESITY, V26, P978, DOI 10.1038/sj.ijo.0801982; Peppa M, 2013, EUR J INTERN MED, V24, P824, DOI 10.1016/j.ejim.2013.07.001; Peppa M, 2013, OBESITY, V21, P1807, DOI 10.1002/oby.20227; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Samocha-Bonet D, 2014, OBES REV, V15, P697, DOI 10.1111/obr.12199; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; van der A DL, 2014, OBESITY, V22, P557, DOI 10.1002/oby.20480; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; WANG QL, 1994, AM J CLIN NUTR, V60, P843, DOI 10.1093/ajcn/60.6.843; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A	36	32	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179635	10.1371/journal.pone.0179635	http://dx.doi.org/10.1371/journal.pone.0179635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644850	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100026
J	Latorre, P; Varona, L; Burgos, C; Carrodeguas, JA; Lopez-Buesa, P				Latorre, Pedro; Varona, Luis; Burgos, Carmen; Carrodeguas, Jose A.; Lopez-Buesa, Pascual			O-GlcNAcylation mediates the control of cytosolic phosphoenolpyruvate carboxykinase activity via Pgc1 alpha	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ASSOCIATION ANALYSIS; FAT DEPOSITION; MUSCLE; GENE; EXPRESSION; EPISTASIS; QUALITY; TRAITS; MODEL	PGC1 alpha is a coactivator of many transcription factors and cytosolic phosphoenolpyruvate carboxykinase (PCK1) is a key enzyme for gluconeogenesis. PGC1a interacts with the transcription factor PPAR. to stimulate PCK1 expression and thus de novo glucose synthesis. These proteins are not only important for central energy metabolism but also for supplying intermediates for other metabolic pathways, including lipidogenesis and protein synthesis and might therefore be important factors in the ethiopathogenesis of metabolic disorders like diabetes but also in other pathologies like cancer. Since polymorphisms in these proteins have been related to some phenotypic traits in animals like pigs and PGC1a G482S polymorphism increases fat deposition in humans, we have investigated the molecular basis of such effects focusing on a commonly studied polymorphism in pig Pgc1 alpha, which changes a cysteine at position 430 (WT) of the protein to a serine (C430S). Biochemical analyses show that Pgc1a WT stimulates higher expression of human PCK1 in HEK293T and HepG2 cells. Paradoxically, Pgc1a WT is less stable than Pgc1 alpha p. C430S in HEK293T cells. However, the study of different post- translational modifications shows a higher OGlcNAcylation level of Pgc1 alpha p. C430S. This higher O-GlcNAcylation level significantly decreases the interaction between Pgc1 alpha and PPAR. demonstrating the importance of post-translational glycosylation of PGC1 alpha in the regulation of PCK1 activity. This, furthermore, could explain at least in part the observed epistatic effects between PGC1a and PCK1 in pigs.	[Latorre, Pedro; Burgos, Carmen; Lopez-Buesa, Pascual] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Latorre, Pedro; Burgos, Carmen; Carrodeguas, Jose A.; Lopez-Buesa, Pascual] Univ Zaragoza, BIFIIQFR CSIC Joint Unit, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Varona, Luis] Univ Zaragoza, Dept Anat Embriol & Genet, Zaragoza, Spain; [Varona, Luis] IA2, Zaragoza, Spain; [Carrodeguas, Jose A.] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Carrodeguas, Jose A.] IIS Aragon, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; University of Zaragoza	Lopez-Buesa, P (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.; Carrodeguas, JA; Lopez-Buesa, P (corresponding author), Univ Zaragoza, BIFIIQFR CSIC Joint Unit, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain.; Carrodeguas, JA (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.; Carrodeguas, JA (corresponding author), IIS Aragon, Zaragoza, Spain.	carrode@unizar.es; plopezbu@unizar.es	Varona, Luis/C-2744-2012; Román, Pedro Ángel Latorre/K-1052-2019	Varona, Luis/0000-0001-6256-5478; Latorre Muro, Pedro/0000-0002-6794-3535	Ministerio de Economia, Industria y Competitividad [AGL2015-66177]; University of Zaragoza [UZ 2014-CIE-03, UZ-2015-BIO-01]; la Caixa' Foundation	Ministerio de Economia, Industria y Competitividad; University of Zaragoza; la Caixa' Foundation(La Caixa Foundation)	This work has been funded by grants AGL2015-66177 to P.L.B. and J.A.C. from Ministerio de Economia, Industria y Competitividad (http://www.mineco.gob.es/portal/site/mineco/), UZ 2014-CIE-03 to P.L.B. and UZ-2015-BIO-01 to J.A.C. from University of Zaragoza (http://www.unizar.es). Funders' role has been limited to financial support. P.L. is supported by a predoctoral fellowship from la Caixa Foundation (https://www.fundacionbancarialacaixa.org/corporate/home_es.html).	Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Bin Ruan H, 2012, CELL METAB, V16, P226; Chen YM, 2013, NUTR RES, V33, P332, DOI 10.1016/j.nutres.2013.02.003; Dekkers JCM, 2012, CURR GENOMICS, V13, P207, DOI 10.2174/138920212800543057; Erkens T, 2010, CZECH J ANIM SCI, V55, P200, DOI 10.17221/263/2009-CJAS; Erkens T, 2009, CZECH J ANIM SCI, V54, P408, DOI 10.17221/12/2009-CJAS; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gandolfi G, 2011, MEAT SCI, V89, P478, DOI 10.1016/j.meatsci.2011.05.015; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Glorian M, 2001, BIOCHIMIE, V83, P933, DOI 10.1016/S0300-9084(01)01343-8; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kunej T, 2005, J ANIM BREED GENET, V122, P7, DOI 10.1111/j.1439-0388.2004.00498.x; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Latorre P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19617; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu R, 2011, J ANIM VET ADV, V10, P2301, DOI 10.3923/javaa.2011.2301.2304; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Plomin R, 2009, GENETICS; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Takikita S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015239; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wood JD, 2004, MEAT SCI, V67, P651, DOI 10.1016/j.meatsci.2004.01.007; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	32	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179988	10.1371/journal.pone.0179988	http://dx.doi.org/10.1371/journal.pone.0179988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644880	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100056
J	Park, J; Kim, IH; Fong, JJ; Koo, KS; Choi, WJ; Tsai, TS; Park, D				Park, Jaejin; Kim, Il-Hun; Fong, Jonathan J.; Koo, Kyo-Soung; Choi, Woo-Jin; Tsai, Tein-Shun; Park, Daesik			Northward dispersal of sea kraits (Laticauda semifasciata) beyond their typical range	PLOS ONE			English	Article							CLIMATE-CHANGE; ELAPIDAE LATICAUDINAE; SNAKE; SERPENTES; SHIFTS; PHYLOGEOGRAPHY; ABUNDANCE; FISHES	Marine reptiles are declining globally, and recent climate change may be a contributing factor. The study of sea snakes collected beyond their typical distribution range provides valuable insight on how climate change affects marine reptile populations. Recently, we collected 12 Laticauda semifasciata (11 females, 1 male) from the waters around southern South Korea-an area located outside its typical distribution range (Japan, China including Taiwan, Philippines and Indonesia). We investigated the genetic origin of Korean specimens by analyzing mitochondrial cytochrome b gene (Cytb) sequences. Six individuals shared haplotypes with a group found in Taiwan-southern Ryukyu Islands, while the remaining six individuals shared haplotypes with a group encompassing the entire Ryukyu Archipelago. These results suggest L. semifasciata moved into Korean waters from the Taiwan-Ryukyu region via the Taiwan Warm Current and/or the Kuroshio Current, with extended survival facilitated by ocean warming. We highlight several contributing factors that increase the chances that L. semifasciata establishes new northern populations beyond the original distribution range.	[Park, Jaejin; Kim, Il-Hun; Koo, Kyo-Soung; Choi, Woo-Jin] Kangwon Natl Univ, Dept Biol, Chunchon, Kangwon, South Korea; [Fong, Jonathan J.] Lingnan Univ, Sci Unit, Tuen Mun, Hong Kong, Peoples R China; [Tsai, Tein-Shun] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Neipu Township, Pingtung County, Taiwan; [Park, Daesik] Kangwon Natl Univ, Div Sci Educ, Chunchon, Kangwon, South Korea; [Kim, Il-Hun] Natl Marine Biodivers Inst Korea, Chungnam, South Korea	Kangwon National University; Lingnan University; National Pingtung University Science & Technology; Kangwon National University; Marine Biodiversity Institute of Korea (MABIK)	Park, D (corresponding author), Kangwon Natl Univ, Div Sci Educ, Chunchon, Kangwon, South Korea.	parkda@kangwon.ac.kr	Tsai, Tein-Shun/P-8928-2019	FONG, Jonathan/0000-0002-3648-6730; Park, Jaejin/0000-0001-8794-5776; Park, Daesik/0000-0001-9209-0493; Tsai, Tein-Shun/0000-0002-7245-1826	National Research Foundation of Korea-Ministry of Education [2014R1A1A4A01005302]	National Research Foundation of Korea-Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	Research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A4A01005302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKLEY RA, 1970, SCI J, V6, P54; Brischoux F, 2007, P 11 ANN M HLTH SCI; Brischoux F, 2007, MAR ECOL PROG SER, V350, P145, DOI 10.3354/meps07133; Brischoux F, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0436; Brischoux F, 2013, J SEA RES, V76, P1, DOI 10.1016/j.seares.2012.10.010; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; 장승민, 2006, 한국해양환경•에너지학회지, V9, P55; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Choi Youn, 2013, Hangug Hwangyeong Saengmul Haghoeji, V31, P45; Dunson WA, 1975, BIOL SEA SNAKES; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goiran C, 2013, CORAL REEFS, V32, P281, DOI 10.1007/s00338-012-0977-x; Gordon Larry, 2015, LOS ANGELES TIMES; Great Barrier Reef Marine Park Authority, 2012, VULNERABILITY ASSESS; Hamann M, 2007, VULNERABILITY MARINE; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Heatwole H, 2005, HERPETOL MONOGR, V19, P1, DOI 10.1655/0733-1347(2005)019[0001:GVISKO]2.0.CO;2; Heatwole H, 1999, SEA SNAKES; Heatwole H, 2016, J SEA RES, V115, P18, DOI 10.1016/j.seares.2016.05.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ineich I, 2007, MAR BIOL, V151, P793, DOI 10.1007/s00227-006-0527-6; Jung S, 2014, REV FISH BIOL FISHER, V24, P443, DOI 10.1007/s11160-013-9310-1; Kang Y. S., 1975, ILLUSTRATED ENCY FAU, V17; Kharin VE, 2009, RUSS J MAR BIOL +, V35, P8, DOI 10.1134/S1063074009010027; Kim Il-Hun, 2016, Journal of Ecology and Environment, V40, P1, DOI 10.1186/s41610-016-0002-3; Kim LT, 2009, FAUNA CHOSUN AMPHIBI; Ko JC, 2015, JFMSE, V27, P319, DOI DOI 10.13000/JFMSE.2015.27.2.319; Kobayashi DR, 2011, ICES J MAR SCI; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee HJ, 2013, KOREAN J HERPETOLOGY, V5, P45; Lee JN, 2003, B BASIC SCI RES CTR, V15, P153; Liu YL, 2010, MAR BIOL, V157, P2369, DOI 10.1007/s00227-010-1501-x; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Mao S. H., 1980, SEA SNAKES TAIWAN NA; Cao NV, 2014, CONSERV BIOL, V28, P1677, DOI 10.1111/cobi.12387; Park J, 2016, KOREAN J HERPETOL, V7, P6; Park Jaejin, 2016, Animal Systematics Evolution and Diversity, V32, P148, DOI 10.5635/ASED.2016.32.2.148; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; SHANNON FREDERICK A., 1956, HERPETOLOGICA, V12, P22; Sheehy CM, 2012, INTEGR COMP BIOL, V52, P321, DOI 10.1093/icb/ics088; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stejneger LH, 1907, HERPETOLOGY JAPAN AD; Su Y, 2005, ZOOL STUD, V44, P403; Tandavanitj Nontivich, 2013, Current Herpetology, V32, P135, DOI 10.5358/hsj.32.135; Tandavanitj N, 2013, ZOOL SCI, V30, P633, DOI 10.2108/zsj.30.633; Toriba M., 1994, P206; TU MC, 1990, J HERPETOL, V24, P119, DOI 10.2307/1564218; Wallace BP, 2016, MARINE REPTILES; Wang SA, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-43; Zhao E, 1993, HERPETOLOGY CHINA, V10	52	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179871	10.1371/journal.pone.0179871	http://dx.doi.org/10.1371/journal.pone.0179871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644894	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100045
J	Reuscher, MG; Baguley, JG; Conrad-Forrest, N; Cooksey, C; Hyland, JL; Lewis, C; Montagna, PA; Ricker, RW; Rohal, M; Washburn, T				Reuscher, Michael G.; Baguley, Jeffrey G.; Conrad-Forrest, Nathan; Cooksey, Cynthia; Hyland, Jeffrey L.; Lewis, Christopher; Montagna, Paul A.; Ricker, Robert W.; Rohal, Melissa; Washburn, Travis			Temporal patterns of Deepwater Horizon impacts on the benthic infauna of the northern Gulf of Mexico continental slope	PLOS ONE			English	Article							SEA SEDIMENT; COMMUNITY; CONSEQUENCES; TOXICITY; MARINE; MODEL	The Deepwater Horizon oil spill occurred in spring and summer 2010 in the northern Gulf of Mexico. Research cruises in 2010 (approximately 2-3 months after the well had been capped), 2011, and 2014 were conducted to determine the initial and subsequent effects of the oil spill on deep-sea soft-bottom infauna. A total of 34 stations were sampled from two zones: 20 stations in the "impact" zone versus 14 stations in the "non-impact" zone. Chemical contaminants were significantly different between the two zones. Polycyclic aromatic hydrocarbons averaged 218 ppb in the impact zone compared to 14 ppb in the non-impact zone. Total petroleum hydrocarbons averaged 1166 ppm in the impact zone compared to 102 ppm in the non-impact zone. While there was no difference between zones for meiofauna and macrofauna abundance, community diversity was significantly lower in the impact zone. Meiofauna taxa richness over the three sampling periods averaged 8 taxa/sample in the impact zone, compared to 10 taxa/sample in the non-impact zone; and macrofauna richness averaged 25 taxa/sample in the impact zone compared to 30 taxa/sample in the non-impact zone. Oil originating from the Deepwater Horizon oil spill reached the seafloor and had a persistent negative impact on diversity of soft-bottom, deep-sea benthic communities. While there are signs of recovery for some benthic community variables, full recovery has not yet occurred four years after the spill.	[Reuscher, Michael G.; Montagna, Paul A.; Rohal, Melissa; Washburn, Travis] Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA; [Baguley, Jeffrey G.; Conrad-Forrest, Nathan] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Cooksey, Cynthia] NOAA, Natl Marine Fisheries Serv, Charleston, SC USA; [Hyland, Jeffrey L.] NOAA, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Lewis, Christopher] Ind Econ Inc, Cambridge, MA USA; [Ricker, Robert W.] NOAA, Off Response & Restorat, Assessment & Restorat Div, Santa Rosa, CA USA	Texas A&M University System; Texas A&M University Corpus Christi; Nevada System of Higher Education (NSHE); University of Nevada Reno; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA	Reuscher, MG (corresponding author), Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA.	michael.reuscher@tamucc.edu	Montagna, Paul A./J-8208-2017; Washburn, Travis/C-2200-2019; Reuscher, Michael/O-5498-2015	Montagna, Paul A./0000-0003-4199-3312; Washburn, Travis/0000-0001-7316-6237; Reuscher, Michael/0000-0001-5150-9876	British Petroleum (BP); National Oceanic and Atmospheric Administration (NOAA); NOAA's Office of Response and Restoration (ORR) [DG133C06NC1729]; Industrial Economics (IE) [1050-TAMUCC, 1050-UNR]; NOAA's Office of Response and Restoration (ORR)	British Petroleum (BP); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Office of Response and Restoration (ORR); Industrial Economics (IE); NOAA's Office of Response and Restoration (ORR)	Sample collection on R/V Gyre and R/V Ocean Veritas during the Deepwater Horizon (DWH) oil spill response phase was funded by British Petroleum (BP) and the National Oceanic and Atmospheric Administration (NOAA). Sample collection on the 2011M/V Sarah Bordelon and 2014 M/V Irish cruises, follow-up sample processing and data analysis, and production of this paper were funded in part under contract DG133C06NC1729 from NOAA's Office of Response and Restoration (ORR) via subcontract 1050-TAMUCC and 1050-UNR from Industrial Economics (IE), and through an internal transfer of funds from NOAA's Office of Response and Restoration (OR&R) to NOAA's National Centers for Coastal Ocean Science (NCCOS), as part of the DWH Natural Resource Damage Assessment. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its personnel. The study design and scope of work for the present deep-water/soft-bottom benthic study was approved jointly by representatives of the DWH NRDA Trustees and BP; neither party had a role in the corresponding sample processing, data analysis, decision to publish, or preparation of the manuscript. Christopher Lewis is employed by Industrial Economics, Incorporated. Industrial Economics, Incorporated provided support in the form of salary for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.; Sample collection on R/V Gyre and R/V Ocean Veritas during the Deepwater Horizon (DWH) oil spill response phase was funded by British Petroleum (BP) and the National Oceanic and Atmospheric Administration (NOAA). Sample collection on the 2011M/V Sarah Bordelon and 2014 M/V Irish cruises, follow-up sample processing and data analysis, and production of this paper were funded in part under contract DG133C06NC1729 from NOAA's Office of Response and Restoration (ORR) via subcontract 1050-TAMUCC and 1050-UNR from Industrial Economics (IE), and through an internal transfer of funds from NOAA's Office of Response and Restoration (OR&R) to NOAA's National Centers for Coastal Ocean Science (NCCOS), as part of the DWH Natural Resource Damage Assessment.	Aulenbach B T, 2007, 20071080 US GEOL SUR, DOI [10.3133/ofr20071080, DOI 10.3133/OFR20071080]; Balthis WL, 2017, INTEG ENVIRON ASSESS; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Carman KR, 2000, MAR ENVIRON RES, V49, P255, DOI 10.1016/S0141-1136(99)00072-0; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; Deepwater Horizon Natural Resource Damage Assessment Trustees, 2016, DEEPWATER HORIZON OI; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; HAAKE B, 1993, DEEP-SEA RES PT I, V40, P1323, DOI 10.1016/0967-0637(93)90114-I; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; KERR RA, 1980, SCIENCE, V208, P484, DOI 10.1126/science.208.4443.484; Kujawinski EB, 2013, ENVIRON SCI TECHNOL, V45, P1298; KUKERT H, 1992, DEEP-SEA RES, V39, P1349, DOI 10.1016/0198-0149(92)90073-3; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Long ER, 1998, ENVIRON TOXICOL CHEM, V17, P714, DOI 10.1002/etc.5620170428; MacDonald IR, 2015, J GEOPHYS RES-OCEANS, V120, P8364, DOI 10.1002/2015JC011062; Masson D. G., 1996, OCEANOGRAPHY ILLUSTR, P136; Montagna PA, 2017, INTEGR ENVIRON ASSES, V13, P342, DOI 10.1002/ieam.1791; Montagna PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070540; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Reuscher MG, 2017, HYDROBIOLOGIA, V790, P233, DOI 10.1007/s10750-016-3034-x; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SWARTZ RC, 1995, ENVIRON TOXICOL CHEM, V14, P1977, DOI 10.1002/etc.5620141120; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505	29	14	14	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179923	10.1371/journal.pone.0179923	http://dx.doi.org/10.1371/journal.pone.0179923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640913	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800083
J	Tikhanovich, I; Zhao, J; Bridges, B; Kumer, S; Roberts, B; Weinman, SA				Tikhanovich, Irina; Zhao, Jie; Bridges, Brian; Kumer, Sean; Roberts, Ben; Weinman, Steven A.			Arginine methylation regulates c-Myc-dependent transcription by altering promoter recruitment of the acetyltransferase p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; MACROPHAGES; METHYLTRANSFERASE; RESPONSES; CARM1; PRMT1	Protein arginine methyltransferase 1 (PRMT1) is an essential enzyme controlling about 85% of the total cellular arginine methylation in proteins. We have shown previously that PRMT1 is an important regulator of innate immune responses and that it is required for M2 macrophage differentiation. c-Myc is a transcription factor that is critical in regulating cell proliferation and also regulates the M2 transcriptional program in macrophages. Here, we sought to determine whether c-Myc in myeloid cells is regulated by PRMT1-dependent arginine methylation. We found that PRMT1 activity was necessary for c-Myc binding to the acetyltransferase p300. PRMT1 inhibition decreased p300 recruitment to c-Myc target promoters and increased histone deacetylase 1 (HDAC1) recruitment, thereby decreasing transcription at these sites. Moreover, PRMT1 inhibition blocked c-Myc-mediated induction of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG) and mannose receptor C-type 1 (MRC1), suggesting that PRMT1 is necessary for c-Myc function in M2 macrophage differentiation. Of note, in primary human blood monocytes, p300-c-Myc binding was strongly correlated with PRMT1 expression, and in liver sections, PRMT1, c-Myc, and M2 macrophage levels were strongly correlated with each other. Both PRMT1 levels and M2 macrophage numbers were significantly lower in livers from individuals with a history of spontaneous bacterial peritonitis, known to have defective cellular immunity. In conclusion, our findings demonstrate that PRMT1 is an important regulator of c-Myc function in myeloid cells. PRMT1 loss in individuals with cirrhosis may contribute to their immune defects.	[Tikhanovich, Irina; Zhao, Jie; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mail Stop 1018, Kansas City, KS 66160 USA; [Bridges, Brian; Roberts, Ben; Weinman, Steven A.] Univ Kansas, Med Ctr, Liver Ctr, Kansas City, KS 66160 USA; [Kumer, Sean] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mail Stop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism [AA012863]; NCRR/NIH from NIGMS Centers of Biomedical Research Excellence (COBRE) [P20 RR021940]; American Association for the Study of Liver Diseases (AASLD); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCRR/NIH from NIGMS Centers of Biomedical Research Excellence (COBRE); American Association for the Study of Liver Diseases (AASLD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants AA012863 from the National Institute on Alcohol Abuse and Alcoholism and NCRR/NIH P20 RR021940 from NIGMS Centers of Biomedical Research Excellence (COBRE). This work also was supported by Pinnacle Research Award 2016 from the American Association for the Study of Liver Diseases (AASLD). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ambade A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1221557; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Croasdell A, 2015, PPAR RES, V2015, DOI 10.1155/2015/549691; Cui YL, 2013, ASIAN PAC J CANCER P, V14, P1003, DOI 10.7314/APJCP.2013.14.2.1003; Davies John Q, 2005, Methods Mol Biol, V290, P91; Eberhardt A, 2016, ONCOTARGET, V7, P63629, DOI 10.18632/oncotarget.11556; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Shirabe K, 2012, SURG TODAY, V42, P1, DOI 10.1007/s00595-011-0058-8; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Tikhanovich I, 2015, HEPATOLOGY, V62, p846A; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yeung OWH, 2015, J HEPATOL, V62, P607, DOI 10.1016/j.jhep.2014.10.029; Zingarelli B, 2005, SHOCK, V23, P393, DOI 10.1097/01.shk.0000160521.91363.88	31	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13333	13344		10.1074/jbc.M117.797928	http://dx.doi.org/10.1074/jbc.M117.797928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28652407	Green Published, hybrid			2022-12-26	WOS:000407465300020
J	Ben Belgacem, Z; Carre, G; Charpentier, E; Le-Bras, F; Maho, T; Robert, E; Pouvesle, JM; Polidor, F; Gangloff, SC; Boudifa, M; Gelle, MP				Ben Belgacem, Zouhaier; Carre, Gaelle; Charpentier, Emilie; Le-Bras, Florian; Maho, Thomas; Robert, Eric; Pouvesle, Jean-Michel; Polidor, Franck; Gangloff, Sophie C.; Boudifa, Mohamed; Gelle, Marie-Paule			Innovative non-thermal plasma disinfection process inside sealed bags: Assessment of bactericidal and sporicidal effectiveness in regard to current sterilization norms	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE; BACILLUS-SUBTILIS; OXYGEN PLASMA; GAS PLASMA; INACTIVATION; SPORES; DISCHARGE; AIR; PARAMETERS; RADIATION	In this work, we developed a device capable to generate a non-thermal plasma discharge inside a sealed bag. The aim of this study was to assess the effectiveness of the oxygen, nitrogen and argon plasma sterilization on Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis spores according to the NF EN 556 Norm. Moreover the bag integrity which is a critical key to maintain the sterile state of items after the end of the process was verified by Fourier Transform Infrared (FTIR) and X-ray Photoelectron Spectrometry (XPS) analyses. After plasma treatments, the bacterial counting showed a 6 log reduction of P. aeruginosa and S. aureus in 45 min and 120 min respectively whatever the gas used and a 4 log reduction of B. subtilis spores in 120 min with only oxygen plasma. These results were confirmed by Scanning Electron Microscopy (SEM) observations showing altered bacteria or spores and numerous debris. Taking into account the studied microorganisms, the oxygen plasma treatment showed the highest efficiency. FTIR and XPS analyses showed that this treatment induced no significant modification of the bags. To conclude this non-thermal plasma sterilization technique could be an opportunity to sterilize heat and chemical-sensitive medical devices and to preserve their sterile state after the end of the process.	[Ben Belgacem, Zouhaier; Carre, Gaelle; Charpentier, Emilie; Le-Bras, Florian; Gangloff, Sophie C.; Gelle, Marie-Paule] Univ Reims, SFR CAP Sante, Lab Biomat & Inflammat Site Osseux EA 4691, Reims, France; [Maho, Thomas; Boudifa, Mohamed] CRITT MDTS, Charleville Mezieres, France; [Maho, Thomas; Robert, Eric; Pouvesle, Jean-Michel] Grp Rech Energet Milieux Ionises UMR 7344, Orleans, France; [Polidor, Franck] Sominex, Bayeux, France	Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS)	Gelle, MP (corresponding author), Univ Reims, SFR CAP Sante, Lab Biomat & Inflammat Site Osseux EA 4691, Reims, France.	marie-paule.gelle@univ-reims.fr	robert, eric/E-7992-2019; POUVESLE, Jean-Michel/L-2087-2018	robert, eric/0000-0002-7894-7080; POUVESLE, Jean-Michel/0000-0002-3236-0102; Charpentier, Emilie/0000-0001-8470-4432; gangloff, sophie/0000-0003-2651-9372	national agency of Research of France Project TecSan PLAS'STER [ANR-12-TECS-0007]	national agency of Research of France Project TecSan PLAS'STER	This work was supported by funding by the national agency of Research of France Project TecSan PLAS'STER ANR-12-TECS-0007 (http://www.agence-nationale-recherche.fr/?Projet=ANR12-TECS-007) (GCECFLB); funding by the Champagne-Ardenne Region(https://www.crchampagne-ardenne.fr/Pages/Accueil.aspx) (ZBB); asso.fr/index.jsp?r=0) TM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Franck Polidor is employed by Sominex. Sominex provided support in the form of salary for author FP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alkawareek MY, 2014, INT J ANTIMICROB AG, V43, P154, DOI 10.1016/j.ijantimicag.2013.08.022; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Ben Belgacem Z, 2016, IRBM, V37, P68, DOI 10.1016/j.irbm.2016.02.006; Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562; Boscariol MR, 2008, INT J PHARMACEUT, V353, P170, DOI [10.1016/j.ijphartn.2007.11.059, 10.1016/j.ijpharm.2007.11.059]; Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013; Connor M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41814; Cotter JJ, 2011, J HOSP INFECT, V78, P204, DOI 10.1016/j.jhin.2011.03.019; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Deng XT, 2006, IEEE T PLASMA SCI, V34, P1310, DOI 10.1109/TPS.2006.877739; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; GALLY D, 1993, J GEN MICROBIOL, V139, P1907, DOI 10.1099/00221287-139-8-1907; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Guo J, 2017, J APPL MICROBIOL, V122, P87, DOI 10.1111/jam.13335; Hertwig C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00774; Holyoak GR, 1996, TOXICOLOGY, V108, P33, DOI 10.1016/S0300-483X(95)03268-K; Justan I, 2014, FOLIA MICROBIOL, V59, P315, DOI 10.1007/s12223-014-0301-y; Kawamura K, 2012, MICROBIOL IMMUNOL, V56, P431, DOI 10.1111/j.1348-0421.2012.00457.x; Keener KM, 2015, Patent, Patent No. [WO/2012/125435, 2012125435]; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; Levif P, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/40/405201; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Moisan M, 2013, EUR PHYS J-APPL PHYS, V63, DOI 10.1051/epjap/2013120510; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Patil S, 2014, J HOSP INFECT, V88, P162, DOI 10.1016/j.jhin.2014.08.009; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Pignata C, 2017, J APPL MICROBIOL; Popot J.M., 2012, Device. Patent, Patent No. [WO2012/038669 A1, 2012038669, 2012/038669]; Raballand V, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115207; Raguse M, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/28/285401; Reineke K, 2015, INNOV FOOD SCI EMERG, V30, P112, DOI 10.1016/j.ifset.2015.03.019; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; Roth S, 2010, J APPL MICROBIOL, V108, P521, DOI 10.1111/j.1365-2672.2009.04453.x; Sarrette JP, 2012, PLASMA PROCESS POLYM, V9, P576, DOI 10.1002/ppap.201100096; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Shintani H, 2016, BIOCONTROL SCI, V21, P1, DOI 10.4265/bio.21.1; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Silhavy T J, 2010, COLD SPRING HARB PER; Steelman VM, 1995, AORN J, V55, P778; Steelman VM, 1995, AORN J, V55, P773; Steelman VM, 1995, AORN J, V55, P782; Surdeau N, 2006, J HOSP INFECT, V62, P487, DOI 10.1016/j.jhin.2005.09.003; Sureshkumar A, 2010, INT J PHARMACEUT, V396, P17, DOI 10.1016/j.ijpharm.2010.05.045; Tanino M., 2007, INT J PLASMA ENV SCI, V1, P102; Tseng S, 2012, APPL MICROBIOL BIOT, V93, P2563, DOI 10.1007/s00253-011-3661-0; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Winter T, 2013, PROTEOMICS, V13, P2608, DOI 10.1002/pmic.201200343; Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5	55	33	34	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180183	10.1371/journal.pone.0180183	http://dx.doi.org/10.1371/journal.pone.0180183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662202	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300119
J	Duong, TM; Gomez, AB; Sherratt, TN				Duong, Tammy M.; Gomez, Ann B.; Sherratt, Thomas N.			Response of adult dragonflies to artificial prey of different size and colour	PLOS ONE			English	Article							PRAYING-MANTIS; APOSEMATIC COLORATION; PREDATORS; SELECTION; MIMICRY; ODONATA; WASPS	Aposematism is an evolved, cross-species association between a preys' unprofitability and the presence of conspicuous signals. Avian predators have been widely employed to understand the evolution of these warning signals However, insect predators are abundant, diverse, and highly visual foragers that have been shown to be capable of learned aversion. Therefore, it is likely that their behaviour also shapes the nature of anti-predator traits. In this study, we evaluated the rates of attack of a community (13 species) of mature adult dragonflies (Odonata) on artificial prey of varying size (2.5-31 mm lengthwise) and colour pattern (black, black/yellow striped). The relative attack rates of dragonflies on prey increased as prey size decreased, but there was no evidence that the attack rates by dragonflies were affected by prey colour pattern and no evidence for an interaction between colour pattern and size. To investigate prey selection by specific predator species under field conditions, we compared the time to attack distributions of black-painted prey presented to two common dragonflies: Leucorrhinia intacta and the larger, Libellula pulchella. We found that the two dragonfly species, as well as the two sexes, had different foraging responses. L. pulchella was more likely to attack larger prey, and females of both species more likely to attack prey than males. Collectively, our results indicate that dragonflies are highly size selective. However, while the nature of this selectivity varies among dragonfly species, there is little evidence that classic black/yellow warning signals deter attack by these aerial invertebrate predators.	[Duong, Tammy M.; Gomez, Ann B.; Sherratt, Thomas N.] Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON, Canada	Carleton University; University of Ottawa	Sherratt, TN (corresponding author), Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON, Canada.	Tom.Sherratt@Carleton.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by The Natural Sciences and Engineering Research Council of Canada.; We thank members of the Sherratt Lab for their input, edits, and feedback, notably Changku Kang and Sophie Potter. We also thank the staff of Queens University Biological Station for their care and assistance. Prof. Robert Olberg and an anonymous referee provided helpful feedback on an earlier version of this paper. This project was funded by Natural Sciences and Engineering Research Council of Canada grants to T.N.S.	ANHOLT BR, 1991, EVOLUTION, V45, P1091, DOI 10.1111/j.1558-5646.1991.tb04377.x; Baird JM, 1997, J INSECT BEHAV, V10, P655, DOI 10.1007/BF02765385; Bates H, 1862, BIOL J LINN SOC, V23, P495; Baum T, 2014, J INSECT BEHAV, V27, P333, DOI 10.1007/s10905-013-9422-4; BEATTY GEORGE H., 1951, BULL BROOKLYN ENT SOC, V46, P29; BERENBAUM MR, 1984, AM MIDL NAT, V111, P64, DOI 10.2307/2425543; BOWDISH TI, 1993, AM MIDL NAT, V129, P215, DOI 10.2307/2426501; Bybee SM, 2012, ORG DIVERS EVOL, V12, P241, DOI 10.1007/s13127-012-0090-6; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cott H.B., 1940, ADAPTIVE COLORATION; Dunham MJ, 1992, DETERMINANTS TERRITO, V9, P112; Edmunds M., 1974, DEFENCE ANIMALS; GELPERIN A, 1968, NATURE, V219, P399, DOI 10.1038/219399a0; GUILFORD T, 1994, J THEOR BIOL, V170, P311, DOI 10.1006/jtbi.1994.1192; Guillermo-Ferreira R, 2015, J INSECT PHYSIOL, V81, P129, DOI 10.1016/j.jinsphys.2015.07.010; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hisada M., 1965, Journal of the Faculty of Science Hokkaido University Zoology, V15, P568; Hossie TJ, 2012, ANIM BEHAV, V84, P167, DOI 10.1016/j.anbehav.2012.04.027; IWASAKI T, 1990, J ETHOL, V8, P75, DOI 10.1007/BF02350277; Jones CD, 2008, FIELD GUIDE DRAGONFL; Kauppinen J, 2003, ANIM BEHAV, V66, P505, DOI 10.1006/anbe.2003.2225; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; MARDEN JH, 1995, J EXP BIOL, V198, P2095; Morris RL, 2016, BEHAV ECOL, V27, P920, DOI 10.1093/beheco/arv233; ODonnell S, 1996, J INSECT BEHAV, V9, P159, DOI 10.1007/BF02213730; Olberg RM, 2005, J COMP PHYSIOL A, V191, P791, DOI 10.1007/s00359-005-0002-8; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Poulton EB, 1890, COLOURS ANIMALS THEI; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; R Core Team, 2013, R LANG ENV STAT COMP; Rashed A, 2005, ANIM BEHAV, V70, P1195, DOI 10.1016/j.anbehav.2005.03.009; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SHELLY TE, 1978, ENVIRON ENTOMOL, V7, P790, DOI 10.1093/ee/7.6.790; Skelhorn J, 2016, BEHAV ECOL; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Taylor LA, 2014, ANIM BEHAV, V90, P149, DOI 10.1016/j.anbehav.2014.01.025; Wallace AR, 1889, DARWINISM; Yang EC, 1996, J COMP PHYSIOL A, V178, P543, DOI 10.1007/BF00190184	38	11	11	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179483	10.1371/journal.pone.0179483	http://dx.doi.org/10.1371/journal.pone.0179483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662042	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300026
J	Mata, GMSC; Ferreira, GM; Spira, B				Silva Campos Mata, Gardenia Marcia; Ferreira, Gerson Moura; Spira, Beny			RpoS role in virulence and fitness in enteropathogenic Escherichia coli	PLOS ONE			English	Article							BUNDLE-FORMING PILI; TRADE-OFF; TRANSCRIPTIONAL REGULATION; CONTROLS EXPRESSION; STRESS RESISTANCE; PROTEIN SECRETION; EPITHELIAL-CELLS; STRAIN VARIATION; GENE-EXPRESSION; III SECRETION	Enteropathogenic Escherichia coli (EPEC) is a diarrheagenic pathogen that afflicts infants in developing countries. The most important virulence trait of EPEC is its ability to intimately adhere to cells in the small intestine, and to elicit diarrhea. The alternative sigma factor RpoS is involved in the virulence of several bacterial species. RpoS coordinates the general stress response and accumulates in cells under stress or in the stationary phase. RpoS levels differ across E. coli strains. High-RpoS strains are highly resistant to environmental stresses, but usually display low nutritional competence, while low-RpoS strains show the opposite phenotype. Here we investigated whether RpoS plays a role in the virulence and fitness of two different EPEC strains, E2348/69 and LRT9. A rpoS null mutation had a small positive effect on LRT9 adherence to epithelial cells, but the expression of the EPEC adhesins BfpA and intimin was not significantly affected by the mutation. E2348/69 adherence was not significantly affected by the rpoS mutation. The intrinsic level of RpoS was higher in LRT9 than in E2348/69 while the latter adhered more strongly and expressed higher levels of the adhesin BfpA than the former. Knockout of rpoS strongly impaired resistance to oxidative, osmotic and acid stress in both E2348/69 and LRT9. However, strain E2348/69 was significantly more sensitive to oxidative stress than LRT9. Finally, competition assays showed that the rpoS mutant of LRT9 displayed higher fitness under continuous culture than its isogenic wild-type strain, while E2348/69 outcompeted its rpoS mutant. In conclusion, RpoS plays mostly a positive role in EPEC biology and at least in the case of strain E2348/69 it is not constrained by the trade-off between vegetative growth and stress resistance.	[Silva Campos Mata, Gardenia Marcia; Ferreira, Gerson Moura; Spira, Beny] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil; [Silva Campos Mata, Gardenia Marcia] Univ Fed Rio Janeiro, Macae, RJ, Brazil; [Ferreira, Gerson Moura] Inst Nacl Canc, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; National Cancer Institute (Inca)	Spira, B (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil.	benys@usp.br	Spira, Beny/D-6928-2012; Spira, Beny/AAR-2287-2020; Ferreira, Gerson Moura/B-4698-2017; Spira, Beny/GSD-2097-2022	Spira, Beny/0000-0001-5394-9074; Ferreira, Gerson Moura/0000-0002-3467-2580; Spira, Beny/0000-0001-5394-9074	Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP); FAPESP; Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq)	Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparoa Pesquisa do Estado de SaoPaulo (FAPESP).We are thankful to Diogo Oshiro for dedicated technical help. G.M.S.M and G.M.F.were supported by FAPESP scholarships. B.S. is a recipient of the Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(CNPq) productivity scholarship.	Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Battesti A, 2011, ANN REV MICROBIOL; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; Bleibtreu A, 2014, J BACTERIOL, V196, P4276, DOI 10.1128/JB.01972-14; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Chiang SM, 2011, APPL ENVIRON MICROB, V77, P7915, DOI 10.1128/AEM.05274-11; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; Conway T, 2015, GUT MICROBIOGY SPECT, V3; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-118; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2016, TRENDS MICROBIOL, V24, P209, DOI 10.1016/j.tim.2015.11.009; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Ferrandiz MJ, 2005, INFECT IMMUN, V73, P1684, DOI 10.1128/IAI.73.3.1684-1694.2005; Ferreira GM, 2008, MICROBIOL-SGM, V154, P2025, DOI 10.1099/mic.0.2008/016634-0; Galbiati HF, 2014, ARCH MICROBIOL, V196, P589, DOI 10.1007/s00203-014-0994-y; GOBER JW, 1992, MOL BIOL CELL, V3, P913, DOI 10.1091/mbc.3.8.913; Handford CL, 2009, CAN J MICROBIOL, V55, P1229, DOI [10.1139/W09-079, 10.1139/w09-079]; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Herbelin CJ, 2000, J BACTERIOL, V182, P5381, DOI 10.1128/JB.182.19.5381-5390.2000; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; King T, 2006, GENETICS, V172, P2071, DOI 10.1534/genetics.105.053892; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; LEVINE MM, 1978, LANCET, V1, P1119; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Maharjan R, 2013, ECOL LETT, V16, P1267, DOI 10.1111/ele.12159; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Miller J. H., 1992, LAB MANUAL HDB ESCHE; Neves HI, 2015, J BACTERIOL, V197, P1378, DOI 10.1128/JB.02566-14; Nisa S, 2013, J BACTERIOL, V195, P4476, DOI 10.1128/JB.00704-13; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Moreno ACR, 2010, DIAGN MICR INFEC DIS, V66, P50, DOI 10.1016/j.diagmicrobio.2008.03.017; Santos AS, 2015, CELL MICROBIOL, V17, P318, DOI 10.1111/cmi.12412; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Snyder E, 2012, G3-GENES GENOM GENET, V2, P1341, DOI 10.1534/g3.112.003855; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Spira B, 2011, BMC MICROBI IN PRESS; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Spira B, 2008, ARCH MICROBIOL, V189, P43, DOI 10.1007/s00203-007-0291-0; Spira B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091703; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Taschner NP, 2004, MICROBIOL-SGM, V150, P2985, DOI 10.1099/mic.0.27124-0; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Munevar NFV, 2017, MOL GENET GENOMICS, V292, P105, DOI 10.1007/s00438-016-1259-z; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	62	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180381	10.1371/journal.pone.0180381	http://dx.doi.org/10.1371/journal.pone.0180381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662183	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300147
J	Weir, GM; Karkada, M; Hoskin, D; Stanford, MM; MacDonald, L; Mansour, M; Liwski, RS				Weir, Genevieve M.; Karkada, Mohan; Hoskin, David; Stanford, Marianne M.; MacDonald, Lisa; Mansour, Marc; Liwski, Robert S.			Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ANTIGEN-PRESENTING CELLS; EXPRESSION; STIMULATION; VACCINATION; INHIBITION; INDUCTION; PLATFORM; LIGANDS; SYNERGY	Vaccines that can rapidly induce strong and robust antibody-mediated immunity could improve protection from certain infectious diseases for which current vaccine formulations are inefficient. For indications such as anthrax and influenza, antibody production in vivo is a correlate of efficacy. Toll-like receptor (TLR) agonists are frequently studied for their role as vaccine adjuvants, largely because of their ability to enhance initiation of immune responses to antigens by activating dendritic cells. However, TLRs are also expressed on B cells and may contribute to effective B cell activation and promote differentiation into antigen-specific antibody producing plasma cells in vivo. We sought to discover an adjuvant system that could be used to augment antibody responses to influenza and anthrax vaccines. We first characterized an adjuvant system in vitro which consisted of two TLR ligands, poly I:C (TLR3) and Pam3CSK4 (TLR2), by evaluating its effects on B cell activation. Each agonist enhanced B cell activation through increased expression of surface receptors, cytokine secretion and proliferation. However, when B cells were stimulated with poly I:C and Pam3CSK4 in combination, further enhancement to cell activation was observed. Using B cells isolated from knockout mice we confirmed that poly I:C and Pam3CSK4 were signaling through TLR3 and TLR2, respectively. B cells activated with Poly I:C and Pam3CSK4 displayed enhanced capacity to stimulate allogeneic CD4(+) T cell activation and differentiate into antibody-producingplasma cells in vitro. Mice vaccinated with influenza or anthrax antigens formulated with poly I:C and Pam3CSK4 in DepoVax (TM) vaccine platform developed a rapid and strong antigen-specific serum antibody titer that persisted for at least 12 weeks after a single immunization. These results demonstrate that combinations of TLR adjuvants promote more effective B cell activation in vitro and can be used to augment antibody responses to vaccines in vivo.	[Weir, Genevieve M.; Karkada, Mohan; Stanford, Marianne M.; MacDonald, Lisa; Mansour, Marc] Immunovaccine Inc, Res & Dev, Halifax, NS, Canada; [Weir, Genevieve M.; Karkada, Mohan; Hoskin, David; Stanford, Marianne M.; Liwski, Robert S.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Hoskin, David; Liwski, Robert S.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Liwski, Robert S.] Queen Elizabeth 2 Hlth Sci Ctr, Div Hematopathol, Dept Pathol & Lab Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Weir, GM (corresponding author), Immunovaccine Inc, Res & Dev, Halifax, NS, Canada.; Weir, GM (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	gweir@imvaccine.com		Stanford, Marianne/0000-0003-0432-3707; Weir, Genevieve/0000-0002-6285-7187	Immunovaccine Inc., Canada Foundation for Innovation Award; Dalhousie University Clinical Research Scholar Award; NSERC Discovery Grant	Immunovaccine Inc., Canada Foundation for Innovation Award; Dalhousie University Clinical Research Scholar Award; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Immunovaccine Inc., Canada Foundation for Innovation Award, Dalhousie University Clinical Research Scholar Award and an NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, SCAND J IMMUNOL, V71, P275, DOI 10.1111/j.1365-3083.2010.02380.x; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berinstein NL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026529; Berinstein NL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-156; Boeglin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025542; Brewer KD, 2014, VACCINE, V32, P6956, DOI 10.1016/j.vaccine.2014.10.058; Buchta CM, 2014, IMMUNOL RES, V59, P12, DOI 10.1007/s12026-014-8523-2; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chiu C, 2014, CURR TOP MICROBIOL; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garman L, 2014, TOXINS, V6, P2424, DOI 10.3390/toxins6082424; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020651; Karkada M, 2010, VACCINE, V28, P6176, DOI 10.1016/j.vaccine.2010.07.025; Karkada M, 2010, J IMMUNOTHER, V33, P250, DOI 10.1097/CJI.0b013e3181c1f1e9; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kaur M, 2013, EXPERT REV VACCINES, V12, P955, DOI 10.1586/14760584.2013.814860; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; Matthews K, 2012, J IMMUNOL, V189, P5729, DOI 10.4049/jimmunol.1200601; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Perez-Giron JV, 2014, J IMMUNOL, V193, P1324, DOI 10.4049/jimmunol.1400222; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Reperant Leslie A, 2014, F1000Prime Rep, V6, P47, DOI 10.12703/P6-47; Rieckmann P, 1997, METHODS, V11, P128, DOI 10.1006/meth.1996.0396; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Vanhoutte F, 2008, IMMUNOL LETT, V116, P86, DOI 10.1016/j.imlet.2007.11.014; Vollmer J, 2004, J ENDOTOXIN RES, V10, P431, DOI 10.1179/096805104225006534; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; WU CQ, 1994, J INTERFERON RES, V14, P357, DOI 10.1089/jir.1994.14.357	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180073	10.1371/journal.pone.0180073	http://dx.doi.org/10.1371/journal.pone.0180073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662082	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300098
J	Zhou, Z; Jordens, Z; Zhang, SG; Zhang, NX; Schmid, J				Zhou, Zhuo; Jordens, Zoe; Zhang, Shuguang; Zhang, Ningxin; Schmid, Jan			Highly mutable tandem DNA repeats generate a cell wall protein variant more frequent in disease-causing Candida albicans isolates than in commensal isolates	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC SIMILARITY; PURPOSE GENOTYPE; SEQUENCE; BACTERIAL; STRAINS; YEAST; IDENTIFICATION; COLONIZATION; MUTATIONS	During adaptation to host environments, many microorganisms alter their cell surface. One mechanism for doing so is variation in the number of amino acid repeats in cell surface proteins encoded by hypermutable DNA tandem repeats. In the yeast Candida albicans, an opportunistic human pathogen, the gene SSR1 encodes a GPI-anchored cell wall protein with a structural role. It contains two regions consisting of tandem repeats, almost exclusively encoding the amino acid pair Ser-Ala. As expected, the repeat regions make SSR1 highly mutable. New SSR1 alleles arose with a frequency of 1.11x10(-4) per cell division in serially propagated cells. We also observed a large number (25) of SSR1 alleles with different repeat lengths in a survey of 131 isolates from a global strain collection. C. albicans is diploid, and combinations of these allele generated 41 different SSR1 genotypes. In both repeat regions, nonsynonymous mutations were largely restricted to one particular repeat unit. Two very similar allele combinations were largely restricted to one clade, clade 1. Each combination was present in similar to 30% of 49 infection-causing clade 1 strains, but one was rare (2%), the other absent in 46 infection-causing strains representing the remainder of the species (P < 0.00018 and 0.00004; Fisher's exact test). These results indicate that both repeat regions are under selection and that amino acid repeat length polymorphisms generate Ssr1 protein variants most suitable for specific genetic backgrounds. One of these two allele combinations was 5.51 times more frequent, the other 1.75 times less frequent in 49 clade 1 strains that caused disease than in 36 commensal clade 1 strains (P = 0.0105; Chi(2) test). This indicates that insertion and deletion of repeats not only generates clade-optimized Ssr1p variants, but may also assist in short-term adaptation when C. albicans makes the transition from commensal to pathogen.	[Zhou, Zhuo; Jordens, Zoe; Zhang, Shuguang; Zhang, Ningxin; Schmid, Jan] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Zhang, Shuguang] Callaghan Innovat, Integrated Bioact Technol, Lower Hutt, New Zealand	Massey University; Callaghan Innovation	Schmid, J (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	j.schmid@massey.ac.nz	Schmid, Jan/A-6863-2011	Schmid, Jan/0000-0001-8794-4175	Maurice and Phyllis Paykel Trust; Massey University Research Fund	Maurice and Phyllis Paykel Trust; Massey University Research Fund	This work was supported by: Maurice and Phyllis Paykel Trust (http://www.paykeltrust. co.nz), no grant numbers are allocated by this trust, JS; Massey University Research Fund, an internal fund to support research by Massey University (http://www.massey.ac.nz) staff 1000015870, JS. The funders had no role in study design, data collection and analysis, decisionto publish,or preparation of the manuscript.	Al-Aidan AW, 2007, YEAST, V24, P155, DOI 10.1002/yea.1462; Ausubel FM, 2014, CURRENT PROTOCOLS MO; Brillowska-Dabrowska A, 2010, SCAND J INFECT DIS, V42, P109, DOI 10.3109/00365540903348336; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Edelmann A, 2005, J CLIN MICROBIOL, V43, P6164, DOI 10.1128/JCM.43.12.6164-6166.2005; Garcera A, 2003, MICROBIOL-SGM, V149, P2137, DOI 10.1099/mic.0.26301-0; Gomez-Raja J, 2013, J MICROBIOL METH, V94, P47, DOI 10.1016/j.mimet.2013.04.007; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Jansen A, 2012, GENOME DYNAM, V7, P108, DOI 10.1159/000337121; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Lott TJ, 1999, MICROBIOL-UK, V145, P1137, DOI 10.1099/13500872-145-5-1137; Lott TJ, 2005, FUNGAL GENET BIOL, V42, P444, DOI 10.1016/j.fgb.2005.01.012; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Odds FC., 1988, CANDIDA CANDIDOSIS; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; REAGAN DR, 1990, J CLIN MICROBIOL, V28, P2733, DOI 10.1128/JCM.28.12.2733-2738.1990; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; SCHMID J, 1993, J CLIN MICROBIOL, V31, P39, DOI 10.1128/JCM.31.1.39-46.1993; Schmid J, 1999, MICROBIOL-UK, V145, P2405, DOI 10.1099/00221287-145-9-2405; Schmid J, 2012, MYCOSES, V55, P67; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; SCHMID J, 1990, J CLIN MICROBIOL, V28, P1236, DOI 10.1128/JCM.28.6.1236-1243.1990; SCHMID J, 1992, J CLIN MICROBIOL, V30, P935, DOI 10.1128/JCM.30.4.935-941.1992; SCHMID J, 1995, J CLIN MICROBIOL, V33, P1223, DOI 10.1128/JCM.33.5.1223-1230.1995; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Sumita T, 2005, EUKARYOT CELL, V4, P1872, DOI 10.1128/EC.4.11.1872-1881.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Xu JP, 1999, J CLIN MICROBIOL, V37, P3835, DOI 10.1128/JCM.37.12.3835-3843.1999; Zhang NX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009614; Zhang NX, 2009, INFECT GENET EVOL, V9, P493, DOI 10.1016/j.meegid.2009.01.007; Zhang NX, 2003, GENOME RES, V13, P2005, DOI 10.1101/gr.1024903; Zhao XM, 2007, FUNGAL GENET BIOL, V44, P1298, DOI 10.1016/j.fgb.2007.05.004; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180246	10.1371/journal.pone.0180246	http://dx.doi.org/10.1371/journal.pone.0180246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662107	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300130
J	Banuet-Martinez, M; Espinosa-de Aquino, W; Elorriaga-Verplancken, FR; Flores-Moran, A; Garcia, OP; Camacho, M; Acevedo-Whitehouse, K				Banuet-Martinez, Marina; Espinosa-de Aquino, Wendy; Elorriaga-Verplancken, Fernando R.; Flores-Moran, Adriana; Garcia, Olga P.; Camacho, Mariela; Acevedo-Whitehouse, Karina			Climatic anomaly affects the immune competence of California sea lions	PLOS ONE			English	Article							PRENATAL STRESS; LIFE-HISTORY; FUR SEALS; MILK; METABOLISM; NUTRITION; IMPACTS; ENERGY; COUNT	The past decades have been characterized by a growing number of climatic anomalies. As these anomalies tend to occur suddenly and unexpectedly, it is often difficult to procure empirical evidence of their effects on natural populations. We analysed how the recent sea surface temperature (SST) anomaly in the northeastern Pacific Ocean affects body condition, nutritional status, and immune competence of California sea lion pups. We found that pup body condition and blood glucose levels of the pups were lower during high SST events, although other biomarkers of malnutrition remained unchanged, suggesting that pups were experiencing early stages of starvation. Glucose-dependent immune responses were affected by the SST anomaly; specifically, pups born during high SST events had lower serum concentrations of IgG and IgA, and were unable to respond to an immune challenge. This means that not only were pups that were born during the SST anomaly less able to synthesize protective antibodies; they were also limited in their ability to respond rapidly to nonspecific immune challenges. Our study provides empirical evidence that atypical climatic conditions can limit energetic reserves and compromise physiological responses that are essential for the survival of a marine top predator.	[Banuet-Martinez, Marina; Espinosa-de Aquino, Wendy; Flores-Moran, Adriana; Acevedo-Whitehouse, Karina] Autonomous Univ Queretaro, Sch Nat Sci, Unit Basic & Appl Microbiol, Queretaro, Mexico; [Elorriaga-Verplancken, Fernando R.] IPN, Dept Fisheries & Marine Biol, Ctr Interdisciplinario Ciencias Marinas, CICIMAR, La Paz, Mexico; [Garcia, Olga P.; Camacho, Mariela] Autonomous Univ Queretaro, Sch Nat Sci, Dept Human Nutr, Queretaro, Mexico; [Acevedo-Whitehouse, Karina] Marine Mammal Ctr, Sausalito, CA 94965 USA	Universidad Autonoma de Queretaro; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Queretaro	Acevedo-Whitehouse, K (corresponding author), Autonomous Univ Queretaro, Sch Nat Sci, Unit Basic & Appl Microbiol, Queretaro, Mexico.; Acevedo-Whitehouse, K (corresponding author), Marine Mammal Ctr, Sausalito, CA 94965 USA.	karina.acevedo.whitehouse@uaq.mx		Garcia, Olga P/0000-0003-4040-8345; Acevedo-Whitehouse, Karina/0000-0001-8954-8782	Autonomous University of Queretaro [142908]; Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT) [CB-181876, CB-153530, 287579, 369084, 778607]; Programa de Fortalecimiento a la Calidad Educativa, PFCE (Mexico)	Autonomous University of Queretaro; Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Fortalecimiento a la Calidad Educativa, PFCE (Mexico)	This work was funded by a grant from the Autonomous University of Queretaro (Fund for the Advancement of Scientific Research, 142908; http://www.uaq.mx/dip/index.php/fofi-uaq) and partly funded by the Mexican Consejo Nacional de Cienciay Tecnologia (CONACYT; http://www.conacyt.gob.mx), grant numbers: CB-181876 and CB-153530. Data from the 2012 cohort was collected during a study funded by CONACYT grant number CB-153530. AFM, WEA and MBM are funded by CONACYT graduate scholarships 287579, 369084, and 778607, respectively. Publication fees were covered by support from the Programa de Fortalecimiento a la Calidad Educativa, PFCE 2016 (Mexico).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestra T, 2015, J EXP MAR BIOL ECOL, V468, P29, DOI 10.1016/j.jembe.2015.03.017; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Cook P, 2011, BIOL LETTERS, V7, P536, DOI 10.1098/rsbl.2011.0127; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Devney CA, SENS TROP SEAB, V90, P1175; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elorriaga-Verplancken FR, 2016, PLOS ONE, V11; Garcia-Rodriguez FJ, 2004, FISH B-NOAA, V102, P47; Georges JY, 2001, PHYSIOL BIOCHEM ZOOL, V74, P548, DOI 10.1086/322164; Gulland FMD, 2012, JAVMA-J AM VET MED A, V241, P943, DOI 10.2460/javma.241.7.943; Hall AJ, 2002, FUNCT ECOL, V16, P462, DOI 10.1046/j.1365-2435.2002.00649.x; Honda T, 2016, CLIN CHIM ACTA, V457, P46, DOI 10.1016/j.cca.2016.03.017; Inelmen EM, 2006, CACHEXIA WASTING MOD, P59; Jeklova E, 2008, VET IMMUNOL IMMUNOP, V122, P231, DOI 10.1016/j.vetimm.2007.11.011; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KERR DS, 1978, METABOLISM, V27, P411, DOI 10.1016/0026-0495(78)90097-5; Kintisch E, 2015, SCIENCE, V348, P17, DOI 10.1126/science.348.6230.17; Kuhn CE, 2014, MAR MAMMAL SCI, V30, P1297, DOI 10.1111/mms.12110; Lawler DF, 2014, PMMC CASE REP MAR MA, V1, P1; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Leung ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062728; LOWRY MS, 1991, FISH B-NOAA, V89, P331; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Maucher JM, 2005, ENVIRON HEALTH PERSP, V113, P461, DOI 10.1289/ehp.7649; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; McClatchie S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150628; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; MONGINI PKA, 1981, J EXP MED, V153, P1, DOI 10.1084/jem.153.1.1; National Oceanic and Atmospheric Administration, EL DISC; National Oceanic and Atmospheric Administration, 2014, FAQS 2013 CALIF SEA; Norberg SE, 2011, J WILDLIFE DIS, V47, P217, DOI 10.7589/0090-3558-47.1.217; Ono KA, 1991, PINNIPEDS EL NINO RE, P185; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PRENTICE AM, 1983, HUM NUTR-CLIN NUTR, V37, P53; R Development Core Team, 2016, R LANG ENV STAT COMP; Ramsdell JS, 2008, MAR DRUGS, V6, P262, DOI [10.3390/md20080013, 10.3390/md6020262]; Rauw WM, 2014, FRONT GENET, V3, P267; Riet-Sapriza FG, 2012, J MAMMAL, V93, P1006, DOI 10.1644/11-MAMM-A-220.2; Robinson CJ, 2016, GEOPHYS RES LETT, V43, P7066, DOI 10.1002/2016GL069356; ROE CF, 1965, ANN SURG, V161, P140, DOI 10.1097/00000658-196501000-00022; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Vera-Massieu C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150108; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Westerman DA, 1999, BRIT J HAEMATOL, V107, P512; WHITEHEAD RG, 1979, POSTGRAD MED J, V55, P303, DOI 10.1136/pgmj.55.643.303; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	54	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179359	10.1371/journal.pone.0179359	http://dx.doi.org/10.1371/journal.pone.0179359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658317	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900022
J	McNamara, JW; Li, A; Lal, S; Bos, JM; Harris, SP; van der Velden, J; Ackerman, MJ; Cooke, R; dos Remedios, CG				McNamara, James W.; Li, Amy; Lal, Sean; Bos, J. Martijn; Harris, Samantha P.; van der Velden, Jolanda; Ackerman, Michael J.; Cooke, Roger; dos Remedios, Cristobal G.			MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							BINDING-PROTEIN-C; REGULATORY LIGHT-CHAIN; MYOSIN ATP TURNOVER; CARDIAC MYOSIN; MUSCLE MYOSIN; EXPRESSION PATTERNS; HEAVY-MEROMYOSIN; ATOMIC MODEL; HEART-MUSCLE; PHOSPHORYLATION	The "super-relaxed state" (SRX) of myosin represents a 'reserve' of motors in the heart. Myosin heads in the SRX are bound to the thick filament and have a very low ATPase rate. Changes in the SRX are likely to modulate cardiac contractility. We previously demonstrated that the SRX is significantly reduced in mouse cardiomyocytes lacking cardiac myosin binding protein C (cMyBP-C). Here, we report the effect of mutations in the cMyBP-C gene (MYBPC3) using samples from human patients with hypertrophic cardiomyopathy (HCM). Left ventricular (LV) samples from 11 HCM patients were obtained following myectomy surgery to relieve LV outflow tract obstruction. HCM samples were genotyped as either MYBPC3 mutation positive (MYBPC3(mut)) or negative (HCMsmn) and were compared to eight non-failing donor hearts. Compared to donors, only MYBPC3mut samples display a significantly diminished SRX, characterised by a decrease in both the number of myosin heads in the SRX and the lifetime of ATP turnover. These changes were not observed in HCMsmn samples. There was a positive correlation (p < 0.01) between the expression of cMyBP-C and the proportion of myosin heads in the SRX state, suggesting cMyBP-C modulates and maintains the SRX. Phosphorylation of the myosin regulatory light chain in MYBPC3mut samples was significantly decreased compared to the other groups, suggesting a potential mechanism to compensate for the diminished SRX. We conclude that by altering both contractility and sarcomeric energy requirements, a reduced SRX may be an important disease mechanism in patients with MYBPC3 mutations.	[McNamara, James W.; Lal, Sean; dos Remedios, Cristobal G.] Univ Sydney, Bosch Inst, Discipline Anat & Histol, Sydney, NSW, Australia; [McNamara, James W.] Univ Cincinnati, Coll Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH USA; [Li, Amy] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Harris, Samantha P.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [van der Velden, Jolanda] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, De Boelelaan 1117, Amsterdam, Netherlands; [Ackerman, Michael J.] Mayo Clin, Dept Cardiovasc Dis, Div Heart Rhythm Serv, Rochester, MN USA; [Cooke, Roger] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of Sydney; University System of Ohio; University of Cincinnati; University of Vermont; Mayo Clinic; Mayo Clinic; University of Arizona; Vrije Universiteit Amsterdam; Mayo Clinic; University of California System; University of California San Francisco	McNamara, JW (corresponding author), Univ Sydney, Bosch Inst, Discipline Anat & Histol, Sydney, NSW, Australia.; McNamara, JW (corresponding author), Univ Cincinnati, Coll Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH USA.	mcnamajw@ucmail.uc.edu	McNamara, James/T-6660-2019	van der Velden, Jolanda/0000-0001-5224-5788; McNamara, James/0000-0003-3754-6405	NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney); National Heart Foundation [GNT1093852, PB 12S 6939]; Netherlands	NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney); National Heart Foundation(National Heart Foundation of Australia); Netherlands(Netherlands Government)	JWM, AL and SL were supported by the NG Macintosh Memorial Fund (Discipline of Anatomy and Histology, The University of Sydney). The National Heart Foundation supports SL (GNT1093852) and AL (PB 12S 6939). We thank Medical Advances Without Animals for funding the Sydney Heart Bank equipment. The study was supported in part by a grant from The Netherlands	AL-Khayat HA, 2013, P NATL ACAD SCI USA, V110, P318, DOI 10.1073/pnas.1212708110; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Colson BA, 2014, BIOCH BIOPHYS RES CO; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; Cooke Roger, 2011, Biophys Rev, V3, P33; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; CRAIG R, 1976, PROC R SOC SER B-BIO, V192, P451, DOI 10.1098/rspb.1976.0023; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; FERENCZI MA, 1978, BIOCHEM J, V171, P165, DOI 10.1042/bj1710165; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Helms AS, 2014, CIRC-CARDIOVASC GENE, V7, P434, DOI 10.1161/CIRCGENETICS.113.000448; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; Houston BA, 2014, CLIN MED INSIGHTS-CA, V8, P53, DOI 10.4137/CMC.S15717; Husberg C, 2012, PROTEOMICS, V12, P973, DOI 10.1002/pmic.201100116; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069671; Lin ZQ, 2016, DEV CELL, V39, P466, DOI 10.1016/j.devcel.2016.09.005; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; Marston S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138568; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; McNamara James W, 2015, Biophys Rev, V7, P5, DOI 10.1007/s12551-014-0151-5; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; MYBURGH KH, 1995, J GEN PHYSIOL, V106, P957, DOI 10.1085/jgp.106.5.957; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Reconditi M, 2017, P NATL ACAD SCI USA, V114, P3240, DOI 10.1073/pnas.1619484114; RosalieWitjas-Paalberends E, 2014, CARDIOVASC RES, V103, P248, DOI 10.1093/cvr/cvu127; Santos S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-17; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; STARR R, 1971, FEBS LETT, V15, P40, DOI 10.1016/0014-5793(71)80075-3; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Theis JL, 2009, CIRC-HEART FAIL, V2, P325, DOI 10.1161/CIRCHEARTFAILURE.108.789735; Towbin JA, 2009, PACE, V32, pS23, DOI 10.1111/j.1540-8159.2009.02381.x; van Dijk SJ, 2015, J MOL CELL CARDIOL, V88, P124, DOI 10.1016/j.yjmcc.2015.09.006; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wijnker PJM, 2016, J MOL CELL CARDIOL; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	67	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180064	10.1371/journal.pone.0180064	http://dx.doi.org/10.1371/journal.pone.0180064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658286	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900055
J	Cortesi, PA; D'Angiolella, LS; Vellucci, R; Allegri, M; Casale, G; Favaretti, C; Kheiraoui, F; Cesana, G; Mantovani, LG				Cortesi, Paolo Angelo; D'Angiolella, Lucia Sara; Vellucci, Renato; Allegri, Massimo; Casale, Giuseppe; Favaretti, Carlo; Kheiraoui, Flavia; Cesana, Giancarlo; Mantovani, Lorenzo Giovanni			Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment	PLOS ONE			English	Article							OPIOID ANALGESICS; CLINICAL-PRACTICE; PREVALENCE; MANAGEMENT; RECOMMENDATIONS; MULTICENTER; THERAPY; HOSPICE; CARE; BTCP	Breakthrough cancer Pain (BTcP) has a high prevalence in cancer population. Patients with BTcP reported relevant health care costs and poor quality of life. The study assessed the cost-effectiveness of the available Oral Fentanyl Formulations (OFFs) for BTcP in Italy. A decision-analytical model was developed to estimate costs and benefits associated with treatments, from the Italian NHS perspective. Expected reductions in pain intensity per BTcP episodes were translated into, percentage of BTcP reduction, resource use and Quality-Adjusted-Life-Years (QALYs). Relative efficacy, resources used and unit costs data were derived from the literature and validated by clinical experts. Probabilistic and deterministic sensitivity analyses were performed. At base-case analysis, Sublingual Fentanyl Citrate (FCSL) compared to other oral formulations reported a lower patient's cost ((sic) 1,960.8) and a higher efficacy (18.7% of BTcP avoided and 0.0507 QALYs gained). The sensitivity analyses confirmed the main results in all tested scenarios, with the highest impact reported by BTcP duration and health care resources consumption parameters. Between OFFs, FCSL is the cost-effective option due to faster reduction of pain intensity. However, new research is needed to better understand the economic and epidemiologic impact of BTcP, and to collect more robust data on economic and quality of life impact of the different fentanyl formulations. Different fentanyl formulations are available to manage BTcP in cancer population. The study is the first that assesses the different impact in terms of cost and effectiveness of OFFs, providing new information to better allocate the resources available to treat BTcP and highlighting the need of better data.	[Cortesi, Paolo Angelo; D'Angiolella, Lucia Sara; Cesana, Giancarlo; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy; [Vellucci, Renato] Univ Hosp Careggi, Palliat Care & Pain Therapy Unit, Florence, Italy; [Allegri, Massimo] Univ Parma, Azienda Osped, Dept Surg Sci, Anesthesia Intens Care & Pain Therapy Serv, Parma, Italy; [Casale, Giuseppe] ANTEA Ctr, Antea Formad Educ, Rome, Italy; [Favaretti, Carlo; Kheiraoui, Flavia] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy	University of Milano-Bicocca; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Parma; University Hospital of Parma; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	D'Angiolella, LS (corresponding author), Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy.	l.dangiolella@campus.unimib.it	Allegri, Massimo/W-1090-2019; Cortesi, Paolo Angelo/AAD-7926-2020; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Allegri, Massimo/0000-0002-8201-980X; vellucci, renato/0000-0002-5462-7920; Cortesi, Paolo Angelo/0000-0001-5241-4473				Abernethy Amy P, 2008, Am J Manag Care, V14, pS129; Agenzia Italiana del Farmaco (AIFA), CONS SPES FARM; Bennet D., 2005, PHARMACOL THERAPEUT, V30, P296; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Chang Andrew, 2015, J Pain Palliat Care Pharmacother, V29, P247, DOI 10.3109/15360288.2015.1063560; Coluzzi PH, 2001, PAIN, V91, P123, DOI 10.1016/S0304-3959(00)00427-9; Cortesi PA, 2015, QIJPH, V4, P1; Darba J, 2014, CLINICOECONOMIC OUTC, V6, P1, DOI 10.2147/CEOR.S52273; Davis MP, 2012, J PAIN SYMPTOM MANAG, V44, pE1, DOI 10.1016/j.jpainsymman.2012.06.002; Deandrea S, 2014, J PAIN SYMPTOM MANAG, V47, P57, DOI 10.1016/j.jpainsymman.2013.02.015; Di Palma M, 2004, B CANCER, V91, P95; Fortner BV, 2002, J PAIN, V3, P38, DOI 10.1054/jpai.2002.27136; Fortner BV, 2003, J PAIN SYMPTOM MANAG, V25, P334, DOI 10.1016/S0885-3924(02)00679-6; Fortner BV, 2003, J PAIN SYMPTOM MANAG, V25, P9, DOI 10.1016/S0885-3924(02)00597-3; Furneri G, 2016, FARMECONOMIA, V17, P67, DOI 10.7175/fe.v17i2.1251; GRANT M, 1995, NURS CLIN N AM, V30, P673; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mercadante S, 2016, SUPPORT CARE CANCER, V24, P961, DOI 10.1007/s00520-015-2951-y; Mercadante S, 2015, CLIN J PAIN, V31, P214, DOI 10.1097/AJP.0000000000000161; Mercadante S, 2012, DRUGS, V72, P181, DOI 10.2165/11597260-000000000-00000; National Institute for Health and Care Excellence (NICE), GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), OP PALL CAR SAF EFF; Novotna S, 2014, CLIN THER, V36, P357, DOI 10.1016/j.clinthera.2014.01.006; Olivieri I, 2008, RHEUMATOLOGY, V47, P1664, DOI 10.1093/rheumatology/ken320; PORTENOY RK, 1990, PAIN, V41, P273, DOI 10.1016/0304-3959(90)90004-W; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 2010, PAIN, V151, P617, DOI 10.1016/j.pain.2010.07.028; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Scalone L, 2013, VALUE HEALTH, V16, P814, DOI 10.1016/j.jval.2013.04.008; Taylor DR, 2013, CLIN PHARMACOL-ADV A, V5, P131, DOI 10.2147/CPAA.S26649; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Vellucci R, 2016, DRUGS, V76, P315, DOI 10.1007/s40265-015-0519-2; Vissers DCJ, 2011, VALUE HEALTH, V14, P274, DOI 10.1016/j.jval.2010.09.007; Walker G, 2003, PALLIATIVE MED, V17, P219, DOI 10.1191/0269216303pm755oa; Zeppetella G, 2001, PALLIATIVE MED, V15, P243, DOI 10.1191/026921601678576220; Zeppetella G, 2000, J PAIN SYMPTOM MANAG, V20, P87, DOI 10.1016/S0885-3924(00)00161-5; Zeppetella G, 2013, COCHRANE DB SYST REV, V21; Zeppetella G, 2014, J PAIN SYMPTOM MANAG, V47, P772, DOI 10.1016/j.jpainsymman.2013.05.020; Zucco F, 2014, ADV THER, V31, P657, DOI 10.1007/s12325-014-0130-z	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179523	10.1371/journal.pone.0179523	http://dx.doi.org/10.1371/journal.pone.0179523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654672	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500017
J	Wang, DJ; Amoozgar, B; Porco, T; Wang, Z; Lin, SC				Wang, Dajiang; Amoozgar, Behzad; Porco, Travis; Wang, Zhen; Lin, Shan C.			Ethnic differences in lens parameters measured by ocular biometry in a cataract surgery population	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; INTRAOCULAR-PRESSURE REDUCTION; ANTERIOR-CHAMBER DEPTH; NARROW ANGLES; UNEVENTFUL PHACOEMULSIFICATION; NONGLAUCOMATOUS EYES; POSITION PARAMETERS; PREVALENCE; EPIDEMIOLOGY; IMPLANTATION	Purpose To investigate whether differences exist in lens position and other lens parameters among major ethnic groups with cataractous eyes, which may help explain racial differences in angle closure risk. Methods This retrospective, cross-sectional study included 807 adult patients who had cataract surgery between years 2014 and 2016 at the University of California, San Francisco (UCSF). Adult patients of white, Asian, Hispanic and African-American ethnicity were included. Lens position (LP), defined as anterior chamber depth (ACD) + 1/2 lens thickness (LT), was assessed using measurements from optical biometry. Other assessed biometric parameters included axial length (AL), relative lens position (RLP) (defined as LP/AL), and anterior chamber depth (ACD). Results A total of 807 patients and 1361 eyes were included in this study from a database of patients having cataract surgery. Mean age was 69.2 years (age range from 18 to 101 years old), and 60.3% of patients were women. The mean LP measurements were 5.54 +/- 0.32 mmfor white, 5.38 +/- 0.32 mmfor Asian, 5.32 +/- 0.30 mm for Hispanic, and 5.40 +/- 0.28 mm for African-American participants. After adjusting for age, sex, and AL, significant differences were found when comparing LP in paired comparisons among White cohort with Asians (P<0.001), Hispanics (P<0.001) and African- Americans (P = 0.003). Additionally, when comparing RLP, similar significant results were found when comparing Whites with Asians (P< 0.001), Hispanics (P< 0.001) and African-Americans (P = 0.002). Lastly, pair-wise comparison of LT between ethnic groups showed significantdifferences while comparing Asians with Whites (P = 0.001) and Asians with African-Americans (P<0.001). Conclusion The results of this study suggest that the LP of Hispanic, Asian, and African-American patients are significantly smaller than that of White patients, and among all ethnic groups, Hispanics and after Asians have the smallest LP (P<0.001) and RLP (P< 0.001). These findings may have implications for the relative risk of angle closure and the potential IOP response after cataract surgery among different ethnic groups.	[Wang, Dajiang; Amoozgar, Behzad; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Wang, Dajiang] Gen Hosp Peoples Liberat Army, Dept Ophthalmol, Beijing, Peoples R China; [Porco, Travis] Univ Calif San Francisco, Proctor Fdn, San Francisco, CA USA; [Wang, Zhen] Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA; [Wang, Zhen] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Wang, Zhen] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	Shan.Lin@ucsf.edu		Wang, Dajiang/0000-0002-8726-1996	NIH-NEI (BETHESDA, Maryland, USA) [EY002162]; Research to Prevent Blindness (New York, New York, USA); That Man May See, Inc (San Francisco, California, USA); Beijing Natural Science Foundation [7162180]; Chinese National Natural Science Fund [81260147]	NIH-NEI (BETHESDA, Maryland, USA); Research to Prevent Blindness (New York, New York, USA)(Research to Prevent Blindness (RPB)); That Man May See, Inc (San Francisco, California, USA); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study was supported by NIH-NEI EY002162-CORE GRANT FOR VISION RESEARCH (BETHESDA, Maryland, USA), Research to Prevent Blindness (New York, New York, USA), and That Man May See, Inc (San Francisco, California, USA). This study was also supported by the Beijing Natural Science Foundation (7162180) and Chinese National Natural Science Fund (81260147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazik M, 2007, J GLAUCOMA, V16, P129, DOI 10.1097/01.ijg.0000212280.80724.e3; ALSBIRK PH, 1975, ACTA OPHTHALMOL, V53, P436; [Anonymous], 2002, SEMINARS OPHTHALMOLO; Chen RI, 2015, JAMA OPHTHALMOL, V133, P437, DOI 10.1001/jamaophthalmol.2014.5864; Coh P, 2016, INVEST OPHTH VIS SCI, V57, P2593, DOI 10.1167/iovs.16-19384; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Congdon NG, 1996, ACTA OPHTHALMOL SCAN, V74, P113; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; Devereux JG, 2000, ARCH OPHTHALMOL-CHIC, V118, P257; Dooley I, 2010, EYE, V24, P520, DOI 10.1038/eye.2009.339; FISHER RF, 1972, J ANAT, V112, P207; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Hsu CH, 2015, INVEST OPHTH VIS SCI, V56, P7807, DOI 10.1167/iovs.15-17926; Huang GF, 2012, J CATARACT REFR SURG, V38, P108, DOI 10.1016/j.jcrs.2011.06.037; Huang GF, 2011, ARCH OPHTHALMOL-CHIC, V129, P1283, DOI 10.1001/archophthalmol.2011.272; Jonas JB, 2015, INVEST OPHTH VIS SCI, V56, P5309, DOI 10.1167/iovs.15-16796; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Lavanya R, 2008, OPHTHALMOLOGY, V115, P1720, DOI 10.1016/j.ophtha.2008.03.015; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; Lee RY, 2012, CURR EYE RES, V37, P486, DOI 10.3109/02713683.2012.669006; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leung CK, 2010, BRIT J OPHTHALMOLOGY; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Lim MCC, 2006, J GLAUCOMA, V15, P260, DOI 10.1097/01.ijg.0000212212.10395.76; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Mierzejewski Andrzej, 2008, Klin Oczna, V110, P11; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Otori Y, 2011, JPN J OPHTHALMOL, V55, P103, DOI 10.1007/s10384-010-0918-6; Pereira FAS, 2003, OPHTHALMOLOGY, V110, P1799, DOI 10.1016/S0161-6420(03)00623-7; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP1, DOI 10.1016/j.ophtha.2015.10.049; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342; Salmon J F, 1994, J Glaucoma, V3, P237; Salmon JF, 1999, PROG RETIN EYE RES, V18, P121, DOI 10.1016/S1350-9462(98)00007-X; SAXENA S, 1993, ANN OPHTHALMOL, V25, P453; Seah SKL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1436, DOI 10.1001/archopht.1997.01100160606014; Shammas HJ, 2012, AM J OPHTHALMOL, V153, P55, DOI 10.1016/j.ajo.2011.06.012; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Slabaugh MA, 2014, CURR OPIN OPHTHALMOL, V25, P122, DOI 10.1097/ICU.0000000000000033; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Vizzeri G, 2010, CURR OPIN OPHTHALMOL, V21, P20, DOI 10.1097/ICU.0b013e328332f562; Wang DD, 2012, CLIN EXP OPHTHALMOL, V40, P162, DOI 10.1111/j.1442-9071.2011.02658.x; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733	48	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179836	10.1371/journal.pone.0179836	http://dx.doi.org/10.1371/journal.pone.0179836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654694	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500035
J	Mackiewicz, P; Moska, M; Wierzbicki, H; Gagat, P; Mackiewicz, D				Mackiewicz, Pawel; Moska, Magdalena; Wierzbicki, Heliodor; Gagat, Przemyslaw; Mackiewicz, Dorota			Evolutionary history and phylogeographic relationships of shrews from Sorex araneus group	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; HYBRID ZONE; CHROMOSOMAL REARRANGEMENTS; MARITIMENSIS INSECTIVORA; GROUP MAMMALIA; S-ARANEUS; SORICIDAE; DIVERSIFICATION	Shrews of the Sorex genus are an evolutionarily successful group that includes more than 77 species widely distributed in Eurasia and North America. The genus is one of the rare cases where karyotypic changes reflect well the evolutionary relationships among its species. The taxa showing the greatest variation in karyotype are usually classified into the Sorex araneus group. Its evolution was associated with chromosomal rearrangements, which could have promoted fast diversification of this group into many chromosomal races and species. These processes were additionally complicated by introgressions of mitochondrial DNA, which made the evolutionary history of this group quite complex and difficult to infer. To tackle the problem, we performed multi-method phylogenetic analyses based on mitochondrial cytochrome b that is considered a good molecular marker available for many representatives of Sorex. The results were compared with phylogenies based on chromosomal rearrangement data and put into temporal and spatial context using molecular dating and historical biogeography methods. We complemented the study with the estimation of diversification rates within the S. araneus group as well as comparing the results with paleontological records and climatic oscillations within the last 4 million years. Based on the gathered data, we proposed a hypothetical scenario for the evolution and geographic dispersion of species belonging to the S. araneus group. The shrews began to diversify about 2.7 million years ago in Eurasia and then migrated at least twice to North America. The evolution of shrews was driven by Pleistocene glacial and interglacial cycles, which increased their speciation rate and the emergence of new lineages. The migrations of populations were accompanied by introgressions of mitochondrial DNA into native shrews and occurred at least twice.	[Mackiewicz, Pawel; Gagat, Przemyslaw; Mackiewicz, Dorota] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland; [Moska, Magdalena; Wierzbicki, Heliodor] Wroclaw Univ Environm & Life Sci, Dept Genet, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Environmental & Life Sciences	Mackiewicz, P (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland.	pamac@smorfland.uni.wroc.pl	Wierzbicki, Heliodor/AAX-3691-2021; Gagat, Przemysław/ABC-2296-2020; Mackiewicz, Dorota/AAJ-8963-2020	Wierzbicki, Heliodor/0000-0003-4937-556X; Gagat, Przemysław/0000-0001-9077-439X; Mackiewicz, Dorota/0000-0001-8922-8615; Moska, Magdalena/0000-0001-9866-9906; Mackiewicz, Pawel/0000-0003-4855-497X	Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW)"	Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018".; We would like to thank three anonymous Reviewers for their valuable comments and insightful remarks that significantly improved the paper. We are very grateful to prof. Jacques Hausser, prof. Larisa Biltueva and prof. Barbara Rzebik-Kowalska for helpful discussion about karyotypes and chromosomal rearrangements in shrews. Publication costs were supported by Wroclaw Center of Biotechnology program "The Leading National Research Center (KNOW) for years 2014-2018".	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Antoine P, 2016, QUATERNARY SCI REV, V149, P338, DOI 10.1016/j.quascirev.2016.07.035; Bannikova AA, 2010, MOL BIOL+, V44, P658, DOI 10.1134/S0026893310040230; Bannikova AA, 2010, BIOL J LINN SOC, V101, P721, DOI 10.1111/j.1095-8312.2010.01510.x; Basset P, 2008, J EVOLUTION BIOL, V21, P842, DOI 10.1111/j.1420-9101.2008.01506.x; Basset P, 2007, CYTOGENET GENOME RES, V116, P282, DOI 10.1159/000100412; Basset P, 2006, MOL ECOL, V15, P1577, DOI 10.1111/j.1365-294X.2006.02891.x; Biltueva L, 2011, CYTOGENET GENOME RES, V135, P51, DOI 10.1159/000330577; Borisov YM, 2012, COMP CYTOGENET, V6, P267, DOI 10.3897/CompCytogen.v6i3.3019; BRUNET-LECOMITE P, 1988, Bulletin Mensuel de la Societe Linneenne de Lyon, V57, P201; Brunner H, 2002, ACTA THERIOL, V47, P245, DOI 10.1007/BF03194146; Brunner H, 2002, CYTOGENET GENOME RES, V96, P85, DOI 10.1159/000063039; DANNELID E, 1991, MAMMAL REV, V21, P1, DOI 10.1111/j.1365-2907.1991.tb00284.x; DANNELID E, 1994, FOLIA ZOOL, V43, P71; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Ezard T, 2009, SPECIES LIMITS THRES; Fumagalli L, 1999, MOL PHYLOGENET EVOL, V11, P222, DOI 10.1006/mpev.1998.0568; Fumagalli L, 1996, HEREDITAS, V125, P191, DOI 10.1111/j.1601-5223.1996.00191.x; Garcia-Perea Rosa, 1997, Mammalian Species, V554, P1; George SB, 1994, SPECIAL PUBLICATION, V18, P289; GRAF J-D, 1979, Bonner Zoologische Beitraege, V30, P14; Grigoryeva OO, 2011, RUSS J GENET+, V47, P1132, DOI 10.1134/S1022795411090067; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; HAUSSER J, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P79; HAUSSER J, 1994, FOLIA ZOOL, V43, P1; Hausser J., 1985, Acta Zoologica Fennica, P125; Hausser Jacques, 1994, Carnegie Museum of Natural History Special Publication, V18, P295; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HOFFMANN R S, 1987, Acta Theriologica Sinica, V7, P100; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hope AG, 2011, MOL ECOL, V20, P4346, DOI 10.1111/j.1365-294X.2011.05226.x; Hope AG, 2010, J MAMMAL, V91, P1041, DOI 10.1644/09-MAMM-A-402.1; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; Ivanitskaya E.Yu., 1994, Carnegie Museum of Natural History Special Publication, V18, P313; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jobb G, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0513-z; Kirkland Gordon L. Jr, 1996, Mammalian Species, V524, P1; Kotsakis Tassos, 2003, Deinsea (Rotterdam), V10, P313; Lapini L, 2001, ACTA THERIOL, V46, P337, DOI 10.1007/BF03192441; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lopez-Fuster MJ, 1999, ACTA THERIOL, V44, P113; Lugon-Moulin N, 1999, MOL ECOL, V8, P419, DOI 10.1046/j.1365-294X.1999.00595.x; Lukacova L, 1996, HEREDITAS, V125, P233, DOI 10.1111/j.1601-5223.1996.00233.x; MEYLAN A, 1973, Zeitschrift fuer Saeugetierkunde, V38, P143; Meylan A, 1991, CYTOGENETICS SOREX A, V19.1, P125; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohdachi SD, 2006, J ZOOL, V270, P177, DOI 10.1111/j.1469-7998.2006.00125.x; OKHOTINA MV, 1983, ZOOL ZH, V62, P409; Orlov V.N., 2010, Povolzhskii Ekologicheskii Zhurnal, V1, P111; Orlov VN, 2011, RUSS J GENET+, V47, P711, DOI 10.1134/S1022795411060159; Osipova VA, 2006, ACTA THERIOL, V51, P129, DOI 10.1007/BF03192664; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Popov Vasil V., 2003, Acta Zoologica Cracoviensia, V46, P43; Prost S, 2013, GLOBAL CHANGE BIOL, V19, P1865, DOI 10.1111/gcb.12153; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2013, R LANG ENV STAT COMP; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2012, FIGTREE V1 4 0; RAUSCH VR, 1993, P BIOL SOC WASH, V106, P410; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rofes J, 2016, PALAEOGEOGR PALAEOCL, V459, P508, DOI 10.1016/j.palaeo.2016.07.021; ROGERS KL, 1985, NATL GEOGR RES, V1, P535; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rzebik-Kowalska Barbara, 2015, Acta Zoologica Cracoviensia, V58, P137, DOI 10.3409/azc.58_2.137; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; SEARLE J B, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P13; SHARMAN GB, 1956, NATURE, V177, P941, DOI 10.1038/177941a0; Shchipanov NA, 2016, BIOL BULL+, V43, P876, DOI 10.1134/S106235901608015X; Sher A.V., 1974, INT GEOL REV, V16, P1; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stewart DT, 2002, CAN J ZOOL, V80, P94, DOI 10.1139/Z01-207; Swofford DL, 1998, PHYLOGENETIC ANAL US; TABERLET P, 1994, EVOLUTION, V48, P623, DOI 10.1111/j.1558-5646.1994.tb01349.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Virina E.I., 1984, IZVESTIA RUSSIAN ACA, V11, P61; VOLOBOUEV V, 1989, Z ZOOL SYST EVOL, V27, P252; VOLOBOUEV V, 1991, Memoires de la Societe Vaudoise des Sciences Naturelles, V19, P131; VOLOBOUEV VT, 1988, CAN J ZOOL, V66, P1968, DOI 10.1139/z88-288; VOLOBOUEV VT, 1989, J HERED, V80, P284, DOI 10.1093/oxfordjournals.jhered.a110855; White TA, 2010, SYST BIOL, V59, P262, DOI 10.1093/sysbio/syq004; WOJCIK JM, 1988, HEREDITY, V61, P225, DOI 10.1038/hdy.1988.109; Yannic G, 2008, MOL PHYLOGENET EVOL, V47, P237, DOI 10.1016/j.ympev.2008.01.029; Yannic G, 2008, J EVOLUTION BIOL, V21, P658, DOI 10.1111/j.1420-9101.2008.01526.x; Yannic G, 2010, MOL PHYLOGENET EVOL, V57, P1062, DOI 10.1016/j.ympev.2010.09.015; Yannic G, 2009, HEREDITY, V102, P616, DOI 10.1038/hdy.2009.19; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zaitsev Mikhail V., 2002, Acta Zoologica Cracoviensia, V45, P283; Zaitsev MV, 2005, ADV BIOL SHREWS II S, V1, P49; Zima J., 1998, EVOLUTION SHREWS, P175	100	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179760	10.1371/journal.pone.0179760	http://dx.doi.org/10.1371/journal.pone.0179760			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650986	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300019
J	Godany, M; Khatri, BS; Goldstein, RA				Godany, Martin; Khatri, Bhavin S.; Goldstein, Richard A.			Optimal chemotactic responses in stochastic environments	PLOS ONE			English	Article							MICROSCALE NUTRIENT PATCHES; BACTERIAL CHEMOTAXIS; BEHAVIORAL-RESPONSES; ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; INTERMITTENT ROTATION; MARINE-BACTERIA; STRATEGIES		[Godany, Martin; Khatri, Bhavin S.; Goldstein, Richard A.] UCL, Div Infect & Immun, London, England; [Godany, Martin; Khatri, Bhavin S.] Francis Crick Inst, London, England	University of London; University College London; Francis Crick Institute	Goldstein, RA (corresponding author), UCL, Div Infect & Immun, London, England.	r.goldstein@ucl.ac.uk		Goldstein, Richard/0000-0001-5148-4672; Khatri, Bhavin/0000-0002-0312-336X	Biotechnology and Biological Sciences Research Council [BB/P007562/1] Funding Source: Medline; Medical Research Council [MC_PC_13056, MC_U117573805] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; ARMITAGE JP, 1987, J BACTERIOL, V169, P514, DOI 10.1128/jb.169.2.514-518.1987; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bespalov VA, 1996, P NATL ACAD SCI USA, V93, P10084, DOI 10.1073/pnas.93.19.10084; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Clark DA, 2005, P NATL ACAD SCI USA, V102, P9150, DOI 10.1073/pnas.0407659102; DANG CV, 1986, J BACTERIOL, V166, P275, DOI 10.1128/jb.166.1.275-280.1986; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Dufour YS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003694; Egbert MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001004; Frankel NW, 2014, ELIFE, V3, DOI 10.7554/eLife.03526; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; GOTZ R, 1987, J BACTERIOL, V169, P3146; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kafri Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238101; MathWorks, 2013, MATLAB IM PROC TOOLB; Mitchell JG, 2002, AM NAT, V160, P727, DOI 10.1086/343874; Packer HL, 2000, FEMS MICROBIOL LETT, V189, P299, DOI 10.1111/j.1574-6968.2000.tb09247.x; POOLE PS, 1988, J BACTERIOL, V170, P5673, DOI 10.1128/jb.170.12.5673-5679.1988; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; SCHNITZER MJ, 1993, PHYS REV E, V48, P2553, DOI 10.1103/PhysRevE.48.2553; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Soyer OS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-240; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724	34	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6												14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644830	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100011
J	Park, CH; Li, XR; Zhao, Y; Jia, RL; Hur, JS				Park, Chan-Ho; Li, Xin Rong; Zhao, Yang; Jia, Rong Liang; Hur, Jae-Seoun			Rapid development of cyanobacterial crust in the field for combating desertification	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; MOJAVE DESERT; HEATED SOILS; DISTURBANCE; INOCULATION; RECOVERY; EROSION; MICROSTRUCTURE; COMMUNITIES; SYSTEMS	Desertification is currently a major concern, and vast regions have already been devastated in the arid zones of many countries. Combined application of cyanobacteria with soil fixing chemicals is a novel method of restoring desertified areas. Three cyanobacteria, Nostoc sp. Vaucher ex Bornet & Flahault, Phormidium sp. Kutzing ex Gomont and Scytonema arcan-geli Bornet ex Flahault were isolated and tested in this study. Tacki-Spray (TM) (TKS7), which consists of bio-polysaccharides and tackifiers, was used as a soil fixing agent. In addition, superabsorbent polymer (SAP) was applied to the soil as a water-holding material and nutrient supplement. Application of cyanobacteria with superabsorbent polymer and TKS7 (CST) remarkably improved macro-aggregate stability against water and erodibility against wind after 12 months of inoculation when compared to the control soil. The mean weight diameter and threshold friction velocity of the CST treated soil were found to be 75% and 88% of those of the approximately 20-year-old natural cyanobacterial crust (N-BSC), respectively, while these values were 68% and 73% of those of the N-BSC soil after a single treatment of cyanobacteria alone (CY). Interestingly, biological activities of CST were similar to those of CY. Total carbohydrate contents, cyanobacterial biomass, microbial biomass, soil respiration, carbon fixation and effective quantum yield of CST treated soil were enhanced by 50-100% of the N-BSC, while those of control soil were negligible. Our results suggest that combined application of cyanobacteria with soil fixing chemicals can rapidly develop cyanobacterial crust formation in the field within 12 months. The physical properties and biological activities of the inoculated cyanobacterial crust were stable during the study period. The novel method presented herein serves as another approach for combating desertification in arid regions.	[Park, Chan-Ho; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, 255 Jungang Ro, Sunchon, South Korea; [Li, Xin Rong; Zhao, Yang; Jia, Rong Liang] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China	Sunchon National University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, 255 Jungang Ro, Sunchon, South Korea.	jshur1@sunchon.ac.kr	Li, Xinrong/GNW-6025-2022		Forest Science & Technology Projects [5111212L030100]; Korea Forest Service; Chinese Academy of Sciences [2013T2Z0007]	Forest Science & Technology Projects; Korea Forest Service(Korea Forest Service); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a grant from the Forest Science & Technology Projects (Project No. 5111212L030100) provided by the Korea Forest Service and the Chinese Academy of Sciences visiting professorship for senior international scientists (Grant No. 2013T2Z0007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acea MJ, 2003, SOIL BIOL BIOCHEM, V35, P513, DOI 10.1016/S0038-0717(03)00005-1; Acea MJ, 2001, BIOL FERT SOILS, V33, P118, DOI 10.1007/s003740000298; Barger NN, 2006, BIOGEOCHEMISTRY, V77, P247, DOI 10.1007/s10533-005-1424-7; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 2007, EARTH SURF PROC LAND, V32, P75, DOI 10.1002/esp.1372; BELNAP J, 1993, GREAT BASIN NAT, V53, P89; Belnap J, 2001, ECOL STU AN, V150, P363; Belnap J, 2001, BIOL SOIL CRUST ECOL; Buttars SM, 1998, ARID SOIL RES REHAB, V12, P165, DOI 10.1080/15324989809381506; Concostrina-Zubiri L, 2014, ECOL APPL, V24, P1863, DOI 10.1890/13-1416.1; Corti A, 2002, MACROMOL CHEM PHYS, V203, P1526, DOI 10.1002/1521-3935(200207)203:10/11<1526::AID-MACP1526>3.0.CO;2-R; de Caire GZ, 2000, SOIL BIOL BIOCHEM, V32, P1985, DOI 10.1016/S0038-0717(00)00174-7; Dorey G., 1991, POLYM INT, V24, P255, DOI [10.1002/pi.4990240409, DOI 10.1002/PI.4990240409]; Felde VJMNL, 2014, BIODIVERS CONSERV, V23, P1687, DOI 10.1007/s10531-014-0693-7; Gog L, 2005, CHEMOECOLOGY, V15, P115, DOI 10.1007/s00049-005-0294-8; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Harper K. T., 1988, Vegetation science applications for rangeland analysis and management.., P135; HOBBIE SE, 1998, CHLOROFORM FUMIGATIO; Jia RL, 2012, SOIL BIOL BIOCHEM, V45, P31, DOI 10.1016/j.soilbio.2011.09.021; Kuske CR, 2012, ISME J, V6, P886, DOI 10.1038/ismej.2011.153; Lan SB, 2014, ENVIRON SCI TECHNOL, V48, P307, DOI 10.1021/es403785j; Lee SS, 2011, J SOIL WATER CONSERV, V66, P172, DOI 10.2489/jswc.66.3.172; Li JR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043245; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; Li Y, 2011, PROCEDIA ENVIRON SCI, V11, P763, DOI 10.1016/j.proenv.2011.12.118; Liu J, 2012, ENVIRON EARTH SCI, V65, P589, DOI 10.1007/s12665-011-1106-9; Liu LC, 2007, AUST J SOIL RES, V45, P422, DOI 10.1071/SR06175; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P1661, DOI 10.1016/S0038-0717(99)00080-2; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Mager DM, 2011, J ARID ENVIRON, V75, P91, DOI 10.1016/j.jaridenv.2010.10.001; Malam Issa O, 2001, GEODERMA, V101, P15, DOI 10.1016/S0016-7061(00)00093-8; Malam Issa O, 2007, PLANT SOIL, V290, P209, DOI 10.1007/s11104-006-9153-9; Maqubela M. P., 2012, African Journal of Biotechnology, V11, P10726; Millennium Ecosystem Assessment, 2005, MILLENNIUM ECOSYSTEM; Nisha R, 2007, GEODERMA, V138, P49, DOI 10.1016/j.geoderma.2006.10.007; Park CH, 2017, ARID LAND RES MANAG, V31, P81, DOI 10.1080/15324982.2016.1198842; Park CH, 2015, ARID LAND RES MANAG, V29, P55, DOI 10.1080/15324982.2014.928835; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rodriguez AR, 2006, CATENA, V66, P228, DOI 10.1016/j.catena.2006.02.001; Rossi F, 2012, SOIL BIOL BIOCHEM, V46, P33, DOI 10.1016/j.soilbio.2011.10.016; SAFARIK I, 1992, PLANT SOIL, V143, P109, DOI 10.1007/BF00009135; Schreiber U., 1998, P320; TIEDEMANN AR, 1980, SOIL BIOL BIOCHEM, V12, P471, DOI 10.1016/0038-0717(80)90082-6; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; UNCCD, 2001, GLOB AL DUST SANDST; Wang QR, 2011, ENVIRON MONIT ASSESS, V174, P241, DOI 10.1007/s10661-010-1454-z; Wang WB, 2009, SOIL BIOL BIOCHEM, V41, P926, DOI 10.1016/j.soilbio.2008.07.001; Warren S.D., 2003, BIOL SOIL CRUST STRU, P327, DOI [10.1007/978-3-642-56475-8_24, DOI 10.1007/978-3-642-56475-8_24]; West N. E., 1990, Advances in Ecological Research, V20, P179, DOI 10.1016/S0065-2504(08)60055-0; Williams AJ, 2012, SOIL SCI SOC AM J, V76, P1685, DOI 10.2136/sssaj2012.0021; Williams WJ, 2008, J ARID ENVIRON, V72, P1064, DOI 10.1016/j.jaridenv.2007.11.017; Wu YW, 2013, PLANT SOIL, V370, P115, DOI 10.1007/s11104-013-1611-6; Yan-Gui S, 2013, LAND DEGRAD DEV, V24, P342, DOI 10.1002/ldr.1131; Yang J, 2007, ENVIRON POLLUT, V149, P125, DOI 10.1016/j.envpol.2006.12.021; Yonter G, 2010, EKOLOJI, V19, P35, DOI 10.5053/ekoloji.2010.776; Yu J, 2003, SOIL SCI SOC AM J, V67, P630, DOI 10.2136/sssaj2003.0630; Zaady E, 2014, AEOLIAN RES, V13, P81, DOI 10.1016/j.aeolia.2014.04.002; Zohuriaan-Mehr MJ, 2008, IRAN POLYM J, V17, P451	61	57	62	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179903	10.1371/journal.pone.0179903	http://dx.doi.org/10.1371/journal.pone.0179903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644849	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100048
J	Gao, J; Shen, B; Xiong, JJ; Lu, YH; Jiang, QW				Gao, Jie; Shen, Bing; Xiong, JianJing; Lu, Yihan; Jiang, Qingwu			The measles epidemic trend over the past 30 years in a central district in Shanghai, China	PLOS ONE			English	Article							OUTBREAK	Background Measles vaccination over the past 50 years has greatly reduced the incidence of measles. However, measles among migrants and the resulting changes in epidemiological characteristics have brought new challenges to the elimination of measles. We aim to describe the measles epidemic trend over the past 30 years in a central district in Shanghai, China. Methods The present study was conducted in the Jing'an District, which is located in the center of Shanghai. Based on historical surveillance data of measles, we calculated the incidence of measles among local residents and migrants separately. Next, we classified all of the cases of the measles among local residents between 1984 and 2015 into 8 age groups and 5 birth cohorts. Finally, we calculated the measles incidence in each time period by the different age groups and birth cohorts, to understand the measles epidemic trend over past 30 years in the Jing'an District. Results A total of 103 cases of measles were reported from the Jing'an District, Shanghai, from 1984 to 2015. For infants less than 1 year of age and adults over 30 years of age, the incidence of measles continued to rise over the past 30 years. For a specific birth cohort, the incidence of measles after measles vaccination declined initially, and was then followed by a rebound. Conclusions The incidence of measles in older adults and infants increased in some developed regions, which slows the process of measles elimination. This suggested that the population immunity against measles after measles vaccination would gradually reduce with time. We recommend supplemental immunization against measles in adults in order to reduce the immunity decline, especially for migrants.	[Gao, Jie; Lu, Yihan; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Minister Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Gao, Jie; Shen, Bing; Xiong, JianJing] Jingan Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention	Lu, YH; Jiang, QW (corresponding author), Fudan Univ, Sch Publ Hlth, Minister Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	luyihan@fudan.edu.cn; jiangqw@shmu.edu.cn		Jiang, Qingwu/0000-0001-8921-3317				Abram L. H., 2016, INT J INFECT DIS, V45, P103; [Anonymous], WKLY EPIDEMIOL REC; Cao L., 2012, CHIN J VACCINES IMMU, V18, P419; Cho HK, 2016, J KOREAN MED SCI, V31, P1957, DOI 10.3346/jkms.2016.31.12.1957; David ND, 2014, VACCINE, V32, P6880; Gao Jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1163; Han K, 2016, HUM VACC IMMUNOTHER, V12, P2181, DOI 10.1080/21645515.2016.1159364; Jordan SM, 2015, BIOMED RES INT; Li J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-986; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h436; Ogbuanu I U, 2016, SAMJ, S. Afr. med. j., V106, P715, DOI [10.7196/samj.2016.v106i7.10651, 10.7196/SAMJ.2016.v106i7.10651]; Shi Y, 2006, CHINESE J VACCINES I, V12, P32; Tang ZZ, 2016, AM J INFECT CONTROL, V44, pE51, DOI 10.1016/j.ajic.2015.11.005; Wang XX, 2015, VACCINE, V33, P6186, DOI 10.1016/j.vaccine.2015.10.008; WHO position papers Measles vaccines, WER 2004, P14130; Williams GA, 2016, SCAND J PUBLIC HEALT, V44, P6, DOI 10.1177/1403494815610182; World Health Organization, 2010, 63 WORLD HLTH ASS PR, V11; Xu TQ, 1997, CHINESE J VACCINES I, V3, P24; Zhang MX, 2016, EMERG INFECT DIS, V22, P144, DOI 10.3201/eid2201.151293	21	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179470	10.1371/journal.pone.0179470	http://dx.doi.org/10.1371/journal.pone.0179470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640919	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800034
J	Qiu, J; Wang, JH; Xu, ZQ; Liu, HQ; Ren, J				Qiu, Jun; Wang, Jinhao; Xu, Zhongqi; Liu, Huiqing; Ren, Jie			Quantitation of underivatized branched-chain amino acids in sport nutritional supplements by capillary electrophoresis with direct or indirect UV absorbance detection	PLOS ONE			English	Article							ZONE-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; PROTEIN-SYNTHESIS; SEPARATION; MASS; ENANTIOMERS; PERFORMANCE; DERIVATIVES; PLASMA; HPLC	The branched-chain amino acids (BCAAs) including leucine (Leu), isoleucine (Ile) and valine (Val) play a pivotal role in the human body. Herein, we developed capillary electrophoresis (CE) coupled with conventional UV detector to quantify underivatized BCAAs in two kinds of sport nutritional supplements. For direct UV detection at 195 nm, the BCAAs (Leu, two enantiomers of Ile and Val) were separated in a background electrolyte (BGE) consisting of 40.0 mmol/L sodium tetraborate, and 40.0 mmol/L beta-cyclodextrin (beta-CD) at pH 10.2. In addition, the indirect UV detection at 264 nm was achieved in a BGE of 2.0 mmol/L Na2HPO4, 10.0 mmol/L p-aminosalicylic acid (PAS) as UV absorbing probe, and 40.0 mmol/L beta-CD at pH 12.2. The beta-CD significantly benefited the isomeric separation of Leu, L- and D-Ile. The optimal conditions allowed the LODs (limit of detections) of direct and indirect UV absorption detection to be tens mu mol/L level, which was comparable to the reported CE inline derivatization method. The RSDs (relative standard deviations) of migration time and peak area were less than 0.91% and 3.66% (n = 6). Finally, CE with indirect UV detection method was applied for the quantitation of BCAAs in two commercial sport nutritional supplements, and good recovery and precision were obtained. Such simple CE method without tedious derivatization process is feasible of quality control and efficacy evaluation of the supplemental proteins.	[Qiu, Jun; Wang, Jinhao] Shanghai Res Inst Sports Sci, Shanghai, Peoples R China; [Xu, Zhongqi; Liu, Huiqing] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China; [Ren, Jie] Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China	Donghua University; Shanghai University of Sport	Xu, ZQ (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China.; Ren, J (corresponding author), Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China.	chemxzq@dhu.edu.cn; renjiemail2008@163.com	, 徐中其@东华/AHB-5022-2022; Xu, Zhongqi/D-1023-2010	, 徐中其@东华/0000-0003-4786-6234; Xu, Zhongqi/0000-0003-4786-6234	Shanghai Municipal Natural Science Foundation [16ZR1401400]; Shanghai Sports Bureau [14ZH024]	Shanghai Municipal Natural Science Foundation; Shanghai Sports Bureau	This work was financed by Shanghai Municipal Natural Science Foundation (16ZR1401400), and partly supported by the General Plan of Science & Technology in 2014 from Shanghai Sports Bureau (Project No. 14ZH024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomstrand E, 2006, J NUTR, V136, p544S, DOI 10.1093/jn/136.2.544S; Boniglia C, 2002, J FOOD SCI, V67, P1352, DOI 10.1111/j.1365-2621.2002.tb10287.x; Cavazza A, 2000, J AGR FOOD CHEM, V48, P3324, DOI 10.1021/jf991368m; Chang PL, 2011, ELECTROPHORESIS, V32, P1080, DOI 10.1002/elps.201000445; Coufal P, 2003, ELECTROPHORESIS, V24, P671, DOI 10.1002/elps.200390079; Cruzat VF, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0061-8; Dai ZL, 2014, J CHROMATOGR B, V964, P116, DOI 10.1016/j.jchromb.2014.03.025; Crespo ICD, 2015, ELECTROPHORESIS, V36, P1179, DOI 10.1002/elps.201400534; Devries MC, 2015, J FOOD SCI, V80, pA8, DOI 10.1111/1750-3841.12802; Falavigna G, 2012, NUTRIENTS, V4, P1767, DOI 10.3390/nu4111767; Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1; Gioia MG, 2007, J PHARMACEUT BIOMED, V45, P456, DOI 10.1016/j.jpba.2007.07.016; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; How ZT, 2014, J CHROMATOGR A, V1370, P135, DOI 10.1016/j.chroma.2014.10.040; Kanda A, 2013, BRIT J NUTR, V110, P981, DOI 10.1017/S0007114512006174; Leao P, 2010, J SEP SCI, V33, P2394; Lin EP, 2013, TALANTA, V114, P297, DOI 10.1016/j.talanta.2013.05.039; Mitsuhashi S, 2014, CURR OPIN BIOTECH, V26, P38, DOI 10.1016/j.copbio.2013.08.020; Moreno-Gonzalez D, 2013, ELECTROPHORESIS, V34, P2615, DOI 10.1002/elps.201300247; Poinsot V, 2010, ELECTROPHORESIS, V31, P105, DOI 10.1002/elps.200900399; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Stalikas CD, 2000, J CHROMATOGR A, V872, P215, DOI 10.1016/S0021-9673(99)01300-X; TAKEUCHI T, 1986, J CHROMATOGR, V370, P83, DOI 10.1016/S0021-9673(00)94676-4; Tian MM, 2014, ELECTROPHORESIS, V35, P577, DOI 10.1002/elps.201300416; Tuma P, 2015, ELECTROPHORESIS, V36, P1969, DOI 10.1002/elps.201400585; Wang T, 2015, J PHARMACEUT BIOMED, V114, P426, DOI 10.1016/j.jpba.2015.06.015; WANG TS, 1992, J CHROMATOGR, V607, P119, DOI 10.1016/0021-9673(92)87061-C; Zampolli MG, 2007, J CHROMATOGR A, V1150, P162, DOI 10.1016/j.chroma.2006.12.033	28	9	9	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179892	10.1371/journal.pone.0179892	http://dx.doi.org/10.1371/journal.pone.0179892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640882	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800079
J	Conduit, SE; Ramaswamy, V; Remke, M; Watkins, DN; Wainwright, BJ; Taylor, MD; Mitchell, CA; Dyson, JM				Conduit, S. E.; Ramaswamy, V.; Remke, M.; Watkins, D. N.; Wainwright, B. J.; Taylor, M. D.; Mitchell, C. A.; Dyson, J. M.			A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma	ONCOGENE			English	Article							INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; COUPLED RECEPTOR GPR161; CEREBELLAR DEVELOPMENT; TUMOR-SUPPRESSOR; MOUSE MODEL; PROTEIN TRAFFICKING; TRANSITION ZONE; PATHWAY; GROWTH; CELLS	Sonic Hedgehog (SHH) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor. Severe side effects associated with conventional treatments and resistance to targeted therapies has led to the need for new strategies. SHH signaling is dependent on primary cilia for signal transduction suggesting the potential for cilia destabilizing mechanisms as a therapeutic target. INPP5E is an inositol polyphosphate 5-phosphatase that hydrolyses PtdIns(4,5)P-2 and more potently, the phosphoinositide (PI) 3-kinase product PtdIns(3,4,5)P-3. INPP5E promotes SHH signaling during embryonic development via PtdIns(4,5)P-2 hydrolysis at cilia, that in turn regulates the cilia recruitment of the SHH suppressor GPR161. However, the role INPP5E plays in cancer is unknown and the contribution of PI3-kinase signaling to cilia function is little characterized. Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells. Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss. PtdIns(3,4,5)P-3, its effector pAKT and the target pGSK3 beta, which when non-phosphorylated promotes cilia assembly/stability, localized to tumor cell cilia. The number of PtdIns(3,4,5)P-3/pAKT/pGSK3 beta-positive cilia was increased in cultured Inpp5e-null tumor cells relative to controls. PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro. INPP5E mRNA and copy number were reduced in human SHH medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival. Therefore our study identifies a compartmentalized PtdIns(3,4,5)P-3/AKT/GSK3 beta signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression.	[Conduit, S. E.; Mitchell, C. A.; Dyson, J. M.] Monash Univ, Dept Biochem & Mol Biol, Canc Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Ramaswamy, V.] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Remke, M.; Taylor, M. D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada; [Watkins, D. N.] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Watkins, D. N.] UNSW, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW, Australia; [Watkins, D. N.] St Vincents Hosp, Dept Thorac Med, Darlinghurst, NSW, Australia; [Wainwright, B. J.] Univ Queensland, Div Mol Genet & Dev, Inst Mol Biosci, Brisbane, Qld, Australia	Monash University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Garvan Institute of Medical Research; University of New South Wales Sydney; St Vincents Hospital Sydney; University of Queensland	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Canc Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu		Ramaswamy, Vijay/0000-0002-6557-895X; Wainwright, Brandon/0000-0003-0406-2092; Taylor, Michael/0000-0001-7009-3466	National Health and Medical Research Council [APP1046174]; Australian Postgraduate Award; Alex's Lemonade Stand; CERN foundation; Pediatric Brain Tumor Foundation; National Institutes of Health [R01CA159859, R01CA148699]; NATIONAL CANCER INSTITUTE [R01CA159859, R01CA148699] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Alex's Lemonade Stand; CERN foundation; Pediatric Brain Tumor Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study utilized the Monash Micro Imaging Facility, Monash University, Victoria, Australia and Monash Histology Platform, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia. This work was funded by a National Health and Medical Research Council project grant (APP1046174). SEC was supported by an Australian Postgraduate Award. VR is supported by a Young Investigator Award from Alex's Lemonade Stand and a Basic Science Fellowship from the CERN foundation. MDT is supported by grants from the Pediatric Brain Tumor Foundation and the National Institutes of Health (R01CA159859 and R01CA148699).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Barakat MT, 2013, CARCINOGENESIS, V34, P1382, DOI 10.1093/carcin/bgt041; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Castellino RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010849; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowther AJ, 2016, CANCER RES, V76, P3211, DOI 10.1158/0008-5472.CAN-15-0025; Crowther AJ, 2013, J NEUROSCI, V33, P18098, DOI 10.1523/JNEUROSCI.2602-13.2013; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Eramo MJ, 2016, BIOCHEM SOC T, V44, P240, DOI 10.1042/BST20150214; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Frick A, 2012, GLIA, V60, P820, DOI 10.1002/glia.22314; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Ge XC, 2015, ELIFE, V4, DOI [10.7554/eLife.07068.001, 10.7554/eLife.07068]; Hakim S, 2016, HUM MOL GENET, V25, P2295, DOI 10.1093/hmg/ddw097; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hamze-Komaiha O, 2016, CELL REP, V17, P2738, DOI 10.1016/j.celrep.2016.11.033; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Heine VM, 2010, CANCER RES, V70, P5220, DOI 10.1158/0008-5472.CAN-10-0554; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Hoffmeister H, 2011, J CELL BIOL, V192, P631, DOI 10.1083/jcb.201007050; Hou CZ, 2014, DEV BIOL, V395, P167, DOI 10.1016/j.ydbio.2014.07.007; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Joo W, 2014, SCIENCE, V346, P626, DOI 10.1126/science.1258996; Julian Elaine, 2010, Neural Dev, V5, P27, DOI 10.1186/1749-8104-5-27; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Luo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066727; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Metcalfe C, 2013, CANCER RES, V73, P7034, DOI 10.1158/0008-5472.CAN-13-1222; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nielsen BS, 2015, J CELL SCI, V128, P3543, DOI 10.1242/jcs.173559; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ooms LM, 2015, CANCER CELL, V28, P155, DOI 10.1016/j.ccell.2015.07.003; Otero JJ, 2014, DEV BIOL, V385, P328, DOI 10.1016/j.ydbio.2013.10.019; Pal K, 2016, J CELL BIOL, V212, P861, DOI 10.1083/jcb.201506132; Park J, 2015, CELL REP, V13, P2808, DOI 10.1016/j.celrep.2015.12.009; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Plotnikova OV, 2015, J CELL SCI, V128, P364, DOI 10.1242/jcs.161323; Poschl J, 2011, ONCOGENE, V30, P4721, DOI 10.1038/onc.2011.173; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Saeed H, 2015, BIOGERONTOLOGY, V16, P733, DOI 10.1007/s10522-015-9596-6; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yee LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005627; Yeh C, 2013, DEV CELL, V26, P358, DOI 10.1016/j.devcel.2013.07.014; Yip SC, 2008, BIOCHEM J, V411, P441, DOI 10.1042/BJ20071179; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298; Zhang H., 2015, EVIDENCE BASED COMPL, V2015, P1; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	92	30	30	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5969	5984		10.1038/onc.2017.208	http://dx.doi.org/10.1038/onc.2017.208			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650469				2022-12-26	WOS:000413841400006
J	Tang, R; Zhang, G; Wang, YC; Mei, XH; Chen, SY				Tang, Rui; Zhang, Gui; Wang, Yung-Chun; Mei, Xiaohan; Chen, Shi-You			The long non-coding RNA GAS5 regulates transforming growth factor (TGF-)-induced smooth muscle cell differentiation via RNA Smad-binding elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; long non-coding RNA (long ncRNA; lncRNA); signal transduction; smooth muscle; TGF-; GAS5; Smad3	SERUM RESPONSE FACTOR; TGF-BETA; CANCER PROGRESSION; TRANSCRIPTION; LNCRNA; INDUCTION; MEMBRANE; INSIGHTS; GENE	Smooth muscle cell (SMC) differentiation is essential for vascular development, and TGF- signaling plays a critical role in this process. Although long non-coding RNAs (lncRNAs) regulate various cellular events, their functions in SMC differentiation remain largely unknown. Here, we demonstrate that the lncRNA growth arrest-specific 5 (GAS5) suppresses TGF-/Smad3 signaling in smooth muscle cell differentiation of mesenchymal progenitor cells. We found that forced expression of GAS5 blocked, but knockdown of GAS5 increased, the expression of SMC contractile proteins. Mechanistically, GAS5 competitively bound Smad3 protein via multiple RNA Smad-binding elements (rSBEs), which prevented Smad3 from binding to SBE DNA in TGF--responsive SMC gene promoters, resulting in suppression of SMC marker gene transcription and, consequently, in inhibition of TGF-/Smad3-mediated SMC differentiation. Importantly, other lncRNAs or artificially synthesized RNA molecules that contained rSBEs also effectively inhibited TGF-/Smad3 signaling, suggesting that lncRNA-rSBE may be a general mechanism used by cells to fine-tune Smad3 activity in both basal and TGF--stimulated states. Taken together, our results have uncovered an lncRNA-based mechanism that modulates TGF-/Smad3 signaling during SMC differentiation.	[Tang, Rui; Zhang, Gui; Wang, Yung-Chun; Mei, Xiaohan; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Tang, Rui] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University System of Georgia; University of Georgia; Stanford University	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu		Wang, Yung-Chun/0000-0002-8775-3472	NHLBI, National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL135854, R01HL119053] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL119053, HL123302, and HL135854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Freedman JE, 2017, ARTERIOSCL THROM VAS, V37, P21, DOI 10.1161/ATVBAHA.116.308513; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120550; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Peng WZ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0197-7; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Sehgal L, 2014, LEUKEMIA, V28, P2376, DOI 10.1038/leu.2014.126; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wang YNZ, 2016, HYPERTENSION, V68, P736, DOI 10.1161/HYPERTENSIONAHA.116.07259; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhao J., 2016, ARTERIOSCLER THROMB, V10, P2088; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	32	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14270	14278		10.1074/jbc.M117.790030	http://dx.doi.org/10.1074/jbc.M117.790030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28659340	Green Published, hybrid			2022-12-26	WOS:000408439800030
J	Izumi, M; Mizuno, T; Yanagi, K; Sugimura, K; Okumura, K; Imamoto, N; Abe, T; Hanaoka, F				Izumi, Masako; Mizuno, Takeshi; Yanagi, Ken-ichiro; Sugimura, Kazuto; Okumura, Katsuzumi; Imamoto, Naoko; Abe, Tomoko; Hanaoka, Fumio			The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA binding protein; DNA helicase; DNA replication; DNA-protein interaction; Mcm10; Mcm2-7	EUKARYOTIC DNA-REPLICATION; INTRINSICALLY UNSTRUCTURED PROTEINS; DOUBLE-HEXAMERIC MCM2-7; POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; S-PHASE; CELL-CYCLE; CDC6 PROTEIN; BINDING PROPERTIES	The protein mini-chromosome maintenance 10 (Mcm10) was originally identified as an essential yeast protein in the maintenance of mini-chromosome plasmids. Subsequently, Mcm10 has been shown to be required for both initiation and elongation during chromosomal DNA replication. However, it is not fully understood how the multiple functions of Mcm10 are coordinated or how Mcm10 interacts with other factors at replication forks. Here, we identified and characterized the Mcm2-7-interacting domain in human Mcm10. The interaction with Mcm2-7 required the Mcm10 domain that contained amino acids 530-655, which overlapped with the domain required for the stable retention of Mcm10 on chromatin. Expression of truncated Mcm10 in HeLa cells depleted of endogenous Mcm10 via siRNA revealed that the Mcm10 conserved domain (amino acids 200-482) is essential for DNA replication, whereas both the conserved and the Mcm2-7-binding domains were required for its full activity. Mcm10 depletion reduced the initiation frequency of DNA replication and interfered with chromatin loading of replication protein A, DNA polymerase (Pol) , and proliferating cell nuclear antigen, whereas the chromatin loading of Cdc45 and Pol E was unaffected. These results suggest that human Mcm10 is bound to chromatin through the interaction with Mcm2-7 and is primarily involved in the initiation of DNA replication after loading of Cdc45 and Pol E.	[Izumi, Masako; Abe, Tomoko] RIKEN, Nishina Ctr Accelerator Based Sci, Accelerator Applicat Res Grp, Wako, Saitama 3510198, Japan; [Mizuno, Takeshi; Yanagi, Ken-ichiro; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Sugimura, Kazuto; Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan; [Hanaoka, Fumio] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo 1718588, Japan; [Hanaoka, Fumio] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	RIKEN; RIKEN; Mie University; Gakushuin University; University of Tsukuba	Izumi, M (corresponding author), RIKEN, Nishina Ctr Accelerator Based Sci, Accelerator Applicat Res Grp, Wako, Saitama 3510198, Japan.	mizumi@riken.jp	Mizuno, Takeshi/I-4432-2017	Mizuno, Takeshi/0000-0003-3664-7212	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Hayashi Memorial Foundation for Female Natural Scientists. The authors declare that they have no conflicts of interest with the contents of this article.	Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Chadha GS, 2016, CELL CYCLE, V15, P2183, DOI 10.1080/15384101.2016.1199305; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Di Perna R, 2013, BIOCHEM J, V454, P333, DOI 10.1042/BJ20130059; Douglas ME, 2016, J BIOL CHEM, V291, P5879, DOI 10.1074/jbc.M115.707802; Douglas NL, 2005, MOL BIOL REP, V32, P197, DOI 10.1007/s11033-005-2312-x; Du WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070518; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fatoba ST, 2013, NUCLEIC ACIDS RES, V41, P4065, DOI 10.1093/nar/gkt131; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Homesley L, 2000, GENE DEV, V14, P913; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, J CELL BIOCHEM, V76, P280, DOI 10.1002/(SICI)1097-4644(20000201)76:2<280::AID-JCB11>3.0.CO;2-0; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Looke M, 2017, GENE DEV, V31, P291, DOI 10.1101/gad.291336.116; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Robertson PD, 2010, J BIOL CHEM, V285, P22942, DOI 10.1074/jbc.M110.131276; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taylor M, 2011, DNA REPAIR, V10, P1154, DOI 10.1016/j.dnarep.2011.09.001; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	72	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13008	13021		10.1074/jbc.M117.779371	http://dx.doi.org/10.1074/jbc.M117.779371			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28646110	hybrid, Green Published			2022-12-26	WOS:000407220100028
J	Jedrusik, P; Symonides, B; Wojciechowska, E; Gryglas, A; Gaciong, Z				Jedrusik, Piotr; Symonides, Bartosz; Wojciechowska, Ewa; Gryglas, Adam; Gaciong, Zbigniew			Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit	PLOS ONE			English	Article							DAILY SALT INTAKE; SODIUM-EXCRETION; PRIMARY ALDOSTERONISM; POPULATION; COLLECTIONS; VALIDATION; CREATININE	Background Primary hyperaldosteronism may be associated with elevated 24-hour urinary potassium excretion. We evaluated the diagnostic value of spot urine (SU) potassium as an index of 24-hour urinary potassium excretion. Methods We measured SU and 24-hour urinary collection potassium and creatinine in 382 patients. Correlations between SU and 24-hour collections were assessed for potassium levels and potassium/creatinine ratios. We used the PAHO formula to estimate 24-hour urinary potassium excretion based on SU potassium level. The agreement between estimated and measured 24-hour urinary potassium excretion was evaluated using the Bland-Altman method. To evaluate diagnostic performance of SU potassium, we calculated areas under the curve (AUC) for SU potassium/creatinine ratio and 24-hour urinary potassium excretion estimated using the PAHO formula. Results Strongest correlation between SU and 24-hour collection was found for potassium/creatinine ratio (r = 0.69, P<0.001). The PAHO formula underestimated 24-hour urinary potassium excretion by mean 8.3 +/- 18 mmol/d (95% limits of agreement-28 to +44 mmol/d). Diagnostic performance of SU potassium/creatinine ratio was borderline good only if 24-hour urinary potassium excretion was largely elevated (AUC 0.802 for 120 mmol K+/24 h) but poor with lower values (AUC 0.696 for 100 mmol K+/24 h, 0.636 for 80 mmol K+/24 h, 0.675 for 40 mmol K+/24 h). Diagnostic performance of 24-hour urinary potassium excretion estimated by the PAHO formula was excellent with values above 120 mmol/d and good with lower values (AUC 0.941 for 120 mmol K+/24 h, 0.819 for 100 mmol K+/24 h, 0.823 for 80 mmol K+/24 h, 0.836 for 40 mmol K+/24 h). Conclusions Spot urine potassium/creatinine ratio might be a marker of increased 24-hour urinary potassium excretion and a potentially useful screening test when reliable 24-hour urine collection is not available. The PAHO formula allowed estimation of the 24-hour urinary potassium excretion based on SU measurements with reasonable clinical accuracy.	[Jedrusik, Piotr; Symonides, Bartosz; Wojciechowska, Ewa; Gryglas, Adam; Gaciong, Zbigniew] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland	Medical University of Warsaw	Jedrusik, P (corresponding author), Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland.	pjedrusik@wum.edu.pl	Symonides, Bartosz/N-1883-2018	Symonides, Bartosz/0000-0002-5933-609X; Jedrusik, Piotr/0000-0003-0037-6035				BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; Chernecky CC, 2008, LAB TESTS DIAGNOSTIC, P399; Doenyas-Barak K, 2015, NEPHRON, V130, P35, DOI 10.1159/000430105; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Han WZ, 2015, AM J HYPERTENS, V28, P1368, DOI 10.1093/ajh/hpv037; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; Huang L., 2014, J HYPERTENS S1, V32, P110; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Ji C, 2014, NUTR METAB CARDIOVAS, V24, P140, DOI 10.1016/j.numecd.2013.06.011; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; KAMEL KS, 1990, AM J NEPHROL, V10, P89, DOI 10.1159/000168062; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; Kawamura M, 2012, HYPERTENS RES, V35, P611, DOI 10.1038/hr.2012.6; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Koo H, 2015, ANN LAB MED, V35, P238, DOI 10.3343/alm.2015.35.2.238; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Martin Helen, 2011, Clin Biochem Rev, V32, P97; McLean R, 2014, J HUM HYPERTENS, V28, P657, DOI 10.1038/jhh.2014.10; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mizehoun-Adissoda C, 2016, J CLIN HYPERTENS, V18, P634, DOI 10.1111/jch.12722; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Organization WH, 2010, DIS PREV POP WID DIE; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Rodby RA, 2016, AM J KIDNEY DIS, V68, P836, DOI 10.1053/j.ajkd.2016.06.025; Stern N., 2018, MANUAL ENDOCRINOLOGY, V5th, P202; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; van Huysduynen EJCH, 2014, PUBLIC HEALTH NUTR, V17, P2505, DOI 10.1017/S1368980014001177; Wang CY, 2013, J NUTR, V143, P1276, DOI 10.3945/jn.113.175927; Woywodt A, 2001, NEPHROL DIAL TRANSPL, V16, P1066, DOI 10.1093/ndt/16.5.1066	32	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180117	10.1371/journal.pone.0180117	http://dx.doi.org/10.1371/journal.pone.0180117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662194	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300105
J	Narayanaswamy, VP; Giatpaiboon, S; Baker, SM; Wiesmann, WP; LiPuma, JJ; Townsend, SM				Narayanaswamy, Vidya P.; Giatpaiboon, Scott; Baker, Shenda M.; Wiesmann, William P.; LiPuma, John J.; Townsend, Stacy M.			Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; ANTIBACTERIAL ACTION; CHITOSAN-ARGININE; INFECTIONS; EPIDEMIOLOGY; BACTERIA; SYNERGY; ISSUES	Burkholderia cepacia complex (Bcc) infection, associated with cystic fibrosis (CF) is intrinsically multidrug resistant to antibiotic treatment making eradication from the CF lung virtually impossible. Infection with Bcc leads to a rapid decline in lung function and is often a contraindication for lung transplant, significantly influencing morbidity and mortality associated with CF disease. Standard treatment frequently involves antibiotic combination therapy. However, no formal strategy has been adopted in clinical practice to guide successful eradication. A new class of direct-acting, large molecule polycationic glycopolymers, derivatives of a natural polysaccharide poly-N-acetyl-glucosamine (PAAG), are in development as an alternative to traditional antibiotic strategies. During treatment, PAAG rapidly targets the anionic structural composition of bacterial outer membranes. PAAG was observed to permeabilize bacterial membranes upon contact to facilitate potentiation of antibiotic activity. Three-dimensional checkerboard synergy analyses were used to test the susceptibility of eight Bcc strains (seven CF clinical isolates) to antibiotic combinations with PAAG or ceftazidime. Potentiation of tobramycin and meropenem activity was observed in combination with 8-128 mu g/mL PAAG. Treatment with PAAG reduced the minimum inhibitory concentration (MIC) of tobramycin and meropenem below their clinical sensitivity breakpoints (<= 4 mu g/mL), demonstrating the ability of PAAG to sensitize antibiotic resistant Bcc clinical isolates. Fractional inhibitory concentration (FIC) calculations showed PAAG was able to significantly potentiate antibacterial synergy with these antibiotics toward all Bcc species tested. These preliminary studies suggest PAAG facilitates a broad synergistic activity that may result in more positive therapeutic outcomes and supports further development of safe, polycationic glycopolymers for inhaled combination antibiotic therapy, particularly for CF-associated Bcc infections.	[Narayanaswamy, Vidya P.; Giatpaiboon, Scott; Baker, Shenda M.; Wiesmann, William P.; Townsend, Stacy M.] Synedgen Inc, Claremont, CA 91711 USA; [LiPuma, John J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Townsend, SM (corresponding author), Synedgen Inc, Claremont, CA 91711 USA.	st@synedgen.com		Baker, Shenda/0000-0002-9985-473X; Narayanaswamy, Vidya/0000-0002-9165-5672	Synedgen Inc.	Synedgen Inc.	The funders, through Synedgen Inc., provides support in the form of salaries for authors SMT, VPN, SG, SMB and WPW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or Preparation of the manuscript. The specific roles of these authors are articulated in their 'author contributions' section.	Aaron SD, 2005, LANCET, V366, P463, DOI 10.1016/S0140-6736(05)67060-2; Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Abbott FK, 2016, INT J ANTIMICROB AG, V48, P521, DOI 10.1016/j.ijantimicag.2016.07.020; Baxter RM, 2013, J BIOMED MATER RES A, V101, P340, DOI 10.1002/jbm.a.34328; BERENBAUM MC, 1980, J INFECT DIS, V142, P476, DOI 10.1093/infdis/142.3.476; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Carla PC, 2011, FRONT CELL INFECT MI, V1, P12; Claudia S, 2015, PLOS ONE, V10; Clinical and Laboratory Standards Institute, 2014, M7A9 CLIN LAB STAND; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; Garbers SM, 2011, WOUND RINSE REMOVES; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gilligan Peter H., 1995, P509; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jones AM, 2001, EUR RESPIR J, V17, P295, DOI 10.1183/09031936.01.17202950; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kwa AL, 2008, ANN ACAD MED SINGAP, V37, P870; Lahmer RA, 2012, FOOD CONTROL, V26, P206, DOI 10.1016/j.foodcont.2012.01.039; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2009, ANTIMICROB AGENTS CH, V53, P249, DOI 10.1128/AAC.00691-08; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahenthiralingam E, 2002, J MED MICROBIOL, V51, P533, DOI 10.1099/0022-1317-51-7-533; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260; Narayanaswamy V, 2016, POTENTIAL TREATMENTS; NIKAIDO H, 1990, ANTIMICROB AGENTS CH, V34, P337, DOI 10.1128/AAC.34.2.337; Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3; NORD NM, 1964, NEW ENGL J MED, V270, P1030, DOI 10.1056/NEJM196405142702002; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Rajyaguru JM, 1997, J ANTIMICROB CHEMOTH, V40, P345, DOI 10.1093/jac/40.3.345; Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000; Roller S, 2000, J FOOD PROTECT, V63, P202, DOI 10.4315/0362-028X-63.2.202; Schneck E, 2010, P NATL ACAD SCI USA, V107, P9147, DOI 10.1073/pnas.0913737107; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Sunagawa Makoto, 2000, Japanese Journal of Antibiotics, V53, P479; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006; Zhou JY, 2007, ANTIMICROB AGENTS CH, V51, P1085, DOI 10.1128/AAC.00954-06	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179776	10.1371/journal.pone.0179776	http://dx.doi.org/10.1371/journal.pone.0179776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662114	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300047
J	Song, Y; Li, JH; Shin, HD; Liu, L; Du, GC; Chen, J				Song, Yang; Li, Jianghua; Shin, Hyun-dong; Liu, Long; Du, Guocheng; Chen, Jian			Tuning the transcription and translation of L-amino acid deaminase in Escherichia coli improves alpha-ketoisocaproate production from L-leucine	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; CORYNEBACTERIUM-GLUTAMICUM; SECONDARY STRUCTURE; BIOSYNTHESIS; EFFICIENCY; DESIGN; REGION; CODON	alpha-Ketoisocaproate (KIC) is used widely in the pharmaceutical and nutraceutical industries. In previous studies, we achieved a one-step biosynthesis of KIC from L-leucine, using an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase (L-AAD) from Proteus vulgaris. Herein, we report the fine-tuning of L-AAD gene expression in E. coli BL21 (DE3) at the transcriptional and translational levels to improve the KIC titer. By optimizing the plasmid origin with different copy numbers, modulating messenger RNA structure downstream of the initiation codon, and designing the sequences at the ribosome binding site, we increased biocatalyst activity to 31.77%, 24.89%, and 30.20%, respectively, above that achieved with BL21/pet28a-lad. The highest KIC titers reached 76.47 g.L-1, 80.29 g.L-1, and 81.41 g.L-1, respectively. Additionally, the integration of these three engineering strategies achieved an even higher KIC production of 86.55 g.L-1 and a higher L-leucine conversion rate of 94.25%. The enzyme-engineering strategies proposed herein may be generally applicable to the construction of other biocatalysts.	[Song, Yang; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Song, Yang; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology	Liu, L; Du, GC (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China.; Liu, L; Du, GC (corresponding author), Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China.	longliu@jiangnan.edu.cn; gcdu@jiangnan.edu.cn	li, jianghua/GXG-4735-2022	Qu, Shan/0000-0003-0016-5422	Enterprise-University-Research Prospective Program Jiangsu Province [BY2013015-37]; Fundamental Research Funds for the Central Universities [JUSRP51307]; 863 Program [2014AA021200, 2015AA021004]	Enterprise-University-Research Prospective Program Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 863 Program(National High Technology Research and Development Program of China)	This work was financially supported by the Enterprise-University-Research Prospective Program Jiangsu Province (BY2013015-37), the Fundamental Research Funds for the Central Universities (JUSRP51307) and the 863 Program (2014AA021200, 2015AA021004).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Aparicio M, 2012, J RENAL NUTR, V22, pS22, DOI 10.1053/j.jrn.2011.09.006; Borujeni AE, 2013, NUCLEIC ACIDS RES; Buckle-Vallant V, 2014, APPL MICROBIOL BIOT, V98, P297, DOI 10.1007/s00253-013-5310-2; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; CHUA B, 1979, J BIOL CHEM, V254, P8358; COOPER AJ, 1983, CHEM REV, V83, P321, DOI 10.1021/cr00055a004; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Escobar J, 2010, J NUTR, V140, P1418, DOI 10.3945/jn.110.123042; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Guan NZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06951; Hossain GS, 2014, J BIOTECHNOL, V169, P112, DOI 10.1016/j.jbiotec.2013.10.026; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Ju YC, 2016, J STRUCT BIOL, V195, P306, DOI 10.1016/j.jsb.2016.07.008; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Norton LE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-67; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Seo SW, 2013, METAB ENG, V15, P67, DOI 10.1016/j.ymben.2012.10.006; Seo SW, 2009, BIOTECHNOL BIOENG, V104, P611, DOI 10.1002/bit.22431; Song Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12614; Vogt M, 2014, METAB ENG, V22, P40, DOI 10.1016/j.ymben.2013.12.001; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846; Zhu YH, 2011, ENZYME MICROB TECH, V49, P321, DOI 10.1016/j.enzmictec.2011.06.008; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	7	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179229	10.1371/journal.pone.0179229	http://dx.doi.org/10.1371/journal.pone.0179229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662040	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300018
J	Ahn, SJ; Kim, JH; Lee, BR				Ahn, Seong Joon; Kim, Ji Hong; Lee, Byung Ro			Choroidal change in acute anterior uveitis associated with human leukocyte antigen-B27	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; THICKNESS; DISEASE	Purpose To evaluate choroidal changes in eyes with acute anterior uveitis associated with human leukocyte antigen (HLA)-B27 Methods In 44 patients with first-onset, unilateral, acute-onset (<1 week) anterior uveitis for which diagnostic work-ups revealed positivity only for HLA-B27, wide-field three-dimensional volumetric raster scan using swept-source optical coherence tomography was performed for both eyes. Choroidal thickness was measured by automated segmentation and thickness mapping and compared between eyes with uveitis and the fellow eyes at baseline. Choroidal thickness was compared before and after topical and/or systemic corticosteroid therapy. Relative choroidal thickening was defined as the choroidal thickness of the uveitic eye minus that of the corresponding eye and correlated with the degree of intraocular inflammation. Results Compared to the fellow eyes, eyes with acute anterior uveitis showed significant choroidal thickening on the subfoveal and parafoveal areas at baseline (all P < 0.05). En face choroidal imaging showed dilation of large choroidal vessels on the macula. Relative choroidal thickening significantly correlated with the degree of anterior chamber inflammation at baseline (correlation coefficient = 0.341, P = 0.023). After treating inflammation, the choroid on the macula thinned significantly (from 262.1 +/- 66.5 to 239.5 +/- 61.0 pm in the subfoveal choroid, P<0.001). Conclusions Eyes with HLA-B27-associated anterior uveitis showed significant choroidal thickening at acute phase that subsequently decreased after treatment, indicating subclinical choroidal inflammation in the eyes. Choroidal thickness might indicate disease activity in acute anterior uveitis associated with HLA-B27.	[Ahn, Seong Joon; Kim, Ji Hong; Lee, Byung Ro] Hanyang Univ Hosp, Dept Ophthalmol, Seoul, South Korea	Hanyang University; Hanyang University Hospital	Lee, BR (corresponding author), Hanyang Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	brlee@hanyang.ac.kr						Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Fleischman D, 2012, OCUL IMMUNOL INFLAMM, V20, P300, DOI 10.3109/09273948.2012.682637; Gehl Z, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-103; Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3; Heinz C, 2016, GRAEF ARCH CLIN EXP, V254, P361, DOI 10.1007/s00417-015-3218-5; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Johnson RN, 2013, FLUORESCEIN ANGIOGRA; Kim M, 2013, INVEST OPHTH VIS SCI, V54, P6033, DOI 10.1167/iovs.13-12231; Kola M, 2014, OCUL IMMUNOL INFLAMM, V22, P434, DOI 10.3109/09273948.2014.928734; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; McCannel CA, 1996, AM J OPHTHALMOL, V121, P35, DOI 10.1016/S0002-9394(14)70532-X; Nakai K, 2012, GRAEF ARCH CLIN EXP, V250, P1089, DOI 10.1007/s00417-011-1910-7; RODRIGUEZ A, 1994, OPHTHALMOLOGY, V101, P1267; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Yan H, 2015, OCUL IMMUNOL INFLAMM, P1	20	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180109	10.1371/journal.pone.0180109	http://dx.doi.org/10.1371/journal.pone.0180109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658315	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900059
J	Malato, G; Shervette, VR; Amaya, RN; Rivera, JV; Salazar, FN; Delgado, PC; Karpan, KC; Aguirre, WE				Malato, Grace; Shervette, Virginia R.; Navarrete Amaya, Ronald; Valdiviezo Rivera, Jonathan; Nugra Salazar, Fredy; Calle Delgado, Paola; Karpan, Kirby C.; Aguirre, Windsor E.			Parallel body shape divergence in the Neotropical fish genus Rhoadsia (Teleostei: Characidae) along elevational gradients of the western slopes of the Ecuadorian Andes	PLOS ONE			English	Article							ECOLOGICAL OPPORTUNITY; GENETIC ASSIMILATION; ADAPTIVE DIVERGENCE; EVOLUTION; SPECIATION; LAKE; CHARACIFORMES; STICKLEBACKS; ASSEMBLAGES; MECHANISMS	Neotropical mountain streams are important contributors of biological diversity. Two species of the characid genus Rhoadsia differing for an ecologically important morphological trait, body depth, have been described from mountain streams of the western slopes of the Andes in Ecuador. Rhoadsia altipinna is a deeper-bodied species reported from low elevations in southwestern Ecuador and northern Peru, and Rhoadsia minor is a more streamlined species that was described from high elevations (>1200 m) in the Esmeraldas drainage in northwestern Ecuador. Little is known about these species and their validity as distinct species has been questioned. In this study, we examine how their body shape varies along replicated elevational gradients in different drainages of western Ecuador using geometric morphometrics and the fineness ratio. We also use sequences of the mitochondrial cytochrome oxidase c I gene and the second intron of the S7 nuclear gene to examine whether genetic data are consistent with the existence of two species. We found that body depth varies continuously among populations within drainages as a function of elevation, and that body shape overlaps among drainages, such that low elevation populations of R. minor in the Esmeraldas drainage have similar body depths to higher elevation R. altipinna in southern drainages. Although a common general trend of declining body depth with elevation is clear, the pattern and magnitude of body shape divergence differed among drainages. Sequencing of mitochondrial and nuclear genes failed to meet strict criteria for the recognition of two species (e.g., reciprocal monophyly and deep genetic structure). However, there was a large component of genetic variation for the COI gene that segregated among drainages, indicating significant genetic divergence associated with geographic isolation. Continued research on Rhoadsia in western Ecuador may yield significant insight into adaptation and speciation in Neotropical mountain streams.	[Malato, Grace; Karpan, Kirby C.; Aguirre, Windsor E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Shervette, Virginia R.] Univ South Carolina, Dept Biol Geol, Aiken, SC USA; [Navarrete Amaya, Ronald] Urbanizac Paraiso Rio 1, Guayaquil, Ecuador; [Valdiviezo Rivera, Jonathan] Museo Ciencias Nat, Inst Nacl Biodiversidad, Quito, Ecuador; [Nugra Salazar, Fredy] Univ Azuay, Lab Zool Vertebrados, Cuenca, Ecuador; [Calle Delgado, Paola] Escuela Super Politecn Litoral, Fac Ciencias Vida, Guayaquil, Ecuador	DePaul University; Universidad del Azuay; Escuela Superior Politecnica del Litoral	Aguirre, WE (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	waguirre@depaul.edu	Salazar, Fredy/GYU-3693-2022	Aguirre, Windsor/0000-0003-3641-5120	Sigma Xi; University Research Council; Department of Biological Sciences; College of Science and Health at DePaul University; USCA Department of Biology/Geology	Sigma Xi; University Research Council; Department of Biological Sciences; College of Science and Health at DePaul University; USCA Department of Biology/Geology	Internal Funding and Student funding through Sigma Xi: Financial support was provided by the University Research Council, the Department of Biological Sciences, and the College of Science and Health at DePaul University, Sigma Xi, and the USCA Department of Biology/Geology.	Aguirre Windsor, 2014, Check List, V10, P382; Aguirre WE, 2016, COPEIA, V104, P554, DOI 10.1643/CG-15-289; Aguirre WE, 2016, EVOL ECOL RES, V17, P373; Aguirre WE, 2014, BIOL J LINN SOC, V113, P204, DOI 10.1111/bij.12316; Aguirre WE, 2013, COPEIA, P312, DOI 10.1643/CI-12-083; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Barriga R. S., 2012, REV POLITECNICA, V30, P83, DOI DOI 10.5962/BHL.TITLE.67474; Bartels P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043641; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; BELL MA, 1976, SYST ZOOL, V25, P211, DOI 10.2307/2412489; Bell MA, 2013, EVOL ECOL RES, V15, P377; BOHLKE JAMES, 1958, PROC ACAD NAT SCI PHILADELPHIA, V110, P1; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Bussing WA, 1987, PECES AGUAS CONTINEN; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cardoso A., 2003, CHECKLIST FRESHWATER, P213; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Chambers EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154363; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chow S, 1998, MOL ECOL, V7, P1255; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooke GM, 2009, FRESHWATER BIOL, V54, P1216, DOI 10.1111/j.1365-2427.2009.02172.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; De La Barra E, 2016, REV BIOL TROP, V64, P173; de Queiroz K, 1998, ENDLESS FORMS, P57; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157419; Drevecky CJ, 2013, J FISH BIOL, V83, P111, DOI 10.1111/jfb.12154; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V24; Elmer KR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6168; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Funk WC, 2016, MOL ECOL, V25, P2176, DOI 10.1111/mec.13605; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; Gavrilets S., 2004, MONOGRAPHS POPULATIO; Georgakopoulou E, 2007, J FISH BIOL, V70, P278, DOI 10.1111/j.1095-8649.2007.01305.x; Gery J., 1977, CHARACOIDS WORLD; Glodek GS, 1978, FRESHWATER FISHES W; Gomez N., 2001, NUEVO ATLAS ECUADOR; Gomez N., 1989, ELEMENTOS GEOGRAFIA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hendry AP, 2002, EVOLUTION, V56, P1199; Hey Jody, 2009, P15; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jimenez Prado P, 2015, GU PECES AGUAS CONTI; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kolbe JJ, 2012, SCIENCE, V335, P1086, DOI 10.1126/science.1209566; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lavinia PD, 2016, J AVIAN BIOL, V47, P84, DOI 10.1111/jav.00766; Licona-Vera Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101870; Loh M, 2014, CONSERV GENET RESOUR, V6, P229, DOI 10.1007/s12686-013-0062-y; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; Lujan NK, 2013, J BIOGEOGR, V40, P1715, DOI 10.1111/jbi.12131; Maldonado-Ocampo JA, 2012, PECES DULCEACU COLAS; Malinsky M, 2015, SCIENCE, V350, P1493, DOI 10.1126/science.aac9927; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Mayr E., 1963, ANIMAL SPECIES EVOLU; Morrison CL, 2006, CONSERV GENET, V7, P129, DOI 10.1007/s10592-005-5681-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Peres-Neto PR, 2004, OECOLOGIA, V140, P352, DOI 10.1007/s00442-004-1578-3; Pigliucci M., 2001, SYN ECO EVO; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Reyes WD, 2015, THESIS; Rohit FJ, 2013, TPSDIG VERSION 2 17; Rohit FJ, 2013, RELATIVE WARPS VERSI; Rohit FJ, 2004, THIN PLATE SPLINE VE; Rohit FJ, 2011, TPSREGR VERSION 1 40; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Sanchez-Romero O, 2015, COMP CYTOGENET, V9, P271, DOI 10.3897/CompCytogen.v9i2.4504; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Ward AB, 2010, INTEGR COMP BIOL, V50, P1106, DOI 10.1093/icb/icq029; Wellborn GA, 2015, ECOL EVOL, V5, P176, DOI 10.1002/ece3.1347; West-Eberhard Mary Jane, 2003, pi; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	94	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179432	10.1371/journal.pone.0179432	http://dx.doi.org/10.1371/journal.pone.0179432			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658255	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900024
J	Lopes, TM; Bailly, D; Almeida, BA; Santos, NCL; Gimenez, BCG; Landgraf, GO; Sales, PCL; Lima-Ribeiro, MS; Cassemiro, FAS; Rangel, TF; Diniz, JAF; Agostinho, AA; Gomes, LC				Lopes, Taise M.; Bailly, Dayani; Almeida, Bia A.; Santos, Natalia C. L.; Gimenez, Barbara C. G.; Landgraf, Guilherme O.; Sales, Paulo C. L.; Lima-Ribeiro, Matheus S.; Cassemiro, Fernanda A. S.; Rangel, Thiago F.; Diniz-Filho, Jose A. F.; Agostinho, Angelo A.; Gomes, Luiz C.			Two sides of a coin: Effects of climate change on the native and non-native distribution of Colossoma macropomum in South America	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; SPECIES DISTRIBUTION MODELS; PROPAGULE PRESSURE; FISH ASSEMBLAGES; RANGE SHIFTS; INVASION; NICHE; AQUACULTURE; ECOSYSTEMS; MANAGEMENT	Climate change and species invasions interact in nature, disrupting biological communities. Based on this knowledge, we simultaneously assessed the effects of climate change on the native distribution of the Amazonian fish Colossoma macropomum as well as on its invasiveness across river basins of South America, using ecological niche modeling. We used six niche models within the ensemble forecast context to predict the geographical distribution of C. macropomum for the present time, 2050 and 2080. Given that this species has been continuously introduced into non-native South American basins by fish farming activities, we added the locations of C. macropomum farms into the modeling process to obtain a more realistic scenario of its invasive potential. Based on modelling outputs we mapped climate refuge areas at different times. Our results showed that a plenty of climatically suitable areas for the occurrence of C. macropomum occurrence are located outside the original basins at the present time and that its invasive potential is greatly amplified by fish farms. Simulations of future geographic ranges revealed drastic range contraction in the native region, implying concerns not only with respect to the species conservation but also from a socio-economic perspective since the species is a cornerstone of artisanal and commercial fisheries in the Amazon. Although the invasive potential is projected to decrease in the face of climate change, climate refugia will concentrate in Parana A River, Southeast Atlantic and East Atlantic basins, putting intense, negative pressures on the native fish fauna these regions. Our findings show that short and long-term management actions are required for: i) the conservation of natural stocks of C. macropomum in the Amazon, and ii) protecting native fish fauna in the climate refuges of the invaded regions.	[Lopes, Taise M.; Bailly, Dayani; Almeida, Bia A.; Santos, Natalia C. L.; Gimenez, Barbara C. G.; Landgraf, Guilherme O.; Sales, Paulo C. L.; Cassemiro, Fernanda A. S.; Agostinho, Angelo A.; Gomes, Luiz C.] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil; [Gimenez, Barbara C. G.] Univ Fed Parana, CEM, Programa Posgrad Sistemas Costeiros & Ocean, Pontal Do Parana, PR, Brazil; [Sales, Paulo C. L.] Univ Fed Piaui, Dept Biol, Picos, PI, Brazil; [Lima-Ribeiro, Matheus S.] Univ Fed Goias, Lab Macroecol, Jatai, Go, Brazil; [Rangel, Thiago F.; Diniz-Filho, Jose A. F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil; [Agostinho, Angelo A.; Gomes, Luiz C.] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura NUPE, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Federal do Parana; Universidade Federal do Piaui; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Estadual de Maringa	Lopes, TM (corresponding author), Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil.	taisemlopes@gmail.com	Agostinho, Angelo Antonio/S-1538-2019; Gomes, Luiz/D-5886-2013; Almeida, Bia/M-7569-2019; LIMA-RIBEIRO, MATHEUS S./H-9503-2014; Rangel, Thiago F/H-8708-2012; Agostini, Angelo/D-5888-2013; Santos, Natália/AAA-1859-2021; Diniz-Filho, José Alexandre Felizola/D-9405-2013	Agostinho, Angelo Antonio/0000-0002-4707-9444; Almeida, Bia/0000-0001-9738-0270; LIMA-RIBEIRO, MATHEUS S./0000-0002-3322-1702; Rangel, Thiago F/0000-0002-2001-7382; Agostini, Angelo/0000-0002-4707-9444; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; gomes, Luiz/0000-0001-7295-723X				Agostinho AA, 2007, ECOLOGIA MANEJO RECU; Agostinho AA, 2010, NAT CONSERVACAO, V8, P103, DOI 10.4322/natcon.00802001; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barcante B., 2015, PUBVET, V9, P287; Beaumont LJ, 2009, ECOGRAPHY, V32, P757, DOI 10.1111/j.1600-0587.2009.05705.x; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Booth DJ, 2011, MAR FRESHWATER RES, V62, P1027, DOI 10.1071/MF10270; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Claro-Jr Luiz, 2004, Acta Amaz., V34, P133, DOI 10.1590/S0044-59672004000100018; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Copp GH, 2005, J APPL ICHTHYOL, V21, P242, DOI 10.1111/j.1439-0426.2005.00690.x; da Costa OTF, 2004, AQUACULTURE, V232, P627, DOI [10.1016/s0044-8486(03)00524-6, 10.1016/S0044-8486(03)00524-6]; de Azevedo-Santos VM, 2011, NEOTROP ICHTHYOL, V9, P915, DOI 10.1590/S1679-62252011000400024; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gois KS, 2015, HYDROBIOLOGIA, V746, P401, DOI 10.1007/s10750-014-2061-8; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Isaac V. J., 1996, Fisheries Management and Ecology, V3, P315, DOI 10.1046/j.1365-2400.1996.d01-154.x; Kroupova H, 2005, VET MED-CZECH, V50, P461, DOI 10.17221/5650-VETMED; Leprieur F, 2009, FISH FISH, V10, P88, DOI 10.1111/j.1467-2979.2008.00314.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lima DP, 2012, NAT CONSERVACAO, V10, P88, DOI 10.4322/natcon.2012.015; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Mata C, 2009, TOXICOL LETT, V189, pS191, DOI 10.1016/j.toxlet.2009.06.577; Meek MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046373; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Ortega JCG, 2015, HYDROBIOLOGIA, V745, P31, DOI 10.1007/s10750-014-2089-9; Parker-Allie F, 2009, CLIMATIC CHANGE, V94, P87, DOI 10.1007/s10584-009-9549-7; Pelicice FM, 2014, CONSERV LETT, V7, P55, DOI 10.1111/conl.12029; Pelicice FM, 2009, BIOL INVASIONS, V11, P1789, DOI 10.1007/s10530-008-9358-3; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poff NL, 2002, PHILOS T R SOC A, V360, P1497, DOI 10.1098/rsta.2002.1012; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Ruffino M.L., 1994, ACTA BIOL VENEZUELIC, V15, P37; Saint-Paul U., 1985, ANIM RES DEV, V22, P7; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; Sipaúba-Tavares LH., 2007, Braz. J. Biol., V67, P459, DOI 10.1590/S1519-69842007000300010; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tomala D, 2014, LAT AM J AQUAT RES, V42, P971, DOI 10.3856/vol42-issue5-fulltext-4; Val A.L., 1995, FISHES AMAZON THEIR, V1st; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; van Vliet MTH, 2013, CLIMATIC CHANGE, V121, P739, DOI 10.1007/s10584-013-0976-0; Wilson JRU, 2007, FRONT ECOL ENVIRON, V5, P409, DOI 10.1890/060077.01; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	74	17	19	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179684	10.1371/journal.pone.0179684	http://dx.doi.org/10.1371/journal.pone.0179684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654663	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500024
J	Nangia, N; Bale, R; Chen, N; Hanna, Y; Patankar, NA				Nangia, Nishant; Bale, Rahul; Chen, Nelson; Hanna, Yohanna; Patankar, Neelesh A.			Optimal specific wavelength for maximum thrust production in undulatory propulsion	PLOS ONE			English	Article							SWIMMING PERFORMANCE; FISH; KINEMATICS; STEADY; HYDRODYNAMICS; FLOW; STIFFNESS; LOCOMOTION; MOTION; DRAG	What wavelengths do undulatory swimmers use during propulsion? In this work we find that a wide range of body/caudal fin (BCF) swimmers, from larval zebrafish and herring to fully-grown eels, use specific wavelength (ratio of wavelength to tail amplitude of undulation) values that fall within a relatively narrow range. The possible emergence of this constraint is interrogated using numerical simulations of fluid-structure interaction. Based on these, it was found that there is an optimal specific wavelength (OSW) that maximizes the swimming speed and thrust generated by an undulatory swimmer. The observed values of specific wavelength for BCF animals are relatively close to this OSW. The mechanisms underlying the maximum propulsive thrust for BCF swimmers are quantified and are found to be consistent with the mechanisms hypothesized in prior work. The adherence to an optimal value of specific wavelength in most natural hydrodynamic propulsors gives rise to empirical design criteria for man-made propulsors.	[Nangia, Nishant; Patankar, Neelesh A.] Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA; [Bale, Rahul; Chen, Nelson; Hanna, Yohanna; Patankar, Neelesh A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Bale, Rahul] RIKEN, AICS, Kobe, Hyogo, Japan; [Chen, Nelson] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Hanna, Yohanna] Univ Southern Calif, Dept Aerosp & Mech Engn, Los Angeles, CA USA	Northwestern University; Northwestern University; RIKEN; University of California System; University of California Berkeley; University of Southern California	Patankar, NA (corresponding author), Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA.; Patankar, NA (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	n-patankar@northwestern.edu	Bale, Rahul/D-2469-2016; Patankar, Neelesh A/B-7603-2009	Bale, Rahul/0000-0003-4586-2782; 	National Science Foundation [CBET-0828749, CMMI-0941674, CBET-1066575, ACI-1053575, DGE-1324585]; Directorate For Engineering [1066575] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation grants CBET-0828749, CMMI-0941674 and CBET-1066575 to NAP. Computational resources were provided by Northwestern University High Performance Computing System-Quest. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1324585 to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; BATTY RS, 1984, J EXP BIOL, V110, P217; Bhalla APS, 2014, J COMPUT PHYS, V256, P88, DOI 10.1016/j.jcp.2013.08.043; Bhalla APS, 2013, J COMPUT PHYS, V250, P446, DOI 10.1016/j.jcp.2013.04.033; Blake R.W., 1983, FISH LOCOMOTION; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; D'Aout K, 1999, BELG J ZOOL, V129, P305; D'Aout K, 1999, J EXP BIOL, V202, P1511; DAout K, 1997, J EXP BIOL, V200, P1863; Donley JM, 2000, J EXP BIOL, V203, P3103; Dowis HJ, 2003, J EXP BIOL, V206, P2749, DOI 10.1242/jeb.00496; Fuiman LA, 1997, J EXP BIOL, V200, P1745; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Gillis GB, 1996, AM ZOOL, V36, P656; GRAHAM JB, 1987, J EXP BIOL, V127, P27; IBAMR, 2016, IBAMR AD DISTR MEM P; JAYNE BC, 1995, J EXP BIOL, V198, P585; Kancharala AK, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/5/056016; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Lauder GV, 2006, FISH PHYSIOL, V23, P425, DOI 10.1016/S1546-5098(05)23011-X; Lauder GV, 2012, INTEGR COMP BIOL; Liao JC, 2002, J EXP BIOL, V205, P2875; Long JH, 1996, J EXP BIOL, V199, P2139; Low KH, 2006, J VIB CONTROL, V12, P1337, DOI 10.1177/1077546306070597; Low KH, 2006, INT J AUTOM COMPUT, V3, P348, DOI 10.1007/s11633-006-0348-6; Lucas KN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056019; Lucas KN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4293; Muller UK, 2008, J EXP BIOL, V211, P196, DOI 10.1242/jeb.005629; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muller UK, 1997, J EXP BIOL, V200, P2893; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shen L, 2003, J FLUID MECH, V484, P197, DOI 10.1017/S0022112003004294; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Tytell ED, 2004, J EXP BIOL, V207, P1825, DOI 10.1242/jeb.00968; van Weerden JF, 2014, FISH FISH, V15, P397, DOI 10.1111/faf.12022; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Webb PW, 2002, J EXP BIOL, V205, P2125; WEBB PW, 1992, J EXP BIOL, V162, P157	41	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179727	10.1371/journal.pone.0179727	http://dx.doi.org/10.1371/journal.pone.0179727			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654649	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500027
J	Okun, E; Marton, D; Cohen, D; Griffioen, K; Kanfi, Y; Illouz, T; Madar, R; Cohen, HY				Okun, Eitan; Marton, Daniel; Cohen, Daniel; Griffioen, Kathleen; Kanfi, Yariv; Illouz, Tomer; Madar, Ravit; Cohen, Haim Y.			Sirt6 alters adult hippocampal neurogenesis	PLOS ONE			English	Article							STEM-CELL FATE; DENTATE GYRUS; NEURONAL DIFFERENTIATION; CALORIE RESTRICTION; PROLIFERATION; DEACETYLASE; GROWTH; MECHANISMS; EXPRESSION; EXERCISE	Sirtuins are pleiotropic NAD(+) dependent histone deacetylases involved in metabolism, DNA damage repair, inflammation and stress resistance. SIRT6, a member of the sirtuin family, regulates the process of normal aging and increases the lifespan of male mice over-expressing Sirt6 by 15%. Neurogenesis, the formation of new neurons within the hippocampus of adult mammals, involves several complex stages including stem cell proliferation, differentiation, migration and network integration. During aging, the number of newly generated neurons continuously declines, and this is correlated with a decline in neuronal plasticity and cognitive behavior. In this study we investigated the involvement of SIRT6 in adult hippocampal neurogenesis. Mice over-expressing Sirt6 exhibit increased numbers of young neurons and decreased numbers of mature neurons, without affecting glial differentiation. This implies of an involvement of SIRT6 in neuronal differentiation and maturation within the hippocampus. This work adds to the expanding body of knowledge on the regulatory mechanisms underlying adult hippocampal neurogenesis, and describes novel roles for SIRT6 as a regulator of cell fate during adult hippocampal neurogenesis.	[Okun, Eitan; Marton, Daniel; Cohen, Daniel; Kanfi, Yariv; Illouz, Tomer; Madar, Ravit; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Okun, Eitan; Marton, Daniel; Cohen, Daniel; Illouz, Tomer; Madar, Ravit] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Okun, Eitan] Bar Ilan Univ, Paul Feder Lab Alzheimers Dis Res, Ramat Gan, Israel; [Griffioen, Kathleen] Liberty Univ, Dept Biol & Chem, Lynchburg, VA USA	Bar Ilan University; Bar Ilan University; Bar Ilan University; Liberty University	Okun, E (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.; Okun, E (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.; Okun, E (corresponding author), Bar Ilan Univ, Paul Feder Lab Alzheimers Dis Res, Ramat Gan, Israel.	eitan.okun@biu.ac.il	okun, eitan/AAC-9571-2019; Kornweitz, Haya/L-6469-2018	okun, eitan/0000-0001-8474-1487; Kornweitz, Haya/0000-0002-3562-0141; Cohen, Haim Y./0000-0002-6613-8710; Madar, Ravit/0000-0002-2025-8178	Paul Feder Laboratory on Alzheimer's disease research; European Foundation for the Study of Diabetes [MSD 2014_1] Funding Source: researchfish	Paul Feder Laboratory on Alzheimer's disease research; European Foundation for the Study of Diabetes	This work was funded and carried out in the Paul Feder Laboratory on Alzheimer's disease research.	Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brandt MD, 2012, STEM CELLS, V30, P2843, DOI 10.1002/stem.1244; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Donoghue JF, 2011, JOVE-J VIS EXP, DOI 10.3791/3157; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Franklin K. B. J., 2008, COMPACT; Gage G. J., 2012, J VIS EXP; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Guo HF, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-56; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Klempin F, 2012, STEM CELLS, V30, P500, DOI 10.1002/stem.1005; Kumar V, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00308; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Ma CY, 2014, DEVELOPMENT, V141, P4697, DOI 10.1242/dev.117937; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Simeoni F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03085; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Sun Wu, 2014, STEM CELLS; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Yao QP, 2014, INT J BIOCH CELL BIO; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216	56	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179681	10.1371/journal.pone.0179681	http://dx.doi.org/10.1371/journal.pone.0179681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644902	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100032
J	van Cleef, EHCB; D'Aaurea, AAP; Favaro, VR; van Cleef, FOS; Barducci, RS; Almeida, MTC; Neto, ORM; Ezequiel, JMB				van Cleef, Eric H. C. B.; D'Aaurea, Andre A. P.; Favaro, Vanessa R.; van Cleef, Flavia O. S.; Barducci, Robson S.; Almeida, Marco T. C.; Machado Neto, Otavio R.; Ezequiel, Jane M. B.			Effects of dietary inclusion of high concentrations of crude glycerin on meat quality and fatty acid profile of feedlot fed Nellore bulls	PLOS ONE			English	Article							CARCASS CHARACTERISTICS; YOUNG BULLS; CHOLESTEROL CONCENTRATION; LONGISSIMUS MUSCLE; OLEIC-ACID; BEEF; TRAITS; PERFORMANCE; SUPPLEMENTATION; LIMOUSIN	Crude glycerin, the main by-product of biodiesel production, can replace dietary energy sources, such as corn. The objective of this study was to evaluate the inclusion of up to 30% of crude glycerin in dry matter (DM) of the total diets, and its effects on meat quality parameters of feedlot Nellore bulls. Thirty animals (227.7 +/- 23.8 kg body weight; 18 months old) were housed in individual pens and fed 5 experimental diets, containing 0, 7.5, 15, 22.5 or 30% crude glycerin (DM basis). After 103 d (21 d adaptation) animals were slaughtered and the Longissimus muscle was collected. The characteristics assessed were chemical composition, fatty acid profile, cholesterol, shear force, pH, color, water-holding capacity, cooking loss and sensory properties. The increasing inclusion of crude glycerin in the diets did not affect the chemical composition of the Longissimus muscle (P > 0.10). A quadratic effect was observed when levels of crude glycerin were increased, on the concentration of pentadecanoic, palmitoleic and eicosenoic fatty acids in meat (P < 0.05), and on the activity of the delta-9 desaturase 16 and delta-9 desaturase 18 enzymes (P < 0.05). The addition of crude glycerin increased the gamma linolenic fatty acid concentration (P < 0.01), and altered the monounsaturated fatty acids in Longissimus muscle of animals (P-quad. < 0.05). Crude glycerin decreased cholesterol content in meat (P < 0.05), and promoted higher flavor score and greasy intensity perception of the meat (P < 0.01). The inclusion of up to 30% crude glycerin in Nellore cattle bulls'diets (DM basis) improves meat cholesterol and sensory attributes, such as flavor, without affecting significantly the physical traits, the main fatty acid concentrations and the chemical composition.	[van Cleef, Eric H. C. B.; D'Aaurea, Andre A. P.; Favaro, Vanessa R.; van Cleef, Flavia O. S.; Barducci, Robson S.; Almeida, Marco T. C.; Ezequiel, Jane M. B.] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Sao Paulo, Brazil; [Machado Neto, Otavio R.] Sao Paulo State Univ Unesp, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [van Cleef, Eric H. C. B.] Univ Fed Triangulo Mineiro, Iturama, MG, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal do Triangulo Mineiro	van Cleef, EHCB (corresponding author), Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Sao Paulo, Brazil.; van Cleef, EHCB (corresponding author), Univ Fed Triangulo Mineiro, Iturama, MG, Brazil.	ericvancleef@gmail.com	Neto, Otávio Machado/AAY-2091-2021; Neto, Otávio R Machado/K-2516-2013; Neto, Otávio R. Machado/AAZ-7544-2020; Almeida, Marco Túlio Costa/AAP-1684-2020; van Cleef, Eric H C B/H-5590-2012; Almeida, Marco Túlio Costa/D-5025-2012; Ezequiel, Jane M. B./L-2154-2019; Ezequiel, Jane M. B./C-3443-2019	Neto, Otávio Machado/0000-0002-4449-7771; Neto, Otávio R Machado/0000-0002-4449-7771; Almeida, Marco Túlio Costa/0000-0001-8730-0425; Almeida, Marco Túlio Costa/0000-0001-8730-0425; Ezequiel, Jane M. B./0000-0002-2503-371X; Ezequiel, Jane M. B./0000-0002-2503-371X; van Cleef, Eric/0000-0003-1656-2502	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/51857-3, 08/53712-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers 09/51857-3,08/53712-0), http://www.fapesp.br/.	ALHASANI SM, 1993, J AOAC INT, V76, P902; Almeida MTC, ANIM PROD SCI; AMSA, 2015, RES GUID COOK SENS E, V2nd ed; AOAC, 1990, OFFICIAL METHODS ANA; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Bass PD, 2008, J ANIM SCI, V86, P1658, DOI 10.2527/jas.2007-0688; Bermingham EN, 2008, AUST J EXP AGR, V48, P726, DOI 10.1071/EA08010; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho JRR, 2014, MEAT SCI, V96, P977, DOI 10.1016/j.meatsci.2013.10.020; Carvalho VB, 2015, MEAT SCI, V110, P285, DOI 10.1016/j.meatsci.2015.08.001; van Cleef EHCB, 2014, REV BRAS ZOOTECN, V43, P86, DOI 10.1590/S1516-35982014000200006; CIE, 2004, COL TECHN REP; Daniel ZCTR, 2004, J ANIM SCI, V82, P747; Duckett SK, 2014, DIABET METAB SYND OB, V7, P553, DOI 10.2147/DMSO.S72695; Egea M, 2014, MEAT SCI, V98, P673, DOI 10.1016/j.meatsci.2014.06.034; Eiras CE, 2014, MEAT SCI, V96, P930, DOI 10.1016/j.meatsci.2013.10.002; Elam NA, 2008, P SW NUTR C AZ US, P21; Faria PB, 2012, MEAT SCI, V90, P733, DOI 10.1016/j.meatsci.2011.11.004; Francozo MC, 2013, BRAZ ARCH BIOL TECHN, V56, P327, DOI 10.1590/S1516-89132013000200019; Geppert J, 2008, BRIT J NUTR, V99, P360, DOI 10.1017/S0007114507801577; Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002; Gilmore LA, 2011, J NUTR, V141, P1188, DOI 10.3945/jn.110.136085; GRUNDY SM, 1994, AM J CLIN NUTR, V60, p986S, DOI 10.1093/ajcn/60.6.986S; Gunn PJ, 2010, J ANIM SCI, V88, P1771, DOI 10.2527/jas.2009-2325; Hamm R., 1986, MUSCLE AS FOOD, P135, DOI DOI 10.1016/B978-0-12-084190-5.50009-6; Houben JH, 2000, MEAT SCI, V55, P331, DOI 10.1016/S0309-1740(99)00161-8; Immonen K, 2000, MEAT SCI, V54, P163, DOI 10.1016/S0309-1740(99)00090-X; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Lage JF, 2014, MEAT SCI, V96, P1158, DOI 10.1016/j.meatsci.2013.10.027; Mach N, 2008, MEAT SCI, V78, P232, DOI 10.1016/j.meatsci.2007.06.021; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; MalauAduli AEO, 1997, AUST J AGR RES, V48, P715, DOI 10.1071/A96083; Maw SJ, 2003, MEAT SCI, V63, P185, DOI 10.1016/S0309-1740(02)00069-4; Meilgaard M.C., 2007, SENSORY EVALUATION T, V4th ed., DOI 10.1201/b16452; Fernandes ARM, 2009, REV BRAS ZOOTECN, V38, P705, DOI 10.1590/S1516-35982009000400017; Muchenje V, 2009, FOOD CHEM, V112, P279, DOI 10.1016/j.foodchem.2008.05.103; NRC, 2000, NAT RES COUNC NUTR R, V7th; *NRC, 1989, DIET HLTH IMPL RED C; Oliveira EA, 2012, MEAT SCI, V90, P28, DOI 10.1016/j.meatsci.2011.05.024; Prado IN, 2008, J ANIM FEED SCI, V17, P307, DOI 10.22358/jafs/66610/2008; Pratiwi NMW, 2006, SMALL RUMINANT RES, V64, P77, DOI 10.1016/j.smallrumres.2005.04.016; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Shackelford S. D., 1991, Journal of Muscle Foods, V2, P289, DOI 10.1111/j.1745-4573.1991.tb00461.x; Thornton KJ, 2012, J ANIM SCI, V90, P1617, DOI 10.2527/jas.2011-4678; Torres E.A.F.S., 2000, CIENCIA TECNOL ALIME, V20, P145, DOI DOI 10.1590/S0101-20612000000200003; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Vahmani P, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0026-z; van Cleef EHCB, 2016, CAN J ANIM SCI, V96, P461, DOI 10.1139/cjas-2015-0170; Vito ES, 2015, MEAT SCI, V100, P17, DOI 10.1016/j.meatsci.2014.09.008; Viturro E, 2009, J STEROID BIOCHEM, V115, P62, DOI 10.1016/j.jsbmb.2009.02.011; WHEELER TL, 1987, J ANIM SCI, V65, P1531, DOI 10.2527/jas1987.6561531x; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0	53	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179830	10.1371/journal.pone.0179830	http://dx.doi.org/10.1371/journal.pone.0179830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644883	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100042
J	Cresswell, JA; Ganaba, R; Sarrassat, S; Cousens, S; Some, H; Diallo, AH; Filippi, V				Cresswell, Jenny A.; Ganaba, Rasmane; Sarrassat, Sophie; Cousens, Simon; Some, Henri; Diallo, Abdoulaye Hama; Filippi, Veronique			Predictors of exclusive breastfeeding and consumption of soft, semi- solid or solid food among infants in Boucle du Mouhoun, Burkina Faso: A cross- sectional survey	PLOS ONE			English	Article							EARLY INITIATION; PROMISE-EBF; DETERMINANTS; MORTALITY; PROMOTION; COMMUNITY; BARRIERS; CARE	Introduction Exclusive breastfeeding is among the most effective interventions for preventing child mortality. The objectives of this paper are to describe infant feeding knowledge and practices in Boucle du Mouhoun, Burkina Faso; to identify predictors of exclusive breastfeeding among infants <6 months, and consumption of soft, semi-solid or solid food among infants 6-11 months; to describe mothers' sources of information regarding breastfeeding. Methods A cross-sectional survey (n = 2288) of a representative sample of women aged 15-49 years with at least one live birth in past year took place during June and July 2015. Crude and multivariable random-effects logistic regressions were used to identify factors predictive of exclusive breastfeeding and consumption of soft, semi-solid or solid food. Results 30% of infants <6 months were exclusively breastfed; 67% of infants age 6-11 months consumed soft, semi-solid or solid food the day and night before the interview. 2% of infants age 6-11 months had a minimum acceptable diet. There was strong evidence of a positive association between knowledge and practice of exclusive breastfeeding, nonetheless 60% of mothers who correctly identified that an infant should be exclusively breastfed for 6 months did not breastfeed their infant exclusively. Only 42% of mothers reported receiving advice on breastfeeding from a health worker, despite all mothers having contact with a health worker at least once during pregnancy or postpartum. Conclusion Given poor practices and low levels of knowledge, targeted interventions are needed to improve infant nutrition in Boucle du Mouhoun during antenatal, delivery and postnatal care. Most women now deliver in a facility in Burkina Faso; increased attention should be paid to ensuring that existing guidelines relating to support and counselling for infant feeding are adhered to. Factors such as social norms are also important and these should be investigated in more detail using qualitative methods.	[Cresswell, Jenny A.; Sarrassat, Sophie; Cousens, Simon; Filippi, Veronique] London Sch Hyg & Trop Med, London, England; [Ganaba, Rasmane; Some, Henri] AFRICSante, Bobo Dioulasso, Burkina Faso; [Diallo, Abdoulaye Hama] Ctr MURAZ, Bobo Dioulasso, Burkina Faso	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz	Cresswell, JA (corresponding author), London Sch Hyg & Trop Med, London, England.	Jenny.Cresswell@lshtm.ac.uk		Cresswell, Jenny/0000-0002-9553-1132; Cherif, ISSIFOU/0000-0002-1590-3312; Sarrassat, Sophie/0000-0001-6872-6455	Bill & Melinda Gates Foundation [OPP50838]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The research was supported by funding from the Bill & Melinda Gates Foundation, Grant Number OPP50838.	Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Blanchet K, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0476-5; Chola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142718; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Diallo AH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-45; Duysburgh E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0562-8; Engebretsen IMS, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-19; Fjeld E, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-26; Ganaba R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0875-2; GUNNLAUGSSON G, 1992, INT J EPIDEMIOL, V21, P935, DOI 10.1093/ije/21.5.935; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Issaka AI, 2015, NUTRIENTS, V7, P948, DOI 10.3390/nu7020948; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Moore SE, 2007, AM J CLIN NUTR, V85, P1075, DOI 10.1093/ajcn/85.4.1075; Quyen Thi Tu Bui, 2016, Global Health Action, V9, P29433; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2003, GLOB STRAT INF YOUNG; WHO UNICEF USAID AED UCDAVIS IFPRI, 2007, IND ASS INF YOUNG CH	23	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179593	10.1371/journal.pone.0179593	http://dx.doi.org/10.1371/journal.pone.0179593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640900	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000404135800041
J	Patel, PG; Selvarajah, S; Guerard, KP; Bartlett, JMS; Lapointe, J; Berman, DM; Okello, JBA; Park, PC				Patel, Palak G.; Selvarajah, Shamini; Guerard, Karl-Philippe; Bartlett, John M. S.; Lapointe, Jacques; Berman, David M.; Okello, John B. A.; Park, Paul C.			Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores	PLOS ONE			English	Article							METHYLATION-SPECIFIC PCR; PROSTATE-CANCER; SAMPLES; QUANTIFICATION; EXPRESSION; BIOMARKERS; QUALITY	Cancer biomarker studies often require nucleic acid extraction from limited amounts of for-malin- fixed, paraffin-embedded (FFPE) tissues, such as histologic sections or needle cores. A major challenge is low quantity and quality of extracted nucleic acids, which can limit our ability to perform genetic analyses, and have a significant influence on overall study design. This study was aimed at identifying the most reliable and reproducible method of obtaining sufficient high-quality nucleic acids from FFPE tissues. We compared the yield and quality of nucleic acids from 0.6-mm FFPE prostate tissue cores across 16 DNA and RNA extraction protocols, using 14 commercially available kits. Nucleic acid yield was determined by fluorometry, and quality was determined by spectrophotometry. All protocols yielded nucleic acids in quantities that are compatible with downstream molecular applications. However, the protocols varied widely in the quality of the extracted RNA and DNA. Four RNA and five DNA extraction protocols, including protocols from two kits for dual-extraction of RNA and DNA from the same tissue source, were prioritized for further quality assessment based on the yield and purity of their products. Specifically, their compatibility with downstream reactions was assessed using both NanoString nCounter gene expression assays and reverse-transcriptase real-time PCR for RNA, and methylation-specific PCR assays for DNA. The kit deemed most suitable for FFPE tissue was the AllPrep kit by Qiagen because of its yield, quality, and ability to purify both RNA and DNA from the same sample, which would be advantageous in biomarker studies.	[Patel, Palak G.; Selvarajah, Shamini; Berman, David M.; Okello, John B. A.; Park, Paul C.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Patel, Palak G.; Berman, David M.; Okello, John B. A.] Queens Univ, Queens Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; [Guerard, Karl-Philippe; Lapointe, Jacques] McGill Univ, Div Urol, Dept Surg, Montreal, PQ, Canada; [Guerard, Karl-Philippe; Lapointe, Jacques] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Bartlett, John M. S.] Ontario Inst Canc Res, Diagnost Dev Program, Toronto, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada; McGill University; McGill University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Park, PC (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	pcp1@queensu.ca	Okello, John B A/B-5157-2018; berman, david/HIR-4177-2022	Okello, John B A/0000-0002-5889-1905; Selvarajah, Shamini/0000-0002-9894-4864; berman, david/0000-0001-5985-3698; Guerard, Karl-Philippe/0000-0002-7229-3952	Movember Foundation Grant through Prostate Cancer Canada [T2014.01]; Movember Foundation [T2014.01]	Movember Foundation Grant through Prostate Cancer Canada; Movember Foundation	Funding for this work was provided by the Movember Foundation Grant #T2014.01 through Prostate Cancer Canada to JMSB, JL, DMB, PCP and others: http://www.prostatecancer.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was awarded by Prostate Cancer Canada and is proudly funded by the Movember Foundation-Grant #T2014.01.	Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen B, 2001, CURRENT PROTOCOLS HU; Daniunaite K, 2014, J UROLOGY, V192, P1849, DOI 10.1016/j.juro.2014.06.075; Demidenko R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1689-8; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; He JT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0418-z; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kalman LV, 2013, ARCH PATHOL LAB MED, V137, P983, DOI 10.5858/arpa.2012-0311-RA; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Ku JL, 2011, METHODS MOL BIOL, V791, P23, DOI 10.1007/978-1-61779-316-5_3; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; Okello JBA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013931; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Patel PG, 2016, JOVE-J VIS EXP, DOI 10.3791/54299; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Ross JS, 2011, BIOMARK MED, V5, P277, DOI [10.2217/BMM.11.29, 10.2217/bmm.11.29]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sheffield J, MICROSC MICROANAL, V13, P200; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01	31	35	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179732	10.1371/journal.pone.0179732	http://dx.doi.org/10.1371/journal.pone.0179732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640876	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800058
J	Carlson, SM; Soulette, CM; Yang, Z; Elias, JE; Brooks, AN; Gozani, O				Carlson, Scott M.; Soulette, Cameron M.; Yang, Ze; Elias, Joshua E.; Brooks, Angela N.; Gozani, Or			RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; SR PROTEINS; PROTEOMIC ANALYSIS; CELL-CULTURE; AMINO-ACIDS; RNA; BIOINFORMATICS; ENRICHMENT; IDENTIFICATION; EXPRESSION	In eukaryotes, precursor mRNA (pre-mRNA) splicing removes non-coding intron sequences to produce mature mRNA. This removal is controlled in part by RNA-binding proteins that regulate alternative splicing decisions through interactions with the splicing machinery. RNA binding motif protein 25 (RBM25) is a putative splicing factor strongly conserved across eukaryotic lineages. However, the role of RBM25 in global splicing regulation and its cellular functions are unknown. Here we show that RBM25 is required for the viability of multiple human cell lines, suggesting that it could play a key role in pre-mRNA splicing. Indeed, transcriptome-wide analysis of splicing events demonstrated that RBM25 regulates a large fraction of alternatively spliced exons throughout the human genome. Moreover, proteomic analysis indicated that RBM25 interacts with components of the early spliceosome and regulators of alternative splicing. Previously, we identified an RBM25 species that is mono-methylated at lysine 77 (RBM25K77me1), and here we used quantitative mass spectrometry to show that RBM25K77me1 is abundant in multiple human cell lines. We also identified a region of RBM25 spanning Lys-77 that binds with high affinity to serine-and arginine-rich splicing factor 2 (SRSF2), a crucial protein in exon definition, but only when Lys-77 is unmethylated. Together, our findings uncover a pivotal role for RBM25 as an essential regulator of alternative splicing and reveal a new potential mechanism for regulation of pre-mRNA splicing by lysine methylation of a splicing factor.	[Carlson, Scott M.; Yang, Ze; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Soulette, Cameron M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95060 USA; [Brooks, Angela N.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA	Stanford University; Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Brooks, AN (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA.	anbrooks@ucsc.edu; ogozani@stanford.edu		Gozani, Or/0000-0002-1365-4463	NCI, National Institutes of Health [R01CA172560, K99CA190803]; W. M. Keck Foundation Medical Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA172560, K99CA190803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058903, T32GM008646] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); W. M. Keck Foundation Medical Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NCI, National Institutes of Health Grant R01CA172560 (to O.G.). O.G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health Grant K99CA190803.; Supported by a grant from the W. M. Keck Foundation Medical Research Program.; Supported in part by a grant from the Damon Runyon Cancer Research Foundation. To whom correspondence may be addressed. E-mail: anbrooks@ucsc.edu.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Bradley T, 2015, RNA, V21, P75, DOI 10.1261/rna.043893.113; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Carlson SM, 2015, J BIOL CHEM, V290, P12040, DOI 10.1074/jbc.M115.641530; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Fortes P, 2007, FEBS LETT, V581, P3087, DOI 10.1016/j.febslet.2007.05.066; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Gottschalk A, 1998, RNA, V4, P374; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Howard JM, 2015, WIRES RNA, V6, P93, DOI 10.1002/wrna.1260; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	43	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13381	13390		10.1074/jbc.M117.784371	http://dx.doi.org/10.1074/jbc.M117.784371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655759	Green Published, hybrid			2022-12-26	WOS:000407465300024
J	Jiang, L; Xiong, JN; Zhan, JS; Yuan, FJ; Tang, M; Zhang, CH; Cao, ZY; Chen, YC; Lu, XP; Li, YL; Wang, H; Wang, LN; Wang, JD; Zhu, WG; Wang, HY				Jiang, Lu; Xiong, Jiannan; Zhan, Junsi; Yuan, Fengjie; Tang, Ming; Zhang, Chaohua; Cao, Ziyang; Chen, Yongcan; Lu, Xiaopeng; Li, Yinglu; Wang, Hui; Wang, Lina; Wang, Jiadong; Zhu, Wei-Guo; Wang, Haiying			Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; RNA-POLYMERASE-I; SIRT7-DEPENDENT DEACETYLATION; HEPATOCELLULAR-CARCINOMA; DEPENDENT DEACETYLATION; CELL-PROLIFERATION; ACTIVATION; EXPRESSION; HAUSP; P53	Sirtuin 7 (SIRT7), a member of theNAD(+)-dependent class III histone deacetylases, is involved in the regulation of various cellular processes and in resisting various stresses, such as hypoxia, low glucose levels, and DNA damage. Interestingly, SIRT7 is linked to the control of glycolysis, suggesting a role in glucose metabolism. Given the important roles of SIRT7, it is critical to clarify how SIRT7 activity is potentially regulated. It has been reported that some transcriptional and post-transcriptional regulatory mechanisms are involved. However, little is known how SIRT7 is regulated by the post-translational modifications. Here, we identified ubiquitin-specific peptidase 7 (USP7), a deubiquitinase, as a negative regulator of SIRT7. We showed that USP7 interacts with SIRT7 both in vitro and in vivo, and we further demonstrated that SIRT7 undergoes endogenous Lys63- linked polyubiquitination, which is removed by USP7. Although the USP7-mediated deubiquitination of SIRT7 had no effect on its stability, the deubiquitination repressed its enzymatic activity. We also showed that USP7 coordinates with SIRT7 to regulate the expression of glucose-6-phosphatase catalytic subunit (G6PC), a gluconeogenic gene. USP7 depletion by RNA interference increased both G6PC expression and SIRT7 enzymatic activity. Moreover, SIRT7 targeted the G6PC promoter through the transcription factor ELK4 but not through forkhead box O1 (FoxO1). In summary, SIRT7 is a USP7 substrate and has a novel role as a regulator of gluconeogenesis. Our study may provide the basis for new clinical approaches to treat metabolic disorders related to glucose metabolism.	[Jiang, Lu; Xiong, Jiannan; Zhan, Junsi; Yuan, Fengjie; Tang, Ming; Zhang, Chaohua; Cao, Ziyang; Chen, Yongcan; Lu, Xiaopeng; Li, Yinglu; Wang, Hui; Wang, Lina; Zhu, Wei-Guo; Wang, Haiying] Peking Univ, Dept Biochem & Mol Biol,Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Zhu, Wei-Guo] Peking Tsinghua Univ, Ctr Life Sci, Beijing 100191, Peoples R China; [Wang, Jiadong] Peking Univ, Sch Basic Med Sci, Dept Radiat Med, Inst Syst Biomed, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China	Peking University; Tsinghua University; Peking University; Shenzhen University	Zhu, WG (corresponding author), Peking Univ, Dept Biochem & Mol Biol,Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.; Zhu, WG (corresponding author), Peking Tsinghua Univ, Ctr Life Sci, Beijing 100191, Peoples R China.; Zhu, WG (corresponding author), Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China.; Wang, HY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn; wendy@bjmu.edu.cn	Li, Yinglu/GWC-7573-2022	Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Key Basic Research Program of China [2013CB911000, 2013CB911001]; National Natural Science Foundation of China [81472627, 91319302]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China Grants 2013CB911000 and 2013CB911001 and National Natural Science Foundation of China Grants 81472627 and 91319302.	Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; Armour SM, 2013, MOL CELL BIOL, V33, P1487, DOI 10.1128/MCB.00971-12; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bellet MM, 2011, COLD SH Q B, V76, P31, DOI 10.1101/sqb.2011.76.010520; Blank MF, 2017, TRANSCR-AUSTIN, V8, P67, DOI 10.1080/21541264.2016.1276658; Blank MF, 2017, NUCLEIC ACIDS RES, V45, P2675, DOI 10.1093/nar/gkx053; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Cioffi M, 2015, CELL REP, V12, P1594, DOI 10.1016/j.celrep.2015.08.006; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Hall JA, 2014, MOL ENDOCRINOL, V28, P912, DOI 10.1210/me.2013-1420; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Hubbi ME, 2013, J BIOL CHEM, V288, P20768, DOI 10.1074/jbc.M113.476903; Hussain M, 2014, VIRUS GENES, V49, P358, DOI 10.1007/s11262-014-1101-9; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Karim MF, 2013, BIOCHEM BIOPH RES CO, V441, P157, DOI 10.1016/j.bbrc.2013.10.020; Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kiran S, 2015, CELL SIGNAL, V27, P673, DOI 10.1016/j.cellsig.2014.11.026; Kiran S, 2015, EXP CELL RES, V331, P123, DOI 10.1016/j.yexcr.2014.11.001; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li L, 2013, CELL RES, V23, P10, DOI 10.1038/cr.2012.112; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu GF, 2016, BBA-GENE REGUL MECH, V1859, P348, DOI 10.1016/j.bbagrm.2015.12.004; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Malik S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09841; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paredes S, 2014, CLIN CANCER RES, V20, P1741, DOI 10.1158/1078-0432.CCR-13-1547; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Shi HY, 2016, ONCOL REP, V36, P3051, DOI 10.3892/or.2016.5063; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sun LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12497; Tang M, 2017, THERANOSTICS, V7, P1346, DOI 10.7150/thno.18804; Vakhrusheva O, 2008, J PHYSIOL PHARMACOL, V59, P201; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Wang GC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00005; Wang HY, 2012, DNA REPAIR, V11, P146, DOI 10.1016/j.dnarep.2011.10.014; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhang C., 2017, PROTEOMICS; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143	91	33	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13296	13311		10.1074/jbc.M117.780130	http://dx.doi.org/10.1074/jbc.M117.780130			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH6KS	28655758	Green Published, hybrid			2022-12-26	WOS:000411286000001
J	Inskip, JA; Ravensbergen, HJC; Sahota, IS; Zawadzki, C; McPhail, LT; Borisoff, JF; Claydon, VE				Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; Zawadzki, Christine; McPhail, Lowell T.; Borisoff, Jaimie F.; Claydon, Victoria E.			Dynamic wheelchair seating positions impact cardiovascular function after spinal cord injury	PLOS ONE			English	Article							CEREBRAL-ARTERY DIAMETER; ORTHOSTATIC HYPOTENSION; AUTONOMIC CONTROL; PREVALENCE; PRESSURE; HUMANS; PEOPLE; HYPERCAPNIA; SPASTICITY; RESPONSES	Background Innovative wheelchairs allow individuals to change position easily for comfort and social situations. While these wheelchairs are beneficial in multiple ways, the effects of position changes on blood pressure might exacerbate hypotension and cerebral hypoperfusion, particularly in those with spinal cord injury (SCI) who can have injury to autonomic nerves that regulate cardiovascular control. Conversely, cardiovascular benefits may be obtained with lowered seating. Here we investigate the effect of moderate changes in wheelchair position on orthostatic cardiovascular and cerebrovascular reflex control. Methods Nineteen individuals with SCI and ten neurologically-intact controls were tested in supine and seated positions (neutral, lowered, and elevated) in the Elevation (TM) wheelchair. Participants with SCI were stratified into two groups by the severity of injury to cardiovascular autonomic pathways. Beat-to-beat blood pressure, heart rate and middle cerebral artery blood flow velocity (MCAv) were recorded non-invasively. Results Supine blood pressure and MCAv were reduced in individuals with lesions to autonomic pathways, and declined further with standard seating compared to those with preserved autonomic control. Movement to the elevated position triggered pronounced blood pressure and MCAv falls in those with autonomic lesions, with minimum values significantly reduced compared to the seated and lowered positions. The cumulative duration spent below supine blood pressure was greatest in this group. Lowered seating bolstered blood pressure in those with lesions to autonomic pathways. Conclusions Integrity of the autonomic nervous system is an important variable that affects cardiovascular responses to orthostatic stress and should be considered when individuals with SCI or autonomic dysfunction are selecting wheelchairs.	[Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; Zawadzki, Christine; Claydon, Victoria E.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Inskip, Jessica A.; Ravensbergen, Henrike (Rianne) J. C.; Sahota, Inderjeet S.; McPhail, Lowell T.; Borisoff, Jaimie F.; Claydon, Victoria E.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Borisoff, Jaimie F.] BCIT, Burnaby, BC, Canada	Simon Fraser University; University of British Columbia; British Columbia Institute of Technology	Claydon, VE (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Claydon, VE (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.	victoria_claydon@sfu.ca		Claydon, Victoria/0000-0002-2720-8042	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada New Investigator Award	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Award	This work was supported in part by the Heart and Stroke Foundation of British Columbia and the Yukon (V.E.C). J.A.I. was supported by a doctoral research award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Evan Hutcheon, Jessica Camp, and Charlotte Mah for their assistance with testing and data processing. Research in our laboratory is supported in part by the Heart and Stroke Foundation of British Columbia and the Yukon (V.E.C). V.E.C. holds a Heart and Stroke Foundation of Canada New Investigator Award. J.A.I. was supported by a doctoral research award from the Canadian Institutes of Health Research. J.F.B. is the Canada Research Chair in Rehabilitation Engineering Design.	[Anonymous], 1996, CLIN AUTON RES, V6, P125; Anton HA, 2008, ARCH PHYS MED REHAB, V89, P538, DOI 10.1016/j.apmr.2007.11.009; Borisoff J, 2011, DEV ULTRALIGHT WHEEL; Chaudhuri K R, 1991, Clin Auton Res, V1, P37, DOI 10.1007/BF01826056; Chelvarajah R, 2009, NEUROREHABILITATION, V24, P237, DOI 10.3233/NRE-2009-0474; Chow JW, 2009, ARCH PHYS MED REHAB, V90, P271, DOI 10.1016/j.apmr.2008.07.019; Claydon VE, 2008, AM J PHYSIOL-HEART C, V294, pH668, DOI 10.1152/ajpheart.00869.2007; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Cobb John, 2014, Top Spinal Cord Inj Rehabil, V20, P277, DOI 10.1310/sci2004-277; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Cragg JJ, 2013, NEUROLOGY, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Crane BA, 2007, AM J PHYS MED REHAB, V86, P988, DOI [10.1097/PHM.0b013e3181583ed9, 10.1097/PHM.Ob013e3181583ed9]; Del-Ama AJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00298; Dhindsa MS, 2011, J SPINAL CORD MED, V34, P594, DOI 10.1179/2045772311Y.0000000040; Dudley-Javoroski S., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P227; Eser P, 2005, OSTEOPOROSIS INT, V16, P26, DOI 10.1007/s00198-004-1638-x; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; GOEMAERE S, 1994, OSTEOPOROSIS INT, V4, P138, DOI 10.1007/BF01623058; Goktepe AS, 2008, J SPINAL CORD MED, V31, P197, DOI 10.1080/10790268.2008.11760712; Harkema SJ, 2008, J NEUROTRAUM, V25, P1467, DOI 10.1089/neu.2008.0572; Harms MPM, 1999, CLIN SCI, V97, P291, DOI 10.1042/CS19990061; Hilz MJ, 2012, ACTA NEUROL SCAND, V126, P162, DOI 10.1111/j.1600-0404.2012.01670.x; HOBSON DA, 1992, J REHABIL RES DEV, V29, P21, DOI 10.1682/JRRD.1992.10.0021; Hopman MTE, 1998, SCAND J REHABIL MED, V30, P167; HUANG CT, 1983, ARCH PHYS MED REHAB, V64, P101; Illman A, 2000, SPINAL CORD, V38, P741, DOI 10.1038/sj.sc.3101089; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; KUNKEL CF, 1993, ARCH PHYS MED REHAB, V74, P73; Lee AKY, 2010, SPINAL CORD, V48, P429, DOI 10.1038/sc.2009.145; MATHIAS CJ, 1975, CLIN SCI MOL MED, V49, P291, DOI 10.1042/cs0490291; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Minkel JL, 2000, PHYS THER, V80, P701, DOI 10.1093/ptj/80.7.701; Ng WF, 2012, QJM-INT J MED, V105, P1191, DOI 10.1093/qjmed/hcs172; Olive JL, 2003, MED SCI SPORT EXER, V35, P901, DOI 10.1249/01.MSS.0000069755.40046.96; Pang CCY, 2001, PHARMACOL THERAPEUT, V90, P179, DOI 10.1016/S0163-7258(01)00138-3; Ravensbergen HJC, 2012, CLIN AUTON RES, V22, P265, DOI 10.1007/s10286-012-0166-6; Ravensbergen HJC, 2014, NEUROREHAB NEURAL RE, V28, P219, DOI 10.1177/1545968313504542; Reenalda J, 2010, SPINAL CORD, V48, P336, DOI 10.1038/sc.2009.138; Sahota IS, 2012, J NEUROTRAUM, V29, P2446, DOI 10.1089/neu.2012.2379; Sankari A, 2014, J CLIN SLEEP MED, V10, P65, DOI 10.5664/jcsm.3362; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Sidorov E, 2008, SPINAL CORD, V46, P65, DOI 10.1038/sj.sc.3102064; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sprigle S, 2003, J SPINAL CORD MED, V26, P236, DOI 10.1080/10790268.2003.11753690; Stenberg G, 2014, DISABILITY REHABILIT, P1; Sutcliffe K, 2010, EUR J CLIN INVEST, V40, P18, DOI 10.1111/j.1365-2362.2009.02225.x; U.S. Food and Drug Administration, 2014, FDA ALL MARK 1 WEAR; VanLieshout JJ, 1997, PACE, V20, P753, DOI 10.1111/j.1540-8159.1997.tb03901.x; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Wadsworth BM, 2009, SPINAL CORD, V47, P274, DOI 10.1038/sc.2008.126; Wecht JM, 2013, J SPINAL CORD MED, V36, P454, DOI 10.1179/2045772313Y.0000000109; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; Wecht JM, 2004, J REHABIL RES DEV, V41, P89, DOI 10.1682/JRRD.2004.01.0089; West CR, 2012, RESP PHYSIOL NEUROBI, V180, P275, DOI 10.1016/j.resp.2011.12.003; World Medical Association, 2008, DECL HELS ETH PRINC	58	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180195	10.1371/journal.pone.0180195	http://dx.doi.org/10.1371/journal.pone.0180195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666000	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700070
J	Lamperska, KM; Kolenda, T; Teresiak, A; Kowalik, A; Kruszyna-Mochalska, M; Jackowiak, W; Blizniak, R; Przybyla, W; Kapalczynska, M; Kozlowski, P				Lamperska, Katarzyna Monika; Kolenda, Tomasz; Teresiak, Anna; Kowalik, Anna; Kruszyna-Mochalska, Marta; Jackowiak, Weronika; Blizniak, Renata; Przybyla, Weronika; Kapalczynska, Marta; Kozlowski, Piotr			Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER-CELLS; BIOGENESIS; RADIOSENSITIVITY; PROGRESSION; MIRNA; HEAD	The implication of the let-7 family in cancer development is multifaceted. The family acts as tumor suppressor miRNA although overexpression of let-7 has also been described in many types of cancer, including head and neck squamous cell carcinoma (HNSCC). The aim of this study includes whether different expression levels of let-7d has an influence on chemo and radiosensitivity. FaDu cell line models with a gradually increased level of let-7d (models from A to E) were generated with the lentiviral system. Expression levels of pluripotency, chemo-radioresistance/apoptosis, and targets of mRNAs were analyzed by real-time reverse transcription-PCR (qRT-PCR). Radiosensitivity was analyzed using a clonogenic assay after irradiation. Response to cisplatin, 5-FU, doxorubicin, and paclitaxel was done with MTT assay. Statistically significant decrease of K-RAS (p = 0.0369) and CASPASE3 (p = 0.0342) were observed with the growing expression level of let-7d. Cisplatin, 5-FU and doxorubicin caused similar decreased of cell survival with the increase of let-7d level (p = 0.004, post-trend p = 0.046; p = 0.004, post trend p = 0.0005 and p<0.0001, post trend p = 0.0001, respectively). All models were resistant to paclitaxel, irrespective of let-7d expression levels. Only two of the generated models (A and C) were radiosensitive (p = 0.0002). Conclusion: the above results indicated that the level of let-7d expression is an important factor for cell response to irradiation and chemotherapeutics.	[Lamperska, Katarzyna Monika; Kolenda, Tomasz; Teresiak, Anna; Blizniak, Renata] Greater Poland Canc Ctr, Canc Genet Lab, Poznan, Poland; [Kolenda, Tomasz] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Kowalik, Anna; Kruszyna-Mochalska, Marta; Jackowiak, Weronika] Greater Poland Canc Ctr, Dept Med Phys, Poznan, Poland; [Przybyla, Weronika] Oslo Univ Hosp, Rikshosp, Div Pediat & Adolescent Med, Pediat Res, Oslo, Norway; [Kapalczynska, Marta] Charite Univ Med Berlin, Max Planck Inst Infect Biol, Dept Gastroenterol & Hepatol, Berlin, Germany; [Kozlowski, Piotr] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Wielkopolskie Centrum Onkologii; Medical University of Warsaw; Wielkopolskie Centrum Onkologii; University of Oslo; National Hospital Norway; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Lamperska, KM (corresponding author), Greater Poland Canc Ctr, Canc Genet Lab, Poznan, Poland.	kasialam@o2.pl	Kozlowski, Piotr/I-1860-2019; Kolenda, Tomasz/AAA-3321-2022	Kozlowski, Piotr/0000-0003-3770-7715; Teresiak, Anna/0000-0002-5327-6698; Kruszyna-Mochalska, Marta/0000-0003-2216-3129; Kolenda, Tomasz/0000-0001-5623-7398; Lamperska, Katarzyna/0000-0001-7583-207X	National Science Centre [2016/22/A/NZ2/00184, 2016/22A/NZ2/00184]; grant Greater Poland Cancer Center [12/2011(16/08/2011PGN/WCO/0003)]; Greater Cancer Center [12/2011(16/08/2011/PGN/WCO/0003)]	National Science Centre(National Science Centre, Poland); grant Greater Poland Cancer Center; Greater Cancer Center	Statistical analysis and manuscript preparing were supported by a grant from the National Science Centre 2016/22/A/NZ2/00184, and grant Greater Poland Cancer Center 12/2011(16/08/2011PGN/WCO/0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant: National Science Centre 2016/22A/NZ2/00184, Greater Cancer Center No 12/2011(16/08/2011/PGN/WCO/0003). The language correctness was checked by American Manuscript Editors.	Arora H, 2011, EXP MOL MED, V43, P298, DOI 10.3858/emm.2011.43.5.031; Barh D., 2008, CANC THERAPY, V6, P969; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chen DL, 2010, J CELL PHYSIOL, V225, P296, DOI 10.1002/jcp.22234; De Leeneer K, 2015, ADV EXP MED BIOL, V867, P263, DOI 10.1007/978-94-017-7215-0_16; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Huleihel L, 2014, AM J PHYSIOL-LUNG C, V306, pL534, DOI 10.1152/ajplung.00149.2013; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kinose Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249393; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kolenda T, 2014, WSPOLCZESNA ONKOL, V18, P293, DOI 10.5114/wo.2014.44467; Lamperska KM, 2016, CANCER BIOMARK, V16, P55, DOI 10.3233/CBM-150540; Liu N, 2015, ONCOTARGET, V6, P34649, DOI 10.18632/oncotarget.5299; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2013, BIOCHEM SOC T, V41, P821, DOI 10.1042/BST20130020; Patel K, 2014, CANCER LETT, V347, P54, DOI 10.1016/j.canlet.2014.01.020; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu LW, 2015, ELIFE, V4, DOI 10.7554/eLife.09431; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu ML, 2011, CIRC J, V75, P703, DOI 10.1253/circj.CJ-10-0393; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhou C, 2012, INT C INTEL HUM MACH, P59, DOI 10.1109/IHMSC.2012.110	49	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180265	10.1371/journal.pone.0180265	http://dx.doi.org/10.1371/journal.pone.0180265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665983	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700079
J	Yen, CH; Wang, KT; Lee, PY; Liu, CC; Hsieh, YC; Kuo, JY; Bulwer, BE; Hung, CL; Chang, SC; Shih, SC; Hu, KC; Yeh, HI; Lam, CSP				Yen, Chih-Hsuan; Wang, Kuang-Te; Lee, Ping-Ying; Liu, Chuan-Chuan; Hsieh, Ya-Ching; Kuo, Jen-Yuan; Bulwer, Bernard E.; Hung, Chung-Lieh; Chang, Shun-Chuan; Shih, Shou-Chuan; Hu, Kuang-Chun; Yeh, Hung-I; Lam, Carolyn S. P.			Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians	PLOS ONE			English	Article							MUSCLE-FIBER TYPE; SKELETAL-MUSCLE; METABOLISM; OBESE; RISK; PHOSPHOKINASE; HYPERTENSION; POPULATION; ESTROGEN; RAT	Background Creatine kinase (CK) is a pivotal regulatory enzyme in energy metabolism linked to both blood pressure and cardio-metabolic components. However, data is lacking in a large population of asymptomatic Asians. Methods and results Cardio-metabolic assessment including anthropometric measures and non-alcoholic fatty liver disease (NAFLD) were evaluated by abdominal echo in 4,562 consecutive subjects who underwent an annual health survey. Serum CK levels were related to blood pressure components [systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP)], anthropometric measures, and excessive adiposity in liver as indicated by NAFLD. Circulating CK levels ranged from 4 to 1842 IU/L (mean [SE]: 108.7 [1.1] IU/L) in the study population which consisted of 2522 males (mean age: 48.7 +/- 11.2) and 2040 females (mean age: 49.4 +/- 11.5). In general, male subjects presented with higher circulating CK levels than females (mean +/- SE: 127.3 +/- 1.5 vs. 85.5 +/- 1.3 IU/L, respectively, p<.001). Gender-differences in circulating CK levels were also observed with increasing age, which showed a more pronounced positive relationship with age in female subjects (gender interaction: p<.05). Furthermore, an elevated circulating CK level was independently associated with higher blood pressure, waist circumference and fat mass (FM), greater body mass index (BMI), increased lower estimated glomerular filtration rate (eGFR) and presence of NAFLD in multivariate analysis (all p<.05), with CK elevation more pronounced with greater BMI and FM in males compared with females (sex interaction: p<.05). Conclusion In a large asymptomatic Asian population, circulating CK levels were increased with more advanced age, higher blood pressure, and greater body mass with gender differences. Our findings may be useful in interpreting elevated CK from subjects free of ongoing myocardial damage.	[Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Yen, Chih-Hsuan; Lee, Ping-Ying; Kuo, Jen-Yuan; Hung, Chung-Lieh] Taipei Med Univ, Taipei, Taiwan; [Wang, Kuang-Te] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan; [Lee, Ping-Ying; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Chang, Shun-Chuan; Yeh, Hung-I] Mackay Med Coll, New Taipei, New Taipei Coun, Taiwan; [Liu, Chuan-Chuan] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan; [Liu, Chuan-Chuan] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Hsieh, Ya-Ching] Peking Univ, Hosp 1, Dept Anesthesiol, Beijing, Peoples R China; [Bulwer, Bernard E.] Brigham & Womens Hosp, Nonivas Cardiol, 75 Francis St, Boston, MA 02115 USA; [Bulwer, Bernard E.] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA; [Shih, Shou-Chuan; Hu, Kuang-Chun] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Mackay Memorial Hospital; Mackay Medical College; National Taiwan University; Mackay Memorial Hospital; Peking University; Harvard University; Brigham & Women's Hospital; Mackay Memorial Hospital; National Heart Centre Singapore; National University of Singapore	Hung, CL (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Nursing & Management Coll, Taipei, Taiwan.; Hung, CL (corresponding author), Taipei Med Univ, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Coll, New Taipei, New Taipei Coun, Taiwan.	jotaro3791@gmail.com	Lam, Carolyn SP/ABD-6810-2021; Hu, Kuang-Chun/L-9095-2019; Kuo, Jen-Yuan/AAX-5448-2021	Lam, Carolyn SP/0000-0003-1903-0018; Hsieh, Ya-Ching/0000-0001-9823-9957				Brewster LM, 2006, CIRCULATION, V114, P2034, DOI 10.1161/CIRCULATIONAHA.105.584490; Brewster LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032471; Brewster LM, 2000, J HYPERTENS, V18, P1537, DOI 10.1097/00004872-200018110-00002; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; CLARK JF, 1994, MOL CELL BIOCHEM, V133, P221, DOI 10.1007/BF01267956; CLARK JF, 1994, BIOCHEM J, V300, P211, DOI 10.1042/bj3000211; CLARKSON PM, 1982, INT J SPORTS MED, V3, P145, DOI 10.1055/s-2008-1026078; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; De Sousa E, 2000, CIRCULATION, V102, P1847; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; GARCIA W, 1974, JAMA-J AM MED ASSOC, V228, P1395, DOI 10.1001/jama.228.11.1395; Gogia S, 2006, LIVER INT, V26, P899, DOI 10.1111/j.1478-3231.2006.01299.x; Grobe YG, 2010, ANN HEPATOL, V9, P402, DOI 10.1016/S1665-2681(19)31616-3; HADJIISKY P, 1991, CELL MOL BIOL, V37, P531; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; KOTANI K, 1994, INT J OBESITY, V18, P207; LINDENA J, 1986, J CLIN CHEM CLIN BIO, V24, P61; Neal RC, 2009, AM J MED, V122, P73, DOI 10.1016/j.amjmed.2008.08.033; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Pandke KE, 2008, AM J PHYSIOL-REG I, V295, pR806, DOI 10.1152/ajpregu.90540.2008; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Ramamani A, 1999, ACTA PHYSIOL SCAND, V166, P91; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Somjen D, 1998, HYPERTENSION, V32, P39, DOI 10.1161/01.HYP.32.1.39; Sun G, 2002, METABOLISM, V51, P451, DOI 10.1053/meta.2002.31324; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; WADE AJ, 1990, LANCET, V335, P805, DOI 10.1016/0140-6736(90)90933-V; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179898	10.1371/journal.pone.0179898	http://dx.doi.org/10.1371/journal.pone.0179898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665956	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700045
J	de Oliveira, HF; Bollela, VR; Anselmo-Lima, WT; Costa, CAPD; Nakanishi, M				de Oliveira, Henrique Fernandes; Bollela, Valdes Roberto; Anselmo-Lima, Wilma Terezinha; Pires de Oliveira Costa, Carlos Augusto; Nakanishi, Marcio			A feasible, low-cost, reproducible lamb's head model for endoscopic sinus surgery training	PLOS ONE			English	Article							CONSTRUCT-VALIDITY; ANIMAL-MODEL; OVINE MODEL; SIMULATOR; RESIDENTS	Objective To describe and standardize a reproducible, viable, low-cost lamb's head model for endoscopic sinus surgery training. Methods Otorhinolaryngology residents performed the following three endoscopic sinus surgeries using the lamb's head model: inferior turbinectomy, bullectomy, and maxillary antrostomy. Each student dissected 10 specimens before training these procedures on human patients, and the benefit of the animal model training was evaluated. Results Nineteen resident physicians of comparable academic level participated in training. All participants agreed that the lamb's head model dissections improved their skills in using surgical and videoendoscopic instruments, 90% agreed that the dissections improved their confidence with respect to training in human patients, and all stated they would recommend the same training to future residents. Discussion Lamb's heads have been used for training in endoscopic sinus surgery. However, no standardization of this training had been performed to ensure that it is a valuable tool for learning and skill-building. The standardized method described in this study increased resident physicians' skills and confidence before beginning their training on human patients. Moreover, our results demonstrate the feasibility of the model, considering its low cost and reproducibility.	[de Oliveira, Henrique Fernandes; Nakanishi, Marcio] Univ Brasilia UnB, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil; [Bollela, Valdes Roberto] Univ Sao Paulo, Ribeirao Preto Sch Med FMRP, Dept Infect & Trop Dis, Ribeirao Preto, Brazil; [Bollela, Valdes Roberto] Fdn Adv Med Educ & Res FAIMER, Philadelphia, PA USA; [Anselmo-Lima, Wilma Terezinha] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, FMRP, Ribeirao Preto, Brazil; [Pires de Oliveira Costa, Carlos Augusto] Univ Brasilia, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Brasilia	de Oliveira, HF (corresponding author), Univ Brasilia UnB, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Brasilia, DF, Brazil.	hfdoliveira@yahoo.com.br		de Oliveira, Henrique/0000-0001-7889-6730				Arora H, 2005, ARCH OTOLARYNGOL, V131, P217, DOI 10.1001/archotol.131.3.217; Awad Z, 2012, OTOLARYNG HEAD NECK, V147, pP119; Awad Z, 2015, LARYNGOSCOPE, V125, P539, DOI 10.1002/lary.24927; Briner HR, 2007, RHINOLOGY, V45, P20; Delgado-Vargas B, 2016, EUR ARCH OTO-RHINO-L, V273, P2085, DOI 10.1007/s00405-015-3877-1; Fried MP, 2010, OTOLARYNG HEAD NECK, V142, P202, DOI 10.1016/j.otohns.2009.11.023; Gardiner Q, 1996, J LARYNGOL OTOL, V110, P425, DOI 10.1017/S0022215100133882; Hosemann W, 2013, GMS Curr Top Otorhinolaryngol Head Neck Surg, V12, pDoc06, DOI 10.3205/cto000098; KINSELLA JB, 1995, LARYNGOSCOPE, V105, P1029, DOI 10.1288/00005537-199510000-00003; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Mladina R, 2011, J LARYNGOL OTOL, V125, P696, DOI 10.1017/S0022215111000776; Mladina R., 2014, ENDOSCOPIC SURG ANAT; Mladina R, 2013, ORL J OTO-RHINO-LARY, V75, P32, DOI 10.1159/000347080; Mladina R, 2013, AM J RHINOL ALLERGY, V27, P251, DOI 10.2500/ajra.2013.27.3886; Nogueira JF, 2008, OTOLARYNG HEAD NECK, V139, P727, DOI 10.1016/j.otohns.2008.07.017; Touska P, 2013, LARYNGOSCOPE, V123, P1598, DOI 10.1002/lary.23974; World Health Organization, 2009, WHO PAT SAF CURR GUI; Zuckerman JD, 2009, AM J RHINOL ALLERGY, V23, P218, DOI 10.2500/ajra.2009.23.3297	18	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180273	10.1371/journal.pone.0180273	http://dx.doi.org/10.1371/journal.pone.0180273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662196	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300135
J	Ge, Y; Hu, KD; Wang, SS; Hu, LY; Chen, XY; Li, YH; Yang, Y; Yang, F; Zhang, H				Ge, Yun; Hu, Kang-Di; Wang, Sha-Sha; Hu, Lan-Ying; Chen, Xiao-Yan; Li, Yan-Hong; Yang, Ying; Yang, Feng; Zhang, Hua			Hydrogen sulfide alleviates postharvest ripening and senescence of banana by antagonizing the effect of ethylene	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; ABSCISIC-ACID; FRUIT; OXYGEN; BIOSYNTHESIS; ARABIDOPSIS; METABOLISM; PLANTS	Accumulating evidence shows that hydrogen sulfide (H2S) acts as a multifunctional signaling molecule in plants, whereas the interaction between H2S and ethylene is still unclear. In the present study we investigated the role of H2S in ethylene-promoted banana ripening and senescence by the application of ethylene released from 1.0 g-L-1 ethephon solution or H2S with 1 mM sodium hydrosulfide (NaHS) as the donor or in combination. Fumigation with ethylene was found to accelerate banana ripening and H2S treatment effectively alleviated ethylene-induced banana peel yellowing and fruit softening in parallel with decreased activity of polygalacturonase (PG). Ethylene+H2S treatment also delayed the decreases in chlorophyll and total phenolics, and increased the accumulation of flavonoid, whereas decreased the contents of carotenoid, soluble protein in banana peel and reducing sugar in pulp compared with ethylene treatment alone. Besides, ethylene+H2S treatment suppressed the accumulation of superoxide radicals (-O-2(-)), hydrogen peroxide (H2O2) and malondialdehyde (MDA) which accumulated highly in ethylene-treated banana peels. Furthermore H2S enhanced total antioxidant capacity in ethylene-treated banana peels with the 2,2'-azobis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) assay. The result of quantitative real-time PCR showed that the combined treatment of ethylene with H2S down-regulated the expression of ethylene synthesis genes MaACS1, MaACS2 and MaACO1 and pectate lyase MaPL compared with ethylene treatment, while the expression of ethylene receptor genes MaETR, MaERS1 and MaERS2 was enhanced in combination treatment compared with ethylene alone. In all, it can be concluded that H2S alleviates banana fruit ripening and senescence by antagonizing the effect of ethylene through reduction of oxidative stress and inhibition of ethylene signaling pathway.	[Ge, Yun; Hu, Kang-Di; Wang, Sha-Sha; Hu, Lan-Ying; Chen, Xiao-Yan; Li, Yan-Hong; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China; [Yang, Ying] Anhui Jianzhu Univ, Coll Environm & Energy Engn, Hefei, Peoples R China; [Yang, Feng] Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Peoples R China	Hefei University of Technology; Anhui Jianzhu University; Jiangsu Academy of Agricultural Sciences	Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China.	hzhanglab@hfut.edu.cn	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022		National Natural Science Foundation of China; Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department	The funders, National Natural Science Foundation of China, Anhui Provincial Science and Technology Major Project, and Anhui Provincial Education Department, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Alvarez C, 2012, NEW PHYTOL, V193, P165, DOI 10.1111/j.1469-8137.2011.03889.x; Ammawath W, 2001, J SCI FOOD AGR, V81, P1166, DOI 10.1002/jsfa.922; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cheng GP, 2008, FOOD CHEM, V109, P319, DOI 10.1016/j.foodchem.2007.12.041; DOMINGUEZ M, 1993, J HORTIC SCI BIOTECH, V68, P63, DOI 10.1080/00221589.1993.11516329; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gao SP, 2013, HORTSCIENCE, V48, P1385, DOI 10.21273/HORTSCI.48.11.1385; Garcia I, 2010, PLANT CELL, V22, P3268, DOI 10.1105/tpc.110.076828; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Girennavar B, 2006, BIOORGAN MED CHEM, V14, P2606, DOI 10.1016/j.bmc.2005.11.039; Golding JB, 1998, POSTHARVEST BIOL TEC, V14, P87, DOI 10.1016/S0925-5214(98)00032-5; GRAY J, 1992, PLANT MOL BIOL, V19, P69, DOI 10.1007/BF00015607; Gupta SM, 2006, POSTHARVEST BIOL TEC, V42, P16, DOI 10.1016/j.postharvbio.2006.05.002; Harris DR, 2000, POSTHARVEST BIOL TEC, V20, P303, DOI 10.1016/S0925-5214(00)00150-2; Hu H., 2014, J FOOD SCI TECHNOL, V49, P399; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jakubowicz M, 2010, J EXP BOT, V61, P3475, DOI 10.1093/jxb/erq177; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Li ZR, 2015, HORTSCIENCE, V50, P416, DOI 10.21273/HORTSCI.50.3.416; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Liu XJ, 1999, PLANT PHYSIOL, V121, P1257, DOI 10.1104/pp.121.4.1257; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; LopezGomez R, 1997, PLANT SCI, V123, P123, DOI 10.1016/S0168-9452(97)04578-0; Menniti AM, 2004, POSTHARVEST BIOL TEC, V31, P269, DOI 10.1016/j.postharvbio.2003.09.009; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohapatra D, 2011, FOOD BIOPROCESS TECH, V4, P327, DOI 10.1007/s11947-010-0377-6; Nath A, 2011, FOOD CHEM, V127, P1510, DOI 10.1016/j.foodchem.2011.02.007; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pathak N, 1998, PHYTOCHEMISTRY, V48, P249, DOI 10.1016/S0031-9422(98)00005-3; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Prabha TN, 1998, PHYTOCHEMISTRY, V48, P915, DOI 10.1016/S0031-9422(97)00931-X; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SEYMOUR GB, 1987, ANN APPL BIOL, V110, P153, DOI 10.1111/j.1744-7348.1987.tb03242.x; Tian SP, 2013, PLANT MOL BIOL, V82, P593, DOI 10.1007/s11103-013-0035-2; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang KL, 2012, PLANT CELL, V14, pS131; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1	46	61	64	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180113	10.1371/journal.pone.0180113	http://dx.doi.org/10.1371/journal.pone.0180113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662156	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300104
J	Raval, SB; Britton, CA; Zhao, TJ; Krishnamurthy, N; Santini, T; Gorantla, VS; Ibrahim, TS				Raval, Shailesh B.; Britton, Cynthia A.; Zhao, Tiejun; Krishnamurthy, Narayanan; Santini, Tales; Gorantla, Vijay S.; Ibrahim, Tamer S.			Ultra-high field upper extremity peripheral nerve and non-contrast enhanced vascular imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; 7 T; HIGH-RESOLUTION; MR-ANGIOGRAPHY; CT ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; FIBER TRACTOGRAPHY; OCCLUSIVE DISEASE; TRANSCEIVER ARRAY; BRACHIAL-PLEXUS	Objective The purpose of this study was to explore the efficacy of Ultra-high field [UHF] 7 Tesla [T] MRI as compared to 3T MRI in non-contrast enhanced [nCE] imaging of structural anatomy in the elbow, forearm, and hand [upper extremity]. Materials and method A wide range of sequences including T1 weighted [T1] volumetric interpolate breath-hold exam [VIBE], T2 weighted [T2] double-echo steady state [DESS], susceptibility weighted imaging [SWI], time-of-flight [TOF], diffusion tensor imaging [DTI], and diffusion spectrum imaging [DSI] were optimized and incorporated with a radiofrequency [RF] coil system composed of a transverse electromagnetic [TEM] transmit coil combined with an 8-channel receive-only array for 7T upper extremity [UE] imaging. In addition, Siemens optimized protocol/ sequences were used on a 3T scanner and the resulting images from T1 VIBE and T2 DESS were compared to that obtained at 7T qualitatively and quantitatively [SWI was only qualitatively compared]. DSI studio was utilized to identify nerves based on analysis of diffusion weighted derived fractional anisotropy images. Images of forearm vasculature were extracted using a paint grow manual segmentation method based on MIPAV [Medical Image Processing, Analysis, and Visualization]. Results High resolution and high quality signal-to-noise ratio [SNR] and contrast-to-noise ratio [CNR] D images of the hand, forearm, and elbow were acquired with nearly homogeneous 7T excitation. Measured [performed on the T1 VIBE and T2 DESS sequences] SNR and CNR values were almost doubled at 7T vs. 3T. Cartilage, synovial fluid and tendon structures could be seen with higher clarity in the 7T T1 and T2 weighted images. SWI allowed high resolution and better quality imaging of large and medium sized arteries and veins,capillary networks and arteriovenous anastomoses at 7T when compared to 3T. 7T diffusion weighted sequence [not performed at 3T] demonstrates that the forearm nerves are clearly delineated by fiber tractography. The proper digital palmar arteries and superficial palmar arch could also be clearly visualized using TOF nCE 7T MRI. Conclusion Ultra-high resolution neurovascular imaging in upper extremities is possible at 7T without use of renal toxic intravenous contrast. 7T MRI can provide superior peripheral nerve [based on fiber anisotropy and diffusion coefficient parameters derived from diffusion tensor/spectrum imaging] and vascular [nCE MRA and vessel segmentation] imaging.	[Raval, Shailesh B.; Krishnamurthy, Narayanan; Santini, Tales; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Raval, Shailesh B.; Britton, Cynthia A.; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Zhao, Tiejun] Siemens Med Solut, New York, NY USA; [Gorantla, Vijay S.] Dept Plast Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Siemens AG	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Gorantla, VS (corresponding author), Dept Plast Surg, Pittsburgh, PA 15213 USA.	gorantlavs@upmc.edu; tibrahim@pitt.edu	Raval, Shailesh/O-5176-2019	Raval, Shailesh/0000-0001-9202-236X; Santini, Tales/0000-0003-4533-9190	National Institutes of Health [5R01EB009848]; U.S. Army Medical Research and Materiel Command (DOD) [W81XWH-10-1-0618]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command (DOD)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (5R01EB009848) to TSI and the U.S. Army Medical Research and Materiel Command (DOD W81XWH-10-1-0618) to VSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard BD, 2003, NEUROSURGERY, V53, P199, DOI 10.1227/01.NEU.0000069534.43067.28; [Anonymous], 2014, MED IM PROC AN VIS M; Anzidei M, 2012, RADIOL MED, V117, P54, DOI 10.1007/s11547-011-0651-3; Aussenhofer SA, 2012, MAGN RESON MED, V68, P1325, DOI 10.1002/mrm.24451; Bae KT, 2010, J MAGN RESON IMAGING, V31, P255, DOI 10.1002/jmri.22019; Barberi EA, 2000, MAGNET RESON MED, V43, P284, DOI 10.1002/(SICI)1522-2594(200002)43:2<284::AID-MRM16>3.0.CO;2-C; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Behr B, 2009, SKELETAL RADIOL, V38, P911, DOI 10.1007/s00256-009-0673-2; Bencardino Jenny T, 2004, Magn Reson Imaging Clin N Am, V12, P333, DOI 10.1016/j.mric.2004.02.010; Biomedical R, 2015, 16 CHANNEL WRIST ARR; Bode AS, 2012, EUR J VASC ENDOVASC, V43, P88, DOI 10.1016/j.ejvs.2011.09.012; BOSKAMP EB, 1985, RADIOLOGY, V157, P449, DOI 10.1148/radiology.157.2.4048454; Bottomley PA, 1978, PHYS MED BIOL, V23; Braidy C, 2012, AM J ROENTGENOL, V199, pW629, DOI 10.2214/AJR.12.8513; Chang G, 2010, J MAGN RESON IMAGING, V31, P740, DOI 10.1002/jmri.22072; Chen CN, 1989, BIOMEDICAL MAGNETIC; Chhabra A, 2010, AM J NEURORADIOL, V31, P1363, DOI 10.3174/ajnr.A2002; Chhabra A, 2012, SKELETAL RADIOL, V41, P257, DOI 10.1007/s00256-011-1146-y; Du R, 2010, J NEUROSURG, V112, P362, DOI 10.3171/2009.7.JNS09414; EDELSTEIN WA, 1986, J MAGN RESON, V67, P156, DOI 10.1016/0022-2364(86)90421-X; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fischer A, 2014, INVEST RADIOL, V49, P331, DOI 10.1097/RLI.0000000000000044; Forster A, 2014, CLIN NEURORADIOL, V24, P347, DOI 10.1007/s00062-013-0261-7; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haider CR, 2011, J MAGN RESON IMAGING, V34, P2, DOI 10.1002/jmri.22469; Haims AH, 2004, AM J ROENTGENOL, V182, P1267, DOI 10.2214/ajr.182.5.1821267; Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; Itagaki MW, 2009, RADIOLOGY, V252, P468, DOI 10.1148/radiol.2523081241; Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5; Jazi MH, 2011, ARYA ATHEROSCLER, V7, P58; Juras V, 2012, EUR J RADIOL, V81, P1846, DOI 10.1016/j.ejrad.2011.05.023; Kang CK, 2016, MAGN RESON MED, V75, P1640, DOI 10.1002/mrm.25600; Karamessini MT, 2004, EUR J RADIOL, V49, P212, DOI 10.1016/S0720-048X(03)00173-6; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; Koopmans PJ, 2008, MAGN RESON MATER PHY, V21, P149, DOI 10.1007/s10334-007-0101-3; Kraff O, 2010, MED PHYS, V37, P6368, DOI 10.1118/1.3517176; Kramer CM, 2009, JACC-CARDIOVASC IMAG, V2, P916, DOI 10.1016/j.jcmg.2009.05.002; Lee WN, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5075; Liu X, 2007, AM J ROENTGENOL, V189, P1326, DOI 10.2214/AJR.07.2805; Masi JN, 2005, RADIOLOGY, V236, P140, DOI 10.1148/radiol.2361040747; Moore KR, 2001, AM J NEURORADIOL, V22, P786; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nezafat R, 2009, NAT REV CARDIOL, V6, P676, DOI 10.1038/nrcardio.2009.184; Obusez EC, 2014, AM J NEURORADIOL, V35, P1527, DOI 10.3174/ajnr.A3909; Pomper MG, 1999, AM J NEURORADIOL, V20, P75; Raghuraman S, 2013, J MAGN RESON IMAGING, V38, P238, DOI 10.1002/jmri.23883; Raval SB, 2015, PLAST RECONSTR SURG; Raval SB, 2016, NMR BIOMED; Raval SB, 2015, ULTRAHIGH FIELD 7T M; Raval SB, 2015, UPPER EXTREMITY NEUR; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sadikin C, 2007, J FORMOS MED ASSOC, V106, P691, DOI 10.1016/S0929-6646(08)60030-3; Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116; Sampath SC, 2013, SPORTS HEALTH, V5, P34, DOI 10.1177/1941738112467941; Schmitter S, 2014, MAGN RESON MED, V71, P966, DOI 10.1002/mrm.24749; Sibley CT, 2009, J AM COLL CARDIOL, V54, P77, DOI 10.1016/j.jacc.2009.04.022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Thakkar R, 2012, AM J ROENTGENOL, V198; Thawait SK, 2012, AM J NEURORADIOL, V33, P203, DOI 10.3174/ajnr.A2465; Tipper G, 2005, CLIN RADIOL, V60, P565, DOI 10.1016/j.crad.2004.09.012; Todua FI, 2013, GEORGIAN MED NEW DEC; Truwit CL, 2007, RADIOLOGY, V245, P362, DOI 10.1148/radiol.2452061670; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; Vargas MI, 2010, EUR J RADIOL, V74, P403, DOI 10.1016/j.ejrad.2010.01.024; VAUGHAN JT, 1994, MAGNET RESON MED, V32, P206, DOI 10.1002/mrm.1910320209; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Viallon M, 2008, EUR RADIOL, V18, P1018, DOI 10.1007/s00330-007-0834-4; Vogelius ES, 2011, MAGN RESON IMAGING C, V19, P567, DOI 10.1016/j.mric.2011.05.004; Wrede K. H., 2016, EUR RADIOL; Yamada H, 2014, PLOS ONE, V9; Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016; Yeh F, 2010, DEP PSYCHOL; Zhang CC, 2014, CANCER MED-US, V3, P462, DOI 10.1002/cam4.215; Zhang N., 2015, PLOS ONE, V10; Zhang W, 2011, RHEUMATOLOGY, V50, P1712, DOI 10.1093/rheumatology/keq453	85	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0175629	10.1371/journal.pone.0175629	http://dx.doi.org/10.1371/journal.pone.0175629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662061	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300001
J	Schonfelder, ML; Bogner, FX				Schoenfelder, Mona Lisa; Bogner, Franz Xaver			Individual perception of bees: Between perceived danger and willingness to protect	PLOS ONE			English	Article							CHILDREN AGED 5-16; ATTITUDES; CONSERVATION; FEAR; ANIMALS; DISGUST; SCHOOLCHILDREN; EXPERIENCE; ORGANISMS; AGREEMENT	The current loss of biodiversity has found its way into the media. Especially the loss of bees as pollinators has recently received much attention aiming to increase public awareness about the consequence of pollinator loss and strategies for protection. However, pollinating insects like bees often prompt considerable anxiety. Negative emotions such as fear and disgust often lead to lack of support for conservation and appropriate initiatives for protection. Our study monitored perceptions of bees in the contexts of conservation and danger bees possibly represent by applying a semantic differential using contrasting adjectives under the heading "I think bees are... ". Additionally, open questions were applied to examine individual perceptions of danger and conservation of bees. Respondents were students from primary school, secondary school and university. We compared these novices (n = 499) to experts (beekeepers, n = 153). An exploratory factor analysis of the semantic differential responses yielded three major oblique factors: Interest, Danger and Conservation & Usefulness. The inter-correlations of these factors were significant. Although all subgroups showed an overall high willingness to protect bees, the perception of danger scored medium. The individual experience of bee stings was the most prevalent reason for expressing fear. Educational programs focusing on pollinator conservation may reduce the perceived danger through removing misinformation, and supporting interest in the species. Based on the overall positive attitude toward bees, we suggest introducing bees (e.g., Apis mellifera) as a flagship species for pollinator conservation.	[Schoenfelder, Mona Lisa; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany	University of Bayreuth	Schonfelder, ML (corresponding author), Univ Bayreuth, Dept Biol Educ, Bayreuth, Germany.	mona.schoenfelder@uni-bayreuth.de			European Union LLP [527891]; University of Bayreuth; German Research Foundation (DFG)	European Union LLP; University of Bayreuth; German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support was granted by the Gree NET Project funded by European Union LLP Grant Agreement No. 527891 (http://greenet.ea.gr/) and the University of Bayreuth. Publishing fees were funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol DP, 2011, POLLINAT BIOL BIODIV, P1; [Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Arrindell WA, 2000, BEHAV RES THER, V38, P509, DOI 10.1016/S0005-7967(99)00097-2; Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; Ballouard JM, 2013, ANTHROZOOS, V26, P93, DOI 10.2752/175303713X13534238631560; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bixler R. D., 1999, J ENV ED, V30, P4, DOI [10.1080/00958969909601871, DOI 10.1080/00958969909601871]; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjerke T, 1998, ANTHROZOOS, V11, P227, DOI 10.2752/089279398787000544; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Bogner F.X., 1996, ENVIRONMENTALIST, V16, P95, DOI [10.1007/BF01325101, DOI 10.1007/BF01325101]; Bogner F. X., 1998, J ENVIRON EDUC, V29, P17, DOI DOI 10.1080/00958969809599124; Breuer GB, 2015, INT J SCI EDUC, V37, P2664, DOI 10.1080/09500693.2015.1099171; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; Byrne A, 2009, APIDOLOGIE, V40, P194, DOI 10.1051/apido/2009017; Calik M, 2005, J RES SCI TEACH, V42, P638, DOI 10.1002/tea.20076; Ceriaco LMP, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-26; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Davey G.C., 1991, ANXIETY RES, V4, P299, DOI [https://doi.org/10.1080/08917779208248798, DOI 10.1080/08917779208248798, 10.1080/08917779208248798]; DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Drissner J, 2013, ISRN ED, V2013, P1; Eagly A. H., 1993, PSYCHOL ATTITUDES; Field A., 2013, DISCOVERING STAT USI; Flavell J. H., 1992, PIAGETS THEORY PROSP, V14, P107; Gerdes ABM, 2009, EVOL HUM BEHAV, V30, P66, DOI 10.1016/j.evolhumbehav.2008.08.005; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gupta R.K., 2014, BEEKEEPING POVERTY A, VVolume 1; Herzog H. A., 1988, ANTHROZOOS, V1, P214, DOI [DOI 10.2752/089279388787058317, 10.2752/089279388787058317]; HILL RJ, 1958, AM SOCIOL REV, V23, P227, DOI 10.2307/2089024; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Killermann W, 1996, INT J SCI EDUC, V18, P333, DOI 10.1080/0950069960180306; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leach J, 1996, INT J SCI EDUC, V18, P19, DOI 10.1080/0950069960180102; Leach J, 1996, INT J SCI EDUC, V18, P129, DOI 10.1080/0950069960180201; Lieflander AK, 2013, ENVIRON EDUC RES, V19, P370, DOI 10.1080/13504622.2012.697545; Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Mayring P, 2010, HDB QUAL FORSCH PSYC, V1, P144; Mingo J, 2013, BEES MAKE BEST PETS; Mintzes JJ, 2005, ELSEVIER, P29; Munstedt K, 2013, ADV STUD MED SCI, V1, P125; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2007, J BIOL EDUC, V42, P36, DOI 10.1080/00219266.2007.9656105; Prokop P, 2010, ANN ZOOL FENN, V47, P417, DOI 10.5735/086.047.0606; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Prokop P, 2009, SOC ANIM, V17, P224, DOI 10.1163/156853009X445398; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Randler, 2015, INT J ENV SCI ED, V10, P477, DOI [DOI 10.12973/IJESE.2015.255A, 10.12973/ijese.2015.255a]; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Schlegel J, 2015, ANTHROZOOS, V28, P229, DOI 10.2752/089279315X14219211661732; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Tautz J., 2007, PHANOMEN HONIGBIENE; Tomazic I, 2011, SOC ANIM, V19, P225, DOI [10.1163/156853011X578901, 10.1163/156853011x578901]; Wilson C., 2005, J SOCIAL SCI, V1, P47, DOI [10.22004/ag.econ.51417, DOI 10.22004/AG.ECON.51417, DOI 10.3844/jssp.2005.47.51]	70	43	44	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180168	10.1371/journal.pone.0180168	http://dx.doi.org/10.1371/journal.pone.0180168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662124	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300118
J	Tanaka, M; Endo, S; Kotake, F; Al-Saari, N; Amin, AKMR; Feng, G; Mino, S; Doi, H; Ogura, Y; Hayashi, T; Suda, W; Hattori, M; Yumoto, I; Sawabe, T; Sawabe, T; Araki, T				Tanaka, Mami; Endo, Shoko; Kotake, Fumihito; Al-Saari, Nurhidayu; Amin, A. K. M. Rohul; Feng, Gao; Mino, Sayaka; Doi, Hidetaka; Ogura, Yoshitoshi; Hayashi, Tetsuya; Suda, Wataru; Hattori, Masahira; Yumoto, Isao; Sawabe, Toko; Sawabe, Tomoo; Araki, Toshiyoshi			Vibrio aphrogenes sp. nov., in the Rumoiensis clade isolated from a seaweed	PLOS ONE			English	Article							RHIZOBIUM-LEGUMINOSARUM-HUPE; TRITONIUS STRAIN AM2; MARINE BACTERIUM	A novel strain Vibrio aphrogenes sp. nov. strain CA-1004(T) isolated from the surface of seaweed collected on the coast of Mie Prefecture in 1994 [1] was characterized using poly phasic taxonomy including multilocus sequence analysis (MLSA) and a genome based comparison. Both phylogenetic analyses on the basis of 16S rRNA gene sequences and MLSA based on eight protein-coding genes (gapA, gyrB, ftsZ, mreB, pyrH, recA, rpoA, and topA) showed the strain could be placed in the Rumoiensis Glade in the genus Vibrio. Sequence similarities of the 16S rRNA gene and the multilocus genes against the Rumoiensis Glade members, V. rumoiensis, V. algivorus, V. casei, and V. litoralis, were low enough to propose V. aphrogenes sp. nov. strain CA-1004(T) as a separate species. The experimental DNA-DNA hybridization data also revealed that the strain CA-1004(T) was separate from four known Rumoiensis Glade species. The G+C content of the V. aphrogenes strain was determined as 42.1% based on the genome sequence. Major traits of the strain were non motile, halophilic, fermentative, alginolytic, and gas production. A total of 27 traits (motility, growth temperature range, amylase, alginase and lipase productions, and assimilation of 19 carbon compounds) distinguished the strain from the other species in the Rumoiensis Glade. The name V. aphrogenes sp. nov. is proposed for this species in the Rumoiensis Glade, with CA-1004(T) as the type strain (JCM 31643(T) = DSM 103759(T)).	[Tanaka, Mami; Endo, Shoko; Kotake, Fumihito; Al-Saari, Nurhidayu; Amin, A. K. M. Rohul; Feng, Gao; Mino, Sayaka; Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido, Japan; [Doi, Hidetaka] Ajinomoto Co Inc, Proc Dev Labs, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka, Japan; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Lab Metagen, Kashiwa, Chiba, Japan; [Suda, Wataru] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Yumoto, Isao] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Sawabe, Toko] Hakodate Jr Coll, Dept Food & Nutr, Hakodate, Hokkaido, Japan; [Araki, Toshiyoshi] Mie Univ, Iga Res Inst, Iga, Japan	Hokkaido University; Ajinomoto Co Inc; Kyushu University; University of Tokyo; Keio University; Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); Mie University	Sawabe, T (corresponding author), Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido, Japan.	sawabe@fish.hokudai.ac.jp	Hattori, Masahira/AAD-3785-2019; Suda, Wataru/AAF-4469-2019; Al-saari, Nurhidayu/V-3466-2019; Hayashi, Tetsuya/ABA-1074-2020; Yumoto, Isao/N-2053-2018	Yumoto, Isao/0000-0001-9525-3155; Al-saari, Nurhidayu/0000-0002-2952-7039	Kaken [16H0497606]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [221S0002]	Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Kaken (16H0497606) (TS). This work was also supported by Grant in Aid for Scientific Research on Innovative Area "Genome Science" from Ministry of Education, Culture, Sports, Science, and Technology of Japan (No.221S0002).	Al-Saari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136279; Albareda M, 2015, METALLOMICS, V7, P691, DOI [10.1039/c4mt00298a, 10.1039/C4MT00298A]; Araki T, 1999, FISHERIES SCI, V65, P937, DOI 10.2331/fishsci.65.937; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bleicher A, 2010, INT J SYST EVOL MICR, V60, P1745, DOI 10.1099/ijs.0.016493-0; Brito B, 2010, J BACTERIOL, V192, P925, DOI 10.1128/JB.01045-09; Doi H, 2016, INT J SYST EVOL MICR, V66, P3164, DOI 10.1099/ijsem.0.001165; Gomez-Gil B., 2014, FAMILY VIBRIONACEAE, V9, P659; Gomez-Gil B, 2016, ANTON LEEUW INT J G, V109, P817, DOI 10.1007/s10482-016-0681-x; Gonzales AD, 2016, SPRINGER HDB MARINE; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Matsumura Y, 2015, INT J HYDROGEN ENERG, V40, P9137, DOI 10.1016/j.ijhydene.2015.05.137; Matsumura Y, 2014, INT J HYDROGEN ENERG, V39, P7270, DOI 10.1016/j.ijhydene.2014.02.164; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nam YD, 2007, INT J SYST EVOL MICR, V57, P562, DOI 10.1099/ijs.0.64653-0; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Rossello-Mora R, 2015, SYST APPL MICROBIOL, V38, P1; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2015, ARCH MICROBIOL, V197, P359, DOI 10.1007/s00203-014-1071-2; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Yumoto I, 1999, APPL ENVIRON MICROB, V65, P67	32	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180053	10.1371/journal.pone.0180053	http://dx.doi.org/10.1371/journal.pone.0180053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662104	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300093
J	Xing, HY; Li, B; Peng, D; Wang, CY; Wang, GY; Li, P; Le, YY; Wang, JM; Ye, G; Chen, JH				Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Chun-Yan; Wang, Guan-Ying; Li, Pan; Le, Ying-Ying; Wang, Ji-Ming; Ye, George; Chen, Jian-Hong			A novel monoclonal antibody against the N terminus of A beta(1-42) reduces plaques and improves cognition in a mouse model of Alzheimer's disease	PLOS ONE			English	Article							AMYLOID-BETA; A-BETA; PHASE-3 TRIALS; BAPINEUZUMAB; THERAPIES; PEPTIDES; BINDING; BURDEN; TARGET; BRAIN	Senile plaques consisting of Amyloid-beta (4) peptides, in particular A beta(1-42), are the hallmark of Alzheimer's disease (AD) and have been the primary therapeutic targets. Passive immunotherapy with monoclonal antibodies (mAbs) has shown initial success in mouse models of AD. However, the existing A beta-directed mAbs mostly were tested on animal models or patients with advanced disease. The effects and mechanisms of mAbs on animals or human trial participants in the prodromal phase of AD are not fully clarified. In the current study, a novel mAb (3F5) directed against the 1-11 amino acids of A beta(1-42) was generated by immunizing mice with an emulsion of full length human A beta(1-42). The mAb (3F5) showed the ability to disrupt A beta(1-42) aggregation and prevent A beta-mediated neurotoxicity in vitro. In a mouse model of AD, administration with 3F5 for 3 months in 6 months-old mice demonstrated that the mAb specifically bound with A beta(1-42) to promote the depolymerization of A beta fibrils, facilitated endocytosis of A beta(1-42) by microglia, and attenuated the death and apoptosis of neuronal cells, accompanied by neurite outgrowth. APP/PS1 double-transgenic mice treated with 3F5 mAb showed reduced memory loss, cognitive decline, and decreased levels of amyloid deposits in the brain. A beta(1-42) levels in cerebral tissues were also significantly reduced, whereas serum A beta(1-42) was markedly increased. Interestingly, the concentration of 3F5 in peripheral circulation is much higher than that in the brain. These results indicate that 3F5 is able to cross the blood-brain barrier (BBB) to bind A beta and initiates the phagocytosis of antibody/A beta complexes by microglia in the amyloid depositing mice. 3F5 also promotes 4 efflux from the brain. As a consequence, the antibody reduces plaques in the AD mouse brain, in association with reduction in the pathology of AD.	[Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Guan-Ying; Li, Pan; Chen, Jian-Hong] Third Mil Med Univ, Dept Pharm, Daping Hosp, Chongqing, Peoples R China; [Xing, Hai-Yan; Li, Bin; Peng, Dan; Wang, Guan-Ying; Li, Pan; Chen, Jian-Hong] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Wang, Chun-Yan; Ye, George] Anogen Yes Biotech, Mississauga, ON, Canada; [Le, Ying-Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Ji-Ming] Natl Canc Inst Frederick, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA	Army Medical University; Army Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, JH (corresponding author), Third Mil Med Univ, Dept Pharm, Daping Hosp, Chongqing, Peoples R China.; Chen, JH (corresponding author), Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China.	chenjh-110@263.net	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899	National Natural Science Foundation of China [81302867, 81273608]; Chongqing Programs for Science and Technology Development [CSTC2015jcyjBX0018]; National Cancer Institute, National Institutes of Health [HHSN 26/200800001E]; Intramural Research Program of NCI, NIH, USA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Programs for Science and Technology Development; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of NCI, NIH, USA	This project was supported by the grants from the National Natural Science Foundation of China (Grant No. 81302867 and 81273608). We also gratefully acknowledge the financial support from the Chongqing Programs for Science and Technology Development (CSTC2015jcyjBX0018). Ji Ming Wang was funded by Federal funds from the National Cancer Institute, National Institutes of Health, under contract No. HHSN 26/200800001E and supported in part by the Intramural Research Program of NCI, NIH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Amanatkar HR, 2017, EXPERT REV NEUROTHER, V17, P7, DOI 10.1080/14737175.2016.1194203; Arai H, 2016, GERIATR GERONTOL INT, V16, P644, DOI 10.1111/ggi.12516; Bachmeier CJ, 2011, MICROCIRCULATION, V18, P373, DOI 10.1111/j.1549-8719.2011.00096.x; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Enache TA, 2016, ANAL CHIM ACTA, V926, P36, DOI 10.1016/j.aca.2016.04.015; Freeman GB, 2012, CURR ALZHEIMER RES, V9, P1059; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Houacine J, 2012, NEUROBIOL AGING, V33, P2704, DOI 10.1016/j.neurobiolaging.2011.12.033; Jiao SS, 2016, NEUROTOX RES, V29, P256, DOI 10.1007/s12640-015-9589-x; Laskowitz DT, 2010, NEUROLOGY, V74, P2026, DOI 10.1212/WNL.0b013e3181e03844; Ma LN, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0517-y; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Underwood E, 2015, SCIENCE, V349, P464, DOI 10.1126/science.349.6247.464; Vandenberghe R, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0189-7; Wang JP, 2016, BRAIN RES, V1635, P169, DOI 10.1016/j.brainres.2016.01.028; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; Yi Keonwoo, 2014, Psychiatr Danub, V26 Suppl 1, P256; Zhang Y, 2011, NEUROSCIENTIST, V17, P163, DOI 10.1177/1073858410381532	27	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180076	10.1371/journal.pone.0180076	http://dx.doi.org/10.1371/journal.pone.0180076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662102	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300099
J	Zhao, P; Hall, J; Durston, M; Voydanoff, A; VanSickle, E; Kelly, S; Nagulapally, AB; Bond, J; Sholler, GS				Zhao, Ping; Hall, Jacob; Durston, Mary; Voydanoff, Austin; VanSickle, Elizabeth; Kelly, Shannon; Nagulapally, Abhinav B.; Bond, Jeffery; Sholler, Giselle Saulnier			BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma	PLOS ONE			English	Article							CHILDHOOD MEDULLOBLASTOMA; PI3K INHIBITOR; BREAST-CANCER; PATHWAY; NVP-BKM120; BUPARLISIB; GLIOBLASTOMA; CELLS; METABOLISM; ACTIVATION	Medulloblastoma (MB) is the most common malignant brain tumor in children, accounting for nearly 20 percent of all childhood brain tumors. New treatment strategies are needed to improve patient survival outcomes and to reduce adverse effects of current therapy. The phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) intracellular signaling pathway plays a key role in cellular metabolism, proliferation, survival and angiogenesis, and is often constitutively activated in human cancers, providing unique opportunities for anticancer therapeutic intervention. The aim of this study was to evaluate the pre-clinical activity of BKM120, a selective pan-class I PI3K inhibitor, on MB cell lines and primary samples. IC50 values of BKM120 in the twelve MB cell lines tested ranged from 0.279 to 4.38 mu M as determined by cell viability assay. IncuCyte ZOOM Live-Cell Imaging system was used for kinetic monitoring of cytotoxicity of BKM120 and apoptosis in MB cells. BKM120 exhibited cytotoxicity in MB cells in a dose and time-dependent manner by inhibiting activation of downstream signaling molecules AKT and mTOR, and activating caspase-mediated apoptotic pathways. Furthermore, BKM120 decreased cellular glycolytic metabolic activity in MB cell lines in a dose-dependent manner demonstrated by ATP level per cell. In MB xenograft mouse study, DAOY cells were implanted in the flank of nude mice and treated with vehicle, BKM120 at 30 mg/kg and 60 mg/kg via oral gavage daily. BKM120 significantly suppressed tumor growth and prolonged mouse survival. These findings help to establish a basis for clinical trials of BKM120, which could be a novel therapy for the treatment of medulloblastoma patients.	[Zhao, Ping; Durston, Mary; VanSickle, Elizabeth; Kelly, Shannon; Nagulapally, Abhinav B.; Bond, Jeffery; Sholler, Giselle Saulnier] Helen DeVos Childrens Hosp, Pediat Oncol Translat Res Program, Grand Rapids, MI 49503 USA; [Hall, Jacob] Calvin Coll, Grand Rapids, MI USA; [Voydanoff, Austin; Sholler, Giselle Saulnier] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA	Calvin University; Michigan State University; Michigan State University College of Human Medicine	Sholler, GS (corresponding author), Helen DeVos Childrens Hosp, Pediat Oncol Translat Res Program, Grand Rapids, MI 49503 USA.; Sholler, GS (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI USA.	Giselle.saulniersholler@helendevoschildrens.org			Swifity Foundation; Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation; Beat NB Foundation (GSS)	Swifity Foundation; Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation; Beat NB Foundation (GSS)	This work was supported by the Swifity Foundation, the Dick and Betsy DeVos Foundation, Meryl and Charles Witmer Foundation, and the Beat NB Foundation (GSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Altomare DA, 2012, CURR MED CHEM, V19, P3748; Anderson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133610; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Bashash D, 2016, INT J BIOCHEM CELL B, V79, P308, DOI 10.1016/j.biocel.2016.09.004; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brown Kristin K, 2015, F1000Prime Rep, V7, P13, DOI 10.12703/P7-13; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clarke JM, 2013, CURR TREAT OPTION ON, V14, P109, DOI 10.1007/s11864-012-0222-4; Delbaldo C, 2011, TARGET ONCOL, V6, P119, DOI 10.1007/s11523-011-0177-6; Dimitrova V, 2015, CURR MOL MED, V15, P82, DOI 10.2174/1566524015666150114115427; Hoang DH, 2014, J NEUROSURG-PEDIATR, V14, P136, DOI 10.3171/2014.5.PEDS13571; Dufour C, 2014, PEDIATR BLOOD CANCER, V61, P1398, DOI 10.1002/pbc.25009; Ellison DW, 2010, ACTA NEUROPATHOL, V120, P305, DOI 10.1007/s00401-010-0726-6; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Frasson C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/973912; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Geuna E, 2015, EXPERT OPIN INV DRUG, V24, P421, DOI 10.1517/13543784.2015.1008132; Gilbertson RJ, 2006, EUR J CANCER, V42, P646, DOI 10.1016/j.ejca.2005.11.023; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Jane EP, 2014, J PHARMACOL EXP THER, V350, P22, DOI 10.1124/jpet.114.212910; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Liu WL, 2014, ONCOTARGET, V5, P3662, DOI 10.18632/oncotarget.1978; MacDonald TJ, 2014, NEURO-ONCOLOGY, V16, P9, DOI 10.1093/neuonc/not147; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; Mayer IA, 2014, J CLIN ONCOL, V32, P1202, DOI 10.1200/JCO.2013.54.0518; McNeill RS, 2017, NEUROONCOLOGY; Milde T, 2012, J NEURO-ONCOL, V110, P335, DOI 10.1007/s11060-012-0978-1; Mohan AL, 2012, ANTICANCER RES, V32, P3141; Netland IA, 2016, J NEURO-ONCOL, V129, P57, DOI 10.1007/s11060-016-2158-1; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Othman RT, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-57; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Peiris-Pages M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0712-6; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Singh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150836; Spiliopoulou P, 2014, WORLD J GASTROENTERO, V20, P10288, DOI 10.3748/wjg.v20.i30.10288; Vansteenkiste JF, 2015, J THORAC ONCOL, V10, P1319, DOI 10.1097/JTO.0000000000000607; Wachsberger PR, 2014, J CANCER RES CLIN, V140, P573, DOI 10.1007/s00432-014-1594-6; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; Wu Xiaochong, 2011, Chin J Cancer, V30, P442, DOI 10.5732/cjc.011.10040; Yogi Kedar, 2015, Oncoscience, V2, P334	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179948	10.1371/journal.pone.0179948	http://dx.doi.org/10.1371/journal.pone.0179948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662162	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300080
J	Sullivan, C; Lage, CR; Yoder, JA; Postlethwait, JH; Kim, CH				Sullivan, Con; Lage, Christopher R.; Yoder, Jeffrey A.; Postlethwait, John H.; Kim, Carol H.			Evolutionary divergence of the vertebrate TNFAIP8 gene family: Applying the spotted gar orthology bridge to understand ohnolog loss in teleosts	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; WHOLE GENOME DUPLICATION; CONSERVED SYNTENY; ZEBRAFISH MODEL; POOR-PROGNOSIS; TIPE2; METASTASIS; REVEALS; PROTEIN; EXPRESSION	Comparative functional genomic studies require the proper identification of gene orthologs to properly exploit animal biomedical research models. To identify gene orthologs, comprehensive, conserved gene synteny analyses are necessary to unwind gene histories that are convoluted by two rounds of early vertebrate genome duplication, and in the case of the teleosts, a third round, the teleost genome duplication (TGD). Recently, the genome of the spotted gar, a holostean outgroup to the teleosts that did not undergo this third genome duplication, was sequenced and applied as an orthology bridge to facilitate the identification of teleost orthologs to human genes and to enhance the power of teleosts as biomedical models. In this study, we apply the spotted gar orthology bridge to help describe the gene history of the vertebrate TNFAIP8 family. Members of the TNFAIP8 gene family have been linked to regulation of immune function and homeostasis and the development of multiple cancer types. Through a conserved gene synteny analysis, we identified zebrafish orthologs to human TNFAIP8L1 and TNFAIP8L3 genes and two co-orthologs to human TNFAIP8L2, but failed to identify an ortholog to human TNFAIP8. Through the application of the orthology bridge, we determined that teleost orthologs to human TNFAIP8 genes were likely lost in a genome inversion event after their divergence from their common ancestor with spotted gar. These findings demonstrate the value of this enhanced approach to gene history analysis and support the development of teleost models to study complex questions related to an array of biomedical issues, including immunity and cancer.	[Sullivan, Con; Kim, Carol H.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA; [Sullivan, Con; Kim, Carol H.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA; [Lage, Christopher R.] Univ Maine, Program Biol, Augusta, ME USA; [Yoder, Jeffrey A.] North Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Augusta; University of Maine Orono; University of North Carolina; North Carolina State University; University of Oregon	Sullivan, C; Kim, CH (corresponding author), Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA.; Sullivan, C; Kim, CH (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.	con.sullivan@maine.edu; carolkim@maine.edu		Kim, Carol/0000-0002-0465-4496; Yoder, Jeffrey/0000-0002-6083-1311	National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103423]; J.H.P [R01RR020833, R01OD011116, PO1HD22486]; C.H.K [R01GM087308, P20GM103534]; U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project [ME021610]; Triangle Center for Evolutionary Medicine (TriCEM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, P20GM103423, R01GM087308] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); J.H.P; C.H.K; U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project; Triangle Center for Evolutionary Medicine (TriCEM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grants to C.S. (Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103423), J.H.P. (R01RR020833, R01OD011116 and PO1HD22486), and C.H.K. (R01GM087308 and P20GM103534), by the U.S. Department of Agriculture National Institute of Food and Agriculture Hatch project number ME021610, and by a grant from the Triangle Center for Evolutionary Medicine (TriCEM) (http://tricem.dreamhosters.com/) to J.A.Y. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Bentley VL, 2015, HAEMATOLOGICA, V100, P70, DOI 10.3324/haematol.2014.110742; Bernut A, 2015, JOVE-J VIS EXP, DOI 10.3791/53130; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; Brothers KM, 2012, JOVE-J VIS EXP, DOI 10.3791/4051; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Catchen JM, 2011, METHOD CELL BIOL, V104, P259, DOI 10.1016/B978-0-12-374814-0.00015-X; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen L, 2016, EXP THER MED, V12, P238, DOI 10.3892/etm.2016.3327; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Ding CB, 2015, INT J MOL MED, V35, P791, DOI 10.3892/ijmm.2015.2063; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Force A, 1999, GENETICS, V151, P1531; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Gabor KA, 2014, DIS MODEL MECH, V7, P1227, DOI 10.1242/dmm.014746; Gao XM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050247, 10.1371/journal.pone.0061801]; Ghotra VPS, 2015, CANCER RES, V75, P230, DOI 10.1158/0008-5472.CAN-14-0629; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; Goldsmith JR, 2017, CELL MOL IMMUNOL, V14, P482, DOI 10.1038/cmi.2017.4; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Harfouche R, 2009, ANGIOGENESIS, V12, P325, DOI 10.1007/s10456-009-9154-4; Horrevoets AJG, 1999, BLOOD, V93, P3418, DOI 10.1182/blood.V93.10.3418.410k23_3418_3431; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu RY, 2016, ONCOTARGETS THER, V9, P4473, DOI 10.2147/OTT.S100593; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Knox BP, 2014, EUKARYOT CELL, V13, P1266, DOI 10.1128/EC.00080-14; Kumar D, J BIOL CHEM; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Li Y K, 2015, J APPL MATH, V2015, DOI DOI 10.1145/2801040.2801062; Li YX, 2015, BIOCHEM BIOPH RES CO, V457, P43, DOI 10.1016/j.bbrc.2014.12.080; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126176; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Ohno S., 1970, P1; Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619; Parichy DM, 2016, NAT GENET, V48, P344, DOI 10.1038/ng.3532; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Phennicie RT, 2010, INFECT IMMUN, V78, P4542, DOI 10.1128/IAI.00302-10; Porturas TP, 2015, J IMMUNOL, V194, P5743, DOI 10.4049/jimmunol.1401987; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134114; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Voelz K, 2015, DIS MODEL MECH, V8, P1375, DOI 10.1242/dmm.019992; Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031; Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280; Yang M, 2014, HISTOPATHOLOGY, V65, P517, DOI 10.1111/his.12413; Zhang BB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102917, 10.1371/journal.pone.0085439]; Zhang CB, 2013, INT J CANCER, V133, P31, DOI 10.1002/ijc.27996; Zhang YH, 2015, INT J ONCOL, V46, P254, DOI 10.3892/ijo.2014.2725; [张志镇 Zhang Zhizhen], 2015, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V34, P1; Zhu Y, 2016, CANCER GENE THER, V23, P98, DOI 10.1038/cgt.2016.6	78	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179517	10.1371/journal.pone.0179517	http://dx.doi.org/10.1371/journal.pone.0179517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658311	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900030
J	Chen, YZ; Jiang, BJ; Zhuang, YG; Peng, H; Chen, WG				Chen, Yuanzhuo; Jiang, Bojie; Zhuang, Yugang; Peng, Hu; Chen, Weiguo			Differential effects of heat shock protein 90 and serine 1179 phosphorylation on endothelial nitric oxide synthase activity and on its cofactors	PLOS ONE			English	Article							AKT-DEPENDENT PHOSPHORYLATION; ENOS ACTIVATION; CELLS; HEAT-SHOCK-PROTEIN-90; MODULATION; HSP90; HSP90-ALPHA; RELEASE; PATHWAY; DOMAIN	Endothelial nitric oxide synthase (eNOS) is responsible for maintaining systemic blood pressure, vascular remodeling and angiogenesis. Previous studies showed that bovine eNOS serine 1179 (Serine 1177 for human eNOS) phosphorylation enhanced NO synthesis. Meanwhile, heat shock protein 90 (Hsp90) plays a critical role in maintenance of eNOS structure and function. However, the regulatory difference and importance between Serine 1179 phosphorylation and Hsp90 on eNOS activity have not been evaluated. In current studies, S1179D eNOS was employed to mimic phospho-eNOS and exhibited markedly increased enzyme activity than wild type eNOS (WT eNOS). Hsp90 showed a dose-dependent increase for both WT eNOS and S1179D eNOS activity at the presence of all eNOS cofactors, such as Calcium/Calmodulin (Ca2+/CaM), BH4, and NADPH etc. The enhancement effects were abolished by dominant-negative mutant Hsp 90 protein. ENOS-cofactors dynamic assay showed that Hsp90 enhanced WT eNOS affinity to NADPH, L-arginine, and CaM but not to Ca2+ and BH4. The impact of eNOS Serine 1179 phosphorylation and Hsp90 on eNOS affinity to cofactors has also been compared. Different from the effect of Hsp90 on eNOS affinity to specific cofactors, Serine 1179 phosphorylation significantly increased eNOS affinity to all cofactors. Moreover, VEGF-induced eNOS phosphorylation in bovine aortic endothelial cells (BAECs) and more NO generation from eNOS compared to control. Inhibition of Hsp90 by geldanamycin decreased eNOS activity and decreased endothelial viability. In conclusion, by changing eNOS structure, Hsp90 profoundly affected eNOS functions, including change of affinity of eNOS to cofactors like Ca2+, L-arginine, BH4 and further affecting NO generation capability. These specific cofactors regulated by Hsp 90 could become potential therapeutic targets of the eNOS-related diseases in future.	[Chen, Yuanzhuo; Jiang, Bojie; Zhuang, Yugang; Peng, Hu; Chen, Weiguo] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai, Peoples R China	Tongji University	Chen, WG (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai, Peoples R China.	1966chenweiguo@tongji.edn.cn		chen, weiguo/0000-0001-9395-0053	National Scientific Foundation of China [81671938, 81501696]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Scientific Foundation of China 81671938, Dr. Hu Peng; and the National Scientific Foundation of China 81501696 Dr. Yuanzhuo Chen.	Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Balligand JL, 2002, CIRC RES, V90, P838, DOI 10.1161/01.RES.0000018173.10175.FF; Barauna VG, 2013, BIOCHEM BIOPH RES CO, V441, P713, DOI 10.1016/j.bbrc.2013.10.108; Chen WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105479; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Grafton JP, 2000, J BIOL CHEM, V275, P22268; Heiss EH, 2014, CURR PHARM DESIGN, V20, P3503, DOI 10.2174/13816128113196660745; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Natarajan M, 2015, AM J PHYSIOL-CELL PH, V308, pC673, DOI 10.1152/ajpcell.00367.2014; Ou J, 2003, FREE RADICAL BIO MED, V34, P269, DOI 10.1016/S0891-5849(02)01299-6; Ou JS, 2003, TOXICOL SCI, V73, P90, DOI 10.1093/toxsci/kfg062; Peng H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142854; Peng H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140365; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Siragusa M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2819; Tanaka M, 2015, ENVIRON TOXICOL, V30, P223, DOI 10.1002/tox.21888; Vellecco V, 2016, DIABETES OBES METAB, V18, P1236, DOI 10.1111/dom.12750; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	27	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179978	10.1371/journal.pone.0179978	http://dx.doi.org/10.1371/journal.pone.0179978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654706	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500044
J	Yun, JS; Bae, JM; Kim, KJ; Jung, YS; Kim, GM; Kim, HR; Lee, JS; Ko, SH; Cha, SA; Ahn, YB				Yun, Jae-Seung; Bae, Jung Min; Kim, Ki-Jo; Jung, Yu Seok; Kim, Gyong Moon; Kim, Hyung-Rae; Lee, Jun-Seok; Ko, Seung-Hyun; Cha, Seon-Ah; Ahn, Yu-Bae			Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; SOUTH-KOREA; ASSOCIATION; PREVALENCE; CANCER; SLE; HYPOTHYROIDISM; MALIGNANCIES; MECHANISMS; DATABASE	We investigated the association between autoimmune thyroid disease and systemic lupus erythematosus (SLE) using nationwide insurance claims data for the entire Korean population. Claims data for the period 2009-2013 were retrieved from the National Health Insurance System database. SLE and thyroid disease were identified using the International Classification of Diseases codes and medication information. Logistic regression analyses were used to evaluate the association between SLE and thyroid disease. The study used records from 17,495 patients with SLE and 52,485 age- and sex-matched control subjects. A greater prevalence of Graves' disease (0.94% vs. 0.46%, P < 0.001), Hashimoto's thyroiditis (2.68% vs. 0.80%, P < 0.001), and thyroid cancer (1.81% vs. 1.30%, P < 0.001) was observed in SLE patients than in control subjects. Multivariate regression analyses demonstrated that SLE was significantly associated with an increased risk of both autoimmune thyroid disease and thyroid cancer (Graves' disease: odds ratio [OR] 2.07, 95% confidence interval [CI] 1.70-2.53; Hashimoto's thyroiditis: OR 3.42, 95% CI 3.00-3.91; thyroid cancer: OR 1.40, 95% CI 1.22-1.60). Age- and sex-stratified analyses revealed that the risk of autoimmune thyroid disease in SLE patients was increased for all age groups and the female group. An association between thyroid cancer and SLE was identified only in the 20- to 59-year-old age group and in the female group. Using a large population-based study, we demonstrated that patients with SLE are at a greater risk of developing thyroid disease than matched control individuals.	[Yun, Jae-Seung; Kim, Hyung-Rae; Lee, Jun-Seok; Ko, Seung-Hyun; Cha, Seon-Ah; Ahn, Yu-Bae] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea; [Bae, Jung Min; Jung, Yu Seok; Kim, Gyong Moon] Catholic Univ Korea, Dept Dermatol, St Vincents Hosp, Coll Med, Suwon, South Korea; [Kim, Ki-Jo] Catholic Univ Korea, Div Rheumatol, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ahn, YB (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, St Vincents Hosp,Coll Med, Suwon, South Korea.	vincentendo@catholic.ac.kr		Ahn, YuBae/0000-0001-8658-2731				Anaya JM, 2012, AUTOIMMUN REV, V11, P781, DOI 10.1016/j.autrev.2012.02.002; Antonelli A, 2015, RHEUMATOLOGY; Antonelli A, 2010, METABOLISM, V59, P896, DOI 10.1016/j.metabol.2009.10.010; Antonelli A, 2010, J CLIN ENDOCR METAB, V95, P314, DOI 10.1210/jc.2009-0677; Aranow C, 2002, J RHEUMATOL, V29, P1674; Azizi G, 2011, ENDOCR PRACT, V17, P201, DOI 10.4158/EP10123.OR; Bakr A, 2014, LUPUS, V23, P825, DOI 10.1177/0961203314525866; Ballotti S, 2006, HORM RES, V66, P132, DOI 10.1159/000094251; BOEY ML, 1993, LUPUS, V2, P51, DOI 10.1177/096120339300200109; Boi F, 2005, EUR J ENDOCRINOL, V153, P637, DOI 10.1530/eje.1.02020; Cao LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122964; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Chang DM, 1998, LUPUS, V7, P462, DOI 10.1191/096120398678920479; Chen YJ, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2010.08.006; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Franco JS, 2015, CLIN ENDOCRINOL, V83, P943, DOI 10.1111/cen.12662; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Garcia MA, 2005, LUPUS, V14, P938, DOI 10.1191/0961203305lu2245oa; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Goobie GC, 2015, CURR OPIN RHEUMATOL, V27, P454, DOI 10.1097/BOR.0000000000000202; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hong JS, 2014, ACTA CARDIOL, V69, P513, DOI 10.1080/AC.69.5.3044878; Jenkins RC, 2002, THYROID, V12, P977, DOI 10.1089/105072502320908312; Ju JH, 2014, J EPIDEMIOL, V24, P295, DOI 10.2188/jea.JE20120204; KAUSMAN D, 1995, BRIT J RHEUMATOL, V34, P361; KINLEN LJ, 1992, J AUTOIMMUN, V5, P363, DOI 10.1016/0896-8411(92)90055-U; Kumar K, 2012, RHEUMATOL INT, V32, P73, DOI 10.1007/s00296-010-1556-5; Lin WY, 2015, J MICROBIOL IMMUNOL, V48, P676, DOI 10.1016/j.jmii.2014.03.004; Mader R, 2007, CLIN RHEUMATOL, V26, P1891, DOI 10.1007/s10067-007-0602-5; MAGARO M, 1992, CLIN EXP RHEUMATOL, V10, P67; Mao S, 2016, J CANCER RES CLIN, V142, P253, DOI 10.1007/s00432-015-2032-0; Robazzi TCMV, 2012, REV BRAS REUMATOL, V52, P417; MILLER FW, 1987, ARTHRITIS RHEUM-US, V30, P1124, DOI 10.1002/art.1780301006; Moon JH, 2013, ENDOCRINOL METAB, V28, P275, DOI 10.3803/EnM.2013.28.4.275; Namjou B, 2005, ARTHRITIS RHEUM-US, V52, P3646, DOI 10.1002/art.21413; Pan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123291; Parikh-Patel A, 2008, CANCER CAUSE CONTROL, V19, P887, DOI 10.1007/s10552-008-9151-8; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; Pyne D, 2002, ANN RHEUM DIS, V61, P70, DOI 10.1136/ard.61.1.70; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Soto ME, 2004, CLIN EXP RHEUMATOL, V22, P713; Stathatos N, 2012, CURR OPIN RHEUMATOL, V24, P70, DOI 10.1097/BOR.0b013e32834ddb27; Trager J, 2001, CURR OPIN RHEUMATOL, V13, P345, DOI 10.1097/00002281-200109000-00002; VIANNA JL, 1991, J RHEUMATOL, V18, P1193; Watad A, 2015, AUTOIMMUNITY, P1; Watad A, 2016, AUTOIMMUN REV, V15, P484, DOI 10.1016/j.autrev.2016.01.019; WHITE RG, 1961, LANCET, V1, P368; Wu H, 2005, ARTHRITIS RHEUM-US, V52, P2396, DOI 10.1002/art.21223; Yurkovich M, 2014, ARTHRIT CARE RES, V66, P608, DOI 10.1002/acr.22173; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	51	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179088	10.1371/journal.pone.0179088	http://dx.doi.org/10.1371/journal.pone.0179088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654679	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500005
J	Villacampa, P; Menger, KE; Abelleira, L; Ribeiro, J; Duran, Y; Smith, AJ; Ali, RR; Luhmann, UF; Bainbridge, JWB				Villacampa, Pilar; Menger, Katja E.; Abelleira, Laura; Ribeiro, Joana; Duran, Yanai; Smith, Alexander J.; Ali, Robin R.; Luhmann, Ulrich F.; Bainbridge, James W. B.			Accelerated oxygen-induced retinopathy is a reliable model of ischemia-induced retinal neovascularization	PLOS ONE			English	Article							PATHOLOGICAL ANGIOGENESIS; MOUSE	Retinal ischemia and pathological angiogenesis cause severe impairment of sight. Oxygen-induced retinopathy (OIR) in young mice is widely used as a model to investigate the underlying pathological mechanisms and develop therapeutic interventions. We compared directly the conventional OIR model (exposure to 75% O-2 from postnatal day (P) 7 to P12) with an alternative, accelerated version (85% O-2 from P8 to P11). We found that accelerated OIR induces similar pre-retinal neovascularization but greater retinal vascular regression that recovers more rapidly. The extent of retinal gliosis is similar but neuroretinal function, as measured by electroretinography, is better maintained in the accelerated model. We found no systemic or maternal morbidity in either model. Accelerated OIR offers a safe, reliable and more rapid alternative model in which pre-retinal neovascularization is similar but retinal vascular regression is greater.	[Villacampa, Pilar; Menger, Katja E.; Abelleira, Laura; Ribeiro, Joana; Duran, Yanai; Smith, Alexander J.; Ali, Robin R.; Luhmann, Ulrich F.; Bainbridge, James W. B.] UCL, UCL Inst Ophthalmol, Div Genet, London, England; [Villacampa, Pilar] Duran i Reynals Hosp, Bellvitge Biomed Res Inst IDIBELL, Gran Via Hosp 199-203, Barcelona, Spain; [Luhmann, Ulrich F.] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Basel, Switzerland	University of London; University College London; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Roche Holding	Bainbridge, JWB (corresponding author), UCL, UCL Inst Ophthalmol, Div Genet, London, England.	j.bainbridge@ucl.ac.uk	Villacampa, Pilar/B-1801-2019	Villacampa, Pilar/0000-0002-2860-7475; Bainbridge, James/0000-0003-1318-8201; Claudio RIbeiro, Joana Filipa/0000-0002-9290-6023; Luhmann, Ulrich F.O./0000-0002-1993-1951; Menger, Katja/0000-0002-6972-7326; Abelleira Hervas, Laura Esther/0000-0003-2423-8307; Ali, Robin/0000-0003-3126-6517	People Programme (Marie Curie Actions); European Union's Seventh Framework Programme under Research Executive Agency [629556]; Special Trustees of Moorfields Eye Hospital [ST1503B]; National Institute for Health Research [NF-SI-0513-10074, NF-SI-0508-10130, NIHR-RP-011-003] Funding Source: researchfish	People Programme (Marie Curie Actions); European Union's Seventh Framework Programme under Research Executive Agency; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the People Programme (Marie Curie Actions, https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions) and the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency grant agreement 629556 to PV and the Special Trustees of Moorfields Eye Hospital (https.//www.mooteldseyecharity.org.uk/) (Grant ST1503B) to JWBB; JWBB is a National Institute of Health Research (NIHR, http://www.nihr.ac.uk/) Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MH, 2004, FREE RADICAL BIO MED, V37, P1885, DOI 10.1016/j.freeradbiomed.2004.09.008; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Okuno Y, 2012, NAT MED, V18, P1208, DOI 10.1038/nm.2846; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101	13	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179759	10.1371/journal.pone.0179759	http://dx.doi.org/10.1371/journal.pone.0179759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650964	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300018
J	Watanabe, T; Nishimoto, T; Mlakar, L; Heywood, J; Malaab, M; Hoffman, S; Feghali-Bostwick, C				Watanabe, Tomoya; Nishimoto, Tetsuya; Mlakar, Logan; Heywood, Jonathan; Malaab, Maya; Hoffman, Stanley; Feghali-Bostwick, Carol			Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis	PLOS ONE			English	Article							ANIMAL-MODEL; BLEOMYCIN; SKIN; FIBROSIS; MICE; SCLERODERMA; INFUSION	The murine bleomycin (BLM)-induced fibrosis model is the most widely used in systemic sclerosis (SSc) studies. It has been reported that systemic delivery of BLM via continuous diffusion from subcutaneously implanted osmotic minipumps can cause fibrosis of the skin, lungs, and other internal organs. However, the mouse strain, dosage of BLM, administration period, and additional important features differ from one report to the next. In this study, by employing the pump model in C57BL/6J mice, we show a dose-dependent increase in lung fibrosis by day 28 and a transient increase in dermal thickness. Dermal thickness and the level of collagen in skin treated with high-dose BLM was significantly higher than in skin treated with low dose BLM or vehicle. A reduction in the thickness of the adipose layer was noted in both high and low dose groups at earlier time points suggesting that the loss of the fat layer precedes the onset of fibrosis. High-dose BLM also induced dermal fibrosis and increased expression of fibrosis-associated genes ex vivo in human skin, thus confirming and extending the in vivo findings, and demonstrating that a human organ culture model can be used to assess the effect of BLM on skin. In summary, our findings suggest that the BLM pump model is an attractive model to analyze the underlying mechanisms of fibrosis and test the efficacy of potential therapies. However, the choice of mouse strain, duration of BLM administration and dose must be carefully considered when using this model.	[Watanabe, Tomoya; Nishimoto, Tetsuya; Mlakar, Logan; Heywood, Jonathan; Malaab, Maya; Hoffman, Stanley; Feghali-Bostwick, Carol] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Feghali-Bostwick, C (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	feghalib@musc.edu			NIH [K24 AR060297, R42 HL127802, R01 HL121262]; iBio Inc.; Kitty Trask Holt Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL127802, R01HL121262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); iBio Inc.; Kitty Trask Holt Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by funding to CF-B from NIH (K24 AR060297, R42 HL127802, and R01 HL121262), iBio Inc, and the Kitty Trask Holt Endowment. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida I, 2011, AUTOIMMUN REV, V10, P693, DOI 10.1016/j.autrev.2011.04.025; FLEISCHMAJER R, 1972, ARCH DERMATOL, V105, P59, DOI 10.1001/archderm.105.1.59; HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Lee R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00140; Lee R, 2014, AM J PHYSIOL-LUNG C, V306, pL736, DOI 10.1152/ajplung.00210.2013; Lemaire R, 2016, ARTHRITIS RHEUMATOL, V68, P473, DOI 10.1002/art.39443; Liang MR, 2015, LAB INVEST, V95, P342, DOI 10.1038/labinvest.2014.145; Mahajan VS, 2016, CELL REP, V15, P1901, DOI 10.1016/j.celrep.2016.04.080; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Scotton CJ, 2010, AM J PHYSIOL-LUNG C, V299, pL439, DOI 10.1152/ajplung.00258.2010; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Yang IV, 2015, TRANSL RES, V165, P48, DOI 10.1016/j.trsl.2014.03.011; Yasuoka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087754	21	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179917	10.1371/journal.pone.0179917	http://dx.doi.org/10.1371/journal.pone.0179917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651005	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300029
J	Advani, M; Weile, DS				Advani, Madhu; Weile, Daniel S.			Position and orientation inference via on-board triangulation	PLOS ONE			English	Article							SMART ANTENNAS; LOCALIZATION	This work proposes a new approach to determine the spatial location and orientation of an object using measurements performed on the object itself. The on-board triangulation algorithm we outline could be implemented in lieu of, or in addition to, well-known alternatives such as Global Positioning System (GPS) or standard triangulation, since both of these correspond to significantly different geometric pictures and necessitate different hardware and algorithms. We motivate the theory by describing situations in which on-board triangulation would be useful and even preferable to standard methods. The on-board triangulation algorithm we outline involves utilizing dumb beacons which broadcast omnidirectional single frequency radio waves, and smart antenna arrays on the object itself to infer the direction of the beacon signals, which may be used for onboard calculation of the position and orientation of the object. Numerical examples demonstrate the utility of the method and its noise tolerance.	[Advani, Madhu] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Weile, Daniel S.] Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA	Harvard University; University of Delaware	Weile, DS (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA.	weile@udel.edu						Appel M., 2015, P 28 INT TECHN M SAT; Bulusu N, 2000, IEEE PERS COMMUN, V7, P28, DOI 10.1109/98.878533; Cuntz M., 2010, P ION GNSS 2010, P21; Hofmann-Wellenhof B., 2012, GLOBAL POSITIONING S; Konovaltsev A, 2014, I NAVIG SAT DIV INT, P2853; Liberti J.C., 1999, PR H COMMUN ENGN EM; Lim CH, 2007, IEEE T CONSUM ELECTR, V53, P618, DOI 10.1109/TCE.2007.381737; Moshtagh N, 2009, IEEE T ROBOT, V25, P851, DOI 10.1109/TRO.2009.2022439; Rife J., 2015, TECHN PRACT ROB APPL, P1; Rife J, 2016, IEEE T ROBOT, V32, P1280, DOI 10.1109/TRO.2016.2593026; Shi J, 2005, IEEE C INT TRANSP SY; Tron R, 2016, IEEE DECIS CONTR P, P1806, DOI 10.1109/CDC.2016.7798527; Weisstein E., INSCRIBED ANGLE; Weisstein E.W., CIRCLE	14	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180089	10.1371/journal.pone.0180089	http://dx.doi.org/10.1371/journal.pone.0180089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644874	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100062
J	Kronborg, TM; Hansen, JF; Rasmussen, AK; Vorkamp, K; Nielsen, CH; Frederiksen, M; Hofman-Bang, J; Hahn, CH; Ramhoj, L; Feldt-Rasmussen, U				Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Rasmussen, Ase Krogh; Vorkamp, Katrin; Nielsen, Claus Henrik; Frederiksen, Marie; Hofman-Bang, Jacob; Hahn, Christoffer Holst; Ramhoj, Louise; Feldt-Rasmussen, Ulla			The flame retardant DE-71 (a mixture of polybrominated diphenyl ethers) inhibits human differentiated thyroid cell function in vitro	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; EPITHELIAL-CELLS; ENVIRONMENTAL CHEMICALS; DEVELOPMENTAL EXPOSURE; PBDE MIXTURE; HORMONES; SERUM; DUST; HYPOTHYROIDISM; THYROGLOBULIN	Background Normal thyroid function is essential for general growth and metabolism, but can be affected by endocrine disrupting chemicals (EDCs). Polybrominated diphenyl ethers (PBDEs) have been used worldwide to reduce flammability in different materials and are suspected to be EDCs. The production of the commercial Penta- and OctaBDE mixtures is banned, but DecaBDEs and existing products may leak PBDEs into the environment. Our aim was to investigate the effect of the PentaBDE mixture DE-71 on human thyroid cells in vitro. Materials and methods Primary human thyroid cells were obtained as paraadenomatous tissue and cultured in monolayers. The influence of DE-71 on cyclic adenosine monophosphate (cAMP) and thyroglobulin (Tg) production was examined in the culture medium by competitive radioimmunoassay and enzyme-linked immunosorbent assay, respectively. Real-time quantitative PCR analysis of thyroid-specific genes was performed on the exposed cell cultures. PBDE concentrations were determined in cellular and supernatant fractions of the cultures. Results DE-71 inhibited Tg-release from TSH-stimulated thyrocytes. At 50 mg/L DE-71, mean Tg production was reduced by 71.9% ( range: 8.5-98.7%), and cAMP by 95.1% ( range: 91.5-98.8%) compared to controls). Expression of mRNA encoding Tg, TPO and TSHr were significantly inhibited (p<0.0001, p = 0.0079, and p = 0.0002, respectively). The majority of DE-71 added was found in the cell fraction. No cytotoxicity was found. Conclusions DE-71 inhibited differentiated thyroid cell functions in a two phase response manner and a concentration-dependent inhibition of Tg and cAMP production, respectively, as well as expression of mRNA encoding Tg, TPO and TSHr. Our findings suggest an inhibiting effect of PBDEs on thyroid cells.	[Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Copenhagen O, Denmark; [Vorkamp, Katrin] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Nielsen, Claus Henrik] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Copenhagen N, Denmark; [Frederiksen, Marie] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Hofman-Bang, Jacob] Univ Copenhagen, Rigshosp, Dept Nephrol, Copenhagen O, Denmark; [Hahn, Christoffer Holst] Rigshosp, Dept Ear Nose Throat Head & Neck Surg, Copenhagen O, Denmark; [Ramhoj, Louise] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark	Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; National Research Centre for the Working Environment; Rigshospitalet; University of Copenhagen; Rigshospitalet; Technical University of Denmark	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Copenhagen O, Denmark.	ufeldt@rh.dk	Ramhøj, Louise/HGC-4949-2022; Frederiksen, Marie/AAW-9783-2021; Feldt-Rasmussen, Ulla/AAB-9218-2021	Ramhøj, Louise/0000-0002-0298-8003; Frederiksen, Marie/0000-0003-1553-5414; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Nielsen, Claus Henrik/0000-0001-7543-9016; Vorkamp, Katrin/0000-0002-1131-5687	Novo Nordisk foundation [13495, 8005, 14266]; Arvid Nilsson's Fund [R129-A4222]; Danish Council for Independent Research [0602-01959B, 35108-001]; Novo Nordisk Fonden [NNF14OC0013495] Funding Source: researchfish	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Fund; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Ulla Feldt-Rasmussen received funding as main supervisor on the scholarship project "Interaction between thyroid autoimmunity and endocrine disrupting chemicals" by the Novo Nordisk foundation (application number: 13495), for Thit Mynster Kronborg's salary. Ulla Feldt-Rasmussen further received funding for research salary, equipment and material from the local region's (RegionH, R129-A4222) research fund, from Arvid Nilsson's Fund, Novo Nordisk Foundation (application number 8005 and 14266) and Danish Council for Independent Research (0602-01959B). Thit Mynster Kronborg received funding from the Danish Foundation "Musikforlaeggernes Agnes og Knut Morks fond" (35108-001), which sponsored equipment and materials. None of the funding agencies had any role or influence on this study, and none of the authors had any conflicts of interest.	Bellanger M, 2015, J CLIN ENDOCR METAB, V100, P1256, DOI 10.1210/jc.2014-4323; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Bondy GS, 2013, ENVIRON TOXICOL, V28, P215, DOI 10.1002/tox.20713; Chevrier J, 2010, ENVIRON HEALTH PERSP, V118, P1444, DOI 10.1289/ehp.1001905; Christiansson A, 2009, ENVIRON SCI POLLUT R, V16, P312, DOI 10.1007/s11356-009-0150-4; Darnerud PO, 2008, INT J ANDROL, V31, P152, DOI 10.1111/j.1365-2605.2008.00869.x; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; de-Miranda AS, 2016, REPROD TOXICOL, V63, P114, DOI 10.1016/j.reprotox.2016.05.017; DIAMANT M, 1991, AUTOIMMUNITY, V11, P21, DOI 10.3109/08916939108994704; Dodson RE, 2012, ENVIRON SCI TECHNOL, V46, P13056, DOI 10.1021/es303879n; ERICSON LE, 1992, TOXICOL LETT, V64-5, P365, DOI 10.1016/0378-4274(92)90209-3; FOWLES JR, 1994, TOXICOLOGY, V86, P49, DOI 10.1016/0300-483X(94)90052-3; Frederiksen M, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-32; Frederiksen M, 2010, INT J HYG ENVIR HEAL, V213, P233, DOI 10.1016/j.ijheh.2010.04.008; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Fromme H, 2016, INT J HYG ENVIR HEAL, V219, P1, DOI 10.1016/j.ijheh.2015.08.004; Geyer H.J., 2004, ORGANOHALOGEN COMP, V66, P3820; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Han GG, 2011, BIOMED ENVIRON SCI, V24, P112, DOI 10.3967/0895-3988.2011.02.004; Hansen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151192; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131168; Harrad S, 2006, ENVIRON SCI TECHNOL, V40, P4633, DOI 10.1021/es0609147; Jacobson MH, 2016, ENVIRON RES, V149, P222, DOI 10.1016/j.envres.2016.05.022; Julander A, 2005, INT ARCH OCC ENV HEA, V78, P584, DOI 10.1007/s00420-005-0627-5; Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034; Kim UJ, 2012, ENVIRON SCI TECHNOL, V46, P6261, DOI 10.1021/es2038678; Kim UJ, 2011, CHEMOSPHERE, V85, P487, DOI 10.1016/j.chemosphere.2011.08.008; Kim YR, 2014, CHEMOSPHERE, V106, P1, DOI 10.1016/j.chemosphere.2013.12.064; Kingsley Ibhazeheibo, 2012, Niger J Physiol Sci, V27, P123; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Koike E, 2013, J APPL TOXICOL, V33, P1451, DOI 10.1002/jat.2809; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lagalante AF, 2011, ENVIRON INT, V37, P899, DOI 10.1016/j.envint.2011.03.007; Legler J, 2003, ENVIRON INT, V29, P879, DOI 10.1016/S0160-4120(03)00104-1; Lv QY, 2015, CHEMOSPHERE, V120, P621, DOI 10.1016/j.chemosphere.2014.08.029; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Martin PA, 2007, ENVIRON TOXICOL CHEM, V26, P988, DOI 10.1897/06-246R.1; Mynster KT, 2016, PLOS ONE, V11; Oulhote Y, 2016, J CLIN ENDOCR METAB, V101, P590, DOI 10.1210/jc.2015-2659; Patel J, 2011, J ENDOCRINOL, V209, P1, DOI 10.1530/JOE-10-0444; Peltier MR, 2012, PLACENTA, V33, P745, DOI 10.1016/j.placenta.2012.06.005; RASMUSSEN AK, 1988, ALLERGY, V43, P435, DOI 10.1111/j.1398-9995.1988.tb00915.x; Rasmussen AK, 2000, EXP CLIN ENDOCR DIAB, V108, P67, DOI 10.1055/s-2000-5797; Rasmussen AK, 1997, ENDOCRINOLOGY, V138, P2043, DOI 10.1210/en.138.5.2043; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Rasmussen AK, 2000, DAN MED BULL, V47, P94; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P165, DOI 10.1016/0303-7207(95)03711-X; Sanders JM, 2006, XENOBIOTICA, V36, P103, DOI 10.1080/00498250500485107; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Stoker TE, 2004, TOXICOL SCI, V78, P144, DOI 10.1093/toxsci/kfh029; Streets SS, 2006, ENVIRON SCI TECHNOL, V40, P7263, DOI 10.1021/es061337p; Vorkamp K, 2014, ARCH ENVIRON CON TOX, V67, P9, DOI 10.1007/s00244-013-9988-z; Vorkamp K, 2011, ENVIRON INT, V37, P1, DOI 10.1016/j.envint.2010.06.001; Wei RG, 2010, TOXICOL IN VITRO, V24, P1078, DOI 10.1016/j.tiv.2010.03.015; Wirth JR, 2014, J APPL TOXICOL; Wu JP, 2008, ENVIRON INT, V34, P1109, DOI 10.1016/j.envint.2008.04.001; Zhang ZL, 2014, SCI TOTAL ENVIRON, V468, P158, DOI 10.1016/j.scitotenv.2013.08.029; Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107	64	14	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179858	10.1371/journal.pone.0179858	http://dx.doi.org/10.1371/journal.pone.0179858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644858	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100044
J	Hirbawi, J; Bialkowska, K; Bledzka, KM; Liu, JM; Fukuda, K; Qin, J; Plow, EF				Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M.; Liu, Jianmin; Fukuda, Koichi; Qin, Jun; Plow, Edward F.			The extreme C-terminal region of kindlin-2 is critical to its regulation of integrin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; integrin; membrane; protein chemistry; talin; kindlin	MONOCLONAL-ANTIBODY; FERM DOMAIN; BINDING; TALIN; ADHESION; PROTEIN; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3; MECHANISM; PLATELETS	Kindlin-2 (K2), a 4.1R-ezrin-radixin-moesin (FERM) domain adaptor protein, mediates numerous cellular responses, including integrin activation. The C-terminal 15-amino acid sequence of K2 is remarkably conserved across species but is absent in canonical FERM proteins, including talin. In CHO cells expressing integrin IIb3, co-expression of K2 with talin head domain resulted in robust integrin activation, but this co-activation was lost after deletion of as few as seven amino acids from the K2 C terminus. This dependence on the C terminus was also observed in activation of endogenous IIb3 in human erythroleukemia (HEL) cells and 1 integrin activation in macrophage-like RAW264.1 cells. Kindlin-1 (K1) exhibited a similar dependence on its C terminus for integrin activation. Expression of the K2 C terminus as an extension of membrane-anchored P-selectin glycoprotein ligand-1 (PSGL-1) inhibited integrin-dependent cell spreading. Deletion of the K2 C terminus did not affect its binding to the integrin 3 cytoplasmic tail, but combined biochemical and NMR analyses indicated that it can insert into the F2 subdomain. We suggest that this insertion determines the topology of the K2 FERM domain, and its deletion may affect the positioning of the membrane-binding functions of the F2 subdomain and the integrin-binding properties of its F3 subdomain. Free C-terminal peptide can still bind to K2 and displace the endogenous K2 C terminus but may not restore the conformation needed for integrin co-activation. Our findings indicate that the extreme C terminus of K2 is essential for integrin co-activation and highlight the importance of an atypical architecture of the K2 FERM domain in regulating integrin activation.	[Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M.; Liu, Jianmin; Fukuda, Koichi; Qin, Jun; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol, NB5-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health SIG Grant [1S10OD019972-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL096062, P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019972] Funding Source: NIH RePORTER	National Institutes of Health SIG Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Imaging Core and the Biotechnology Core of the Lerner Research Institute for assistance. The Leica SP8 confocal microscope utilized in this work was purchased with funding from National Institutes of Health SIG Grant 1S10OD019972-01.	Ali RH, 2014, MOL PHYLOGENET EVOL, V80, P193, DOI 10.1016/j.ympev.2014.08.008; Bialkowska K, 2015, J BIOL CHEM, V290, P6226, DOI 10.1074/jbc.M114.634436; Bledzka K, 2016, J CELL BIOL, V213, P97, DOI 10.1083/jcb.201501006; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; BoudignonProudhon C, 1996, BLOOD, V87, P968, DOI 10.1182/blood.V87.3.968.bloodjournal873968; BRAY PF, 1986, P NATL ACAD SCI USA, V83, P1480, DOI 10.1073/pnas.83.5.1480; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Huet-Calderwood C, 2014, J CELL SCI, V127, P4308, DOI 10.1242/jcs.155879; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Meller J, 2015, MOL BIOL CELL, V26, P786, DOI 10.1091/mbc.E14-08-1294; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Perera H. D. D., 2010, THESIS; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Plow E. F., 2016, DISCOVERIES; Plow EF, 2014, CURR OPIN HEMATOL, V21, P241, DOI 10.1097/MOH.0000000000000042; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; SHATTIL SJ, 1987, BLOOD, V70, P307; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WOODS VL, 1986, J BIOL CHEM, V261, P5242; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Xu Z, 2013, BIOCHEM BIOPH RES CO, V434, P382, DOI 10.1016/j.bbrc.2013.03.086; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469	54	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14258	14269		10.1074/jbc.M117.776195	http://dx.doi.org/10.1074/jbc.M117.776195			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28652408	hybrid, Green Published			2022-12-26	WOS:000408439800029
J	Kozlowski, E; Wasserman, GA; Morgan, M; O'Carroll, D; Ramirez, NGP; Gummuluru, S; Rah, JY; Gower, AC; Ieong, M; Quinton, LJ; Mizgerd, JP; Jones, MR				Kozlowski, Elyse; Wasserman, Gregory A.; Morgan, Marcos; O'Carroll, Donal; Ramirez, Nora-Guadalupe P.; Gummuluru, Suryaram; Rah, Jasmine Y.; Gower, Adam C.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.			The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses	PLOS ONE			English	Article							HISTONE MESSENGER-RNAS; ALVEOLAR MACROPHAGES; MICRORNA BIOGENESIS; CYTOPLASMIC RNA; GENE-EXPRESSION; EMERGING ROLES; PRE-MICRORNA; URIDYLATION; LIN28; TUT4	Alveolar macrophages orchestrate pulmonary innate immunity and are essential for early immune surveillance and clearance of microorganisms in the airways. Inflammatory signaling must be sufficiently robust to promote host defense but limited enough to prevent excessive tissue injury. Macrophages in the lungs utilize multiple transcriptional and post-transcriptional mechanisms of inflammatory gene expression to delicately balance the elaboration of immune mediators. RNA terminal uridyltransferases (TUTs), including the closely homologous family members Zcchc6 (TUT7) and Zcchc11 (TUT4), have been implicated in the post-transcriptional regulation of inflammation from studies conducted in vitro. In vivo, we observed that Zcchc6 is expressed in mouse and human primary macrophages. Zcchc6-deficient mice are viable and born in Mendelian ratios and do not exhibit an observable spontaneous phenotype under basal conditions. Following an intratracheal challenge with S. pneumoniae, Zcchc6 deficiency led to a modest but significant increase in the expression of select cytokines including IL-6, CXCL1, and CXCL5. These findings were recapitulated in vitro whereby Zcchc6-deficient macrophages exhibited similar increases in cytokine expression due to bacterial stimulation. Although loss of Zcchc6 also led to increased neutrophil emigration to the airways during pneumonia, these responses were not sufficient to impact host defense against infection.	[Kozlowski, Elyse; Wasserman, Gregory A.; Rah, Jasmine Y.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kozlowski, Elyse; Wasserman, Gregory A.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wasserman, Gregory A.; Ramirez, Nora-Guadalupe P.; Gummuluru, Suryaram; Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Morgan, Marcos; O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [O'Carroll, Donal] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Gower, Adam C.] Boston Univ, Sch Med, Clin & Translat Sci Inst, Boston, MA 02118 USA; [Quinton, Lee J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University; Boston University; European Molecular Biology Laboratory (EMBL); University of Edinburgh; Boston University; Boston University; Boston University	Jones, MR (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.; Jones, MR (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	mattj@bu.edu	Gummuluru, Rahm/AAV-5691-2020; Mizgerd, Joseph/GRY-6369-2022	Jones, Matthew/0000-0003-4647-2962; Morgan, Marcos/0000-0002-3549-0375; Quinton, Lee/0000-0003-1938-2507; Mizgerd, Joseph/0000-0002-4042-3169; O'Carroll, Donal/0000-0002-8626-2217; Wasserman, Gregory/0000-0002-0136-272X; Gower, Adam/0000-0002-6122-7511; Ramirez, Nora-Guadalupe/0000-0002-7992-1683; Gummuluru, Suryaram/0000-0002-8606-8481	National Institutes of Health [R01 HL-104053, R01 HL-0068153, R01 HL-079392, R00 HL-092956, R01 HL-111449, R01 AI-064099, T32 HL-007035, T32 AI-899673, F31 HL-127978]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007035, R01HL104053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064099, R01AI115053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120060] Funding Source: NIH RePORTER; Medical Research Council [MR/K017047/1] Funding Source: researchfish; MRC [MR/K017047/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by National Institutes of Health Grants R01 HL-104053 (to M. R.J.), R01 HL-0068153 (to J.P.M.), R01 HL-079392 (to J.P.M.), R00 HL-092956 (to L.J.Q.), R01 HL-111449 (to L.J.Q.), R01 AI-064099 (to S. G.), T32 HL-007035 (for E.K.), and T32 AI-899673 (for G.A.W.) and F31 HL-127978 (to G.A.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Akiyama H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004751; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blahna MT, 2011, J BIOL CHEM, V286, P42381, DOI 10.1074/jbc.M111.259689; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Carpenter S, 2015, J INTERF CYTOK RES, V35, P79, DOI 10.1089/jir.2014.0120; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hyatt LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109072; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones MR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003105; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kamata H, 2016, AM J RESP CELL MOL, V55, P407, DOI 10.1165/rcmb.2015-0261OC; Kim B, 2015, EMBO J, V34, P1801, DOI 10.15252/embj.201590931; Kirby AC, 2006, J INFECT DIS, V193, P205, DOI 10.1086/498874; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lee SR, 2013, TRENDS CELL BIOL, V23, P504, DOI 10.1016/j.tcb.2013.05.001; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; LeTonqueze O, 2012, RNA BIOL, V9, P871, DOI 10.4161/rna.20806; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2015, ANNU REV PHYSIOL, V77, P407, DOI 10.1146/annurev-physiol-021014-071937; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Slevin MK, 2014, MOL CELL, V53, P1020, DOI 10.1016/j.molcel.2014.02.027; Thomas MP, 2013, IMMUNOL REV, V253, P237, DOI 10.1111/imr.12052; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179797	10.1371/journal.pone.0179797	http://dx.doi.org/10.1371/journal.pone.0179797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665939	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700040
J	Anton-Sanchez, L; Larranaga, P; Benavides-Piccione, R; Fernaud-Espinosa, I; DeFelipe, J; Bielza, C				Anton-Sanchez, Laura; Larranaga, Pedro; Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier; Bielza, Concha			Three-dimensional spatial modeling of spines along dendritic networks in human cortical pyramidal neurons	PLOS ONE			English	Article							POINT PATTERNS; INNERVATION	We modeled spine distribution along the dendritic networks of pyramidal neurons in both basal and apical dendrites. To do this, we applied network spatial analysis because spines can only lie on the dendritic shaft. We expanded the existing 2D computational techniques for spatial analysis along networks to perform a 3D network spatial analysis. We analyzed five detailed reconstructions of adult human pyramidal neurons of the temporal cortex with a total of more than 32,000 spines. We confirmed that there is a spatial variation in spine density that is dependent on the distance to the cell body in all dendrites. Considering the dendritic arborizations of each pyramidal cell as a group of instances of the same observation (the neuron), we used replicated point patterns together with network spatial analysis for the first time to search for significant differences in the spine distribution of basal dendrites between different cells and between all the basal and apical dendrites. To do this, we used a recent variant of Ripley's Kfunction defined to work along networks. The results showed that there were no significant differences in spine distribution along basal arbors of the same neuron and along basal arbors of different pyramidal neurons. This suggests that dendritic spine distribution in basal dendritic arbors adheres to common rules. However, we did find significant differences in spine distribution along basal versus apical networks. Therefore, not only do apical and basal dendritic arborizations have distinct morphologies but they also obey different rules of spine distribution. Specifically, the results suggested that spines are more clustered along apical than in basal dendrites. Collectively, the results further highlighted that synaptic input information processing is different between these two dendritic domains.	[Anton-Sanchez, Laura; Larranaga, Pedro; Bielza, Concha] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Madrid, Spain; [Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier] Univ Politecn Madrid, Lab Cajal Circuitos Cort, Ctr Tecnol Biomed, Madrid, Spain; [Benavides-Piccione, Ruth; Fernaud-Espinosa, Isabel; DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Anton-Sanchez, L (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingenieros Informat, Dept Inteligencia Artificial, Madrid, Spain.	l.anton-sanchez@upm.es	Fernaud-Espinosa, Isabel/H-1875-2015; Bielza, Concha/F-9277-2013; DEFELIPE, JAVIER/D-1195-2014; benavides-piccione, ruth/D-7889-2014; Larranaga, Pedro/F-9293-2013	Fernaud-Espinosa, Isabel/0000-0003-2391-0704; Bielza, Concha/0000-0001-7109-2668; DEFELIPE, JAVIER/0000-0001-5484-0660; benavides-piccione, ruth/0000-0003-3288-9820; Larranaga, Pedro/0000-0003-0652-9872; Anton-Sanchez, Laura/0000-0002-5556-1759	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain [C080020-09, TIN2016-79684-P]; Regional Government of Madrid [S2013/ICE-2845-CASI-CAM-CM]; European Union [720270]; Spanish MINECO scholarship at the Residencia de Estudiantes	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain(Spanish Government); Regional Government of Madrid; European Union(European Commission); Spanish MINECO scholarship at the Residencia de Estudiantes	This research has been partially supported by the Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain (C080020-09; the Spanish partner of the Blue Brain initiative from EPFL) and TIN2016-79684-P projects, by the Regional Government of Madrid through the S2013/ICE-2845-CASI-CAM-CM project, and by the European Union Horizon 2020 research and innovation programme under grant agreement No. 720270. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang QW, 2012, SCAND J STAT, V39, P591, DOI 10.1111/j.1467-9469.2011.00752.x; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A., 2010, ANAL SPATIAL POINT P, P232; Baddeley A, 2015, SPATIAL POINT PATTER; Baddeley A.J., 1993, APPL STAT, V42, DOI [10.2307/2986181, DOI 10.2307/2986181]; Baddeley A, 2014, J R STAT SOC C-APPL, V63, P673, DOI 10.1111/rssc.12054; Baddeley AJ, 2000, STAT NEERL, V54, P329, DOI 10.1111/1467-9574.00144; Benavides-Piccione R, 2005, CEREB CORTEX, V15, P1584, DOI 10.1093/cercor/bhi036; Benavides-Piccione R, 2013, CEREB CORTEX, V23, P1798, DOI 10.1093/cercor/bhs154; BERMAN M, 1986, J R STAT SOC C-APPL, V35, P54; Blazquez-Llorca L, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00020; Burguet J, 2011, PATTERN RECOGN LETT, V32, P1894, DOI 10.1016/j.patrec.2011.07.008; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Diggle P., 2003, STAT ANAL SPATIAL PO; DIGGLE PJ, 1991, J AM STAT ASSOC, V86, P618, DOI 10.2307/2290390; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Elston GN, 2002, PROG BRAIN RES, V136, P109; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Garcia-Marin V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.028.2009; Hahn U, 2012, J AM STAT ASSOC, V107, P754, DOI 10.1080/01621459.2012.688463; Illian J, 2008, STAT ANAL MODELLING; Jafari-Mamaghani M, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fninf.2010.00009; Jammalamadaka A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-287; McSwiggan G, 2016, SCANDINAVIAN J STAT; Myllymaki M, 2012, J MICROSC-OXFORD, V247, P228, DOI 10.1111/j.1365-2818.2012.03636.x; Okabe A, 2001, GEOGR ANAL, V33, P271, DOI 10.1111/j.1538-4632.2001.tb00448.x; Okabe A., 2009, INT J GEOGR INF SYST, V23, P1, DOI DOI 10.1080/13658810802475491; Okabe A., 2012, SPATIAL ANAL NETWORK; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Vaught J, 2012, BIOPRESERV BIOBANK, V10, P76, DOI [10.1089/bio.2012.1024, 10.1089/bio.2012.1025]; Wager CG, 2004, J R STAT SOC B, V66, P429, DOI 10.1046/j.1369-7412.2003.05285.x	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180400	10.1371/journal.pone.0180400	http://dx.doi.org/10.1371/journal.pone.0180400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662210	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300151
J	Bovo, S; Mazzoni, G; Ribani, A; Utzeri, VJ; Bertolini, F; Schiavo, G; Fontanesi, L				Bovo, Samuele; Mazzoni, Gianluca; Ribani, Anisa; Utzeri, Valerio Joe; Bertolini, Francesca; Schiavo, Giuseppina; Fontanesi, Luca			A viral metagenomic approach on a non-metagenomic experiment: Mining next generation sequencing datasets from pig DNA identified several porcine parvoviruses for a retrospective evaluation of viral infections	PLOS ONE			English	Article							COPY NUMBER; ASSOCIATION; GENOMES; QUALITY; PIPELINE; VIRUSES; SAMPLES; TRAITS; VIROME	Shot-gun next generation sequencing (NGS) on whole DNA extracted from specimens collected from mammals often produces reads that are not mapped (i.e. unmapped reads) on the host reference genome and that are usually discarded as by-products of the experiments. In this study, we mined Ion Torrent reads obtained by sequencing DNA isolated from archived blood samples collected from 100 performance tested Italian Large White pigs. Two reduced representation libraries were prepared from two DNA pools constructed each from 50 equimolar DNA samples. Bioinformatic analyses were carried out to mine unmapped reads on the reference pig genome that were obtained from the two NGS data sets. In silico analyses included read mapping and sequence assembly approaches for a viral metagenomic analysis using the NCBI Viral Genome Resource. Our approach identified sequences matching several viruses of the Pantoviridae family: porcine parvovirus 2 (PPV2), PPV4, PPV5 and PPV6 and porcine bocavirus 1-H18 isolate (PBoV1-H18). The presence of these viruses was confirmed by PCR and Sanger sequencing of individual DNA samples. PPV2, PPV4, PPV5, PPV6 and PBoV1-H18 were all identified in samples collected in 1998-2007,1998-2000,1997-2000,1998-2004 and 2003, respectively. For most of these viruses (PPV4, PPV5, PPV6 and PBoV1-H18) previous studies reported their first occurrence much later (from 5 to more than 10 years) than our identification period and in different geographic areas. Our study provided a retrospective evaluation of apparently asymptomatic parvovirus infected pigs providing information that could be important to define occurrence and prevalence of different parvoviruses in South Europe. This study demonstrated the potential of mining NGS datasets non-originally derived by metagenomics experiments for viral metagenomics analyses in a livestock species.	[Bovo, Samuele; Mazzoni, Gianluca; Ribani, Anisa; Utzeri, Valerio Joe; Bertolini, Francesca; Schiavo, Giuseppina; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Bovo, Samuele] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Biocomp Grp, Bologna, Italy; [Mazzoni, Gianluca] Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Bertolini, Francesca] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Bologna; University of Bologna; University of Copenhagen; Iowa State University	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci DISTAL, Bologna, Italy.	luca.fontanesi@unibo.it	Mazzoni, Gianluca/AAC-6041-2019; Bovo, Samuele/M-4179-2019; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	Mazzoni, Gianluca/0000-0003-2397-1064; Bovo, Samuele/0000-0002-5712-8211; Fontanesi, Luca/0000-0001-7050-3760; Bertolini, Francesca/0000-0003-4181-3895	Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; University of Bologna, grant RFO	Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; University of Bologna, grant RFO	Funders: 1) Ministero delle Politiche Agricole, Alimentari e Forestall, grant INNOVAGEN; 2) University of Bologna, grant RFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Crcer DA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-989; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Bibby K, 2013, TRENDS BIOTECHNOL, V31, P11, DOI 10.1016/j.tibtech.2013.01.016; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Bovo S, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/950737; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Cadar D, 2013, J GEN VIROL, V94, P2330, DOI 10.1099/vir.0.055129-0; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Daly GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129059; Fontanesi L, 2008, MEAT SCI, V80, P780, DOI 10.1016/j.meatsci.2008.03.022; Fontanesi L, 2010, J ANIM SCI, V88, P2235, DOI 10.2527/jas.2009-2560; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gunn Lynda, 2015, Infection Ecology & Epidemiology, V5, P27270, DOI 10.3402/iee.v5.27270; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Lee D, 2011, ANIM BIOTECHNOL, V22, P175, DOI 10.1080/10495398.2011.595294; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2015, J GEN VIROL, V96, P2721, DOI 10.1099/vir.0.000199; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Ndze VN, 2013, INFECT GENET EVOL, V17, P277, DOI 10.1016/j.meegid.2013.03.006; Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Ni JQ, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0203-2; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Sauvage V, 2016, TRANSFUS CLIN BIOL, V23, P28, DOI 10.1016/j.tracli.2015.12.002; Schirtzinger EE, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0401-6; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits SL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00714; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Streck AF, 2013, ARCH VIROL, V158, P1173, DOI 10.1007/s00705-013-1603-0; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Warr A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00338; Wen LB, 2015, ARCH VIROL, V160, P371, DOI 10.1007/s00705-014-2242-9; Whitacre LK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2313-7; Xiao CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065312; Xiao CT, 2013, INFECT GENET EVOL, V16, P369, DOI 10.1016/j.meegid.2013.03.017	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179462	10.1371/journal.pone.0179462	http://dx.doi.org/10.1371/journal.pone.0179462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662150	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300025
J	Decker, S; Rempis, E; Schnack, A; Braun, V; Rubaihayo, J; Busingye, P; Tumwesigye, NM; Harms, G; Theuring, S				Decker, Sarah; Rempis, Eva; Schnack, Alexandra; Braun, Vera; Rubaihayo, John; Busingye, Priscilla; Tumwesigye, Nazarius Mbona; Harms, Gundel; Theuring, Stefanie			Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda	PLOS ONE			English	Article							FOLLOW-UP; ANTIRETROVIRAL PROPHYLAXIS; UNINFECTED CHILDREN; WOMEN; CARE; PMTCT; RETENTION; PREGNANCY; THERAPY; PROGRAM	Since 2012, the WHO recommends Option B+ for the prevention of mother-to-child transmission of HIV. This approach entails the initiation of lifelong antiretroviral therapy in all HIV positive pregnant women, also implying protection during breastfeeding for 12 months or longer. Research on long-term adherence to Option B+ throughout breastfeeding is scarce to date. Therefore, we conducted a prospective observational cohort study in Fort Portal, Western Uganda, to assess adherence to Option B+ until 18 months postpartum. In 2013, we recruited 67 HIV-positive, Option B+ enrolled women six weeks after giving birth and scheduled them for follow-up study visits after six, twelve and 18 months. Two adherence measures, self-reported drug intake and amount of drug refill visits, were combined to define adherence, and were assessed together with feeding information at all study visits. At six months postpartum, 51% of the enrolled women were considered to be adherent. Until twelve and 18 months postpartum, adherence for the respective follow-up interval decreased to 19% and 20.5% respectively. No woman was completely adherent until 18 months. At the same time, 76.5% of the women breastfed for >= 12 months. Drug adherence was associated with younger age (p<0.01), lower travel costs (p = 0.02), and lower number of previous deliveries (p = 0.04). Long-term adherence to Option B+ seems to be challenging. Considering that in our cohort, prolonged breastfeeding until >= 12 months was widely applied while postpartum adherence until the end of breastfeeding was poor, a potential risk of postpartum vertical transmission needs to be taken seriously into account for Option B+ implementation.	[Decker, Sarah; Rempis, Eva; Schnack, Alexandra; Braun, Vera; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Rubaihayo, John] Mt Moon Univ, Dept Publ Hlth, Ft Portal, Uganda; [Busingye, Priscilla] Holy Family Virika Hosp, Ft Portal, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Makerere University	Theuring, S (corresponding author), Charite, Inst Trop Med & Int Hlth, Berlin, Germany.	stefanie.theuring@charite.de	Rubaihayo, John/HDO-2747-2022	Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Rubaihayo, Prof. John/0000-0002-3421-2242	German Federal Ministry for Economic Cooperation and Development via the ESTHER programme; HW&J Hector Foundation Germany	German Federal Ministry for Economic Cooperation and Development via the ESTHER programme; HW&J Hector Foundation Germany	The study was funded by the German Federal Ministry for Economic Cooperation and Development via the ESTHER programme (Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, http://health.bmz.de/what_we_do/Partnersriips-for-global-health/Hospital_partnerships_ESFHER_/index.htm), and by the HW&J Hector Foundation Germany (hilps://www.hector-stiflung.de/startseite/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BREASTFEEDING; [Anonymous], 2016, THAIL IS 1 COUNTR AS; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Finocchario-Kessler S, 2014, AIDS, V28, pS313, DOI 10.1097/QAD.0000000000000332; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3; Joint United Nations Programme for HIV/ AIDS (UNAIDS), 2014, THE GAP REP 2014; Jones SA, 2005, AIDS CARE, V17, P466, DOI 10.1080/09540120412331319723; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kurewa E N, 2011, Open AIDS J, V5, P51, DOI 10.2174/1874613601105010051; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Ngoma MS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19352; Odeny TA, 2014, AIDS, V28, P2307, DOI 10.1097/QAD.0000000000000409; Okawa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0697-7; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Peltzer K, 2011, ACTA PAEDIATR, V100, P1253, DOI 10.1111/j.1651-2227.2011.02253.x; Psaros C, 2015, CURR HIV-AIDS REP, V12, P1, DOI 10.1007/s11904-014-0252-6; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; The Republic of Uganda, 2014, HIV AIDS UG COUNTR P; UNAIDS, 2016, FAST TRACK UPD INV N; UNICEF, 2014, EXECUTIVE SUMMARY; World Health Organisation, 2010, PREV MOTH TO CHILD T; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2010, GUID HIV INT FEED 20	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179448	10.1371/journal.pone.0179448	http://dx.doi.org/10.1371/journal.pone.0179448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662036	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300021
J	Knopfel, T; Atanassoff, A; Hernando, N; Biber, J; Wagner, CA				Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.			Renal localization and regulation by dietary phosphate of the MCT14 orphan transporter	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORTER; AMINO-ACID TRANSPORTER; VITAMIN-D METABOLISM; MONOCARBOXYLATE TRANSPORTER; P-I; MOUSE MODEL; FUNCTIONAL-CHARACTERIZATION; PROXIMAL TUBULE; GENE-EXPRESSION; RAT-KIDNEY	MCT14 is an orphan transporter belonging to the SLC16 transporter family mediating the transport of monocarboxylates, aromatic amino acids, creatine, and thyroid hormones. The expression, tissue localization, regulation, and function of MCT14 are unknown. In mouse MCT14 mRNA abundance is highest in kidney. Using a newly developed and validated antibody, MCT14 was localized to the luminal membrane of the thick ascending limb of the loop of Henle colocalizing in the same cells with uromodulin and NKCC2. MCT14 mRNA and protein was found to be highly regulated by dietary phosphate intake in mice being increased by high dietary phosphate intake at both mRNA and protein level. In order to identify the transport substrate(s), we expressed MCT14 in Xenopus laevis oocytes where MCT14 was integrated into the plasma membrane. However, no transport was discovered for the classic substrates of the SLC16 family nor for phosphate. In summary, MCT14 is an orphan transporter regulated by phosphate and highly enriched in kidney localizing to the luminal membrane of one specific nephron segment.	[Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Knoepfel, Thomas; Atanassoff, Alexander; Hernando, Nati; Biber, Juerg; Wagner, Carsten A.] NCCR Kidney CH, Zurich, Switzerland	University of Zurich	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Wagner, CA (corresponding author), NCCR Kidney CH, Zurich, Switzerland.	Wagnerca@access.uzh.ch		Knopfel, Thomas/0000-0002-8274-0736	National Center for Excellence in Research NCCR Kidney; Swiss National Science Foundation	National Center for Excellence in Research NCCR Kidney; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the National Center for Excellence in Research NCCR Kidney. CH was financed by the Swiss National Science Foundation to JB and CAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Ansermet C, 2016, J AM SOC NEPHROL; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Biber J, 2004, AM J PHYSIOL-RENAL, V287, pF871, DOI 10.1152/ajprenal.00244.2004; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Dhayat N, 2016, J AM SOC NEPHROL, V27, P1426, DOI 10.1681/ASN.2015040411; Eladari D, 1999, J BIOL CHEM, V274, P28420, DOI 10.1074/jbc.274.40.28420; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hattenhauer O, 1999, AM J PHYSIOL-GASTR L, V277, pG756, DOI 10.1152/ajpgi.1999.277.4.G756; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kirat D, 2013, CELL TISSUE RES, V352, P585, DOI 10.1007/s00441-013-1570-5; Kirat D, 2009, HISTOCHEM CELL BIOL, V132, P447, DOI 10.1007/s00418-009-0621-1; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Murakami Y, 2005, DRUG METAB DISPOS, V33, P1845, DOI 10.1124/dmd.105.005264; Murer H, 1999, AM J PHYSIOL-RENAL, V277, pF676, DOI 10.1152/ajprenal.1999.277.5.F676; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Park SY, 2005, ARCH PHARM RES, V28, P421, DOI 10.1007/BF02977671; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Roshanbin S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0274-7; Scanni R, 2014, J AM SOC NEPHROL, V25, P2730, DOI 10.1681/ASN.2013101076; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Thomas L, 2016, J AM SOC NEPHROLOGY; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Xie WS, 2000, BIOCHEM J, V352, P227, DOI 10.1042/0264-6021:3520227; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177942	10.1371/journal.pone.0177942	http://dx.doi.org/10.1371/journal.pone.0177942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662032	gold, Green Accepted, Green Published			2022-12-26	WOS:000404608300003
J	Kropackova, L; Pechmanova, H; Vinkler, M; Svobodova, J; Velova, H; Tesicky, M; Martin, JF; Kreisinger, J				Kropackova, Lucie; Pechmanova, Hana; Vinkler, Michal; Svobodova, Jana; Velova, Hana; Tesicky, Martin; Martin, Jean-Francois; Kreisinger, Jakub			Variation between the oral and faecal microbiota in a free-living passerine bird, the great tit (Parus major)	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL COMMUNITIES; ELIZABETHKINGIA-MENINGOSEPTICA; INTESTINAL MICROBIOTA; WILD; ENERGY; HEALTH; TRACT; DIVERSITY; SEQUENCES	The gastrointestinal tract of vertebrates is inhabited by diverse bacterial communities that induce marked effects on the host physiology and health status. The composition of the gastrointestinal microbiota is characterized by pronounced taxonomic and functional variability among different regions of the vertebrate gastrointestinal tract. Despite the relatively solid knowledge on the among-region variations of the gastrointestinal microbiota in model mammalian species, there are only a few studies concerning among-region variations of the gastrointestinal microbiota in free-living non-mammalian vertebrate taxa. We used Illumina MiSeq sequencing of bacterial 16S rRNA amplicons to compare the diversity as well as taxonomic composition of bacterial communities in proximal vs. distal parts of the gastrointestinal tract (represented by oral swabs and faecal samples, respectively) in a wild passerine bird, the great tit (Parus major). The diversity of the oral microbiota was significantly higher compared to the faecal microbiota, whereas interindividual variation was higher in faecal than in oral samples. We also observed a pronounced difference in taxonomic content between the oral and faecal microbiota. Bacteria belonging to the phyla Proteobacteria, Firmicutes and Actinobacteria typically dominated in both oral and faecal samples. A high abundance of bacteria belonging to Tenericutes was observed only in faecal samples. Surprisingly, we found only a slight correlation between the faecal and oral microbiota at the within-individual level, suggesting that the microbial composition in these body sites is shaped by independent regulatory processes. Given the independence of these two communities at the individual level, we propose that simultaneous sampling of the faecal and oral microbiota will extend our understanding of host vs. microbiota interactions in wild populations.	[Kropackova, Lucie; Pechmanova, Hana; Vinkler, Michal; Velova, Hana; Tesicky, Martin; Kreisinger, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Svobodova, Jana] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, Montferrier Sur Lez, France	Charles University Prague; Czech University of Life Sciences Prague; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Kropackova, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	lucie.kropackova@gmail.com	Martin, Jean-Francois/M-9426-2017; Těšický, Martin/AAX-5593-2021; Bainova, Hana/I-3888-2012; Vinkler, Michal/G-2072-2011; Martin, Jean-Francois/AAD-3883-2019; Schmiedová, Lucie/S-3351-2017; Svobodova, Jana/G-9692-2012; Tesicky, Martin/L-3370-2017; Kreisinger, Jakub/H-4020-2011	Martin, Jean-Francois/0000-0001-9176-4476; Těšický, Martin/0000-0001-8097-5331; Bainova, Hana/0000-0002-4578-633X; Vinkler, Michal/0000-0003-3572-9494; Martin, Jean-Francois/0000-0001-9176-4476; Schmiedová, Lucie/0000-0003-2180-5281; Svobodova, Jana/0000-0001-6161-4899; Tesicky, Martin/0000-0001-8097-5331; 	Czech Science foundation project [15-11782S]; Czech Science foundation [14-16596P]; Grant Agency of Charles University [281315]; SW project [260 434/2017]	Czech Science foundation project(Grant Agency of the Czech Republic); Czech Science foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; SW project	Field works were funded by Czech Science foundation project 15-11782S (http://www.gacr.cz/). Wet-lab procedures and data analyses were funded by Czech Science foundation project 14-16596P, and by Grant Agency of Charles University (project 281315, http://www.cuni.cz/UK-33.html). LK, HP, HV and MT were supported by SW project no. 260 434/2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; [Anonymous], 2009, ORAL MICROBIOLOGY; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benskin CMH, 2015, ECOL EVOL, V5, P821, DOI 10.1002/ece3.1384; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bik EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10516; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Boutin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102649; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Colston TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128793; Costea PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057521; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Escallon C, 2017, FUNCT ECOL, V31, P192, DOI 10.1111/1365-2435.12696; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Han GG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2604-8; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]; Hird SM, 2014, PEERJ, V2, DOI 10.7717/peerj.321; Jackson MK, 1996, AVIAN DIS, V40, P473, DOI 10.2307/1592248; Jean SS, 2014, J HOSP INFECT, V86, P244, DOI 10.1016/j.jhin.2014.01.009; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kienzle E, 2001, J ANIM PHYSIOL AN N, V85, P148, DOI 10.1046/j.1439-0396.2001.00311.x; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohl KD, 2013, ENV MICROBIOL REP, V5, P899, DOI 10.1111/1758-2229.12092; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kreisinger J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00050; Kreisinger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137401; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Lear G, 2008, FEMS MICROBIOL ECOL, V65, P463, DOI 10.1111/j.1574-6941.2008.00548.x; Lee NK, 2015, LWT-FOOD SCI TECHNOL, V64, P1036, DOI 10.1016/j.lwt.2015.07.019; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lewis WB, 2017, AUK, V134, P137, DOI 10.1642/AUK-16-120.1; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2016, FRONT MICROBIOL, P7; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; Li ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114513; Loch TP, 2015, J ADV RES, V6, P283, DOI 10.1016/j.jare.2014.10.009; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Luerce TD, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-33; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Matthews DM, 2013, BEHAV PROCESS, V96, P27, DOI 10.1016/j.beproc.2013.02.007; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; Meyer JM, 2002, APPL ENVIRON MICROB, V68, P2745, DOI 10.1128/AEM.68.6.2745-2753.2002; Mirn L., 2014, METAGENOMICS, V3, P1, DOI [10.4303/mg/235853, DOI 10.4303/MG/235853]; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nazef L, 2008, POULTRY SCI, V87, P329, DOI 10.3382/ps.2007-00282; Nelson KE, 2015, ILAR J, V56, P163, DOI 10.1093/ilar/ilv033; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ouyang JQ, 2013, J EVOLUTION BIOL, V26, P1988, DOI 10.1111/jeb.12202; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira GH, 2013, BRAZ J INFECT DIS, V17, P606, DOI 10.1016/j.bjid.2013.02.011; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Core Team, 2021, R LANGUAGE ENV STAT; Rampelli S, 2013, J NUTR HEALTH AGING, V17, P166, DOI 10.1007/s12603-012-0372-x; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Robertson PAW, 2000, AQUACULTURE, V185, P235, DOI 10.1016/S0044-8486(99)00349-X; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Seccareccia I, 2015, APPL ENVIRON MICROB, V81, P7098, DOI 10.1128/AEM.01781-15; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Sumithra TG, 2013, EUR J WILDLIFE RES, V59, P769, DOI 10.1007/s10344-013-0769-9; Suzuki TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163720; van Schijndel RJMS, 2006, CLIN NUTR, V25, P758, DOI 10.1016/j.clnu.2005.11.012; Voegeli B, 2012, J EVOLUTION BIOL, V25, P584, DOI 10.1111/j.1420-9101.2011.02445.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Walker SE, 2002, AVIAN DIS, V46, P1045, DOI 10.1637/0005-2086(2002)046[1045:COPAIA]2.0.CO;2; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinberger M, 2004, EPIDEMIOL INFECT, V132, P1023, DOI 10.1017/S0950268803001109; WELLS CL, 1988, REV INFECT DIS, V10, P958; Wichert B, 2007, J ANIM PHYSIOL AN N, V91, P278, DOI 10.1111/j.1439-0396.2007.00705.x; Wienemann T, 2011, SYST APPL MICROBIOL, V34, P542, DOI 10.1016/j.syapm.2011.06.003; Wilkinson N, 2016, APPL MICROBIOL BIOT, V100, P4201, DOI 10.1007/s00253-015-7280-z; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185	111	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179945	10.1371/journal.pone.0179945	http://dx.doi.org/10.1371/journal.pone.0179945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662106	Green Published, gold			2022-12-26	WOS:000404608300078
J	Song, YS; Joo, HW; Park, IH; Shen, GY; Lee, Y; Shin, JH; Kim, H; Kim, KS				Song, Yi-Sun; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Lee, Yonggu; Shin, Jeong Hun; Kim, Hyuck; Kim, Kyung-Soo			Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction	PLOS ONE			English	Article							ISCHEMIC-HEART; FUNCTIONAL IMPROVEMENT; MOUSE MODEL; TRANSPLANTATION; MICRORNAS; VEGF; CARDIOMYOCYTES; EXPRESSION; ANGIOGENESIS; MECHANISMS	Bone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular diseases. Here, we investigated the mechanisms underlying the effects of BM-MSC-derived paracrine factors and cardiac miRNAs on myocardial regeneration after MI. In our study, MI was induced by permanent ligation of the left anterior descending (LAD) coronary artery. BM-MSCs transplanted in infarcted rats significantly downregulated the expression of miRNA-23a and miRNA-92a and inhibited apoptosis in the myocardium. An in vitro experiment showed that supernatant from BM-MSCs cultured under hypoxia contained higher levels of vascular endothelial growth factor (VEGF) than that from BM-MSCs under normoxia. In addition, inhibition of miRNA-23a and miRNA-92a reduced cardiac apoptosis. Moreover, the VEGF-containing BM-MSC supernatant inhibited miRNA-23a and miRNA-92a expression and reduced apoptotic signaling in cardiomyocytes under hypoxia. These effects were inhibited when the supernatant was treated with neutralizing antibodies against VEGF. Our results indicate that the paracrine factor, VEGF, derived from transplanted BM-MSCs, regulated the expression of miRNAs such as miRNA-23a and miRNA-92a and exerted anti-apoptotic effects in cardiomyocytes after MI.	[Song, Yi-Sun; Joo, Hyun-Woo; Park, In-Hwa; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Shen, Guang-Yin; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Yonggu; Shin, Jeong Hun] Hanyang Univ, Guri Hosp, Dept Internal Med, Guri, South Korea; [Kim, Hyuck] Hanyang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University	Kim, KS (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea.	kskim@hanyang.ac.kr	Lee, Yonggu/Q-3832-2018; Shin, Jeong Hun/O-1273-2019	Lee, Yonggu/0000-0002-3757-3692; Shin, Jeong Hun/0000-0002-6718-9763	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A02062008]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A02062008).	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Fang CH, 2012, CELL TRANSPLANT, V21, P1687, DOI 10.3727/096368912X653039; Feygin J, 2007, AM J PHYSIOL-HEART C, V293, pH1772, DOI 10.1152/ajpheart.00242.2007; Frost RJA, 2010, J CARDIOVASC TRANSL, V3, P280, DOI 10.1007/s12265-010-9173-y; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; GOMEZ JP, 1994, PFLUG ARCH EUR J PHY, V428, P241, DOI 10.1007/BF00724503; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kishore R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060161; Lee KM, 2012, BIOCHEM BIOPH RES CO, V428, P50, DOI 10.1016/j.bbrc.2012.09.145; Liu LF, 2014, APOPTOSIS, V19, P19, DOI 10.1007/s10495-013-0899-2; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Marko SB, 2008, AM J PHYSIOL-HEART C, V294, pH2646, DOI 10.1152/ajpheart.00291.2008; Matsubayashi Keiji, 2003, Circulation, V108 Suppl 1, pII219, DOI 10.1161/01.cir.0000087450.34497.9a; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nguyen BK, 2010, J CARDIOVASC TRANSL, V3, P547, DOI 10.1007/s12265-010-9171-0; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Seideman J, 2002, J IMMUNOL METHODS, V267, P165, DOI 10.1016/S0022-1759(02)00168-0; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Shin JH, 2014, CARDIOVASC DRUG THER, V28, P211, DOI 10.1007/s10557-014-6519-8; Song YS, 2014, CELL TRANSPLANT; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006; Zhang BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100298	55	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179972	10.1371/journal.pone.0179972	http://dx.doi.org/10.1371/journal.pone.0179972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662151	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300083
J	Bijleveld, E; Baalbergen, J				Bijleveld, Erik; Baalbergen, Joost			Prenatal exposure to testosterone (2D:4D) and social hierarchy together predict voice behavior in bankers	PLOS ONE			English	Article							DIGIT RATIO 2D4D; EMPLOYEE SILENCE; FINGER LENGTHS; 2ND; RESPONSES; 2D/4D; ASSOCIATIONS; METAANALYSIS; ANTECEDENTS; PERFORMANCE	Prohibitive voice behaviors are employees' expressions of concern about practices, incidents, or behaviors that may potentially harm the organization. In this study, we examined a potential biological correlate of prohibitive voice: prenatal exposure to testosterone. In a sample of bankers, we used 2D:4D (i.e., the ratio of the length of the index finger to the length of the ring finger) as a marker for prenatal exposure to testosterone (lower 2D:4D suggests higher prenatal exposure to testosterone). We used a self-report scale to measure prohibitive voice. For low-ranked employees, lower 2D:4D was related to using less voice. No such relation was found for high-ranked employees. Conclusions should be drawn with caution, because the findings only applied to voice regarding the organization as a whole (and not to voice regarding the own team), and because of methodological limitations. However, the findings are consistent with the ideas that (a) people low in 2D:4D tend to strive to attain and maintain social status and that (b) remaining silent about perceived problems in the organization is at least for low-ranked employees a means to achieve this goal.	[Bijleveld, Erik] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands; [Baalbergen, Joost] Univ Utrecht, Dept Psychol, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University	Bijleveld, E (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands.	e.bijleveld@psych.ru.nl			Netherlands Organisation for Scientific Research [016-165-100]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	During the analysis and writing stages of this paper, EB was supported by grant 016-165-100 from the Netherlands Organisation for Scientific Research (pmw.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson C, 2010, RES ORGAN BEHAV, V30, P55, DOI 10.1016/j.riob.2010.08.002; [Anonymous], 2013, THESIS COLUMBIA U NE; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Apicella CL, 2015, ADAPT HUM BEHAV PHYS, V1, P358, DOI 10.1007/s40750-014-0020-2; Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Boksem MAS, 2013, PSYCHOL SCI, V24, P2306, DOI 10.1177/0956797613495063; BOOTH A, 1989, HORM BEHAV, V23, P556, DOI 10.1016/0018-506X(89)90042-1; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Coates JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008036; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Detert JR, 2007, ACAD MANAGE J, V50, P869; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Garza P, 2011, PLOS ONE, V6; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Howlett C, 2015, BEHAV ECOL SOCIOBIOL, V69, P61, DOI 10.1007/s00265-014-1817-5; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; LePine JA, 1998, J APPL PSYCHOL, V83, P853, DOI 10.1037/0021-9010.83.6.853; Liang J, 2012, ACAD MANAGE J, V55, P71, DOI 10.5465/amj.2010.0176; Loi R, 2014, INT J HOSP MANAG, V36, P23, DOI 10.1016/j.ijhm.2013.08.001; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2008, AM J HUM BIOL, V20, P110, DOI 10.1002/ajhb.20689; Millet K, 2007, PERS INDIV DIFFER, V43, P289, DOI 10.1016/j.paid.2006.11.024; Millet K, 2011, PERS INDIV DIFFER, V51, P397, DOI 10.1016/j.paid.2010.04.005; Milliken FJ, 2003, J MANAGE STUD, V40, P1453, DOI 10.1111/1467-6486.00387; Milliken FJ, 2003, J MANAGE STUD, V40, P1563, DOI 10.1111/1467-6486.00391; Morrison EW, 2011, ACAD MANAG ANN, V5, P373, DOI 10.1080/19416520.2011.574506; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Neyse L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23294; Puts DA, 2015, HORM BEHAV, V70, P14, DOI 10.1016/j.yhbeh.2015.01.006; Ronay R, 2010, J BEHAV DECIS MAKING, V23, P473, DOI 10.1002/bdm.671; RUSBULT CE, 1988, ACAD MANAGE J, V31, P599, DOI 10.2307/256461; Ryan KD, 1998, DRIVING FEAR OUT WOR, V2nd; Ryckmans J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143307; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Simmons J. P., 2013, M SOC PERS SOC PSYCH; Stamper CL, 2001, J ORGAN BEHAV, V22, P517, DOI 10.1002/job.100; Stenstrom E, 2011, PERS INDIV DIFFER, V51, P412, DOI 10.1016/j.paid.2010.07.003; Tangirala S, 2008, PERS PSYCHOL, V61, P37, DOI 10.1111/j.1744-6570.2008.00105.x; Van den Bergh B, 2006, P ROY SOC LOND B BIO, P273; Van den Broeck A, 2010, J OCCUP ORGAN PSYCH, V83, P981, DOI 10.1348/096317909X481382; Van Dyne L, 2003, J MANAGE STUD, V40, P1359, DOI 10.1111/1467-6486.00384; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Voracek M, 2009, PSICOTHEMA, V21, P382; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weis SE, 2007, PERS INDIV DIFFER, V43, P485, DOI 10.1016/j.paid.2006.12.017; WITHEY MJ, 1989, ADMIN SCI QUART, V34, P521, DOI 10.2307/2393565; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	59	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180008	10.1371/journal.pone.0180008	http://dx.doi.org/10.1371/journal.pone.0180008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658299	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900052
J	Castellanos, N; Martinez, LC; Silva, EH; Teodoro, AV; Serrao, JE; Oliveira, EE				Castellanos, Nathaly; Martinez, Luis C.; Silva, Eder H.; Teodoro, Adenir V.; Serrao, Jose Eduardo; Oliveira, Eugenio E.			Ultrastructural analysis of salivary glands in a phytophagous stink bug revealed the presence of unexpected muscles	PLOS ONE			English	Article							DIGESTIVE ENZYMES; GROSS MORPHOLOGY; PREDATORY BUG; SOYBEAN SEED; HEMIPTERA; HETEROPTERA; PENTATOMIDAE; COCKROACH; AMYLASE; DAMAGE	The exceptional abilities of stink bugs (Hemiptera: Pentatomidae) to colonize a diverse group of plants have been attributed to the feeding behaviors and the functions of the salivary complex of these insects. Here, we describe the ultrastructure of the salivary glands of the Neotropical brown stink bug, Euschistus heros, which is a major component of the pentatomid pest complex on soybeans, Glycine max, in the neotropics. Our results revealed a salivary gland complex consisting of two lobes (i.e., anterior and posterior), with a constriction between them (i.e., the hilum), in which the salivary and accessory gland ducts are inserted. The principal gland epithelium has a single layer of cells lining an enlarged lumen filled with saliva, and these cells are cuboidal, rich in rough endoplasmic reticulum and secretory vesicles, with well-developed nuclei, all of which are typical features of protein-secreting cells. We report, for the first time in insects, the presence of a layer of muscle cells surrounding the columnar hilum epithelium. The accessory salivary gland cells are cuboidal with nuclei containing condensed chromatin and cytoplasm rich in vacuoles and rough endoplasmic reticulum, indicating the potential involvement of these glands in water transport/secretion. The lumen content of each lobe of the principal gland suggests that the lobes produce different compounds. Thus, our results suggest that the E. heros salivary complex might have unconventional mechanisms to mix/release saliva, which might help explain the polyphagous abilities of these insects.	[Castellanos, Nathaly; Silva, Eder H.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Martinez, Luis C.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Teodoro, Adenir V.] Embrapa Tabuleiros Costeiros, Av Beira Mar 3250, Aracaju, SE, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	eugenio@ufv.br	de Oliveira, Eugenio Eduardo/ABE-8935-2021; Teodoro, Adenir/AAY-1190-2021; Martínez, Luis Carlos/H-4495-2013; de Oliveira, Eugênio Eduardo/F-4045-2016	de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Martínez, Luis Carlos/0000-0001-7741-2984; Castellanos, Nathaly/0000-0001-8713-5183	Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao Arthur Bernardes (FUNARBE)	Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao Arthur Bernardes (FUNARBE)	This work was supported by awards from the Coordenacao a de Aperfeicaoamento de Pessoal de Nivel Superior (CAPES Foundation), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Fundacao Arthur Bernardes (FUNARBE). The funders had no role in study design, data collection	AMMAR E, 1986, INT J INSECT MORPHOL, V15, P417, DOI 10.1016/0020-7322(86)90034-6; Azambuja R, 2013, NEOTROP ENTOMOL, V42, P359, DOI 10.1007/s13744-013-0132-6; Azevedo DD, 2007, BRAZ ARCH BIOL TECHN, V50, P469, DOI 10.1590/S1516-89132007000300013; Baptist BA, 1941, Q J MICROSC SCI, V83, P91; Baumann O., 2002, BMC PHYSIOL, V2, P1, DOI [10.1186/1472-6793-2-9, DOI 10.1186/1472-6793-2-9]; Borges M., 2006, METODOLOGIAS CRIACAO; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; COHEN AC, 1995, ANNU REV ENTOMOL, V40, P85, DOI 10.1146/annurev.en.40.010195.000505; Cohen Allen Carson, 1998, American Entomologist, V44, P103; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Costa Lima A, 1942, ESCOLA NACL AGRONOMI, V2; De Castro AA, 2013, ANN ENTOMOL SOC AM, V106, P273, DOI 10.1603/AN12070; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Kumar SM, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.1901; Martinez LC, 2015, MICROSC MICROANAL, V21, P1514, DOI 10.1017/S1431927615015469; Martinez LC, 2014, PROTOPLASMA, V251, P535, DOI 10.1007/s00709-013-0549-0; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES PW, 1976, EXPERIENTIA, V32, P1011, DOI 10.1007/BF01933942; MILES PW, 1964, J INSECT PHYSIOL, V10, P147, DOI 10.1016/0022-1910(64)90103-9; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; Nodari EF, 2011, EXP PARASITOL, V128, P151, DOI 10.1016/j.exppara.2011.02.003; Nunes PH, 2006, MICRON, V37, P57, DOI 10.1016/j.micron.2005.06.005; Oliveira JA, 2006, B ENTOMOL RES, V96, P251, DOI 10.1079/BER2006420; Panizzi A.R., 2012, SOJA MANEJO INTEGRAD, P335; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roma Gislaine Cristina, 2003, Cytologia (Tokyo), V68, P101, DOI 10.1508/cytologia.68.101; Santos CA, 2005, SOCIOBIOLOGY, V46, P579; Serrao JE, 2008, J MED ENTOMOL, V45, P991, DOI 10.1603/0022-2585(2008)45[991:UOTSGI]2.0.CO;2; Silva CC, 2008, PESQUI AGROPECU BRAS, V43, P575, DOI 10.1590/S0100-204X2008000500004; Silva FAC, 2012, NEOTROP ENTOMOL, V41, P386, DOI 10.1007/s13744-012-0061-9; Silva FAC, 2011, NEOTROP ENTOMOL, V40, P35, DOI 10.1590/S1519-566X2011000100005; Smaniotto LF, 2015, FLA ENTOMOL, V98, P7, DOI 10.1653/024.098.0103; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; SUTHERLA.DJ, 1968, J INSECT PHYSIOL, V14, P21, DOI 10.1016/0022-1910(68)90130-3; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Torres JB, 2009, BRAZ ARCH BIOL TECHN, V52, P1199, DOI 10.1590/S1516-89132009000500018; Tuelher ES, 2016, COMPETITION PHYTOPHA; Vinokurov K, 2014, J INSECT PHYSIOL, V60, P58, DOI 10.1016/j.jinsphys.2013.11.005; WHITEHEAD AT, 1971, J MORPHOL, V135, P483, DOI 10.1002/jmor.1051350405; Zeng F, 2000, COMP BIOCHEM PHYS A, V126, P101, DOI 10.1016/S1095-6433(00)00193-8; Zhong HY, 2013, MICRON, V45, P83, DOI 10.1016/j.micron.2012.10.019	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179478	10.1371/journal.pone.0179478	http://dx.doi.org/10.1371/journal.pone.0179478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658296	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900026
J	Chatterjee, S; Talaat, KR; van Seventer, EE; Feng, CG; Scott, AL; Jedlicka, A; Dziedzic, A; Nutman, TB				Chatterjee, Soumya; Talaat, Kawsar R.; van Seventer, Emily E.; Feng, Carl G.; Scott, Alan L.; Jedlicka, Anne; Dziedzic, Amanda; Nutman, Thomas B.			Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages	PLOS ONE			English	Article							IMMUNE-RESPONSE; TUBERCULOSIS INFECTION; WUCHERERIA-BANCROFTI; LYMPHATIC FILARIASIS; EFFECTOR FUNCTION; GENE-EXPRESSION; DENDRITIC CELLS; HUMAN MONOCYTES; PATHOGENS; LUNG	IL-4 drives expansion of Th2 cells that cause generation of alternatively activated macrophages (AAMs). Filarial infections are established early in life, induce increased IL-4 production are co-endemic with tuberculosis (TB). We sought to understand, therefore, how mycobacteria are handled in the context of IL-4-induced AAM. Comparing IL-4 generated in vitro monocyte derived human AAMs to LPS and IFN-gamma generated classically macrophages (CAMs), both infected with mycobacteria (BCG), we demonstrated increased early BCG uptake and increased IL-10 production in AAMs compared to CAMs. We further demonstrated that increased IL-10 production is mediated by upregulation of tumor progression locus 2 (TPL-2), an upstream activator of extracellular signal related kinases (ERKs) in AAMs but not in CAMs, both at the transcript as well as the protein level. Pharmacologic inhibition of TPL-2 significantly diminished IL-10 production only in BCG-infected AAMs. Finally, we validated our findings in an in vivo C57Bl/6 model of filarial infection, where an exaggerated Th2 induced lung-specific alternative activation led to TPL-2 and IL-10 upregulation on subsequent TB infection. These data show that in response to mycobacterial infection, IL-4 generated AAMs in chronic filarial infections have impaired immune responses to TB infection by increasing IL-10 production in a TPL-2 mediated manner.	[Chatterjee, Soumya; Talaat, Kawsar R.; van Seventer, Emily E.; Feng, Carl G.; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Scott, Alan L.; Jedlicka, Anne; Dziedzic, Amanda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Chatterjee, Soumya] St Louis Univ, Doisy Res Ctr, Div Infect Dis Allergy & Immunol, Dept Internal Med, St Louis, MO 63103 USA; [Talaat, Kawsar R.] Johns Hopkins Univ, Dept Int Hlth, Div Global Epidemiol & Control, Baltimore, MD USA; [Feng, Carl G.] Univ Sydney, Cent Clin Sch, Div Infect Dis & Immunol, Dept Med, Sydney, NSW, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Saint Louis University; Johns Hopkins University; University of Sydney	Chatterjee, S (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.; Chatterjee, S (corresponding author), St Louis Univ, Doisy Res Ctr, Div Infect Dis Allergy & Immunol, Dept Internal Med, St Louis, MO 63103 USA.	chatterjees@slu.edu		Chatterjee, Soumya/0000-0003-3628-3738; feng, carl/0000-0003-4301-4640	Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197] Funding Source: NIH RePORTER	Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported [in part] by the Division of Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Anuradha R, 2013, J IMMUNOL, V191, P2466, DOI 10.4049/jimmunol.1300911; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Bonecini-Almeida MG, 1998, MEM I OSWALDO CRUZ, V93, P399, DOI 10.1590/S0074-02761998000300023; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hamlin KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001941; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Katz MS, 2013, J PEDIATR SURG, V48, P345, DOI 10.1016/j.jpedsurg.2012.11.013; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nutman TB, 2001, PARASITE IMMUNOL, V23, P389, DOI 10.1046/j.1365-3024.2001.00399.x; O'Leary S., 2011, CELL MOL BIOL, V45, P172, DOI [10.1165/rcmb.2010-0319OC, DOI 10.1165/RCMB.2010-03190C]; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Porthouse KH, 2006, INFECT IMMUN, V74, P2366, DOI 10.1128/IAI.74.4.2366-2372.2006; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rothfuchs AG, 2009, J IMMUNOL, V182, P6915, DOI 10.4049/jimmunol.0900074; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Schlesinger LS, 1996, J INVEST MED, V44, P312; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Semnani RT, 2011, INFECT IMMUN; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; WHO, 2014, GLOB TUB REP 2014; Yoneda T, 1998, AM J RESP CRIT CARE, V158, P395, DOI 10.1164/ajrccm.158.2.9707102	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179701	10.1371/journal.pone.0179701	http://dx.doi.org/10.1371/journal.pone.0179701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658262	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900038
J	Langbein, J				Langbein, Joerg			Firewood, smoke and respiratory diseases in developing countries-The neglected role of outdoor cooking	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; SOLID-FUEL USE; PARTICULATE MATTER; BIOMASS FUELS; PNEUMONIA; BEHAVIOR; HEALTH; RISK; COMBUSTION; HOUSEHOLDS	Smoke from cooking in the kitchen is one of the world's leading causes of premature child death, claiming the lives of 500,000 children under five annually. This study analyses the role of outdoor cooking and the prevalence of respiratory diseases among children under five years by means of probit regressions using information from 41 surveys conducted in 30 developing countries from Asia, Africa and Latin America. I find that outdoor cooking reduces respiratory diseases among young children aged 0-4 by around 9 percent, an effect that reaches 13 percent among children aged 0-1. The results suggest that simple behavioral interventions, such as promoting outdoor cooking, can have a substantial impact on health hazards.	[Langbein, Joerg] RWI Leibniz Inst Econ Res, Hohenzollernstr 1-3, D-45128 Essen, Germany; [Langbein, Joerg] Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany	RWI - Leibniz Institut fur Wirtschaftsforschung; Ruhr University Bochum	Langbein, J (corresponding author), RWI Leibniz Inst Econ Res, Hohenzollernstr 1-3, D-45128 Essen, Germany.; Langbein, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	joerg.langbein@rwi-essen.de			Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	This research was under taken while I was part of the junior research group at RWI led by Prof. Dr. Jorg Peters.The group itself is parly financed by the Ministerium fur Innovation,Wissenschaft und Forschung des landes Nordrhein-Westfalen under the following programme : http://www.wissenschaft.nrw.de/forschung/foerderung/sonstigefoerderprogramme/foerderprogrammnachwuchsforschungsgruppennrw-2015-2021/. Further funding by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum is acknowledged.The funders had no role in study design,data collection and analysis, decision to publish,orpreparation of the manuscript.	Albalak R, 1999, THORAX, V54, P1004, DOI 10.1136/thx.54.11.1004; Amegah AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113920; Anenberg SC, 2013, ENVIRON SCI TECHNOL, V47, P3944, DOI 10.1021/es304942e; [Anonymous], 2014, BURD DIS JOINT EFF H; Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069; Balakrishnan K, 2014, IND QUAL GUID HOUS F; Barnes B, 2015, J HEALTH COMMUN, V20, P3, DOI 10.1080/10810730.2014.996305; Barnes BR, 2014, INT J ENV RES PUB HE, V11, P4607, DOI 10.3390/ijerph110504607; Bensch G, 2015, J HEALTH ECON, V42, P44, DOI 10.1016/j.jhealeco.2015.03.006; Boadi KO, 2006, J BIOSOC SCI, V38, P403, DOI 10.1017/S0021932005026635; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; Buchner H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128933; Dasgupta S, 2009, INDOOR AIR, V19, P22, DOI 10.1111/j.1600-0668.2008.00558.x; Dasgupta S, 2006, HEALTH POLICY PLANN, V21, P444, DOI 10.1093/heapol/czl027; Dasgupta S, 2015, J ENVIRON DEV, V24, P345, DOI 10.1177/1070496515588590; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; DHS Demographic and Health Survey, 2006, GUIDE DHS STAT DEMOG; ESMAP Energy Sector Management Assistance Program, 2015, STAT GLOB CLEAN IMPR; Ezzati M, 2002, ENVIRON HEALTH PERSP, V110, P1057, DOI 10.1289/ehp.021101057; Goodwin NJ, 2015, J HEALTH COMMUN, V20, P43, DOI 10.1080/10810730.2014.1002958; Haspil-Corgan TA, 2004, ANN EMERG MED, V44, pS37, DOI 10.1016/j.annemergmed.2004.07.121; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; Jin Y, 1982, SOC SCI MED, V62, p3161 ; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martin WJ, 2011, SCIENCE, V334, P180, DOI 10.1126/science.1213088; McCracken JP, 2012, GLOB HEART, V7, P223, DOI 10.1016/j.gheart.2012.06.010; Moya J, 2004, PEDIATRICS, V113, P996; Nasir ZA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024002; Pande JN, 1998, RESP MED TROPICS; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Rao S, 2012, ENVIRON MODEL ASSESS, V17, P613, DOI 10.1007/s10666-012-9317-3; Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685; Rosa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091011; Ruth M, 2013, INT J SERVICE LEARNI, P151; SA Sy., 2022, ENERGY RES SOC SCI, V89; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Van Vliet EDS, 2013, ENVIRON RES, V127, P40, DOI 10.1016/j.envres.2013.08.009; WHO, 2014, IND AIR QUAL GUID HO; Yu F, 2011, ENVIRON RESOUR ECON, V50, P495, DOI 10.1007/s10640-011-9479-5	43	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178631	10.1371/journal.pone.0178631	http://dx.doi.org/10.1371/journal.pone.0178631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658290	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900007
J	Myers, NM; Leung, IC; Mcgee, SW; Eggleson, K; Lieberman, M				Myers, Nicholas M.; Leung, Ivan C.; McGee, Sean W.; Eggleson, Kathleen; Lieberman, Marya			Green design of a paper test card for urinary iodine analysis	PLOS ONE			English	Article							SANDELL-KOLTHOFF REACTION; DEFICIENCY; CHILDREN; PHONES; IRON; IONS	When young children do not receive adequate amounts of the micronutrient iodine in their diet, their growth and cognitive development can be impaired. Nearly every country in the world has programs in place to track iodine intake and provide supplemental iodine if needed, usually in the form of fortified salt. The iodine nutrition status of a population can be tracked by monitoring iodine levels in urine samples to see if the median value falls in the range of 100-300 micrograms of iodine per liter of urine (mu g I/L), which indicates adequate or more than adequate iodine nutrition. Many low and middle-income countries (LMIC) do not have a laboratory capable of carrying out this challenging assay, so samples must be sent out for assay in external labs, which is expensive and time-consuming. In most LMIC, population iodine surveys are carried out every 5-10 years, which limits the utility of the data for program monitoring and evaluation. To solve this problem, we developed a field-friendly paper test card that uses the Sandell-Kolthoff reaction to measure urinary iodine levels. A blind internal validation study showed that 93% of samples (n = 60) of iodide in an artificial urine matrix were categorized correctly by visual analysis as deficient, adequate, or excessive for levels set forth by the World Health Organization. Quantitative measurements based on computer image analysis had an error of 40 +/- 20 mu g I/L (n = 35 for samples in the calibration range) and these results categorized 88% of the samples (n = 60) correctly. We employed lifecycle analysis principles to address the known toxicity of arsenic, which is an obligatory reagent in the Sandell-Kolthoff reaction. Disposal of the cards in a landfill (their most likely destination after use) could let arsenic leach into groundwater; toxicity characteristic leaching procedure (TCLP) tests showed that the level of arsenic leached from the cards was 28.78 ppm, which is above the United States Environmental Protection Agency's limit of 5 parts per million for solid waste. We integrated a remediation module into the card. This module contains oxone, to oxidize As(III) to As(V) oxyacids, and the iron oxide goethite. TCLP testing showed that the leachable amount of arsenic was reduced by at least 97.6% - from 28.8 ppm to lower than 0.7 +/- 0.7 ppm (n = 20). This upstream intervention rendered the test card suitable for landfilling while retaining its functionality to perform a critical public health evaluation.	[Myers, Nicholas M.; Leung, Ivan C.; Lieberman, Marya] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [McGee, Sean W.; Eggleson, Kathleen] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA; [Leung, Ivan C.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Eggleson, Kathleen] Indiana Univ Sch Med, Dept Med, South Bend, IN 46615 USA; [Eggleson, Kathleen] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA	University of Notre Dame; University of Notre Dame; Georgetown University; Indiana University System; Indiana University South Bend; Indiana University System; Indiana University South Bend	Lieberman, M (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Eggleson, K (corresponding author), Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA.; Eggleson, K (corresponding author), Indiana Univ Sch Med, Dept Med, South Bend, IN 46615 USA.; Eggleson, K (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA.	keggleso@nd.edu; mlieberm@nd.edu	Lieberman, Marya/AAG-9542-2021	Myers, Nicholas/0000-0003-0270-2930; Lieberman, Marya/0000-0003-3968-8044	Global Alliance for Improved Nutrition; Notre Dame College of Science Undergraduate Research Fellowship; Serim Research Corporation; Center for Nano Science and Technology	Global Alliance for Improved Nutrition; Notre Dame College of Science Undergraduate Research Fellowship; Serim Research Corporation; Center for Nano Science and Technology	This work was supported by Global Alliance for Improved Nutrition (http://www.gainhealth.org/) (NMM); Notre Dame College of Science Undergraduate Research Fellowship (http://science.nd.edu/research/undergraduate-research/) (ICL); Serim Research Corporation (http://www.serim.com/) (ICL); and The Center for Nano Science and Technology (http://nano.nd.edu/) (SWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Anastas P. T., 1998, GREEN CHEM THEORY PR; [Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2015, GLOBAL IODINE NUTR S; [Anonymous], 2004, TOXICITY CHARACTERIS, P1; [Anonymous], 2016, EQUIP ROUND 43; Bourdoux P, 1988, IDD NEWSLETTER, V4, P8; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chaplan CA, 2014, ANAL METHODS-UK, V6, P1296, DOI 10.1039/c4ay00205a; Dixit S, 2003, ENVIRON SCI TECHNOL, V37, P4182, DOI 10.1021/es030309t; DUNN JT, 1993, THYROID, V3, P119, DOI 10.1089/thy.1993.3.119; Ferreira T., IMAGEJ USER GUIDE IJ; Giles DE, 2011, J ENVIRON MANAGE, V92, P3011, DOI 10.1016/j.jenvman.2011.07.018; Gnat D, 2003, CLIN CHEM, V49, P186, DOI 10.1373/49.1.186; Lee DK, 2011, PHYS CHEM CHEM PHYS, V13, P1239, DOI 10.1039/c003991h; Makhmudov AA., 2011, CHALLENGE IODINE DEF; Markou KB, 2002, THYROID, V12, P407, DOI 10.1089/105072502760043495; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Ohashi T, 2000, CLIN CHEM, V46, P529; Pino S, 1998, EXP CLIN ENDOCR DIAB, V106, pS22, DOI 10.1055/s-0029-1212041; Putman DF, 1971, COMPOSITION CONCENTR; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; Rendl J, 1998, J CLIN ENDOCR METAB, V83, P1007, DOI 10.1210/jc.83.3.1007; Sandell EB, 1934, J AM CHEM SOC, V56, P1426, DOI 10.1021/ja01321a510; Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741h, 10.1039/c2lc40741]; STOLC V, 1961, FRESEN Z ANAL CHEM, V183, P262, DOI 10.1007/BF00474698; Viera AJ, 2005, FAM MED, V37, P360; Yagoda H., 1937, IND ENG CHEM ANAL ED, V9, P79; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	32	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179716	10.1371/journal.pone.0179716	http://dx.doi.org/10.1371/journal.pone.0179716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658293	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900040
J	Fu, J; Liu, ZH; Li, ZT; Wang, YF; Yang, KJ				Fu, Jian; Liu, Zhihua; Li, Zuotong; Wang, Yufeng; Yang, Kejun			Alleviation of the effects of saline-alkaline stress on maize seedlings by regulation of active oxygen metabolism by Trichoderma asperellum	PLOS ONE			English	Article							IMPROVES SALT TOLERANCE; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; CUCUMBER GROWTH; ZEA-MAYS; HARZIANUM; ACID; RESPONSES; ENZYMES	This study investigated the influence of Trichoderma asperellum on active oxygen production in maize seedlings under saline-alkaline stress conditions. Two maize cultivars were tested: 'Jiangyu 417' ('JY417'), which can tolerate saline-alkaline stress; and, 'Xianyu 335' ('XY335'), which is sensitive to saline-alkaline stress. The seedlings were grown on natural saline-alkaline soil (pH 9.30) in plastic pots. To each liter of saline-alkaline soil, 200 mL of T. asperellum spore suspension was applied; three fungal suspensions were used, namely, 1 x 10(3), 1 x 10(6), and 1 x 10(9) spores/L. A control with only the vehicle applied was also established, along with a second control in which untreated meadow soil (pH 8.23) was used. Root and leaf samples were collected when the seedlings had three heart-shaped leaves and the fourth was in the developmental phase. Physical and biochemical parameters related to oxidation resistance were assessed. The results indicated that the 'JY417' and 'XY335' seedlings showed different degrees of oxidative damage and differences in their antioxidant defense systems under saline-alkaline stress. As the spore density of the fungal suspension increased, the K+ and Ca2+ contents in the seedlings increased, but Na+ content decreased. Moreover, fungal treatment promoted the synthesis or accumulation of osmolytes, which enhanced the water absorbing capacity of the cells, increased antioxidant enzyme activities, enhanced the content of non-enzyme antioxidants, and reduced the accumulation of reactive oxygen species. Fungal treatment alleviated oxidative damage caused by the saline-alkaline stress in roots and leaves of the seedlings. The application of T. asperellum overcame the inhibitory effect of saline-alkaline soil stress on the growth of maize seedlings. In the present experiment, application with 1 x 10 9 spores/L gave the optimal results.	[Fu, Jian; Li, Zuotong; Wang, Yufeng; Yang, Kejun] Heilongjiang Bayi Agr Univ, Key Lab Crop Germplasm Improvement & Cultivat Col, Educ Dept, Coll Agron, Daqing, Peoples R China; [Liu, Zhihua] Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Forestry University - China	Yang, KJ (corresponding author), Heilongjiang Bayi Agr Univ, Key Lab Crop Germplasm Improvement & Cultivat Col, Educ Dept, Coll Agron, Daqing, Peoples R China.	byndykj@163.com			National science and technology support plan of China [2013BAD07B01]; Chinese National science and technology support plan [2015BAD23B05-04]; Heilongjiang Bayi Agricultural university graduate student innovation fund projects [YJSCX2016-Z01]	National science and technology support plan of China; Chinese National science and technology support plan; Heilongjiang Bayi Agricultural university graduate student innovation fund projects	This work was supported by grants from National science and technology support plan of China (2013BAD07B01); Chinese National science and technology support plan (2015BAD23B05-04); Heilongjiang Bayi Agricultural university graduate student innovation fund projects (YJSCX2016-Z01).; Our thanks go to the Forestry College of Northeast Forestry University "Trichoderma research team" for providing the "Dedicated trichoderma of maize. This work was supported by grants from the National Science and Technology Support Plan of China (2013BAD07B01); Chinese National Science and Technology Support Plan (2015BAD23B05-04); Heilongjiang Bayi Agricultural University graduate student innovation fund projects (YJSCX2016-Z01).	Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Aebi H, 1984, Methods Enzymol, V105, P121; Ahmad P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00868; Akcin A, 2016, BRAZ J BOT, V39, P101, DOI 10.1007/s40415-015-0218-y; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Arora A, 2002, CURR SCI INDIA, V82, P1227; Azarmi R, 2011, AFR J BIOTECHNOL, V10, P5850; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brotman Y, 2013, PLOS PATHOG, V9, P14; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Ci DW, 2009, CHEMOSPHERE, V77, P1620, DOI 10.1016/j.chemosphere.2009.08.062; EGLEY GH, 1983, PLANTA, V157, P224, DOI 10.1007/BF00405186; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guler NS, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2153-3; Hashem A, 2014, J PLANT INTERACT, V9, P857, DOI 10.1080/17429145.2014.983568; Hermosa R, 2011, J PLANT PHYSIOL, V168, P1295, DOI 10.1016/j.jplph.2011.01.027; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kim SY, 2005, J BIOCHEM MOL BIOL, V38, P218; Kim Y, 2004, PLANT GROWTH REGUL, V44, P87, DOI 10.1007/s10725-004-2746-5; Kumar K, 2017, J BASIC MICROB, V57, P141, DOI 10.1002/jobm.201600369; Li J, 2012, PLANT PHYSIOL, V159, P1771, DOI 10.1104/pp.112.195370; Mastouri F, 2012, MOL PLANT MICROBE IN, V25, P1264, DOI 10.1094/MPMI-09-11-0240; Mastouri F, 2010, PHYTOPATHOLOGY, V100, P1213, DOI 10.1094/PHYTO-03-10-0091; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neto ADD, 2006, ENVIRON EXP BOT, V56, P87, DOI 10.1016/j.envexpbot.2005.01.008; Pandey V, 2016, PLANTA, V243, P1251, DOI 10.1007/s00425-016-2482-x; Petrov VD, 2012, AOB PLANTS, V10, P4; Qi WZ, 2013, J BASIC MICROB, V53, P355, DOI 10.1002/jobm.201200031; Rawat L, 2011, PLANT SOIL, V347, P387, DOI 10.1007/s11104-011-0858-z; SCHAEDLE M, 1977, PLANT PHYSIOL, V59, P1011, DOI 10.1104/pp.59.5.1011; Sekmen AH, 2012, ENVIRON EXP BOT, V77, P63, DOI 10.1016/j.envexpbot.2011.10.012; Shoresh M, 2008, PLANT PHYSIOL, V147, P2147, DOI 10.1104/pp.108.123810; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Singh PK, 2013, PHYSIOL MOL BIOL PLA, V19, P53, DOI 10.1007/s12298-012-0126-6; Sohrabi Y, 2012, SYMBIOSIS, V56, P5, DOI 10.1007/s13199-012-0152-8; Stepien P, 2005, PHYSIOL PLANTARUM, V125, P31, DOI 10.1111/j.1399-3054.2005.00534.x; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Viterbo A, 2010, FEMS MICROBIOL LETT, V305, P42, DOI 10.1111/j.1574-6968.2010.01910.x; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wang XP, 2011, SCI HORTIC-AMSTERDAM, V130, P248, DOI 10.1016/j.scienta.2011.07.006; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu LH, 2014, BIOL PLANTARUM, V58, P751, DOI 10.1007/s10535-014-0442-5; Yin LN, 2013, ACTA PHYSIOL PLANT, V35, P3099, DOI 10.1007/s11738-013-1343-5; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zhang FG, 2013, PLANT SOIL, V368, P433, DOI 10.1007/s11104-012-1519-6; Zhang S, 2016, FRONTIERS PLANT SCI, V7; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x	54	34	35	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179617	10.1371/journal.pone.0179617	http://dx.doi.org/10.1371/journal.pone.0179617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654652	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500021
J	Zhao, MZ; Wang, TL; Wu, P; Guo, WY; Su, LT; Wang, Y; Liu, YJ; Yan, F; Wang, QY				Zhao, Mingzhu; Wang, Tianliang; Wu, Ping; Guo, Wenyun; Su, Liantai; Wang, Ying; Liu, Yajing; Yan, Fan; Wang, Qingyu			Isolation and characterization of GmMYBJ3, an R2R3-MYB transcription factor that affects isoflavonoids biosynthesis in soybean	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; SYNTHASE; DROUGHT; FAMILY; PLANTS	Isoflavonoids are secondary metabolites that play a variety of roles in plant-microbe interactions and plant defenses against abiotic stresses. Here we report a new MYB transcription factor (TF) gene, GmMYBJ3, that is involved in the isoflavonoids biosynthesis. The GmMYBJ3 gene is 1,002 bp long and encodes a protein of 333 amino acids. Amino acid sequence analysis showed that GmMYBJ3 is a typical R2R3 MYB TF. Yeast expression experiment demonstrated that GmMYBJ3 has its transcription activity in the nucleus and is transiently expressed in onion epidermal cells. The GmMYBJ3 gene was transformed into soybean and the expression activity of the GmMYBJ3 gene was significantly positively correlated with total isoflavonoid accumulation in soybean. Transient expression assays indicated that GmMYBJ3 can activate CHS8 expression. Furthermore, we analyzed the expressions of several genes known involved in the isoflavonoid biosynthesis, including CHS8, CHI1A, PAL1, IFS2 and F3H, in the GmMYBJ3 transgenic plants. The results showed that the expression levels of CHS8 and CHI1A were significantly increased in the transgenic plants compared to wild-type plants, but those of PAL1, IFS2 and F3H remained similar between the transgenic and wild-type plants. These results suggest that GmMYBJ3 participates in the isoflavonoid biosynthesis through regulation of CHS8 and CHI1A in soybean.	[Zhao, Mingzhu; Wang, Tianliang; Wu, Ping; Guo, Wenyun; Su, Liantai; Wang, Ying; Liu, Yajing; Yan, Fan; Wang, Qingyu] Jilin Univ, Coll Plant Sci, Jilin Key Lab Crop Genet Engn, Changchun, Jilin, Peoples R China	Jilin University	Wang, QY (corresponding author), Jilin Univ, Coll Plant Sci, Jilin Key Lab Crop Genet Engn, Changchun, Jilin, Peoples R China.	qywang@jlu.edu.cn			National Natural Science Foundation of China [31671714]; Major Science and Technology Sponsored Program for Transgenic Biological Breeding [2014ZX08004-003, 016ZX08004-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Sponsored Program for Transgenic Biological Breeding	This work was supported by the National Natural Science Foundation of China (No.31671714) and the Major Science and Technology Sponsored Program for Transgenic Biological Breeding (No. 2014ZX08004-003, No. (016ZX08004-003).	Aoki T, 2000, J PLANT RES, V113, P475, DOI 10.1007/PL00013958; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Dastmalchi M, 2015, PLANTA, V241, P507, DOI 10.1007/s00425-014-2200-5; Dhaubhadel S, 2007, PLANT PHYSIOL, V143, P326, DOI 10.1104/pp.106.086306; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gomez-Maldonado J, 2004, PLANT J, V39, P513, DOI 10.1111/j.1365-313X.2004.02153.x; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Gutierrez-Gonzalez JJ, 2011, THEOR APPL GENET, V123, P1375, DOI 10.1007/s00122-011-1673-x; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kassem MA, 2004, J BIOMED BIOTECHNOL, P52, DOI 10.1155/S1110724304304018; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Liu XQ, 2013, PLANT BIOTECHNOL REP, V7, P445, DOI 10.1007/s11816-013-0283-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Pueppke SG, 1996, CRIT REV BIOTECHNOL, V16, P1, DOI 10.3109/07388559609146599; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Smallwood C.J, 2012, DETECTION QUANTITATI; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Su LT, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1889-5; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2008, CROP SCI, V48, pS49, DOI 10.2135/cropsci2007.10.0542tpg; Vadivel AKA, 2016, PHYTOCHEM REV, V15, P391, DOI 10.1007/s11101-015-9431-3; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; Yi JX, 2010, PLANTA, V231, P741, DOI 10.1007/s00425-009-1079-z; Yu O, 2003, PHYTOCHEMISTRY, V63, P753, DOI 10.1016/S0031-9422(03)00345-5; Zeng GL, 2009, THEOR APPL GENET, V118, P1455, DOI 10.1007/s00122-009-0994-5	51	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179990	10.1371/journal.pone.0179990	http://dx.doi.org/10.1371/journal.pone.0179990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654660	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500047
J	Fernandez-Tendero, E; Day, A; Legros, S; Habrant, A; Hawkins, S; Chabbert, B				Fernandez-Tendero, Eva; Day, Arnaud; Legros, Sandrine; Habrant, Anouck; Hawkins, Simon; Chabbert, Brigitte			Changes in hemp secondary fiber production related to technical fiber variability revealed by light microscopy and attenuated total reflectance Fourier transform infrared spectroscopy	PLOS ONE			English	Article							CANNABIS-SATIVA L.; FT-IR SPECTROSCOPY; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; INDUSTRIAL HEMP; HARVEST TIME; BAST FIBERS; CELL-WALL; QUALITY; YIELD	Interest in hemp (Cannabis sativa L.) is increasing due to the development of a new range of industrial applications based on bast fibers. However the variability of bast fiber yield and quality represents an important barrier to further exploitation. Primary and secondary fiber content was examined in two commercial hemp varieties (Fedora 17, Santhica 27) grown under contrasted sowing density and irrigation conditions. Both growing conditions and hemp varieties impact stem tissue architecture with a large effect on the proportion of secondary fibers but not primary fibers. Attenuated total reflectance infrared spectroscopy allowed the discrimination of manually-isolated native primary fibers and secondary fibers but did not reveal any clustering according to growing conditions and variety. Infrared data were confirmed by wet chemistry analyses that revealed slight but significant differences between primary and secondary fiber cell wall composition. Infrared spectroscopy of technical fibers obtained after mechanical defibering revealed differences with native primary, but not secondary fibers and also discriminated samples obtained from plants grown under different conditions. Altogether the results suggested that the observed variability of hemp technical fibers could be partially explained by i) differences in secondary fiber production and ii) differential behavior during mechanical defibering resulting in unequal separation of primary and secondary fibers.	[Fernandez-Tendero, Eva; Habrant, Anouck; Chabbert, Brigitte] Univ Reims, INRA, FARE Lab, Reims, France; [Fernandez-Tendero, Eva; Day, Arnaud; Hawkins, Simon] Univ Lille, CNRS, UGSF, UMR 8576, Lille, France; [Fernandez-Tendero, Eva; Day, Arnaud] Fibres Rech Dev, Troyes, France; [Legros, Sandrine] Terres Inovia, Troyes, France	INRAE; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Chabbert, B (corresponding author), Univ Reims, INRA, FARE Lab, Reims, France.	brigitte.chabbert@inra.fr	Chabbert, Brigitte/Q-8746-2019; chabbert, brigitte/A-3438-2009	Chabbert, Brigitte/0000-0001-9887-3122; chabbert, brigitte/0000-0001-9887-3122	Champagne-Ardenne Region; Nord - Pas de Calais Region; European Union (FEDER funds); French Association for Research and Technology; Troyes Champagne Metropole	Champagne-Ardenne Region(Region Grand-Est); Nord - Pas de Calais Region(Region Hauts-de-FranceEuropean Commission); European Union (FEDER funds)(European Commission); French Association for Research and Technology; Troyes Champagne Metropole	This work was performed in the frame of the project MAPROFI (MAitrise des PROprietes des fibres de chanvre (fibre / chenevotte), dans le cadre de valorisations en agro-composites base polymere) funded by the Champagne-Ardenne and Nord - Pas de Calais Regions, the European Union (FEDER funds), the French Association for Research and Technology, and Troyes Champagne Metropole.	Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Abot A, 2013, J COMPOS MATER, V47, P1067, DOI 10.1177/0021998313477669; Akerholm M, 2001, POLYMER, V42, P963, DOI 10.1016/S0032-3861(00)00434-1; Amaducci S, 2000, IND CROP PROD, V11, P179, DOI 10.1016/S0926-6690(99)00063-1; Amaducci S, 2008, FIELD CROP RES, V107, P161, DOI 10.1016/j.fcr.2008.02.002; Arend M, 2007, TREE PHYSIOL, V27, P985, DOI 10.1093/treephys/27.7.985; Beaugrand J, 2004, CARBOHYD RES, V339, P2529, DOI 10.1016/j.carres.2004.08.012; Berta M, 2009, J PLANT PHYSIOL, V166, P521, DOI 10.1016/j.jplph.2008.08.005; Blake AW, 2008, PLANTA, V228, P1, DOI 10.1007/s00425-008-0713-5; Bonatti PM, 2004, EUPHYTICA, V140, P55, DOI 10.1007/s10681-004-4755-x; Cronier D, 2005, J AGR FOOD CHEM, V53, P8279, DOI 10.1021/jf051253k; Dai DS, 2011, VIB SPECTROSC, V55, P300, DOI 10.1016/j.vibspec.2010.12.009; FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21; Faruk O, 2012, PROG POLYM SCI, V37, P1552, DOI 10.1016/j.progpolymsci.2012.04.003; Gorshkova T, 2012, CRIT REV PLANT SCI, V31, P201, DOI 10.1080/07352689.2011.616096; Hanninen T, 2012, IND CROP PROD, V39, P7, DOI 10.1016/j.indcrop.2012.01.025; Hoppner F., 1995, Journal of the International Hemp Association, V2, P18; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Islam MS, 2010, J POLYM ENVIRON, V18, P696, DOI 10.1007/s10924-010-0225-9; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Kabir MM, 2012, COMPOS PART B-ENG, V43, P159, DOI 10.1016/j.compositesb.2011.06.003; Kostic MM, 2010, IND CROP PROD, V32, P169, DOI 10.1016/j.indcrop.2010.04.014; Le Troedec M, 2008, COMPOS PART A-APPL S, V39, P514, DOI 10.1016/j.compositesa.2007.12.001; Liu M, 2015, IND CROP PROD, V76, P880, DOI 10.1016/j.indcrop.2015.07.046; Liu M, 2015, IND CROP PROD, V69, P29, DOI 10.1016/j.indcrop.2015.02.010; Lupoi JS, 2014, BIOENERG RES, V7, P1, DOI 10.1007/s12155-013-9352-1; Mediavilla V., 1999, Agrarforschung, V6, P393; Mediavilla V, 2001, IND CROP PROD, V13, P49, DOI 10.1016/S0926-6690(00)00052-2; Ouajai S, 2005, MACROMOL BIOSCI, V5, P124, DOI 10.1002/mabi.200400151; Pickering KL, 2007, J BIOBASED MATER BIO, V1, P109, DOI 10.1166/jbmb.2007.012; Placet V, 2014, J MATER SCI, V49, P8317, DOI 10.1007/s10853-014-8540-5; Ranalli P, 2004, EUPHYTICA, V140, P121, DOI 10.1007/s10681-004-4760-0; Sankari HS, 2000, IND CROP PROD, V11, P73, DOI 10.1016/S0926-6690(99)00038-2; Santos JDG, 2013, CARBOHYD POLYM, V92, P1997, DOI 10.1016/j.carbpol.2012.11.089; Schafer TA, 2006, IND CROP PROD, V23, P88, DOI 10.1016/j.indcrop.2005.04.003; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; Thygesen LG, 2011, J MATER SCI, V46, P2135, DOI 10.1007/s10853-010-5049-4; Westerhuis W, 2009, ANN APPL BIOL, V155, P225, DOI 10.1111/j.1744-7348.2009.00334.x	38	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179794	10.1371/journal.pone.0179794	http://dx.doi.org/10.1371/journal.pone.0179794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640922	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800066
J	Furui, A; Hayashi, H; Nakamura, G; Chin, T; Tsuji, T				Furui, Akira; Hayashi, Hideaki; Nakamura, Go; Chin, Takaaki; Tsuji, Toshio			An artificial EMG generation model based on signal-dependent noise and related application to motion classification	PLOS ONE			English	Article							MYOELECTRIC SIGNAL; OPTIMAL MYOPROCESSOR; VOLUME CONDUCTOR; ELECTROMYOGRAPHY; CONTRACTIONS; MUSCLES	This paper proposes an artificial electromyogram (EMG) signal generation model based on signal-dependent noise, which has been ignored in existing methods, by introducing the stochastic construction of the EMG signals. In the proposed model, an EMG signal variance value is first generated from a probability distribution with a shape determined by a commanded muscle force and signal-dependent noise. Artificial EMG signals are then generated from the associated Gaussian distribution with a zero mean and the generated variance. This facilitates representation of artificial EMG signals with signal-dependent noise superimposed according to the muscle activation levels. The frequency characteristics of the EMG signals are also simulated via a shaping filter with parameters determined by an autoregressive model. An estimation method to determine EMG variance distribution using rectified and smoothed EMG signals, thereby allowing model parameter estimation with a small number of samples, is also incorporated in the proposed model. Moreover, the prediction of variance distribution with strong muscle contraction from EMG signals with low muscle contraction and related artificial EMG generation are also described. The results of experiments conducted, in which the reproduction capability of the proposed model was evaluated through comparison with measured EMG signals in terms of amplitude, frequency content, and EMG distribution demonstrate that the proposed model can reproduce the features of measured EMG signals. Further, utilizing the generated EMG signals as training data for a neural network resulted in the classification of upper limb motion with a higher precision than by learning from only measured EMG signals. This indicates that the proposed model is also applicable to motion classification.	[Furui, Akira] Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Hayashi, Hideaki; Tsuji, Toshio] Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Nakamura, Go] Hyogo Rehabil Ctr, Robot Rehabil Ctr, Kobe, Hyogo, Japan; [Chin, Takaaki] Hyogo Rehabil Ctr Hosp, Dept Orthoped Surgeon, Kobe, Hyogo, Japan	Hiroshima University; Hiroshima University	Furui, A (corresponding author), Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan.; Tsuji, T (corresponding author), Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan.	furui@bsys.hiroshima-u.ac.jp; tsuji@bsys.hiroshima-u.ac.jp	Furui, Akira/AAA-1127-2019; Tsuji, Toshio/D-6210-2011	Furui, Akira/0000-0003-1554-6607; Tsuji, Toshio/0000-0002-7689-3963; Hayashi, Hideaki/0000-0002-4800-1761				Bilodeau M, 1997, J ELECTROMYOGR KINES, V7, P87, DOI 10.1016/S1050-6411(96)00024-7; Blok JH, 2002, ANN BIOMED ENG, V30, P566, DOI 10.1114/1.1475345; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Burg J., 1967, 37 ANN INT MEET; Clancy EA, 2001, IEEE ENG MED BIOL, V20, P47, DOI 10.1109/51.982275; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Farina D, 2004, IEEE T BIO-MED ENG, V51, P415, DOI 10.1109/TBME.2003.820998; Fukuda O, 2003, IEEE T ROBOTIC AUTOM, V19, P210, DOI 10.1109/TRA.2003.808873; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hayashi H, 2017, IEEE TRANS BIOMED EN; HOGAN N, 1980, IEEE T BIO-MED ENG, V27, P396, DOI 10.1109/TBME.1980.326653; HOGAN N, 1980, IEEE T BIO-MED ENG, V27, P382, DOI 10.1109/TBME.1980.326652; Huang H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056005; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; HUNTER IW, 1987, MED BIOL ENG COMPUT, V25, P121, DOI 10.1007/BF02442838; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Ju ZJ, 2014, IEEE-ASME T MECH, V19, P456, DOI 10.1109/TMECH.2013.2240312; Khezri M, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-45; Lowery MM, 2002, IEEE T BIO-MED ENG, V49, P446, DOI 10.1109/10.995683; Lucas MF, 2008, BIOMED SIGNAL PROCES, V3, P169, DOI 10.1016/j.bspc.2007.09.002; Nazarpour K, 2013, BRAIN RES BULL, V90, P88, DOI 10.1016/j.brainresbull.2012.09.012; PARKER PA, 1986, CRIT REV BIOMED ENG, V13, P283; PERSON RS, 1970, ELECTROEN CLIN NEURO, V28, P625, DOI 10.1016/0013-4694(70)90205-1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHWEDYK E, 1977, IEEE T BIO-MED ENG, V24, P417, DOI 10.1109/TBME.1977.326175; Song R, 2008, IEEE T NEUR SYS REH, V16, P371, DOI 10.1109/TNSRE.2008.926707; Tanizaki H., 2008, EC B, V3, P1; Tsuji T, 1999, IEEE T SYST MAN CY C, V29, P60, DOI 10.1109/5326.740670; Vredenbregt J., 1973, CLIN BIOMECH, V24, P607, DOI [10.1159/000394062, DOI 10.1159/000394062]; Witkovsky V, 2001, KYBERNETIKA, V37, P79; WOODS JJ, 1983, AM J PHYS MED REHAB, V62, P287	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0180112	10.1371/journal.pone.0180112	http://dx.doi.org/10.1371/journal.pone.0180112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640883	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800091
J	Zhang, D; Lee, H; Haspel, JA; Jin, Y				Zhang, Duo; Lee, Heedoo; Haspel, Jeffrey A.; Jin, Yang			Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150	FASEB JOURNAL			English	Article						epithelial cell; hyperoxia; lncRNA array; lung injury; epigenetic regulation	IN-VITRO; INFLAMMATION; HOMEOSTASIS	The function of most human long noncoding RNAs (lncRNAs) remains unclear. Our studies identified a highly up-regulated mammalian lncRNA, FOXD3-AS1, known as linc1623 in mice, in the setting of hyperoxia/reactive oxygen species (ROS)-induced lung injury. We found that ROS induced a robust expression of FOXD3-AS1 in mouse lung tissue. Functionally, FOXD3-AS1 promoted oxidative stress-induced lung epithelial cell death. In human lung epithelial cells, the microRNA-150 (miR-150) was identified to interact with FOXD3-AS1; this finding was confirmed using the luciferase reporter assays. Consistently, mutation on the miR-150 pairing sequence in FOXD3-AS1 abolished the interactions between FOXD3-AS1 and miR-150. Additionally, miR-150 mimics suppressed the level of FOXD3-AS1. The antisense oligos of FOXD3-AS1 significantly augmented the intracellular level of miR-150, supporting the theory of sponging effects of FOXD3-AS1 on miR-150. We further investigated the cellular function of miR-150 in our lung injury models. MiR-150 conferred a cytoprotective role in lung epithelial cells after oxidative stress, whereas FOXD3-AS1 promoted cell death. Taken together, our studies indicated that FOXD3-AS1 serves as a sponge or as a competing endogenous noncoding RNA for miR-150, restricting its capability to promote cell growth and thereby exaggerating hyperoxia-induced lung epithelial cell death.-Zhang, D., Lee, H., Haspel, J. A., Jin, Y. Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150.	[Zhang, Duo; Lee, Heedoo; Jin, Yang] Boston Univ, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Haspel, Jeffrey A.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA	Boston University; Washington University (WUSTL)	Jin, Y (corresponding author), Boston Univ, Div Pulm & Crit Care Med, Dept Med, 72 E Concord St, N Andover, MA 02118 USA.	yjin1@bu.edu	Haspel, J./K-3563-2019; Zhang, Duo/U-6203-2019; Zhang, Duo/GYU-8678-2022; Zhang, Duo/S-2034-2016	Lee, Heedoo/0000-0001-7652-3930; Zhang, Duo/0000-0003-0361-4174	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL102076]; NIH National Institute of Allergy and Infectious Diseases [R21AI121644]; NIH National Institute of General Medical Sciences [R01GM111313]; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111313] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01HL102076 (to Y.J.), NIH National Institute of Allergy and Infectious Diseases Grant R21AI121644 (to Y.J.), and NIH National Institute of General Medical Sciences Grant R01GM111313 (to Y.J.). Funding for open access is from the NIH.	Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao MH, 2014, EUR J CANCER, V50, P1013, DOI 10.1016/j.ejca.2013.12.024; Chen WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132734; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Dalessandri T, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00347; Fang ZH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.256; Gomes AQ, 2013, INT J MOL SCI, V14, P16010, DOI 10.3390/ijms140816010; Groppera MA, 2008, CURR OPIN CRIT CARE, V14, P11, DOI 10.1097/MCC.0b013e3282f417a0; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Isakov O, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks228; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35250; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li J, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0052-6; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rajput C, 2016, ARTERIOSCL THROM VAS, V36, P380, DOI 10.1161/ATVBAHA.115.306997; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vir P, 2014, APMIS, V122, P268, DOI 10.1111/apm.12141; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yin QW, 2015, INT J CLIN EXP PATHO, V8, P842; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhang D, 2016, CELL REP, V16, P757, DOI 10.1016/j.celrep.2016.06.040; Zhang D, 2016, AM J PHYSIOL-LUNG C, V310, pL700, DOI 10.1152/ajplung.00392.2015	33	47	50	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4472	4481		10.1096/fj.201700091R	http://dx.doi.org/10.1096/fj.201700091R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28655711	Green Published			2022-12-26	WOS:000413397400024
J	Lima, KM; Vago, JP; Caux, TR; Negreiros-Lima, GL; Sugimoto, MA; Tavares, LP; Arribada, RG; Carmo, AAF; Galvao, I; Costa, BRC; Soriani, FM; Pinho, V; Solito, E; Perretti, M; Teixeira, MM; Sousa, LP				Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Galvao, Izabela; Costa, Bruno Rocha C.; Soriani, Frederico M.; Pinho, Vanessa; Solito, Egle; Perretti, Mauro; Teixeira, Mauro M.; Sousa, Lirlndia P.			The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FORMYL PEPTIDE RECEPTOR; 2/LIPOXIN A(4) RECEPTOR; NITRIC-OXIDE SYNTHASE; NEUTROPHIL APOPTOSIS; PROTEIN-KINASE; LIPOCORTIN 1; NUCLEOTIDE PHOSPHODIESTERASES; SIGNALING PATHWAY; DOWN-REGULATION	Annexin A1 (AnxA1) is a glucocorticoid-regulated protein known for its anti-inflammatory and pro-resolving effects. We have shown previously that the cAMP-enhancing compounds rolipram (ROL; a PDE4 inhibitor) and Bt(2)cAMP (a cAMP mimetic) drive caspase-dependent resolution of neutrophilic inflammation. In this follow-up study, we investigated whether AnxA1 could be involved in the pro-resolving properties of these compounds using a model of LPS-induced inflammation in BALB/c mice. The treatment with ROL or Bt(2)cAMP at the peak of inflammation shortened resolution intervals, improved resolution indices, and increased AnxA1 expression. In vitro studies showed that ROL and Bt(2)cAMP induced AnxA1 expression and phosphorylation, and this effect was prevented by PKA inhibitors, suggesting the involvement of PKA in ROL-induced AnxA1 expression. Akin to these in vitro findings, H89 prevented ROL- and Bt(2)cAMP-induced resolution of inflammation, and it was associated with decreased levels of intact AnxA1. Moreover, two different strategies to block the AnxA1 pathway (by using N-t-Boc-Met-Leu-Phe, a nonselective AnxA1 receptor antagonist, or by using an anti-AnxA1 neutralizing antiserum) prevented ROL-and Bt(2)cAMP-induced resolution and neutrophil apoptosis. Likewise, the ability of ROL or Bt(2)cAMP to induce neutrophil apoptosis was impaired in AnxA-knock-out mice. Finally, in in vitro settings, ROL and Bt(2)cAMP overrode the survival-inducing effect of LPS in human neutrophils in an AnxA1-dependent manner. Our results show that AnxA1 is at least one of the endogenous determinants mediating the pro-resolving properties of cAMP-elevating agents and cAMP-mimetic drugs.	[Lima, Katia M.; Vago, Juliana P.; Pinho, Vanessa; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Programa Posgrad Biol Celular, BR-31270901 Belo Horizonte, MG, Brazil; [Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Costa, Bruno Rocha C.; Pinho, Vanessa; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, BR-31270901 Belo Horizonte, MG, Brazil; [Lima, Katia M.; Vago, Juliana P.; Caux, Thais R.; Negreiros-Lima, Graziele Leticia; Sugimoto, Michelle A.; Tavares, Luciana P.; Arribada, Raquel G.; Carmo, Aline Alves F.; Galvao, Izabela; Costa, Bruno Rocha C.; Pinho, Vanessa; Teixeira, Mauro M.; Sousa, Lirlndia P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, BR-31270901 Belo Horizonte, MG, Brazil; [Soriani, Frederico M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Genet, BR-31270901 Belo Horizonte, MG, Brazil; [Solito, Egle; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of London; Queen Mary University London	Sousa, LP (corresponding author), Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	lipsousa72@gmail.com	Pinho, Vanessa/AAR-1686-2021; Sugimoto, Michelle Amantea/ABB-2024-2020; Pinho, Vanessa/GXM-8532-2022; pinho, vanessa/AAC-8437-2020; DA SILVA, JULIANA PRISCILA VAGO/F-7386-2019; Soriani, Frederico M/A-8896-2013; Teixeira, Mauro M/A-4587-2008	Sugimoto, Michelle Amantea/0000-0002-4527-6065; pinho, vanessa/0000-0003-1038-2324; DA SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; Soriani, Frederico M/0000-0003-4720-6746; Teixeira, Mauro M/0000-0002-6944-3008; Padua Tavares, Luciana/0000-0002-5319-0210; Negreiros Lima, Graziele/0000-0001-7212-6006; Solito, Egle/0000-0001-5279-0049	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil; European Community [HEALTH-F4-2011-281608]; William Harvey Research Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil; European Community(European Commission); William Harvey Research Foundation	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil), Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais-PRPq, Brazil, and the European Community's Seventh Framework Programme (FP7-2007-2013) under Grant Agreement HEALTH-F4-2011-281608. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the William Harvey Research Foundation.	Ahmad F, 2015, ORAL DIS, V21, pE25, DOI 10.1111/odi.12275; Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Antonicelli F, 2001, EUR J BIOCHEM, V268, P62, DOI 10.1046/j.1432-1327.2001.01840.x; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; Brancaleone V, 2011, J IMMUNOL, V186, P4905, DOI 10.4049/jimmunol.1003145; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Castro-Caldas M, 2003, MEDIAT INFLAMM, V12, P329, DOI 10.1080/09629350310001633351; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Ding L, 2016, SCI REP-UK, V6, DOI 10.1038/srep34374; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Ferlazzo V, 2003, INT IMMUNOPHARMACOL, V3, P1363, DOI 10.1016/S1567-5769(03)00133-4; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Lucas CD, 2013, FASEB J, V27, P1084, DOI 10.1096/fj.12-218990; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Minghetti L, 1999, BRIT J PHARMACOL, V126, P1307, DOI 10.1038/sj.bjp.0702423; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Montero J, 2016, FISH SHELLFISH IMMUN, V55, P632, DOI 10.1016/j.fsi.2016.06.044; Montero-Melendez T, 2013, CELL DEATH DIFFER, V20, P567, DOI 10.1038/cdd.2012.154; Montero-Melendez T, 2011, AM J PATHOL, V179, P259, DOI 10.1016/j.ajpath.2011.03.042; Murphy MP, 2015, IMMUNOL RES, V62, P225, DOI 10.1007/s12026-015-8655-z; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; Oh J, 2000, FEBS LETT, V477, P244, DOI 10.1016/S0014-5793(00)01812-3; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Parkkonen J, 2008, PULM PHARMACOL THER, V21, P499, DOI 10.1016/j.pupt.2007.11.003; Parvathenani LK, 1998, J BIOL CHEM, V273, P6736, DOI 10.1074/jbc.273.12.6736; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Rossi AG, 1995, BIOCHEM BIOPH RES CO, V217, P892, DOI 10.1006/bbrc.1995.2855; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Shishikura K, 2016, BRIT J PHARMACOL, V173, P319, DOI 10.1111/bph.13373; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Sousa LP, 2013, CURR OPIN PHARMACOL, V13, P625, DOI 10.1016/j.coph.2013.03.007; Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154; Souza DG, 2005, BRIT J PHARMACOL, V145, P246, DOI 10.1038/sj.bjp.0706190; Tabe Y, 2007, CELL DEATH DIFFER, V14, P1443, DOI 10.1038/sj.cdd.4402139; Takahashi HK, 2009, J PHARMACOL EXP THER, V331, P656, DOI 10.1124/jpet.109.157594; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Taylor AD, 2000, ENDOCRINOLOGY, V141, P2209, DOI 10.1210/en.141.6.2209; Teixeira MM, 1997, BRIT J PHARMACOL, V121, P77, DOI 10.1038/sj.bjp.0701107; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tiwari S, 2004, BLOOD, V103, P2661, DOI 10.1182/blood-2003-06-2154; Vago JP, 2016, J IMMUNOL, V196, P1922, DOI 10.4049/jimmunol.1500886; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; WU CC, 1995, P NATL ACAD SCI USA, V92, P3473, DOI 10.1073/pnas.92.8.3473; Yang JH, 2012, EXP NEUROL, V236, P199, DOI 10.1016/j.expneurol.2012.05.008; Yazid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058963; Yazid S, 2010, ARTERIOSCL THROM VAS, V30, P1718, DOI 10.1161/ATVBAHA.110.209536; Yazid S, 2009, BIOCHEM PHARMACOL, V77, P1814, DOI 10.1016/j.bcp.2009.03.010	78	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13758	13773		10.1074/jbc.M117.800391	http://dx.doi.org/10.1074/jbc.M117.800391			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655761	Green Published, hybrid			2022-12-26	WOS:000407942400015
J	Trautz, B; Wiedemann, H; Luchtenborg, C; Pierini, V; Kranich, J; Glass, B; Krausslich, HG; Brocker, T; Pizzato, M; Ruggieri, A; Brugger, B; Fackler, OT				Trautz, Birthe; Wiedemann, Hannah; Luechtenborg, Christian; Pierini, Virginia; Kranich, Jan; Glass, Barbel; Kreausslich, Hans-Georg; Brocker, Thomas; Pizzato, Massimo; Ruggieri, Alessia; Bruegger, Britta; Fackler, Oliver T.			The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHOTGUN MASS-SPECTROMETRY; PATHOGENICITY FACTOR NEF; HEPATITIS-C VIRUS; NF-KAPPA-B; PHOSPHATIDYLSERINE RECEPTORS; IMMUNOLOGICAL SYNAPSE; LACTADHERIN BINDS; T-CELLS; MEMBRANE	The host-cell restriction factor SERINC5 potently suppresses the infectivity of HIV, type 1 (HIV-1) particles, and is counteracted by the viral pathogenesis factor Nef. However, the molecular mechanism by which SERINC5 restricts HIV-1 particle infectivity is still unclear. Because SERINC proteins have been suggested to facilitate the incorporation of serine during the biosynthesis of membrane lipids and because lipid composition of HIV particles is a major determinant of the infectious potential of the particles, we tested whether SERINC5-mediated restriction of HIV particle infectivity involves alterations of membrane lipid composition. We produced and purified HIV-1 particles from SERINC5293T cells with very low endogenous SERINC5 levels under conditions in which ectopically expressed SERINC5 restricts HIV-1 infectivity and is antagonized by Nef and analyzed both virions and producer cells with quantitative lipid MS. SERINC5 restriction and Nef antagonism were not associated with significant alterations in steady-state lipid composition of producer cells and HIV particles. Sphingosine metabolism kinetics were also unaltered by SERINC5 expression. Moreover, the levels of phosphatidylserine on the surface of HIV-1 particles, which may trigger uptake into non-productive internalization pathways in target cells, did not change upon expression of SERINC5 or Nef. Finally, saturating the phosphatidylserine-binding sites on HIV target cells did not affect SERINC5 restriction or Nef antagonism. These results demonstrate that the restriction of HIV-1 particle infectivity by SERINC5 does not depend on alterations in lipid composition and organization of HIV-1 particles and suggest that channeling serine into lipid biosynthesis may not be a cardinal cellular function of SERINC5.	[Trautz, Birthe; Pierini, Virginia; Fackler, Oliver T.] Univ Hosp Heidelberg, Dept Infect Dis, Integrat Virol, INF 324, D-69120 Heidelberg, Germany; [Glass, Barbel; Kreausslich, Hans-Georg] Univ Hosp Heidelberg, Dept Infect Dis, Virol, INF 324, D-69120 Heidelberg, Germany; [Wiedemann, Hannah; Luechtenborg, Christian; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, INF 328, D-69120 Heidelberg, Germany; [Ruggieri, Alessia] Univ Hosp Heidelberg, Dept Infect Dis, Mol Virol, INF 345, D-69120 Heidelberg, Germany; [Pizzato, Massimo] Univ Trento, Ctr Integrat Biol, I-38122 Trento, Italy; [Kranich, Jan; Brocker, Thomas] Ludwig Maximilians Univ Munchen, Inst Immunol, Grosshardener Str 9, D-82152 Planegg Martinsried, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Trento; University of Munich	Fackler, OT (corresponding author), Univ Hosp Heidelberg, Dept Infect Dis, Integrat Virol, INF 324, D-69120 Heidelberg, Germany.; Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, INF 328, D-69120 Heidelberg, Germany.	britta.bruegger@bzh.uni-heidelberg.de; oliver.fackler@med.uni-heidelberg.de	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Brocker, Thomas/0000-0001-7060-5433; Ruggieri, Alessia/0000-0001-9981-3308; Kranich, Jan/0000-0002-9928-4132; Fackler, Oliver Till/0000-0003-2982-4209; Krausslich, Hans-Georg/0000-0002-8756-329X	Deutsche Forschungsgemeinschaft [TRR83, SFB1129];  [RU 1950/1-1];  [FA 378/17-1];  [KR 906/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; 	This work was supported by Deutsche Forschungsgemeinschaft TRR83 Projects 1 (to B. B.), 14 (to H. G. K.), and 15 (to O. T. F.); SFB1129 Project 10 (to B. B.); as well as Projects RU 1950/1-1 (to A. R.), FA 378/17-1 (to O. T. F.), and KR 906/8-1 (to H. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469; Arakelyan A, 2013, J CLIN INVEST, V123, P3716, DOI 10.1172/JCI67042; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chan WT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002713; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Chu EPF, 2017, MOL IMMUNOL, V82, P19, DOI 10.1016/j.molimm.2016.12.007; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 2015, VIRUSES-BASEL, V7, P6730, DOI 10.3390/v7122970; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gerl MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153009; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Imle A, 2016, VIROLOGY, V498, P44, DOI 10.1016/j.virol.2016.08.012; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Murrell B, 2016, J VIROL, V90, P8085, DOI 10.1128/JVI.00972-16; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ozbalci C, 2013, METHODS MOL BIOL, V1033, P3, DOI 10.1007/978-1-62703-487-6_1; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Sood C, 2017, J BIOL CHEM, V292, P6014, DOI 10.1074/jbc.M117.777714; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Wang J, 2017, J VIROL, V91, DOI 10.1128/JVI.01583-16	73	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13702	13713		10.1074/jbc.M117.797332	http://dx.doi.org/10.1074/jbc.M117.797332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28659343	Green Published, hybrid			2022-12-26	WOS:000407942400028
J	Cai, GT; Chen, BH; Li, Z; Wei, W; Wang, P; Dong, WQ				Cai, Gaotai; Chen, Bohong; Li, Zhen; Wei, Wei; Wang, Ping; Dong, Wenqi			The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis	PLOS ONE			English	Article							BIOMARKER CANDIDATES; HEPATIC-FIBROSIS; CYTOGLOBIN; ACTIVATION; CELLS	Liver fibrosis, a common pathological process of chronic liver diseases, is the final stage of liver dysfunction that has severely deleterious impact on human health. Cytoglobin was first discovered in 2001 by proteomic analysis in rat stellate cells and was reported to play an important role in controlling tissue fibrosis. However, the mechanism by which cytoglobin inhibits or reverses the progression of fibrosis remains unclear. The present study examines the effect of recombinant human cytoblobin (rhCygb) in a rat model of liver fibrosis. Proteomic approaches were employed to identify differentially expressed proteins in the fibrosis model. Optimized conditions for two-dimensional gel electrophoresis were developed to provide improved protein detection and separation. A total of 43 spots were obtained and, through the use of matrix-assisted laser desorption ionization time-of-flight mass spectrometry, 30 differentially expressed proteins were identified. Gene ontology term annotation and KEGG pathway analysis allowed us to explore the function of the represented proteins. Based on these results, we provide a theory of the molecular mechanism related to rhCygb reversion of fibrosis and which will assist in the identification of biomarkers in patient serum to improve early diagnosis of liver fibrosis.	[Cai, Gaotai; Chen, Bohong; Li, Zhen; Wei, Wei; Wang, Ping; Dong, Wenqi] Southern Med Univ, Dept Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Chen, Bohong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Dong, WQ (corresponding author), Southern Med Univ, Dept Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China.	dongwq63@263.net		Bohong, Chen/0000-0003-2745-1015	Guangdong Province Science and Technology Plan Project [20106031500012, 2013A022100027]; Guangzhou Science and Technology Project [201510010104]	Guangdong Province Science and Technology Plan Project; Guangzhou Science and Technology Project	This study was supported by the Guangdong Province Science and Technology Plan Project (No. 20106031500012, No. 2013A022100027) and the Guangzhou Science and Technology Project (No. 201510010104).	Chen S, 2015, EVID BASED COMPL ALT; Cheng HT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5185317; Cowan ML, 2010, TRENDS MOL MED, V16, P171, DOI 10.1016/j.molmed.2010.01.006; Cugno G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151599; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Han YH, 2012, BIOCHEM BIOPH RES CO, V426, P427, DOI 10.1016/j.bbrc.2012.08.113; Jimi Eijiro, 2016, Clin Calcium, V26, P298, DOI CliCa1602298304; Kataoka T, 2012, RENAL FAILURE, V34, P1181, DOI 10.3109/0886022X.2012.717496; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Latina A, 2016, ONCOGENE, V35, P1493, DOI 10.1038/onc.2015.222; Thuy LTT, 2015, AM J PATHOL, V185, P1045, DOI 10.1016/j.ajpath.2014.12.017; Lee JE, 2015, ASIAN AUSTRAL J ANIM, V28, P788, DOI 10.5713/ajas.14.0790; Li L., 2009, J PROTEOM BIOINFORM, V2, P485, DOI DOI 10.4172/JPB.1000110; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep23508; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Oleksiewicz U, 2011, CELL MOL LIFE SCI, V68, P3869, DOI 10.1007/s00018-011-0764-9; Raatschen N, 2012, CURR PROTOC MICROBIO; Ratib S, 2014, J HEPATOL, V60, P282, DOI 10.1016/j.jhep.2013.09.027; Roche S, 2009, J PROTEOMICS, V72, P945, DOI 10.1016/j.jprot.2009.03.008; Shi CC, 2016, AM J TRANSL RES, V8, P125; Sopena B, 1996, LIVER, V16, P303; Tejero J, 2016, BBA-MOL CELL BIOL L, V1861, P391, DOI 10.1016/j.bbalip.2016.02.022; Toosi AEK, 2015, ROM J INTERN MED, V53, P304, DOI 10.1515/rjim-2015-0039; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Wang JY, 1998, LIVER, V18, P180; Westermeier Reiner, 2011, Methods Biochem Anal, V54, P411; Yang LB, 2011, DIGEST DIS SCI, V56, P3305, DOI 10.1007/s10620-011-1745-4	29	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177968	10.1371/journal.pone.0177968	http://dx.doi.org/10.1371/journal.pone.0177968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662027	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300004
J	Cai, SS; Fischer, QS; He, Y; Zhang, L; Liu, HX; Daw, NW; Yang, YP				Cai, Shanshan; Fischer, Quentin S.; He, Yu; Zhang, Li; Liu, Hanxiao; Daw, Nigel W.; Yang, Yupeng			GABA(B) receptor-dependent bidirectional regulation of critical period ocular dominance plasticity in cats	PLOS ONE			English	Article							ADULT VISUAL-CORTEX; LONG-TERM POTENTIATION; DENDRITIC CA2+ SPIKES; PROTEIN-KINASE-A; MONOCULAR DEPRIVATION; RAT-BRAIN; INHIBITORY PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; DIFFERENT LAYERS	Gama amino butyric acid (GABA) inhibition plays an important role in the onset and offset of the critical period for ocular dominance (OD) plasticity in the primary visual cortex. Previous studies have focused on the involvement of GABAA receptors, while the potential contribution of GABAB receptors to OD plasticity has been neglected. In this study, the GABAB receptor antagonist SCH50911 or agonist baclofen was infused into the primary visual cortex of cats concurrently with a period of monocular deprivation (MD). Using single-unit recordings we found that the OD shift induced by four days of MD during the critical period was impaired by infusion of the antagonist SCH50911, but enhanced by infusion of the agonist baclofen. In contrast, seven days of MD in adult cats did not induce any significant OD shift, even when combined with the infusion of SCH50911 or baclofen. Together, these findings indicate that an endogenous GABAB receptor-mediated inhibition contributes to juvenile, but not adult, OD plasticity.	[Cai, Shanshan; He, Yu; Zhang, Li; Liu, Hanxiao; Yang, Yupeng] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei, Peoples R China; [Fischer, Quentin S.; Daw, Nigel W.; Yang, Yupeng] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Fischer, Quentin S.] Virginia Tech, Caril Res Inst, Roanoke, VA USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yale University; Virginia Polytechnic Institute & State University	Yang, YP (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei, Peoples R China.; Yang, YP (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	yangyp@ustc.edu.cn	Liu, Han/GVT-8296-2022; Yang, Yupeng/G-5107-2018	Yang, Yupeng/0000-0002-9473-9994; Fischer, Quentin/0000-0002-7803-1179; Liu, Hanxiao/0000-0002-9460-4803	National Natural Science Foundation of China [31371112, 30870809]; National Institutes of Health, National Eye Institute [EY00053, EY11353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Natural Science Foundation of China www.nsfc.gov.cn (31371112 and 30870809) to YY and National Institutes of Health, National Eye Institute of USA www.nei.nih.goV (EY00053 and EY11353) to NWD. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscrip	An X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093115; BEAR MF, 1990, J NEUROSCI, V10, P909; Beaver CJ, 2002, J NEUROPHYSIOL, V88, P1933, DOI 10.1152/jn.2002.88.4.1933; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Bowery NG, 1997, CNS DRUGS, V7, P167, DOI 10.2165/00023210-199707030-00001; Caddick SJ, 1996, MOL NEUROBIOL, V13, P23, DOI 10.1007/BF02740750; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Daw N, 2004, VISION RES, V44, P3377, DOI 10.1016/j.visres.2004.09.004; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Dichter MA, 1997, EPILEPSIA, V38, pS2, DOI 10.1111/j.1528-1157.1997.tb05200.x; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; Gu Y., 2016, ELIFE, V5, P5; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Heimel JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/391763; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang SY, 2010, J NEUROSCI, V30, P16636, DOI 10.1523/JNEUROSCI.4384-10.2010; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivenshitz M, 2006, J NEUROSCI, V26, P1199, DOI 10.1523/JNEUROSCI.2964-05.2006; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; JONES KR, 1984, J NEUROSCI, V4, P2543; Kamikubo Y, 2007, J PHYSIOL-LONDON, V585, P549, DOI 10.1113/jphysiol.2007.141010; KARBON EW, 1985, MOL PHARMACOL, V27, P53; KASAMATSU T, 1981, J NEUROPHYSIOL, V45, P254, DOI 10.1152/jn.1981.45.2.254; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Liu SL, 2003, CEREB CORTEX, V13, P864, DOI 10.1093/cercor/13.8.864; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHAW C, 1987, DEV BRAIN RES, V37, P67, DOI 10.1016/0165-3806(87)90229-X; Shimegi S, 2003, J NEUROPHYSIOL, V90, P4027, DOI 10.1152/jn.00313.2003; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Tabata T, 2010, ADV PHARMACOL, V58, P149, DOI 10.1016/S1054-3589(10)58007-4; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Uriguen L, 2011, J PSYCHOPHARMACOL, V25, P105, DOI 10.1177/0269881109358204; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Vorobyov V, 2013, J NEUROSCI, V33, P234, DOI 10.1523/JNEUROSCI.2283-12.2013; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wang L, 2014, J NEUROSCI, V34, P1083, DOI 10.1523/JNEUROSCI.4711-13.2014	67	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180162	10.1371/journal.pone.0180162	http://dx.doi.org/10.1371/journal.pone.0180162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662175	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300117
J	Ishizaki, A; Tran, VT; Nguyen, CH; Tanimoto, T; Hoang, HTT; Pham, HV; Phan, CTT; Bi, XQ; Pham, TV; Ichimura, H				Ishizaki, Azumi; Vuong Thi Tran; Cuong Hung Nguyen; Tanimoto, Tomoaki; Huyen Thi Thanh Hoang; Hung Viet Pham; Chung Thi Thu Phan; Bi, Xiuqiong; Thuc Van Pham; Ichimura, Hiroshi			Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; NORTHERN VIETNAM; INJECT DRUGS; HAI PHONG; COINFECTION; INFECTION; PEOPLE; RISK; INDIVIDUALS; DISEASE	We previously reported a significant reduction in the prevalence of human immunodeficiency virus type 1 (HIV) from 2007 to 2012 in people who inject drugs (PWID; 35.9% to 18.5%, p < 0.001) and female sex workers (FSW; 23.1% to 9.8%, p < 0.05), but not in blood donors (BD) or pregnant women, in Haiphong, Vietnam. Our aim in the present study was to assess trends in the prevalence of infection with hepatitis B and C viruses (HBV and HCV, respectively). We also investigated the coinfection rates of HBV and HCV with HIV in the same groups. Between 2007 and 2012, HBV prevalence was significantly decreased in BD (18.1% vs. 9.0%, p = 0.007) and slightly decreased in FSW (11.0% vs. 3.9%, p = 0.21), but not in PWID (10.7% vs. 11.1%, p = 0.84). HCV prevalence was significantly decreased in PWID (62.1% in 2007 vs. 42.7% in 2008, p < 0.0001), but it had rebounded to 58.4% in 2012 (2008 vs. 2012, p < 0.0001). HCV prevalence also increased in FSW: 28.6% in 2007 and 2009 vs. 35.3% in 2012; however, this difference was not significant (2007 vs. 2012, p = 0.41). Rates of coinfection with HBV and HCV among HIV-infected PWID and FSW did not change significantly during the study period. Our findings suggest that the current harm reduction programs designed to prevent HIV transmission in PWID and FSW may be insufficient to prevent the transmission of hepatitis viruses, particularly HCV, in Haiphong, Vietnam. New approaches, such as the introduction of catch-up HBV vaccination to vulnerable adult populations and the introduction of HCV treatment as prevention, should be considered to reduce morbidity and mortality due to HIV and hepatitis virus coinfection in Vietnam.	[Ishizaki, Azumi; Tanimoto, Tomoaki; Hung Viet Pham; Chung Thi Thu Phan; Bi, Xiuqiong; Ichimura, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan; [Vuong Thi Tran; Cuong Hung Nguyen; Huyen Thi Thanh Hoang; Thuc Van Pham] Hai Phong Univ Med & Pharm, Hai Phong, Vietnam	Kanazawa University; Hai Phong University Medicine & Pharmacy	Ichimura, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan.	ichimura@med.kanazawa-u.ac.jp	ICHIMURA, Hiroshi/L-3605-2015	ICHIMURA, Hiroshi/0000-0003-4478-1964	Japan Society for the Promotion of Science KAKENHI [JP15H05289]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number JP15H05289.	Ahmed T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1404-3; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; Bruggmann P, 2015, INT J DRUG POLICY, V26, pS22, DOI 10.1016/j.drugpo.2014.08.014; Huy BV, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/581021; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; Degenhardt L, 2016, LANCET INFECT DIS, V16, P1385, DOI 10.1016/S1473-3099(16)30325-5; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Pham HV, 2015, AIDS RES HUM RETROV, V31, P757, DOI [10.1089/AID.2015.0071, 10.1089/aid.2015.0071]; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Lima VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143836; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Ministry of Health Socialist Rebulic of Viet Nam, VIETN AIDS RESP REP; Nadol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118304; Palmateer NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104515; Pollack TM, 2016, J VIRUS ERAD, V2, P102; Scott N, 2016, J GASTROEN HEPATOL, V31, P872, DOI 10.1111/jgh.13223; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Nguyen TH, 2014, VACCINE, V32, P217, DOI 10.1016/j.vaccine.2013.11.004; Treloar C, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0107-0; van Santen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163488; Tran VT, 2012, AIDS RES HUM RETROV, V28, P1349, DOI 10.1089/aid.2012.0006; WHO, 2016, MYANM NATL SIMPL TRE; Ye SD, 2014, CURR HIV-AIDS REP, V11, P128, DOI 10.1007/s11904-014-0206-z; Zhang FJ, 2014, LANCET INFECT DIS, V14, P1065, DOI 10.1016/S1473-3099(14)70946-6; Zhang L, 2015, EUR J GASTROEN HEPAT, V27, P550, DOI 10.1097/MEG.0000000000000321	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179616	10.1371/journal.pone.0179616	http://dx.doi.org/10.1371/journal.pone.0179616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662105	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300040
J	Lee, JH; Giger, U; Kim, HY				Lee, Jae Ho; Giger, Urs; Kim, Hee Young			Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies	PLOS ONE			English	Article							TRANSFUSION COMPATIBILITY; BLOOD-GROUPS; GEL	Dog Erythrocyte Antigens (DEA) have thus far been found by sensitizing dogs with canine allogeneic blood and are clinically important regarding blood transfusion incompatibilities, but remain poorly defined. The goals of this study were to discover and characterize two DEAs, named as Kai 1 and Kai 2. The monoclonal antibodies were produced by mouse hybridoma techniques and examined by ELISA isotyping, immunoblotting, and affinity chromatography. Canine blood samples were typed and the development of alloantibodies was examined in transfused dogs. The monoclonal Kai 1 and Kai 2 antibodies were isotyped as IgM kappa and IgG3 lamda, respectively, and identified two different erythrocyte membrane proteins of 200 kDa and 80 kDa in molecular weights, respectively. Either Kai 1 or Kai 2 can be expressed but not both in an individual dog. There were no naturally occurring anti-Kai 1 or Kai 2 alloantibodies. In addition, Kai 1-and/or Kai 2- dogs developed Kai 1 and Kai 2 alloantibodies, respectively, when transfused with mismatched blood. This is the first discovery of canine blood types by screening monoclonal antibodies. Kai 1 and Kai 2 are novel blood types which can induce anti-Kai 1 or anti-Kai 2 alloantibodies when Kai 1-and/or Kai 2- dogs are transfused with Kai 1+ or Kai 2+ blood. These canine blood types may explain some of the blood incompatibilities and transfusion reactions observed in dogs in clinical practice.	[Lee, Jae Ho; Kim, Hee Young] Daegu Haany Univ, Coll Korean Med, Dept Physiol, KABB Bio Lab, Daegu, South Korea; [Giger, Urs] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA	Daegu Haany University; University of Pennsylvania	Kim, HY (corresponding author), Daegu Haany Univ, Coll Korean Med, Dept Physiol, KABB Bio Lab, Daegu, South Korea.	hykim@dhu.ac.kr		Kim, Hee Young/0000-0002-2495-9115	National Research Foundation of Korea [2014R1A2A1A11053104]; National Institutes of Health [OD 010939]	National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Research Foundation of Korea (2014R1A2A1A11053104; vv-ww.nrf.rekr) and National Institutes of Health (OD 010939; https:// wmi.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno MM, 2014, J VET INTERN MED, V28, P592, DOI 10.1111/jvim.12321; ANDREWS GA, 1992, J AM VET MED ASSOC, V201, P1549; Blais MC, 2009, J VET INTERN MED, V23, P462, DOI 10.1111/j.1939-1676.2009.0286.x; CALLAN MB, 1995, J VET INTERN MED, V9, P277, DOI 10.1111/j.1939-1676.1995.tb01080.x; Canard B, 2013, J VET EMERG CRIT CAR, V23, pS12; Corato A, 1997, VET IMMUNOL IMMUNOP, V59, P213, DOI 10.1016/S0165-2427(97)00080-9; Ernst Manfred, 1999, Human Antibodies, V9, P165; Euler CC, 2016, J VET INTERN MED, V30, P1642, DOI 10.1111/jvim.14572; GIGER U, 1995, J AM VET MED ASSOC, V206, P1358; Goulet S, 2017, J VET INTERN MED, V31, P751, DOI 10.1111/jvim.14693; Goulet S, 2017, J VET INTERN MED; Goulet S, 2017, VET PATHOL; Green JL, 2000, COMP HAEMATOL INT, V10, P30, DOI 10.1007/s005800070024; HALE AS, 1995, VET CLIN N AM-SMALL, V25, P1323, DOI 10.1016/S0195-5616(95)50157-3; HARA Y, 1991, J VET MED SCI, V53, P1105, DOI 10.1292/jvms.53.1105; Kessler RJ, 2010, VET CLIN PATH, V39, P306, DOI 10.1111/j.1939-165X.2010.00249.x; Klaus T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30938; Luethy D, 2016, J VET INTERN MED, V30, P1864, DOI 10.1111/jvim.14604; Moller M, 2016, BLOOD ADV, V1, P240, DOI 10.1182/bloodadvances.2016001867; Ognean L, 2014, PAK VET J, V34, P96; Polak K, 2015, VET CLIN PATH, V44, P369, DOI 10.1111/vcp.12284; Power D A, 1990, Hum Antibodies Hybridomas, V1, P34; Quraishy N, 2016, ADV CLIN CHEM, V77, P221, DOI 10.1016/bs.acc.2016.06.006; Roux FA, 2007, XENOTRANSPLANTATION, V14, P208, DOI 10.1111/j.1399-3089.2007.00404.x; Safra N, 2014, VET CLIN PATH, V43, pE12; Wardrop KJ, 2007, J VET INTERN MED, V21, P205, DOI 10.1111/j.1939-1676.2007.tb02949.x	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179932	10.1371/journal.pone.0179932	http://dx.doi.org/10.1371/journal.pone.0179932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662180	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300073
J	Uematsu, H; Yamashita, K; Kunisawa, S; Otsubo, T; Imanaka, Y				Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Otsubo, Tetsuya; Imanaka, Yuichi			Prediction of pneumonia hospitalization in adults using health checkup data	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; RISK-FACTORS; BENZODIAZEPINES; PERFORMANCE; FRAMEWORK; MORTALITY; EFFICACY	Objectives Community-acquired pneumonia is a common cause of hospitalization, and pneumococcal vaccinations are recommended for high-risk individuals. Although risk factors for pneumonia have been identified, there are currently no pneumonia hospitalization prediction models based on the risk profiles of healthy subjects. This study aimed to develop a predictive model for pneumonia hospitalization in adults to accurately identify high-risk individuals to facilitate the efficient prevention of pneumonia. Methods We conducted a retrospective database analysis using health checkup data and health insurance claims data for residents of Kyoto prefecture, Japan, between April 2010 and March 2015. We chose adults who had undergone health checkups in the first year of the study period, and tracked pneumonia hospitalizations over the next 5 years. Subjects were randomly divided into training and test sets. The outcome measure was pneumonia hospitalization, and candidate predictors were obtained from the health checkup data. The prediction model was developed and internally validated using a LASSO logistic regression analysis. Lastly, we compared the new model with comparative models. Results The study sample comprised 54,907 people who had undergone health checkups. Among these, 921 were hospitalized for pneumonia during the study period. The c-statistic for the prediction model in the test set was 0.71 (95% confidence interval: 0.69-0.73). In contrast, a comparative model with only age and comorbidities as predictors had a lower c-statistic of 0.55 (95% confidence interval: 0.54-0.56). Conclusions Our predictive model for pneumonia hospitalization performed better than comparative models, and may be useful for supporting the development of pneumonia prevention measures.	[Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Otsubo, Tetsuya; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan	Kyoto University	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan.	imanaka-y@umin.net	Otsubo, Tetsuya/HCH-1434-2022; KUNISAWA, Susumu/HCH-1094-2022		Ministry of Health, Labour and Welfare of Japan [H27-iryo-ippan-005, H27-shinkogyosei-shitei-005, H29-shinkogyosei-shitei-005]; Japan Society for the Promotion of Science [[A]16H02634]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (H27-iryo-ippan-005, H27-shinkogyosei-shitei-005, H29-shinkogyosei-shitei-005; http://sci-hub.io/http://www.mhlw.go.jp), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. ([A]16H02634; http://sci-hub.io/https://www.jsps.go.jp/j-grantsinaid) YI received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario CV, 2015, EUR J GASTROEN HEPAT, V27, P1259, DOI 10.1097/MEG.0000000000000444; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Brown JS, 2012, CLIN MED, V12, P538, DOI 10.7861/clinmedicine.12-6-538; Chien YF, 2015, J CRIT CARE, V30, P506, DOI 10.1016/j.jcrc.2015.01.001; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Diao WQ, 2016, VACCINE, V34, P1496, DOI 10.1016/j.vaccine.2016.02.023; Dublin S, 2011, J AM GERIATR SOC, V59, P1899, DOI 10.1111/j.1532-5415.2011.03586.x; Friedman J, GLMNET LASSO ELASTIC; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Ishida T., 2011, EFFICACY OF PNEUMOCO; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Miller ER, 2016, VACCINE, V34, P2841, DOI 10.1016/j.vaccine.2016.04.021; Ministry of Health, 2007, LAB WELF JAP STAND P; Ministry of Health, 2007, LAB WERLF JAP STAND; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Orimo Hajime, 2006, Nihon Ronen Igakkai Zasshi, V43, P27; Remington LT, 2014, CURR OPIN PULM MED, V20, P215, DOI 10.1097/MCP.0000000000000052; Rossi RG, 2004, INT J TUBERC LUNG D, V8, P528; Schierenberg A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149895; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taneja C, 2010, J HOSP MED, V5, P528, DOI 10.1002/jhm.704; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Uematsu H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-203; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Whiteside J, 2006, CLIN INQUIRIES	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180159	10.1371/journal.pone.0180159	http://dx.doi.org/10.1371/journal.pone.0180159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662167	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300115
J	Tung, CH; Chen, CW; Sun, HH; Chu, YW				Tung, Chi-Hua; Chen, Chi-Wei; Sun, Han-Hao; Chu, Yen-Wei			Predicting human protein subcellular localization by heterogeneous and comprehensive approaches	PLOS ONE			English	Article							GENE ONTOLOGY TERMS; SINGLE; SITES; MODES	Drug development and investigation of protein function both require an understanding of protein subcellular localization. We developed a system, REALoc, that can predict the subcellular localization of singleplex and multiplex proteins in humans. This system, based on comprehensive strategy, consists of two heterogeneous systematic frameworks that integrate one-to-one and many-to-many machine learning methods and use sequence-based features, including amino acid composition, surface accessibility, weighted sign aa index, and sequence similarity profile, as well as gene ontology function-based features. REALoc can be used to predict localization to six subcellular compartments (cell membrane, cytoplasm, endoplasmic reticulum/Golgi, mitochondrion, nucleus, and extracellular). REALoc yielded a 75.3% absolute true success rate during five-fold cross-validation and a 57.1% absolute true success rate in an independent database test, which was >10% higher than six other prediction systems. Lastly, we analyzed the effects of Vote and GANN models on singleplex and multiplex localization prediction efficacy. REALoc is freely available at http://predictor.nchu.edu.tw/REALoc.	[Tung, Chi-Hua] Chung Hua Univ, Dept Bioinformat, Hsinchu, Taiwan; [Chen, Chi-Wei; Sun, Han-Hao; Chu, Yen-Wei] Natl Chung Hsing Univ 250, Inst Genom & Bioinformat, Taichung 402, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ 250, Ctr Biotechnol, Agr Biotechnol Ctr, Inst Mol Biol,Grad Inst Biotechnol, Taichung 402, Taiwan	Chung Hua University; National Chung Hsing University; National Chung Hsing University	Chu, YW (corresponding author), Natl Chung Hsing Univ 250, Inst Genom & Bioinformat, Taichung 402, Taiwan.; Chu, YW (corresponding author), Natl Chung Hsing Univ 250, Ctr Biotechnol, Agr Biotechnol Ctr, Inst Mol Biol,Grad Inst Biotechnol, Taichung 402, Taiwan.	ywchu@nchu.edu.tw	Chu, Yen-Wei/AAJ-4508-2020	Chu, Yen-Wei/0000-0002-5525-4011; Chen, Chi-Wei/0000-0002-5799-9017	Ministry of Science and Technology,Taiwan, R.O.C [105-2221-E-216-021]	Ministry of Science and Technology,Taiwan, R.O.C(Ministry of Science and Technology, Taiwan)	This research was supported by Ministry of Science and Technology,Taiwan, R.O.C. under grant number 105-2221-E-216-021.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2016, BRIEF BIOINFORM; Cherian BS, 2010, BIOCHEM BIOPH RES CO, V391, P1670, DOI 10.1016/j.bbrc.2009.12.118; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Guo XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28087; He JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037155; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Liu B, 2016, NEUROCOMPUTING, V217, P46, DOI 10.1016/j.neucom.2015.12.138; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Lu Z, 2005, PAC S BIOC PAC S BIO; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wan S, 2012, 2012 IEEE INT C; Wan SB, 2011, IEEE INT WORKS MACH; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091160; Wei LY, 2016, NEUROCOMPUTING, V217, P73, DOI 10.1016/j.neucom.2015.09.137; Yoon Y, 2012, IEEE ACM T COMPUT BI, V9, P609, DOI 10.1109/TCBB.2011.131; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178832	10.1371/journal.pone.0178832	http://dx.doi.org/10.1371/journal.pone.0178832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658305	Green Published, gold			2022-12-26	WOS:000404607900009
J	Wang, YY; Chi, JW; Che, K; Chen, Y; Sun, XL; Wang, YG; Wang, ZC				Wang, Yunyang; Chi, Jingwei; Che, Kui; Chen, Ying; Sun, Xiaolin; Wang, Yangang; Wang, Zhongchao			Fasting plasma glucose and serum uric acid levels in a general Chinese population with normal glucose tolerance: A U-shaped curve	PLOS ONE			English	Article							DOUBLE-BLIND; URATE; SODIUM; INSULIN; IDENTIFICATION; ASSOCIATION; RESISTANCE; EXCRETION; TRANSPORT; METFORMIN	Objective Although several epidemiological studies assessed the relationship between fasting plasma glucose (FPG) and serum uric acid (SUA) levels, the results were inconsistent. A cross-sectional study was conducted to investigate this relationship in Chinese individuals with normal glucose tolerance. Research design and methods A total of 5,726 women and 5,457 men with normal glucose tolerance were enrolled in the study. All subjects underwent a 75-g oral glucose tolerance test. Generalized additive models and two-piecewise linear regression models were applied to assess the relationship. Results A U-shaped relationship between FPG and SUA was observed. After adjusting for potential confounders, the inflection points of FPG levels in the curves were 4.6 mmol/L in women and 4.7 mmol/L in men respectively. SUA levels decreased with increasing fasting plasma glucose concentrations before the inflection points (regression coefficient [beta] = -36.4, P < 0.001 for women; beta = -33.5, P < 0.001 for men), then SUA levels increased = 17.8, P < 0.001 for women; beta = 13.9, P < 0.001 for men). Additionally, serum insulin levels were positively associated with FPG and SUA (P < 0.05). Conclusions A U-shaped relationship between FPG and SUA levels existed in Chinese individuals with normal glucose tolerance. The association is partly mediated through serum insulin levels.	[Wang, Yunyang; Chen, Ying; Sun, Xiaolin; Wang, Yangang; Wang, Zhongchao] Qingdao Univ, Affiliated Hosp, Dept Endocrinol & Metab, Qingdao, Shandong, Peoples R China; [Chi, Jingwei; Che, Kui] Qingdao Univ, Affiliated Hosp, Lab Thyroid Dis, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University	Wang, YG; Wang, ZC (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol & Metab, Qingdao, Shandong, Peoples R China.	nlwang@yeah.net; tony_qdu@126.com			National Natural Science Foundation of China [81571625, 81600601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81571625 and No. 81600601, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RG, 1976, AM J PHYSIOL, V230, P1276, DOI 10.1152/ajplegacy.1976.230.5.1276; [Anonymous], 2007, J AM STAT ASSOC, DOI DOI 10.1198/JASA.2007.S188; Aswani R, 2011, CLIN PEDIATR, V50, P1057, DOI 10.1177/0009922811414288; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Chaudhary K, 2013, CARDIORENAL MED, V3, P208, DOI 10.1159/000355405; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Cicero AFG, 2014, DIABETES RES CLIN PR, V104, P183, DOI 10.1016/j.diabres.2014.02.005; Cicero AFG, 2017, ANN MED, V49, P275, DOI 10.1080/07853890.2016.1222451; Clemencon B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108852; COOK DG, 1986, POSTGRAD MED J, V62, P1001, DOI 10.1136/pgmj.62.733.1001; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HERMAN JB, 1982, LANCET, V2, P240; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVINSON DJ, 1980, ANN RHEUM DIS, V39, P173, DOI 10.1136/ard.39.2.173; Li HB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003456; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Nan HR, 2010, DIABETES VASC DIS RE, V7, P40, DOI 10.1177/1479164109347408; Oda E, 2009, INTERNAL MED, V48, P1785, DOI 10.2169/internalmedicine.48.2426; OLEFSKY J, 1973, DIABETES, V22, P507, DOI 10.2337/diab.22.7.507; PODEVIN R, 1968, NEPHRON, V5, P134, DOI 10.1159/000179623; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Su JX, 2014, ARCH PHARM RES, V37, P1336, DOI 10.1007/s12272-014-0413-6; terMaaten JC, 1997, CLIN SCI, V92, P51; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; WHITEHEAD TP, 1992, ANN CLIN BIOCHEM, V29, P159, DOI 10.1177/000456329202900206; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; WU JM, 1977, ENZYME, V22, P60, DOI 10.1159/000458509	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180111	10.1371/journal.pone.0180111	http://dx.doi.org/10.1371/journal.pone.0180111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658284	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900060
J	Kim, JW; Lim, CW; Kim, B				Kim, Jong Won; Lim, Chae Woong; Kim, Bumseok			Effects of nicotine on corneal wound healing following acute alkali burn	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CIGARETTE-SMOKE; FIBROSIS; PROLIFERATION; NEOVASCULARIZATION; PROTEIN; ALPHA; CELLS; PROGRESSION; KERATOCYTES	Epidemiological studies have indicated that smoking is a pivotal risk factor for the progression of several chronic diseases. Nicotine, the addictive component of cigarettes, has powerful pathophysiological properties in the body. Although the effects of cigarette smoking on corneal re-epithelialization have been studied, the effects of nicotine on corneal wound healing-related neovascularization and fibrosis have not been fully demonstrated. The aim of this study was to evaluate the effects of chronic administration of nicotine on corneal wound healing following acute insult induced by an alkali burn. BALB/C female mice randomly received either vehicle (2% saccharin) or nicotine 100 or 200 mu g/ml in 2% saccharin) in drinking water ad libitum. After 1 week, animals were re-randomized and the experimental group was subjected to a corneal alkali burn, and then nicotine was administered until day 14 after the alkali burn. A corneal alkali burn model was generated by placing a piece of 2 mm-diameter filter paper soaked in 1N NaOH on the right eye. Histopathological analysis and the expression level of the pro-angiogenic genes vascular endothelial growth factor VEGF) and matrix metalloproteinase-9 MMP9) revealed that chronic nicotine administration enhanced alkali burn-induced corneal neovascularization. Furthermore, the mRNA expression of the pro-fibrogenic factors alpha-smooth muscle actin alpha SMA), transforming growth factor-beta TGF-beta), and collagen alpha 1 Col1) was enhanced in the high-concentration nicotine-treated group compared with the vehicle group after corneal injury. Immunohistochemical analysis also showed that the alpha SMA-positive area was increased in chronic nicotine-treated mice after corneal alkali burn. An in vitro assay found that expression of the alpha 3, alpha 7, and beta 1 nicotinic acetylcholine receptor nAChR) subunits was significantly increased by chemical injury in human corneal fibroblast cells. Moreover, alkali-induced fibrogenic gene expression and proliferation of fibroblast cells were further increased by treatment with nicotine and cotinine. The proliferation of such cells induced by treatment of nicotine and cotinine was reduced by inhibition of the PI3K and PKC pathways using specific inhibitors. In conclusion, chronic administration of nicotine accelerated the angiogenic and fibrogenic healing processes in alkali-burned corneal tissue.	[Kim, Bumseok] Chonbuk Natl Univ, Coll Vet Med, Biosafety Res Inst, Iksan, South Korea; Chonbuk Natl Univ, Coll Vet Med, Pathol Lab, Plus Program BK21, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, B (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Biosafety Res Inst, Iksan, South Korea.	bskims@jbnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2011-0009309]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science, and Technology (2011-0009309)	Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Ari S, 2013, CUTAN OCUL TOXICOL, V32, P9, DOI 10.3109/15569527.2012.686078; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Balansky R, 2007, CARCINOGENESIS, V28, P2236, DOI 10.1093/carcin/bgm122; Boor P, 2009, J CELL MOL MED, V13, P4484, DOI 10.1111/j.1582-4934.2008.00518.x; Boretsky A, 2015, CURR EYE RES, V40, P368, DOI 10.3109/02713683.2014.924147; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Chung EJ, 2014, BIOTECHNOL LETT, V36, P1217, DOI 10.1007/s10529-014-1487-4; Condon ET, 2007, J SURG RES, V140, P135, DOI 10.1016/j.jss.2007.01.008; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Ebihara N, 2007, INVEST OPHTH VIS SCI, V48, P3069, DOI 10.1167/iovs.06-0968; Ejaz S, 2009, FOOD CHEM TOXICOL, V47, P601, DOI 10.1016/j.fct.2008.12.018; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Goette A, 2007, HEART, V93, P1056, DOI 10.1136/hrt.2005.087171; Gu Y, 2014, PPAR RES, V2014, DOI 10.1155/2014/464935; Hou HY, 2008, EXP EYE RES, V86, P983, DOI 10.1016/j.exer.2008.03.018; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jensen K, 2013, DIGEST LIVER DIS, V45, P754, DOI 10.1016/j.dld.2013.02.023; Jeon HS, 2012, CYTOKINE, V59, P280, DOI 10.1016/j.cyto.2012.04.006; Jester JV, 1997, CORNEA, V16, P177; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Jetton JA, 2014, CORNEA, V33, P453, DOI 10.1097/ICO.0000000000000100; John G, 2014, CLIN SCI, V126, P207, DOI 10.1042/CS20130117; Kara S, 2015, SEMIN OPHTHALMOL, P1; Kiuchi K, 2008, INVEST OPHTH VIS SCI, V49, P1705, DOI 10.1167/iovs.07-0089; Lee HS, 2014, GRAEF ARCH CLIN EXP, V252, P951, DOI 10.1007/s00417-014-2633-3; Li T, 2011, MOL VIS, V17, P797; LIN NG, 1992, CURR EYE RES, V11, P899, DOI 10.3109/02713689209033487; Lu PR, 2007, CORNEA, V26, P199, DOI 10.1097/01.ico.0000248385.16896.34; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Ma CZ, 2009, WOUND REPAIR REGEN, V17, P387, DOI 10.1111/j.1524-475X.2009.00478.x; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Okada Y, 2014, LAB INVEST, V94, P1030, DOI 10.1038/labinvest.2014.85; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Pan HW, 2011, MOL BIOL REP, V38, P4501, DOI 10.1007/s11033-010-0581-5; Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030; Park YJ, 2008, VASC PHARMACOL, V49, P32, DOI 10.1016/j.vph.2008.05.001; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; Rehan VK, 2005, AM J PHYSIOL-LUNG C, V289, pL667, DOI 10.1152/ajplung.00358.2004; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sharma GD, 2007, EXP EYE RES, V85, P289, DOI 10.1016/j.exer.2007.05.004; Sloniecka M, 2015, INT IMMUNOPHARMACOL, V29, P57, DOI 10.1016/j.intimp.2015.05.039; Snoek SA, 2010, BRIT J PHARMACOL, V160, P322, DOI 10.1111/j.1476-5381.2010.00699.x; Soeda J, 2012, BIOCHEM BIOPH RES CO, V417, P17, DOI 10.1016/j.bbrc.2011.10.151; Suner IJ, 2004, INVEST OPHTH VIS SCI, V45, P311, DOI 10.1167/iovs.03-0733; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; White LA, 2000, BBA-GENE STRUCT EXPR, V1490, P259, DOI 10.1016/S0167-4781(00)00002-6; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Yang LL, 2010, TOXICOL PATHOL, V38, P560, DOI 10.1177/0192623310368983; Zengin MO, 2014, BRIT J OPHTHALMOL, V98, P233, DOI 10.1136/bjophthalmol-2013-304044; Zhou WJ, 2012, INT J OPHTHALMOL-CHI, V5, P251, DOI 10.3980/j.issn.2222-3959.2012.03.01	56	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179982	10.1371/journal.pone.0179982	http://dx.doi.org/10.1371/journal.pone.0179982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644870	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100055
J	Lan, CC; Peng, CK; Tang, SE; Huang, KL; Wu, CP				Lan, Chou-Chin; Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun; Wu, Chin-Pyng			Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury	PLOS ONE			English	Article							THERAPEUTIC APPLICATIONS; ACETAZOLAMIDE; TRANSPLANTATION; HYPERCAPNIA; ACTIVATORS; CYTOKINES; PATHWAYS; RATS	Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions including lung transplantation, cardiopulmonary bypass surgery, re-expansion of collapsed lung from pneumothorax or pleural effusion and etc. IR-induced ALI remains a challenge in the current treatment. Carbonic anhydrase has important physiological function and influences on transport of CO2. Some investigators suggest that CO2 influences lung injury. Therefore, carbonic anhydrase should have the role in ALI. This study was undertaken to define the effect of a carbonic anhydrase inhibitor, acetazolamide (AZA), in IR-induced ALI, that was conducted in a rat model of isolated-perfused lung with 30 minutes of ischemia and 90 minutes of reperfusion. The animals were divided into six groups (n = 6 per group): sham, sham + AZA 200 mg/kg body weight (BW), IR, IR + AZA 100 mg/kg BW, IR + AZA 200 mg/kg BW and IR+ AZA 400 mg/kg BW. IR caused significant pulmonary microvascular hyper-permeability, pulmonary edema, pulmonary hypertension, neutrophilic sequestration, and an increase in the expression of pro-inflammatory cytokines. Increases in carbonic anhydrase expression and perfusate pCO(2) levels were noted, while decreased Na-K-ATPase expression was noted after IR. Administration of 200mg/kg BW and 400mg/kg BW AZA significantly suppressed the expression of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6 and IL-17) and attenuated IR-induced lung injury, represented by decreases in pulmonary hyper-permeability, pulmonary edema, pulmonary hypertension and neutrophilic sequestration. AZA attenuated IR-induced lung injury, associated with decreases in carbonic anhydrase expression and pCO2 levels, as well as restoration of Na-K-ATPase expression.	[Lan, Chou-Chin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Lan, Chou-Chin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun] Triserv Gen Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun] Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan; [Wu, Chin-Pyng] Li Shin Hosp, Dept Crit Care Med, Taichung, Tao Yuan County, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; Tri-Service General Hospital; National Defense Medical Center	Huang, KL (corresponding author), Triserv Gen Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.; Huang, KL (corresponding author), Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan.; Wu, CP (corresponding author), Li Shin Hosp, Dept Crit Care Med, Taichung, Tao Yuan County, Taiwan.	kun@ndmctsgh.edu.tw; chinpyng@mail.ndmctsgh.edu.tw	Wu, Chin-Pyng/W-8447-2019		Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation [TCRD-TPE-103-38, TCRD TPE-104-33]; Li-Shin Hospital [LS-2013-02, LS2014-02]	Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; Li-Shin Hospital	This study was supported by grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-38 and TCRD TPE-104-33), and the Li-Shin Hospital (LS-2013-02 and LS2014-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	An Y, 2013, CELL PHYSIOL BIOCHEM, V32, P1151, DOI 10.1159/000354515; Bejaoui M, 2015, J PHARMACOL EXP THER, V355, P191, DOI 10.1124/jpet.115.225177; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; BROMBERG BB, 1993, INVEST OPHTH VIS SCI, V34, P339; Chen J, 2008, AM J RESP CELL MOL, V38, P32, DOI 10.1165/rcmb.2007-0121OC; CRANDALL ED, 1978, J CLIN INVEST, V62, P618, DOI 10.1172/JCI109168; Effros RM, 2008, AM J RESP CELL MOL, V39, P124, DOI 10.1165/ajrcmb.39.1.124; Esbaugh AJ, 2006, RESP PHYSIOL NEUROBI, V154, P185, DOI 10.1016/j.resp.2006.03.007; Ferrari RS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/590987; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; Kvarstein Gunnvald, 1997, Tidsskrift for den Norske Laegeforening, V117, P4251; Lan CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159922; Lehmann S, 2012, ANN THORAC SURG, V93, P913, DOI 10.1016/j.athoracsur.2011.11.033; Liang GY, 2011, ACTA CARDIOL, V66, P323, DOI 10.1080/AC.66.3.2114132; Lin PT, 2015, INT J CLIN EXP MED, V8, P12736; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; Sharma AK, 2011, AM J RESP CRIT CARE, V183, P1539, DOI 10.1164/rccm.201007-1173OC; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FUTURE MED CHEM, V3, P1165, DOI [10.4155/fmc.11.69, 10.4155/FMC.11.69]; Thys F, 2001, RESUSCITATION, V49, P105, DOI 10.1016/S0300-9572(00)00339-7; Tsuang WM, 2013, ANN INTERN MED, V158, P650, DOI 10.7326/0003-4819-158-9-201305070-00004; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Veldhuizen RAW, 2001, EUR RESPIR J, V17, P488, DOI 10.1183/09031936.01.17304880; Wang C, 2016, CYTOKINE, V83, P110, DOI 10.1016/j.cyto.2016.04.003; Wang JZ, 2014, LECT NOTES COMPUT SC, V8673, P73, DOI 10.1007/978-3-319-10404-1_10; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Yu X, 2016, BIOMED PHARMACOTHER, V82, P489, DOI 10.1016/j.biopha.2016.05.025; Yumoto Masato, 2005, J Anesth, V19, P287, DOI 10.1007/s00540-005-0338-9	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179822	10.1371/journal.pone.0179822	http://dx.doi.org/10.1371/journal.pone.0179822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644844	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100041
J	Lek, MT; Cruz, S; Ibe, NU; Beck, WHJ; Bielicki, JK; Weers, PMM; Narayanaswami, V				Lek, Mark T.; Cruz, Siobanth; Ibe, Nnejiuwa U.; Beck, Wendy H. J.; Bielicki, John K.; Weers, Paul M. M.; Narayanaswami, Vasanthy			Swapping the N- and C-terminal domains of human apolipoprotein E3 and Al reveals insights into their structure/activity relationship	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR-BINDING DOMAIN; AMPHIPATHIC ALPHA-HELIX; CHOLESTEROL EFFLUX; MASS-SPECTROMETRY; APOA-I; CRYSTAL-STRUCTURE; LIPID ASSOCIATION; SELF-ASSOCIATION; AQUEOUS-SOLUTION	Apolipoprotein (apo) E3 and apoAl are exchangeable apolipoproteins that play a dominant role in regulating plasma lipoprotein metabolism. ApoE3 (299 residues) is composed of an N-terminal (NT) domain bearing a 4-helix bundle and a C-terminal (CT) domain bearing a series of amphipathic a-helices. ApoAl (243 residues) also comprises a highly helical NT domain and a less structured CT tail. The objective of this study was to understand their structural and functional role by generating domain swapped chimeras: apoE3-NT/apoAlCT and apoAl-NT/apoE-CT. The bacterially overexpressed chimeras were purified by affinity chromatography and their identity confirmed by immunoblotting and mass spectrometry. Their a-helical content was comparable to that of the parent proteins. ApoE3-NT/apoAl-CT retained the denaturation profile of apoE3 NT domain, with apoAl CT tail eliciting a relatively unstructured state; its lipid binding ability improved dramatically compared to apoE3 indicative of a significant role of apoAl CT tail in lipid binding interaction. The LDL receptor interaction and ability to promote ABCA1-mediated cholesterol efflux of apoE3-NT/apoAl-CT was comparable to that of apoE3. In contrast, apoAl-NT/apoE-CT elicited an unfolding pattern and lipid binding ability that were similar to that of apoAl. As expected, DMPC/apoAl-NT/ apoE-CT discoidal particles did not elicit LDLr binding ability, and promoted SR-B1 mediated cellular uptake of lipids to a limited extent. However, apoAl-NT/apoE-CT displayed an enhanced ability to promote cholesterol efflux compared to apoAl, indicative of a significant role for apoE CT domain in mediating this function. Together, these results indicate that the functional attributes of apoAl and apoE3 can be conferred on each other and that NT-CT domain interactions significantly modulate their structure and function.	[Lek, Mark T.; Cruz, Siobanth; Ibe, Nnejiuwa U.; Beck, Wendy H. J.; Weers, Paul M. M.; Narayanaswami, Vasanthy] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Bielicki, John K.] Lawrence Berkeley Natl Lab, Donner Lab, Berkeley, CA USA	California State University System; California State University Long Beach; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Narayanaswami, V (corresponding author), Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA.	vas.narayanaswami@csulb.edu		Narayanaswami, Vasanthy/0000-0001-7088-4057	National Institutes of Health/ National Institute of General Medical Sciences [GM105561, GM008074, GM089564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM105561, T34GM008074, SC3GM089564] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by VN: National Institutes of Health/ National Institute of General Medical Sciences (GM105561) https//www.nigms.nih.gov/ Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript VN & NUI: National Institutes of Health/ National Institute of General Medical Sciences (GM008074) littps://www.nigms.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript PM MW: National Institutes of Health/ National Institute of General Medical Sciences (GM089564) https://www.nigms.nih.gov/ Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226; Beckstead JA, 2005, BIOCHEMISTRY-US, V44, P4591, DOI 10.1021/bi0477135; Bielicki JK, 2016, CURR OPIN LIPIDOL, V27, P40, DOI 10.1097/MOL.0000000000000258; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Castellani LW, 2001, ARTERIOSCL THROM VAS, V21, P1870, DOI 10.1161/atvb.21.12.1870; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chetty PS, 2013, J LIPID RES, V54, P1589, DOI 10.1194/jlr.M034785; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; DONOVAN JM, 1987, BIOCHEMISTRY-US, V26, P8116, DOI 10.1021/bi00399a015; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Fabilane CS, 2016, PROTEIN PEPTIDE LETT, V23, P404, DOI 10.2174/0929866523666160223122257; Fan DP, 2004, BIOCHEMISTRY-US, V43, P5055, DOI 10.1021/bi035958w; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Frank PG, 2000, J LIPID RES, V41, P853; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Gursky O, 2013, J MOL BIOL, V425, P1, DOI 10.1016/j.jmb.2012.09.027; Hafiane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131997; Hafiane A, 2014, BBA-MOL CELL BIOL L, V1841, P1498, DOI 10.1016/j.bbalip.2014.07.018; Holvoet P, 1998, J CLIN INVEST, V102, P379, DOI 10.1172/JCI3038; Huang RYC, 2011, BIOCHEMISTRY-US, V50, P9273, DOI 10.1021/bi2010027; JOHNSON JD, 1979, BIOCHEMISTRY-US, V18, P1292, DOI 10.1021/bi00574a027; Khumsupan P, 2011, BBA-BIOMEMBRANES, V1808, P352, DOI 10.1016/j.bbamem.2010.09.007; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135130; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; LI WH, 1988, J LIPID RES, V29, P245; Li XP, 2002, J BIOL CHEM, V277, P21149, DOI 10.1074/jbc.M200658200; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maletinska L, 2000, CANCER RES, V60, P2300; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; NG DS, 1995, ARTERIOSCL THROM VAS, V15, P2157, DOI 10.1161/01.ATV.15.12.2157; Nguyen D, 2014, BIOCHEMISTRY-US, V53, P4025, DOI 10.1021/bi500340z; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Perez K, 2006, J VIROL METHODS, V135, P254, DOI 10.1016/j.jviromet.2006.03.020; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Sivashanmugam A, 2009, J BIOL CHEM, V284, P14657, DOI 10.1074/jbc.M901012200; SWANEY JB, 1978, J BIOL CHEM, V253, P7069; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Thuahnai ST, 2003, J LIPID RES, V44, P1132, DOI 10.1194/jlr.M200429-JLR200; Tran TN, 2014, BIOCHEMISTRY-US, V53, P361, DOI 10.1021/bi401404u; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Weers PMM, 2003, BIOPHYS CHEM, V100, P481, DOI 10.1016/S0301-4622(02)00300-9; Wei DS, 2004, ANAL BIOCHEM, V331, P401, DOI 10.1016/j.ab.2004.04.019; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Zheng Y, 2012, BIOCHEMISTRY-US, V51, P6400, DOI 10.1021/bi300626g; Zheng Y, 2011, BIOCHEMISTRY-US, V50, P4068, DOI 10.1021/bi2002955	67	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178346	10.1371/journal.pone.0178346	http://dx.doi.org/10.1371/journal.pone.0178346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644829	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100003
J	Zhou, L; Zeng, QY; Jin, SS; Cheng, GY				Zhou, Lin; Zeng, Qiyan; Jin, Shaosheng; Cheng, Guangyan			The impact of changes in dietary knowledge on adult overweight and obesity in China	PLOS ONE			English	Article							NUTRITION KNOWLEDGE; SOCIOECONOMIC-STATUS; TRENDS; ASSOCIATION; PREVALENCE	Overweight and obesity are rapidly growing threats in China. Improvement in dietary knowledge can potentially prevent overweight and obesity, conditions which are receiving substantial attention from international organizations and governments. The purpose of this study was to investigate the impact of changes in dietary knowledge on adult overweight and obesity, using a balanced panel data consisting of 10,401 samples from the 2006, 2009, and 2011 iterations of the China Health and Nutrition Survey. Results indicate that overweight and obesity are becoming increasingly problematic in China, and the level of dietary knowledge among Chinese adults needs improvement. Moreover, the empirical results indicate that changes in dietary knowledge among adults has no significant influence on adult overweight and obesity, a likely result of lacking systematic dietary knowledge and having inadequate guidance on overweight/obesity-related behaviors.	[Zhou, Lin; Cheng, Guangyan] Minist Agr, Inst Food & Nutr Dev, Beijing, Peoples R China; [Zeng, Qiyan] Renmin Univ China, Sch Agr Econ & Rural Dev, Beijing, Peoples R China; [Jin, Shaosheng] Zhejiang Univ, Sch Publ Affairs, CARD, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Renmin University of China; Zhejiang University	Jin, SS (corresponding author), Zhejiang Univ, Sch Publ Affairs, CARD, Hangzhou, Zhejiang, Peoples R China.	ssjin@zju.edu.cn		Zeng, Qiyan/0000-0002-8598-447X	National Natural Science Foundation of China [NNSFC-71273233]; Major Program of the Key Research Institute of Chinese Ministry of Education [15JJD790032]; Chinese Academic of Agricultural Science [ASTIPI FND-2016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the Key Research Institute of Chinese Ministry of Education; Chinese Academic of Agricultural Science	Jin acknowledges funding support from the National Natural Science Foundation of China (NNSFC-71273233) and the Major Program of the Key Research Institute of Chinese Ministry of Education (No.15JJD790032). Zhou and Cheng acknowledge funding support from the Agricultural Science and Technology Innovation Program from Chinese Academic of Agricultural Science (ASTIPI FND-2016).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaccio M, 2013, APPETITE, V68, P139, DOI 10.1016/j.appet.2013.04.026; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Dallongeville J, 2001, PUBLIC HEALTH NUTR, V4, P27, DOI 10.1079/PHN200052; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gomez CG, 2011, ARCH LATINOAM NUTR, V61, P396; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP 2016 P, DOI 10.2499/9780896295841; Jin SS, 2014, FOOD QUAL PREFER, V36, P144, DOI 10.1016/j.foodqual.2014.04.005; Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001; Laz TH, 2015, J COMMUN HEALTH, V40, P542, DOI 10.1007/s10900-014-9969-9; Liu RD, 2015, FOOD QUAL PREFER, V41, P103, DOI 10.1016/j.foodqual.2014.11.007; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; O'Brien G, 2007, HEALTH EDUC RES, V22, P571, DOI 10.1093/her/cyl119; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Qin XZ, 2016, HEALTH ECON, V25, P1291, DOI 10.1002/hec.3217; Reinehr T, 2003, NUTR RES, V23, P645, DOI 10.1016/S0271-5317(03)00025-3; Roemling C, 2012, APPETITE, V58, P1005, DOI 10.1016/j.appet.2012.02.053; Shimokawa S, 2013, FOOD POLICY, V38, P35, DOI 10.1016/j.foodpol.2012.09.001; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J., 1984, MARRIAGE FAM REV, V7, P115, DOI DOI 10.1300/J002V07N01_10; Thakur N, 1999, Fam Med, V31, P122; Tineke DV, 2009, APPETITE, V52, P788; Verweij LM, 2011, J OCCUP ENVIRON MED, V53, P722, DOI 10.1097/JOM.0b013e318222af9b; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Wagner MG, 2016, APPETITE, V100, P94, DOI 10.1016/j.appet.2016.02.002; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	28	26	27	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179551	10.1371/journal.pone.0179551	http://dx.doi.org/10.1371/journal.pone.0179551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644891	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100022
J	Zimmermannova, O; Doktorova, E; Stuchly, J; Kanderova, V; Kuzilkova, D; Strnad, H; Starkova, J; Alberich-Jorda, M; Falkenburg, JHF; Trka, J; Petrak, J; Zuna, J; Zaliova, M				Zimmermannova, O.; Doktorova, E.; Stuchly, J.; Kanderova, V.; Kuzilkova, D.; Strnad, H.; Starkova, J.; Alberich-Jorda, M.; Falkenburg, J. H. F.; Trka, J.; Petrak, J.; Zuna, J.; Zaliova, M.			An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; TEL-ABL; CYTOGENETIC CHARACTERIZATION; IMATINIB-MESYLATE; FUSION PROTEINS; BLAST CRISIS; REARRANGEMENT; PATIENT	Leukemias harboring the ETV6-ABL1 fusion represent a rare subset of hematological malignancies with unfavorable outcomes. The constitutively active chimeric Etv6-Abl1 tyrosine kinase can be specifically inhibited by tyrosine kinase inhibitors (TKIs). Although TKIs represent an important therapeutic tool, so far, the mechanism underlying the potential TKI resistance in ETV6-ABL1-positive malignancies has not been studied in detail. To address this issue, we established a TKI-resistant ETV6-ABL1-positive leukemic cell line through long-term exposure to imatinib. ETV6-ABL1-dependent mechanisms (including fusion gene/protein mutation, amplification, enhanced expression or phosphorylation) and increased TKI efflux were excluded as potential causes of resistance. We showed that TKI effectively inhibited the Etv6-Abl1 kinase activity in resistant cells, and using short hairpin RNA (shRNA)-mediated silencing, we confirmed that the resistant cells became independent from the ETV6-ABL1 oncogene. Through analysis of the genomic and proteomic profiles of resistant cells, we identified an acquired mutation in the GNB1 gene, K89M, as the most likely cause of the resistance. We showed that cells harboring mutated GNB1 were capable of restoring signaling through the phosphoinositide-3-kinase (PI3K)/Akt/mTOR and mitogen-activated protein kinase (MAPK) pathways, whose activation is inhibited by TKI. This alternative GNB1(K89M)-mediated pro-survival signaling rendered ETV6-ABL1-positive leukemic cells resistant to TKI therapy. The mechanism of TKI resistance is independent of the targeted chimeric kinase and thus is potentially relevant not only to ETV6-ABL1-positive leukemias but also to a wider spectrum of malignancies treated by kinase inhibitors.	[Zimmermannova, O.; Stuchly, J.; Kanderova, V.; Kuzilkova, D.; Starkova, J.; Alberich-Jorda, M.; Trka, J.; Zuna, J.; Zaliova, M.] CLIP Childhood Leukaemia Invest, Prague, Czech Republic; [Zimmermannova, O.; Stuchly, J.; Kanderova, V.; Kuzilkova, D.; Starkova, J.; Trka, J.; Zuna, J.; Zaliova, M.] Charles Univ Prague, Dept Paediat Haematol & Oncol, Fac Med 2, Prague, Czech Republic; [Doktorova, E.; Petrak, J.] Charles Univ Prague, BIOCEV, Fac Med 1, Vestec, Czech Republic; [Strnad, H.] Czech Acad Sci, Dept Genom & Bioinformat, Inst Mol Genet, Prague, Czech Republic; [Alberich-Jorda, M.] Czech Acad Sci, Lab Mol Hematooncol, Inst Mol Genet, Prague, Czech Republic; [Falkenburg, J. H. F.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Trka, J.; Zuna, J.; Zaliova, M.] Univ Hosp Motol, V Uvalu 84, Prague 15006, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Motol University Hospital	Zaliova, M (corresponding author), Univ Hosp Motol, V Uvalu 84, Prague 15006, Czech Republic.; Zaliova, M (corresponding author), Charles Univ Prague, Dept Paediat Haematol & Oncol, Fac Med 2, CLIP, V Uvalu 84, Prague 15006, Czech Republic.	marketa.zaliova@lfmotol.cuni.cz	Jorda, Meritxell Alberich/G-3137-2014; Trka, Jan/Y-4820-2019; Stuchly, jan/B-7608-2019; Petrak, Jiri/I-8950-2017; Zuna, Jan/ABA-4620-2021	Jorda, Meritxell Alberich/0000-0002-8093-641X; Stuchly, jan/0000-0003-1896-9533; Petrak, Jiri/0000-0002-8695-4803; Kanderova, Veronika/0000-0001-8513-1066; Kuzilkova, Daniela/0000-0001-8086-9790; Starkova, Julia/0000-0002-2269-5849; Zuna, Jan/0000-0002-0887-3709	Czech Ministry of Health [IGA MZ NT/13170-4]; Grant Agency of Charles University [GAUK 596912]; Czech Science Foundation [P302/12/G101, P304/12/2214]; NPU I [LO1604]; NPU II [LQ1604]; University Hospital Motol [00064203]; ERDF [CZ.1.05/1.1.00/02.0109 BIOCEV]; Ministry of Education, Youth and Sports of the Czech Republic [PRVOUK P24/LF1/3, SVV 260 374/2017]; Charles University [Primus/MED/28]	Czech Ministry of Health(Ministry of Health, Czech Republic); Grant Agency of Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); NPU I; NPU II; University Hospital Motol; ERDF(European Commission); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University	This study was supported by grants from the Czech Ministry of Health (IGA MZ NT/13170-4), the Grant Agency of Charles University (GAUK 596912), the Czech Science Foundation (no. P302/12/G101 and P304/12/2214), by NPU I (no. LO1604) and NPU II (no. LQ1604) and by the project for the conceptual development of research organization (00064203, University Hospital Motol). The authors also acknowledge the support from ERDF (CZ.1.05/1.1.00/02.0109 BIOCEV), from the Ministry of Education, Youth and Sports of the Czech Republic (PRVOUK P24/LF1/3 and SVV 260 374/2017) and from Charles University (Primus/MED/28).	Asari K, 2016, ANN M ABSTR BLOOD, V128, P3957; Baeumler J, 2008, CANCER GENET CYTOGEN, V185, P37, DOI 10.1016/j.cancergencyto.2008.05.001; Barbouti A, 2003, BRIT J HAEMATOL, V122, P85, DOI 10.1046/j.1365-2141.2003.04391.x; Bernt KM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00054; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Eide CA, 2015, CURR HEMATOL MALIG R, V10, P158, DOI 10.1007/s11899-015-0248-3; Gambacorti-Passerini C, 2016, AM J HEMATOL, V91, P67, DOI 10.1002/ajh.24247; Gancheva K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-39; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Hannemann JR, 1998, BRIT J HAEMATOL, V102, P475, DOI 10.1046/j.1365-2141.1998.00803.x; Jones D, 2008, CANCER-AM CANCER SOC, V113, P985, DOI 10.1002/cncr.23666; Kawamata N, 2008, GENE CHROMOSOME CANC, V47, P919, DOI 10.1002/gcc.20593; Kelly JC, 2009, CANCER GENET CYTOGEN, V192, P36, DOI 10.1016/j.cancergencyto.2009.02.012; Kotrova M, 2016, BLOOD, V128, P2263, DOI 10.1182/blood-2016-07-725861; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Malinge S, 2006, ONCOGENE, V25, P3589, DOI 10.1038/sj.onc.1209390; Malone A, 2010, BRIT J HAEMATOL, V151, P101, DOI 10.1111/j.1365-2141.2010.08323.x; Mozziconacci MJ, 2007, AM J HEMATOL, V82, P688, DOI 10.1002/ajh.20873; Nand R, 2009, LEUKEMIA RES, V33, P1144, DOI 10.1016/j.leukres.2009.03.011; O'Brien SG, 2002, BLOOD, V99, P3465, DOI 10.1182/blood.V99.9.3465; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Okuda K, 2001, BLOOD, V97, P2440, DOI 10.1182/blood.V97.8.2440; Okuda K, 1996, ONCOGENE, V13, P1147; Perna F, 2011, HAEMATOL-HEMATOL J, V96, P342, DOI 10.3324/haematol.2010.036673; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Pospisilova J, 2013, INT J MOL MED, V31, P1273, DOI 10.3892/ijmm.2013.1302; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Tirado CA, 2005, CANCER GENET CYTOGEN, V157, P74, DOI 10.1016/j.cancergencyto.2004.06.001; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Yamamoto K, 2014, ANN HEMATOL, V93, P1435, DOI 10.1007/s00277-013-1975-y; Yeung DT, 2015, LEUKEMIA, V29, P230, DOI 10.1038/leu.2014.256; Yoda A, 2015, NAT MED, V21, P71, DOI 10.1038/nm.3751; Zaliova M, 2016, HAEMATOLOGICA, V101, P1082, DOI 10.3324/haematol.2016.144345; Zuna J, 2010, GENE CHROMOSOME CANC, V49, P873, DOI 10.1002/gcc.20796	35	12	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5985	5994		10.1038/onc.2017.210	http://dx.doi.org/10.1038/onc.2017.210			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650474	Green Published, hybrid			2022-12-26	WOS:000413841400007
J	Koide, M; Matsuo, A; Shimoo, S; Takamatsu, K; Kyodo, A; Tsuji, Y; Mera, K; Tsubakimoto, Y; Isodono, K; Sakatani, T; Inoue, K; Fujita, H				Koide, Masahiro; Matsuo, Akiko; Shimoo, Satoshi; Takamatsu, Kazuaki; Kyodo, Atsushi; Tsuji, Yumika; Mera, Kayoko; Tsubakimoto, Yoshinori; Isodono, Koji; Sakatani, Tomohiko; Inoue, Keiji; Fujita, Hiroshi			Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; COHERENCE TOMOGRAPHY; ARTERY; RUPTURE	Background The involvement of cholesterol crystals (CCs) in plaque progression and destabilization of atherosclerotic plaques has been recently recognized. This study aimed to evaluate the association between the intraplaque localization of CCs and plaque vulnerability. Methods We investigated 55 acute coronary syndrome (ACS) and 80 stable angina pectoris (stable AP) lesions using optical frequency domain imaging (OFDI) prior to percutaneous coronary intervention. The distance between CCs and the luminal surface of coronary plaques was defined as CC depth. Results Although the incidence of CCs had similar frequencies in the ACS and stable AP groups (95% vs. 89%, p = 0.25), CC depth was significantly less in patients with ACS than in those with stable AP (median [25th to 75th percentile]: 68 mu m [58 to 92 mu m] vs. 152 mu m [115 to 218 mu m]; p < 0.001). The incidences of plaque rupture, thrombus, lipid-rich plaques, and thin-cap fibroatheroma were significantly greater in patients with ACS than in those with stable AP (62% vs. 18%, p < 0.001; 67% vs. 16%, p < 0.001; 84% vs. 57%, p < 0.01; and 56% vs. 19%, p < 0.001, respectively). Conclusion OFDI analysis revealed that CCs were found in the more superficial layers within the coronary atherosclerotic plaques in patients with ACS than in those with stable AP, suggesting that CC depth is associated with plaque vulnerability. CC depth, a novel OFDI-derived parameter, could be potentially used as an alternative means of evaluating plaque vulnerability in coronary arteries.	[Koide, Masahiro; Matsuo, Akiko; Shimoo, Satoshi; Takamatsu, Kazuaki; Kyodo, Atsushi; Tsuji, Yumika; Mera, Kayoko; Tsubakimoto, Yoshinori; Isodono, Koji; Sakatani, Tomohiko; Inoue, Keiji; Fujita, Hiroshi] Kyoto Daini Hosp, Japanese Red Cross Soc, Dept Cardiovasc Med, Kyoto, Japan		Koide, M (corresponding author), Kyoto Daini Hosp, Japanese Red Cross Soc, Dept Cardiovasc Med, Kyoto, Japan.	koide@koto.kpu-m.ac.jp	koide, masahiro/AAZ-3823-2021					Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; Abela GS, 2005, CLIN CARDIOL, V28, P413, DOI 10.1002/clc.4960280906; Cheng JM, 2014, EUR HEART J, V35, P639, DOI 10.1093/eurheartj/eht484; Dai JN, 2016, ATHEROSCLEROSIS, V247, P111, DOI 10.1016/j.atherosclerosis.2016.02.010; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Kataoka Y, 2015, J AM COLL CARDIOL, V65, P630, DOI 10.1016/j.jacc.2014.11.039; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura S, 2014, CLIN RES CARDIOL, V103, P1015, DOI 10.1007/s00392-014-0748-5; Nishimura S, 2017, J CARDIOL, V69, P253, DOI 10.1016/j.jjcc.2016.04.003; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Oemrawsingh RM, 2014, J AM COLL CARDIOL, V64, P2510, DOI 10.1016/j.jacc.2014.07.998; Sinclair H, 2015, JACC-CARDIOVASC IMAG, V8, P198, DOI 10.1016/j.jcmg.2014.12.005; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tanaka A, 2008, AM J CARDIOL, V102, P975, DOI 10.1016/j.amjcard.2008.05.062; Taruya A, 2015, J AM COLL CARDIOL, V65, P2469, DOI 10.1016/j.jacc.2015.04.020; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	25	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180303	10.1371/journal.pone.0180303	http://dx.doi.org/10.1371/journal.pone.0180303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665970	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700082
J	De Marco, C; Laudanna, C; Rinaldo, N; Oliveira, DM; Ravo, M; Weisz, A; Ceccarelli, M; Caira, E; Rizzuto, A; Zoppoli, P; Malanga, D; Viglietto, G				De Marco, Carmela; Laudanna, Carmelo; Rinaldo, Nicola; Oliveira, Duarte Mendes; Ravo, Maria; Weisz, Alessandro; Ceccarelli, Michele; Caira, Elvira; Rizzuto, Antonia; Zoppoli, Pietro; Malanga, Donatella; Viglietto, Giuseppe			Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; ACTIVATING TRANSCRIPTION FACTOR-3; CYCLIN-DEPENDENT KINASE; LIPOCALIN 2; INDUCED APOPTOSIS; AKT ACTIVATION; PHOSPHORYLATION; GROWTH; PTEN; P53	Hyperactivation of the phosphatydil-inositol-3' phosphate kinase (PI3K)/AKT pathway is observed in most NSCLCs, promoting proliferation, migration, invasion and resistance to therapy. AKT can be activated through several mechanisms that include loss of the negative regulator PTEN, activating mutations of the catalytic subunit of PI3K (PIK3CA) and/or mutations of AKT1 itself. However, number and identity of downstream targets of activated PI3K/AKT pathway are poorly defined. To identify the genes that are targets of constitutive PI3K/AKT signalling in lung cancer cells, we performed a comparative transcriptomic analysis of human lung epithelial cells (BEAS-2B) expressing active mutant AKT1 (AKT1-E17K), active mutant PIK3CA (PIK3CA-E545K) or that are silenced for PTEN. We found that, altogether, aberrant PI3K/AKT signalling in lung epithelial cells regulated the expression of 1,960/20,436 genes (9%), though only 30 differentially expressed genes (DEGs) (15 up-regulated, 12 down-regulated and 3 discordant) out of 20,436 that were common among BEAS-AKT1E17K, BEAS-PIK3CA-E545K and BEAS-shPTEN cells (0.1%). Conversely, DEGs specific for mutant AKT1 were 133 (85 up-regulated; 48 down-regulated), DEGs specific for mutant PIK3CA were 502 (280 up-regulated; 222 down-regulated) and DEGs specific for PTEN loss were 1549 (799 up-regulated, 750 down-regulated). The results obtained from array analysis were confirmed by quantitative RT-PCR on selected up-and down-regulated genes (n = 10). Treatment of BEAS-C cells and the corresponding derivatives with pharmacological inhibitors of AKT (MK2206) or PI3K (LY294002) further validated the significance of our findings. Moreover, mRNA expression of selected DEGs (SGK1, IGFBP3, PEG10, GDF15, PTGES, S100P, respectively) correlated with the activation status of the PI3K/AKT pathway assessed by S473 phosphorylation in NSCLC cell lines (n = 6). Finally, we made use of Ingenuity Pathway Analysis (IPA) to investigate the relevant BioFunctions enriched by the costitutive activation of AKT1-, PI3K-or PTEN-dependent signalling in lung epithelial cells. Expectedly, the analysis of the DEGs common to all three alterations highlighted a group of BioFunctions that included Cell Proliferation of tumor cell lines (14 DEGs), Invasion of cells (10 DEGs) and Migration of tumour cell lines (10 DEGs), with a common core of 5 genes (ATF3, CDKN1A, GDF15, HBEGF and LCN2) that likely represent downstream effectors of the pro-oncogenic activities of PI3K/AKT signalling. Conversely, IPA analysis of exclusive DEGs led to the identification of different downstream effectors that are modulated by mutant AKT1 (TGFBR2, CTSZ, EMP1), mutant PIK3CA (CCND2, CDK2, IGFBP2, TRIB1) and PTEN loss (ASNS, FHL2). These findings not only shed light on the molecular mechanisms that are activated by aberrant signalling through the PI3K/AKT pathway in lung epithelial cells, but also contribute to the identification of previously unrecognised molecules whose regulation takes part in the development of lung cancer.	[De Marco, Carmela; Laudanna, Carmelo; Oliveira, Duarte Mendes; Caira, Elvira; Zoppoli, Pietro; Malanga, Donatella; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Rinaldo, Nicola; Viglietto, Giuseppe] Biogem Scarl, Inst Rihe Genet Gaetano Salvatore, Ariano Irpino, Italy; [Ravo, Maria; Weisz, Alessandro] Univ Salerno, Lab Med Mol & Genom, Fac Med & Chirurg, Baronissi, Italy; [Ceccarelli, Michele] Univ Sannio, Dipartimento Biol & Ambientali, Benevento, Italy; [Rizzuto, Antonia] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy	Magna Graecia University of Catanzaro; University of Salerno; University of Sannio; Magna Graecia University of Catanzaro	Zoppoli, P (corresponding author), Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy.	zoppoli.pietro@gmail.com; viglietto@unicz.it	ravegnini, gloria/K-1330-2016; Viglietto, Giuseppe/AAC-2852-2019; rizzuto, antonia/GVT-4842-2022; De Marco, Carmela/J-6797-2015; Zoppoli, Pietro/J-9954-2018; Ceccarelli, Michele/AGP-1739-2022; Malanga, Donatella/J-4877-2018; Weisz, Alessandro/A-1317-2014	ravegnini, gloria/0000-0002-7774-402X; Viglietto, Giuseppe/0000-0003-2327-7515; rizzuto, antonia/0000-0003-4359-4702; De Marco, Carmela/0000-0002-4893-4246; Zoppoli, Pietro/0000-0002-7860-9655; Malanga, Donatella/0000-0002-0491-7698; Weisz, Alessandro/0000-0003-0455-2083; Mendes Oliveira, Duarte/0000-0003-3922-3060; LAUDANNA, Carmelo/0000-0002-0397-6020; Ravo, Maria/0000-0003-1003-2922	Associazione Italiana Ricerca sul Cancro (Al RC) [IG-12969, IG-17426]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2010W4J4RM_001, PON01_27082]; Ministero Italiano per la Salute (Young Researcher Grants) [GR- 2011-02350476]	Associazione Italiana Ricerca sul Cancro (Al RC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano per la Salute (Young Researcher Grants)	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (Al RC) to GV (IG-12969) and to AW (IG-17426), from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (2010W4J4RM_001 and PON01_27082) to GV and from Ministero Italiano per la Salute to MR (Young Researcher Grants, GR- 2011-02350476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; [Anonymous], INT J PHOTOENERGY, DOI DOI 10.1186/1476-511X-13-189; Anttila MA, 1999, BRIT J CANCER, V79, P1870, DOI 10.1038/sj.bjc.6690298; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bukholm IK, 2000, VIRCHOWS ARCH, V436, P224, DOI 10.1007/s004280050034; Caffo O, 1996, CLIN CANCER RES, V2, P1591; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106812; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Datta S.R., 1999, CELLULAR SURVIVAL PL; De Marco C, 2015, ONCOTARGET, V6, P39634, DOI 10.18632/oncotarget.4022; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gartel AL, 2006, MOL CANCER THER, V5, P1385, DOI 10.1158/1535-7163.MCT-06-0163; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hettmer S, 2015, ELIFE, V4, DOI 10.7554/eLife.09436; Hirsch FR, 2004, THYMUS HEART, V7, P16; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang XJ, 2016, ANTICANCER RES, V36, P509; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim KW, 2008, ASIAN SPINE J, V2, P1, DOI 10.4184/asj.2008.2.1.1; Koh SA, 2015, ONCOL REP, V34, P2179, DOI 10.3892/or.2015.4189; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lee DH, 2003, CANCER RES, V63, P4648; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046677; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim WT, 2007, ONCOL REP, V17, P853; Lin CW, 2012, ORAL DIS, V18, P734, DOI 10.1111/j.1601-0825.2012.01938.x; Liu YF, 2016, FEBS LETT, V590, P2594, DOI 10.1002/1873-3468.12304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu S, 2006, INT J ONCOL, V28, P245; Malanga D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147334; Malanga D, 2015, ONCOTARGET, V6, P42667, DOI 10.18632/oncotarget.5626; Mandal M, 1998, ONCOGENE, V16, P217, DOI 10.1038/sj.onc.1201529; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mongre R, 2016, INT J ONCOL, V48, P84, DOI 10.3892/ijo.2015.3245; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Ogawa M, 2001, INT J MOL MED, V7, P479; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Papadimitrakopoulou V, 2006, J THORAC ONCOL, V1, P749, DOI 10.1016/S1556-0864(15)30399-3; Reddel RR, 1998, ANN NY ACAD SCI, V854, P8, DOI 10.1111/j.1749-6632.1998.tb09887.x; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; SAMBROOK J, 1992, MOL CLONING LAB MANU; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Wang J, 2011, PLOS ONE, V6; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wilhelm F, 2015, GROWTH HORM IGF RES, V25, P115, DOI 10.1016/j.ghir.2015.03.003; Wu M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.68; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Xu JB, 2007, LUNG CANCER, V58, P36, DOI 10.1016/j.lungcan.2007.04.019; Yamaguchi K, 2004, J BIOL CHEM, V279, P49617, DOI 10.1074/jbc.M408796200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhang L, 2017, EFFECTS IGF 1 INF AL; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	94	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178865	10.1371/journal.pone.0178865	http://dx.doi.org/10.1371/journal.pone.0178865			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662101	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300010
J	Garza, DA; Riley, SP; Martinez, JJ				Garza, Daniel A.; Riley, Sean P.; Martinez, Juan J.			Expression of Rickettsia Adr2 protein in E-coli is sufficient to promote resistance to complement- mediated killing, but not adherence to mammalian cells	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MEDITERRANEAN SPOTTED-FEVER; CRYSTAL-STRUCTURE; CONORII; INVASION; INFECTION; VITRONECTIN; ROMPB	Bacteria exposed to host serum are subject to the antibacterial effects to the complement system. However, pathogenic microorganisms have evolved mechanisms of evading this immune attack. We have previously demonstrated that at least two R. conorii antigens, RC1281/Adr1 and OmpB beta-peptide, contribute to the evasion of complement-mediated killing by binding the complement regulatory proteins vitronectin and factor H. RC1282/Adr2, a protein related to Adr1, is predicted to share similar structural features, suggesting that this protein may also contribute to evasion of complement-mediated killing. Interestingly, the R. prowazekii Adr1 and Adr2(RP828) proteins were originally found to interact with host cell surface proteins, suggesting their putative roles as adhesins in this pathogenic rickettsial species. In this study, we expressed both R. conorii and R. prowazekii Adr2 on the surface of a non-adherent, serum-sensitive strain of E. coli to examine the potential role of this protein to mediate evasion of complement-mediated killing and adherence to host cells. We demonstrate that, similar to R. conorii Adr1, R. conorii and R. prowazekii Adr2 are sufficient to mediate serum resistance and to promote interaction with the host complement regulator vitronectin. Furthermore, we demonstrate that expression of Adr2 in a non-adherent strain of E. coli is insufficient to mediate adherence to cultured mammalian endothelial cells. Together, our data demonstrate that the R. conorii and R. prowazekii Adr2 protein does not participate in the interactions with mammalian cells, but rather, participates in the evasion of killing by complement.	[Garza, Daniel A.; Riley, Sean P.; Martinez, Juan J.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Martinez, JJ (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA.	jmartinez@lsu.edu	Martinez, Juan/GXM-4393-2022	Riley, Sean P/0000-0002-4384-4540	The National Institues of Health, National Institute of Allergy and Infectious Diseases [AI072606, AI10392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103912, R01AI072606] Funding Source: NIH RePORTER	The National Institues of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by awards from The National Institues of Health, National Institute of Allergy and Infectious Diseases (AI072606 and AI10392) to JJM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Crespo P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1042-3; Espejo E, 2016, EPIDEMIOLOGY INFECT, P1; Fish AI, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00061; Garcia-Magallon B, 2015, REV ESP SALUD PUBLIC, V89, P321, DOI 10.4321/S1135-57272015000300009; Gong W, 2014, VACCINE, V32, P2027; Gong WP, 2015, VACCINE, V33, P985, DOI 10.1016/j.vaccine.2015.01.017; Gong WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100253; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee JH, 2013, PROTEIN SCI, V22, P1425, DOI 10.1002/pro.2322; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Li M, 2015, ACTA CRYSTALLOGR D, V71, P2109, DOI 10.1107/S1399004715013905; Madasu Y, 2013, P NATL ACAD SCI USA, V110, pE2677, DOI 10.1073/pnas.1307235110; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Otterdal K, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.010; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Riley SP, 2014, CELL MICROBIOL, V16, P849, DOI 10.1111/cmi.12243; Riley SP, 2012, INFECT IMMUN, V80, P2735, DOI 10.1128/IAI.00349-12; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Rovery C, 2008, EMERG INFECT DIS, V14, P1360, DOI 10.3201/eid1409.071133; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Vellaiswamy M, 2011, MICROB PATHOGENESIS, V50, P233, DOI 10.1016/j.micpath.2011.01.009; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179544	10.1371/journal.pone.0179544	http://dx.doi.org/10.1371/journal.pone.0179544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662039	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300032
J	Populo, H; Batista, R; Sampaio, C; Pardal, J; Lopes, JM; Soares, P				Populo, Helena; Batista, Rui; Sampaio, Cristina; Pardal, Joana; Lopes, Jose Manuel; Soares, Paula			SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; SUCCINATE-DEHYDROGENASE; UVEAL-MELANOMA; BRAF MUTATIONS; PATHWAY ACTIVATION; ENZYMATIC-ACTIVITY; NRAS MUTATIONS; MTOR PATHWAY; COMPLEX-II; TERT	Background SDHD promoter mutations were reported in 4-10% of cutaneous melanomas. The advanced clinico-pathological and patient survival association with SDHD mutation and/or expression in cutaneous melanoma remains controversial. Objectives To evaluate the presence of SDHD promoter mutations and SDHD protein expression in a melanoma series and its possible association with prognosis and survival of the patients. Methods We assessed SDHD promoter status in cutaneous melanomas (CM), ocular melanomas (OM) and melanoma cell lines, and the expression of SDHD protein by immunohistochemistry in CM and OM, and by western blot in melanoma cell lines. We explored the putative association between SDHD protein expression and clinico-pathological and prognostic parameters of melanoma. Results We detected 2% of SDHD promoter mutations in CM, but none in OM and cell lines. SDHD protein expression was present in all CM, in OM and in all CM and OM derived cell lines analysed. A significant association between lower SDHD mean protein expression and presence of ulceration and higher pT stage was found. Conclusions SDHD promoter mutation seems to be a rare event in CM but SDHD lower expression might associate with worst prognostic features in CM.	[Populo, Helena; Batista, Rui; Sampaio, Cristina; Lopes, Jose Manuel; Soares, Paula] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Populo, Helena; Batista, Rui; Sampaio, Cristina; Lopes, Jose Manuel; Soares, Paula] Univ Porto, Inst Res & Innovat Hlth, Oporto, Portugal; [Batista, Rui; Sampaio, Cristina] Univ Porto, Fac Med, Oporto, Portugal; [Pardal, Joana; Lopes, Jose Manuel] Hosp Sao Joao, Dept Pathol, Oporto, Portugal; [Lopes, Jose Manuel; Soares, Paula] Univ Porto, Fac Med, Dept Pathol & Oncol, Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Populo, H (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.; Populo, H (corresponding author), Univ Porto, Inst Res & Innovat Hlth, Oporto, Portugal.	hpopulo@ipatimup.pt	Soares, Paula/B-6054-2008; Lopes, José Manuel Manuel/J-7428-2013; Pópulo, Helena I M/K-2964-2013; Batista, Rui/K-9177-2014	Soares, Paula/0000-0001-9607-6998; Lopes, José Manuel Manuel/0000-0001-8597-3474; Pópulo, Helena I M/0000-0002-6353-6879; Batista, Rui/0000-0002-6512-5328; Sampaio, Cristina/0000-0002-2974-210X	Portuguese Foundation for Science and Technology through Post-Docgrant to HP [SFRH/BPD/85249/2012]; FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences [POCI-01-0145-FEDER-007274]; "Advancing cancer research: from basic knowledgment to application" [NORTE-01-0145F EDER-000029]; "Projetos Estruturados de IDI"; Norte2020-ProgramaOperacional Regional do Norte	Portuguese Foundation for Science and Technology through Post-Docgrant to HP; FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences; "Advancing cancer research: from basic knowledgment to application"; "Projetos Estruturados de IDI"; Norte2020-ProgramaOperacional Regional do Norte	This study was supported by the Portuguese Foundation for Science and Technology through Post-Docgrant to HP(Ref.: SFRH/BPD/85249/2012). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT. This work was financed by FEDER-Fundo Europeude Desenvolvimen to Regional funds through the COMPETE2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT-Fundacao para a Ciencia e aTecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences"(POCI-01-0145-FEDER-007274). Further funding was obtained from the project "Advancing cancer research: from basic knowledgment to application"; NORTE-01-0145F EDER-000029; "Projetos Estruturados de I&D&I", funded by Norte2020-ProgramaOperacional Regional do Norte.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Barletta JA, 2012, ADV ANAT PATHOL, V19, P193, DOI 10.1097/PAP.0b013e31825c6bc6; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chen PW, 1997, CLIN EXP METASTAS, V15, P509, DOI 10.1023/A:1018479011340; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Cruz F, 2003, CANCER RES, V63, P5761; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dono M, 2014, BRIT J CANCER, V110, P1058, DOI 10.1038/bjc.2013.804; El-Shabrawi Y, 1999, ACTA OPHTHALMOL SCAN, V77, P31, DOI 10.1034/j.1600-0420.1999.770107.x; Farber M, 1998, J AM ACAD DERMATOL, V38, P971, DOI 10.1016/S0190-9622(98)70162-8; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gear J, 2004, INVEST OPHTH VIS SCI, V45, P2484, DOI 10.1167/iovs.04-0093; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Goldenberg-Cohen N, 2005, INVEST OPHTH VIS SCI, V46, P3027, DOI 10.1167/iovs.04-1449; Griewank KG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju246; Griewank KG, 2013, CLIN CANCER RES, V19, P3143, DOI 10.1158/1078-0432.CCR-13-0163; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang SB, 2013, CURR OPIN PLANT BIOL, V16, P344, DOI 10.1016/j.pbi.2013.02.007; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KSANDER BR, 1991, INVEST OPHTH VIS SCI, V32, P3198; Lopez-Bergami P, 2008, PHOTOCHEM PHOTOBIOL, V84, P289, DOI 10.1111/j.1751-1097.2007.00254.x; Luyten GPM, 1996, INT J CANCER, V66, P380, DOI 10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F; Mediouni A, 2014, EUR ANN OTORHINOLARY, V131, P159, DOI 10.1016/j.anorl.2013.05.003; Melanoma Bertolotto C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/635203; Pawlu C, 2005, FAM CANCER, V4, P49, DOI 10.1007/s10689-004-4227-4; Populo H, 2011, PIGM CELL MELANOMA R, V24, P254, DOI 10.1111/j.1755-148X.2010.00796.x; Populo H, 2014, J INVEST DERMATOL, V134, P2251, DOI 10.1038/jid.2014.163; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Populo H, 2011, BRIT J OPHTHALMOL, V95, P715, DOI 10.1136/bjo.2009.174417; Rimoldi D, 2003, CANCER RES, V63, P5712; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Scholz SL, 2015, ONCOTARGET, V6, P25868, DOI 10.18632/oncotarget.4665; Seregard S, 1998, SURV OPHTHALMOL, V42, P321, DOI 10.1016/S0039-6257(97)00122-7; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Spendlove HE, 2004, MELANOMA RES, V14, P449, DOI 10.1097/00008390-200412000-00003; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Xekouki P, 2012, J CLIN ENDOCR METAB, V97, pE357, DOI 10.1210/jc.2011-1179	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							E0180392	10.1371/journal.pone.0180392	http://dx.doi.org/10.1371/journal.pone.0180392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662141	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300150
J	Xiao, F; Zheng, R; Yang, D; Cao, KJ; Zhang, SJ; Wu, BR; Shao, YF; Zhou, B				Xiao, Feng; Zheng, Rui; Yang, Di; Cao, Kejiang; Zhang, Shijiang; Wu, Bingruo; Shao, Yongfeng; Zhou, Bin			Sex-dependent aortic valve pathology in patients with rheumatic heart disease	PLOS ONE			English	Article							NF-KAPPA-B; ATRIAL-FIBRILLATION; INTERSTITIAL-CELLS; GENDER-DIFFERENCES; ACTIVATION; PATHOGENESIS; STENOSIS; TISSUE; RISK; DIFFERENTIATION	Background Rheumatic heart disease is an autoimmune disease caused by group A streptococci infection and frequently affects the aortic valve. Sex differences are common in the disease progression, treatment, and outcome. However, little is known about the sex differences in the pathology of aortic valves in rheumatic heart disease. Design We studied the end-stage calcific aortic valves from male versus female patients to reveal the sex-dependent pathology differences and molecular changes associated with requiring valve replacement. Methods Aortic valves from 39 patients with rheumatic heart disease (19 males and 20 females) were collected at the time of aortic valve replacement for comparative pathology, immunohistochemistry, and gene expression analyses. Clinical characteristics were also analyzed and compared between the two groups. Results Aortic valves from female patients exhibited increased expression of collagens, infiltration of monocytes/macrophages and neovascularization. Aortic valves from female patients also had increased expression of inflammatory genes involved in the NFKB pathway (phosphorylated NFKB p65 subunit, IL8, and NOS3) and Th1 cytokine genes (IFNA and IL12B). The severe valve pathology in female patients was correlated with a higher serum level of antistreptolysin O antibodies. Conclusion Inflammation is more prominent in aortic valves of female patients with rheumatic heart disease. This sex difference may contribute to the severe valve pathology and worse outcome of female patients.	[Xiao, Feng; Yang, Di; Cao, Kejiang; Zhou, Bin] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Xiao, Feng; Wu, Bingruo; Zhou, Bin] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Genet, Dept Pediat, Bronx, NY 10467 USA; [Xiao, Feng; Wu, Bingruo; Zhou, Bin] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10467 USA; [Zheng, Rui; Zhang, Shijiang; Shao, Yongfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Nanjing Medical University	Zhou, B (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.; Zhou, B (corresponding author), Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Genet, Dept Pediat, Bronx, NY 10467 USA.; Zhou, B (corresponding author), Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10467 USA.; Shao, YF (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China.	yongfengshao30@hotmail.com; bin_zhou@yahoo.com		Zhou, Bin/0000-0003-0832-4002	The National Natural Science Foundation of China [81170212]; The National Heart, Lung, and Blood Institute [R01HL111770]; China Scholarship Council [201508320269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111770] Funding Source: NIH RePORTER	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study wassupported by The National Natural Science Foundation of China (81170212) and The National Heart, Lung, and Blood Institute (R01HL111770) and China Scholarship Council (201508320269).The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	AlFaleh HF, 2016, ANGIOLOGY, V67, P647, DOI 10.1177/0003319715607298; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bright PD, 2016, HEART, V102, P1527, DOI 10.1136/heartjnl-2015-309188; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carapetis JR, 2008, CIRCULATION, V118, P2748, DOI 10.1161/CIRCULATIONAHA.108.774307; Cheng G, 2002, DEV DYNAM, V223, P119, DOI 10.1002/dvdy.1244; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Duan XX, 2017, MOL IMMUNOL, V81, P160, DOI 10.1016/j.molimm.2016.12.005; Eveborn GW, 2015, HEART, V101, P1895, DOI 10.1136/heartjnl-2015-307807; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guilherme Luiza, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940501015X; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Mathieu P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/851945; McCormick Sally P A, 2004, Clin Biochem Rev, V25, P69; MERZ CNB, 2006, J AM COLL CARDIOL, V47, pS21, DOI [DOI 10.1016/J.JACC.2004.12.084, 10.1016/j.jacc.2004.12.084]; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Moreno PR, 1996, CIRCULATION, V94, P3090, DOI 10.1161/01.CIR.94.12.3090; Nadlonek N, 2013, ANN THORAC SURG, V96, P155, DOI 10.1016/j.athoracsur.2013.04.013; Novo G, 2011, CURR DRUG TARGETS, V12, P115, DOI 10.2174/138945011793591545; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Ogah OS, 2015, CLIN RES CARDIOL, V104, P481, DOI 10.1007/s00392-015-0810-y; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Patel V, 2015, FASEB J, V29, P1859, DOI 10.1096/fj.14-257808; Procter NEK, 2016, J GERIATR CARDIOL, V13, P202, DOI 10.11909/j.issn.1671-5411.2016.03.005; Sorimachi K, 1999, CYTOKINE, V11, P571, DOI 10.1006/cyto.1998.0472; Tian L, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-64; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Wang Y, 2015, EUROPEAN HEART J; Xie ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002543; Yao GH, 2016, EUR HEART J-CARD IMG, V17, P512, DOI 10.1093/ehjci/jev330; Yu PJ, 2009, J THORAC CARDIOV SUR, V138, P196, DOI 10.1016/j.jtcvs.2008.10.045; Zeng QC, 2013, ARTERIOSCL THROM VAS, V33, P1580, DOI 10.1161/ATVBAHA.112.300912; Zhou JX, 2016, INT J CARDIOL, V221, P998, DOI 10.1016/j.ijcard.2016.07.036; Zhu QW, 2016, CLIN INTERV AGING, V11, P245, DOI 10.2147/CIA.S98151; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180230	10.1371/journal.pone.0180230	http://dx.doi.org/10.1371/journal.pone.0180230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662157	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300129
J	Vincent, WJB; Harvie, EA; Sauer, JD; Huttenlocher, A				Vincent, William J. B.; Harvie, Elizabeth A.; Sauer, John-Demian; Huttenlocher, Anna			Neutrophil derived LTB4 induces macrophage aggregation in response to encapsulated Streptococcus iniae infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; LEUKOTRIENE B-4; KLEBSIELLA-PNEUMONIAE; TRANSGENIC ZEBRAFISH; HOST-DEFENSE; T-CELLS; VIRULENCE; INFLAMMATION; ACTIVATION; RELEASE	Immune cells sense and react to a multitude of factors including both host and microbe-derived signals. Understanding how cells translate these cues into particular cellular behaviors is a complex yet critical area of study. We have previously shown that both neutrophils and macrophages are important for controlling the fish pathogen Streptococcus iniae. Here, we report both host and bacterial determinants leading to the formation of organized macrophage aggregates as part of the host inflammatory response in a subset of infected larvae. Streptococcal capsule was a required signal for aggregate formation. Macrophage aggregation coincided with NF kappa B activity, and the formation of these aggregates is mediated by leukotriene B4 (LTB4) produced by neutrophils. Depletion, inhibition, or genetic deletion of leukotriene A4 hydrolase (Lta4h), which catalyzes the last step in LTB4 synthesis, resulted in the absence of macrophage aggregation. Larvae with impaired neutrophil function also had impaired macrophage aggregation; however, aggregate formation was partially rescued with the addition of exogenous LTB4. Neutrophil-specific expression of lta4h was sufficient to rescue macrophage aggregation in Lta4h-deficient larvae and increased host survival following infection. In summary, our findings highlight a novel innate immune response to infection in which specific bacterial products drive neutrophils that modulate macrophage behavior through eicosanoid signaling.	[Vincent, William J. B.; Harvie, Elizabeth A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Microbiol Doctoral Training Program, Madison, WI 53706 USA; [Vincent, William J. B.; Harvie, Elizabeth A.; Sauer, John-Demian; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.; Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Sauer, John-Demian/AAV-8538-2020	Sauer, John-Demian/0000-0001-9367-794X	National Institutes of Health, National Research Service [AI55397]; Molecular Biosciences Training Grant [T32-GM07215, R01-CA188034, R35-GM118027]; NATIONAL CANCER INSTITUTE [R01CA188034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118027, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health, National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biosciences Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Research Service Award AI55397 (EAH), Molecular Biosciences Training Grant T32-GM07215 (WJBV), R01-CA188034 (JDS) and R35-GM118027 (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bailie MB, 1996, J IMMUNOL, V157, P5221; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Davey MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002040; DEMITSU T, 1989, DERMATOLOGICA, V179, P129, DOI 10.1159/000248472; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; DEWALD B, 1985, BIOCHEM BIOPH RES CO, V128, P297, DOI 10.1016/0006-291X(85)91678-X; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Fuller JD, 2001, INFECT IMMUN, V69, P1994, DOI 10.1128/IAI.69.4.1994-2000.2001; GOLDMAN G, 1993, SURGERY, V113, P297; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Kalyan S, 2014, CELL MOL LIFE SCI, V71, P2335, DOI 10.1007/s00018-013-1495-x; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; LeBert DC, 2014, SEMIN IMMUNOL, V26, P315, DOI 10.1016/j.smim.2014.04.007; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Oehlers SH, 2016, J INFECT DIS, V137, P1; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Sabbione F, 2014, EUR J IMMUNOL, V44, P819, DOI 10.1002/eji.201343664; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Talvani A, 2002, INFECT IMMUN, V70, P4247, DOI 10.1128/IAI.70.8.4247-4253.2002; Tauzin S, 2014, J CELL BIOL, V207, P589, DOI 10.1083/jcb.201408090; Tobin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067828; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vincent WJB, 2016, CELL MICROBIOL, V18, P591, DOI 10.1111/cmi.12536; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179574	10.1371/journal.pone.0179574	http://dx.doi.org/10.1371/journal.pone.0179574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658259	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900033
J	Nam, HY; Raghavendran, HRB; Pingguan-Murphy, B; Abbas, AA; Merican, AM; Kamarul, T				Nam, Hui Yin; Raghavendran, Hanumantha Rao Balaji; Pingguan-Murphy, Belinda; Abbas, Azlina A.; Merican, Azhar M.; Kamarul, Tunku			Fate of tenogenic differentiation potential of human bone marrow stromal cells by uniaxial stretching affected by stretch-activated calcium channel agonist gadolinium	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ION CHANNELS; SIGNALING PATHWAYS; MECHANICAL-STRESS; TENDON REPAIR; STRAIN; CHONDROCYTES; OSTEOBLASTS; APOPTOSIS; DEATH	The role for mechanical stimulation in the control of cell fate has been previously proposed, suggesting that there may be a role of mechanical conditioning in directing mesenchymal stromal cells (MSCs) towards specific lineage for tissue engineering applications. Although previous studies have reported that calcium signalling is involved in regulating many cellular processes in many cell types, its role in managing cellular responses to tensile loading (mechanotransduction) of MSCs has not been fully elucidated. In order to establish this, we disrupted calcium signalling by blocking stretch-activated calcium channel (SACC) in human MSCs (hMSCs) in vitro. Passaged-2 hMSCs were exposed to cyclic tensile loading (1 Hz + 8% for 6, 24, 48, and 72 hours) in the presence of the SACC blocker, gadolinium. Analyses include image observations of immunochemistry and immunofluorescence staining from extracellular matrix (ECM) production, and measuring related tenogenic and apoptosis gene marker expression. Uniaxial tensile loading increased the expression of tenogenic markers and ECM production. However, exposure to strain in the presence of 20 mu M gadolinium reduced the induction of almost all tenogenic markers and ECM staining, suggesting that SACC acts as a mechanosensor in strain-induced hMSC tenogenic differentiation process. Although cell death was observed in prolonged stretching, it did not appear to be apoptosis mediated. In conclusion, the knowledge gained in this study by elucidating the role of calcium in MSC mechanotransduction processes, and that in prolonged stretching results in non-apoptosis mediated cell death may be potential useful for regenerative medicine applications.	[Nam, Hui Yin; Raghavendran, Hanumantha Rao Balaji; Abbas, Azlina A.; Merican, Azhar M.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia; [Pingguan-Murphy, Belinda] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Nam, HY; Kamarul, T (corresponding author), Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Tissue Engn Grp, Kuala Lumpur, Malaysia.	huiyin26@yahoo.com; tkzrea@um.edu.my	ABBAS, AZLINA AMIR/B-5405-2010; Merican, Azhar M/S-2982-2019; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; raghavendran, hanumantha rao balaji/B-8507-2012; Nam, Hui Yin/F-5013-2013; Pingguan-Murphy, Belinda/B-8332-2010	ABBAS, AZLINA AMIR/0000-0003-4423-4653; Merican, Azhar M/0000-0001-6442-8776; Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Pingguan-Murphy, Belinda/0000-0001-5567-1141	High Impact Research Ministry of Education, HIR-MoE [UM.C/625/1/HIR/MOHE/CHAN/03, A000003-50001]; University of Malaya	High Impact Research Ministry of Education, HIR-MoE; University of Malaya(Universiti Malaya)	This work was supported by High Impact Research Ministry of Education, HIR-MoE Grant (Reference number - UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). We also thank the University of Malaya for a PhD thesis scholarship for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by High Impact Research-Ministry of Education, HIR-MoE Grant (Reference number UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). We also thank the University of Malaya for a PhD thesis scholarship for the first author.	Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356; Banes AJ., 2001, CURR OPIN ORTHOP, V12, P389; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blatt NB, 2001, BIOORGAN MED CHEM, V9, P1371, DOI 10.1016/S0968-0896(01)00041-4; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Boudreault F, 2002, AM J PHYSIOL-CELL PH, V282, pC219, DOI 10.1152/ajpcell.00317.2001; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coirault C, 1999, EUR RESPIR J, V14, P1297, DOI 10.1183/09031936.99.14612979; Costa P, 2012, INT J BIOCHEM CELL B, V44, P2233, DOI 10.1016/j.biocel.2012.09.003; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Dook JE, 1997, MED SCI SPORT EXER, V29, P291, DOI 10.1097/00005768-199703000-00002; Ge DX, 2009, BIOCHEM BIOPH RES CO, V381, P317, DOI 10.1016/j.bbrc.2009.01.173; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; Huo B, 2010, PHILOS T R SOC A, V368, P617, DOI 10.1098/rsta.2009.0221; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4; Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Killian ML, 2012, J SHOULDER ELB SURG, V21, P228, DOI 10.1016/j.jse.2011.11.002; Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Massoud EIE, 2013, WORLD J ORTHOP, V4, P229, DOI 10.5312/wjo.v4.i4.229; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; McKayed KK, 2012, STEM CELLS CANC STEM, P199; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Nam HY, 2015, BIOMECH MODEL MECHAN, V14, P649, DOI 10.1007/s10237-014-0628-y; Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309; Nowycky MC, 2002, J CELL SCI, V115, P3715, DOI 10.1242/jcs.00078; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323; Pingguan-Murphy B, 2005, ARCH BIOCHEM BIOPHYS, V444, P45, DOI 10.1016/j.abb.2005.09.015; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015; Tan JL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.3; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Upadhyay R. K, 2015, J REGEN MED TISSUE E, V4, P1; Wall M. E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P70; Wang ECY, 2003, AM J PHYSIOL-RENAL, V285, pF651, DOI 10.1152/ajprenal.00403.2002; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639; Wedhas N, 2005, FASEB J, V19, P1986, DOI 10.1096/fj.05-4198com; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843	67	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0178117	10.1371/journal.pone.0178117	http://dx.doi.org/10.1371/journal.pone.0178117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654695	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500012
J	Osugi, T; Sasakura, Y; Satake, H				Osugi, Tomohiro; Sasakura, Yasunori; Satake, Honoo			The nervous system of the adult ascidian Ciona intestinalis Type A (Ciona robusta): Insights from transgenic animal models	PLOS ONE			English	Article							GONADOTROPIN-RELEASING HORMONES; ANCESTRAL CHORDATE BRAIN; EVOLUTIONARY ORIGIN; OOCYTE GROWTH; PROTOCHORDATE; FAMILY; GENES; SUPERFAMILY; TUNICATES; RECEPTOR	The nervous system of ascidians is an excellent model system to provide insights into the evolutionary process of the chordate nervous system due to their phylogenetic positions as the sister group of vertebrates. However, the entire nervous system of adult ascidians has yet to be functionally and anatomically investigated. In this study, we have revealed the whole dorsal and siphon nervous system of the transgenic adult ascidian of Ciona intestinalis Type A (Ciona robusta) in which a Kaede reporter gene is expressed in a pan-neuronal fashion. The fluorescent signal of Kaede revealed the innervation patterns and distribution of neurons in the nervous system of Ciona. Precise microscopic observation demonstrated the clear innervation of the anterior and posterior main nerves to eight and six lobes of the oral and atrial siphons, respectively. Moreover, visceral nerves, previously identified as unpaired nerves, were found to be paired; one nerve was derived from the posterior end of the cerebral ganglion and the other from the right posterior nerve. This study further revealed the full trajectory of the dorsal strand plexus and paired visceral nerves on either side from the cerebral ganglion to the ovary, and precise innervation between the cerebral ganglion and the peripheral organs including the gonoduct, cupular organ, rectum and ovary. The differential innervation patterns of visceral nerves and the dorsal strand plexus indicate that the peripheral organs including the ovary undergo various neural regulations. Collectively, the present anatomical analysis revealed the major innervation of the dorsal and siphon nervous systems of adult Ciona.	[Osugi, Tomohiro; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan; [Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka, Japan	Suntory Holdings Ltd; University of Tsukuba	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan.	satake@sunbor.or.jp		Osugi, Tomohiro/0000-0001-6987-9576	Japan Society for the promotion of Science [26840108, 25440161]; Grants-in-Aid for Scientific Research [16K07430] Funding Source: KAKEN	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the promotion of Science (http://www.isps.go.jp/english/index.html) to TO (26840108) and HS (25440161). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Adams BA, 2003, ENDOCRINOLOGY, V144, P1907, DOI 10.1210/en.2002-0216; Aoyama M, 2008, ENDOCRINOLOGY, V149, P4346, DOI 10.1210/en.2008-0323; Aoyama M, 2012, PEPTIDES, V34, P186, DOI 10.1016/j.peptides.2011.07.019; Auger H, 2010, DEV BIOL, V339, P374, DOI 10.1016/j.ydbio.2009.12.040; Bollner T, 1997, P ROY SOC B-BIOL SCI, V264, P1117, DOI 10.1098/rspb.1997.0154; BONE Q, 1978, J ZOOL, V186, P417; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Braun K, 2016, ZOOMORPHOLOGY, V135, P351, DOI 10.1007/s00435-016-0317-8; Brunetti R, 2015, J ZOOL SYST EVOL RES, V53, P186, DOI 10.1111/jzs.12101; Burighel P, 2001, INVERTEBR BIOL, V120, P185, DOI 10.1111/j.1744-7410.2001.tb00123.x; Dahlberg C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004458; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Delsuc F, 2008, GENESIS, V46, P592, DOI 10.1002/dvg.20450; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Egertova M, 2007, J COMP NEUROL, V502, P660, DOI 10.1002/cne.21331; FEDELE M, 1938, ATTI ACCADEMIA NAZIO, V27, P370; GOODBODY I, 1974, ADV MAR BIOL, V12, P1; Hasunuma I, 2013, ZOOL SCI, V30, P311, DOI 10.2108/zsj.30.311; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Hozumi A, 2015, DEV DYNAM, V244, P1375, DOI 10.1002/dvdy.24317; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; Jeffery WR, 2015, GENESIS, V53, P48, DOI 10.1002/dvg.22799; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; Kawada T, 2008, PEPTIDES, V29, P1672, DOI 10.1016/j.peptides.2008.05.030; Kawada T, 2011, ENDOCRINOLOGY, V152, P2416, DOI 10.1210/en.2010-1348; Kawada T, 2009, PEPTIDES, V30, P2200, DOI 10.1016/j.peptides.2009.08.014; Lacalli TC, 1998, PHILOS T ROY SOC B, V353, P1943, DOI 10.1098/rstb.1998.0347; Mackie GO, 2006, CAN J ZOOL, V84, P1146, DOI 10.1139/Z06-106; Mackie GO, 2005, CAN J ZOOL, V83, P151, DOI 10.1139/Z04-177; MACKIE GO, 1995, J MAR BIOL ASSOC UK, V75, P141, DOI 10.1017/S0025315400015253; Manni L, 2006, J COMP NEUROL, V495, P363, DOI 10.1002/cne.20867; Manni L, 2015, STRUCTURE EVOLUTION; Markman B, 1958, ACTA ZOOLOGICA, V34, P13; Matsubara S, 2016, GEN COMP ENDOCR, V227, P101, DOI 10.1016/j.ygcen.2015.05.010; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; Ohta N, 2010, ZOOL SCI, V27, P842, DOI 10.2108/zsj.27.842; Olinski RP, 2006, PEPTIDES, V27, P2535, DOI 10.1016/j.peptides.2006.06.008; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; Pennati R, 2012, EUR J HISTOCHEM, V56, P96, DOI [10.4081/ejh.2012.e16, 10.4081/ejh.2012.16]; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rigon F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-112; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satake H, 2004, J BIOL CHEM, V279, P53798, DOI 10.1074/jbc.M408161200; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sekiguchi T, 2007, GEN COMP ENDOCR, V150, P233, DOI 10.1016/j.ygcen.2006.08.010; Sekiguchi T, 2012, J ENDOCRINOL, V213, P99, DOI 10.1530/JOE-11-0410; Sekiguchi T, 2009, FEBS J, V276, P4437, DOI 10.1111/j.1742-4658.2009.07151.x; Takamura K, 2010, ZOOL SCI, V27, P191, DOI 10.2108/zsj.27.191; Terakado K, 2001, GEN COMP ENDOCR, V124, P277, DOI 10.1006/gcen.2001.7728; Terakubo HQ, 2010, DEV DYNAM, V239, P2278, DOI 10.1002/dvdy.22361; Tsutsui H, 1998, GEN COMP ENDOCR, V112, P426, DOI 10.1006/gcen.1998.7160; Wada H, 1998, DEVELOPMENT, V125, P1113; Yamana Y, 2005, NIPPON SUISAN GAKK, V71, P299, DOI 10.2331/suisan.71.299	57	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180227	10.1371/journal.pone.0180227	http://dx.doi.org/10.1371/journal.pone.0180227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651020	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300043
J	Pardo, E; Carcamo, C; Martin, RUS; Ciampi, E; Segovia-Miranda, F; Curkovic-Pena, C; Montecino, F; Holmes, C; Tichauer, JE; Acuna, E; Osorio-Barrios, F; Castro, M; Cortes, P; Oyanadel, C; Valenzuela, DM; Pacheco, R; Naves, R; Soza, A; Gonzalez, A				Pardo, Evelyn; Carcamo, Claudia; Uribe-San Martin, Reinaldo; Ciampi, Ethel; Segovia-Miranda, Fabian; Curkovic-Pena, Cristobal; Montecino, Fabian; Holmes, Christopher; Enrique Tichauer, Juan; Acuna, Eric; Osorio-Barrios, Francisco; Castro, Marjorie; Cortes, Priscilla; Oyanadel, Claudia; Valenzuela, David M.; Pacheco, Rodrigo; Naves, Rodrigo; Soza, Andrea; Gonzalez, Alfonso			Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; ALPHA-4 INTEGRIN EXPRESSION; INTRATHECAL IGM SYNTHESIS; B-CELLS; LUPUS-ERYTHEMATOSUS; CEREBROSPINAL-FLUID; POTASSIUM CHANNEL; OLIGOCLONAL IGM; DENDRITIC CELLS	Galectin-8 (Gal-8) is a member of a glycan-binding protein family that regulates the immune system, among other functions, and is a target of antibodies in autoimmune disorders. However, its role in multiple sclerosis (MS), an autoimmune inflammatory disease of the central nervous system (CNS), remains unknown. We study the consequences of Gal-8 silencing on lymphocyte subpopulations and the development of experimental autoimmune encephalitis (EAE), to then assess the presence and clinical meaning of anti-Gal-8 antibodies in MS patients. Lgals8/Lac-Z knock-in mice lacking Gal-8 expression have higher polarization toward Th17 cells accompanied with decreased CCR6(+) and higher CXCR3(+) regulatory T cells (Tregs) frequency. These conditions result in exacerbated MOG(35-55) peptide-induced EAE. Gal-8 eliminates activated Th17 but not Th1 cells by apoptosis and ameliorates EAE in C57BL/6 wild-type mice. beta-gal histochemistry reflecting the activity of the Gal-8 promoter revealed Gal-8 expression in a wide range of CNS regions, including high expression in the choroid-plexus. Accordingly, we detected Gal-8 in human cerebrospinal fluid, suggesting a role in the CNS immune-surveillance circuit. In addition, we show that MS patients generate function-blocking anti-Gal-8 antibodies with pathogenic potential. Such antibodies block cell adhesion and Gal-8-induced Th17 apoptosis. Furthermore, circulating anti-Gal-8 antibodies associate with relapsing-remitting MS (RRMS), and not with progressive MS phenotypes, predicting clinical disability at diagnosis within the first year of follow-up. Our results reveal that Gal-8 has an immunosuppressive protective role against autoimmune CNS inflammation, modulating the balance of Th17 and Th1 polarization and their respective Tregs. Such a role can be counteracted during RRMS by anti-Gal-8 antibodies, worsening disease prognosis. Even though anti-Gal-8 antibodies are not specific for MS, our results suggest that they could be a potential early severity biomarker in RRMS.	[Pardo, Evelyn; Segovia-Miranda, Fabian; Curkovic-Pena, Cristobal; Montecino, Fabian; Holmes, Christopher; Cortes, Priscilla; Oyanadel, Claudia; Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile; [Pardo, Evelyn] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Gerosci Ctr Brain Hlth & Metab, Santiago, Chile; [Carcamo, Claudia; Uribe-San Martin, Reinaldo; Ciampi, Ethel] Pontificia Univ Catolica Chile, Fac Med, Dept Neurol, Santiago, Chile; [Enrique Tichauer, Juan; Acuna, Eric; Naves, Rodrigo] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Osorio-Barrios, Francisco; Oyanadel, Claudia; Pacheco, Rodrigo] Fdn Ciencia & Vida, Santiago, Chile; [Castro, Marjorie] Univ San Sebastian, Fac Ciencias Salud, Santiago, Chile; [Cortes, Priscilla; Oyanadel, Claudia; Soza, Andrea] Univ San Sebastian, Fac Ciencia, Santiago, Chile; [Valenzuela, David M.] Regeneron Pharmaceut, New York, NY USA; [Pacheco, Rodrigo] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Santiago, Chile; [Gonzalez, Alfonso] Univ San Sebastian, Fac Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad San Sebastian; Universidad San Sebastian; Regeneron; Universidad Andres Bello; Universidad San Sebastian	Soza, A; Gonzalez, A (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile.; Soza, A (corresponding author), Univ San Sebastian, Fac Ciencia, Santiago, Chile.; Gonzalez, A (corresponding author), Univ San Sebastian, Fac Med, Santiago, Chile.	andrea.soza@uss.cl; agonzara@uss.cl	Naves, Rodrigo/H-4829-2014	Naves, Rodrigo/0000-0002-1203-3593; Oyanadel, Claudia/0000-0002-5018-9767; Osorio-Barrios, Francisco/0000-0002-6853-7846; Soza, Andrea/0000-0003-3783-5231; Pacheco, Rodrigo/0000-0001-8057-9806; Pardo, Evelyn/0000-0002-2516-5632	CONICYT [PFB12/2007, PFB-16]; FONDECYT [1131122, 1130271, 1140049]; Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT [22140120]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT	Financial support: Grants CONICYT PFB12/2007 (A.G), FONDECYT #1131122 (A.S), FONDECYT 1130271(R.P.), FONDECYT 1140049 (R.N.) and PFB-16 from CONICYT (R.P.). F.O.-B holds a scholarship (22140120) of the Programa de Formacion de Capital Human Avanzado Magister Nacional from CONICYT. CAPES CONICYT FB 0002 (Line 3) to FB (P.C.). FONDECYT N 3120061 (E.P.). The funder provided support in the form of salaries for authors EP, CC, CH, CC, CH, PC, CO, RP, RN, AS and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arellano G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00492; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Benarroch EE, 2016, NEUROLOGY, V86, P286, DOI 10.1212/WNL.0000000000002298; Brickshawana A, 2014, LANCET NEUROL, V13, P795, DOI 10.1016/S1474-4422(14)70141-3; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Dhaeze T, 2015, AUTOIMMUN REV, V14, P735, DOI 10.1016/j.autrev.2015.04.006; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fraussen J, 2014, AUTOIMMUN REV, V13, P1126, DOI 10.1016/j.autrev.2014.07.002; Garcia-Barragan N, 2009, EUR J NEUROL, V16, P380, DOI 10.1111/j.1468-1331.2008.02504.x; Glatigny S, 2011, J IMMUNOL, V187, P6176, DOI 10.4049/jimmunol.1102515; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Harrison DM, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-7-201404010-01004; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Huber AK, 2014, NEUROLOGY, V83, P1500, DOI 10.1212/WNL.0000000000000908; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaltner H, 2012, HISTOL HISTOPATHOL, V27, P397, DOI 10.14670/HH-27.397; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mandrioli J, 2008, J NEUROL, V255, P1023, DOI 10.1007/s00415-008-0827-5; Massardo L, 2009, LUPUS, V18, P539, DOI 10.1177/0961203308099973; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; Metz C, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0091-6; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Naves R, 2013, J IMMUNOL, V191, P2967, DOI 10.4049/jimmunol.1300419; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Norambuena A, 2009, J BIOL CHEM, V284, P12670, DOI 10.1074/jbc.M808949200; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Ottum PA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00539; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; Pal Z, 2012, BBA-GEN SUBJECTS, V1820, P1512, DOI 10.1016/j.bbagen.2012.05.015; Pardo E, 2006, REV MED CHILE, V134, P159; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Probstel AK, 2015, INT J MOL SCI, V16, P16576, DOI 10.3390/ijms160716576; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Ransohoff RM, 2015, NATURE REV NEUROLOGY; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rieckmann P, 2001, TRENDS NEUROSCI, V24, P548, DOI 10.1016/S0166-2236(00)01860-9; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Rowse AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052658; Ruiz FM, 2014, FEBS J, V281, P1446, DOI 10.1111/febs.12716; Sampson JF, 2016, IMMUNOL CELL BIOL, V94, P213, DOI 10.1038/icb.2015.72; Sampson JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130772; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Segovia-Miranda F, 2015, ARTHRITIS RHEUMATOLO; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Sie C, 2014, EXP NEUROL, V262, P18, DOI 10.1016/j.expneurol.2014.03.009; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Steelman AJ, 2013, J BIOL CHEM, V288, P23776, DOI 10.1074/jbc.M113.451658; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Swanton J, 2014, HAND CLINIC, V122, P371, DOI 10.1016/B978-0-444-52001-2.00015-7; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vicuna L, 2013, BIOL RES, V46, P275, DOI 10.4067/S0716-97602013000300008; Villar LM, 2012, MULT SCLER J, V18, P250, DOI 10.1177/1352458511415890; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zhang SD, 2015, P NATL ACAD SCI USA, V112, P5585, DOI 10.1073/pnas.1506220112; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhuo Y, 2008, J BIOL CHEM	86	26	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0177472	10.1371/journal.pone.0177472	http://dx.doi.org/10.1371/journal.pone.0177472			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650992	Green Submitted, gold, Green Published			2022-12-26	WOS:000404537300045
J	Tu, XJ; Hwang, WJ; Ma, HI; Chang, LH; Hsu, SP				Tu, Xiao-Jing; Hwang, Wen-Juh; Ma, Hui-Ing; Chang, Ling-Hui; Hsu, Shih-Pin			Determinants of generic and specific healthrelated quality of life in patients with Parkinson's disease	PLOS ONE			English	Article							MDS-UPDRS; NONMOTOR SYMPTOMS; CHINESE VERSION; QUESTIONNAIRE PDQ-39; RATING-SCALES; DISORDER; RECOMMENDATIONS; VALIDATION; CRITIQUE; PROGRESSION	Objectives Generic and disease-specific health-related quality of life (HRQoL) instruments may reflect different aspects of lives in patients with Parkinson's disease (PD) and thus be associated with different determinants. We used the same cluster of predictors for the generic and disease- specific HRQoL instruments to examine and compare the determinants of HRQoL. Method HRQoL was measured in 92 patients with PD by the 36-item Short-Form Health Survey (SF-36) and the 39-item Parkinson's Disease Questionnaire (PDQ-39). The predictors included demographic and disease characteristics, and motor and non-motor symptoms. Multiple regression analyses were used to identify HRQoL determinants. Results Depressive symptoms and motor difficulties of daily living were the first two significant determinants for both instruments. The other significant determinant for the SF-36 was fatigue and non-motor difficulties of daily living, and for the PDQ-39 was motor signs of PD. Conclusions The results suggest the importance of the evaluation and intervention focused on depressive symptoms and motor difficulties of daily living in patients with PD. In addition, the SF-36 seems more related to non-motor symptoms, while the PDQ-39 appears more associated with motor symptoms. This information is important for understanding results from these two instruments and for choosing which to use.	[Tu, Xiao-Jing; Ma, Hui-Ing; Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan; [Hwang, Wen-Juh] Natl Cheng Kung Univ, Dept Neurol, Coll Med, Tainan, Taiwan; [Ma, Hui-Ing; Chang, Ling-Hui] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan; [Hsu, Shih-Pin] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Shih-Pin] I Shou Univ, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; E-Da Hospital; I Shou University	Ma, HI (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan.; Ma, HI (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.; Hsu, SP (corresponding author), E Da Hosp, Dept Neurol, Kaohsiung, Taiwan.; Hsu, SP (corresponding author), I Shou Univ, Kaohsiung, Taiwan.	huingma@mail.ncku.edu.tw; a.pin.hsu@gmail.com	Chang, Ling-Hui/AAG-2410-2019	Chang, Ling Hui/0000-0003-4129-6947	E-Da Hospital, Kaohsiung, Taiwan [NCKUEDA 10214]	E-Da Hospital, Kaohsiung, Taiwan	The study was supported by grant NCKUEDA 10214 from E-Da Hospital, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell DM, 1999, QUAL LIFE RES, V8, P345, DOI 10.1023/A:1008979705027; Caap-Ahlgren M, 2001, ARCH GERONTOL GERIAT, V32, P23, DOI 10.1016/S0167-4943(00)00087-X; Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P1408, DOI 10.1002/mds.21408; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Cubo E, 2002, EUR J NEUROL, V9, P589, DOI 10.1046/j.1468-1331.2002.00484.x; Den Oudsten BL, 2007, MOVEMENT DISORD, V22, P1528, DOI 10.1002/mds.21567; Den Oudsten BL, 2007, MOVEMENT DISORD, V22, P1390, DOI 10.1002/mds.21539; Dowding CH, 2006, DRUG AGING, V23, P693, DOI 10.2165/00002512-200623090-00001; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Friedman JH, 2010, MOVEMENT DISORD, V25, P805, DOI 10.1002/mds.22989; Fuh JL, 2000, QUAL LIFE RES, V9, P675, DOI 10.1023/A:1008993821633; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hu MH, 2010, J LONG TERM CARE, V14, P267; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jenkinson C, 1999, PHARMACOECONOMICS, V15, P157, DOI 10.2165/00019053-199915020-00004; Lawrence BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102294; Ma HI, 2005, QUAL LIFE RES, V14, P565, DOI 10.1007/s11136-004-0687-0; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Martinez-Martin P, 2014, EUR J NEUROL, V21, P519, DOI 10.1111/ene.12349; Martinez-Martin P, 1998, J NEUROL, V245, pS2, DOI 10.1007/PL00007733; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; Martinez-Martin P, 2011, J NEUROL SCI, V310, P12, DOI 10.1016/j.jns.2011.05.006; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Qin ZH, 2009, CLIN NEUROL NEUROSUR, V111, P733, DOI 10.1016/j.clineuro.2009.07.001; Reuther M, 2007, PARKINSONISM RELAT D, V13, P108, DOI 10.1016/j.parkreldis.2006.07.009; Rodriguez-Blazquez C, 2013, PARKINSONISM RELAT D, V19, P889, DOI 10.1016/j.parkreldis.2013.05.017; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Simpson J, 2014, DISABIL REHABIL, V36, P1964, DOI 10.3109/09638288.2014.883442; Skorvanek M, 2015, J NEUROL SCI, V353, P87, DOI 10.1016/j.jns.2015.04.013; Skorvanek M, 2013, J GERIATR PSYCH NEUR, V26, P237, DOI 10.1177/0891988713500587; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Verbaan D, 2011, PARKINSONISM RELAT D, V17, P632, DOI 10.1016/j.parkreldis.2011.05.022; Wang MY, 2016, QUAL LIFE RES, V25, P89, DOI 10.1007/s11136-015-1056-x; Yu RL, 2017, MOV DISORD CLIN PRAC, V4, P68, DOI 10.1002/mdc3.12349	42	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178896	10.1371/journal.pone.0178896	http://dx.doi.org/10.1371/journal.pone.0178896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650957	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300048
J	Waisi, H; Jankovic, B; Jankovic, M; Nikolic, B; Dimkic, I; Lalevic, B; Raicevic, V				Waisi, Hadi; Jankovic, Bojan; Jankovic, Marija; Nikolic, Bogdan; Dimkic, Ivica; Lalevic, Blazo; Raicevic, Vera			New insights in dehydration stress behavior of two maize hybrids using advanced distributed reactivity model (DRM). Responses to the impact of 24-epibrassinolide	PLOS ONE			English	Article							DESICCATION TOLERANCE; WATER RELATIONS; ABIOTIC STRESS; DROUGHT; BRASSINOSTEROIDS; KINETICS; GROWTH; SUGARS; PHOTOSYNTHESIS; TREHALOSE	Proposed distributed reactivity model of dehydration for seedling parts of two various maize hybrids (ZP434, ZP704) was established. Dehydration stresses were induced thermally, which is also accompanied by response of hybrids to heat stress. It was found that an increased value of activation energy counterparts within radicle dehydration of ZP434, with a high concentration of 24-epibrassinolide (24-EBL) at elevated operating temperatures, probably causes activation of diffusion mechanisms in cutin network and may increases likelihood of formation of free volumes, large enough to accommodate diffusing molecule. Many small random effects were detected and can be correlated with micro-disturbing in a space filled with water caused by thermal gradients, increasing capillary phenomena, and which can induce thermo-capillary migration. The influence of seedling content of various sugars and minerals on dehydration was also examined. Estimated distributed reactivity models indicate a dependence of reactivity on structural arrangements, due to present interactions between water molecules and chemical species within the plant.	[Waisi, Hadi] Inst Dev Water Resources Jaroslav Cerni, Dept Sci Res & Informat Technol, Belgrade, Serbia; [Jankovic, Bojan] Univ Belgrade, Fac Phys Chem, Dept Gen & Phys Chem, Belgrade, Serbia; [Jankovic, Marija] Univ Belgrade, Inst Nucl Sci Vinca, Radiat & Environm Protect Dept, Belgrade, Serbia; [Nikolic, Bogdan] Inst Plant Protect & Environm, Dept Phytopharm & Environm Protect, Belgrade, Serbia; [Dimkic, Ivica] Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia; [Lalevic, Blazo; Raicevic, Vera] Univ Belgrade, Dept Environm Microbiol, Fac Agr, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Waisi, H (corresponding author), Inst Dev Water Resources Jaroslav Cerni, Dept Sci Res & Informat Technol, Belgrade, Serbia.	hadiwaisi@yahoo.com	Dimkić, Ivica/AAE-1508-2019; Dimkic, Ivica/GWR-2445-2022	Dimkic, Ivica/0000-0002-0425-5938; Waisi, Hadi/0000-0001-7654-8329; Jankovic, Bojan/0000-0001-7520-1972	Serbian Ministry of Education, Science and Technological Development [172015, TR31080, III43009]	Serbian Ministry of Education, Science and Technological Development	This research work was partially supported by the Serbian Ministry of Education, Science and Technological Development under the projects number 172015, TR31080 and III43009.	Abreu JM, 2000, INTAKE NUTRITIVE VAL, P1; Aguilera JM, 1999, MICROSTRUCTURAL PRIN; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 2007, 3051B EPA US; Aquino P, 1999, CIMMYT WORLD MAIZE F, P18; Arnholdt-Schmitt B, 2004, PLANT PHYSIOL, V136, P2579, DOI 10.1104/pp.104.042531; Bajguz A, 2007, PLANT PHYSIOL BIOCH, V45, P95, DOI 10.1016/j.plaphy.2007.01.002; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Berg JM, 2002, BIOCHEMISTRY-US, P40; Bertoia LM, 2002, CROP SCI, V42, P365, DOI 10.2135/cropsci2002.0365; Bolan N, 2012, HDB SOIL SCI RESOURC, P11; Brenac P, 1997, J PLANT PHYSIOL, V150, P481, DOI 10.1016/S0176-1617(97)80102-2; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Burke EJ, 2010, J HYDROL, V388, P131, DOI 10.1016/j.jhydrol.2010.04.035; Burnham AK, 1999, ENERG FUEL, V13, P1, DOI 10.1021/ef9800765; CHIRIFE J, 1973, J AGR FOOD CHEM, V21, P936, DOI 10.1021/jf60190a041; de Mendonca JRG, 1998, J STAT PHYS, V92, P651, DOI 10.1023/A:1023044822735; Du HW, 2016, EUPHYTICA, V208, P113, DOI 10.1007/s10681-015-1599-5; Farooq M, 2009, J AGRON CROP SCI, V195, P262, DOI 10.1111/j.1439-037X.2009.00368.x; FRIEDMAN HL, 1964, J POLYM SCI POL SYM, P183; Galagali N, 2015, CHEM ENG SCI, V123, P170, DOI 10.1016/j.ces.2014.10.030; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Goubet I, 1998, J AGR FOOD CHEM, V46, P1981, DOI 10.1021/jf970709y; Guichard S, 2005, J PLANT GROWTH REGUL, V24, P201, DOI 10.1007/s00344-005-0040-z; Gururani MA, 2015, INT J MOL SCI, V16, P19055, DOI 10.3390/ijms160819055; Halford NG, 2011, ANN APPL BIOL, V158, P1, DOI 10.1111/j.1744-7348.2010.00443.x; HASHIMOTO K, 1982, AICHE J, V28, P737, DOI 10.1002/aic.690280506; International Seed Testing Association, 1996, SUPPL SEED SCI TECHN, V24, P1; Kim KN, 2013, PLANT BIOTECHNOL REP, V7, P1, DOI 10.1007/s11816-012-0228-1; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; KUO TM, 1988, J AGR FOOD CHEM, V36, P32, DOI 10.1021/jf00079a008; Levitt J, 1980, CHILLING FREEZING HI; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; Lucarini M, 2003, J AM CHEM SOC, V125, P8318, DOI 10.1021/ja034963k; Mader T, FEEDING HIGH MOISTUR; Naseem H, 2014, J PLANT INTERACT, V9, P689, DOI 10.1080/17429145.2014.902125; Nautiyal PC, 2008, EUPHYTICA, V159, P43, DOI 10.1007/s10681-007-9455-x; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; Simon P, 2004, J THERM ANAL CALORIM, V76, P123, DOI 10.1023/B:JTAN.0000027811.80036.6c; Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906; Sootsuwan K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-180; Stanojevic M, 2015, PLANT FOOD HUM NUTR, V70, P433, DOI 10.1007/s11130-015-0515-4; Sun Wendell Q., 2002, P47, DOI 10.1079/9780851995342.0047; Sun WQ, 1998, BBA-GEN SUBJECTS, V1425, P235, DOI 10.1016/S0304-4165(98)00076-2; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; Talaat NB, 2016, J PLANT GRO IN PRESS; Thussagunpanit J, 2015, J PLANT GROWTH REGUL, V34, P320, DOI 10.1007/s00344-014-9467-4; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Vardharajula S, 2011, J PLANT INTERACT, V6, P1, DOI 10.1080/17429145.2010.535178; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vyazovkin S, 1997, ANNU REV PHYS CHEM, V48, P125, DOI 10.1146/annurev.physchem.48.1.125; Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034; Waisi HK, 2016, HEM IND IN PRESS; Walters C, 1997, SEED SCI RES, V7, P125, DOI 10.1017/S0960258500003469; Williams B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005705; Yu JQ, 2004, J EXP BOT, V55, P1135, DOI 10.1093/jxb/erh124; Zeng HT, 2010, J PLANT GROWTH REGUL, V29, P44, DOI 10.1007/s00344-009-9111-x	61	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179650	10.1371/journal.pone.0179650	http://dx.doi.org/10.1371/journal.pone.0179650			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644899	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100029
J	Hussain, MZ; Abbas, S; Irshad, M				Hussain, Malik Zawwar; Abbas, Samreen; Irshad, Misbah			Quadratic trigonometric B-spline for image interpolation using GA	PLOS ONE			English	Article							CURVE	In this article, a new quadratic trigonometric B-spline with control parameters is constructed to address the problems related to two dimensional digital image interpolation. The newly constructed spline is then used to design an image interpolation scheme together with one of the soft computing techniques named as Genetic Algorithm (GA). The idea of GA has been formed to optimize the control parameters in the description of newly constructed spline. The Feature SIMilarity (FSIM), Structure SIMilarity (SSIM) and Multi-Scale Structure SIMilarity (MS-SSIM) indices along with traditional Peak Signal-to-Noise Ratio (PSNR) are employed as image quality metrics to analyze and compare the outcomes of approach offered in this work, with three of the present digital image interpolation schemes. The upshots show that the proposed scheme is better choice to deal with the problems associated to image interpolation.	[Hussain, Malik Zawwar; Abbas, Samreen] Univ Punjab, Dept Math, Lahore, Pakistan; [Irshad, Misbah] Women Univ, Dept Math, Lahore Coll, Lahore, Pakistan	University of Punjab	Hussain, MZ (corresponding author), Univ Punjab, Dept Math, Lahore, Pakistan.	malikzawwar.math@pu.edu.pk	ABBAS, SAMREEN/AAZ-4993-2020	ABBAS, SAMREEN/0000-0003-3708-0115; Hussain, Malik Zawwar/0000-0002-9335-3117				Bartels R., 1984, CS8340 U WAT; Danielsson PE, LITHISYI11521990 LIN; Fevralev D., 2011, EURASIP J ADV SIG PR, V2011, P1, DOI DOI 10.1186/1687-6180-2011-41; Foley T. A., 1986, Computer-Aided Geometric Design, V3, P281, DOI 10.1016/0167-8396(86)90004-X; Han X., 2002, COMPUT AIDED GEOM D, V19, P479; Han XA, 2009, APPL MATH LETT, V22, P226, DOI 10.1016/j.aml.2008.03.015; Han XL, 2004, COMPUT AIDED GEOM D, V21, P535, DOI 10.1016/j.cagd.2004.03.001; Holland JH., 1975, Q REV BIOL; Hoschek J, 1993, FUNDAMENTALS COMPUTE; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Hung KW, 2015, SIGNAL PROCESS-IMAGE, V39, P26, DOI 10.1016/j.image.2015.07.003; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Lewis J., 1975, SIAM SIGNUM M SAN FR; Li JC, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/731648; Li X, 2001, IEEE T IMAGE PROCESS, V10, P1521, DOI 10.1109/83.951537; Li XH, 2008, 2008 IEEE PHOTONICSGLOBAL@SINGAPORE (IPGC), VOLS 1 AND 2, P341; Luu L, 2011, OPT LETT, V36, P3070, DOI 10.1364/OL.36.003070; LYCHE T, 1979, J APPROX THEORY, V25, P266, DOI 10.1016/0021-9045(79)90017-0; Parker J, 1983, IEEE Trans Med Imaging, V2, P31, DOI 10.1109/TMI.1983.4307610; Sarfraz M, 2008, INTERACTIVE CURVE MO; Sarfraz M, 2010, INT J COMPUT MATH, V87, P797, DOI 10.1080/00207160802196009; SCHOENBERG IJ, 1964, J MATH MECH, V13, P795; Schoenberg J., 1981, SPLINE FUNCTION BASI; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P821, DOI 10.1109/78.193220; Walz G, 1997, BIT, V37, P189, DOI 10.1007/BF02510180; Wang GZ, 2004, COMPUT AIDED GEOM D, V21, P193, DOI 10.1016/j.cagd.2003.10.002; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179721	10.1371/journal.pone.0179721	http://dx.doi.org/10.1371/journal.pone.0179721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640906	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800056
J	Sauer, AJ; Fritsch, E; Undorf-Spahn, K; Nguyen, P; Marec, F; Heckel, DG; Jehle, JA				Sauer, Annette J.; Fritsch, Eva; Undorf-Spahn, Karin; Nguyen, Petr; Marec, Frantisek; Heckel, David G.; Jehle, Johannes A.			Novel resistance to Cydia pomonella granulovirus (CpGV) in codling moth shows autosomal and dominant inheritance and confers cross-resistance to different CpGV genome groups	PLOS ONE			English	Article							SEX-CHROMOSOMES; BACULOVIRUS RESISTANCE; LEPIDOPTERA; KARYOTYPE; ISOLATE; INSECTICIDE; SEQUENCE; VIRUS	Commercial Cydia pomonella granulovirus (CpGV) products have been successfully applied to control codling moth (CM) in organic and integrated fruit production for more than 30 years. Since 2005, resistance against the widely used isolate CpGV-M has been reported from different countries in Europe. The inheritance of this so-called type I resistance is dominant and linked to the Z chromosome. Recently, a second form (type II) of CpGV resistance in CM was reported from a field population (NRW-WE) in Germany. Type II resistance confers reduced susceptibility not only to CpGV-M but to most known CpGV isolates and it does not follow the previously described Z-linked inheritance of type I resistance. To further analyze type II resistance, two CM strains, termed CpR5M and CpR5S, were generated from parental NRW-WE by repeated mass crosses and selection using the two isolates CpGV-M and CpGV-S, respectively. Both CpR5M and CpR5S were considered to be genetically homogeneous for the presence of the resistance allele(s). By crossing and backcrossing experiments with a susceptible CM strain, followed by resistance testing of the offspring, an autosomal dominant inheritance of resistance was elucidated. In addition, cross-resistance to CpGV-M and CpGV-S was detected in both strains, CpR5M and CpR5S. To test the hypothesis that the autosomal inheritance of type II resistance was caused by a large interchromosomal rearrangement involving the Z chromosome, making type I resistance appear to be autosomal in these strains; fluorescence in situ hybridization with bacterial artificial chromosome probes (BAC-FISH) was used to physically map the Z chromosomes of different CM strains. Conserved synteny of the Z-linked genes in CpR5M and other CM strains rejects this hypothesis and argues for a novel genetic and functional mode of resistance in CM populations with type II resistance.	[Sauer, Annette J.; Fritsch, Eva; Undorf-Spahn, Karin; Jehle, Johannes A.] JKI, Fed Res Ctr Cultivated Plants, Inst Biol Control, Darmstadt, Germany; [Nguyen, Petr; Marec, Frantisek] Czech Acad Sci, Inst Entomol, Biol Ctr, Ceske Budejovice, Czech Republic; [Nguyen, Petr] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	Julius Kuhn-Institut; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society	Jehle, JA (corresponding author), JKI, Fed Res Ctr Cultivated Plants, Inst Biol Control, Darmstadt, Germany.	Johannes.Jehle@julius-kuehn.de	Marec, Frantisek/G-7943-2014; Nguyen, Petr/G-5826-2010; Nguyen, Petr/AAI-5203-2020; Heckel, David G/K-2138-2013	Marec, Frantisek/0000-0002-6745-5603; Nguyen, Petr/0000-0003-1395-4287; Nguyen, Petr/0000-0003-1395-4287; Heckel, David G/0000-0001-8991-2150; Jehle, Johannes A./0000-0002-8143-7743	Federal Organic Farming Scheme [050EO23/1]; Deutsche Forschungsgemeinschaft [Je245/14-1]; Czech Science Foundation [14-22765S, 14-35819P]; Max-Planck-Gesellschaft	Federal Organic Farming Scheme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Czech Science Foundation(Grant Agency of the Czech Republic); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the Federal Organic Farming Scheme (www.ble.de) (grant 050EO23/1) and by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grant Je245/14-1) to JAJ. Cytogenetic experiments were financed by the Czech Science Foundation (grants 14-22765S and 14-35819P) to FM. DGH was supported by the Max-Planck-Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks Dr. Doreen Gabriel for her support in the statistical analyses and Sarah Schilling, Doris El Mazouar and Birgit Weihrauch for excellent technical assistance in insect rearing. We appreciate useful suggestions and corrections of the manuscript by Katharina Saar. This work was supported by the Federal Organic Farming Scheme (www.ble.de) (grant 050EO23/1) and by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grant Je245/14-1) to JAJ. Cytogenetic experiments were financed by the Czech Science Foundation (grants 14-22765S and 14-35819P) to FM. DGH was supported by the Max-Planck-Gesellschaft The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; Ahola V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5737; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Asser-Kaiser S, 2011, VIROLOGY, V410, P360, DOI 10.1016/j.virol.2010.11.021; Berling M, 2013, PEST MANAG SCI, V69, P1261, DOI 10.1002/ps.3493; Berling M, 2009, APPL ENVIRON MICROB, V75, P925, DOI 10.1128/AEM.01998-08; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Eberle KE, 2008, J INVERTEBR PATHOL, V98, P293, DOI 10.1016/j.jip.2008.03.003; Eberle KE, 2006, J INVERTEBR PATHOL, V93, P201, DOI 10.1016/j.jip.2006.07.001; Eberle KE, 2009, J GEN VIROL, V90, P662, DOI 10.1099/vir.0.006999-0; Fritsch E., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P29; Fritsch E, EC 2006; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Gebhardt MM, 2014, P NATL ACAD SCI USA, V111, P15711, DOI 10.1073/pnas.1411089111; Graillot B, 2014, VIRUSES-BASEL, V6, P5135, DOI 10.3390/v6125135; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Ivaldi-Sender C, 1974, ECOLOGIE ANIMALE, V6, P337; Jehle JA, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02330-16, 10.1128/aem.02330-16]; Jehle J. A., 2014, Ecofruit. 16th International Conference on Organic-Fruit Growing: Proceedings, 17-19 February 2014, Hohenheim, Germany, P244; Jehle JA, EC 2006; Kienzle J, EC 2008; KRAPPA R, 1991, J VIROL, V65, P805, DOI 10.1128/JVI.65.2.805-812.1991; Lacey LA, 2008, BIOCONTROL SCI TECHN, V18, P639, DOI 10.1080/09583150802267046; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Sauphanor B., 2006, PHYTOMA DEFENSE VEGE, V590, P24; Schmitt A, 2013, J APPL ENTOMOL, V137, P641, DOI 10.1111/jen.12046; SMITH IRL, 1988, VIROLOGY, V166, P240, DOI 10.1016/0042-6822(88)90165-1; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TANADA Y, 1964, J INSECT PATHOL, V6, P378; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Undorf-Spahn K, 2012, J INVERTEBR PATHOL, V111, P136, DOI 10.1016/j.jip.2012.07.005; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Wolf KW, 1996, INT J INSECT MORPHOL, V25, P37, DOI 10.1016/0020-7322(95)00021-6; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Zichova T, 2013, BIOCONTROL, V58, P525, DOI 10.1007/s10526-013-9507-1	38	18	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179157	10.1371/journal.pone.0179157	http://dx.doi.org/10.1371/journal.pone.0179157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640892	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800019
J	Susek, K; Braszewska-Zalewska, A; Bewick, AJ; Hasterok, R; Schmitz, RJ; Naganowska, B				Susek, Karolina; Braszewska-Zalewska, Agnieszka; Bewick, Adam J.; Hasterok, Robert; Schmitz, Robert J.; Naganowska, Barbara			Epigenomic diversification within the genus Lupinus	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; 5-METHYLCYTOSINE-RICH REGIONS; HISTONE MODIFICATIONS; H3 LYSINE-9; CHROMOSOMES; ANGUSTIFOLIUS; POLYPLOIDY; GENES; MAPS; L.	Deciphering the various chemical modifications of both DNA and the histone compound of chromatin not only leads to a better understanding of the genome-wide organisation of epigenetic landmarks and their impact on gene expression but may also provide some insights into the evolutionary processes. Although both histone modifications and DNA methylation have been widely investigated in various plant genomes, here we present the first study for the genus Lupinus. Lupins, which are members of grain legumes (pulses), are beneficial for food security, nutrition, health and the environment. In order to gain a better understanding of the epigenetic organisation of genomes in lupins we applied the immunostaining of methylated histone H3 and DNA methylation as well as whole-genome bisulfite sequencing. We revealed variations in the patterns of chromatin modifications at the chromosomal level among three crop lupins, i.e. L. angustifolius (2n = 40), L. albus (2n = 50) and L. luteus (2n = 52), and the legume model plant Medicago truncatula (2n = 16). Different chromosomal patterns were found depending on the specific modification, e.g. H3K4me2 was localised in the terminal parts of L. angustifolius and M. truncatula chromosomes, which is in agreement with the results that have been obtained for other species. Interestingly, in L. albus and L. luteus this modification was limited to one arm in the case of all of the chromosomes in the complement. Additionally, H3K9me2 was detected in all of the analysed species except L. luteus. DNA methylation sequencing (CG, CHG and CHH contexts) of aforementioned crop but also wild lupins such as L. cosentinii (2n = 32), L. digitatus (2n = 36), L. micranthus (2n = 52) and L. pilosus (2n = 42) supported the range of interspecific diversity. The examples of epigenetic modifications illustrate the diversity of lupin genomes and could be helpful for elucidating further epigenetic changes in the evolution of the lupin genome.	[Susek, Karolina; Naganowska, Barbara] Polish Acad Sci, Inst Plant Genet, Dept Genom, Poznan, Poland; [Braszewska-Zalewska, Agnieszka; Hasterok, Robert] Univ Silesia Katowice, Dept Plant Anat & Cytol, Katowice, Poland; [Bewick, Adam J.; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Silesia in Katowice; University System of Georgia; University of Georgia	Susek, K (corresponding author), Polish Acad Sci, Inst Plant Genet, Dept Genom, Poznan, Poland.	ksus@igr.poznan.pl	susek, karolina/V-2494-2019; Schmitz, Robert/AAY-7659-2020; Hasterok, Robert/A-1629-2008	susek, karolina/0000-0002-8518-4720; Schmitz, Robert/0000-0001-7538-6663; Hasterok, Robert/0000-0001-6667-2721; Braszewska, Agnieszka/0000-0003-0997-8753	National Science Centre, Poland [2011/03/B/NZ2/01420]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland, grant no. 2011/03/B/NZ2/01420 to KS (https://,www.ncn.gov.pl/?language=en). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick AJ, 2016, G3-GENES GENOM GENET, V6, P447, DOI 10.1534/g3.115.025668; Borowska N, 2011, CHROMOSOME RES, V19, P955, DOI 10.1007/s10577-011-9243-2; Braszewska-Zalewska A, 2012, GENOME, V55, P68, DOI [10.1139/G11-076, 10.1139/g11-076]; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; Braszewska-Zalewska AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069204; Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6; Cannon SB, 2015, MOL BIOL EVOL, V32, P193, DOI 10.1093/molbev/msu296; Castiglione MR, 2008, PROTOPLASMA, V233, P107, DOI 10.1007/s00709-008-0296-9; Chen XS, 2013, CURR OPIN PLANT BIOL, V16, P164, DOI 10.1016/j.pbi.2013.03.004; Chen X, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00836; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Diez CM, 2014, CURR OPIN PLANT BIOL, V18, P1, DOI 10.1016/j.pbi.2013.11.017; Drummond CS, 2012, SYST BIOL, V61, P443, DOI 10.1093/sysbio/syr126; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Feitoza L, 2011, GENETICA, V139, P305, DOI 10.1007/s10709-011-9550-8; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Fonseca A, 2014, CYTOGENET GENOME RES, V143, P168, DOI 10.1159/000360572; Frediani M, 1996, CHROMOSOME RES, V4, P141, DOI 10.1007/BF02259707; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Gladstones J. S., 1998, P1; Hane JK, 2016, PLANT BIOTECH J; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Jordan WT, 2016, GENOME BIOL, V17, P1; Kim KD, 2015, PLANT PHYSIOL, V168, P1433, DOI 10.1104/pp.15.00408; Kroc M, 2014, THEOR APPL GENET, V127, P1237, DOI 10.1007/s00122-014-2294-y; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lesniewska K, 2011, J HERED, V102, P228, DOI 10.1093/jhered/esq107; Li Q, 2014, PLANT CELL, V26, P4602, DOI 10.1105/tpc.114.133140; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Naganowska B, 2003, ANN BOT-LONDON, V92, P349, DOI 10.1093/aob/mcg145; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nelson MN, 2010, DNA RES, V17, P73, DOI 10.1093/dnares/dsq001; Neumann P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00234; Nevado B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12384; Niederhuth CE, 2016, BIORXIV; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; de Paula CMP, 2016, PLANT CELL REP, V35, P1359, DOI 10.1007/s00299-016-1969-z; Rigal M, 2016, P NATL ACAD SCI USA, V113, pE2083, DOI 10.1073/pnas.1600672113; Riggs A.D., 1996, COLD SPRING HARBOR M, V32, P29; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Springer NM, 2016, PLANT CELL, V28, P314, DOI 10.1105/tpc.15.00911; Susek K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01152; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; West PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105267; Wyrwa K, 2016, CHROMOSOME RES; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	58	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179821	10.1371/journal.pone.0179821	http://dx.doi.org/10.1371/journal.pone.0179821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640886	gold, Green Published			2022-12-26	WOS:000404135800070
J	Li, ZH; Li, DC; Choi, EY; Lapidus, R; Zhang, L; Huang, SM; Shapiro, P; Wang, HB				Li, Zhihui; Li, Daochuan; Choi, Eun Yong; Lapidus, Rena; Zhang, Lei; Huang, Shiew-Mei; Shapiro, Paul; Wang, Hongbing			Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE LYASE; GENOMIC ORGANIZATION; FUNCTIONAL FEATURES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; MAMMALIAN-CELLS; TRANSPORTER; METABOLISM; RECEPTOR; NACT	The solute carrier family 13 member 5 (SLC13A5), a sodium-coupled citrate transporter, plays a key role in importing citrate from the circulation into liver cells. Recent evidence has revealed that SLC13A5 deletion protects mice from high-fat diet-induced hepatic steatosis and that mutation of the SLC13A5 orthologues in Drosophila melanogaster and Caenorhabditis elegans promotes longevity. However, despite the emerging importance of SLC13A5 in energy homeostasis, whether perturbation of SLC13A5 affects the metabolism and malignancy of hepatocellular carcinoma is unknown. Here, we sought to determine whether SLC13A5 regulates hepatic energy homeostasis and proliferation of hepatoma cells. RNAi-mediated silencing of SLC13A5 expression in two human hepatoma cell lines, HepG2 and Huh7, profoundly suppressed cell proliferation and colony formation, and induced cell cycle arrest accompanied by increased expression of cyclin-dependent kinase inhibitor p21 and decreased expression of cyclin B1. Furthermore, such suppressive effects were also observed on the growth of HepG2 cell-derived xenografts expressing SLC13A5-shRNA in nude mice. Metabolically, knockdown of SLC13A5 in HepG2 and Huh7 cells was associated with a decrease in intracellular levels of citrate, the ratio of ATP/ADP, phospholipid content, and ATP citrate lyase expression. Moreover, both in vitro and in vivo assays demonstrated that SLC13A5 depletion promotes activation of the AMP-activated protein kinase, which was accompanied by deactivation of oncogenic mechanistic target of rapamycin signaling. Together, our findings expand the role of SLC13A5 from facilitating hepatic energy homeostasis to influencing hepatoma cell proliferation and suggest a potential role of SLC13A5 in the progression of human hepatocellular carcinoma.	[Li, Zhihui; Shapiro, Paul; Wang, Hongbing] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA; [Choi, Eun Yong; Lapidus, Rena; Shapiro, Paul; Wang, Hongbing] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, 20 Penn St, Baltimore, MD 21201 USA; [Zhang, Lei; Huang, Shiew-Mei] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Off Translat Sci, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Wang, HB (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	hongbing.wang@rx.umaryland.edu			National Institutes of Health [GM107058]; Research Participation Program at the Center for Drug Evaluation and Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Participation Program at the Center for Drug Evaluation and Research	The study was partially supported by National Institutes of Health Grant GM107058 (to H.W.). This work was also supported in part by the Research Participation Program at the Center for Drug Evaluation and Research, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U. S. Department of Energy and FDA (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the FDA.	Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Brito AF, 2012, CHEMOTHERAPY, V58, P381, DOI 10.1159/000343656; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dai BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1404; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Lee JH, 2015, FEBS J, V282, P361, DOI 10.1111/febs.13139; Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Migita T, 2014, INT J CANCER, V135, P37, DOI 10.1002/ijc.28652; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Neuschafer-Rube F, 2015, TOXICOLOGY, V337, P1, DOI 10.1016/j.tox.2015.08.007; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pesta DH, 2015, AGING-US, V7, P1086, DOI 10.18632/aging.100854; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; von Loeffelholz C, 2017, HEPATOLOGY, V66, P616, DOI 10.1002/hep.29089; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130953; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zulato E, 2014, BRIT J CANCER, V111, P25, DOI 10.1038/bjc.2014.274	47	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13890	13901		10.1074/jbc.M117.783860	http://dx.doi.org/10.1074/jbc.M117.783860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655760	hybrid, Green Published			2022-12-26	WOS:000407942400014
J	Iki, T; Tanaka, M; Kitajiri, S; Kita, T; Kawasaki, Y; Mizukoshi, A; Fujibuchi, W; Nakagawa, T; Nakahata, T; Ito, J; Omori, K; Saito, MK				Iki, Takehiro; Tanaka, Michihiro; Kitajiri, Shin-ichiro; Kita, Tomoko; Kawasaki, Yuri; Mizukoshi, Akifumi; Fujibuchi, Wataru; Nakagawa, Takayuki; Nakahata, Tatsutoshi; Ito, Juichi; Omori, Koichi; Saito, Megumu K.			Microarray analyses of otospheres derived from the cochlea in the inner ear identify putative transcription factors that regulate the characteristics of otospheres	PLOS ONE			English	Article							HAIR CELL REGENERATION; EMBRYONIC STEM-CELLS; DIFFERENTIAL EXPRESSION; DIRECT CONVERSION; SELF-RENEWAL; SENSORY EPITHELIA; SUPPORTING CELLS; GENE GJB3; MOUSE; PLURIPOTENCY	Various tissues possess tissue-specific stem/progenitor cells, including the inner ears. Stem/progenitor cells of the inner ear can be isolated as so-called otospheres from differentiated cells using a sphere forming assay. Although recent studies have demonstrated the characteristics of otospheres to some extent, most of the features of these cells are unknown. In this report, we describe the findings of transcriptome analyses with a cDNA microarray of otospheres derived from the cochleae of the inner ears of neonatal mice in order to clarify the gene expression profile of otic stem/progenitor cells. There were common transcription factors between otospheres and embryonic stem cells, which were supposed to be due to the stemness of otospheres. In comparison with the cochlear sensory epithelium, the otospheres shared characteristics with the cochlea, although several transcription factors specific for otospheres were identified. These transcription factors are expected to be essential for maintaining the characteristics of otospheres, and appear to be candidate genes that promote the direct conversion of cells into otic stem/progenitor cells.	[Iki, Takehiro; Kawasaki, Yuri; Mizukoshi, Akifumi; Nakagawa, Takayuki; Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan; [Iki, Takehiro; Kita, Tomoko; Mizukoshi, Akifumi; Nakagawa, Takayuki; Ito, Juichi; Omori, Koichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tanaka, Michihiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, Informat & Secur Off, Kyoto, Japan; [Kitajiri, Shin-ichiro] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Kyoto, Japan; [Fujibuchi, Wataru] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Ito, Juichi] Shiga Med Ctr Res Inst, Hearing Commun Med Ctr, Shiga, Japan	Kyoto University; Kyoto University; Kyoto University; Shinshu University; Kyoto University	Saito, MK (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan.	msaito@cira.kyoto-u.ac.jp	Omori, Koichi/AAU-9017-2021	Omori, Koichi/0000-0003-3404-5461	Japan Society for the Promotion of Science (JSPS) [26293369]; KAKENHI [16H05352]; Takeda Science Foundation [16K15719]; Grants-in-Aid for Scientific Research [17H06277] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS, 26293369) to [SK], KAKENHI grant number 16H05352 to [MKS], the second step of Visionary Research Grant (a stepwise encouraging program) by Takeda Science Foundation to [SK], and Grant-in-Aid for Challenging Exploratory Research (JSPS, 16K15719) to [TI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bassiouni M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164579; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Chen KHJ, 2016, ASIA PAC EDUC REV, V17, P1, DOI 10.1007/s12564-016-9415-z; Chen P, 1999, DEVELOPMENT, V126, P1581; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Doherty JM, 2008, STEM CELLS, V26, P2124, DOI 10.1634/stemcells.2008-0380; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fekete DM, 1998, J NEUROSCI, V18, P7811; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forge A, 1998, J COMP NEUROL, V397, P69; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kiernan AE, 2005, SOX2 IS REQUIRED SEN, V426, P423; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin JZ, 2007, CURR MED CHEM, V14, P2937, DOI 10.2174/092986707782360051; Lou XX, 2013, CELL REPROGRAM, V15, P514, DOI 10.1089/cell.2013.0020; Lou XX, 2013, NEUROSCI LETT, V534, P18, DOI 10.1016/j.neulet.2012.12.001; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malgrange B, 2002, MECH DEVELOP, V112, P79, DOI 10.1016/S0925-4773(01)00642-6; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; NADOL JB, 1993, NEW ENGL J MED, V329, P1092, DOI 10.1056/NEJM199310073291507; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oh SH, 1996, J NEUROSCI, V16, P6463; Oiticica J, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-119; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima Kazuo, 2009, V493, P141, DOI 10.1007/978-1-59745-523-7_9; Plum A, 2002, GENOMICS, V79, P24, DOI 10.1006/geno.2001.6671; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Resendes BL, 2004, JARO-J ASSOC RES OTO, V5, P185, DOI 10.1007/s10162-003-4042-x; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Roccio M, 2015, NAT PUBL GR NATURE P, V5, P1; Saunders JC, 2010, ILAR J, V51, P326, DOI 10.1093/ilar.51.4.326; Savary E, 2008, MECH DEVELOP, V125, P674, DOI 10.1016/j.mod.2008.05.001; Schepens J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063006; Shang JL, 2010, JARO-J ASSOC RES OTO, V11, P203, DOI 10.1007/s10162-009-0206-7; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Smeti I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088757; Smeti I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042987; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Taniguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048544; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; TSUE TT, 1994, OTOLARYNG HEAD NECK, V111, P281, DOI 10.1016/S0194-5998(94)70603-4; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waldhaus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036066; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Waryah AM, 2009, CLIN GENET, V76, P270, DOI 10.1111/j.1399-0004.2009.01209.x; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yerukhimovich MV, 2007, DEV NEUROSCI-BASEL, V29, P251, DOI 10.1159/000096415; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhai SQ, 2005, J NEUROBIOL, V65, P282, DOI 10.1002/neu.20190; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang Y, 2007, J NEUROSCI METH, V164, P271, DOI 10.1016/j.jneumeth.2007.05.009; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	85	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179901	10.1371/journal.pone.0179901	http://dx.doi.org/10.1371/journal.pone.0179901			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662075	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300067
J	Mothes, H; Leukel, C; Seelig, H; Fuchs, R				Mothes, Hendrik; Leukel, Christian; Seelig, Harald; Fuchs, Reinhard			Do placebo expectations influence perceived exertion during physical exercise?	PLOS ONE			English	Article							COMPRESSION GARMENTS; PERFORMANCE; INTENSITY; MOOD; DISPLEASURE; EXPECTANCY; CONSUMERS; PLEASURE; RATINGS	This study investigates the role of placebo expectations in individuals' perception of exertion during acute physical exercise. Building upon findings from placebo and marketing research, we examined how perceived exertion is affected by expectations regarding a) the effects of exercise and b) the effects of the exercise product worn during the exercise. We also investigated whether these effects are moderated by physical self-concept. Seventy-eight participants conducted a moderate 30 min cycling exercise on an ergometer, with perceived exertion (RPE) measured every 5 minutes. Beforehand, each participant was randomly assigned to 1 of 4 conditions and watched a corresponding film clip presenting "scientific evidence" that the exercise would or would not result in health benefits and that the exercise product they were wearing (compression garment) would additionally enhance exercise benefits or would only be worn for control purposes. Participants' physical self-concept was assessed via questionnaire. Results partially demonstrated that participants with more positive expectations experienced reduced perceived exertion during the exercise. Furthermore, our results indicate a moderator effect of physical self-concept: Individuals with a high physical self-concept benefited (in terms of reduced perceived exertion levels) in particular from an induction of generally positive expectations. In contrast, individuals with a low physical self-concept benefited when positive expectations were related to the exercise product they were wearing. In sum, these results suggest that placebo expectations may be a further, previously neglected class of psychological factors that influence the perception of exertion.	[Mothes, Hendrik; Leukel, Christian; Fuchs, Reinhard] Univ Freiburg, Dept Sports Sci, Schwarzwaldstr 175, Freiburg, Germany; [Leukel, Christian] Univ Freiburg, Bernstein Ctr Freiburg, Hansastr 9a, Freiburg, Germany; [Seelig, Harald] Univ Basel, Dept Sport Exercise & Hlth, Birsstr 320 B, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Basel	Mothes, H (corresponding author), Univ Freiburg, Dept Sports Sci, Schwarzwaldstr 175, Freiburg, Germany.	hendrik.mothes@sport.uni-freiburg.de	Seelig, Harald/AAH-6584-2020	Seelig, Harald/0000-0002-2178-4807; Mothes, Hendrik/0000-0003-1784-6398	Konrad Adenauer Foundation; German Research Foundation (DFG); University of Freiburg	Konrad Adenauer Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This research was supported by a grant to H. Mothes from the Konrad Adenauer Foundation (www.kas.de). The article processing charge was funded by the German Research Foundation (DFG) (www.dtg.de) and the University of Freiburg (www.uni-freiburg.de) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden DA, 2004, J SPORT EXERCISE PSY, V26, P215, DOI 10.1123/jsep.26.2.215; Beliard S, 2015, J SPORT SCI MED, V14, P75; BORG G, 1978, ERGONOMICS, V21, P215, DOI 10.1080/00140137808931715; Borg G., 1962, PHYS PERFORMANCE PER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Bryan AD, 2011, PSYCHOL SPORT EXERC, V12, P20, DOI 10.1016/j.psychsport.2010.05.002; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; de la Fuente-Fernandez R, 2012, EUR J NEUROL, V19, P1305, DOI 10.1111/j.1468-1331.2012.03719.x; Deusinger IM, 1998, FRANKFURTER KORPERKO; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Ekkekakis P, 2006, INT J OBESITY, V30, P652, DOI 10.1038/sj.ijo.0803052; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garvey AM, 2016, J CONSUM RES, V42, P931, DOI 10.1093/jcr/ucv094; Geers AL, 2006, J BEHAV MED, V29, P171, DOI 10.1007/s10865-005-9040-5; Geers AL, 2011, J BEHAV MED, V34, P208, DOI 10.1007/s10865-010-9301-9; Haile L., 2015, PERCEIVED EXERTION L; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hutchinson JC, 2015, ANN BEHAV MED, V49, P199, DOI 10.1007/s12160-014-9647-2; Jaksic N, 2013, PSYCHIAT DANUB, V25, P17; Kamata, 2012, MEASUREMENT SPORT EX, P265, DOI [10.5040/9781492596332.ch-024, DOI 10.5040/9781492596332.CH-024]; Killen LG, 2013, EUR J APPL PHYSIOL, V113, P721, DOI 10.1007/s00421-012-2480-z; Kirsch I., 1999, EXPECTANCIES SHAPE E; Lane AM, 2011, APPL PSYCHOPHYS BIOF, V36, P181, DOI 10.1007/s10484-011-9156-z; Lindheimer JB, 2017, PSYCHOSOM MED, V79, P243, DOI 10.1097/PSY.0000000000000381; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; Mishra H, 2011, PSYCHOL SCI, V22, P733, DOI 10.1177/0956797611407208; MORGAN WP, 1994, MED SCI SPORT EXER, V26, P1071, DOI 10.1249/00005768-199409000-00001; MORGAN WP, 1973, INT J CLIN EXP HYP, V21, P86, DOI 10.1080/00207147308409309; Mothes H., 2016, J BEHAV MED; Noble B., 1996, PERCEIVED EXERTION; O'Halloran PD, 2002, PSYCHOL REP, V90, P834, DOI 10.2466/PR0.90.3.834-840; Oken BS, 2008, J CLIN EXP NEUROPSYC, V30, P7, DOI 10.1080/13803390701775428; Robertson R J, 1997, Exerc Sport Sci Rev, V25, P407; Shiv B, 2005, J MARKETING RES, V42, P383, DOI 10.1509/jmkr.2005.42.4.383; Sigall H, 1998, Pers Soc Psychol Rev, V2, P218, DOI 10.1207/s15327957pspr0203_5; Simonoff J.S., 2003, ANAL CATEGORICAL DAT; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Sudeck G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00900; Travlos AK, 1996, PERCEPT MOTOR SKILL, V82, P419, DOI 10.2466/pms.1996.82.2.419; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; Weimer K, 2015, LANCET PSYCHIAT, V2, P246, DOI 10.1016/S2215-0366(14)00092-3; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4	52	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180434	10.1371/journal.pone.0180434	http://dx.doi.org/10.1371/journal.pone.0180434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662168	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300155
J	Chen, ZH; Liu, LG; Tu, JF; Qin, GM; Su, WW; Geng, XG; Chen, XJ; Wu, HG; Pan, WS				Chen, Zhihao; Liu, Lingang; Tu, Jiangfeng; Qin, Guangming; Su, Weiwei; Geng, Xiaoge; Chen, Xiaojun; Wu, Hongguang; Pan, Wensheng			Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; ENDOSCOPIC SEDATION; GASTRIC CARDIA; PROPOFOL; CANCER; TONE; CONTRACTION; PRESSURE	Background and study aims Although sedation esophagogastroduodenoscopy (EGD) is now widely used, previous research has reported that sedation during EGD exhibits a negative effect on esophagogastric junction (EGJ) exposure. Atropine might improve EGJ exposure, as noted in clinical practice. The aim of this study was to examine whether sedation had a negative effect on EGJ observation in the Chinese population, and whether atropine had some ability to act as an antidote to this unexpected secondary effect of sedation. Patients and methods In this cross-sectional study, subjects were divided into the following three groups according to the methods of EGD examination: the non-sedation group, the propofol-fentanyl combined sedation group and the combined sedation with atropine administration group. The EGJ observation was assessed by a key photograph taken with the endoscopic camera 1 cm from the EGJ, which was rated on the following four-degree scale: excellent (score = 4), good (score = 3), fair (score = 2) and poor (score = 1). Results The EGJ exposure was better in the sedation group administered atropine (score = 2.64 +/- 1.05) than in the sedation group (score = 1.99 +/- 1.08, P < 0.05) but not as good as in the non-sedation group (score = 3.24 +/- 1.12, P < 0.05). Reduced detection of EGJ diseases in the sedation group was also found, compared to the non-sedation group (P < 0.05). Only the use of atropine (OR = 2.381, 95%CI: 1.297-4.371, P = 0.005) was independently associated with excellent observation of the EGJ during sedation EGD. Conclusions Combined propofol-fentanyl sedation reduces the extent of exposure of the EGJ during EGD and reduces the detection of EGJ diseases. The application of atropine in the sedation endoscopy examination helped to achieve better EGJ observation, but still cannot achieve an equal extent of exposure compared to non-sedation EGD.	[Chen, Zhihao; Liu, Lingang; Tu, Jiangfeng; Su, Weiwei; Geng, Xiaoge; Chen, Xiaojun; Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Liu, Lingang] Longsai Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China; [Tu, Jiangfeng; Pan, Wensheng] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Qin, Guangming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab, Hangzhou, Zhejiang, Peoples R China; [Wu, Hongguang] Quzhou Second Peoples Hosp, Dept Gastroenterol, Quzhou, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.; Pan, WS (corresponding author), Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	wspan223@163.com	Geng, Xiaoge/GQA-5474-2022; chen, zhihao/GXM-3816-2022; su, wei/GZM-3986-2022		National Natural Science Foundation of China [81372302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (general project No. 81372302), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; Bhardwaj Atul, 2012, Patholog Res Int, V2012, P814146, DOI 10.1155/2012/814146; Blaser MJ, 2002, EUR J GASTROEN HEPAT, V14, P107, DOI 10.1097/00042737-200202000-00003; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; COHEN S, 1971, J CLIN INVEST, V50, P449, DOI 10.1172/JCI106512; COTTON BR, 1984, BRIT J ANAESTH, V56, P37, DOI 10.1093/bja/56.1.37; Farre R, 2008, BRIT J PHARMACOL, V153, P858, DOI 10.1038/sj.bjp.0707572; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Horiguchi T, 2002, ANESTH ANALG, V95, P389, DOI 10.1097/00000539-200208000-00027; Japan Gastroenterological Endoscopy Society postgraduate education committee, 2006, GUID GASTR END; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim ES, 2014, WORLD J GASTROENTERO, V20, P5527, DOI 10.3748/wjg.v20.i18.5527; Li ZS., 2014, CHIN J PRACT INTERN, V34, P756; MAZUR JM, 1973, SURGERY, V73, P818; MITTAL RK, 1995, AM J PHYSIOL-GASTR L, V269, pG577, DOI 10.1152/ajpgi.1995.269.4.G577; Muir WW, 1998, AM J VET RES, V59, P157; Physicians' Desk Reference, 1998, PROBL POSS IMPR; Powley TL, 2013, AUTON NEUROSCI-BASIC, V177, P129, DOI 10.1016/j.autneu.2013.03.008; PREIKSAITIS HG, 1994, GASTROENTEROLOGY, V106, P381, DOI 10.1016/0016-5085(94)90596-7; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rantanen T, 2016, ANTICANCER RES, V36, P2323; Riphaus A, 2010, Z GASTROENTEROL, V48, P392, DOI 10.1055/s-0028-1109765; Shaker R, 2004, AM J PHYSIOL-GASTR L, V287, pG815, DOI 10.1152/ajpgi.00120.2004; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Stein HJ, 2000, SURG ONCOL, V9, P35, DOI 10.1016/S0960-7404(00)00021-9; STURDEVANT RA, 1974, GASTROENTEROLOGY, V67, P551; Tournadre JP, 1998, CAN J ANAESTH, V45, P479, DOI 10.1007/BF03012585; Wadhwa V, 2017, CLIN GASTROENTEROL H, V15, P194, DOI 10.1016/j.cgh.2016.07.013; Zhou YN, 2008, CANCER LETT, V269, P18, DOI 10.1016/j.canlet.2008.04.013	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179490	10.1371/journal.pone.0179490	http://dx.doi.org/10.1371/journal.pone.0179490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654639	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500015
J	Jo, JH; Cho, IR; Jung, JH; Lee, HS; Chung, MJ; Bang, S; Park, SW; Chung, JB; Song, SY; Park, JY				Jo, Jung Hyun; Cho, In Rae; Jung, Jang Han; Lee, Hee Seung; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; Song, Si Young; Park, Jeong Youp			Clinical characteristics of second primary pancreatic cancer	PLOS ONE			English	Article							MALIGNANCIES; PREVALENCE; SURVIVAL; RISK	Purpose Several studies reported the increased risk of second primary pancreatic ductal adenocarcinoma (2nd PDAC) in cancer survivors. However, data on the characteristics of 2nd PDAC are insufficient. Methods This retrospective cohort study included 1759 patients with PDAC. They were classified as having 2nd PDAC or first primary PDAC (1st PDAC) according to a prior diagnosed cancer of different origin, at least 6 months before PDAC diagnosis. Results There were 110 patients (6.4%) with 2nd PDAC and 1606 (93.6%) patients with 1st PDAC. Patients with 2nd PDAC presented with older age (66.5 vs. 62.2 years, p < 0.001) and higher rate of resectability (26.4% vs. 15.9%, p = 0.004) at diagnosis than those with 1st PDAC. Multivariate analysis without considering resectable status showed that 2nd PDAC (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.56-0.94, p = 0.016) was associated with better overall survival. After adjusting for resectable status, however, 2nd PDAC (HR 0.85, 95% CI 0.66-1.09, p = 0.198) was no longer associated with overall survival. When subgroups were separately analyzed according to initial treatment modality, the effectiveness of surgery and chemotherapy were similar between 2nd and 1st PDAC (33.1 vs. 28.5 months, p = 0.860 and 10.8 vs. 10.7 months, p = 0.952). Conclusions The proportion of resectable cases was significantly higher in 2nd PDAC. When surgery with curative aim was possible, the overall survival was increased even in patients with 2nd PDAC. These results suggest the importance of screening for second primary cancer in cancer survivors.	[Jo, Jung Hyun; Cho, In Rae; Jung, Jang Han; Lee, Hee Seung; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; Song, Si Young; Park, Jeong Youp] Yonsei Univ, Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Park, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea.	SENSASS@yuhs.ac	Jo, Jung Hyun/V-8316-2019; Song, SY/E-2891-2012	Jo, Jung Hyun/0000-0002-2641-8873; Park, Seung Woo/0000-0001-8230-964X; Park, Jeong Youp/0000-0003-0110-8606; Lee, HEE SEUNG/0000-0002-2825-3160; Chung, Moon Jae/0000-0002-5920-8549; Song, Si Young/0000-0002-1417-4314				Amin S, 2012, CANCER-AM CANCER SOC, V118, P1244, DOI 10.1002/cncr.26414; Boice J D Jr, 1985, Natl Cancer Inst Monogr, V68, P3; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Chong I, 2012, HARRISONS PRINCIPLES; Donin N, 2016, CANCER-AM CANCER SOC, V122, P3075, DOI 10.1002/cncr.30164; Duchateau CSJ, 2005, CHEST, V127, P1152, DOI 10.1378/chest.127.4.1152; Hackert T, 2012, PANCREAS, V41, P212, DOI 10.1097/MPA.0b013e3182240602; Hemminki K, 2003, INT J CANCER, V103, P525, DOI 10.1002/ijc.10863; Howlader N., 2016, SEER CANC STAT REV 1; Kebudi R, 2016, CURR PEDIAT REV; NEUGUT AI, 1995, CANCER, V76, P589, DOI 10.1002/1097-0142(19950815)76:4<589::AID-CNCR2820760408>3.0.CO;2-9; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Park JE, 2016, ALCOHOL ALCOHOL; Rahimi E, 2016, DIGEST DIS SCI, V61, P1652, DOI 10.1007/s10620-016-4170-x; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Shen M, 2006, AM J EPIDEMIOL, V163, P502, DOI 10.1093/aje/kwj073; Soliman Hatem, 2008, Cancer Control, V15, P55	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179784	10.1371/journal.pone.0179784	http://dx.doi.org/10.1371/journal.pone.0179784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650984	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300023
J	Li, XH; Wang, BN; Yang, TW; Zhu, DW; Nie, ZN; Xu, JC				Li, Xinghua; Wang, Baona; Yang, Tewu; Zhu, Duanwei; Nie, Zhongnan; Xu, Junchi			Identification of soil P fractions that are associated with P loss from surface runoff under various cropping systems and fertilizer rates on sloped farmland	PLOS ONE			English	Article							PHOSPHORUS FRACTIONS; OVERLAND-FLOW; DETACHMENT RATE; SEDIMENT; FORMS; ERODIBILITY; TRANSPORT; STRENGTH; NITROGEN	Soil phosphorus (P) fractions and runoff P concentration were measured to understand the fate of soil P entering surface runoff water during summer cropping season of different double cropping systems under two fertilizer regimes. The dominant form of runoff P was particulate P (PP). Runoff total P (TP) was higher at the vegetative growth stage and lower at the crop reproductive stage. TP and PP were derived mainly from soil Olsen-P, Al-P and Fe-P and amounts increased with sediment content in runoff water. Runoff P discharge was closely related to the changes in soil P forms. Soil Olsen-P, mainly consisting of some Ca-2-P and Al-P, was increased by elevating fertilizer rate. Along with crop growth, there were active interconversions among Olsen-P, Org-P, Fe-P and O-Al-P in the soil, and some available P converted into Ca-10-P, with O-Fe-P possibly being a transitional form for this conversion. The oilseed rape/corn system had less runoff TP at the early stage, and wheat/sweet potato system had a lower runoff P at the late stage. Intercropping corn with sweet potato in the field with oilseed rape as a previous crop may be helpful for alleviating runoff P load during the summer in this region.	[Li, Xinghua; Wang, Baona; Yang, Tewu; Xu, Junchi] Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Peoples R China; [Yang, Tewu; Zhu, Duanwei] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China; [Zhu, Duanwei] Huazhong Agr Univ, Lab Plant Nutr & Ecol Environm Res, Wuhan, Peoples R China; [Nie, Zhongnan] Dept Econ Dev Jobs Transport & Resources, Hamilton, Vic, Australia	Huazhong Agricultural University; Huazhong Agricultural University	Yang, TW (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Peoples R China.; Yang, TW (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China.	yangtewu@mail.hzau.edu.cn	Xu, Junchi/J-1462-2017	Xu, Junchi/0000-0001-6370-6041	National Key Research and Development Program of China [SQ2017YFNC060063]; Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project [2007BAD87B09]	National Key Research and Development Program of China; Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project	This work was supported by the National Key Research and Development Program of China (grant no. SQ2017YFNC060063) and Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project (grant no. 2007BAD87B09).; This work was supported by the National Key Research and Development Program of China (Grant No. SQ2017YFNC060063) and Research and Demonstration on Agro-Ecological Restoration Technology in Danjiangkou Reservoir Region for the South-to-North Water Transfer Project (Grant No. 2007BAD87B09). The authors thank Mr. Andy Bruere, the Bay of Plenty Regional Council, New Zealand, for his helpful comments on the language/grammar of the manuscript.	Ai Y, 2010, PROGRESSES COMPREHEN, P46; Bao SD, 2000, AGROCHEMICAL SOIL AN, P25; Buehler S, 2002, SOIL SCI SOC AM J, V66, P868, DOI 10.2136/sssaj2002.0868; Casermeiro MA, 2004, CATENA, V57, P91, DOI 10.1016/S0341-8162(03)00160-7; Chen Xin, 2000, China Environmental Science, V20, P284; [成庆利 CHENG Qingli], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P202; do Nascimento CAC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17967; Doody D, 2006, SCI TOTAL ENVIRON, V372, P247, DOI 10.1016/j.scitotenv.2006.08.029; Dougherty WJ, 2011, SOIL RES, V49, P523, DOI 10.1071/SR11151; Douglas CL, 1998, J ENVIRON QUAL, V27, P1170, DOI 10.2134/jeq1998.00472425002700050023x; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Gao Yang, 2008, China Environmental Science, V28, P542; GREENHILL NB, 1983, AUST J SOIL RES, V21, P139, DOI 10.1071/SR9830139; Gu YC., 1990, SOILS, V22, P101; GU YC, 1997, CHIN J SOIL SCI, V29, P13; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Jackson ML., 1957, SOIL SCI, V84, P1334; Jalali M, 2013, ENVIRON MONIT ASSESS, V185, P8557, DOI 10.1007/s10661-013-3195-2; Kirkby MJ, 1996, J SOIL WATER CONSERV, V51, P391; Kwong KFNK, 2002, AGR ECOSYST ENVIRON, V91, P147, DOI 10.1016/S0167-8809(01)00237-7; Lei HongJun, 2007, Acta Pedologica Sinica, V44, P860; Leytem AB, 2005, SOIL SCI SOC AM J, V69, P1516, DOI 10.2136/sssaj2004.0315; [李承力 LI Chengli], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P83; Mamo M, 2001, T ASAE, V44, P1175; Mamo M, 2001, T ASAE, V44, P1167; Marquez CO, 2004, SOIL SCI SOC AM J, V68, P725, DOI 10.2136/sssaj2004.0725; McDowell R, 2002, J ENVIRON QUAL, V31, P217, DOI 10.2134/jeq2002.0217; McDowell RW, 2004, NEW ZEAL J AGR RES, V47, P137, DOI 10.1080/00288233.2004.9513581; McDowell RW, 2003, NEW ZEAL J AGR RES, V46, P239, DOI 10.1080/00288233.2003.9513550; Moody PW, 2011, SOIL RES, V49, P247, DOI 10.1071/SR10140; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nash David, 2002, P225, DOI 10.1079/9780851995458.0225; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pagliari PH, 2013, BIOL FERT SOILS, V49, P987, DOI 10.1007/s00374-013-0798-2; Pan CZ, 2006, J HYDROL, V331, P178, DOI 10.1016/j.jhydrol.2006.05.011; Pikul JL, 2003, SOIL SCI SOC AM J, V67, P859, DOI 10.2136/sssaj2003.0859; Pote DH, 1999, J ENVIRON QUAL, V28, P170, DOI 10.2134/jeq1999.00472425002800010020x; Pote DH, 1996, SOIL SCI SOC AM J, V60, P855, DOI 10.2136/sssaj1996.03615995006000030025x; Reddy KR, 1998, SOIL SCI SOC AM J, V62, P1134, DOI 10.2136/sssaj1998.03615995006200040039x; Robertson FA, 2008, AGR ECOSYST ENVIRON, V126, P195, DOI 10.1016/j.agee.2008.01.023; Samadi A, 1998, AUST J SOIL RES, V36, P585, DOI 10.1071/S97060; SEPA, 2003, TECHN SPEC REQ MON S; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; [盛海君 Sheng Haijun], 2004, [生态学报, Acta Ecologica Sinica], V24, P2837; Shigaki F, 2006, J ENVIRON QUAL, V35, P2229, DOI 10.2134/jeq2006.0112; Sui YB, 1999, SOIL SCI SOC AM J, V63, P1174, DOI 10.2136/sssaj1999.6351174x; Wang J, 2010, PEDOSPHERE, V20, P304, DOI 10.1016/S1002-0160(10)60018-5; [向万胜 Xiang Wansheng], 2004, [植物营养与肥料学报, Plant nutrition and fertitizer science], V10, P663; Yu S, 2006, SOIL BIOL BIOCHEM, V38, P619, DOI 10.1016/j.soilbio.2005.02.040; Yu SF, 2003, CHIN J SOIL SCI, V34, P422; 刘建玲, 1999, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V5, P14	53	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179275	10.1371/journal.pone.0179275	http://dx.doi.org/10.1371/journal.pone.0179275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650990	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300004
J	Ward, NP; Poff, AM; Koutnik, AP; D'Agostino, DP				Ward, Nathan P.; Poff, Angela M.; Koutnik, Andrew P.; D'Agostino, Dominic P.			Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; MULTIPLE-MYELOMA CELLS; GLUCOSE-METABOLISM; STEM-CELLS; METFORMIN; CANCER; RESISTANCE; MECHANISMS; APOPTOSIS; SURVIVAL	The robust glycolytic metabolism of glioblastoma multiforme (GBM) has proven them susceptible to increases in oxidative metabolism induced by the pyruvate mimetic dichloroacetate (DCA). Recent reports demonstrate that the anti- diabetic drug metformin enhances the damaging oxidative stress associated with DCA treatment in cancer cells. We sought to elucidate the role of metformin's reported activity as a mitochondrial complex I inhibitor in the enhancement of DCA cytotoxicity in VM-M3 GBM cells. Metformin potentiated DCA- induced superoxide production, which was required for enhanced cytotoxicity towards VM- M3 cells observed with the combination. Similarly, rotenone enhanced oxidative stress resultant from DCA treatment and this too was required for the noted augmentation of cytotoxicity. Adenosine monophosphate kinase (AMPK) activation was not observed with the concentration of metformin required to enhance DCA activity. Moreover, addition of an activator of AMPK did not enhance DCA cytotoxicity, whereas an inhibitor of AMPK heightened the cytotoxicity of the combination. Our data indicate that metformin enhancement of DCA cytotoxicity is dependent on complex I inhibition. Particularly, that complex I inhibition cooperates with DCA- induction of glucose oxidation to enhance cytotoxic oxidative stress in VM-M3 GBM cells.	[Ward, Nathan P.; Poff, Angela M.; Koutnik, Andrew P.; D'Agostino, Dominic P.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	D'Agostino, DP (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ddagosti@health.usf.edu	D'Agostino, Dominic/GPJ-9744-2022; Koutnik, Andrew/U-5194-2017	Koutnik, Andrew/0000-0002-5491-3919; Ward, Nathan/0000-0003-4920-0081; Ward, Nathan/0000-0001-7714-2494	Scivation, Inc.	Scivation, Inc.	This study was funded through a charitable donation from Scivation, Inc. to DPD; however, they had no role in the design of the study, collection, analysis and interpretation of the data, or writing of this manuscript	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Chu QSC, 2015, INVEST NEW DRUG, V33, P603, DOI 10.1007/s10637-015-0221-y; Clark PM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0613-6; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dunbar EM, 2014, INVEST NEW DRUG, V32, P452, DOI 10.1007/s10637-013-0047-4; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Gritti M, 2014, ONCOTARGET, V5, P11252, DOI 10.18632/oncotarget.2617; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Haugrud AB, 2014, BREAST CANCER RES TR, V147, P539, DOI 10.1007/s10549-014-3128-y; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Jiang W, 2016, ONCOTARGET; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Kumar A, 2013, TOXICOL APPL PHARM, V273, P196, DOI 10.1016/j.taap.2013.09.005; Kumar K, 2013, J MOL MED, V91, P749, DOI 10.1007/s00109-013-0996-2; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pathak RK, 2014, ACS CHEM BIOL, V9, P1178, DOI 10.1021/cb400944y; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Pfister AS, 2015, J BIOL CHEM, V290, P10905, DOI 10.1074/jbc.M114.634246; Poff AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127407; Poff AM, 2014, INT J CANCER, V135, P1711, DOI 10.1002/ijc.28809; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Roh JL, 2016, CANCER LETT, V371, P20, DOI 10.1016/j.canlet.2015.11.023; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0130-0; Shen YC, 2013, BRIT J CANCER, V108, P72, DOI 10.1038/bjc.2012.559; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun RC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-142; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Ta NL, 2015, LIPIDS, V50, P1167, DOI 10.1007/s11745-015-4075-z; Tebbe C, 2014, ONCOTARGET, V5, P4746, DOI 10.18632/oncotarget.2012; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xuan Y, 2014, EXP CELL RES, V321, P219, DOI 10.1016/j.yexcr.2013.12.009; Yu ZY, 2016, ONCOL LETT, V11, P2792, DOI 10.3892/ol.2016.4315; Yu ZY, 2015, ONCOTARGET, V6, P32930, DOI 10.18632/oncotarget.5405; Zhao Z, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/140913; Zhong F, 2015, ONCOL LETT, V10, P1416, DOI 10.3892/ol.2015.3391; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou P, 2005, BRIT J HAEMATOL, V128, P636, DOI 10.1111/j.1365-2141.2005.05369.x; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444	67	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180061	10.1371/journal.pone.0180061	http://dx.doi.org/10.1371/journal.pone.0180061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644886	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100060
J	D'Amico, M; Kinel, E; Roncoletta, P				D'Amico, Moreno; Kinel, Edyta; Roncoletta, Piero			Normative 3D opto-electronic stereophotogrammetric posture and spine morphology data in young healthy adult population	PLOS ONE			English	Article							LOW-BACK-PAIN; LEG LENGTH DISCREPANCY; STANDING LATERAL RADIOGRAPHS; BIOMECHANICAL SKELETON MODEL; SAGITTAL PLANE; RECIPROCAL ANGULATION; IDIOPATHIC SCOLIOSIS; THORACIC KYPHOSIS; MOVEMENT ANALYSIS; VERTEBRAL BODIES	Design: Observational cross-sectional study. The current study aims to yield normative data: i.e., the physiological standard for 30 selected quantitative 3D parameters that accurately capture and describe a full-skeleton, upright-standing attitude. Specific and exclusive consideration was given to three distinct categories: postural, spine morphology and pelvic parameters. To capture such 3D parameters, the authors selected a non-ionising 3D optoelectronic stereo-photogrammetric approach. This required the identification and measurement of 27 body landmarks, each specifically tagged with a skin marker. As subjects for the measurement of these parameters, a cohort of 124 asymptomatic young adult volunteers was recruited. All parameters were identified and measured within this group. Postural and spine morphology data have been compared between genders. In this regard, only five statistically significant differences were found: pelvis width, pelvis torsion, the "lumbar" lordosis angle value, the lumbar curve length, and the T12-L5 anatomically-bound lumbar angle value. The "thoracic" kyphosis mean angle value was the same in both sexes and, even if, derived from skin markers placed on spinous processes it resulted in perfect agreement with the X-ray based literature. As regards lordosis, a direct comparison was more difficult because methods proposed in the literature differ as to the number and position of vertebrae under consideration, and their related angle values. However, when the L1 superior-L5 inferior end plate Cobb angle was considered, these results aligned strongly with the existing literature. Asymmetry was a standard postural-spinal feature for both sexes. Each subject presented some degree of leg length discrepancy (LLD) with mu = 9.37mm. This was associated with four factors: unbalanced posture and/or underfoot loads, spinal curvature in the frontal plane, and pelvis torsion. This led to the additional study of the effect of LLD equalisation influence on upright posture, relying on a sub-sample of 100 subjects (51 males, 49 females). As a result of the equalisation, about 82% of this sub-sample showed improvement in standing posture, mainly in the frontal plane; while in the sagittal plane less than 1/3 of the sub-sample showed evidence of change in spinal angles. A significant variation was found in relation to pelvis torsion: 46% of subjects showed improvement, 49% worsening. The method described in study presents several advantages: non-invasive aspect; relatively short time for a complete postural evaluation with many clinically useful 3D and 2D anatomical/biomechanical/ clinical parameters; analysis of real neutral unconstrained upright standing posture.	[D'Amico, Moreno; Roncoletta, Piero] SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy; [Kinel, Edyta] Univ Med Sci, Dept Rheumatol & Rehabil, Clin Rehabil, Poznan, Poland		D'Amico, M (corresponding author), SMART Lab Skeleton Movement Anal & Adv Rehabil Te, Pescara, Italy.	damicomoreno@gmail.com	Kinel, Edyta/AAX-9964-2020; Kinel, Edyta/F-5251-2012	Kinel, Edyta/0000-0001-9106-8016; 	Bioengineering & Biomedicine Company Srl	Bioengineering & Biomedicine Company Srl	The Bioengineering & Biomedicine Company Srl provided access to its Posture and Movement Biomechanical laboratory for free, letting the authors to freely use without any limitations this facility to carry out the measurements for the study. Bioengineering & Biomedicine Company Srl also provided funding for the publication fee. The Bioengineering & Biomedicine Company Srl did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomedicine Company Srl did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz YI, 1971, P S CLOS RANG PHOT G; Amabile C, 2016, EUR SPINE J, P1; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Beaudoin L, 1999, EUR SPINE J, V8, P40, DOI 10.1007/s005860050125; Been E, 2014, SPINE J, V14, P87, DOI 10.1016/j.spinee.2013.07.464; Blondel B, 2012, ORTHOP TRAUMATOL-SUR, V98, P109, DOI 10.1016/j.otsr.2011.12.001; Borghese NA, 2001, MED BIOL ENG COMPUT, V39, P76, DOI 10.1007/BF02345269; Campos MH, 2015, J BIOMECH, V48, P969, DOI 10.1016/j.jbiomech.2015.02.011; Cerveri P, 1998, J BIOMECH, V31, P935, DOI 10.1016/S0021-9290(98)00104-3; Cheng XG, 1998, SKELETAL RADIOL, V27, P380, DOI 10.1007/s002560050402; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Chong AK, 2009, PHOTOGRAMM REC, V24, P264, DOI 10.1111/j.1477-9730.2009.00540.x; CLEVELAND RH, 1988, INVEST RADIOL, V23, P301, DOI 10.1097/00004424-198804000-00010; D'Amico M, 2002, STUD HEALTH TECHNOL, V88, P285; D'Amico M, 2002, ST HEAL T, V88, P365; D'Amico M, 2008, STUD HEALTH TECHNOL, V140, P79, DOI 10.3233/978-1-58603-888-5-79; D'Amico M., 1997, KINESIOLOGY, V29, P5; D'Amico M., 2001, P 18 ISB INT SOC BIO; D'Amico M., 2007, EUR MED PHYS, V43, P1; D'Amico M., 1996, INT C SIRER SCOL STA, P279; D'Amico M, 2011, GAIT POSTURE, V33, pS37; D'Amico M, 2011, 2011 IEEE INT WORKSH, P605, DOI [DOI 10.1109/MEMEA.2011.5966711, 10.1109/MeMeA.2011.5966711]; D'Amico M, 2006, ST HEAL T, V123, P409; D'Amico M, 2006, STUD HEALTH TECHNOL, V123, P188; D'Amico Moreno, 2002, Stud Health Technol Inform, V91, P149; D'Amico M, 2012, STUD HEALTH TECHNOL, V176, P108, DOI 10.3233/978-1-61499-067-3-108; D'Amico M, 2012, STUD HEALTH TECHNOL, V176, P146, DOI 10.3233/978-1-61499-067-3-146; D'Amico M, 2010, STUD HEALTH TECHNOL, V158, P118, DOI 10.3233/978-1-60750-573-0-118; Damasceno Luiz Henrique Fonseca, 2006, Acta ortop. bras., V14, P193, DOI 10.1590/S1413-78522006000400003; DAMICO M, 1992, MED BIOL ENG COMPUT, V30, P193, DOI 10.1007/BF02446130; DAMICO M, 1990, MED BIOL ENG COMPUT, V28, P407, DOI 10.1007/BF02441963; DAmico M, 1997, ST HEAL T, V37, P161; DAmico M, 1997, ST HEAL T, V37, P155; DAmico M, 1997, ST HEAL T, V37, P151; DAmico M, 1997, ST HEAL T, V37, P143; DAMICO M, 1995, ST HEAL T, V15, P33; DAPENA J, 1982, J BIOMECH, V15, P11, DOI 10.1016/0021-9290(82)90030-6; De Boor C., 2001, PRACTICAL GUIDE SPLI; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Leva P, 1996, J BIOMECH, V29, P1231, DOI 10.1016/0021-9290(96)00021-8; de Oliveira TS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/186156; Don R, 2012, EUR J PHYS REHAB MED, V48, P255; Engsberg JR, 2008, J APPL BIOMECH, V24, P94, DOI 10.1123/jab.24.1.94; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; Ferreira EA, 2011, J MANIP PHYSIOL THER, V34, P371, DOI 10.1016/j.jmpt.2011.05.018; Ferreira EAG, 2010, CLINICS, V65, P675, DOI 10.1590/S1807-59322010000700005; Ferrigno G, 1992, FREQUENCY DOMAIN IMP, P1093; FON GT, 1980, AM J ROENTGENOL, V134, P979, DOI 10.2214/ajr.134.5.979; Fortin C, 2012, PHYSIOTHERAPY, V98, P64, DOI 10.1016/j.physio.2010.12.006; Furlanetto TS, 2016, WORLD J ORTHOP, V7, P136, DOI 10.5312/wjo.v7.i2.136; Furlanetto TS, 2012, COMPUT METH PROG BIO, V108, P203, DOI 10.1016/j.cmpb.2012.03.012; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; GRACOVETSKY S, 1995, SPINE, V20, P1036, DOI 10.1097/00007632-199505000-00010; Gracovetsky SA, 1998, SPINE, V23, P568, DOI 10.1097/00007632-199803010-00009; GREIGELMORRIS P, 1992, PHYS THER, V72, P425; GROSS RH, 1983, AM J SPORT MED, V11, P121, DOI 10.1177/036354658301100303; Guigui P, 2003, REV CHIR ORTHOP, V89, P496; Hay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133685; Jackson RP, 2000, SPINE, V25, P2808, DOI 10.1097/00007632-200011010-00014; Jackson RP, 1998, SPINE, V23, P1750, DOI 10.1097/00007632-199808150-00008; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Kandel Eric R, 2012, PRINCIPLES NEURAL SC; Knutson Gary A, 2005, Chiropr Osteopat, V13, P11, DOI 10.1186/1746-1340-13-11; Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010; Kotwicki T, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-18; Krawczky B, 2014, J MANIP PHYSIOL THER, V37, P269, DOI 10.1016/j.jmpt.2014.01.002; Leroux MA, 2000, SPINE, V25, P1689, DOI 10.1097/00007632-200007010-00012; Liu YK, 1973, PERSPECTIVES BIOMEDI, P203; Manchikanti L, PAIN PHYS, V12, pE35; Marks M, 2009, SPINE, V34, P949, DOI 10.1097/BRS.0b013e318199650a; Mincer AE, 1997, J PHYS THER SCI, P1; NEGRINI A, 1995, ST HEAL T, V15, P101; Negrini A, 2001, EUR MEDICOPHYS, V37, P135; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; Norton BJ, 2004, J ORTHOP SPORT PHYS, V34, P524, DOI 10.2519/jospt.2004.34.9.524; Ranavolo A, 2013, APPL ERGON, V44, P192, DOI 10.1016/j.apergo.2012.07.004; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Saad KR, 2012, J BODYW MOV THER, V16, P210, DOI 10.1016/j.jbmt.2011.03.005; Schmid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135689; SEIDEL GK, 1995, J BIOMECH, V28, P995, DOI 10.1016/0021-9290(94)00149-X; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Soukka A, 1976, ASS MILD INEQUALITY; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; STOKES IAF, 1994, SPINE, V19, P236, DOI 10.1097/00007632-199401001-00020; Takacs M, 2015, ANN BIOMED ENG, V43, P348, DOI 10.1007/s10439-014-1160-z; Tsuji T, 2001, J Orthop Sci, V6, P307, DOI 10.1007/s007760100023; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; van der Jagt-Willems HC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0018-z; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; VOUTSINAS SA, 1986, CLIN ORTHOP RELAT R, P235; Vygodsky M, 1987, MATH HDB HIGHER MATH; White A.A., 1990, CLIN BIOMECH; World Health Organization, GLOB DAT BOD MASS IN; Zagyapan R, 2012, ANAT RES INT ANAT RE, V2012; Zaiontz C, 2016, REAL STAT USING EXCE; Zatsiorsky V, 1990, VIVO BODY SEGMENT IN, P186; Zemp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095426; Zhao GR, 2008, J BIONIC ENG, V5, P328, DOI 10.1016/S1672-6529(08)60177-8	101	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179619	10.1371/journal.pone.0179619	http://dx.doi.org/10.1371/journal.pone.0179619			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640899	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800045
J	To, SKY; Mak, ASC; Fung, YME; Che, CM; Li, SS; Deng, W; Ru, B; Zhang, J; Wong, AST				To, S. K. Y.; Mak, A. S. C.; Fung, Y. M. Eva; Che, C-M; Li, S-S; Deng, W.; Ru, B.; Zhang, J.; Wong, A. S. T.			beta-catenin downregulates Dicer to promote ovarian cancer metastasis	ONCOGENE			English	Article							CLINICOPATHOLOGICAL FEATURES; POOR-PROGNOSIS; STEM-CELLS; EXPRESSION; ROLES; CARCINOMAS; CONTRIBUTE; PATTERN; GRADE	Ovarian cancer is a nearly uniform lethal disease and its highly aggressive metastatic phenotype portends a poor prognosis. Lack of a well-controlled, relevant experimental model has been a major obstacle to identifying key molecules causing metastasis. Here we describe the creation of a new isogenic model of spontaneous human ovarian cancer metastasis exhibiting opposite phenotypes-highly metastatic (HM) and non-metastatic (NM)-both in vitro and in vivo. HM was unique in its ability to metastasize consistently to the peritoneum, mimicking the major dissemination route of human ovarian cancer. In contrast, NM failed to form detectable metastases, although it was equally tumorigenic. Using comparative label-free quantitative liquid chromatography tandem mass spectrometry (LC-MS/MS), we identified beta-catenin, which we demonstrated for the first time as having a direct role in the pathogenesis of ovarian cancer metastasis. Our studies also revealed a previously unrecognized role of beta-catenin in the downregulation of multiple microRNAs (miRNAs) through attenuating miRNA biogenesis by targeting Dicer, a key component of the miRNA-processing machinery. One such downregulated miRNAs was miR-29s involved in epithelial-to-mesenchymal transition and subsequent stem cell traits. Silencing beta-catenin or overexpressing Dicer or miR-29 mimics in HM significantly reduced the ability of these cells to migrate. beta-catenin-knockdown cells also failed to metastasize in an orthotopic model of ovarian cancer. Meta-analysis revealed an increase in CTNNB1 and a decrease in DICER1 expression levels in the high-risk group. These results uncover beta-catenin as a critical factor in promoting ovarian cancer aggressiveness and a new mechanism linking between beta-catenin and miRNA downregulation underlying this process.	[To, S. K. Y.; Mak, A. S. C.; Li, S-S; Ru, B.; Zhang, J.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Fung, Y. M. Eva; Che, C-M] Univ Hong Kong, Dept Chem, Chem Biol Ctr, State Key Lab Synthet Chem, Hong Kong, Hong Kong, Peoples R China; [Deng, W.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	awong1@hku.hk	Deng, Wen/M-5208-2019; Zhang, Jiangwen/A-7654-2013; Wong, Alice/AFJ-4595-2022; Ru, Beibei/F-3830-2011	Zhang, Jiangwen/0000-0002-2911-8446; Wong, Alice/0000-0002-0676-6475; To, Sally Kit Yan/0000-0002-8683-2101	Research Grant Council [17141216]; University Grants Committee of the Hong Kong Special Administrative Region, China [SEG_HKU02]; Croucher Senior Research Fellowship	Research Grant Council(Hong Kong Research Grants Council); University Grants Committee of the Hong Kong Special Administrative Region, China; Croucher Senior Research Fellowship	We thank the assistance of the Faculty Core Facility of the Li Ka Shing Faculty of Medicine at the University of Hong Kong. The work described in this paper was supported by the Research Grant Council grant (17141216) and partially the Special Equipment Grant from the University Grants Committee of the Hong Kong Special Administrative Region, China (Project Code: SEG_HKU02). ASTW is a recipient of the Croucher Senior Research Fellowship.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Ayantunde AA, 2007, ANN ONCOL, V18, P945, DOI 10.1093/annonc/mdl499; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Brodsky AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094476; BUICK RN, 1985, CANCER RES, V45, P3668; Burgos-Ojeda D, 2012, CANCER LETT, V322, P1, DOI 10.1016/j.canlet.2012.02.002; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Dai FR, 2014, HUM PATHOL, V45, P1285, DOI 10.1016/j.humpath.2014.02.008; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Faggad A, 2010, J PATHOL, V220, P382, DOI 10.1002/path.2658; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hasan N, 2015, TRANSL CANCER RES, V4, P14, DOI 10.3978/j.issn.2218-676X.2015.01.02; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Jiang HS, 2014, ONCOL REP, V31, P1509, DOI 10.3892/or.2014.3036; Kang KS, 2013, BIOCHEM BIOPH RES CO, V432, P333, DOI 10.1016/j.bbrc.2013.01.102; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kildal W, 2005, EUR J CANCER, V41, P1127, DOI 10.1016/j.ejca.2005.01.022; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; McCloskey CW, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00053; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pampalakis G, 2010, CLIN BIOCHEM, V43, P324, DOI 10.1016/j.clinbiochem.2009.09.014; Ricci F, 2013, CANCER TREAT REV, V39, P561, DOI 10.1016/j.ctrv.2013.01.005; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stahl S, 2009, MOL CELL PROTEOMICS, V8, P1117, DOI 10.1074/mcp.M800274-MCP200; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Teng Y, 2015, ONCOTARGET, V6, P40799, DOI 10.18632/oncotarget.5695; Toth K, 2004, CANCER RES, V64, P3638, DOI 10.1158/0008-5472.CAN-03-3882; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang H, 2014, INT J CLIN EXP PATHO, V7, P264; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	33	34	0	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5927	5938		10.1038/onc.2017.185	http://dx.doi.org/10.1038/onc.2017.185			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650464				2022-12-26	WOS:000413841400002
J	Dogan, T; Gnad, F; Chan, J; Phu, L; Young, A; Chen, MJ; Doll, S; Stokes, MP; Belvin, M; Friedman, LS; Kirkpatrick, DS; Hoeflich, KP; Hatzivassiliou, G				Dogan, Taner; Gnad, Florian; Chan, Jocelyn; Phu, Lilian; Young, Amy; Chen, Mark J.; Doll, Sophia; Stokes, Matthew P.; Belvin, Marcia; Friedman, Lori S.; Kirkpatrick, Donald S.; Hoeflich, Klaus P.; Hatzivassiliou, Georgia			Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SUBSTRATE RECOGNITION; TUMOR-GROWTH; PHOSPHORYLATION; PROTEIN; UBIQUITYLATION; INHIBITION; APOPTOSIS; IDENTIFICATION; PROTEOLYSIS	The interconnected PI3K and MAPK signaling pathways are commonly perturbed in cancer. Dual inhibition of these pathways by the small-molecule PI3K inhibitor pictilisib (GDC-0941) and the MEK inhibitor cobimetinib (GDC-0973) suppresses cell proliferation and induces cell death better than either single agent in several preclinical models. Using mass spectrometry-based phosphoproteomics, we have identified the RING finger E3 ubiquitin ligase RNF157 as a target at the intersection of PI3K and MAPK signaling. We demonstrate that RNF157 phosphorylation downstream of the PI3K and MAPK pathways influences the ubiquitination and stability of RNF157 during the cell cycle in an anaphase-promoting complex/cyclosome-CDH1-dependent manner. Deletion of these phosphorylation-targeted residues on RNF157 disrupts binding to CDH1 and protects RNF157 from ubiquitination and degradation. Expression of the cyclin-dependent kinase 2 (CDK2), itself a downstream target of PI3K/MAPK signaling, leads to increased phosphorylation of RNF157 on the same residues modulated by PI3K andMAPKsignaling. Inhibition of PI3K and MEK in combination or of CDK2 by their respective small-molecule inhibitors reduces RNF157 phosphorylation at these residues and attenuates RNF157 interaction with CDH 1 and its subsequent degradation. Knockdown of endogenous RNF157 in melanoma cells leads to late S phase and G(2)/M arrest and induces apoptosis, the latter further potentiated by concurrent PI3K/MEK inhibition, consistent with a role for RNF157 in the cell cycle. We propose that RNF157 serves as a novel node integrating oncogenic signaling pathways with the cell cycle machinery and promoting optimal cell cycle progression in transformed cells.	[Dogan, Taner; Chan, Jocelyn; Young, Amy; Belvin, Marcia; Friedman, Lori S.; Hoeflich, Klaus P.; Hatzivassiliou, Georgia] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Gnad, Florian; Chen, Mark J.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Phu, Lilian; Doll, Sophia; Kirkpatrick, Donald S.] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Belvin, Marcia] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Stokes, Matthew P.] Cell Signaling Technol, Danvers, MA 01923 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hoeflich, KP (corresponding author), Blueprint Med, 38 Sidney St,Suite 200, Cambridge, MA 02139 USA.; Hatzivassiliou, G (corresponding author), Genentech Inc, 1 DNA Way,MS231A, San Francisco, CA 94080 USA.	khoeflich@blueprintmedicines.com; georgiah@gene.com	Chen, Mark/O-3937-2014	Chen, Mark/0000-0003-1169-563X; Gnad, Florian/0000-0002-2287-2251; Kirkpatrick, Donald/0000-0003-3091-2804				Aguzzi A, 2009, CELL, V137, P994, DOI 10.1016/j.cell.2009.05.041; Aviner R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005554; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cooray SN, 2011, ENDOCRINOLOGY, V152, P4224, DOI 10.1210/en.2011-0147; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jarvis MA, 2016, METHODS MOL BIOL, V1342, P287, DOI 10.1007/978-1-4939-2957-3_18; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kirkpatrick DS, 2013, P NATL ACAD SCI USA, V110, P19426, DOI 10.1073/pnas.1309473110; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lents NH, 2002, J BIOL CHEM, V277, P47469, DOI 10.1074/jbc.M207425200; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Matz A, 2015, CELL DEATH DIFFER, V22, P626, DOI 10.1038/cdd.2014.163; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Overton JD, 2011, J BIOL CHEM, V286, P18914, DOI 10.1074/jbc.M111.224592; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wierod L, 2007, CELL PROLIFERAT, V40, P475, DOI 10.1111/j.1365-2184.2007.00451.x; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou JLX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131043; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	48	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14311	14324		10.1074/jbc.M117.792754	http://dx.doi.org/10.1074/jbc.M117.792754			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28655764	Green Published, hybrid			2022-12-26	WOS:000408747500001
J	Prestigiacomo, V; Weston, A; Messner, S; Lampart, F; Suter-Dick, L				Prestigiacomo, Vincenzo; Weston, Anna; Messner, Simon; Lampart, Franziska; Suter-Dick, Laura			Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis	PLOS ONE			English	Article							HEPATIC-FIBROSIS; HEPATOTOXICITY; PROLIFERATION; HEPATOCYTES; MECHANISMS; EXPRESSION; SPHEROIDS; REPAIR	Background & Aims Currently most liver fibrosis research is performed in vivo, since suitable alternative in vitro systems which are able to recapitulate the cellular events leading to liver fibrosis are lacking. Here we aimed at generating a system containing cells representing the three key players of liver fibrosis (hepatocyte, Kupffer cells and stellate cells) and assess their response to profibrotic compounds such as TGF-beta 1, methotrexate (MTX) and thioacetamide (TAA). Methods Human cell lines representing hepatocytes (HepaRG), Kupffer cell (THP-1 macrophages) and stellate cells (hTERT-HSC) were co-cultured using the InSphero hanging drop technology to generate scaffold-free 3D microtissues, that were treated with pro-fibrotic compounds (TGF-beta 1, MTX, TAA) for up to 14 days. The response of the microtissues was evaluated by determining the expression of cytokines (TNF-alpha, TGF-beta 1 and IL6), the deposition and secretion of ECM proteins and induction of gene expression of fibrosis biomarkers (e.g. alpha SMA). Induction of Nrf2 and Keap1, as key player of defence mechanism, was also evaluated. Results We could demonstrate that the multicellular 3D microtissue cultures could be maintained in a non-activated status, based on the low expression levels of activation markers. Macrophages were activated by stimulation with LPS and hTERT-HSC showed activation by TGF-beta 1. In addition, MTX and TAA elicited a fibrotic phenotype, as assessed by gene-expression and protein-deposition of ECM proteins such as collagens and fibronectin. An involvement of the antioxidant pathway upon stimulation with pro-fibrotic compounds was also observed. Conclusion Here, for the first time, we demonstrate the in vitro recapitulation of key molecular and cellular events leading to liver fibrosis: hepatocellular injury, antioxidant defence response, activation of Kupffer cells and activation of HSC leading to deposition of ECM.	[Prestigiacomo, Vincenzo; Weston, Anna; Lampart, Franziska; Suter-Dick, Laura] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland; [Prestigiacomo, Vincenzo] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Messner, Simon] InSphero AG, Schlieren, Canton Of Zuric, Switzerland	FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Basel; InSphero AG	Prestigiacomo, V (corresponding author), Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland.; Prestigiacomo, V (corresponding author), Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland.	vincenzo.prestigiacomo@fhnw.ch	Sharma, Ashwani/AAK-3879-2020; Suter-Dick, Laura/A-9093-2019	Sharma, Ashwani/0000-0001-9835-1973; Suter-Dick, Laura/0000-0002-1449-3913; Lampart, Franziska/0000-0001-9040-0574; Weston, Anna/0000-0003-4339-3839	CTI (Commission for Technology and Innovation); SCANT (Swiss Center for Applied Human Toxicology); Swiss Commission for Innovation and Technology (CTI); Swiss Centre for Applied Human Toxicology (SCAHT)	CTI (Commission for Technology and Innovation); SCANT (Swiss Center for Applied Human Toxicology); Swiss Commission for Innovation and Technology (CTI); Swiss Centre for Applied Human Toxicology (SCAHT)	The work performed at FHNW was partly funded by the CTI (Commission for Technology and Innovation) and partly by SCANT (Swiss Center for Applied Human Toxicology), both Swiss federal organisations. The studies performed at InSphero AG were funded internally. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; We would like to acknowledge the financial support of the Swiss Commission for Innovation and Technology (CTI), the Swiss Centre for Applied Human Toxicology (SCAHT) and the scientific support of Dr. Jens Kelm. We are very thankful to Dr. B. Schnabl for making the hTERT-HSC available for our research.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Arias M, 2002, CELL GROWTH DIFFER, V13, P265; Barker J, 2011, J EUR ACAD DERMATOL, V25, P758, DOI 10.1111/j.1468-3083.2010.03932.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brophy CM, 2009, HEPATOLOGY, V49, P578, DOI 10.1002/hep.22674; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Ding ZB, 2013, J GASTROEN HEPATOL, V28, P188, DOI 10.1111/j.1440-1746.2012.07265.x; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Horvat T, 2016, ARCH TOXICOL; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kasuya J, 2015, J TISSUE ENG REGEN M, V9, P247, DOI 10.1002/term.1630; Kikuchi S, 2005, J BIOL CHEM, V280, P15398, DOI 10.1074/jbc.M414048200; Kostadinova R, 2013, TOXICOL APPL PHARM, V268, P1, DOI 10.1016/j.taap.2013.01.012; Leite SB, 2016, BIOMATERIALS, V78, P1, DOI 10.1016/j.biomaterials.2015.11.026; Marques TG, 2012, ACTA CIR BRAS, V27, P589, DOI 10.1590/S0102-86502012000800013; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Panesar N, 1999, J SURG RES, V85, P251, DOI 10.1006/jsre.1999.5648; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Preaux AM, 1999, HEPATOLOGY, V30, P944, DOI 10.1002/hep.510300432; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Takahashi Y., 2015, BIOSCI REP; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011; Yang JJ, 2014, CELL SIGNAL, V26, P2381, DOI 10.1016/j.cellsig.2014.07.016	34	61	65	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179995	10.1371/journal.pone.0179995	http://dx.doi.org/10.1371/journal.pone.0179995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665955	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700050
J	Boncler, M; Golanski, J; Lukasiak, M; Redzynia, M; Dastych, J; Watala, C				Boncler, Magdalena; Golanski, Jacek; Lukasiak, Magdalena; Redzynia, Malgorzata; Dastych, Jaroslaw; Watala, Cezary			A new approach for the assessment of the toxicity of polyphenol-rich compounds with the use of high content screening analysis	PLOS ONE			English	Article							LIVER-INJURY; CYTOTOXICITY; TOXICOLOGY; HEPATOTOXICITY; MECHANISMS; VIABILITY; HORMESIS; ASSAYS; CELLS	The toxicity of in vitro tested compounds is usually evaluated based on AC50 values calculated from dose-response curves. However, there is a large group of compounds for which a standard four -parametric sigmoid curve fitting may be inappropriate for estimating AC50. In the present study, 22 polyphenol-rich compounds were prioritized from the least to the most toxic based on the total area under and over the dose-response curves (AUOC) in relation to baselines. The studied compounds were ranked across three key cell indicators (mitochondria) membrane potential, cell membrane integrity and nuclear size) in a panel of five cell lines (HepG2, Caco-2, A549, HMEC-1, and 3T3), using a high-content screening (HCS) assay. Regarding AUOC score values, naringin (negative control) was the least toxic phenolic compound. Aronox, spent hop extract and kale leaf extract had very low cytotoxicity with regard to mitochondrial membrane potential and cell membrane integrity, as well as nuclear morphology (nuclear area). Kaempferol (positive control) exerted strong cytotoxic effects on the mitochondrial and nuclear compartments. Extracts from buckthorn bark, walnut husk and hollyhock flower were highly cytotoxic with regard to the mitochondrion and cell membrane, but not the nucleus. We propose an alternative algorithm for the screening of a large number of agents and for identifying those with adverse cellular effects at an early stage of drug discovery, using high content screening analysis. This approach should be recommended for series of compounds producing a non-sigmoidal cell response, and for agents with unknown toxicity or mechanisms of action.	[Boncler, Magdalena; Golanski, Jacek; Watala, Cezary] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland; [Lukasiak, Magdalena] Proteon Pharmaceut SA, Lodz, Poland; [Redzynia, Malgorzata] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Tech Biochem, Lodz, Poland; [Dastych, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lab Cellular Immunol, Lodz, Poland	Medical University Lodz; Lodz University of Technology; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Boncler, M (corresponding author), Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland.	magdalena.boncler@umed.lodz.pl	BONCLER, MAGDALENA Agnieszka/S-9252-2016; Redzynia, Małgorzata/M-2775-2018; Watala, Cezary/ABF-4863-2020; Golanski, Jacek/S-9556-2016	BONCLER, MAGDALENA Agnieszka/0000-0002-4860-5338; Redzynia, Małgorzata/0000-0003-4625-9678; Watala, Cezary/0000-0002-5627-7872; Golanski, Jacek/0000-0003-4392-8274	grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA" [UDA-POIG.01.03.01-10-129/08-00]; European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme	grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA"; European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme	This work was supported by the grant "Production of polyphenol extracts of plant origin with antiplatelet and cardioprotective properties FLAWOPIRYNA" UDA-POIG.01.03.01-10-129/08-00, financed by The European Union from the European Regional Development Fund within the framework of the Innovative Economy Operational Programme. The part of the grant was used to pay for the contract with private company Proteon Pharmaceuticals. Proteon Pharmaceuticals and one of the co-authors (Magdalena Lukasiak) were responsible mainly for cell culture and for performing of HCS analysis. Raw data gathered by Proteon Pharmaceuticals were further analyzed by co-workers of the Medical University of Lodz.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Abraham VC, 2008, J BIOMOL SCREEN, V13, P527, DOI 10.1177/1087057108318428; Bacanli M, 2015, FOOD CHEM TOXICOL, V81, P160, DOI 10.1016/j.fct.2015.04.015; Bharti S, 2014, PLANTA MED, V80, P437, DOI 10.1055/s-0034-1368351; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bordonaba JG, 2008, J AGR FOOD CHEM, V56, P7422, DOI 10.1021/jf8009377; Bunel V, 2014, PLANTA MED, V80, P1210, DOI 10.1055/s-0033-1360273; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese EJ, 1999, RISK ANAL, V19, P261, DOI 10.1111/j.1539-6924.1999.tb00404.x; Clarke R, 2015, Toxicol Lett, V233, P278, DOI 10.1016/j.toxlet.2015.01.011; Dhanya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132429; Domingos MC, 2014, BASIC CLIN PHARMACOL, V115, P145, DOI 10.1111/bcpt.12219; Forbes AM, 2014, INT J ONCOL, V45, P831, DOI 10.3892/ijo.2014.2452; George S, 2010, ACS NANO, V4, P15, DOI 10.1021/nn901503q; Gorlach S, 2011, J AGR FOOD CHEM, V59, P6985, DOI 10.1021/jf200639e; Gustafsson F, 2014, TOXICOL SCI, V137, P189, DOI 10.1093/toxsci/kft223; Hayes DP, 2008, AM J CLIN NUTR, V88, p578S, DOI 10.1093/ajcn/88.2.578S; Jan E, 2008, ACS NANO, V2, P928, DOI 10.1021/nn7004393; Lattanzio V, 2012, REC ADV POLYPHEN RES, V3, P1; Li W, 2009, CHEM-BIOL INTERACT, V177, P121, DOI 10.1016/j.cbi.2008.10.048; Lieggi NT, 2010, TOXICOL IN VITRO, V24, P2063, DOI 10.1016/j.tiv.2010.07.014; Luo HT, 2008, NUTR CANCER, V60, P800, DOI 10.1080/01635580802100851; Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Middleton E, 2000, PHARMACOL REV, V52, P673; Morelli JK, 2006, CELL BIOL TOXICOL, V22, P15, DOI 10.1007/s10565-006-0176-z; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; O'Brien PJ, 2014, BASIC CLIN PHARMACOL, V115, P4, DOI 10.1111/bcpt.12227; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Rajendran P, 2014, EUR J MED CHEM, V86, P103, DOI 10.1016/j.ejmech.2014.08.011; Ramesh E, 2013, FOOD CHEM TOXICOL, V51, P97, DOI 10.1016/j.fct.2012.07.033; Rawlinson LAB, 2010, J CONTROL RELEASE, V146, P84, DOI 10.1016/j.jconrel.2010.05.002; Rouhollahi E, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0534-6; Tolosa L, 2016, TOXICOL SCI, V152, P214, DOI 10.1093/toxsci/kfw078; Vukovic LD, 2016, INT REV CEL MOL BIO, V322, P1, DOI 10.1016/bs.ircmb.2015.11.001; Walters AD, 2012, J CELL BIOCHEM, V113, P2813, DOI 10.1002/jcb.24178; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	45	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180022	10.1371/journal.pone.0180022	http://dx.doi.org/10.1371/journal.pone.0180022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662177	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300088
J	Nunes, DCD; Bispo-Da-Silva, LB; Napolitano, DR; Costa, MS; Figueira, MMNR; Rodrigues, RS; Rodrigues, VD; Yoneyama, KAG				de Oliveira Nunes, Debora Cristina; Bispo-da-Silva, Luiz Borges; Napolitano, Danielle Reis; Costa, Monica Soares; Nunes Rocha Figueira, Marcia Moura; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo; Geraldo Yoneyama, Kelly Aparecida			In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; SODIUM STIBOGLUCONATE; ORAL KETOCONAZOLE; PROLIFERATION; MILTEFOSINE; COMBINATION; ANTAGONISM; SIMULATION; DIAGNOSIS; EFFICACY	Leishmaniasis is a group of diseases caused by protozoa of Leishmania genus. The currently available treatments for this disease are expensive, present high toxicity and are associated to difficulties of healing and parasite resistance. Therefore, the development of strategies for leishmaniasis treatment is indispensable and includes reposition of existing drugs, as well as drug combination therapy. The aim of this study was to assess the nature of ketoconazole and antimony association on the cytotoxic effect against Leishmania (Leishmania) amazonensis amastigotes. The calculated mean sum of fractional 50% inhibitory concentration (x Sigma FIC50) was 2.54 and 1.43 for free and intracellular amastigotes, respectively, values that suggest an additive interaction between ketoconazole and antimony concerning to Leishmania toxicity only in the intramacrophage parasite form. Despite the clinical efficacy of ketoconazole-antimony combination has been shown in the literature, our study is the first to describe the nature of ketoconazole-antimony interaction against L. (L.) amazonensis amastigotes. Moreover, our results point out the need for future in vivo studies to confirm the nature of ketoconazole-antimony interaction and also to determine possible effective dosage regimens related to ketoconazole administration in association with the optimal lower dose of antimony.	[de Oliveira Nunes, Debora Cristina; Costa, Monica Soares; Nunes Rocha Figueira, Marcia Moura; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo; Geraldo Yoneyama, Kelly Aparecida] Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil; [de Oliveira Nunes, Debora Cristina; Napolitano, Danielle Reis; Rodrigues, Renata Santos; Rodrigues, Veridiana de Melo] Inst Nacl Ciencia & Tecnol Nanobiofarmaceut N Bio, Belo Horizonte, MG, Brazil; [Bispo-da-Silva, Luiz Borges; Napolitano, Danielle Reis] Univ Fed Uberlandia, Inst Ciencias Biomed, Area Ciencias Fisiol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Yoneyama, KAG (corresponding author), Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil.	kelly.tudini@ufu.br	Veiga, Monica/AAU-6590-2021; Yoneyama, Kelly A. G./B-2690-2013; rodrigues, veridiana/A-3662-2013; Yoneyama, Kelly Aparecida Geraldo/GPP-0867-2022; Rodrigues, Renata Santos/AAD-3887-2021	rodrigues, veridiana/0000-0002-3386-9197; Yoneyama, Kelly Aparecida Geraldo/0000-0003-0329-5521; Nunes, Debora/0000-0001-5784-0519; Costa, Monica/0000-0001-5563-5116; Rodrigues, Renata Santos/0000-0002-3779-5236	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02731-08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [APQ-00376-10];  [479000/2013-1]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. Award Number: APQ-02731-08; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. Award Number: APQ-00376-10; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Award Number: 479000/2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALEH QA, 1995, INT J DERMATOL, V34, P495, DOI 10.1111/j.1365-4362.1995.tb00622.x; [Anonymous], 2014, ACTA TROP, V130, P112; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Boecken G, 2011, J DTSCH DERMATOL GES, V9, P1, DOI 10.1111/j.1610-0379.2011.07820.x; Callahan HL, 1997, ANTIMICROB AGENTS CH, V41, P818, DOI 10.1128/AAC.41.4.818; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; de Morais-Teixeira E, 2014, J ANTIMICROB CHEMOTH, V69, P150, DOI 10.1093/jac/dkt318; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; El-Sayed M, 2010, J EUR ACAD DERMATOL, V24, P335, DOI 10.1111/j.1468-3083.2009.03417.x; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Fontes CO, 2005, J MED MICROBIOL, V54, P1071, DOI 10.1099/jmm.0.46070-0; Goodwin LG, 1943, BIOCHEM J, V37, P198, DOI 10.1042/bj0370198; Gupta N, 2001, TRENDS PARASITOL, V17, P150, DOI 10.1016/S1471-4922(00)01811-0; Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; JOLLIFFE DS, 1986, CLIN EXP DERMATOL, V11, P62, DOI 10.1111/j.1365-2230.1986.tb00425.x; Elmahallawy EK, 2014, J INFECT DEV COUNTR, V8, P961, DOI 10.3855/jidc.4310; Le Bras J, 2011, MANUAL CLIN MICROBIO, P2113; Lepesheva GI, 2011, CURR TOP MED CHEM, V11, P2060; Maes L, 2013, DRUG RESISTANCE LEIS, P407; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; Nunes DCO, 2013, PARASITOLOGY, V140, P844, DOI 10.1017/S0031182013000012; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pandharkar T, 2014, ANTIMICROB AGENTS CH, V58, P4682, DOI 10.1128/AAC.02405-14; SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L; Salmanpour R, 2001, J DERMATOL TREAT, V12, P159, DOI 10.1080/09546630152607899; Seifert K, 2011, J ANTIMICROB CHEMOTH, V66, P850, DOI 10.1093/jac/dkq542; Shakya N, 2011, ACTA TROP, V119, P188, DOI 10.1016/j.actatropica.2011.05.017; Te Dorsthorst DTA, 2002, ANTIMICROB AGENTS CH, V46, P702, DOI [10.1128/AAC.46.3.702-707.2002, 10.1128/AAC.46.3.702.2002]; Trinconi CT, 2014, ANTIMICROB AGENTS CH, V58, P2608, DOI 10.1128/AAC.01315-13; URCUYO FG, 1982, INT J DERMATOL, V21, P414, DOI 10.1111/j.1365-4362.1982.tb03163.x; Zhang G, 2009, HDB DRUG SCREENING, P142	36	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180530	10.1371/journal.pone.0180530	http://dx.doi.org/10.1371/journal.pone.0180530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662149	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300164
J	Haun, CT; Roberts, MD; Romero, MA; Osburn, SC; Mobley, CB; Anderson, RG; Goodlett, MD; Pascoe, DD; Martin, JS				Haun, Cody T.; Roberts, Michael D.; Romero, Matthew A.; Osburn, Shelby C.; Mobley, Christopher B.; Anderson, Richard G.; Goodlett, Michael D.; Pascoe, David D.; Martin, Jeffrey S.			Does external pneumatic compression treatment between bouts of overreaching resistance training sessions exert differential effects on molecular signaling and performance-related variables compared to passive recovery? An exploratory study	PLOS ONE			English	Article							UBIQUITIN PROTEASOME SYSTEM; MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; DYNAMIC COMPRESSION; CREATINE-KINASE; PAIN THRESHOLD; EXERCISE; SINGLE; SYMPTOMS; PROTEIN	Purpose We sought to compare the effects of external pneumatic compression (EPC) and sham when used concurrently with resistance training on performance-related outcomes and molecular measures related to recovery. Methods Twenty (N = 20) resistance-trained male participants (aged 21.6 +/- 2.4 years) were randomized to balanced sham or EPC intervention groups. The protocol consisted of 3 consecutive days of heavy, voluminous back squat exercise followed by EPC/sham treatment (Days2-4) and 3 consecutive days of recovery (Days5-7) with EPC/sham only on Days5-6. On Day1 (PRE), and Days3-7, venipuncture, flexibility and pressure-to-pain threshold (PPT) measures were performed. Vastsus lateralis muscle tissue was biopsied at PRE, 1-h post-EPC/ sham treatment on Day2 (POST1) and 24-h post-EPC/sham treatment on Day? (POST2). Isokinetic peak torque was assessed at PRE and POST2. Results Peak isokinetic strength did not change from PRE to POST2 in either group. The PPT was significantly lower on Days3-6 with sham, indicating greater muscle soreness, though this was largely abolished in the EPC group. A significant decrease in flexibility with sham was observed on Day3 (+/- 16.2 +/- 4.6% knee joint angle; P<0.01) whereas there was no change with EPC (+2.8 3.8%; P>0.01). Vastus lateralis poly-ubiquitinated proteins significantly increased at the POST2 time point relative to PRE with sham (+66.6 +/- 24.6%; P<0.025) and were significantly greater (P<0.025) than those observed with EPC at the same time point (-18.6 8.5%). 4-hydroxynonenal values were significantly lower at POST2 relative to PRE with EPC (-16.2 +/- 5.6%; P<0.025) and were significantly lower (P<0.025) than those observed with sham at the same time point (+11.8 +/- 5.9%). Conclusion EPC mitigated a reduction in flexibility and PPT that occurred with sham. Moreover, EPC reduced select skeletal muscle oxidative stress and proteolysis markers during recovery from heavy resistance exercise.	[Haun, Cody T.; Roberts, Michael D.; Romero, Matthew A.; Osburn, Shelby C.; Mobley, Christopher B.; Anderson, Richard G.; Pascoe, David D.; Martin, Jeffrey S.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Roberts, Michael D.; Goodlett, Michael D.; Martin, Jeffrey S.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA; [Goodlett, Michael D.] Auburn Univ, Athlet Dept, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Martin, JS (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Martin, JS (corresponding author), Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA.	jmartin@auburn.vcom.edu	Mobley, Christopher/AAC-2123-2020	Mobley, C. Brooks/0000-0002-4045-9962				Attaix D, 1998, REPROD NUTR DEV, V38, P153, DOI 10.1051/rnd:19980202; Augustsson J, 2000, SCAND J MED SCI SPOR, V10, P164, DOI 10.1034/j.1600-0838.2000.010003164.x; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Baker S J, 1997, Eur J Pain, V1, P229, DOI 10.1016/S1090-3801(97)90108-7; BERRY MJ, 1990, CAN J SPORT SCI, V15, P244; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; Cochrane DJ, 2013, INT J SPORTS MED, V34, P969, DOI 10.1055/s-0033-1337944; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Duffield R, 2010, J SCI MED SPORT, V13, P136, DOI 10.1016/j.jsams.2008.10.006; Gill ND, 2006, BRIT J SPORT MED, V40, P260, DOI 10.1136/bjsm.2005.022483; Gulick Dawn T., 1996, Journal of Athletic Training, V31, P145; HAMILL J, 1991, INT J SPORT BIOMECH, V7, P125, DOI 10.1123/ijsb.7.2.125; Hilbert JE, 2003, BRIT J SPORT MED, V37, P72, DOI 10.1136/bjsm.37.1.72; JENSEN R, 1992, PAIN, V48, P197, DOI 10.1016/0304-3959(92)90059-K; Kephart WC, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0142-y; Kephart WC, 2015, EXP PHYSIOL, V100, P852, DOI 10.1113/EP085160; Koch AJ, 2014, J MUSCULOSKEL NEURON, V14, P68; KOSEK E, 1993, SCAND J REHABIL MED, V25, P117; Kraemer WJ, 2001, J ORTHOP SPORT PHYS, V31, P282, DOI 10.2519/jospt.2001.31.6.282; Krivickas LS, 1996, ARCH PHYS MED REHAB, V77, P1139, DOI 10.1016/S0003-9993(96)90137-9; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; MacDonald GZ, 2013, J STRENGTH COND RES, V27, P812, DOI 10.1519/JSC.0b013e31825c2bc1; Martin JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13029; Martin JS, 2015, APPL PHYSIOL NUTR ME, V40, P1214, DOI 10.1139/apnm-2015-0247; Martin JS, 2015, EUR J APPL PHYSIOL, V115, P2019, DOI 10.1007/s00421-015-3187-8; Martin JS, 2015, J STRENGTH COND RES, V29, P2900, DOI 10.1519/JSC.0000000000000928; Martin JS, 2016, CLIN PHYSL FUNCT IMA; Mascher H, 2008, AM J PHYSIOL-ENDOC M, V294, pE43, DOI 10.1152/ajpendo.00504.2007; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pillon NJ, 2012, ENDOCRINOLOGY, V153, P2099, DOI 10.1210/en.2011-1957; Proske U, 1999, J MUSCLE RES CELL M, V20, P433, DOI 10.1023/A:1005573625675; Raue U, 2007, J GERONTOL A-BIOL, V62, P1407, DOI 10.1093/gerona/62.12.1407; Sands WA, 2015, J STRENGTH COND RES, V29, P1263, DOI 10.1519/JSC.0000000000000412; Sands WA, 2014, J STRENGTH COND RES, V28, P1058, DOI 10.1519/JSC.0000000000000244; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siu PM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-58; THOMPSON HS, 1994, BIOCHEM BIOPH RES CO, V204, P1193, DOI 10.1006/bbrc.1994.2589; Van Thienen R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.286; WORRELL T W, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P118; Yang YF, 2006, J APPL PHYSIOL, V101, P1442, DOI 10.1152/japplphysiol.00438.2006; Zarkovic Neven, 2003, Molecular Aspects of Medicine, V24, P281, DOI 10.1016/S0098-2997(03)00023-2	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180429	10.1371/journal.pone.0180429	http://dx.doi.org/10.1371/journal.pone.0180429			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662152	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300154
J	Jia, LP; Zhang, Y; Liu, LY; Dong, HJ; Zhao, LQ; Qian, Y				Jia, Liping; Zhang, You; Liu, Liying; Dong, Huijin; Zhao, Linqing; Qian, Yuan			High prevalence of GII norovirus in hospitalized children with acute diarrhea, in Beijing	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; NORWALK VIRUS; DISEASE; EPIDEMIOLOGY; INFECTIONS; SUSCEPTIBILITY; SURVEILLANCE; TRANSMISSION; GENOTYPES; OUTBREAK	This study was addressed to the relationship between norovirus and acute diarrhea in hospitalized children, including hospital-acquired infection (HAI) and community-acquired infection (CAI) in a children's hospital in Beijing. RT-PCR was used to detect norovirus in stool specimen, followed by sequence analysis for PCR products. From 2010 to 2013, a total of 1248 specimens, including 661 from the HAI group and 587 from the CAI group were tested for norovirus. Norovirus were detected in 380 of 1248 (30.4%) diarrheal specimens. The positive rate for norovirus detection was higher in children within HAI group than CAI group (35.3%, 232/661 vs. 25.6%, 148/587), and the difference was significant (X-2 = 14.35, P<0.05). For age distribution, the highest positivity rates of norovirus were in age of 0-5 months for HAI group and 12-23 months for CAI group. In the study, 262 amplicons of the VP1 region from norovirus-positive specimens were sequenced, which showed GII. 3 and GII. 4 norovirus were the most common genotypes detected in 50.0% (n = 131) and 48.9% (n = 128) of the positive specimens, respectively. Regarding the wards distribution, GII. 3 norovirus was mainly detected in ward for neonatal diseases (36/85 in HAI group; 19/46 in CAI group), GII. 4 norovirus was mainly detected in ward for respiratory and digestive diseases (21/85 in HAI group; 15/33 in CAI group). Conclusion: The data elaborated the importance of norovirus in hospital associated infectious diarrhea. The prevalence of norovirus is higher from HAI group than CAI group, and the norovirus from the patients in CAI group could be the source of infection in HAI group.	[Jia, Liping; Zhang, You; Liu, Liying; Dong, Huijin; Zhao, Linqing; Qian, Yuan] Capital Inst Pediat, Lab Virol, Beijing Key Lab Etiol Viral Dis Children, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Qian, Y (corresponding author), Capital Inst Pediat, Lab Virol, Beijing Key Lab Etiol Viral Dis Children, Beijing, Peoples R China.	yqianbjc@263.net	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022	Jia, Liping/0000-0003-4528-7693	Beijing Municipal Science and Technology Commission [Z111107056811041]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the grant (No. Z111107056811041) from Beijing Municipal Science and Technology Commission, (http://www. bjnsf.org:8081/search/search_simp_p.jsp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Beersma MFC, 2009, J HOSP INFECT, V71, P199, DOI 10.1016/j.jhin.2008.11.018; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Esposito S, 2014, PEDIATR INFECT DIS J, V33, P314, DOI 10.1097/INF.0000000000000035; Franck KT, 2015, J INFECT DIS, V212, P881, DOI 10.1093/infdis/jiv105; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green J, 1998, J HOSP INFECT, V39, P39, DOI 10.1016/S0195-6701(98)90241-9; Green K.Y., 2001, FIELDS VIROLOGY, P949; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Jia LP, 2014, INFECT GENET EVOL, V28, P71, DOI 10.1016/j.meegid.2014.09.006; Kapikian AZ, 2000, J INFECT DIS, V181, pS295, DOI 10.1086/315584; KAPLAN JE, 1982, AM J PUBLIC HEALTH, V72, P1329, DOI 10.2105/AJPH.72.12.1329; Kesson AM, 2010, MED J AUSTRALIA, V192, P108, DOI 10.5694/j.1326-5377.2010.tb03434.x; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Li CSY, 2009, J MED VIROL, V81, P1903, DOI 10.1002/jmv.21611; Liu LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088791; Lorrot M, 2011, EUR J CLIN MICROBIOL, V30, P361, DOI 10.1007/s10096-010-1094-9; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Munir N, 2014, J MED VIROL, V86, P1203, DOI 10.1002/jmv.23774; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rasanen S, 2011, EUR J PEDIATR, V170, P1413, DOI 10.1007/s00431-011-1443-4; Rydell GE, 2011, REV MED VIROL, V21, P370, DOI 10.1002/rmv.704; Solano R, 2014, EUR J GASTROEN HEPAT, V26, P1160, DOI 10.1097/MEG.0000000000000179; Spackova M, 2010, INFECT CONT HOSP EP, V31, P1273, DOI 10.1086/657133; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2011, J CLIN MICROBIOL, V49, P602, DOI 10.1128/JCM.01443-10; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Tsai CN, 2014, J MED VIROL, V86, P335, DOI 10.1002/jmv.23728; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	35	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179839	10.1371/journal.pone.0179839	http://dx.doi.org/10.1371/journal.pone.0179839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662103	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300055
J	Agersnap, S; Larsen, WB; Knudsen, SW; Strand, D; Thomsen, PF; Hesselsoe, M; Mortensen, PB; Vralstad, T; Moller, PR				Agersnap, Sune; Larsen, William Brenner; Knudsen, Steen Wilhelm; Strand, David; Thomsen, Philip Francis; Hesselsoe, Martin; Mortensen, Peter Bondgaard; Vralstad, Trude; Moller, Peter Rask			Monitoring of noble, signal and narrow-clawed crayfish using environmental DNA from freshwater samples	PLOS ONE			English	Article							APHANOMYCES-ASTACI; ORCONECTES-LIMOSUS; POPULATION-SIZE; EDNA; TOOL; BIODIVERSITY; EUROPE; DETECT; LAKE	For several hundred years freshwater crayfish (Crustacea-Decapoda-Astacidea) have played an important ecological, cultural and culinary role in Scandinavia. However, many native populations of noble crayfish Astacus astacus have faced major declines during the last century, largely resulting from human assisted expansion of non-indigenous signal crayfish Pacifastacus leniusculus that carry and transmit the crayfish plague pathogen. In Denmark, also the non-indigenous narrow-clawed crayfish Astacus leptodactylus has expanded due to anthropogenic activities. Knowledge about crayfish distribution and early detection of non-indigenous and invasive species are crucial elements in successful conservation of indigenous crayfish. The use of environmental DNA (eDNA) extracted from water samples is a promising new tool for early and non-invasive detection of species in aquatic environments. In the present study, we have developed and tested quantitative PCR (qPCR) assays for species-specific detection and quantification of the three above mentioned crayfish species on the basis of mitochondrial cytochrome oxidase 1 (mtDNA-CO1), including separate assays for two clades of A. leptodactylus. The limit of detection (LOD) was experimentally established as 5 copies/PCR with two different approaches, and the limit of quantification (LOQ) were determined to 5 and 10 copies/PCR, respectively, depending on chosen approach. The assays detected crayfish in natural freshwater ecosystems with known populations of all three species, and show promising potentials for future monitoring of A. astacus, P. leniusculus and A. leptodactylus. However, the assays need further validation with data 1) comparing traditional and eDNA based estimates of abundance, and 2) representing a broader geographical range for the involved crayfish species.	[Agersnap, Sune; Larsen, William Brenner; Knudsen, Steen Wilhelm; Moller, Peter Rask] Univ Copenhagen, Sect Evolutionary Genom, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark; [Strand, David; Vralstad, Trude] Norwegian Vet Inst, Oslo, Norway; [Thomsen, Philip Francis] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Oster Voldgade 5-7, Copenhagen, Denmark; [Hesselsoe, Martin] Amphi Consult ApS, Niels Jernes Vej 10, Aalborg O, Denmark; [Mortensen, Peter Bondgaard] Eurofins Miljo AS, Ladelundsvej 85, Vejen, Denmark	University of Copenhagen; Norwegian Veterinary Institute; University of Copenhagen	Agersnap, S (corresponding author), Univ Copenhagen, Sect Evolutionary Genom, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark.	suneagersnap@gmail.com	Hesselsøe, Martin/AAI-1342-2021; Knudsen, Steen W/C-1072-2015; Knudsen, Steen/X-7948-2019; Thomsen, Philip Francis/AAE-9354-2019	Knudsen, Steen W/0000-0003-0428-9940; Knudsen, Steen/0000-0003-0428-9940; Thomsen, Philip Francis/0000-0002-9867-4366; Hesselsoe, Martin/0000-0001-5323-4108; Vralstad, Trude/0000-0002-5859-8039; Agersnap, Sune/0000-0001-9193-8069	Danish Innovation Foundation [104-2012-1]; University of Copenhagen; Amphi Consult ApS; Eurofins A/S; TARGET project [NFR/243907]	Danish Innovation Foundation; University of Copenhagen; Amphi Consult ApS; Eurofins A/S; TARGET project	This study was partly funded by the Danish Innovation Foundation 104-2012-1 in collaboration with University of Copenhagen, Amphi Consult ApS and Eurofins A/S. The part of this study performed at the Norwegian Veterinary Institute was funded by the TARGET project (NFR/243907). The funder provided support in the form of salaries for author SWK and research materials for authors SA, WBL, SWK, DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was partly funded by the Danish Innovation Foundation 104-2012-1 in collaboration with University of Copenhagen, Amphi Consult ApS and Eurofins Miljo A/S. The part of this study performed at the Norwegian Veterinary Institute was funded by the TARGET project (NFR/243907). Thanks to private lake owners, local municipalities, and the Danish Nature Agency for permission to sample their lakes. Thanks to Marcus A. Krag, Henrik Carl and Tore Hejl-Holm Hansen for assisting with various parts of field work.	Akhan S, 2014, GENETICA, V142, P381, DOI 10.1007/s10709-014-9782-5; [Anonymous], 2016, VERSION RAY BROWNRIG; [Anonymous], 2015, TRANSITION PLAN 9 CO; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Berdal KG, 2008, EUROPEAN FOOD RES TE; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bolat Y, 2011, AFR J BIOTECHNOL, V10, P11778; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Forsstrom T, 2016, MAR POLLUT BULL, V109, P350, DOI 10.1016/j.marpolbul.2016.05.054; Fricke R, 2016, GUIDE FISH COLLECTIO; Fuereder Leopold, 2002, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck, V89, P169; Gherardi F., 1999, CRAYFISH EUROPE ALIE; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Ikeda K, 2016, CONSERV GENET RESOUR, V8, P231, DOI 10.1007/s12686-016-0541-z; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kahle D, 2013, R J, V5, P144; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kouba A, 2014, KNOWL MANAG AQUAT EC, p05P1, DOI 10.1051/kmae/2014007; Kozubikova E, 2011, DIS AQUAT ORGAN, V97, P113, DOI 10.3354/dao02411; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Larson ER, 2017, HYDROBIOLOGIA, V800, P173, DOI 10.1007/s10750-017-3210-7; Luciani TJ, 2014, RSVGDEVICE R SVG GRA; Maguire I, 2014, INVERTEBR SYST, V28, P117, DOI 10.1071/IS13030; Maier MA, 2016, APPL ENVIRON MICROB, V82, P3868, DOI 10.1128/AEM.00087-16; Makkonen J, 2012, DIS AQUAT ORGAN, V102, P129, DOI 10.3354/dao02547; Marchesi U, 2015, JRC95544 ENGL EUR CO; Matheson C.D., 2010, OPEN ENZYME INHIB J, V3, P38, DOI [10.2174/1874940201003010038, DOI 10.2174/1874940201003010038]; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nychka D, 2015, U CORPORATION ATMOSP; Parkyn S., 2015, Freshwater crayfish: a global overview, P205; Pebesma E.J., 2005, R NEWS, V5; Pilotto F, 2008, J CRUSTACEAN BIOL, V28, P633, DOI 10.1651/07-2967.1; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; R Core Team, 2013, LANG ENV STAT COMP; Reynolds J., 2011, MANAGEMENT FRESHWATE, DOI [10.1017/CBO9781139031790, DOI 10.1017/CBO9781139031790]; Richard A.B., 2016, MAPS DRAW GEOGRAPHIC; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrimpf A, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011065; Sigsgaard EE, 2015, BIOL CONSERV; Sigsgaard EE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0004; Snow, 2016, TEACHINGDEMOS DEMONS; South A, 2011, R J, V3, P35; Souty-Grosset C, 2006, ATLAS CRAYFISH EUROP; Spens J, 2016, METHODS ECOLOGY EVOL; Strand DA, 2014, J APPL ECOL, V51, P544, DOI 10.1111/1365-2664.12218; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Vralstad T, 2009, VET MICROBIOL, V137, P146, DOI 10.1016/j.vetmic.2008.12.022; Wickham H., 2016, SCALES SCALE FUNCTIO; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Ramirez-Castillo FY, 2015, PATHOGENS, V4, P307, DOI 10.3390/pathogens4020307	76	48	49	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179261	10.1371/journal.pone.0179261	http://dx.doi.org/10.1371/journal.pone.0179261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654642	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500008
J	Huang, WP; Chou, LS				Huang, Wan-Ping; Chou, Lien-Siang			Temperature effects on life history traits of two sympatric branchiopods from an ephemeral wetland	PLOS ONE			English	Article							ANDRODIOECIOUS CLAM SHRIMP; EULIMNADIA-TEXANA; INBREEDING DEPRESSION; PHENOTYPIC PLASTICITY; METABOLIC-RATE; DAPHNIA-MAGNA; BRINE SHRIMP; GROWTH-RATE; BODY-SIZE; HYPOXIA	Temperature effects on organisms are of multiple scientific interests, such as for their life history performance and for the study of evolutionary strategies. We have cultured two sympatric branchiopod species from an ephemeral pond in northern Taiwan, Branchinella kugenumaensis and Eulimnadia braueriana, and compared their hatching rate, maturation time, sex ratio, growth of body length, survivorship, clutch size, net reproductive rate R-0, generation time T-G, and intrinsic rate of natural increase r in relation to temperature (15, 20, 25 and 30 degrees C). We found that E. braueriana had a significantly higher temperature-dependent fecundity and intrinsic population growth pattern (R-0 and r). In contrast, B. kugenumaensis reproduced much slower than E. braueriana with much lower R-0 (90-100 folds less) and r (about 10 folds less) at 15, 20 and 25 degrees C and with a double as long T-G at 20 and 25 degrees C. In addition, E. braueriana increased its chance of hermaphroditic sexual reproductive mode at higher temperature because of a significantly delayed maturation of males from hermaphrodites. In contrast, B. kugenumaensis showed no significant change in reproductive mode with temperature. This is the first study indicating a significant differentiation in life history parameters of two sympatric branchiopods mediated by temperature.	[Huang, Wan-Ping; Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan	National Taiwan University	Chou, LS (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan.	chouls@ntu.edu.tw			Yangmingshan National Park [095-301020300G-1008]; National Science Council [NSC101-2311-B002-004, MOST106-2119-M-002-028]	Yangmingshan National Park; National Science Council(Ministry of Science and Technology, Taiwan)	Funding support was received from Yangmingshan National Park (Grant: 095-301020300G-1008), and partial support from National Science Council (NSC101-2311-B002-004 and MOST106-2119-M-002-028).; We appreciate funding support from Yangmingshan National Park (Grant: 095-301020300G-1008), and partial support from National Science Council (NSC101-2311-B002-004 and MOST106-2119-M-002-028). We are grateful to Dr. Siang-Lin Huang, Chun-Chieh Wang, Chew-Yuen Lee and Jer-Yuh Liu for helping in field egg collections and indoor culturing works, and early suggestion in statistic methods by Hui-Wen Yang.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allan EL, 2006, J EXP MAR BIOL ECOL, V337, P103, DOI 10.1016/j.jembe.2006.06.006; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Bonato O, 1993, INT J ACAROL, V16, P241; Booth DT, 2007, J INSECT PHYSIOL, V53, P950, DOI 10.1016/j.jinsphys.2007.03.009; Boven L, 2008, MAR FRESHWATER RES, V59, P940, DOI 10.1071/MF08154; CARPENTER JH, 1966, LIMNOL OCEANOGR, V11, P264, DOI 10.4319/lo.1966.11.2.0264; Chapman LJ, 2000, ECOL LETT, V3, P387, DOI 10.1046/j.1461-0248.2000.00160.x; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; Crispo E, 2010, J EVOLUTION BIOL, V23, P2091, DOI 10.1111/j.1420-9101.2010.02069.x; Eder E, 1997, HYDROBIOLOGIA, V359, P13, DOI 10.1023/A:1003146416563; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Geister TL, 2008, J INSECT PHYSIOL, V54, P1253, DOI 10.1016/j.jinsphys.2008.06.002; Geister TL, 2009, J COMP PHYSIOL B, V179, P87, DOI 10.1007/s00360-008-0293-5; Glatz J, 2017, B ENTOMOL RES, V107, P39, DOI 10.1017/S0007485316000572; Goldmann T, 1999, HISTOCHEM CELL BIOL, V112, P335, DOI 10.1007/PL00007905; Guadagnoli JA, 2005, J EXP BIOL, V208, P3543, DOI 10.1242/jeb.01794; Henry Y, 2017, ECOTOX ENVIRON SAFE, V137, P42, DOI 10.1016/j.ecoenv.2016.11.011; Hollenbeck VG, 2002, BEHAV ECOL, V13, P561, DOI 10.1093/beheco/13.4.561; Huang SL, 2010, J CRUSTACEAN BIOL, V30, P366, DOI 10.1651/09-3235.1; Huang WP, 2015, J CRUSTACEAN BIOL, V35, P330, DOI 10.1163/1937240X-00002336; Isla JA, 2004, J PLANKTON RES, V26, P579, DOI 10.1093/plankt/fbh049; Jager T, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3030-8; Lamkemeyer T, 2003, CAN J ZOOL, V81, P237, DOI 10.1139/Z03-001; Landry CL, 2007, NEW PHYTOL, V176, P891, DOI 10.1111/j.1469-8137.2007.02228.x; Mondal RP, 2017, ACTA TROP, V166, P262, DOI 10.1016/j.actatropica.2016.11.034; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Olmstead AW, 2007, INT J BIOL SCI, V3, P77; Panov VE, 1998, CAN J ZOOL, V76, P1107, DOI 10.1139/cjz-76-6-1107; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Petrov B, 1997, HYDROBIOLOGIA, V359, P23, DOI 10.1023/A:1003186014746; Pirow R, 2007, FEBS J, V274, P3374, DOI 10.1111/j.1742-4658.2007.05871.x; Rogers DC, 2015, J LIMNOL, V74, P85, DOI 10.4081/jlimnol.2014.1036; Scanabissi F, 2002, HYDROBIOLOGIA, V486, P263, DOI 10.1023/A:1021371306687; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Spicer JI, 1999, J EXP BIOL, V202, P3637; SPICER JI, 1994, J EXP ZOOL, V270, P508, DOI 10.1002/jez.1402700604; Stewart AD, 2002, GENETICS, V160, P975; Theodorou K, 2006, GENET SEL EVOL, V38, P371, DOI 10.1051/gse:2006010; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Timms BV, 2016, ZOOTAXA, V4066, P351, DOI 10.11646/zootaxa.4066.4.1; Timms BV, 2005, J ROY SOC NEW ZEAL, V35, P409, DOI 10.1080/03014223.2005.9517792; Timms BV, 2002, HYDROBIOLOGIA, V486, P239, DOI 10.1023/A:1021315221708; Wang CC, 2012, J CRUSTACEAN BIOL, V32, P39, DOI 10.1163/193724011X615316; Wang LH, 2017, PESTIC BIOCHEM PHYS, V136, P64, DOI 10.1016/j.pestbp.2016.08.002; Wang YJ, 2011, MAR POLLUT BULL, V63, P201, DOI 10.1016/j.marpolbul.2011.05.035; Weeks SC, 2010, J EVOLUTION BIOL, V23, P1100, DOI 10.1111/j.1420-9101.2010.01963.x; Weeks SC, 2009, J EVOLUTION BIOL, V22, P1781, DOI 10.1111/j.1420-9101.2009.01813.x; Weeks SC, 1999, CAN J ZOOL, V77, P1402, DOI 10.1139/cjz-77-9-1402; Weeks SC, 2004, J EVOLUTION BIOL, V17, P475, DOI 10.1111/j.1420-9101.2004.00712.x; Weeks SC, 2006, INTEGR COMP BIOL, V46, P449, DOI 10.1093/icb/icj048; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhu XX, 2017, BIOTECHNOL LETT, V39, P85, DOI 10.1007/s10529-016-2223-z	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179449	10.1371/journal.pone.0179449	http://dx.doi.org/10.1371/journal.pone.0179449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654929	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500014
J	Ulfenborg, B; Karlsson, A; Riveiro, M; Ameen, C; Akesson, K; Andersson, CX; Sartipy, P; Synnergren, J				Ulfenborg, Benjamin; Karlsson, Alexander; Riveiro, Maria; Ameen, Caroline; Akesson, Karolina; Andersson, Christian X.; Sartipy, Peter; Synnergren, Jane			A data analysis framework for biomedical big data: Application on mesoderm differentiation of human pluripotent stem cells	PLOS ONE			English	Article							CARDIAC DEVELOPMENT; EXPRESSION ANALYSIS; HEART; INDUCTION; PATHWAY; ALGORITHMS; SYSTEM; GENES; ROLES; VIEW	The development of high-throughput biomolecular technologies has resulted in generation of vast omics data at an unprecedented rate. This is transforming biomedical research into a big data discipline, where the main challenges relate to the analysis and interpretation of data into new biological knowledge. The aim of this study was to develop a framework for biomedical big data analytics, and apply it for analyzing transcriptomics time series data from early differentiation of human pluripotent stem cells towards the mesoderm and cardiac lineages. To this end, transcriptome profiling by microarray was performed on differentiating human pluripotent stem cells sampled at eleven consecutive days. The gene expression data was analyzed using the five-stage analysis framework proposed in this study, including data preparation, exploratory data analysis, confirmatory analysis, biological knowledge discovery, and visualization of the results. Clustering analysis revealed several distinct expression profiles during differentiation. Genes with an early transient response were strongly related to embryonic-and mesendoderm development, for example CER1 and NODAL. Pluripotency genes, such as NANOG and SOX2, exhibited substantial downregulation shortly after onset of differentiation. Rapid induction of genes related to metal ion response, cardiac tissue development, and muscle contraction were observed around day five and six. Several transcription factors were identified as potential regulators of these processes, e.g. POU1F1, TCF4 and TBP for muscle contraction genes. Pathway analysis revealed temporal activity of several signaling pathways, for example the inhibition of WNT signaling on day 2 and its reactivation on day 4. This study provides a comprehensive characterization of biological events and key regulators of the early differentiation of human pluripotent stem cells towards the mesoderm and cardiac lineages. The proposed analysis framework can be used to structure data analysis in future research, both in stem cell differentiation, and more generally, in biomedical big data analytics.	[Ulfenborg, Benjamin; Sartipy, Peter; Synnergren, Jane] Univ Skovde, Sch Biosci, Skovde, Sweden; [Karlsson, Alexander; Riveiro, Maria] Univ Skovde, Sch Informat, Skovde, Sweden; [Ameen, Caroline; Akesson, Karolina; Andersson, Christian X.] Takara Bio Europe AB, Gothenburg, Sweden; [Sartipy, Peter] AstraZeneca, Cardiovasc & Metab Dis Global Med Dev Unit, Gothenburg Molndal, Sweden	University of Skovde; Takara Bio Inc.; AstraZeneca	Ulfenborg, B (corresponding author), Univ Skovde, Sch Biosci, Skovde, Sweden.	benjamin.ulfenborg@his.se	Riveiro, Maria/D-6238-2015; Riveiro, Maria/N-3417-2019; Synnergren, Jane/AAY-3149-2021; Synnergren, Jane/T-4247-2018; Ulfenborg, Benjamin/G-7865-2019	Riveiro, Maria/0000-0003-2900-9335; Synnergren, Jane/0000-0003-4697-0590; Synnergren, Jane/0000-0003-4697-0590; Ulfenborg, Benjamin/0000-0001-9242-4852	Knowledge Foundation [2013/89, 2014/0301, 2014/0294]	Knowledge Foundation	This study was supported by grants to JS from the Knowledge Foundation [2013/89, 2014/0301, 2014/0294]. The Knowledge Foundation provided support in the form of salaries for authors (BU, AK, MR, PS, JS). CXA, KA and CA are employed by Takara Bio Europe AB, and PS is employed by AstraZeneca. The commercial funders did contribute with data collection and analysis, as well as in preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antoine L., 2014, AMAP ANOTHER MULTIDI; Bacardit J, 2014, BIG DATA, V2, P164, DOI 10.1089/big.2014.0023; Binder H, 2015, DTSCH ARZTEBL INT, V112, P137, DOI 10.3238/arztebl.2015.0137; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Calderon D, 2016, DEV DYNAM, V245, P1130, DOI 10.1002/dvdy.24441; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Han D, 2015, J MOL NEUROSCI, V55, P109, DOI 10.1007/s12031-014-0382-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Ho PJ, 2012, CELL TRANSPLANT, V21, P801, DOI 10.3727/096368911X627507; Holzinger A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S6-I1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim DS, 2014, PLOS ONE, V9; Klein D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02178; Li FF, 2016, MOL MED REP, V14, P1459, DOI 10.3892/mmr.2016.5428; Li K, 2016, BIOCHEM BIOPH RES CO, V471, P1, DOI 10.1016/j.bbrc.2016.01.182; Louw JJ, 2015, AM J MED GENET A, V167, P1142, DOI 10.1002/ajmg.a.36989; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Mazzotta S, 2016, STEM CELL REP, V7, P764, DOI 10.1016/j.stemcr.2016.08.008; Moretti A, 2007, CELL MOL LIFE SCI, V64, P674, DOI 10.1007/s00018-007-6520-5; Nair R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042580; Piccini I, 2016, GENOM DATA, V10, P71, DOI 10.1016/j.gdata.2016.09.007; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; Rao J, 2016, CELL STEM CELL, V18, P341, DOI 10.1016/j.stem.2015.11.019; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Ruiz-Villalba A, 2016, DEV DYNAM, V245, P294, DOI 10.1002/dvdy.24372; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Satish L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0119-8; SHNEIDERMAN B, 1992, ACM T GRAPHIC, V11, P92, DOI 10.1145/102377.115768; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thies RS, 2015, DEVELOPMENT, V142, P3077, DOI [10.1242/dev.126482, 10.1242/dev.131250]; Tukey JW, 1977, EXPLORATORY DATA ANA; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu Rui, 2010, IEEE Rev Biomed Eng, V3, P120, DOI 10.1109/RBME.2010.2083647; Yang Z, 2015, INT J MOL MED, V35, P579, DOI 10.3892/ijmm.2014.2051; Zhang M, 2015, STEM CELLS, V33, P1456, DOI 10.1002/stem.1964; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179613	10.1371/journal.pone.0179613	http://dx.doi.org/10.1371/journal.pone.0179613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654683	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500020
J	Wszedybyl-Winklewska, M; Wolf, J; Swierblewska, E; Kunicka, K; Mazur, K; Gruszecki, M; Winklewski, PJ; Frydrychowski, AF; Bieniaszewski, L; Narkiewicz, K				Wszedybyl-Winklewska, Magdalena; Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Mazur, Kamila; Gruszecki, Marcin; Winklewski, Pawel J.; Frydrychowski, Andrzej F.; Bieniaszewski, Leszek; Narkiewicz, Krzysztof			Increased inspiratory resistance affects the dynamic relationship between blood pressure changes and subarachnoid space width oscillations	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CEREBROSPINAL-FLUID PULSATILITY; PIAL ARTERY PULSATION; MUELLER MANEUVER; HEALTHY-ADULTS; HEMODYNAMICS; RESPIRATION; HUMANS; FLOW; INDIVIDUALS	Background and objective Respiration is known to affect cerebrospinal fluid (CSF) movement. We hypothesised that increased inspiratory resistance would affect the dynamic relationship between blood pressure (BP) changes and subarachnoid space width (SAS) oscillations. Methods Experiments were performed in a group of 20 healthy volunteers undergoing controlled intermittent Mueller Manoeuvres (the key characteristic of the procedure is that a studied person is subjected to a controlled, increased inspiratory resistance which results in marked potentiation of the intrathoracic negative pressure). BP and heart rate (HR) were measured using continuous finger-pulse photoplethysmography; oxyhaemoglobin saturation with an ear-clip sensor; end-tidal CO2 with a gas analyser; cerebral blood flow velocity (CBFV), pulsatility and resistive indices with Doppler ultrasound. Changes in SAS were recorded with a new method i.e. near-infrared transillumination/backscattering sounding. Wavelet transform analysis was used to assess the BP and SAS oscillations coupling. Results Initiating Mueller manoeuvres evoked cardiac SAS component decline (-17.8%, P<0.001), systolic BP, diastolic BP and HR increase (+6.3%, P<0.001; 6.7%, P<0.001 and +2.3%, P<0.05, respectively). By the end of Mueller manoeuvres, cardiac SAS component and HR did not change (+2.3% and 0.0%, respectively; both not statistically significant), but systolic and diastolic BP was elevated (+12.6% and +8.9%, respectively; both P<0.001). With reference to baseline values there was an evident decrease in wavelet coherence between BP and SAS oscillations at cardiac frequency in the first half of the Mueller manoeuvres (-32.3%, P<0.05 for left hemisphere and -46.0%, P<0.01 for right hemisphere) which was followed by subsequent normalization at end of the procedure (+3.1% for left hemisphere and +23.1% for right hemisphere; both not statistically significant). Conclusions Increased inspiratory resistance is associated with swings in the cardiac contribution to the dynamic relationship between BP and SAS oscillations. Impaired cardiac performance reported in Mueller manoeuvres may influence the pattern of cerebrospinal fluid pulsatility.	[Wszedybyl-Winklewska, Magdalena; Winklewski, Pawel J.; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Narkiewicz, Krzysztof] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Wolf, Jacek; Narkiewicz, Krzysztof] St Annes Univ Hosp Brno FNUSA, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Mazur, Kamila] Gdansk Univ Technol, Fac Elect Telecommun & Informat, Dept Biomed Engn, Gdansk, Poland; [Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Winklewski, Pawel J.] Pomeranian Univ Slupsk, Inst Hlth Sci, Slupsk, Poland; [Bieniaszewski, Leszek] Med Univ Gdansk, Ctr Med Simulat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; St Anne's University Hospital Brno (FNUSA-ICRC); Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Wszedybyl-Winklewska, M (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	magdalenawinklewska@gumed.edu.pl	Bieniaszewski, Leszek/U-9635-2018	Bieniaszewski, Leszek/0000-0001-6237-521X; Wszedybyl-Winklewska, Magdalena/0000-0001-5180-7224; Gruszecki, Marcin/0000-0003-1709-3939; Narkiewicz, Krzysztof/0000-0001-5949-5018; Winklewski, Pawel/0000-0002-1671-2163	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; REGPOT ICRC-ERA Human Bridge grant [316345]	European Regional Development Fund - Project FNUSA-ICRC; REGPOT ICRC-ERA Human Bridge grant	Drs. Jacek Wolf, and Krzysztof Narkiewicz are supported by the European Regional Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the REGPOT ICRC-ERA Human Bridge grant No. 316345 provided by the EU.	Bateman GA, 2002, NEURORADIOLOGY, V44, P740, DOI 10.1007/s00234-002-0812-0; Beggs CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153960; Beggs CB, 2016, J NEUROIMAGING, V26, P136, DOI 10.1111/jon.12249; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; Chen LY, 2015, NEUROIMAGE, V122, P281, DOI 10.1016/j.neuroimage.2015.07.073; Clemson PT, 2014, PHYS REP, V542, P297, DOI 10.1016/j.physrep.2014.04.001; CONDOS WR, 1987, CIRCULATION, V76, P1020, DOI 10.1161/01.CIR.76.5.1020; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037529; GREITZ D, 1993, ACTA RADIOL, V34, P321; GUNTHEROTH WG, 1967, CIRC RES, V20, P381, DOI 10.1161/01.RES.20.4.381; HANLY PJ, 1989, CHEST, V95, P735, DOI 10.1378/chest.95.4.735; Jolly TAD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00782; Konecny T, 2014, CATHETER CARDIO INTE, V84, P1138, DOI 10.1002/ccd.25433; Koshino Y, 2010, CIRC-CARDIOVASC IMAG, V3, P282, DOI 10.1161/CIRCIMAGING.109.901561; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; Magnano C, 2012, J MAGN RESON IMAGING, V36, P825, DOI 10.1002/jmri.23730; Orban M, 2008, AM J CARDIOL, V102, P1557, DOI 10.1016/j.amjcard.2008.07.050; Reinhard M, 2000, CLIN PHYSIOL, V20, P292; ROBOTHAM JL, 1979, J APPL PHYSIOL, V47, P1295, DOI 10.1152/jappl.1979.47.6.1295; SCHRIJEN F, 1975, PFLUG ARCH EUR J PHY, V355, P205, DOI 10.1007/BF00583684; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; SOMERS VK, 1993, J AUTONOM NERV SYST, V44, P253, DOI 10.1016/0165-1838(93)90038-V; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135429; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135751; Wszedybyl-Winklewska M, 2017, PLOS ONE UNPUB; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179503	10.1371/journal.pone.0179503	http://dx.doi.org/10.1371/journal.pone.0179503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654638	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500016
J	Abebe, M; Ali, I; Ayele, S; Overbo, J; Aseffa, A; Mihret, A				Abebe, Meseret; Ali, Ibrahim; Ayele, Samuel; Overbo, Johakim; Aseffa, Abraham; Mihret, Adane			Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia	PLOS ONE			English	Article							BLOOD-DONORS; HIGHLY PREVALENT; VIRAL-HEPATITIS; CLINICAL-COURSE; HEV INFECTION; ANTIBODIES; FRANCE; EPIDEMIOLOGY; AFRICA	Background Hepatitis E virus (HEV) is highly endemic in several African countries with high mortality rate among pregnant women. The prevalence of antibodies to HEV in Ethiopian pregnant women is not known. The study was conducted to investigate the prevalence of anti-HEV IgG and anti-HEV IgM among pregnant women. Material and methods A total of 386 serum samples were collected from pregnant women between April 2014 to January 2015 in Gandhi Memorial Hospital and four selected Health centers in Addis Ababa, Ethiopia. Data were collected for socio demographic characteristics using a structured questionnaire. Serum samples were examined for anti-HEV IgG and anti-HEV IgM using ELISA. The association of anti-HEV status with risk factors was assessed. Factors demonstrating significant association in bivariate analysis were included in multivariate logistic regression models. Analyses were performed using SPSS version 21. Results Anti-HEV IgG antibody was detected in 122 (31.6%) women and two women (0.5%) were positive for anti-HEV IgM from the total 386 women. Age and educational status had statistically significant association with HEV infection. There was no significant association between anti-HEV antibody seroprevalence rate with trimester, parity, HIV status and other risk factors. Conclusion In this study we found a high seroprevalence rate of anti-HEV IgG among pregnant women in Addis Ababa Ethiopia. Preventive measures like improvement of education and creating awareness may reduce the risk in pregnant women. Moreover nationwide surveillance of HEV especially in rural setting should be conducted to establish a national estimate and validate our findings.	[Abebe, Meseret; Ayele, Samuel; Aseffa, Abraham; Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Ali, Ibrahim] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Overbo, Johakim] Norwegian Inst Publ Hlth, Oslo, Norway	Addis Ababa University; Norwegian Institute of Public Health (NIPH)	Mihret, A (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	adane_mihret@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Mihret, Adane/0000-0003-3183-4772				Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Al-Tayeb ZA, 2004, AM J RECOMMUNICATI, V2; Begum N, 2009, INDIAN J MED RES, V130, P709; Blut Arbeitskreis, 2009, TRANSFUS MED HEMOTH, V36, P40, DOI DOI 10.1159/; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Huang F, 2013, BRAZ J INFECT DIS, V17, P716, DOI 10.1016/j.bjid.2013.02.006; Johargy AK, 2013, J PAK MED ASSOC, V63, P185; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kar P, 2012, MEDICINE, V22, P459; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Lindemann MLM, 2010, J MED VIROL, V82, P1666, DOI 10.1002/jmv.21840; Mousavi SSB, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.6993; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Renou C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-68; Shukla S, 2011, JBIOSCI TECH, V2, P279; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Tabarraei A, 2011, GORGAN IRAN N E CASP, P162; Teo CG, 2012, EPIDEMIOL INFECT, V140, P767, DOI 10.1017/S0950268811002925; Traore KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048125; TSEGA E, 1992, CLIN INFECT DIS, V14, P961, DOI 10.1093/clinids/14.4.961; Vasickova P, 2007, VET MED-CZECH, V52, P365, DOI 10.17221/1999-VETMED; World Health Organization, 2002, HEP E DEP COMM DIS S	29	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180078	10.1371/journal.pone.0180078	http://dx.doi.org/10.1371/journal.pone.0180078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650982	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000404537300039
J	Nagano, H; Kishaba, T; Nei, Y; Yamashiro, S; Takara, H				Nagano, Hiroaki; Kishaba, Tomoo; Nei, Yuichirou; Yamashiro, Shin; Takara, Hiroaki			Indications of airway stenting for severe central airway obstruction due to advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRACHEOBRONCHIAL STENOSIS; METAL STENTS; LUNG-CANCER; MANAGEMENT	Background Management of severe central airway obstruction due to advanced cancer is a medical and technical challenge. The impact of airway stenting on the clinical outcome of such patients is unclear. Method This single-center, retrospective study evaluated 21 patients who underwent airway stenting for advanced cancer. We examined predictors of the post-stenting mortality, including age, serum albumin, tracheal diameter, smoking, opioid use, respiratory failure, and performance status (PS). We also compared survival according to the PS. Results The mean survival period after stenting was 85.2 days. On univariate analysis, age, albumin, PS before airway stenting, respiratory failure, admission route, and PS grade were the candidates as possible predictors of prognosis after the procedure. On multivariate analysis, PS before airway stenting was identified as possible predictor of prognosis after stenting (HR 1.6180, 95% CI 0.969 to 2.7015, p = 0.066). The mean survival period after stenting was significantly longer in the good PS group, compared to the poor PS group (147.8 days vs. 38.2 days, p = 0.0346). Conclusion Airway stenting for advanced cancer may be more effective for patients in good general condition than in those with poor performance status.	[Nagano, Hiroaki; Kishaba, Tomoo; Nei, Yuichirou; Yamashiro, Shin] Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan; [Takara, Hiroaki] Okinawa Chubu Hosp, Dept Radiol, Uruma, Okinawa, Japan; [Nagano, Hiroaki] 281 Miyazato, Uruma City, Okinawa, Japan	Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital	Nagano, H (corresponding author), Okinawa Chubu Hosp, Dept Resp Med, Uruma, Okinawa, Japan.; Nagano, H (corresponding author), 281 Miyazato, Uruma City, Okinawa, Japan.	hiroakinoko322violin@gmail.com		Nagano, Hiroaki/0000-0001-5587-5662				Agrafiotis M, 2009, RESPIRATION, V78, P69, DOI 10.1159/000213244; Bolliger CT, 2002, EUR RESPIR J, V19, P356, DOI 10.1183/09031936.02.00204602; Conacher ID, 2003, BRIT J ANAESTH, V90, P367, DOI 10.1093/bja/aeg053; Davis N, 2006, BRIT J ANAESTH, V96, P132, DOI 10.1093/bja/aei267; Eon Ji, 2013, KOREAN J THORACIC CA, V46, P80; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Fabrice Paganin, 2008, PLOS ONE, V3, P1; Gang Ma, 2008, CHIN J CANCER, V27, P153; Hardavella G, 2015, BREATHE, V11, P203, DOI 10.1183/20734735.008415; Herth FJF, 2010, EUR RESPIR J, V36, P1370, DOI 10.1183/09031936.00049809; Hong Y, 2013, J CRIT CARE, V28, P669, DOI 10.1016/j.jcrc.2013.05.020; Jonathan Puchalski, 2012, PAKISTAN J CHEST MED, V18, P38; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Keisuke Matsuo, 2009, J JAPAN SOC RESP END, V29, P26; Masamichi Takagi, 2006, OURNAL JAPANESE RESP, V44, P997; McGrath EE, 2012, ARCH BRONCONEUMOL, V48, P43, DOI 10.1016/j.arbres.2011.09.008; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Puchalski J, 2013, CLIN CHEST MED, V34, P557, DOI 10.1016/j.ccm.2013.05.002; Saji H, 2010, INTERACT CARDIOV TH, V11, P425, DOI 10.1510/icvts.2010.238196; Wallace Akerley, 2015, NATL COMPREHENSIVE C, P32; Wilson GE, 1996, THORAX, V51, P248, DOI 10.1136/thx.51.3.248; Wood DE, 2003, ANN THORAC SURG, V76, P167, DOI 10.1016/S0003-4975(03)00033-X; Zakaluzny SA, 2003, OTOLARYNG HEAD NECK, V128, P478, DOI 10.1016/S0194-5998(03)00002-0	24	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179795	10.1371/journal.pone.0179795	http://dx.doi.org/10.1371/journal.pone.0179795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651011	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300024
J	Vanneste, S; Ost, J; Van Havenbergh, T; De Ridder, D				Vanneste, Sven; Ost, Jan; Van Havenbergh, Tony; De Ridder, Dirk			Resting state electrical brain activity and connectivity in fibromyalgia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ELECTROMAGNETIC TOMOGRAPHY; ANTERIOR THALAMUS; CLINICAL PAIN; PHASE SYNCHRONY; INSULAR CORTEX; LOCALIZATION; STIMULATION; EEG; NETWORK	The exact mechanism underlying fibromyalgia is unknown, but increased facilitatory modulation and/or dysfunctional descending inhibitory pathway activity are posited as possible mechanisms contributing to sensitization of the central nervous system. The primary goal of this study is to identify a fibromyalgia neural circuit that can account for these abnormalities in central pain. The second goal is to gain a better understanding of the functional connectivity between the default and the executive attention network (salience network plus dorsal lateral prefrontal cortex) in fibromyalgia. We examine neural activity associated with fibromyalgia (N = 44) and compare these with healthy controls (N = 44) using resting state source localized EEG. Our data support an important role of the pregenual anterior cingulate cortex but also suggest that the degree of activation and the degree of integration between different brain areas is important. The inhibition of the connectivity between the dorsal lateral prefrontal cortex and the posterior cingulate cortex on the pain inhibitory pathway seems to be limited by decreased functional connectivity with the pregenual anterior cingulate cortex. Our data highlight the functional dynamics of brain regions integrated in brain networks in fibromyalgia patients.	[Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Ost, Jan; Van Havenbergh, Tony] Sint Augustinus Hosp Antwerp, BRAI2N, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Sect Neurosurg, Dept Surg Sci, Dunedin, New Zealand	University of Texas System; University of Texas Dallas; University of Otago	Vanneste, S (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	sven.vanneste@utdallas.edu		Vanneste, Sven/0000-0003-1513-5752				[Anonymous], 1950, PSYCHOSURGERY; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Chen Andrew C. N., 1994, Brain Topography, V7, P129, DOI 10.1007/BF01186771; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Congedo M., 2002, EUREKA VERSION 3 0 C; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Domnick Claudia, 2009, J Pain Res, V2, P49; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Fallon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159198; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Huber MT, 2006, EXP BRAIN RES, V173, P14, DOI 10.1007/s00221-006-0366-1; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Ichesco E, 2014, J PAIN, V15, P815, DOI 10.1016/j.jpain.2014.04.007; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Llinas RR, 2009, PHILOS T R SOC B, V364, P1301, DOI 10.1098/rstb.2008.0309; Loggia ML, 2014, ARTHRITIS RHEUMATOL, V66, P203, DOI [10.1002/art.38396, 10.1002/art.38191]; Martinez-Lavin M, 2009, RHEUM DIS CLIN N AM, V35, P285, DOI 10.1016/j.rdc.2009.05.005; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Moriarty O, 2012, J NEUROSCI METH, V204, P1, DOI 10.1016/j.jneumeth.2011.10.024; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Napadow V, 2012, ARTHRITIS RHEUM-US, V64, P2398, DOI 10.1002/art.34412; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Nir RR, 2010, BRAIN RES, V1344, P77, DOI 10.1016/j.brainres.2010.05.004; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 2007, 07103341 ARXIV; Pereira EAC, 2014, BRIT J NEUROSURG, V28, P471, DOI 10.3109/02688697.2013.857006; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rahm B, 2015, COMPR PSYCHIAT, V59, P80, DOI 10.1016/j.comppsych.2015.02.005; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Roelofs J, 2003, PAIN, V101, P299, DOI 10.1016/S0304-3959(02)00338-X; Rotge J., 2014, SOC COGN AFFECT NEUR; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Schacter DL, 2012, AM PSYCHOL, V67, P603, DOI 10.1037/a0029869; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Schmidt-Wilcke T, 2014, PAIN MED, V15, P1346, DOI 10.1111/pme.12460; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Truini A, 2016, CLIN EXP RHEUMATOL, V34, pS129; Vanneste S., 2010, CLIN NEUROPHYSIOL; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, NAT REV RHEUMATOL, V9, P751, DOI 10.1038/nrrheum.2013.96; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zaehle T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-63; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	82	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178516	10.1371/journal.pone.0178516	http://dx.doi.org/10.1371/journal.pone.0178516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2KD	28650974	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300047
J	Panzuto, F; Cicchese, N; Partelli, S; Rinzivillo, M; Capurso, G; Merola, E; Manzoni, M; Pucci, E; Iannicelli, E; Pilozzi, E; Rossi, M; Doglioni, C; Falconi, M; Delle Fave, G				Panzuto, Francesco; Cicchese, Noemi; Partelli, Stefano; Rinzivillo, Maria; Capurso, Gabriele; Merola, Elettra; Manzoni, Marco; Pucci, Eugenio; Iannicelli, Elsa; Pilozzi, Emanuela; Rossi, Michele; Doglioni, Claudio; Falconi, Massimo; Delle Fave, Gianfranco			Impact of Ki67 re-assessmentat time of disease progression in patients with pancreatic neuroendocrine neoplasms	PLOS ONE			English	Article							TUMORS; GUIDELINES; METASTASES; MANAGEMENT; INDEX	Background Although re-assessment of proliferative activity by K67 evaluation during the course of neuroendocrine neoplasms (NENs) is recommended in selected patients, its impact on patients' management is not clear due to the lack of data supporting this practice. Aim To investigate Ki67 change at time of progressive disease (PD) in entero-pancreatic NENs (EP-NENs). Patients and methods Retrospective analysis of sporadic EP-NENs which received histological re-assessment after PD once radiologically documented. Results Forty-three patients were evaluated, including 24 pancreatic NENs (PNENs), and 19 small intestine NENs (SI-NENs). At time of initial histological evaluation, 19 patients had grade 1 (G1) NETs (44.2%), and 24 grade 2 (G2) NETs (55.8%), overall median Ki67 being 3% (range 1%-20%). At time of PD, 13 patients had G1 NETs (30.2%), 26 G2 NETs (60.5%), and 4 had grade 3 (G3) NECs (9.3%), thus resulting in a significant median Ki67 increase (8%, range 1%-70%; p = 0.0006), and a G upgrading in 12 patients (27.9%). A statistically significant Ki67 increase and G grading change at time of PD was observed in PNENs (p = 0.0005 and p = 0.028, respectively). Conversely, no statistically significant change occurred in non-PNENs. Conclusions In PNENs with documented PD, Ki67 increase occurs in a significant proportion of patients, providing useful information necessary to choose appropriate therapeutic options.	[Panzuto, Francesco; Cicchese, Noemi; Rinzivillo, Maria; Capurso, Gabriele; Merola, Elettra; Delle Fave, Gianfranco] Sapienza Univ Rome, St Andrea Hosp, Digest & Liver Dis Unit, Rome, Italy; [Partelli, Stefano; Falconi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Pancreat Surg Unit, Milan, Italy; [Manzoni, Marco] San Raffaele Hosp Sci Inst, Dept Endocrinol & Internal Med, Milan, Italy; [Pucci, Eugenio; Pilozzi, Emanuela] Sapienza Univ Rome, St Andrea Hosp, Dept Expt Med & Pathol, Rome, Italy; [Iannicelli, Elsa; Rossi, Michele] Sapienza Univ Rome, St Andrea Hosp, Dept Radiol, Rome, Italy; [Doglioni, Claudio] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Pathol, Milan, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Panzuto, F (corresponding author), Sapienza Univ Rome, St Andrea Hosp, Digest & Liver Dis Unit, Rome, Italy.	francesco.panzuto@ospedalesantandrea.it	Manzoni, Marco Federico/AAB-1738-2021; Panzuto, Francesco/Y-2882-2019; merola, elettra/AAJ-1189-2020; Capurso, Gabriele/AAB-1389-2019; PILOZZI, Emanuela/AAC-1854-2022; Partelli, Stefano/K-3787-2018	Panzuto, Francesco/0000-0003-2789-4289; merola, elettra/0000-0001-9553-7684; Capurso, Gabriele/0000-0002-0019-8753; PILOZZI, Emanuela/0000-0002-7110-9172; Partelli, Stefano/0000-0001-8938-6170; Falconi, Massimo/0000-0001-9654-7243	AIRC [IG 2015, Id 17177]	AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC grant IG 2015, Id 17177.	Coriat R, 2016, ONCOLOGIST, V21, P1191, DOI 10.1634/theoncologist.2015-0476; Frilling A, 2014, LANCET ONCOL, V15, pE8, DOI 10.1016/S1470-2045(13)70362-0; Grillo F, 2016, NEUROENDOCRINOLOGY, V103, P452, DOI 10.1159/000439434; Miller HC, 2014, WORLD J SURG, V38, P1353, DOI 10.1007/s00268-014-2451-0; Oberg K, 2012, ANN ONCOL, V23, P124, DOI 10.1093/annonc/mds295; Panzuto F, 2005, ENDOCR-RELAT CANCER, V12, P1083, DOI 10.1677/erc.1.01017; Panzuto F, 2012, NEUROENDOCRINOLOGY, V96, P32, DOI 10.1159/000334038; Panzuto F, 2011, J CLIN ONCOL, V29, P2372, DOI 10.1200/JCO.2010.33.0688; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Pavel M, 2016, NEUROENDOCRINOLOGY, V103, P172, DOI 10.1159/000443167; Rindi G, 2012, JNCI-J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Rindi G., 2010, WHO CLASSIFICATION T, pS13; Rindi G, 2011, DIGEST LIVER DIS, V43, pS356, DOI 10.1016/S1590-8658(11)60591-4; Simsek DH, 2014, J NUCL MED, V55, P1811, DOI 10.2967/jnumed.114.142224; Singh S, 2014, EJSO-EUR J SURG ONC, V40, P1517, DOI 10.1016/j.ejso.2014.06.016; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	16	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179445	10.1371/journal.pone.0179445	http://dx.doi.org/10.1371/journal.pone.0179445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644861	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100015
J	Wang, J; Wang, ZL; Du, XF; Yang, HQ; Han, F; Han, YH; Yuan, F; Zhang, LY; Peng, SZ; Guo, EH				Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Han, Fang; Han, Yuanhuai; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu			A high-density genetic map and QTL analysis of agronomic traits in foxtail millet [Setaria italica (L.) P. Beauv.] using RAD-seq	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MARKERS; CONSTRUCTION; SEQUENCE; DNA; MODEL; RICE; LOCI; DIVERSITY; VIRIDIS	Foxtail millet (Setaria italica), a very important grain crop in China, has become a new model plant for cereal crops and biofuel grasses. Although its reference genome sequence was released recently, quantitative trait loci (QTLs) controlling complex agronomic traits remains limited. The development of massively parallel genotyping methods and next-generation sequencing technologies provides an excellent opportunity for developing single-nucleotide polymorphisms (SNPs) for linkage map construction and QTL analysis of complex quantitative traits. In this study, a high-throughput and cost-effective RAD-seq approach was employed to generate a high-density genetic map for foxtail millet. A total of 2,668,587 SNP loci were detected according to the reference genome sequence; meanwhile, 9,968 SNP markers were used to genotype 124 F-2 progenies derived from the cross between Hongmiaozhangu and Changnong35; a high-density genetic map spanning 1648.8 cM, with an average distance of 0.17 cM between adjacent markers was constructed; 11 major QTLs for eight agronomic traits were identified; five co-dominant DNA markers were developed. These findings will be of value for the identification of candidate genes and marker-assisted selection in foxtail millet.	[Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu] Shanxi Acad Agr Sci, Millet Res Inst, Changzhi, Shanxi, Peoples R China; [Wang, Jun; Wang, Zhilan; Du, Xiaofen; Yang, Huiqing; Yuan, Feng; Zhang, Linyi; Peng, Shuzhong; Guo, Erhu] Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China; [Han, Fang] Res Inst Agr Sci Yanan, Yanan, Shaanxi, Peoples R China; [Han, Yuanhuai] Shanxi Agr Univ, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Wang, J; Guo, EH (corresponding author), Shanxi Acad Agr Sci, Millet Res Inst, Changzhi, Shanxi, Peoples R China.; Wang, J; Guo, EH (corresponding author), Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China.	128wan@163.com; guoerhu2003@163.com			Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences [2015ZZCX-09, 2016ZZCX-9]; Shanxi Province Youth Fund [2015021143]; Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences [ZDSYS1504]; Chinese Agricultural Research System [CRRS-07]	Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences; Shanxi Province Youth Fund; Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences; Chinese Agricultural Research System	This research was supported by the Science and Technology Independent Innovation Ability Upgrading Project of Shanxi Province Academy of Agricultural Sciences (2015ZZCX-09,2016ZZCX-9), Shanxi Province Youth Fund (2015021143), the Agricultural Science and Technology Innovation Research Project of Shanxi Academy of Agricultural Sciences (ZDSYS1504), and the Chinese Agricultural Research System (CRRS-07).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barakat MN, 2013, BIOL PLANTARUM, V57, P79, DOI 10.1007/s10535-012-0138-7; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Fang XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2628-z; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Herlina L, 2016, MAKARA J SCI, V20, P17, DOI 10.7454/mss.v20i1.5657; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0503-9; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li W, 2016, PHYSIOL PLANTARUM, V157, P24, DOI 10.1111/ppl.12405; Liu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071067; Liu MinXuan, 2013, Acta Agronomica Sinica, V39, P398, DOI 10.3724/SP.J.1006.2013.00398; Liu SanCai, 2009, Scientia Agricultura Sinica, V42, P3812; Liu XT, 2016, J EXP BOT, V67, P3237, DOI 10.1093/jxb/erw135; MARKLUND S, 1995, ANIM GENET, V26, P193, DOI 10.1111/j.1365-2052.1995.tb03162.x; Masumoto H, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0481-z; Mauro-Herrera M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151346; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Obidiegwu ON, 2013, GENES GENOM, V35, P609, DOI 10.1007/s13258-013-0110-8; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Sato K, 2013, MOL BREEDING, V31, P675, DOI 10.1007/s11032-012-9825-5; [邵丽华 Shao Lihua], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1265; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tasma IM, 2016, JURNAL AGROBIOGEN, V4, P1; Tomaszewski C, 2012, PLANT BREEDING, V131, P345, DOI 10.1111/j.1439-0523.2011.01944.x; Wang HaiGang, 2016, Acta Agronomica Sinica, V42, P19; [王晓宇 Wang Xiaoyu], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P871; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xue CX, 2016, CROP SCI, V56, P95, DOI 10.2135/cropsci2015.05.0331; Yadav CB, 2015, DNA RES, V22, P79, DOI 10.1093/dnares/dsu039; Zeng DL, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.31; Zhai HJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01617; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78	61	31	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179717	10.1371/journal.pone.0179717	http://dx.doi.org/10.1371/journal.pone.0179717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644843	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100035
J	Bernaudo, S; Khazai, S; Honarparvar, E; Kopteva, A; Peng, C				Bernaudo, Stefanie; Khazai, Shahin; Honarparvar, Eilyad; Kopteva, Alina; Peng, Chun			Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; KAPPA-B-ALPHA; PHOSPHORYLATION SITES; DOWN-REGULATION; EXPRESSION; PROTEIN; KINASE; UBIQUITIN; ACTIVATION; PATHWAY	Cyclin G2 (CCNG2) is an atypical cyclin that functions to inhibit cell cycle progression and is often dysregulated in human cancers. We have previously shown that cyclin G2 is highly unstable and can be degraded through the ubiquitin/proteasome pathway. Furthermore, cyclin G2 contains a PEST domain, which has been suggested to act as a signal for degradation by multiple proteases. In this study, we determined if calpains, a family of calciumdependent proteases, are also involved in cyclin G2 degradation. The addition of calpain inhibitors or silencing of calpain expression by siRNAs strongly enhanced cyclin G2 levels. On the other hand, incubation of cell lysates with purified calpains or increasing the intracellular calcium concentration resulted in a decrease in cyclin G2 levels. Interestingly, the effect of calpain was found to be dependent on the phosphorylation of cyclin G2. Using a kinase inhibitor library, we found that Epidermal Growth Factor (EGF) Receptor is involved in cyclin G2 degradation and treatment with its ligand, EGF, induced cyclin G2 degradation. In addition, the presence of the PEST domain is necessary for calpain and EGF action. When the PEST domain was completely removed, calpain or EGF treatment failed to trigger degradation of cyclin G2. Taken together, these novel findings demonstrate that EGF-induced, calpain-mediated proteolysis contributes to the rapid destruction of cyclin G2 and that the PEST domain is critical for EGF/calpain actions.	[Bernaudo, Stefanie; Khazai, Shahin; Honarparvar, Eilyad; Kopteva, Alina; Peng, Chun] York Univ, Dept Biol, Toronto, ON, Canada; [Peng, Chun] York Univ, Fac Sci, Ctr Res Biomol Interact, Toronto, ON, Canada	York University - Canada; York University - Canada	Peng, C (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.; Peng, C (corresponding author), York Univ, Fac Sci, Ctr Res Biomol Interact, Toronto, ON, Canada.	cpeng@yorku.ca			Canadian Institutes of Health Research [MOP-89931]; Ontario Graduate Scholarship; National Science and Engineering Research Council of Canada Graduate Studentship; York University Susan Mann Dissertation Scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Science and Engineering Research Council of Canada Graduate Studentship; York University Susan Mann Dissertation Scholarships	This study was supported by an operating grant from Canadian Institutes of Health Research to CP (MOP-89931). SB was supported by Ontario Graduate Scholarship, The National Science and Engineering Research Council of Canada Graduate Studentship, and The York University Susan Mann Dissertation Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, MOL CANCER RES, V10, P636, DOI 10.1158/1541-7786.MCR-11-0502; Alberti C, 2012, ONCOGENE, V31, P4139, DOI 10.1038/onc.2011.572; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bernaudo S, 2016, ONCOGENE, V35, P4828, DOI 10.1038/onc.2016.65; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheng C, 2016, MOL MED REP, V13, P3763, DOI 10.3892/mmr.2016.5037; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Fan X., 2014, PLOS ONE, V9; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gali-Muhtasib H, 2002, CURR CANCER DRUG TAR, V2, P309, DOI 10.2174/1568009023333809; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jeong KJ, 2013, MOL ONCOL, V7, P121, DOI 10.1016/j.molonc.2012.10.001; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Liu J, 2004, WORLD J GASTROENTERO, V10, P1357; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ohno S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39091; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Schrevel M, 2011, MODERN PATHOL, V24, P720, DOI 10.1038/modpathol.2010.239; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; So WK, 2015, FEBS LETT, V589, P302, DOI 10.1016/j.febslet.2014.12.012; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Wang S, 2016, MOL MED REP, V13, P273, DOI 10.3892/mmr.2015.4557; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Yin GZ, 2016, ONCOL REP, V36, P1111, DOI 10.3892/or.2016.4876; Zimmermann M, 2016, CELL CYCLE, V15, P3278, DOI 10.1080/15384101.2016.1243189	54	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179906	10.1371/journal.pone.0179906	http://dx.doi.org/10.1371/journal.pone.0179906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640887	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800081
J	Casonato, A; Daidone, V; Galletta, E; Bertomoro, A				Casonato, Alessandra; Daidone, Viviana; Galletta, Eva; Bertomoro, Antonella			Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue	PLOS ONE			English	Article							1-DESAMINO-8-D-ARGININE VASOPRESSIN DDAVP; IIB VONWILLEBRANDS DISEASE; PLATELET-AGGREGATION; THROMBOCYTOPENIA; BINDING; RISTOCETIN; PLASMA; MUTATIONS; PATIENT; PSEUDOTHROMBOCYTOPENIA	Most, but not all patients with type 2B von Willebrand disease (VWD) D which features gain-of- function mutations in the A1 domain of von Willebrand factor (VWF) D have no circulating large VWF multimers. Similarities and differences were analysed in 33 type 2B patients, 12 with a normal and 21 with an abnormal multimer pattern, to see whether they should be considered separately. The minimum aggregating dose of ristocetin was similarly reduced in both patient groups, and modulated by their underlying VWF mutations. Platelet VWF content was normal in all patients lacking in large multimers, but sometimes reduced in those with a normal multimer pattern. All the former patients and none of the latter had persistent or transient thrombocytopenia. A short VWF half-life (affecting plasma VWF levels) was seen in both groups, but more pronounced in patients without large multimers. Bleeding scores were also high in all patients, but more so in those without large multimers, apparently regardless of their platelet count. The marked phenotypic heterogeneity of type 2B VWD concerns not only patients' VWF multimer pattern, but also their bleeding risk, and consequently their appropriate treatment too. Hence the need to clearly distinguish between type 2B VWD with normal or abnormal VWF multimers.	[Casonato, Alessandra; Daidone, Viviana; Galletta, Eva] Univ Padua, Dept Med, Thrombohaemorrhag Disorders Unit, Padua, Italy; [Bertomoro, Antonella] Univ Padua, Dept Med, Internal Med, Padua, Italy	University of Padua; University of Padua	Casonato, A (corresponding author), Univ Padua, Dept Med, Thrombohaemorrhag Disorders Unit, Padua, Italy.	sandra.casonato@unipd.it			Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(60%, 2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASONATO A, 1991, BLOOD COAGUL FIBRIN, V2, P33, DOI 10.1097/00001721-199102000-00005; CASONATO A, 1994, BLOOD COAGUL FIBRIN, V5, P959, DOI 10.1097/00001721-199412000-00013; Casonato A, 1997, J LAB CLIN MED, V129, P251, DOI 10.1016/S0022-2143(97)90147-5; CASONATO A, 1989, BLOOD, V74, P2028; CASONATO A, 1990, EUR J HAEMATOL, V45, P36; CASONATO A, 1990, THROMB HAEMOSTASIS, V64, P117; Casonato A, 1999, THROMB HAEMOSTASIS, V81, P224; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Casonato A, 2015, BRIT J HAEMATOL, V171, P845, DOI 10.1111/bjh.13785; Casonato A, 2010, HAEMATOL-HEMATOL J, V95, P1366, DOI 10.3324/haematol.2009.019927; COONEY KA, 1991, J CLIN INVEST, V87, P1227, DOI 10.1172/JCI115123; DEMARCO L, 1987, J CLIN INVEST, V80, P475, DOI 10.1172/JCI113095; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; GRALNICK HR, 1981, BLOOD, V58, P387; HOLMBERG L, 1993, J CLIN INVEST, V91, P2169, DOI 10.1172/JCI116443; HOLMBERG L, 1983, NEW ENGL J MED, V309, P816, DOI 10.1056/NEJM198310063091402; HOWARD MA, 1973, BLOOD, V41, P687, DOI 10.1182/blood.V41.5.687.687; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; HOYER LW, 1980, BLOOD, V55, P1056; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; HULTIN MB, 1990, AM J HEMATOL, V33, P64, DOI 10.1002/ajh.2830330113; Jackson SC, 2009, BLOOD, V113, P3348, DOI 10.1182/blood-2008-06-165233; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Ozeki M, 2010, THROMB RES, V125, pE17, DOI 10.1016/j.thromres.2009.08.012; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; Rayes J, 2007, J THROMB HAEMOST, V5, P321, DOI 10.1111/j.1538-7836.2007.02296.x; RICK ME, 1987, BLOOD, V69, P786; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Ruggeri ZM, 2004, J THROMB HAEMOST, V2, P2, DOI 10.1111/j.1538-7836.2003.00523.x; RUGGERI ZM, 1981, BLOOD, V57, P1140; WEISS HJ, 1986, BLOOD, V68, P149	33	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179566	10.1371/journal.pone.0179566	http://dx.doi.org/10.1371/journal.pone.0179566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640903	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800039
J	Ren, T; Zhang, H; Wang, J; Zhu, J; Jin, M; Wu, Y; Guo, X; Ji, L; Huang, Q; Zhang, H; Yang, H; Xing, J				Ren, T.; Zhang, H.; Wang, J.; Zhu, J.; Jin, M.; Wu, Y.; Guo, X.; Ji, L.; Huang, Q.; Zhang, H.; Yang, H.; Xing, J.			MCU-dependent mitochondrial Ca2+ inhibits NAD(+)/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells	ONCOGENE			English	Article							OPERATED CALCIUM-ENTRY; HEPATOCELLULAR-CARCINOMA; PYRUVATE-DEHYDROGENASE; TUMOR PROGRESSION; CANCER CELLS; UNIPORTER; MIGRATION; PROTEIN; DEATH; JNK	Mitochondrial Ca2+ signaling, which is strongly dependent on the mitochondrial Ca2+ uniporter (MCU) complex, has a series of key roles in physiopathological processes, including energy metabolism, reactive oxygen species (ROS) production and cell apoptosis. However, a mechanistic understanding of how the mitochondrial Ca2+ signaling is remodeled and its functional roles remains greatly limited in cancers, especially in hepatocellular carcinoma. Here we demonstrated that the MCU complex was dysregulated in hepatocellular carcinoma (HCC) cells and significantly correlated with metastasis and poor prognosis of HCC patients. Upregulation of MCU clearly enhanced the Ca2+ uptake into mitochondria, which significantly promoted ROS production by downregulating nicotinamide adenine dinucleotide(+) (NAD(+))/reduced form of nicotinamide adenine dinucleotid (NADH) ratio and the NAD+-dependent deacetylase activity of sirtuin 3 to inhibit superoxide dismutase 2 (SOD2) activity. Moreover, our data indicated that the MCU-dependent mitochondrial Ca2+ uptake promotes matrix metalloproteinase-2 activity and cell motility by ROS-activated c-Jun N-terminal kinase pathway, and thus contributed to the increased ability of invasion and migration in vitro and intrahepatic and distal lung metastasis in vivo of HCC cells. In addition, treatment with the mitochondrial Ca2+-buffering protein parvalbumin significantly suppressed ROS production and the ability of HCC metastasis. Our study uncovers a mechanism that links the remodeling of mitochondrial Ca2+ homeostasis to ROS production, and provides evidence supporting a metastasis-promoting role for the MCU-dependent mitochondrial Ca2+ uptake in HCC. Our findings suggest that the mitochondrial Ca2+ uptake machinery may potentially be a novel therapeutic target for HCC metastasis.	[Ren, T.; Wang, J.; Zhu, J.; Jin, M.; Wu, Y.; Guo, X.; Ji, L.; Huang, Q.; Xing, J.] Fourth Mil Med Univ, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Ren, T.; Wang, J.; Zhu, J.; Jin, M.; Wu, Y.; Guo, X.; Ji, L.; Huang, Q.; Xing, J.] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Zhang, H.; Zhang, H.] Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian, Shaanxi, Peoples R China; [Yang, H.] Thomas Jefferson Univ, Dept Med Oncol, Kimmel Canc Ctr, Div Populat Sci, Philadelphia, PA 19107 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Jefferson University	Xing, J (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.; Xing, J (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	xingjl@fmmu.edu.cn			National Natural Science Foundation of China [81572727, 81320108021]; National Basic Research Program [2015CB553703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grants 81572727 and 81320108021) and National Basic Research Program (grant 2015CB553703).	Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Arvizo RR, 2013, J BIOL CHEM, V288, P17610, DOI 10.1074/jbc.M112.435206; Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Campanella M, 2004, BIOL RES, V37, P653; Chaudhari S, 2014, FASEB J, V28; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chiba T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084807; Curry MC, 2013, BIOCHEM BIOPH RES CO, V434, P695, DOI 10.1016/j.bbrc.2013.04.015; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hall DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096866; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Hsu CC, 2013, BBA-GEN SUBJECTS, V1830, P4743, DOI 10.1016/j.bbagen.2013.06.004; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Ke ZJ, 2006, INT J CANCER, V119, P8, DOI 10.1002/ijc.21769; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Marchi S, 2013, CURR BIOL, V23, P58, DOI 10.1016/j.cub.2012.11.026; MCCORMACK JG, 1985, BIOCHEM J, V231, P581, DOI 10.1042/bj2310581; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Son G, 2006, J HEPATOL, V45, P688, DOI 10.1016/j.jhep.2006.04.011; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Sun YY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0210-7; Tang SH, 2015, BIOCHEM BIOPH RES CO, V458, P186, DOI 10.1016/j.bbrc.2015.01.092; Tosatto A, 2016, EMBO MOL MED, V8, P569, DOI 10.15252/emmm.201606255; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu P, 2010, MECH AGEING DEV, V131, P287, DOI 10.1016/j.mad.2010.03.006; Ying WH, 2008, FRONT BIOSCI-LANDMRK, V13, P1141, DOI 10.2741/2751; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zeng X, 2011, HEPATOLOGY, V54, P2036, DOI 10.1002/hep.24647; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182	51	101	109	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5897	5909		10.1038/onc.2017.167	http://dx.doi.org/10.1038/onc.2017.167			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28650465	Bronze			2022-12-26	WOS:000413292900011
J	Houston, DMJ; Bugert, JJ; Denyer, SP; Heard, CM				Houston, David M. J.; Bugert, Joachim J.; Denyer, Stephen P.; Heard, Charles M.			Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV	PLOS ONE			English	Article							ACID; ELLAGITANNINS; REPLICATION; HUSK	Background There is a clinical need for new therapeutic products against Herpes simplex virus (HSV). The pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection. This work probed the activity of pomegranate rind extract (PRE) and co-administered zinc (II) ions. Materials and methods PRE was used in conjunction with zinc (II) salts to challenge HSV-1 and aciclovir-resistant HSV in terms of virucidal plaque assay reduction and antiviral activities in epithelial Vero host cells. Cytotoxicity was determined by the MTS assay using a commercial kit. Results Zinc sulphate, zinc citrate, zinc stearate and zinc gluconate demonstrated similar potentiated virucidal activity with PRE against HSV-1 by up to 4-fold. A generally parabolic relationship was observed when HSV-1 was challenged with PRE and varying concentrations of ZnSO4, with a maximum potentiation factor of 5.5. Punicalagin had 8-fold greater virucidal activity than an equivalent mass of PRE. However, antiviral data showed that punicalagin had significantly lower antiviral activity compared to the activity of PRE (EC50 = 0.56 mu g mL(-1)) a value comparable to aciclovir (EC50 = 0.18 mu g mL(-1)); however, PRE also demonstrated potency against aciclovir-resistant HSV (EC50 = 0.02 mu mL(-1)), whereas aciclovir showed no activity. Antiviral action of PRE was not influenced by ZnSO4. No cytotoxicity was detected with any test solution. Conclusions The potentiated virucidal activity of PRE by coadministered zinc (II) has potential as a multiaction novel topical therapeutic agent against HSV infections, such as coldsores.	[Houston, David M. J.; Denyer, Stephen P.; Heard, Charles M.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales; [Houston, David M. J.; Bugert, Joachim J.] Cardiff Univ, Sch Med, Dept Microbiol & Infect Dis, Cardiff, S Glam, Wales; [Bugert, Joachim J.] Inst Mikrobiol Bundeswehr, Neuherbergstr 11, Munich, Germany; [Denyer, Stephen P.] Univ Brighton, Mithras House,Lewes Rd, Brighton, E Sussex, England	Cardiff University; Cardiff University; University of Brighton	Heard, CM (corresponding author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales.	heard@cardiff.ac.uk	Bugert, Joachim/AAK-6459-2021; Heard, Charles/O-3362-2014; Bugert, Joachim Jakob/D-1705-2012	Heard, Charles/0000-0001-9703-9777; Bugert, Joachim Jakob/0000-0002-0556-3211	Welsh Assembly Government [RESSA07-03-013]	Welsh Assembly Government	This work was funded by the Welsh Assembly Government RESSA07-03-013.	Aranha-Creado H, 1999, PDA J PHARM SCI TECH, V53, P75; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Braga LKA, 2011, AFR J PHARM PHARMACO, V5, P2145, DOI 10.5897/AJPP11.414; Cam M, 2009, FOOD CHEM, V112, P721, DOI 10.1016/j.foodchem.2008.06.009; Colombo E, 2013, EVIDENCE BASED COMPL; Corao GMD, 2001, THESIS; Ekambaram SP, 2016, PHYTOTHER RES, V30, P1035, DOI 10.1002/ptr.5616; Golstein J, 1996, J ENDOCRINOL INVEST, V19, P119, DOI 10.1007/BF03349847; Greenwood N.N., 1997, CHEM ELEMENTS; Hobden JA, 2011, INVEST OPHTH VIS SCI, V52, P830, DOI 10.1167/iovs.10-5671; Houston DMJ, 2017, EUR J PHARM BIOPHARM, V112, P30, DOI 10.1016/j.ejpb.2016.11.014; Houston DMJ, 2017, EUR J PHARM SCI, V96, P99, DOI 10.1016/j.ejps.2016.08.013; Houston DM, 2011, THESIS; Hulisz Darrell, 2004, J Am Pharm Assoc (2003), V44, P594, DOI 10.1331/1544-3191.44.5.594.Hulisz; Kenney J, 2013, ANTIMICROB AGENTS CH, V57, P4001, DOI 10.1128/AAC.00796-13; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8; Lu JJ, 2007, J CHROMATOGR B, V857, P175, DOI 10.1016/j.jchromb.2007.06.038; Mahajan B B, 2013, Indian J Sex Transm Dis AIDS, V34, P32, DOI 10.4103/0253-7184.112867; Murthy KNC, 2002, J AGR FOOD CHEM, V50, P4791, DOI 10.1021/jf0255735; Nagai T, 1993, ANTIVIR RES, V21, P289; Negi P.S., 2003, FOOD MICROBIOL SAF, V68, P1136; Neurath AR, 2005, ANN NY ACAD SCI, V1056, P311, DOI 10.1196/annals.1352.015; Patel C, 2008, FOOD CHEM TOXICOL, V46, P2728, DOI 10.1016/j.fct.2008.04.035; Pieren M, 2012, CURR OPIN PHARMACOL, V12, P551, DOI 10.1016/j.coph.2012.07.005; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Qiu M, 2013, ANTIVIR RES, V100, P44, DOI 10.1016/j.antiviral.2013.07.001; Sanchez-Lamar A, 2008, J ETHNOPHARMACOL, V115, P416, DOI 10.1016/j.jep.2007.10.011; Sarisky RT, 2001, CLIN INFECT DIS, V33, P2034, DOI 10.1086/338046; Seeram N, 2005, SEP PURIF TECHNOL, V41, P49, DOI 10.1016/j.seppur.2004.04.003; Seeram NP, 2005, J NUTR BIOCHEM, V16, P360, DOI 10.1016/j.jnutbio.2005.01.006; Seeram NP, 2006, POMEGRANATES ANCIENT, P193; Stewart GSAB, 1998, J APPL MICROBIOL, V84, P777, DOI 10.1046/j.1365-2672.1998.00408.x; Vilhelmova-Ilieva N, 2014, ANTIVIR RES, V110, P104, DOI 10.1016/j.antiviral.2014.07.017; Wei ZY, 2012, VET MICROBIOL, V160, P468, DOI 10.1016/j.vetmic.2012.06.019	37	32	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179291	10.1371/journal.pone.0179291	http://dx.doi.org/10.1371/journal.pone.0179291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665969	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000404608700032
J	Madani, A; Garakani, K; Mofrad, MRK				Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.			Molecular mechanics of Staphylococcus aureus adhesin, CNA, and the inhibition of bacterial adhesion by stretching collagen	PLOS ONE			English	Article							BINDING PROTEIN; EXPERIMENTAL ENDOCARDITIS; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS; VIRULENCE FACTOR; HUG MODEL; DYNAMICS; MSCRAMM; LIGAND; DOMAIN	Bacterial adhesion to collagen, the most abundant protein in humans, is a critical step in the initiation and persistence of numerous bacterial infections. In this study, we explore the collagen binding mechanism of the multi-modular cell wall anchored collagen adhesin (CNA) in Staphylococcus aureus and examine how applied mechanical forces can modulate adhesion ability. The common structural-functional elements and domain organization of CNA are present across over 50 genera of bacteria. Through the use of molecular dynamics models and normal mode analysis, we shed light on the CNA's structural and conformational dynamics and its interactions with collagen that lead to collagen binding. Our results suggest that the linker region, CNA(165-173), acts as a hinge exhibiting bending, extensional, and torsional modes of structural flexibility and its residues are key in the interaction of the CNA-collagen complex. Steered molecular dynamics simulations were conducted with umbrella sampling. During the course of these simulations, the ` locking' latch from the CNA N2 domain was dissociated from its groove in the CNA N1 domain, implying the importance of the latch for effective ligand binding. Finally, we observed that the binding efficiency of the CNA N1-N2 domains to collagen decreases greatly with increasing tensile force application to the collagen peptides. Thus, CNA and similar adhesins might preferentially bind to sites in which collagen fibers are cleaved, such as in wounded, injured, or inflamed tissues, or in which the collagenous tissue is less mature. As alternative techniques for control of bacterial infection are in-demand due to the rise of bacterial antibiotic resistance, results from our computational studies with respect to the mechanoregulation of the collagen binding site may inspire new therapeutics and engineering solutions by mechanically preventing colonization and/or further pathogenesis.	[Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; [Madani, Ali; Garakani, Kiavash; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Mofrad, Mohammad R. K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.; Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.; Mofrad, MRK (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; Garakani, Kiavash/0000-0002-2896-3234	National Science Foundation [CMMI 1538707]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant CMMI 1538707 to M.R. K.M.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Anderson D., 2005, THESIS U CAMBRIDGE; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Consortium TU, 2017, UN U PROT KNOWL, V45, P158; Devi AS, 2012, BBA-GEN SUBJECTS, V1820, P819, DOI 10.1016/j.bbagen.2012.04.006; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fratzl P, 2008, SPRINGER SCI BUSINES; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIPENBERGLERCHE C, 1995, INFECT IMMUN, V63, P3222, DOI 10.1128/IAI.63.8.3222-3226.1995; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Herman-Bausier P, MECH STRENGTH INHIBI; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar V, 2014, ROBBINS COTRAN PATHO; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904; Nakano K, 2010, ARCH ORAL BIOL, V55, P34, DOI 10.1016/j.archoralbio.2009.11.008; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4120, DOI 10.1128/IAI.00376-08; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179601	10.1371/journal.pone.0179601	http://dx.doi.org/10.1371/journal.pone.0179601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665944	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608700037
J	Timmis, MA; Bijl, H; Turner, K; Basevitch, I; Taylor, MJD; van Paridon, KN				Timmis, Matthew A.; Bijl, Herre; Turner, Kieran; Basevitch, Itay; Taylor, Matthew J. D.; van Paridon, Kjell N.			The impact of mobile phone use on where we look and how we walk when negotiating floor based obstacles	PLOS ONE			English	Article							PERIPHERAL-VISION; CELL PHONE; LIMB DOMINANCE; ATTENTION; GAIT; INJURIES; SYMMETRY; TALKING	Pedestrians regularly engage with their mobile phone whilst walking. The current study investigated how mobile phone use affects where people look (visual search behaviour) and how they negotiate a floor based hazard placed along the walking path. Whilst wearing a mobile eye tracker and motion analysis sensors, participants walked up to and negotiated a surface height change whilst writing a text, reading a text, talking on the phone, or without a phone. Differences in gait and visual search behaviour were found when using a mobile phone compared to when not using a phone. Using a phone resulted in looking less frequently and for less time at the surface height change, which led to adaptations in gait by negotiating it in a manner consistent with adopting an increasingly cautious stepping strategy. When using a mobile phone, writing a text whilst walking resulted in the greatest adaptions in gait and visual search behaviour compared to reading a text and talking on a mobile phone. Findings indicate that mobile phone users were able to adapt their visual search behaviour and gait to incorporate mobile phone use in a safe manner when negotiating floor based obstacles.	[Timmis, Matthew A.; Bijl, Herre; Turner, Kieran; Basevitch, Itay; van Paridon, Kjell N.] Anglia Ruskin Univ, Dept Sport & Exercise Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England; [Taylor, Matthew J. D.] Univ Essex, Sch Biol Sci, Ctr Sports & Exercise Sci, Colchester, Essex, England	Anglia Ruskin University; University of Essex	Timmis, MA (corresponding author), Anglia Ruskin Univ, Dept Sport & Exercise Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England.	Matthew.Timmis@anglia.ac.uk	Basevitch, Itay/AFR-2861-2022; Basevitch, Itay/V-2211-2019	Basevitch, Itay/0000-0001-7505-4597				Ahlstrom C, 2016, TRANSPORT RES F-TRAF, V41, P204, DOI 10.1016/j.trf.2015.01.010; [Anonymous], 2012, BEST WORST MOBILE CO; [Anonymous], [No title captured], DOI DOI 10.1016/S0166-4115(01)80008-X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; CTIA- The Wireless Association, 2011, CTIA ADV; Da Rocha ES, 2013, HUMAN MOVEMENT, V14, P138; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; GHSA. Everyone Walks, 2015, UND ADDR PED SAF; HE PY, 1992, VISION RES, V32, P2151, DOI 10.1016/0042-6989(92)90076-U; HILZ R, 1974, VISION RES, V14, P1333, DOI 10.1016/0042-6989(74)90006-6; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Kao PC, 2015, GAIT POSTURE, V41, P947, DOI 10.1016/j.gaitpost.2015.03.347; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lamble D, 1999, ERGONOMICS, V42, P807, DOI 10.1080/001401399185306; Lopresti-Goodman SM, 2012, APPL COGNITIVE PSYCH, V26, P644, DOI 10.1002/acp.2846; MANDELBAUM J, 1947, AM J OPHTHALMOL, V30, P581, DOI 10.1016/0002-9394(47)92311-8; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Murray M P, 1966, Am J Phys Med, V45, P8; Nagano H, 2011, CLIN BIOMECH, V26, P962, DOI 10.1016/j.clinbiomech.2011.05.013; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Oulasvirta Antti, 2005, P SIGCHI C HUM FACT, P919, DOI [DOI 10.1145/1054972.1055101, 10.1145/1054972.1055101]; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Perry MC, 2007, EUR J APPL PHYSIOL, V100, P553, DOI 10.1007/s00421-006-0247-0; Pew Research Center, 2008, PEW INT AM LIF PROJ; Plummer P, 2015, GAIT POSTURE, V41, P46, DOI 10.1016/j.gaitpost.2014.08.007; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainie, 2012, CELL PHONE ACTIVITIE; Rhea C K., 2011, GAIT POSTURE, V34, P439; Richtel M, 2010, NY TIMES, P17; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Schabrun SM, 2014, PLOS ONE, V22; SCHLINGENSIEPEN KH, 1986, VISION RES, V26, P1111, DOI 10.1016/0042-6989(86)90045-3; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Sky UK, 2015, GO SLOW SMARTPH WALK; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Summala H, 1996, HUM FACTORS, V38, P442, DOI 10.1518/001872096778701944; The Radicati Group, 2013, EMA STAT REP 2013 20; Thornton B, 2014, SOC PSYCHOL-GERMANY, V45, P479, DOI 10.1027/1864-9335/a000216; Timmis MA, 2016, GAIT POSTURE, V44, P55, DOI 10.1016/j.gaitpost.2015.11.008; Tornros JEB, 2005, ACCIDENT ANAL PREV, V37, P902, DOI 10.1016/j.aap.2005.04.007; Vansteenkiste P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102792; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright RD, 1998, VISUAL ATTENTION, P132; Wrightson JG, 2016, MOTOR CONTROL, V20, P109, DOI 10.1123/mc.2014-0060; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	56	30	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179802	10.1371/journal.pone.0179802	http://dx.doi.org/10.1371/journal.pone.0179802			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665942	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000404608700041
J	Alexeev, EE; He, X; Slupsky, CM; Lonnerdal, B				Alexeev, Erica E.; He, Xuan; Slupsky, Carolyn M.; Lonnerdal, Bo			Effects of iron supplementation on growth, gut microbiota, metabolomics and cognitive development of rat pups	PLOS ONE			English	Article							BREAST-FED INFANTS; CATCH-UP GROWTH; NITRIC-OXIDE; AFRICAN CHILDREN; RANDOMIZED TRIAL; YOUNG-CHILDREN; ADULT MICE; DEFICIENCY; REPLETE; TAURINE	Background Iron deficiency is common during infancy and therefore iron supplementation is recommended. Recent reports suggest that iron supplementation in already iron replete infants may adversely affect growth, cognitive development, and morbidity. Methods Normal and growth restricted rat pups were given iron daily (30 or 150 mu g/d) from birth to postnatal day (PD) 20, and followed to PD56. At PD20, hematology, tissue iron, and the hepatic metabolome were measured. The plasma metabolome and colonic microbial ecology were assessed at PD20 and PD56. T-maze (PD35) and passive avoidance (PD40) tests were used to evaluate cognitive development. Results Iron supplementation increased iron status in a dose-dependent manner in both groups, but no significant effect of iron on growth was observed. Passive avoidance was significantly lower only in normal rats given high iron compared with controls. In plasma and liver of normal and growth-restricted rats, excess iron increased 3-hydroxybutyrate and decreased several amino acids, urea and myo-inositol. While a profound difference in gut microbiota of normal and growth-restricted rats was observed, with iron supplementation differences in the abundance of strict anaerobes were observed. Conclusion Excess iron adversely affects cognitive development, which may be a consequence of altered metabolism and/or shifts in gut microbiota.	[Alexeev, Erica E.; He, Xuan; Slupsky, Carolyn M.; Lonnerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [He, Xuan; Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Lonnerdal, B (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu			USDA National Institution of Food and Agricultural Hatch Project [1005945]; Mead Johnson Nutrition	USDA National Institution of Food and Agricultural Hatch Project; Mead Johnson Nutrition	This study was funded by Mead Johnson Nutrition to BL.Additionally, CS acknowledges support of USDA National Institution of Food and Agricultural Hatch Project 1005945. The funders had no role in study design, data collections and analysis, decision to Publish, or Preparation of the manuscript.	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Alexeev Erica E., 2015, BMC Physiology, V15, P3, DOI 10.1186/s12899-015-0017-5; Arboleya S, 2012, GUT MICROBES, V3, P583, DOI 10.4161/gmic.21942; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brodziak A, 2014, MED SCI MONITOR, V20, P2733, DOI 10.12659/MSM.891056; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi L, 2011, HEMATOLOGY, V16, P261, DOI 10.1179/102453311X13085644679980; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dewey KG, 2002, J NUTR, V132, P3249, DOI 10.1093/jn/132.11.3249; Domellof M, 2004, AM J CLIN NUTR, V79, P111; Domellof M, 2002, AM J CLIN NUTR, V76, P198, DOI 10.1093/ajcn/76.1.198; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fredriksson A, 1999, TOXICOL APPL PHARM, V159, P25, DOI 10.1006/taap.1999.8711; Fredriksson A, 2000, DEV BRAIN RES, V119, P65, DOI 10.1016/S0165-3806(99)00160-1; Galleano Monica, 2004, Molecular Aspects of Medicine, V25, P141, DOI 10.1016/j.mam.2004.02.015; Garcia-Calatayud S, 2005, PEDIATR RES, V57, P719, DOI 10.1203/01.PDR.0000156506.03057.AD; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; He X, 2013, J AGR FOOD CHEM, V61, P9559, DOI 10.1021/jf4029046; Hida AI, 2003, FREE RADICAL BIO MED, V34, P1426, DOI 10.1016/S0891-5849(03)00143-6; IDJRADINATA P, 1994, LANCET, V343, P1252, DOI 10.1016/S0140-6736(94)92151-2; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; Jou MY, 2013, PEDIATR RES, V73, P596, DOI 10.1038/pr.2013.27; Kaur D, 2007, NEUROBIOL AGING, V28, P907, DOI 10.1016/j.neurobiolaging.2006.04.003; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Leong I, 2003, AM J CLIN NUTR, V78, P1203, DOI 10.1093/ajcn/78.6.1203; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Lind T, 2008, ACTA PAEDIATR, V97, P770, DOI 10.1111/j.1651-2227.2008.00773.x; Lonnerdal B, 2015, J PEDIATR-US, V167, pS8, DOI 10.1016/j.jpeds.2015.07.014; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lozoff B, 2012, ARCH PEDIAT ADOL MED, V166, P208, DOI 10.1001/archpediatrics.2011.197; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Majumdar I, 2003, J TROP PEDIATRICS, V49, P84, DOI 10.1093/tropej/49.2.84; Miller JL, 2013, COLD SPRING HARB PER, V3; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Paul V, 2011, INDIAN J MED RES, V133, P471; Puiman P, 2008, CURR OPIN CLIN NUTR, V11, P601, DOI 10.1097/MCO.0b013e32830b5b15; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Zhang ZY, 2014, MOL MED REP, V10, P2255, DOI 10.3892/mmr.2014.2544; Ziegler EE, 2009, AM J CLIN NUTR, V90, P76, DOI 10.3945/ajcn.2008.27350; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	51	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179713	10.1371/journal.pone.0179713	http://dx.doi.org/10.1371/journal.pone.0179713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662197	Green Published, gold			2022-12-26	WOS:000404608300044
J	Pickering, K; Monahan, M; Guariglia, A; Roberts, TE				Pickering, Karen; Monahan, Mark; Guariglia, Alessandra; Roberts, Tracy E.			Time to tighten the belts? Exploring the relationship between savings and obesity	PLOS ONE			English	Article							BODY-MASS INDEX; PREFERENCE; OVERWEIGHT; WOMEN; RISK; DECISIONS; HEALTH; MEN; AGE	Background Literature suggests that the higher the rate of time preference people have, the less likely they are to save for the future. Likewise, it has been hypothesised that rising rates of being overweight/obesity are associated with an increase in peoples' marginal rate of time preference. Aim To investigate the relationship between being overweight/obese and the rate of time preference in an older English population, using savings as a proxy for time preference. Methods Three different econometric methods Random-effects Probit Estimation, Fixed-effects Estimation, and Generalised Method of Moments Estimation were used to explore the link between being overweight/obese and rate of time preference in the English Longitudinal Study of Ageing dataset. Six waves of panel data spanning eleven years provided the data to test whether savings variables are related to being overweight/obese. Results The decision to save was shown to hold a statistically significant negative relationship with body mass index but only in the Generalised Method of Moments model. Placing savings in safe, low risk investments was significantly related to a lower probability of being obese but only in the random-effects Probit model. The proportion that people saved relative to their income was not found to be significantly associated with the probability of being overweight/obese in any of the models. Conclusion There is an unclear relationship between saving behaviour and being overweight/obese in an older English population. A financial variable such as savings is a potentially appropriate but imperfect proxy for the rate of time preference of the population. Further research is required to clarify the relationship in order to help develop strategies for obesity prevention. The inconsistency in the results between methods highlights the importance of using a wide range of alternative techniques before implementing important policy decisions.	[Pickering, Karen; Monahan, Mark; Roberts, Tracy E.] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Guariglia, Alessandra] Univ Birmingham, Dept Econ, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Roberts, TE (corresponding author), Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England.	t.e.roberts@bham.ac.uk	Monahan, Mark/AAO-3992-2021; Roberts, Tracy/AAO-4610-2021	Monahan, Mark/0000-0002-1175-9421; Roberts, Tracy/0000-0002-0624-0537; Pickering, Karen/0000-0001-8982-5540; Guariglia, Alessandra/0000-0001-5417-2615	National Institute for Health Research [EoH-2014-03-01-101] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], [No title captured]; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Averett SL, 2014, ECON HUM BIOL, V15, P201, DOI 10.1016/j.ehb.2013.12.004; Banks J, 2010, ECON J, V120, pF381, DOI 10.1111/j.1468-0297.2010.02395.x; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Borghans L, 2006, ECON HUM BIOL, V4, P39, DOI 10.1016/j.ehb.2005.10.001; Brown H, 2016, SOC SCI MED, V158, P75, DOI 10.1016/j.socscimed.2016.04.016; Butland BJ, 2007, FORESIGHT TACKLING O; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Courtemanche C, 2014, EC J; Crossley T. F., 2010, WEALTH SAVING UK FAM; Duvigneaud N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-23; Fonda SJ, 2004, RES AGING, V26, P153, DOI 10.1177/0164027503258739; Gujarati D. N., 2009, BASIC ECONOMETRICS; Gujarati D. N., 2005, BASIC ECONOMETRICS, Vfifth; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Ikeda S, 2010, J HEALTH ECON, V29, P268, DOI 10.1016/j.jhealeco.2010.01.002; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Keese M, 2014, REV INCOME WEALTH, V60, P525, DOI 10.1111/roiw.12002; Khwaja A, 2007, J HEALTH ECON, V26, P927, DOI 10.1016/j.jhealeco.2007.02.004; Komlos J, 2004, OBESITY RATE TIME PR; Lifestyles Statistics Team HaSCIC, 2016, STAT OB PHYS ACT DIE; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Moody A., 2013, HLTH SURV ENGL, V1; Observatory NO, 2010, EC BURD OB; PAXSON CH, 1992, AM ECON REV, V82, P15; Pouliou T, 2010, HEALTH PLACE, V16, P389, DOI 10.1016/j.healthplace.2009.11.011; Regidor E, 2004, EUR J CLIN NUTR, V58, P488, DOI 10.1038/sj.ejcn.1601835; Research NS, 2015, US GUID NURS DAT; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Seeyave DM, 2009, ARCH PEDIAT ADOL MED, V163, P303, DOI 10.1001/archpediatrics.2009.12; Smith PK, 2005, ECON HUM BIOL, V3, P259, DOI 10.1016/j.ehb.2005.05.001; Sutter M, 2010, WORKING PAPERS EC ST; Sutter M, 2013, AM ECON REV, V103, P510, DOI 10.1257/aer.103.1.510; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Who.int. WHO, WHO OB OV 2015; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang L, 2007, J BIOSOC SCI, V40	39	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179921	10.1371/journal.pone.0179921	http://dx.doi.org/10.1371/journal.pone.0179921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662132	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300072
J	Wang, J; Hu, WJ; Li, LZ; Huang, XP; Liu, YG; Wang, D; Teng, LR				Wang, Juan; Hu, Wenji; Li, Lanzhou; Huang, Xinping; Liu, Yange; Wang, Di; Teng, Lirong			Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes	PLOS ONE			English	Article							NF-KAPPA-B; OPHIOPOGON-JAPONICUS; SUBMERGED CULTURE; PROTECTS MICE; RENAL INJURY; DRY-MATTER; NEPHROPATHY; INFLAMMATION; EXPRESSION; EXTRACT	This study evaluated the effects of Inonotus obliquus polysaccharides (IOs) on diabetes and other underlying mechanisms related to inflammatory factors and oxidative stress in a mouse model of streptozotocin (STZ)-induced diabetes. Four weeks administration of metformin (120 mg/kg) and IO1-4 (50%-80% alcohol precipitation), or IO5 (total 80% alcohol precipitation) at doses of 50 mg/kg reverses the abnormal changes of bodyweights and fasting blood glucose levels of diabetic mice. IOs significantly increased the insulin and pyruvate kinase levels in serum, and improved the synthesis of glycogen, especially for IO5. IOs restored the disturbed serum levels of superoxide dismutase, catalase, glutathione peroxidase, and malondialdehyde. The down-regulation of interleukin-2 receptor, matrix metalloproteinase-9, and the enhancement of interleukin-2 in serum of diabetic mice were significantly attenuated by IOs. Histologic and morphology examinations showed that IOs repaired the damage on kidney tissues, inhibited inflammatory infiltrate and extracellular matrix deposit injuries in diabetic mice. Compared with untreated diabetic mice, IOs decreased the expression of phosphor-NF-.B in the kidneys. These results show that IOs treatment attenuated diabetic and renal injure in STZ-induced diabetic mice, possibly through the modulation of oxidative stress and inflammatory factors. These results provide valuable evidences to support the use of I. obliquus as a hypoglycemic functional food and/or medicine.	[Wang, Juan; Hu, Wenji; Li, Lanzhou; Huang, Xinping; Liu, Yange; Wang, Di; Teng, Lirong] Jilin Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Wang, Di; Teng, Lirong] Jilin Univ, Zhuhai Coll, Zhuhai, Guangdong, Peoples R China	Jilin University; Jilin University	Wang, D; Teng, LR (corresponding author), Jilin Univ, Sch Life Sci, Changchun, Jilin, Peoples R China.; Wang, D; Teng, LR (corresponding author), Jilin Univ, Zhuhai Coll, Zhuhai, Guangdong, Peoples R China.	jluwangdi@outlook.com; tenglr@jlu.edu.cn			Science and Technology Key Project in Jilin Province of China [20140311072YY, 20150203002NY, 20160204029YY]	Science and Technology Key Project in Jilin Province of China	The manuscript has been supported by the funding of Science and Technology Key Project in Jilin Province of China (Grant No. 20140311072YY, 20150203002NY and 20160204029YY).The funder had no role in study design, data collection andanalysis,decision to publish, or preparation of the manuscript.	Adler SG, 2000, KIDNEY INT, V57, P2084, DOI 10.1046/j.1523-1755.2000.00058.x; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; Bertelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111285; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2013, DIABETES CARE, V36, P4104, DOI 10.2337/dc13-0750; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Chen XM, 2011, CARBOHYD POLYM, V83, P749, DOI 10.1016/j.carbpol.2010.08.050; Chou YJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091535; Cui HL, 2011, J SCI FOOD AGR, V91, P2180, DOI 10.1002/jsfa.4436; Cui Y, 2005, J ETHNOPHARMACOL, V96, P79, DOI 10.1016/j.jep.2004.08.037; Dong Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160980; Du LN, 2016, MOL MED REP, V13, P1701, DOI 10.3892/mmr.2015.4736; Dun CP, 2016, NEUROPSYCH DIS TREAT, V12, P1617, DOI 10.2147/NDT.S106123; Goyal SN, 2016, CHEM-BIOL INTERACT, V244, P49, DOI 10.1016/j.cbi.2015.11.032; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Habibi F, 2016, ADV PHARM BULL, V6, P99, DOI 10.15171/apb.2016.015; Harlev E, 2013, PLANTA MED, V79, P425, DOI 10.1055/s-0032-1328331; Jellestad L, 2014, EUR J PHARMACOL, V724, P175, DOI 10.1016/j.ejphar.2013.12.029; Jiang S, 2013, INT J BIOL MACROMOL, V55, P118, DOI 10.1016/j.ijbiomac.2012.12.035; Jothivel N, 2007, J HEALTH SCI, V53, P655, DOI 10.1248/jhs.53.655; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kim MJ, 2006, LIFE SCI, V79, P2288, DOI 10.1016/j.lfs.2006.07.027; KOHLER SM, 1994, ACTA DIABETOL, V31, P119, DOI 10.1007/BF00570363; Lelongt B, 2001, J EXP MED, V193, P793, DOI 10.1084/jem.193.7.793; Li X, 2015, CELL PHYSIOL BIOCHEM, V37, P2125, DOI 10.1159/000438570; Liu YT, 2013, FOOD CHEM TOXICOL, V62, P285, DOI 10.1016/j.fct.2013.08.082; Ma CH, 2015, J ETHNOPHARMACOL, V172, P108, DOI 10.1016/j.jep.2015.06.015; Ma L, 2015, NUTR RES, V35, P431, DOI 10.1016/j.nutres.2015.04.011; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; Melin J, 2002, KIDNEY INT, V61, P1383, DOI 10.1046/j.1523-1755.2002.00284.x; Nabben M, 2016, CARDIOVASC DRUG THER, V30, P233, DOI 10.1007/s10557-016-6669-y; Pan D, 2014, FOOD CHEM TOXICOL, V63, P111, DOI 10.1016/j.fct.2013.10.046; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Sainaghi PP, 2007, EXP CLIN ENDOCR DIAB, V115, P112, DOI 10.1055/s-2007-949151; Saksida T, 2013, J NEUROIMMUNOL, V262, P72, DOI 10.1016/j.jneuroim.2013.07.001; Seto S, 2012, BIOORGAN MED CHEM, V20, P1188, DOI 10.1016/j.bmc.2011.12.046; Sim YC, 2016, MOL MED REP, V14, P4263, DOI 10.3892/mmr.2016.5763; Singh J, 2013, FOOD CHEM TOXICOL, V62, P722, DOI 10.1016/j.fct.2013.09.035; Song JJ, 2016, FOOD FUNCT, V7, P2006, DOI [10.1039/C5FO01017A, 10.1039/c5fo01017a]; Sun JE, 2008, J ETHNOPHARMACOL, V118, P7, DOI 10.1016/j.jep.2008.02.030; Wang J, 2014, MAR DRUGS, V12, P3292, DOI 10.3390/md12063292; Wang J, 2013, CARBOHYD POLYM, V95, P143, DOI 10.1016/j.carbpol.2013.02.076; Wang J, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4368380; Wang L, 2013, INT J BIOL MACROMOL, V61, P317, DOI 10.1016/j.ijbiomac.2013.07.028; Wang Y, 2015, INT J MOL SCI, V16, P22473, DOI 10.3390/ijms160922473; Wei JT, 2014, INT J BIOL MACROMOL, V64, P1, DOI 10.1016/j.ijbiomac.2013.11.013; Xu HY, 2010, NAT PROD RES, V24, P542, DOI 10.1080/14786410902751009; Xu W, 2015, INT J BIOL MACROMOL, V72, P575, DOI 10.1016/j.ijbiomac.2014.09.011; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang J., 2016, INT J MOL SCI, V17, pE1810, DOI 10.3390/ijms17111810; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850; Zhu ZY, 2016, INT J BIOL MACROMOL, V82, P959, DOI 10.1016/j.ijbiomac.2015.10.075	55	35	40	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180476	10.1371/journal.pone.0180476	http://dx.doi.org/10.1371/journal.pone.0180476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662169	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300161
J	Liu, YQ; Gao, Y; Liang, GM; Lu, YH				Liu, Yongqiang; Gao, Yu; Liang, Gemei; Lu, Yanhui			Chlorantraniliprole as a candidate pesticide used in combination with the attracticides for lepidopteran moths	PLOS ONE			English	Article							ARMIGERA HUBNER LEPIDOPTERA; SPODOPTERA-LITURA LEPIDOPTERA; VOLATILE-BASED ATTRACTICIDE; HELICOVERPA-ARMIGERA; AGROTIS-IPSILON; NOCTUIDAE; INSECTICIDES; RESISTANCE; MIGRATION; TOXICITY	Methomyl is currently used as a toxicant for the attracticide BioAttract in cotton and vegetables in China. However, methomyl is highly toxic to non-target organisms and a more environmental friendly acceptable alternative is required. Larvae of three lepidopteran insects Helicoverpa armigera, Agrotis ipsilon and Spodoptera litura are important pests of these crops in China. In the present study, the toxicity of 23 commonly used insecticides were tested on H. armigera, then tested the susceptibility of A. ipsilon and S. litura moths to the insecticides which were the most toxic to H. armigera, and the acute toxicity of the most efficacious insecticides were further investigated under laboratory conditions. Chlorantraniliprole, emamectin benzoate, spinetoram, spinosad and methomyl exhibited high levels of toxicity to H. armigera moths with a mortality of 86.67%, 91.11%, 73.33%, 57.78% and 80.00%, respectively, during 24 h period at the concentration of 1 mg a.i.L-1. Among these five insecticides, A. ipsilon and S. litura moths were more sensitive to chlorantraniliprole, emamectin benzoate and methomyl. The lethal time (LT50) values of chlorantraniliprole and methomyl were shorter than emamectin benzoate for all three lepidopteran moth species at 1000 mg a.i.L-1 compared to concentrations of 500, 100 and 1 mg a.i L-1. Chlorantraniliprole was found to have similar levels of toxicity and lethal time on the three lepidopteran moths tested to the standard methomyl, and therefore, can be used as an alternative insecticide to methomyl in the attracticide for controlling these pest species.	[Liu, Yongqiang; Gao, Yu; Liang, Gemei; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	yhlu@ippcaas.cn		Lu, Yanhui/0000-0002-6552-0248	National Natural Science Foundation of China [31621064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (grant number 31621064). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger KE, 2010, PEST MANAG SCI, V66, P1075, DOI 10.1002/ps.1977; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Del Socorro AP, 2010, AUST J ENTOMOL, V49, P10, DOI 10.1111/j.1440-6055.2009.00733.x; Del Socorro AP, 2010, AUST J ENTOMOL, V49, P31, DOI 10.1111/j.1440-6055.2009.00735.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Farre M, 2002, ANAL BIOANAL CHEM, V373, P704, DOI 10.1007/s00216-002-1413-9; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Gao M., 2011, AGROCHEMIC RES APPL, V15, P17; Gregg PC, 2016, J CHEM ECOL, V42, P666, DOI 10.1007/s10886-016-0725-8; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; IPPCAAS (Institute of Plant Protection Chinese Academy of Agricultural Sciences) CSPP (China Society of Plant Protection), 2015, CROP DIS INS PESTS C, V1-3; Kong D.S., 2016, SHANDONG AGR, V48, P102; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Leonova IN, 1996, ARCH INSECT BIOCHEM, V32, P157, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;157::AID-ARCH1&gt;3.0.CO;2-W; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39060; Liu YQ, 2015, ANN ENTOMOL SOC AM, V108, P519, DOI 10.1093/aesa/sav050; Lopez JD, 2011, PEST MANAG SCI, V67, P220, DOI 10.1002/ps.2055; Lopez JD, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8901; Ma X.F., 2013, THE J, V41, P6697; Ma XF, 2013, J ANHUI AGR SCI, V41, P6709; Mensah RK, 2013, CROP PASTURE SCI, V64, P763, DOI 10.1071/CP13060; Murata M, 1998, APPL ENTOMOL ZOOL, V33, P419, DOI 10.1303/aez.33.419; Saleem MA, 2008, J ECON ENTOMOL, V101, P1667, DOI 10.1603/0022-0493(2008)101[1667:RTSOOC]2.0.CO;2; Shad SA, 2012, J PEST SCI, V85, P153, DOI 10.1007/s10340-011-0404-z; Su Jian-Wei, 2001, Entomological Knowledge, V38, P405; Sun BB, 2013, ARCH INSECT BIOCHEM, V82, P1, DOI 10.1002/arch.21067; Wang Y.H., 2016, THE J, V44, P149; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; [谢圣华 Xie Shenghua], 2010, [植物保护, Plant Protection], V36, P175; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Younger CD, 2000, THESIS	32	17	22	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180255	10.1371/journal.pone.0180255	http://dx.doi.org/10.1371/journal.pone.0180255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658277	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900070
J	Post, DMB; Schilling, B; Reinders, LM; D'Souza, AK; Ketterer, MR; Kiel, SJ; Chande, AT; Apicella, MA; Gibson, BW				Post, Deborah M. B.; Schilling, Birgit; Reinders, Lorri M.; D'Souza, Alexandria K.; Ketterer, Margaret R.; Kiel, Steven J.; Chande, Aroon T.; Apicella, Michael A.; Gibson, Bradford W.			Identification and characterization of AckA-dependent protein acetylation in Neisseria gonorrhoeae	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ACETYLOME ANALYSIS REVEALS; LARGE GENE LISTS; LYSINE ACETYLATION; SALMONELLA-ENTERICA; PROTEOMIC ANALYSIS; METABOLIC ENZYMES; HEME OXYGENASE; COA SYNTHETASE; COLI	Neisseria gonorrhoeae, the causative agent of gonorrhea, has a number of factors known to contribute to pathogenesis; however, a full understanding of these processes and their regulation has proven to be elusive. Post-translational modifications (PTMs) of bacterial proteins are now recognized as one mechanism of protein regulation. In the present study, Western blot analyses, with an anti-acetyl-lysine antibody, indicated that a large number of gonococcal proteins are post-translationally modified. Previous work has shown that Ne-lysine acetylation can occur non-enzymatically with acetyl-phosphate (AcP) as the acetyl donor. In the current study, an acetate kinase mutant (1291ackA), which accumulates AcP, was generated in N. gonorrhoeae. Broth cultures of N. gonorrhoeae 1291wt and 1291ackA were grown, proteins extracted and digested, and peptides containing acetylated-lysines (K-acetyl) were affinity-enriched from both strains. Mass spectrometric analyses of these samples identified a total of 2686 unique acetylation sites. Label-free relative quantitation of the K-acetyl peptides derived from the ackA and wild-type (wt) strains demonstrated that 109 acetylation sites had an ackA/wt ratio>2 and p-values <0.05 in at least 2/3 of the biological replicates and were designated as "AckA-dependent". Regulated K-acetyl sites were found in ribosomal proteins, central metabolism proteins, iron acquisition and regulation proteins, pilus assembly and regulation proteins, and a two-component response regulator. Since AckA is part of a metabolic pathway, comparative growth studies of the ackA mutant and wt strains were performed. The mutant showed a growth defect under aerobic conditions, an inability to grow anaerobically, and a defect in biofilm maturation. In conclusion, the current study identified AckA-dependent acetylation sites in N. gonorrhoeae and determined that these sites are found in a diverse group of proteins. This work lays the foundation for future studies focusing on specific acetylation sites that may have relevance in gonococcal pathogenesis and metabolism.	[Post, Deborah M. B.; Schilling, Birgit; Reinders, Lorri M.; D'Souza, Alexandria K.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Ketterer, Margaret R.; Kiel, Steven J.; Chande, Aroon T.; Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Chande, Aroon T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Buck Institute for Research on Aging; University of Iowa; University of California System; University of California San Francisco; University System of Georgia; Georgia Institute of Technology	Post, DMB; Gibson, BW (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Gibson, BW (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	dpost@buckinstitute.org; bgibson@buckinstitute.org		Schilling, Birgit/0000-0001-9907-2749; Chande, Aroon/0000-0001-5260-3135	National Institutes of Health [R01 A108255]; National Center for Research Resources shared instrumentation [1S10 0D016281, 1 S10 RR025439-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources shared instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health Grant R01 A108255 (to MAA and BWG). The purchase of the TripleTOF instrument was supported by an National Center for Research Resources shared instrumentation grant 1S10 0D016281 (to BWG). The purchase of the Zeiss LSM710 confocal microscope was supported by National Center for Research Resources shared instrumentation grant 1 S10 RR025439-01 to the CMRF at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; APICELLA MA, 1974, J INFECT DIS, V130, P619, DOI 10.1093/infdis/130.6.619; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Bozicevic I, 2006, SEX TRANSM DIS, V33, P289, DOI 10.1097/01.olq.0000194582.44222.c9; Centers for Disease Control and Prevention (CDC), 2015, SEX TRANSM DIS SURV; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; D'Souza A. K., 2013, P 61 ANN ASMS C MASS; Edwards JL, 2001, CELL MICROBIOL, V3, P611, DOI 10.1046/j.1462-5822.2001.00140.x; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Friedman J, 2003, J BIOL CHEM, V278, P34654, DOI 10.1074/jbc.M302985200; HANSFIELD HH, 2005, PRINCIPLES PRACTICE, P2514; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; Hook EW., 2008, SEX TRANSM DIS, V4th ed., P627; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang D, 2015, APPL MICROBIOL BIOT, V99, P1399, DOI 10.1007/s00253-014-6144-2; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KNAPP JS, 1984, INFECT IMMUN, V46, P176, DOI 10.1128/IAI.46.1.176-181.1984; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Liao GJ, 2014, J PROTEOMICS, V106, P260, DOI 10.1016/j.jprot.2014.04.017; Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962; Lynnes T, 2013, FEMS MICROBIOL LETT, V344, P95, DOI 10.1111/1574-6968.12174; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MCCORMACK WM, 1977, LANCET, V1, P1182; Mo R, 2015, J PROTEOME RES, V14, P1275, DOI 10.1021/pr501275a; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Ouidir T, 2016, PROTEOMICS, V16, P301, DOI 10.1002/pmic.201500258; Ouidir T, 2015, PROTEOMICS, V15, P2152, DOI 10.1002/pmic.201500056; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; PEDERSEN A H B, 1971, Northwest Medicine, V70, P255; Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Rohde KH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1186, DOI 10.2741/1133; Rychli K, 2014, METHODS MOL BIOL, V1157, P187, DOI 10.1007/978-1-4939-0703-8_16; Schilling B, 2015, MOL MICROBIOL; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Sule P, 2009, LETT APPL MICROBIOL, V49, P299, DOI 10.1111/j.1472-765X.2009.02659.x; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2016, CURR GENET, V62, P335, DOI 10.1007/s00294-015-0552-4; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2012, GLOB ACT PLAN CONTR; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000; Zielke RA, 2016, MOL CELL PROTEOMICS, V15, P2338, DOI 10.1074/mcp.M116.058800	66	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179621	10.1371/journal.pone.0179621	http://dx.doi.org/10.1371/journal.pone.0179621			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654654	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500022
J	Akiyama, T; Katsumura, T; Nakagome, S; Lee, SI; Joh, K; Soejima, H; Fujimoto, K; Kimura, R; Ishida, H; Hanihara, T; Yasukouchi, A; Satta, Y; Higuchi, S; Oota, H				Akiyama, Tokiho; Katsumura, Takafumi; Nakagome, Shigeki; Lee, Sang-il; Joh, Keiichiro; Soejima, Hidenobu; Fujimoto, Kazuma; Kimura, Ryosuke; Ishida, Hajime; Hanihara, Tsunehiko; Yasukouchi, Akira; Satta, Yoko; Higuchi, Shigekazu; Oota, Hiroki			An ancestral haplotype of the human PERIOD2 gene associates with reduced sensitivity to light-induced melatonin suppression	PLOS ONE			English	Article							DIURNAL PREFERENCE; CLOCK GENE; NATURAL-SELECTION; POLYMORPHISM; EVOLUTION; MOUSE; POPULATIONS; MELANOPSIN; SECRETION; INSIGHTS	Humans show various responses to the environmental stimulus in individual levels as "physiological variations." However, it has been unclear if these are caused by genetic variations. In this study, we examined the association between the physiological variation of response to light-stimulus and genetic polymorphisms. We collected physiological data from 43 subjects, including light-induced melatonin suppression, and performed haplotype analyses on the clock genes, PER2 and PER3, exhibiting geographical differentiation of allele frequencies. Among the haplotypes of PER3, no significant difference in light sensitivity was found. However, three common haplotypes of PER2 accounted for more than 96% of the chromosomes in subjects, and 1 of those 3 had a significantly low-sensitive response to light-stimulus (P < 0.05). The homozygote of the low-sensitive PER2 haplotype showed significantly lower percentages of melatonin suppression (P 0.05), and the heterozygotes of the haplotypes varied their ratios, indicating that the physiological variation for light-sensitivity is evidently related to the PER2 polymorphism. Compared with global haplotype frequencies, the haplotype with a low-sensitive response was more frequent in Africans than in non-Africans, and came to the root in the phylogenetic tree, suggesting that the low light-sensitive haplotype is the ancestral type, whereas the other haplotypes with high sensitivity to light are the derived types. Hence, we speculate that the high light-sensitive haplotypes have spread throughout the world after the Out-of-Africa migration of modern humans.	[Akiyama, Tokiho; Katsumura, Takafumi; Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan; [Akiyama, Tokiho] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa, Japan; [Akiyama, Tokiho; Satta, Yoko] SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Nakagome, Shigeki] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo, Japan; [Nakagome, Shigeki] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Lee, Sang-il; Yasukouchi, Akira; Higuchi, Shigekazu] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka, Japan; [Joh, Keiichiro; Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga, Japan; [Fujimoto, Kazuma] Saga Univ, Fac Med, Dept Internal Med, Saga, Japan; [Kimura, Ryosuke; Ishida, Hajime] Univ Ryukyus, Fac Med, Dept Human Biol & Anat, Nishihara, Okinawa, Japan; [Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Grad Sch Med Sci, Dept Biol Struct, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Chicago; Kyushu University; Saga University; Saga University; University of the Ryukyus; Kitasato University	Oota, H (corresponding author), Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan.; Higuchi, S (corresponding author), Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, Fukuoka, Japan.; Oota, H (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Biol Struct, Sagamihara, Kanagawa, Japan.	higu-s@design.kyushu-u.ac.jp; hiroki_oota@med.kitasato-u.ac.jp	HIGUCHI, Shigekazu/AAM-5800-2020	Satta, Yoko/0000-0002-5305-493X; Nakagome, Shigeki/0000-0001-9613-975X; Akiyama, Tokiho/0000-0002-9050-1014; Lee, Sangil/0000-0001-8998-5827; higuchi, shigekazu/0000-0001-7131-0792; Soejima, Hidenobu/0000-0001-5076-6563	Japan Society for the Promotion of Science (JSPS) [22370087]; University of the Ryukyus Strategic Research Grant; JSPS [24370102, 25251046, 24370099]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of the Ryukyus Strategic Research Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	HI was supported by Grants-in-Aid for Scientific Research (B) (22370087) from the Japan Society for the Promotion of Science (JSPS) and University of the Ryukyus Strategic Research Grant. SH was supported by Grant-in-Aid for Scientific Research (B) (24370102) from JSPS. AY and HO were supported by Grant-in-Aid for Scientific Research (A) (25251046) from JSPS. HO was supported by Grant-in-Aid for Scientific Research (B) (24370099) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Carpen JD, 2005, J SLEEP RES, V14, P293, DOI 10.1111/j.1365-2869.2005.00471.x; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Cruciani F, 2008, EUR J HUM GENET, V16, P1526, DOI 10.1038/ejhg.2008.105; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Daneault V, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0091-9; Ebisawa T, 2007, J PHARMACOL SCI, V103, P150, DOI 10.1254/jphs.FMJ06003X5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Gooley Joshua J, 2011, J Clin Endocrinol Metab, V96, pE463, DOI 10.1210/jc.2010-2098; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han Y, 2007, AM J HUM GENET, V80, P441, DOI 10.1086/512485; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Higuchi S, 2008, NEUROSCI LETT, V440, P23, DOI 10.1016/j.neulet.2008.05.037; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; Higuchi S, 2007, CHRONOBIOL INT, V24, P31, DOI 10.1080/07420520601139805; Higuchi S, 2014, J CLIN ENDOCR METAB, V99, P3298, DOI 10.1210/jc.2014-1629; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; ISHIHARA K, 1984, PERCEPT MOTOR SKILL, V59, P863, DOI 10.2466/pms.1984.59.3.863; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; LAAKSO ML, 1991, NATO ADV SCI I A-LIF, V204, P307; Lee HJ, 2011, BEHAV GENET, V41, P273, DOI 10.1007/s10519-010-9396-3; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Matsuo M, 2007, SLEEP BIOL RHYTHMS, V5, P141, DOI 10.1111/j.1479-8425.2007.00264.x; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; Nakagome S, 2012, MOL BIOL EVOL, V29, P1569, DOI 10.1093/molbev/mss006; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Ojeda DA, 2013, NEUROSCI LETT, V553, P52, DOI 10.1016/j.neulet.2013.08.016; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh K, 2003, SLEEP, V26, P416, DOI 10.1093/sleep/26.4.416; Satta Y, 2004, J MOL EVOL, V59, P478, DOI 10.1007/s00239-004-2639-2; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Song HM, 2016, CHRONOBIOL INT, V33, P1455, DOI 10.1080/07420528.2016.1231199; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yasukouchi Akira, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P243, DOI 10.2114/jpa.24.243	83	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0178373	10.1371/journal.pone.0178373	http://dx.doi.org/10.1371/journal.pone.0178373			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650999	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300001
J	Shanmugasundaram, B; Aher, YD; Aradska, J; Ilic, M; Feyissa, DD; Kalaba, P; Aher, NY; Dragacevic, V; Marouf, BS; Langer, T; Sitte, HH; Hoeger, H; Lubec, G; Korz, V				Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Ilic, Marija; Feyissa, Daniel Daba; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry; Sitte, Harald H.; Hoeger, Harald; Lubec, Gert; Korz, Volker			R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOPAMINE TRANSPORTER; REACTION-TIME; IN-VIVO; ARMODAFINIL; PERFORMANCE; DRUG; MAZE; RATS; STIMULATION	Modafinil is a wake promoting drug approved for clinical use and also has cognitive enhancing properties. Its enantiomer R-Modafinil (R-MO) is not well studied in regard to cognitive enhancing properties. Hence we studied its effect in a spatial memory paradigm and its possible effects on dentate gyrus long-term potentiation (DG-LTP). Clinically relevant doses of R-MO, vehicle dimethyl sulfoxide (DMSO) or saline were administered for three days during the hole-board test and in in vivo DG-LTP. Synaptic levels of dopamine receptors D1R, D2R, dopamine transporter (DAT), and its phosphorylated form (ph-DAT) in DG tissue 4 h after LTP induction were quantified by western blot analysis. Monoamine reuptake and release assays were performed by using transfected HEK-293 cells. Possible neurotoxic side effects on general behaviour were also studied. R-MO at both doses significantly enhanced spatial reference memory during the last training session and during memory retrieval compared to DMSO vehicle but not when compared to saline treated rats. Similarly, R-MO rescues DG-LTP from impairing effects of DMSO. DMSO reduced memory performance and LTP magnitude when compared to saline treated groups. The synaptic DR1 levels in R-MO groups were significantly decreased compared to DMSO group but were comparable with saline treated animals. We found no effect of R-MO in neurotoxicity tests. Thus, our results support the notion that LTP-like synaptic plasticity processes could be one of the factors contributing to the cognitive enhancing effects of spatial memory traces. D1R may play an important regulatory role in these processes.	[Shanmugasundaram, Bharanidharan; Aher, Yogesh D.; Aradska, Jana; Feyissa, Daniel Daba; Korz, Volker] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Ilic, Marija; Kalaba, Predrag; Aher, Nilima Y.; Dragacevic, Vladimir; Marouf, Babak Saber; Langer, Thierry] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria; [Sitte, Harald H.] Med Univ Vienna, Ctr Addict Res & Sci, Vienna, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, Himberg, Austria; [Lubec, Gert] Neuroprote Lab, Sci Pk, Bratislava, Slovakia	Medical University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Korz, V (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.; Lubec, G (corresponding author), Neuroprote Lab, Sci Pk, Bratislava, Slovakia.	gert.lubec@lubeclab.com; volker.korz@medunwien.ac.at	Sitte, Harald/N-2681-2013; Kalaba, Predrag/D-4227-2018; Langer, Thierry/U-8621-2017	Sitte, Harald/0000-0002-1339-7444; Langer, Thierry/0000-0002-5242-1240; Kalaba, Predrag/0000-0003-0480-2337; Lubec, Jana/0000-0003-0657-7647; Feyissa, Daniel/0000-0002-5623-3693	Medical University of Viennato GL	Medical University of Viennato GL	This work was supported by the Medical University of Viennato GL.	Andrade C, 2016, J CLIN PSYCHIAT, V77, pE25, DOI 10.4088/JCP.15f10580; Andrade C, 2015, J CLIN PSYCHIAT, V76, P1633, DOI 10.4088/JCP.15f10514; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barch DM, 2004, PSYCHOPHARMACOLOGY, V174, P126, DOI 10.1007/s00213-003-1732-3; Baumann MH, 2013, NEUROPSYCHOPHARMACOL, V38, P552, DOI 10.1038/npp.2012.204; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burgos H, 2010, BRAIN RES BULL, V83, P238, DOI 10.1016/j.brainresbull.2010.08.010; Burrows BT, 2015, J DRUG ALCOHOL RES, V4; Cao BJ, 1996, BEHAV PHARMACOL, V7, P810; Chapman JL, 2016, EUR RESPIR J, V47, P1420, DOI 10.1183/13993003.01509-2015; Darwish M, 2009, CLIN DRUG INVEST, V29, P613, DOI 10.2165/11315280-000000000-00000; DRAYER DE, 1986, CLIN PHARMACOL THER, V40, P125, DOI 10.1038/clpt.1986.150; Engber TM, 1998, NEUROSCIENCE, V87, P905, DOI 10.1016/S0306-4522(98)00015-3; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gangarossa G, 2014, HIPPOCAMPUS, V24, P1466, DOI 10.1002/hipo.22327; Gilbert ME, 2006, BRAIN RES, V1069, P10, DOI 10.1016/j.brainres.2005.10.049; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; JARBE TUC, 1994, PHARMACOL BIOCHEM BE, V47, P113, DOI 10.1016/0091-3057(94)90119-8; Karabacak Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3339/fnbeh.2015.00215, 10.3389/fnbeh.2015.00215]; KNOWLES WD, 1981, J NEUROSCI, V1, P318; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; KRUG M, 1983, BRAIN RES BULL, V11, P1, DOI 10.1016/0361-9230(83)90048-5; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; Markvartova V, 2013, NEUROSCI LETT, V543, P142, DOI 10.1016/j.neulet.2013.03.034; McElhiney M, 2013, J CLIN EXP NEUROPSYC, V35, P718, DOI 10.1080/13803395.2013.823910; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mehta MA, 2006, CURR PHARM DESIGN, V12, P2487, DOI 10.2174/138161206777698891; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Morgan RE, 2007, PHARMACOL BIOCHEM BE, V86, P531, DOI 10.1016/j.pbb.2007.01.015; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Niu L, 2009, HIPPOCAMPUS, V19, P649, DOI 10.1002/hipo.20540; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Penazzi L, 2017, NEUROPHARMACOLOGY, V113, P434, DOI 10.1016/j.neuropharm.2016.10.020; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Sabine S., 2011, DISSECTION RODENT BR, P13; Saper CB, 2004, SLEEP, V27, P11; Saroja SR, 2016, BEHAV BRAIN RES, V312, P127, DOI 10.1016/j.bbr.2016.06.011; Sase A, 2016, NEUROPHARMACOLOGY, V102, P186, DOI 10.1016/j.neuropharm.2015.07.039; Scholze P, 2000, J PHARMACOL EXP THER, V293, P870; Shanmugasundaram B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00220; Shuman T, 2009, BEHAV NEUROSCI, V123, P257, DOI 10.1037/a0014366; Spencer RC, 2015, BIOL PSYCHIAT, V77, P940, DOI 10.1016/j.biopsych.2014.09.013; STANTON PK, 1985, BRAIN RES, V361, P276, DOI 10.1016/0006-8993(85)91299-5; Stanton PK, 2006, SYNAPTIC PLASTICITY; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sutton LP, 2015, NEUROPHARMACOLOGY, V99, P610, DOI 10.1016/j.neuropharm.2015.08.024; Taneja I, 2005, HYPERTENSION, V45, P612, DOI 10.1161/01.HYP.0000158267.66763.63; Tsanov M, 2010, NEUROPHARMACOLOGY, V59, P9, DOI 10.1016/j.neuropharm.2010.03.010; Waters KA, 2005, J PSYCHOPHARMACOL, V19, P149, DOI 10.1177/0269881105048995; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wittkampf LC, 2012, THER ADV PSYCHOPHARM, V2, P115, DOI 10.1177/2045125312441815; Yang K, 2014, J NEUROSCI, V34, P15888, DOI 10.1523/JNEUROSCI.2400-14.2014	60	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179675	10.1371/journal.pone.0179675	http://dx.doi.org/10.1371/journal.pone.0179675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644892	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100031
J	Droz, BA; Sneed, BL; Jackson, CV; Zimmerman, KM; Michael, MD; Emmerson, PJ; Coskun, T; Peterson, RG				Droz, Brian A.; Sneed, Bria L.; Jackson, Charles V.; Zimmerman, Karen M.; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer; Peterson, Richard G.			Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse	PLOS ONE			English	Article							OBESE-HYPERGLYCEMIC MICE; BETA-CELL FUNCTION; METABOLIC SYNDROME; INSULIN-RESISTANCE; LEPTIN; C57BL/6J; INFLAMMATION; ONSET; OUTCOMES; STRAINS	Obesity in many current pre-clinical animal models of obesity and diabetes is mediated by monogenic mutations; these are rarely associated with the development of human obesity. A new mouse model, the FATZO mouse, has been developed to provide polygenic obesity and a metabolic pattern of hyperglycemia and hyperinsulinemia, that support the presence of insulin resistance similar to metabolic disease in patients with insulin resistance/type 2 diabetes. The FATZO mouse resulted from a cross of C57BL/6J and AKR/J mice followed by selective inbreeding for obesity, increased insulin and hyperglycemia. Since many clinical studies have established a close link between higher body weight and the development of type 2 diabetes, we investigated whether time to progression to type 2 diabetes or disease severity in FATZO mice was dependent on weight gain in young animals. Our results indicate that lighter animals developed metabolic disturbances much slower and to a lesser magnitude than their heavier counterparts. Consumption of a diet containing high fat, accelerated weight gain in parallel with disease progression. A naturally occurring and significant variation in the body weight of FATZO offspring enables these mice to be identified as low, mid and high body weight groups at a young age. These weight groups remain into adulthood and correspond to slow, medium and accelerated development of type 2 diabetes. Thus, body weight inclusion criteria can optimize the FATZO model for studies of prevention, stabilization or treatment of type 2 diabetes.	[Droz, Brian A.; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Sneed, Bria L.] Ball State Univ, Muncie, IN 47306 USA; [Jackson, Charles V.; Zimmerman, Karen M.; Peterson, Richard G.] Crown Biosci Indiana, Indianapolis, IN 46268 USA	Eli Lilly; Ball State University	Peterson, RG (corresponding author), Crown Biosci Indiana, Indianapolis, IN 46268 USA.	rpeterson@crownbio.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065	SBIR grant from NIH [2R44DK082065]; Eli Lilly and Company; Crown Bioscience Indiana	SBIR grant from NIH; Eli Lilly and Company(Eli Lilly); Crown Bioscience Indiana	This project was partially funded by an SBIR grant from NIH (2R44DK082065) to PreClinOmics. The remainder of the funding was supplied by Eli Lilly and Company in the form of salaries for authors BAD, BLS, MDM, PJE, and TC but it did not have any additional role in the study design, data collection and analysis. Funding was also supplied by PreClinOmics (now Crown Bioscience Indiana) for authors CVJ, KMZ, and RGP in the form of salaries and other compensation. RGP was one of the owners and CSO for PreClinOmics and was the principal investigator on the SBIR grants and as such was responsible for the animal model development before, during and after the tenure of the SBIR funding and as such, was involved in study design, data collection, data analysis and manuscript production. CVJ is the general manager and CSO of Crown Bioscience Indiana and as such, since March 2016, was partially responsible for the continued support of the project in the form of material, salaries, study design, data collection, data analysis and manuscript production. The other specific roles of these authors are articulated in the "author contributions" section.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Artham SM, 2009, OCHSNER J, V9, P124; Aydin S, 2014, NUTRITION, V30, P1, DOI 10.1016/j.nut.2013.05.013; Bowles L, 2001, J CLIN PATHOL, V54, P1, DOI 10.1136/jcp.54.1.1; Cottrell Elizabeth C, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-24716-3_1; Crespo PS, 2007, PUBLIC HEALTH NUTR, V10, P1121, DOI 10.1017/S1368980007000596; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Davis RC, 2010, DIABETES, V59, P1616, DOI 10.2337/db09-0878; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Deshmukh VL, 2016, J OBSTET GYN INDIA, V66, P192, DOI 10.1007/s13224-015-0825-3; Do OH, 2016, DIABETOLOGIA, V59, P1222, DOI 10.1007/s00125-016-3942-3; DUBUC PU, 1982, HORM METAB RES, V14, P532, DOI 10.1055/s-2007-1019069; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Goday A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.36; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Hannema SE, 2016, HORM RES PAEDIAT, V85, P412, DOI 10.1159/000444055; Imai Y, 2008, PHYSIOL GENOMICS, V36, P43, DOI 10.1152/physiolgenomics.00050.2008; Kanat M, 2015, WORLD J DIABETES, V6, P1207, DOI 10.4239/wjd.v6.i12.1207; Kozak LP, 2002, ANN NY ACAD SCI, V967, P80; Krug EG, 2016, LANCET, V387, P1485, DOI 10.1016/S0140-6736(16)30163-5; Leow MK, 2015, NEW ENGL J MED, V372, P1266, DOI 10.1056/NEJMc1501146; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lichtenstein AH, 1998, NUTR REV, V56, pS3; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Lindstrom P, 2010, ADV EXP MED BIOL, V654, P463, DOI 10.1007/978-90-481-3271-3_20; Ling C, 2016, DIABETOLOGIA, V59, P2295, DOI 10.1007/s00125-016-4109-y; Lopez-Candales Angel, 2001, Journal of Medicine (Westbury), V32, P283; Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662; Madan JC, 2009, CYTOKINE, V47, P61, DOI 10.1016/j.cyto.2009.05.004; Medina-Gomez G, 2009, DIS MODEL MECH, V2, P582, DOI 10.1242/dmm.003251; Mingrone G, 2016, SURG OBES RELAT DIS, V12, P1199, DOI 10.1016/j.soard.2016.05.013; Mirhashemi F, 2008, OBESITY FACTS, V1, P292, DOI 10.1159/000176064; Nagayama D, 2016, J HYPERTENS, V34, pE73, DOI 10.1097/01.hjh.0000500040.08261.74; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicolau J, 2015, ACTA DIABETOL, V52, P1037, DOI 10.1007/s00592-015-0742-z; NISHINA PM, 1993, J LIPID RES, V34, P1413; Peterson RG, 2017, GLUCOSE DYSREGULATIO; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Reaven GM, 2009, CAN MED ASSOC J, V180, P601, DOI 10.1503/cmaj.090092; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Scheithauer TPM, 2016, MOL METAB, V5, P759, DOI 10.1016/j.molmet.2016.06.002; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; Shafrir E, 1999, ANN NY ACAD SCI, V892, P223, DOI 10.1111/j.1749-6632.1999.tb07798.x; Smith BK, 2000, AM J PHYSIOL-REG I, V278, pR797, DOI 10.1152/ajpregu.2000.278.4.R797; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stanford J, 2012, J DIABETES MELLITUS, V2, P126, DOI DOI 10.4236/JDM.2012.21021; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uchoa M.F., 2016, FRONT NEUROENDOCRINO; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Weker Halina, 2006, Med Wieku Rozwoj, V10, P3; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025	61	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179808	10.1371/journal.pone.0179808	http://dx.doi.org/10.1371/journal.pone.0179808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640904	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800068
J	Jiang, C; Geng, JJ; Hu, HD; Ma, HJ; Gao, XS; Ren, HQ				Jiang, Cong; Geng, Jinju; Hu, Haidong; Ma, Haijun; Gao, Xingsheng; Ren, Hongqiang			Impact of selected non-steroidal anti-inflammatory pharmaceuticals on microbial community assembly and activity in sequencing batch reactors	PLOS ONE			English	Article							WASTE-WATER TREATMENT; AEROBIC GRANULAR SLUDGE; PERSONAL CARE PRODUCTS; SEWAGE-TREATMENT PLANTS; ACTIVATED-SLUDGE; MEMBRANE BIOREACTOR; BACTERIAL COMMUNITIES; ACIDIC PHARMACEUTICALS; PYROSEQUENCING REVEALS; OXIDATIVE STRESS	This study covers three widely detected non-steroidal anti-inflammatory pharmaceuticals (NSAIDs), diclofenac (DCF), ibuprofen (IBP) and naproxen (NPX), as NSAIDs pollutants. The objective is to evaluate the impact of NSAIDs at their environmental concentrations on microbial community assembly and activity. The exposure experiments were conducted under three conditions (5 mu g L-1 DCF, 5 mu g L-1 DCF+5 mu g L-1 IBP and 5 mu g L-1 DCF+5 mu g L-1 IBP+5 mu g L-1 NPX) in sequencing batch reactors (SBRs) for 130 days. Removals of COD and NH4+-N were not affected but total nitrogen (TN) removal decreased. IBP and NPX had the high removal efficiencies (79.96% to 85.64%), whereas DCF was more persistent (57.24% to 64.12%). In addition, the decreased removals of TN remained the same under the three conditions (p > 0.05). The results of oxidizing enzyme activities, live cell percentages and extracellular polymeric substances (EPS) indicated that NSAIDs damaged the cell walls or microorganisms and the mixtures of the three NSAIDs increased the toxicity. The increased Shannon-Wiener diversity index suggested that bacterial diversity was increased with the addition of selected NSAIDs. Bacterial ribosomal RNA small subunit (16S) gene sequencing results indicated that Actinobacteria and Bacteroidetes were enriched, while Micropruina and Nakamurella decreased with the addition of NSAIDs. The enrichment of Actinobacteria and Bacteroidetes indicated that both of them might have the ability to degrade NSAIDs and thereby could adapt well with the presence of NSAIDs.	[Jiang, Cong; Geng, Jinju; Hu, Haidong; Ma, Haijun; Gao, Xingsheng; Ren, Hongqiang] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing, Jiangsu, Peoples R China	Nanjing University	Geng, JJ (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing, Jiangsu, Peoples R China.	jjgeng@nju.edu.cn	hq, ren/AGA-1128-2022	Hu, Haidong/0000-0003-0193-0333; Ren, Hong-qiang/0000-0001-6136-800X	National Natural Science Foundation of China [21677071, 51278241]; Jiangsu Natural Science Foundation [BK20161474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (http://www.nstc.gov.cn/) (No. 21677071, 51278241) and the Jiangsu Natural Science Foundation (http://www.jstd.gov.cn/) (No. BK20161474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 21677071, 51278241) and the Jiangsu Natural Science Foundation (No. BK20161474).	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Amorim CL, 2014, WATER RES, V50, P101, DOI 10.1016/j.watres.2013.10.043; Arriaga S, 2016, WATER RES, V107, P37, DOI 10.1016/j.watres.2016.10.046; Bag S, 1995, ECOTOX ENVIRON SAFE, V42, P163; Martin MMB, 2011, J IND MICROBIOL BIOT, V38, P1171, DOI 10.1007/s10295-010-0892-5; Brozinski JM, 2013, ENVIRON SCI TECHNOL, V47, P342, DOI 10.1021/es303013j; Caracciolo AB, 2015, J PHARMACEUT BIOMED, V106, P25, DOI 10.1016/j.jpba.2014.11.040; Carr DL, 2011, WATER AIR SOIL POLL, V216, P633, DOI 10.1007/s11270-010-0558-y; Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031; Cycon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01969; Delgado LF, 2010, BIORESOURCE TECHNOL, V101, P527, DOI 10.1016/j.biortech.2009.08.051; Diniz MS, 2015, SCI TOTAL ENVIRON, V505, P282, DOI 10.1016/j.scitotenv.2014.09.103; Domaradzka D, 2015, REV ENVIRON SCI BIO, V14, P229, DOI 10.1007/s11157-015-9364-8; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Duan YP, 2013, ENVIRON SCI POLLUT R, V20, P108, DOI 10.1007/s11356-012-1000-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; El-Megharbel SM, 2015, SPECTROCHIM ACTA A, V135, P915, DOI 10.1016/j.saa.2014.07.101; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Gargouri B, 2014, J CHEM TECHNOL BIOT, V89, P978, DOI 10.1002/jctb.4188; Grenni P, 2014, ENVIRON SCI POLLUT R, V21, P13470, DOI 10.1007/s11356-014-3276-y; Huang MH, 2015, J HAZARD MATER, V298, P303, DOI 10.1016/j.jhazmat.2015.05.039; Kermia AEB, 2016, CR CHIM, V19, P963, DOI 10.1016/j.crci.2016.05.005; Kimura K, 2007, ENVIRON SCI TECHNOL, V41, P3708, DOI 10.1021/es061684z; Kor-Bicakci G, 2016, BIORESOURCE TECHNOL, V206, P65, DOI 10.1016/j.biortech.2016.01.069; Kraigher B, 2008, WATER RES, V42, P4578, DOI 10.1016/j.watres.2008.08.006; Kruglova A, 2014, SCI TOTAL ENVIRON, V499, P394, DOI 10.1016/j.scitotenv.2014.08.069; Lawrence JR, 2007, ENVIRON TOXICOL CHEM, V26, P573, DOI 10.1897/06-340R.1; Li D, 2011, WATER RES, V45, P6063, DOI 10.1016/j.watres.2011.09.002; Louvet JN, 2010, PROCESS BIOCHEM, V45, P1787, DOI 10.1016/j.procbio.2010.03.036; Ma SJ, 2016, BIORESOURCE TECHNOL, V214, P645, DOI 10.1016/j.biortech.2016.04.132; Okuda T, 2009, ENVIRON INT, V35, P815, DOI 10.1016/j.envint.2009.01.006; Pala-Ozkok I, 2014, BIOCHEM ENG J, V90, P195, DOI 10.1016/j.bej.2014.06.003; Prior JE, 2010, APPL MICROBIOL BIOT, V85, P625, DOI 10.1007/s00253-009-2135-0; Quan XC, 2015, SCI TOTAL ENVIRON, V506, P226, DOI [10.1016/j.sdtotenv.2014.11.015, 10.1016/j.scitotenv.2014.11.015]; Radjenovic J, 2009, WATER RES, V43, P831, DOI 10.1016/j.watres.2008.11.043; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Schnell A, 2000, WATER RES, V34, P493, DOI 10.1016/S0043-1354(99)00160-8; Shi YJ, 2013, BIORESOURCE TECHNOL, V139, P170, DOI 10.1016/j.biortech.2013.03.037; Sui Q, 2011, ENVIRON SCI TECHNOL, V45, P3341, DOI 10.1021/es200248d; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Tixier C, 2003, ENVIRON SCI TECHNOL, V37, P1061, DOI 10.1021/es025834r; Verlicchi P, 2012, SCI TOTAL ENVIRON, V429, P123, DOI 10.1016/j.scitotenv.2012.04.028; Vieno N, 2014, ENVIRON INT, V69, P28, DOI 10.1016/j.envint.2014.03.021; Wakelin S, 2012, J GEOCHEM EXPLOR, V112, P262, DOI 10.1016/j.gexplo.2011.09.005; Wang S, 2008, ENVIRON SCI TECHNOL, V42, P1091, DOI 10.1021/es072026x; Wang SY, 2011, WATER RES, V45, P3398, DOI 10.1016/j.watres.2011.03.055; Wang SY, 2011, CHEMOSPHERE, V82, P565, DOI 10.1016/j.chemosphere.2010.10.007; Wang XC, 2016, APPL MICROBIOL BIOT, V100, P8213, DOI 10.1007/s00253-016-7577-6; Wang ZW, 2009, WATER RES, V43, P2504, DOI 10.1016/j.watres.2009.02.026; Wang ZC, 2016, BIORESOURCE TECHNOL, V205, P213, DOI 10.1016/j.biortech.2016.01.067; Zhang DQ, 2016, ECOL ENG, V90, P215, DOI 10.1016/j.ecoleng.2015.12.043; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang Y, 2015, ECOTOX ENVIRON SAFE, V119, P132, DOI 10.1016/j.ecoenv.2015.04.034; Zhang YY, 2016, SCI TOTAL ENVIRON, V571, P479, DOI 10.1016/j.scitotenv.2016.07.014; Zhao X, 2015, APPL MICROBIOL BIOT, V99, P425, DOI 10.1007/s00253-014-5984-0; Zhu Y, 2015, BIORESOURCE TECHNOL, V180, P345, DOI 10.1016/j.biortech.2015.01.006	56	21	24	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179236	10.1371/journal.pone.0179236	http://dx.doi.org/10.1371/journal.pone.0179236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640897	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800024
J	Wu, YH; Cheng, H; Xu, L; Jin, XB; Wang, CS; Xu, XW				Wu, Yue-Hong; Cheng, Hong; Xu, Lin; Jin, Xiong-Bin; Wang, Chun-Sheng; Xu, Xue-Wei			Physiological and genomic features of a novel violacein-producing bacterium isolated from surface seawater	PLOS ONE			English	Article							POLYSACCHARIDE-PRODUCING BACTERIUM; DEEP-SEA SEDIMENT; SP-NOV.; MAXIMUM-LIKELIHOOD; SEQUENCE DATA; GEN. NOV.; RNA GENES; SOFTWARE; SERVER; ENVIRONMENT	Strains JW1(T) and JW3, isolated from surface seawater of the Arabian Sea, were subjected to polyphasic taxonomic analysis. Cells of both strains were Gram-stain-negative, aerobic, and rod-shaped. They formed violet pigment and produced violacein. On the basis of 16S rRNA gene sequence analysis, strains JW1(T) and JW3 showed high 16S rRNA gene sequence similarity with Pseudoalteromonas byunsanensis JCM12483(T) (98.2%), P. shioyasakiensis SE3(T) (97.8%), P. arabiensis JCM 17292(T) (97.3%), and P. gelatinilytica NH153(T) (97.1%). The 16S rRNA gene sequence similarity between JW1T and JW3 was 100%. Phylogenetic analyses revealed that both strains fell within the cluster of the genus Pseudoalteromonas and represented an independent lineage. The average nucleotide identity and in silico DNA-DNA hybridization values between JW1(T) and type strains of the closely related Pseudoalteromonas species were 70.9-83.3% and 20.0-26.4%, respectively. The sole respiratory quinone in both strains is ubiquinone 8 (Q-8). The principal fatty acids are summed feature 3 (C-16: 1.omega 7c and/or iso-C-15:0 2OH), C-18: 1 omega 7c, and C-16:0. The major polar lipids are phosphatidylethanolamine, phosphatidylglycerol, one unidentified glycolipid, one unidentified aminolipid, and one unidentified phospholipid. The DNA G+C content was 43.3 mol%. Differential phylogenetic distinctiveness, chemotaxonomic differences, and phenotypic properties indicated that strains JW1(T) and JW3 could be differentiated from the Pseudoalteromonas species with validly published names. Therefore, it is proposed that strains JW1(T) and JW3 represent a novel species of the genus Pseudoalteromonas, for which the name Pseudoalteromonas amylolytica sp. nov. (type strain, JW1(T) = CGMCC 1.15681(T) = KCTC 52406(T) = MCCC 1K02162(T)) is proposed.	[Wu, Yue-Hong; Cheng, Hong; Xu, Lin; Jin, Xiong-Bin; Wang, Chun-Sheng; Xu, Xue-Wei] State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China	State Oceanic Administration	Xu, XW (corresponding author), State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China.	xuxw@sio.org.cn			National Natural Science Foundation of China [41406174]; National Key Basic Research Program of China [2014CB441503]; Natural Science Foundation of Zhejiang Province [LR17D060001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China granted to YW (no. 41406174, http://ww.nstc.gov.cn/publish/portal-1/); the National Key Basic Research Program of China granted to XX (2014CB441503, htt:// most.gov.cn/); the Natural Science Foundation of Zhejiang Province granted to XX (LR17D060001, http://www.zjnst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye AM, 2015, MICROBIOL-SGM, V161, P2039, DOI 10.1099/mic.0.000147; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bowman JP, 2005, BERGEYS MANUAL SYSTE, P467; Chen C, 2017, INT J SYST EVOL MICR, V67, P778, DOI 10.1099/ijsem.0.001580; Dong XZ, 2001, DETERMINATIVE MANUAL; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Farmer J.J., 2005, BERGEYS MANUAL SYSTE, V2, P494; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GAUTHIER G, 1995, INT J SYST BACTERIOL, V45, P755, DOI 10.1099/00207713-45-4-755; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Ivanova E.P., 2014, PROKARYOTES, V28, P575, DOI [10.1007/978-3-642-38922-1_229, DOI 10.1007/978-3-642-38922-1_229]; Ivanova EP, 2004, INT J SYST EVOL MICR, V54, P1773, DOI 10.1099/ijs.0.02997-0; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; LEIFSON E, 1963, J BACTERIOL, V85, P1183, DOI 10.1128/JB.85.5.1183-1184.1963; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsuyama H, 2014, INT J SYST EVOL MICR, V64, P101, DOI 10.1099/ijs.0.055558-0; Matsuyama H, 2013, INT J SYST EVOL MICR, V63, P1805, DOI 10.1099/ijs.0.043604-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Park YD, 2005, INT J SYST EVOL MICR, V55, P2519, DOI 10.1099/ijs.0.63750-0; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Romanenko LA, 2003, INT J SYST EVOL MICR, V53; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sun HN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0545-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tindall B. J., 2007, METHODS GEN MOL MICR, P330, DOI DOI 10.1128/9781555817497.CH15; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Wu YH, 2015, INT J SYST EVOL MICR, V65, P3645, DOI 10.1099/ijsem.0.000469; Wu YH, 2014, INT J SYST EVOL MICR, V64, P116, DOI 10.1099/ijs.0.052951-0; Xu XW, 2007, INT J SYST EVOL MICR, V57, P1619, DOI 10.1099/ijs.0.65022-0; Xu XW, 2010, INT J SYST EVOL MICR, V60, P2176, DOI 10.1099/ijs.0.017673-0; Yada S, 2008, MAR BIOTECHNOL, V10, P128, DOI 10.1007/s10126-007-9046-9; Yan J, 2016, INT J SYST EVOL MICR, V66, P3538, DOI 10.1099/ijsem.0.001224; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179997	10.1371/journal.pone.0179997	http://dx.doi.org/10.1371/journal.pone.0179997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640915	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800089
J	Roarty, K; Pfefferle, AD; Creighton, CJ; Perou, CM; Rosen, JM				Roarty, K.; Pfefferle, A. D.; Creighton, C. J.; Perou, C. M.; Rosen, J. M.			Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression	ONCOGENE			English	Article							BREAST-CANCER; GENE-EXPRESSION; TYROSINE KINASE; ERM PROTEINS; PATHWAY; HETEROGENEITY; ROR2; MODEL; ACTIVATION; PREDICTS	Cellular heterogeneity is a common feature in breast cancer, yet an understanding of the coexistence and regulation of various tumor cell subpopulations remains a significant challenge in cancer biology. In the current study, we approached tumor cell heterogeneity from the perspective of Wnt pathway biology to address how different modes of Wnt signaling shape the behaviors of diverse cell populations within a heterogeneous tumor landscape. Using a syngeneic TP53-null mouse model of breast cancer, we identified distinctions in the topology of canonical Wnt beta-catenin-dependent signaling activity and non-canonical beta-catenin-independent Ror2-mediated Wnt signaling across subtypes and within tumor cell subpopulations in vivo. We further discovered an antagonistic role for Ror2 in regulating canonical Wnt/beta-catenin activity in vivo, where lentiviral shRNA depletion of Ror2 expression augmented canonical Wnt/beta-catenin signaling activity across multiple basal-like models. Depletion of Ror2 expression yielded distinct phenotypic outcomes and divergent alterations in gene expression programs among different tumors, despite all sharing basal-like features. Notably, we uncovered cell state plasticity and adhesion dynamics regulated by Ror2, which influenced Ras Homology Family Member A (RhoA) and Rho-Associated Coiled-Coil Kinase 1 (ROCK1) activity downstream of Dishevelled-2 (Dvl2). Collectively, these studies illustrate the integration and collaboration of Wnt pathways in basal-like breast cancer, where Ror2 provides a spatiotemporal function to regulate the balance of Wnt signaling and cellular heterogeneity during tumor progression.	[Roarty, K.; Rosen, J. M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Pfefferle, A. D.; Perou, C. M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Texas Med Ctr, One Baylor Plaza,M638A, Houston, TX 77030 USA.	jrosen@bcm.edu	Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247	Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Lester and Sue Smith Breast Center Pathology Core; National Cancer Institute [NCI R01 CA016303-40, NIH R01 CA195754]; Department of Defense [W81XWH-10-0356, NIH CA125123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007495, P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA195754, R01CA016303, K22CA207463, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Lester and Sue Smith Breast Center Pathology Core; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was conducted with the help of the Baylor College of Medicine Cytometry and Cell Sorting Core (National Institutes of Health [NIH] P30 AI036211 and S10 RR024574), the Genomics and RNA Profiling Core, the Integrated Microscopy Core (NIH HD007495, DK56338 and CA125123), with funding from the Dan L. Duncan Cancer Center, the John S. Dunn Gulf Coast Consortium for Chemical Genomics and the Lester and Sue Smith Breast Center Pathology Core. We would also like to thank Yiqun Zhang for help and expertise with the microarray analysis. This work was funded by a National Cancer Institute Award NCI R01 CA016303-40 to JMR, NIH R01 CA195754 to CMP and JMR, a Department of Defense Award W81XWH-10-0356 to KPR and NIH CA125123 to CJC.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Beermann A, 2011, DEVELOPMENT, V138, P2793, DOI 10.1242/dev.063644; Borcherding N, 2015, CANCER RES, V75, P1972, DOI 10.1158/0008-5472.CAN-14-2761; Brechbuhl HM, 2011, AM J PATHOL, V179, P367, DOI 10.1016/j.ajpath.2011.03.016; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dass RA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006217; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Dembowy J, 2015, ONCOGENE, V34, P3514, DOI 10.1038/onc.2014.279; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Huang SX, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r84; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Jonsson M, 2002, CANCER RES, V62, P409; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Lawson CD, 2016, CANCER RES, V76, P3826, DOI 10.1158/0008-5472.CAN-15-2923; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Martelotto LG, 2013, BREAST CANCER RES, V16, P210; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ng CKY, 2012, EXPERT REV ANTICANC, V12, P1021, DOI [10.1586/ERA.12.85, 10.1586/era.12.85]; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Puvirajesinghe TM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10318; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Roarty K, 2015, J CELL BIOL, V208, P351, DOI 10.1083/jcb.201408058; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wang JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007963; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhang M, 2015, CANCER DISCOV, V5, P520, DOI 10.1158/2159-8290.CD-14-1101; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	75	25	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5958	5968		10.1038/onc.2017.206	http://dx.doi.org/10.1038/onc.2017.206			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650466	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000413841400005
J	Wang, J; Kho, DH; Zhou, JY; Davis, RJ; Wu, GS				Wang, J.; Kho, D. H.; Zhou, J-Y; Davis, R. J.; Wu, G. S.			MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance	ONCOGENE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; OVARIAN-CANCER CELLS; ADP-RIBOSE POLYMERASE; HUMAN BREAST-CANCER; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; EXCISION-REPAIR; THERAPEUTIC TARGET; DRUG-RESISTANCE; CARCINOMA-CELLS	Understanding the mechanisms of platinum compound resistance, including cisplatin resistance, has important implications for improving cancer treatments. Previous studies identified a potential role for mitogen-activated protein kinase phosphatase-1 (MKP-1) in cisplatin resistance. This work focuses on the regulation of poly(ADP-ribose) polymerase-1 (PARP-1) expression by MKP-1. We found that MKP-1 overexpression stimulates PARP-1 and poly(ADP-ribose) (PAR) protein expression and cisplatin resistance while its downregulation suppresses PARP-1 and PAR protein expression and cisplatin resistance. Silencing MKP-1 promoted PARP-1 ubiquitination, which decreased PARP-1 protein levels. We also found that silencing c-Jun N-terminal kinase 1/2 (JNK1/2) decreased PARP-1 ubiquitination while increasing total PARP-1 protein levels. Furthermore, we showed that acquired cisplatin-resistant ovarian cancer cells expressed high levels of MKP-1 and PARP-1 proteins, and that silencing MKP-1 or PARP-1 increased cisplatin sensitivity in resistant cells. Notably, the pharmacologic inhibition of PARP activity restored cisplatin sensitivity in MKP-1 overexpressing cells. Thus, this work indicates that suppression of JNK1/2 activity by MKP-1 maintains PARP-1 levels and suggests that MKP-1-mediated cisplatin resistance can be bypassed by PARP-1 inhibition.	[Wang, J.; Kho, D. H.; Zhou, J-Y; Wu, G. S.] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Wang, J.; Kho, D. H.; Zhou, J-Y; Wu, G. S.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Wang, J.; Kho, D. H.; Zhou, J-Y; Wu, G. S.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Davis, R. J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Davis, R. J.] Howard Hughes Med Inst, Worcester, MA USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Wu, GS (corresponding author), Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA.; Wu, GS (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA.; Wu, GS (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.	wug@karmanos.org		Davis, Roger/0000-0002-0130-1652	NIH [R01CA174949]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA174949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was, in part, supported by the NIH (R01CA174949).	Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Beale PJ, 2000, BRIT J CANCER, V82, P436; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Cheng TC, 2006, CANCER CHEMOTH PHARM, V58, P384, DOI 10.1007/s00280-005-0171-8; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; Cullen KJ, 2003, CANCER RES, V63, P8097; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson SW, 1996, EXP CELL RES, V226, P133, DOI 10.1006/excr.1996.0211; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Kwong J, 2006, NEOPLASIA, V8, P268, DOI 10.1593/neo.05502; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Michels J, 2013, CANCER RES, V73, P2271, DOI 10.1158/0008-5472.CAN-12-3000; Perego P, 1996, CANCER RES, V56, P556; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tomicic MT, 2011, CELL MOL LIFE SCI, V68, P1785, DOI 10.1007/s00018-010-0546-9; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tummala Mohan K, 2005, Clin Adv Hematol Oncol, V3, P723; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang J, 2016, AUTOPHAGY, V12, P1791, DOI 10.1080/15548627.2016.1203483; Wang J, 2014, J BIOL CHEM, V289, P17163, DOI 10.1074/jbc.M114.558288; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; WHITACRE CM, 1995, CANCER RES, V55, P3697; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	52	19	19	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5939	5947		10.1038/onc.2017.197	http://dx.doi.org/10.1038/onc.2017.197			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650468	Green Accepted			2022-12-26	WOS:000413841400003
J	Groeneveld, KM; Koenderman, L; Warren, BL; Jol, S; Leenen, LPH; Hietbrink, F				Groeneveld, Kathelijne M.; Koenderman, Leo; Warren, Brian L.; Jol, Saskia; Leenen, Luke P. H.; Hietbrink, Falco			Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: An international cohort study	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; MIGRATORY ACTIVITY; IMMUNE-RESPONSE; MAJOR TRAUMA; EXPRESSION; PATHOPHYSIOLOGY; DEFINITIONS; MECHANISMS; SEVERITY; KINETICS	Background Severe trauma can lead to the development of infectious complications after several days, such as sepsis. Early identification of patients at risk will aid anticipating these complications. The aim of this study was to test the relation between the acute (<24 hours) inflammatory response after injury measured by neutrophil responsiveness and the late (>5 days) development of septic complications and validate this in different trauma populations. Methods and findings Two prospective, observational, cohort series in the Netherlands and South Africa, consisting of severely injured trauma patients. Neutrophil responsiveness by fMLF-induced active Fc(Upsilon)RII was measured in whole blood flowcytometry, as read out for the systemic immune response within hours after trauma. Sepsis was scored daily. Ten of the 36 included Dutch patients developed septic shock. In patients with septic shock, neutrophils showed a lower expression of fMLF-induced active Fc(Upsilon)RII immediately after trauma when compared to patients without septic shock (P = 0.001). In South Africa 11 of 73 included patients developed septic shock. Again neutrophils showed lower expression of fMLF induced active Fc(Upsilon)RII (P = 0.001). In the combined cohort, all patients who developed septic shock demonstrated a decreased neutrophil responsiveness. Conclusions Low responsiveness of neutrophils for the innate stimulus fMLF immediately after trauma preceded the development of septic shock during admission by almost a week and did not depend on a geographical/racial background, hospital protocols and health care facilities. Decreased neutrophil responsiveness appears to be a prerequisite for septic shock after trauma. This might enable anticipation of this severe complication in trauma patients.	[Groeneveld, Kathelijne M.; Jol, Saskia; Leenen, Luke P. H.; Hietbrink, Falco] UMC Utrecht, Dept Surg, Utrecht, Netherlands; [Koenderman, Leo] UMC Utrecht, Dept Resp Med, Utrecht, Netherlands; [Koenderman, Leo] UMC Utrecht, Lab Translat Immunolgy, Utrecht, Netherlands; [Warren, Brian L.] Stellenbosch Univ, Tygerberg Hosp, Div Surg, Cape Town, South Africa	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Stellenbosch University; Tygerberg Hospital	Hietbrink, F (corresponding author), UMC Utrecht, Dept Surg, Utrecht, Netherlands.	F.Hietbrink@umcutrecht.nl						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Botha AJ, 1997, INTENS CARE MED, V23, P504, DOI 10.1007/s001340050365; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DEHAAS M, 1994, J IMMUNOL, V152, P900; FONTES B, 1995, J SURG RES, V58, P599, DOI 10.1006/jsre.1995.1094; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; Hietbrink F, 2006, SHOCK, V26, P558, DOI 10.1097/01.shk.0000233196.40989.78; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; Hietbrink F, 2009, INJURY, V40, P851, DOI 10.1016/j.injury.2008.11.002; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Leliefeld PHC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1250-4; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Oudijk EJD, 2006, RESP MED, V100, P1791, DOI 10.1016/j.rmed.2006.01.022; Pallister I, 2006, J TRAUMA, V60, P844, DOI 10.1097/01.ta.0000215583.08765.ce; Pallister I, 2002, CRIT CARE MED, V30, P1717, DOI 10.1097/00003246-200208000-00007; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Wang X, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0972-z	31	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180145	10.1371/journal.pone.0180145	http://dx.doi.org/10.1371/journal.pone.0180145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665985	Green Published, gold			2022-12-26	WOS:000404608700065
J	Gentillon, C; Connell, AJ; Kirk, RW; Butchbach, MER				Gentillon, Cinsley; Connell, Andrew J.; Kirk, Ryan W.; Butchbach, Matthew E. R.			The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells	PLOS ONE			English	Article							RETINAL GANGLION-CELL; MOTOR-NEURON 2; MOUSE MODEL; SPLICING MODIFIERS; SINGLE NUCLEOTIDE; PROTECTIVE ACTION; DECAPPING ENZYME; SMN EXPRESSION; PCR DATA; SURVIVAL	C5-substituted 2,4-diaminoquinazolines (2,4-DAQs) ameliorate disease severity in SMA mice. It is uncertain, however, that these compounds increase SMN protein levels in vivo even though they were identified as activators of the SMN2 promoter. These compounds also regulate the expression of other transcripts in neuroblastoma cells. In this study, we investigate the mechanism by which the 2,4-DAQs regulate the expression of SMN2 as well as other targets. D156844, D158872, D157161 and D157495 (RG3039) increased SMN2 promoter-driven reporter gene activity by at least 3-fold in NSC-34 cells. These compounds, however, did not significantly increase SMN2 mRNA levels in type II SMA fibroblasts nor in NSC-34 cells, although there was a trend for these compounds increasing SMN protein in SMA fibroblasts. The number of SMN-containing gems was increased in SMA fibroblasts in response to 2,4-DAQ treatment in a dose-dependent manner. ATOH7 mRNA levels were significantly lower in type II SMA fibroblasts. 2,4-DAQs significantly increased ATOH7, DRNT1 and DRTN2 transcript levels in type II SMA fibroblasts and restored ATOH7 levels to those observed in healthy fibroblasts. These compounds also increase Atoh7 mRNA expression in NSC-34 cells. In conclusion, 2,4-DAQs regulate SMN2 by increasing protein levels and gem localization. They also increase ATOH7, DRNT1 and DRNT2 transcript levels. This study reveals that the protective effects of 2,4-DAQs in SMA may be independent of SMN2 gene regulation. These compounds could be used in concert with a proven SMN2 inducer to develop a multi-faceted approach to treating SMA.	[Gentillon, Cinsley; Connell, Andrew J.; Kirk, Ryan W.; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Genom, Nemours Biomed Res, Wilmington, DE USA; [Gentillon, Cinsley; Butchbach, Matthew E. R.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Pediat Res, Nemours Biomed Res, Wilmington, DE USA; [Butchbach, Matthew E. R.] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Nemours Alfred I. duPont Hospital for Children; Jefferson University	Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Genom, Nemours Biomed Res, Wilmington, DE USA.; Butchbach, MER (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE USA.; Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Pediat Res, Nemours Biomed Res, Wilmington, DE USA.; Butchbach, MER (corresponding author), Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA.	butchbach@nemoursresearch.org		Butchbach, Matthew/0000-0003-2912-6400	Nemours Foundation (MERB); Cure SMA (MERB); National Institutes of Health [P30GM114736]; University of Delaware	Nemours Foundation (MERB); Cure SMA (MERB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Delaware	This work was supported in part by the Nemours Foundation (MERB), Cure SMA (MERB) and National Institutes of Health [grant number P30GM114736; MERB]. CG was supported by the University of Delaware.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00007; Butchbach MER, 2014, EXP NEUROL, V256, P1, DOI 10.1016/j.expneurol.2014.03.005; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen JH, 2012, INVEST OPHTH VIS SCI, V53, P779, DOI 10.1167/iovs.11-8277; Cherry JJ, 2014, ASSAY DRUG DEV TECHN, V12, P315, DOI 10.1089/adt.2014.587; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Cusco I, 2002, BJOG-INT J OBSTET GY, V109, P1244, DOI 10.1016/S1470-0328(02)02983-X; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Echaniz-Laguna A, 1999, AM J HUM GENET, V64, P1365, DOI 10.1086/302372; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Ghiasvand NM, 2011, NAT NEUROSCI, V14, P578, DOI 10.1038/nn.2798; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Harris ALW, 2015, NEUROMUSCULAR DISORD, V25, P699, DOI 10.1016/j.nmd.2015.05.008; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Husseiny MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094591; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SH, 2014, OPHTHALMIC GENET, V35, P1, DOI 10.3109/13816810.2012.752017; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Liu H, 2011, DEV NEUROBIOL, V71, P153, DOI 10.1002/dneu.20840; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Liu YT, 2014, INVEST OPHTH VIS SCI, V55, P8251, DOI 10.1167/iovs.14-15712; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Mack SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115473; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Milac AL, 2014, BBA-GENE REGUL MECH, V1839, P452, DOI 10.1016/j.bbagrm.2014.04.007; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasov L, 2012, HUM MOL GENET, V21, P3681, DOI 10.1093/hmg/dds197; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Prasov L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012315; Ratni H, 2016, J MED CHEM, V59, P6086, DOI 10.1021/acs.jmedchem.6b00459; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCUDIERO DA, 1986, MUTAT RES, V159, P125, DOI 10.1016/0027-5107(86)90121-1; Shen V, 2008, RNA, V14, P1132, DOI 10.1261/rna.1008208; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Singh RN, 2017, BBA-GENE REGUL MECH, V1860, P299, DOI 10.1016/j.bbagrm.2016.12.008; Stabley DL, 2017, NEUROMUSCULAR DISORD, V27, P439, DOI 10.1016/j.nmd.2017.02.002; Stabley DL, 2015, MOL GENET GENOM MED, V3, P248, DOI 10.1002/mgg3.141; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Tisdale S, 2015, J NEUROSCI, V35, P8691, DOI 10.1523/JNEUROSCI.0417-15.2015; van Dijk E, 2003, P NATL ACAD SCI USA, V100, P12081, DOI 10.1073/pnas.1635192100; Van Meerbeke JP, 2013, HUM MOL GENET, V22, P4074, DOI 10.1093/hmg/ddt257; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venturini C, 2014, BRIT J OPHTHALMOL, V98, P562, DOI 10.1136/bjophthalmol-2013-304080; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Woll MG, 2016, J MED CHEM, V59, P6070, DOI 10.1021/acs.jmedchem.6b00460; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhou M, 2015, RNA, V21, P1306, DOI 10.1261/rna.051573.115	72	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180657	10.1371/journal.pone.0180657	http://dx.doi.org/10.1371/journal.pone.0180657			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662219	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300172
J	Haufe, S; Wiechmann, K; Stein, L; Kuck, M; Smith, A; Meineke, S; Zirkelbach, Y; Duarte, SR; Drupp, M; Tegtbur, U				Haufe, Sven; Wiechmann, Klaus; Stein, Lothar; Kueck, Momme; Smith, Andrea; Meineke, Stefan; Zirkelbach, Yvonne; Duarte, Samuel Rodriguez; Drupp, Michael; Tegtbur, Uwe			Low-dose, non-supervised, health insurance initiated exercise for the treatment and prevention of chronic low back pain in employees. Results from a randomized controlled trial	PLOS ONE			English	Article							OSWESTRY DISABILITY INDEX; PHYSICAL-ACTIVITY; HIGH-INTENSITY; WORK ABILITY; FOLLOW-UP; GRADED ACTIVITY; CARE; INTERVENTION; PROGRAM; LIFE	Objective Back pain is a major problem requiring pragmatic interventions, low in costs for health care providers and feasible for individuals to perform. Our objective was to test the effectiveness of a low-dose 5-month exercise intervention with small personnel investment on low back strength and self-perceived pain. Methods Two hundred twenty-six employees (age: 42.7 +/- 10.2 years) from three mid-size companies were randomized to 5-month non-supervised training at home (3 times/week for 20 minutes) or wait-list-control. Health insurance professionals instructed the participants on trunk exercises at the start and then supervised participants once a month. Results Muscle strength for back extension increased after the 5-month intervention with a significant between-group difference (mean 27.4 Newton [95% CI 2.2; 60.3]) favoring the exercise group (p = 0.035). Low back pain was reduced more in subjects after exercise than control (mean difference -0.74 cm [95% CI-1.17; -0.27], p = 0.002). No between-group differences were observed for back pain related disability and work ability. After stratified analysis only subjects with preexisting chronic low back pain showed a between-group difference (exercise versus controls) after the intervention in their strength for back extension (mean 55.7 Newton [95% CI 2.8; 108.5], p = 0.039), self-perceived pain (mean -1.42 cm [95% CI-2.32; -0.51], p = 0.003) and work ability (mean 2.1 points [95% CI 0.2; 4.0], p = 0.032). Significant between-group differences were not observed in subjects without low back pain: strength for back extension (mean 23.4 Newton [95% CI -11.2; 58.1], p = 0.184), self-perceived pain (mean-0.48 cm [95% CI -0.99; 0.04], p = 0.067) and work ability (mean -0.1 points [95% CI -0.9; 0.9], p = 0.999). An interaction between low back pain subgroups and the study intervention (exercise versus control) was exclusively observed for the work ability index (p = 0.016). Conclusion In middle-aged employees a low-dose, non-supervised exercise program implemented over 20 weeks improved trunk muscle strength and low back pain, and in those with preexisting chronic low back pain improved work ability.	[Haufe, Sven; Wiechmann, Klaus; Stein, Lothar; Kueck, Momme; Tegtbur, Uwe] Hannover Med Sch, Inst Sports Med, Hannover, Germany; [Haufe, Sven] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Smith, Andrea] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Meineke, Stefan; Zirkelbach, Yvonne; Duarte, Samuel Rodriguez; Drupp, Michael] AOK Hlth Insurance, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Haufe, S (corresponding author), Hannover Med Sch, Inst Sports Med, Hannover, Germany.; Haufe, S (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany.	haufe.sven@mh-hannover.de	Haufe, Sven/G-1944-2011	Haufe, Sven/0000-0002-5259-4352	OK health insurance	OK health insurance	The study was a cooperation project between Hannover Medical School and AOK health insurance. Part of the study was supported by AOK health insurance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavinia SM, 2009, SCAND J WORK ENV HEA, V35, P325, DOI 10.5271/sjweh.1340; Andersen LN, 2015, SCAND J PUBLIC HEALT, V43, P694, DOI 10.1177/1403494815591687; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bruce-Low S, 2012, ERGONOMICS, V55, P500, DOI 10.1080/00140139.2011.644329; Bullinger M., 1996, REHABILITATION STUTT, V35, pXVII; Carpenter DM, 1999, MED SCI SPORT EXER, V31, P18, DOI 10.1097/00005768-199901000-00005; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hagen EM, 2003, SPINE, V28, P2309, DOI 10.1097/01.BRS.0000085817.33211.3F; Harts CC, 2008, AUST J PHYSIOTHER, V54, P23, DOI 10.1016/S0004-9514(08)70062-X; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Helmhout PH, 2004, EUR SPINE J, V13, P537, DOI 10.1007/s00586-004-0671-y; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hemmila HM, 2002, SPINE, V27, P647, DOI 10.1097/00007632-200203150-00015; Heymans MW, 2006, SPINE, V31, P1075, DOI 10.1097/01.brs.0000216443.46783.4d; Jacobs W, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008326.pub2; Karjalainen K, 2004, SPINE, V29, P1069, DOI 10.1097/00007632-200405150-00004; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; Kettunen O, 2014, INT J ENV RES PUB HE, V11, P3859, DOI 10.3390/ijerph110403859; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lambeek LC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1035; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Marras WS, 2007, SPINE, V32, P2387, DOI 10.1097/BRS.0b013e3181557be9; MCNEILL T, 1980, SPINE, V5, P529, DOI 10.1097/00007632-198011000-00008; Mehra M, 2012, J MED ECON, V15, P245, DOI 10.3111/13696998.2011.642090; Moon HJ, 2013, ANN REHABIL MED-ARM, V37, P110, DOI 10.5535/arm.2013.37.1.110; Nurminen E, 2002, SCAND J WORK ENV HEA, V28, P85, DOI 10.5271/sjweh.652; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pohjonen T, 2001, PREV MED, V32, P465, DOI 10.1006/pmed.2001.0837; RISCH SV, 1993, SPINE, V18, P232, DOI 10.1097/00007632-199302000-00010; Schaafsma FG, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD001822.PUB2; Scheuer R, 2010, ARCH PHYS MED REHAB, V91, P1878, DOI 10.1016/j.apmr.2010.09.009; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Schneider S, 2007, EUR J PAIN, V11, P387, DOI 10.1016/j.ejpain.2006.05.005; Smeets R, 2011, ARTHRIT CARE RES, V63, pS158, DOI 10.1002/acr.20542; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Torstensen TA, 1998, SPINE, V23, P2616, DOI 10.1097/00007632-199812010-00017; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P58; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; White AP, 2011, SPINE, V36, pS131, DOI 10.1097/BRS.0b013e31822f178f	47	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178585	10.1371/journal.pone.0178585	http://dx.doi.org/10.1371/journal.pone.0178585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662094	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300006
J	Hawley, D; Ding, J; Thotakura, S; Haskett, S; Aluri, H; Kublin, C; Michel, A; Clapisson, L; Mingueneau, M; Zoukhri, D				Hawley, Dillon; Ding, Jian; Thotakura, Suharika; Haskett, Scott; Aluri, Hema; Kublin, Claire; Michel, Audrey; Clapisson, Lisa; Mingueneau, Michael; Zoukhri, Driss			RNA-Seq and CyTOF immuno-profiling of regenerating lacrimal glands identifies a novel subset of cells expressing muscle-related proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; SJOGRENS-SYNDROME; RADIATION-INJURY; GENE-EXPRESSION; TGF-BETA; MORPHOGENESIS; INTERLEUKIN-1-BETA; INFLAMMATION; IRRADIATION	The purpose of the present studies was to use CyTOF and RNA-Seq technologies to identify cells and genes involved in lacrimal gland repair that could be targeted to treat diseases of lacrimal gland dysfunction. Lacrimal glands of female BALB/c mice were experimentally injured by intra-glandular injection of interleukin 1 alpha (IL-1 alpha). The lacrimal glands were harvested at various time points following injury (1 to 14 days) and used to either prepare single cell suspensions for CyTOF immuno-phenotyping analyses or to extract RNA for gene expression studies using RNA-Seq. CyTOF immuno-phenotyping identified monocytes and neutrophils as the major infiltrating populations 1 and 2 days post injury. Clustering of significantly differentially expressed genes identified 13 distinct molecular signatures: 3 associated with immune/inflammatory processes included genes up-regulated at days 1-2 and 3 associated with reparative processes with genes up-regulated primarily between days 4 and 5. Finally, clustering identified 65 genes which were specifically up-regulated 2 days post injury which was enriched for muscle specific genes. The expression of select muscle-related proteins was confirmed by immunohistochemistry which identified a subset of cells expressing these proteins. Double staining experiments showed that these cells are distinct from the myoepithelial cells. We conclude that experimentally induced injury to the lacrimal gland leads to massive infiltration by neutrophils and monocytes which resolved after 3 days. RNAseq and immunohistochemistry identified a group of cells, other than myoepithelial cells, that express muscle-related proteins that could play an important role in lacrimal gland repair.	[Hawley, Dillon; Thotakura, Suharika; Aluri, Hema; Kublin, Claire; Michel, Audrey; Clapisson, Lisa; Zoukhri, Driss] Tufts Univ, Sch Dent Med, Dept Comprehens Care, Boston, MA 02111 USA; [Ding, Jian; Haskett, Scott; Mingueneau, Michael] Biogen, Immunol Res, Cambridge, MA USA; [Zoukhri, Driss] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University; Biogen; Tufts University	Zoukhri, D (corresponding author), Tufts Univ, Sch Dent Med, Dept Comprehens Care, Boston, MA 02111 USA.; Zoukhri, D (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	driss.zoukhri@tufts.edu	Mingueneau, Michael/O-5313-2019; Aluri, Hema/F-2807-2018	Mingueneau, Michael/0000-0002-3873-7329; Aluri, Hema/0000-0002-7592-8466; Hawley, Dillon/0000-0003-0053-9842	National Institutes of Health/National Eye Institute [RO1 EY12383]; Biogen; NATIONAL EYE INSTITUTE [R01EY012383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Biogen(Biogen); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Eye Institute (https://nei.nih.gov/) grant RO1 EY12383. An unrestricted research grant from Biogen (https://www.biogen.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigildeev AE, 2013, CYTOKINE, V64, P131, DOI 10.1016/j.cyto.2013.07.003; Burgess RW, 2006, J NEUROSCI, V26, P5756, DOI 10.1523/JNEUROSCI.0736-06.2006; Chiquet-Ehrismann R., 2011, COLD SPRING HARBOR P, V3; Chiquet-Ehrismann R, 2014, MATRIX BIOL, V37, P112, DOI 10.1016/j.matbio.2014.01.007; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; de la Cuadra-Blanco C, 2003, J ANAT, V203, P531, DOI 10.1046/j.1469-7580.2003.00233.x; Fang Y, 2005, INVEST OPHTH VIS SCI, V46, P461, DOI 10.1167/iovs.04-0677; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Haskett S, 2016, J IMMUNOL, V197, P3806, DOI 10.4049/jimmunol.1600407; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Johnston CJ, 1996, RADIAT RES, V145, P762, DOI 10.2307/3579368; Karrich JJ, 2012, BLOOD, V119, P5191, DOI 10.1182/blood-2011-07-370239; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Liu YZ, 2016, GENE, V581, P152, DOI 10.1016/j.gene.2016.01.036; Makarenkova Helen P, 2015, Curr Mol Biol Rep, V1, P115; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Mingueneau M, 2016, J ALLERGY CLIN IMMUN, V137, P1809, DOI 10.1016/j.jaci.2016.01.024; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Neidhardt J, 2003, MOL CELL NEUROSCI, V23, P193, DOI 10.1016/S1044-7431(03)00012-5; Nguyen DH, 2004, PHYSIOL GENOMICS, V18, P108, DOI 10.1152/physiolgenomics.00011.2004; Park C., 2007, J INEQUAL APPL, V2007, P13; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Sadler T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0193-6; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Simian M, 2001, DEVELOPMENT, V128, P3117; STEPHENS LC, 1986, AM J PATHOL, V124, P469; STEPHENS LC, 1991, CANCER, V67, P1539, DOI 10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q; STEPHENS LC, 1986, RADIOTHER ONCOL, V7, P165; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; Weiser M, 2016, INFLAMM BOWEL DIS, V22, pS2; You S, 2012, INVEST OPHTH VIS SCI, V53, P126, DOI 10.1167/iovs.11-7893; You S, 2011, CELL TISSUE RES, V346, P317, DOI 10.1007/s00441-011-1271-x; Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep17901; Zoukhri D, 2007, EXP EYE RES, V84, P894, DOI 10.1016/j.exer.2007.01.015; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018; Zoukhri D, 2010, OCUL SURF, V8, P60, DOI 10.1016/S1542-0124(12)70070-8	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179385	10.1371/journal.pone.0179385	http://dx.doi.org/10.1371/journal.pone.0179385			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662063	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300020
J	Klimza, H; Jackowska, J; Tokarski, M; Piersiala, K; Wierzbicka, M				Klimza, H.; Jackowska, J.; Tokarski, M.; Piersiala, K.; Wierzbicka, M.			Narrow-band imaging (NBI) for improving the assessment of vocal fold leukoplakia and overcoming the umbrella effect	PLOS ONE			English	Article							LESIONS; CLASSIFICATION; CANCER	Background It is crucial to find a balance between functional and oncological outcome when choosing an adequate method for the management of vocal fold leukoplakia. Therefore, a detailed examination is a milestone in the decision-making process. Aim To examine whether narrow-band imaging (NBI) can be helpful in vocal fold assessment in the case of leukoplakia and how to overcome the "umbrella effect"- understood as the submucosal vascular pattern hidden under the plaque. Material and methods Prospective cohort of 41 consecutive patients. Inclusion criteria: vocal fold leukoplakia, no previous procedures (surgery, radiotherapy), and preoperative endoscopy with an optical filter for NBI. Two groups: "suspicious" and "normal", according to the submucosal microvascular pattern of peripheral regions of the mucosa surrounding the plaque, were distinguished. Patients were qualified for a full-thickness or partial-thickness biopsy, respectively. Criteria defining suspected characters were well-demarcated brownish areas with scattered brown spots corresponding to type IV, Va, Vb, and Vc NI classifications. Results In 22/41 (53.7%) patients with "suspected" microvascular pattern, full-thickness biopsy was performed. Moderate and severe dysplasia was revealed in 15 type IV and 7 type Va NI patients. In 19/41 (46.3%) patients with proper NBI vessel pattern treated by partial-thickness biopsy, hyperkeratosis was diagnosed. There was a strong correlation between the NBI pattern and final histology: Chi2 (2) = 41.0 (p = 0.0000).	[Klimza, H.; Jackowska, J.; Tokarski, M.; Wierzbicka, M.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland; [Piersiala, K.] Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Student Res Grp, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Klimza, H (corresponding author), Poznan Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Poznan, Poland.	hnogala@wp.pl	Piersiala, Krzysztof/AAC-5351-2021	Wierzbicka, Malgorzata/0000-0003-0006-6352; Jackowska, Joanna/0000-0002-5189-5823; Piersiala, Krzysztof/0000-0003-3844-5999				Ahn A, 2016, LARYNGOSCOPE, V126, P923, DOI 10.1002/lary.25609; Barnes L., 2005, WHO CLASSIFICATION T; Bartlett RS, 2012, LARYNGOSCOPE, V122, P336, DOI 10.1002/lary.22417; Burkhardt A, 1997, ACTA OTO-LARYNGOL, P12; Fang TJ, 2016, HEAD NECK-J SCI SPEC, V38, pE1998, DOI 10.1002/hed.24368; Gale N., 2005, WHO CLASSIFICATION T, P143; Gale N, 2014, HISTOPATHOLOGY, V65, P456, DOI 10.1111/his.12427; Gale N, 2014, HEAD NECK PATHOL, V8, P16, DOI 10.1007/s12105-014-0530-z; Kambic V, 1997, ACTA OTO-LARYNGOL, P7; Kono T, 2017, LARYNGOSCOPE, V127, P679, DOI 10.1002/lary.26210; Ma LJ, 2013, CHINESE MED J-PEKING, V126, P3523, DOI 10.3760/cma.j.issn.0366-6999.20131206; Ni XG, 2011, J LARYNGOL OTOL, V125, P288, DOI 10.1017/S0022215110002033; Peretti G, 2006, OTOLARYNG CLIN N AM, V39, P173, DOI 10.1016/j.otc.2005.10.003; Piazza C, 2010, ORAL ONCOL, V46, P307, DOI 10.1016/j.oraloncology.2010.01.020; Qi XM, 2014, INT J CLIN EXP MED, V7, P3305; Stanikova L, 2017, EUR ARCH OTO-RHINO-L, V274, P355, DOI 10.1007/s00405-016-4244-6; van Hulst AM, 2015, HEAD NECK-J SCI SPEC, V38, P24185; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1	18	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180590	10.1371/journal.pone.0180590	http://dx.doi.org/10.1371/journal.pone.0180590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662209	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300169
J	Vongpunsawad, S; Intharasongkroh, D; Thongmee, T; Poovorawan, Y				Vongpunsawad, Sompong; Intharasongkroh, Duangnapa; Thongmee, Thanunrat; Poovorawan, Yong			Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SOUTHERN THAILAND; INFECTION; DISEASE; SINGAPORE; CHILDREN; ADULTS; SEROEPIDEMIOLOGY; TRANSMISSION; PATHOGENESIS	The abundance of Aedes mosquito species enabled widespread transmission of mosquito-borne chikungunya virus (CHIKV) and dengue virus (DENV) in Southeast Asia. Periodic seroprevalence surveys are therefore necessary to assess the viral burden in the population and the effectiveness of public health interventions. Since the current seroprevalence for CHIKV and DENV in Thailand are unknown, we evaluated evidence of past infection among Thais. Eight-hundred and thirty-five serum samples obtained from individuals living in central and southern Thailand were assessed for anti-CHIKV and anti-DENV IgG antibodies using commercial enzyme-linked immunosorbent assays. Overall, 26.8% (224/835) of individuals were seropositive for CHIKV, the majority of whom were also DENV-seropositive (91.1%, 204/224). Approximately half of all adults in their fifth decade of life had attained CHIKV seropositivity. Children under 15 years of age in southern Thailand were significantly more likely to be CHIKV-seropositive compared to those residing in central Thailand. In contrast, 79.2% (661/835) of Thais were DENV-seropositive, 30.9% (204/661) of whom also had antibodies to CHIKV. CHIKV/DENV dual seropositivity among Thais was 24.4% (204/835). The age-standardized seroprevalence for DENV was three times that of CHIKV (80.5% vs. 27.2%). Relatively high CHIKV seroprevalence among adults living in central Thailand revealed an under-recognized CHIKV burden in the region, while the low-to-moderate transmission intensity of DENV (seroprevalence <50% at 9 years) is expected to reduce the impact of DENV vaccination in Thailand. This most recent seroprevalence data provide serological baselines for two of the most common mosquito-borne viruses in this region.	[Vongpunsawad, Sompong; Intharasongkroh, Duangnapa; Thongmee, Thanunrat; Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	The National Research Council of Thailand; National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project [CU56HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; The Out standing Professor of Thailand Research Fund [DPG5480002]; The National Research University Project, Office of Higher Education Commission [NRU59-002-HR]; Chulalongkorn University Fund	The National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); The Out standing Professor of Thailand Research Fund; The National Research University Project, Office of Higher Education Commission; Chulalongkorn University Fund(Chulalongkorn University)	This work was supported by The National Research Council of Thailand, The Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093),The Out standing Professor of Thailand Research Fund (DPG5480002), and The National Research University Project, Office of Higher Education Commission (NRU59-002-HR). This research was also supported by the 100th Anniversary Chulalongkorn University Fund for adoctoral scholarship to Duangnapa Intharasongkroh. The funders had n orole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Azami NAM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-67; BURKE DS, 1985, T ROY SOC TROP MED H, V79, P419, DOI 10.1016/0035-9203(85)90398-0; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Ditsuwan T, 2011, ANN EPIDEMIOL, V21, P253, DOI 10.1016/j.annepidem.2010.12.002; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; Halstead SB, 1988, SCIENCE, P239; Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879; HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102; Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025; JOHNSON D E, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P184; Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065; Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d; Lertanekawattana Sujet, 2013, Southeast Asian J Trop Med Public Health, V44, P780; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; NELSON ER, 1960, J PEDIATR-US, V56, P101, DOI 10.1016/S0022-3476(60)80294-6; Nkoghe D, 2012, INFECT DIS REP, V4, P11, DOI 10.4081/idr.2012.e5; Pongsiri P, 2010, TROP BIOMED, V27, P167; Pongsiri P, 2012, J HEALTH POPUL NUTR, V30, P366; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Suwannakarn K, 2011, ASIAN PAC J TROP MED, V4, P535, DOI 10.1016/S1995-7645(11)60141-7; Thaikruea Lakkana, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P359; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	39	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180560	10.1371/journal.pone.0180560	http://dx.doi.org/10.1371/journal.pone.0180560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662144	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300165
J	Ma, XL; Li, XC; Tian, FJ; Zhang, SM; Liu, XR; Zhang, Y; Fan, JX; Lin, Y				Ma, Xiao-Ling; Li, Xiao-Cui; Tian, Fu-Ju; Zhang, Si-Ming; Liu, Xiao-Rui; Zhang, Yan; Fan, Jian-Xia; Lin, Yi			Effect of the p53-tristetraprolin-stathmin-1 pathway on trophoblasts at maternal-fetal interface	PLOS ONE			English	Article							CANCER-CELL-LINES; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVITY; RECURRENT MISCARRIAGE; PREGNANCY LOSS; EMBRYO LOSS; MUTANT P53; TRISTETRAPROLIN; EXPRESSION; STATHMIN	Problem To reveal the effect of p53-tristetraprolin-stathmin-1 signaling on trophoblasts and recurrent spontaneous abortion (RSA). Method of study Stathmin-1 (STMN1), p53, and tristetraprolin (TTP) expression in paraffin-embedded villus tissue was determined using immunohistochemistry. HTR-8/SVneo cells were treated with doxorubicin to activate p53; STMN1 and TTP levels were detected by quantitative reverse transcription-PCR and western blotting. Western blotting and immunofluorescence were used to investigate STMN1 expression after TTP overexpression or knockdown in HTR-8 cells. Results STMN1 was downregulated and p53 was upregulated in the villus tissue from patients with RSA. Doxorubicin decreased STMN1 expression but enhanced TTP expression in HTR-8 cells. In vitro, TTP overexpression inhibited STMN1 production; TTP knockdown promoted it. TTP downregulated STMN1 expression in trophoblasts by directly binding its 3 A untranslated region. Conclusions TTP modulates trophoblast function and interacts with STMN1 and p53, and is related to pregnancy outcomes.	[Ma, Xiao-Ling; Tian, Fu-Ju; Zhang, Si-Ming; Liu, Xiao-Rui; Fan, Jian-Xia; Lin, Yi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China; [Li, Xiao-Cui] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Zhang, Yan] Wuhan Univ, Renmin Hosp, Dept Obstet & Gynecol, Wuhan, Peoples R China	Shanghai Jiao Tong University; Tongji University; Wuhan University	Lin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China.	yilinonline@126.com	MA, XIAO/HHN-5611-2022	Tian, FuJu/0000-0002-3638-8620	National Basic Research Program of China [2013CB967404]; National Natural Science Foundation of China [81401274, 81401218, 81370767, 81501250, 31671567]; Fund for Outstanding Academic Leaders in Shanghai, China [2013-049]; Shanghai Natural Science Fund Project [14ZR1443800]; key projects of Shanghai Municipal Health and Family Planning Commission [201640012]; key support projects of Health and Family Planning Commission, Hubei Province [WJ2017Z002]; Shanghai Municipal Commission of Health and Family Planning Program [15GWZK0701]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Outstanding Academic Leaders in Shanghai, China; Shanghai Natural Science Fund Project; key projects of Shanghai Municipal Health and Family Planning Commission; key support projects of Health and Family Planning Commission, Hubei Province; Shanghai Municipal Commission of Health and Family Planning Program	This work was supported by the National Basic Research Program of China (No. 2013CB967404), the National Natural Science Foundation of China (No. 81401274, 81401218, 81370767, 81501250 and 31671567), the Fund for Outstanding Academic Leaders in Shanghai, China (2013-049), the Shanghai Natural Science Fund Project (No. 14ZR1443800), key projects of Shanghai Municipal Health and Family Planning Commission (201640012), key support projects of Health and Family Planning Commission, Hubei Province (No.WJ2017Z002), and Shanghai Municipal Commission of Health and Family Planning Program (No.15GWZK0701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2007, ONCOGENE, V26, P1003, DOI 10.1038/sj.onc.1209864; Balmer MT, 2014, CANCER BIOL THER, V15, P1000, DOI 10.4161/cbt.29112; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Fraga LR, 2014, MOL BIOL REP, V41, P1871, DOI 10.1007/s11033-014-3036-6; Hardle L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15112; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Khalaj K, 2015, AM J REPROD IMMUNOL, V73, P402, DOI 10.1111/aji.12347; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee JY, 2013, NUCLEIC ACIDS RES, V41, P5614, DOI 10.1093/nar/gkt222; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Li LP, 2013, CELL IMMUNOL, V286, P1, DOI 10.1016/j.cellimm.2013.10.007; Li LP, 2013, J MATERN-FETAL NEO M, V26, P1212, DOI 10.3109/14767058.2013.773307; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Lin YT, 2011, AD HOC NETW, V9, P713, DOI 10.1016/j.adhoc.2010.07.001; Lin Y, 2008, CLIN IMMUNOL, V126, P104, DOI 10.1016/j.clim.2007.09.006; Lin Y, 2006, J IMMUNOL, V176, P4147, DOI 10.4049/jimmunol.176.7.4147; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Qin CM, 2016, AM J REPROD IMMUNOL, V76, P38, DOI 10.1111/aji.12515; Qin XL, 2014, AM J REPROD IMMUNOL, V71, P229, DOI 10.1111/aji.12194; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shang W, 2013, EUR REV MED PHARMACO, V17, P3376; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sivaraman L, 2001, P NATL ACAD SCI USA, V98, P12379, DOI 10.1073/pnas.221459098; Sonego M, 2013, EMBO MOL MED, V5, P707, DOI 10.1002/emmm.201201504; Stoecklin G, 2001, RNA, V7, P1578; Tamura K, 2003, ENDOCRINOLOGY, V144, P1464, DOI 10.1210/en.2002-220834; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Tian FJ, 2015, AM J PATHOL, V185, P2709, DOI 10.1016/j.ajpath.2015.06.010; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Werno C, 2010, AM J PATHOL, V177, P1104, DOI 10.2353/ajpath.2010.091212; Yin GJ, 2011, J CELL BIOCHEM, V112, P773, DOI 10.1002/jcb.22893	42	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179852	10.1371/journal.pone.0179852	http://dx.doi.org/10.1371/journal.pone.0179852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658321	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900043
J	Yukimori, A; Oikawa, Y; Morita, K; Nguyen, CTK; Harada, H; Yamaguchi, S; Kayamori, K; Yamaguchi, A; Ikeda, T; Sakamoto, K				Yukimori, Akane; Oikawa, Yu; Morita, Kei-ichi; Chi Thi Kim Nguyen; Harada, Hiroyuki; Yamaguchi, Satoshi; Kayamori, Kou; Yamaguchi, Akira; Ikeda, Tohru; Sakamoto, Kei			Genetic basis of calcifying cystic odontogenic tumors	PLOS ONE			English	Article							BETA-CATENIN; BRAF V600E; MUTATIONS; CRANIOPHARYNGIOMA; AMELOBLASTOMAS; PILOMATRIXOMA; EXPRESSION; MELANOMA; CELLS	Calcifying cystic odontogenic tumors (CCOTs) are benign cystic tumors that form abnormally keratinized ghost cells. Mutations in CTNNB1, which encodes beta-catenin, have been implicated in the development of these tumors, but a causal relationship has not been definitively established. Thus, mutational hot spots in 50 cancer genes were examined by targeted next-generation sequencing in 11 samples of CCOT. Mutations in CTNNB1, but not in other genes, were observed in 10 of 11 cases. These mutations constitutively activate beta-catenin signaling by abolishing the phosphorylation sites Asp32, Ser33, or Ser37, and are similar to those reported in pilomatrixoma and adamantinomatous craniopharyngioma. In contrast, BRAF or NRAS mutations were observed in 12 and two control samples of ameloblastoma, respectively. In HEK293 cells, overexpression of mutated CTNNB1 also upregulated hair keratin, a marker of ghost cells. Furthermore, ghost cells were present in two cases of ameloblastoma with BRAF and CTNNB1 mutations, indicating that ghost cells form due to mutations in CTNNB1. The data suggest that mutations in CTNNB1 are the major driver mutations of CCOT, and that CCOT is the genetic analog of pilomatrixoma and adamantinomatous craniopharyngioma in odontogenic tissue.	[Yukimori, Akane; Chi Thi Kim Nguyen; Kayamori, Kou; Ikeda, Tohru; Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan; [Oikawa, Yu; Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi; Yamaguchi, Satoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi] Tokyo Med & Dent Univ, Dept Bioresource Res Ctr, Tokyo, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Dept Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Dental College	Sakamoto, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan.	s-kei.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020		Japanese Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 25462848, KAKENHI 16K11438]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 25462848 and KAKENHI 16K11438 to KS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES L, 2005, PATHOLOGY GENETICS; Barras David, 2015, Biomark Cancer, V7, P9, DOI 10.4137/BIC.S25248; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Brown NA, 2014, CLIN CANCER RES, V20, P5517, DOI 10.1158/1078-0432.CCR-14-1069; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; de Sousa SF, 2016, ORAL ONCOL, V57, pE1, DOI 10.1016/j.oraloncology.2016.04.010; Guadarrama-Orozco JA, 2016, CLIN TRANSL ONCOL, V18, P863, DOI 10.1007/s12094-015-1469-6; Hassanein AM, 2003, AM J CLIN PATHOL, V120, P732, DOI 10.1309/EALEG7LD6W7167PX; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kleihues P, 2000, PATHOLOGY GENETICS T; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kurppa KJ, 2014, J PATHOL, V232, P492, DOI 10.1002/path.4317; Kusama K, 2005, AM J CLIN PATHOL, V123, P376, DOI 10.1309/WVTR-R1DX-YMC8-PBMK; LeBoit P.E., 2006, PATHOLOGY GENETICS S; Ledesma-Montes C, 2008, J ORAL PATHOL MED, V37, P302, DOI 10.1111/j.1600-0714.2007.00623.x; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ni D, 2016, IMMUNOBLOTTING IMMUN, V10; PRAETORIUS F, 1981, ACTA ODONTOL SCAND, V39, P227, DOI 10.3109/00016358109162284; Rajesh E, 2015, J PHARM BIOALLIED SC, V7, pS142, DOI 10.4103/0975-7406.155864; Robinson RA, 2012, TUMORS CYSTS JAWS AM; Roden AC, 2016, ARCH PATHOL LAB MED, V140, P230, DOI 10.5858/arpa.2015-0246-RA; Rumayor A, 2015, J ORAL PATHOL MED, V44, P284, DOI 10.1111/jop.12234; Sekine S, 2003, AM J PATHOL, V163, P1707, DOI 10.1016/S0002-9440(10)63528-6; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Wu SW, 2014, CANCER CAUSE CONTROL, V25, P1379, DOI 10.1007/s10552-014-0443-x	27	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180224	10.1371/journal.pone.0180224	http://dx.doi.org/10.1371/journal.pone.0180224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658279	gold, Green Submitted, Green Published			2022-12-26	WOS:000404607900067
J	Cerda, IA; Chinsamy, A; Pol, D; Apaldetti, C; Otero, A; Powell, JE; Martinez, RN				Alejandro Cerda, Ignacio; Chinsamy, Anusuya; Pol, Diego; Apaldetti, Cecilia; Otero, Alejandro; Eduardo Powell, Jaime; Nestor Martinez, Ricardo			Novel insight into the origin of the growth dynamics of sauropod dinosaurs	PLOS ONE			English	Article							BONE-HISTOLOGY; PHYLOGENETIC-RELATIONSHIPS; DEVELOPMENTAL PLASTICITY; PLATEOSAURUS-ENGELHARDTI; BASAL SAUROPODOMORPH; HINDLIMB MUSCULATURE; PROSAUROPOD DINOSAUR; SEXUAL-MATURITY; LIFE-HISTORY; SOUTH-AFRICA	Sauropod dinosaurs include the largest terrestrial animals and are considered to have uninterrupted rapid rates of growth, which differs from their more basal relatives, which have a slower cyclical growth. Here we examine the bone microstructure of several sauropodo-morph dinosaurs, including basal taxa, as well as the more derived sauropods. Although our results agree that the plesiomorphic condition for Sauropodomorpha is cyclical growth dynamics, we found that the hypothesized dichotomy between the growth patterns of basal and more derived sauropodomorphs is not supported. Here, we show that sauropod-like growth dynamics of uninterrupted rapid growth also occurred in some basal sauropodomorphs, and that some basal sauropods retained the plesiomorphic cyclical growth patterns. Among the sauropodomorpha it appears that the basal taxa exploited different growth strategies, but the more derived Eusauropoda successfully utilized rapid, uninterrupted growth strategies.	[Alejandro Cerda, Ignacio] Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Museo Carlos Ameghino, Cipolletti, Rio Negro, Argentina; [Chinsamy, Anusuya] Univ Cape Town, Dept Biol Sci, Rondebosch, South Africa; [Pol, Diego; Apaldetti, Cecilia] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Apaldetti, Cecilia; Nestor Martinez, Ricardo] Univ Nacl San Juan, IMCN, San Juan, Argentina; [Otero, Alejandro] Museo La Plata, CONICET, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Eduardo Powell, Jaime] Univ Nacl Tucuman, Fac Ciencias Nat, CONICET, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Cape Town; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidad Nacional de Tucuman	Cerda, IA (corresponding author), Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Museo Carlos Ameghino, Cipolletti, Rio Negro, Argentina.	nachocerda6@yahoo.com.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517; Chinsamy-Turan, Anusuya/0000-0002-9786-5080	National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina; National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform	National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina; National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform	This work was supported by National Geographic Society, Ministerio de Ciencia, Tecnologia e Innovacion Productiva of the Repliblica Argentina and the National Research Foundation (NRF), South Africa, Agencia Nacional de Promocion Cientifica y Tecnica, African Origins platform.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; Apaldetti C, 2013, PALAEONTOLOGY, V56, P277, DOI 10.1111/j.1475-4983.2012.01198.x; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Gallina PA, 2012, AMEGHINIANA, V49, P289, DOI 10.5710/AMGH.v49i3(519); Bennell KL, 1996, BRIT J SPORT MED, V30, P200, DOI 10.1136/bjsm.30.3.200; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 1986, P247; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; CASTANET J, 1991, Amphibia-Reptilia, V12, P81, DOI 10.1163/156853891X00356; Castanet J., 1993, BONE, P245; Cerda IA, 2014, ANAT REC, V297, P1385, DOI 10.1002/ar.22954; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy Turan A., 2005, MICROSTRUCTURE DINOS; Colombi Carina E, 2015, Rev. Asoc. Geol. Argent., V72, P445; Company J, 2011, NATURWISSENSCHAFTEN, V98, P67, DOI 10.1007/s00114-010-0742-3; Cooper M. R, 1981, NATURAL SCI, V6, P689; Currey J.D., 2002, BONES STRUCTURE MECH; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; de Fabregues CP, 2016, PEERJ, V4, DOI 10.7717/peerj.1639; de Ricqles A., 1983, Acta Palaeontologica Polonica, V28, P225; De Ricqles A., 1968, ANN U MADAGASCAR, V6, P157; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Fechner R., 2010, THESIS; Fostowicz Frelik L, 2010, LETHAIA, V43, P137; Francillon-Vieillot H., 1990, P471; Galton P.M., 1990, P320; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Hedrick BP, 2014, ACTA PALAEONTOL POL, V59, P295, DOI 10.4202/app.2012.0049; Hofmann R, 2014, PEERJ, V2, DOI 10.7717/peerj.458; Houssaye A, 2016, BIOL J LINN SOC, V117, P350, DOI 10.1111/bij.12660; Ikejiri T, 2012, ANAT REC, V295, P18, DOI 10.1002/ar.21495; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036907; Klein N, 2009, GEOL SOC SPEC PUBL, V315, P217, DOI 10.1144/SP315.15; Knonsue W., 2010, TROPICAL NATURAL HIS, V10, P181; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Langer Max Cardoso, 2003, Paleobios, V23, P1; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Otero A, 2008, AMEGHINIANA, V45, P333; Otero A, 2015, ZOOL J LINN SOC-LOND, V174, P589, DOI 10.1111/zoj.12247; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Otero A, 2010, HERPETOL J, V20, P173; OXNARD CE, 1993, J BIOMECH, V26, P63, DOI 10.1016/0021-9290(93)90080-X; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Pol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014572; Reid REH., 1996, GEOLOGY STUDIES, V41, P25; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander P. Martin, 2011, P276; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Stein K., 2010, THESIS; Stein K, 2014, BIOL REV, V89, P24, DOI 10.1111/brv.12041; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates Adam M., 2010, Palaeontologia Africana, V45, P7	81	43	44	35	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179707	10.1371/journal.pone.0179707	http://dx.doi.org/10.1371/journal.pone.0179707			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654696	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500026
J	de Castilho, FM; Ribeiro, ALP; da Silva, JLP; Nobre, V; de Sousa, MR				de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; da Silva, Jose Luiz P.; Nobre, Vandack; de Sousa, Marcos R.			Heart rate variability as predictor of mortality in sepsis: A prospective cohort study	PLOS ONE			English	Article							SEPTIC SHOCK; DEFINITIONS; ACTIVATION; STATEMENT; ENDOTOXIN; RELEASE	Background Sepsis is a serious medical condition with increasing prevalence and high mortality. The role of the autonomic nervous system in pathophysiology of sepsis has been increasingly researched. The objective of this study is to evaluate the Heart rate variability (HRV) as a predictor of mortality in septic patients. Methods This was a prospective cohort of patients diagnosed with sepsis. Patient recruitment was carried out at ICU in tertiary university hospital between March 2012 and February 2014. Clinical data and laboratory exams were collected at admission. Each patient underwent a 20-minute Holter and a 24-hour Holter on the first day of enrollment. The primary outcome was the 28-day all-cause mortality. Results A total of 63 patients were included. Patients were categorized into nonsurvivor group (n = 16) or survivor group (n = 47) depending on this endpoint. Survivors were younger (48.6 years vs. 63.0 years), had better renal function and lower values in severity scores (APACHE II and SOFA) compared to nonsurvivors. In the 20-minute Holter, SDNN, Total Power, VLF Power, LF Power and LF/HF of nonsurvivors were significantly lower than those of survivors (p = < 0.001, p = 0.003, p = 0.002, p = 0.006, p = 0.009 respectively). ROC curve of SDNN was built, showing area under the curve of 0.772 (0.638-0.906) for mortality. The value of 17ms was chosen as best SDNN cutoff to discriminate survivors and nonsurvivors. In the Cox proportional regression, adjusted for SOFA score and for APACHE II, a SDNN <= 17ms was associated with a greater risk of death, with hazard ratios of 6.3 (1.4-28.0; p = 0.015) and 5.5 (1,2-24,8; p = 0.027), respectively. The addition of the dichotomized SDNN to the SOFA model reduced AIC and increased the concordance statistic and the R-2, indicating that predictive power of the SDNN + SOFA model is better than predictive power of SOFA only. Conclusions Several HRV parameters are reduced in nonsurviving septic patients. SDNN <= 17 is a risk factor for death in septic patients, even after adjusting for severity scores.	[de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; Nobre, Vandack; de Sousa, Marcos R.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [de Castilho, Fabio M.; Ribeiro, Antonio Luiz P.; Nobre, Vandack; de Sousa, Marcos R.] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [da Silva, Jose Luiz P.] Univ Fed Minas Gerais, Dept Stat, Belo Horizonte, MG, Brazil; [Nobre, Vandack] Univ Fed Minas Gerais, NIIMI, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Castilho, FM (corresponding author), Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.; de Castilho, FM (corresponding author), Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil.	fabiomorcastilho@gmail.com	Ribeiro, Ana Cristina/HHN-7466-2022; Ribeiro, Antonio L/C-2707-2009	Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Foundation for the Support of Research in the state of Minas Gerais - APQ) [04713-10]; ICU team; Pro-Rectory of Research of UFMG	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Foundation for the Support of Research in the state of Minas Gerais - APQ); ICU team; Pro-Rectory of Research of UFMG	This study received financial support from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG http://www.fapemig.br, Foundation for the Support of Research in the state of Minas Gerais - APQ-04713-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the ICU team and Pro-Rectory of Research of UFMG for their support.	Aboab J, 2008, CRIT CARE MED, V36, P1481, DOI 10.1097/CCM.0b013e31816f48f2; AKSMSBIM C, 2004, REV SOC CARDIOLOGIA, V03, P1; Alamili M, 2015, ACTA ANAESTH SCAND, V59, P457, DOI 10.1111/aas.12472; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ebelt H, 2015, CLIN EXP PHARMACOL P, V42, P874, DOI 10.1111/1440-1681.12415; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Duque MG, 2012, MED INTENSIVA, V36, P343, DOI 10.1016/j.medin.2011.11.008; Kim GM, 2011, J KOREAN MED SCI, V26, P1293, DOI 10.3346/jkms.2011.26.10.1293; Klockner U, 2011, J MOL CELL CARDIOL, V51, P226, DOI 10.1016/j.yjmcc.2011.05.004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Pagani M, 1984, J HYPERTENS        S, V2, P5383; Papaioannou VE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.11.010; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavon A, 2013, CRIT CARE MED, V41, P2600, DOI 10.1097/CCM.0b013e31829a6e89; R Core Team, 2021, R LANGUAGE ENV STAT; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Steyerberg EW, 2009, CLIN PREDICTION MODE, Vxxviii; Tang CHH, 2009, IEEE ENG MED BIO, P1781, DOI 10.1109/IEMBS.2009.5334005; Tateishi Y, 2007, SHOCK, V28, P549, DOI 10.1097/shk.0b013e3180638d1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Zhao YD, 2008, STAT MED, V27, P462, DOI 10.1002/sim.2912; Zygmunt A, 2010, ARCH MED SCI, V6, P11, DOI 10.5114/aoms.2010.13500	42	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180060	10.1371/journal.pone.0180060	http://dx.doi.org/10.1371/journal.pone.0180060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654692	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500052
J	Guan, M; Wu, XW; Chu, PG; Chow, WA				Guan, Min; Wu, Xiwei; Chu, Peiguo; Chow, Warren A.			Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; PROSTATE-CANCER; INHIBITION; APOPTOSIS; PHENOTYPE; MEDIATOR; GROWTH; GRADE	SK-UT-1 uterine leiomyosarcomas (Ut-LMS) cells were transduced with a fatty acid synthase (FASN)-containing retroviral vector to recapitulate the "lipogenic phenotype of cancer." Consistent with this model, forced expression of FASN enhanced SK-UT-1 proliferation, migration, and cellular motion. Further investigation showed FASN promotes tri-methylation of H3K9 (H3K9me3) and acetylation of H3K27 (H3K27ac) in SK-UT-1 cells. In contrast, siRNA targeting of FASN in high endogenous FASN expressing SK-LMS-1 UtLMS cells inhibits tri-methylation of H3K9 and acetylation of H3K27. Palmitate, the predominant fatty acid product of FASN, increased H3K9me3, H3K27ac and H3K27me3 detection in SK-UT-1 cells. FASN promoted histone 3 methylation and acetylation through alteration of histone 3-modifying enzymatic activities (HDAC, HDM, HMT and HAT). ChIP-seq in SKUT- 1-FASN cells with anti-H3K9me3 antibody identified regions of enriched binding compared to vector-only cells. One differentially-enriched gene, CRISP1, was investigated further by ChIP-PCR. The transcriptionally repressive function of H3K9me3 was confirmed in CRISP1. Our results provide mechanistic insight into the pathobiology of the "lipogenic phenotype of cancer." Here, FASN reprograms the Ut-LMS epigenome through chromatin remodeling to promote the "malignant phenotype."	[Guan, Min; Chow, Warren A.] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA; [Chu, Peiguo] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Chow, WA (corresponding author), City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA.	wchow@coh.org		Chow, Warren/0000-0003-0889-5841	National Cancer Institute of the National Institutes of Health [P30CA033572]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health, Award Number: P30CA033572, Grant Recipient: Warren Chow.	Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; D'Angelo E, 2010, GYNECOL ONCOL, V116, P131, DOI 10.1016/j.ygyno.2009.09.023; Dean E FG, 2016, J CLIN ONCOL, p2512a; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Guan M, 2012, FEBS J, V279, P2399, DOI 10.1111/j.1742-4658.2012.08619.x; Hensley ML, 2013, CANCER-AM CANCER SOC, V119, P1555, DOI 10.1002/cncr.27942; Keung EZ, 2015, J CLIN INVEST, V125, P2965, DOI 10.1172/JCI77976; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Pizer ES, 2000, CANCER RES, V60, P213; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Svensson RU, 2016, NATURE MED; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Taylor BS, 2011, CANCER DISCOV, V1, P587, DOI 10.1158/2159-8290.CD-11-0181; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WB, 2003, CANCER RES, V63, P7330	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179692	10.1371/journal.pone.0179692	http://dx.doi.org/10.1371/journal.pone.0179692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654693	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500025
J	Miyake, M; Kuroda, M; Kiyonari, H; Takehana, K; Hisanaga, S; Morimoto, M; Zhang, J; Oyadomari, M; Sakaue, H; Oyadomari, S				Miyake, Masato; Kuroda, Masashi; Kiyonari, Hiroshi; Takehana, Kenji; Hisanaga, Satoshi; Morimoto, Masatoshi; Zhang, Jun; Oyadomari, Miho; Sakaue, Hiroshi; Oyadomari, Seiichi			Ligand-induced rapid skeletal muscle atrophy in HSA-Fv2E-PERK transgenic mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME PATHWAY; AMINO-ACID-METABOLISM; PROTEIN-SYNTHESIS; TRANSLATION INITIATION; INSULIN SENSITIVITY; POSTABSORPTIVE RATS; GLYCOGEN-SYNTHASE; CANCER CACHEXIA; ER STRESS	Background Formation of 43S and 48S preinitiation complexes plays an important role in muscle protein synthesis. There is no muscle-wasting mouse model caused by a repressed 43S preinitiation complex assembly. Objective The aim of the present study was to develop a convenient mouse model of skeletal muscle wasting with repressed 43S preinitiation complex assembly. Material and methods A ligand-activatable PERK derivative Fv2E-PERK causes the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha), which inhibits 43S preinitiation complex assembly. Thus, muscle atrophic phenotypes, intracellular signaling pathways, and intracellular free amino acid profiles were investigated in human skeletal muscle alpha-actin (HSA) promoter-driven Fv2EPERK transgenic (Tg) mice. Results HSA-Fv2E-PERK Tg mice treated with the artificial dimerizer AP20187 phosphorylates eIF2a in skeletal muscles and leads to severe muscle atrophy within a few days of ligand injection. Muscle atrophy was accompanied by a counter regulatory activation of mTORC1 signaling. Moreover, intracellular free amino acid levels were distinctively altered in the skeletal muscles of HSA-Fv2E-PERK Tg mice. Conclusions As a novel model of muscle wasting, HSA-Fv2E-PERK Tg mice provide a convenient tool for studying the pathogenesis of muscle loss and for assessing putative therapeutics.	[Miyake, Masato; Hisanaga, Satoshi; Morimoto, Masatoshi; Zhang, Jun; Oyadomari, Miho; Oyadomari, Seiichi] Tokushima Univ, Inst Adv Med Sci, Inst Genome Res, Div Mol Biol, Tokushima, Japan; [Miyake, Masato; Zhang, Jun; Oyadomari, Miho; Sakaue, Hiroshi; Oyadomari, Seiichi] Tokushima Univ, Dept Mol Res, Diabet Therapeut & Res Ctr, Tokushima, Japan; [Miyake, Masato; Oyadomari, Seiichi] Tokushima Univ, Fujii Mem Inst Med Sci, Tokushima, Japan; [Kuroda, Masashi; Sakaue, Hiroshi] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Nutr & Metab, Tokushima, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Takehana, Kenji] EA Pharma Co Ltd, Dept R&D Planning, Tokyo, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; RIKEN; RIKEN; Eisai Co Ltd	Oyadomari, S (corresponding author), Tokushima Univ, Inst Adv Med Sci, Inst Genome Res, Div Mol Biol, Tokushima, Japan.; Oyadomari, S (corresponding author), Tokushima Univ, Dept Mol Res, Diabet Therapeut & Res Ctr, Tokushima, Japan.; Oyadomari, S (corresponding author), Tokushima Univ, Fujii Mem Inst Med Sci, Tokushima, Japan.	oyadomar@tokushima-u.ac.jp	Oyadomari, Seiichi/GZA-7157-2022; Sakaue, Hiroshi/ABE-2337-2021; Oyadomari, Seiichi/GZA-7072-2022	Sakaue, Hiroshi/0000-0002-2468-2363; Miyake, Masato/0000-0003-2242-1706	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan; Japan Society for Promotion of Science (JSPS); Inoue Foundation for Science; Mitsubishi Foundation; Uehara Memorial Foundation; Naito Foundation; Cell Science Research Foundation; Takeda Science Foundation; Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation; Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [16H05222] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan; Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inoue Foundation for Science(Inoue Foundation for Science); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sankyo Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Ube Foundation(UBE Foundation); Kowa Life Science Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported mainly by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Culture (MEXT) of Japan and Grants-in-Aid for Young Scientist from Japan Society for Promotion of Science (JSPS), and partly by the Inoue Foundation for Science, the Mitsubishi Foundation, the Uehara Memorial Foundation, the Naito Foundation, the Cell Science Research Foundation, Takeda Science Foundation, Sankyo Foundation, Ono Medical Research Foundation, Mochida Memorial Foundation, the Ube Foundation, Kowa Life Science Foundation, Suzuken Memorial Foundation, Kanae Foundation and Japan Diabetes Foundation. The funders provided support in the form of research grant for SO or MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Anthony JC, 2000, J NUTR, V130, P2413; Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; Biolo G, 1997, AM J PHYSIOL-ENDOC M, V273, pE122, DOI 10.1152/ajpendo.1997.273.1.E122; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hershey JW, 2012, COLD SPRING HARB PER, V4; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Hwee DT, 2009, J GERONTOL A-BIOL, V64, P618, DOI 10.1093/gerona/glp026; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jiao GY, 2017, MOL MED REP, V15, P366, DOI 10.3892/mmr.2016.6014; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Volpi E, 2003, AM J CLIN NUTR, V78, P250, DOI 10.1093/ajcn/78.2.250; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	45	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179955	10.1371/journal.pone.0179955	http://dx.doi.org/10.1371/journal.pone.0179955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644884	gold, Green Submitted, Green Published			2022-12-26	WOS:000404145100052
J	Liu, CY; Lai, S; Kawel-Boehm, N; Chahal, H; Venkatesh, BA; Lima, JAC; Bluemke, DA				Liu, Chia-Ying; Lai, Shenghan; Kawel-Boehm, Nadine; Chahal, Harjit; Venkatesh, Bharath Ambale; Lima, Joao A. C.; Bluemke, David A.			Healthy aging of the left ventricle in relationship to cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							CARDIAC MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME; HEART; MASS; AGE; HYPERTROPHY; INSIGHTS; OUTCOMES; DISEASE; OBESITY	Background Understanding the relationship of cardiovascular structure and function to age is confounded by the high prevalence of traditional risk factors in the United States. The purpose of the study is to compare left ventricular (LV) and aortic structural, and functional parameters in individuals with and without traditional risk factors in a population-based cohort. Methods and results 3015 study participants (48% men, age 55-94, mean 69.01 +/- 9.17 years) in the Multi-Ethnic Study of Atherosclerosis (MESA) underwent cardiovascular magnetic resonance (CMR) imaging from 2010-2012. Absence of cardiovascular (CV) risk factors (no hypertension, diabetes or impaired fasting glucose, obesity, smoking or hypercholesterolemia) was infrequent, occurring in just 314 (10.4%, 38% men) of 3015 participants. In multivariable analyses adjusting for age, sex and race, individuals with CV risk factors had significantly larger LV mass index (by 17%) and lower LV contractibility (circumference strain, lower by 14%). Indexed LV volumes and stroke volume were inversely associated with age, but such relationships were not statistically significant in risk-free male subjects (p>0.05). Men with CV risk factors showed positive association of CMR T1 indices of myocardial fibrosis with age. Aortic function was similar in individuals with and without risk factors; age was associated with decline of aortic function in both CV and no CV risk factor groups. Conclusion Our results support that LV structure and function are better preserved in senescent hearts in the absence of traditional cardiovascular risk factors, and such protection is more prominent in men than in women.	[Liu, Chia-Ying; Kawel-Boehm, Nadine; Bluemke, David A.] NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Lai, Shenghan] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Kawel-Boehm, Nadine] Clin Radiol, Kantonsspital Graubuenden, Chur, Switzerland; [Chahal, Harjit; Venkatesh, Bharath Ambale; Lima, Joao A. C.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; Johns Hopkins University; Johns Hopkins Medicine; Kantonsspital Graubunden; Johns Hopkins University; Johns Hopkins Medicine	Bluemke, DA (corresponding author), NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA.	bluemked@nih.gov	Ambale Venkatesh, Bharath/F-4941-2016; Bluemke, David/GYU-8169-2022	Ambale Venkatesh, Bharath/0000-0002-2330-2373; Bluemke, David/0000-0002-8323-8086	National Heart, Lung, and Blood Institute [N01-HC-95159]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by contracts N01-HC-95159 from the National Heart, Lung, and Blood Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all investigators, staff, and participants of the MESA Study for their valuable contributions. A full list of participating MESA Investigators and institutions can be found at http://www.mesa-nhlbi.org. This research was supported by contracts N01-HC-95159 from the National Heart, Lung, and Blood Institute. This manuscript has been reviewed by the MESA Investigators for scientific content and consistency of data interpretation with previous MESA publications and significant comments have been incorporated prior to submission for publication.	Akasheva DU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135883; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Cuspidi C, 2014, J HYPERTENS, V32, P16, DOI 10.1097/HJH.0b013e328364fb58; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Gidding SS, 2010, J AM SOC ECHOCARDIOG, V23, P816, DOI 10.1016/j.echo.2010.05.023; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; LEVY D, 1988, DRUGS, V35, P1, DOI 10.2165/00003495-198800355-00002; Lieb W, 2014, JACC-CARDIOVASC IMAG, V7, P870, DOI 10.1016/j.jcmg.2014.05.008; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Mizukoshi K, 2016, J AM SOC ECHOCARDIOG, V29, P51, DOI 10.1016/j.echo.2015.09.009; Movahed MR, 2009, OBESITY, V17, P606, DOI 10.1038/oby.2008.563; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; Ohyama Y, 2016, EUROPEAN HEART J CAR; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; RAIZADA V, 1994, J MOL CELL CARDIOL, V26, P293, DOI 10.1006/jmcc.1994.1037; Roth DA, 1998, J APPL PHYSIOL, V84, P177, DOI 10.1152/jappl.1998.84.1.177; Sado DM, 2012, HEART, V98, P1436, DOI 10.1136/heartjnl-2012-302346; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481; Vishram JKK, 2014, DAN MED J, V61; Yeon SB, 2015, J MAGN RESON IMAGING, V41, P1038, DOI 10.1002/jmri.24649; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179947	10.1371/journal.pone.0179947	http://dx.doi.org/10.1371/journal.pone.0179947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640873	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800084
J	Naziroglu, M; Cig, B; Blum, W; Vizler, C; Buhala, A; Marton, A; Katona, R; Josvay, K; Schwaller, B; Olah, Z; Pecze, L				Naziroglu, Mustafa; Cig, Bilal; Blum, Walter; Vizler, Csaba; Buhala, Andrea; Marton, Annamaria; Katona, Robert; Josvay, Katalin; Schwaller, Beat; Olah, Zoltan; Pecze, Laszlo			Targeting breast cancer cells by MRS1477, a positive allosteric modulator of TRPV1 channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-1; CAPSAICIN RECEPTOR; OXIDATIVE STRESS; ION-CHANNEL; ACTIVATION; APOPTOSIS; EXPRESSION; TOXICITY; RELEASE; NEURONS	There is convincing epidemiological and experimental evidence that capsaicin, a potent natural transient receptor potential cation channel vanilloid member 1 (TRPV1) agonist, has anticancer activity. However, capsaicin cannot be given systemically in large doses, because of its induction of acute pain and neurological inflammation. MRS1477, a dihydropyridine derivative acts as a positive allosteric modulator of TRPV1, if added together with capsaicin, but is ineffective, if given alone. Addition of MRS1477 evoked Ca2+ signals in MCF7 breast cancer cells, but not in primary breast epithelial cells. This indicates that MCF7 cells not only express functional TRPV1 channels, but also produce endogenous TRPV1 agonists. We investigated the effects of MRS1477 and capsaicin on cell viability, caspase-3 and -9 activities and reactive oxygen species production in MCF7 cells. The fraction of apoptotic cells was increased after 3 days incubation with capsaicin (10 mu M) paralleled by increased reactive oxygen species production and caspase activity. These effects were even more pronounced, when cells were incubated with MRS1477 (2 mu M) either alone or together with CAPS (10 mu M). Capsazepine, a TRPV1 blocker, inhibited both the effect of capsaicin and MRS1477. Whole-cell patch clamp recordings revealed that capsaicinevoked TRPV1-mediated current density levels were increased after 3 days incubation with MRS1477 (2 mu M). However, the tumor growth in MCF7 tumor-bearing immunodeficient mice was not significantly decreased after treatment with MRS1477 (10 mg/kg body weight, i.p., injection twice a week). In conclusion, in view of a putative in vivo treatment with MRS1477 or similar compounds further optimization is required.	[Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, Isparta, Turkey; [Naziroglu, Mustafa; Cig, Bilal] Suleyman Demirel Univ, Hlth Sci Inst, Dept Neurosci, Isparta, Turkey; [Blum, Walter; Schwaller, Beat; Pecze, Laszlo] Univ Fribourg, Dept Med, Unit Anat, Fribourg, Switzerland; [Vizler, Csaba; Buhala, Andrea; Marton, Annamaria; Katona, Robert; Josvay, Katalin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Olah, Zoltan] Univ Miskolc, Fac Mat Sci & Engn, Inst Chem, Miskolc, Hungary; [Olah, Zoltan] Acheuron Ltd, Szeged, Hungary	Suleyman Demirel University; Suleyman Demirel University; University of Fribourg; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Miskolc	Pecze, L (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Fribourg, Switzerland.	laszlo.pecze@unifr.ch	ÇİĞ, BILAL/A-1747-2018; Blum, Walter/A-5996-2016	ÇİĞ, BILAL/0000-0001-7832-066X; Schwaller, Beat/0000-0002-8277-7555; Blum, Walter/0000-0003-2219-9180	Swiss National Science Foundation SNSF [130680]; Acheuron Ltd.;  [GINOP-2.3.2-15-2016-00001];  [GINOP-2.3.2-15-201600039]	Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); Acheuron Ltd.; ; 	This project was supported by GINOP-2.3.2-15-2016-00001 and GINOP-2.3.2-15-201600039 to VC and the Swiss National Science Foundation SNSF grant # 130680 to BS. Acheuron Ltd. provided support in the form of salaries for the author ZO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.	Azimi I, 2014, BRIT J PHARMACOL, V171, P945, DOI 10.1111/bph.12486; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barar J, 2012, BIOIMPACTS, V2, P1, DOI 10.5681/bi.2012.001; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Bode AM, 2011, CANCER RES, V71, P2809, DOI 10.1158/0008-5472.CAN-10-3756; BRUCE RD, 1985, FUND APPL TOXICOL, V5, P151, DOI 10.1016/0272-0590(85)90059-4; Carnevale V, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030052; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cetin ES, 2017, J RECEPT SIG TRANSD, V37, P84, DOI 10.3109/10799893.2016.1160931; Cig B, 2015, BBA-BIOMEMBRANES, V1848, P2756, DOI 10.1016/j.bbamem.2015.02.013; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; Ding XZ, 2001, INT J CANCER, V94, P630, DOI 10.1002/ijc.1527.abs; GAO X, 1995, UROLOGY, V46, P227, DOI 10.1016/S0090-4295(99)80198-8; Gerry AB, 2014, ATHEROSCLEROSIS, V233, P537, DOI 10.1016/j.atherosclerosis.2014.01.014; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; Jankovic Bojana, 2010, Can Urol Assoc J, V4, pE9; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kaszas K, 2012, J PHARMACOL EXP THER, V340, P152, DOI 10.1124/jpet.111.183053; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kosar PA, 2016, J MEMBRANE BIOL, V249, P129, DOI 10.1007/s00232-015-9855-0; Lebovitz EE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-70; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lv J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3942; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Natarajan Rama, 1998, Frontiers in Bioscience, V3, pE81; Neelands TR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-28; Nie D, 1998, CANCER RES, V58, P4047; Olah Z, 2002, J BIOL CHEM, V277, P35752, DOI 10.1074/jbc.M201551200; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Pecze L, 2016, BBA-MOL CELL RES, V1863, P2905, DOI 10.1016/j.bbamcr.2016.09.013; Pecze L, 2016, BBA-MOL CELL RES, V1863, P2054, DOI 10.1016/j.bbamcr.2016.05.007; Pecze L, 2013, BBA-MOL CELL RES, V1833, P1680, DOI 10.1016/j.bbamcr.2012.08.018; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Roh EJ, 2008, BIOORGAN MED CHEM, V16, P9349, DOI 10.1016/j.bmc.2008.08.048; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; STAMPFER MR, 1982, IN VITRO CELL DEV B, V18, P531; Stampfer MR, 2002, CULTURE EPITHELIAL C, P95; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Uguz AC, 2009, J MEMBRANE BIOL, V232, P15, DOI 10.1007/s00232-009-9212-2; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vercelli C, 2014, J BREAST CANCER, V17, P332, DOI 10.4048/jbc.2014.17.4.332; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Weber LV, 2016, BREAST CANCER-TARGET, V8, P243, DOI 10.2147/BCTT.S121610; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Wu C LY, 2012, CANC RES S, V72; Wu TTL, 2014, CELL CALCIUM, V56, P59, DOI 10.1016/j.ceca.2014.04.006; Xie CQ, 2011, ENDOCRINOLOGY, V152, P3811, DOI 10.1210/en.2011-0141; Zhou YiMing, 2013, Nature Communications, V4, P2408; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	59	22	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179950	10.1371/journal.pone.0179950	http://dx.doi.org/10.1371/journal.pone.0179950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640864	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800085
J	Zhao, TT; Wang, ZM; Su, LY; Sun, XM; Cheng, J; Zhang, LL; Karungo, SK; Han, YP; Li, SH; Xin, HP				Zhao, Tingting; Wang, Zemin; Su, Lingye; Sun, Xiaoming; Cheng, Jun; Zhang, Langlang; Karungo, Sospeter Karanja; Han, Yuepeng; Li, Shaohua; Xin, Haiping			An efficient method for transgenic callus induction from Vitis amurensis petiole	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SOMATIC EMBRYOGENESIS; PLANT-REGENERATION; VINIFERA L.; GENETIC-TRANSFORMATION; TRANSCRIPTION FACTOR; SHOOT ORGANOGENESIS; MUSCADINE GRAPE; COLD-STRESS; ARABIDOPSIS	Transformation is the main platform for genetic improvement and gene function studies in plants. However, the established somatic embryo transformation system for grapevines is time-consuming and has low efficiency, which limits its utilization in functional genomics research. Vitis amurensis is a wild Vitis species with remarkable cold tolerance. The lack of an efficient genetic transformation system for it has significantly hindered the functional identification of cold stress related genes in the species. Herein, an efficient method was established to produce transformed calli of V. amurensis. Segments of petioles from micro-propagated plantlets of V. amurensis exhibited better capacity to differentiate calli than leaf-discs and stem segments, and thus was chosen as target tissue for Agrobacterium-mediated transformation. Both neomycin phosphotransferase II (NPTII) and enhanced green fluorescent protein (eGFP) genes were used for simultaneous selection of transgenic calli based on kanamycin resistance and eGFP fluorescence. Several parameters affecting the transformation efficiency were optimized including the concentration of kanamycin, Agrobacterium stains, bacterial densities, infection treatments and co-cultivation time. The transgenic callus lines were verified by checking the integration of NPTII gene into calli genomes, the expression of eGFP gene and the fluorescence of eGFP. Up to 20% of the petiole segments produced transformed calli after 2 months of cultivation. This efficient transformation system will facilitate the functional analysis of agronomic characteristics and related genes not only in V. amurensis but also in other grapevine species.	[Zhao, Tingting; Wang, Zemin; Sun, Xiaoming; Zhang, Langlang; Karungo, Sospeter Karanja; Han, Yuepeng; Li, Shaohua; Xin, Haiping] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Zhao, Tingting; Su, Lingye; Zhang, Langlang; Karungo, Sospeter Karanja] Univ Chinese Acad Sci, Beijing, Peoples R China; [Su, Lingye; Sun, Xiaoming; Cheng, Jun; Li, Shaohua] Chinese Acad Sci, Beijing Key Lab Grape Sci & Enol, Inst Bot, CAS Key Lab Plant Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Xin, HP (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	xinhaiping215@hotmail.com	Sun, Xiaoming/AHA-6034-2022	Sun, Xiaoming/0000-0002-0788-3382; Wang, Zemin/0000-0001-7936-5229; Xin, Haiping/0000-0002-4652-1683	National Natural Science Foundation of China [31471857, 31672132]; Youth Innovation Promotion Association of CAS [2015281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS	This study was supported by the National Natural Science Foundation of China, no. 31471857, HX, ham://www.nsfc.gov.cn/; the National Natural Science Foundation of China, no. 31672132, HX, http://wtwvwl.nsfc.gov.cn/; and the Youth Innovation Promotion Association of CAS, no. 2015281, HX, http://www.yicas.cn/.	Aguero CB, 2006, VITIS, V45, P1; Ahmed M, 2015, VEGETOS, V28, P171; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; CHENG ZM, 1989, PLANT CELL REP, V8, P403, DOI 10.1007/BF00270079; CLOG E, 1990, PLANT CELL REP, V8, P726, DOI 10.1007/BF00272104; COLBY SM, 1990, PLANT CELL REP, V9, P237, DOI 10.1007/BF00232291; Das DK, 2002, PLANT CELL REP, V20, P999, DOI 10.1007/s00299-002-0441-4; Dhekney SA, 2008, PLANT CELL REP, V27, P865, DOI 10.1007/s00299-008-0512-2; Fan CH, 2008, PLANT CELL TISS ORG, V92, P197, DOI 10.1007/s11240-007-9324-2; Fang LC, 2016, J EXP BOT, V67, P2829, DOI 10.1093/jxb/erw122; Fennell A., 2004, Journal of Crop Improvement, V10, P201, DOI 10.1300/J411v10n01_09; Franks T, 1998, MOL BREEDING, V4, P321, DOI 10.1023/A:1009673619456; GRAY DJ, 1987, PLANT CELL TISS ORG, V9, P73, DOI 10.1007/BF00046081; GRAY DJ, 1992, AM J BOT, V79, P542, DOI 10.2307/2444865; Harst M, 2000, VITIS, V39, P99; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Li ZT, 2006, IN VITRO CELL DEV-PL, V42, P220, DOI 10.1079/IVP2006770; Li ZJT, 2008, PLANT CELL TISS ORG, V93, P311, DOI 10.1007/s11240-008-9378-9; Lopez-Perez AJ, 2008, PLANT CELL TISS ORG, V94, P189, DOI 10.1007/s11240-008-9404-y; MARTINELLI L, 1993, PLANT CELL REP, V12, P207, DOI 10.1007/BF00237055; Mezzetti Bruno, 2002, BMC Biotechnol, V2, P18, DOI 10.1186/1472-6750-2-18; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; MULLINS MG, 1976, J EXP BOT, V27, P1022, DOI 10.1093/jxb/27.5.1022; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ROBACKER C, 1993, HORTSCIENCE, V28, P53, DOI 10.21273/HORTSCI.28.1.53; Salunkhe CK, 1997, PLANT CELL REP, V17, P65, DOI 10.1007/s002990050353; STAMP JA, 1990, PLANT CELL TISS ORG, V22, P127, DOI 10.1007/BF00043688; STAMP JA, 1990, J AM SOC HORTIC SCI, V115, P1038, DOI 10.21273/JASHS.115.6.1038; Sun X. X., 2016, SCI REP, V6; Tillett RL, 2012, PLANT BIOTECHNOL J, V10, P105, DOI 10.1111/j.1467-7652.2011.00648.x; Torregrosa L, 2002, AM J ENOL VITICULT, V53, P183; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vidal JR, 2006, TRANSGENIC RES, V15, P69, DOI 10.1007/s11248-005-4423-5; Wang HL, 2015, SCI HORTIC-AMSTERDAM, V191, P82, DOI 10.1016/j.scienta.2015.04.039; Wang QC, 2005, PLANT SCI, V168, P565, DOI 10.1016/j.plantsci.2004.09.033; Xie XQ, 2016, PLANT CELL TISS ORG, V126, P541, DOI 10.1007/s11240-016-1023-4; Xin HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058740; Xu W., 2014, MATER RES LETT, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0102303; Xu WR, 2014, PLANT MOL BIOL, V86, P527, DOI 10.1007/s11103-014-0245-2; Xu WR, 2014, MOL BIOL REP, V41, P5329, DOI 10.1007/s11033-014-3404-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan YY, 2016, PLANT CELL REP, V35, P655, DOI 10.1007/s00299-015-1910-x; Zhao FX, 2011, AGR SCI CHINA, V10, P686, DOI 10.1016/S1671-2927(11)60051-5; Zhou Q, 2014, PLANT CELL TISS ORG, V118, P157, DOI 10.1007/s11240-014-0471-y; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4	46	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179730	10.1371/journal.pone.0179730	http://dx.doi.org/10.1371/journal.pone.0179730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640905	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800057
J	Kang, SM; Rosales, JL; Meier-Stephenson, V; Kim, S; Lee, KY; Narendran, A				Kang, S. M.; Rosales, J. L.; Meier-Stephenson, V.; Kim, S.; Lee, K. Y.; Narendran, A.			Genome-wide loss-of-function genetic screening identifies opioid receptor mu 1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia	ONCOGENE			English	Article							DOWN-REGULATION; CELLS; SYNTHETASE; SENSITIVITY; ACTIVATION; EXPRESSION	L-asparaginase is a critical chemotherapeutic agent for acute lymphoblastic leukemia (ALL). It hydrolyzes plasma asparagine into aspartate and NH3, causing asparagine deficit and inhibition of protein synthesis and eventually, leukemic cell death. However, patient relapse often occurs due to development of resistance. The molecular mechanism by which ALL cells acquire resistance to L-asparaginase is unknown. Therefore, we sought to identify genes that are involved in L-asparaginase resistance in primary leukemic cells. By unbiased genome-wide RNAi screening, we found that among 10 resistant ALL clones, six hits were for opioid receptor mu 1 (oprm1), two hits were for carbonic anhydrase 1 (ca1) and another two hits were for ubiquitin-conjugating enzyme E2C (ube2c). We also found that OPRM1 is expressed in all leukemic cells tested. Specific knockdown of OPRM1 confers L-asparaginase resistance, validating our genome-wide retroviral shRNA library screening data. Methadone, an agonist of OPRM1, enhances the sensitivity of parental leukemic cells, but not OPRM1-depleted cells, to L-asparaginase treatment, indicating that OPRM1 is required for the synergistic action of L-asparaginase and methadone, and that OPRM1 loss promotes leukemic cell survival likely through downregulation of the OPRM1-mediated apoptotic pathway. Consistent with this premise, patient leukemic cells with relatively high levels of OPRM1 are more sensitive to L-asparaginase treatment compared to OPRM1-depleted leukemic cells, further indicating that OPRM1 loss has a crucial role in L-asparaginase resistance in leukemic patients. Thus, our study demonstrates for the first time, a novel OPRM1-mediated mechanism for L-asparaginase resistance in ALL, and identifies OPRM1 as a functional biomarker for defining high-risk subpopulations and for the detection of evolving resistant clones. Oprm1 may also be utilized for effective treatment of L-asparaginase-resistant ALL.	[Kang, S. M.; Lee, K. Y.] Univ Calgary, Arnie Charbonneau Canc Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Kang, S. M.; Meier-Stephenson, V.; Narendran, A.] Univ Calgary, Div Pediat Oncol, Alberta Childrens Hosp, Calgary, AB, Canada; [Kang, S. M.; Meier-Stephenson, V.; Narendran, A.] Univ Calgary, POETIC Lab Preclin & Drug Discovery Studies, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Rosales, J. L.] Univ Calgary, Snyder Inst Chron Dis, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Kim, S.] Univ Calgary, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Lee, KY (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	kylee@ucalgary.ca		Rosales, Jesusa/0000-0002-2543-3801	CIHR [MOP-123400]; NSERC [RGPIN/312985-2011]	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by grants from the CIHR (MOP-123400) and NSERC (RGPIN/312985-2011) to KYL.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SH, 2015, PEDIATR NEONATOL, V56, P287, DOI 10.1016/j.pedneo.2014.10.006; Friesen C, 2008, CANCER RES, V68, P6059, DOI 10.1158/0008-5472.CAN-08-1227; Friesen C, 2014, CELL CYCLE, V13, P1560, DOI 10.4161/cc.28493; Friesen C, 2013, ONCOTARGET, V4, P677, DOI 10.18632/oncotarget.952; Howlader N, 2016, SEER CANC STAT REV; KILLANDER D, 1976, CANCER, V37, P220, DOI 10.1002/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; Li BS, 2006, LEUKEMIA, V20, P2199, DOI 10.1038/sj.leu.2404423; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; Su N, 2008, PEDIATR BLOOD CANCER, V50, P274, DOI 10.1002/pbc.21213; Supuran CT, 2017, EXPERT OPIN DRUG DIS, V12, P61, DOI 10.1080/17460441.2017.1253677; Xie CL, 2014, INT J BIOCHEM CELL B, V47, P113, DOI 10.1016/j.biocel.2013.11.023	14	16	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5910	5913		10.1038/onc.2017.211	http://dx.doi.org/10.1038/onc.2017.211			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28650467	hybrid, Green Published			2022-12-26	WOS:000413292900012
J	del Pino, LM; Arana, A; Alfonso, L; Mendizabal, JA; Soret, B				Martinez del Pino, Lara; Arana, Ana; Alfonso, Leopoldo; Antonio Mendizabal, Jose; Soret, Beatriz			Adiposity and adipogenic gene expression in four different muscles in beef cattle	PLOS ONE			English	Article							ACID-BINDING PROTEIN; INTRAMUSCULAR FAT DEPOSITION; MEAT-PRODUCING ANIMALS; SKELETAL-MUSCLE; ADIPOCYTE DIFFERENTIATION; RELATIVE QUANTIFICATION; FIBER CHARACTERISTICS; LONGISSIMUS MUSCLE; SIZE DISTRIBUTION; HOLSTEIN BULLS	Anatomical site and divergent functionalities of muscles can be related to differences in IMF content, metabolism and adipogenic gene expression. Then, potential differences in different muscles in beef cattle were studied. As a second objective, the main sources of experimental variability associated to RT-qPCR results were analyzed following a nested design in order to implement appropriate experimental designs minimizing gene expression variability. To perform the study Longissimus thoracis (LT), Semitendinosus (SM), Masseter (MS), Sternomandibularis (ST) and subcutaneous adipose tissue (SAT) samples of Pirenaica young bulls (n = 4) were collected for IMF, collagen and protein quantification, analysis of adipocyte size distribution and gene expression (PPARG, CEBPA, FAPB4 and WNT10B). A greater IMF content was observed in MS and SM muscles, which had a bimodal adipocyte size distribution while it was unimodal in the muscles LT and ST. This suggest that the different IMF accretion in the muscles studied might be related to different rates of hyperplasia and hypertrophy and that IMF might develop later in LT and ST muscles. The former differences were not mirrored by the expression of the genes analyzed, which might be related to the different contribution of mature and non-mature adipocytes to the total gene expression. When comparing IMF and SAT gene expression, late and early developing tissues respectively, expression of PPARG, CEBPA and FABP4 was higher in the SAT, in agreement with bigger cell size and numbers. The variability study indicates that the analytical factors that add higher variability to the gene expression are the sampling and RT and therefore, it would be appropriate to include those replicates in the design of future experiments. Based on the results, the use of MS and SM muscles could allow less expensive experimental designs and bigger sample size that could permit the detection of lower relevant differences in gene expression.	[Martinez del Pino, Lara; Arana, Ana; Alfonso, Leopoldo; Antonio Mendizabal, Jose; Soret, Beatriz] Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain	Universidad Publica de Navarra	Soret, B (corresponding author), Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain.	soret@unavarra.es	Alfonso, Leopoldo/AAG-3790-2021; Alfonso, Leopoldo/G-2998-2015; Mendizabal, José Antonio/F-9844-2014; Soret, Beatriz/L-5776-2014	Alfonso, Leopoldo/0000-0002-5662-9997; Alfonso, Leopoldo/0000-0002-5662-9997; Mendizabal, José Antonio/0000-0003-1316-4293; Soret, Beatriz/0000-0001-9214-8595				Alberti P, 2013, MEAT SCI, V94, P208, DOI 10.1016/j.meatsci.2013.01.015; Albrecht E., 2017, J ANIM SCI, V95; Alfonso L, 2016, ITEA-INF TEC ECON AG, V112, P147; Alzon M, 2007, ANIMAL, V1, P261, DOI 10.1017/S1751731107392744; Barendse W, 2009, ANIM GENET, V40, P770, DOI 10.1111/j.1365-2052.2009.01913.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Bonnet M, 2010, ANIMAL, V4, P1093, DOI 10.1017/S1751731110000601; CIANZIO DS, 1982, J ANIM SCI, V55, P305, DOI 10.2527/jas1982.552305x; Costa P, 2008, MEAT SCI, V78, P502, DOI 10.1016/j.meatsci.2007.07.020; Cruz GD, 2014, J ANIM SCI, V92, P4761, DOI 10.2527/jas.2014-8180; Dai FW, 2009, S AFR J ANIM SCI, V39, P267; DEVINE CE, 1984, MEAT SCI, V10, P35, DOI 10.1016/0309-1740(84)90030-5; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Eguinoa P, 2003, J ANIM SCI, V81, P432; Freeman JB, 2013, BEHAV RES METHODS, V45, P83, DOI 10.3758/s13428-012-0225-x; Gerbens F, 1998, MAMM GENOME, V9, P1022, DOI 10.1007/s003359900918; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Harper GS, 2004, AUST J EXP AGR, V44, P653, DOI 10.1071/EA02114; Hartigan J. A., 1985, ANN STAT, P70; Hauser N, 1997, REPROD NUTR DEV, V37, P617, DOI 10.1051/rnd:19970601; Hocquette J, 2003, EAAP PUBLIC, P513; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 2000, PROD ANIM, V13, P185; HOOD RL, 1973, J LIPID RES, V14, P605; Hwang YH, 2010, MEAT SCI, V86, P456, DOI 10.1016/j.meatsci.2010.05.034; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jeremiah LE, 2003, MEAT SCI, V65, P1013, DOI 10.1016/S0309-1740(02)00309-1; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Le Roy P., 2003, INRA PROD ANIM, V16, P159; Lee HJ, 2000, ASIAN AUSTRAL J ANIM, V13, P155, DOI 10.5713/ajas.2000.155; Listrat Anne, 2016, ScientificWorldJournal, V2016, P3182746, DOI 10.1155/2016/3182746; Luo HF, 2009, LIPIDS, V44, P999, DOI 10.1007/s11745-009-3346-y; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Martins TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139943; MATARESE V, 1988, J BIOL CHEM, V263, P14544; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Moreno-Sanchez N, 2010, FUNCT INTEGR GENOMIC, V10, P609, DOI 10.1007/s10142-010-0175-2; Oddy VH, 2001, AUST J EXP AGR, V41, P921, DOI 10.1071/EA00029; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard B, 1996, BASIC APPL MYOL, V6; Pickworth CL, 2011, J ANIM SCI, V89, P355, DOI 10.2527/jas.2010-3229; ROBELIN J, 1993, REPROD NUTR DEV, V33, P25, DOI 10.1051/rnd:19930103; Roberts SL, 2015, J ANIM SCI, V93, P4302, DOI 10.2527/jas.2015-8886; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sainz R. D., 2000, Modelling nutrient utilization in farm animals, P175, DOI 10.1079/9780851994499.0175; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Smith SB, 1998, COMP BIOCHEM PHYS B, V120, P165, DOI 10.1016/S0305-0491(98)10005-6; Smith SB, 2009, ASIAN AUSTRAL J ANIM, V22, P1225, DOI 10.5713/ajas.2009.r.10; Soret B, 2016, ANIMAL, V10, P2018, DOI 10.1017/S175173111600118X; Soula HA, 2013, J THEOR BIOL, V332, P89, DOI 10.1016/j.jtbi.2013.04.025; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thaller G, 2003, ANIM GENET, V34, P354, DOI 10.1046/j.1365-2052.2003.01011.x; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; Torrescano G, 2003, MEAT SCI, V64, P85, DOI 10.1016/S0309-1740(02)00165-1; TOTLAND GK, 1991, ANAT EMBRYOL, V184, P441, DOI 10.1007/BF01236050; Tume RK, 2010, MEAT SCI, V84, P66, DOI 10.1016/j.meatsci.2009.08.013; Urrutia O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156765; Vernon R. G., 1986, Control and manipulation of animal growth. Proceedings of the 43rd Nottingham Easter School in Agricultural Science., P67; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8	68	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179604	10.1371/journal.pone.0179604	http://dx.doi.org/10.1371/journal.pone.0179604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665940	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700038
J	Khadaroo, RG; Churchill, TA; Tso, V; Madsen, KL; Lukowski, C; Salim, SY				Khadaroo, Rachel G.; Churchill, Thomas A.; Tso, Victor; Madsen, Karen L.; Lukowski, Chris; Salim, Saad Y.			Metabolomic profiling to characterize acute intestinal ischemia/reperfusion injury	PLOS ONE			English	Article							ACUTE MESENTERIC ISCHEMIA; MULTIPLE ORGAN FAILURE; BACTERIAL TRANSLOCATION; CRITICALLY-ILL; KIDNEY-TRANSPLANTS; REPERFUSION INJURY; HEMORRHAGIC-SHOCK; XANTHINE-OXIDASE; GUT; PERMEABILITY	Sepsis and septic shock are the leading causes of death in critically ill patients. Acute intestinal ischemia/reperfusion (AII/R) is an adaptive response to shock. The high mortality rate from AII/R is due to the severity of the disease and, more importantly, the failure of timely diagnosis. The objective of this investigation is to use nuclear magnetic resonance (NMR) analysis to characterize urine metabolomic profile of AII/R injury in a mouse model. Animals were exposed to sham, early (30 min) or late (60 min) acute intestinal ischemia by complete occlusion of the superior mesenteric artery, followed by 2 hrs of reperfusion. Urine was collected and analyzed by NMR spectroscopy. Urinary metabolite concentrations demonstrated that different profiles could be delineated based on the duration of the intestinal ischemia. Metabolites such as allantoin, creatinine, proline, and methylamine could be predictive of AII/R injury. Lactate, currently used for clinical diagnosis, was found not to significantly contribute to the classification model for either early or late ischemia. This study demonstrates that patterns of changes in urinary metabolites are effective at distinguishing AII/R progression in an animal model. This is a proof-of-concept study to further support examination of metabolites in the clinical diagnosis of intestinal ischemia reperfusion injury in patients. The discovery of a fingerprint metabolite profile of AII/R will be a major advancement in the diagnosis, treatment, and prevention of systemic injury in critically ill patients.	[Khadaroo, Rachel G.; Churchill, Thomas A.; Lukowski, Chris; Salim, Saad Y.] Univ Alberta, Fac Med & Dent, Dept Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Fac Med & Dent, Div Gen Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Khadaroo, Rachel G.; Tso, Victor; Madsen, Karen L.; Lukowski, Chris; Salim, Saad Y.] Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Div Gen Surg, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada.; Khadaroo, RG (corresponding author), Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada.	khadaroo@ualberta.ca	Madsen, Karen L/H-5898-2011					Adams JM, 2001, CRIT CARE MED, V29, P2194, DOI 10.1097/00003246-200111000-00023; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; De Preter Vicky, 2013, World J Gastrointest Pharmacol Ther, V4, P97, DOI 10.4292/wjgpt.v4.i4.97; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; De-Souza DA, 2005, CRIT CARE MED, V33, P1125, DOI 10.1097/01.CCM.0000162680.52397.97; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025; Dryland P.A., 2008, OPEN BIOACTIVE COMPO, V1, P6; Fahrner R, 2012, J SURG RES; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glenister KM, 2004, ANZ J SURG, V74, P260, DOI 10.1111/j.1445-2197.2004.02956.x; Goytia M, 2010, INFECT IMMUN, V78, P3187, DOI 10.1128/IAI.01301-09; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kand'ar R, 2006, CLIN CHIM ACTA, V365, P249, DOI 10.1016/j.cca.2005.09.002; Kassahun WT, 2008, LANGENBECK ARCH SURG, V393, P163, DOI 10.1007/s00423-007-0263-5; Khadaroo RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115242; Khadaroo RG, 2008, CRIT CARE, V12, DOI 10.1186/cc7001; Kim Seoung Bum, 2008, Stat Anal Data Min, V1, P57, DOI 10.1002/sam.10005; Klempnauer J, 1997, SURGERY, V121, P239, DOI 10.1016/S0039-6060(97)90351-2; Kohler I, 2016, BIOANALYSIS, V8, P1509, DOI 10.4155/bio-2016-0090; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nieuwenhuijzen G A, 1999, Curr Opin Clin Nutr Metab Care, V2, P399, DOI 10.1097/00075197-199909000-00008; NISHINO T, 1994, J BIOCHEM, V116, P1; Pastores SM, 1996, AM J GASTROENTEROL, V91, P1697; Pelantova H, 2016, ANAL BIOANAL CHEM, V408, P567, DOI 10.1007/s00216-015-9133-0; Perez-Chanona E, 2014, AM J PATHOL, V184, P2965, DOI 10.1016/j.ajpath.2014.07.014; Rotstein O D, 2000, Surg Infect (Larchmt), V1, P217, DOI 10.1089/109629600750018141; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Salim SY, 2013, BENEF MICROBES, V4, P357, DOI 10.3920/BM2013.0026; Salim SY, 2016, J SURG RES; Sekirov I, 2006, NAT MED, V12, P736, DOI 10.1038/nm0706-736; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; SHENG ZY, 1991, CHINESE MED J-PEKING, V104, P897; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Taylor D E, 1998, Respir Care Clin N Am, V4, P611; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; WILCOX MG, 1995, DIGEST DIS SCI, V40, P709, DOI 10.1007/BF02064966; Wishart DS, 2006, CURR OPIN NEPHROL HY, V15, P637, DOI 10.1097/01.mnh.0000247499.64291.52; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yardim-Akaydin S, 2006, SCAND J RHEUMATOL, V35, P61, DOI 10.1080/03009740510026878; Yoav B, 1995, J ROY STAT SOC, V57, P289	51	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179326	10.1371/journal.pone.0179326	http://dx.doi.org/10.1371/journal.pone.0179326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662085	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300019
J	Khoury, AL; Morey, MC; Wong, TC; McNeil, DL; Humphries, B; Frankey, K; Pieper, CF; Hicks, CB; Huffman, K; McKellar, MS				Khoury, Audrey L.; Morey, Miriam C.; Wong, Tammy C.; McNeil, Donna Lynn; Humphries, Barlett; Frankey, Katherine; Pieper, Carl F.; Hicks, Charles B.; Huffman, Kim; McKellar, Mehri S.			Diminished physical function in older HIV infected adults in the Southeastern US despite successful antiretroviral therapy	PLOS ONE			English	Article							PERFORMANCE-MEASURES; REFERENCE VALUES; 6-MINUTE WALK; AGE; ASSOCIATION; IMPAIRMENT; DECLINE; SPEED; TIME	Background As antiretroviral therapy efficacy improves, HIV is gradually being recognized more as a chronic disease within the aging HIV-infected population. While these individuals are surviving into old age, they may, however, be experiencing "accelerated aging" with greater declines in physical function than that observed among comparably matched individuals free of HIV. This decline is not well understood and it remains unclear if physical decline correlates with the degree of immunosuppression based on CD4 lymphocyte nadir. Methods In a cross-sectional study of accelerated aging in the older HIV-infected population on antiretroviral therapy (ART), physical performance evaluations were completed on a cohort of 107 HIV-infected subjects, age 50 years or older (with no HIV-1 RNA >200 copies/mL in the prior 12 months), and compared to reference ranges for age-and gender-matched HIV uninfected persons. Physical performance testing consisted of four validated assessments: the 2.4-meter walk, 30-second chair stand, grip strength and 6-minute walk test. Results When compared to age-and gender-matched HIV-uninfected reference controls, older HIV infected persons had diminished physical function. No correlation was found between physical function and degree of immunosuppression as determined by pre-ART CD4 nadir. Conclusions Despite improved survival, HIV infected adults on suppressive ART have diminished physical function compared to HIV-uninfected persons. The degree of HIV-associated immunosuppression does not correlate with the observed degree of physical function decline in older HIV-infected persons, suggesting the decline is mediated by other mechanisms.	[Khoury, Audrey L.; Wong, Tammy C.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA; [Morey, Miriam C.; Pieper, Carl F.; Huffman, Kim; McKellar, Mehri S.] Duke Univ, Sch Med, Dept Med, Claude D Pepper Older Amer Independence Ctr, Durham, NC 27706 USA; [Morey, Miriam C.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [McNeil, Donna Lynn] Duke Canc Inst, Off Res Support, Durham, NC USA; [Humphries, Barlett; Frankey, Katherine] Duke Univ, Med Ctr, Ctr Appl Genom & Precis Med, Durham, NC USA; [Pieper, Carl F.] Duke Dept Biostat & Bioinformat, Durham, NC USA; [Hicks, Charles B.] Univ Calif San Diego, Sch Med, Div Infect Dis, San Diego, CA 92103 USA; [Huffman, Kim] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [McKellar, Mehri S.] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University; University of California System; University of California San Diego; Duke University; Duke University	McKellar, MS (corresponding author), Duke Univ, Sch Med, Dept Med, Claude D Pepper Older Amer Independence Ctr, Durham, NC 27706 USA.; McKellar, MS (corresponding author), Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27708 USA.	mehri.mckellar@duke.edu		Pieper, Carl/0000-0003-4809-1725	Duke University Center for AIDS Research (CFAR) [A1064518]; Duke Claude D Pepper Older Americans Independence Center (OAIC) [P30 AG028716]; NIH funded program [5P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); Duke Claude D Pepper Older Americans Independence Center (OAIC); NIH funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the following: Duke University Center for AIDS Research (CFAR grant number A1064518) - MSM; and Duke Claude D Pepper Older Americans Independence Center (OAIC grant number P30 AG028716) - MSM. The funders contributed to the study design and preparation of this manuscript.; This publication resulted (in part) from research supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (5P30 AI064518). Additionally, research funding was obtained from the Duke Claude D Pepper Older Americans Independence Center (P30 AG028716). The authors would also like to thank the subjects for their participation.	Asher L, 2012, AGE AGEING, V41, P690, DOI 10.1093/ageing/afs076; Beans J, 2013, J AIDS CLIN RES, V4, DOI [DOI 10.4172/2155-6113.S9-003, 10.4172/2155-6113.S9-003]; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Centers for Disease Control and Prevention, HIV SO US; Centers for Disease Control and Prevention, 2013, HIV SURVEILLANCE S, V18; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Erlandson KM, 2016, AIDS, V30, P445, DOI 10.1097/QAD.0000000000000932; Erlandson KM, 2013, J INFECT DIS, V208, P249, DOI 10.1093/infdis/jit147; Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e; Erlandson KM, 2012, HIV CLIN TRIALS, V13, P324, DOI 10.1310/hct1306-324; Erlandson KM, 2012, JAIDS-J ACQ IMM DEF, V61, P484, DOI 10.1097/QAI.0b013e3182716e38; Gill CJ, 2002, J ACQ IMMUN DEF SYND, V30, P485, DOI 10.1097/00126334-200208150-00004; Greene M, 2014, AIDS, V28, P2711, DOI 10.1097/QAD.0000000000000507; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; North Carolina Health and Human Services, FACTS FIG N CAR HIV; Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Richert L, 2014, AIDS, V28, P1441, DOI 10.1097/QAD.0000000000000246; Richert L, 2011, AIDS, V25, P797, DOI 10.1097/QAD.0b013e3283455dff; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; SAS Institute Inc, 2013, SAS 9 4 SOFTW; Schrack JA, 2015, JAIDS-J ACQ IMM DEF, V70, P370, DOI 10.1097/QAI.0000000000000731; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; United States Census Bureau, 2015 INT POP EST PRO; Wilson IB, 1996, MED CARE, V34, P610, DOI 10.1097/00005650-199606000-00010; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515	32	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179874	10.1371/journal.pone.0179874	http://dx.doi.org/10.1371/journal.pone.0179874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662079	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300063
J	Chang, YS; Weng, SF; Chang, C; Wang, JJ; Chen, HI; Ko, SY; Tu, IT; Chien, CC; Wang, JJ; Wang, CM; Jan, RL				Chang, Yuh-Shin; Weng, Shih-Feng; Chang, Chun; Wang, Jhi-Joung; Chen, Hong-I; Ko, Shun-Yao; Tu, I-Te; Chien, Chih-Chiang; Wang, Jian-Jhong; Wang, Ching-Min; Jan, Ren-Long			Risk of serous retinal detachment in patients with end-stage renal disease on dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PIGMENT EPITHELIAL DETACHMENTS; PREVALENCE; HEMODIALYSIS; INFLAMMATION; OCCLUSION; IMPACT; COHORT; CKD	The aim of this retrospective, nationwide, matched cohort study was to investigate the association of serous retinal detachment with having end-stage renal disease (ESRD) while on dialysis. The cohort study included 94,024 patients with ESRD on dialysis registered between January 2000 to December 2009 in the Taiwan National Health Insurance Research Database. An age-and sex-matched control group comprised 94,024 patients selected from the Taiwan Longitudinal Health Insurance Database 2000. Information for each patient was collected from the index date until December 2011. Twenty-seven ESRD patients and 11 controls developed serous retinal detachment (P < 0.001) during follow-up, demonstrating a significantly increased risk of serous retinal detachment in patients with ESRD on dialysis compared with controls (incidence rate ratio = 3.39, 95% confidence interval [CI] = 1.68 +/- 6.83). After adjustment for potential confounders, patients were 3.86 times more likely to develop serous retinal detachment than the full cohort (adjusted HR = 3.86, 95% CI = 1.15 +/- 12.96). In conclusion, patients with ESRD on dialysis demonstrate an increased risk of serous retinal detachment. Interdisciplinary collaboration between nephrologists and ophthalmologists is important to deal with serous retinal detachment in patients with ESRD on dialysis and prevent impairments of visual acuity.	[Chang, Yuh-Shin] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Chang, Yuh-Shin; Chen, Hong-I; Ko, Shun-Yao] Chang Jung Christian Univ, Coll Hlth Sci, Grad Inst Med Sci, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chang, Chun] Univ Taipei, Dept Educ, Taipei, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Tu, I-Te; Wang, Jian-Jhong; Wang, Ching-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Jan, Ren-Long] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan, Taiwan; [Jan, Ren-Long] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan	Chi Mei Hospital; Chang Jung Christian University; Kaohsiung Medical University; University of Taipei; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital	Jan, RL (corresponding author), Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan, Taiwan.; Jan, RL (corresponding author), Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan.	renlongjan@gmail.com		Weng, Shih-Feng/0000-0001-8684-3487; Wang, Jian-Jhong/0000-0002-5530-0719				Basu S, 2010, INDIAN J OPHTHALMOL, V58, P261, DOI 10.4103/0301-4738.62670; BRODY JM, 1995, ACTA OPHTHALMOL SCAN, V73, P81; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003174; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003474; Chang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003281; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; GANGAN PA, 1994, AM J OPHTHALMOL, V118, P212, DOI 10.1016/S0002-9394(14)72901-0; GASS JDM, 1992, GRAEF ARCH CLIN EXP, V230, P454; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; GOLDSTEIN M, 1979, ANN OPHTHALMOL, V11, P923; Hassan K, 2015, J INT MED RES, V43, P42, DOI 10.1177/0300060514550013; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; JABS DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P230; Jumper JM, 2000, RETINA-J RET VIT DIS, V20, P190, DOI 10.1097/00006982-200003000-00012; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; Mullaem G, 2012, SEMIN DIALYSIS, V25, P403, DOI 10.1111/j.1525-139X.2012.01098.x; MURPHY JA, 1991, CLIN LAB HAEMATOL, V13, P217; RAO NA, 1995, INT OPHTHALMOL CLIN, V35, P69, DOI 10.1097/00004397-199503520-00007; Rathinam SR, 1998, OCUL IMMUNOL INFLAMM, V6, P155, DOI 10.1076/ocii.6.3.155.4041; Reddy SC, 1998, ACTA OPHTHALMOL SCAN, V76, P700, DOI 10.1034/j.1600-0420.1998.760614.x; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197, DOI 10.1164/ajrccm.162.1.9907098; Troiano P, 1998, NEPHROL DIAL TRANSPL, V13, P2135, DOI 10.1093/ndt/13.8.2135; WAGDI S, 1978, CAN J OPHTHALMOL, V13, P157; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; Wang IK, 2016, RETINA-J RET VIT DIS, V36, P1866, DOI 10.1097/IAE.0000000000001011; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28675; Wolfensberger T J, 2000, Curr Opin Ophthalmol, V11, P455, DOI 10.1097/00055735-200012000-00012; ZACCHEI AC, 1995, AM J OPHTHALMOL, V120, P796, DOI 10.1016/S0002-9394(14)72734-5	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180133	10.1371/journal.pone.0180133	http://dx.doi.org/10.1371/journal.pone.0180133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658289	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900063
J	Natt, M; Lonnstedt, OM; McCormick, MI				Natt, Michael; Lonnstedt, Oona M.; McCormick, Mark I.			Coral reef fish predator maintains olfactory acuity in degraded coral habitats	PLOS ONE			English	Article							CHEMICAL ALARM CUES; RISK-ASSESSMENT; OCEAN ACIDIFICATION; PREY INTERACTIONS; CLIMATE-CHANGE; DEGRADATION; IMPACTS; PROSPECTUS; MORTALITY; ECOLOGY	Coral reefs around the world are rapidly degrading due to a range of environmental stress ors. Habitat degradation modifies the sensory landscape within which predator-prey interactions occur, with implications for olfactory-mediated behaviours. Predator na ve settlement stage damselfish rely on conspecific damage-released odours (i.e., alarm odours) to inform risk assessments. Yet, species such as the Ambon damselfish, Pomacentrus amboinensis, become unable to respond appropriately to these cues when living in dead-degraded coral habitats, leading to increased mortality through loss of vigilance. Reef fish predators also rely on odours from damaged prey to locate, assess prey quality and engage in prey-stealing, but it is unknown whether their responses are also modified by the change to dead degraded coral habitats. Implications for prey clearly depend on how their predatory counterparts are affected, therefore the present study tested whether olfactory-mediated foraging responses in the dusky dottyback, Pseudochromis fuscus, a common predator of P. amboinensis, were similarly affected by coral degradation. A y-maze was used to measure the ability of Ps. fuscus to detect and move towards odours, against different background water sources. Ps. fuscus were exposed to damage-released odours from juvenile P. amboinensis, or a control cue of seawater, against a background of seawater treated with either healthy or dead-degraded hard coral. Predators exhibited an increased time allocation to the chambers of y-mazes injected with damage-released odours, with comparable levels of response in both healthy and dead-degraded coral treated waters. In control treatments, where damage-released odours were replaced with a control seawater cue, fish showed no increased preference for either chamber of the y-maze. Our results suggest that olfactory-mediated foraging behaviours may persist in Ps. fuscus within dead-degraded coral habitats. Ps. fuscus may consequently gain a sensory advantage over P. amboinensis, potentially altering the outcome of predator-prey interactions.	[Natt, Michael; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Natt, Michael; McCormick, Mark I.] James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia; [Lonnstedt, Oona M.] Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden	James Cook University; James Cook University; Uppsala University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; McCormick, MI (corresponding author), James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council Centre of Excellence for Coral Reef Studies [E1140100117]; Australian Research Council [DP170103372]	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies (E1140100117) to MIM and the Australian Research Council (DP170103372) to MIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Ashworth EC, 2014, J FISH BIOL, V84, P1031, DOI 10.1111/jfb.12343; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Brooker R. M., 2016, CHEM SIGNALS VERTEBR, V13, P17; Bruintjes R, 2014, PEERJ, V2, DOI 10.7717/peerj.594; Caiger PE, 2012, MAR ECOL PROG SER, V466, P225, DOI 10.3354/meps09933; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chivers DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32542; Chivers DP, 2013, ECOL EVOL, V3, P3925, DOI 10.1002/ece3.760; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2017, P ROY SOC B, V284; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gill AC, 2004, S AFRICAN I AQUATIC; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; Lonnstedt OM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2038; Lonnstedt OM, 2014, J ANIM ECOL, V83, P1178, DOI 10.1111/1365-2656.12209; Lonnstedt OM, 2013, ECOL EVOL, V3, P3565, DOI 10.1002/ece3.684; Lonnstedt OM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02259; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Lonnstedt OM, 2012, OECOLOGIA, V168, P651, DOI 10.1007/s00442-011-2116-8; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; McCormick MI, 2007, CORAL REEFS, V26, P571, DOI 10.1007/s00338-007-0221-2; Mccormick MI, 2008, ANIM BEHAV, V75, P1973, DOI 10.1016/j.anbehav.2007.12.007; McCormick MI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00521-0; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; McCormick MI, 2016, P BIOL SCI, V283; McCormick MI, 2016, GLOB CHANG BIOL; Meekan MG, 2001, MAR BIOL, V139, P373; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wenger AS, 2013, CORAL REEFS, V32, P369, DOI 10.1007/s00338-012-0991-z	48	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179300	10.1371/journal.pone.0179300	http://dx.doi.org/10.1371/journal.pone.0179300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658295	Green Published, gold, Green Accepted			2022-12-26	WOS:000404607900020
J	Kim, SH; Park, WS; Park, EY; Park, B; Joo, J; Joung, JY; Seo, HK; Lee, KH; Chung, J				Kim, Sung Han; Park, Weon Seo; Park, Eun Young; Park, Boram; Joo, Jungnam; Joung, Jae Young; Seo, Ho Kyung; Lee, Kang Hyun; Chung, Jinsoo			The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; CANCER INCIDENCE; EXPRESSION; METASTASES; SURVIVAL; MORTALITY; OUTCOMES; PROTEIN; TUMORS; KI67	Objective To assess the prognostic roles of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue biomarkers in localized renal cell carcinoma (RCC). Methods Patients who underwent a nephrectomy during 1992-2015 and had a primary specimen of their kidney tumor were included. The nine tissue biomarkers were immunohistochemically stained on tissue microarrays of RCC, and the semi-quantitative H-score, including intensity score, was used to grade the sample. The Cox proportional hazards model was used to evaluate tissue markers significant for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) after adjusting for significant clinicopathological parameters. Results Samples from 351 RCC patients were included. The mean age of the patients was 53.9 years; the rates of pathologic T1-2/>= T3 stage, Fuhrman 1+2/3+4 grade, recurrence, and death were 269/65(80.5/19.5%), 222/107 (67.5/32.5%), 6.6%, and 10.5%, respectively. Median OS, CSS, and RFS were 220.6, 220.6, and 147.1 months, respectively. The multi-variable analysis showed that pathologic T stage and Fuhrman nuclear grade were significantly associated with OS and CSS. Pathologic T stage and tumor size were associated with RFS. After adjusting for these significant prognostic clinicopathological factors, Ki-67 was significantly associated with OS (hazard ratio [HR], 2.7), CSS (HR, 3.82), and RFS (HR, 4.85) and pS6 was associated with CSS (HR, 8.63) and RFS (HR, 8.51) in the multivariable model (p<0.05). Conclusion pS6 and Ki-67 are significant prognostic factors of RCC; however, BAP1, PBRM1, TGase 2, PD-L1, CA9, PTEN loss, and PSMA markers did not show this association.	[Kim, Sung Han; Park, Weon Seo; Joung, Jae Young; Seo, Ho Kyung; Lee, Kang Hyun; Chung, Jinsoo] Res Inst & Hosp Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Weon Seo] Res Inst & Hosp Natl Canc Ctr, Dept Pathol, Ctr Prostate Canc, Goyang, South Korea; [Park, Eun Young; Park, Boram; Joo, Jungnam] Res Inst & Hosp Natl Canc Ctr, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, J (corresponding author), Res Inst & Hosp Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	cjs5225@ncc.re.kr		Park, Boram/0000-0003-2683-8795; KIM, Sung Han/0000-0002-1689-5203	Korean National Cancer Center [1510650-1, 1710100-1]	Korean National Cancer Center	This study was supported by the Korean National Cancer Center Grants (nos. 1510650-1 and 1710100-1). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Chang SS, 1999, CANCER RES, V59, P3192; Choueiri TK, 2015, CLIN CANCER RES, V21, P1071, DOI 10.1158/1078-0432.CCR-14-1993; da Costa WH, 2012, INT BRAZ J UROL, V38, P456, DOI 10.1590/S1677-55382012000400004; de la Fouchardiere A, 2015, CLIN GENET, V88, P273, DOI 10.1111/cge.12472; Dumas F, 1999, INT J CANCER, V80, P799, DOI 10.1002/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.3.CO;2-L; Ebru T, 2017, INT BRAZ J UROL, V43, P440, DOI [10.1590/S1677-5538.IBJU.2015.0521, 10.1590/s1677-5538.ibju.2015.0521]; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Hager M, 2012, PATHOL ONCOL RES, V18, P277, DOI 10.1007/s12253-011-9439-y; Jilaveanu LB, 2014, J CANCER, V5, P166, DOI 10.7150/jca.8167; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Joseph RW, 2014, CANCER-AM CANCER SOC, V120, P1059, DOI 10.1002/cncr.28521; Jung KW, 2016, CANCER RES TREAT, V48, P451, DOI 10.4143/crt.2016.092; Kang JH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.14; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122498; Ku BM, 2014, J CANCER RES CLIN, V140, P757, DOI 10.1007/s00432-014-1623-5; Li P, 2015, EUR UROL, V67, P1134, DOI 10.1016/j.eururo.2014.11.001; Liontos M, 2017, WORLD J UROL, V35, P411, DOI 10.1007/s00345-016-1890-7; Moch H, 2016, PATHOLOGE, V37, P355, DOI 10.1007/s00292-016-0171-y; Phuoc NB, 2008, ONCOL REP, V20, P525, DOI 10.3892/or_00000037; Semeniuk-Wojtas A, 2016, UROL ONCOL-SEMIN ORI, V34, P215, DOI 10.1016/j.urolonc.2015.12.013; Skolarikos AA, 2006, AM J NEPHROL, V26, P218, DOI 10.1159/000093631; Stewart GD, 2014, EUR UROL, V66, P85, DOI 10.1016/j.eururo.2014.03.004; Tan PH, 2013, AM J SURG PATHOL, V37, P1518, DOI 10.1097/PAS.0b013e318299f12e; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Zhou M, 2005, CLIN LAB MED, V25, P247, DOI 10.1016/j.cll.2005.01.004; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	30	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179610	10.1371/journal.pone.0179610	http://dx.doi.org/10.1371/journal.pone.0179610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654655	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500019
J	Proschel, M; Kraner, ME; Horn, AHC; Schafer, L; Sonnewald, U; Sticht, H				Proeschel, Marlene; Kraner, Max E.; Horn, Anselm H. C.; Schaefer, Lena; Sonnewald, Uwe; Sticht, Heinrich			Probing the potential of CnaB-type domains for the design of tag/catcher systems	PLOS ONE			English	Article							INTRAMOLECULAR ISOPEPTIDE BONDS; SPYTAG-SPYCATCHER CHEMISTRY; MOLECULAR-DYNAMICS; CROSS-LINKS; STREPTOCOCCUS-PYOGENES; SURFACE-PROTEINS; THIOESTER BOND; PEPTIDE TAG; PILUS; ADHESIN	Building proteins into larger, post-translational assemblies in a defined and stable way is still a challenging task. A promising approach relies on so-called tag/catcher systems that are fused to the proteins of interest and allow a durable linkage via covalent intermolecular bonds. Tags and catchers are generated by splitting protein domains that contain intramolecular isopeptide or ester bonds that form autocatalytically under physiological conditions. There are already numerous biotechnological and medical applications that demonstrate the usefulness of covalent linkages mediated by these systems. Additional covalent tag/catcher systems would allow creating more complex and ultra-stable protein architectures and networks. Two of the presently available tag/catcher systems were derived from closely related CnaB-domains of Streptococcus pyogenes and Streptococcus dysgalactiae proteins. However, it is unclear whether domain splitting is generally tolerated within the CnaBfamily or only by a small subset of these domains. To address this point, we have selected a set of four CnaB domains of low sequence similarity and characterized the resulting tag/catcher systems by computational and experimental methods. Experimental testing for intermolecular isopeptide bond formation demonstrated two of the four systems to be functional. For these two systems length and sequence variations of the peptide tags were investigated revealing only a relatively small effect on the efficiency of the reaction. Our study suggests that splitting into tag and catcher moieties is tolerated by a significant portion of the naturally occurring CnaB-domains, thus providing a large reservoir for the design of novel tag/catcher systems.	[Proeschel, Marlene; Kraner, Max E.; Sonnewald, Uwe] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biochem, Erlangen, Germany; [Horn, Anselm H. C.; Schaefer, Lena; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Bioinformat, Inst Biochem, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Sonnewald, U (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biochem, Erlangen, Germany.; Sticht, H (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Bioinformat, Inst Biochem, Erlangen, Germany.	uwe.sonnewald@fau.de; heinrich.sticht@fau.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Horn, Anselm/0000-0003-3539-8103; Sticht, Heinrich/0000-0001-5644-045X	Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology"; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology"	Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology"	This work was supported by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat-Erlangen-Nurnberg (FAU), project "Synthetic Biology" to US and HS (http://www.archiv.efi.tau.eu/projects/synthetc-biology/). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU), project "Synthetic Biology" to US and HS. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. We thank Benedikt Schmid (Lehrstuhl fur Biotechnik, FAU) for help with the CD-spectroscopic analysis.	Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Brune KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19234; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Case D.A., 2014, AMBER, V14, P29; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fierer JO, 2014, P NATL ACAD SCI USA, V111, pE1176, DOI 10.1073/pnas.1315776111; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Giessen TW, 2016, CHEMBIOCHEM, V17, P1931, DOI 10.1002/cbic.201600431; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Horn AHC, 2010, J PHYS CHEM B, V114, P2219, DOI 10.1021/jp100023q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jardin C, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2597-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070521; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2014, ACTA CRYSTALLOGR D, V70, P1190, DOI 10.1107/S1399004714001400; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kwon H, 2014, P NATL ACAD SCI USA, V111, P1367, DOI 10.1073/pnas.1316855111; Laursen T, 2015, TRENDS PLANT SCI, V20, P20, DOI 10.1016/j.tplants.2014.11.002; Leonard JD, 2015, MOL CELL, V57, P850, DOI 10.1016/j.molcel.2015.01.008; Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021; Linke-Winnebeck C, 2014, J BIOL CHEM, V289, P177, DOI 10.1074/jbc.M113.523761; Liu ZD, 2014, SCI REP-UK, V4, DOI 10.1038/srep07266; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proschel M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00168; Qiagen, 1997, QLAEXPRESSIONIST HDB; Reddington SC, 2015, CURR OPIN CHEM BIOL, V29, P94, DOI 10.1016/j.cbpa.2015.10.002; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schoene C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21151; Schoene C, 2014, ANGEW CHEM INT EDIT, V53, P6101, DOI 10.1002/anie.201402519; Schwarz-Linek U, 2014, P NATL ACAD SCI USA, V111, P1229, DOI 10.1073/pnas.1322482111; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sun F, 2014, P NATL ACAD SCI USA, V111, P11269, DOI 10.1073/pnas.1401291111; Tan LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165074; Veggiani G, 2016, P NATL ACAD SCI USA, V113, P1202, DOI 10.1073/pnas.1519214113; Veggiani G, 2014, TRENDS BIOTECHNOL, V32, P506, DOI 10.1016/j.tibtech.2014.08.001; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wang JD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0490-5; Young PG, 2017, CHEM COMMUNICATIONS; Zakeri B, 2015, CHEMBIOCHEM, V16, P2277, DOI 10.1002/cbic.201500372; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a; Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452	53	20	23	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179740	10.1371/journal.pone.0179740	http://dx.doi.org/10.1371/journal.pone.0179740			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654665	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500030
J	Rueda-Roa, D; Mendoza, J; Muller-Karger, F; Cardenas, JJ; Achury, A; Astor, Y				Rueda-Roa, Digna; Mendoza, Jeremy; Muller-Karger, Frank; Cardenas, Juan Jose; Achury, Alina; Astor, Yrene			Spatial variability of Spanish sardine (Sardinella aurita) abundance as related to the upwelling cycle off the southeastern Caribbean Sea	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; PELAGIC FISH; SURFACE TEMPERATURE; CURRENT ECOSYSTEM; HABITAT; POPULATIONS; PACIFIC; ANCHOVY; COAST; SAGAX	The Sardinella aurita fishery off northeastern Venezuela, region of seasonal wind-driven coastal-upwelling, accounts for 90% of the Caribbean Sea small pelagic catch. This law-protected artisanal fishery takes place up to similar to 10 km offshore. The spatial distribution, number of schools, and biomass of S. aurita were studied using eight hydro-acoustic surveys (1995-1998). The study included the analysis of satellite-derived sea surface temperature and chlorophyll-a. Surveys were grouped by strong, weak, and transitional upwelling seasons. Relationships between these observations were analyzed using Generalized Additive Models. Results show that during the primary upwelling season (January-May) sardines were widely distributed in upwelling plumes that extended up to 70 km offshore. In the other hand, during the weak upwelling season (September-October) higher sardine densities were found within 10 Km off the coastal upwelling foci. The number of small pelagic schools was directly correlated with small pelagic densities; however, regardless of the season, higher numbers of small pelagic schools were always closer to the shoreline, especially during warm conditions. These two behaviors increase the availability and catchability of sardines for the artisanal fishery during the warm season, regardless of the total stock size. Using this evidence, we pose the hypothesis that the collapse of the regional S. aurita fishery in 2005 was due to a combination of stressful habitat conditions sustained since 2004. These included bottom-up factors due to food scarcity caused by weak upwelling, combined with top-down stress due to overfishing, as sardines accumulated in narrow diminished upwelling plumes located close to the coast. The increased catchability within easily accessible upwelling foci led to the demise of this biological resource, which as of 2014 had not yet recovered. Environmental conditions affecting the sardine habitat needs to be taken into account for the management of this stock. For example, during years with weak upwelling, special measures should be taken during the warm season on the second half of the year to avoid further pressure on the stock.	[Rueda-Roa, Digna; Muller-Karger, Frank] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Mendoza, Jeremy] Univ Oriente, Inst Oceanog Venezuela, Cumana, Estado Sucre, Venezuela; [Cardenas, Juan Jose] Nature Conservancy, Caracas, Distrito Capita, Venezuela; [Achury, Alina; Astor, Yrene] Fdn Salle Ciencias Nat, Estn Invest Marinas, Punta De Piedras, Estado Nueva Es, Venezuela	State University System of Florida; University of South Florida	Rueda-Roa, D (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL USA.	druedaro@mail.usf.edu	Rueda, Digna/J-8045-2019; Rueda-Roa, Digna/AHD-3202-2022	Rueda-Roa, Digna/0000-0003-4621-009X	National Science Foundation (NSF, USA) [OCE-0752139, OCE-9216626, OCE-9729284, OCE-9401537, OCE-9729697, OCE-9415790, OCE-9711318, OCE-0326268, OCE-0963028]; National Aeronautics and Space Administration (NASA, USA) [NAG5-6448, NAS5-97128]; Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA) [96280221]; Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela) [2000001702, 2011000353]; LOCTI [CON-EDIMAR 23914]; European Union [UE-VECEP ALA 92/43]; Directorate For Geosciences [1259043] Funding Source: National Science Foundation	National Science Foundation (NSF, USA)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA, USA)(National Aeronautics & Space Administration (NASA)); Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA); Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela); LOCTI; European Union(European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was carried out under the CARIACO Time-Series program, funded by: the National Science Foundation (NSF, USA, Grants OCE-0752139, OCE-9216626, OCE-9729284, OCE-9401537, OCE-9729697, OCE-9415790, OCE-9711318, OCE-0326268 and OCE-0963028), the National Aeronautics and Space Administration (NASA, USA, Grants NAG5-6448 and NAS5-97128), the Consejo Nacional de Investgaciones Cientificas y Tecnologicas (CONICIT, VENEZUELA, Grant 96280221), the Fondo Nacional de Investigaciones Cientificas y Tecnologicas (FONACIT, Venezuela, Grant 2000001702 and 2011000353), and LOCTI (Grant CON-EDIMAR 23914). Acoustic surveys were funded by the Regional Technical Cooperation Fishing Programme VECEP (UE-VECEP ALA 92/43) between the European Union and Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; [Anonymous], [No title captured]; Aparicio R., 2003, SARDINA SARDINELLA A, P171; Barange M, 1997, FISH OCEANOGR, V6, P94, DOI 10.1046/j.1365-2419.1997.00032.x; Barange M, 1997, ICES J MAR SCI, V62, P645; Barrios Alexander, 2010, Zootecnia Trop., V28, P457; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2016, PROG OCEANOGR, V146, P199, DOI 10.1016/j.pocean.2016.07.002; BINET D, 1982, OCEANOL ACTA, V5, P443; BLAXTER J. H. S., 1963, ADVAN MAR BIOL, V1, P261, DOI 10.1016/S0065-2881(08)60261-8; Brierley AS, 2015, CURR BIOL, V25, P75, DOI 10.1016/j.cub.2014.10.062; Brown AM, 2006, IDENTITIES WORK, P13; BROWN OB, 1985, J GEOPHYS RES-OCEANS, V90, P1667, DOI 10.1029/JC090iC06p11667; Cardenas J., 2003, SARDINA SARDINELLA A, P401; CARDENAS JJ, 2000, MEMORIA SOCIEDAD CIE, V154, P39; Castillo J, 2000, EVALUACION ACITSTICA; Cellamare Maria, 2007, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V46, P23; Cole J, 1998, REV FISH BIOL FISHER, V8, P445, DOI 10.1023/A:1008861224731; Demer DA, 2012, FISH B-NOAA, V110, P52; FAO, FISH GLOB INF SYST F; Foote K., 1987, ICES COOP RES REP, V144, P69; Freon P, 1997, MAR BIOL, V128, P363, DOI 10.1007/s002270050102; Freon P, 2005, B MAR SCI, V76, P385; Freon P, 2003, SARDINE SARDINELLA A, P451; Freon P, 2003, SARDINE SARDINELLA A; Gassman JPD, 2012, 3 C VEN DIV BIOL LIB, p[148, 148]; GERLOTTO F, 1986, Proceedings of the Gulf and Caribbean Fisheries Institute, P67; Gerlotto F., 1993, THESIS; Gerlotto FY, 1988, MEMORIA SOC CIENCIAS, V3; GOMEZ G., 1998, ZOOTECNIA TROPICAL, V16, P149; Gomez Gaspar Alfredo, 2012, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V51, P173; Gonzalez Leo W., 2007, Boletin del Centro de Investigaciones Biologicas Universidad del Zulia, V41, P457; Gonzalez LW, 2005, B CTR INVEST BIOL, V39, P197; Gu H, 2010, J COMPUT GRAPH STAT, V19, P531, DOI 10.1198/jcgs.2010.07139; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Guzman R., 2003, SARDINE SARDINELLA A, P427; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HERRERA L. E., 1975, B I OCEANOGR U ORIEN, V14, P165; Hu CM, 2009, IEEE T GEOSCI REMOTE, V47, P1607, DOI 10.1109/TGRS.2008.2007425; Jablonski S, 2004, SCI MAR, V68, P385, DOI 10.3989/scimar.2004.68n3385; Johannesson KA, 1983, FAO FISH TECH PAP, V240; Lanz E, 2009, CAL COOP OCEAN FISH, V50, P134; Larsson M, 2012, CURR ZOOL, V58, P116, DOI 10.1093/czoolo/58.1.116; Longhurst AR, 1971, OCEANOGR MAR BIOL AN, V9, P349; Lopez H., 1976, INF TEC, V46, P1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Mais K., 1974, Fish Bull California, VNo. 162, P1; MARAVELIAS CD, 1995, SCI MAR, V59, P427; Maravelias CD, 1999, CAN J FISH AQUAT SCI, V56, P437, DOI 10.1139/cjfas-56-3-437; Masse J., 1988, DR88030RHNANTES IFRE; McClain E. P., 1982, Advances in Space Research, V2, P43, DOI 10.1016/0273-1177(82)90120-X; Mendoza J, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P293; Mendoza J, 2003, SARDINA SARDINELLA A, P473; Mendoza J., 2015, WORKING PAPER SERIES; MINNETT PJ, 1991, J GEOPHYS RES-OCEANS, V96, P18475, DOI 10.1029/91JC01816; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; MULLERKARGER FE, 1989, PROG OCEANOGR, V23, P23, DOI 10.1016/0079-6611(89)90024-4; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; Niquen M, 2004, DEEP-SEA RES PT II, V51, P563, DOI 10.1016/j.dsr2.2004.03.001; O'Reilly J. E., 2000, SEAWIFS POSTLAUNCH C, P9, DOI [DOI 10.1029/98JC02160, DOI 10.1103/PHYSREVLETT.104.255302]; Odegaard J, 1971, 32 MACPNUDFAO; Odegaard J, 1971, 33 MACPNUDFAO; Odriozola AL, 2007, CONT SHELF RES, V27, P1447, DOI 10.1016/j.csr.2007.01.012; Overland JE, 2010, J MARINE SYST, V79, P305, DOI 10.1016/j.jmarsys.2008.12.009; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Peltonen H, 2007, ICES J MAR SCI, V64, P487, DOI 10.1093/icesjms/fsl044; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; RCore Team, 2020, R LANG ENV STAT COMP; RICHARDS FA, 1960, DEEP-SEA RES, V7, P163, DOI 10.1016/0146-6313(60)90023-X; Rincon F, 2008, MEMORIA FDN SALLE CI, V2007, P7; Rueda-Roa DT, 2013, DEEP-SEA RES PT I, V78, P102, DOI 10.1016/j.dsr.2013.04.008; Schismenou E, 2008, HYDROBIOLOGIA, V612, P201, DOI 10.1007/s10750-008-9502-1; Simmonds EJ, 1992, ACOUSTIC SURVEY DESI, V187; Smtersdal G, 1999, FAO FISHERIES TECHNI, V391; Stroemme T, 1989, REPORTS SURVEYS F NA, V1; STRONG AE, 1984, B AM METEOROL SOC, V65, P138, DOI 10.1175/1520-0477(1984)065<0138:IOSTFS>2.0.CO;2; Taylor GT, 2012, P NATL ACAD SCI USA, V109, P19315, DOI 10.1073/pnas.1207514109; THOMAS AC, 1988, J GEOPHYS RES-OCEANS, V93, P15733, DOI 10.1029/JC093iC12p15733; Thomas RM, 1985, COLLN SCI PAP INT CO, V12, P181; Tilman J, 1999, EC FISHERIES B, V12, P45; Tsikliras AC, 2006, SCI MAR, V70, P281, DOI 10.3989/scimar.2006.70n2281; Varela R, 2003, SARDINA MEDIO AMBIEN, P263; WALTON CC, 1988, J APPL METEOROL, V27, P115, DOI 10.1175/1520-0450(1988)027<0115:NMAFES>2.0.CO;2; Whitehead P. J. P., 1985, FAO FISH SYNOP 2, V7, P305; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S., 2015, R PACKAGE VERSION, V1, P729; Zwolinski JP, 2011, ICES J MAR SCI, V68, P867, DOI 10.1093/icesjms/fsr038	89	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179984	10.1371/journal.pone.0179984	http://dx.doi.org/10.1371/journal.pone.0179984			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654685	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500046
J	Seo, JW; Moon, H; Kim, SY; Moon, JY; Jeong, KH; Lee, YH; Kim, YG; Lee, TW; Ihm, CG; Kim, CD; Chung, BH; Kim, YH; Lee, SH				Seo, Jung-Woo; Moon, Haena; Kim, Se-Yun; Moon, Ju-Young; Jeong, Kyung Hwan; Lee, Yu-Ho; Kim, Yang-Gyun; Lee, Tae-Won; Ihm, Chun-Gyoo; Kim, Chan-Duck; Chung, Byung Ha; Kim, Yeong Hoon; Lee, Sang Ho			Both absolute and relative quantification of urinary mRNA are useful for non-invasive diagnosis of acute kidney allograft rejection	PLOS ONE			English	Article							DROPLET DIGITAL PCR; REAL-TIME PCR; DNA COPY NUMBER; MITOCHONDRIAL-DNA; QUANTITATIVE PCR; GENE-EXPRESSION; NORMALIZATION; OPTIMIZATION	Urinary mRNA analysis with three-gene set (18S rRNA, CD3 epsilon, and IP-10) has been suggested as a non-invasive biomarker of acute rejection (AR) in kidney transplant recipients using quantitative real-time PCR (qPCR). Application of droplet digital PCR (ddPCR), which has been suggested to provide higher sensitivity, accuracy, and absolute quantification without standard curves, could be a useful method for the quantifying low concentration of urinary mRNA. We investigated the urinary expression of these three genes in Korean patients with kidney transplantation and also evaluated the usefulness of ddPCR. 90 urine samples were collected at time of allograft biopsy in kidney recipients (n = 67) and from patients with stable renal function more than 10 years (n = 23). Absolute quantification with both PCR system showed significant higher mRNA levels of CD3 epsilon and IP-10 in AR patients compared with stable transplants (STA), but there was no difference in 18S rRNA expression across the patient groups. To evaluate discrimination between AR and STA, ROC curve analyses of CTOT-4 formula yielded area under the curve values of 0.72 (95% CI 0.60-0.83) and 0.77 (95% CI 0.66-0.88) for qPCR and ddPCR, respectively. However, 18S normalization of absolute quantification and relative quantification with 18S showed better discrimination of AR from STA than those of the absolute method. Our data indicate that ddPCR system without standard curve would be useful to determine the absolute quantification of urinary mRNA from kidney transplant recipients. However, comparative method also could be useful and convenient in both qPCR and ddPCR analysis.	[Seo, Jung-Woo; Kim, Se-Yun; Moon, Ju-Young; Jeong, Kyung Hwan; Lee, Yu-Ho; Kim, Yang-Gyun; Lee, Tae-Won; Ihm, Chun-Gyoo; Lee, Sang Ho] Kyung Hee Univ, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Haena] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Chan-Duck] Kyung Pook Natl Univ, Div Nephrol, Dept Internal Med, Sch Med, Daegu, South Korea; [Chung, Byung Ha] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Yeong Hoon] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med,Div Nephrol, Busan, South Korea	Kyung Hee University; Kyung Hee University; Kyungpook National University; Catholic University of Korea; Seoul St. Mary's Hospital; Inje University	Lee, SH (corresponding author), Kyung Hee Univ, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea.	lshkidney@khu.ac.kr	KIM, YANG GYUN/AAI-9821-2020; /W-5371-2019	KIM, YANG GYUN/0000-0002-3497-5514; 	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant no. HI13C1232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharuthram A, 2014, INFECT GENET EVOL, V25, P28, DOI 10.1016/j.meegid.2014.03.028; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Furness PN, 2001, KIDNEY INT, V60, P1998, DOI 10.1046/j.1523-1755.2001.00030.x; Galichon P, 2016, AM J TRANSPLANT; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Li XY, 2015, MOL MED REP, V11, P1304, DOI 10.3892/mmr.2014.2841; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Medeiros M, 2003, J IMMUNOL METHODS, V279, P135, DOI 10.1016/S0022-1759(03)00237-0; Mikeska T, 2010, EPIGENOMICS-UK, V2, P561, DOI 10.2217/EPI.10.32; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Roedder S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001759; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Szeto CC, 2005, NEPHROL DIAL TRANSPL, V20, P105, DOI 10.1093/ndt/gfh574; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Williams WW, 2012, NAT REV NEPHROL, V8, P110, DOI 10.1038/nrneph.2011.213; Zhao LM, 2014, ASIAN PAC J CANCER P, V15, P5815, DOI 10.7314/APJCP.2014.15.14.5815	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180045	10.1371/journal.pone.0180045	http://dx.doi.org/10.1371/journal.pone.0180045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654700	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500050
J	Braga, JU; Bressan, C; Dalvi, APR; Calvet, GA; Daumas, RP; Rodrigues, N; Wakimoto, M; Nogueira, RMR; Nielsen-Saines, K; Brito, C; de Filippis, AMB; Brasil, P				Braga, Jose Ueleres; Bressan, Clarisse; Razal Dalvi, Ana Paula; Amaral Calvet, Guilherme; Daumas, Regina Paiva; Rodrigues, Nadia; Wakimoto, Mayumi; Ribeiro Nogueira, Rita Maria; Nielsen-Saines, Karin; Brito, Carlos; Bispo de Filippis, Ana Maria; Brasil, Patricia			Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics	PLOS ONE			English	Article							OUTBREAK; ILLNESS; BRAZIL	Background Zika is a new disease in the American continent and its surveillance is of utmost importance, especially because of its ability to cause neurological manifestations as Guillain-Barre A syndrome and serious congenital malformations through vertical transmission. The detection of suspected cases by the surveillance system depends on the case definition adopted. As the laboratory diagnosis of Zika infection still relies on the use of expensive and complex molecular techniques with low sensitivity due to a narrow window of detection, most suspected cases are not confirmed by laboratory tests, mainly reserved for pregnant women and new-borns. In this context, an accurate definition of a suspected Zika case is crucial in order for the surveillance system to gauge the magnitude of an epidemic. Methodology We evaluated the accuracy of various Zika case definitions in a scenario where Dengue and Chikungunya viruses co-circulate. Signs and symptoms that best discriminated PCR confirmed Zika from other laboratory confirmed febrile or exanthematic diseases were identified to propose and test predictive models for Zika infection based on these clinical features. Results and discussion Our derived score prediction model had the best performance because it demonstrated the highest sensitivity and specificity, 86.6% and 78.3%, respectively. This Zika case definition also had the highest values for auROC (0.903) and R-2 (0.417), and the lowest Brier score 0.096. Conclusions In areas where multiple arboviruses circulate, the presence of rash with pruritus or conjunctival hyperemia, without any other general clinical manifestations such as fever, petechia or anorexia is the best Zika case definition.	[Braga, Jose Ueleres; Razal Dalvi, Ana Paula; Daumas, Regina Paiva; Rodrigues, Nadia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil; [Bressan, Clarisse; Amaral Calvet, Guilherme; Wakimoto, Mayumi; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil; [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA; [Brito, Carlos] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade Federal de Pernambuco	Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.	ueleres@gmail.com	Braga, Jose Ueleres/AAB-1326-2021; Brasil, Patricia/P-3536-2014; Calvet, GA/G-6959-2013; DAUMAS, REGINA P/M-9387-2013; amsalu, ribka/G-8780-2019; Barros de Castro, Daniel/J-9358-2016	Braga, Jose Ueleres/0000-0001-5247-007X; Calvet, GA/0000-0002-3545-5238; DAUMAS, REGINA P/0000-0002-8923-7711; Brasil, Patricia/0000-0001-9555-7976; Barros de Castro, Daniel/0000-0001-5969-544X	Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES/88887.116627/2016-01]; NATIONAL EYE INSTITUTE [R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129534] Funding Source: NIH RePORTER	Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/88887.116627/2016-01).	de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Brasil. Ministerio da Saude Secretaria de Vigilancia em Sande Departamento de Vigilancia das Doencas Transmissiveis, 2016, SECR VIG SANDE DEP V; Brasil. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2016, SECRETARIA VIGILANCI; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Pan American Health Organization / World Health Organization, 2015, EP UPD ZIK VIR  1016; Pan American Health Organization / World Health Organization (PAHO / WHO), 2014, EP AL CHIK DENG FEV; Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201; Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001; Solet J. L., 2007, PLOS BIOL, V77, P727; World Health Organization, 2016, ZIKA VIRUS DIS  0212; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2017, SIT REP	17	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179725	10.1371/journal.pone.0179725	http://dx.doi.org/10.1371/journal.pone.0179725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650987	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300015
J	Cespedes, N; Suen, CSNLW; Koepfli, C; Franca, CT; Felger, I; Nebie, I; Arevalo-Herrera, M; Mueller, I; Corradin, G; Herrera, S				Cespedes, Nora; Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Felger, Ingrid; Nebie, Issa; Arevalo-Herrera, Myriam; Mueller, Ivo; Corradin, Giampietro; Herrera, Socrates			Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria	PLOS ONE			English	Article							FALCIPARUM; ANTIBODIES; INFECTION; ANTIGENS; EPIDEMIOLOGY; DOMAINS; DISEASE; FORCE	Protein alpha-helical coiled coil structures are known to induce antibodies able to block critical functions in different pathogens. In a previous study, a total of 50 proteins of Plasmodium vivax erythrocytic asexual stages containing alpha-helical coiled coil structural motifs were identified in silico, and the corresponding peptides were chemically synthesized. A total of 43 peptides were recognized by naturally acquired antibodies in plasma samples from both Papua New Guinea (PNG) and Colombian adult donors. In this study, the association between IgG antibodies to these peptides and clinical immunity was further explored by measuring total IgG antibody levels to 24 peptides in baseline samples from a longitudinal study of children aged 1-3 years (n = 164) followed for 16 months. Samples were reactive to all peptides tested. Eight peptides were recognized by >50% of individuals, whereas only one peptide had < 20% reactivity. Children infected at baseline were seropositive to 23/24 peptides. No significant association was observed between antibody titers and age or molecular force of infection, suggesting that antibody levels had already reached an equilibrium. There was a strong association between antibody levels to all peptides and protection against P. vivax clinical episodes during the 16 months follow-up. These results suggest that the selected coiled coil antigens might be good markers of both exposure and acquired immunity to P. vivax malaria, and further preclinical investigation should be performed to determine their potential as P. vivax vaccine antigens.	[Cespedes, Nora; Arevalo-Herrera, Myriam; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia; [Cespedes, Nora; Arevalo-Herrera, Myriam] Univ Valle, Sch Hlth, Cali, Colombia; [Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Suen, Connie S. N. Li Wai; Koepfli, Cristian; Franca, Camila T.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Nebie, Issa] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Mueller, Ivo] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasites & Hosts Unit, Paris, France; [Mueller, Ivo] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain; [Corradin, Giampietro] Univ Lausanne, Biochem Dept, Epalinges, Switzerland; [Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia	Universidad del Valle; Walter & Eliza Hall Institute; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; ISGlobal; University of Lausanne	Herrera, S (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia.; Herrera, S (corresponding author), Caucaseco Sci Res Ctr, Cali, Colombia.	sherrera@inmuno.org	Koepfli, Cristian/H-8772-2019; Franca, Camila/I-4877-2019	Koepfli, Cristian/0000-0002-9354-0414; Franca, Camila/0000-0001-5885-4410; Li Wai Suen, Connie/0000-0003-0529-0804; Nebie, Issa/0000-0003-3051-3600	Colciencias [278-2008, 360-2011, 719-2013]; NIAID (ICEMR) [U19A1089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIAID (ICEMR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Colciencias (Contract 278-2008, Contract 360-2011 and Contract 719-2013) and a grant from NIAID (ICEMR grant U19A1089702). Also, this work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agak GW, 2008, VACCINE, V26, P1963, DOI 10.1016/j.vaccine.2008.02.020; ATHERTON E, 1981, H-S Z PHYSIOL CHEM, V362, P833, DOI 10.1515/bchm2.1981.362.2.833; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Cespedes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100440; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Dembele L, 2014, NAT MED, V20, P307, DOI 10.1038/nm.3461; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005014; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004639, 10.1371/journal.pntd.0005091]; Geleta G, 2016, MALAR RES TREAT, V2016; Gupta Bal Kishan, 2015, Infect Dis (Auckl), V8, P45, DOI 10.4137/IDRT.S34039; Gustchina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078187; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jiang ZQ, 2016, BIOPOLYMERS, V106, P144, DOI 10.1002/bip.22808; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Koepfli C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002403; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; malERA Consultative Group on Vaccines, 2011, PLOS MED, V8; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mitra S, 2015, J VECTOR DIS, V52, P281; Mueller I, 2015, VACCINE, V33, P7489, DOI 10.1016/j.vaccine.2015.09.060; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Nicolete VC, 2016, J INFECT DIS, V214, P1539, DOI 10.1093/infdis/jiw407; Olugbile S, 2011, VACCINE, V29, P7090, DOI 10.1016/j.vaccine.2011.06.122; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Team RC, 2016, R LANG ENV STAT COMP; Tripet B, 2006, J STRUCT BIOL, V155, P176, DOI 10.1016/j.jsb.2006.03.019; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; White MT, 2014, ELIFE, V3, DOI 10.7554/eLife.04692; WHO, 2015, WORLD MAL REP 2015	39	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179863	10.1371/journal.pone.0179863	http://dx.doi.org/10.1371/journal.pone.0179863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651021	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000404537300026
J	Madon-Simon, M; Grad, I; Bayo, P; Perez, P; Picard, D				Madon-Simon, Marta; Grad, Iwona; Bayo, Pilar; Perez, Paloma; Picard, Didier			Defective glucocorticoid receptor signaling and keratinocyte-autonomous defects contribute to skin phenotype of mouse embryos lacking the Hsp90 co-chaperone p23	PLOS ONE			English	Article							MOLECULAR CHAPERONE; ATPASE CYCLE; CELL-DEATH; COCHAPERONE P23; PROTEIN P23; APOPTOSIS; DYNAMICS; CANCER; MICE; DNA	p23 is a small acidic protein with intrinsic molecular chaperone activity. It is best known as a co-chaperone of the major cytosolic molecular chaperone Hsp90. p23 binds the N-terminus of Hsp90 and stabilizes the ATP-bound and N-terminally closed Hsp90 dimer. It is in this configuration that many Hsp90 clients are most stably bound. Considering the important role of p23 in the Hsp90 cycle, it came as a surprise that it is not absolutely essential for viability in the budding yeast or for mouse development. Mice without p23 develop quite normally until birth and then all die perinatally because of immature lungs. The only other apparent phenotype of late stage embryos and newborns is a skin defect, which we have further characterized here. We found that skin differentiation is impaired, and that both apoptosis and cell proliferation are augmented in the absence of p23; the consequences are a severe thinning of the stratum corneum and reduced numbers of hair follicles. The altered differentiation, spontaneous apoptosis and proliferation are all mimicked by isolated primary keratinocytes indicating that they do require p23 functions in a cell-autonomous fashion. Since the phenotype of p23-null embryos is strikingly similar to that of embryos lacking the glucocorticoid receptor, a paradigmatic Hsp90-p23 client protein, we investigated glucocorticoid signaling. We discovered that it is impaired in vivo and for some aspects in isolated keratinocytes. Our results suggest that part of the phenotype of p23-null embryos can be explained by an impact on this particular Hsp90 client, but do not exclude that p23 by itself or in association with Hsp90 affects skin development and homeostasis through yet other pathways.	[Madon-Simon, Marta; Grad, Iwona; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Sci 3, 30 Quai Ernest Ansermet, Geneva 4, Switzerland; [Bayo, Pilar; Perez, Paloma] CSIC, IBV, Jaime Roig 11, Valencia, Spain	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Picard, D (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, 30 Quai Ernest Ansermet, Geneva 4, Switzerland.	didier.picard@unige.ch	Perez, Paloma/K-8841-2017	Perez, Paloma/0000-0002-7166-2824	Swiss National Science Foundation; Canton de Geneve	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton de Geneve	This work was supported by the Swiss National Science Foundation and the Canton de Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Lilia Bernasconi, Diana Wider, and Rocio Tapia Pastrana for their technical assistance. This work was supported by the Swiss National Science Foundation and the Canton de Geneve.	ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Boix J, 2016, J INVEST DERMATOL, V136, P2417, DOI 10.1016/j.jid.2016.07.018; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Cato Laura, 2014, Nucl Recept Signal, V12, pe005, DOI 10.1621/nrs.12005; Cheng CF, 2010, CURR SIGNAL TRANSD T, V5, P121, DOI 10.2174/157436210791112208; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echtenkamp FJ, 2016, MOL CELL, V64, P888, DOI 10.1016/j.molcel.2016.09.040; Echtenkamp FJ, 2014, CURR PROTEIN PEPT SC, V15, P216, DOI 10.2174/1389203715666140331112230; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jimenez-Canino R, 2016, ENDOCRINOLOGY, V157, P2515, DOI 10.1210/en.2015-2055; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Krebs J, 2002, BBA-PROTEINS PROTEOM, V1600, P68, DOI 10.1016/S1570-9639(02)00446-6; Latorre V, 2013, J INVEST DERMATOL, V133, P2771, DOI 10.1038/jid.2013.255; Li W, 2000, NEUROSCIENCE, V96, P161, DOI 10.1016/S0306-4522(99)00531-X; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Martinet W, 2003, CARDIOVASC RES, V60, P259, DOI 10.1016/S0008-6363(03)00537-6; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Patwardhan CA, 2013, J BIOL CHEM, V288, P7313, DOI 10.1074/jbc.M112.427328; Perez P, 2011, DERM-ENDOCRINOL, V3, P166, DOI [10.4161/derm.3.3.15332, 10.4161/derm.15332]; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Picard D, 2006, EXP CELL RES, V312, P3949, DOI 10.1016/j.yexcr.2006.08.026; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; RAFESTINOBLIN ME, 1989, J BIOL CHEM, V264, P9304; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Reebye V, 2012, MOL ENDOCRINOL, V26, P1694, DOI 10.1210/me.2012-1056; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Sevilla LM, 2013, J INVEST DERMATOL, V133, P361, DOI 10.1038/jid.2012.281; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, EXP DERMATOL, V23, P369, DOI 10.1111/exd.12376; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Voss AK, 2000, DEVELOPMENT, V127, P1; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Wintermantel TM, 2004, HORM METAB RES, V36, P387, DOI 10.1055/s-2004-814567; Zelin E, 2012, MOL CELL, V48, P459, DOI 10.1016/j.molcel.2012.08.026	60	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180035	10.1371/journal.pone.0180035	http://dx.doi.org/10.1371/journal.pone.0180035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650975	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300037
J	Di Ruscio, F; Bjornholt, JV; Leegaard, TM; Moen, AEF; de Blasio, BF				Di Ruscio, Francesco; Bjornholt, Jorgen Vildershoj; Leegaard, Truls Michael; Moen, Aina E. Fossum; de Blasio, Birgitte Freiesleben			MRSA infections in Norway: A study of the temporal evolution, 2006-2015	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; COMMUNITY; DENMARK; SWEDEN	Background Norway has one of the lowest prevalences of methicillin-resistant Staphylococcus aureus (MRSA) infections in the world. This study exploits the extensive data on MRSA infections in the Norwegian surveillance system to investigate the important factors defining the MRSA epidemiology. Methods We performed a quasi-Poisson regression of the monthly notification rate (NR) of MRSA infections reported from January 2006 to December 2015, comparing the time trend among people with an immigrant vs. Norwegian background and domestic vs. imported infections, stratified by age groups. Findings A total of 5289 MRSA infections were reported during the study period, of which 2255 (42.6%) were acquired in Norway, 1370 (25.9%) abroad, and 1664 (31.5%) with an unknown place of acquisition. Overall, the monthly NR increased significantly from 2006 to 2015 (+0.8% each month). The monthly increase in immigrants (+1.3%) was steeper than that in people with a Norwegian background (+0.6%). There was a significant growth (+0.4%) in the rate of domestically acquired infections, however, the NR of infections acquired abroad increased faster (+0.8%). For both imported and domestic infections, the increase occurred in persons aged < 70 years. Interpretation Our analysis suggests that immigration and importation, especially among persons aged < 40 years, represent important factors for the increasing notification rate of MRSA infections in Norway.	[Di Ruscio, Francesco; Bjornholt, Jorgen Vildershoj; de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Infect Dis Epidemiol, Oslo, Norway; [Di Ruscio, Francesco; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Di Ruscio, Francesco; Leegaard, Truls Michael] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Bjornholt, Jorgen Vildershoj; Leegaard, Truls Michael; Moen, Aina E. Fossum] Univ Oslo, Inst Clin Med, Oslo, Norway; [Moen, Aina E. Fossum] Akershus Univ Hosp, Div Med, Dept Clin Mol Biol EpiGen, Lorenskog, Norway; [Bjornholt, Jorgen Vildershoj] Oslo Univ Hosp, Dept Clin Microbiol, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Di Ruscio, F (corresponding author), Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Infect Dis Epidemiol, Oslo, Norway.; Di Ruscio, F (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway.; Di Ruscio, F (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.	f.d.ruscio@medisin.uio.no	Moen, Aina/M-5209-2019	Moen, Aina/0000-0002-1892-846X; Bjornholt, Jorgen Vildershoj/0000-0002-0079-8062	South-Eastern Norway Regional Health Authority [2014002]	South-Eastern Norway Regional Health Authority	This study was funded by a grant from the South-Eastern Norway Regional Health Authority, https./www.helse-sorost.no (project number 2014002) to TML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the South-Eastern Norway Regional Health Authority (project number 2014002).	Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Center for Disease Dynamics and Policy, 2015, STAT WORLDS ANT 2015; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; ECDC, 2014, ANN EP REP 2014; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; Glasner C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.010; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Kristiansen JE, 2015, STAT SENTRALBYRA SSB; Larsen AR, 2008, J CLIN MICROBIOL, V46, P62, DOI 10.1128/JCM.01381-07; Larsson AK, 2014, EUR J CLIN MICROBIOL, V33, P61, DOI 10.1007/s10096-013-1929-2; Moen AEF, 2013, APMIS, V121, P1091, DOI 10.1111/apm.12077; Moen AEF, 2010, FEMS IMMUNOL MED MIC, V58, P374, DOI 10.1111/j.1574-695X.2009.00649.x; Monecke S, 2014, APMIS, V122, P580, DOI 10.1111/apm.12181; Moxnes JF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007163; Moxnes JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070499; National Institute of Public Health, 2009, NORW DIR HLTH; NORM/NORM-VET, 2015, US ANT AG OCC ANT RE; Norwegian Institute of Public Health, NORW SURV SYST COMM; R Core Team, 2018, R LANG ENV STAT COMP; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Steens A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-57; Stenhem M, 2010, EMERG INFECT DIS, V16, P189, DOI 10.3201/eid1602.081655; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhou YP, 2014, J TRAVEL MED, V21, P272, DOI 10.1111/jtm.12133	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179771	10.1371/journal.pone.0179771	http://dx.doi.org/10.1371/journal.pone.0179771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640901	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000404135800062
J	Zhang, F; Gannon, M; Chen, YJ; Zhou, LF; Jiao, K; Wang, Q				Zhang, Fang; Gannon, Mary; Chen, Yunjia; Zhou, Lufang; Jiao, Kai; Wang, Qin			The amyloid precursor protein modulates alpha(2A)-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment	FASEB JOURNAL			English	Article						internalization; desensitization; interactions; cell surface receptor	ALPHA(2A) ADRENERGIC-RECEPTOR; CULTURED SYMPATHETIC NEURONS; INTERACTING PROTEINS; COUPLED RECEPTORS; DENDRITIC SPINES; DEFICIENT MICE; KINASE-A; IN-VITRO; SPINOPHILIN; APP	The amyloid precursor protein (APP) has long been appreciated for its role in Alzheimer's disease (AD) pathology. However, less is known about the physiologic function of APP outside of AD. Particularly, whether and how APP may regulate functions of cell surface receptors, including GPCRs, remains largely unclear. In this study, we identified a novel direct interaction between APP and the alpha(2A)-adrenergic receptor (alpha(2A)AR) that occurs at the intracellular domains of both proteins. The APP interaction with alpha(2A)AR is promoted by agonist stimulation and competes with arrestin 3 binding to the receptor. Consequently, the presence of APP attenuates alpha(2A)AR internalization and desensitization, which are arrestin-dependent processes. Furthermore, in neuroblastoma neuro-2A cells and primary superior cervical ganglion neurons, where APP is highly expressed, the lack of APP leads to a dramatic increase in plasma membrane recruitment of endogenous arrestin 3 following alpha(2A)AR activation. Concomitantly, agonist-induced internalization of alpha(2A)AR is significantly enhanced in these neuronal cells. Our study provided the first evidence that APP fine tunes GPCR signaling and trafficking. Given the important role of alpha(2A)AR in controlling norepinephrine release and response, this novel regulation of alpha(2A)AR by APP may have an impact on modulation of noradrenergic activity and sympathetic tone.-Zhang, F., Gannon, M., Chen, Y., Zhou, L., Jiao, K., Wang, Q. The amyloid precursor protein modulates alpha(2A)-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.	[Zhang, Fang; Gannon, Mary; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,986 MCLM, Birmingham, AL 35294 USA; [Zhou, Lufang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,986 MCLM, Birmingham, AL 35294 USA.	qinwang@uab.edu	Zhang, Fang/AAT-5087-2020	Zhang, Fang/0000-0001-6403-9009; Zhou, Lufang/0000-0002-1321-8442; jiao, kai/0000-0002-1901-8329; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	U.S. National Institutes of Health, National Institute of Mental Health [MH081917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121206, R21HL127599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Jeffrey Benovic (Thomas Jefferson University, Philadelphia PA, USA) for generously providing the anti-arrestin 3 Ab. This work was supported by U.S. National Institutes of Health, National Institute of Mental Health Grant MH081917 (to Q.W.). The authors declare no conflicts of interest.	ALLINQUANT B, 1994, J NEUROSCI, V14, P6842; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Chen YJ, 2014, P NATL ACAD SCI USA, V111, P17296, DOI 10.1073/pnas.1409513111; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cottingham C, 2013, J BIOL CHEM, V288, P29193, DOI 10.1074/jbc.M113.469494; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Deyts C, 2016, TRENDS PHARMACOL SCI, V37, P390, DOI 10.1016/j.tips.2016.01.005; Duce JA, 2013, MOL PSYCHIATR, V18, P245, DOI 10.1038/mp.2011.168; Edwards SW, 1999, J BIOL CHEM, V274, P16331, DOI 10.1074/jbc.274.23.16331; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Gilsbach R, 2012, BRIT J PHARMACOL, V165, P90, DOI 10.1111/j.1476-5381.2011.01533.x; Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31; Gyires K, 2009, NEUROCHEM INT, V55, P447, DOI 10.1016/j.neuint.2009.05.014; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Masse F, 2006, PSYCHOPHARMACOLOGY, V183, P471, DOI 10.1007/s00213-005-0220-3; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nelson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074680; Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Schlicker E, 1998, BRAIN RES BULL, V47, P129, DOI 10.1016/S0361-9230(98)00068-9; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Trendelenburg AU, 2001, N-S ARCH PHARMACOL, V363, P110; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang Q, 2007, BIOCHEM PHARMACOL, V73, P1135, DOI 10.1016/j.bcp.2006.12.024; Wang Q, 2006, J BIOL CHEM, V281, P25948, DOI 10.1074/jbc.M605415200; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; Zhang Q, 2014, J ALZHEIMERS DIS, V40, P605, DOI 10.3233/JAD-130017; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	52	17	17	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4434	4446		10.1096/fj.201700346R	http://dx.doi.org/10.1096/fj.201700346R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646018	Green Published			2022-12-26	WOS:000413397400021
J	Ha, S; Jeong, SH; Yi, K; Chung, KM; Hong, CJ; Kim, SW; Kim, EK; Yu, SW				Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Seong Who; Kim, Eun-Kyoung; Yu, Seong-Woon			Phosphorylation of p62 by AMP-activated protein kinase mediates autophagic cell death in adult hippocampal neural stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN WITHDRAWAL; MITOPHAGY; P62/SQSTM1; DEGRADATION; APOPTOSIS; PATHWAY; SURVIVAL; PROLIFERATION; MITOCHONDRIA; MECHANISMS	In the adult brain, programmed death of neural stem cells is considered to be critical for tissue homeostasis and cognitive function and is dysregulated in neurodegeneration. Previously, we have reported that adult rat hippocampal neural (HCN) stem cells undergo autophagic cell death (ACD) following insulin withdrawal. Because the apoptotic capability of the HCN cells was intact, our findings suggested activation of unique molecular mechanisms linking insulin withdrawal to ACD rather than apoptosis. Here, we report that phosphorylation of autophagy-associated protein p62 by AMP-activated protein kinase (AMPK) drives ACD and mitophagy in HCN cells. Pharmacological inhibition of AMPK or genetic ablation of the AMPK alpha 2 subunit by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing suppressed ACD, whereas AMPK activation promoted ACD in insulin-deprived HCN cells. We found that following insulin withdrawal AMPK phosphorylated p62 at a novel site, Ser-293/Ser-294 (in rat and human p62, respectively). Phosphorylated p62 translocated to mitochondria and induced mitophagy and ACD. Interestingly, p62 phosphorylation at Ser-293 was not required for staurosporine-induced apoptosis in HCN cells. To the best of our knowledge, this is the first report on the direct phosphorylation of p62 by AMPK. Our data suggest that AMPK-mediated p62 phosphorylation is an ACD-specific signaling event and provide novel mechanistic insight into the molecular mechanisms in ACD.	[Ha, Shinwon; Jeong, Seol-Hwa; Yi, Kyungrim; Chung, Kyung Min; Hong, Caroline Jeeyeon; Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 42988, South Korea; [Kim, Eun-Kyoung; Yu, Seong-Woon] Gyeongbuk Inst Sci & Technol, Neurometab Res Ctr, Daegu 42988, South Korea; [Kim, Seong Who] Univ Ulsan, Dept Biochem & Mol Biol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea	University of Ulsan	Yu, SW (corresponding author), DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea.	yusw@dgist.ac.kr			Bio and Medical Technology Development Program of the National Research Foundation of Korea [2012M3A9C6049935, 2013M3C7A1056099]; Korea Brain Research Institute Basic Research Program [17-BR-04]; Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program of the Ministry of Science, ICT and Future Planning of Korea [17-BD-04]	Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea); Korea Brain Research Institute Basic Research Program; Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program of the Ministry of Science, ICT and Future Planning of Korea	This work was supported by Bio and Medical Technology Development Program of the National Research Foundation of Korea Grants (2012M3A9C6049935 and 2013M3C7A1056099), Korea Brain Research Institute Basic Research Program (17-BR-04), and Daegu Gyeongbuk Institute of Science and Technology Convergence Science Center Program (17-BD-04) of the Ministry of Science, ICT and Future Planning of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.4161/auto.5.2.7641; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chung KM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00116; Chung KM, 2015, STEM CELLS, V33, P3052, DOI 10.1002/stem.2082; Chung KM, 2013, BMB REP, V46, P383, DOI 10.5483/BMBRep.2013.46.8.164; Clarke PGH, 2012, AUTOPHAGY, V8, P867, DOI 10.4161/auto.20380; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0119-9; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hong CJ, 2016, BRAIN RES, V1649, P166, DOI 10.1016/j.brainres.2016.02.048; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim NY, 2014, ANIM CELLS SYST, V18, P183, DOI 10.1080/19768354.2014.923045; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitani T, 2015, CELL SIGNAL, V27, P1994, DOI 10.1016/j.cellsig.2015.07.009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yeo BK, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0212-8; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153	68	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13795	13808		10.1074/jbc.M117.780874	http://dx.doi.org/10.1074/jbc.M117.780874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655770	Green Published, hybrid			2022-12-26	WOS:000407942400008
J	Vig, AT; Foldi, I; Szikora, S; Migh, E; Gombos, R; Toth, MA; Huber, T; Pinter, R; Talian, GC; Mihaly, J; Bugyi, B				Vig, Andrea Terez; Foldi, Istvan; Szikora, Szilard; Migh, Ede; Gombos, Rita; Toth, Monika Agnes; Huber, Tamas; Pinter, Reka; Talian, Gabor Csaba; Mihaly, Jozsef; Bugyi, Beata			The activities of the C-terminal regions of the formin protein disheveled-associated activator of morphogenesis (DAAM) in actin dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; FILAMENT BARBED END; CAPPING PROTEIN; HOMOLOGY-2 DOMAIN; FILOPODIA FORMATION; STRUCTURAL BASIS; BINDING PROTEIN; MOUSE FORMIN; FH2 DOMAIN; WH2 DOMAIN	Disheveled-associated activator of morphogenesis (DAAM) is a diaphanous-related formin protein essential for the regulation of actin cytoskeleton dynamics in diverse biological processes. The conserved formin homology 1 and 2 (FH1-FH2) domains of DAAM catalyze actin nucleation and processively mediate filament elongation. These activities are indirectly regulated by the N- and C-terminal regions flanking the FH1-FH2 domains. Recently, the C-terminal diaphanous-autoregulatory domain (DAD) and the C terminus (CT) of formins have also been shown to regulate actin assembly by directly interacting with actin. Here, to better understand the biological activities of DAAM, we studied the role of DAD-CT regions of Drosophila DAAM in its interaction with actin with in vitro biochemical and in vivo genetic approaches. We found that the DAD-CT region binds actin in vitro and that its main actin-binding element is the CT region, which does not influence actin dynamics on its own. However, we also found that it can tune the nucleating activity and the filament end-interaction properties of DAAM in an FH2 domain-dependent manner. We also demonstrate that DAD-CT makes the FH2 domain more efficient in antagonizing with capping protein. Consistently, in vivo data suggested that the CT region contributes to DAAM-mediated filopodia formation and dynamics in primary neurons. In conclusion, our results demonstrate that the CT region of DAAM plays an important role in actin assembly regulation in a biological context.	[Vig, Andrea Terez; Toth, Monika Agnes; Huber, Tamas; Pinter, Reka; Talian, Gabor Csaba; Bugyi, Beata] Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary; [Foldi, Istvan; Szikora, Szilard; Migh, Ede; Gombos, Rita; Mihaly, Jozsef] Hungarian Acad Sci, Inst Genet, Biol Res Ctr, MTA SZBK NAP B Axon Growth & Regenerat Grp, Temesvari Krt 62, H-6726 Szeged, Hungary; [Bugyi, Beata] Szentagothai Res Ctr, Ifjusag Str 34, H-7624 Pecs, Hungary	University of Pecs; Hungarian Academy of Sciences; Hungarian Biological Research Center	Bugyi, B (corresponding author), Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	beata.bugyi@aok.pte.hu		Mihaly, Jozsef/0000-0003-3399-2424; Migh, Ede/0000-0002-8312-6463	Hungarian Science Foundation (OTKA) [K109689, K109330]; Hungarian Brain Research Program Grant [KTIA_NAP_13-2-2014-0007]; National Research, Development, and Innovation Office [GINOP-2.3.2-15-2016-00001]; National Innovation Office "Baross Gabor" Program [REG-DD-09-1-2009-0009]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities [UNKP-16-4]	Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program Grant; National Research, Development, and Innovation Office; National Innovation Office "Baross Gabor" Program; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities	This work was supported by Hungarian Science Foundation (OTKA) Grants K109689 (to B. B.) and K109330 (to J. M.); Hungarian Brain Research Program Grant KTIA_NAP_13-2-2014-0007 (to J. M.); National Research, Development, and Innovation Office Grant GINOP-2.3.2-15-2016-00001 (to J. M.); National Innovation Office "Baross Gabor" Program Grant REG-DD-09-1-2009-0009 Tirfm 09 (to B. B.); grants from the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program"; New National Excellence Program of the Ministry of Human Capacities (to B. B. and T. H.); and UNKP-16-4 New National Excellence Program of the Ministry of Human Capacities (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bao BH, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-63; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Bugyi B, 2010, EMBO J, V29, P14, DOI 10.1038/emboj.2009.316; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; HANSON J, 1963, J MOL BIOL, V6, P46, DOI 10.1016/S0022-2836(63)80081-9; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; ISENBERG G, 1980, NATURE, V288, P455, DOI 10.1038/288455a0; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Molnar I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004166; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Renault L, 2013, CYTOSKELETON, V70, P686, DOI 10.1002/cm.21140; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Toth MA, 2016, J BIOL CHEM, V291, P667, DOI 10.1074/jbc.M115.683904; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vogler G, 2014, J CELL BIOL, V206, P909, DOI 10.1083/jcb.201405075; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	61	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13566	13583		10.1074/jbc.M117.799247	http://dx.doi.org/10.1074/jbc.M117.799247			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642367	Green Published, hybrid			2022-12-26	WOS:000407942400030
J	Dutta, P; Li, WX				Dutta, Pranabananda; Li, Willis X.			The SERTAD protein Taranis plays a role in Polycomb-mediated gene repression	PLOS ONE			English	Article							GROUP RESPONSE ELEMENTS; TRITHORAX GROUP GENES; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; ENGRAILED EXPRESSION; MOLECULAR-GENETICS; EMBRYONIC PATTERN; BINDING-PROTEIN; IMAGINAL-DISCS; CELL IDENTITY	The Polycomb group (PcG) proteins have been implicated in epigenetic transcriptional repression in development, stem cell maintenance and in cancer. The chromodomain protein Polycomb (Pc) is a key member of the PcG. Pc binds to the histone mark, trimethylated histone 3 lysine 27 (H3K27me3), to initiate transcriptional repression. How PcG proteins are recruited to target loci is not fully understood. Here we show that the Drosophila SERTA domain protein Taranis (Tara) is involved in transcriptional regulation of Pc target genes. Embryos lacking Tara exhibit a partial homeotic transformation of cuticular the segments, a phenotype associated with the loss of Pc function. Moreover, Drosophila embryos homozygous for a tara hypomorphic allele also misexpress engrailed, a Pc-regulated gene, and this phenotype is associated with the loss of Pc binding to the cis response element in the engrailed enhancer. In relation to that, Pc recruitment is reduced on the salivary gland polytene chromosomes and specifically at the engrailed locus. These results suggest that Tara might be required for positioning Pc to a subset of its target genes.	[Dutta, Pranabananda; Li, Willis X.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dutta, Pranabananda; Li, Willis X.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Dutta, Pranabananda] Charles R Drew Univ Med & Sci, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA	University of California System; University of California San Diego; University of Rochester; Charles R. Drew University of Medicine & Science	Dutta, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Dutta, P (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.; Dutta, P (corresponding author), Charles R Drew Univ Med & Sci, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA.	pranabandutta@cdrewu.edu	Li, Willis/ABC-5695-2020; Li, Willis X/AAL-7212-2020	Li, Willis/0000-0001-9041-7341; Li, Willis X/0000-0001-9041-7341	NIH [5R01CA131326-04]; University of California San Diego Cancer Research Coordinating Committee; National Institutes of Health; University of California Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [R03CA212727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Cancer Research Coordinating Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by previous NIH 5R01CA131326-04 and by University of California San Diego Cancer Research Coordinating Committee.; We Thank Dr. G. Cavalli (CNRS, France) for kindly providing Fab-X flies, Dr. Judith Kassis (NIH, USA) for the P(EN1) plasmid, Dr. Dirk Bohmann (Rochester, NY) for Sgs3-Gal4 flies and various other fly strains and reagents, Dr. Henri-Marc Bourbon (Toulouse Cedex, France) for providing the pUbi-TaraB plasmid. We thank the Drosophila Stock Center (Bloomington, IN) and the Vienna Drosophila Resource Center (Vienna, Austria) for various strains, the Developmental Studies Hybridoma Bank for various antibodies. The work is supported, in part, by grants from the National Institutes of Health and the University of California Cancer Research Coordinating Committee.	Bajusz I, 2001, GENETICS, V159, P1135; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Calgaro S, 2002, GENETICS, V160, P547; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CASTELLIGAIR JE, 1990, GENETICS, V126, P177; Chanas G, 2004, DEV BIOL, V272, P522, DOI 10.1016/j.ydbio.2004.05.020; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Gildea JJ, 2000, GENETICS, V156, P645; GONZALEZGAITAN MA, 1990, GENETICS, V126, P139; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Hagstrom K, 1997, GENETICS, V146, P1365; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; KARR TL, 1989, DEVELOPMENT, V105, P605; KASSIS JA, 1994, GENETICS, V136, P1025; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; Lim SJ, 2014, RNA BIOL, V11, P1171, DOI 10.4161/rna.34381; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; MOAZED D, 1992, DEVELOPMENT, V116, P805; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Orsi GA, 2014, GENOME RES, V24, P809, DOI 10.1101/gr.163642.113; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuster KJ, 2015, DEV CELL, V34, P119, DOI 10.1016/j.devcel.2015.04.017; SERRANO N, 1995, DEVELOPMENT, V121, P1691; SIMON J, 1992, DEVELOPMENT, V114, P493; SOTO MC, 1995, GENETICS, V140, P231; Stepanik VA, 2012, DEV BIOL, V364, P249, DOI 10.1016/j.ydbio.2011.12.007; Takashi S, 1985, DEV BIOL, V110, P53; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e018002	10.1371/journal.pone.0180026	http://dx.doi.org/10.1371/journal.pone.0180026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665982	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700056
J	Li, SS; Jin, XQ; Wu, H; Wang, Y; Li, XQ; Guo, YX; Liang, SY				Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan			HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6	PLOS ONE			English	Article							TRANS-RETINOIC ACID; SELF-RENEWAL; CYCLE ARREST; RESISTANCE; GENE; IDENTIFICATION; PROLIFERATION; MECHANISMS	All-trans retinoic acid (ATRA) induces complete remission in almost all patients with acute promyelocytic leukemia (APL) via its ability to induce the in vivo differentiation of APL blasts. However, prolonged ATRA treatment can result in drug resistance. In previous studies, we generated a multi-drug-resistant HL60/ATRA cell line and found it to contain a new drug resistance-related gene segment, HA117. In this study, we demonstrate that ATRA induces multi-drug-resistant subpopulations of HL60 cells with a putative stem-like signature by up-regulating the expression of the new gene segment HA117. Western blot analysis and quantitative real-time PCR demonstrated that HA117 causes alternative splicing of regulator of G-protein signaling 6 (RGS6) and down-regulation of the expression of the GGL domain of RGS6, which plays an important role in DNA methyltransferase 1 (DNMT1) degradation. Moreover, DNMT1 expression was increased in multi-drug resistance HL60/ATRA cells. Knockdown of HA117 restored expression of the GGL domain and blocked DNMT1 expression. Moreover, resistant cells displayed a putative stem-like signature with increased expression of cancer steam cell markers CD133 and CD123. The stem cell marker, Nanog, was significantly up-regulated. In conclusion, our study shows that HA117 potentially promotes the stem-like signature of the HL60/ATRA cell line by inhibiting by the ubiquitination and degradation of DNMT1 and by down-regulating the expression of the GGL domain of RGS6. These results throw light on the cellular events associated with the ATRA-induced multi-drug resistance phenotype in acute leukemia.	[Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Dept Gastrointestinal Surg & Neonatal Surg, Key Lab Child Dev & Disorders, Childrens Hosp,Minist Educ, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Li, Shuangshuang; Jin, Xianqing; Wu, Huan; Wang, Yi; Li, Xiaoqing; Guo, Yuxia; Liang, Shaoyan] Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Jin, XQ (corresponding author), Chongqing Med Univ, Dept Gastrointestinal Surg & Neonatal Surg, Key Lab Child Dev & Disorders, Childrens Hosp,Minist Educ, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, Chongqing Key Lab Pediat, Chongqing, Peoples R China.; Jin, XQ (corresponding author), Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China.	etzhl@163.com		Li, Shuangshuang/0000-0002-5885-3706	National Natural Science Foundation of China [NSFC 81370474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	JXQ received The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (NSFC 81370474) for this work. This found had roles in study design, reagent and matieral providing, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2000, ANNU REV BIOCHEM, V69, P33; [Anonymous], 2000, MED PEDIATR ONCOL, V35, P6; [Anonymous], 2014, J PEDIATRIC HEMATOLO, V36, P6; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Cao J, 2013, LEUKEMIA RES, V37, P1170, DOI 10.1016/j.leukres.2013.04.021; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; DELVA L, 1993, BLOOD, V82, P2175; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Dohlma HG, 1997, J BIOL CHEM, V272, P4; Fung TK, 2013, ONCOTARGET, V4, P1128, DOI 10.18632/oncotarget.1244; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Guo YX, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-63; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Harding PL, MOL THERAPY, V15, P157; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hossain MM, 2012, NEUROCHEM INT, V61, P1102, DOI 10.1016/j.neuint.2012.08.002; Huang JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-839; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Liu CC, 2015, INT J CANCER, V136, P547, DOI 10.1002/ijc.29033; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Pathania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7910; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shi J, 2008, CANCER LETT, V270, P19, DOI 10.1016/j.canlet.2008.04.048; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Tomita A, 2013, INT J HEMATOL, V97, P717, DOI 10.1007/s12185-013-1354-4; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang W, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/417432; Zheng GH, 2009, LEUKEMIA RES, V33, P1120, DOI 10.1016/j.leukres.2008.11.018	36	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180142	10.1371/journal.pone.0180142	http://dx.doi.org/10.1371/journal.pone.0180142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665981	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700064
J	Altszyler, E; Ventura, AC; Colman-Lerner, A; Chernomoretz, A				Altszyler, Edgar; Ventura, Alejandra C.; Colman-Lerner, Alejandro; Chernomoretz, Ariel			Ultrasensitivity in signaling cascades revisited: Linking local and global ultrasensitivity estimations	PLOS ONE			English	Article							PROTEIN-KINASE CASCADES; MULTISITE PHOSPHORYLATION; COVALENT MODIFICATION; SWITCH-LIKE; SEQUESTRATION; BISTABILITY; RESPONSES; FEEDBACK; BIOLOGY; SYSTEMS	Ultrasensitive response motifs, capable of converting graded stimuli into binary responses, are well-conserved in signal transduction networks. Although it has been shown that a cascade arrangement of multiple ultrasensitive modules can enhance the system's ultrasensitivity, how a given combination of layers affects a cascade's ultrasensitivity remains an open question for the general case. Here, we introduce a methodology that allows us to determine the presence of sequestration effects and to quantify the relative contribution of each module to the overall cascade's ultrasensitivity. The proposed analysis framework provides a natural link between global and local ultrasensitivity descriptors and it is particularly well suited to characterize and understand mathematical models used to study real biological systems. As a case study, we have considered three mathematical models introduced by O'Shaughnessy et al. to study a tunable synthetic MAPK cascade, and we show how our methodology can help modelers better understand alternative models.	[Altszyler, Edgar] Univ Buenos Aires, Dept Comp, Lab Inteligencia Artificial Aplicada, CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.; Colman-Lerner, Alejandro] Univ Buenos Aires, IFIBYNE, CONICET, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina; [Ventura, Alejandra C.; Colman-Lerner, Alejandro] Univ Buenos Aires, Dept Fisiol Biol Mol & Celular, Fac Ciencias Exactas & Nat, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina; [Chernomoretz, Ariel] UBA, Dept Fis, FCEN, IFIBA,CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina; [Chernomoretz, Ariel] Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Chernomoretz, A (corresponding author), UBA, Dept Fis, FCEN, IFIBA,CONICET, Ciudad Univ,Pabellon 1,C1428EHA, Buenos Aires, DF, Argentina.; Chernomoretz, A (corresponding author), Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	ariel@df.uba.ar	Colman-Lerner, Alejandro/ABC-3808-2020	Colman-Lerner, Alejandro/0000-0002-2557-8883	Argentine Agency of Research and Technology [PICT2010-2248, PICT2013-2210, PICT2014-2701]; National Institute of General Medical Sciences, National Institutes of Health [1R01GM097479-01, 0000713502]; University of Buenos Aires [20020130100582BA]	Argentine Agency of Research and Technology; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Buenos Aires(University of Buenos Aires)	ACL acknowledges that this work was supported by grants PICT2010-2248 and PICT2013-2210 from the Argentine Agency of Research and Technology, and grant 1R01GM097479-01, subaward 0000713502 from the National Institute of General Medical Sciences, National Institutes of Health. AC acknowledges support from grant 20020130100582BA from University of Buenos Aires, and grant PICT2014-2701 from the Argentine Agency of Research and Technology.	Altszyler E, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/066003; Ang J, 2013, ACS SYNTH BIOL, V2, P547, DOI 10.1021/sb4000564; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bluthgen N., 2001, 2 WORKSH COMP BIOCH, P55; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P496, DOI 10.1016/j.tibs.2014.08.003; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Karsten R., 1997, BIF FUTURA, V12, P20; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Racz E, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036004; Srividhya J, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046005; Tsvetanova NG, 2016, MOL PHARM; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Wang G., 2016, SCI REPORTS, V6; Zechner C, 2016, P NATL ACAD SCI USA, V113, P4729, DOI 10.1073/pnas.1517109113; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180083	10.1371/journal.pone.0180083	http://dx.doi.org/10.1371/journal.pone.0180083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662096	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300101
J	Chiu, WT; Hong, CT; Chi, NF; Hu, CJ; Hu, HH; Chan, L				Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung			The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; CONTROLLED-TRIAL; EARLY MANAGEMENT; ECASS II; THERAPY; RUPTURE; TRANSFORMATION; ASSOCIATION; PREVALENCE	Background The presence of an intracranial aneurysm is contraindicated to recombinant tissue plasminogen activator (r-tPA) treatment for acute ischemic stroke. However, it is difficult to exclude asymptomatic intracranial aneurysms by using conventional, noncontrast head computed tomography (CT), which is the only neuroimaging suggested before r-tPA. Recent case reports and series have shown that administering r-tPA to patients with a pre-existing aneurysm does not increase the bleeding risk. However, Asians are known to have a relatively higher bleeding risk, and little evidence is available regarding the risk of using r-tPA on Asian patients with intracranial aneurysms. Methods Medical records from the Shuang Ho hospital stroke registration between July 2010 and December 2014 were retrospectively reviewed, and 144 patients received r-tPA. Unruptured intracranial aneurysms were detected using CT, or magnetic resonance or conventional angiography after r-tPA. The primary and secondary outcomes were the difference in overall intracranial hemorrhage (ICH) and symptomatic ICH after r-tPA. The differences were analyzed using Fisher's exact or Mann Whitney U tests, and p < 0.05 was defined as the statistical significance. Results A total of 144 patients were reviewed, and incidental unruptured intracranial aneurysms were found in 11 of them (7.6%). No significant difference was observed in baseline demographic data between the aneurysm and nonaneurysm groups. Among patients with an unruptured aneurysm, two had giant aneurysms (7.7 and 7.4 mm, respectively). The bleeding risk was not significant different between aneurysm group (2 out of 11, 18%) with nonaneurysm group (7 out of 133, 5.3%) (p = 0.14). None of the patients with an unruptured aneurysm had symptomatic ICH, whereas one patient without an aneurysm exhibited symptomatic ICH. Conclusions The presence of an unruptured intracranial aneurysm did not significantly increase the risk of overall and symptomatic ICH in Taiwanese patients after they received r-tPA.	[Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Chiu, Wei Ting; Hong, Chien Tai; Chi, Nai Fang; Hu, Chaur Jong; Hu, Han Hwa; Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chan, L (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan.; Chan, L (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan.; Chan, L (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan.	cjustinmd@gmail.com	Chan, Lung/AAI-6349-2020; Chan, Lung/AAM-3231-2021; Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017	Chan, Lung/0000-0001-5795-4460; Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923				Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Almeida A, 2014, CASE REPORTS NEUROLO, V2014; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Dharmasaroja PA, 2013, J STROKE CEREBROVASC, V22, P227, DOI 10.1016/j.jstrokecerebrovasdis.2011.08.001; Ding JY, 2016, AM J EMERG MED, V34, P636, DOI 10.1016/j.ajem.2015.12.025; Edwards NJ, 2012, STROKE, V43, P412, DOI 10.1161/STROKEAHA.111.634147; Ganesalingam J, 2013, JRSM CARDIOVASC DIS, V2, DOI 10.1177/2048004013478808; Garibaldi AA, 2006, J ENDOVASC THER, V13, P111, DOI 10.1583/05-1551.1; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Haji F, 2014, CAN J NEUROL SCI, V41, P95, DOI 10.1017/S0317167100016358; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kim JE, 2012, J BREAST CANCER, V15, P197, DOI 10.4048/jbc.2012.15.2.197; Lansberg MG, 2007, CEREBROVASC DIS, V24, P1, DOI 10.1159/000103110; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Mehta RH, 2014, STROKE, V45, P2263, DOI 10.1161/STROKEAHA.114.005019; Mowla A, 2015, INT J STROKE, V10, P113, DOI 10.1111/ijs.12616; Rammos SK, 2012, NEUROSURGERY, V70, pE1603, DOI 10.1227/NEU.0b013e31822e1097; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Saver JL, 2007, STROKE, V38, P2279, DOI 10.1161/STROKEAHA.107.487009; Sheth KN, 2012, NEUROCRIT CARE, V17, P199, DOI 10.1007/s12028-012-9734-9; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wang Hsin-Fan, 2013, Acta Neurol Taiwan, V22, P43; Xu M, 2014, CNS NEUROSCI THER, V20, P473, DOI 10.1111/cns.12254; Yoneda Y, 2009, CASE REP NEUROL, V1, P20, DOI 10.1159/000224714; Zaldivar-Jolissaint JF, 2015, J STROKE CEREBROVASC, V24, pE63, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.004	28	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180021	10.1371/journal.pone.0180021	http://dx.doi.org/10.1371/journal.pone.0180021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662192	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300087
J	Jiang, HC; Su, M; Kui, LY; Huang, HL; Qiu, LJ; Li, L; Ma, J; Du, TY; Fan, M; Sun, QM; Liu, XM				Jiang, Hongchao; Su, Min; Kui, Liyue; Huang, Hailin; Qiu, Lijuan; Li, Li; Ma, Jing; Du, Tingyi; Fan, Mao; Sun, Qiangming; Liu, Xiaomei			Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015	PLOS ONE			English	Article							CONJUGATE VACCINE; EPIDEMIOLOGY; CHILDHOOD; SURVEILLANCE; TURKEY; PCR	Acute bacterial meningitis is still considered one of the most dangerous infectious diseases in children. To investigate the prevalence and antibiotic resistance profiles of cerebrospinal fluid (CSF) pathogens in children with acute bacterial meningitis in Southwest China, CSF samples from 179 meningitis patients ( 3 days to 12 years old) with positive culture results were collected from 2012 to 2015. Isolated pathogens were identified using the Vitek-32 system. Gram stain results were used to guide subcultures and susceptibility testing. The antimicrobial susceptibility of isolates was determined using the disc diffusion method. Of the isolates, 50.8% were Gram-positive bacteria, and 49.2% were Gram-negative bacteria. The most prevalent pathogens were E. coli (28.5%), Streptococcus pneumoniae (17.8%), Staphylococcus epidermidis (10.0%), Haemophilus influenzae type b (9.5%), and group B streptococcus (7.2%). In young infants aged <= 3 months, E. coli was the organism most frequently isolated from CSF (39/76; 51.3%), followed by group B streptococcus (13/76; 17.1%) and Streptococcus pneumoniae (8/76; 10.5%). However, in young infants aged >3 months, the most frequently isolated organism was Streptococcus pneumoniae (24/103; 23.3%), followed by Staphylococcus epidermidis (18/103; 17.5%) and Haemophilus influenzae type b (16/103; 15.5%). Antimicrobial susceptibility tests indicated that for E. coli isolates, the susceptibility rates to aminoglycosides ranged from 56.8% to 100.0%, among them, amikacin was identified as the most effective against E. coli. As for cephalosporins, the susceptibility rates ranged from 29.4% to 78.4%, and cefoxitin was identified as the most effective cephalosporin. In addition, the susceptibility rates of piperacillin/tazobactam and imipenem against E. coli were 86.3% and 100%. Meanwhile, the susceptibility rates of Streptococcus pneumoniae isolates to penicillin G, erythromycin, chloramphenicol, ceftriaxone and tetracycline were 68.8%, 0.0%, 87.5%, 81.3% and 0.0%, respectively. Gentamycin, ofloxacin, linezolid and vancomycin were identified as the most effective antibiotics for Streptococcus pneumoniae, each with susceptibility rates of 100%. It was notable that other emerging pathogens, such as Listeria monocytogenes and group D streptococcus, cannot be underestimated in meningitis.	[Jiang, Hongchao; Su, Min; Kui, Liyue; Huang, Hailin; Qiu, Lijuan; Li, Li; Ma, Jing; Du, Tingyi; Fan, Mao; Liu, Xiaomei] Kunming Med Univ, Affiliated Childrens Hosp, Kunming, Peoples R China; [Jiang, Hongchao; Qiu, Lijuan; Sun, Qiangming] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Jiang, Hongchao; Qiu, Lijuan; Sun, Qiangming] Peking Union Med Coll, Kunming, Peoples R China; [Sun, Qiangming] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China	Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases	Liu, XM (corresponding author), Kunming Med Univ, Affiliated Childrens Hosp, Kunming, Peoples R China.; Sun, QM (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.; Sun, QM (corresponding author), Peking Union Med Coll, Kunming, Peoples R China.; Sun, QM (corresponding author), Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	msun08@yahoo.com; liuxiaomei2@yahoo.com	Sun, Qiangming/GYE-2002-2022		National Natural Science Foundation of China [81171946]; Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M) [2016-I2M-1-19]; Natural Science Foundation of Yunnan Province [2012FB188, 2016FA029]; Yunnan Science and Technology Department and Kunming Medical University [2014FZ058]; Training Project for the Medical Science and Technology Experts in Kunming City [2016-SW-51]; Foundation of the Yunnan Medical Science and Technology [2016NS124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Yunnan Science and Technology Department and Kunming Medical University; Training Project for the Medical Science and Technology Experts in Kunming City; Foundation of the Yunnan Medical Science and Technology	Our research was supported by the National Natural Science Foundation of China (grant no. 81171946), the Foundation of the CAMS Initiative for Innovative Medicine (CAMS-I2M) (grant no. 2016-I2M-1-19), the Natural ScienceFoundation of Yunnan Province (grant no. 2012FB188 and 2016FA029), the Joint Fund of the Yunnan Science and Technology Department and Kunming Medical University (grant no.2014FZ058), the Training Project for the Medical Science and Technology Experts in Kunming City (grant no. 2016-SW-51), and Foundation of the Yunnan Medical Science and Technology (grant no. 2016NS124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdinia B, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17616; Al Jarousha AM, 2014, IRAN J PUBLIC HEALTH, V43, P1176; Ba O, 2010, AM J TROP MED HYG, V83, P1330, DOI 10.4269/ajtmh.2010.10-0346; Briand C, 2016, OUTCOMES BACTERIAL M; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; de Souza SF, 2012, REV SOC BRAS MED TRO, V45, P323, DOI 10.1590/S0037-86822012000300009; Elenga N, 2015, MED MALADIES INFECT, V45, P441, DOI 10.1016/j.medmal.2015.10.003; Furyk JS, 2011, TROP MED INT HEALTH, V16, P672, DOI 10.1111/j.1365-3156.2011.02750.x; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gervaix A, 2012, PEDIATR INFECT DIS J, V31, P1084, DOI 10.1097/INF.0b013e318260552d; Gounder PP, 2015, J INFECTION, V71, P179, DOI 10.1016/j.jinf.2015.04.001; Gonzalez-Granado LI, 2010, LANCET INFECT DIS, V10, P596, DOI 10.1016/S1473-3099(10)70184-5; Iregbu Kenneth C, 2015, Niger Med J, V56, P297, DOI 10.4103/0300-1652.169749; Juganariu G, 2012, MED-SURG J, V116, P722; Karou SD, 2012, ASIAN PAC J TROP MED, V5, P848, DOI 10.1016/S1995-7645(12)60158-8; Kilic A, 2006, J CLIN MICROBIOL, V44, P222, DOI 10.1128/JCM.44.1.222-224.2006; Kuti BP, 2015, J NEUROSCI RURAL PRA, V6, P549, DOI 10.4103/0976-3147.165424; Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69; Madhi SA, 2015, J PEDIAT-BRAZIL, V91, P108, DOI 10.1016/j.jped.2014.11.001; McCormick DW, 2013, PEDIATR INFECT DIS J, V32, pE54, DOI 10.1097/INF.0b013e31826faf5a; Mebonia N, GEORGIAN MED NEWS, V2010, P44; Molyneux EM, 2015, CURR OPIN INFECT DIS, V28, P215, DOI 10.1097/QCO.0000000000000162; Namani S, 2012, J CHILD NEUROL, V27, P46, DOI 10.1177/0883073811413280; Nickerson JW, 2013, MMWR MORBIDITY MORTA, V64; Nwadioha S I, 2013, Niger Postgrad Med J, V20, P9; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Papavasileiou K, 2011, MOL DIAGN THER, V15, P109, DOI 10.2165/11587690-000000000-00000; Pelkonen T, 2008, SCAND J INFECT DIS, V40, P859, DOI 10.1080/00365540802262091; Piet JR, 2014, J INFECT DIS, V209, P1781, DOI 10.1093/infdis/jit818; Porobic-Jahic Humera, 2013, Med Arch, V67, P13, DOI 10.5455/medarh.2013.67.13-16; Sadarangani M, 2011, ADV EXP MED BIOL, V719, P185, DOI 10.1007/978-1-4614-0204-6_16; Shrestha RG, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0416-6; Snaebjarnardottir K, 2013, SCAND J INFECT DIS, V45, P819, DOI 10.3109/00365548.2013.817680; Toprak D, 2014, PEDIATR INFECT DIS J, V33, P1087, DOI 10.1097/INF.0000000000000378	35	21	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e180161	10.1371/journal.pone.0180161	http://dx.doi.org/10.1371/journal.pone.0180161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662145	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300116
J	Marquez-Lona, EM; Torres-Machorro, AL; Gonzales, FR; Pillus, L; Patrick, GN				Marquez-Lona, Esther Magdalena; Torres-Machorro, Ana Lilia; Gonzales, Frankie R.; Pillus, Lorraine; Patrick, Gentry N.			Phosphorylation of the 19S regulatory particle ATPase subunit, Rpt6, modifies susceptibility to proteotoxic stress and protein aggregation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; YEAST; DISEASE; PROTEOLYSIS; MUTANTS; MODEL; INHIBITION; GENES	The ubiquitin proteasome system (UPS) is a highly conserved and tightly regulated biochemical pathway that degrades the majority of proteins in eukaryotic cells. Importantly, the UPS is responsible for counteracting altered protein homeostasis induced by a variety of proteotoxic stresses. We previously reported that Rpt6, the ATPase subunit of the 19S regulatory particle (RP) of the 26S proteasome, is phosphorylated in mammalian neurons at serine 120 in response to neuronal activity. Furthermore, we found that Rpt6 S120 phosphorylation, which regulates the activity and distribution of proteasomes in neurons, is relevant for proteasome-dependent synaptic remodeling and function. To better understand the role of proteasome phosphorylation, we have constructed models of altered Rpt6 phosphorylation in S. cerevisiae by introducing chromosomal point mutations that prevent or mimic phosphorylation at the conserved serine (S119). We find that mutants which prevent Rpt6 phosphorylation at this site (rpt6-S119A), had increased susceptibility to proteotoxic stress, displayed abnormal morphology and had reduced proteasome activity. Since impaired proteasome function has been linked to the aggregation of toxic proteins including the Huntington's disease (HD) related huntingtin (Htt) protein with expanded polyglutamine repeats, we evaluated the extent of Htt aggregation in our phospho-dead (rpt6-S119A) and phospho-mimetic (rpt6-S119D) mutants. We showed Htt103Q aggregate size to be significantly larger in rpt6-S119A mutants compared to wild-type or rpt6-S119D strains. Furthermore, we observed that phosphorylation of endogenous Rpt6 at S119 is increased in response to various stress conditions. Together, these data suggest that Rpt6 phosphorylation at S119 may play an important function in proteasome-dependent relief of proteotoxic stress that can be critical in protein aggregation pathologies.	[Marquez-Lona, Esther Magdalena; Gonzales, Frankie R.; Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Torres-Machorro, Ana Lilia; Pillus, Lorraine] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; [Torres-Machorro, Ana Lilia; Pillus, Lorraine] Univ Calif San Diego, Moores Canc Ctr, Div Biol Sci, La Jolla, CA 92093 USA; [Marquez-Lona, Esther Magdalena] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Torres-Machorro, Ana Lilia] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, CONACYT, Mexico City, DF, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Tennessee System; University of Tennessee Health Science Center	Patrick, GN (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu	Torres-Machorro, Ana Lilia/GPX-8416-2022; Torres-Machorro, Ana Lilia/ABC-4610-2021	Torres-Machorro, Ana Lilia/0000-0003-3100-6897	National Institutes of Health [NS060847, GM090177]; Center for Systems Biology [P50-GM085764]; University of California Institute for Mexico; United States (UCMEXUS); National Council of Science and Technology of Mexico (CONACYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Systems Biology; University of California Institute for Mexico; United States (UCMEXUS); National Council of Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS060847 to GNP and GM090177 to LP) and the Center for Systems Biology (grant P50-GM085764 to GNP). We thank Chalongrat Noree for technical advice on microscopy. ALTM was supported by the University of California Institute for Mexico and the United States (UCMEXUS) and the National Council of Science and Technology of Mexico (CONACYT).	Adams J, 1999, CANCER RES, V59, P2615; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; BOND JF, 1986, CELL, V44, P461, DOI 10.1016/0092-8674(86)90467-8; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Braun RJ, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmol.7015.00008, 10.3389/fnmol.2015.00008]; Chang CS, 2012, G3-GENES GENOM GENET, V2, P1223, DOI 10.1534/g3.112.003558; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; Chen QH, 2005, BIOGERONTOLOGY, V6, P1, DOI 10.1007/s10522-004-7379-6; Chouduri Aktar Uzzaman, 2008, BMC Biochemistry, V9, P20, DOI 10.1186/1471-2091-9-20; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 2009, BIOCHEM BIOPH RES CO, V387, P1, DOI 10.1016/j.bbrc.2009.06.065; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Ehlinger A, 2013, STRUCTURE, V21, P753, DOI 10.1016/j.str.2013.02.021; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; ETLINGER JD, 1993, ENZYME PROTEIN, V47, P325, DOI 10.1159/000468690; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hieter P, 2014, GENETICS, V198, P443, DOI 10.1534/genetics.114.170217; Jana NR, 2012, NEUROCHEM INT, V60, P443, DOI 10.1016/j.neuint.2012.02.009; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kumeda SI, 1999, ANTICANCER RES, V19, P3961; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Machiels BM, 1997, CYTOMETRY, V28, P243; Mason RP, 2011, PRION, V5, P269, DOI [10.4161/pri.5.4.18005, 10.4161/pri.18005]; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mitchell L, 2013, P NATL ACAD SCI USA, V110, pE1641, DOI 10.1073/pnas.1218515110; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pereira C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/941232; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SAUER B, 1994, BIOTECHNIQUES, V16, P1086; SCHWARTZ AL, 1992, AM J RESP CELL MOL, V7, P463, DOI 10.1165/ajrcmb/7.5.463; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Sokolova V, 2015, SCI REP-UK, V5, DOI 10.1038/srep14909; Stolzing A, 2001, CLIN EXP DERMATOL, V26, P566, DOI 10.1046/j.1365-2230.2001.00867.x; Tanaka K, 2014, BBA-MOL CELL RES, V1843, P197, DOI 10.1016/j.bbamcr.2013.03.012; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wirz KTS, 2014, J ALZHEIMERS DIS, V38, P719, DOI 10.3233/JAD-130920; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; XU QL, 1995, MOL CELL BIOL, V15, P6025; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	89	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179893	10.1371/journal.pone.0179893	http://dx.doi.org/10.1371/journal.pone.0179893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662109	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300065
J	Sobalska-Kwapis, M; Suchanecka, A; Slomka, M; Siewierska-Gorska, A; Kepka, E; Strapagiel, D				Sobalska-Kwapis, Marta; Suchanecka, Aleksandra; Slomka, Marcin; Siewierska-Gorska, Anna; Kepka, Ewa; Strapagiel, Dominik			Genetic association of FTO/IRX region with obesity and overweight in the Polish population	PLOS ONE			English	Article							FTO RS9939609 POLYMORPHISM; BODY-MASS INDEX; FAT MASS; CHILDHOOD OBESITY; ENERGY-INTAKE; LIFE-COURSE; VARIANT; LOCI; METAANALYSIS; BMI	Background/Objectives Genome-wide association studies (GWAS) have identified many loci associated with body mass index (BMI) in many different populations. Variants in the FTO locus are reported to be one of the strongest genetic predictors of obesity. Recent publications pointed also to a topologically associated domain (TAD) which is identified as a novel region affecting BMI. The TAD area encompasses the IRXB cluster (IRX3, IRX5, IRX6), FTO and RPGRIP1L genes. Subjects/Methods In this study, we investigated the relationship between variation of the FTO and IRX genes and obesity in Poles. We presented a case-control association analysis (normal versus overweight and/or obesity group) of Polish adult individuals (N = 5418). We determined whether or not the chromosomal region 16: 53 500 000-55 500 000 contains polymorphic variants which are correlated with BMI in Polish population, including sex and age stratified analysis. Results The obtained results showed that the problem of weight-height abnormalities differently affects populations of Polish women and men (chi(2) = 187.1; p<0.0001). From 353 SNPs enrolled to this study, 86 were statistically significant (highest chi(2) = 15.72; p = 7.35E-05 observed for rs1558902). Linkage disequilibrium (LD) analysis revealed 61 blocks in the tested region of chromosome 16, with 24 SNPs located within the same block (block 8) of approximately 40 kb, in almost complete LD (vertical bar D'vertical bar>0.98, r(2)>0.80). We confirmed presence of the genetic susceptibility loci located in intron 1 of the FTO gene, which were correlated with BMI in our study group. For the first time, our analyses revealed strong association of FTO intronic variants (block 8) with overweight in group of men only. We have also identified association of the IRX region with overweight and/or obesity in Polish individuals. Conclusion Our study demonstrated how tested SNPs make differential contributions to obesity and overweight risk. We revealed sex dependent differences in the distribution of tested loci which are associated with BMI in the population of Poles.	[Sobalska-Kwapis, Marta; Slomka, Marcin; Strapagiel, Dominik] Univ Lodz, Dept Mol Biophys, Biobank Lab, Lodz, Poland; [Sobalska-Kwapis, Marta; Suchanecka, Aleksandra; Slomka, Marcin; Strapagiel, Dominik] BBMRI Pl Consortium, Lodz, Poland; [Siewierska-Gorska, Anna; Kepka, Ewa] Univ Lodz, Dept Mol Biophys, Lodz, Poland	University of Lodz; University of Lodz	Strapagiel, D (corresponding author), Univ Lodz, Dept Mol Biophys, Biobank Lab, Lodz, Poland.; Strapagiel, D (corresponding author), BBMRI Pl Consortium, Lodz, Poland.	dominik.strapagiel@biol.uni.lodz.pl	Suchanecka, Aleksandra/R-1892-2019; Strapagiel, Dominik/AAD-4351-2020; Suchanecka, Aleksandra/Q-2963-2017	Suchanecka, Aleksandra/0000-0002-7137-1429; Strapagiel, Dominik/0000-0001-9752-4270; Suchanecka, Aleksandra/0000-0002-7137-1429; Sobalska-Kwapis, Marta/0000-0003-1982-2621; Slomka, Marcin/0000-0002-7906-5549	POIG TESTOPLEK from the European Regional Development Fund [01.01.02-10-005/08]; Polish Ministry of Science and Higher Education [DIR/WK/2017/01]	POIG TESTOPLEK from the European Regional Development Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish POIG grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund and through the Polish Ministry of Science and Higher Education Grant DIR/WK/2017/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Field SF, 2007, DIABETOLOGIA, V50, P2218, DOI 10.1007/s00125-007-0767-0; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Graff M, 2013, DIABETES, V62, P1763, DOI 10.2337/db12-0863; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Huh I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138700; Hunt LE, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0250-3; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Lally P, 2008, INT J OBESITY, V32, P700, DOI 10.1038/sj.ijo.0803771; Landgraf K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161739; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Luczynski W, 2012, J PHYSIOL PHARMACOL, V63, P241; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Park SL, 2013, AM J EPIDEMIOL, V178, P780, DOI 10.1093/aje/kwt028; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rosset I, 2016, ANTHROPOL REV, V79, P17, DOI DOI 10.1515/anre-2016-0002; Saldana-Alvarez Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145984; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Singh RK, C R BIOL, V340, P87; Sitek A, 2014, ANTHROPOL REV, V77, P33, DOI DOI 10.2478/anre-2014-0003; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strapagiel D., 2015, INVENTORS METHOD DET; Strapagiel D., 2016, POLAND OPEN J BIORES, V3, pe6, DOI DOI 10.5334/OJB.22; Sung YJ, 2016, INT J OBESITY, V40, P662, DOI 10.1038/ijo.2015.217; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Wrzosek M, 2016, INDIAN J MED RES, V143, P281, DOI 10.4103/0971-5916.182617; Zhang MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097545	57	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180295	10.1371/journal.pone.0180295	http://dx.doi.org/10.1371/journal.pone.0180295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662178	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300138
J	Wang, YP; Guo, SG; Tian, SW; Zhang, J; Ren, Y; Sun, HH; Gong, GY; Zhang, HY; Xu, Y				Wang, Yanping; Guo, Shaogui; Tian, Shouwei; Zhang, Jie; Ren, Yi; Sun, Honghe; Gong, Guoyi; Zhang, Haiying; Xu, Yong			Abscisic acid pathway involved in the regulation of watermelon fruit ripening and quality trait evolution	PLOS ONE			English	Article							TRIGGERING ETHYLENE BIOSYNTHESIS; STRAWBERRY FRUIT; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; GENE-EXPRESSION; ABA; SUPPRESSION; METABOLISM; LYCOPENE; SLNCED1; ENZYMES	Watermelon (Citrullus lanatus (Thunb.) Matsum. & Nakai) is a non-climacteric fruit. The modern sweet-dessert watermelon is the result of years of cultivation and selection for fruits with desirable qualities. To date, the mechanisms of watermelon fruit ripening, and the role of abscisic acid (ABA) in this process, has not been well understood. We quantified levels of free and conjugated ABA contents in the fruits of cultivated watermelon (97103; C. lanatus subsp. vulgaris), semi-wild germplasm (PI179878; C. lanatus subsp. mucosospermus), and wild germplasm (PI296341-FR; C. lanatus subsp. lanatus). Results showed that ABA content in the fruits of 97103 and PI179878 increased during fruit development and ripening, but maintained a low steady state in the center flesh of PI296341-FR fruits. ABA levels in fruits were highest in 97103 and lowest in PI296341-FR, but no obvious differences in ABA levels were observed in seeds of these lines. Examination of 31 representative watermelon accessions, including different C. lanatus subspecies and ancestral species, showed a correlation between soluble solids content (SSC) and ABA levels in ripening fruits. Furthermore, injection of exogenous ABA or nordihydroguaiaretic acid (NDGA) into 97103 fruits promoted or inhibited ripening, respectively. Transcriptomic analyses showed that the expression levels of several genes involved in ABA metabolism and signaling, including Cla009779 (NCED), Cla005404 (NCED), Cla020673 (CYP707A), Cla006655 (UG7) and Cla020180 (SnRK2), varied significantly in cultivated and wild watermelon center flesh. Three SNPs (-738, C/A;-1681, C/T;-1832, G/T) in the promoter region of Cla020673 (CYP707A) and one single SNP (-701, G/A) in the promoter of Cla020180 (SnRK2) exhibited a high level of correlation with SSC variation in the 100 tested accessions. Our results not only demonstrate for the first time that ABA is involved in the regulation of watermelon fruit ripening, but also provide insights into the evolutionary mechanisms of this phenomenon.	[Wang, Yanping; Guo, Shaogui; Tian, Shouwei; Zhang, Jie; Ren, Yi; Sun, Honghe; Gong, Guoyi; Zhang, Haiying; Xu, Yong] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Key Lab Vegetable Germplasm Improvement, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Xu, Y (corresponding author), Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Key Lab Vegetable Germplasm Improvement, Beijing, Peoples R China.	xuyong@nercv.org			Beijing Municipal Science and Technology Commission of China [6141001, Z161100004916081, 2014000021223TD03, 2016000021223ZK19]; Beijing Scholar Program [BSP026]; Ministry of Agriculture of China [CARS-26]; National Natural Science Foundation of China [31401893, 31361140355]; Ministry of Science and Technology of China [2016YFD0100506]; BAAFS Innovation Team [JNKYT301601]	Beijing Municipal Science and Technology Commission of China; Beijing Scholar Program; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); BAAFS Innovation Team	This work was supported by grants from Beijing Municipal Science and Technology Commission of China (SG, 6141001; JZ, Z161100004916081; SG, 2014000021223TD03; JZ, 2016000021223ZK19; http://www.bjkw.gov.cn/), Beijing Scholar Program (YX, BSP026), Ministry of Agriculture of China (YX, CARS-26; http://www.moa.gov.cn/), National Natural Science Foundation of China (JZ, 31401893; YX, 31361140355; http://www.nsfc.gov.cn/), Ministry of Science and Technology of China (YR, 2016YFD0100506; littp://www.most.gov.cn/), and BAAFS Innovation Team (YX, JNKYT301601; http://www.baafs.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Chai L, 2016, SCI HORTIC-AMSTERDAM, V210, P34, DOI 10.1016/j.scienta.2016.07.015; Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Chen S, 1988, ACTA HORT SINICA, V25, P313; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; COOMBE B G, 1989, Acta Horticulturae (Wageningen), P149; Cutting J. G. M., 1989, Yearbook - South African Avocado Growers' Association, V12, P53; ELKASHIF ME, 1989, J AM SOC HORTIC SCI, V114, P81; ELKASHIF ME, 1988, J AM SOC HORTIC SCI, V113, P378; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Guo S, 2015, PLOS ONE, V10, P16; Han Y, 2015, PLANT PHYSIOL, V167, P915, DOI 10.1104/pp.114.251314; Huang CongLin, 2001, Acta Horticulturae Sinica, V28, P385; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Ji K, 2012, FUNCT PLANT BIOL, V39, P351, DOI 10.1071/FP11293; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HF, 2016, J PLANT GROWTH REGUL, V35, P987, DOI 10.1007/s00344-016-9597-y; Karakurt Y, 2002, PHYSIOL PLANTARUM, V116, P398, DOI 10.1034/j.1399-3054.2002.1160316.x; Kojima K., 1996, Chemical Regulation of Plants, V31, P68; Li D, 2016, SCI REP; Li Q, 2015, J EXP BOT, V66, P3765, DOI 10.1093/jxb/erv169; Li Q, 2013, PLANT J, V76, P24, DOI 10.1111/tpj.12272; Li Q, 2012, J PLANT PHYSIOL, V169, P78, DOI 10.1016/j.jplph.2011.08.005; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Paris HS, 2015, ANN BOT-LONDON, V116, P133, DOI 10.1093/aob/mcv077; Perkins-Veazie P., 1995, Hortscience, V30, P825; Reddy UK, 2015, J HERED, V106, P166, DOI 10.1093/jhered/esu077; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Sun L, 2012, PLANT PHYSIOL, V158, P283, DOI 10.1104/pp.111.186866; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Sun Y, 2013, J PLANT GROWTH REGUL, V32, P233, DOI 10.1007/s00344-012-9293-5; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Villalobos-Gonzalez L, 2016, PLANT PHYSIOL BIOCH, V105, P213, DOI 10.1016/j.plaphy.2016.04.012; Wang XH, 2016, SCI HORTIC-AMSTERDAM, V201, P175, DOI 10.1016/j.scienta.2015.12.024; Wang YP, 2013, PLANT PHYSIOL BIOCH, V64, P70, DOI 10.1016/j.plaphy.2012.12.015; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Zaharah SS, 2013, POSTHARVEST BIOL TEC, V75, P37, DOI 10.1016/j.postharvbio.2012.07.009; Zhang J, 2016, NEW PHYTOL; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang Y, 2011, ACTA BOT BOREALI-OCC, V6, P17; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhou M, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2248-x	52	31	32	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179944	10.1371/journal.pone.0179944	http://dx.doi.org/10.1371/journal.pone.0179944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662086	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300077
J	Zhang, LR; Xie, FX; Wang, XG; Peng, DZ; Bi, CR; Jiang, LB; Zhao, DM; Tian, XX; Qi, DB				Zhang, Liran; Xie, Fengxiang; Wang, Xinguo; Peng, Dezhi; Bi, Chunrui; Jiang, Lingbo; Zhao, Dongman; Tian, Xinxin; Qi, Debo			Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; POOLED ANALYSIS; INTRAEPITHELIAL NEOPLASIA; PAPANICOLAOU TESTS; FOLLOW-UP; CANCER; HPV; WOMEN; DNA; RECRUITMENT	Background Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. Methods A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. Results A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). Conclusions The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China.	[Zhang, Liran; Xie, Fengxiang; Wang, Xinguo; Zhao, Dongman; Qi, Debo] Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China; [Peng, Dezhi; Bi, Chunrui; Jiang, Lingbo; Tian, Xinxin] Jinan KingMed Diagnost, Dept Lab Med, Jinan, Shandong, Peoples R China		Qi, DB (corresponding author), Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China.	bobo8369@163.com						Blatt AJ, 2015, CANCER CYTOPATHOL, V123, P282, DOI 10.1002/cncy.21544; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Li YX, 2015, PLOS ONE, V10; Li ZB, 2012, ARCH PATHOL LAB MED, V136, P1533, DOI 10.5858/arpa.2011-0609-OA; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Mezei AK, 2017, INT J CANC; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Pan QJ, 2014, GYNECOL ONCOL, V133, P172, DOI 10.1016/j.ygyno.2014.03.008; Pan QJ, 2013, CANCER CYTOPATHOL, V121, P473, DOI 10.1002/cncy.21297; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Tao X, 2015, CANCER CYTOPATHOL, V123, P421, DOI 10.1002/cncy.21545; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Xu He, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P399; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971; Zeng ZY, 2016, AM J CLIN PATHOL, V145, P622, DOI [10.1093/ajcp/aqw010, 10.1093/AJCP/AQW010]; Zhao CQ, 2015, ARCH PATHOL LAB MED, V139, P184, DOI 10.5858/arpa.2014-0028-OA; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4; Zheng Baowen, 2015, J Am Soc Cytopathol, V4, P84, DOI 10.1016/j.jasc.2014.10.005; Zheng BW, 2015, CANCER CYTOPATHOL, V123, P428, DOI 10.1002/cncy.21557; Zheng BW, 2015, ARCH PATHOL LAB MED, V139, P373, DOI 10.5858/arpa.2014-0070-OA	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180618	10.1371/journal.pone.0180618	http://dx.doi.org/10.1371/journal.pone.0180618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662160	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300171
J	Rodgveller, CJ; Hutchinson, CE; Harris, JP; Vulstek, SC; Guthrie, CM				Rodgveller, Cara J.; Hutchinson, Charles E.; Harris, Jeremy P.; Vulstek, Scott C.; Guthrie, Charles M., III			Otolith shape variability and associated body growth differences in giant grenadier, Albatrossia pectoralis	PLOS ONE			English	Article							STOCK DISCRIMINATION; SPAWNING AREAS; COD; TOOL; IDENTIFICATION; SEPARATION; SEBASTES; REDFISH; GULF	Fish stocks can be defined by differences in their distribution, life history, and genetics. Managing fish based on stock structure is integral to successful management of a species because fishing may affect stocks disproportionately. Genetic and environmental differences can affect the shape and growth of otoliths and these differences may be indicative of stock structure. To investigate the potential for speciation or stock structure in giant grenadier, Albatrossia pectoralis, we quantified the shape of female giant grenadier otoliths and compared body growth rates for fish with three otolith shapes; shape types were classified visually by an experienced giant grenadier age reader, and were not defined by known distribution or life history differences. We found extreme variation in otolith shape among individuals; however, the shapes were a gradation and not clearly defined into three groups. The two more extreme shapes, visually defined as "hatchet" and "comb", were discernable based on principal component analyses of elliptical Fourier descriptors, and the "mixed" shape overlapped both of the extreme shapes. Fish with hatchet-shaped otoliths grew faster than fish with comb-shaped otoliths. A genetic test (cytochrome coxidase 1 used by the Fish Barcode of Life Initiative) showed almost no variability among samples, indicating that the samples were all from one species. The lack of young specimens makes it difficult to link otolith shape and growth difference to life history. In addition, shape could not be correlated with adult movement patterns because giant grenadiers experience 100% mortality after capture and, therefore, cannot be tagged and released. Despite these limitations, the link between body growth and otolith shape indicates measurable differences that deserve more study.	[Rodgveller, Cara J.; Vulstek, Scott C.; Guthrie, Charles M., III] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99802 USA; [Hutchinson, Charles E.; Harris, Jeremy P.] NOAA, Resource Ecol & Fisheries Management Div, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Rodgveller, CJ (corresponding author), NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99802 USA.	cara.rodgveller@noaa.gov			National Oceanic and Atmospheric Administration, National Marine Fisheries Service	National Oceanic and Atmospheric Administration, National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by the National Oceanic and Atmospheric Administration, National Marine Fisheries Service.	Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Bonhomme V, 2014, J STAT SOFTW, V56, P1; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Cardinale M, 2004, CAN J FISH AQUAT SCI, V61, P158, DOI 10.1139/F03-151; Claude J, 2008, MORPHOMETRICS R; Clausen DM, 2008, AM FISH S S, V63, P413; Clausen DM, 2013, NMFSAFSC247 NOAA US; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; DeVries DA, 2002, FISH RES, V57, P51, DOI 10.1016/S0165-7836(01)00332-0; Ferguson GJ, 2011, FISH RES, V110, P75, DOI 10.1016/j.fishres.2011.03.014; Galley EA, 2006, ICES J MAR SCI, V63, P1710, DOI 10.1016/j.icesjms.2006.06.014; Godiken JA, 2015, PLOS ONE, V10; HILBORN R, 1992; Hussy K, 2008, J EXP MAR BIOL ECOL, V364, P35, DOI 10.1016/j.jembe.2008.06.026; Hussy K, 2016, FISH RES, V174, P210, DOI 10.1016/j.fishres.2015.10.010; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; Keating JP, 2014, FISH RES, V157, P1, DOI 10.1016/j.fishres.2014.03.009; Legua J, 2013, LAT AM J AQUAT RES, V41, P479, DOI 10.3856/vol41-issue3-fulltext-11; Mahe K, 2016, CAN J FISH AQUAT SCI, V73, P1363, DOI 10.1139/cjfas-2015-0332; Orlov AM, 2008, AM FISH S S, V63, P225; Paul K, 2013, J APPL ICHTHYOL, V29, P743, DOI 10.1111/jai.12145; Petursdottir G, 2006, FISH RES, V80, P182, DOI 10.1016/j.fishres.2006.05.002; Ponton D, 2006, J MORPHOL, V267, P750, DOI 10.1002/jmor.10439; R Core Team, 2013, R LANG ENV STAT COMP; Rodgveller C, 2016, ASSESSMENT GRENADIER, P1; Rodgveller CJ, 2010, MAR COAST FISH, V2, P73, DOI 10.1577/C09-028.1; Rutecki TL, 2016, NATL MARINE FISHERIE; Sadighzadeh Z, 2014, FISH RES, V155, P59, DOI 10.1016/j.fishres.2014.02.024; SAS Institute Inc, 2015, JMP VERS 12; Stransky C, 2005, ICES J MAR SCI, V62, P1691, DOI 10.1016/j.icesjms.2005.05.012; Stransky C, 2005, CAN J FISH AQUAT SCI, V62, P2265, DOI 10.1139/F05-143; Stransky C, 2008, FISH RES, V90, P26, DOI 10.1016/j.fishres.2007.09.009; Tracey SR, 2006, FISH RES, V77, P138, DOI 10.1016/j.fishres.2005.10.013; Treinen-Crespo C, 2012, REVMAR-REV CIENC MAR, V4, P157; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Zar JH., 2010, BIOSTAT ANAL, V5th	37	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180020	10.1371/journal.pone.0180020	http://dx.doi.org/10.1371/journal.pone.0180020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658326	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900053
J	Winkler, MT; Bushey, RT; Gottlin, EB; Campa, MJ; Guadalupe, ES; Volkheimer, AD; Weinberg, JB; Patz, EF				Winkler, Mark T.; Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Guadalupe, Eross S.; Volkheimer, Alicia D.; Weinberg, J. Brice; Patz, Edward F., Jr.			Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody	PLOS ONE			English	Article							DEPENDENT CYTOTOXICITY; REGULATORY PROTEINS; EXPRESSION; OFATUMUMAB; LYMPHOMAS; EFFICACY; IMPROVES; THERAPY; CANCER; CD59	Rituximab therapy for B cell chronic lymphocytic leukemia (B-CLL) has met with mixed success. Among several factors to which resistance can be attributed is failure to activate complement dependent cytotoxicity (CDC) due to protective complement regulatory proteins, including the soluble regulator complement factor H (CFH). We hypothesized that rituximab killing of non-responsive B-CLL cells could be augmented by a novel human monoclonal antibody against CFH. The B cells from 11 patients with B-CLL were tested ex vivo in CDC assays with combinations of CFH monoclonal antibody, rituximab, and a negative control antibody. CDC of rituximab non-responsive malignant B cells from CLL patients could in some cases be augmented by the CFH monoclonal antibody. Antibody-mediated cytotoxicity of cells was dependent upon functional complement. In one case where B-CLL cells were refractory to CDC by the combination of rituximab plus CFH monoclonal antibody, additionally neutralizing the membrane complement regulatory protein CD59 allowed CDC to occur. Inhibiting CDC regulatory proteins such as CFH holds promise for overcoming resistance to rituximab therapy in B-CLL.	[Winkler, Mark T.; Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Patz, Edward F., Jr.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Guadalupe, Eross S.; Volkheimer, Alicia D.; Weinberg, J. Brice] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Volkheimer, Alicia D.; Weinberg, J. Brice] Durham VA Med Ctr, Durham, NC USA; [Weinberg, J. Brice] Duke Univ, Dept Immunol, Med Ctr, Durham, NC USA; [Patz, Edward F., Jr.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Patz, EF (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.; Patz, EF (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA.	patz0002@mc.duke.edu		Gottlin, Elizabeth/0000-0003-0886-0024; Cooper-Volkheimer, Alicia/0000-0002-0275-4450; Patz, Edward/0000-0003-3374-1596	Veterans Affairs Research Service	Veterans Affairs Research Service(US Department of Veterans Affairs)	This research was supported in part by funding from the Veterans Affairs Research Service to Dr.Weinberg. There was no additional external fundin greceived for this study. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; Campa MJ, 2015, CANCER IMMUNOL RES, V3, P1325, DOI 10.1158/2326-6066.CIR-15-0122; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Dwojak M, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.27; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Guc D, 2000, EUR J HAEMATOL, V64, P3, DOI 10.1034/j.1600-0609.2000.80097.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Harjunpaa A, 2000, SCAND J IMMUNOL, V51, P634; Horl S, 2013, LEUKEMIA, V27, P2200, DOI 10.1038/leu.2013.169; Horl S, 2013, HAEMATOLOGICA, V98, P1939, DOI 10.3324/haematol.2013.089615; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Jamroziak K, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0448-2; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Mamidi S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.979688; Middleton O, 2015, LEUKEMIA, V29, P107, DOI 10.1038/leu.2014.146; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Perez-Callejo D, 2015, CANCER TREAT REV, V41, P680, DOI 10.1016/j.ctrv.2015.05.007; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Smolewski P, 2015, EXPERT OPIN DRUG DIS, V10, P791, DOI 10.1517/17460441.2015.1045295; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Volkheimer AD, 2007, BLOOD, V109, P1559, DOI 10.1182/blood-2006-05-020644; Weinberg JB, 2007, AM J HEMATOL, V82, P1063, DOI 10.1002/ajh.20987; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Zelenetz AD, 2015, J NATL COMPR CANC NE, V13, P326, DOI 10.6004/jnccn.2015.0045	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179841	10.1371/journal.pone.0179841	http://dx.doi.org/10.1371/journal.pone.0179841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658265	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900042
J	de Miguel, A; Tapia-Rojo, R; Utesch, T; Mroginski, MA				de Miguel, Alejandra; Tapia-Rojo, Rafael; Utesch, Tillmann; Mroginski, Maria Andrea			Structure, dynamics and kinetics of two-component Lantibiotic Lichenicidin	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; BACILLUS-LICHENIFORMIS; FORCE-FIELD; SIMULATIONS; BACTERIOCINS; PEPTIDES; PARAMETERS; PROTEINS; IMMUNITY	Two variants of the two-component Lantibiotic Lichenicidin, produced by the strains B. Licheniformis VK21 and I89 (Lch alpha/Lch beta and Bli alpha/Bli beta peptides, respectively) have been investigated by means of 2 mu s-long all-atom molecular dynamics simulations combined with Markov State Models. This rigorous statistical analysis enabled to evaluate the dynamic and kinetic properties of the aforementioned systems which are not accessible via experimental techniques. The structural flexibility characteristic of these small peptides is understood by a delicate equilibrium between random coil, alpha-helices and beta-sheet structures. The undergoing secondary structure transitions from an alpha-helix to a beta-sheet observed for Lch alpha and Lch beta peptides, were not present in the Bli alpha component and provide new insights to understand their mechanism of action.	[de Miguel, Alejandra; Utesch, Tillmann; Mroginski, Maria Andrea] Tech Univ Berlin, Inst Chem, Dept Biophys Chem, Berlin, Germany; [Tapia-Rojo, Rafael] Univ Zaragoza, Dept Fis Mat Condensada, Zaragoza, Spain; [Tapia-Rojo, Rafael] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain; [Tapia-Rojo, Rafael] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Technical University of Berlin; University of Zaragoza; University of Zaragoza; Columbia University	Mroginski, MA (corresponding author), Tech Univ Berlin, Inst Chem, Dept Biophys Chem, Berlin, Germany.	andrea.mroginski@tu-berlin.de	Tapia-Rojo, Rafael/AAX-3028-2020	Tapia-Rojo, Rafael/0000-0002-9460-2859	Cluster of Excellence Unifying Concepts in Catalysis	Cluster of Excellence Unifying Concepts in Catalysis(German Research Foundation (DFG))	This work was funded by grants from the Cluster of Excellence Unifying Concepts in Catalysis launched by the German federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Becker O.M., 2001, COMPUTATIONAL BIOCH; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bolintineanu DS, 2011, PEPTIDES, V32, P188, DOI 10.1016/j.peptides.2010.10.006; Bowman Gregory R., 2014, INTRO MARKOV STATE M; Caetano T, 2011, CHEM BIOL, V18, P90, DOI 10.1016/j.chembiol.2010.11.010; Chapple DS, 2004, ANTIMICROB AGENTS CH, V48, P2190, DOI 10.1128/AAC.48.6.2190-2198.2004; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dennington Roy, 2009, GAUSSVIEW 5 CITATION; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch G.T. M., 2009, GAUSSIAN 09 CITATION; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Langham A, 2010, METHODS MOL BIOL, V618, P267, DOI 10.1007/978-1-60761-594-1_17; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mendo S, 2004, BIOTECHNOL LETT, V26, P115, DOI 10.1023/B:BILE.0000012888.72489.3f; Nawrot R, 2014, FOLIA MICROBIOL, V59, P181, DOI 10.1007/s12223-013-0280-4; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Prada-Gracia D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000415; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Rebuffat S, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P55, DOI 10.1007/978-1-4419-7692-5_4; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salas CE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102129; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shenkarev ZO, 2010, BIOCHEMISTRY-US, V49, P6462, DOI 10.1021/bi100871b; Thormann M, 1998, J MOL STRUC-THEOCHEM, V431, P79, DOI 10.1016/S0166-1280(97)00422-3; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Turpin ER, 2014, RSC ADV, V4, P48621, DOI 10.1039/c4ra09897h; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Xiao Yao, 2011, Biomol Concepts, V2, P27, DOI 10.1515/bmc.2011.006; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhou N, 2004, BIOMETALS, V17, P217, DOI 10.1023/B:BIOM.0000027695.99874.ea	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179962	10.1371/journal.pone.0179962	http://dx.doi.org/10.1371/journal.pone.0179962			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654661	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500041
J	Kaese, S; Larbig, R; Rohrbeck, M; Frommeyer, G; Dechering, D; Olligs, J; Schonhofer-Merl, S; Wessely, R; Klingel, K; Seebohm, G; Eckardt, L				Kaese, Sven; Larbig, Robert; Rohrbeck, Matthias; Frommeyer, Gerrit; Dechering, Dirk; Olligs, Jan; Schoenhofer-Merl, Sabine; Wessely, Rainer; Klingel, Karin; Seebohm, Guiscard; Eckardt, Lars			Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis	PLOS ONE			English	Article							ENTEROVIRUS-INDUCED MYOCARDITIS; DILATED CARDIOMYOPATHY; HEART-FAILURE; POSTREPOLARIZATION REFRACTORINESS; INDUCED PANCREATITIS; TRANSGENIC MICE; REPOLARIZATION; INFECTION; MOUSE; OVEREXPRESSION	Introduction Coxsackievirus B3 (CVB3) is known to induce acute and chronic myocarditis. Most infections are clinically unapparent but some patients suffer from ventricular arrhythmias (VA) and sudden cardiac death (SCD). Studies showed that acute CVB3 infection may cause impaired function of cardiac ion channels, creating a proarrhythmic substrate. However, it is unknown whether low level CVB3+ expression in myocytes may cause altered cardiac electrophysiology leading to VA. Methods Cellular electrophysiology was used to analyze cellular action potentials (APs) and occurrence of afterdepolarizations from isolated cardiomyocytes of wildtype (WT) and transgenic CVB3.VP0 (CVB3+) mice. Further, we studied surface ECGs, monophasic APs, ventricular effective refractory period (VERP) and inducibility of VAs in Langendorff-perfused whole hearts. All used cardiomyocytes and whole hearts originated from male mice. Results Cellular action potential duration (APD) in WT and CVB3+ myocytes was unchanged. No difference in mean occurrence or amplitude of afterdepolarizations in WT and CVB3+ myocytes was found. Interestingly, resting membrane potential in CVB3+ myocytes was significantly hyperpolarized (WT: -90.0 +/- 2.2 mV, n = 7; CVB3+: -114.1 +/- 3.0 mV, n = 14; p < 0.005). Consistently, in Langendorff-perfused hearts, APDs were also not different between WT and CVB3+ whole hearts. Within both groups, we found a heart rate dependent shortening of ADP90 with increasing heart rate in Langendorff-perfused hearts. VERP was significantly prolonged in CVB3+ hearts compared to WT ( WT: 36.0 +/- 2.7 ms, n = 5; CVB3+: 47.0 +/- 2.0 ms, n = 7; p = 0.018). Resting heart rate ( HR) in Langendorff-perfused hearts was not significantly different between both genotypes. Electrical pacing protocols induced no VA in WT and CVB3+ hearts. Conclusion In CVB3+ mice, prolonged ventricular refractoriness and hyperpolarized resting membrane potentials in presence of unchanged APD were observed, suggesting that low level CVB3 expression does not promote VA by altered cardiac electrophysiology in this type of chronic myocarditis. These findings may suggest that other mechanisms such as chronic myocardial inflammation or fibrosis may account for arrhythmias observed in patients with chronic enteroviral myocarditis.	[Kaese, Sven; Larbig, Robert; Frommeyer, Gerrit; Dechering, Dirk; Olligs, Jan; Eckardt, Lars] Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany; [Rohrbeck, Matthias; Seebohm, Guiscard] Univ Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, Munster, Germany; [Rohrbeck, Matthias; Seebohm, Guiscard] Univ Munster, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Schoenhofer-Merl, Sabine; Wessely, Rainer] Univ Technol, Klinikum Rechts Isar, Deutsch Herzzentrum, Munich, Germany; [Schoenhofer-Merl, Sabine; Wessely, Rainer] Univ Technol, Klinikum Rechts Isar, Med Klin, Munich, Germany; [Wessely, Rainer] Zentrum Herz & Gefassmed, Mediapk 2, Cologne, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany	University of Munster; University of Munster; University of Munster; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen	Kaese, S (corresponding author), Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany.	sven.kaese@ukmuenster.de			Deutsche Forschungsgemeinschaft [Se1077(3-3), KL595/2-3]; Innovative Medizinische Forschung [IMF140919]; Interdisciplinary Centre for Clinical Research IZKF Munster [See1/012/13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medizinische Forschung; Interdisciplinary Centre for Clinical Research IZKF Munster	GS was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant Se1077(3-3), Innovative Medizinische Forschung (https://campus.uni-muenster.de/imf/das-imf/) IMF140919 and Interdisciplinary Centre for Clinical Research IZKF Munster (https://campus.uni-muenster.de/izkf.html) grant See1/012/13. KK was was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant KL595/2-3. LE holds the Peter Osypka Professorship of Experimental and Clinical Electrophysiology (http://www.osypka.de/index.php?lang=de&cat=2&art=931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; Baumann S., 2006, THESIS; Bogeholz N, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1210, DOI 10.1161/CIRCEP.115.002927; Bouin A, 2016, EMERG INFECT DIS, V22, P1488, DOI 10.3201/eid2208.160186; Boulaksil M, 2010, EUR J HEART FAIL, V12, P913, DOI 10.1093/eurjhf/hfq092; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Brouillette J, 2003, J PHYSIOL-LONDON, V546, P403, DOI 10.1113/jphysiol.2002.030460; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Connolly AJ, 2016, CLIN MED INSIGHTS-CA, V10, P27, DOI 10.4137/CMC.S39708; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Daley AJ, 1998, J PAEDIATR CHILD H, V34, P196, DOI 10.1046/j.1440-1754.1998.00176.x; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Fabritz L, 2003, CARDIOVASC RES, V57, P1085, DOI 10.1016/S0008-6363(02)00839-8; Fabritz L, 2003, BASIC RES CARDIOL, V98, P25, DOI 10.1007/s00395-003-0386-y; Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7; Frommeyer G, 2012, J CARD FAIL, V18, P939, DOI 10.1016/j.cardfail.2012.10.017; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Hunziker IP, 2004, VIROLOGY, V330, P196, DOI 10.1016/j.virol.2004.09.035; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; KANDOLF R, 1985, J MOL CELL CARDIOL, V17, P167, DOI 10.1016/S0022-2828(85)80019-5; KANDOLF R, 1993, INTERVIROLOGY, V35, P140, DOI 10.1159/000150305; Kim KS, 2001, REV MED VIROL, V11, P355, DOI 10.1002/rmv.326; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Maass K, 2009, CARDIOVASC RES, V84, P361, DOI 10.1093/cvr/cvp250; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; Massilamany C, 2014, INT J CARDIOL, V177, P330, DOI 10.1016/j.ijcard.2014.09.136; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Milberg P, 2012, J CARDIOVASC PHARM, V59, P92, DOI 10.1097/FJC.0b013e3182377a11; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Podrid PJ, 2005, CLIN CARDIOL, V28, pI3; Pott C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0247-7; Ramsingh AI, 2008, CURR TOP MICROBIOL, V323, P241; Rohrbeck M, 2015, THESIS; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Steinke K, 2013, FASEB J, V27, P4108, DOI 10.1096/fj.13-230193; Tracy S, 2000, J MED VIROL, V62, P70, DOI 10.1002/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R; Trepanier-Boulay W, 2001, CIRC RES, V89, P437, DOI 10.1161/hh1701.095644; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wessely R, 1998, CIRCULATION, V98, P450, DOI 10.1161/01.CIR.98.5.450; Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972	46	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180029	10.1371/journal.pone.0180029	http://dx.doi.org/10.1371/journal.pone.0180029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644868	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100058
J	Matono, T; Kutsuna, S; Kato, Y; Katanami, Y; Yamamoto, K; Takeshita, N; Hayakawa, K; Kanagawa, S; Kaku, M; Ohmagari, N				Matono, Takashi; Kutsuna, Satoshi; Kato, Yasuyuki; Katanami, Yuichi; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Kaku, Mitsuo; Ohmagari, Norio			Role of classic signs as diagnostic predictors for enteric fever among returned travellers: Relative bradycardia and eosinopenia	PLOS ONE			English	Article							TYPHOID-FEVER; TROPICAL DISEASES; BONE-MARROW; RECTAL-SWAB; CASE SERIES; SEPSIS; BLOOD; PATTERNS; CULTURES; TYPHUS	Background The lack of characteristic clinical findings and accurate diagnostic tools has made the diagnosis of enteric fever difficult. We evaluated the classic signs of relative bradycardia and eosinopenia as diagnostic predictors for enteric fever among travellers who had returned from the tropics or subtropics. Methods This matched case-control study used data from 2006 to 2015 for culture-proven enteric fever patients as cases. Febrile patients (> 38.3 degrees C) with non-enteric fever, who had returned from the tropics or subtropics, were matched to the cases in a 1: 3 ratio by age (+/- 3 years), sex, and year of diagnosis as controls. Cunha's criteria were used for relative bradycardia. Absolute eosinopenia was defined as an eosinophilic count of 0/mu L. Results Data from 160 patients (40 cases and 120 controls) were analysed. Cases predominantly returned from South Asia (70% versus 18%, p < 0.001). Relative bradycardia (88% versus 51%, p < 0.001) and absolute eosinopenia (63% versus 38%, p = 0.008) were more frequent in cases than controls. In multivariate logistic regression analysis, return from South Asia (aOR: 21.6; 95% CI: 7.17-64.9) and relative bradycardia (aOR: 11.7; 95% CI: 3.21-42.5) were independent predictors for a diagnosis of enteric fever. The positive likelihood ratio was 4.00 (95% CI: 2.58-6.20) for return from South Asia, 1.72 (95% CI: 1.39-2.13) for relative bradycardia, and 1.63 (95% CI: 1.17-2.27) for absolute eosinopenia. The negative predictive values of the three variables were notably high (83-92%);. however, positive predictive values were 35-57%. Conclusions The classic signs of relative bradycardia and eosinopenia were not specific for enteric fever; however both met the criteria for being diagnostic predictors for enteric fever. Among febrile returned travellers, relative bradycardia and eosinopenia should be re-evaluated for predicting a diagnosis of enteric fever in non-endemic areas prior to obtaining blood cultures.	[Matono, Takashi; Kutsuna, Satoshi; Kato, Yasuyuki; Katanami, Yuichi; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Matono, Takashi; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Internal Med, Sendai, Miyagi, Japan	National Center for Global Health & Medicine - Japan; Tohoku University	Kato, Y (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	ykato@hosp.ncgm.go.jp	Hayakawa, Kayoko/GNW-2394-2022; Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Matono, Takashi/0000-0001-9957-0510	Japan Agency for Medical Research and Development; AMED [15fk0108046h0003]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED	This study was supported in part by research grants from the Japan Agency for Medical Research and Development, AMED (15fk0108046h0003).The funder had no role in this study such as study design, data collection, or decision to publish.	Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883; Andualem Gizachew, 2014, BMC Res Notes, V7, P653, DOI 10.1186/1756-0500-7-653; BASS DA, 1980, J CLIN INVEST, V65, P1265, DOI 10.1172/JCI109789; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P111, DOI 10.1016/S0891-5520(03)00094-1; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; Date KA, 2016, CLIN INFECT DIS, V63, P322, DOI 10.1093/cid/ciw232; Davis TME, 1999, CLIN INFECT DIS, V28, P582, DOI 10.1086/515143; Ganesh R, 2010, INDIAN J PEDIATR, V77, P1089, DOI 10.1007/s12098-010-0196-9; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; GILMAN RH, 1975, LANCET, V1, P1211; Goodacre S, 2002, BRIT MED J, V324, P594, DOI 10.1136/bmj.324.7337.594; GOTUZZO E, 1994, ANTIMICROB AGENTS CH, V38, P558, DOI 10.1128/AAC.38.3.558; Hamaguchi S, 2015, AM J TROP MED HYG, V92, P972, DOI 10.4269/ajtmh.14-0806; HOFFMAN SL, 1984, J INFECT DIS, V149, P157, DOI 10.1093/infdis/149.2.157; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Jog S, 2008, J Assoc Physicians India, V56, P237; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Koizumi N, 2008, JPN J INFECT DIS, V61, P465; Kuvandik C, 2009, NEW MICROBIOL, V32, P25; Lateef A, 2007, EMERG INFECT DIS, V13, P650, DOI 10.3201/eid1304.061212; Lokhandwala A, 2012, IBNOSIMA J MED BS, V4, P249; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; Matono T, 2016, AM J TROP MED HYG, V95, P19, DOI 10.4269/ajtmh.15-0714; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Osler W., 1892, PRINCIPLES PRACTICES, P2; Ostergaard L, 1996, J INFECTION, V33, P185, DOI 10.1016/S0163-4453(96)92225-2; Patel TA, 2010, AM J TROP MED HYG, V82, P1121, DOI 10.4269/ajtmh.2010.10-0007; Pitman MC, 2013, CRIT CARE MED, V41, pE286, DOI 10.1097/CCM.0b013e3182923755; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Spira AM, 2003, LANCET, V361, P1459, DOI 10.1016/S0140-6736(03)13141-8; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; World Health Organization, IMM VACC BIOL VACC D	35	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179814	10.1371/journal.pone.0179814	http://dx.doi.org/10.1371/journal.pone.0179814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644847	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100039
J	Leijendekkers, RA; van Hinte, G; Sman, AD; Staal, JB; Nijhuis-van der Sanden, MWG; Hoogeboom, TJ				Leijendekkers, Ruud A.; van Hinte, Gerben; Sman, Amy D.; Staal, J. Bart; Nijhuis-van der Sanden, Maria W. G.; Hoogeboom, Thomas J.			Clinimetric properties of hip abduction strength measurements obtained using a handheld dynamometer in individuals with a lower extremity amputation	PLOS ONE			English	Article							MUSCLE STRENGTH; RELIABILITY; VALIDITY; AMPUTEES; WALKING; GAIT; REHABILITATION; STABILIZATION; AGREEMENT; FIXATION	Introduction Suitable handheld dynamometer (HHD)-techniques to test hip abduction strength in individuals with a lower extremity amputation, irrespective of their amputation level are absent. The aim of this study was to optimise a HHD-technique and to test its reproducibility and validity. Methods This study involved three phases, in which two techniques were evaluated. Both HHD-techniques used a lever-arm of 22 centimetre. HHD-technique 1 used a break-technique. After obtaining within-session test-retest reproducibility (phase 1) we optimised the HHD-technique by adding a fixation-belt and using a make-technique (HHD-technique 2). We tested the within-session test-retest and inter-rater reproducibility (phase 2) and the validity (phase 3) of HHD-technique 2 using an isokinetic dynamometer. New cohorts of participants were recruited for each phase. Results Phase 1: we tested HHD-technique 1 in 26 participants with a lower extremity amputation. It was test-retest reproducible (ICC3.1(agreement): 0.80-0.92, standard error of measurement (SEM): 3.1-4.4 Nm and smallest detectable change (SDC): 8.6-12.3 Nm). There were questions regarding the validity of the measurement, because the mean muscle torque of the residual limb and sound limb were similar, which is uncommon. Phase 2: reproducibility of HHD-technique 2 was tested in 44 participants with a lower extremity amputation. It was test-retest reproducible (ICC3.1(agreement): 0.96-0.97, SEM: 3.9-4.7 Nm and SDC: 10.9-12.9 Nm) but not inter-rater reproducible despite having good reliability (ICC3.1(agreement:) 0.92, SEM: 6.9-7.6 Nm and SDC: 19.2-21.2 Nm). Systematic bias and bias related to the magnitude of the muscle torque was suspected. Phase 3: the concurrent validity was established in 30 healthy participants (r = 0.84). Systematic bias in measurement error was present, including a consistent overestimation of the muscle torque of 28% using the HHD. Conclusion HHD-technique 2 is a test-retest reproducible and valid measuring technique The technique may be further optimised by the use of an external device to stabilise the HHD.	[Leijendekkers, Ruud A.; van Hinte, Gerben; Sman, Amy D.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands; [Staal, J. Bart; Nijhuis-van der Sanden, Maria W. G.; Hoogeboom, Thomas J.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands; [Staal, J. Bart] HAN Univ Appl Sci, Res Grp Musculoskeletal Rehabil, Nijmegen, Netherlands; [Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Leijendekkers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands.	Ruud.Leijendekkers@radboudumc.nl	van Hinte, MSc G.J./L-4374-2015; Hoogeboom, Thomas J/G-8767-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Sman, Amy D/C-1705-2014; Staal, J. Bart/A-9632-2014; Leijendekkers, R.A./L-4485-2015; Staal, Bart/ABA-4313-2020	van Hinte, MSc G.J./0000-0001-9357-5388; Hoogeboom, Thomas J/0000-0003-2103-419X; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Sman, Amy D/0000-0002-2052-0818; Staal, J. Bart/0000-0002-0083-6380; Leijendekkers, R.A./0000-0002-6158-6901; Staal, Bart/0000-0002-0083-6380				Aramaki Hidefumi, 2016, J Phys Ther Sci, V28, P2123, DOI 10.1589/jpts.28.2123; Atsma F, 2005, J CLIN EPIDEMIOL, V58, P1282, DOI 10.1016/j.jclinepi.2005.04.005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Burns SP, 2005, ARCH PHYS MED REHAB, V86, P1420, DOI 10.1016/j.apmr.2004.12.041; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Donachy JE, 2004, DISABIL REHABIL, V26, P495, DOI 10.1080/09638280410001663067; Fenter PC, 2003, BRIT J SPORT MED, V37, P331, DOI 10.1136/bjsm.37.4.331; Hagberg K, 2009, J REHABIL RES DEV, V46, P331, DOI 10.1682/JRRD.2008.06.0080; Hebert LJ, 2011, PEDIATR PHYS THER, V23, P289, DOI 10.1097/PEP.0b013e318227ccff; Heitzmann DWW, 2013, BIOMED ENG-BIOMED TE, V58, P195, DOI 10.1515/bmt-2012-0036; International Standards Organization, 1993, 85482 ISO; Jackson SM, 2017, MUSCULOSKEL SCI PRAC, V27, P137, DOI 10.1016/j.math.2016.07.010; JAEGERS SMHJ, 1995, ARCH PHYS MED REHAB, V76, P736, DOI 10.1016/S0003-9993(95)80528-1; JAEGERS SMHJ, 1995, CLIN ORTHOP RELAT R, P276; Keating JL, 1996, PHYS THER, V76, P866, DOI 10.1093/ptj/76.8.866a; Kowal M, 2014, BIOMED HUM KINET, V6, P63, DOI 10.2478/bhk-2014-0011; Krause DA, 2007, ARCH PHYS MED REHAB, V88, P37, DOI 10.1016/j.apmr.2006.09.011; Krause DA, 2014, J SPORT REHABIL, V23, P56, DOI [10.1123/JSR.2012-0070, 10.1123/jsr.2012-0070]; Leijendekkers RA, 2017, PHYSIOTHER THEOR PR, V33, P147, DOI 10.1080/09593985.2016.1265620; Leijendekkers RA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1341-z; Li RC, 2006, ARCH PHYS MED REHAB, V87, P411, DOI 10.1016/j.apmr.2005.11.011; Lu YM, 2011, J STRENGTH COND RES, V25, P1065, DOI 10.1519/JSC.0b013e3181d650a6; Malliaras P, 2009, BRIT J SPORT MED, V43, P739, DOI 10.1136/bjsm.2008.055749; Martin HJ, 2006, GERONTOLOGY, V52, P154, DOI 10.1159/000091824; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Molina-Rueda F, 2014, BRAZ J PHYS THER, V18, P252, DOI 10.1590/bjpt-rbf.2014.0032; Nadollek Heidi, 2002, Physiother Res Int, V7, P203, DOI 10.1002/pri.260; Nolan L, 2012, J REHABIL MED, V44, P241, DOI 10.2340/16501977-0921; Paul DJ, 2014, J SPORT SCI, V32, P1318, DOI 10.1080/02640414.2014.927069; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Pua YH, 2008, ARCH PHYS MED REHAB, V89, P1146, DOI 10.1016/j.apmr.2007.10.028; RYSER DK, 1988, ARCH PHYS MED REHAB, V69, P840; Salsich GB, 1997, CLIN REHABIL, V11, P60, DOI 10.1177/026921559701100109; Schalk SAF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001416; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; STRATFORD PW, 1994, J ORTHOP SPORT PHYS, V19, P28, DOI 10.2519/jospt.1994.19.1.28; SULLIVAN S J, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P213; SURBURG PR, 1992, ARCH PHYS MED REHAB, V73, P535; Thorborg K, 2010, SCAND J MED SCI SPOR, V20, P493, DOI 10.1111/j.1600-0838.2009.00958.x; Thorborg K, 2013, KNEE SURG SPORT TR A, V21, P550, DOI 10.1007/s00167-012-2115-2; TRUDELLEJACKSON E, 1994, J ORTHOP SPORT PHYS, V20, P302, DOI 10.2519/jospt.1994.20.6.302; VANDERPLOEG RJO, 1991, J NEUROL NEUROSUR PS, V54, P248, DOI 10.1136/jnnp.54.3.248; Visser JMA, 2011, PROSTHET ORTHOT INT, V35, P451, DOI 10.1177/0309364611422268; Wong CK, 2016, PROSTHET ORTHOT INT, V40, P8, DOI 10.1177/0309364614546926	46	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179887	10.1371/journal.pone.0179887	http://dx.doi.org/10.1371/journal.pone.0179887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640926	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800078
J	Li, X; Baker, J; Cracknell, T; Haynes, AR; Blanco, G				Li, Xiang; Baker, Jane; Cracknell, Tobias; Haynes, Andrew R.; Blanco, Gonzalo			IGFN1_v1 is required for myoblast fusion and differentiation	PLOS ONE			English	Article							KY; PROTEIN; DROSOPHILA; MUTATION; MOUSE; RAC1; GENE; DEFICIENCY; EXPRESSION; MUSCLES	Igfn1 is a complex locus that codes for multiple splicing variants of Immunoglobulin-and Fibronectin-like domain containing proteins predominantly expressed in skeletal muscle. To reveal possible roles for Igfn1, we applied non-selective knock-down by shRNAs as well as specific targeting of Igfn1 exon 13 by CRISPR/Cas9 mutagenesis in C2C12 cells. Decreased expression of Igfn1 variants via shRNAs against the common 3'-UTR region caused a total blunting of myoblast fusion, but did not prevent expression of differentiation markers. Targeting of N-terminal domains by elimination of exon 13 via CRISPR/Cas9 mediated homologous recombination, also resulted in fusion defects as well as large multinucleated cells. Expression of IGFN1_v1 partially rescued fusion and myotube morphology in the Igfn1 exon 13 knock-out cell line, indicating a role for this variant in myoblast fusion and differentiation. However, in vivo overexpression of IGFN1_v1 or the Igfn1 Exon 13 CRISPR/Cas9 targeting vector did not result in significant size changes in transfected fibres.	[Li, Xiang; Cracknell, Tobias; Blanco, Gonzalo] Univ York, Dept Biol, York, N Yorkshire, England; [Baker, Jane; Haynes, Andrew R.] MRC Harwell Inst, Mammalian Genet Unit, Harwell, Berks, England	University of York - UK; MRC Harwell	Blanco, G (corresponding author), Univ York, Dept Biol, York, N Yorkshire, England.	gonzalo.blanco@york.ac.uk	Blanco, Gonzalo/D-8735-2014	Blanco, Gonzalo/0000-0003-3827-3111	Medical Research Council [MC_U142684168]; Biotechnology and Biological Sciences Research Council [BB/M011151/1]; BBSRC [1642919] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1642919] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by the Medical Research Council (MC_U142684168 to Andy Haynes) and Biotechnology and Biological Sciences Research Council (BB/M011151/1 to Tobias Cracknell).	Baker J, 2010, EXP CELL RES, V316, P1856, DOI 10.1016/j.yexcr.2010.02.027; Beatham J, 2004, HUM MOL GENET, V13, P2863, DOI 10.1093/hmg/ddh308; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Fernandes JJ, 2005, DEV BIOL, V285, P11, DOI 10.1016/j.ydbio.2005.05.040; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hedberg-Oldfors C, 2016, EUR J HUM GENET, V24, P1771, DOI 10.1038/ejhg.2016.98; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Pinotsis N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001261; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Straussberg R, 2016, ACTA NEUROPATHOL, V132, P475, DOI 10.1007/s00401-016-1602-9; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106	20	95	97	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180217	10.1371/journal.pone.0180217	http://dx.doi.org/10.1371/journal.pone.0180217			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665998	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000404608700074
J	Tamura, M; Sugiura, S; Takagi, T; Satoh, T; Sumaru, K; Kanamori, T; Okada, T; Matsui, H				Tamura, Masato; Sugiura, Shinji; Takagi, Toshiyuki; Satoh, Taku; Sumaru, Kimio; Kanamori, Toshiyuki; Okada, Tomoko; Matsui, Hirofumi			Morphology-based optical separation of subpopulations from a heterogeneous murine breast cancer cell line	PLOS ONE			English	Article							INTRA-TUMOR HETEROGENEITY; CULTURE; TECHNOLOGY; HYDROGELS; MATRIGEL; GROWTH; MODELS; 3D	Understanding tumor heterogeneity is an urgent and unmet need in cancer research. In this study, we used a morphology-based optical cell separation process to classify a heterogeneous cancer cell population into characteristic subpopulations. To classify the cell subpopulations, we assessed their morphology in hydrogel, a three-dimensional culture environment that induces morphological changes according to the characteristics of the cells (i.e., growth, migration, and invasion). We encapsulated the murine breast cancer cell line 4T1E, as a heterogeneous population that includes highly metastatic cells, in click-crosslinkable and photodegradable gelatin hydrogels, which we developed previously. We observed morphological changes within 3 days of encapsulating the cells in the hydrogel. We separated the 4T1E cell population into colony-and granular-type cells by optical separation, in which local UVinduced degradation of the photodegradable hydrogel around the target cells enabled us to collect those cells. The obtained colony-and granular-type cells were evaluated in vitro by using a spheroid assay and in vivo by means of a tumor growth and metastasis assay. The spheroid assay showed that the colony-type cells formed compact spheroids in 2 days, whereas the granular-type cells did not form spheroids. The tumor growth assay in mice revealed that the granular-type cells exhibited lower tumor growth and a different metastasis behavior compared with the colony-type cells. These results suggest that morphology-based optical cell separation is a useful technique to classify a heterogeneous cancer cell population according to its cellular characteristics.	[Tamura, Masato; Sugiura, Shinji; Takagi, Toshiyuki; Satoh, Taku; Sumaru, Kimio; Kanamori, Toshiyuki] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan; [Tamura, Masato] Japan Soc Promot Sci, Tokyo, Japan; [Okada, Tomoko] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Matsui, Hirofumi] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Tamura, Masato] Osaka Univ, Res Ctr Nucl Phys, Ibaraki, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Society for the Promotion of Science; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Osaka University	Sugiura, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	shinji.sugiura@aist.go.jp	Okada, Tomoko/L-7055-2018; Sumaru, Kimio/M-1022-2018; Kanamori, Toshiyuki/M-1009-2018; Sugiura, Shinji/J-2565-2018; Takagi, Toshiyuki/L-9665-2018	Okada, Tomoko/0000-0003-3723-1147; Sumaru, Kimio/0000-0002-2583-0647; Kanamori, Toshiyuki/0000-0002-4856-0037; Sugiura, Shinji/0000-0002-1070-2482; Takagi, Toshiyuki/0000-0002-3854-8456	Japan Society for the Promotion of Science, KAKENHI [14J07186]; Japan Agency for Medical Research and Development [16hm0102044h0001]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science, KAKENHI (No. 14J07186) (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT 14J07186) to Masato Tamura; and Japan Agency for Medical Research and Development, No. 16hm0102044h0001 (http://www.amed.go.jp/news/release_20160711.html to Shinji Sugiura.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fitzgerald KA, 2015, J CONTROL RELEASE, V215, P39, DOI 10.1016/j.jconrel.2015.07.020; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kronig M, 2015, ONCOTARGET, V6, P1302; Lamb R, 2015, ONCOTARGET, P6; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sasaki H, 2016, J BIOSCI BIOENG, V121, P117, DOI 10.1016/j.jbiosc.2015.05.011; Sumaru K, 2014, METHOD CELL BIOL, V120, P185, DOI 10.1016/B978-0-12-417136-7.00012-4; Sun XX, 2015, ACTA PHARMACOL SIN, V36, P1219, DOI 10.1038/aps.2015.92; Takahashi M, 2008, CLIN EXP METASTAS, V25, P517, DOI 10.1007/s10585-008-9163-5; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Tamura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15060; Tamura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04793; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yanagawa F, 2016, REGEN THER, V3, P45, DOI 10.1016/j.reth.2016.02.007	25	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179372	10.1371/journal.pone.0179372	http://dx.doi.org/10.1371/journal.pone.0179372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665963	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700033
J	Masugi, Y; Obata, H; Inoue, D; Kawashima, N; Nakazawa, K				Masugi, Yohei; Obata, Hiroki; Inoue, Daisuke; Kawashima, Noritaka; Nakazawa, Kimitaka			Neural effects of muscle stretching on the spinal reflexes in multiple lower-limb muscles	PLOS ONE			English	Article							H-REFLEX; GROUP-I; SOLEUS MUSCLE; CROSSED INHIBITION; CORD-INJURY; AFFERENTS; HUMANS; EXCITABILITY; STIMULATION; MODULATION	While previous studies have shown that muscle stretching suppresses monosynaptic spinal reflex excitability in stretched muscles, its effects on non-stretched muscles is still largely unknown. The purpose of this study was to examine the effects of muscle stretching on monosynaptic spinal reflex in non-stretched muscles. Ten healthy male subjects participated in this study. Muscle stretching of the right triceps surae muscle was performed using a motor torque device for 1 minute. Three different dorsiflexion torques (at approximately 5, 10, and 15 Nm) were applied during muscle stretching. Spinal reflexes evoked by transcutaneous spinal cord stimulation were recorded in both the lower-limb muscles before, during, and at 0 and 5 min following muscle stretching. The amplitudes of the spinal reflexes in both the stretched and non-stretched muscles in the right (ipsilateral) leg were smaller during stretching compared to before, and at 0 and 5 min after stretching. Furthermore, the degree of reduction in the amplitude of the spinal reflexes in the right (ipsilateral) leg muscles increased significantly as the dorsiflexion torque (i.e., stretching of the right triceps surae muscles) increased. In contrast, reduction in the amplitude of the spinal reflexes with increasing dorsiflexion torque was not seen in the left (contralateral) leg muscles. Our results clearly indicate that muscle stretching has inhibitory effects on monosynaptic spinal reflexes, not only in stretched muscles, but also in non-stretched muscles of the ipsilateral leg.	[Masugi, Yohei; Obata, Hiroki; Inoue, Daisuke; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Masugi, Yohei; Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Masugi, Yohei] Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan; [Obata, Hiroki] Kyushu Inst Technol, Inst Liberal Arts, Dept Humanities & Social Sci, Tobata Ku, Sensui Cho, Kitakyushu, Fukuoka, Japan	University of Tokyo; Kyushu Institute of Technology	Masugi, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.; Masugi, Y (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.; Masugi, Y (corresponding author), Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan.	ymasugi@tiu.ac.jp		Masugi, Yohei/0000-0001-8156-8586	Japan Society for the Promotion [26242056]; JSPS [26350564, 16H07456]; Tokyo International University, CREST from the Japan Science and Technology Agency	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo International University, CREST from the Japan Science and Technology Agency	This work was supported by a Grant-in-Aid for Scientific Research (A) (#26242056) to Kimitaka Nakazawa from the Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/en/), A Grant-in-Aid for Scientific Research (C) (#26350564) to Hiroki Obata from the JSPS, A Grant-in-Aid for Research Activity Start-up (#16H07456) to Yohei Masugi from the JSPS, A research grant to Yohei Masugi from Tokyo International University, CREST from the Japan Science and Technology Agency (http://www.jst. go.jp/kisoken/crest/en/about/index.html) to Kimitaka Nakazawa. The funders had no role in study design, data collection anda nalysis, decision to publish, or preparation of the manuscript.	AGGELOPOULOS NC, 1995, NEUROSCI LETT, V185, P60, DOI 10.1016/0304-3940(94)11225-8; Behm DG, 2013, J ELECTROMYOGR KINES, V23, P1215, DOI 10.1016/j.jelekin.2013.05.002; Behm DG, 2016, EUR J APPL PHYSIOL, V116, P241, DOI 10.1007/s00421-015-3270-1; Chaouachi A, 2017, CLIN PHYSIOL FUNCT I, V37, P23, DOI 10.1111/cpf.12263; Cheng JG, 1998, BRAIN RES, V779, P280, DOI 10.1016/S0006-8993(97)01168-2; COLLINS DF, 1993, BRAIN RES, V603, P96, DOI 10.1016/0006-8993(93)91303-A; CONDON SM, 1987, PHYS THER, V67, P24, DOI 10.1093/ptj/67.1.24; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRONE C, 1987, J PHYSIOL-LONDON, V389, P163, DOI 10.1113/jphysiol.1987.sp016652; Danner SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147479; DELWAIDE PJ, 1991, J PHYSIOL-LONDON, V439, P161, DOI 10.1113/jphysiol.1991.sp018662; DEVANAND.MS, 1965, ACTA PHYSIOL SCAND, V63, P46, DOI 10.1111/j.1748-1716.1965.tb04040.x; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ETNYRE BR, 1986, ELECTROEN CLIN NEURO, V63, P174, DOI 10.1016/0013-4694(86)90010-6; Funase K, 2003, ADV EXERC SPORTS PHY, V9, P119; Gervasio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168557; GUISSARD N, 1988, EUR J APPL PHYSIOL O, V58, P47; Guissard N, 2004, MUSCLE NERVE, V29, P248, DOI 10.1002/mus.10549; HARRISON PJ, 1984, J PHYSIOL-LONDON, V356, P263, DOI 10.1113/jphysiol.1984.sp015463; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Jankowska E, 2009, J PHYSIOL-LONDON, V587, P401, DOI 10.1113/jphysiol.2008.159236; Knikou M, 2002, CLIN NEUROPHYSIOL, V113, P1698, DOI 10.1016/S1388-2457(02)00285-7; Knikou M, 2002, EXP BRAIN RES, V143, P149, DOI 10.1007/s00221-001-0978-4; Marque P, 2001, J PHYSIOL-LONDON, V536, P313, DOI 10.1111/j.1469-7793.2001.t01-1-00313.x; Masugi Y, 2016, NEUROSCI LETT, V627, P100, DOI 10.1016/j.neulet.2016.05.047; MEUNIER S, 1993, EXP BRAIN RES, V96, P534; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; ROBINSON KL, 1982, J NEUROL NEUROSUR PS, V45, P699, DOI 10.1136/jnnp.45.8.699; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Stubbs PW, 2011, MUSCLE NERVE, V43, P845, DOI 10.1002/mus.21964; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180275	10.1371/journal.pone.0180275	http://dx.doi.org/10.1371/journal.pone.0180275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662201	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300137
J	Nagata, Y; Wu, VCC; Otsuji, Y; Takeuchi, M				Nagata, Yasufumi; Wu, Victor Chien-Chia; Otsuji, Yutaka; Takeuchi, Masaaki			Normal range of myocardial layer-specific strain using two-dimensional speckle tracking echocardiography	PLOS ONE			English	Article							LEFT-VENTRICULAR STRAIN; CARDIAC MAGNETIC-RESONANCE; SEVERE AORTIC-STENOSIS; EJECTION FRACTION; LONGITUDINAL STRAIN; CHRONIC PRESSURE; HEART-FAILURE; DEFORMATION; DYSFUNCTION; FIBROSIS	Background Newer 2D strain software has a potential to assess layer-specific strain. However, normal reference values for layer-specific strain have not been established. We aimed to establish the normal ranges of layer-specific longitudinal and circumferential strain ( endocardial global longitudinal strain (GLS), transmural GLS, epicardial GLS, endocardial global circumferential strain (GCS), transmural GCS, and epicardial GCS). Methods and results We retrospectively analyzed longitudinal and circumferential strain parameters in 235 healthy subjects, with use of layer-specific 2D speckle tracking software (GE). The endocardial strain/epicardial strain (Endo/Epi) ratio was also measured to assess the strain gradient across the myocardium. The endocardial, transmural, and epicardial GLS values and the Endo/Epi ratio in the normal subjects were -23.1 +/- 2.3, -20.0 +/- 2.0, -17.6 +/- 1.9, and 1.31 +/- 0.07, respectively. The corresponding values of GCS were -28.5 +/- 3.0, -20.8 +/- 2.3, -15.3 +/- 2.0, and 1.88 +/- 0.17, respectively. The layer-specific global strain parameters exhibited no age dependency but did exhibit gender dependency except for endocardial GCS. A subgroup analysis revealed that basal and middle levels of endocardial LS was decreased in the middle and elderly aged group. However, apical endocardial LS was preserved even in the elderly subjects. Conclusions We proposed normal reference values for layer-specific strain based on both age and gender. This detailed strain analysis provides layer-oriented information with the potential to characterize abnormal findings in various cardiovascular diseases.	[Nagata, Yasufumi; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Wu, Victor Chien-Chia] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; Chang Gung Memorial Hospital; Chang Gung University; University of Occupational & Environmental Health - Japan	Nagata, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan.	nyasufumi1979@yahoo.co.jp	Wu, Victor Chien-Chia/ABB-6872-2021; Wu, Victor Chien-Chia/GXF-4623-2022	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wu, Victor Chien-Chia/0000-0002-9918-4369; Nagata, Yasufumi/0000-0001-5481-7524				Abbate A, 2015, INT J CARDIOL, V179, P430, DOI 10.1016/j.ijcard.2014.11.106; Altiok E, 2012, J AM SOC ECHOCARDIOG, V25, P1179, DOI 10.1016/j.echo.2012.07.019; Andre F, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0123-3; Augustine D, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-8; Becker M, 2009, EUR HEART J, V30, P1467, DOI 10.1093/eurheartj/ehp112; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; BUCHI M, 1990, BASIC RES CARDIOL, V85, P367; Cheng S, 2013, CIRC-CARDIOVASC IMAG, V6, P692, DOI 10.1161/CIRCIMAGING.112.000627; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hamada S, 2016, J AM SOC ECHOCARDIOG, V29, P412, DOI 10.1016/j.echo.2016.02.001; Haruki N, 2010, EUR J ECHOCARDIOGR, V11, P352, DOI 10.1093/ejechocard/jep215; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hoffmann R, 2014, AM J CARDIOL, V114, P1083, DOI 10.1016/j.amjcard.2014.07.018; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee HF, 2013, J CARDIOL, V62, P301, DOI 10.1016/j.jjcc.2013.05.001; Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004; Mizuguchi Y, 2008, J AM SOC ECHOCARDIOG, V21, P1138, DOI 10.1016/j.echo.2008.07.016; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ng ACT, 2009, AM J CARDIOL, V104, P1398, DOI 10.1016/j.amjcard.2009.06.063; Ozawa K, 2015, INT J CARDIOL, V184, P237, DOI 10.1016/j.ijcard.2015.01.070; PALMON LC, 1994, CIRCULATION, V89, P122, DOI 10.1161/01.CIR.89.1.122; PATH G, 1990, CIRC RES, V67, P660, DOI 10.1161/01.RES.67.3.660; Sarvari SI, 2013, JACC-CARDIOVASC IMAG, V6, P535, DOI 10.1016/j.jcmg.2013.01.009; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Sengupta Shantanu P, 2013, Indian Heart J, V65, P48, DOI 10.1016/j.ihj.2012.12.009; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; VINTENJOHANSEN J, 1980, CIRC RES, V46, P139, DOI 10.1161/01.RES.46.1.139; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Yan GH, 2012, HEART RHYTHM, V9, P928, DOI 10.1016/j.hrthm.2012.01.007; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Yukihiro K, 2000, J CARDIOL, V35, P205; Zhang L, 2016, ACTA BIOMATER, V42, P90, DOI 10.1016/j.actbio.2016.06.031	39	52	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180584	10.1371/journal.pone.0180584	http://dx.doi.org/10.1371/journal.pone.0180584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662186	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300168
J	Steele, CC; Pirkle, JRA; Kirkpatrick, K				Steele, Catherine C.; Pirkle, Jesseca R. A.; Kirkpatrick, Kimberly			Diet-induced impulsivity: Effects of a high-fat and a high-sugar diet on impulsive choice in rats	PLOS ONE			English	Article							INDUCED OBESITY; INDIVIDUAL-DIFFERENCES; PATHOLOGICAL GAMBLERS; MECHANISMS; ADDICTION; BEHAVIOR; WEIGHT	Impulsive choice is a common charactertistic among individuals with gambling problems, obesity, and substance abuse issues. Impulsive choice has been classified as a trans-disease process, and understanding the etiology of trait impulsivity could help to understand how diseases and disorders related to impulsive choice are manifested. The Western diet is a possible catalyst of impulsive choice as individuals who are obese and who eat diets high in fat and sugar are typically more impulsive. However, such correlational evidence is unable to discern the direction and causal nature of the relationship. The present study sought to determine how diet may directly contribute to impulsive choice. After 8 weeks of dietary exposure (high-fat, high-sugar, chow), the rats were tested on an impulsive choice task, which presented choices between a smaller-sooner reward (SS) and a larger-later reward (LL). Then, the rats were transferred to a chow diet and retested on the impulsive choice task. The high-sugar and high-fat groups made significantly more impulsive choices than the chow group. Both groups became more self-controlled when they were off the diet, but there were some residual effects of the diet on choice behavior. These results suggest that diet, specifically one high in processed fat or sugar, induces impulsive choice. This diet-induced impulsivity could be a precursor to other disorders that are characterized by impulsivity, such as diet-induced obesity, and could offer potential understanding of the trans-disease nature of impulsive choice.	[Steele, Catherine C.; Pirkle, Jesseca R. A.; Kirkpatrick, Kimberly] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Steele, CC (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	cchill1@ksu.edu		Steele, Catherine/0000-0002-1898-3338	National Institutes of Health [MH085739]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by R01 grant MH085739 from the National Institutes of Health awarded to Kimberly Kirkpatrick and Kansas State University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrit.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Bickel WK, 2014, APPETITE, V75, P82, DOI 10.1016/j.appet.2013.12.018; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Fields SA, 2013, APPETITE, V70, P60, DOI 10.1016/j.appet.2013.06.089; Jarmolowicz DP, 2014, APPETITE, V78, P63, DOI 10.1016/j.appet.2014.02.013; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; Kirkpatrick K, 2014, BEHAV BRAIN RES, V269, P115, DOI 10.1016/j.bbr.2014.04.024; Kirkpatrick K, 2013, BEHAV NEUROSCI, V127, P712, DOI 10.1037/a0034124; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Lumley J, 2016, PERS INDIV DIFFER, V97, P178, DOI 10.1016/j.paid.2016.03.055; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216; Marshall AT, 2014, J EXP ANAL BEHAV, V102, P86, DOI 10.1002/jeab.88; McClure J, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00003; Narayanaswami V, 2013, INT J OBESITY, V37, P1095, DOI 10.1038/ijo.2012.178; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; SCHEMMEL R, 1970, J NUTR, V100, P1041; Smith AP, 2015, BEHAV PROCESS, V112, P29, DOI 10.1016/j.beproc.2014.10.010; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; TATHAM TA, 1989, BEHAV RES METH INSTR, V21, P294, DOI 10.3758/BF03205598; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Wileyto EP, 2004, BEHAV RES METH INS C, V36, P41, DOI 10.3758/BF03195548	37	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e180510	10.1371/journal.pone.0180510	http://dx.doi.org/10.1371/journal.pone.0180510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662133	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300162
J	Wang, CC; Fang, YB; Zhang, P; Zhu, X; Hong, B; Xu, Y; Liu, JM; Huang, QH				Wang, Chuan-Chuan; Fang, Yi-Bin; Zhang, Ping; Zhu, Xuan; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai			Reconstructive endovascular treatment of vertebral artery dissecting aneurysms with the Low-profile Visualized Intraluminal Support (LVIS) device	PLOS ONE			English	Article							PIPELINE EMBOLIZATION DEVICE; STENT; FUSIFORM; OCCLUSION	Introduction The Low-profile Visualized Intraluminal Support (LVIS) device is a new generation of self expanding braided stent recently introduced in China for stent assisted coiling of intracranial aneurysms. The aim of our study is to evaluate the feasibility, safety, and efficacy of the LVIS device in reconstructive treatment of vertebral artery dissecting aneurysms (VADAs). Methods We retrospectively reviewed the neurointerventional database of our institution from June 2014 to May 2016. Patients who underwent endovascular treatment of VADAs with LVIS stents were included in this study. Clinical presentation, aneurysmal characteristics, technical feasibility, procedural complications, and angiographic and clinical follow-up results were evaluated. Results 38 patients with VADAs who underwent treatment with LVIS stent were identified, including 3 ruptured VADAs. All VADAs were successfully treated with reconstructive techniques including the stent-assisted coiling (n = 34) and stenting only (n = 4). Post-procedural complications developed in 3 patients (7.9%) including two small brainstem infarctions and one delayed thromboembolic event. Complications resulted in one case of minor permanent morbidity (2.6%). There was no procedure-related mortality. The follow-up angiogram was available in 30 patients at an average of 8.3 months (range, 2 to 30 months), which revealed complete occlusion in 23 patients (76.7%), residual neck in five patients (16.7%), and residual sac in two patients (6.7%). The follow-up of 25 aneurysms with incomplete immediate occlusion revealed 22 aneurysms (88%) with improvement in the Raymond class. One aneurysm (3.3%) showed recanalization and required retreatment. Clinical followed-up at 5-28 months (mean 14.1 months) was achieved in 36 patients because two patients died of pancreatic cancer and basal ganglia hemorrhage, respectively. No new neurologic deterioration or aneurysm (re)bleeding was observed. Conclusions Our preliminary experience with reconstruction of VADAs with the LVIS device demonstrates that this treatment approach is feasible with good short-term angiographic and clinical outcomes. Long-term and larger cohort studies are necessary to determine long-term outcomes of this therapy.	[Wang, Chuan-Chuan; Fang, Yi-Bin; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Fang, Yi-Bin; Zhang, Ping; Zhu, Xuan; Hong, Bo; Xu, Yi; Liu, Jian-Min; Huang, Qing-Hai] Second Mil Med Univ, Changhai Hosp, Changhai Stroke Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, JM; Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.; Liu, JM; Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Changhai Stroke Ctr, Shanghai, Peoples R China.	chstroke@163.com; ocinhqh@163.com			National key research and development program of China [2016YFC1300700]; National Natural Science Foundation of China [81301004]; Key Program of Shanghai Science and Technology Commission Foundation [13411950300]	National key research and development program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Shanghai Science and Technology Commission Foundation	This work was supported by National key research and development program of China during the 13th Five-Year Plan Period (2016YFC1300700), National Natural Science Foundation of China (81301004), and Key Program of Shanghai Science and Technology Commission Foundation (13411950300).	Faria MD, 2011, AM J NEURORADIOL, V32, P2192, DOI 10.3174/ajnr.A2671; Fang YB, 2016, CLIN NEURORADIOL; Fang YB, 2015, CARDIOVASC INTER RAD, V38, P592, DOI 10.1007/s00270-014-0981-3; Fiorella D, 2010, NEUROSURGERY, V67, DOI 10.1227/01.NEU.0000383875.08681.23; Fusco MR, 2011, NEUROSURGERY, V68, P242, DOI 10.1227/NEU.0b013e3182012323; Guan J., 2016, J NEUROINTERV SURG; Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597; Kai Y, 2011, NEUROSURGERY, V69, P1085, DOI 10.1227/NEU.0b013e3182262adf; Klisch J, 2011, AM J NEURORADIOL, V32, P627, DOI 10.3174/ajnr.A2571; Kuhn AL, 2016, J NEUROINTERV SURG, V8, P1048, DOI 10.1136/neurintsurg-2015-012028; Lee JM, 2010, ACTA NEUROCHIR, V152, P1455, DOI 10.1007/s00701-010-0683-9; Leibowitz R, 2003, AM J NEURORADIOL, V24, P902; Levitt MR, 2016, POSTERIOR INFERIOR C, V37, P487; Li HQ, 2016, SOL ENERGY, V126, P243, DOI 10.1016/j.solener.2015.12.045; Mazur MD, 2016, J NEUROINTERV SURG, V8, P1041, DOI 10.1136/neurintsurg-2015-012040; Natarajan SK, 2016, J NEUROSURG, V125, P111, DOI 10.3171/2015.6.JNS1565; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Sonmez O, 2015, AM J NEURORADIOL, V36, P1293, DOI 10.3174/ajnr.A4360; Suh SH, 2009, J NEUROSURG, V111, P48, DOI 10.3171/2009.2.JNS081418; US FDA, 2011, SUMM SAF EFF DAT; Wakhloo AK, 2008, STROKE, V39, P3288, DOI 10.1161/STROKEAHA.107.512996; Wang C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0959-9; Yeung TW, 2012, J NEUROSURG, V116, P882, DOI 10.3171/2011.12.JNS111514; Zhang XG, 2017, J NEUROINTERV SURG, V9, P553, DOI 10.1136/neurintsurg-2016-012403; Zhao KJ, 2014, EUR RADIOL, V24, P2088, DOI 10.1007/s00330-014-3225-7; Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067169	26	22	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180079	10.1371/journal.pone.0180079	http://dx.doi.org/10.1371/journal.pone.0180079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662097	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300100
J	Graci, JD; Michaels, D; Chen, GM; Lester, GMS; Nodder, S; Weetall, M; Karp, GM; Gu, ZX; Colacino, JM; Henderson, AJ				Graci, Jason D.; Michaels, Daniel; Chen, Guangming; Lester, Gillian M. Schiralli; Nodder, Sarah; Weetall, Marla; Karp, Gary M.; Gu, Zhengxian; Colacino, Joseph M.; Henderson, Andrew J.			Identification of benzazole compounds that induce HIV-1 transcription	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; VALPROIC ACID; GENE-EXPRESSION; LATENT HIV-1; HIV-1-INFECTED PATIENTS; DEACETYLASE INHIBITORS; COMBINATION THERAPY; VIRAL RESERVOIRS	Despite advances in antiretroviral therapy, HIV-1 infection remains incurable in patients and continues to present a significant public health burden worldwide. While a number of factors contribute to persistent HIV-1 infection in patients, the presence of a stable, long-lived reservoir of latent provirus represents a significant hurdle in realizing an effective cure. One potential strategy to eliminate HIV-1 reservoirs in patients is reactivation of latent provirus with latency reversing agents in combination with antiretroviral therapy, a strategy termed "shock and kill". This strategy has shown limited clinical effectiveness thus far, potentially due to limitations of the few therapeutics currently available. We have identified a novel class of benzazole compounds effective at inducing HIV-1 expression in several cellular models. These compounds do not act via histone deacetylase inhibition or T cell activation, and show specificity in activating HIV-1 in vitro. Initial exploration of structure-activity relationships and pharmaceutical properties indicates that these compounds represent a potential scaffold for development of more potent HIV-1 latency reversing agents.	[Graci, Jason D.; Chen, Guangming; Weetall, Marla; Karp, Gary M.; Gu, Zhengxian; Colacino, Joseph M.] PTC Therapeut Inc, South Plainfield, NJ 07080 USA; [Michaels, Daniel; Nodder, Sarah; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med & Microbiol, Infect Dis Sect, Boston, MA 02118 USA; [Lester, Gillian M. Schiralli] Univ Rochester, Med Ctr, Dept Pediat, Neonatol,Sch Med & Dent, Rochester, NY 14642 USA; [Gu, Zhengxian] WuXi AppTec Shanghai Co Ltd, Shanghai, Peoples R China	Boston University; University of Rochester	Colacino, JM (corresponding author), PTC Therapeut Inc, South Plainfield, NJ 07080 USA.; Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med & Microbiol, Infect Dis Sect, Boston, MA 02118 USA.	jcolacino@ptcbio.com; Andrew.Henderson@bmc.org	Belkina, Anna C/F-4816-2014	Belkina, Anna C/0000-0001-7967-6254; Schiralli Lester, Gillian/0000-0002-1750-7751; Graci, Jason/0000-0002-6329-9164	Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative [OPP1045786]; National Institutes of Health [1R21A1108447, A1097117]; PTC Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108447, R56AI118682, P30AI042853] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PTC Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by a grant from the Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative (OPP1045786 to Z.G.) and National Institutes of Health grants 1R21A1108447 (to A.J.H. and J.D.G.) and A1097117 (to A.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PTC Therapeutics, Inc. provided support in the form of financial compensation for authors J.D.G, G.C, M.W., G.W.K, Z.G, and J.M.C and experimental compounds but did not have any additional role in the study design, data collection and analysis, decision to publish other than providing approval for disclosure, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agosto LM, 2015, GENES-BASEL, V6, P957, DOI 10.3390/genes6040957; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Balimane PV, 2006, AAPS J, V8, pE1, DOI 10.1208/aapsj080101; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Blankson JN, 2014, INFECT DIS CLIN N AM, V28, P633, DOI 10.1016/j.idc.2014.08.007; Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Cillo AR, 2016, CURR OPIN VIROL, V18, P14, DOI 10.1016/j.coviro.2016.02.001; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Fakhari FD, 2002, J VIROL, V76, P6213, DOI 10.1128/JVI.76.12.6213-6223.2002; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Graci Jason D., 2009, Antiviral Chemistry & Chemotherapy, V19, P177; He GC, 2002, DNA CELL BIOL, V21, P697, DOI 10.1089/104454902760599672; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Kaczmarek Katarzyna, 2013, Virology (Auckl), V2013, P41; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Li YM, 2003, COMB CHEM HIGH T SCR, V6, P757; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Mcgee B, 2006, HIV CLIN TRIALS, V7, P142, DOI 10.1310/AW2H-TP5C-NP43-K6BY; Micheva-Viteva S, 2005, ANTIMICROB AGENTS CH, V49, P5185, DOI 10.1128/AAC.49.12.5185-5188.2005; Micheva-Viteva S, 2011, J BIOL CHEM, V286, P21083, DOI 10.1074/jbc.M110.195537; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Natarajan M, 2013, J BIOL CHEM, V288, P25995, DOI 10.1074/jbc.M113.496489; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; PULVERTA.RJ, 1965, J CLIN PATHOL, V18, P261, DOI 10.1136/jcp.18.3.261; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Schiralli Lester Gillian M, 2012, Mol Biol Int, V2012, P614120, DOI 10.1155/2012/614120; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; SPATZENEGGER M, 1995, DRUG METAB REV, V27, P397, DOI 10.3109/03602539508998329; Spivak AM, 2016, TRENDS MOL MED, V22, P10, DOI 10.1016/j.molmed.2015.11.004; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; UNAIDS, 2015, AIDS NUMB 2015; Weinberg MS, 2006, DNA CELL BIOL, V25, P223, DOI 10.1089/dna.2006.25.223; Williams SAF, 2005, TRENDS MICROBIOL, V13, P137, DOI 10.1016/j.tim.2005.02.006; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yukl S, 2009, VIROLOGY, V387, P98, DOI 10.1016/j.virol.2009.01.013; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	83	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179100	10.1371/journal.pone.0179100	http://dx.doi.org/10.1371/journal.pone.0179100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658263	Green Submitted, gold, Green Published			2022-12-26	WOS:000404607900015
J	Santosa, E; Lian, CL; Sugiyama, N; Misra, RS; Boonkorkaew, P; Thanomchit, K				Santosa, Edi; Lian, Chun Lan; Sugiyama, Nobuo; Misra, Raj Shekhar; Boonkorkaew, Patchareeya; Thanomchit, Kanokwan			Population structure of elephant foot yams (Amorphophallus paeoniifolius (Dennst.) Nicolson) in Asia	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENE FLOW; PROGRAM; ARACEAE; COLLECTIONS; INFERENCE; SOFTWARE; DISTANCE; PLANTS	The corms and leaves of elephant foot yams (Amorphophallus paeoniifolius (Dennst.) Nicolson) are important foods in the local diet in many Asian regions. The crop has high productivity and wide agroecological adaptation and exhibits suitability for the agroforestry system. Although the plant is assumed to reproduce via panmixia, a comprehensive study on the genetic background across regions to enhance wider consumer palatability is still lacking. Here, ten informative microsatellites were analyzed in 29 populations across regions in India, Indonesia and Thailand to understand the genetic diversity, population structure and distribution to improve breeding and conservation programs. The genetic diversity was high among and within regions. Some populations exhibited excess heterozygosity and bottlenecking. Pairwise FST indicated very high genetic differentiation across regions (F-ST = 0.274), and the Asian population was unlikely to be panmictic. Phylogenetic tree construction grouped the populations according to country of origin with the exception of the Medan population from Indonesia. The current gene flow was apparent within the regions but was restricted among the regions. The present study revealed that Indonesia and Thailand populations could be alternative centers of the gene pool, together with India. Consequently, regional action should be incorporated in genetic conservation and breeding efforts to develop new varieties with global acceptance.	[Santosa, Edi] Bogor Agr Univ, Fac Agr, Dept Agron & Hort, Bogor, West Java, Indonesia; [Lian, Chun Lan] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo, Japan; [Sugiyama, Nobuo] Univ Tokyo, Dept Hort, Fac Agr, Bunkyo Ku, Tokyo, Japan; [Misra, Raj Shekhar] Cent Tuber Crops Res Inst, Thiruvananthapuram, Kerala, India; [Boonkorkaew, Patchareeya; Thanomchit, Kanokwan] Kasetsart Univ, Dept Hort, Fac Agr, Bangkok, Thailand; [Sugiyama, Nobuo] Tokyo Univ Agr, Dept Hort Sci, Fac Agr, Atsugi, Kanagawa, Japan	Bogor Agricultural University; University of Tokyo; University of Tokyo; Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Kasetsart University; Tokyo University of Agriculture	Santosa, E (corresponding author), Bogor Agr Univ, Fac Agr, Dept Agron & Hort, Bogor, West Java, Indonesia.	edisang@gmail.com	Santosa, Edi/CAJ-0748-2022; Santosa, Edi/S-1975-2017	Santosa, Edi/0000-0001-5560-4598; Santosa, Edi/0000-0001-5560-4598	Japan Society for the Promotion of Science; Japan Science Foundation [16-007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Foundation	The research was financially supported by Grant-In-Aid from Japan Society for the Promotion of Science (https://www.jsps.go.jp); and Japan Science Foundation Grant No. 16-007 (http://www2.jsf.or.jp) to ES.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Anil S. R., 2014, International Journal of Vegetable Science, V20, P305, DOI 10.1080/19315260.2013.803509; Anil SR, 2011, GENET RESOUR CROP EV, V58, P1263, DOI 10.1007/s10722-011-9752-z; Archita Behera, 2014, International Journal of Pharmacy and Life Sciences (IJPLS), V5, P3512; Azmi C., 2006, THESIS; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Chair H, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157712, 10.13]; Devi A.A., 2013, J ROOT CROPS, V39, P51; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Hetterscheid W., 1996, AROIDEANA, V19, P7; Hetterscheid WLA, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-2; HOLDEN S, 1995, AGR SYST, V49, P237, DOI 10.1016/0308-521X(94)00046-T; Kabir ME, 2008, BIOTROPICA, V40, P95, DOI 10.1111/j.1744-7429.2007.00346.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kite GC, 1997, PHYTOCHEMISTRY, V46, P71, DOI 10.1016/S0031-9422(97)00221-5; Kurniawan A., 2011, BIODIVERSITAS, V12, P7; LEINBACH TR, 1989, HABITAT INT, V13, P81, DOI 10.1016/0197-3975(89)90023-4; Lian CL, 2001, J PLANT RES, V114, P381, DOI 10.1007/PL00014001; Lukitaningsih E, 2012, J NATURAL, V12, P1; Mandal R, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016160439; Maneenoon K, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0031-5; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matthews P.J., 1995, TROPICS, V4, P105, DOI [10.3759/tropics.4.105, DOI 10.3759/TROPICS.4.105]; Mekkerdchoo O., 2011, Thai Journal of Agricultural Science, V44, P129; Mekkerdchoo O, 2016, PHYTOTAXA, V282, P81, DOI 10.11646/phytotaxa.282.2.1; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paul K.K., 2013, J SCI RES, V5, P371, DOI [10.3329/jsr.v5i2.13853, DOI 10.3329/JSR.V5I2.13853]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peckover W. S., 1985, AROIDEANA, V8, P70; Phornvillay S., 2015, Advances in Bio Research, V6, P128; Piry S, 1999, BOTTLENECK PROGRAM D; Pritchard JK, 2000, GENETICS, V155, P945; Punekar SA, 2010, FLORA; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ravi V., 2009, J ROOT CROPS, V35, P131; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sankaran M, 2008, P NAT SEM AM INN TEC, P91; Santosa E., 2006, Japanese Journal of Tropical Agriculture, V50, P87; Santosa E., 2004, Japanese Journal of Tropical Agriculture, V48, P235; Santosa E., 2003, Japanese Journal of Tropical Agriculture, V47, P83; Santosa E., 2002, Japanese Journal of Tropical Agriculture, V46, P265; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Santosa E., 2016, Tropical Agriculture and Development, V60, P53; Santosa E., 2010, Journal of Applied Horticulture (Lucknow), V12, P125; Shepherd LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152455; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Shilpi JA, 2005, FITOTERAPIA, V76, P367, DOI 10.1016/j.fitote.2005.03.024; Singh A., 2016, INT J FOOD STUDIES, V5, P146; Singh A., 2014, INT J PHARM SCI REV, V24, P55; Sprintall J, 2014, NAT GEOSCI, V7, P487, DOI [10.1038/NGEO2188, 10.1038/ngeo2188]; Stanyon Roscoe, 2009, Journal of Biology (London), V8, P18, DOI 10.1186/jbiol115; Sugiyama N., 2006, Japanese Journal of Tropical Agriculture, V50, P215; Sugiyama N., 2010, Tropical Agriculture and Development, V54, P33; Sugiyama N., 2008, EDIBLE AMORPHOPHALLU; Takezaki N, 2009, MOL BIOL EVOL; Utami AR, 2008, THESIS; Van der Wilk, 1996, PLANT RESOURCES S E, P45; Wahyuni S, 2012, PROS SEM NAS PERH IL, P183; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WIDJAJA E A, 1987, Reinwardtia, V10, P271; Yuzammi A., 2017, AMORPHOPHALLUS INDON	68	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180000	10.1371/journal.pone.0180000	http://dx.doi.org/10.1371/journal.pone.0180000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658282	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900049
J	Arora, S; Mahato, AK; Singh, S; Mandal, P; Bhutani, S; Dutta, S; Kumawat, G; Singh, BP; Chaudhary, AK; Yadav, R; Gaikwad, K; Sevanthi, AM; Datta, S; Raje, RS; Sharma, TR; Singh, NK				Arora, Sheetal; Mahato, Ajay Kumar; Singh, Sangeeta; Mandal, Paritra; Bhutani, Shefali; Dutta, Sutapa; Kumawat, Giriraj; Singh, Bikram Pratap; Chaudhary, A. K.; Yadav, Rekha; Gaikwad, K.; Sevanthi, Amitha Mithra; Datta, Subhojit; Raje, Ranjeet S.; Sharma, Tilak R.; Singh, Nagendra Kumar			A high-density intraspecific SNP linkage map of pigeonpea (Cajanas cajan L. Millsp.)	PLOS ONE			English	Article							GENETIC-MAP; WILD RELATIVES; DIVERSITY; SOFTWARE; MARKERS; TRAITS	Pigeonpea (Cajanus cajan (L.) Millsp.) is a major food legume cultivated in semi-arid tropical regions including the Indian subcontinent, Africa, and Southeast Asia. It is an important source of protein, minerals, and vitamins for nearly 20% of the world population. Due to high carbon sequestration and drought tolerance, pigeonpea is an important crop for the development of climate resilient agriculture and nutritional security. However, pigeonpea productivity has remained low for decades because of limited genetic and genomic resources, and sparse utilization of landraces and wild pigeonpea germplasm. Here, we present a dense intraspecific linkage map of pigeonpea comprising 932 markers that span a total adjusted map length of 1,411.83 cM. The consensus map is based on three different linkage maps that incorporate a large number of single nucleotide polymorphism (SNP) markers derived from next generation sequencing data, using Illumina GoldenGate bead arrays, and genotyping with restriction site associated DNA (RAD) sequencing. The genotyping-by-sequencing enhanced the marker density but was met with limited success due to lack of common markers across the genotypes of mapping population. The integrated map has 547 bead-array SNP, 319 RAD-SNP, and 65 simple sequence repeat (SSR) marker loci. We also show here correspondence between our linkage map and published genome pseudomole-cules of pigeonpea. The availability of a high-density linkage map will help improve the anchoring of the pigeonpea genome to its chromosomes and the mapping of genes and quantitative trait loci associated with useful agronomic traits.	[Arora, Sheetal; Mahato, Ajay Kumar; Singh, Sangeeta; Mandal, Paritra; Bhutani, Shefali; Dutta, Sutapa; Kumawat, Giriraj; Singh, Bikram Pratap; Gaikwad, K.; Sevanthi, Amitha Mithra; Sharma, Tilak R.; Singh, Nagendra Kumar] Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Chaudhary, A. K.; Datta, Subhojit] Indian Inst Pulses Res, Kanpur, Uttar Pradesh, India; [Yadav, Rekha] Indian Agr Res Inst, Div Genet, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, NK (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	nksingh4@gmail.com	Singh, Nouratan/N-9377-2017; Kumawat, Giriraj/AAK-1121-2020; Datta, Subhojit/AAR-8209-2021	Singh, Nouratan/0000-0002-8063-8375; Kumawat, Giriraj/0000-0003-3380-1173; Datta, Subhojit/0000-0002-5924-4355; MAHATO, AJAY KUMAR/0000-0003-1359-6643; SINGH, SANGEETA/0000-0003-3600-9982	NPTC Project of the Indian Council of Agricultural Research (ICAR) [3052]	NPTC Project of the Indian Council of Agricultural Research (ICAR)	This study was financially supported by the NPTC Project Grant No-3052 of the Indian Council of Agricultural Research (ICAR).	Bohra A, 2012, THEOR APPL GENET, V125, P1325, DOI 10.1007/s00122-012-1916-5; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Dutta S, 2013, PLANT BREEDING, V132, P191, DOI 10.1111/pbr.12014; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gnanesh BN, 2011, FIELD CROP RES, V123, P53, DOI 10.1016/j.fcr.2011.04.011; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Greilhuber J, 1998, PLANT SYST EVOL, V212, P135, DOI 10.1007/BF00985225; Holtz Y, 2017, BIOINFORMATICS, V33, P1387, DOI 10.1093/bioinformatics/btw816; Kumawat G, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-84; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Odeny D A, 2009, BMC Res Notes, V2, P35, DOI 10.1186/1756-0500-2-35; Ooijen Van, JOUNMAP 4 0 SOFTWAR; RATNAPARKHE MB, 1995, THEOR APPL GENET, V91, P893, DOI 10.1007/BF00223897; Singh NK, 2004, FUNCT INTEGR GENOMIC, V4, P102, DOI 10.1007/s10142-004-0109-y; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z	24	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179747	10.1371/journal.pone.0179747	http://dx.doi.org/10.1371/journal.pone.0179747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654689	gold, Green Published, Green Submitted			2022-12-26	WOS:000404541500031
J	Hargreaves-Allen, VA; Mourato, S; Milner-Gulland, EJ				Hargreaves-Allen, Venetia Alexa; Mourato, Susana; Milner-Gulland, Eleanor Jane			Drivers of coral reef marine protected area performance	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; SHORTFALLS; GOVERNANCE; BENEFITS; RESERVES; COSTS; LESSONS; SUCCESS; SYSTEMS	Coral reefs are severely threatened and a principal strategy for their conservation is marine protected areas (MPAs). However the drivers of MPA performance are complex and there are likely to be trade-offs between different types of performance (e.g. conservation or welfare related outcomes). We compiled a global dataset from expert knowledge for 76 coral reef MPAs in 33 countries and identified a set of performance measures reflecting ecological and socio-economic outcomes, achievement of aims and reduction of threats, using spatial or temporal comparisons wherever possible. We wanted to test the extent to which distinct types of performance occurred simultaneously, understood as win-win outcomes. Although certain performance measures were correlated, most were not, suggesting trade-offs that limit the usefulness of composite performance scores. Hypotheses were generated as to the impact of MPA features, aims, location, management and contextual variables on MPA performance from the literature. A multivariate analysis was used to test hypotheses as to the relative importance of these "drivers" on eight uncorrelated performance measures. The analysis supported some hypotheses (e.g. benefit provision for the local community improved performance), but not others (e.g. higher overall budget and more research activity did not). Factors endogenous to the MPA (such as size of the no-take area) were generally more significant drivers of performance than exogenous ones (such as national GDP). Different types of performance were associated with different drivers, exposing the tradeoffs inherent in management decisions. The study suggests that managers are able to influence MPA performance in spite of external threats and could inform adaptive management by providing an approach to test for the effects of MPA features and management actions in different contexts and so to inform decisions for allocation of effort or funds to achieve specific goals.	[Hargreaves-Allen, Venetia Alexa] Imperial Coll, Ctr Environm Policy, London, England; [Mourato, Susana] London Sch Econ & Polit Sci, Dept Geog & Environm, London, England; [Milner-Gulland, Eleanor Jane] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Milner-Gulland, Eleanor Jane] Univ Oxford, Dept Zool, Oxford, England	Imperial College London; University of London; London School Economics & Political Science; Imperial College London; University of Oxford	Hargreaves-Allen, VA (corresponding author), Imperial Coll, Ctr Environm Policy, London, England.	vhargreavesallen@gmail.com			UK government (NERC-ESRC)	UK government (NERC-ESRC)	The authors received no funding specific to this work. The lead author had a general academic scholarship from the UK government (NERC-ESRC), but this was for open-ended research.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Aswani S, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00050; Axford JC, 2008, ECOL SOC, V13; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Ban NC, 2012, AQUAT CONSERV, V22, P262, DOI 10.1002/aqc.2224; Bennett NJ, 2014, MAR POLICY, V50, P96, DOI 10.1016/j.marpol.2014.05.005; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Bhagwat S, 2001, SCIENCE, V293, P1045; Brooks JS, 2012, P NATL ACAD SCI USA, V109, P21265, DOI 10.1073/pnas.1207141110; Browning LJ, 2006, CONSERV BIOL SER, P419; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bunce M, 2010, ENVIRON SCI POLICY, V13, P485, DOI 10.1016/j.envsci.2010.06.003; Burke L., 1998, REEFS RISK MAP BASED; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Christie P, 2002, J ENVIRON MANAGE, V66, P441, DOI 10.1006/jema.2002.0595; Christie P, 2004, AM FISHERIES SOC S S; Christie P, 2009, COAST MANAGE, V37, P349, DOI 10.1080/08920750902851740; Cicin-Sain B, 2005, OCEAN COAST MANAGE, V48, P847, DOI 10.1016/j.ocecoaman.2006.01.001; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Dalton T, 2015, MAR POLICY, V54, P69, DOI 10.1016/j.marpol.2014.12.009; Day J, 2008, MAR POLICY, V32, P823, DOI 10.1016/j.marpol.2008.03.023; deFontaubert C., 1996, BIODIVERSITY SEAS PR; DIXON JA, 1993, OCEANUS, V36, P35; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Evans L, 2011, J ENVIRON MANAGE, V92, P1983; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0267; Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0270; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Fox HE, 2014, COAST MANAGE, V42, P207, DOI 10.1080/08920753.2014.904178; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gravestock P, 2008, OCEAN COAST MANAGE, V51, P272, DOI 10.1016/j.ocecoaman.2007.09.004; Gurney GG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0277; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HALLS AS, 2002, INTERDISCIPLINARY MU; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hargreaves-Allen V, 2011, ENVIRON MANAGE, V47, P684, DOI 10.1007/s00267-011-9616-5; Heck N, 2011, OCEAN COAST MANAGE, V54, P687, DOI 10.1016/j.ocecoaman.2011.07.003; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; Hockings M., 2003, EVALUATING EFFECTIVE, V2; Horigue V, 2014, OCEAN COAST MANAGE, V95, P11, DOI 10.1016/j.ocecoaman.2014.03.023; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jentoft S, 2007, HUM ECOL, V35, P611, DOI 10.1007/s10745-007-9125-6; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Leisher C., 2007, NATURES INVESTMENT B; Leisher C, 2012, MAR POLICY, V36, P1005, DOI 10.1016/j.marpol.2012.02.022; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Leverington F., 2008, MANAGEMENT EFFECTIVE; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Mascia, 2004, MARINE RESERVES GUID, P154; Mascia MB, 1999, COAST MANAGE, V27, P391, DOI 10.1080/089207599263794; Mascia MB, 2014, BIOL CONSERV, V169, P258, DOI 10.1016/j.biocon.2013.11.017; McClanahan T, 2005, ENVIRON CONSERV, V32, P42, DOI 10.1017/S0376892904001791; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Pavese HB, 2007, NAT CONSERVACAO, V5, P152; Plaganyi EE, 2013, P NATL ACAD SCI USA, V110, P3639, DOI 10.1073/pnas.1217822110; Pollnac R, 2011, ENVIRON MANAGE, V47, P584, DOI 10.1007/s00267-010-9540-0; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Pomeroy R. S., 2007, FAO EXP WORKSH MAR P, P149; Pomeroy RS, 2006, MAR POLICY, V30, P786, DOI 10.1016/j.marpol.2006.02.003; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Pressey RL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0280; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 2000, FULLY PROTECED MARIN; Rudd MA, 2003, FISH FISH, V4, P65, DOI 10.1046/j.1467-2979.2003.00110.x; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Salm R.V., 2000, MARINE COASTAL PROTE; Sanchirico J.N., 2000, MARINE PROTECTED ARE; Sanchirico J.N., 2002, 0226 RES FUT; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; STAUB F, 2003, SCORE CARD ASSESS PR; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Stern M.J., 2006, MEASURING CONSERVATI; STONE R, 1993, J ROY STAT SOC B MET, V55, P455; SYMS C, 2001, GUID MEAS MAN EFF MA; Torell E, 2010, COAST MANAGE, V38, P216, DOI 10.1080/08920753.2010.483166; Toropova C., 2010, GLOBAL OCEAN PROTECT; TUPPER M, 2008, REEFBASE GLOBAL INFO; TUPPER M, 2008, LESSONS LEARNED BEST; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; Warner TE, 2012, MAR POLICY, V36, P922, DOI 10.1016/j.marpol.2012.01.003; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wells S, 2006, CONSERV BIOL SER, P314; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilkinson C, 2006, CONSERV BIOL SER, P3; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	99	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179394	10.1371/journal.pone.0179394	http://dx.doi.org/10.1371/journal.pone.0179394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644890	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000404145100013
J	Khananshvili, D				Khananshvili, Daniel			How a helix imposes palmitoylation of a membrane protein: What one can learn from NCX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NA+/CA2+ EXCHANGER	Palmitoylation is a critical post-translational modification that anchors proteins to, and regulates transport across, the lipid bilayer. Palmitoylation enzymes have been assumed to select their substrates based on a protein's primary sequence, but a consensus sequence has been slow to emerge. A study of the sodium/calcium exchanger now suggests that secondary structure may hold the key to understanding the determinants of this modification.	[Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966				Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Giladi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01102-x; Giladi M, 2016, FRONT PHYSIOL, V7, DOI [10.3359/fphys.7016.00030, 10.3389/fphys.2016.00030]; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Plain F, 2017, J BIOL CHEM, V292, P10745, DOI 10.1074/jbc.M116.773945; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007	10	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10753	10754		10.1074/jbc.H116.773945	http://dx.doi.org/10.1074/jbc.H116.773945			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28646126	Green Published, hybrid			2022-12-26	WOS:000404115400035
J	Paz-Levy, D; Schreiber, L; Erez, O; Goshen, S; Richardson, J; Drunov, V; Chacham, OS; Shany, E				Paz-Levy, Dorit; Schreiber, Letizia; Erez, Offer; Goshen, Sharon; Richardson, Justin; Drunov, VIadimir; Chacham, Orna Staretz; Shany, Eilon			Inflammatory and vascular placental lesions are associated with neonatal amplitude integrated EEG recording in early premature neonates	PLOS ONE			English	Article							SONOGRAPHIC SHORT CERVIX; PRETERM INFANTS YOUNGER; VAGINAL PROGESTERONE; ELECTROENCEPHALOGRAPHIC ACTIVITY; HISTOLOGICAL CHORIOAMNIONITIS; PREGNANT-WOMEN; CEREBRAL-PALSY; BIRTH; PREVENTION; CERCLAGE	Introduction Placental histologic examination can assist in revealing the mechanism leading to preterm birth. Accumulating evidence suggests an association between intrauterine pathological processes, morbidity and mortality of premature infants, and their long term outcome. Neonatal brain activity is increasingly monitored in neonatal intensive care units by amplitude integrated EEG (aEEG) and indices of background activity and sleep cycling patterns were correlated with long term outcome. We hypothesized an association between types of placental lesions and abnormal neonatal aEEG patterns. Objective To determine the association between the placental lesions observed in extreme preterm deliveries, and their neonatal aEEG patterns and survival. Patients and methods This prospective cohort study included extreme premature infants, who were born <= 28 weeks of gestation, their placentas were available for histologic examination, and had a continues aEEG, soon after birth)n = 34). Infants and maternal clinical data were collected. aEEG data was assessed for percentage of depressed daily activity in the first 3 days of life and for sleep cycling. Associations of placental histology with clinical findings and aEEG activity were explored using parametric and non-parametric statistics. Results Twenty two out of the 34 newborns survived to discharge. Preterm prelabor rupture of membranes (PPROM) or chorioamnionitis were associated with placental lesions consistent with fetal amniotic fluid infection (AFI) or maternal under perfusion (MUP) (P < 0.05). Lesions consistent with fetal response to AFI were associated with absence of SWC pattern during the 1st day of life. Fetal-vascular-thrombo-occlusive lesions of inflammatory type were negatively associated with depressed cerebral activity during the 1st day of life, and with aEEG cycling during the 2nd day of life (P<0.05). Placental lesions associated with MUP were associated with depressed neonatal cerebral activity during the first 3 days of life (P = 0.007). Conclusions Depressed neonatal aEEG patterns are associated with placental lesions consistent with maternal under perfusion, and amniotic fluid infection of fetal type, but not with fetal thrombo-oclusive vascular disease of inflammatory type. Our findings highlight the association between the intrauterine mechanisms leading to preterm parturition and subsequent depressed neonatal cerebral function early after birth, which eventually may put premature infants at risk for abnormal neurodevelopmental outcome.	[Paz-Levy, Dorit; Erez, Offer] Ben Gurion Univ Negev Beer Sheva, Sch Med, Fac Hlth Sci, Dept Obstet & Gynecol,Soroka Univ Med Ctr, Beer Sheva, Israel; [Schreiber, Letizia] Wolfson Med Ctr, Pathol Inst, Hulon, Israel; [Goshen, Sharon] Ben Gurion Univ Negev, Sch Med, Dept Epidemiol, Fac Hlth Sci, Beer Sheva, Israel; [Goshen, Sharon; Richardson, Justin; Chacham, Orna Staretz; Shany, Eilon] Ben Gurion Univ Negev, Sch Med, Fac Hlth Sci, Dept Neonatol,Soroka Univ Med Ctr, Beer Sheva, Israel; [Drunov, VIadimir] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Med, Dept Pathol,Soroka Univ Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Erez, O (corresponding author), Ben Gurion Univ Negev Beer Sheva, Sch Med, Fac Hlth Sci, Dept Obstet & Gynecol,Soroka Univ Med Ctr, Beer Sheva, Israel.	erezof@bgu.ac.il	Shany, Eilon/F-2108-2012	Shany, Eilon/0000-0003-4142-3707				Adams-Chapman Ira, 2002, J Perinatol, V22, P236, DOI 10.1038/sj.jp.7210685; Alfirevic Z, 2013, ULTRASOUND OBST GYN, V41, P146, DOI 10.1002/uog.12300; Amiel-Tison C, 1976, Curr Probl Pediatr, V7, P1, DOI 10.1016/S0045-9380(76)80008-4; Amiel-Tison C, 1978, Ciba Found Symp, P107; Amiel-Tison C, 2002, PEDIATR NEUROL, V27, P196, DOI 10.1016/S0887-8994(02)00436-8; AMIELTISON C, 1968, ARCH DIS CHILD, V43, P89, DOI 10.1136/adc.43.227.89; Aylward GP, 2004, J PEDIATR PSYCHOL, V29, P555, DOI 10.1093/jpepsy/jsh057; Aylward GP, 2000, DEV MED CHILD NEUROL, V42, P25, DOI 10.1017/S0012162200000062; Barinov SV, 2016, J MATERN-FETAL NEO M, P1; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Conde-Agudelo A, 2016, AM J OBSTET GYNECOL, V214, P235, DOI 10.1016/j.ajog.2015.09.102; Erdemir G, 2013, PEDIATR NEONATOL, V54, P267, DOI 10.1016/j.pedneo.2013.03.012; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GIBBS RS, 1980, AM J OBSTET GYNECOL, V136, P709, DOI 10.1016/0002-9378(80)90445-7; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Goya M, 2016, AM J OBSTET GYNECOL, V214, P145, DOI 10.1016/j.ajog.2015.11.012; Harteman JC, 2012, PLACENTA, V33, P839, DOI 10.1016/j.placenta.2012.06.014; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hellstrom-Westas L., 2006, NEOREVIEWS, DOI [DOI 10.1542/NEO.7-2-E76, 10.1542/neo.7-2-e76]; Henderson JJ, 2012, J MATERN-FETAL NEO M, V25, P642, DOI 10.3109/14767058.2011.597899; Hirvonen M, 2014, PEDIATRICS, V134, pE1584, DOI 10.1542/peds.2014-0945; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Klebermass K, 2006, BIOL NEONATE, V89, P120, DOI 10.1159/000088912; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Kuint J, 2007, J CHILD NEUROL, V22, P277, DOI 10.1177/0883073807299860; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Lee J, 2013, PLACENTA, V34, P681, DOI 10.1016/j.placenta.2013.04.014; Lee J, 2013, AM J REPROD IMMUNOL, V70, P265, DOI 10.1111/aji.12142; Liu ZW, 2014, PEDIATR NEONATOL, V55, P35, DOI 10.1016/j.pedneo.2013.05.007; Markham KB, 2014, CLIN PERINATOL, V41, P773, DOI 10.1016/j.clp.2014.08.003; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; MAYNARD D, 1969, ELECTROEN CLIN NEURO, V27, P672; Mercer BM, 2004, CLIN PERINATOL, V31, P765, DOI 10.1016/j.clp.2004.06.004; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Moscuzza F, 2011, GYNECOL ENDOCRINOL, V27, P319, DOI 10.3109/09513590.2010.487619; Nijman TAJ, 2016, PLACENTA, V48, P56, DOI 10.1016/j.placenta.2016.10.006; Olischar M, 2004, PEDIATRICS, V113, pE61, DOI 10.1542/peds.113.1.e61; Owen J, 2012, OBSTET GYN CLIN N AM, V39, P25, DOI 10.1016/j.ogc.2011.12.001; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; PHELAN JP, 1987, J REPROD MED, V32, P540; Pri-Paz S, 2012, ULTRASOUND OBST GYN, V39, P648, DOI 10.1002/uog.10093; PRIOR PF, 1971, BRIT MED J, V2, P736, DOI 10.1136/bmj.2.5764.736; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Redline RW, 2007, SEMIN DIAGN PATHOL, V24, P5, DOI 10.1053/j.semdp.2007.01.001; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Redline RW, 2015, SEMIN PERINATOL, V39, P2, DOI 10.1053/j.semperi.2014.10.002; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Romero R, 2016, ULTRASOUND OBST GYN, V48, P308, DOI 10.1002/uog.15953; Romero R, 2017, ULTRASOUND OBSTET GY; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Romero R, 2013, J PERINAT MED, V41, P27, DOI 10.1515/jpm-2012-0272; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sentilhes L, 2017, EUR J OBSTET GYN R B, V210, P217, DOI 10.1016/j.ejogrb.2016.12.035; Song J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13810; Soraisham AS, 2013, J PERINATOL, V33, P70, DOI 10.1038/jp.2012.49; Szychowski JM, 2012, J MATERN-FETAL NEO M, V25, P2686, DOI 10.3109/14767058.2012.717128; Wikstrom S, 2012, ACTA PAEDIATR, V101, P719, DOI 10.1111/j.1651-2227.2012.02677.x; Wood SL, 2016, CLIN OBSTET GYNECOL, V59, P302, DOI 10.1097/GRF.0000000000000190; Wood SL, 2016, CLIN OBSTET GYNECOL, V59, P270, DOI 10.1097/GRF.0000000000000191; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035	71	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179481	10.1371/journal.pone.0179481	http://dx.doi.org/10.1371/journal.pone.0179481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644831	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100016
J	Yang, Y; Kim, HJ; Woo, KJ; Cho, D; Bang, SI				Yang, Yoolhee; Kim, Hee Jung; Woo, Kyong-Je; Cho, Daeho; Bang, Sa Ik			Lipo-PGE1 suppresses collagen production in human dermal fibroblasts via the ERK/Ets-1 signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; CATHELICIDIN LL-37; PEPTIDE LL-37; TGF-BETA; FIBROSIS; ACTIVATION; ERK; SCLERODERMA; KELOIDS	Dysregulation of collagen production contributes to various pathological processes, including tissue fibrosis as well as impaired wound healing. Lipo-prostaglandin E1 (Lipo-PGE1), a lipid microsphere-incorporated prostaglandin E1, is used as a vasodilator for the treatment of peripheral vascular diseases. Lipo-PGE1 was recently shown to enhance human dermal fibroblast (HDF) migration and in vivo wound healing. No published study has characterized the role of Lipo-PGE1 in collagen regulation in HDFs. Here, we investigated the cellular signaling mechanism by which Lipo-PGE1 regulates collagen in HDFs. Collagen production was evaluated by the Sircol collagen assay, Western blot analysis of type I collagen and real time PCR. Unexpectedly, Lipo-PGE1 decreased mRNA expression of collagen 1A1, 1A2, and 3A1. Lipo-PGE1 markedly inhibited type I collagen and total soluble collagen production. In addition, Lipo-PGE1 inhibited transforming growth factor-beta-induced collagen expression via Smad2 phosphorylation. To further investigate whether extracellular signalregulated kinase (ERK)/Ets-1 signaling, a crucial pathway in collagen regulation, is involved in Lipo-PGE1-inhibited collagen production, cells were pretreated with an ERK-specific inhibitor, PD98059, prior to the addition of Lipo-PGE1. Lipo-PGE1-inhibited collagen mRNA expression and total soluble collagen production were recovered by pretreatment with PD98059. Moreover, Lipo-PGE1 directly induced the phosphorylation of ERK. Furthermore, silencing of Ets-1 recovered Lipo- PGE1-inhibited collagen production and PD98059 blocked Lipo-PGE1-enhanced Ets-1 expression. The present study reveals an important role for Lipo-PGE1 as a negative regulator of collagen gene expression and production via ERK/Ets-1 signaling. These results suggest that Lipo-PGE1 could potentially be a therapeutic target in diseases with deregulated collagen turnover.	[Yang, Yoolhee; Woo, Kyong-Je; Bang, Sa Ik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul, South Korea; [Kim, Hee Jung] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Inst Womens Life Med Sci, Seoul, South Korea; [Cho, Daeho] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Sookmyung Women's University	Bang, SI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul, South Korea.; Cho, D (corresponding author), Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea.	cdhkor@sookmyung.ac.kr; si55.bang@samsung.com	Kim, Hee Jung/O-4581-2019	Kim, Hee Jung/0000-0002-6122-6906	National Research Foundation of Korea (NRF)-Ministry of Education [S-2016-1852-000]; National Research Foundation of Korea (NRF)-Ministry of Science, ICT and Future Planning [2016M3D1A1021387]	National Research Foundation of Korea (NRF)-Ministry of Education; National Research Foundation of Korea (NRF)-Ministry of Science, ICT and Future Planning	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (S-2016-1852-000) and the Creative Materials Discovery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2016M3D1A1021387).	Bhogal RK, 2005, J CLIN IMMUNOL, V25, P592, DOI 10.1007/s10875-005-7827-3; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Cevikbas F, 2011, EXP DERMATOL, V20, P69, DOI 10.1111/j.1600-0625.2010.01184.x; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; FRIEDMAN DW, 1993, J SURG RES, V55, P214, DOI 10.1006/jsre.1993.1132; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Jeon BJ, 2013, EXP CELL RES, V319, P2526, DOI 10.1016/j.yexcr.2013.04.014; Leask Andrew, 2004, Keio Journal of Medicine, V53, P74, DOI 10.2302/kjm.53.74; Lee DJ, 2000, EXP CELL RES, V257, P190, DOI 10.1006/excr.2000.4866; Lim IJ, 2003, J BIOL CHEM, V278, P40851, DOI 10.1074/jbc.M305759200; MAUVIEL A, 1994, J BIOL CHEM, V269, P25; McCormick LL, 1999, J IMMUNOL, V163, P5693; Mizui M, 2006, KIDNEY INT, V70, P298, DOI 10.1038/sj.ki.5001541; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Park HJ, 2010, EXP DERMATOL, V19, pE258, DOI 10.1111/j.1600-0625.2010.01070.x; Park HJ, 2009, J INVEST DERMATOL, V129, P843, DOI 10.1038/jid.2008.320; Salvado MD, 2013, ARTERIOSCL THROM VAS, V33, P1965, DOI 10.1161/ATVBAHA.113.301851; Sobota RM, 2008, BIOCHEM J, V412, P65, DOI 10.1042/BJ20071572; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Yang Y, 2012, EXP DERMATOL, V21, P75, DOI 10.1111/j.1600-0625.2011.01406.x	23	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179614	10.1371/journal.pone.0179614	http://dx.doi.org/10.1371/journal.pone.0179614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644845	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100025
J	Zhang, YC; Boxberger, KH; Hagenbuch, B				Zhang, Yuchen; Boxberger, Kelli H.; Hagenbuch, Bruno			Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN 10; BILE-ACID TRANSPORTER; HUMAN OATP1B1; EXPRESSION; PROTEIN; BOSENTAN; LIVER; DISPOSITION; SILDENAFIL	OATP1B3 is a 12 transmembrane domain protein expressed at the basolateral membrane of human hepatocytes where it mediates the uptake of numerous drugs and endogenous compounds. Previous western blot results suggest the formation of OATP1B3 multimers. In order to better understand the function of OATP1B3 under normal physiological conditions, we investigated its oligomerization status. We transiently transfected OATP1B3 with a C-terminal His-, FLAG- or HA-tag in HEK293 cells and used co-immunoprecipitation and a Proximity Ligation Assay to detect interactions between the different constructs. All three constructs retained similar transport rates as wild-type OATP1B3. Immunofluorescence experiments indicated that in contrast to wild-type, His- and FLAG- tagged OATP1B3, where the C-terminal end is on the cytoplasmic side of the membrane, the C-terminal end of HA-tagged OATP1B3 is extracellular. After cross-linking, anti-FLAG antibodies were able to pull down FLAG- tagged OATP1B3 (positive control) and co-transfected His- or HA-tagged OATP1B3, demonstrating the formation of homo-oligomers and suggesting that the C-terminal part is not involved in oligomer formation. We confirmed co-localization of His- and FLAG- tagged OATP1B3 in transfected HEK293 cells with the Proximity Ligation Assay. Transport studies with a non-functional OATP1B3 mutant suggest that the individual sub-units and not the whole oligomer are the functional units in the homo-oligomers. In addition, we also detected OATP1B3-FLAG co-localization with OATP1B1-His or NTCP-His, suggesting that OATP1B3 also hetero-oligomerizes with other transport proteins. Using the Proximity Ligation Assay with transporter specific antibodies, we demonstrate close association of OATP1B3 with NTCP in frozen human liver tissue. These findings demonstrate that OATP1B3 can form homo- and hetero-oligomers and suggest a potential co-regulation of the involved transporters.	[Zhang, Yuchen; Boxberger, Kelli H.; Hagenbuch, Bruno] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Hagenbuch, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	bhagenbuch@kumc.edu	Zhang, Yuchen/GYI-8858-2022; Hagenbuch, Bruno/M-5294-2016	Hagenbuch, Bruno/0000-0002-2938-8630	National Institute of General Medical Sciences [GM077336, P20GM103549, P30GM118247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077336, P30GM118247] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institute of General Medical Sciences GM077336 (BH). The Cell Isolation Core and the Analytical Core in the Department of Pharmacology, Toxicology and Therapeutics at University of Kansas Medical Center were supported in part by grants from the National Institute of General Medical Sciences P20GM103549 and P30GM118247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, GASTROENTEROLOGY, V120, P1689, DOI 10.1053/gast.2001.24804; Bijsmans ITGW, 2012, BIOCHEM J, V441, P1007, DOI 10.1042/BJ20111234; Burgess G, 2008, EUR J CLIN PHARMACOL, V64, P43, DOI 10.1007/s00228-007-0408-z; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Fernandes CF, 2007, BIOCHEM BIOPH RES CO, V361, P26, DOI 10.1016/j.bbrc.2007.06.160; Godoy JR, 2007, EUR J CELL BIOL, V86, P445, DOI 10.1016/j.ejcb.2007.06.001; Gui C, 2008, BIOCHEMISTRY-US, V47, P9090, DOI 10.1021/bi8008455; Gui C, 2008, EUR J PHARMACOL, V584, P57, DOI 10.1016/j.ejphar.2008.01.042; Gui CS, 2009, PROTEIN SCI, V18, P2298, DOI 10.1002/pro.240; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Kandel SE, 2014, CHEM RES TOXICOL, V27, P1474, DOI 10.1021/tx500203s; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Kindla J, 2011, DRUG METAB DISPOS, V39, P1047, DOI 10.1124/dmd.110.037622; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Kramer W, 2001, J BIOL CHEM, V276, P36020, DOI 10.1074/jbc.M104665200; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Martinez-Becerra P, 2011, MOL PHARMACOL, V79, P596, DOI 10.1124/mol.110.069971; Mayati A, 2015, BIOCHEM PHARMACOL, V98, P703, DOI 10.1016/j.bcp.2015.10.007; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Ni CX, 2017, MOL PHARMACEUT, V14, P359, DOI 10.1021/acs.molpharmaceut.6b00649; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Ohnishi S, 2014, BIOCHEMISTRY-US, V53, P2261, DOI 10.1021/bi500176e; Powell John, 2014, Drug Metab Dispos, V42, P1964, DOI 10.1124/dmd.114.056945; Ramsden Diane, 2014, Drug Metab Dispos, V42, P1940, DOI 10.1124/dmd.114.057901; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Roth M, 2011, DRUG METAB DISPOS, V39, P920, DOI 10.1124/dmd.110.036640; Stieger B, 2014, CURR TOP MEMBR, V73, P205, DOI 10.1016/B978-0-12-800223-0.00005-0; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; van Giersbergen PLM, 2007, CLIN PHARMACOL THER, V81, P414, DOI 10.1038/sj.clpt.6100075; Yan H, 2014, ELIFE, P3; Zhang YC, 2013, J NAT PROD, V76, P368, DOI 10.1021/np3007292; Zhao W, 2015, TOXICOL SCI, V146, P363, DOI 10.1093/toxsci/kfv102	34	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180257	10.1371/journal.pone.0180257	http://dx.doi.org/10.1371/journal.pone.0180257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644885	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100066
J	Sun, Y; Liu, CH; Wang, ZX; Meng, SS; Burnim, SB; SanGiovanni, JP; Kamenecka, TM; Solt, LA; Chen, J				Sun, Ye; Liu, Chi-Hsiu; Wang, Zhongxiao; Meng, Steven S.; Burnim, Samuel B.; SanGiovanni, John Paul; Kamenecka, Theodore M.; Solt, Laura A.; Chen, Jing			ROR alpha modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis	FASEB JOURNAL			English	Article						retinopathy; SEMA3E; nuclear receptor; neovascularization	ORPHAN RECEPTOR-ALPHA; OXYGEN-INDUCED RETINOPATHY; MURINE MODEL; MOUSE MODEL; FACTOR-I; EXPRESSION; ACTIVATION; VASCULATURE; SUPPRESSION; INHIBITION	Pathological proliferation of retinal blood vessels commonly causes vision impairment in proliferative retinopathies, including retinopathy of prematurity. Dysregulated crosstalk between the vasculature and retinal neurons is increasingly recognized as a major factor contributing to the pathogenesis of vascular diseases. Class 3 semaphorins (SEMA3s), a group of neuron-secreted axonal and vascular guidance factors, suppress pathological vascular growth in retinopathy. However, the upstream transcriptional regulators that mediate the function of SEMA3s in vascular growth are poorly understood. Here we showed that retinoic acid receptor-related orphan receptor (ROR alpha), a nuclear receptor and transcription factor, is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in a mouse model of oxygen-induced proliferative retinopathy. We found that genetic deficiency of ROR alpha substantially induced Sema3e expression in retinopathy. Both ROR alpha and SEMA3E were expressed in retinal ganglion cells. ROR alpha directly bound to a specific ROR alpha response element on the promoter of Sema3e and negatively regulated Sema3e promoter-driven luciferase expression. Suppression of Sema3e using adeno-associated virus 2 carrying short hairpin RNA targeting Sema3e promoted disoriented pathological neovascularization and partially abolished the inhibitory vascular effects of ROR alpha deficiency in retinopathy. Our findings suggest that ROR alpha is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in pathological retinal angiogenesis.Sun, Y., Liu, C.-H., Wang, Z., Meng, S. S., Burnim, S. B., SanGiovanni, J. P., Kamenecka, T. M., Solt, L. A., Chen, J. ROR modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.	[Sun, Ye; Liu, Chi-Hsiu; Wang, Zhongxiao; Meng, Steven S.; Burnim, Samuel B.; Chen, Jing] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [SanGiovanni, John Paul] NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD USA; [SanGiovanni, John Paul] Georgetown Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA; [Solt, Laura A.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Scripps Research Institute; Scripps Research Institute	Chen, J (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	jing.chen@childrens.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020	Sun, Ye/0000-0002-7674-9056	U.S. National Institutes of Health (NIH) National Eye Institute [R01 EY024963]; BrightFocus Foundation; Boston Children's Hospital Career Development Award; Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund; NIH National Institute of Allergy and Infectious Diseases [1R01 AI116885-01A1]; Margaret Q. Landenberger Research Foundation; NATIONAL EYE INSTITUTE [R01EY024963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116885] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BrightFocus Foundation(BrightFocus Foundation); Boston Children's Hospital Career Development Award; Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Margaret Q. Landenberger Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Drs. Lois Smith, Zhongjie Fu, and Yan Gong (all from Boston Children's Hospital) for helpful discussions and Peyton Morss, Thomas Fredrick, and Nicholas Saba (all from Boston Children's Hospital) for excellent technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grant R01 EY024963; the BrightFocus Foundation; a Boston Children's Hospital Career Development Award; the Boston Children's Hospital Ophthalmology Foundation and Massachusetts Lions Eye Research Fund (to J.C.), NIH National Institute of Allergy and Infectious Diseases Grant 1R01 AI116885-01A1 (to L.A.S.); and funds from the Margaret Q. Landenberger Research Foundation (to L.A.S.). The authors declare no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2013, ANGIOGENESIS, V16, P985, DOI 10.1007/s10456-013-9374-5; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chenoweth JM, 2016, FLA MUS NAT HIST-RIP, P1; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kamata Y, 2015, J DERMATOL SCI, V79, P84, DOI 10.1016/j.jdermsci.2015.03.015; Kern TS, 2014, DIABETES METAB J, V38, P163, DOI 10.4093/dmj.2014.38.3.163; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kwon SH, 2015, OPHTHALMOLOGY, V122, P968, DOI 10.1016/j.ophtha.2015.01.007; Lechtken A, 2006, PROTEIN EXPRES PURIF, V49, P114, DOI 10.1016/j.pep.2006.03.012; Li J, 2014, INVEST OPHTH VIS SCI, V55, P8267, DOI 10.1167/iovs.14-15623; Liu CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33947; Michan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085031; Migita H, 2004, FEBS LETT, V557, P269, DOI 10.1016/S0014-5793(03)01502-3; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Nakahara T, 2013, J PHARMACOL SCI, V123, P79, DOI 10.1254/jphs.13R03CP; Nasarre P, 2014, ONCOTARGETS THER, V7, P1663, DOI 10.2147/OTT.S37744; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ochsenbein AM, 2016, DEVELOPMENT, V143, P589, DOI 10.1242/dev.127670; Park YK, 2008, NUCLEIC ACIDS RES, V36, pW97, DOI 10.1093/nar/gkn280; Qian HH, 2011, EXP DIABETES RES, DOI 10.1155/2011/693426; Rao RC, 2013, NEW ENGL J MED, V368, P1161, DOI 10.1056/NEJMc1301021; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Serini G, 2013, J INTERN MED, V273, P138, DOI 10.1111/joim.12017; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Solt LA, 2015, ENDOCRINOLOGY, V156, P869, DOI 10.1210/en.2014-1677; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; Sun Y, 2015, ARCHAEA, V2015, DOI 10.1155/2015/397924; Talia DM, 2016, ARTERIOSCL THROM VAS, V36, P1186, DOI 10.1161/ATVBAHA.115.307080; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; Ueda K, 2010, NEUROSCI LETT, V485, P55, DOI 10.1016/j.neulet.2010.08.061; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Wang ZX, 2016, AM J PATHOL, V186, P2588, DOI 10.1016/j.ajpath.2016.06.015; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yang WJ, 2015, EMBO MOL MED, V7, P1267, DOI 10.15252/emmm.201404922; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	62	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4492	4502		10.1096/fj.201700172R	http://dx.doi.org/10.1096/fj.201700172R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646017	Green Published			2022-12-26	WOS:000413397400026
J	Yang, J; Kasberg, WC; Celo, A; Liang, Z; Quispe, K; Stack, MS				Yang, Jing; Kasberg, William C.; Celo, Angela; Liang, Zhong; Quispe, Kristal; Stack, M. Sharon			Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; MICROENVIRONMENTAL REGULATION; EXTRACELLULAR-MATRIX; CARCINOMA CELLS; INVASION; EXPRESSION; METASTASIS; ADHESION; PHOSPHORYLATION; ANGIOGENESIS	Membrane type 1 matrix metalloproteinase (MT1-MMP, MMP-14) is a transmembrane collagenase highly expressed in metastatic ovarian cancer and correlates with poor survival. Accumulating evidence shows that the cytoplasmic tail of MT1-MMP is subjected to phosphorylation, and this post-translational modification regulates enzymatic activity at the cell surface. To investigate the potential role of MT1-MMPcytoplasmic residue Thr(567) phosphorylation in regulation of metastasis-associated behaviors, ovarian cancer cells that express low endogenous levels of MT1-MMP were engineered to express wild-type MT1-MMP, a phosphomimetic mutant (T567E), or a phosphodeficient mutant (T567A). Results show that Thr(567)modulation influences behavior of both individual cells and multicellular aggregates (MCAs). The acquisition of either wild-type or mutant MT1-MMP expression results in altered cohesion of epithelial sheets and the formation of more compact MCAs relative to parental cells. Cells expressing MT1-MMP-T567E phosphomimetic mutants exhibit enhanced cell migration. Furthermore, MCAs formed from MT1-MMP-T567E-expressing cells adhere avidly to both intact ex vivo peritoneal explants and three-dimensional collagen gels. Interaction of these MCAs with peritoneal mesothelium disrupts mesothelial integrity, exposing the submesothelial collagen matrix on which MT1-MMP-T567E MCAs rapidly disperse. Together, these findings suggest that post-translational regulation of the Thr(567) in the MT1-MMP cytoplasmic tail may function as a regulatory mechanism to impact ovarian cancer metastatic success.	[Yang, Jing; Kasberg, William C.; Liang, Zhong; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46617 USA; [Yang, Jing; Kasberg, William C.; Celo, Angela; Quispe, Kristal; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame	Stack, MS (corresponding author), Univ Notre Dame, 1234 Notre Dame Ave,A200 Harper Hall, South Bend, IN 46617 USA.	sstack@nd.edu		Kasberg, William/0000-0003-3553-7505	National Institutes of Health [RO1CA109545, RO1CA086984]; Leo and Anne Albert Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leo and Anne Albert Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants RO1CA109545 (to M. S. S.) and RO1CA086984 (to M. S. S) and the Leo and Anne Albert Charitable Trust (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Annabi B, 2001, BIOCHEM J, V353, P547, DOI 10.1042/0264-6021:3530547; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2013, J BIOL CHEM, V288, P141, DOI 10.1074/jbc.M112.431411; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Bruney L, 2016, ONCOTARGET, V7, P21968, DOI 10.18632/oncotarget.7880; Bruney L, 2014, BIOL CHEM, V395, P1221, DOI 10.1515/hsz-2014-0155; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Coffman LG, 2016, TRANSL RES, V175, P92, DOI 10.1016/j.trsl.2016.03.016; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Doi T, 2011, EXP MOL PATHOL, V90, P91, DOI 10.1016/j.yexmp.2010.10.008; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Kaimal R, 2013, CANCER RES, V73, P2457, DOI 10.1158/0008-5472.CAN-12-1426; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Klymenko Y, 2017, NEOPLASIA, V19, P549, DOI 10.1016/j.neo.2017.04.002; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Liu YY, 2015, CANCER RES, V75, P5046, DOI 10.1158/0008-5472.CAN-15-0706; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sakata K, 2000, INT J ONCOL, V17, P673; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sieracki N. A., 2013, GENETIC MANIPULATION, P381; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069	50	13	13	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13111	13121		10.1074/jbc.M117.800904	http://dx.doi.org/10.1074/jbc.M117.800904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655772	hybrid, Green Published			2022-12-26	WOS:000407465300003
J	Esposito, MR; Guillari, A; Angelillo, IF				Esposito, Maria Rosaria; Guillari, Assunta; Angelillo, Italo Francesco			Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; EVIDENCE-BASED GUIDELINES; DISEASES WORKING PARTY; RISK-FACTORS; MANAGEMENT; CANCER; HOSPITALS; SOCIETY; PATIENT; IMPACT	The objectives of the cross-sectional study were to delineate the knowledge, attitudes, and behavior among nurses regarding the prevention of central line-associated bloodstream infections (CLABSIs) and to identify their predisposing factors. A questionnaire was self-administered from September to November 2011 to nurses in oncology and outpatient chemotherapy units in 16 teaching and non-teaching public and private hospitals in the Campania region (Italy). The questionnaire gathered information on demographic and occupational characteristics; knowledge about evidence-based practices for the prevention of CLABSIs; attitudes towards guidelines, the risk of transmitting infections, and hand-washing when using central venous catheter (CVC); practices about catheter site care; and sources of information. The vast majority of the 335 nurses answered questions correctly about the main recommendations to prevent CLABSIs (use sterile gauze or sterile transparent semi-permeable dressing to cover the catheter site, disinfect the needleless connectors before administer medication or fluid, disinfect with hydrogen peroxide the catheter insertion site, and use routinely anticoagulants solutions). Nurses aged 36 to 50 years were less likely to know these main recommendations to prevent CLABSIs, whereas this knowledge was higher in those who have received information about the prevention of these infections from courses. Nurses with lower education and those who do not know two of the main recommendations on the site's care to prevent the CLABSIs, were more likely to perceive the risk of transmitting an infection. Higher education, attitude toward the utility allow to dry antiseptic, and the need of washing hands before wearing gloves for access to port infusion were predictors of performing skin antiseptic and aseptic technique for dressing the catheter insertion site. Educational interventions should be implemented to address the gaps regarding knowledge and practice regarding the prevention of CLABSIs and to ensure that nurses use evidence-based prevention interventions.	[Esposito, Maria Rosaria] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy; [Guillari, Assunta; Angelillo, Italo Francesco] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	italof.angelillo@unicampania.it	Angelillo, Italo Francesco/AAK-1301-2021; GUILLARI, ASSUNTA/AAT-2669-2020	Angelillo, Italo Francesco/0000-0003-1213-6602; esposito, maria rosaria/0000-0002-8578-1250; GUILLARI, ASSUNTA/0000-0001-8423-8195				AHRQ Projects to Prevent Healthcare-Associated Infections, 2014, FISC YEAR 2011; Al-Sayaghi KM, 2011, SAUDI MED J, V32, P275; Alkubati SA, 2015, AM J INFECT CONTROL, V43, P26, DOI 10.1016/j.ajic.2014.09.021; Apostolopoulou E, 2013, AM J CRIT CARE, V22, pE12, DOI 10.4037/ajcc2013324; Bianco A, 2013, AM J INFECT CONTROL, V41, P107, DOI 10.1016/j.ajic.2012.02.038; Boersma RS, 2010, EUR J ONCOL NURS, V14, P200, DOI 10.1016/j.ejon.2009.12.005; Centers for Disease Control and Prevention, 2013, NAT STAT HEALTHC ASS; Chopra V, 2013, MAKING HLTH CARE SAF; Dedunska K, 2015, AM J INFECT CONTROL, V43, P1368, DOI 10.1016/j.ajic.2015.07.022; Flodgren G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006559.pub2; Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452; Guembe M, 2012, EUR J CLIN MICROBIOL, V31, P2799, DOI 10.1007/s10096-012-1630-x; Hentrich M, 2014, ANN ONCOL, V25, P936, DOI 10.1093/annonc/mdt545; Ider BE, 2012, INT J INFECT DIS, V16, pE551, DOI 10.1016/j.ijid.2012.03.006; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Koutzavekiaris I, 2011, AM J INFECT CONTROL, V39, P542, DOI 10.1016/j.ajic.2010.11.003; Krein SL, 2015, BMJ QUAL SAF, V24, P385, DOI 10.1136/bmjqs-2014-003870; Labeau SO, 2009, CRIT CARE MED, V37, P320, DOI 10.1097/CCM.0b013e3181926489; Ling ML, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0116-5; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Moureau NL, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/796762; Nelson RE, 2015, INFECT CONT HOSP EP, V36, P534, DOI 10.1017/ice.2015.22; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Raad I, 2014, CLIN INFECT DIS, V59, pS340, DOI 10.1093/cid/ciu670; Rickard CM, 2004, J ADV NURS, V48, P247, DOI 10.1111/j.1365-2648.2004.03193.x; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Sessa A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-148; Shapey IM, 2009, J HOSP INFECT, V71, P117, DOI 10.1016/j.jhin.2008.09.016; Snarski E, 2015, TRANSPL INFECT DIS, V17, P558, DOI 10.1111/tid.12399; The Joint Commission, 2012, PREV CENTR LIN ASS B; Tomlinson D, 2011, CLIN INFECT DIS, V53, P697, DOI 10.1093/cid/cir523; Ullman Amanda J, 2014, Br J Nurs, V23, pS14; Vaz LE, 2015, INFECT CONT HOSP EP, V36, P649, DOI 10.1017/ice.2015.38; Wang TY, 2015, J FORMOS MED ASSOC, V114, P1055, DOI 10.1016/j.jfma.2015.06.013; Yacobovich J, 2015, PEDIATR BLOOD CANCER, V62, P471, DOI 10.1002/pbc.25281; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011	36	18	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180473	10.1371/journal.pone.0180473	http://dx.doi.org/10.1371/journal.pone.0180473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665993	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700010
J	Ji, WJ; Zhao, M; Wang, M; Yan, WH; Liu, Y; Ren, ST; Lu, J; Wang, B; Chen, LN				Ji, Wenjun; Zhao, Mei; Wang, Meng; Yan, Wenhui; Liu, Yuan; Ren, Shuting; Lu, Jun; Wang, Bing; Chen, Lina			Effects of canagliflozin on weight loss in highfat diet-induced obese mice	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE-2 DGAT2; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; EXPRESSION; SAFETY	Canagliflozin, an inhibitor of sodium glucose co-transporter (SGLT) 2, has been shown to reduce body weight during the treatment of type 2 diabetes mellitus (T2DM). In this study, we sought to determine the role of canagliflozin in body weight loss and liver injury in obesity. C57BL/6J mice were fed a high-fat diet to simulate diet-induced obesity (DIO). Canagliflozin (15 and 60 mg/kg) was administered to DIO mice for 4 weeks. Orlistat (10 mg/kg) was used as a positive control. The body weight, liver weight, liver morphology, total cholesterol (TC) and triglyceride (TG) levels were examined. Signaling molecules, including diacylgycero1 acyltransferase-2 (DGAT2), peroxisome proliferation receptor alpha-1 (PPAR alpha 1), PPAR gamma 1, PPAR gamma 2 mRNA levels and the protein expression of SGLT2 were evaluated. Canagliflozin reduced body weight, especially the high-dose canagliflozin, and resulted in increased body weight loss compared with orlistat. Moreover, canagliflozin reduced the liver weight and the ratio of liver weight to body weight, lowered the serum levels of TC and TG, and ameliorated liver steatosis. During the canagliflozin treatment, SGLT2, DGAT2, PPAR gamma 1 and PPAR gamma 2 were inhibited, and PPARa1 was elevated in the liver tissues. This finding may explain why body weight was reduced and secondary liver injury was ameliorated in response to canagliflozin. Together, the results suggest that canagliflozin may be a potential anti-obesity strategy.	[Ji, Wenjun; Zhao, Mei; Wang, Meng; Yan, Wenhui; Liu, Yuan; Chen, Lina] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Ji, Wenjun] Taizhou Peoples Hosp, Dept Pharm, Taizhou, Jiangsu, Peoples R China; [Zhao, Mei] 302 Mil Hosp China, Dept Pharm, Beijing, Peoples R China; [Wang, Meng] Shijiazhuang Matern Hosp, Dept Pharm, Shijiazhuang, Hebei, Peoples R China; [Ren, Shuting; Wang, Bing; Chen, Lina] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Ren, Shuting; Wang, Bing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Shaanxi, Peoples R China; [Lu, Jun] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Clin Res Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Fifth Medical Center of Chinese PLA General Hospital; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Chen, LN (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian, Shaanxi, Peoples R China.; Chen, LN (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	chenlin@mail.xjtu.edu.cn			National Natural Science Foundation of China [81471031, 30901808]; e Technology and Innovation Project of Shaanxi Province [2011KTCL03-20]; Key Novel Drug Discovery of Major National Science and Technology Projects [2013ZX09509106]; Natural Science Foundation of Shaanxi Province [2015JM8415]; Fundamental Research Funds for the Central Universities [xjj2014143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); e Technology and Innovation Project of Shaanxi Province; Key Novel Drug Discovery of Major National Science and Technology Projects; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The present study was supported by grants from the National Natural Science Foundation of China (no. 81471031, 30901808), the Technology and Innovation Project of Shaanxi Province (no. 2011KTCL03-20), the Key Novel Drug Discovery of Major National Science and Technology Projects (no. 2013ZX09509106), the Natural Science Foundation of Shaanxi Province (no. 2015JM8415) and the Fundamental Research Funds for the Central Universities (no. xjj2014143).	Blasio A, 2014, BEHAV PHARMACOL, V25, P609, DOI 10.1097/FBP.0000000000000059; Boyle LD, 2014, EXPERT OPIN DRUG SAF, V13, P1535, DOI 10.1517/14740338.2014.959488; Gao BZ, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/501272; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Gu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/342561; Haque M, 2002, BEST PRACT RES CL GA, V16, P709, DOI 10.1053/bega.2002.0325; Honda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146337; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Kim Hyoung-Jun, 2014, J Exerc Nutrition Biochem, V18, P249, DOI 10.5717/jenb.2014.18.3.249; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Krentz AJ, 2016, DIABETES OBES METAB, V18, P558, DOI 10.1111/dom.12657; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Palacios-Martinez D, 2013, INT J ENDOCRINOL MET, V11, DOI 10.5812/ijem.6721; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Ross PK, 2009, TOXICOL APPL PHARM, V235, P199, DOI 10.1016/j.taap.2008.12.011; Takahashi N, 2011, MOL NUTR FOOD RES, V55, P1791, DOI 10.1002/mnfr.201100401; Triplitt C, 2015, CLIN MED INSIGHTS-EN, V8, P73, DOI [10.4137/CMED.S31526, 10.4137/CMEDED.S31526]; WHO, 2014, OB OV; Wilding JPH, 2013, INT J CLIN PRACT, V67, P1267, DOI 10.1111/ijcp.12322; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; You DY, 2015, J ENDOCRINOL INVEST, V38, P901, DOI 10.1007/s40618-015-0272-0	25	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179960	10.1371/journal.pone.0179960	http://dx.doi.org/10.1371/journal.pone.0179960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665967	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700047
J	Fomina, T; Weichwald, S; Synofzik, M; Just, J; Schols, L; Scholkopf, B; Grosse-Wentrup, M				Fomina, Tatiana; Weichwald, Sebastian; Synofzik, Matthis; Just, Jenifer; Schoels, Ludger; Schoelkopf, Bernhard; Grosse-Wentrup, Moritz			Absence of EEG correlates of self-referential processing depth in ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DEFAULT MODE NETWORK; SLEEP DISORDERS; CONSCIOUSNESS; DEGENERATION; IMPAIRMENT; PREVALENCE; DEFICITS; SCALE; ONSET	Self-referential processing is a key cognitive process, associated with the serotonergic system and the default mode network (DMN). Decreased levels of serotonin and reduced activations of the DMN observed in amyotrophic lateral sclerosis (ALS) suggest that self-referential processing might be altered in patients with ALS. Here, we investigate the effects of ALS on the electroencephalography correlates of self-referential thinking. We find that electroencephalography (EEG) correlates of self-referential thinking are present in healthy individuals, but not in those with ALS. In particular, thinking about themselves or others significantly modulates the bandpower in the medial prefrontal cortex in healthy individuals, but not in ALS patients. This finding supports the view of ALS as a complex multisystem disorder which, as shown here, includes dysfunctional processing of the medial prefrontal cortex. It points towards possible alterations of self-consciousness in ALS patients, which might have important consequences for patients' self-conceptions, personal relations, and decision-making.	[Fomina, Tatiana; Weichwald, Sebastian; Schoelkopf, Bernhard; Grosse-Wentrup, Moritz] Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany; [Fomina, Tatiana] Univ Tubingen, Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] German Ctr Neu rodegenerat Dis DZNE, Tubingen, Germany; [Synofzik, Matthis; Just, Jenifer; Schoels, Ludger] Hertie Inst Clin Brain Res, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fomina, T (corresponding author), Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany.; Fomina, T (corresponding author), Univ Tubingen, Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany.	tfomina@tuebingen.mpg.de	Schölkopf, Bernhard/A-7570-2013; Schöls, Ludger/ABB-2482-2021	Schölkopf, Bernhard/0000-0002-8177-0925; Schöls, Ludger/0000-0001-7774-5025; Synofzik, Matthis/0000-0002-2280-7273; Weichwald, Sebastian/0000-0003-0169-7244				Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Ahmed RM, 2016, SLEEP MED REV, V26, P33, DOI 10.1016/j.smrv.2015.05.007; Arnulf I, 2000, AM J RESP CRIT CARE, V161, P849, DOI 10.1164/ajrccm.161.3.9805008; Averill AJ, 2007, AMYOTROPH LATERAL SC, V8, P243, DOI 10.1080/17482960701374643; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Birbaumer N, 2012, PSYCHOL RES-PSYCH FO, V76, P183, DOI 10.1007/s00426-012-0412-5; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dentel C, 2013, BRAIN, V136, P483, DOI 10.1093/brain/aws274; Dupuis L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013346; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Esslen M, 2008, NEUROIMAGE, V42, P437, DOI 10.1016/j.neuroimage.2008.01.060; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Grosse-Wentrup M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046001; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hagemann D, 2001, CLIN NEUROPHYSIOL, V112, P215, DOI 10.1016/S1388-2457(00)00541-1; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; Harvey PO, 2011, SCHIZOPHR RES, V127, P171, DOI 10.1016/j.schres.2010.11.011; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00264; Lehrer Douglas S, 2014, Innov Clin Neurosci, V11, P10; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; Marchetti M, 2015, CLIN NEUROPHYSIOL, V126, P1255, DOI 10.1016/j.clinph.2014.09.017; Massman PJ, 1996, J NEUROL NEUROSUR PS, V61, P450, DOI 10.1136/jnnp.61.5.450; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Mosher J C, 2005, 5 INT S NON FUNCT SO; Mu Y, 2010, NEUROIMAGE, V53, P757, DOI 10.1016/j.neuroimage.2010.07.008; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nihei K, 1993, ACTA NEUROPATHOL, V86, P55; Pinkhardt EH, 2008, J NEUROL, V255, P532, DOI 10.1007/s00415-008-0734-9; Portas CM, 2000, SEROTONIN SLEEP WAKE; Portet F, 2001, RES GROUP MOTOR NEUR, V2, P23; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rosen HJ, 2011, NEUROCASE, V17, P231, DOI 10.1080/13554794.2010.522588; Salmon E, 2005, 2 ASPECTS IMPAIRED C; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schmidt R, 2014, HUM BRAIN MAPP, V35, P4386, DOI 10.1002/hbm.22481; SCHONBACH P, 1972, EUR J SOC PSYCHOL, V2, P327, DOI 10.1002/ejsp.2420020309; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Soekadar SR, 2013, J CLIN SLEEP MED, V9, P951, DOI 10.5664/jcsm.3002; Starkstein SE, 2014, ANOSOGNOSIA ALZHEIME; Strong MJ, 2003, ANN NEUROLOGY, V54; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; WOHLFART G, 1957, NEUROLOGY, V7, P124, DOI 10.1212/WNL.7.2.124; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	63	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180136	10.1371/journal.pone.0180136	http://dx.doi.org/10.1371/journal.pone.0180136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662161	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300111
J	Yuste-Checa, P; Vega, AI; Martin-Higueras, C; Medrano, C; Gamez, A; Desviat, LR; Ugarte, M; Perez-Cerda, C; Perez, B				Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen			DPAGT1-CDG: Functional analysis of disease causing pathogenic mutations and role of endoplasmic reticulum stress	PLOS ONE			English	Article							CONGENITAL MYASTHENIC SYNDROME; N-LINKED GLYCOSYLATION; CDG-IJ; DISORDER; MECHANISM	Pathogenic mutations in DPAGT1 are manifested as two possible phenotypes: congenital disorder of glycosylation DPAGT1-CDG (also known as CDG-Ij), and limb-girdle congenital myasthenic syndrome (CMS) with tubular aggregates. UDP-N-acetylglucosamine-dolichylphosphate N-acetylglucosamine phosphotransferase (GPT), the protein encoded by DPAGT1, is an endoplasmic reticulum (ER)-resident protein involved in an initial step in the N-glycosylation pathway. The aim of the present study was to examine the effect of six variants in DPAGT1 detected in patients with DPAGT1-CDG, and the role of endoplasmic reticulum stress, as part of the search for therapeutic strategies to use against DPAGT1-CDG. The effect of the six mutations, i.e., c.358C>A (p.Leu120Met), c.791T>G (p.Val264Gly), c.901C>T (p.Arg301Cys), c.902G>A (p.Arg301 His), c.1154T>G (p.Leu385Arg), and of the novel mutation c.329T>C (p.Phe110Ser), were examined via the analysis of DPAGT1 transcriptional profiles and GTP levels in patient-derived fibroblasts. In addition, the transient expression of different mutations was analysed in COS-7 cells. The results obtained, together with those of bioinformatic studies, revealed these mutations to affect the splicing process, the stability of GTP, or the ability of this protein to correctly localise in the ER membrane. The unfolded protein response (UPR; the response to ER stress) was found not to be active in patient-derived fibroblasts, unlike that seen in cells from patients with PMM2-CDG or DPM1-CDG. Even so, the fibroblasts of patients with DPAGT1-CDG seemed to be more sensitive to the stressor tunicamycin. The present work improves our knowledge of DPAGT1-CDG and provides bases for developing tailored splicing and folding therapies.	[Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, Madrid, Spain; [Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] CIBERER, Madrid, Spain; [Yuste-Checa, Patricia; Vega, Ana I.; Martin-Higueras, Cristina; Medrano, Celia; Gamez, Alejandra; Desviat, Lourdes R.; Ugarte, Magdalena; Perez-Cerda, Celia; Perez, Belen] Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz	Perez, B (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, Madrid, Spain.; Perez, B (corresponding author), CIBERER, Madrid, Spain.; Perez, B (corresponding author), Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain.	bperez@cbm.csic.es	Martin-Higueras, Cristina/AAU-3749-2020; Gamez, Alejandra/T-6898-2017; Medrano, Celia/ABF-8994-2021; DESVIAT, LOURDES R/L-3055-2013	Martin-Higueras, Cristina/0000-0003-1139-4642; Gamez, Alejandra/0000-0002-2414-2586; Medrano, Celia/0000-0001-9634-7874; DESVIAT, LOURDES R/0000-0003-0492-3323; Yuste Checa, Patricia/0000-0002-1056-3849	Fundacion Isabel Gemio [PI16/00573]	Fundacion Isabel Gemio	This work was funded by grant PI16/00573 (www.isciii.es/ISCIII/es) and Fundacion Isabel Gemio (www.fundacionsabelgemio.com).	Carrera IA, 2012, AM J MED GENET A, V158A, P2027, DOI 10.1002/ajmg.a.35472; Belaya K, 2012, ANN NY ACAD SCI, V1275, P29, DOI 10.1111/j.1749-6632.2012.06790.x; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Cline A, 2012, MOL BIOL CELL, V23, P4175, DOI 10.1091/mbc.E12-05-0411; Denny RA, 2013, BIOORG MED CHEM LETT, V23, P1935, DOI 10.1016/j.bmcl.2013.01.089; Dey I, 2016, J GENET SYNDR GENE T, V7; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Finlayson S, 2013, J NEUROL NEUROSUR PS, V84, P1119, DOI 10.1136/jnnp-2012-304716; Ganetzky R, 2015, AM J MED GENET A, V167, P2411, DOI 10.1002/ajmg.a.37184; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Garcia-Silva MT, 2004, J INHERIT METAB DIS, V27, P591, DOI 10.1023/B:BOLI.0000042984.42433.d8; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Houlden H, 2013, BRAIN, V136, P692, DOI 10.1093/brain/awt042; Imtiaz F, 2012, JIMD REP, V2, P107, DOI 10.1007/8904_2011_57; Jaeken J, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.146; Lecca MR, 2004, FASEB J, V18, P240, DOI 10.1096/fj.04-2397fje; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; MARQUARDT T, 1995, EUR J CELL BIOL, V66, P268; Muntau AC, 2014, J INHERIT METAB DIS, V37, P505, DOI 10.1007/s10545-014-9701-z; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Selcen D, 2014, NEUROLOGY, V82, P1822, DOI 10.1212/WNL.0000000000000435; Shang J, 2002, GLYCOBIOLOGY, V12, P307, DOI 10.1093/glycob/12.5.307; Sun LW, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-52; Wolfe LA, 2013, DEV DISABIL RES REV, V17, P211, DOI 10.1002/ddrr.1115; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Wurde AE, 2012, MOL GENET METAB, V105, P634, DOI 10.1016/j.ymgme.2012.01.001; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yuste-Checa P, 2015, HUM MUTAT, V36, P851, DOI 10.1002/humu.22817	30	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179456	10.1371/journal.pone.0179456	http://dx.doi.org/10.1371/journal.pone.0179456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662078	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300023
J	Smid, J; Kalousova, M; Mandak, B; Houska, J; Chladova, A; Pinedo, M; Lojka, B				Smid, Jans; Kalousova, Marie; Mandak, Bohumil; Houska, Jakub; Chladova, Anna; Pinedo, Mario; Lojka, Bohdan			Morphological and genetic diversity of camu-camu [Myrciaria dubia (Kunth) McVaugh] in the Peruvian Amazon	PLOS ONE			English	Article							HBK MCVAUGH; DIFFERENTIATION; MYRTACEAE; PROGRAM; FRUIT	Camu-camu [Myrciaria dubia (Kunth) McVaugh] is currently an important and promising fruit species grown in the Peruvian Amazon, as well as in Brazil, Colombia, and Bolivia. The species is valued for its high content of fruit-based vitamin C. Large plantations have been established only in the last two decades, and a substantial part of the production is still obtained by collecting fruits from the wild. Domestication of the species is at an early stage; most farmers cultivate the plants without any breeding, or only through a simple mass selection process. The main objective of the study was to characterize morphological and genetic variation within and among cultivated and natural populations of camu-camu in the Peruvian Amazon. In total, we sampled 13 populations: ten wild in the Iquitos region, and three cultivated in the Pucallpa region in the Peruvian Amazon. To assess the genetic diversity using seven microsatellite loci, we analyzed samples from ten individual trees per each population (n = 126). Morphological data was collected from five trees from each population (n = 65). The analysis did not reveal statistically significant differences for most of the morphological descriptors. For wild and cultivated populations, the observed heterozygosity was 0.347 and 0.404 (expected 0.516 and 0.506), and the fixation index was 0.328 and 0.200, respectively. Wild populations could be divided into two groups according to the UPGMA and STRUCTURE analysis. In cultivated populations, their approximate origin was determined. Our findings indicate a high genetic diversity among the populations, but also a high degree of inbreeding within the populations. This can be explained by either the isolation of these populations from each other or the low number of individuals in some populations. This high level of genetic diversity can be explored for the selection of superior individuals for further breeding.	[Smid, Jans; Kalousova, Marie; Chladova, Anna; Lojka, Bohdan] Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Kamycka 129, Prague, Czech Republic; [Mandak, Bohumil] Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Kamycka 129, Prague, Czech Republic; [Mandak, Bohumil; Houska, Jakub] Acad Sci Czech Republ, Inst Bot, Zamek 1, Pruhonice, Czech Republic; [Houska, Jakub] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic; [Pinedo, Mario] IIAP PROBOSQUES, Peruvian Amazon Res Inst, Av Abelardo Quinones, Iquitos, Peru	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Lojka, B (corresponding author), Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Kamycka 129, Prague, Czech Republic.	lojka@ftz.czu.cz	Houska, Jakub/K-4404-2012; Lojka, Bohdan/O-6131-2016; Kalousová, Marie/AAM-3253-2020	Houska, Jakub/0000-0003-2163-4486; Lojka, Bohdan/0000-0002-5059-1975; Chladova, Anna/0000-0001-8427-062X; Mandak, Bohumil/0000-0002-9545-7497; Kalousova, Marie/0000-0001-7078-4064	Internal Grant Agency of CULS Prague [20145005, 20175017]; National University of Ucayali, Peru; Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); Foundation of the Czech Literature Fund	Internal Grant Agency of CULS Prague; National University of Ucayali, Peru; Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); Foundation of the Czech Literature Fund	This study was funded by several research grants provided by The Internal Grant Agency of CULS Prague (No. 20145005, No. 20175017); The Scholarship of the National University of Ucayali, Peru; The Foundation Nadace Nadani Josefa, Mariea Zdenky Hlavkovych, Czech Republic (Foundation Grant); The Foundation of the Czech Literature Fund.	Andrade J. S., 1995, Acta Horticulturae, P177; [Anonymous], 2021, LANG ENV STAT COMP; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chirinos R, 2010, FOOD CHEM, V120, P1019, DOI 10.1016/j.foodchem.2009.11.041; Doyle J. J., 1987, PHYTOCHEM B, P11; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Franceschinelli EV, 2007, J TROP ECOL, V23, P361, DOI 10.1017/S0266467407004099; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hammer H. Q., 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Justi KC, 2000, ARCH LATINOAM NUTR, V50, P405; Khan Suphiya, 2010, Physiology and Molecular Biology of Plants, V16, P149, DOI 10.1007/s12298-010-0016-8; Koshikene D., 2009, THESIS; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Martin MP, 2014, ECON BOT, V68, P169, DOI 10.1007/s12231-014-9269-4; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Penn JW, 2008, FOCUS GEOGR, V51, P18, DOI DOI 10.1111/J.1949-8535.2008.TB00222.X; Peters C. M., 1990, Advances in Economic Botany, V8, P159; Pinedo M, 2004, PLAN MEJORAMIENTO GE; Pritchard JK, 2000, GENETICS, V155, P945; Rodrigues R. B., 2006, Ernahrung, V30, P376; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rojas S., 2011, Revista Corpoica - Ciencia y Tecnologia Agropecuarias, V12, P51; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sommano S, 2013, INT J FOOD PROP, V16, P1394, DOI 10.1080/10942912.2011.580485; Tchoundjeu P, 2007, INDIGENOUS FRUIT TRE; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams DJ, 2014, FOOD RES INT, V66, P100, DOI 10.1016/j.foodres.2014.09.003; ZAPATA SM, 1993, J SCI FOOD AGR, V61, P349, DOI 10.1002/jsfa.2740610310	33	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179886	10.1371/journal.pone.0179886	http://dx.doi.org/10.1371/journal.pone.0179886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658316	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900045
J	Sakowicz, A; Pietrucha, T; Rybak-Krzyszkowska, M; Huras, H; Gach, A; Sakowicz, B; Banaszczyk, M; Grzesiak, M; Biesiada, L				Sakowicz, Agata; Pietrucha, Tadeusz; Rybak-Krzyszkowska, Magda; Huras, Hubert; Gach, Agnieszka; Sakowicz, Bartosz; Banaszczyk, Mateusz; Grzesiak, Mariusz; Biesiada, Lidia			Double hit of NEMO gene in preeclampsia	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA STABILITY; REGULATORY RNA; TARGET GENES; EXPRESSION; MECHANISMS; REGIONS; CELLS; FETAL; GAMMA	The precise etiology of preeclampsia is unknown. Family studies indicate that both genetic and environmental factors influence its development. One of these factors is NFkB, whose activation depends on NEMO (NFkB essential modulator. This is the first study to investigate the association between the existence of single nucleotide variant of the NEMO gene and the appearance of preeclampsia. A total of 151 women (72 preeclamptic women and 79 controls) and their children were examined. Sanger sequencing was performed to identify variants in the NEMO gene in the preeclamptic mothers. The maternal identified variants were then sought in the studied groups of children, and in the maternal and child controls, using RFLP-PCR. Real-time RT-PCR was performed to assess NEMO gene expression in maternal blood, umbilical cord blood and placentas. The sequencing process indicated the existence of two different variants in the 3'UTR region of the NEMO gene of preeclamptic women (IKBKG: c.*368C > A and IKBKG: c.*402C > T). The simultaneous occurrence of the TT genotype in the mother and the TT genotype in the daughter or a T allele in the son increased the risk of preeclampsia development 2.59 fold. Additionally, we found that the configuration of maternal/fetal genotypes (maternal TT/daughter TT or maternal TT/son T) of IKBKG: c.*402C/T variant is associated with the level of NEMO gene expression. Our results showed that, the simultaneous occurrence of the maternal TT genotype (IKBKG: c.*402C > T variants) and TT genotype in the daughter or T allele in the son correlates with the level of NEMO gene expression and increases the risk of preeclampsia development. Our observations may offer a new insight into the genetic etiology and pathogenesis of preeclampsia.	[Sakowicz, Agata; Pietrucha, Tadeusz] Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland; [Rybak-Krzyszkowska, Magda; Huras, Hubert] Univ Hosp Krakow, Dept Obstet & Perinatol, Krakow, Poland; [Gach, Agnieszka] Polish Mothers Mem Hosp, Res Inst Lodz, Dept Genet, Lodz, Poland; [Sakowicz, Bartosz] Lodz Univ Technol, Dept Microelect & Comp Sci, Lodz, Poland; [Banaszczyk, Mateusz] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Grzesiak, Mariusz; Biesiada, Lidia] Polish Mothers Mem Hospital, Res Inst Lodz, Dept Obstet & Gynecol, Lodz, Poland	Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Lodz University of Technology; Medical University Lodz	Sakowicz, A (corresponding author), Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland.	agata.sakowicz@gmail.com	Rybak-Krzyszkowska, Magda/AAX-7848-2021; Sakowicz, Bartosz/Q-2809-2019; Huras, Hubert/U-3179-2018	Rybak-Krzyszkowska, Magda/0000-0002-6993-8078; Sakowicz, Bartosz/0000-0001-5153-2398; Sakowicz, Agata/0000-0002-5083-2046; Huras, Hubert/0000-0001-6661-6893; Grzesiak, Mariusz/0000-0002-6900-4347; Pietrucha, Tadeusz/0000-0002-0806-4899; Gach, Agnieszka/0000-0002-6590-5797	National Science Center (Poland) [DEC-2013/11/D/NZ5/01783]; National Science Center (NCN), Poland [DEC-2013/11/D/NZ5/01783]	National Science Center (Poland); National Science Center (NCN), Poland	This work was supported by grant DEC-2013/11/D/NZ5/01783 from the National Science Center (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant no. DEC-2013/11/D/NZ5/01783 funded by The National Science Center (NCN), Poland. We also thank all mothers who agreed to participate in this study.	Akdeli N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-87; Akehurst C, 2015, J HYPERTENS, V33, P2068, DOI 10.1097/HJH.0000000000000656; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo L, 2013, PLACENTA, V34, P599, DOI 10.1016/j.placenta.2013.04.007; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446; Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954; Kumar A, 2012, GENOMICS, V100, P352, DOI 10.1016/j.ygeno.2012.08.006; Kuntz TB, 2001, PEDIATR RES, V50, P743, DOI 10.1203/00006450-200112000-00019; Laivuori H, 2007, FRONT BIOSCI-LANDMRK, V12, P2372, DOI 10.2741/2239; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Maiti GP, 2015, BBA-MOL BASIS DIS, V1852, P1059, DOI 10.1016/j.bbadis.2015.02.009; Martinez-Varea A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/210241; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Mouillet JF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110049; Nemchenko A, 2010, CIRC RES, V106, P10, DOI 10.1161/CIRCRESAHA.109.211185; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Perez-Sepulveda A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00244; Rahardjo B, 2014, PREGNANCY HYPERTENS, V4, P187, DOI 10.1016/j.preghy.2014.03.001; Sakowicz A, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.002; Salgado SS, 2011, JCPSP-J COLL PHYSICI, V21, P482, DOI 08.2011/JCPSP.482486; Sankar KD, 2013, ANAT CELL BIOL, V46, P285, DOI 10.5115/acb.2013.46.4.285; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Wang J, 2014, INT J CLIN EXP MED, V7, P5303	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180065	10.1371/journal.pone.0180065	http://dx.doi.org/10.1371/journal.pone.0180065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654673	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500053
J	Abraham, PR; Pathak, N; Pradhan, G; Sumanlatha, G; Mukhopadhyay, S				Abraham, Philip Raj; Pathak, Niteen; Pradhan, Gourango; Sumanlatha, Gaddam; Mukhopadhyay, Sangita			The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients	PLOS ONE			English	Article							B-CELL RESPONSE; LOW-INCOME COUNTRIES; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; EXPRESSION; DIAGNOSIS; GENE; IDENTIFICATION; PATHOGENICITY; ANTIGENS	The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable Cterminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against NPPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein.	[Abraham, Philip Raj; Pathak, Niteen; Pradhan, Gourango; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Mol Cell Biol, Hyderabad, Andhra Pradesh, India; [Pradhan, Gourango] Manipal Univ, Grad Studies, Manipal, Karnataka, India; [Sumanlatha, Gaddam] Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Mol Cell Biol, Hyderabad, Andhra Pradesh, India.	sangita@cdfd.org.in		Pradhan, Gourango/0000-0002-4206-9634; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India [80/796/2013-ECD]; Department of Biotechnology, Government of India [BT/PR11605/NNT/28/758/2014, BT/PR12817/COE/34/23/2015]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	PRA was supported by the Research Associateship from the Indian Council of Medical Research, Government of India (80/796/2013-ECD). This work was supported by the Grants from Department of Biotechnology, Government of India (BT/PR11605/NNT/28/758/2014 and BT/PR12817/COE/34/23/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham PR, 2016, INFECT GENET EVOL, V40, P339, DOI 10.1016/j.meegid.2015.09.005; Abraham PR, 2014, INFECT GENET EVOL, V22, P244, DOI 10.1016/j.meegid.2013.06.023; Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Bonanni D, 2005, J MED MICROBIOL, V54, P443, DOI 10.1099/jmm.0.45960-0; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057517; Fol M, 2015, ACTA BIOCHIM POL, V62, P633, DOI 10.18388/abp.2015_1130; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Khalilullah SA, 2014, EGYPT J CHEST DIS TU, V63, P173, DOI 10.1016/j.ejcdt.2013.12.002; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Lv Z, 2017, BIOMED RES INT; Marchetti G, 1998, J CLIN MICROBIOL, V36, P1512, DOI 10.1128/JCM.36.6.1512-1517.1998; Monterrubio-Lopez GP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/483150; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686, DOI 10.1128/JCM.33.10.2686-2691.1995; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Muttucumaru D, 2002, TUBERCULOSIS EDINB, V84, P239; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Pfyffer GE, 2012, J CLIN MICROBIOL, V50, P4188, DOI 10.1128/JCM.02283-12; Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001; Raja A, 2004, INDIAN J MED RES, V120, P213; Rindi L, 2007, FEMS IMMUNOL MED MIC, V51, P381, DOI 10.1111/j.1574-695X.2007.00315.x; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Udgata A, 2016, J IMMUNOL, V197, P1776, DOI 10.4049/jimmunol.1501816; World Health Organization, GLOB TUB REP 2015; Xu JN, 2012, CLIN VACCINE IMMUNOL, V19, P536, DOI 10.1128/CVI.05708-11; Zhang Guoqiang, 2009, Genomics Proteomics & Bioinformatics, V7, P107, DOI 10.1016/S1672-0229(08)60039-X; Zhang HM, 2007, CLIN MICROBIOL INFEC, V13, P139, DOI 10.1111/j.1469-0691.2006.01561.x	43	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179965	10.1371/journal.pone.0179965	http://dx.doi.org/10.1371/journal.pone.0179965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651002	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300034
J	Singh, A; Sharma, AK; Singh, NK; Sharma, TR				Singh, Akshay; Sharma, Ajay Kumar; Singh, Nagendra Kumar; Sharma, Tilak Raj			PpTFDB: A pigeonpea transcription factor database for exploring functional genomics in legumes	PLOS ONE			English	Article								Pigeonpea (Cajanus cajan L.), a diploid legume crop, is a member of the tribe Phaseoleae. This tribe is descended from the millettioid (tropical) clade of the subfamily Papilionoideae, which includes many important legume crop species such as soybean (Glycine max), mung bean (Vigna radiata), cowpea (Vigna ungiculata), and common bean (Phaseolus vulgaris). It plays major role in food and nutritional security, being rich source of proteins, minerals and vitamins. We have developed a comprehensive Pigeonpea Transcription Factors Database (PpTFDB) that encompasses information about 1829 putative transcription factors (TFs) and their 55 TF families. PpTFDB provides a comprehensive information about each of the identified TFs that includes chromosomal location, protein physicochemical properties, sequence data, protein functional annotation, simple sequence repeats (SSRs) with primers derived from their motifs, orthology with related legume crops, and gene ontology (GO) assignment to respective TFs. (PpTFDB: http://14.139.229.199/PpTFDB/Home. aspx) is a freely available and user friendly web resource that facilitates users to retrieve the information of individual members of a TF family through a set of query interfaces including TF ID or protein functional annotation. In addition, users can also get the information by browsing interfaces, which include browsing by TF Categories and by, GO Categories. This PpTFDB will serve as a promising central resource for researchers as well as breeders who are working towards crop improvement of legume crops.	[Singh, Akshay; Singh, Nagendra Kumar; Sharma, Tilak Raj] Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Singh, Akshay] Dr APJ Abdul Kalam Tech Univ, Lucknow, Uttar Pradesh, India; [Sharma, Ajay Kumar] Meerut Inst Engn & Technol, Meerut, Uttar Pradesh, India; [Sharma, Tilak Raj] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Meerut Institute of Engineering & Technology; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sharma, TR (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.; Sharma, TR (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	trsharma@nabi.res.in	Sharma, Ajay Kumar/HHC-1334-2022; Singh, Nouratan/N-9377-2017; Singh, Akshay/AAZ-8886-2020	Singh, Nouratan/0000-0002-8063-8375; Singh, Akshay/0000-0001-7599-6699	Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) [2049-3004]	Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC)	This work was carried out under the Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) project code (2049-3004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out under the Indian Council of Agricultural Research-Network Project on Transgenics in Crops (ICAR-NPTC) project code (2049-3004).	Agarwal G., 2016, PLANT BIOTECHNOL J, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Bhawna Bonthala VS, 2016, DATABASE OXFORD; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dash S, 2016, NUCLEIC ACIDS RES, V44, pD1181, DOI 10.1093/nar/gkv1159; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Garg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088947; Huaiyu M, 2015, NUCLEIC ACIDS RES, V44, pD336; Jinpu J, 2016, NUCL ACIDS RES; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Maibam A., 2015, MOL PLANT BREED, V6, P1; Malviya N, 2015, MOL BIOL REP, V42, P535, DOI 10.1007/s11033-014-3797-y; Priyanka B, 2010, MOL GENET GENOMICS, V283, P273, DOI 10.1007/s00438-010-0516-9; Qiao ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00034; Rathi D, 2016, PROTEOMICS, V16, P310, DOI 10.1002/pmic.201500257; Satheesh V, 2014, MOL BIOL REP, V41, P7763, DOI 10.1007/s11033-014-3669-5; Seo E, 2015, BRIEF FUNCT GENOMICS, V14, P260, DOI 10.1093/bfgp/elv011; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Sirhindi G, 2016, J PLANT BIOCHEM BIOT, V25, P301, DOI 10.1007/s13562-015-0342-6; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Yanagisawa S, 1998, J PLANT RES, V111, P363, DOI 10.1007/BF02507800; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179736	10.1371/journal.pone.0179736	http://dx.doi.org/10.1371/journal.pone.0179736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651001	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300017
J	Pennino, MG; Arcangeli, A; Fonseca, VP; Campana, I; Pierce, GJ; Rotta, A; Bellido, JM				Grazia Pennino, Maria; Arcangeli, Antonella; Prado Fonseca, Vinicius; Campana, Ilaria; Pierce, Graham J.; Rotta, Andrea; Maria Bellido, Jose			A spatially explicit risk assessment approach: Cetaceans and marine traffic in the Pelagos Sanctuary (Mediterranean Sea)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; FIN WHALES; HABITAT; ARCHIPELAGO; MODELS; HARBOR; SHIPS	Spatially explicit risk assessment is an essential component of Marine Spatial Planning (MSP), which provides a comprehensive framework for managing multiple uses of the marine environment, minimizing environmental impacts and conflicts among users. In this study, we assessed the risk of the exposure to high intensity vessel traffic areas for the three most abundant cetacean species (Stenella coeruleoalba, Tursiops truncatus and Balaenoptera physalus) in the southern area of the Pelagos Sanctuary, which is the only pelagic Marine Protected Area (MPA) for marine mammals in the Mediterranean Sea. In particular, we modeled the occurrence of the three cetacean species as a function of habitat variables in June by using hierarchical Bayesian spatial-temporal models. Similarly, we modelled the marine traffic intensity in order to find high risk areas and estimated the potential conflict due to the overlap with the cetacean home ranges. Results identified two main hot-spots of high intensity marine traffic in the area, which partially overlap with the area of presence of the studied species. Our findings emphasize the need for nationally relevant and transboundary planning and management measures for these marine species.	[Grazia Pennino, Maria; Prado Fonseca, Vinicius; Maria Bellido, Jose] Univ Valencia, Dept Estadist & Invest Operat, Stat Modeling Ecol Grp, Valencia, Spain; [Grazia Pennino, Maria; Maria Bellido, Jose] Ctr Oceanog Murcia, Inst Espanol Oceanog, Murcia, Spain; [Arcangeli, Antonella] ISPRA Dept Nat Conservat, Rome, Italy; [Prado Fonseca, Vinicius] Univ Fed Rio Grande do Norte, Dept Ecol, Natal, RN, Brazil; [Campana, Ilaria] Tuscia Univ, Ichthyogen Expt Marine Ctr CISMAR, Dept Ecol & Biol Sci, Viterbo, Italy; [Campana, Ilaria] Accademia Leviatano, Rome, Italy; [Pierce, Graham J.] Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Rotta, Andrea] Univ Sassari, Dipartimento Med Vet, Sassari, Italy	University of Valencia; Spanish Institute of Oceanography; Italian Institute for Environmental Protection & Research (ISPRA); Universidade Federal do Rio Grande do Norte; Tuscia University; University of Aberdeen; Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Sassari	Pennino, MG (corresponding author), Univ Valencia, Dept Estadist & Invest Operat, Stat Modeling Ecol Grp, Valencia, Spain.; Pennino, MG (corresponding author), Ctr Oceanog Murcia, Inst Espanol Oceanog, Murcia, Spain.	grazia.pennino@mu.ieo.es	Grazia, Maria/E-3454-2015; Pierce, Graham/A-5404-2018; Bellido-Millán, J.M./ABG-5128-2020; Arcangeli, Antonella/I-1209-2019	Grazia, Maria/0000-0002-7577-2617; Pierce, Graham/0000-0002-4744-4501; Bellido-Millán, J.M./0000-0002-6887-4391; Arcangeli, Antonella/0000-0003-2156-9987; CAMPANA, ILARIA/0000-0003-0801-0927; Rotta, Alexandre/0000-0002-4406-2276	"Banco di Sardegna" Foundation [BAN6077]	"Banco di Sardegna" Foundation(Fondazione Banco di Sardegna)	This work was supported by the "Banco di Sardegna" Foundation (BAN6077). The funder had no role instudy design, data collection and analysis, decision to publish, o rpreparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], PROT SPEC PROT AR BI; Arcangeli A., 2014, SCI REP PORT CROS NA, V28, P37, DOI DOI 10.1111/MAEC.12272; Arcangeli A, 2016, MAR ECOL-EVOL PERSP, V37, P269, DOI 10.1111/maec.12272; Buckland S.T., 2001, pi; Campana I, 2017, MAR POLLUT BULL, V115, P282, DOI 10.1016/j.marpolbul.2016.12.008; Campana I, 2015, MAR ENVIRON RES, V109, P1, DOI 10.1016/j.marenvres.2015.05.009; Coomber FG, 2016, MAR POLICY, V69, P102, DOI 10.1016/j.marpol.2016.04.013; Cribb N., 2015, OPEN J MAR SCI, V5, P335, DOI [10.4236/ojms.2015.53028, DOI 10.4236/OJMS.2015.53028]; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; EC, MOT SEA IMPL ART 12A; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Freeman E., 2012, PACKAGE PRESENCEABSE; Grech A, 2011, MAR POLICY, V35, P560, DOI 10.1016/j.marpol.2011.03.003; Hijmans R.J., 2015, CIRCLES, V9, P1; HIJMANS RJ, 2015, GEOGRAPHIC DATA ANAL; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; ISPRA (Italian Institute for Environmental Research and Protection), 2012, FIX LIN TRANS US FER; Kahru M., 2010, WINDOW IMAGE MANAGER; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Olesiuk PF, 2002, MAR MAMMAL SCI, V18, P843, DOI 10.1111/j.1748-7692.2002.tb01077.x; Panigada S, 2015, REMOTESENS ENV, V112, P3400; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; Pennino M. G., 2016, HYDROBIOLOGIA, P1; Pennino MG, 2015, HYDROBIOLOGIA, V747, P69, DOI 10.1007/s10750-014-2127-7; Pennino MG, 2016, DEEP SEA 2 IN PRESS; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; R Development Core Team, 2016, R LANG ENV STAT COMP; Rako N, 2013, MAR POLLUT BULL, V68, P77, DOI 10.1016/j.marpolbul.2012.12.019; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sini MI, 2005, J MAR BIOL ASSOC UK, V85, P1547, DOI 10.1017/S0025315405012774; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Vaes, 2013, MAPPING POTENTIAL RI, DOI 10.2788/8520; VIEILLEDENT G, 2014, HSDM HIERARCHICAL BA; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	44	30	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179686	10.1371/journal.pone.0179686	http://dx.doi.org/10.1371/journal.pone.0179686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644882	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100034
J	Taylor, O; Van Laeken, N; Polis, I; Dockx, R; Vlerick, L; Dobbeleir, A; Goethals, I; Saunders, J; Sadones, N; Baeken, C; De Vos, F; Peremans, K				Taylor, Olivia; Van Laeken, Nick; Polis, Ingeborgh; Dockx, Robrecht; Vlerick, Lise; Dobbeleir, Andre; Goethals, Ingeborg; Saunders, Jimmy; Sadones, Nele; Baeken, Chris; De Vos, Filip; Peremans, Kathelijne			Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [C-11] DASB	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SEROTONIN TRANSPORTER; CITALOPRAM	Although the favourable characteristics of escitalopram as being the most selective serotonin reuptake inhibitor and having an increased therapeutic efficacy via binding on an additional allosteric binding site of the serotonin transporter, its dosing regimen has not yet been optimized for its use in dogs. This study aimed to estimate the optimal dosing frequency and the required dose for achieving 80% occupancy of the serotonin transporters in the basal ganglia. The dosing frequency was investigated by determining the elimination half-life after a four day oral pre-treatment period with 0.83 mg/kg escitalopram (3 administrations/day) and a subsequent i. v. injection 0.83 mg/ kg. Blood samples were taken up to 12 hours after i. v. injection and the concentration of escitalopram in plasma was analysed via LC-MSMS. The dose-occupancy relationship was then determined by performing two PET scans in five adult beagles: a baseline PET scan and a second scan after steady state conditions were achieved following oral treatment with a specific dose of escitalopram ranging from 0.5 to 2.5 mg/kg/day. As the elimination half-life was determined to be 6.7 hours a dosing frequency of three administrations a day was proposed for the second part of the study. Further it was opted for a treatment period of four days, which well exceeded the minimum period to achieve steady state conditions. The optimal dosing regimen to achieve 80% occupancy in the basal ganglia and elicit a therapeutic effect, was calculated to be 1.85 mg/kg/day, divided over three administrations. Under several circumstances, such as insufficient response to other SSRIs, concurrent drug intake or in research studies focused on SERT, the use of escitalopram can be preferred over the use of the already for veterinary use registered fluoxetine, however, in case of long-term treatment with escitalopram, regularly cardiac screening is recommended.	[Taylor, Olivia; Polis, Ingeborgh; Dockx, Robrecht; Vlerick, Lise; Saunders, Jimmy; Peremans, Kathelijne] Univ Ghent, Dept Vet Med, Ghent, Belgium; [Van Laeken, Nick; De Vos, Filip] Univ Ghent, Lab Radiopharm, Ghent, Belgium; [Dockx, Robrecht; Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Ghent, Belgium; [Dobbeleir, Andre; Goethals, Ingeborg] Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium; [Sadones, Nele] Univ Ghent, Toxicol Lab, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University	Van Laeken, N (corresponding author), Univ Ghent, Lab Radiopharm, Ghent, Belgium.	nick.vanlaeken@ugent.be	Baeken, Chris/D-6790-2013					Andree B, 2000, NUCL MED BIOL, V27, P515, DOI 10.1016/S0969-8051(00)00121-9; Baldinger P, 2014, NEUROIMAGE, V88, P252, DOI 10.1016/j.neuroimage.2013.10.002; Brmstrup C, 2004, INT J PSYCHIAT CL S1, V8, P11; Dua-Sharma S., 1970, CANINE BRAIN STEREOT; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Le Bloc'h Y, 2003, THER DRUG MONIT, V25, P600, DOI 10.1097/00007691-200310000-00010; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; Marken Patricia A., 2000, Prim Care Companion J Clin Psychiatry, V2, P205; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; NIGROVIC V, 1993, BRIT J ANAESTH, V71, P908, DOI 10.1093/bja/71.6.908; OVERO KF, 1982, PROG NEURO-PSYCHOPH, V6, P297, DOI 10.1016/S0278-5846(82)80180-2; Passchier J, 2002, METHODS, V27, P278, DOI 10.1016/S1046-2023(02)00084-1; Rao N, 2007, CLIN PHARMACOKINET, V46, P281, DOI 10.2165/00003088-200746040-00002; Sanchez C, 2014, INT CLIN PSYCHOPHARM, V29, P185, DOI 10.1097/YIC.0000000000000023; Taylor O, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0622-3; Toutain PL, 2010, HANDB EXP PHARMACOL, V199, P19, DOI 10.1007/978-3-642-10324-7_2; Van Laeken N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148943; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Waade RB, 2014, EUR J CLIN PHARMACOL, V70, P933, DOI 10.1007/s00228-014-1696-8; Wilson AA, 2002, NUCL MED BIOL, V29, P509, DOI 10.1016/S0969-8051(02)00316-5	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179927	10.1371/journal.pone.0179927	http://dx.doi.org/10.1371/journal.pone.0179927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644875	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100051
J	Qian, ZM; Chen, YQ				Qian, Zhi-Ming; Chen, Yan Qiu			Feature point based 3D tracking of multiple fish from multi-view images	PLOS ONE			English	Article							ZEBRAFISH; KINEMATICS; BEHAVIOR	A feature point based method is proposed for tracking multiple fish in 3D space. First, a simplified representation of the object is realized through construction of two feature point models based on its appearance characteristics. After feature points are classified into occluded and non-occluded types, matching and association are performed, respectively. Finally, the object's motion trajectory in 3D space is obtained through integrating multi-view tracking results. Experimental results show that the proposed method can simultaneously track 3D motion trajectories for up to 10 fish accurately and robustly.	[Qian, Zhi-Ming; Chen, Yan Qiu] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Sch Comp Sci, Shanghai, Peoples R China; [Qian, Zhi-Ming] Chuxiong Normal Univ, Chuxiong, Peoples R China	Fudan University; Chuxiong Normal University	Chen, YQ (corresponding author), Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Sch Comp Sci, Shanghai, Peoples R China.	chenyq@fudan.edu.cn			National Natural Science Foundation of China [61175036, 61363023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work presented in this paper is supported by National Natural Science Foundation of China (Grant No. 61175036 to YQC and No. 61363023 to ZMQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; Chuang MC, 2015, IEEE T CIRC SYST VID, V25, P167, DOI 10.1109/TCSVT.2014.2357093; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Ebert D., 2002, P S DATA VISUALISATI, P251; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Maaswinkel H, 2013, JOVE-J VIS EXP, DOI 10.3791/50681; Mao JF, 2016, NEUROCOMPUTING, V214, P61, DOI 10.1016/j.neucom.2016.05.067; Martineau PR, 2013, METHODS, V62, P292, DOI 10.1016/j.ymeth.2013.05.002; Mendelson L, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-015-2003-x; Nimkerdphol K, 2008, J BIOSCI BIOENG, V105, P486, DOI 10.1263/jbb.105.486; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Qian ZM, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1138-y; Stewart AM, 2015, J NEUROSCI METH, V255, P66, DOI 10.1016/j.jneumeth.2015.07.023; Voesenek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146682; Wang SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154714; Wu B, 2007, INT J COMPUT VISION, V75, P247, DOI 10.1007/s11263-006-0027-7; Wu GH, 2010, J BIONIC ENG, V7, P49, DOI 10.1016/S1672-6529(09)60190-6; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zhiping X, 2017, SCI REPORTS, P7; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023	23	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180254	10.1371/journal.pone.0180254	http://dx.doi.org/10.1371/journal.pone.0180254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665966	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608700078
J	Hari, P; Aakala, T; Hilasvuori, E; Hakkinen, R; Korhola, A; Korpela, M; Linkosalo, T; Makinen, H; Nikinmaa, E; Nojd, P; Seppa, H; Sulkava, M; Terhivuo, J; Tuomenvirta, H; Weckstrom, J; Hollmen, J				Hari, Pertti; Aakala, Tuomas; Hilasvuori, Emmi; Hakkinen, Risto; Korhola, Atte; Korpela, Mikko; Linkosalo, Tapio; Makinen, Harri; Nikinmaa, Eero; Nojd, Pekka; Seppa, Heikki; Sulkava, Mika; Terhivuo, Juhani; Tuomenvirta, Heikki; Weckstrom, Jan; Hollmen, Jaakko			Reliability of temperature signal in various climate indicators from northern Europe	PLOS ONE			English	Article							STABLE CARBON ISOTOPES; RING-WIDTH; SUMMER SUNSHINE; TREE-RINGS; ICE-COVER; LAKE; RECONSTRUCTION; DROUGHT; RECORDS; DENSITY	We collected relevant observational and measured annual-resolution time series dealing with climate in northern Europe, focusing in Finland. We analysed these series for the reliability of their temperature signal at annual and seasonal resolutions. Importantly, we analysed all of the indicators within the same statistical framework, which allows for their meaningful comparison. In this framework, we employed a cross-validation procedure designed to reduce the adverse effects of estimation bias that may inflate the reliability of various temperature indicators, especially when several indicators are used in a multiple regression model. In our data sets, timing of phenological observations and ice break-up were connected with spring, tree ring characteristics (width, density, carbon isotopic composition) with summer and ice formation with autumn temperatures. Baltic Sea ice extent and the duration of ice cover in different watercourses were good indicators of winter temperatures. Using combinations of various temperature indicator series resulted in reliable temperature signals for each of the four seasons, as well as a reliable annual temperature signal. The results hence demonstrated that we can obtain reliable temperature information over different seasons, using a careful selection of indicators, combining the results with regression analysis, and by determining the reliability of the obtained indicator.	[Hari, Pertti; Aakala, Tuomas; Nikinmaa, Eero] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Hilasvuori, Emmi] Univ Helsinki, Finnish Museum Nat Hist, Lab Chronol, Helsinki, Finland; [Hakkinen, Risto; Linkosalo, Tapio] Nat Resources Inst Finland Luke, Helsinki, Finland; [Korhola, Atte; Weckstrom, Jan] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Korpela, Mikko; Hollmen, Jaakko] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Korpela, Mikko; Seppa, Heikki] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Makinen, Harri; Nojd, Pekka] Nat Resources Inst Finland Luke, Helsinki, Finland; [Sulkava, Mika] Nat Resources Inst Finland Luke, Stat Serv, Helsinki, Finland; [Terhivuo, Juhani] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Tuomenvirta, Heikki] Finnish Meteorol Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke); University of Helsinki; Aalto University; University of Helsinki; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Helsinki; Finnish Meteorological Institute	Aakala, T (corresponding author), Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	tuomas.aakala@helsinki.fi	Mäkinen, Harri/C-9817-2015; Aakala, Tuomas/AAA-2574-2020; Weckstrom, Jan/N-7665-2013	Mäkinen, Harri/0000-0002-1820-6264; Aakala, Tuomas/0000-0003-0160-6410; Korhola, Atte A./0000-0003-2577-6502; Weckstrom, Jan/0000-0001-5604-617X; Seppa, Heikki/0000-0003-2494-7955	Academy of Finland [276255, 257641, 265504]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (www.aka.fi; proj. no 276255 for TA, and 257641 and 265504 for HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, GEOPHYSICA; [Anonymous], 2011, SWIPA SNOW WATER ICE; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Battarbee RW, 2005, FRESHWATER BIOL, V50, P1772, DOI 10.1111/j.1365-2427.2005.01427.x; Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028; Bjorklund JA, 2014, CLIM PAST, V10, P877, DOI 10.5194/cp-10-877-2014; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Christiansen B, 2017, REV GEOPHYS, V55, P40, DOI 10.1002/2016RG000521; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cook E.R., 1990, METHODS DENDROCHRONO, P97, DOI [10.2307/1551446, DOI 10.1007/978-94-015-7879-0_3, 10.1007/978-94-015-7879-0_3]; Cook ER, 2004, QUATERNARY SCI REV, V23, P2063, DOI 10.1016/j.quascirev.2004.08.013; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; DARRIGO RD, 1992, CAN J FOREST RES, V22, P1290, DOI 10.1139/x92-171; De Jong R, 2011, J QUATERNARY SCI, V26, P268, DOI 10.1002/jqs.1451; Douglas Marianne S.V., 1999, P227; Drew DM, 2013, TREE PHYSIOL, V33, P37, DOI 10.1093/treephys/tps111; Duda R.O., 2000, PATTERN CLASSIFICATI; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Esper J, 2014, J QUATERNARY SCI, V29, P487, DOI 10.1002/jqs.2726; Fang X, 1998, COLD REG SCI TECHNOL, V27, P119, DOI 10.1016/S0165-232X(97)00027-X; Gagen M, 2011, DEV PALEOENVIRON RES, V11, P147, DOI 10.1007/978-1-4020-5725-0_6; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Gebre S, 2014, CRYOSPHERE, V8, P1589, DOI 10.5194/tc-8-1589-2014; Grudd H, 2002, HOLOCENE, V12, P657, DOI 10.1191/0959683602hl578rp; Gurskaya M, 2012, DENDROCHRONOLOGIA, V30, P302, DOI 10.1016/j.dendro.2012.04.002; Hafner P, 2014, CLIM DYNAM, V43, P971, DOI 10.1007/s00382-013-1864-z; Hafner P, 2011, TREES-STRUCT FUNCT, V25, P1141, DOI 10.1007/s00468-011-0589-z; HAKKINEN R, 1995, TREE PHYSL, V15; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; Haykins S., 1999, NEURAL NETWORKS COMP; Hegerl GC, 2007, J CLIMATE, V20, P650, DOI 10.1175/JCLI4011.1; Helama S, 2017, HOLOCENE, V27, P172, DOI 10.1177/0959683616652709; Helama S, 2009, J QUATERNARY SCI, V24, P450, DOI 10.1002/jqs.1291; Helama S, 2009, GEOLOGY, V37, P175, DOI 10.1130/G25329A.1; Hilasvuori E, 2009, J QUATERNARY SCI, V24, P469, DOI 10.1002/jqs.1260; Holopainen J, 2013, INT J BIOMETEOROL, V57, P423, DOI 10.1007/s00484-012-0568-0; Holtta T, 2010, TREE PHYSIOL, V30, P1235, DOI 10.1093/treephys/tpq068; Hommel R, 2016, PLANT BIOLOGY, V18, P785, DOI 10.1111/plb.12461; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jensen AM, 2015, ANN BOT-LONDON, V116, P821, DOI 10.1093/aob/mcv115; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jylha K, 2008, CLIMATIC CHANGE, V86, P441, DOI 10.1007/s10584-007-9310-z; Klein T, 2015, NEW PHYTOL, V205, P147, DOI 10.1111/nph.12993; Kuusisto E, 2001, INT VER THEOR ANGEW, V27, P2761; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Latifovic R, 2007, REMOTE SENS ENVIRON, V106, P492, DOI 10.1016/j.rse.2006.09.015; Leijonhufvud L, 2008, HOLOCENE, V18, P333, DOI 10.1177/0959683607086770; Leijonhufvud L, 2010, CLIMATIC CHANGE, V101, P109, DOI 10.1007/s10584-009-9650-y; Leuenberger M, 2007, TERR ECOL SER, V1, P211; Li B, 2010, J AM STAT ASSOC, V105, P883, DOI 10.1198/jasa.2010.ap09379; Linkosalo T, 2008, TREE PHYSIOL, V28, P1873, DOI 10.1093/treephys/28.12.1873; Loader NJ, 2013, QUATERNARY SCI REV, V62, P97, DOI 10.1016/j.quascirev.2012.11.014; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Luomaranta A, 2014, TELLUS A, V66, DOI 10.3402/tellusa.v66.22617; McCarroll D, 2013, HOLOCENE; Mccarroll D, 2011, J QUATERNARY SCI, V26, P7, DOI 10.1002/jqs.1408; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Olano JM, 2013, NEW PHYTOL, V198, P486, DOI 10.1111/nph.12113; National Research Council, 2007, SURF TEMP REC LAST 2; Oiva Database, 2008, OIVA ENV GEOGR INF S; Omstedt A, 2001, J GEOPHYS RES-OCEANS, V106, P4493, DOI 10.1029/1999JC000173; PALECKI MA, 1986, J CLIM APPL METEOROL, V25, P893, DOI 10.1175/1520-0450(1986)025<0893:FUABUO>2.0.CO;2; Pla-Rabes S, 2011, J PALEOLIMNOL, V46, P139, DOI 10.1007/s10933-011-9529-6; Prowse T, 2011, AMBIO, V40, P53, DOI 10.1007/s13280-011-0216-7; Prowse T, 2011, AMBIO, V40, P46, DOI 10.1007/s13280-011-0214-9; ROBERTSON DM, 1992, CLIMATIC CHANGE, V21, P407, DOI 10.1007/BF00141379; Robertson I, 1997, GEOPHYS RES LETT, V24, P1487, DOI 10.1029/97GL01293; Sarvas R., 1974, COMMUNICATIONES I FO, V84, P1; Sarvas R., 1972, COMMUN I FOREST FENN, V76, P1; Schneider L, 2014, OIKOS, V123, P559, DOI 10.1111/j.1600-0706.2013.00836.x; Seina A, 1996, MERI, V27, P79; Stove B, 2012, J CLIMATE, V25, P7173, DOI 10.1175/JCLI-D-11-00632.1; Sulkava M, 2006, ECOL MODEL, V191, P118, DOI 10.1016/j.ecolmodel.2005.08.016; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; Thompson R, 2005, ARCT ANTARC ALP RES, V37; Tingley MP, 2013, NATURE, V496, P201, DOI 10.1038/nature11969; Tinz B, 1996, GEOPHYSICA, V32, P319; Tomkins JD, 2009, J PALEOLIMNOL, V41, P225, DOI 10.1007/s10933-008-9255-x; Tuovinen Mervi, 2005, Dendrochronologia, V22, P83, DOI 10.1016/j.dendro.2005.02.001; Vaganov E.A., 2006, ECOL STU AN, V183, DOI 10.1007/3-540-31298-6_6; Vihma T, 2009, PROG OCEANOGR, V80, P129, DOI 10.1016/j.pocean.2009.02.002; Walsh J., 2005, ARCTIC CLIMATE IMPAC, P183; Weckstrom J, 2014, GEOPHYS RES LETT, V41, P2026, DOI 10.1002/2014GL059474; Wilson R, 2016, QUATERNARY SCI REV, V134, P1, DOI 10.1016/j.quascirev.2015.12.005; Wynne RH, 1998, PHOTOGRAMM ENG REM S, V64, P607	89	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180042	10.1371/journal.pone.0180042	http://dx.doi.org/10.1371/journal.pone.0180042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662166	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300092
J	Goncharova, K; Lozinska, L; Sureda, EA; Wolinski, J; Westrom, B; Pierzynowski, S				Goncharova, Kateryna; Lozinska, Liudmyla; Sureda, Ester Arevalo; Wolinski, Jaroslaw; Westrom, Bjorn; Pierzynowski, Stefan			Importance of neonatal immunoglobulin transfer for hippocampal development and behaviour in the newborn pig	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PRETERM BIRTH; CEREBROSPINAL-FLUID; BRAIN CONNECTIVITY; GROWTH RESTRICTION; SPINE APPARATUS; SYNAPTOPODIN; EXPRESSION; RECOGNITION; COLOSTRUM	Neurological disorders are among the main clinical problems affecting preterm children and often result in the development of communication and learning disabilities later in life. Several factors are of importance for brain development, however the role of immunoglobulins (passive immunity transfer) has not yet been investigated. Piglets are born agammaglobulinemic, as a result of the lack of transfer of maternal immunoglobulins in utero, thus, they serve as an ideal model to mimic the condition of immunoglobulin deficiency in preterm infants. Thirty six, unsuckled newborn piglets were fed an infant formula or colostrum and supplemented orally or intravenously with either species-specific or foreign immunoglobulin and then compared to both newborn and sow-reared piglets. Two days after the piglets were born behavioural tests (novel recognition and olfactory discrimination of conspecifics scent) were performed, after which the piglets were sacrificed and blood, cerebrospinal fluid and hippocampi samples were collected for analyses. Both parameters of neuronal plasticity (neuronal maturation and synapse-associated proteins) and behavioural test parameters appeared to be improved by the appearance of species-specific porcine immunoglulin in the circulation and cerebrospinal fluid of the piglets. In conclusion, we postulate possible positive clinical effects following intravenous infusion of human immunoglobulin in terms of neuronal plasticity and cognitive function in preterm infants born with low blood immunoglobulin levels.	[Goncharova, Kateryna; Lozinska, Liudmyla; Sureda, Ester Arevalo; Westrom, Bjorn; Pierzynowski, Stefan] Lund Univ, Dept Biol, Lund, Sweden; [Goncharova, Kateryna; Lozinska, Liudmyla; Pierzynowski, Stefan] R&D Anara AB, Trelleborg, Sweden; [Goncharova, Kateryna; Wolinski, Jaroslaw] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland; [Pierzynowski, Stefan] Inst Rural Hlth, Dept Med Biol, Lublin, Poland	Lund University; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Institute of Rural Health in Lublin, Poland	Goncharova, K (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Goncharova, K (corresponding author), R&D Anara AB, Trelleborg, Sweden.; Goncharova, K (corresponding author), Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Anim Physiol, Jablonna, Poland.	Katerina.Goncharova@biol.lu.se	Woliński, Jarosław/AAH-3109-2021; Sureda, Ester Arévalo/AAN-2171-2020; Arevalo Sureda, Ester/GPF-8594-2022; Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Weström, Björn R/N-2232-2016	Woliński, Jarosław/0000-0001-8645-1045; Sureda, Ester Arévalo/0000-0002-3299-1510; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Weström, Björn R/0000-0001-9296-2845; Pierzynowska, Kateryna/0000-0002-3290-339X	Royal Physiographic Society of Lund; COST Action [FM401]; Anara AB, Sweden	Royal Physiographic Society of Lund; COST Action(European Cooperation in Science and Technology (COST)); Anara AB, Sweden	The study was funded by The Royal Physiographic Society of Lund (http://www.fysiografen.se) and COST Action FM401 (http://www.cost.eu/COST_Actions/fa/FA1401). Anara AB, Sweden provided support in the form of salaries for authors KG, LL and SGP. All the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bayry J, 2003, TRANSFUS CLIN BIOL, V10, P165, DOI 10.1016/S1246-7820(03)00035-1; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Botton PH, 2010, BEHAV BRAIN RES, V214, P254, DOI 10.1016/j.bbr.2010.05.034; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dachet F, 2015, BRAIN, V138, P356, DOI 10.1093/brain/awu350; Dehmelt L, 2005, GENOME BIOL, V6; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Di Rosa R, 2014, EUR J INTERN MED, V25, P511, DOI 10.1016/j.ejim.2014.05.002; Eastwood SL, 2006, HIPPOCAMPUS, V16, P645, DOI 10.1002/hipo.20194; EASTWOOD SL, 1994, NEUROSCIENCE, V59, P881, DOI 10.1016/0306-4522(94)90292-5; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ERZURUMLU RS, 1990, J COMP NEUROL, V292, P443, DOI 10.1002/cne.902920310; FAHEY JL, 1965, J IMMUNOL, V94, P84; Fischi-Gomez E, 2015, CEREB CORTEX, V25, P2793, DOI 10.1093/cercor/bhu073; Foulder-Hughes LA, 2003, DEV MED CHILD NEUROL, V45, P97, DOI 10.1017/S0012162203000197; Gardiner J, 2011, SYNAPSE, V65, P249, DOI 10.1002/syn.20841; Grodzki AC, 2010, METHODS MOL BIOL, V588, P15, DOI 10.1007/978-1-59745-324-0_3; Grujic D, 2017, J BIOL REGUL HOMEOST, V31, P87; Harada E, 2002, J VET MED A, V49, P358, DOI 10.1046/j.1439-0442.2002.00457.x; Heegaard PM, 2016, SCI REP, V6, P36816; Held S, 2000, ANIM BEHAV, V59, P569, DOI 10.1006/anbe.1999.1322; HIRAYAMA H, 1986, INT J CLIN PHARM TH, V24, P109; Kornum BR, 2007, BEHAV BRAIN RES, V181, P210, DOI 10.1016/j.bbr.2007.04.007; Kristensen HH, 2001, APPL ANIM BEHAV SCI, V72, P321, DOI 10.1016/S0168-1591(00)00209-4; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunemann JD, 2016, NEUROTHERAPEUTICS, V13, P34, DOI 10.1007/s13311-015-0391-5; Modanlou HD, 1996, CAN J PHYSIOL PHARM, V74, P368, DOI 10.1139/cjpp-74-4-368; Neve RL, 1998, J NEUROSCI, V18, P7757; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Ohlsson A., 2013, COCHRANE DB SYST REV, V7; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Oygucu SE, 2014, INT IMMUNOPHARMACOL, V21, P51, DOI 10.1016/j.intimp.2014.04.002; Ozdemir SA, 2016, J MATERN-FETAL NEO M, V29, P972, DOI 10.3109/14767058.2015.1027680; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Pammi M, 2015, EXPERT REV ANTI-INFE, V13, P487, DOI 10.1586/14787210.2015.1008450; Pandit AS, 2014, CEREB CORTEX, V24, P2324, DOI 10.1093/cercor/bht086; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pierzynowski S, 2014, INT J DEV NEUROSCI, V35, P64, DOI 10.1016/j.ijdevneu.2014.03.003; Piorkowska K, 2014, DEV NEUROSCI-BASEL, V36, P465, DOI 10.1159/000363696; Relkin N, 2014, CLIN EXP IMMUNOL, V178, P27, DOI 10.1111/cei.12500; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Shen RL, 2015, AM J PHYSIOL-GASTR L, V309, pG310, DOI 10.1152/ajpgi.00163.2015; Sretavan DW, 1998, J NEUROSCI, V18, P10502; Sutton PS, 2013, J TROP PEDIATRICS, V59, P258, DOI 10.1093/tropej/fmt012; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Villani F, 2002, NEUROL SCI, V23, pS33, DOI 10.1007/s100720200013; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	57	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180002	10.1371/journal.pone.0180002	http://dx.doi.org/10.1371/journal.pone.0180002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658291	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900051
J	Sukenik, N; Iluz, D; Amar, Z; Varvak, A; Workman, V; Shamir, O; Ben-Yosef, E				Sukenik, Naama; Iluz, David; Amar, Zohar; Varvak, Alexander; Workman, Vanessa; Shamir, Orit; Ben-Yosef, Erez			Early evidence (late 2nd millennium BCE) of plant-based dyeing of textiles from Timna, Israel	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; EXTRACTION METHODS; TYRIAN PURPLE; AGE; INSIGHTS; ANTHRAQUINONES; IDENTIFICATION; DYESTUFFS; ECONOMY; DYES	In this article, we focus on the analysis of dyed textile fragments uncovered at an early Iron Age (11th-10th centuries BCE) copper smelting site during new excavations in the Timna Valley conducted by the Central Timna Valley (CTV) Project, as well as those found by the Arabah Expedition at the Hathor Temple (Site 200), dated to the Late Bronze/early Iron Ages (13th-11th centuries BCE). Analysis by HPLC-DAD identified two organic dyestuffs, Rubia tinctorum L. and indigotin, from a plant source (probably Isatis tinctoria L.). They are among the earliest plants known in the dyeing craft and cultivated primarily for this purpose. This study provides the earliest evidence of textiles dyed utilizing a chemical dyeing process based on an industrial dyeing plant from the Levant. Moreover, our results shed new light on the society operating the copper mines at the time, suggesting the existence of an elite that was interested in these high quality textiles and invested efforts in procuring them by longdistance trade.	[Sukenik, Naama; Shamir, Orit] Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel; [Iluz, David; Varvak, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Amar, Zohar] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Workman, Vanessa; Ben-Yosef, Erez] Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel; [Sukenik, Naama] Beth Shemesh Ind Zone West, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh Storage & Res Facil, Jerusalem, Israel	Bar Ilan University; Bar Ilan University; Tel Aviv University	Sukenik, N (corresponding author), Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel.; Sukenik, N (corresponding author), Beth Shemesh Ind Zone West, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh Storage & Res Facil, Jerusalem, Israel.	naamasuk@gmail.com		Workman, Vanessa/0000-0003-4436-7130	Marie Curie FP7-PEOPLE-CIG [334274]; Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology [5171]	Marie Curie FP7-PEOPLE-CIG; Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology	This study was partially supported by the Marie Curie FP7-PEOPLE-2012-CIG grant #334274 to E.B.Y. The field work related to the current research was provided by the Yad Hanadiv The Rothschild Foundation, through the Yizhar Hirschfeld Memorial Fellowships in Archaeology Grant #5171 to E.B.Y. There was no additional external (or internal) funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar Z, 2012, FLORA BIBLE NEW INVE; [Anonymous], 2004, COLOURFUL ORIGINS CH; Avner U., 2002, STUDIES MAT SPIRITUA; Ben-Yosef E, 2016, J ARCHAEOL SCI, V72, P71, DOI 10.1016/j.jas.2016.05.010; Ben-Yosef E., 2010, TECHNOLOGY SOCIAL PR; Ben-Yosef E., 2012, TEL AVIV, V367, P31; Ben-Yosef E., 2016, B AM SCH ORIENT RES, V376, P169, DOI [10.5615/bullamerschoorie.376.0169, DOI 10.5615/BULLAMERSCHOORIE.376.0169]; Ben-Yosef E, 2017, J ARCHAEOL SCI-REP, V11, P411, DOI 10.1016/j.jasrep.2016.12.010; Bertman Stephen, 1961, BIBLIC ARCHAEOL, V24, P119; Boertien JH, 2013, UNRAVELLING FABRIC T; Bohmer H., 2003, DYE HIST ARCHAEOL, V19, P88; Brenner Yosef Haim, 1977, STORIES ESSAYS SCH H; Bruins H.J., 2006, CROSSING RIFT RESOUR, P29; Brunello F., 1973, ART DYEING HIST MANK; Cardon D, 2007, NATURAL DYES SOURCES; Cardon D., 2010, TEXT SOC AM S P TEXT, P1; Chenciner R., 2000, MADDER RED HIST LUXU; Conrad H.G, 1980, ANTIKES KUPFER TIMNA; Cooksey CJ, 2001, MOLECULES, V6, P736, DOI 10.3390/60900736; Daniels V., 2014, BRIT MUSEUM TECHNICA, P13; Danin A., 1983, DESERT VEGETATION IS; Derksen GCH, 2002, J CHROMATOGR A, V978, P119, DOI 10.1016/S0021-9673(02)01412-7; Eastwood G., 1985, AMARNA REPORTS, p191 ; Eliade Mircea., 1978, FORGE CRUCIBLE; Epigraphic Survey, 1986, EP SURV BATTL REL KI; Forbes RJ., 1964, BITUMEN PETROLEUM AN; Freud L., 2008, TEL AVIV, V35, P169; Gaspa S., 2013, TEXTILE PRODUCTION C, V12, P224; Gleba M., 2014, GOTARC, P145; Gleba M, 2013, ARCHAEOL INT, V16, P54, DOI 10.5334/ai.1602; Glueck N., 1935, EXPLORATIONS E PALES, V15, p1 ; Good I, 2001, ANNU REV ANTHROPOL, V30, P209, DOI 10.1146/annurev.anthro.30.1.209; Gromer K., 2016, ART PREHISTORIC TEXT; Hanan L., 1988, EGYPTIAN MINING TEMP, p246 ; Hanan L., 1988, EGYPTIAN MINING TEMP, P241; Hartl A, 2015, J ARCHAEOL SCI-REP, V2, P9, DOI 10.1016/j.jasrep.2014.12.001; Hauptmann A, 2007, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-72238-0; Hoskin NA, 2011, JARCE, V47, p199 ; Iluz D, 2009, JUD SAMARIA RES STUD, V18, p223 ; Karapanagiotis I, 2013, MICROCHEM J, V110, P70, DOI 10.1016/j.microc.2013.02.008; Keijzer R. Hofmann-de, 2013, NESAT, P125; Kemp B.J., 2001, ANCIENT TEXTILE IND; Kislev ME., 1988, EGYPTIAN MINING TEMP, P236; Koren Z.C., 1999, ATIQOT, V38, P129; Koren Z. C., 2008, DYES HIST ARCHAEOLOG, V21, P26; Koren ZC, 1996, ACS SYM SER, V625, P269, DOI 10.1021/bk-1996-0625.ch021; Koren ZC, 1998, CAVE WARRIOR 4 MILLE, P100; Koren ZC, 1995, DYE HIST ARCHAEOL, V13, P27; Koren ZC, 2008, P ART2008 9 INT C NO; Koren ZC, 1994, MASADA 4 YIGAEL YADI, p257 ; Koren ZC, 2006, INDIRUBIN, THE RED SHADE OF INDIGO, P45; Koren ZC, 2013, ACS SYM SER, V1147, P43; Kramell A, 2014, QUATERN INT, V348, P214, DOI 10.1016/j.quaint.2014.05.012; Lucas, 1948, ANCIENT EGYPTIAN MAT; Mantzouris D, 2014, MICROCHEM J, V115, P78, DOI 10.1016/j.microc.2014.02.010; Melamed Y., 2005, ATIQOT, V49, P139; Mouri C, 2012, MICROCHIM ACTA, V179, P105, DOI 10.1007/s00604-012-0868-4; Na'aman N., 2015, MAARAV, V20.1, P39; Namdar D, 2013, MEDITERR ARCHAEOL AR, V13, P1; Pinch Geraldine, 1993, VOTIVE OFFERINGS HAT; Robinson Stuart, 1969, HIST DYED TEXTILES; Rothenberg B., 1988, EGYPTIAN MINING TEMP; Rothenberg B, 1990, ANCIENT METALLURGY C; Rothenberg B., 1972, TIMNA VALLEY BIBLICA; Sanyova J, 2006, J CULT HERIT, V7, P229, DOI 10.1016/j.culher.2006.06.003; Sapir-Hen L, MINING ANCI IN PRESS; Sapir-Hen L, 2014, ANTIQUITY, V88, P775, DOI 10.1017/S0003598X00050687; Schick T., 1998, CAVE WARRIOR 4 MILLE, P6; Serrano A, 2013, J CHROMATOGR A, V1318, P102, DOI 10.1016/j.chroma.2013.09.062; Shamir O, 1993, ARCHEOL TEXT NEWSL, V16, p9 ; Shamir O., 2014, PREHISTORIC ANCIENT, p297 ; Shamir O, 2013, HOARDS GENIZOT CHAPT, P87; Shamir O., 2014, GLOBAL TEXTILE ENCOU; Shamir O., 2007, MAYER EXCAVATIONS KA, P255; Sheffer A., 2012, KUNTILLET AJRUD HORV, P289; Sheffer A, 1991, ATIQOT, V20, P1; Sheffer A, 1994, MASADA 4, P153; Sheffer A, 1988, EGYPTIAN MINING TEMP, p224 ; Singer-Avitz, 2006, TEL AVIV, V33, P196; Spector N., 2017, NBC NEWS 0902; Strand EA, 2010, EUR J ARCHAEOL, V13, P149, DOI 10.1177/1461957110365513; Sukenik N, 2013, ARCHAEOL TEXT REV, V55, P46; Sukenik N, 2015, J ARCHAEOL SCI-REP, V3, P565, DOI 10.1016/j.jasrep.2015.08.003; Sukenik Naama, 2013, THESIS; Taylor GW, 1986, REV PROG COLOR RELAT, V16, P53, DOI [DOI 10.1111/J.1478-4408.1986.TB03744.X, 10.1111/j.1478-4408.1986.tb03744.x]; Tebes J.-M., 2014, UNEARTHING WILDERNES, V45, P103; Vajanto K, 2014, FENNOSCANDIA ARCHAEO, VXXXI, P61; Vanden Berghe I, 2009, J ARCHAEOL SCI, V36, P1910, DOI 10.1016/j.jas.2009.04.019; Vogelsang-Eastwo G., TEXTILES, P57; Workman V., 2016, THESIS; Wouters J., 1985, STUD CONSERV, V30; Wouters J., 2005, SCI ANAL ANCIENT HIS, P187; Yadin Y, 1963, IEJ; Zhang X, 2005, ANAL CHEM, V77, P2022, DOI 10.1021/ac048380k; Zhang X, 2008, J ARCHAEOL SCI, V35, P1095, DOI 10.1016/j.jas.2007.08.001; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary M, 1978, FLORA PALAESTINA	97	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179014	10.1371/journal.pone.0179014	http://dx.doi.org/10.1371/journal.pone.0179014			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658314	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900011
J	Tian, D; Xie, GX; Tian, J; Tseng, KH; Shum, CK; Lee, J; Liang, S				Tian, Di; Xie, Gengxin; Tian, Jing; Tseng, Kuo-Hsin; Shum, C. K.; Lee, Jiyoung; Liang, Song			Spatiotemporal variability and environmental factors of harmful algal blooms (HABs) over western Lake Erie	PLOS ONE			English	Article							ADAPTIVE REGRESSION SPLINES; CLIMATE-CHANGE; GREAT-LAKES; TOXIC CYANOBACTERIA; EUTROPHICATION; IMPACTS; WATER; PHYCOCYANIN; MODELS	Over the past decades, numerous studies have been carried out in understanding causes of Harmful Algal Blooms (HABs) and their dynamics, yielding great knowledge in this field. Lake Erie, the fourth-largest lake of the five Great Lake, is among those highly vulnerable to the impacts of HABs and has received substantial attention from the public, water management sectors, and academic field. Building upon previous work, this study aims to characterize spatiotemporal variability of Chlorophyll a (Chl-a), which is an important indicator of HABs, and to explore relative importance of environmental factors associated with HABs in the west Lake Erie. Ten years of biweekly Chl-a information over western Lake Erie were derived from MERIS data at the pixel scale. Based on the MERIS-derived information high concentrations of Chl-a were observed in the south near shore area in spring and fall and in the west corner area of western Lake Erie in all three seasons except winter. Wavelet analysis suggested that the 0.5- and 1-year periods were dominant modes for the Chl-a series. The Multivariate Adaptive Regression Splines (MARS) analysis was performed to explore factors associated with the dynamics of Chl-a. The results suggested that overall both phenological (e.g. wind) and ecological (e.g. nutrient levels) factors exhibited significant correlations with the remotely-sensed imagery based observations of Chl-a despite spatial and temporal variations. The important phenological and ecological factors include solar radiation and wind speed in spring, water temperature, solar radiation, and total Kjeldahl nitrogen concentration in summer, wind speed in fall, and water temperature and streamflow in winter. Both consistency and differences of findings of the study with others in the region may suggest strengths and limitations of the remotely sensed imagery-based analysis, offering valuable information for future work.	[Tian, Di] Auburn Univ, Coll Agr & Climate Human & Earth Syst Sci Cluster, Dept Crop Soil & Environm Sci, Auburn, AL 36849 USA; [Xie, Gengxin] Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China; [Tian, Jing] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Tseng, Kuo-Hsin] Natl Cent Univ, Ctr Space & Remote Sensing Res, Taoyuan, Taiwan; [Shum, C. K.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Auburn University System; Auburn University; Chongqing University; State University System of Florida; University of Florida; National Central University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lee, J (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA.; Liang, S (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.; Liang, S (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.	jlee@cph.osu.edu; songliang@ufl.edu		Tian, Di/0000-0001-7752-947X; Shum, C K/0000-0001-9378-4067	EPA STAR Program [RD835192010]; Auburn University; Emerging Pathogens Institute, University of Florida; Chongqing University, China; University of Florida Open Access Publishing Fund	EPA STAR Program(United States Environmental Protection Agency); Auburn University; Emerging Pathogens Institute, University of Florida(University of Florida); Chongqing University, China; University of Florida Open Access Publishing Fund	This study was funded by the EPA STAR Program (funding # RD835192010). DT was supported in part by Auburn University. SL was supported in part by the Emerging Pathogens Institute, University of Florida. GX acknowledges the support from Chongqing University, China. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund.	Adamowski J, 2012, J HYDROINFORM, V14, P731, DOI 10.2166/hydro.2011.044; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson Donald M., 2000, Protist, V151, P97, DOI 10.1078/1434-4610-00010; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; [Anonymous], [No title captured]; Botana L.M, 2015, PHYCOTOXINS CHEM BIO; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Cheung MY, 2013, J MICROBIOL, V51, P1, DOI 10.1007/s12275-013-2549-3; De Veaux RD, 1994, SELECTING MODELS DAT, P393; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Ho JC, 2015, J GREAT LAKES RES, V41, P317, DOI 10.1016/j.jglr.2015.01.001; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; Jones ML, 2006, CAN J FISH AQUAT SCI, V63, P457, DOI 10.1139/F05-239; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Kisi O, 2016, J HYDROL, V534, P104, DOI 10.1016/j.jhydrol.2015.12.014; Kroll CN, 2013, WATER RESOUR RES, V49, P3756, DOI 10.1002/wrcr.20315; Leon LF, 2011, J GREAT LAKES RES, V37, P41, DOI 10.1016/j.jglr.2010.12.007; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Milborrow S, 2013, NOTES EARTH PACKAGE; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Murphy R. J., 2003, TECHNICAL REPORT SER, V16; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Obenour DR, 2014, WATER RESOUR RES, V50, P7847, DOI 10.1002/2014WR015616; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Samat SB, 2000, BRIT J RADIOL, V73, P867, DOI 10.1259/bjr.73.872.11026863; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Simis SGH, 2005, LIMNOL OCEANOGR, V50, P237, DOI 10.4319/lo.2005.50.1.0237; Simis SGH, 2007, REMOTE SENS ENVIRON, V106, P414, DOI 10.1016/j.rse.2006.09.008; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI 10.1016/j.jglr.2013.12.012; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Trumpickas J, 2009, J GREAT LAKES RES, V35, P454, DOI 10.1016/j.jglr.2009.04.005; Van Dolah FM, 2001, J AOAC INT, V84, P1617; Vincent RK, 2004, REMOTE SENS ENVIRON, V89, P381, DOI 10.1016/j.rse.2003.10.014; Wynne TT, 2015, TOXINS, V7, P1649, DOI 10.3390/toxins7051649; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025; York TP, 2006, STAT MED, V25, P1355, DOI 10.1002/sim.2292; Zhou YT, 2015, ENVIRON SCI TECHNOL, V49, P800, DOI 10.1021/es503981n	49	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179622	10.1371/journal.pone.0179622	http://dx.doi.org/10.1371/journal.pone.0179622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658260	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900035
J	Liu, TZ; Wang, FZ; Zhang, S; Wang, F; Meng, QL; Zhang, GM; Cui, FQ; Dunzhu, D; Yin, WJ; Bi, SL; Shen, LP				Liu, Tiezhu; Wang, Fuzhen; Zhang, Shuang; Wang, Feng; Meng, Qingling; Zhang, Guomin; Cui, Fuqiang; Dunzhu, Dorji; Yin, Wenjiao; Bi, Shengli; Shen, Liping			Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China	PLOS ONE			English	Article							IDENTIFICATION; SUBGENOTYPES; HISTORY	Tibet is a highly hepatitis B virus (HBV) endemic area. Two types of C/D recombinant HBV are commonly isolated in Tibet and have been previously described. In an effort to better understand the molecular characteristic of these C/D recombinant strains from Tibet, we undertook a multistage random sampling project to collect HBsAg positive samples. Molecular epidemiological and bio-informational technologies were used to analyze the characteristics of the sequences found in this study. There were 60 samples enrolled in the survey, and we obtained 19 whole-genome sequences. 19 samples were all C/D recombinant, and could be divided into two sub-types named C/D1 and C/D2 according to the differences in the location of the recombinant breakpoint. The recombination breakpoint of the 10 strains belonging to the C/D1 sub-type was located at nt750, while the 9 stains belonging to C/D2 had their recombination break point at nt1530. According to whole-genome sequence analysis, the 19 identified strains belong to genotype C, but the nucleotide distance was more than 5% between the 19 strains and sub-genotypes C1 to C15. The distance between C/D1with C2 was 5.8 +/- 2.1%, while the distance between C/D2 with C2 was 6.4 +/- 2.1%. The parental strain was most likely sub-genotype C2. C/D1 strains were all collected in the middle and northern areas of Tibet including Lhasa, Linzhi and Ali, while C/D2 was predominant in Shannan in southern Tibet. This indicates that the two recombinant genotypes are regionally distributed in Tibet. These results provide important information for the study of special HBV recombination events, gene features, virus evolution, and the control and prevention policy of HBV in Tibet.	[Liu, Tiezhu; Zhang, Shuang; Wang, Feng; Meng, Qingling; Yin, Wenjiao; Bi, Shengli; Shen, Liping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Fuzhen; Zhang, Guomin; Cui, Fuqiang] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Dunzhu, Dorji] Tibetan Ctr Dis Control & Prevent, Lhasa, Tibet, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Shen, LP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shenlp@ivdc.chinacdc.cn		Bi, Shengli/0000-0002-0380-5790	Chinese National Science and Technology Major Project [2012ZX10002-001-005-001, 2012ZX10002-001-005]	Chinese National Science and Technology Major Project	This research is supported by the Chinese National Science and Technology Major Project (Grant No. 2012ZX10002-001-005-001; No. 2012ZX10002-001-005 to SLB). The funders had no role in study design, data collection and analysis and preparation of the manuscript.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Chauhan R, 2008, WORLD J GASTROENTERO, V14, P6228, DOI 10.3748/wjg.14.6228; Chekaraou MA, 2010, J GEN VIROL, V91, P1609, DOI 10.1099/vir.0.018127-0; Gandhe SS, 2003, J MED VIROL, V69, P324, DOI 10.1002/jmv.10292; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Sayan M, 2012, HEPAT MON, V12, P118, DOI [10.5812/hepatmon.4878, 10.5812/hepatmon.826]; Shen LP, 2014, J MED VIROL, V86, P1307, DOI 10.1002/jmv.23965; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Su HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084005; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Zhao Shu Ming, 2001, Asian Pac J Cancer Prev, V2, P299; Zhou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018708	23	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179846	10.1371/journal.pone.0179846	http://dx.doi.org/10.1371/journal.pone.0179846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654691	gold, Green Published, Green Submitted			2022-12-26	WOS:000404541500036
J	Zielinski, DP; Sorensen, PW				Zielinski, Daniel P.; Sorensen, Peter W.			Silver, bighead, and common carp orient to acoustic particle motion when avoiding a complex sound	PLOS ONE			English	Article							DIPOLE SOURCE LOCALIZATION; PLAINFIN MIDSHIPMAN FISH; LATERAL-LINE; PORICHTHYS-NOTATUS; ATLANTIC SALMON; MOTTLED SCULPIN; ILLINOIS RIVER; ASIAN CARP; RESPONSES; HEARING	Behavioral responses of silver carp (Hypopthalmichthys molitrix), bighead carp (H. nobilis), and common carp (Cyprinus carpio) to a complex, broadband sound were tested in the absence of visual cues to determine whether these species are negatively phonotaxic and the roles that sound pressure and particle motion might play mediating this response. In a dark featureless square enclosure, groups of 3 fish were tracked and the distance of each fish from speakers and their swimming trajectories relative to sound pressure and particle acceleration were analyzed before, and then while an outboard motor sound was played. All three species exhibited negative phonotaxis during the first two exposures after which they ceased responding. The median percent time fish spent near the active speaker for the first two trials decreased from 7.0% to 1.3% for silver carp, 7.9% to 1.1% for bighead carp, and 9.5% to 3% for common carp. Notably, when close to the active speaker fish swam away from the source and maintained a nearly perfect 0 degrees orientation to the axes of particle acceleration. Fish did not enter sound fields greater than 140 dB (ref. 1 mu Pa). These results demonstrate that carp avoid complex sounds in darkness and while initial responses may be informed by sound pressure, sustained oriented avoidance behavior is likely mediated by particle motion. This understanding of how invasive carp use particle motion to guide avoidance could be used to design new acoustic deterrents to divert them in dark, turbid river waters.	[Zielinski, Daniel P.; Sorensen, Peter W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Zielinski, Daniel P.] Great Lakes Fishery Commiss, Millersburg, MI USA	University of Minnesota System; University of Minnesota Twin Cities	Zielinski, DP (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	dzielinski@usgs.gov	Zielinski, Daniel/GPF-5806-2022	Sorensen, Peter/0000-0003-0321-1279	Minnesota Environment and Natural Resources Trust Fund	Minnesota Environment and Natural Resources Trust Fund	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative Citizen Commission on Minnesota Resources (LCCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Minnesota Environmental and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR) and administered by the Minnesota Aquatic Invasive Species Research Center. We thank Dan Krause, Reid Swanson, and Clark Dennis III for their help with fish care, construction of experimental equipment, and data collection.	ACRCC (Asian Carp Regional Coordinating Committee), 2014, AS CARP CONTR STRAT; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Batschelet E, 1981, CIRCULAR STAT BIOL; BOMFORD M, 1990, WILDLIFE SOC B, V18, P411; Braun Christopher B., 2008, V32, P99; Coffin AB, 2014, J EXP BIOL, V217, P2078, DOI 10.1242/jeb.093831; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Coombs S, 1997, J COMP PHYSIOL A, V180, P387, DOI 10.1007/s003590050057; Coombs S, 1997, J COMP PHYSIOL A, V180, P401, DOI 10.1007/s003590050058; Fay Richard R., 2008, V32, P49; Gray MD, 2016, ADV EXP MED BIOL, V875, P363, DOI 10.1007/978-1-4939-2981-8_43; Hansen A, 2014, J EXP BIOL, V217, P3945, DOI 10.1242/jeb.107870; Higgs DM, 2013, J EXP BIOL, V216, P1484, DOI 10.1242/jeb.078816; Higgs Dennis M., 2006, P389; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Kalmijn A.J., 1988, P83; Karlsen HE, 2004, J EXP BIOL, V207, P4185, DOI 10.1242/jeb.01274; KNUDSEN FR, 1992, J FISH BIOL, V40, P523, DOI 10.1111/j.1095-8649.1992.tb02602.x; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lovell JM, 2006, COMP BIOCHEM PHYS A, V143, P286, DOI 10.1016/j.cbpa.2005.11.015; Lu ZM, 2001, J COMP PHYSIOL A, V187, P453, DOI 10.1007/s003590100218; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; Mensinger A., 2016, P M ACOUS, V27, P010032, DOI [10.1121/2.0000314, DOI 10.1121/2.0000314]; Murchy KA, 2017, FISHERIES MANAG ECOL, V24, P208, DOI 10.1111/fme.12220; Nestler John M., 1992, North American Journal of Fisheries Management, V12, P667, DOI 10.1577/1548-8675(1992)012<0667:ROBHTH>2.3.CO;2; Noatch MR, 2012, ENVIRON REV, V20, P71, DOI [10.1139/A2012-001, 10.1139/a2012-001]; Pegg MA, 2004, ANS0101 ILL IND SEA; Plachta DTT, 2003, ACOUST RES LETT ONL, V4, P25, DOI 10.1121/1.1558376; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; POPPER AN, 1972, J ACOUST SOC AM, V52, P1714, DOI 10.1121/1.1913305; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Rogers PH, 2016, ADV EXP MED BIOL, V875, P933, DOI 10.1007/978-1-4939-2981-8_115; Romine JG, 2015, N AM J FISH MANAGE, V35, P440, DOI 10.1080/02755947.2015.1012279; Ruebush BC, 2012, AQUAT INVASIONS, V7, P37, DOI 10.3391/ai.2012.7.1.005; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sass GG, 2014, J GREAT LAKES RES, V40, P911, DOI 10.1016/j.jglr.2014.08.010; Schrank SJ, 2003, T AM FISH SOC, V132, P1222, DOI 10.1577/T02-071; SCHUIJF A, 1975, J COMP PHYSIOL, V98, P307, DOI 10.1007/BF00709803; SCHUIJF A, 1983, NATURE, V302, P143, DOI 10.1038/302143a0; Sisler SP, 2008, BEHAVIOUR, V145, P1409, DOI 10.1163/156853908785765881; Standdon JR, 1993, ADAPT BEHAV, V1, P421; Taylor RM, 2005, FISHERIES MANAG ECOL, V12, P283, DOI 10.1111/j.1365-2400.2005.00446.x; Vetter BJ, 2016, J GREAT LAKES RES, P1; Vetter BJ, 2015, BIOL INV, P1; Webb JJ, 2008, BIOACOUSTICS LATERAL, P145; Weber M. J., 2009, Reviews in Fisheries Science, V17, P524, DOI 10.1080/10641260903189243; Welton JS, 2002, FISHERIES MANAG ECOL, V9, P11, DOI 10.1046/j.1365-2400.2002.00252.x; Wilson M, 2008, J ACOUST SOC AM, V124, pEL243, DOI 10.1121/1.2960899; Wilson M, 2011, J EXP BIOL, V214, P22, DOI 10.1242/jeb.043323; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020; Zeddies DG, 2012, J EXP BIOL, V215, P152, DOI 10.1242/jeb.064998; Zeddies DG, 2010, J ACOUST SOC AM, V127, P3104, DOI 10.1121/1.3365261; Zielinski DP, 2016, N AM J FISH MANAGE, V36, P267, DOI 10.1080/02755947.2015.1120834; Zielinski DP, 2015, FISHERIES MANAG ECOL, V22, P181, DOI 10.1111/fme.12108; Zielinski DP, 2014, ECOL ENG, V67, P95, DOI 10.1016/j.ecoleng.2014.03.003; [No title captured]	58	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180110	10.1371/journal.pone.0180110	http://dx.doi.org/10.1371/journal.pone.0180110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654676	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500056
J	Zhu, XS; Chen, YH; Li, YJ; Deng, ZJ				Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun; Deng, Zhijun			Automatic non-symbolic numerosity processing in preschoolers	PLOS ONE			English	Article							NUMBER-SIZE INTERFERENCE; APPROXIMATE NUMBER; ARABIC NUMERALS; YOUNG-CHILDREN; MAGNITUDE; ACUITY; TASK; REPRESENTATIONS; PERFORMANCE; JUDGMENTS	There has recently been an increasing focus on the development of automatic processing of numerical magnitude. However, little effort has been made to explore automatic access to non-symbolic numerical magnitude in preschool children. In experiment 1, we used a non symbolic physical size comparison task in 3- to 6-year-olds to examine developmental changes and the effect of ratio and counting principle knowledge. Results showed that the existence of automatic non-symbolic numerical processing began at age 3-4 years and size congruity effects tended to reduce with increasing age from 4 years old. The study also found that non-counting-principle knowers had a larger congruity effect, and in low ratio conditions the size congruity effect was more easily found. In addition, symbolic number comparison ability was negatively related to size congruity effect. In experiment 2, we explored the relationship between inhibition skill and size congruity effects, as well as interference and facilitatory components in children aged 4 years old. Results showed no correlation between inhibition skills and the size congruity effect and only interference effects were found. We also found a larger interference effect in low ratio conditions than in high ratio conditions.	[Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun; Deng, Zhijun] Beijing Normal Univ, Inst Dev Psychol, Fac Psychol, Beijing, Peoples R China	Beijing Normal University	Chen, YH (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Fac Psychol, Beijing, Peoples R China.	chenyinghe@bnu.edu.cn	zhu, xiaoshuang/GYV-0942-2022		Major Project of the National Social Science Foundation of China [14ZDB160]; National Natural Science Foundation of China [31271106]	Major Project of the National Social Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Major Project of the National Social Science Foundation of China (14ZDB160;http://www.npopss-cn.gov.cn) and National Natural Science Foundation of China (31271106;http://www.nstc.gov.cn). The funders support the decision to publish and data collection.	Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Chan WWL, 2011, J EXP CHILD PSYCHOL, V109, P263, DOI 10.1016/j.jecp.2011.01.010; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; Cohen HH, 2014, J EXP CHILD PSYCHOL, V121, P96, DOI 10.1016/j.jecp.2013.11.005; Condry KF, 2008, J EXP PSYCHOL GEN, V137, P22, DOI 10.1037/0096-3445.137.1.22; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FUENTES LJ, 1993, ACTA PSYCHOL, V84, P213, DOI 10.1016/0001-6918(93)90061-U; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2010, NEUROPSYCHOLOGIA, V48, P394, DOI 10.1016/j.neuropsychologia.2009.09.027; Gebuis T, 2009, EUR J NEUROSCI, V30, P1999, DOI 10.1111/j.1460-9568.2009.06994.x; Gebuis T, 2009, COGN PROCESS, V10, P133, DOI 10.1007/s10339-008-0219-x; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Girelli L, 2000, J EXP CHILD PSYCHOL, V76, P104, DOI 10.1006/jecp.2000.2564; Huntley-Fenner G, 2000, PSYCHOL SCI, V11, P147, DOI 10.1111/1467-9280.00230; Jiang T, 2016, MEM COGNITION, V44, P162, DOI 10.3758/s13421-015-0542-2; Kadosh RC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00002; Kaufmann L, 2006, NEUROREPORT, V17, P587, DOI 10.1097/00001756-200604240-00007; Kiselev S, 2009, J EXP CHILD PSYCHOL, V102, P150, DOI 10.1016/j.jecp.2008.02.002; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P546, DOI 10.1016/j.jecp.2008.12.006; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Merkley R, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01903; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mussolin C, 2007, J CLIN EXP NEUROPSYC, V29, P225, DOI 10.1080/13803390600629759; Negen J, 2015, BRIT J DEV PSYCHOL, V33, P92, DOI 10.1111/bjdp.12071; Odic D, 2013, DEV PSYCHOL, V49, P1103, DOI 10.1037/a0029472; Patro K, 2012, J EXP CHILD PSYCHOL, V111, P534, DOI 10.1016/j.jecp.2011.09.006; Pina V, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00375; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rubinsten O, 2002, J EXP CHILD PSYCHOL, V81, P74, DOI 10.1006/jecp.2001.2645; Santens S, 2011, COGNITION, V118, P94, DOI 10.1016/j.cognition.2010.10.014; Sasanguie D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087739; Schwarz W, 2003, J EXP PSYCHOL HUMAN, V29, P507, DOI 10.1037/0096-1523.29.3.507; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; Stock P, 2009, LEARN INDIVID DIFFER, V19, P419, DOI 10.1016/j.lindif.2009.03.002; Szucs D, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-23; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Tzelgov J, 1996, J EXP PSYCHOL LEARN, V22, P336; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Zhou XL, 2007, MEM COGNITION, V35, P464, DOI 10.3758/BF03193286	46	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0178396	10.1371/journal.pone.0178396	http://dx.doi.org/10.1371/journal.pone.0178396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644834	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100004
J	Song, ZB; Wu, P; Ni, JS; Liu, T; Fan, C; Bao, YL; Wu, Y; Sun, LG; Yu, CL; Huang, YX; Li, YX				Song, Z-B; Wu, P.; Ni, J-S; Liu, T.; Fan, C.; Bao, Y-L; Wu, Y.; Sun, L-G; Yu, C-L; Huang, Y-X; Li, Y-X			Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling	ONCOGENE			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; GROWTH-FACTOR; TGF-BETA; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; CYCLE ARREST; TSP50; ACTIVATION; APOPTOSIS	Testes-specific protease 50 (TSP50), a novelly identified oncogene, has the capacity to induce cell proliferation, cell invasion and tumor growth. Further studies indicated that CAGA-luc (an activin-responsive reporter construct) reporter activity could be significantly suppressed by TSP50 overexpression, implying that the activin signaling may participate in TSP50-mediated cell proliferation. Here, we reported that TSP50 had an inhibitory effect on activin signaling. Mechanistic studies revealed that TSP50 could interact with ActRIIA, inhibit activin type. receptor (ActRIB) phosphorylation, repress Smad2/3 nuclear accumulation and finally promote cell proliferation by reducing the expression of activin signal target gene p27. Additionally, we found that ActRIB activation could reverse TSP50-mediated cell proliferation and tumor growth. Furthermore, analysis of human breast cancer specimens by immunohistochemistry indicated that TSP50 expression was negatively related to p-Smad2/3 and p27 protein levels. Most importantly, breast cancer diagnosis-related indicators such as tumor size, tumor grade, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) levels, were correlated well with TSP50/p-Samd2/3 and TSP50/p27 expression status. Thus, our studies revealed a novel regulatory mechanism underlying TSP50-induced cell proliferation and provided a new favorable intervention target for the treatment of breast cancer.	[Song, Z-B; Wu, P.; Fan, C.; Bao, Y-L; Sun, L-G; Yu, C-L] Northeast Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China; [Song, Z-B; Wu, Y.; Sun, L-G; Yu, C-L; Huang, Y-X; Li, Y-X] Northeast Normal Univ, Inst Genet & Cytol, Changchun, Jilin, Peoples R China; [Ni, J-S; Liu, T.] Jilin Univ, Dept Pathol, Hosp 1, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Jilin University	Bao, YL; Li, YX (corresponding author), Northeast Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.	baoyl800@nenu.edu.cn; liyx486@nenu.edu.cn			National Natural Science Foundation of China [81272242, 81502284]; National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University [130014561, 130028683]; Jilin outstanding young talent Foundation [20170520031JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University; Jilin outstanding young talent Foundation	This research was supported by grants from the National Natural Science Foundation of China (Grant no. 81272242 and 81502284), the Open Project of the National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University (No. 130014561 and 130028683) and Jilin outstanding young talent Foundation (Grant no. 20170520031JH).	Alexander JM, 1996, J CLIN ENDOCR METAB, V81, P783, DOI 10.1210/jc.81.2.783; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Chen XS, 2010, TUMORI J, V96, P103, DOI 10.1177/030089161009600117; Chen YG, 2006, EXP BIOL MED, V231, P534; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dai Jian-Yi, 2003, Ai Zheng, V22, P1093; Danila DC, 2002, J CLIN ENDOCR METAB, V87, P4741, DOI 10.1210/jc.2002-020527; Deli A, 2008, WORLD J GASTROENTERO, V14, P1699, DOI 10.3748/wjg.14.1699; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Franzen A, 2001, BIOCHEM BIOPH RES CO, V285, P773; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Galizia G, 2004, DIS COLON RECTUM, V47, P1904, DOI 10.1007/s10350-004-0695-8; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Huang HJ, 2005, J CLIN PATHOL, V58, P611, DOI 10.1136/jcp.2004.022772; Kaneda H, 2011, BRIT J CANCER, V105, P1210, DOI 10.1038/bjc.2011.348; Landis MD, 2005, ONCOGENE, V24, P5173, DOI 10.1038/sj.onc.1208712; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035030; Liu F, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/498246; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Mylonas I, 2005, ONCOL REP, V13, P81; Panopoulou E, 2005, CANCER RES, V65, P1877, DOI 10.1158/0008-5472.CAN-04-2828; Reis FM, 2004, MOL CELL ENDOCRINOL, V225, P77, DOI 10.1016/j.mce.2004.02.016; Shan JD, 2002, CANCER RES, V62, P290; Shav-Tal Y, 2002, STEM CELLS, V20, P493, DOI 10.1634/stemcells.20-6-493; Shi Y, 2011, J BIOMOL SCREEN, V16, P525, DOI 10.1177/1087057111398486; Song ZB, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.61; Song ZB, 2014, CELL SIGNAL, V26, P2266, DOI 10.1016/j.cellsig.2014.07.012; Song ZB, 2011, BIOCHEM J, V436, P457, DOI 10.1042/BJ20101780; Sozzani S, 2011, BLOOD, V117, P5013, DOI 10.1182/blood-2011-03-342691; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; Tsuchida Kunihiro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P157, DOI 10.2174/1568008043339901; Wang X, 2011, MED ONCOL, V28, P1225, DOI 10.1007/s12032-010-9552-x; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Ying SY, 1997, P SOC EXP BIOL MED, V214, P114; Yuan J, 2015, CELL BIOCHEM BIOPHYS, V71, P891, DOI 10.1007/s12013-014-0279-8; Yuan LM, 1999, CANCER RES, V59, P3215; Zhang Y, 2010, CHEM-BIOL INTERACT, V185, P174, DOI 10.1016/j.cbi.2010.03.035	47	6	6	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					5948	5957		10.1038/onc.2017.198	http://dx.doi.org/10.1038/onc.2017.198			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28650473				2022-12-26	WOS:000413841400004
J	Asciolla, JJ; Miele, MM; Hendrickson, RC; Resh, MD				Asciolla, James J.; Miele, Matthew M.; Hendrickson, Ronald C.; Resh, Marilyn D.			An in vitro fatty acylation assay reveals a mechanism for Wnt recognition by the acyltransferase Porcupine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG ACYLTRANSFERASE; SONIC-HEDGEHOG; IDENTIFICATION; CANCER; PALMITOYLATION; PROTEINS; RESIDUES; WLS	Wnt proteins are a family of secreted signaling proteins that play key roles in regulating cell proliferation in both embryonic and adult tissues. Production of active Wnt depends on attachment of palmitoleate, a monounsaturated fatty acid, to a conserved serine by the acyltransferase Porcupine (PORCN). Studies of PORCN activity relied on cell-based fatty acylation and signaling assays as no direct enzyme assay had yet been developed. Here, we present the first in vitro assay that accurately recapitulates PORCN-mediated fatty acylation of a Wnt substrate. The critical feature is the use of a double disulfide-bonded Wnt peptide that mimics the two-dimensional structure surrounding the Wnt acylation site. PORCN-mediated Wnt acylation was abolished when the Wnt peptide was treated with DTT, and did not occur with a linear (non-disulfide-bonded) peptide, or when the double disulfide-bonded Wnt peptide contained Ala substituted for the Ser acylation site. We exploited this in vitro Wnt acylation assay to provide direct evidence that the small molecule LGK974, which is in clinical trials for managing Wnt-driven tumors, is a bona fide PORCN inhibitor whose IC50 for inhibition of Wnt fatty acylation in vitro closely matches that for inhibition of Wnt signaling. Side-by-side comparison of PORCN and Hedgehog acyltransferase (HHAT), two enzymes that attach 16-carbon fatty acids to secreted proteins, revealed that neither enzyme will accept the other's fatty acyl-CoA or peptide substrates. These findings illustrate the unique enzyme-substrate selectivity exhibited by members of the membrane-bound O-acyl transferase family.	[Asciolla, James J.; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA; [Miele, Matthew M.; Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Prote & Microchem Core Lab, New York, NY 10065 USA; [Asciolla, James J.; Resh, Marilyn D.] Weill Cornell Grad Sch Med Sci, Biochem Cell Biol & Mol Biol Grad Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466; Miele, Matthew/0000-0001-7495-2133	Cancer Center Core Support Grant from National Institutes of Health [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539, R01GM116860] Funding Source: NIH RePORTER	Cancer Center Core Support Grant from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Raisa Louft-Nisenbaum for expert technical assistance, and Dr. San-San Yi for initial input into the synthesis and analysis of double disulfide-bonded peptides. Memorial Sloan Kettering Cancer Center is funded by Cancer Center Core Support Grant P30 CA008748 from the National Institutes of Health.	Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Janda CY, 2015, BIOCHEM SOC T, V43, P211, DOI 10.1042/BST20140249; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Langton PF, 2016, TRENDS CELL BIOL, V26, P756, DOI 10.1016/j.tcb.2016.05.011; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Tuladhar R, 2015, BIOCHEM SOC T, V43, P235, DOI 10.1042/BST20140282; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	21	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13507	13513		10.1074/jbc.C117.800136	http://dx.doi.org/10.1074/jbc.C117.800136			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28655768	Green Published, hybrid			2022-12-26	WOS:000407942400001
J	Wandera, B; Tumwesigye, NM; Nankabirwa, JI; Kambugu, AD; Mafigiri, DK; Kapiga, S; Sethi, AK				Wandera, Bonnie; Tumwesigye, Nazarius M.; Nankabirwa, Joaniter I.; Kambugu, Andrew D.; Mafigiri, David K.; Kapiga, Saidi; Sethi, Ajay K.			Hazardous alcohol consumption is not associated with CD4+T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study	PLOS ONE			English	Article							HIV DISEASE PROGRESSION; ANTIRETROVIRAL ADHERENCE; USE DISORDERS; INFECTION; IMMUNODEFICIENCY; METAANALYSIS; INDIVIDUALS; THERAPY; HEALTH; IMPACT	Introduction There is limited data on the effects of alcohol on immunological response among persons living with HIV (PLHIV) in sub-Saharan Africa. We assessed the relationship between hazardous alcohol use and CD4+ T-cell count, among PLHIV in Uganda. Methods PLHIV aged >= 18 years were enrolled in a cohort study at the Infectious diseases clinic Kampala, Uganda. Alcohol consumption was assessed at enrolment (baseline) and 6 monthly thereafter using the alcohol use disorders identification test (AUDIT). The CD4+ T-cell counts, assessed at baseline and over the next 12 months were compared between alcohol use strata, using linear mixed effects regression. Using longitudinal mediation analysis methods, we estimated the effect of alcohol induced ART non-adherence on CD4+ T-cell count. Results Of the 1566 participants enrolled, 863(44.1%) were non-alcohol users (AUDIT score = 0), 433(27.7%) were non-hazardous (AUDIT score 1 - 7) alcohol users while 270 (17.2%) were hazardous (AUDIT score >= 8) alcohol users. The overall median (IQR) baseline CD4+ T-cell count was 356 (243 - 516) cells/mu l. There were no differences in the median baseline CD4+ T-cell count between hazardous and nonhazardous alcohol users compared to non-alcohol users in both the non-ART (p = 0.43) and ART group (p = 0.77). The mean CD4+ T-cell count over 12 months was not different between hazardous alcohol users and non-alcohol users (non-ART group p = 0.88 and ART group p = 0.62), nor between non-hazardous alcohol users and non-alcohol users (and non-ART group p = 0.66 and ART group p = 0.20). Alcohol use was not associated with a significant natural direct effect on CD4(+) T-cell count (1.37 95% CI [-1.78, 4.52] cells/mu l, p = 0.39) but had a statistically significant natural indirect effect on reduction of CD4(+) T-cell count (-0.91 cells/mu l [-1.36, -0.45], p < 0.001) mediated through ART non-adherence. Conclusion Hazardous alcohol use among PLHIV was not directly associated with lower CD4+ T-cell count but had a significant natural indirect effect on CD4+ T-cell count mediated through ART non-adherence. Among PLHIV with lower than expected CD4+ T-cell count, alcohol consumption should be excluded as an underlying factor for non-adherence to ART and any interventions targeting alcohol use should tackle possible ART non-adherence.	[Wandera, Bonnie; Tumwesigye, Nazarius M.] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Wandera, Bonnie; Kambugu, Andrew D.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nankabirwa, Joaniter I.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mafigiri, David K.] Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda; [Kapiga, Saidi] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Sethi, Ajay K.] Univ Wisconsin Madison, Dept Populat Hlth Sci, Madison, WI USA	Makerere University; Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine; University of Wisconsin System; University of Wisconsin Madison	Wandera, B (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Wandera, B (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	bonniewandera@gmail.com		Mafigiri, David/0000-0002-2699-4248; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Kapiga, Saidi/0000-0003-1753-4060	Wellcome Trust Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium [087540]; Infectious Diseases Institute, Makerere College of Health Sciences	Wellcome Trust Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium; Infectious Diseases Institute, Makerere College of Health Sciences	This study was supported by the Wellcome Trust through Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium grant no. 087540. Additional funding was obtained from the Infectious Diseases Institute, Makerere College of Health Sciences.	Asiimwe SB, 2015, ALCOHOL CLIN EXP RES, V39, P1518, DOI 10.1111/acer.12781; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Bryan J, 2004, BIOSTATISTICS, V5, P361, DOI 10.1093/biostatistics/kxg041; Carney MA, 1998, J STUD ALCOHOL, V59, P447, DOI 10.15288/jsa.1998.59.447; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chandiwana S. K., 1999, Central African Journal of Medicine, V45, P303; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Conen A, 2013, JAIDS-J ACQ IMM DEF, V64, P472, DOI 10.1097/QAI.0b013e3182a61ea9; Conen A, 2009, ANTIVIR THER, V14, P349; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Finucane Mariel M, 2007, Epidemiol Perspect Innov, V4, P8, DOI 10.1186/1742-5573-4-8; Ghebremichael M, 2009, AIDS CARE, V21, P834, DOI 10.1080/09540120802537864; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Hahn JA, CURR HIV AIDS REP, V7, P226; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kader R, 2014, AIDS BEHAV, V18, P525, DOI 10.1007/s10461-013-0587-9; Kahler C. W., 2016, AIDS BEHAV; KASLOW RA, 1989, JAMA-J AM MED ASSOC, V261, P3424, DOI 10.1001/jama.261.23.3424; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kowalski S, 2012, JAIDS-J ACQ IMM DEF, V61, P455, DOI 10.1097/QAI.0b013e3182712d39; Marcondes MCG, 2008, ALCOHOL CLIN EXP RES, V32, P1583, DOI 10.1111/j.1530-0277.2008.00730.x; Miguez-Burbano MJ, 2009, ALCOHOL ALCOHOLISM, V44, P366, DOI 10.1093/alcalc/agp024; Pellowski JA, 2016, AIDS CARE, P1; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sankar A, 2007, AIDS BEHAV, V11, P195, DOI 10.1007/s10461-006-9144-0; Scott-Sheldon LAJ, 2013, CURR HIV-AIDS REP, V10, P314, DOI 10.1007/s11904-013-0177-5; Szabo G, 2015, ALCOHOL RES-CURR REV, V37, P159; Vagenas P, 2015, CURR HIV-AIDS REP, V12, P421, DOI 10.1007/s11904-015-0285-5; Wandera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126236; World Health Organization, 2001, ALCOHOL USE DISORDER	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180015	10.1371/journal.pone.0180015	http://dx.doi.org/10.1371/journal.pone.0180015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3KB	28665974	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000404608700054
J	Cao, LZ; Lafyatis, R; Burkly, LC				Cao, Lizhi; Lafyatis, Robert; Burkly, Linda C.			Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs	PLOS ONE			English	Article							ANIMAL-MODEL; SKIN; SCLERODERMA; DISEASE; BLEOMYCIN; SCORE; HETEROGENEITY; ARCHITECTURE; MORPHOMETRY; THICKNESS	Systemic sclerosis (SSc) is a devastating disease affecting the skin and internal organs. Dermal fibrosis manifests early and Modified Rodnan Skin Scores (MRSS) correlate with disease progression. Transcriptomics of SSc skin biopsies suggest the role of the in vivo microenvironment in maintaining the pathological myofibroblasts. Therefore, defining the structural changes in dermal collagen in SSc patients could inform our understanding of fibrosis pathogenesis. Here, we report a method for quantitative whole-slide image analysis of dermal collagen from SSc patients, and our findings of more aligned dermal collagen bundles in diffuse cutaneous SSc (dcSSc) patients. Using the bleomycin-induced mouse model of SSc, we identified a distinct high dermal collagen bundle alignment gene signature, characterized by a concerted upregulation in cell migration, adhesion, and guidance pathways, and downregulation of spindle, replication, and cytokinesis pathways. Furthermore, increased bundle alignment induced a cell migration gene signature in fibroblasts in vitro, and these cells demonstrated increased directed migration on aligned ECM fibers that is dependent on expression of Arhgdib (Rho GDP-dissociation inhibitor 2). Our results indicate that increased cell migration is a cellular response to the increased collagen bundle alignment featured in fibrotic skin. Moreover, many of the cell migration genes identified in our study are shared with human SSc skin and may be new targets for therapeutic intervention.	[Cao, Lizhi; Burkly, Linda C.] Biogen, Dept Neuroimmunol, Cambridge, MA 02142 USA; [Lafyatis, Robert] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Biogen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cao, LZ (corresponding author), Biogen, Dept Neuroimmunol, Cambridge, MA 02142 USA.	lizhicao1986@gmail.com						Agarwal NK, 2013, ONCOGENE, V32, P2521, DOI 10.1038/onc.2012.287; Assassi S, 2015, ARTHRITIS RHEUMATOL, V67, P3016, DOI 10.1002/art.39289; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; de Vries HJC, 2000, LAB INVEST, V80, P1281, DOI 10.1038/labinvest.3780136; Drifka CR, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0128-1; Furst DE, 1998, J RHEUMATOL, V25, P84; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gnavi S, 2016, J TISSUE ENG REGENER; Greenblatt MB, 2012, AM J PATHOL, V180, P1080, DOI 10.1016/j.ajpath.2011.11.024; Hall MS, 2016, P NATL ACAD SCI; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; Kimmel JN, 2016, NEUROGASTROENT MOTIL, V28, P1157, DOI 10.1111/nmo.12813; Kissin EY, 2006, ARTHRITIS RHEUM-US, V54, P3655, DOI 10.1002/art.22186; Li XR, 2016, SMALL, V12, P5009, DOI 10.1002/smll.201601285; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niu HY, 2015, TUMOR BIOL, V36, P409, DOI 10.1007/s13277-014-2671-9; Okutucu S, 2016, CARDIOL J, V23, P242, DOI 10.5603/CJ.a2016.0021; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Pendergrass SA, 2012, J INVEST DERMATOL, V132, P1363, DOI 10.1038/jid.2011.472; Sargent JL, 2011, EXPERT REV CLIN IMMU, V7, P463, DOI [10.1586/ECI.11.41, 10.1586/eci.11.41]; Schulz JN, 2015, J INVEST DERMATOL, V135, P1435, DOI 10.1038/jid.2015.24; Scleroderma Fett N., 2013, CLIN DERMATOL, V31, P432; Sharma Ved P, 2012, Intravital, V1, P77; van Zuijlen PPM, 2002, J PATHOL, V198, P284, DOI 10.1002/path.1219; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Verhaegen PDHM, 2009, WOUND REPAIR REGEN, V17, P649, DOI 10.1111/j.1524-475X.2009.00533.x; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Yamamoto T, 2004, ARCH DERMATOL RES, V295, P453, DOI 10.1007/s00403-003-0439-y; Yamamoto T, 2001, J INVEST DERMATOL, V117, P999, DOI 10.1046/j.0022-202x.2001.01509.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Yi B, 2014, INT J MOL MED, V34, P205, DOI 10.3892/ijmm.2014.1765	31	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180751	10.1371/journal.pone.0180751	http://dx.doi.org/10.1371/journal.pone.0180751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662216	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300175
J	Chin, MC; Sivasampu, S; Khoo, EM				Chin, May Chien; Sivasampu, Sheamini; Khoo, Ee Ming			Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; QUESTIONNAIRE SURVEY; ASIA-PACIFIC; SALBUTAMOL; MANAGEMENT; CHILDREN; COUNTRIES; DOCTORS; ADULTS; CARE	Objective Use of oral short-acting beta 2-agonist (SABA) persists in non-resource poor countries despite concerns for its lower efficacy and safety. Utilisation and reasons for such use is needed to support the effort to discourage the use of oral SABA in asthma. This study examined the frequency of oral short-acting Beta 2-agonist (SABA) usage in the management of asthma in primary care and determined correlates of its usage. Methods Data used were from the 2014 National Medical Care Survey in Malaysia, a nationally representative survey of primary care encounters (weighted n = 325818). Using methods of analysis of data for complex surveys, we determined the frequency of asthma diagnosis in primary care and the rate of asthma medication prescription, which includes oral SABA. Multivariate logistic regression models were built to assess associations with the prescription of oral SABA. Results A weighted estimate of 9241 encounters presented to primary care with asthma in 2014. The mean age of the patients was 39.1 years. The rate of oral SABA, oral steroids, inhaled SABA and inhaled corticosteroids prescriptions were 33, 33, 50 and 23 per 100 asthma encounters, respectively. It was most commonly used in patients with the age ranged between 20 to less than 40 years. Logistic regression models showed that there was a higher odds of oral SABA usage in the presence of respiratory infection, prescription of oral corticosteroids and in the private sector. Conclusion Oral SABA use in asthma is found to be common in a non-resource poor setting and its use could be attributed to a preference for oral medicines along undesirable clinical practices within a fragmented health system.	[Chin, May Chien; Sivasampu, Sheamini] Natl Clin Res Ctr, Healthcare Stat Unit, Kuala Lumpur, Malaysia; [Khoo, Ee Ming] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Malaya	Chin, MC (corresponding author), Natl Clin Res Ctr, Healthcare Stat Unit, Kuala Lumpur, Malaysia.	chinmc@crc.gov.my	KHOO, EE MING/B-8785-2010	KHOO, EE MING/0000-0003-3191-1264; Sivasampu, Sheamini/0000-0003-2314-6048	Ministry of Health, Malaysia [NMRR-09-842-4718]	Ministry of Health, Malaysia	This study was supported by a grant from the Ministry of Health, Malaysia (grant number: NMRR-09-842-4718). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medicine of Malaysia Malaysian Thoracic Society Lung Foundation of Malaysia, 2014, CLIN PRACT GUID MAN; Ait-Khaled N, 2006, INT J TUBERC LUNG D, V10, P104; Ait-Khaled N, 2000, INT J TUBERC LUNG D, V4, P268; [Anonymous], 2017, GLOB STRAT ASTHM MAN; [Anonymous], 2016, SIGN 153 BRIT GUID M; Babar Z, 2005, SURVEY MED PRICES AV; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; BARTFIELD JM, 1995, AM J EMERG MED, V13, P375, DOI 10.1016/0735-6757(95)90224-4; Bernama, 2016, NEW STRAITS TIM 0723; Bonner S, 2006, J ASTHMA, V43, P31, DOI 10.1080/02770900500446989; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Craig S, 2016, AUST FAM PHYSICIAN, V45, P245; Gilks WR, 1996, MARKOV CHAIN MONTE C; Global_Asthma_Network, GLOB ASTHM REP 2014; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Hosmer DW, 2005, APPL LOGISTIC REGRES, P91, DOI 10.1002/0471722146.ch4; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; Ko Fanny W. S., 2010, Hong Kong Medical Journal, V16, P86; Laforest L, 2005, FUND CLIN PHARMACOL, V19, P107, DOI 10.1111/j.1472-8206.2004.00302.x; Lahariya C., 2013, INTRO HEALTHCARE LOW, V2013; Loh LC, 2005, ASIAN PAC J ALLERGY, V23, P7; LOURIDAS G, 1983, RESPIRATION, V44, P439, DOI 10.1159/000194582; National Asthma Council Australia, 2014, AUSTR ASTHM HDB VERS; Pharmaceutical Services Divisions. National Essential Medicine List (NEML), 2016, NAT ESS MED LIST NEM; Ranganathan SS, 2011, 18 EXP COMM M SEL US; Reiter J. P., 2006, SURV METHODOL, V32, P143; Reschovsky JD, 2015, J GEN INTERN MED, V30, P555, DOI 10.1007/s11606-015-3366-7; Safurah J, 2012, HLTH SYSTEMS TRANSIT, V2, P10; SCALABRIN DMF, 1993, J ASTHMA, V30, P51, DOI 10.3109/02770909309066380; Singapore Ministry of Health, 2008, CLIN PRACT GUID MAN; Sivasampu S., 2016, NATL MED CARE STAT N; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sy D. Q., 2007, SMJ Singapore Medical Journal, V48, P294; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tan NC, 2009, SINGAP MED J, V50, P312; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; Van Sickle D, 2006, INT J TUBERC LUNG D, V10, P1386; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Watson JP, 1997, THORAX, V52, P605, DOI 10.1136/thx.52.7.605; *WHO, 1998, GUID ATC CLASS DDD A; Wong GWK, 2013, ALLERGY, V68, P524, DOI 10.1111/all.12117; World Health Organization, 2011, SEL US ESS MED; Yuksel N, 2000, PHARMACOTHERAPY, V20, P387, DOI 10.1592/phco.20.5.387.35050; Zainudin BMZ, 2005, RESPIROLOGY, V10, P579, DOI 10.1111/j.1440-1843.2005.00753.x	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180443	10.1371/journal.pone.0180443	http://dx.doi.org/10.1371/journal.pone.0180443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662193	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300156
J	Dossou-Yovo, ER; Baggie, I; Djagba, JF; Zwart, SJ				Dossou-Yovo, Elliott Ronald; Baggie, Idriss; Djagba, Justin Fagnombo; Zwart, Sander Jaap			Diversity of inland valleys and opportunities for agricultural development in Sierra Leone	PLOS ONE			English	Article							SUSTAINABLE DEVELOPMENT; SOIL; SCHISTOSOMIASIS; AFRICA; WETLANDS	Inland valleys are becoming increasingly important agricultural production areas for rural households in sub-Saharan Africa due to their relative high and secure water availability and soil fertility. In addition, inland valleys are important as water buffer and biodiversity hot spots and they provide local communities with forest, forage, and fishing resources. As different inland-valley ecosystem functions may conflict with agricultural objectives, indiscriminate development should be avoided. This study aims to analyze the diversity of inland valleys in Sierra Leone and to develop guidelines for more precise interventions. Land use, biophysical and socio-economic data were analyzed on 257 inland valleys using spatial and multivariate techniques. Five cluster groups of inland valleys were identified: (i) semi -permanently flooded with high soil organic carbon (4.2%) and moderate available phosphorus (10.2 ppm), mostly under natural vegetation; (ii) semi -permanently flooded with low soil organic carbon (1.5%) and very low available phosphorus (3.1 ppm), abandoned by farmers; (iii) seasonally flooded with moderate soil organic carbon (3.1%) and low available phosphorus (8.3 ppm), used for rainfed rice and off-season vegetables produced without fertilizer application for household consumption and market; (iv) well drained with moderate soil organic carbon (3.8%) and moderate available phosphorus (10.0 ppm), used for rainfed rice and off-season vegetables produced with fertilizer application for household consumption and market; and (v) well drained with moderate soil organic carbon (3.6%) and moderate available phosphorus (11 ppm), used for household consumption without fertilizer application. Soil organic carbon, available phosphorus, hydrological regime, physical accessibility and market opportunity were the major factors affecting agricultural intensification of inland valleys. Opening up the areas in which inland valleys occur through improved roads and markets, and better water control through drainage infrastructures along with an integrated nutrient management would promote the sustainable agricultural use of inland valleys.	[Dossou-Yovo, Elliott Ronald; Djagba, Justin Fagnombo; Zwart, Sander Jaap] Africa Rice Ctr AfricaRice, Geog Informat Syst & Remote Sensing Unit, Cotonou, Benin; [Baggie, Idriss] SLARI, RARC, Rokupr, Sierra Leone	CGIAR; Africa Rice Center	Dossou-Yovo, ER (corresponding author), Africa Rice Ctr AfricaRice, Geog Informat Syst & Remote Sensing Unit, Cotonou, Benin.	e.dossou-yovo@cgiar.org	Zwart, Sander J/D-8366-2011; Zwart, Sander/GQA-3460-2022	Zwart, Sander J/0000-0002-5091-1801; Dossou-Yovo, Elliott/0000-0002-3565-8879	European Union [C-ECG-65-WARDA]	European Union(European Commission)	This research was conducted in the framework of the project "Realizing the agricultural potential of the inland valley lowlands in sub-Saharan Africa while maintaining their environmental services" (RAP-IV), funded by the European Union (C-ECG-65-WARDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WM, 1993, GEOGR J, V159, P209, DOI 10.2307/3451412; ANDRIESSE W, 1994, NETH J AGR SCI, V42, P159; Andriesse W., 1986, P INT WETL UT RIC PR, P15; Balasubramanian V, 2007, ADV AGRON, V94, P55, DOI 10.1016/S0065-2113(06)94002-4; Becker L, 1992, CHARACTERISATION CLA; Bontemps D, 2013, ELECTRON J STAT, V7, P2344, DOI 10.1214/13-EJS844; Conteh A. M. H., 2012, Agricultural Sciences, V3, P462, DOI 10.4236/as.2012.34054; Crowley EL, 2000, HUM ECOL, V28, P383, DOI 10.1023/A:1007005514841; Diagne A, 2013, REALIZING AFRICA'S RICE PROMISE, P35, DOI 10.1079/9781845938123.0035; Dixon AB, 2003, NAT RESOUR FORUM, V27, P117, DOI 10.1111/1477-8947.00047; DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001; Drechsel P, 2001, ECOL ECON, V38, P251, DOI 10.1016/S0921-8009(01)00167-7; Dugan PJ., 1990, WETLAND CONSERVATION; Erenstein O, 2006, AGR ECOSYST ENVIRON, V117, P205, DOI 10.1016/j.agee.2006.03.033; Frausin V, 2014, HUM ECOL, P1; GBAKIMA AA, 1994, PUBLIC HEALTH, V108, P149, DOI 10.1016/S0033-3506(05)80020-4; Giller KE, 2006, AGR SYST, V88, P8, DOI 10.1016/j.agsy.2005.06.016; Hodges MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001694; Issaka RN, 1997, GEODERMA, V75, P99, DOI 10.1016/S0016-7061(96)00083-3; Issaka RN, 1996, SOIL SCI PLANT NUTR, V42, P71, DOI 10.1080/00380768.1996.10414690; Kamara AR, 2010, IRRIGATION W AFRICA, P287; Kassam A, 2011, PADDY WATER ENVIRON, V9, P163, DOI 10.1007/s10333-011-0259-1; Kiepe P., 2006, Integrated irrigation and aquaculture in West Africa: concepts, practices and potential, P1; Koroma JB, 2011, OPHTHAL EPIDEMIOL, V18, P150, DOI 10.3109/09286586.2011.594204; Lynch K, 1999, GEOFORUM, V30, P171, DOI 10.1016/S0016-7185(99)00014-7; Lynch K, 2013, APPL GEOGR, V36, P31, DOI 10.1016/j.apgeog.2012.06.007; Masiyandima M, 2003, WETLANDS BASED LIVEL; McCartney M. P., 2004, SUSTAINABLE DEV MANA; McCartney MP, 2009, NAT RESOUR FORUM, V33, P99, DOI 10.1111/j.1477-8947.2009.01214.x; Narteh L.T., 2007, GHANA J AGR SCI, V40, P141; Novella NS, 2013, J APPL METEOROL CLIM, V52, P588, DOI 10.1175/JAMC-D-11-0238.1; Olindo P., 1992, P KWWGS SEM WETL KEN, P173; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebelo LM, 2010, WETL ECOL MANAG, V18, P557, DOI 10.1007/s11273-009-9142-x; Reeuwijk L., 1986, 9 INT SOIL REF INF C; Rodenburg J, 2014, AGR SYST, V123, P1, DOI 10.1016/j.agsy.2013.09.004; Rodenburg J, 2013, REALIZING AFRICA'S RICE PROMISE, P276, DOI 10.1079/9781845938123.0276; Saito K, 2013, REALIZING AFRICA'S RICE PROMISE, P188, DOI 10.1079/9781845938123.0188; Sakane N, 2011, WETLANDS, V31, P1103, DOI 10.1007/s13157-011-0221-4; Sys C, 1993, LAND EVALUATION AGR, V7, P67; Verhoeven JTA, 2010, ANN BOT-LONDON, V105, P155, DOI 10.1093/aob/mcp172; Windmeijer P, 1993, INT I LAND RECLAMATI; Wood A, 2008, 33 FOOD AGR ORG UN R; Yapi YG, 2005, ACTA TROP, V93, P201, DOI 10.1016/j.actatropica.2004.11.005	45	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180059	10.1371/journal.pone.0180059	http://dx.doi.org/10.1371/journal.pone.0180059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662093	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300095
J	Hingston, P; Chen, J; Allen, K; Hansen, LT; Wang, S				Hingston, Patricia; Chen, Jessica; Allen, Kevin; Hansen, Lisbeth Truelstrup; Wang, Siyun			Strand specific RNA-sequencing and membrane lipid profiling reveals growth phase-dependent cold stress response mechanisms in Listeria monocytogenes	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALTERNATIVE SIGMA-FACTORS; CELL-WALL SYNTHESIS; DNA-POLYMERASE-X; BACILLUS-SUBTILIS; HEAT-SHOCK; ESCHERICHIA-COLI; STATIONARY-PHASE; GLYCINE BETAINE; GENE-EXPRESSION	The human pathogen Listeria monocytogenes continues to pose a challenge in the food industry, where it is known to contaminate ready-to-eat foods and grow during refrigerated storage. Increased knowledge of the cold-stress response of this pathogen will enhance the ability to control it in the food-supply-chain. This study utilized strand-specific RNA sequencing and whole cell fatty acid (FA) profiling to characterize the bacterium's cold stress response. RNA and FAs were extracted from a cold-tolerant strain at five time points between early lag phase and late stationary-phase, both at 4(circle)C and 20(circle)C. Overall, more genes (1.3x) were suppressed than induced at 4(circle)C. Late stationary-phase cells exhibited the greatest number (n = 1,431) and magnitude (>1,000-fold) of differentially expressed genes (>2-fold, p<0.05) in response to cold. A core set of 22 genes was upregulated at all growth phases, including nine genes required for branched-chain fatty acid (BCFA) synthesis, the osmolyte transporter genes opuCBCD, and the internalin A and D genes. Genes suppressed at 4(circle)C were largely associated with cobalamin (B12) biosynthesis or the production/export of cell wall components. Antisense transcription accounted for up to 1.6% of total mapped reads with higher levels (2.5x) observed at 4(circle)C than 20(circle)C. The greatest number of upregulated antisense transcripts at 4 C occurred in early lag phase, however, at both temperatures, antisense expression levels were highest in late stationary-phase cells. Cold induced FA membrane changes included a 15% increase in the proportion of BCFAs and a 15% transient increase in unsaturated FAs between lag and exponential phase. These increases probably reduced the membrane phase transition temperature until optimal levels of BCFAs could be produced. Collectively, this research provides new information regarding cold-induced membrane composition changes in L. monocytogenes, the growth-phase dependency of its cold-stress regulon, and the active roles of antisense transcripts in regulating its cold stress response.	[Hingston, Patricia; Chen, Jessica; Allen, Kevin; Wang, Siyun] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Hansen, Lisbeth Truelstrup] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Chen, Jessica] IHRC Inc, Atlanta, GA USA	University of British Columbia; Technical University of Denmark	Wang, S (corresponding author), Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada.	siyun.wang@ubc.ca		Wang, Siyun/0000-0003-2468-2483; Hansen, Lisbeth Truelstrup/0000-0003-0485-5252	Alberta Innovates Bio Solutions; University of British Columbia [FSC-12-030]; Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program	Alberta Innovates Bio Solutions; University of British Columbia; Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program	This work was funded by an investment agreement between Alberta Innovates Bio Solutions and the University of British Columbia (FSC-12-030, http://bio.albertainnovates.ca.). P. Hingston was funded by an Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program Scholarship (http//www.nserc-crog.gc.ca/ Students Etudiants/PG-CS/BellandPostgrad- BelletSuperieures_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 1998, J BACTERIOL, V180, P2194, DOI 10.1128/JB.180.8.2194-2200.1998; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Ake FMD, 2011, MOL MICROBIOL, V81, P274, DOI 10.1111/j.1365-2958.2011.07692.x; Andrews S., 2010, FASTQC QUALITY CONTR; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Angelidis AS, 2002, APPL ENVIRON MICROB, V68, P2644, DOI 10.1128/AEM.68.6.2644-2650.2002; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Arguedas-Villa C, 2010, FOOD MICROBIOL, V27, P653, DOI 10.1016/j.fm.2010.02.009; Arous S, 2004, MICROBIOL-SGM, V150, P1581, DOI 10.1099/mic.0.26860-0; Balachandran P, 2012, United States patent, Patent No. [US20120009575, 20120009575]; Ballesteros M, 2001, EMBO J, V20, P5280, DOI 10.1093/emboj/20.18.5280; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967; Bayles DO, 2000, LETT APPL MICROBIOL, V30, P23, DOI 10.1046/j.1472-765X.2000.00646.x; Becker LA, 2000, J BACTERIOL, V182, P7083, DOI 10.1128/JB.182.24.7083-7087.2000; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Behrens S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083979; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; BEUMER RR, 1994, APPL ENVIRON MICROB, V60, P1359, DOI 10.1128/AEM.60.4.1359-1363.1994; Bisbiroulas P, 2011, LETT APPL MICROBIOL, V52, P275, DOI 10.1111/j.1472-765X.2010.02995.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; Bowman JP, 2008, MICROBIOL-SGM, V154, P462, DOI 10.1099/mic.0.2007/010314-0; BOYLAN SA, 1993, J BACTERIOL, V175, P3957, DOI 10.1128/JB.175.13.3957-3963.1993; Buchanan RL, 1997, J FOOD PROTECT, V60, P918, DOI 10.4315/0362-028X-60.8.918; Cabedo L, 2008, J FOOD PROTECT, V71, P855, DOI 10.4315/0362-028X-71.4.855; Cacace G, 2010, J PROTEOMICS, V73, P2021, DOI 10.1016/j.jprot.2010.06.011; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chan YC, 2008, J FOOD PROTECT, V71, P420, DOI 10.4315/0362-028X-71.2.420; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6019, DOI 10.1128/AEM.00714-07; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723; Chassaing D, 2007, FEMS MICROBIOL LETT, V275, P31, DOI 10.1111/j.1574-6968.2007.00840.x; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chen YH, 2003, J FOOD PROTECT, V66, P570, DOI 10.4315/0362-028X-66.4.570; Cordero N, 2016, FRONT MICROBIOL, P7; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; DAMMEL CS, 1995, GENE DEV, V9, P626, DOI 10.1101/gad.9.5.626; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Diaz-Acosta A, 2006, ARCH MICROBIOL, V185, P429, DOI 10.1007/s00203-006-0113-9; Diomande SE, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw174; Doyle ME, 2001, J FOOD PROTECT, V64, P410, DOI 10.4315/0362-028X-64.3.410; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Durack J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073603; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fenlon DR, 1996, J APPL BACTERIOL, V81, P641; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Fraser KR, 2003, APPL ENVIRON MICROB, V69, P2015, DOI 10.1128/AEM.69.4.2015-2022.2003; Fredriksson A, 2006, CURR OPIN MICROBIOL, V9, P612, DOI 10.1016/j.mib.2006.10.010; Gardan R, 2003, APPL ENVIRON MICROB, V69, P154, DOI 10.1128/AEM.69.1.154-161.2003; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; GARWIN JL, 1980, J BACTERIOL, V141, P1457, DOI 10.1128/JB.141.3.1457-1459.1980; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gerhardt PNM, 2000, J BACTERIOL, V182, P2544, DOI 10.1128/JB.182.9.2544-2550.2000; Gianotti A, 2008, INT J FOOD MICROBIOL, V123, P9, DOI 10.1016/j.ijfoodmicro.2007.11.039; Glaser P, 2001, SCIENCE, V294, P849; Gounot AM, 1999, PHYSL COLD ADAPTED M, P33; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Gueriri I, 2008, MICROBIOL-SGM, V154, P2251, DOI 10.1099/mic.0.2008/017590-0; Hanawa T, 2000, CELL STRESS CHAPERON, V5, P21, DOI 10.1379/1466-1268(2000)005<0021:CSATAO>2.0.CO;2; Hebraud M, 2000, FEMS MICROBIOL LETT, V190, P29, DOI 10.1016/S0378-1097(00)00310-4; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Hingston P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00369; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ivy RA, 2012, APPL ENVIRON MICROB, V78, P3824, DOI 10.1128/AEM.00051-12; Izar B, 2011, INT J MOL SCI, V12, P5070, DOI 10.3390/ijms12085070; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2008, J BACTERIOL; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Juneja V. K., 1993, J RAPID METH AUT MIC, V2, P73, DOI [10.1111/j.1745-4581.1993.tb00338.x, DOI 10.1111/J.1745-4581.1993.TB00338.X]; JUNEJA VK, 1993, J FOOD PROTECT, V56, P302, DOI 10.4315/0362-028X-56.4.302; Juneja VK, 1998, J FOOD PROTECT, V61, P683, DOI 10.4315/0362-028X-61.6.683; Jung K, 1997, J BIOL CHEM, V272, P10847; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Karatzas KAG, 2003, MOL MICROBIOL, V49, P1227, DOI 10.1046/j.1365-2958.2003.03636.x; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Knothe G, 2009, J AM OIL CHEM SOC, V86, P843, DOI 10.1007/s11746-009-1423-2; Knudsen GM, 2004, FEMS MICROBIOL LETT, V240, P171, DOI 10.1016/j.femsle.2004.09.039; KO R, 1994, J BACTERIOL, V176, P426, DOI 10.1128/JB.176.2.426-431.1994; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kovacevic J, 2013, APPL ENVIRON MICROB, V79, P1915, DOI 10.1128/AEM.03341-12; Kozak J, 1996, FOOD CONTROL, V7, P215, DOI 10.1016/S0956-7135(96)00042-4; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kullik I, 1997, ARCH MICROBIOL, V167, P151, DOI 10.1007/s002030050428; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Landolfo S, 2010, INT J FOOD MICROBIOL, V141, P229, DOI 10.1016/j.ijfoodmicro.2010.05.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasa I, 2012, RNA BIOL, V9, P1039, DOI 10.4161/rna.21167; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Lei Y, 2013, J BACTERIOL, V195, P1697, DOI 10.1128/JB.02201-12; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu SQ, 2006, APPL ENVIRON MICROB, V72, P3955, DOI 10.1128/AEM.02607-05; Liu SQ, 2002, APPL ENVIRON MICROB, V68, P1697, DOI 10.1128/AEM.68.4.1697-1705.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Markkula A, 2012, ENVIRON MICROBIOL, V14, P2223, DOI 10.1111/j.1462-2920.2012.02761.x; Mastronicolis SK, 2005, FOOD MICROBIOL, V22, P213, DOI 10.1016/j.fm.2004.08.002; Mastronicolis SK, 2010, ANTON LEEUW INT J G, V98, P307, DOI 10.1007/s10482-010-9439-z; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Mattila M, 2012, FOOD MICROBIOL, V32, P152, DOI 10.1016/j.fm.2012.05.005; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Mellin JR, 2012, RNA BIOL, V9, P372, DOI 10.4161/rna.19235; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; METZGER R, 1994, GENE, V151, P161, DOI 10.1016/0378-1119(94)90649-1; Miladi H, 2013, J FOOD BIOCHEM, V37, P136, DOI 10.1111/j.1745-4514.2011.00607.x; Mohedano ML, 2005, J BACTERIOL, V187, P2357, DOI 10.1128/JB.187.7.2357-2367.2005; Moorhead SM, 2004, INT J FOOD MICROBIOL, V91, P63, DOI 10.1016/S0168-1605(03)00332-5; Moorman MA, 2008, J FOOD PROTECT, V71, P182, DOI 10.4315/0362-028X-71.1.182; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nair S, 2000, MOL MICROBIOL, V35, P800, DOI 10.1046/j.1365-2958.2000.01752.x; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Nickel M, 2004, MOL GENET GENOMICS, V272, P98, DOI 10.1007/s00438-004-1038-0; Okada Y, 2006, FEMS MICROBIOL LETT, V263, P54, DOI 10.1111/j.1574-6968.2006.00405.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Passalacqua KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043350; PEEL M, 1988, J GEN MICROBIOL, V134, P2171; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phan-Thanh L, 1999, ELECTROPHORESIS, V20, P2214, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2214::AID-ELPS2214>3.0.CO;2-G; Pieta L, 2014, ANN MICROBIOL, V64, P1707, DOI 10.1007/s13213-014-0814-2; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Pontinen A, 2015, APPL ENVIRON MICROB, V81, P3994, DOI 10.1128/AEM.00626-15; Raimann E, 2009, FOODBORNE PATHOG DIS, V6, P583, DOI 10.1089/fpd.2008.0248; RAINES LJ, 1968, J BACTERIOL, V96, P2175, DOI 10.1128/JB.96.6.2175-2177.1968; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; SALOTRA P, 1995, FEMS MICROBIOL LETT, V131, P57, DOI 10.1111/j.1574-6968.1995.tb07754.x; SATO N, 1980, BIOCHIM BIOPHYS ACTA, V619, P353, DOI 10.1016/0005-2760(80)90083-1; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Schmid B, 2009, APPL ENVIRON MICROB, V75, P1621, DOI 10.1128/AEM.02154-08; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; SUUTARI M, 1992, BIOCHIM BIOPHYS ACTA, V1126, P119, DOI 10.1016/0005-2760(92)90281-Y; Team RC, 2015, R LANG ENV STAT COMP; Thieringer HA, 1998, BIOESSAYS, V20, P49; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOONE WM, 1991, J BACTERIOL, V173, P3291, DOI 10.1128/jb.173.11.3291-3302.1991; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Vadyvaloo V, 2002, APPL ENVIRON MICROB, V68, P5223, DOI 10.1128/AEM.68.11.5223-5230.2002; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; Verheul A, 1997, APPL ENVIRON MICROB, V63, P3451, DOI 10.1128/AEM.63.9.3451-3457.1997; Voigt K, 2014, ISME J, V8, P2056, DOI 10.1038/ismej.2014.57; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Way SS, 2004, CELL MICROBIOL, V6, P235, DOI 10.1046/j.1462-5822.2004.00360.x; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Wehner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108639; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P2912, DOI 10.1128/AEM.70.5.2912-2918.2004; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Zhang CM, 2005, J BACTERIOL, V187, P7243, DOI 10.1128/JB.187.21.7243-7253.2005; ZHENG W, 1995, APPL ENVIRON MICROB, V61, P4310, DOI 10.1128/AEM.61.12.4310-4314.1995; ZHENG W, 1994, FEMS MICROBIOL LETT, V121, P287, DOI 10.1111/j.1574-6968.1994.tb07114.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zhu K, 2005, APPL ENVIRON MICROB, V71, P8002, DOI 10.1128/AEM.71.12.8002-8007.2005; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0; Zimmermann RA, 2003, CELL, V115, P130, DOI 10.1016/S0092-8674(03)00804-3	189	25	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180123	10.1371/journal.pone.0180123	http://dx.doi.org/10.1371/journal.pone.0180123			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662112	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300107
J	Ricoldi, MST; Furlaneto, FAC; Oliveira, LFF; Teixeira, GC; Pischiotini, JP; Moreira, ALG; Ervolino, E; de Oliveira, MN; Bogsan, CSB; Salvador, SL; Messora, MR				Ricoldi, Milla S. T.; Furlaneto, Flavia A. C.; Oliveira, Luiz F. F.; Teixeira, Gustavo C.; Pischiotini, Jessica P.; Moreira, Andre L. G.; Ervolino, Edilson; de Oliveira, Marice N.; Bogsan, Cristina S. B.; Salvador, Sergio L.; Messora, Michel R.			Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats	PLOS ONE			English	Article							SALIVARY MUTANS STREPTOCOCCI; LACTOBACILLUS-RHAMNOSUS; ICE-CREAM; MICROBIOTA; LOZENGES; INFLAMMATION; MECHANISMS; ADHESION; THERAPY; STRAINS	Lactobacillus probiotics have been investigated in periodontitis. However, the effects of the genus Bifidobacterium on periodontitis are hardly known. This study evaluated the effects of the probiotic (PROB) Bifidobacterium animalis subsp. lactis (B. lactis) HN019 as an adjunct to scaling and root planing (SRP) in rats with experimental periodontitis (EP). At baseline, 32 rats were assigned to 4 groups: C (control), PROB, EP-SRP and EP-SRP-PROB. In groups EP-SRP and EP-SRP-PROB, the mandibular first molars of the animals received a ligature. At day 14, the ligatures were removed and SRP was performed. Animals of groups PROB and EP-SRP-PROB were orally administered with 10 mL/day of 10(9) colony forming units of B. lactis HNO19 for 15 days, starting at day 14. Animals were euthanized at day 29. Histomorphometric, microtomographic and immunohistochemical analyses were performed. Microbiological effects of B. lactis on biofilm were also evaluated. Data were statistically analyzed (ANOVA, Tukey; Kruskal-Wallis, Dunn's; Two-tailed t-test; p<0.05). Group EP-SRP-PROB presented reduced alveolar bone resorption and attachment loss when compared with Group EP-SRP (p<0.05). Group EP-SRP-PROB showed significantly fewer osteoclasts, increased expression of anti-inflammatory cytokines and reduced expression of proinflammatory cytokines compared with Group EP-SRP (p<0.05). B. lactis promoted a higher ratio between aerobic and anaerobic bacteria in biofilm samples (p<0.05). B. lactis HNO19 may have a role in the treatment of EP in rats, as an adjunct to SRP.	[Ricoldi, Milla S. T.; Furlaneto, Flavia A. C.; Oliveira, Luiz F. F.; Teixeira, Gustavo C.; Pischiotini, Jessica P.; Messora, Michel R.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ribeirao Preto, SP, Brazil; [Ervolino, Edilson] UNESP Univ Estadual Paulista, Dent Sch Aracatuba, Div Histol, Dept Basic Sci, Aracatuba, SP, Brazil; [de Oliveira, Marice N.; Bogsan, Cristina S. B.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, SP, Brazil; [Salvador, Sergio L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Messora, MR (corresponding author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, Ribeirao Preto, SP, Brazil.	m.messora@forp.usp.br	Ervolino, Edilson/D-1500-2018; Bogsan, Cristina S. B./E-7911-2011; Salvador, Sergio/G-1015-2019; Furlaneto, Flavia/C-4171-2013; Messora, Michel/F-3480-2012	Bogsan, Cristina S. B./0000-0003-1778-4043; Furlaneto, Flavia/0000-0002-8072-3983; ervolino, edilson/0000-0003-4859-0583; Salvador, Sergio Luiz/0000-0002-4867-7294; Messora, Michel/0000-0001-8485-9645	Sao Paulo Research Foundation (FAPESP) [2012/18313-2, 2012/18785-1]; Sao Paulo Research Foundation (FAPESP scholarship)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP scholarship)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) - www.fapesp.br; Scholarship to GCT (#2012/18313-2); Scholarship to JPP (#2012/18785-1).; The authors thank Sao Paulo Research Foundation (FAPESP scholarship to GCT and JPP). The authors also thank Marina Del Arco (Laboratory Assistant, Department Clinical Analyses, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo USP, Ribeirao Preto / SP, Brazil) for technical support during the microbiological procedures.	Araya M, 2002, JOINT FAO WHO WORK G; Biavati B, 2000, ANN MICROBIOL, V50, P117; Caglar E, 2008, ACTA ODONTOL SCAND, V66, P154, DOI 10.1080/00016350802089467; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dereka XE, 2006, GROWTH FACTORS, V24, P260, DOI 10.1080/08977190601060990; Furlaneto FAC, 2014, J PERIODONTOL, V85, P1291, DOI 10.1902/jop.2014.130581; Gill HS, 2000, BRIT J NUTR, V83, P167, DOI 10.1017/S0007114500000210; Grossner-Schreiber B, 2006, J CLIN PERIODONTOL, V33, P478, DOI 10.1111/j.1600-051X.2006.00942.x; Haukioja A, 2006, ORAL MICROBIOL IMMUN, V21, P326, DOI 10.1111/j.1399-302X.2006.00299.x; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Hoffman FA, 2008, CLIN INFECT DIS, V46, pS53, DOI 10.1086/523342; Ince G, 2015, J PERIODONTOL, V86, P746, DOI 10.1902/jop.2015.140612; Lisboa MRP, 2015, J PERIODONTOL, V86, P801, DOI 10.1902/jop.2015.140630; Liu C, 2010, WORLD J GASTROENTERO, V16, P2283, DOI 10.3748/wjg.v16.i18.2283; Maekawa T, 2014, J PERIODONTAL RES, V49, P785, DOI 10.1111/jre.12164; Martins AKS, 2010, ARCH MICROBIOL, V192, P995, DOI 10.1007/s00203-010-0626-0; Messora MR, 2016, ARCH ORAL BIOL, V66, P108, DOI 10.1016/j.archoralbio.2016.02.014; Messora MR, 2013, J PERIODONTOL, V84, P1818, DOI 10.1902/jop.2013.120644; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nissen L, 2014, ANN MICROBIOL, V64, P611, DOI 10.1007/s13213-013-0694-x; Oliveira LFF, 2016, J PERIODONTOL, V23, P1; Ouwehand AC, 2008, FEMS IMMUNOL MED MIC, V53, P18, DOI 10.1111/j.1574-695X.2008.00392.x; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Prasad J, 1998, INT DAIRY J, V8, P993, DOI 10.1016/S0958-6946(99)00024-2; Prescott SL, 2008, CLIN EXP ALLERGY, V38, P1606, DOI 10.1111/j.1365-2222.2008.03061.x; Shah MP, 2013, J CLIN DIAGN RES, V7, P595, DOI 10.7860/JCDR/2013/5225.2834; Singh R, 2011, ACTA ODONTOL SCAND, V69, P389, DOI 10.3109/00016357.2011.572289; Tekce M, 2015, J CLIN PERIODONTOL, V42, P363, DOI 10.1111/jcpe.12387; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Teughels W, 2013, J CLIN PERIODONTOL, V40, P1025, DOI 10.1111/jcpe.12155; Teughels W, 2011, J CLIN PERIODONTOL, V38, P159, DOI 10.1111/j.1600-051X.2010.01665.x; Toiviainen A, 2015, CLIN ORAL INVEST, V19, P77, DOI 10.1007/s00784-014-1221-6; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Vivekananda M R, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5344; Zhang Y, 2015, J PERIODONTAL RES, V50, P141, DOI 10.1111/jre.12193	35	35	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179946	10.1371/journal.pone.0179946	http://dx.doi.org/10.1371/journal.pone.0179946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662142	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300079
J	Bocalini, DS; Bergamin, M; Evangelista, AL; Rica, RL; Pontes, FL; Figueira, A; Serra, AJ; Rossi, EM; Tucci, PJF; dos Santos, L				Bocalini, Danilo Sales; Bergamin, Marco; Evangelista, Alexandre Lopes; Rica, Roberta Luksevicius; Pontes Junior, Francisco Luciano; Figueira Junior, Aylton; Serra, Andrey Jorge; Rossi, Emilly Martinelli; Ferreira Tucci, Paulo Jose; dos Santos, Leonardo			Post-exercise hypotension and heart rate variability response after water- and landergometry exercise in hypertensive patients	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; PHYSICAL-EXERCISE; IMMERSION; REDUCTION; FITNESS; HUMANS	Background systemic arterial hypertension is the most prevalent cardiovascular disease; physical activity for hypertensive patients is related to several beneficial cardiovascular adaptations. This paper evaluated the effect of water- and land-ergometry exercise sessions on post-exercise hypotension (PEH) of healthy normotensive subjects versus treated or untreated hypertensive patients. Methods Forty-five older women composed three experimental groups: normotensive (N, n = 10), treated hypertensive (TH, n = 15) and untreated hypertensive (UH, n = 20). The physical exercise acute session protocol was performed at 75% of maximum oxygen consumption (VO2max) for 45 minutes; systolic (SBP), diastolic (DBP) and mean (MBP) blood pressure were evaluated at rest, peak and at 15, 30, 45, 60, 75 and 90 minutes after exercise cessation. Additionally, the heart rate variability (HRV) was analyzed by R-R intervals in the frequency domain for the assessment of cardiac autonomic function. Results In both exercise modalities, equivalent increases in SBP were observed from rest to peak exercise for all groups, and during recovery, significant PEH was noted. At 90 minutes after the exercise session, the prevalence of hypotension was significantly higher in water-than in the land-based protocol. Moreover, more pronounced reductions in SBP and DBP were observed in the UH patients compared to TH and N subjects. Finally, exercise in the water was more effective in restoring HRV during recovery, with greater effects in the untreated hypertensive group. Conclusion Our data demonstrated that water-ergometry exercise was able to induce expressive PEH and improve cardiac autonomic modulation in older normotensive, hypertensive treated or hypertensive untreated subjects when compared to conventional land-ergometry.	[Bocalini, Danilo Sales; Rica, Roberta Luksevicius; Figueira Junior, Aylton] Univ Sao Judas Tadeu, Postgrad Program Phys Educ, Translat Physiol Lab, Sao Paulo, Brazil; [Bocalini, Danilo Sales] Univ Sao Judas Tadeu, Postgrad Program Aging, Sao Paulo, Brazil; [Bergamin, Marco] Univ Padua, Dept Med, Sport & Exercise Med Div, Padua, Italy; [Evangelista, Alexandre Lopes] Univ Sao Paulo, Dept Phys Educ, Sao Paulo, Brazil; [Pontes Junior, Francisco Luciano] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Serra, Andrey Jorge] Nove de Julho Univ, Postgrad Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Rossi, Emilly Martinelli; dos Santos, Leonardo] Univ Fed Espirito Santo, Dept Physiol Sci, Espirito Santo, Brazil; [Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, Sao Paulo Med Sch, Div Cardiol, Dept Med, Sao Paulo, Brazil	Universidade Sao Judas Tadeu; Universidade Sao Judas Tadeu; University of Padua; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	dos Santos, L (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Espirito Santo, Brazil.	leodossantos@hotmail.com	Serra, Andrey Jorge/E-7460-2015; dos Santos, Leonardo/B-6509-2013; Júnior, Francisco Luciano Pontes/ABG-1497-2020; Figueira, Aylton Jose/AAO-2458-2021; Evangelista, Alexandre L/S-2409-2016	Serra, Andrey Jorge/0000-0002-5407-8183; dos Santos, Leonardo/0000-0002-4340-6364; Júnior, Francisco Luciano Pontes/0000-0002-8358-0260; Figueira Junior, Aylton/0000-0002-6635-8019				[Anonymous], 2010, IND RISK PROT FACT; Anunciacao PG, 2011, ARQ BRAS CARDIOL, V96, pE100, DOI 10.1590/S0066-782X2011005000025; Aquatic Exercise Association, 2006, AQ FITN MAN; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bocalini DS, 2008, GERIATR GERONTOL INT, V8, P265, DOI 10.1111/j.1447-0594.2008.00485.x; Bocalini DS, 2010, CLINICS, V65, P1305, DOI 10.1590/S1807-59322010001200013; Jardim PCBV, 2016, ARQ BRAS CARDIOL, V107, P93, DOI 10.5935/abc.20160120; Casonatto J, 2009, REV BRAS MED ESPORTE, V15, P151, DOI 10.1590/S1517-86922009000200014; Cozza IC, 2012, HYPERTENS RES, V35, P82, DOI 10.1038/hr.2011.162; Elvan-Taspinar A, 2006, AM J OBSTET GYNECOL, V195, P1590, DOI 10.1016/j.ajog.2006.05.007; EPSTEIN M, 1992, PHYSIOL REV, V72, P563, DOI 10.1152/physrev.1992.72.3.563; FERNHALL B, 1992, MED SCI SPORT EXER, V24, P139; Fitz-Simon Nicola, 2005, Ther Clin Risk Manag, V1, P93, DOI 10.2147/tcrm.1.2.93.62915; Forjaz CLM, 2004, J SPORT MED PHYS FIT, V44, P54; Gabrielsen A, 1996, J Gravit Physiol, V3, P22; Gabrielsen A, 2000, AM J PHYSIOL-REG I, V278, pR1583, DOI 10.1152/ajpregu.2000.278.6.R1583; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Graef Fabiane Inês, 2006, Rev Bras Med Esporte, V12, P221, DOI 10.1590/S1517-86922006000400011; Guimaraes GV, 2013, BLOOD PRESS MONIT, V18, P342, DOI 10.1097/MBP.0000000000000000; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Kanavos P, 2007, HIGH BLOOD PRESSURE; Kulics JM, 1999, AM J PHYSIOL-HEART C, V276, pH27, DOI 10.1152/ajpheart.1999.276.1.H27; LIN YC, 1984, UNDERSEA BIOMED RES, V11, P123; Lovato NS, 2012, REV BRAS MED ESPORTE, V18, P22, DOI 10.1590/S1517-86922012000100004; MacDonald JR, 2000, J HUM HYPERTENS, V14, P125, DOI 10.1038/sj.jhh.1000953; Malliani Alberto, 2005, Eur J Intern Med, V16, P12, DOI 10.1016/j.ejim.2004.06.016; Manikonda JP, 2008, J HUM HYPERTENS, V22, P138, DOI 10.1038/sj.jhh.1002275; Meyer K, 2004, MED SCI SPORT EXER, V36, P2017, DOI 10.1249/01.MSS.0000147591.19416.39; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Perkins SE, 2016, J SCI MED SPORT, V16, P30152; PESCATELLO LS, 1991, CIRCULATION, V83, P1557, DOI 10.1161/01.CIR.83.5.1557; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Pontes Júnior Francisco Luciano, 2010, Rev. Bras. Ciênc. Esporte, V32, P229; Quinn TJ, 2000, J HUM HYPERTENS, V14, P547, DOI 10.1038/sj.jhh.1001106; Reilly T, 2003, J SPORT SCI, V21, P959, DOI 10.1080/02640410310001641368; Rodriguez D, 2011, INT J GEN MED, V4, P549, DOI 10.2147/IJGM.S23094; Rondon MUP, 2002, J AM COLL CARDIOL, V39, P676, DOI 10.1016/S0735-1097(01)01789-2; Routledge FS, 2010, CAN J CARDIOL, V26, P303, DOI 10.1016/S0828-282X(10)70395-0; Serra AJ, 2009, CONSCIENTIAE SAUDE, V8, P19, DOI [10.1364/OE.22.031568, DOI 10.1364/OE.22.031568]; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Takeshima N, 2002, MED SCI SPORT EXER, V34, P544, DOI 10.1097/00005768-200203000-00024; Tuomainen P, 2005, LIFE SCI, V77, P2723, DOI 10.1016/j.lfs.2005.05.023; Wallace JP, 1999, J HUM HYPERTENS, V13, P361, DOI 10.1038/sj.jhh.1000797; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P621, DOI 10.1152/jappl.2000.89.2.621; WHO, 2002, RED RISKS PROM HLTH	47	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180216	10.1371/journal.pone.0180216	http://dx.doi.org/10.1371/journal.pone.0180216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658266	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900066
J	Junot, S; Keroak, S; Del Castillo, JRE; Ayoub, JY; Paquet, C; Bonnet-Garin, JM; Troncy, E				Junot, Stephane; Keroak, Stephanie; Del Castillo, Jerome R. E.; Ayoub, Jean-Yves; Paquet, Christian; Bonnet-Garin, Jeanne-Marie; Troncy, Eric			Inhaled nitric oxide prevents NSAID-induced renal impairment in pseudo-normovolaemic piglets	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-FLOW; MECHANISMS; RISK; NO; CYCLOOXYGENASE-2; METAANALYSIS; ANESTHETICS; THERAPY	Objective Inhaled nitric oxide (iNO) is commonly used as a treatment of pulmonary hypertension. Its action is purported to be specific to the lung, but extrapulmonary effects have been reported. The objective of this study was to evaluate if iNO could compensate the renal impairment induced by ketoprofen, a conventional non-steroidal anti-inflammatory drug (NSAID), during general anaesthesia. Methods Under pseudo-normovolaemic condition, thirty piglets were randomly assigned into 5 equal groups and equipped for renal and systemic parameters measurements. A first experiment was carried out to validate methods and reproduce the renal effects of iNO (40 ppm) in comparison with a placebo (100% oxygen). In a second experiment, iNO was inhaled for 120 minutes right after NSAID treatment (ketoprofen 2 mgxkg(-1) IV, and 40 ppm iNO; group KiNO) and its effects were compared to ketoprofen alone (2 mgxkg(-1) IV; group K) and placebo (saline; group C). Results In this model, iNO increased significantly renal blood flow measured by ultrasonic (RBFUL: +53.2 +/- 17.2%; p = 0.008) and by PAH clearance (RBFPAH: +78.6 +/- 37.6%; p = 0.004) methods, glomerular filtration rate (GFR: +72.6 +/- 32.5%; p = 0.006) and urinary output (UO: +47.4 +/- 24.2%; p = 0.01). In the second experiment, no significant temporal variation was noted for renal parameters in groups KiNO and C, whereas a significant and constant decrease was observed in the group K for RBFUL (max - 19.0 +/- 7.1%), GFR (max -26.6 +/- 10.4%) and UO (max -30.3 +/- 10.5%). Clinical significance Our experiments show that iNO, released from its transport forms after its inhalation, can improve renal safety of NSAIDs. This result is promising regarding the use of NSAIDs in critical conditions, but needs to receive clinical confirmation.	[Junot, Stephane; Ayoub, Jean-Yves; Paquet, Christian; Bonnet-Garin, Jeanne-Marie] Univ Lyon, VetAgro Sup, APCSE unit, Vet Campus Lyon, Marcy Letoile, France; [Keroak, Stephanie; Del Castillo, Jerome R. E.; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Vet Biomed, GREPAQ Res Grp Anim Pharmacol Quebec, St Hyacinthe, PQ, Canada	VetAgro Sup; Universite de Montreal	Junot, S (corresponding author), Univ Lyon, VetAgro Sup, APCSE unit, Vet Campus Lyon, Marcy Letoile, France.	stephane.junot@vetagro-sup.fr	del Castillo, Jérôme RE/J-6976-2013; Troncy, Eric/J-6650-2013; del Castillo, Jerome/AAM-9409-2020	del Castillo, Jérôme RE/0000-0001-5046-7926; Troncy, Eric/0000-0003-0209-5261; del Castillo, Jerome/0000-0001-5046-7926; Bonnet Garin, Jeanne-Marie/0000-0001-5350-338X	Scientific Council of Ecole Nationale Veterinaire de Lyon; Canadian Institutes of Health Research Strategic and Training Initiative in Health Research; Gasotransmitter REsearch And Training (GREAT) Program; Canada Foundation for Innovation [9483]; French Agriculture Ministry [EA4173]	Scientific Council of Ecole Nationale Veterinaire de Lyon; Canadian Institutes of Health Research Strategic and Training Initiative in Health Research(Canadian Institutes of Health Research (CIHR)); Gasotransmitter REsearch And Training (GREAT) Program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); French Agriculture Ministry	This study has been supported by an unrestricted operating grant (Troncy) from the Scientific Council of Ecole Nationale Veterinaire de Lyon, a Canadian Institutes of Health Research Strategic and Training Initiative in Health Research: Gasotransmitter REsearch And Training (GREAT) Program grant, a Canada Foundation for Innovation (#9483,Troncy) supporting materials, and internal grant from French Agriculture Ministry (EA4173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DSC, 2009, CLIN DRUG INVEST, V29, p703 ; BATTILANA C, 1991, AM J PHYSIOL, V261, pF726, DOI 10.1152/ajprenal.1991.261.4.F726; Beierwaltes WH, 2002, AM J PHYSIOL-RENAL, V283, pF68, DOI 10.1152/ajprenal.00364.2001; Bennett WM, 1996, AM J KIDNEY DIS, V28, pS56, DOI 10.1016/S0272-6386(96)90570-3; Brater DC, 1999, AM J MED, V107, P65, DOI [10.1016/s0002-9343(99)00369-1, DOI 10.1016/S0002-9343(99)00369-1]; Calvert S, 2012, PERIOPER MED-LONDON, V1, DOI 10.1186/2047-0525-1-6; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Crawford JH, 2015, FUTUR SCI OA, V1, DOI 10.4155/FSO.15.34; Cuzzocrea S, 2007, KIDNEY INT, V71, P290, DOI 10.1038/sj.ki.5002058; Decosterd LA, 1997, J CHROMATOGR B, V703, P25, DOI 10.1016/S0378-4347(97)00396-4; Finlay S, 2013, CLIN MED, V13, P233, DOI 10.7861/clinmedicine.13-3-233; Fox-Robichaud A, 1998, J CLIN INVEST, V101, P2497, DOI 10.1172/JCI2736; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Gameiro J, 2016, CLIN KIDNEY J, V9, P192, DOI 10.1093/ckj/sfv144; Gianetti J, 2004, J THORAC CARDIOV SUR, V127, P44, DOI 10.1016/j.jtcvs.2002.08.001; Goranson SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096594; Goren O, 2015, BRIT J ANAESTH, V115, P3, DOI 10.1093/bja/aev380; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Junot S, 2008, CAN J PHYSIOL PHARM, V86, P55, DOI [10.1139/Y07-123, 10.1139/y07-123]; Kam PCA, 2001, ANAESTHESIA, V56, P494, DOI 10.1046/j.1365-2044.2001.02047-18.x; KING AJ, 1991, J AM SOC NEPHROL, V1, P1271; KUEHNLE HF, 1992, NEPHRON, V62, P104, DOI 10.1159/000187006; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; LINK L, 1985, PFLUG ARCH EUR J PHY, V405, P66, DOI 10.1007/BF00591099; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; McMahon Timothy J, 2006, Proc Am Thorac Soc, V3, P153, DOI 10.1513/pats.200507-066BG; Mockel M, 2001, KIDNEY INT, V59, P1439, DOI 10.1046/j.1523-1755.2001.0590041439.x; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Onuigbo MAC, 2015, J RENAL INJ PREV, V4, P61, DOI 10.12861/jrip.2015.13; Ruan SY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0880-2; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Toto R D, 1995, Curr Opin Nephrol Hypertens, V4, P505, DOI 10.1097/00041552-199511000-00009; Troncy E, 1997, BRIT J ANAESTH, V79, P631, DOI 10.1093/bja/79.5.631; Troncy E, 2006, NITRIC OXIDE-BIOL CH, V14, P261, DOI 10.1016/j.niox.2006.01.004; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang TL, 2003, CAN J ANAESTH, V50, P839, DOI 10.1007/BF03019384; Whelton A., 1999, AM J MED, V106, p13S, DOI [10.1016/s0002-9343(99)00113-8, DOI 10.1016/S0002-9343(99)00113-8]; Wraight WM, 2001, BRIT J ANAESTH, V86, P267, DOI 10.1093/bja/86.2.267; Yoo YC, 2014, KIDNEY INT, V86, P414, DOI 10.1038/ki.2013.532; Ziyyat A, 1996, BRIT J PHARMACOL, V119, P388, DOI 10.1111/j.1476-5381.1996.tb15998.x	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179475	10.1371/journal.pone.0179475	http://dx.doi.org/10.1371/journal.pone.0179475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658254	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900025
J	Abriouel, H; Montoro, BP; Munoz, MDC; Knapp, CW; Galvez, A; Benomar, N				Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Knapp, Charles W.; Galvez, Antonio; Benomar, Nabil			In silico genomic insights into aspects of food safety and defense mechanisms of a potentially probiotic Lactobacillus pentosus MP-10 isolated from brines of naturally fermented Alorena green table olives	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTIC-RESISTANCE; ANTIVIRAL DEFENSE; IDENTIFICATION; SEQUENCE; GENES; PROKARYOTES; ANNOTATION; DIVERSITY; EMPHASIS	Lactobacillus pentosus MP-10, isolated from brines of naturally fermented Alorena green table olives, exhibited high probiotic potential. The genome sequence of L. pentosus MP10 is currently considered the largest genome among lactobacilli, highlighting the microorganism's ecological flexibility and adaptability. Here, we analyzed the complete genome sequence for the presence of acquired antibiotic resistance and virulence determinants to understand their defense mechanisms and explore its putative safety in food. The annotated genome sequence revealed evidence of diverse mobile genetic elements, such as prophages, transposases and transposons involved in their adaptation to brine-associated niches. In-silico analysis of L. pentosus MP-10 genome sequence identified a CRISPR (clustered regularly interspaced short palindromic repeats)/cas (CRISPR-associated protein genes) as an immune system against foreign genetic elements, which consisted of six arrays (4-12 repeats) and eleven predicted cas genes [CRISPR1 and CRISPR2 consisted of 3 (Type II-C) and 8 (Type I) genes] with high similarity to L. pentosus KCA1. Bioinformatic analyses revealed L. pentosus MP-10 to be absent of acquired antibiotic resistance genes, and most resistance genes were related to efflux mechanisms; no virulence determinants were found in the genome. This suggests that L. pentosus MP-10 could be considered safe and with high-adaptation potential, which could facilitate its application as a starter culture and probiotic in food preparations.	[Abriouel, Hikmate; Perez Montoro, Beatriz; Casado Munoz, Maria del Carmen; Galvez, Antonio; Benomar, Nabil] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain; [Knapp, Charles W.] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland	Universidad de Jaen; University of Strathclyde	Abriouel, H (corresponding author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen, Spain.	hikmate@ujaen.es	Galvez, Antonio/M-2359-2014; Abriouel, Hikmate/K-9769-2017; Knapp, Charles W/D-3373-2009	Galvez, Antonio/0000-0002-5894-5029; Knapp, Charles W/0000-0001-7997-8543; Abriouel, Hikmate/0000-0002-0666-3978; CASADO MUNOZ, MARIA DEL CARMEN/0000-0002-1526-424X	Ministerio de Economia y Competitividad, MINECO, FEDER [AGL2013-43571-P]; Plan Propio UJA [UJA2014/07/02];  [EI_BI01_2017]	Ministerio de Economia y Competitividad, MINECO, FEDER; Plan Propio UJA; 	Research grant AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), HA. Research grant UJA2014/07/02 (Plan Propio UJA), HA. Research Team EI_BI01_2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge research grants AGL2013-43571-P (Ministerio de Economia y Competitividad, MINECO, FEDER), UJA2014/07/02 (Plan Propio UJA) and Research Team EI_BIO01_2017.	Abriouel H, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00854-16; Abriouel H, 2011, J BACTERIOL, V193, P4559, DOI 10.1128/JB.05171-11; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Andreoletti O, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.923; Anukam KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059239; Bartkiene E, 2013, FOOD TECHNOL BIOTECH, V51, P471; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cammarota M, 2009, INT J FOOD MICROBIOL, V135, P90, DOI 10.1016/j.ijfoodmicro.2009.08.022; Munoz MDC, 2016, INT J FOOD MICROBIOL, V222, P8, DOI 10.1016/j.ijfoodmicro.2016.01.012; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; Di Cagno R, 2010, FOOD MICROBIOL, V27, P381, DOI 10.1016/j.fm.2009.11.012; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Florez AB, 2006, FEMS MICROBIOL LETT, V263, P21, DOI 10.1111/j.1574-6968.2006.00371.x; Food and Agriculture Organization of the United Nations World Health Organization, 2002, REP JOINT FAO WHO WO; Fournier B, 2000, J BACTERIOL, V182, P664, DOI 10.1128/JB.182.3.664-671.2000; Granato D, 2010, COMPR REV FOOD SCI F, V9, P292, DOI 10.1111/j.1541-4337.2010.00110.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaomanjaka F, 2013, INT J FOOD MICROBIOL, V166, P331, DOI 10.1016/j.ijfoodmicro.2013.06.032; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Maldonado-Barragan A, 2011, J BACTERIOL, V193, P5605, DOI 10.1128/JB.05736-11; Mercanti DJ, 2016, APPL ENVIRON MICROB, V82, P95, DOI 10.1128/AEM.02723-15; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Ranadheera RDCS, 2010, FOOD RES INT, V43, P1, DOI 10.1016/j.foodres.2009.09.009; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shanahan F, 2012, GASTROENTEROL CLIN N, V41, P869, DOI 10.1016/j.gtc.2012.08.006; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Spurr Harvey W. Jr., 1994, P11; Swain MR, 2012, BIOTECHNOL RES INT, V2014; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Venema K, 2015, PROBIOTICS AND PREBIOTICS: CURRENT RESEARCH AND FUTURE TRENDS, P29; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wacher C., 2010, FERMENTED FOODS BEVE, P149, DOI DOI 10.1201/EBK1420094954-C5; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yoon BH, 2011, ARCH VIROL, V156, P1681, DOI 10.1007/s00705-011-1048-2; Yoshida K, 2004, J BACTERIOL, V186, P5640, DOI 10.1128/JB.186.17.5640-5648.2004; Young JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038077; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang WY, 2010, INT J DAIRY TECHNOL, V63, P413, DOI 10.1111/j.1471-0307.2010.00576.x; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	47	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0176801	10.1371/journal.pone.0176801	http://dx.doi.org/10.1371/journal.pone.0176801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651019	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000404537300044
J	Davoine, C; Abreu, IN; Khajeh, K; Blomberg, J; Kidd, BN; Kazan, K; Schenk, PM; Gerber, L; Nilsson, O; Moritz, T; Bjorklund, S				Davoine, Celine; Abreu, Ilka N.; Khajeh, Khalil; Blomberg, Jeanette; Kidd, Brendan N.; Kazan, Kemal; Schenk, Peer M.; Gerber, Lorenz; Nilsson, Ove; Moritz, Thomas; Bjorklund, Stefan			Functional metabolomics as a tool to analyze Mediator function and structure in plants	PLOS ONE			English	Article							RNA-POLYMERASE-II; GLUCOSINOLATE-DERIVED ISOTHIOCYANATES; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; SALICYLIC-ACID; SUBUNIT MED25; COMPLEX; DEFENSE; RESISTANCE; JASMONATE	Mediator is a multiprotein transcriptional co-regulator complex composed of four modules; Head, Middle, Tail, and Kinase. It conveys signals from promoter-bound transcriptional regulators to RNA polymerase II and thus plays an essential role in eukaryotic gene regulation. We describe subunit localization and activities of Mediator in Arabidopsis through metabolome and transcriptome analyses from a set of Mediator mutants. Functional metabolomic analysis based on the metabolite profiles of Mediator mutants using multivariate statistical analysis and heat-map visualization shows that different subunit mutants display distinct metabolite profiles, which cluster according to the reported localization of the corresponding subunits in yeast. Based on these results, we suggest localization of previously unassigned plant Mediator subunits to specific modules. We also describe novel roles for individual subunits in development, and demonstrate changes in gene expression patterns and specific metabolite levels in med18 and med25, which can explain their phenotypes. We find that med18 displays levels of phytoalexins normally found in wild type plants only after exposure to pathogens. Our results indicate that different Mediator subunits are involved in specific signaling pathways that control developmental processes and tolerance to pathogen infections.	[Davoine, Celine; Khajeh, Khalil; Blomberg, Jeanette; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Abreu, Ilka N.; Gerber, Lorenz; Nilsson, Ove; Moritz, Thomas] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Kidd, Brendan N.; Schenk, Peer M.] Univ Queensland, Plant Microbe Interact Lab, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Kidd, Brendan N.; Kazan, Kemal] CSIRO Agr & Food, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld, Australia; [Kazan, Kemal] Univ Queensland, QAAFI, St Lucia, Qld, Australia; [Kidd, Brendan N.] CSIRO Agr & Food, Ctr Environm & Life Sci, Floreat, WA, Australia	Umea University; Swedish University of Agricultural Sciences; Umea University; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	stefan.bjorklund@umu.se	Kidd, Brendan N/D-9801-2017; Kazan, Kemal/B-8032-2008; Schenk, Peer/B-7879-2016; Kidd, Brendan/J-9672-2014	Kazan, Kemal/0000-0002-5169-8934; Schenk, Peer/0000-0003-4878-3799; Abreu, Ilka N/0000-0003-4728-0161; Kidd, Brendan/0000-0003-1770-1404; Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning; Swedish Cancer Society [15 0537]; Swedish Research Council; Swedish Governmental Agency for Innovation Systems; Knut and Alice Wallenberg Foundation; Kempe Foundation; Australian Research Council [DP110104354]	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe Foundation; Australian Research Council(Australian Research Council)	This work was supported by grants from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (www.formas.se) to TM; the Swedish Cancer Society (www.cancerfonden.se Grant no. 15 0537) to SB; the Swedish Research Council (www.vr.se) to SB and ON; the Swedish Governmental Agency for Innovation Systems (www.vinnova.se/en) to SB and ON; the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw) to SB and TM, the Kempe Foundation (www.kempe.com) to SB, TM, and the Australian Research Council (http://www.arc.gov.au, Grant no. DP110104354) to PMS, BK and KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; An CF, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23182; Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Blomberg J, 2012, NUCLEIC ACIDS RES, V40, P5938, DOI 10.1093/nar/gks265; Bottcher C, 2007, PLANTA, V226, P629, DOI 10.1007/s00425-007-0511-5; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Fallath T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176022; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gobel C, 2009, PHYTOCHEMISTRY, V70, P1485, DOI 10.1016/j.phytochem.2009.07.040; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pinto RC, 2012, ANAL CHEM, V84, P8675, DOI 10.1021/ac301869p; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Stotz HU, 2011, PLANT J, V67, P81, DOI 10.1111/j.1365-313X.2011.04578.x; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; van den Burg HA, 2010, PLANT CELL, V22, P1998, DOI 10.1105/tpc.109.070961; Wasternack C., 2007, ANN BOT, V4, P1933; Yang WY, 2007, J BIOL CHEM, V282, P18116, DOI 10.1074/jbc.M700405200; Yang Y, 2014, PLANT J, V77, P838, DOI 10.1111/tpj.12440; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179640	10.1371/journal.pone.0179640	http://dx.doi.org/10.1371/journal.pone.0179640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640868	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800047
J	Dulau, V; Estrade, V; Fayan, J				Dulau, Violaine; Estrade, Vanessa; Fayan, Jacques			Identifying key demographic parameters of a small island-associated population of Indo-Pacific bottlenose dolphins (Reunion, Indian Ocean)	PLOS ONE			English	Article							ESTIMATE TEMPORARY EMIGRATION; CAPTURE-RECAPTURE DATA; TURSIOPS-ADUNCUS; SITE FIDELITY; ROBUST DESIGN; VIABILITY ANALYSIS; COASTAL WATERS; SOUTH-AFRICA; ALGOA BAY; SIZE	Photo-identification surveys of Indo-Pacific bottlenose dolphins were conducted from 2009 to 2014 off Reunion Island (55 degrees E33'/21 degrees S07'), in the Indian Ocean. Robust Design models were applied to produce the most reliable estimate of population abundance and survival rate, while accounting for temporary emigration from the survey area (west coast). The sampling scheme consisted of a five-month (June-October) sampling period in each year of the study. The overall population size at Reunion was estimated to be 72 individuals (SE = 6.17, 95% CI = 61-85), based on a random temporary emigration (gamma") of 0.096 and a proportion of 0.70 (SE = 0.03) distinct individuals. The annual survival rate was 0.93 (+/- 0.018 SE, 95% CI = 0.886-0.958) and was constant over time and between sexes. Models considering gender groups indicated different movement patterns between males and females. Males showed null or quasi-null temporary emigration (gamma" = gamma' < 0.01), while females showed a random temporary emigration (gamma") of 0.10, suggesting that a small proportion of females was outside the survey area during each primary sampling period. Sex-specific temporary migration patterns were consistent with movement and residency patterns observed in other areas. The Robust Design approach provided an appropriate sampling scheme for deriving island-associated population parameters, while allowing to restrict survey effort both spatially (i.e. west coast only) and temporally (five months per year). Although abundance and survival were stable over the six years, the small population size of fewer than 100 individuals suggested that this population is highly vulnerable. Priority should be given to reducing any potential impact of human activity on the population and its habitat.	[Dulau, Violaine; Estrade, Vanessa] GLOBICE Reunion, St Pierre, Reunion Island, France; [Fayan, Jacques] BNOI ONCFS, Parc Providence, St Denis, Reunion Island, France		Dulau, V (corresponding author), GLOBICE Reunion, St Pierre, Reunion Island, France.	violaine.dulau@globice.org		Dulau-Drouot, Violaine/0000-0002-2228-3959	Direction de l'Environnement de l'Amenagement et du Logement [DEAL/CP02011/11, CP02014/02]; Office Nationale de la Chasse et de la Faune Sauvage [BN01/2011-14]; GLOBICE; Conseil Regional Reunion [DEE/20151302]	Direction de l'Environnement de l'Amenagement et du Logement; Office Nationale de la Chasse et de la Faune Sauvage; GLOBICE; Conseil Regional Reunion	Data collection was funded by Direction de l'Environnement de l'Amenagement et du Logement (DEAL/CP02011/11, CP02014/02), http://www.reunion.developmetn-durable.gouv. fr/; Office Nationale de la Chasse et de la Faune Sauvage (BN01/2011-14), http://www.oncfs.gouv. fr/ and GLOBICE, http://globice.org/. Data analysis and preparation of the manuscript was funded by Conseil Regional Reunion (DEE/20151302), http:// www.regionreunion.com.	Amir Omar A., 2002, Western Indian Ocean Journal of Marine Science, V1, P155; Ansmann IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065239; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Berube M, 1996, MOL ECOL, V5, P283; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Bouveroux T., 2014, Journal of Cetacean Research and Management, V14, P37; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burkhart SM, 2003, NEW ZEAL J MAR FRESH, V37, P553, DOI 10.1080/00288330.2003.9517189; Burnham K.P., 1987, MONOGRAPH, V5; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Condet M, 2016, CONT SHELF RES, V125, P18, DOI 10.1016/j.csr.2016.06.010; Connor RC, 2000, CETACEAN SOCIETIES, P91; Crone EE, 2001, EVOLUTION, V55, P2611; Dirtu AC, 2016, ENVIRON RES, V146, P263, DOI 10.1016/j.envres.2016.01.006; Dulau-Drouot V, 2008, J MAR BIOL ASSOC UK, V88, P1263, DOI 10.1017/S0025315408001069; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Heithaus MR, 2016, MAR MAMM SC IN PRESS; Huang S-L, 2013, J BIODIVERS ENDANGER, V1, P115; IUCN MNHN SEOR ARDA, 2013, LIST ROUG MEN FRANC; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; McCarthy MA, 2001, ANIM CONSERV, V4, P351, DOI 10.1017/S136794300100141X; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Patterson E. M., 2012, THESIS; Perez-Jorge S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133265; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pusineri C, 2014, ENDANGER SPECIES RES, V23, P23, DOI 10.3354/esr00555; Randic S, 2012, P ROY SOC B-BIOL SCI, V279, P3083, DOI 10.1098/rspb.2012.0264; Reisinger RR, 2010, MAR MAMMAL SCI, V26, P86, DOI 10.1111/j.1748-7692.2009.00324.x; ROSS GJB, 1987, S AFR J ZOOL, V22, P50; Sarnblad A, 2011, MAR MAMMAL SCI, V27, P431, DOI 10.1111/j.1748-7692.2010.00416.x; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Song KJ, 2014, PAC SCI, V68, P555, DOI 10.2984/68.4.9; Sprogis KR, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00012; Sprogis KR, 2016, MAR MAMMAL SCI, V32, P287, DOI 10.1111/mms.12260; Stensland E, 2006, MAR MAMMAL SCI, V22, P667, DOI 10.1111/j.1748-7692.2006.00051.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; Webster I, 2014, AFRICAN J MARINE SCI, P1, DOI https://doi.org/10.2989/1814232X.2014.946448; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Zanardo N, 2013, MAR MAMMAL SCI, V32, P1381	64	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179780	10.1371/journal.pone.0179780	http://dx.doi.org/10.1371/journal.pone.0179780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640918	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800064
J	Khanna, S; Stewart, R; Gnyawali, S; Harris, H; Balch, M; Spieldenner, J; Sen, CK; Rink, C				Khanna, Savita; Stewart, Richard; Gnyawali, Surya; Harris, Hallie; Balch, Maria; Spieldenner, James; Sen, Chandan K.; Rink, Cameron			Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke	FASEB JOURNAL			English	Article						phytonutrient; ischemia; brain	LIPOPOLYSACCHARIDE-INDUCED DAMAGE; FOCAL CEREBRAL-ISCHEMIA; PROTECTS DOPAMINERGIC-NEURONS; ESTROGEN-RELATED RECEPTORS; NEURAL CELL-DEATH; VITAMIN-E ACTION; ALPHA-TOCOTRIENOL; DOWN-REGULATION; IN-VITRO; THERAPEUTIC TARGET	In the pathophysiologic setting of cerebral ischemia, excitotoxic levels of glutamate contribute to neuronal cell death. Our previous work demonstrated the ability of glutamate oxaloacetate transaminase (GOT) to metabolize neurotoxic glutamate in the stroke-affected brain. Here, we seek to identify small-molecule inducers of GOT expression to mitigate ischemic stroke injury. From a panel of phytoestrogen isoflavones, biochanin A (BCA) was identified as the most potent inducer of GOT gene expression in neural cells. BCA significantly increased GOT mRNA and protein expression at 24 h and protected against glutamate-induced cell death. Of note, this protection was lost when GOT was knocked down. To validate outcomes in vivo, C57BL/6 mice were intraperitoneally injected with BCA (5 and 10 mg/kg) for 4 wk and subjected to ischemic stroke. BCA levels were significantly increased in plasma and brain of mice. Immunohistochemistry demonstrated increased GOT protein expression in the brain. BCA attenuated stroke lesion volume as measured by 9.4T MRI and improved sensorimotor function-this protection was lost with GOT knockdown. BCA increased luciferase activity in cells that were transfected with the pERRE(3)tk-LUC plasmid, which demonstrated transactivation of GOT. This increase was lost when estrogen-related receptor response element sites were mutated. Taken together, BCA represents a natural phytoestrogen that mitigates stroke-induced injury by inducing GOT expression.-Khanna, S., Stewart, R., Gnyawali, S., Harris, H., Balch, M., Spieldenner, J., Sen, C. K., Rink, C. Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke.	[Khanna, Savita; Stewart, Richard; Gnyawali, Surya; Harris, Hallie; Balch, Maria; Spieldenner, James; Sen, Chandan K.; Rink, Cameron] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Khanna, S; Rink, C (corresponding author), Ohio State Univ, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	savita.khanna@osumc.edu; cameron.rink@osumc.edu	Gnyawali, Surya/AAC-3082-2020; Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Balch, Maria/0000-0003-2011-6345; Gnyawali, Surya/0000-0002-4214-8068	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [R01NS085272]; NIH NINDS [R01NS42617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085272, R01NS042617] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) Grant R01NS085272 (to C.R. and S.K.), and supported, in part, by NIH NINDS Grant R01NS42617 (to C.K.S.).	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Aras AB, 2015, INFLAMMATION, V38, P1311, DOI 10.1007/s10753-014-0102-0; Aras AB, 2015, NEURAL REGEN RES, V10, P146, DOI 10.4103/1673-5374.150724; Audet-Walsh E, 2015, ACTA PHARMACOL SIN, V36, P51, DOI 10.1038/aps.2014.121; Burguete MC, 2006, EUR J NEUROSCI, V23, P703, DOI 10.1111/j.1460-9568.2006.04599.x; Castillo J, 2016, J CEREBR BLOOD F MET, V36, P292, DOI 10.1177/0271678X15606721; Chan HY, 2003, BRIT J NUTR, V90, P87, DOI 10.1079/BJN2003868; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen HQ, 2007, NEUROSCI LETT, V417, P112, DOI 10.1016/j.neulet.2006.11.045; Cornara L, 2016, CRIT REV FOOD SCI, V56, pS149, DOI 10.1080/10408398.2015.1038378; Cortina B, 2013, EUR J PHARMACOL, V708, P88, DOI 10.1016/j.ejphar.2013.02.016; de Rijke E, 2001, J CHROMATOGR A, V932, P55, DOI 10.1016/S0021-9673(01)01231-6; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Ghatak S, 2016, NANOMED-NANOTECHNOL, V12, P1827, DOI 10.1016/j.nano.2016.03.004; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Harini R, 2012, EUR J PHARMACOL, V676, P89, DOI 10.1016/j.ejphar.2011.11.051; Hubbard WJ, 2015, SHOCK, V44, P3, DOI 10.1097/SHK.0000000000000364; Hurtado O, 2012, NEUROCHEM INT, V61, P119, DOI 10.1016/j.neuint.2012.04.007; Khanna S, 2005, FREE RADICAL BIO MED, V39, P1310, DOI 10.1016/j.freeradbiomed.2005.06.013; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; Khanna S, 2015, FASEB J, V29, P828, DOI 10.1096/fj.14-263723; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Khanna S, 2009, ANTIOXID REDOX SIGN, V11, P449, DOI 10.1089/ARS.2008.2230; Kim E, 2015, J NEUROSCI, V35, P15113, DOI 10.1523/JNEUROSCI.2890-15.2015; Kurzer MS, 1997, ANNU REV NUTR, V17, P353, DOI 10.1146/annurev.nutr.17.1.353; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Liang K, 2014, J NEUROL SCI, V344, P100, DOI 10.1016/j.jns.2014.06.033; Moran J, 2017, CELL MOL NEUROBIOL, V37, P405, DOI 10.1007/s10571-016-0372-1; Nestel P, 2004, EUR J CLIN NUTR, V58, P403, DOI 10.1038/sj.ejcn.1601796; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Patel V, 2012, J NUTR, V142, P513, DOI 10.3945/jn.111.151902; Qian YS, 2015, PHARM BIOL, V53, P1124, DOI 10.3109/13880209.2014.962057; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Rink C, 2017, FASEB J, V31, P1709, DOI 10.1096/fj.201601033R; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1889, DOI 10.1089/ars.2010.3474; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Roy S, 2002, METHOD ENZYMOL, V352, P326; Sen CK, 2017, FASEB J, V31, P927, DOI 10.1096/fj.201600437R; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Spagnuolo P, 2014, FITOTERAPIA, V94, P62, DOI 10.1016/j.fitote.2014.01.027; Stein RA, 2006, ENDOCR-RELAT CANCER, V13, pS25, DOI 10.1677/erc.1.01292; Stout JM, 2013, BEHAV BRAIN RES, V256, P428, DOI 10.1016/j.bbr.2013.08.027; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Tan JW, 2013, NEUROCHEM RES, V38, P512, DOI 10.1007/s11064-012-0943-6; Teede HJ, 2003, ARTERIOSCL THROM VAS, V23, P1066, DOI 10.1161/01.ATV.0000072967.97296.4A; Turner JV, 2007, J PHARM SCI-US, V96, P1879, DOI 10.1002/jps.20987; Wang J, 2016, NEUROTOX RES, V30, P486, DOI 10.1007/s12640-016-9648-y; Wang J, 2015, PHARMACOL BIOCHEM BE, V138, P96, DOI 10.1016/j.pbb.2015.09.013; Wang SQ, 2014, INT J BIOL SCI, V10, P457, DOI 10.7150/ijbs.7562; Wang WB, 2015, J NEUROL SCI, V348, P121, DOI 10.1016/j.jns.2014.11.018; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhu HB, 2014, PLANTA MED, V80, P262, DOI 10.1055/s-0033-1360340; Zhumadilov A, 2015, EXPERT REV NEUROTHER, V15, P501, DOI 10.1586/14737175.2015.1032259	63	19	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4533	4544		10.1096/fj.201700353	http://dx.doi.org/10.1096/fj.201700353			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28655710	Green Published			2022-12-26	WOS:000413397400029
J	von Stemann, JH; Rigas, AS; Thorner, LW; Rasmussen, DGK; Pedersen, OB; Rostgaard, K; Erikstrup, C; Ullum, H; Hansen, MB				von Stemann, Jakob Hjorth; Rigas, Andreas Stribolt; Thorner, Lise Wegner; Rasmussen, Daniel Guldager Kring; Pedersen, Ole Birger; Rostgaard, Klaus; Erikstrup, Christian; Ullum, Henrik; Hansen, Morten Bagge			Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study	PLOS ONE			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; IGG AUTOANTIBODIES; NEUTRALIZING AUTOANTIBODIES; ANTIBODY; PLASMA; IL-6; INTERLEUKIN-1-ALPHA; INTERFERON; AIRE; AGE	Natural cytokine-specific autoantibodies (c-aAb) have been measured in healthy and diseased individuals, and have been considered as both endogenous immune-regulators and pathogenic factors. Overall, the etiology and potential pathology of c-aAb are still undefined. To further characterize the sero-prevalence, predictors and consequences of high c-aAb levels, we performed the largest population-based study of c-aAb to date, using participants and epidemiological data from the Danish Blood Donor Study. Using a validated beadbased multiplex assay we assessed plasma levels of IL-1 alpha, IL-6, IL-10, IFN alpha and GM-CSFspecific c-aAb in 8,972 healthy blood donors. Trace levels of at least one of the investigated c-aAb could be measured in 86% of the participants. The presence of high levels of potentially inhibitory c-aAb was generally associated with increasing age and male or female sex, depending on the c-aAb in question. A negative correlation between high levels of IL-6-specific c-aAb and plasma levels of C-reactive protein was observed, indicating cytokineneutralizing levels of c-aAb in healthy blood donors. There was no substantial correlation between high levels of the five individual c-aAb investigated in this study. These data suggest that autoimmunity against endogenous cytokines is a relatively common phenomenon in healthy individuals, and that predictive factors for high, potentially neutralizing c-aAb levels vary depending on the cytokine in question, and may differ from predictors of general c-aAb presence.	[von Stemann, Jakob Hjorth; Rigas, Andreas Stribolt; Thorner, Lise Wegner; Rasmussen, Daniel Guldager Kring; Ullum, Henrik; Hansen, Morten Bagge] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Pedersen, Ole Birger] Naestved Sygehus, Dept Clin Immunol, Naestved, Denmark; [Rostgaard, Klaus] Statens Serum Inst, Epidemiol Res, Copenhagen, Denmark; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Naestved Hospital; Statens Serum Institut; Aarhus University	von Stemann, JH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	jakob.hjorth.von.stemann@regionh.dk	Pedersen, Ole Birger/W-8679-2019	Pedersen, Ole Birger/0000-0003-2312-5976; Ullum, Henrik/0000-0001-7306-9058; Thorner, Lise Wegner/0000-0003-4391-4956; Erikstrup, Christian/0000-0001-6551-6647; Rostgaard, Klaus/0000-0001-6220-9414	Danish Council for Independent Research-medical sciences [09-069412]; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laevidenskabens Fremme; Danish Bio and Genome Bank; Rigshospitalet Research Foundation	Danish Council for Independent Research-medical sciences(Det Frie Forskningsrad (DFF)); Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laevidenskabens Fremme; Danish Bio and Genome Bank; Rigshospitalet Research Foundation	The Danish Blood Donor Study was funded by: The Danish Council for Independent Research-medical sciences (http://ufm.dk/en/research-and-innovation/councils-and-commission/the-danish-council-for-independent-research, grant number: 09-069412); The Danish Administrative Regions (http://www.regioner.dk); Bloddonorernes Forskningsfond (https://forening. bloddonor.dk/om-bloddonorerne-idanmark/fonde); Fonden til Laevidenskabens Fremme (https://www.apmollerfonde.dk/ansoegning/laegefonden.aspx); The Danish Bio and Genome Bank (http:// www.regioner.dk/rbgben). The first author was funded by Rigshospitalet Research Foundation (https://www.forskningspuljer-rh.dk). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Ben-Dov I, 2014, AUTOIMMUN REV, V13, P513, DOI 10.1016/j.autrev.2014.01.046; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2010, IMMUNOL CELL BIOL, V88, P614, DOI 10.1038/icb.2010.72; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Cappellano G, 2012, AM J CLIN EXP IMMUNO, V1, P136; Ferretti A, 2016, J IMMUNOL; Fosgerau K, 2010, J ENDOCRINOL, V204, P265, DOI 10.1677/JOE-09-0413; Galle P, 2004, EUR J IMMUNOL, V34, P3267, DOI 10.1002/eji.200425268; Galle P, 2004, EUR J IMMUNOL, V34, P291, DOI 10.1002/eji.200324338; Galle P, 2007, INT IMMUNOPHARMACOL, V7, P1704, DOI 10.1016/j.intimp.2007.08.026; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Graudal NA, 2002, ANN RHEUM DIS, V61, P598, DOI 10.1136/ard.61.7.598; Guldager DKR, 2015, J IMMUNOL METHODS, V425, P62, DOI 10.1016/j.jim.2015.06.010; Gupta S, 2016, ARTHRITIS RHEUMATOL, V68, P1677, DOI 10.1002/art.39607; Hansen MB, 2007, VOX SANG, V92, P213, DOI 10.1111/j.1423-0410.2006.00881.x; HANSEN MB, 1994, EUR J CLIN INVEST, V24, P212, DOI 10.1111/j.1365-2362.1994.tb00991.x; HANSEN MB, 1991, IMMUNOL LETT, V30, P133, DOI 10.1016/0165-2478(91)90102-G; Homann C, 1996, SCAND J IMMUNOL, V44, P623, DOI 10.1046/j.1365-3083.1996.d01-344.x; Jouvenne P, 1997, SCAND J IMMUNOL, V46, P413, DOI 10.1046/j.1365-3083.1997.d01-139.x; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kildey K, 2014, HUM IMMUNOL, V75, P973, DOI 10.1016/j.humimm.2014.08.200; KIRCHNER H, 1991, CANCER, V67, P1862, DOI 10.1002/1097-0142(19910401)67:7<1862::AID-CNCR2820670708>3.0.CO;2-R; Kisand K, 2008, BLOOD, V112, P2657, DOI 10.1182/blood-2008-03-144634; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; Maniwa K, 2000, Respirology, V5, P315, DOI 10.1046/j.1440-1843.2000.00269.x; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; MenetrierCaux C, 1996, CLIN EXP IMMUNOL, V104, P173, DOI 10.1046/j.1365-2249.1996.d01-646.x; Nanki T, 2013, ANN RHEUM DIS, V72, P1100, DOI 10.1136/annrheumdis-2012-202768; Ndongo-Thiam N, 2016, ANN RHEUM DIS, V75, P1420, DOI 10.1136/annrheumdis-2016-209149; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Perricone C, 2016, AUTOIMMUN REV, V15, P354, DOI 10.1016/j.autrev.2016.01.001; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Rieper CD, 2010, CYTOKINE, V51, P286, DOI 10.1016/j.cyto.2010.06.009; Rieper CD, 2009, CYTOKINE GROWTH F R, V20, P61, DOI 10.1016/j.cytogfr.2009.01.003; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Rosenberg JM, 2016, J ALLERGY CLIN IMMUN, V137, P204, DOI 10.1016/j.jaci.2015.07.032; Ross C, 1997, BLOOD, V90, P2376; ROSS C, 1995, J CLIN INVEST, V95, P1974, DOI 10.1172/JCI117881; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Strobel P, 2007, J PATHOL, V211, P563, DOI 10.1002/path.2141; SUZUKI H, 1991, CLIN EXP IMMUNOL, V85, P407; Svenson M, 1998, BLOOD, V91, P2054, DOI 10.1182/blood.V91.6.2054.2054_2054_2061; SVENSON M, 1991, CYTOKINE, V3, P125, DOI 10.1016/1043-4666(91)90032-9; SVENSON M, 1989, SCAND J IMMUNOL, V29, P489, DOI 10.1111/j.1365-3083.1989.tb01149.x; Svenson M, 2000, J IMMUNOL METHODS, V236, P1, DOI 10.1016/S0022-1759(99)00232-X; van Rooijen M, 2006, J THROMB HAEMOST, V4, P77, DOI 10.1111/j.1538-7836.2005.01690.x; VANDELOO AAJ, 1995, AM J PATHOL, V146, P239; Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001; Vincent T, 2015, AUTOIMMUN REV, V14, P528, DOI 10.1016/j.autrev.2015.01.015	56	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0179981	10.1371/journal.pone.0179981	http://dx.doi.org/10.1371/journal.pone.0179981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665954	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608700048
J	Wang, QZ; Liu, HC; Wang, Q; Zhou, FH; Liu, YX; Zhang, YW; Ding, HY; Yuan, M; Li, FJ; Chen, YC				Wang, Qiaozhen; Liu, Huancai; Wang, Qing; Zhou, Fenghua; Liu, Yongxin; Zhang, Yawen; Ding, Haoyu; Yuan, Meng; Li, Fengjie; Chen, Yanchun			ocr v56 Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9	PLOS ONE			English	Article							SIGNALING PATHWAY; PROTEIN	Osteosarcoma (OS) is an aggressive bone tumor, and proto-oncogene c-Fos is involved in this lethal disease. However, the role and molecular mechanism of c-Fos in the development and progression of OS remain enigmatic. As one of the Wnt family members, Wnt2 is closely associated with the development of several malignant tumors. In the present study, the expression of c-Fos, Wnt2, and its receptor Fzd9 in human OS tissues, MG63 OS cell line, and human osteoblast hFOB 1.19 cell line was detected by Western blot analysis, immunohistochemical staining, or reverse transcription-polymerase chain reaction. The role of c-Fos in the OS was clarified by treating MG63 cells with small interfering RNA to knockdown c-Fos. Then, cell migration and invasion were assayed by transwell assays and wound healing assay; cell proliferation was assayed by MTS method and 5-ethynyl-2'-deoxyuridine DNA proliferation in vitro detection; cell apoptosis was assayed by flow cytometric method. Co-immunoprecipitation kit was used to confirm the relationship between c-Fos and Wnt2/Fzd9. We found that the expression of c-Fos, Wnt2, and Fzd9 protein was distinctly higher in human OS tissues than that in the adjacent non-cancerous tissues, and their expression in the MG63 OS cell line was markedly increased compared with that in the human osteoblast hFOB 1.19 cell line. Knockdown of c-Fos inhibited the proliferation, migration, and invasion of MG63 cells, and promoted the apoptosis of MG63 cells. Moreover, knockdown of c-Fos inhibited the expression of Wnt2 and Fzd9 mRNA and protein. Our data enforced the evidence that knockdown of c-Fos inhibited cell proliferation, migration, and invasion, and promoted the apoptosis of OS cells accompanied by altered expression of Wnt2 and Fzd9. These findings offer new clues for OS development and progression, and c-Fos may be a potential therapeutic target for OS.	[Wang, Qiaozhen; Wang, Qing] Weifang Med Univ, Dept Human Anat, Weifang, Shandong, Peoples R China; [Liu, Huancai] Weifang Med Univ, Affiliated Hosp, Weifang, Shandong, Peoples R China; [Zhou, Fenghua] Weifang Med Univ, Dept Pathol, Weifang, Shandong, Peoples R China; [Liu, Yongxin; Zhang, Yawen; Ding, Haoyu; Yuan, Meng; Li, Fengjie; Chen, Yanchun] Weifang Med Univ, Dept Histol & Embryol, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Chen, YC (corresponding author), Weifang Med Univ, Dept Histol & Embryol, Weifang, Shandong, Peoples R China.	cyc7907@163.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [81401066]; Shandong Province Natural Science Foundation of China [ZR2016HM60, ZR2012HQ021, ZR2016HL20]; Shandong Medical and Health Science and Technology Development Program [2016WS0691, 2016WS0666]; Shandong Provincial Education Department [J11LF16]; Science and Technology Development Program of Weifang in China [201301074]; Technology Innovation Fund of Weifang Medical University [KX2016009, KX2016015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation of China; Shandong Medical and Health Science and Technology Development Program; Shandong Provincial Education Department; Science and Technology Development Program of Weifang in China; Technology Innovation Fund of Weifang Medical University	This study was supported by National Natural Science Foundation of China (81401066), the Shandong Province Natural Science Foundation of China (ZR2016HM60; ZR2012HQ021; ZR2016HL20), Shandong Medical and Health Science and Technology Development Program (2016WS0691; 2016WS0666), Shandong Provincial Education Department (J11LF16), the Science and Technology Development Program of Weifang in China (201301074), Technology Innovation Fund of Weifang Medical University (KX2016009; KX2016015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CSX, 2017, PROSTATE, V77, P72, DOI 10.1002/pros.23250; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Cai Y, 2014, J CELL BIOCHEM, V115, P625, DOI 10.1002/jcb.24708; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Chen YC, 2015, AM J TRANSL RES, V7, P1574; Chen YC, 2012, BIOCHEM BIOPH RES CO, V420, P397, DOI 10.1016/j.bbrc.2012.03.006; Dale TC, 1996, CANCER RES, V56, P4320; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fan Q, 2013, CELL BIOCHEM FUNCT, V31, P319, DOI 10.1002/cbf.2902; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He HT, 2014, ONCOL LETT, V7, P1352, DOI 10.3892/ol.2014.1935; He JP, 2014, ASIAN PAC J CANCER P, V15, P5967, DOI 10.7314/APJCP.2014.15.15.5967; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Huang CB, 2015, AM J CANCER RES, V5, P1032; Jung YS, 2015, ONCOTARGET, V6, P37257, DOI 10.18632/oncotarget.6133; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Kim Mijin, 2016, J Menopausal Med, V22, P6, DOI 10.6118/jmm.2016.22.1.6; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Liu ZG, 2016, ONCOTARGET, V7, P65946, DOI 10.18632/oncotarget.11779; Marino-Enriquez Adrian, 2016, Surg Pathol Clin, V9, P457, DOI 10.1016/j.path.2016.04.009; Nouri H, 2015, J BONE ONCOL, V4, P115, DOI 10.1016/j.jbo.2015.07.002; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; VANDENBERG S, 1993, CARCINOGENESIS, V14, P925, DOI 10.1093/carcin/14.5.925; Wang W, 2010, CANCER INVEST, V28, P230, DOI 10.3109/07357900903095698; Weekes D, 2016, ONCOGENE, V35, P2948, DOI 10.1038/onc.2015.420; Wu CH, 2013, ADV MECH ENG, DOI 10.1155/2013/627124; Xiao Q, 2016, TUMOR BIOL, V37, P6315, DOI 10.1007/s13277-015-4466-z; Yang J., 2016, ELIFE, V5, P5, DOI DOI 10.1155/2016/1690896; Zhao YH, 2016, J BIOL CHEM, V291, P6831, DOI 10.1074/jbc.M115.704361	30	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180558	10.1371/journal.pone.0180558	http://dx.doi.org/10.1371/journal.pone.0180558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665975	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700017
J	Fernandez-Nino, M; Giraldo, D; Gomez-Porras, JL; Dreyer, I; Barrios, AFG; Arevalo-Ferro, C				Fernandez-Nino, Miguel; Giraldo, Daniel; Lucia Gomez-Porras, Judith; Dreyer, Ingo; Gonzalez Barrios, Andres Fernando; Arevalo-Ferro, Catalina			A synthetic multi-cellular network of coupled self-sustained oscillators	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUPRACHIASMATIC NUCLEUS; MAMMALIAN-CELLS; GENE-EXPRESSION; TOGGLE SWITCH; QUORUM; SYNCHRONIZATION; CONSTRUCTION; CLOCKS; POPULATIONS	Engineering artificial networks from modular components is a major challenge in synthetic biology. In the past years, single units, such as switches and oscillators, were successfully constructed and implemented. The effective integration of these parts into functional artificial self-regulated networks is currently on the verge of breakthrough. Here, we describe the design of a modular higher-order synthetic genetic network assembled from two independent self-sustained synthetic units: repressilators coupled via a modified quorum-sensing circuit. The isolated communication circuit and the network of coupled oscillators were analysed in mathematical modelling and experimental approaches. We monitored clustering of cells in groups of various sizes. Within each cluster of cells, cells oscillate synchronously, whereas the theoretical modelling predicts complete synchronization of the whole cellular population to be obtained approximately after 30 days. Our data suggest that self-regulated synchronization in biological systems can occur through an intermediate, long term clustering phase. The proposed artificial multicellular network provides a system framework for exploring how a given network generates a specific behaviour.	[Fernandez-Nino, Miguel; Arevalo-Ferro, Catalina] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Giraldo, Daniel; Gonzalez Barrios, Andres Fernando] Univ Los Andes, Dept Ingn Quim, Grp Diseno Prod & Proc GDPP, Bogota, Colombia; [Lucia Gomez-Porras, Judith; Dreyer, Ingo] Univ Talca, Ctr Bioinformat & Simulac Mol CBSM, Talca, Chile; [Dreyer, Ingo] Univ Potsdam, Heisenberg Grp BPMPB, Potsdam, Germany	Universidad Nacional de Colombia; Universidad de los Andes (Colombia); Universidad de Talca; University of Potsdam	Arevalo-Ferro, C (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	carevalof@unal.edu.co	Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Gonzalez Barrios, Andres Fernando/0000-0003-2517-2020; Fernandez-Nino, Miguel/0000-0002-8231-7989	DAAD (German Academic Exchange Service); PROCOL [340/2009 (201010013775)]	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); PROCOL	We thank DAAD (German Academic Exchange Service) and the program PROCOL (Interchange of researchers in the framework of joint research projects) grant No. 340/2009 (201010013775) for the financial support.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Chen BS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-136; Chen Y, 2015, SCIENCE, V349, P986, DOI 10.1126/science.aaa3794; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dockery JD, 2001, B MATH BIOL, V63, P95, DOI 10.1006/bulm.2000.0205; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Honma S, 2012, PROG BRAIN RES, V199, P129, DOI 10.1016/B978-0-444-59427-3.00029-0; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Mina P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0612; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; NJUS D, 1981, CELL BIOPHYS, V3, P223, DOI 10.1007/BF02782625; Pikovsky A, 2003, CAMBRIDGE NONLINEAR, V432; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ryback BM, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-26; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180155	10.1371/journal.pone.0180155	http://dx.doi.org/10.1371/journal.pone.0180155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662174	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300114
J	Fung, RSK; Bai, J; Yuen, KWY; Wong, AOL				Fung, Roger S. K.; Bai, Jin; Yuen, Karen W. Y.; Wong, Anderson O. L.			Activin/follistatin system in grass carp pituitary cells: - Regulation by local release of growth hormone and luteinizing hormone and its functional role in growth hormone synthesis and secretion	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; RIBONUCLEIC-ACID LEVELS; BETA-PROMOTER ACTIVITY; GENE-EXPRESSION; ACTIVIN-A; SIGNAL-TRANSDUCTION; MESSENGER-RNA; FEEDBACK LOOP; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-2	Gonadotrophin regulation by activin/follistatin system is well-documented, but the corresponding effect on growth hormone (GH) has not been fully characterized and with little information available in lower vertebrates, especially in fish models. In grass carp, local interactions of GH and luteinizing hormone (LH) can induce GH release and gene expression at pituitary level via autocrine/paracrine mechanisms. To shed light on the role of activin/follistatin system in GH regulation by local actions of GH and LH, grass carp activin beta A and beta B were cloned, shown to be single-copy genes expressed in the pituitary, and confirmed to encode activin proteins capable of transactivating promoter with activin-responsive elements. In grass carp pituitary cells, activin A and B were effective in reducing GH secretion and GH cell content with concurrent drop in GH mRNA level whereas the opposite was true for follistatin, the activin-binding protein known to neutralize the effects of endogenous activin. Treatment with activin A and B not only could suppress basal but also inhibit GH mRNA expression induced by GH and human chorionic gonadotropin (hCG), a functional analogue of LH in fish model. Apparently, down-regulation of GH mRNA by activin was mediated by reducing GH transcript stability with concurrent inhibition on GH promoter activity via the SMAD pathway. In reciprocal experiments, GH treatment was found to up-regulate activin beta A, activin beta B and follistatin mRNA levels in carp pituitary cells but the opposite was noted by removing endogenous GH with GH antiserum. Interestingly, parallel treatment with hCG could also inhibit basal as well as GH-induced activin beta A, activin beta B and follistatin gene expression. These results, as a whole, indicate that the pituitary activin/follistatin system can serve as a regulatory target for local interactions of GH and LH and contribute to GH regulation by autocrine/paracrine mechanisms in the carp pituitary.	[Fung, Roger S. K.; Bai, Jin; Yuen, Karen W. Y.; Wong, Anderson O. L.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, AOL (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	olwong@hku.hk	Bai, Jin/AAO-3960-2021; Wong, Anderson O L/S-1667-2017	Bai, Jin/0000-0002-4241-8814; Wong, Anderson O L/0000-0003-4224-4110	GRF [780312, 781113, 17128215, 17117716]; NSFC/RGC Research Grant Council, Hong Kong [N_HKU732/12]; School of Biological Sciences,University of Hong Kong	GRF; NSFC/RGC Research Grant Council, Hong Kong; School of Biological Sciences,University of Hong Kong(University of Hong Kong)	The project was supported by GRF grants (780312, 781113, 17128215 and 17117716) and NSFC/RGC Joint Grant (N_HKU732/12) from Research Grant Council,Hong Kong (toAOLW). Financial support from the School of Biological Sciences,University of Hong Kong,in theform of postgraduate studentship (toRSKF&JB) is also acknowledged.The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript	Abe Y, 2004, GROWTH FACTORS, V22, P105, DOI 10.1080/08977190410001704688; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Beyersmann D, 2000, EXS, V89, P11; BILEZIKJIAN LM, 1990, ENDOCRINOLOGY, V126, P2369, DOI 10.1210/endo-126-5-2369; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; BILLESTRUP N, 1990, MOL ENDOCRINOL, V4, P356, DOI 10.1210/mend-4-2-356; Cheng GFY, 2007, J ENDOCRINOL, V195, P373, DOI 10.1677/JOE-07-0265; Choi SC, 2011, VITAM HORM, V85, P79, DOI 10.1016/B978-0-12-385961-7.00005-6; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; DANIELS M, 1993, J ENDOCRINOL, V137, P329, DOI 10.1677/joe.0.1370329; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; DiMuccio T, 2005, GEN COMP ENDOCR, V143, P287, DOI 10.1016/j.ygcen.2005.04.003; ERAMAA M, 1994, J CLIN ENDOCR METAB, V79, P1670, DOI 10.1210/jc.79.6.1670; Fortin J, 2015, MOL ENDOCRINOL, V29, P963, DOI 10.1210/me.2015-1004; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Ge W, 1997, J MOL ENDOCRINOL, V19, P37, DOI 10.1677/jme.0.0190037; GE W, 1994, GEN COMP ENDOCR, V95, P213, DOI 10.1006/gcen.1994.1118; GE W, 1992, ENDOCRINOLOGY, V131, P1922, DOI 10.1210/en.131.4.1922; Gong Feng-Ying, 2010, Shengli Xuebao, V62, P49; Graham Heather, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P45; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; HADDAD G, 1994, J CLIN ENDOCR METAB, V79, P1399, DOI 10.1210/jc.79.5.1399; Hedger MP, 2012, MOL CELL ENDOCRINOL, V359, P30, DOI 10.1016/j.mce.2011.09.031; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; HO WKK, 1991, BIOCHIM BIOPHYS ACTA, V1090, P245, DOI 10.1016/0167-4781(91)90110-8; Hu GF, 2014, ENDOCRINOLOGY, V155, P3582, DOI 10.1210/en.2014-1105; Huo LF, 2005, ENDOCRINOLOGY, V146, P3821, DOI 10.1210/en.2004-1508; Jiang Q, 2013, AM J PHYSIOL-ENDOC M, V304, pE176, DOI 10.1152/ajpendo.00455.2012; Jiang X, 2016, J ENDOCRINOL, V229, P171, DOI 10.1530/JOE-15-0423; Kanamaru C, 2002, HEPATOL RES, V23, P211, DOI 10.1016/S1386-6346(01)00175-9; Kang HY, 2011, VITAM HORM, V85, P129, DOI 10.1016/B978-0-12-385961-7.00007-X; Knight PG, 2012, MOL CELL ENDOCRINOL, V359, P53, DOI 10.1016/j.mce.2011.04.024; LAPOLT PS, 1990, ENDOCRINOLOGY, V127, P823, DOI 10.1210/endo-127-2-823; Lau MT, 2005, GEN COMP ENDOCR, V141, P22, DOI 10.1016/j.ygcen.2004.10.019; Li YN, 2017, J BIOL CHEM, V292, P2301, DOI 10.1074/jbc.M116.759167; Lin CY, 2015, MOL CELL ENDOCRINOL, V399, P267, DOI 10.1016/j.mce.2014.10.010; Lin SW, 2009, GEN COMP ENDOCR, V160, P183, DOI 10.1016/j.ygcen.2008.11.020; LING N, 1986, BIOCHEM BIOPH RES CO, V138, P1129, DOI 10.1016/S0006-291X(86)80400-4; Loomans HA, 2016, AM J CANCER RES, V6, P2431; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; NIELSEN DA, 1990, MOL ENDOCRINOL, V4, P953, DOI 10.1210/mend-4-7-953; ODA S, 1995, BIOCHEM BIOPH RES CO, V210, P581, DOI 10.1006/bbrc.1995.1699; Reindl KM, 2011, AM J PHYSIOL-REG I, V301, pR236, DOI 10.1152/ajpregu.00414.2010; Rejon CA, 2013, CELL SIGNAL, V25, P2717, DOI 10.1016/j.cellsig.2013.09.002; ROBERTS V, 1989, ENDOCRINOLOGY, V124, P552, DOI 10.1210/endo-124-1-552; ROBERTS VJ, 1992, NEUROENDOCRINOLOGY, V56, P214, DOI 10.1159/000126231; Robertson DM, 2012, MOL CELL ENDOCRINOL, V359, P78, DOI 10.1016/j.mce.2011.05.016; Rodriguez-Martinez G, 2012, CNS NEUROL DISORD-DR, V11, P844, DOI 10.2174/1871527311201070844; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Tada T, 1998, MOL MAR BIOL BIOTECH, V7, P72; Tamura N, 2000, EUR J ENDOCRINOL, V142, P506, DOI 10.1530/eje.0.1420506; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vejda S, 2002, J MOL ENDOCRINOL, V28, P137, DOI 10.1677/jme.0.0280137; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wang YJ, 2003, GEN COMP ENDOCR, V134, P308, DOI 10.1016/S0016-6480(03)00275-2; Wang YJ, 2003, ENDOCRINOLOGY, V144, P491, DOI 10.1210/en.2002-220734; Wijayarathna R, 2016, ACTIVINS REPROD BIOL, P22; Winters SJ, 2004, REPRODUCTION, V128, P13, DOI 10.1530/rep.1.00195; Wong AOL, 2006, COMP BIOCHEM PHYS A, V144, P284, DOI 10.1016/j.cbpa.2005.11.021; Wong AOL, 1998, GEN COMP ENDOCR, V110, P29, DOI 10.1006/gcen.1997.7045; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yam KM, 1999, GEN COMP ENDOCR, V116, P81, DOI 10.1006/gcen.1999.7339; Yuen CW, 2004, GEN COMP ENDOCR, V135, P108, DOI 10.1016/j.ygcen.2003.08.012; Zhou H, 2005, J MOL ENDOCRINOL, V34, P415, DOI 10.1677/jme.1.01629; Zhou H, 2004, ENDOCRINOLOGY, V145, P5548, DOI 10.1210/en.2004-0362; Zhou H, 2004, ENDOCRINOLOGY, V145, P4615, DOI 10.1210/en.2004-0163	74	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179789	10.1371/journal.pone.0179789	http://dx.doi.org/10.1371/journal.pone.0179789			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662143	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300048
J	Hofmann, L; Karl, F; Sommer, C; Uceyler, N				Hofmann, Lukas; Karl, Franziska; Sommer, Claudia; Ueceyler, Nurcan			Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; ANIMAL-MODELS; ANXIETY; MICE; INFLAMMATION; GENE; GLOBOTRIAOSYLCERAMIDE; DEPRESSION; MALES; PAIN	Fabry disease is an X-linked inherited lysosomal storage disorder with intracellular accumulation of globotriaosylceramide (Gb3) due to alpha-galactosidase A (alpha-Gal A) deficiency. Fabry patients frequently report of anxiety, depression, and impaired cognitive function. We characterized affective and cognitive phenotype of male mice with alpha-Gal A deficiency ( Fabry KO) and compared results with those of age-matched male wildtype (WT) littermates. Young (3 months) and old (>= 18 months) mice were tested in the naive state and after i.pl. injection of complete Freund's adjuvant (CFA) as an inflammatory pain model. We used the elevated plus maze (EPM), the light-dark box (LDB) and the open field test (OF) to investigate anxiety-like behavior. The forced swim test (FST) and Morris water maze (MWM) were applied to assess depressive-like and learning behavior. The EPM test revealed no inter-group difference for anxiety-like behavior in naive young and old Fabry KO mice compared to WT littermates, except for longer time spent in open arms of the EPM for young WT mice compared to young Fabry KO mice (p<0.05). After CFA injection, young Fabry KO mice showed increased anxiety-like behavior compared to young WT littermates (p<0.05) and naive young Fabry KO mice (p<0.05) in the EPM as reflected by shorter time spent in EPM open arms. There were no relevant differences in the LDB and the OF test, except for longer time spent in the center zone of the OF by young WT mice compared to young Fabry KO mice (p<0.05). Complementary to this, depression-like and learning behavior were not different between genotypes and age-groups, except for the expectedly lower memory performance in older age-groups compared to young mice. Our results indicate that genetic influences on affective and cognitive symptoms in FD may be of subordinate relevance, drawing attention to potential influences of environmental and epigenetic factors.	[Hofmann, Lukas; Karl, Franziska; Sommer, Claudia; Ueceyler, Nurcan] Univ Wurzburg, Dept Neurol, Wurzburg, Germany	University of Wurzburg	Hofmann, L (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	Hofmann_L3@ukw.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002	University of Wurzburg [N-260]; European Union [602133]	University of Wurzburg; European Union(European Commission)	The study was financially supported by research funds of the Interdisciplinary Center for Clinical Research (Interdisziplinares Zentrum fur Klinische Forschung, IZKF, http://www.izkf.ukw.de/) of the University of Wurzburg (N.UE.: N-260). N.UE. and C.S. are funded by the European Union's Seventh Framework Programme 2013-2017 ("ncRNAPain", grant agreement number 602133, http://www.ncrna-pain.eu/). The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Allen AL, 2003, BRAIN RES, V961, P147, DOI 10.1016/S0006-8993(02)03948-3; Balwani M, 2009, GENET MED, V11, P722, DOI 10.1097/GIM.0b013e3181b182c3; Bangari DS, 2015, AM J PATHOL, V185, P651, DOI 10.1016/j.ajpath.2014.11.004; Bolsover FE, 2014, J INHERIT METAB DIS, V37, P177, DOI 10.1007/s10545-013-9643-x; Bugescu N, 2015, AM J MED GENET B, V168, P204, DOI 10.1002/ajmg.b.32297; Chen Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-13; Cole AL, 2007, J INHERIT METAB DIS, V30, P943, DOI 10.1007/s10545-007-0708-6; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Finn DA, 2003, NEUROGENETICS, V4, P109, DOI 10.1007/s10048-003-0143-2; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Glass JM, 2008, J CLIN PSYCHIAT, V69, P20; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; ISHII S, 1993, BIOCHEM BIOPH RES CO, V197, P1585, DOI 10.1006/bbrc.1993.2659; Lakoma J, 2016, MOL PAIN, V12, DOI 10.1177/1744806916663729; Laney DA, 2015, GENET MED, V17, P323, DOI 10.1038/gim.2014.120; Laney DA, 2010, J INHERIT METAB DIS, V33, pS73, DOI 10.1007/s10545-009-9025-6; Lelieveld IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137603; Lohle M, 2015, NEUROLOGY, V84, P1454, DOI 10.1212/WNL.0000000000001450; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Miners AH, 2002, QUAL LIFE RES, V11, P127, DOI 10.1023/A:1015009210639; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Nekovarova T, 2014, FRONTIERS BEHAV NEUR, V8; Ohshima T, 1995, GENE, V166, P277, DOI 10.1016/0378-1119(95)00592-7; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Refsgaard LK, 2016, J NEUROSCI METH, V262, P85, DOI 10.1016/j.jneumeth.2016.01.019; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Schermuly I, 2011, EUR J NEUROL, V18, P347, DOI 10.1111/j.1468-1331.2010.03155.x; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shiozuka C, 2011, J BIOCHEM, V149, P161, DOI 10.1093/jb/mvq125; Sigmundsdottir L, 2014, ARCH CLIN NEUROPSYCH, V29, P642, DOI 10.1093/arclin/acu047; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; Uceyler N, 2016, MOL PAIN, V12, DOI 10.1177/1744806916646379; Uceyler N, 2014, CLIN J PAIN, V30, P915, DOI 10.1097/AJP.0000000000000041; Yang X.H., 2009, CHINESE BUSINESS, V9, P5, DOI DOI 10.1016/J.PAIN.2009.04.005; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	49	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180601	10.1371/journal.pone.0180601	http://dx.doi.org/10.1371/journal.pone.0180601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662189	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300170
J	Mehta, JH; Williams, GW; Harvey, BC; Grewal, NK; George, EE				Mehta, Jaideep H.; Williams, George W., II; Harvey, Brian C.; Grewal, Navneet K.; George, Edward E.			The relationship between minute ventilation and end tidal CO2 in intubated and spontaneously breathing patients undergoing procedural sedation	PLOS ONE			English	Article							RESPIRATORY VOLUME MONITOR; MODERATE SEDATION; CONTROLLED-TRIAL; CARBON-DIOXIDE; PULSE OXIMETRY; CAPNOGRAPHY; SURGERY; MODEL	Background Monitoring respiratory status using end tidal CO2 (EtCO2), which reliably reflects arterial PaCO2 in intubated patients under general anesthesia, has often proven both inaccurate and inadequate when monitoring non-intubated and spontaneously breathing patients. This is particularly important in patients undergoing procedural sedation (e.g., endoscopy, colonoscopy). This can be undertaken in the operating theater, but is also often delivered outside the operating room by non-anesthesia providers. In this study we evaluated the ability for conventional EtCO2 monitoring to reflect changes in ventilation in non-intubated surgical patients undergoing monitored anesthesia care and compared and contrasted these findings to both intubated patients under general anesthesia and spontaneously breathing volunteers. Methods M1winute Ventilation (MV), tidal volume (TV), and respiratory rate (RR) were continuously collected from an impedance-based Respiratory Volume Monitor (RVM) simultaneously with capnography data in 160 patients from three patient groups: non-intubated surgical patients managed using spinal anesthesia and Procedural Sedation (n = 58); intubated surgical patients under General Anesthesia (n = 54); and spontaneously breathing Awake Volunteers (n = 48). EtCO2 instrument sensitivity was calculated for each patient as the slope of a Deming regression between corresponding measurements of EtCO2 and MV and expressed as angle from the x-axis (theta). All data are presented as mean +/- SD unless otherwise indicated. Results While, as expected, EtCO2 and MV measurements were negatively correlated in most patients, we found gross systematic differences across the three cohorts. In the General Anesthesia patients, small changes in MV resulted in large changes in EtCO2 (high sensitivity, theta = -83.6 +/- 9.9 degrees). In contrast, in the Awake Volunteers patients, large changes in MV resulted in insignificant changes in EtCO2 (low sensitivity, theta = -24.7 +/- 19.7 degrees, p < 0.0001 vs General Anesthesia). In the Procedural Sedation patients, EtCO2 sensitivity showed a bimodal distribution, with an approximately even split between patients showing high EtCO2 instrument sensitivity, similar to those under General Anesthesia, and patients with low EtCO2 instrument sensitivity, similar to the Awake Volunteers. Conclusions When monitoring non-intubated patients undergoing procedural sedation, EtCO2 often provides inadequate instrument sensitivity when detecting changes in ventilation. This suggests that augmenting standard patient care with EtCO2 monitoring is a less than optimal solution for detecting changes in respiratory status in non-intubated patients. Instead, adding direct monitoring of MV with an RVM may be preferable for continuous assessment of adequacy of ventilation in non-intubated patients.	[Mehta, Jaideep H.; Williams, George W., II; Grewal, Navneet K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA; [Harvey, Brian C.] Resp Motion Inc, Waltham, MA USA; [George, Edward E.] Massachusetts Gen Hosp, Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	University of Texas System; University of Texas Health Science Center Houston; Harvard University; Massachusetts General Hospital	Mehta, JH (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA.	Jaideep.H.Mehta@uth.tmc.edu		Mehta, Jaideep/0000-0001-9274-7010	Respiratory Motion, Inc	Respiratory Motion, Inc	Respiratory Motion, Inc. (www.respiratorymotion.com) provided the respiratory volume monitors used for data collection in this study. BCH, an employee of Respiratory Motion, Inc., collaborated with co-authors on data analysis and manuscript preparation. Respiratory Motion, Inc. provided support for author BCH in the form of salary, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Respiratory Care Protocol Committee, 2003, AD MECH VENT PROT; American Heart Association, 2005, CIRCULATION, V112, pIV; American Society of Anesthesiologists, 2010, STAND BAS AN MON; Belenkiy S, 2013, SHOCK, V39, P495, DOI 10.1097/SHK.0b013e318292c331; Castro LNG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172750; Covidien, 2014, CAPN 20 PORT BEDS CA; Delorio NM, 2005, EMERG MED J, V22, P490, DOI 10.1136/emj.2004.015818; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Ebert TJ, 2017, J CLIN MONIT COMPUT, V31, P53, DOI 10.1007/s10877-015-9809-1; ECRI Institute, 2016, EXC HLTH DEV; Galvagno SM, 2016, J TRAUMA ACUTE CARE; Heines SJH, 2013, J EMERG MED, V45, P130, DOI 10.1016/j.jemermed.2012.11.019; Holley K, 2014, OPEN J ANESTHESIOL, V4, P281, DOI DOI 10.4236/OJANES.2014.411041; Holley K, 2016, J CLIN MONIT COMPUT, V30, P33, DOI 10.1007/s10877-015-9674-y; Jabre P, 2009, AM J EMERG MED, V27, P1056, DOI 10.1016/j.ajem.2008.08.017; Kerr ME, 1996, CRIT CARE MED, V24, P785, DOI 10.1097/00003246-199605000-00010; Kodali B -S, 1992, CAN J ANAESTH, V39, P617; Lightdale JR, 2006, PEDIATRICS, V117, pE1170, DOI 10.1542/peds.2005-1709; Lumb AB, 2017, NUNNS APPL RESP PHYS, VEighth, DOI [10.2307/20024538, DOI 10.2307/20024538]; Medical D, 2005, AP OP INSTR MAN; Mehta JH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0352-0; Mehta PP, 2016, AM J GASTROENTEROL, V111, P395, DOI 10.1038/ajg.2015.437; Miner JR, 2002, ACAD EMERG MED, V9, P275, DOI 10.1197/aemj.9.4.275; Ortega Rafael, 2012, N Engl J Med, V367, pe27, DOI 10.1056/NEJMvcm1105237; Parrillo JE, 2014, CRITICAL CARE MED PR; Pavlin EG, 2011, ANESTHESIA CONTROL V; Poirier MP, 1998, AM J EMERG MED, V16, P350, DOI 10.1016/S0735-6757(98)90125-5; Razi E, 2012, ARCH TRAUMA RES, V1, P58, DOI 10.5812/atr.6444; van Loon K, 2014, ANESTH ANALG, V119, P49, DOI 10.1213/ANE.0b013e3182a1f0a2; Vargo JJ, 2002, GASTROINTEST ENDOSC, V55, P826, DOI 10.1067/mge.2002.124208; Voscopoulos C, 2013, ANESTH ANALG, V117, P91, DOI 10.1213/ANE.0b013e3182918098; Voscopoulos CJ, 2015, J CLIN MONIT COMPUT, V29, P223, DOI 10.1007/s10877-014-9596-0; Wahba RWM, 1996, CAN J ANAESTH, V43, P862, DOI 10.1007/BF03013040; Waugh JB, 2011, J CLIN ANESTH, V23, P189, DOI 10.1016/j.jclinane.2010.08.012; Williams GW, 2017, ANESTH ANALG, V124, P120, DOI 10.1213/ANE.0000000000001395	35	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180187	10.1371/journal.pone.0180187	http://dx.doi.org/10.1371/journal.pone.0180187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662195	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300121
J	Wani, TA; Pandith, SA; Gupta, AP; Chandra, S; Sharma, N; Lattoo, SK				Wani, Tareq A.; Pandith, Shahzad A.; Gupta, Ajai P.; Chandra, Suresh; Sharma, Namrata; Lattoo, Surrinder K.			Molecular and functional characterization of two isoforms of chalcone synthase and their expression analysis in relation to flavonoid constituents in Grewia asiatica L	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; TARGETED MUTAGENESIS; MULTIGENE FAMILY; GENE-EXPRESSION; EVOLUTION; CLONING; POLLEN; DUPLICATION; GENOME; FLOWER	Chalcone synthase constitutes a functionally diverse gene family producing wide range of flavonoids by catalyzing the initial step of the phenylpropanoid pathway. There is a pivotal role of flavonoids in pollen function as they are imperative for pollen maturation and pollen tube growth during sexual reproduction in flowering plants. Here we focused on medicinally important fruit-bearing shrub Grewia asiatica. It is a rich repository of flavonoids. The fruits are highly acclaimed for various putative health benefits. Despite its importance, full commercial exploitation is hampered due to two drawbacks which include short shelf life of its fruits and larger seed volume. To circumvent these constraints, seed abortion is one of the viable options. Molecular interventions tested in a number of economic crops have been to impair male reproductive function by disrupting the chalcone synthase (CHS) gene activity. Against this backdrop the aim of the present study included cloning and characterization of two full-length cDNA clones of GaCHS isoforms from the CHS multigene family. These included GaCHS1 (NCBI acc. KX129910) and GaCHS2 (NCBI acc. KX129911) with an ORF of 1176 and 1170 bp, respectively. GaCHSs were heterologously expressed and purified in E. coli to validate their functionality. Functionality of CHS isoforms was also characterized via enzyme kinetic studies using five different substrates. We observed differential substrate specificities in terms of their Km and Vmax values. Accumulation of flavonoid constituents naringenin and quercetin were also quantified and their relative concentrations corroborated well with the expression levels of GaCHSs. Further, our results demonstrate that GaCHS isoforms show differential expression patterns at different reproductive phenological stages. Transcript levels of GaCHS2 were more than its isoform GaCHS1 at the anthesis stage of flower development pointing towards its probable role in male reproductive maturity.	[Wani, Tareq A.; Chandra, Suresh] CSIR, Indian Inst Integrat Med, Genet Resources & Agrotechnol Div, Jammu, India; [Pandith, Shahzad A.; Lattoo, Surrinder K.] CSIR, Indian Inst Integrat Med, Plant Biotechnol Div, Jammu, India; [Gupta, Ajai P.] CSIR, Indian Inst Integrat Med, Qual Control & Qual Assurance Div, Jammu, India; [Sharma, Namrata] Univ Jammu, Dept Bot, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); University of Jammu	Lattoo, SK (corresponding author), CSIR, Indian Inst Integrat Med, Plant Biotechnol Div, Jammu, India.	sklattoo@iiim.ac.in	Sharma, Namrata/AAU-4833-2021; GUPTA, AJAI/AAJ-1171-2021; Pandith, Shahzad/AAX-7067-2020	Pandith, Shahzad/0000-0002-0849-9745	Council of Scientific and Industrial Research, Government of India, New Delhi [BSC0110]; Institutional Major Laboratory [MLP3012]; UGC	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Institutional Major Laboratory; UGC(University Grants Commission, India)	We gratefully acknowledge the financial grant from the Council of Scientific and Industrial Research, Government of India, New Delhi under Network Project BSC0110 and Institutional Major Laboratory Project MLP3012. SAP is thankful to UGC for providing Senior Research Fellowship.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Aiswarya G, 2016, PLANT CELL REP, V35, P2077, DOI 10.1007/s00299-016-2020-0; Ashkenazy H, 2010, CONSURF 2010 CALCULA; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Barbacar N, 1997, PLANT J, V12, P805, DOI 10.1046/j.1365-313X.1997.12040805.x; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Clark MS, 2013, PLANT MOL BIOL A LAB; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Deng XB, 2014, NEW PHYTOL, V201, P1469, DOI 10.1111/nph.12610; Ding LP, 2016, EVOLUTIONARY DYNAMIC; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Durbin ML, 2003, MOL PHYLOGENET EVOL, V29, P507, DOI 10.1016/S1055-7903(03)00196-9; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Farzad M, 2003, PLANT SCI, V165, P1333, DOI 10.1016/j.plantsci.2003.08.001; Fenske MP, 2015, P NATL ACAD SCI USA, V112, P9775, DOI 10.1073/pnas.1422875112; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Han YY, 2006, GENETICA, V128, P429, DOI 10.1007/s10709-006-7668-x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HELARIUTTA Y, 1993, PLANT MOL BIOL, V22, P183, DOI 10.1007/BF00014927; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; Hihara Y, 1996, PLANT MOL BIOL, V30, P1181, DOI 10.1007/BF00019551; Ito M, 1997, MOL GEN GENET, V255, P28, DOI 10.1007/s004380050471; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jones B, 2016, NATURE REV GENETICS; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Lang D, 2016, ADV BOT RES, V78, P97, DOI 10.1016/bs.abr.2016.01.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei W, 2010, GENET MOL BIOL, V33, P285, DOI 10.1590/S1415-47572010005000031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matousek J, 2005, J AGR FOOD CHEM, V53, P4793, DOI 10.1021/jf050175y; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; MCKHANN HI, 1994, PLANT MOL BIOL, V24, P767, DOI 10.1007/BF00029858; Meng XC, 2004, PLANT GROWTH REGUL, V44, P243, DOI 10.1007/s10725-004-4454-6; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Nakatsuka A, 2009, SCI HORTIC-AMSTERDAM, V121, P84, DOI 10.1016/j.scienta.2009.01.008; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Pandith SA, 2016, PLANT PHYSIOL; Pietiainen M, 2016, PLANT J; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; Saito R, 2006, PLANT SCI, V170, P828, DOI 10.1016/j.plantsci.2005.12.003; Samappito S, 2002, PLANTA, V216, P64, DOI 10.1007/s00425-002-0872-8; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Sun W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119054; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson A, 2016, GENETICS, V202, P765, DOI 10.1534/genetics.115.178137; Treacy BK, 1998, MOL CHARACTERIZATION; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Uddin G, 2013, NAT PROD RES, V27, P215, DOI 10.1080/14786419.2012.666749; Wang SL, 2015, PLANT CELL REP, V34, P1459, DOI 10.1007/s00299-015-1800-2; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; Wani T, 2016, J PLANT BIOCHEMPHYSI, V4, P167; Wani TA, 2015, FLORA, V211, P62, DOI 10.1016/j.flora.2014.11.002; Wass MN, 2010, 3DLIGANDSITE PREDICT; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; WINKEL BSJ, 2006, BIOSYNTHESIS FLAVONO, P71; WOLLENWEBER E, 1979, Z NATURFORSCH C, V34, P1289; Yadav A.K., 1999, PERSPECTIVES NEW CRO, P348; Yang J, 2006, CHINESE SCI BULL, V51, P505, DOI 10.1007/s11434-006-0505-x; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; YLSTRA B, 1992, PLANT PHYSIOL, V100, P902, DOI 10.1104/pp.100.2.902	75	15	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179155	10.1371/journal.pone.0179155	http://dx.doi.org/10.1371/journal.pone.0179155			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662128	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300016
J	Acevedo, A; Conejeros, R; Aroca, G				Acevedo, Alejandro; Conejeros, Raul; Aroca, German			Ethanol production improvement driven by genome-scale metabolic modeling and sensitivity analysis in Scheffersomyces stipitis	PLOS ONE			English	Article							YEAST PICHIA-STIPITIS; CONSTRAINT-BASED MODELS; SACCHAROMYCES-CEREVISIAE; XYLOSE FERMENTATION; NADH AVAILABILITY; ESCHERICHIA-COLI; CARBON SOURCE; GROWTH; OPTIMIZATION; GENE	The yeast Scheffersomyces stipitis naturally produces ethanol from xylose, however reaching high ethanol yields is strongly dependent on aeration conditions. It has been reported that changes in the availability of NAD(H/(+)) cofactors can improve fermentation in some microorganisms. In this work genome-scale metabolic modeling and phenotypic phase plane analysis were used to characterize metabolic response on a range of uptake rates. Sensitivity analysis was used to assess the effect of ARC on ethanol production indicating that modifying ARC by inhibiting the respiratory chain ethanol production can be improved. It was shown experimentally in batch culture using Rotenone as an inhibitor of the mitochondria) NADH dehydrogenase complex I (CINADH), increasing ethanol yield by 18%. Furthermore, trajectories for uptakes rates, specific productivity and specific growth rate were determined by modeling the batch culture, to calculate ARC associated to the addition of CI NADH inhibitor. Results showed that the increment in ethanol production via respiratory inhibition is due to excess in ARC, which generates an increase in ethanol production. Thus ethanol production improvement could be predicted by a change in ARC.	[Acevedo, Alejandro; Conejeros, Raul; Aroca, German] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Ave Brasil 2085, Valparaiso, Chile; [Acevedo, Alejandro] Univ Chile, Fac Ciencias, Inst Milenio Biol, Las Encinas 3370, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Chile	Conejeros, R (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Ave Brasil 2085, Valparaiso, Chile.	raul.conejeros@pucv.cl	Aroca, German/ABG-6714-2020; Conejeros, Raul/ABG-5517-2020; Conejeros, Raul/A-2466-2011; Aroca, German/B-3798-2011	Conejeros, Raul/0000-0002-1273-535X; Aroca, German/0000-0003-1376-7940	CONICYT; FONDECYT [1151295]; PUCV [DI 037.424]; INNOVA CHILE Project Technological Consortium Bioenercel S.A. [208-7320]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PUCV; INNOVA CHILE Project Technological Consortium Bioenercel S.A.	Financial support granted to A. Acevedo by CONICYT's Doctoral Scholarship is gratefully acknowledged. The authors would like to acknowledge as well the financial support of project FONDECYT 1151295, PUCV research grant DI 037.424 and the support of INNOVA CHILE Project 208-7320 Technological Consortium Bioenercel S.A. The funder provided support in the form of salaries for authors AA, RC and GA, but did	Acevedo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087494; Balagurunathan B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-27; Baranyi J., 2010, DOCTORAL SCH INFORM, V13, P6720; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24; Chowdhury A, 2015, COMPUT CHEM ENG, V72, P363, DOI 10.1016/j.compchemeng.2014.06.007; Damiani AL, 2015, BIOTECHNOL BIOENG, V112, P1250, DOI 10.1002/bit.25535; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DELLWEG H, 1989, J BIOTECHNOL, V12, P111, DOI 10.1016/0168-1656(89)90010-2; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; DUPREEZ JC, 1994, ENZYME MICROB TECH, V16, P944, DOI 10.1016/0141-0229(94)90003-5; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Farias D, 2014, APPL BIOCHEM BIOTECH, V172, P361, DOI 10.1007/s12010-013-0546-y; Freese S, 2011, YEAST, V28, P309, DOI 10.1002/yea.1840; Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027316; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Goldemberg J, 2007, SCIENCE, V315, P808, DOI 10.1126/science.1137013; HAHNHAGERDAL B, 1994, ENZYME MICROB TECH, V16, P933, DOI 10.1016/0141-0229(94)90002-7; Hanly TJ, 2014, BIOTECHNOL BIOENG, V111, P272, DOI 10.1002/bit.25101; Hanly TJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-44; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hou J, 2010, APPL ENVIRON MICROB, V76, P851, DOI 10.1128/AEM.02040-09; Huang EL, 2012, J IND MICROBIOL BIOT, V39, P1507, DOI 10.1007/s10295-012-1147-4; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; Kuhad RC, 2011, RENEW SUST ENERG REV, V15, P4950, DOI 10.1016/j.rser.2011.07.058; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Lee T.Y., 2000, BIOTECHNOL BIOPROC E, V5, P27, DOI [10.1007/BF02932349, DOI 10.1007/bf02932349]; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Liang M, 2014, ACS SUSTAIN CHEM ENG, V2, P38, DOI 10.1021/sc400265g; LIGHTHELM ME, 1988, APPL MICROBIOL BIOT, V29, P67, DOI 10.1007/BF00258353; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; Portugal-Nunes D, 2015, BIORESOURCES BIOPROC, V2, P1; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Reznik E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003195; RIZZI M, 1989, BIOTECHNOL BIOENG, V34, P509, DOI 10.1002/bit.260340411; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Shi NQ, 1999, YEAST, V15, P1021, DOI 10.1002/(SICI)1097-0061(199908)15:11<1021::AID-YEA429>3.0.CO;2-V; Silva JPA, 2012, RENEW ENERG, V37, P259, DOI 10.1016/j.renene.2011.06.032; Silva JPA, 2010, APPL BIOCHEM BIOTECH, V162, P1306, DOI 10.1007/s12010-009-8867-6; SKOOG K, 1990, APPL ENVIRON MICROB, V56, P3389, DOI 10.1128/AEM.56.11.3389-3394.1990; SKOOG K, 1992, APPL BIOCHEM BIOTECH, V34-5, P369, DOI 10.1007/BF02920560; Slininger PJ, 2014, BIOTECHNOL BIOENG, V111, P1532, DOI 10.1002/bit.25215; SLININGER PJ, 1991, BIOTECHNOL BIOENG, V37, P973, DOI 10.1002/bit.260371012; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; Su YK, 2015, BIOTECHNOL BIOENG, V112, P457, DOI 10.1002/bit.25445; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Unrean P, 2013, APPL BIOCHEM BIOTECH, V169, P1895, DOI 10.1007/s12010-013-0100-y; Unrean P, 2012, BIOTECHNOL PROGR, V28, P1119, DOI 10.1002/btpr.1595; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Wang YP, 2013, CURR OPIN BIOTECH, V24, P994, DOI 10.1016/j.copbio.2013.03.022; Yuan TZ, 2011, APPL MICROBIOL BIOT, V92, P1237, DOI 10.1007/s00253-011-3607-6	63	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180074	10.1371/journal.pone.0180074	http://dx.doi.org/10.1371/journal.pone.0180074			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658270	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900056
J	Griffith, JC; Lee, WG; Orlovich, DA; Summerfield, TC				Griffith, Jocelyn C.; Lee, William G.; Orlovich, David A.; Summerfield, Tina C.			Contrasting bacterial communities in two indigenous Chionochloa (Poaceae) grassland soils in New Zealand	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; NITROGEN-FIXATION; DIAZOTROPH COMMUNITY; DIVERSITY; GENES; FERTILIZATION; HISTORY; BIODIVERSITY; ORGANIZATION	The cultivation of grasslands can modify both bacterial community structure and impact on nutrient cycling as well as the productivity and diversity of plant communities. In this study, two pristine New Zealand grassland sites dominated by indigenous tall tussocks (Chiono-chloa pallens or C. teretifolia) were examined to investigate the extent and predictability of variation of the bacterial community. The contribution of free-living bacteria to biological nitrogen fixation is predicted to be ecologically significant in these soils; therefore, the diazo-trophic community was also examined. The C. teretifolia site had N-poor and poorly-drained peaty soils, and the C. pallens had N-rich and well-drained fertile soils. These soils also differ in the proportion of organic carbon (C), Olsen phosphorus (P) and soil pH. The nutrien-trich soils showed increased relative abundances of some copiotrophic bacterial taxa (including members of the Proteobacteria, Bacteroidetes and Firmicutes phyla). Other copiotrophs, Actinobacteria and the oliogotrophic Acidobacteria showed increased relative abundance in nutrient-poor soils. Greater diversity based on 16S rRNA gene sequences and the Tax4Fun prediction of enhanced spore formation associated with nutrient-rich soils could indicate increased resilience of the bacterial community. The two sites had distinct diazotrophic communities with higher diversity in C. teretifolia soils that had less available nitrate and ammonium, potentially indicating increased resilience of the diazotroph community at this site. The C. teretifolia soils had more 16S rRNA gene and nifH copies per g soil than the nutrient rich site. However, the proportion of the bacterial community that was diazotrophic was similar in the two soils. We suggest that edaphic and vegetation factors are contributing to major differences in the composition and diversity of total bacterial and diazotrophic communities at these sites. We predict the differences in the communities at the two sites will result in different responses to environmental change.	[Griffith, Jocelyn C.; Orlovich, David A.; Summerfield, Tina C.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Lee, William G.] Landcare Res, Dunedin, New Zealand	University of Otago; Landcare Research - New Zealand	Summerfield, TC (corresponding author), Univ Otago, Dept Bot, Dunedin, New Zealand.	tina.summerfield@otago.ac.nz	Orlovich, David Allan/L-8581-2013	Orlovich, David Allan/0000-0002-9266-2188; Summerfield, Tina/0000-0003-1878-7019	Miss EL Hellaby Indigenous Grasslands Research Trust	Miss EL Hellaby Indigenous Grasslands Research Trust	The work was funded by the Miss EL Hellaby Indigenous Grasslands Research Trust.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Anderson M.J., 2005, PERMUTATIONAL MULTIV; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; Berthrong ST, 2014, APPL ENVIRON MICROB, V80, P3103, DOI 10.1128/AEM.04034-13; Bier RL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv113; Blair JM, 2014, ECOLOGY ENV, P389, DOI DOI 10.1007/978-1-4614-7501-9_14; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavaletti L, 2006, APPL ENVIRON MICROB, V72, P4360, DOI 10.1128/AEM.00132-06; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; CHRISTIANSENWENIGER C, 1991, BIOL FERT SOILS, V12, P100, DOI 10.1007/BF00341483; Coleman DC, 2018, FUNDAMENTALS SOIL EC, P77, DOI DOI 10.1016/B978-0-12-805251-8.00004; CONNOR HE, 1991, NEW ZEAL J BOT, V29, P219, DOI 10.1080/0028825X.1991.10416605; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Crews TE, 2000, ECOSYSTEMS, V3, P386, DOI 10.1007/s100210000034; Cusack DF, 2009, ECOSYSTEMS, V12, P1299, DOI 10.1007/s10021-009-9290-0; DIMENNA ME, 1966, NEW ZEAL J AGR RES, V9, P218, DOI 10.1080/00288233.1966.10420775; DuBois John D, 1983, Am J Bot, V70, P8, DOI [10.2307/2443198, 10.1002/j.1537-2197.1983.tb12426.x]; Duc L, 2009, MICROB ECOL, V57, P179, DOI 10.1007/s00248-008-9408-5; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; FRITZSHERIDAN RP, 1988, J PHYCOL, V24, P302, DOI 10.1111/j.1529-8817.1988.tb04470.x; Gaby JC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau001; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Gaby JC, 2011, ENVIRON MICROBIOL, V13, P1790, DOI 10.1111/j.1462-2920.2011.02488.x; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Halloy SRP, 2003, ARCT ANTARCT ALP RES, V35, P248, DOI 10.1657/1523-0430(2003)035[0248:CEOAPB]2.0.CO;2; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; Herzog S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145575; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Koyama A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00516; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEE WG, 1989, J ECOL, V77, P704, DOI 10.2307/2260980; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Leppanen SM, 2013, ENVIRON EXP BOT, V90, P62, DOI 10.1016/j.envexpbot.2012.12.006; Liengen T, 1999, CAN J MICROBIOL, V45, P573, DOI 10.1139/cjm-45-7-573; Lindsay EA, 2010, APPL ENVIRON MICROB, V76, P5547, DOI 10.1128/AEM.03054-09; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luo CW, 2014, APPL ENVIRON MICROB, V80, P1777, DOI 10.1128/AEM.03712-13; Mark AF, 2005, NEW ZEAL J BOT, V43, P235; Mark AF, 1969, ECOLOGY SNOW TUSSOCK, V18, P289; Mark AF, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P1; McAlpine KG, 2009, CONSERVATION DELIVER, P81; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Niederberger TD, 2012, FEMS MICROBIOL ECOL, V82, P376, DOI 10.1111/j.1574-6941.2012.01390.x; Nylander J.A.A., MRMODELTEST V2 PROGR; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; OCONNOR KF, 1983, NEW ZEAL J ECOL, V6, P1; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Penton CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00746; Pereira e Silva MC, 2013, PLOS ONE, V8; Pirie MD, 2010, J BIOGEOGR, V37, P379, DOI 10.1111/j.1365-2699.2009.02205.x; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rosenberg E, 2014, FAMILY BRADYRHIZOBIA, P135; Sangwan P, 2004, APPL ENVIRON MICROB, V70, P5875, DOI 10.1128/AEM.70.10.5875-5881.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Steenwerth KL, 2002, SOIL BIOL BIOCHEM, V34, P1599, DOI 10.1016/S0038-0717(02)00144-X; STIENSTRA AW, 1994, FEMS MICROBIOL ECOL, V14, P45, DOI 10.1111/j.1574-6941.1994.tb00089.x; Tanentzap AJ, 2012, ECOLOGY, V93, P462, DOI 10.1890/11-1750.1; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wakelin SA, 2013, SOIL BIOL BIOCHEM, V57, P675, DOI 10.1016/j.soilbio.2012.07.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00592-13; Warnes GR, 2013, GPLOTS VARIOUS R PRO, P2; Weber CF, 2014, SOIL BIOL BIOCHEM, V69, P242, DOI 10.1016/j.soilbio.2013.11.010; White R.P., 2000, GRASSLAND ECOSYSTEMS; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; WILLIAMS P A, 1976, New Zealand Journal of Botany, V14, P29; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2	99	10	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179652	10.1371/journal.pone.0179652	http://dx.doi.org/10.1371/journal.pone.0179652			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658306	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900036
J	Hung, YM; Lin, LC; Chen, CM; Chiou, JY; Wang, YH; Wang, PYP; Wei, JCC				Hung, Yao-Min; Lin, Lichi; Chen, Chyong-Mei; Chiou, Jeng-Yuan; Wang, Yu-Hsun; Wang, Paul Yung-Pou; Wei, James Cheng-Chung			The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INSURANCE RESEARCH DATABASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; PSORIATIC-ARTHRITIS; CELECOXIB; ROFECOXIB; EVENTS; ATHEROSCLEROSIS	Objectives To determine whether anti-rheumatic drug usage is associated with risk of coronary artery diseases (CAD) in incident Rheumatoid Arthritis (RA) patients. Methods Data were obtained from the Taiwan National Health Insurance Research Database. The study cohort comprised 6260 patients who were newly diagnosed with RA between 20012010. The study endpoint was occurrence of CAD according to the ICD-9-CM codes. We used the WHO Defined Daily Dose (DDD) as a tool to assess the drugs exposure. The Cox proportional hazards regression model was used to estimate the hazard ratio (HR) of disease after controlling for demographic and other co-morbidities. When the proportionality assumption is violated, a spline curve of the Scaled Schoenfeld residuals is fitted to demonstrate the estimated effect on CAD over time for drug usage. Results Among RA patients, use of celecoxib, and etoricoxib was associated with significantly decreased incidence of CAD. The adjusted HR(95% CI) of CAD for low-dose celecoxib (DDD1) and high-dose user were 0.47(0.34, 0.65) and 0.37(0.24, 0.58) during the 4 year follow-up time; however, it became 0.98(0.70, 1.37) and1.29(0.85, 1.95). Adjusted HR(95% CI) of CAD for etoricoxib users remained 0.47(0.26, 0.84). Conclusions This study revealed association of decreased CAD risk in RA patients taking 2 different kinds of COX -2i in comparison with nonusers. The effect might be changed over time, after about 4 years.	[Hung, Yao-Min] Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Hung, Yao-Min; Chen, Chyong-Mei] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei, Taiwan; [Hung, Yao-Min] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Lin, Lichi] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Lin, Lichi; Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Lichi; Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiou, Jeng-Yuan] Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan; [Wang, Yu-Hsun] Chung Shan Med Univ, Dept Med Res, Taichung, Taiwan; [Wang, Paul Yung-Pou] Kaiser Permanente Baldwin Pk Med Ctr, Div Nephrol, Baldwin Pk, CA USA; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Oklahoma State University System; Oklahoma State University - Stillwater; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Kaiser Permanente; China Medical University Taiwan	Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Chiou, JY (corresponding author), Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan.; Wei, JCC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.	tom@csmu.edu.tw; jccwei@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679	Chung Shan Medical University [CSMU-INT-104-04]	Chung Shan Medical University	This work was supported by the Chung Shan Medical University grant number CSMU-INT-104-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari MC, 2012, SEMIN ARTHRITIS RHEU, V41, P669, DOI 10.1016/j.semarthrit.2011.08.003; ANDERSON TJ, 1995, AM J CARDIOL, V75, pB71, DOI 10.1016/0002-9149(95)80017-M; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bernatsky S, 2005, RHEUMATOLOGY, V44, P677, DOI 10.1093/rheumatology/keh610; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bhosale Uma A, 2014, Niger Med J, V55, P417, DOI 10.4103/0300-1652.140386; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chung CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2098; Crowson CS, 2013, AM HEART J, V166, P622, DOI 10.1016/j.ahj.2013.07.010; del Rincon I, 2015, ANN RHEUM DIS, V74, P1118, DOI 10.1136/annrheumdis-2013-205058; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FitzGerald GA, 2017, CIRCULATION, V135, P113, DOI 10.1161/CIRCULATIONAHA.116.026324; Food and Drug Administration [Internet]. Silver Spring MD, FDA BRIEF INF; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Han CL, 2006, J RHEUMATOL, V33, P2167; Hermann M, 2003, CIRCULATION, V108, P2308, DOI 10.1161/01.CIR.0000101683.30157.0B; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Kaplan MJ, 2010, RHEUM DIS CLIN N AM, V36, P405, DOI 10.1016/j.rdc.2010.02.002; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Levi EH, 2016, AUTOIMMUN REV, V15, P393, DOI 10.1016/j.autrev.2016.01.006; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; R Core Team, 2013, R LANG ENV STAT COMP; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Roman MJ, 2007, CIRCULATION, V116, P2346, DOI 10.1161/CIRCULATIONAHA.106.678334; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Sharma TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002867; Solomon DH, 2008, ARTHRIT RHEUM-ARTHR, V59, P1097, DOI 10.1002/art.23911; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Suissa S, 2006, ARTHRIT RHEUM-ARTHR, V55, P531, DOI 10.1002/art.22094; Tam HW, 2017, INT J RHEUM DIS, V20, P363, DOI 10.1111/1756-185X.12986; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Halm VP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2045; World Health Organization, DEF INTR DEF DAILY D; Wu LC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004792	51	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179081	10.1371/journal.pone.0179081	http://dx.doi.org/10.1371/journal.pone.0179081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658301	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900014
J	Barnes, DKA; Sands, CJ				Barnes, David K. A.; Sands, Chester J.			Functional group diversity is key to Southern Ocean benthic carbon pathways	PLOS ONE			English	Article							BIODIVERSITY; ECOSYSTEM; GEORGIA; SHELF; SEA	High latitude benthos are globally important in terms of accumulation and storage of ocean carbon, and the feedback this is likely to have on regional warming. Understanding this ecosystem service is important but difficult because of complex taxonomic diversity, history and geography of benthic biomass. Using South Georgia as a model location (where the history and geography of benthic biology is relatively well studied) we investigated whether the composition of functional groups were critical to benthic accumulation, immobilization and burial pathway to sequestration-and also aid their study through simplification of identification. We reclassified [1], [2]) morphotype and carbon mass data to 13 functional groups, for each sample of 32 sites around the South Georgia continental shelf. We investigated the influence on carbon accumulation, immobilization and sequestration estimate by multiple factors including the compositions of functional groups. Functional groups showed high diversity within and between sites, and within and between habitat types. Carbon storage was not linked to a functional group in particular but accumulation and immobilization increased with the number of functional groups present and the presence of hard substrata. Functional groups were also important to carbon burial rate, which increased with the presence of mixed (hard and soft substrata). Functional groups showed high surrogacy for taxonomic composition and were useful for examining contrasting habitat categorization. Functional groups not only aid marine carbon storage investigation by reducing time and the need for team size and speciality, but also important to benthic carbon pathways per se. There is a distinct geography to seabed carbon storage; seabed boulder-fields are hotspots of carbon accumulation and immobilization, whilst the interface between such boulder-fields and sediments are key places for burial and sequestration.	[Barnes, David K. A.; Sands, Chester J.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Barnes, DKA (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge, England.	dkab@bas.ac.uk		Sands, Chester/0000-0003-1028-0328; Barnes, David/0000-0002-9076-7867	Darwin Initiative (DEFRA) [18-019, EIDCF013]; Darwin Initiative grants, DEFRA [18-019, EIDCF013]; Natural Environment Research Council [bas0100036] Funding Source: researchfish; NERC [bas0100036] Funding Source: UKRI	Darwin Initiative (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Darwin Initiative grants, DEFRA; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The funders Darwin Initiative (DEFRA), through grants 18-019 and EIDCF013, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the crew of RRS James Clark Ross and the scientists who participated on benthic scientific cruises JR262 and JR287. The South Georgia component of both cruises was funded by Darwin Initiative grants (18-019 and EIDCF013), DEFRA. Thanks also to Carl Robinson for technical development of the Shelf Underwater Camera System (SUCS) and Laura Gerrish for construction of the map in Fig 1. Finally we thank K Mintenbeck and an anonymous referee for helpful suggestions leading to an improved ms. Neither authors have conflicts of interest to declare. This work forms part of the Antarctic Seabed Carbon Capture Change project (www.asece.co.uk)	Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barlow NLM, 2016, QUATERNARY SCI REV, V154, P157, DOI 10.1016/j.quascirev.2016.11.007; Barnes DKA, 2015, CURR BIOL, V25, pR789, DOI 10.1016/j.cub.2015.07.042; Barnes DKA, 2017, GLOBAL CHANGE BIOL, V23, P2649, DOI 10.1111/gcb.13523; Barnes DKA, 2016, J BIOGEOGR, V43, P2391, DOI 10.1111/jbi.12855; Barnes DKA, 2016, GLOBAL CHANGE BIOL, V22, P1110, DOI 10.1111/gcb.13157; Barnes DKA, 2016, GLOB CHANGE BIOL; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; Benedet RA, 2015, BOTTOM LONGLINE FISH; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Buschke FT, 2011, AFR INVERTEBR, V52, P217, DOI 10.5733/afin.052.0112; Douglass LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100551; Dunlop KM, 2014, POLAR BIOL, V37, P1741, DOI 10.1007/s00300-014-1558-y; Fillinger L, 2013, CURR BIOL, V23, P1330, DOI 10.1016/j.cub.2013.05.051; Findlay HS, 2015, POLAR RES, V34; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Graham AGC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001993; Grant S., 2006, BIOREGIONALISATION S; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hodgson DA, 2014, QUATERNARY SCI REV, V89, P129, DOI 10.1016/j.quascirev.2013.12.005; Hogg OT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33163; Hogg OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019795; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; Parker SJ, 2009, WGTASO20099 CCAMI, V9; Pearson TH, 2001, OCEANOGR MAR BIOL, V39, P233; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Pinkerton MH, 2010, CCAMLR SCI, V17, P1; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; ROWE GT, 1988, CONT SHELF RES, V8, P511, DOI 10.1016/0278-4343(88)90066-0; SALONEN K, 1976, LIMNOL OCEANOGR, V21, P724, DOI 10.4319/lo.1976.21.5.0724; Schmidt K, 2016, CURR BIOL, V26, P2667, DOI 10.1016/j.cub.2016.07.058	36	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179735	10.1371/journal.pone.0179735	http://dx.doi.org/10.1371/journal.pone.0179735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654664	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000404541500028
J	Han, ZP; Gao, Y; Gao, Y; Huang, QY				Han, Zengpeng; Gao, Yue; Gao, Yue; Huang, Qingyang			Functional annotation of Alzheimer's disease associated loci revealed by GWASs	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; GENOME-WIDE IDENTIFICATION; VARIANTS; BINDING; ONSET; SNPS; PHOSPHORYLATION; POLYMORPHISMS; EXPRESSION; COMMON	Genome-wide association studies (GWASs) discovered a number of SNPs and genes associated with Alzheimer's disease (AD). However, how these SNPs and genes influence the liability to AD is not fully understood. We deployed computational approaches to explore the function and action mechanisms of AD -related SNPs and genes identified by GWASs, including the effects of 195 GWAS lead SNPs and 338 proxy SNPs on miRNAs binding and protein phosphorylation, their RegulomeDB and 3DSNP scores, and gene ontology, pathway enrichment and protein-protein interaction network of 126 AD-associated genes. Our computational analysis identified 6 lead SNPs (rs10119, rs1048699, rs148763909, rs610932, rs6857 and rs714948) and 2 proxy SNPs (rs12539172 and rs2847655) that potentially impacted the miRNA binding. Lead SNP rs2296160 and proxy SNPs rs679620 and rs2228145 were identified as PhosSNPs potentially influencing protein phosphorylation. AD-associated genes showed enrichment of "regulation of beta-amyloid formation", "regulation of neurofibrillary tangle assembly", "leukocyte mediated immunity" and "protein-lipid complex assembly" signaling pathway. Protein-protein interaction network and functional module analyses identified highly-interconnected "hub" genes (APOE, PICALM, BIN1, ABCA7, CD2AP, CLU, CR1, MS4A4E and MS4A6A) and bottleneck genes (APOE, TOMM40, NME8, PICALM, CD2AP, ZCWPW1, FAM180B, GAB2 and PTK2B) that created three tight subnetworks. Our results provided the targets for further experimental assessment and further insight on AD pathophysiology.	[Han, Zengpeng; Gao, Yue; Gao, Yue; Huang, Qingyang] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Central China Normal University	Huang, QY (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China.	huangqy@mail.ccnu.cn		Han, Zengpeng/0000-0001-7451-6390	National Natural Science Foundation of China [31371275]; Students Innovation Training Plan Project of Central China Normal University [62015186]; self-determined research funds of Central China Normal University [CCNU16JCZX03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Students Innovation Training Plan Project of Central China Normal University; self-determined research funds of Central China Normal University	This work was supported by the National Natural Science Foundation of China (No. 31371275), Students Innovation Training Plan Project of Central China Normal University (No. 62015186) and self-determined research funds of Central China Normal University (No. CCNU16JCZX03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 31371275), Students Innovation Training Plan Project of Central China Normal University (No. B2015186) and self-determined research funds of Central China Normal University (No. CCNU16JCZX03).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cheng MR, 2017, J DIABETES, V9, P362, DOI 10.1111/1753-0407.12421; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Czerwinska U, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0189-4; Delay C, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0186-x; Deng FY, 2013, J BONE MINER RES, V28, P2498, DOI 10.1002/jbmr.1997; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ghanbari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28387; Ghanbari M, 2015, CIRC-CARDIOVASC GENE, V8, P473, DOI 10.1161/CIRCGENETICS.114.000968; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gong J, 2015, DATABASE, V2015, P1; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hauw JJ, 2002, CR BIOL, V325, P655, DOI 10.1016/S1631-0691(02)01479-8; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lu YM, 2017, NUCLEIC ACIDS RES, V45, pD643, DOI 10.1093/nar/gkw1022; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Meyer JM, 1998, AM J MED GENET, V81, P92, DOI 10.1002/(SICI)1096-8628(19980207)81:1<92::AID-AJMG16>3.0.CO;2-R; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Niu TH, 2016, J BONE MINER RES, V31, P358, DOI 10.1002/jbmr.2687; Qin LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150070; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	40	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179677	10.1371/journal.pone.0179677	http://dx.doi.org/10.1371/journal.pone.0179677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650998	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300006
J	Wang, BY; Yang, J; Li, ST; Lv, M; Chen, ZL; Li, EX; Yi, M; Yang, J				Wang, Biyuan; Yang, Jiao; Li, Shuting; Lv, Meng; Chen, Zheling; Li, Enxiao; Yi, Min; Yang, Jin			Tumor location as a novel high risk parameter for stage II colorectal cancers	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; SIDED COLON-CANCER; SURGICAL ADJUVANT BREAST; MISMATCH REPAIR STATUS; MICROSATELLITE-INSTABILITY; BRAF MUTATION; DUKES-B; CHEMOTHERAPY; FLUOROURACIL; SURVIVAL	Current studies do not accurately evaluate the influence of tumor location on survival of colorectal cancer patients. This study aimed to explore whether tumor location could be identified as another high-risk factor in stage II colorectal cancer by using data identified from the Surveillance, Epidemiology, and End Results database. All colorectal cancer patients between 2004 and 2008 were grouped into three according to tumor location. Of 33,789 patients diagnosed with stage II colorectal cancer, 46.8% were right colon cancer, 37.5% were left colon cancer and 15.7% were rectal cancer. The 5-year cancer specific survivals were examined. Right colon cancer was associated with the female sex, older age (> 50), and having over 12 lymph nodes resected. Conversely, rectal cancer was associated with the male sex, patients younger than 50 years of age and insufficient lymph node resection. The characteristics of left colon cancer were between them and associated with Asian or Pacific Islander populations, T4 stage, and Grade II patients. The prognostic differences between three groups were significant and retained after stratification by T stage, histological grade, number of regional nodes dissected, age at diagnose, race and sex. Furthermore, the significant difference of location was retained as an independent high-risk parameter. Thus, stage II colorectal cancers of different locations have different clinic-pathological features and cancer-specific survivals, and tumor location should be recognized as another high-risk parameter in stage II colorectal cancer.	[Wang, Biyuan; Yang, Jiao; Li, Shuting; Lv, Meng; Chen, Zheling; Li, Enxiao; Yang, Jin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol 1Med, Xian, Shaanxi Provinc, Peoples R China; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol 1Med, Xian, Shaanxi Provinc, Peoples R China.	yangjin@mail.xjtu.edu	Chen, Zheling/L-6089-2019					Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Andreoni Bruno, 2007, World J Surg Oncol, V5, P73, DOI 10.1186/1477-7819-5-73; [Anonymous], 1985, NEW ENGL J MED, V312, P1465; Arrington AK, 2012, INT J MOL SCI, V13, P12153, DOI 10.3390/ijms131012153; Benedix F, COLON CARCINOMA CLAS, P1532; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Cunningham JM, 1998, CANCER RES, V58, P3455; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; Figueredo A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005390.pub2; Gervaz P, 2001, DIS COLON RECTUM, V44, P364, DOI 10.1007/BF02234734; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jernvall P, 1999, EUR J CANCER, V35, P197, DOI 10.1016/S0959-8049(98)00306-2; Joern F, 2015, INT J COLORECTAL DIS, V30, P797, DOI 10.1007/s00384-015-2219-5; Kim CW, 2013, ANN SURG ONCOL, V20, P2914, DOI 10.1245/s10434-013-2919-4; KIM HG, 1994, AM J PATHOL, V145, P148; Klingbiel D, 2015, ANN ONCOL, V26, P126, DOI 10.1093/annonc/mdu499; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; LaPointe LC, MAP DIFFERENTIAL TRA, P1531; Lee S, 2008, PATHOL INT, V58, P104, DOI 10.1111/j.1440-1827.2007.02197.x; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Marsoni S, 2001, SEMIN ONCOL, V28, P14, DOI 10.1053/sonc.2001.19723; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Minoo, 2010, INT J ONCOLOGY, V37; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Quah HM, 2008, DIS COLON RECTUM, V51, P503, DOI 10.1007/s10350-008-9246-z; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; TAYLOR I, 1985, BRIT J SURG, V72, P359, DOI 10.1002/bjs.1800720509; Teufel A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1404-9; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; WOLMARK N, 1990, J CLIN ONCOL, V8, P1466, DOI 10.1200/JCO.1990.8.9.1466; Worthley DL, DNA METHYLATION NORM, P1476; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167540; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179910	10.1371/journal.pone.0179910	http://dx.doi.org/10.1371/journal.pone.0179910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644878	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100049
J	Ding, LY; Dong, DM; Jiao, LZ; Zheng, WG				Ding, Luyu; Dong, Daming; Jiao, Leizi; Zheng, Wengang			Potential using of infrared thermal imaging to detect volatile compounds released from decayed grapes	PLOS ONE			English	Article							INDICATORS	Previous studies have demonstrated variations in volatile compound content during fruit spoilage. Infrared spectroscopy was proposed as an alternative method to discriminate the various states of decayed fruit through the makeup of their volatile compounds. Based on the infrared spectra of volatile compounds obtained from decayed grapes, this study simplified the extraction of their feature spectra and visualized their gas plumes by using a commercial infrared thermal camera equipped with a custom-made wavelength filter. As a function of volatilization gradients, accumulated gray value and imaging area were proposed as indicators for semi-quantitative analysis in a volatilization range similar to that of ethanol solutions ranging from 10% to 70%. Fresh, seriously decayed, and slightly or moderately decayed grapes were rapidly discriminated through their alcoholic volatiles by thermal images with correct classification ratings of 100%, 93.3%, and 90%, respectively.	[Ding, Luyu; Dong, Daming; Jiao, Leizi; Zheng, Wengang] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Dong, DM (corresponding author), Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China.	damingdong@hotmail.com		Dong, Daming/0000-0003-1684-3072	NSFC [31622040]	NSFC(National Natural Science Foundation of China (NSFC))	This study was funded by NSFC (31622040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogo H, 2012, PROG COLL POL SCI S, V139, P1, DOI 10.1007/978-3-642-28974-3_1; Castillo S, 2010, POSTHARVEST BIOL TEC, V57, P183, DOI 10.1016/j.postharvbio.2010.04.006; Dong D, 2016, FOOD CHEM, V194, P95, DOI 10.1016/j.foodchem.2015.08.005; Dong D, 2014, ANALYST, V139, P5028, DOI [10.1039/c4an00586d, 10.1039/C4AN00586D]; Dong D, 2014, FOOD CHEM, V155, P45, DOI 10.1016/j.foodchem.2014.01.025; Dong DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02585; Furry D, 2005, INFRAMATION 2005 P; Graff DL, 2016, REAL TIME VIDEO IMAG, V9761; Hui GH, 2012, FOOD CONTROL, V28, P25, DOI 10.1016/j.foodcont.2012.04.025; Kalua CM, 2009, J AGR FOOD CHEM, V57, P3818, DOI 10.1021/jf803471n; Li CY, 2011, LWT-FOOD SCI TECHNOL, V44, P1019, DOI 10.1016/j.lwt.2010.11.036; Liger-Belair G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030628; Love SP, 2013, J MICRO-NANOLITH MEM, V8618, P1214; Polychroniadou E, 2003, BIORESOURCE TECHNOL, V87, P337, DOI 10.1016/S0960-8524(02)00237-7; Sanchez-Palomo E, 2005, TALANTA, V66, P1152, DOI 10.1016/j.talanta.2005.01.015; Saraiva C, 2015, J FOOD SCI TECH MYS, V52, P3887, DOI 10.1007/s13197-014-1447-y; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Ueno H, 2010, BUNSEKI KAGAKU, V59, P293, DOI 10.2116/bunsekikagaku.59.293; Vollmer M, 2010, INFRARED THERMAL IMA, P397; Yang CX, 2011, FOOD CHEM, V128, P823, DOI 10.1016/j.foodchem.2010.11.029; Yang CX, 2009, FOOD CHEM, V114, P1106, DOI 10.1016/j.foodchem.2008.10.061	21	12	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180649	10.1371/journal.pone.0180649	http://dx.doi.org/10.1371/journal.pone.0180649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665984	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608700022
J	Ho, CH; Fan, CK; Yu, HJ; Wu, CC; Chen, KC; Liu, SP; Cheng, PC				Ho, Chen-Hsun; Fan, Chia-Kwung; Yu, Hong-Jeng; Wu, Chia-Chang; Chen, Kuan-Chou; Liu, Shih-Ping; Cheng, Po-Ching			Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway	PLOS ONE			English	Article							ANDROGEN RECEPTOR ACTIVATION; IMMUNE-RESPONSES; BACTERIAL; MACROPHAGES	Prostatitis is a common condition in adult men of all ages. Uropathogenic Escherichia coli (UPEC) are most frequent pathogen involved in bacterial prostatitis by refluxing the infected urine into prostatic ducts and resulting in an ascending urethral infection. However, the study about the mechanisms of UPEC to invade, replicate and persist in normal prostate epithelial cell is only few. Given the fact that UPEC is pathogen most frequently involved in prostatitis and that testosterone has been demonstrated to attenuate prostate inflammation caused by other etiologies. In this study we investigated whether the testosterone reduces the prostatitis and related mechanism by regulating IFN-Upsilon/STAT1 signaling pathway. In the current study aimed to clarify whether testosterone influences the process of UPEC-induced prostate inflammation and invasion into the prostate epithelial cells. In addition, we set up a normal prostate cell model for UPEC infection to evaluate the ability to invade the urothelial cells as well as the colonization of intercellular bacterial communities in vitro. By using the model, we examine the effects of testosterone to suppress effectively the invasion and survival of UPEC in the prostate cells, and inhibit LPS-induced inflammatory responses through the JAK/STAT1 pathway have also been indicated. Our results demonstrated testosterone not only suppressed the invasion and colonization of UPEC, but also inhibited the expression of pro-inflammatory IL-1 beta, IL-6 and IL-8 cytokines expression induced by UPEC in a dose-dependent manner. We found the effective dose of testosterone to suppress UPEC infect prostate cells may be appropriate under 40 mu g/ml. Our data also revealed 20 mu g/ml testosterone treated PZ-HPV-7 cells significantly suppressed the LPS-induced JAK/STAT1 pathway and inflammatory responses, and reached to maximal effects at 40 mu g/ml treatment. These results indicate that testosterone plays an anti-inflammatory role in LPS-induced prostate cell inflammation by down-regulating JAK/STAT1 signaling pathway.	[Ho, Chen-Hsun; Wu, Chia-Chang; Chen, Kuan-Chou] Taipei Med Univ, Sch Med, Dept Urol, Taipei, Taiwan; [Ho, Chen-Hsun; Wu, Chia-Chang; Chen, Kuan-Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, Taipei, Taiwan; [Fan, Chia-Kwung; Cheng, Po-Ching] Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan; [Fan, Chia-Kwung; Cheng, Po-Ching] Taipei Med Univ, Sch Med, Ctr Int Trop Med, Taipei, Taiwan; [Yu, Hong-Jeng; Liu, Shih-Ping] Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Cheng, PC (corresponding author), Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan.; Cheng, PC (corresponding author), Taipei Med Univ, Sch Med, Ctr Int Trop Med, Taipei, Taiwan.; Liu, SP (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Urol, Taipei, Taiwan.	spliu@ntuh.gov.tw; bonjovi@tmu.edu.tw		Cheng, Po-Ching/0000-0002-1172-2485; LIU, SHIH-PING/0000-0002-8015-0695; YU, HONG-JENG/0000-0003-3287-5736; Ho, Chen-Hsun/0000-0002-8706-7464	Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan [104 TMU-SHH-19]	Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan	This study was supported by a grant 104 TMU-SHH-19 from Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Badger TM, 2003, ENDOCRINOLOGY, V144, P3969, DOI 10.1210/en.2002-0163; Baune BT, 2008, NEUROBIOL AGING, V29, P937, DOI 10.1016/j.neurobiolaging.2006.12.003; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Breser ML, 2013, J IMMUNOL, V190, P3121, DOI 10.4049/jimmunol.1202482; de Souza JAC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/650812; Condorelli RA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/915752; Conte MP, 2016, INFECT IMMUN, V84, P3105, DOI 10.1128/IAI.00438-16; Dhabhar FS, 2005, AM J PHYSIOL-REG I, V289, pR738, DOI 10.1152/ajpregu.00145.2005; Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Hanafi LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099211; Jia YL, 2015, INT UROL NEPHROL, V47, P39, DOI 10.1007/s11255-014-0845-4; La Vignera S, 2016, ANDROLOGIA; Lee JH, 2016, J SEX MED, V13, P1047, DOI 10.1016/j.jsxm.2016.04.070; Leimgruber C, 2013, J CELL PHYSIOL, V228, P1551, DOI 10.1002/jcp.24314; Leimgruber C, 2011, PROSTATE, V71, P1097, DOI 10.1002/pros.21322; Letourneau J, 2011, JOVE; Liao PW, 2016, J SEX MED, V13, P1872, DOI 10.1016/j.jsxm.2016.10.002; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Liu L, 2014, J MOL CELL CARDIOL, V76, P15, DOI 10.1016/j.yjmcc.2014.07.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longhi C, 2016, NEW MICROBIOL, V39, P146; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; NASLUND MJ, 1988, J UROLOGY, V140, P1049, DOI 10.1016/S0022-5347(17)41924-0; Qi ZL, 2013, INFLAMM RES, V62, P845, DOI 10.1007/s00011-013-0639-7; Qiu X, 2016, PLOS ONE, V11; Rudick CN, 2011, INFECT IMMUN, V79, P628, DOI 10.1128/IAI.00910-10; Saldana Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101200; Song J, 2008, CURR OPIN MICROBIOL, V11, P66, DOI 10.1016/j.mib.2007.12.001; Takahashi A, 2011, LIFE SCI, V89, P337, DOI 10.1016/j.lfs.2011.06.027; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Vignozzi L, 2013, PROSTATE, V73, P789, DOI 10.1002/pros.22623; Vignozzi L, 2012, J ENDOCRINOL, V214, P31, DOI 10.1530/JOE-12-0142; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Wilson GS, 2013, CANCER LETT, V341, P224, DOI 10.1016/j.canlet.2013.08.009; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180244	10.1371/journal.pone.0180244	http://dx.doi.org/10.1371/journal.pone.0180244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665978	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700077
J	Hu, TX; Sun, L; Hu, HQ; Guo, FT				Hu, Tongxin; Sun, Long; Hu, Haiqing; Guo, Futao			Effects of fire disturbance on soil respiration in the non-growing season in a Larix gmelinii forest in the Daxing'an Mountains, China	PLOS ONE			English	Article							SURFACE CO2 FLUX; SNOW WATER EQUIVALENT; CARBON-DIOXIDE; ROOT RESPIRATION; ARCTIC TUNDRA; 3 SITES; EFFLUX; TEMPERATURE; WINTER; ECOSYSTEM	In boreal forests, fire is an important part of the ecosystem that greatly influences soil respiration, which in turn affects the carbon balance. Wildfire can have a significant effect on soil respiration and it depends on the fire severity and environmental factors (soil temperature and snow water equivalent) after fire disturbance. In this study, we quantified post-fire soil respiration during the non-growing season (from November to April) in a Larix gmelinii forest in Daxing'an Mountains of China. Soil respiration was measured in the snow-covered and snow-free conditions with varying degrees of natural burn severity forests. We found that soil respiration decreases as burn severity increases. The estimated annual C efflux also decreased with increased burn severity. Soil respiration during the non-growing season approximately accounted for 4%-5% of the annual C efflux in all site types. Soil temperature (at 5 cm depth) was the predominant determinant of non-growing season soil respiration change in this area. Soil temperature and snow water equivalent could explain 73%-79% of the soil respiration variability in winter snow-covering period (November to March). Mean spring freeze-thaw cycle (FTC) period (April) soil respiration contributed 63% of the non-growing season C efflux. Our finding is key for understanding and predicting the potential change in the response of boreal forest ecosystems to fire disturbance under future climate change.	[Hu, Tongxin; Sun, Long; Hu, Haiqing] Northeast Forestry Univ, Coll Forestry, Harbin, Peoples R China; [Guo, Futao] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China	Northeast Forestry University - China; Fujian Agriculture & Forestry University	Sun, L; Hu, HQ (corresponding author), Northeast Forestry Univ, Coll Forestry, Harbin, Peoples R China.	sunlong365@126.com; hhq@nefu.edu.cn	Hu, Tongxin/J-9582-2019		Fundamental Research Funds for the Central Universities [2572015DA01]; National Natural Science Foundation [31070544, 31470657]; Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper	This research was financially supported by the Fundamental Research Funds for the Central Universities (No. 2572015DA01), National Natural Science Foundation (No. 31070544, 31470657), and the Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper.; This research was financially supported by the Fundamental Research Funds for the Central Universities (No. 2572015DA01), National Natural Science Foundation (No. 31070544, 31470657), and the Chinese Forest Ecosystem Research Network and Gene (CFERN & GENE) Award Funds on Ecological paper. We also greatly appreciate the field assistance provided by the Nanweng River Forest Ecological Research Station.	Baker DG, 1971, BULLETIN, V37, P24; Bodi MB, 2014, EARTH-SCI REV, V130, P103, DOI 10.1016/j.earscirev.2013.12.007; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Brooks PD, 2011, GEOGR COMPASS, V5, DOI 10.1111/j.1749-8198.2011.00420.x; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Brooks PD, 1997, OECOLOGIA, V110, P403, DOI 10.1007/s004420050175; Brown RD, 2003, ATMOS OCEAN, V41, P1, DOI 10.3137/ao.410101; Campbell JL, 2005, FRONT ECOL ENVIRON, V3, P314, DOI 10.2307/3868565; Chen AJ, 2011, DESERT OASIS METEORO, V5, P5, DOI DOI 10.1088/0957-4484/22/31/315712; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Czimczik CI, 2006, GLOBAL CHANGE BIOL, V12, P957, DOI 10.1111/j.1365-2486.2006.01107.x; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Fahnestock JT, 1998, J GEOPHYS RES-ATMOS, V103, P29023, DOI 10.1029/98JD00805; Granier A, 2000, FUNCT ECOL, V14, P312, DOI 10.1046/j.1365-2435.2000.00434.x; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Grogan P, 2001, CLIMATIC CHANGE, V50, P129, DOI 10.1023/A:1010610131277; Grogan P, 2006, GLOBAL CHANGE BIOL, V12, P1479, DOI 10.1111/j.1365-2486.2006.01184.x; Haei M, 2011, SOIL BIOL BIOCHEM, V43, P2069, DOI 10.1016/j.soilbio.2011.06.005; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Harpold A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011949; Hashimoto S., 2011, PLOS ONE, V7; Hicke JA, 2003, GLOBAL CHANGE BIOL, V9, P1145, DOI 10.1046/j.1365-2486.2003.00658.x; Hu Hai-Qing, 2012, Chinese Journal of Plant Ecology, V36, P629, DOI 10.3724/SP.J.1258.2012.00629; Hubbard RM, 2005, BIOGEOCHEMISTRY, V73, P93, DOI 10.1007/s10533-004-1990-0; Jonas T, 2009, J HYDROL, V378, P161, DOI 10.1016/j.jhydrol.2009.09.021; Joo Seung Jin, 2011, Journal of Ecology and Field Biology, V34, P95, DOI 10.5141/JEFB.2011.012; Kasischke ES, 2000, ECOL STU AN, V138, P19; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Kasischke ES, 2000, ECOL STU AN, V138, P173; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kelsey KC, 2012, ARCT ANTARCT ALP RES, V44, P457, DOI 10.1657/1938-4246-44.4.457; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Landsberg J.J, 1997, APPL PHYSL ECOLOGY F; Laternser M, 2003, INT J CLIMATOL, V23, P733, DOI 10.1002/joc.912; Liang NS, 2004, AGR FOREST METEOROL, V123, P97, DOI 10.1016/j.agrformet.2003.10.002; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Liptzin D, 2009, BIOGEOCHEMISTRY, V95, P151, DOI 10.1007/s10533-009-9303-2; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma YC, 2014, AGR FOREST METEOROL, V184, P179, DOI 10.1016/j.agrformet.2013.10.008; Maranon-Jimenez S, 2011, FOREST ECOL MANAG, V261, P1436, DOI 10.1016/j.foreco.2011.01.030; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; McDowell NG, 2000, TREE PHYSIOL, V20, P745; McGuire AD, 2003, LAND CHANGE SCI, V6, P139; Merbold L, 2012, BIOGEOCHEMISTRY, V111, P287, DOI 10.1007/s10533-011-9647-2; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Munoz-Rojas M, 2016, SCI TOTAL ENVIRON, V572, P1385, DOI 10.1016/j.scitotenv.2016.02.086; Nakane K, 1996, ECOL RES, V11, P111, DOI 10.1007/BF02347678; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; Niinisto SM, 2011, BIOGEOSCIENCES, V8, P3169, DOI 10.5194/bg-8-3169-2011; O'Neill KP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000443; ONeill KP, CANADIAN J FOREST RE, V200, P1525; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rastogi M, 2002, CURR SCI INDIA, V82, P510; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Richter DD, 2000, POSTFIRE STIMULATION; Rodriguez A, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008092; Santin C, 2012, EUR J FOREST RES, V131, P1245, DOI 10.1007/s10342-012-0595-8; Schimel JP, 2006, ARCT ANTARCT ALP RES, V38, P249, DOI 10.1657/1523-0430(2006)38[249:CPOCIA]2.0.CO;2; Schimel JP, 2005, SOIL BIOL BIOCHEM, V37, P1411, DOI 10.1016/j.soilbio.2004.12.011; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Smith DR, 2010, BIOGEOSCIENCES, V7, P1375, DOI 10.5194/bg-7-1375-2010; Sommerfeld RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P473, DOI 10.1029/96GB01610; SOMMERFELD RA, 1993, NATURE, V361, P140, DOI 10.1038/361140a0; Sun L, 2014, J FORESTRY RES, V25, P613, DOI 10.1007/s11676-014-0499-1; Suzuki S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006595; Takakai F, 2008, SOIL SCI PLANT NUTR, V54, P938, DOI 10.1111/j.1747-0765.2008.00309.x; Tang XL, 2006, J INTEGR PLANT BIOL, V48, P654, DOI 10.1111/j.1744-7909.2006.00263.x; Tedeschi V, 2006, GLOBAL CHANGE BIOL, V12, P110, DOI 10.1111/j.1365-2486.2005.01081.x; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang C, 2013, AGR FOREST METEOROL, V177, P83, DOI 10.1016/j.agrformet.2013.04.008; [王庆丰 WANG QingFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P1883; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Welker JM, 2000, CLIMATIC CHANGE, V44, P139, DOI 10.1023/A:1005555012742; Widen B, 2001, CAN J FOREST RES, V31, P786, DOI 10.1139/cjfr-31-5-786; Xu HC, 1998, XINGAN MOUNTAINS FOR; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yang Jin-Yan, 2006, Zhiwu Shengtai Xuebao, V30, P286; [杨阔 Yang Kuo], 2010, [生态学报, Acta Ecologica Sinica], V30, P3155; You WZ, 2013, TREES-STRUCT FUNCT, V27, P1417, DOI 10.1007/s00468-013-0889-6; Zhang YJ, 2015, ECOL ENG, V74, P196, DOI 10.1016/j.ecoleng.2014.10.003	92	8	9	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180214	10.1371/journal.pone.0180214	http://dx.doi.org/10.1371/journal.pone.0180214			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665958	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700072
J	Jiao, W; Blackmore, NJ; Nazmi, AR; Parker, EJ				Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.			Quaternary structure is an essential component that contributes to the sophisticated allosteric regulation mechanism in a key enzyme from Mycobacterium tuberculosis	PLOS ONE			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; SIZE-DISTRIBUTION ANALYSIS; AMINO-ACID BIOSYNTHESIS; SYNERGISTIC ALLOSTERY; SHIKIMATE PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC MECHANISM; MOLECULAR-DYNAMICS; PROTEINS	The first enzyme of the shikimate pathway, 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS), adopts a range of distinct allosteric regulation mechanisms in different organisms, related to different quaternary assemblies. DAH7PS from Mycobacterium tuberculosis (MtuDAH7PS) is a homotetramer, with the allosteric sites in close proximity to the interfaces. Here we examine the importance of the quaternary structure on catalysis and regulation, by amino acid substitution targeting the tetramer interface of MtuDAH7PS. Using only single amino acid substitutions either in, or remote from the interface, two dimeric variants of MtuDAH7PS (MtuDAH7PS(F227D) and MtuDAH7PS(G232P)) were successfully generated. Both dimeric variants maintained activity due to the distance between the sites of amino acid substitution and the active sites, but attenuated catalytic efficiency was observed. Both dimeric variants showed significantly disrupted allosteric regulation with greatly impaired binding affinity for one of the allosteric ligands. Molecular dynamics simulations revealed changes in protein dynamics and average conformations in the dimeric variant caused by amino acid substitution remote to the tetramer interface (MtuDAH7PS(G232P)), which are consistent with the observed reduction in catalytic efficiency and loss of allosteric response.	[Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch, New Zealand; [Jiao, Wanting; Blackmore, Nicola J.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch, New Zealand; [Jiao, Wanting; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand; [Nazmi, Ali Reza] Scion, Rotorua, New Zealand	University of Canterbury; University of Canterbury; Victoria University Wellington; Scion	Parker, EJ (corresponding author), Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch, New Zealand.; Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Christchurch, New Zealand.; Parker, EJ (corresponding author), Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand.	emily.parker@vuw.ac.nz	Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Parker, Emily/0000-0002-9571-9987; Nazmi, Ali Reza/0000-0003-1262-5078	Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund [U0C1105]; Biomolecular Interaction Centre	Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund; Biomolecular Interaction Centre	This work was supported by the Maurice Wilkins Centre for Molecular Biodiscovery New Zealand Marsden fund (U0C1105) and the Biomolecular Interaction Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Devenish SRA, 2009, ORG BIOMOL CHEM, V7, P833, DOI 10.1039/b818251p; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P67, DOI 10.1016/j.coph.2009.10.002; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reichau S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.211649; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1998, ARCH MICROBIOL, V169, P517, DOI 10.1007/s002030050605; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segura-Pena D, 2007, STRUCTURE, V15, P1555, DOI 10.1016/j.str.2007.09.025; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; WALLACE BJ, 1967, J BACTERIOL, V93, P237, DOI 10.1128/JB.93.1.237-244.1967; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; Xu XL, 2014, BIOCHEMISTRY-US, V53, P4239, DOI 10.1021/bi500469d	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180052	10.1371/journal.pone.0180052	http://dx.doi.org/10.1371/journal.pone.0180052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665948	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700058
J	Fosmark, S; Hellwege, S; Dahlrot, RH; Jensen, KL; Derand, H; Lohse, J; Sorensen, MD; Hansen, S; Kristensen, BW				Fosmark, Sigurd; Hellwege, Sofie; Dahlrot, Rikke H.; Jensen, Kristian L.; Derand, Helene; Lohse, Jesper; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.			APNG as a prognostic marker in patients with glioblastoma	PLOS ONE			English	Article							BASE EXCISION-REPAIR; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; DNA GLYCOSYLASE; ADJUVANT TEMOZOLOMIDE; GRADE GLIOMAS; RADIOTHERAPY; EXPRESSION; RESISTANCE; 3-METHYLADENINE; SENSITIVITY	Aim Expression of the base excision repair enzyme alkylpurine-DNA-N-glycosylase (APNG) has been correlated to temozolomide resistance. Our aim was to evaluate the prognostic value of APNG in a population-based cohort with 242 gliomas including 185 glioblastomas (GBMs). Cellular heterogeneity of GBMs was taken into account by excluding APNG expression in non-tumor cells from the analysis. Methods APNG expression was evaluated using automated image analysis and a novel quantitative immunohistochemical (IHC) assay (qIHC), where APNG protein expression was evaluated through countable dots. Non-tumor cells were excluded using an IHC/qIHC double-staining. For verification, APNG was measured by a quantitative double-immunofluorescence (IF) assay. As validation APNG mRNA expression was evaluated using independent TCGA data. Results Using qIHC, high levels of APNG were associated with better overall survival (OS) in univariate (HR = 0.50; P < 0.001) and multivariate analysis (HR = 0.53; P = 0.001). Patients with methylated MGMT promoters and high APNG expression demonstrated better OS, than patients with methylated MGMT promoters and low APNG expression (HR = 0.59; P = 0.08). Retesting the cohort using IF showed similar results in both univariate (HR = 0.61; P = 0.002) and multivariate analysis (HR = 0.81; P = 0.2). The results were supported by data from the TCGA database. Conclusions Using two different assays combined with quantitative image analysis excluding non-tumour cells, APNG was an independent prognostic factor among patients with a methylated MGMT promoter. We expect that APNG qIHC can potentially identify GBM patients who will not benefit from treatment with temozolomide.	[Fosmark, Sigurd; Hellwege, Sofie; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Fosmark, Sigurd; Hellwege, Sofie; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Dahlrot, Rikke H.; Hansen, Steinbjorn] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Jensen, Kristian L.; Derand, Helene; Lohse, Jesper] DAKO Denmark AS, Glostrup, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kristensen, BW (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Kristensen, BW (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	bjarne.winther.kristensen@rsyd.dk	Kristensen, Bjarne Winther/A-6690-2012; Kristensen, Bjarne Winther/AAX-5491-2020	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Hansen, Steinbjorn/0000-0001-5651-6493; Dahlrot, Rikke/0000-0003-1538-4361	Kretens Bekarnpelse; The Danish Cancer Society [R74-A4929] Funding Source: researchfish	Kretens Bekarnpelse; The Danish Cancer Society(Danish Cancer Society)	This study was supported by Kretens Bekarnpelse, www.cancer.dk. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2012, J CLIN INVEST, V122, P253, DOI 10.1172/JCI59334; Andersson U, 2004, CLIN NEUROPATHOL, V23, P21; Araki Y, 2011, BRAIN TUMOR PATHOL, V28, P25, DOI 10.1007/s10014-010-0004-2; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bobola MS, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00176; Bobola MS, 2001, CLIN CANCER RES, V7, P613; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chiesa-Vottero AG, 2003, AM J CLIN PATHOL, V120, P902, DOI 10.1309/8UAUFK2NBDMVTNU; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinot OL, 2007, J CLIN ONCOL, V25, P1470, DOI 10.1200/JCO.2006.07.4807; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8; Dahlrot RH, 2013, J NEURO-ONCOL, V114, P309, DOI 10.1007/s11060-013-1186-3; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jensen K, 2016, MODERN PATHOLOGY OFF; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Liu C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/760679; Lohse J, 2014, BIOCONJUGATE CHEM, V25, P1036, DOI 10.1021/bc400311g; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Music D, 2016, J NEUROONCOLOGY; Nakagawa T, 2009, NEUROPATHOLOGY, V29, P379, DOI 10.1111/j.1440-1789.2008.00983.x; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Smith SA, 2000, NUCLEIC ACIDS RES, V28, P3294, DOI 10.1093/nar/28.17.3294; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; The WHO, 2020, CLASSIFICATION TUMOU; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178693	10.1371/journal.pone.0178693	http://dx.doi.org/10.1371/journal.pone.0178693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662073	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300008
J	Pergantas, P; Tsatsaris, A; Malesios, C; Kriparakou, G; Demiris, N; Tselentis, Y				Pergantas, Panagiotis; Tsatsaris, Andreas; Malesios, Chrisovalantis; Kriparakou, Georgia; Demiris, Nikolaos; Tselentis, Yiannis			A spatial predictive model for malaria resurgence in central Greece integrating entomological, environmental and social data	PLOS ONE			English	Article							CLIMATE-CHANGE; TRANSMISSION; TEMPERATURE; AFRICA	Malaria constitutes an important cause of human mortality. After 2009 Greece experienced a resurgence of malaria. Here, we develop a model-based framework that integrates entomological, geographical, social and environmental evidence in order to guide the mosquito control efforts and apply this framework to data from an entomological survey study conducted in Central Greece. Our results indicate that malaria transmission risk in Greece is potentially substantial. In addition, specific districts such as seaside, lakeside and rice field regions appear to represent potential malaria hotspots in Central Greece. We found that appropriate maps depicting the basic reproduction number, R-0, are useful tools for informing policy makers on the risk of malaria resurgence and can serve as a guide to inform recommendations regarding control measures.	[Pergantas, Panagiotis; Kriparakou, Georgia] Bioapplicat Ltd, Levadeia, Greece; [Tsatsaris, Andreas] Technol Educ Inst Athens, Dept Dept Civil Surveying & Geoinformat Engn, Athens, Greece; [Malesios, Chrisovalantis] Democritus Univ Thrace, Dept Rural Dev, Orestiada, Greece; [Demiris, Nikolaos] Athens Univ Econ & Business, Dept Stat, Athens, Greece; [Tselentis, Yiannis] Univ Crete, Reg Publ Hlth Lab, Fac Med, Iraklion, Greece	University of West Attica; Democritus University of Thrace; Athens University of Economics & Business; University of Crete	Malesios, C (corresponding author), Democritus Univ Thrace, Dept Rural Dev, Orestiada, Greece.	malesios@agro.duth.gr	Malesios, Chrisovalantis/C-6659-2018; TSATSARIS, ANDREAS/R-6973-2018	Malesios, Chrisovalantis/0000-0003-0378-3939; TSATSARIS, ANDREAS/0000-0003-3509-6551	Continental Greece Region	Continental Greece Region	The entomological survey was financed by the Continental Greece Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioapplications Ltd, a commercial company, provided support in the form of salary for authors PP and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Danis K, 2013, TRAVEL MED INFECT DI, V11, P8, DOI 10.1016/j.tmaid.2013.01.001; Gomes E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164788; Hardy A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0652-5; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hellenic Center for Disease Control and Prevention (HCDCP), 2015, EP DAT MAL GREEC; Hellenic Center for Disease Control and Prevention (HCDCP), 2012, EP DAT MAL GREEC; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Kampen H, 2003, PARASITOL RES, V89, P252, DOI 10.1007/s00436-002-0746-9; Leedale J, 2016, GEOSPATIAL HEALTH, V11, P102, DOI 10.4081/gh.2016.393; Lindsay S.W., 2001, GLOB CHANGE HUM HLTH, V2, P80, DOI DOI 10.1023/A:1011995115713; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Piperaki ET, 2016, CLIN MICROBIOL INFEC, V22, P487, DOI 10.1016/j.cmi.2016.04.023; R Core Team, 2018, R LANG ENV STAT COMP; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-307; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Starzengruber P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-16; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Tseroni M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004215; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; World Health Organization, 2015, WORLD MAL REP 2015	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178836	10.1371/journal.pone.0178836	http://dx.doi.org/10.1371/journal.pone.0178836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662158	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000404608300009
J	Epskamp, S; Kruis, J; Marsman, M				Epskamp, Sacha; Kruis, Joost; Marsman, Maarten			Estimating psychopathological networks: Be careful what you wish for	PLOS ONE			English	Article							BAYESIAN INFORMATION CRITERIA; MODEL SELECTION; DEPRESSION; SYMPTOMS; COMORBIDITY; ANXIETY	Network models, in which psychopathological disorders are conceptualized as a complex interplay of psychological and biological components, have become increasingly popular in the recent psychopathological literature (Borsboom, et. al., 2011). These network models often contain significant numbers of unknown parameters, yet the sample sizes available in psychological research are limited. As such, general assumptions about the true network are introduced to reduce the number of free parameters. Incorporating these assumptions, however, means that the resulting network will lead to reflect the particular structure assumed by the estimation method-a crucial and often ignored aspect of psychopathological networks. For example, observing a sparse structure and simultaneously assuming a sparse structure does not imply that the true model is, in fact, sparse. To illustrate this point, we discuss recent literature and show the effect of the assumption of sparsity in three simulation studies.	[Epskamp, Sacha; Kruis, Joost; Marsman, Maarten] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands	University of Amsterdam	Epskamp, S (corresponding author), Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands.	s.epskamp@uva.nl	Epskamp, Sacha/I-4515-2019	Kruis, Joost/0000-0001-8700-0326	NWO (Netherlands Organisation for Scientific Research) [406-11-06]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	This work was supported by NWO (Netherlands Organisation for Scientific Research) "research talent" Grant Number 406-11-06 (http.//WWW.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; [Anonymous], [No title captured]; Barber RF, 2015, ELECTRON J STAT, V9, P567, DOI 10.1214/15-EJS1012; Beard C, 2016, PSYCHOL MED, V46, P3359, DOI 10.1017/S0033291716002300; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Boschloo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137621; Chandrasekaran V, 2012, ANN STAT, V40, P1935, DOI 10.1214/11-AOS949; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Chen Y., 2016, ARXIV160608925; COX DR, 1993, STAT SCI, V8, P204, DOI 10.1214/ss/1177010887; Cramer AOJ, 2012, PSYCHOL MED, V42, P957, DOI 10.1017/S003329171100211X; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Dalege J, 2016, PSYCHOL REV, V123, P2, DOI 10.1037/a0039802; Epskamp S., 2014, ISINGSAMPLER SAMPLIN; Epskamp S., 2017, PSYCHOMETRIKA; Epskamp S., HDB PSYCHOM IN PRESS; Epskamp S., 2016, ELASTICISING ISING N; Epskamp S., 2016, ARXIV160408462; Epskamp S, 2016, ARXIV160701367; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Foygel R., 2010, ARXIV10116640; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Fried EI, 2015, J ABNORM PSYCHOL, V124, P256, DOI 10.1037/abn0000028; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Isvoranu A. M., 2016, SCHIZOPHRENIA B; Kac M., 1966, MATH MECH PHASE TRAN; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kossakowski JJ, 2016, QUAL LIFE RES, V25, P781, DOI 10.1007/s11136-015-1127-z; Kruis J, 2016, SCI REPORTS, P6; Kruis J, 2015, THESIS; Langley DJ, 2015, ECIS 2015 RES IN PRO; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Levinson CA, 2017, J ABNORM PSYCHOL, V126, P340, DOI 10.1037/abn0000254; Pan J., PSYCHOL MET IN PRESS; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Rhemtulla M, 2016, DRUG ALCOHOL DEPEN, V161, P230, DOI 10.1016/j.drugalcdep.2016.02.005; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Borkulo C.D., 2014, R PACKAG VERSION; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; Voets E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14798; Wichers M, 2016, PSYCHOTHER PSYCHOSOM, V85, P114, DOI 10.1159/000441458	46	111	111	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179891	10.1371/journal.pone.0179891	http://dx.doi.org/10.1371/journal.pone.0179891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY7CO	28644856	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100046
J	Sinharoy, P; Bratz, IN; Sinha, S; Showalter, LE; Andrei, SR; Damron, DS				Sinharoy, Pritam; Bratz, Ian N.; Sinha, Sayantani; Showalter, Loral E.; Andrei, Spencer R.; Damron, Derek S.			TRPA1 and TRPV1 contribute to propofol-mediated antagonism of U46619-induced constriction in murine coronary arteries	PLOS ONE			English	Article							SENSORY NEURONS; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; CHANNELS; ACTIVATION; CAPSAICIN; CA2+; PATHOPHYSIOLOGY; DESENSITIZATION; VASODILATION	Background Transient receptor potential (TRP) ion channels have emerged as key components contributing to vasoreactivity. Propofol, an anesthetic is associated with adverse side effects including hypotension and acute pain upon infusion. Our objective was to determine the extent to which TRPA1 and/or TRPV1 ion channels are involved in mediating propofol-induced vasorelaxation of mouse coronary arterioles in vitro and elucidate the potential cellular signal transduction pathway by which this occurs. Methods Hearts were excised from anesthetized mice and coronary arterioles were dissected from control C57Bl/6J, TRPA1(-/-), TRPV1(-/-) and double-knockout mice (TRPAV(-/-)). Isolated micro-vessels were cannulated and secured in a temperature-controlled chamber and allowed to equilibrate for 1 hr. Vasoreactivity studies were performed in microvessels pre-constricted with U46619 to assess the dose-dependent relaxation effects of propofol on coronary microvascular tone. Results Propofol-induced relaxation was unaffected in vessels obtained from TRPV1(-/-) mice, markedly attenuated in pre-constricted vessels obtained from TRPA1(-/-) mice and abolished in vessels obtained from TRPAV (-/-) mice. Furthermore, NOS inhibition with L-NAME or endothelium denuding abolished the proporfol-induced depressor response in pre-constricted vessels obtained from all mice. In the absence of L-NAME, BKCa inhibition with penitrem A markedly attenuated propofol-mediated relaxation in vessels obtained from wild-type mice and to a lesser extent in vessels obtained from TRPV1(-/-), mice with no effect in vessels obtained from TRPA1(-/-) or TRPAV(-/-) mice. Conclusions TRPA1 and TRPV1 appear to contribute to the propofol-mediated antagonism of U46619-induced constriction in murine coronary microvessels that involves activation of NOS and BKCa.	[Sinharoy, Pritam] Stanford Sch Med, Dept Anesthesia Perioperat & Pain Med, Stanford, CA USA; [Bratz, Ian N.] Northeast Ohio Med Coll, Dept Integrat Med Sci, Rootstown, OH USA; [Sinha, Sayantani] Childrens Hosp Philadelphia, Dept Surg, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Showalter, Loral E.; Andrei, Spencer R.; Damron, Derek S.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Stanford University; Northeast Ohio Medical University (NEOMED); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Damron, DS (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	ddamron@kent.edu	Roy, Pritam Sinha/P-7955-2019; Sinha, Sayantani/S-9063-2019	Roy, Pritam Sinha/0000-0002-6322-260X; 	National Heart, Lung, and Blood Institute [HL 65701-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065701] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute, HL 65701-12 to DSD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 1996, AM J PHYSIOL-LUNG C, V271, pL719, DOI 10.1152/ajplung.1996.271.5.L719; Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Andrei SR, 2016, CHANNELS, V10, P395, DOI 10.1080/19336950.2016.1185579; Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bratz IN, 2008, AM J PHYSIOL-HEART C, V294, pH2489, DOI 10.1152/ajpheart.01191.2007; Byrne MF, 2008, CAN J GASTROENTEROL, V22, P457, DOI 10.1155/2008/268320; CHANG KSK, 1993, ANESTH ANALG, V76, P24; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Guarini G, 2012, AM J PHYSIOL-HEART C, V303, pH216, DOI 10.1152/ajpheart.00011.2012; Hiett SC, 2014, CARDIOVASC RES, V103, P607, DOI 10.1093/cvr/cvu152; Hopps JJ, 2012, EUR J PHARMACOL, V681, P88, DOI 10.1016/j.ejphar.2012.02.019; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Klockgether-Radke AP, 2004, EUR J ANAESTH, V21, P226, DOI 10.1017/S0265021504003126; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Lam CF, 2010, CRIT CARE RESUSC, V12, P186; Liu Y, 2009, VASC PHARMACOL, V51, P182, DOI 10.1016/j.vph.2009.06.003; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; PARK KW, 1995, ANESTH ANALG, V81, P1191, DOI 10.1097/00000539-199512000-00013; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Pozsgai G, 2010, CARDIOVASC RES, V87, P760, DOI 10.1093/cvr/cvq118; Robbins N, 2013, TRANSL RES, V161, P469, DOI 10.1016/j.trsl.2013.02.003; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sinha S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122189; Sinharoy P, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.153; Spahn V, 2013, MOL PHARM; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; STONE DJ, 1989, ANESTHESIOLOGY, V71, P126, DOI 10.1097/00000542-198907000-00021; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Wickley PJ, 2010, ANESTHESIOLOGY, V113, P833, DOI 10.1097/ALN.0b013e3181eaa9a0; YAMANOUE T, 1994, ANESTHESIOLOGY, V81, P443, DOI 10.1097/00000542-199408000-00023; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zhang HY, 2011, ANESTHESIOLOGY, V114, P1169, DOI 10.1097/ALN.0b013e31820dee67	41	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180106	10.1371/journal.pone.0180106	http://dx.doi.org/10.1371/journal.pone.0180106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644897	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100063
J	Zhu, H				Zhu, Hua			Floristic characteristics and affinities in Lao PDR, with a reference to the biogeography of the Indochina peninsula	PLOS ONE			English	Article							YUNNAN; ASIA; FRAMEWORK; EVOLUTION; FLORA; SHEAR	The flora of Laos is composed of 5,005 species in 1,373 genera and 188 families of seed plants. Floristic and geographical attributes of the flora were analyzed. Tropical floristic elements at the family and generic levels contributed a majority (62.23% of the families and 82.30% of the genera) of the flora, of which the dominant geographical elements were pantropical distribution (42.02% of families) and tropical Asian distribution (30.08% of genera). This revealed that the flora of Lao PDR is tropical in nature and has a conspicuously tropical Asian affinity. Compared with the neighbouring countries of the Indochina peninsula, the flora of Laos has similar floristic composition and geographical elements. The floras of these Indochinese countries have similarities of more than 77.84% at the generic level, which suggests that they compose an affiliated biogeographical region. However, the flora of Laos showed the highest similarity to the flora of Vietnam (92.13%), followed by Myanmar (86.01%) at the generic level, but has less East Asian and North Temperate elements than Vietnam, and less North Temperate elements than Myanmar. These differences among the compared countries could be explained by the extrusion of the Indochinese block with the uplift of the Himalayas.	[Zhu, Hua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhu, H (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022		national science foundation of China	national science foundation of China(National Natural Science Foundation of China (NSFC))	The research funded by the national science foundation of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubreville A., 1960, FLORA CAMBODGE LAOS; Blasco F, 1996, J VEG SCI, V7, P623, DOI 10.2307/3236374; Blasco F, 2000, BIOL CONSERV, V95, P175, DOI 10.1016/S0006-3207(00)00032-X; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Callaghan M., 2004, CHECKLIST LAO PLANT; Chan L. T., 1999, SOME BASIC CHARACTER; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Fortey R. A., 1998, P43; Jain AK, 2014, CURR SCI INDIA, V106, P254; Kress W. John, 2003, Contributions from the United States National Herbarium, V45, P1; Lecomte H., 1907, FLORA GEN INDOCHINE; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Leloup PH, 1995, TECTONOPHYSICS, V251, P3, DOI 10.1016/0040-1951(95)00070-4; Lou reiro J.D, 1790, FLORA COCHINCHINENSE; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Messerli Peter, 2008, GEOGRAPHY POVERTY IN; Metcalfe I, 2014, GONDWANA RES, V26, P1159, DOI 10.1016/j.gr.2013.09.004; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; Metcalfe I, 2011, GONDWANA RES, V19, P3, DOI 10.1016/j.gr.2010.02.016; MITCHELL AHG, 1993, J GEOL SOC LONDON, V150, P1089, DOI 10.1144/gsjgs.150.6.1089; Newman M, 2007, CHECKLIST VASCULAR P; Smitinand T., 2001, THAI PLANT NAMESS; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Vidal J., 1960, Bois et Forets des Tropiques, P5; Vidal J., 1959, EXTRAIT B ECOLE FRAN, VXLIX; Vidal J., 1972, VEGETATION LAOS; Watkinson I, 2008, J STRUCT GEOL, V30, P1554, DOI 10.1016/j.jsg.2008.09.001; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Zhu H., 2004, Telopea, V10, P639; Zhu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151941; Zhu H, 2009, BOT STUD, V50, P467; Zhu H, 2008, ANN MO BOT GARD, V95, P661, DOI 10.3417/2006081; [朱华 Zhu Hua], 2003, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V42, P98	36	7	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179966	10.1371/journal.pone.0179966	http://dx.doi.org/10.1371/journal.pone.0179966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644895	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100054
J	Ota, S; Ogawa, Y; Ota, H; Fujiwara, T; Sugiyama, T; Ochi, A				Ota, Susumu; Ogawa, Yukari; Ota, Hiroki; Fujiwara, Tomoya; Sugiyama, Tadashi; Ochi, Akira			Beneficial effects of a gait used while wearing a kimono to decrease the knee adduction moment in healthy adults	PLOS ONE			English	Article							HIP ABDUCTOR FUNCTION; MEDIAL CONTACT FORCE; TOE-OUT GAIT; DISEASE PROGRESSION; FLEXION MOMENTS; JOINT LOAD; BASE-LINE; OSTEOARTHRITIS; PEOPLE; INDIVIDUALS	The knee adduction moment (KAM) relates to medial knee osteoarthritis (OA). Several gait modifications to reduce the KAM for the prevention of knee OA have been studied. Most of the modifications, however, involve voluntary changes in leg alignment. Here we investigated the biomechanical effects for reducing the KAM of a walking style with a small trunk rotation and arm swing gait, which is a natural walking style used while wearing a kimono (Nanba walk) that shifts the ground reaction force toward the stance leg (reduced lever arm). Twenty-nine healthy adults (21.5 +/- 0.6 years) participated in the present study. A three-dimensional analysis system with 10 cameras and 1 force plate was used to obtain the KAM and other biomechanical data. Surface electromyography (EMG) of the hip and trunk muscles (internal obliquus abdominal muscle: IO, external obliquus abdominal muscle: EO, multifidus muscle: MF, and gluteus medius muscle: Gmed) was also assessed, and integrated EMG (iEMG) of the four muscles was assessed in the first and second halves of the stance phase. The 1st and 2nd peak KAMs were significantly decreased during Nanba walking (0.40 +/- 0.09 and 0.37 +/- 0.13 Nm/kg) compared with normal walking (0.45 +/- 0.09 and 0.45 +/- 0.13 Nm/kg; P = 0.002, P<0.001, respectively). The lever arm lengths at the 1st and 2nd peak KAMs were also significantly decreased during Nanba walking compared with normal walking (p = 0.023 and p<0.001, respectively). The iEMGs of IO, EO and Gmed muscles during the first half, and the iEMGs of EO and GM during the second half of the stance phase were significantly increased during Nanba walking compared with normal walking. The Nanba gait modification could be a useful strategy for reducing the KAM with high activation of the trunk and hip joint muscles for the prevention and/or treatment of medial knee OA.	[Ota, Susumu; Ochi, Akira] Seijoh Univ, Dept Rehabil & Care, Tokai, Ibaraki, Japan; [Ogawa, Yukari; Ota, Hiroki] Nagoya Tokushukai Gen Hosp, Dept Phys Med & Rehabil, Kasugai, Aichi, Japan; [Fujiwara, Tomoya] Yachiyo Hosp, Rehabil Ctr, Anjo, Japan; [Sugiyama, Tadashi] Natl Ctr Geriatr & Gerontol, Dept Rehabil Med, Obu, Japan	National Center for Geriatrics & Gerontology	Ota, S (corresponding author), Seijoh Univ, Dept Rehabil & Care, Tokai, Ibaraki, Japan.	ota-s@seijoh-u.ac.jp		Ochi, Akira/0000-0003-2754-7383	 [15H03047];  [24500577]	; 	The present study was partially supported by a Grant-in-Aid for Scientific Research [B] (15H03047) and [C] (24500577). There was no additional external funding received for this study.; The present study was partially supported by a Grant-in-Aid for Scientific Research [B] (15H03047) and [C] (24500577).	Ae M., 1992, BIOMECHANISM, V11, P23; Magalhaes CMB, 2013, J ELECTROMYOGR KINES, V23, P1243, DOI 10.1016/j.jelekin.2013.05.013; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Biomedical Health and Research Program of the European Union, SENIAM PROJ; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Chang AH, 2015, OSTEOARTHR CARTILAGE, V23, P1099, DOI 10.1016/j.joca.2015.02.005; Chehab EF, 2014, OSTEOARTHR CARTILAGE, V22, P1833, DOI 10.1016/j.joca.2014.08.009; Criswell E., 2011, CRAMS INTRO SURFACE; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Henriksen M, 2009, J BIOMECH, V42, P1236, DOI 10.1016/j.jbiomech.2009.03.021; Hinman RS, 2010, ARTHRIT CARE RES, V62, P1190, DOI 10.1002/acr.20199; Hunt MA, 2014, OSTEOARTHR CARTILAGE, V22, P904, DOI 10.1016/j.joca.2014.04.007; Hunt MA, 2011, KNEE, V18, P231, DOI 10.1016/j.knee.2010.05.014; Jenkyn TR, 2008, J BIOMECH, V41, P276, DOI 10.1016/j.jbiomech.2007.09.015; Kemp G, 2008, ARTHRIT RHEUM-ARTHR, V59, P609, DOI 10.1002/art.23578; Kidera E, 2004, HONTOUNO NANBA NAMIA; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Ogata M, 2006, J HUM MOVEMENT STUD, V50, P171; Ota S, 2015, J ARTHRITIS, V4; Ota S, 2015, J PHYS THER SCI, V27, P3077, DOI 10.1589/jpts.27.3077; Perry J., 1992, GAIT ANAL NORMAL PAT; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Robbins SMK, 2009, GAIT POSTURE, V30, P543, DOI 10.1016/j.gaitpost.2009.08.236; Rutherford DJ, 2014, CLIN BIOMECH, V29, P545, DOI 10.1016/j.clinbiomech.2014.03.009; Shull PB, 2013, J ORTHOP RES, V31, P1020, DOI 10.1002/jor.22340; Simic M, 2013, OSTEOARTHR CARTILAGE, V21, P1272, DOI 10.1016/j.joca.2013.06.001; Simic M, 2012, ARTHRIT CARE RES, V64, P1545, DOI 10.1002/acr.21724; Simic M, 2011, ARTHRIT CARE RES, V63, P405, DOI 10.1002/acr.20380; Takacs J, 2012, J BIOMECH, V45, P2791, DOI 10.1016/j.jbiomech.2012.08.041; van den Noort JC, 2013, HUM MOVEMENT SCI, V32, P412, DOI 10.1016/j.humov.2012.02.009; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Watarai K, 2007, UTSUKUSHIKU TATSU; Yamaguchi T, 2009, J BIOMECHANICAL SCI, V4, P468; Yang HS, 2015, GAIT POSTURE, V42, P430, DOI 10.1016/j.gaitpost.2015.07.010; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379	38	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179260	10.1371/journal.pone.0179260	http://dx.doi.org/10.1371/journal.pone.0179260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640896	gold, Green Submitted, Green Published			2022-12-26	WOS:000404135800025
J	Moreno-Navarrete, JM; Moreno, M; Ortega, F; Xifra, G; Hong, SY; Asara, JM; Serrano, JCE; Jove, M; Pissios, P; Bluher, M; Ricart, W; Portero-Otin, M; Fernandez-Real, JM				Maria Moreno-Navarrete, Jose; Moreno, Maria; Ortega, Francisco; Xifra, Gemma; Hong, Shangyu; Asara, John M.; Serrano, Jose C. E.; Jove, Mariona; Pissios, Pavlos; Blueher, Matthias; Ricart, Wifredo; Portero-Otin, Manuel; Manuel Fernandez-Real, Jose			TSHB mRNA is linked to cholesterol metabolism in adipose tissue	FASEB JOURNAL			English	Article						adipocyte; lipidomic; obesity; statins; HMGCR	THYROID-STIMULATING HORMONE; SERUM-LIPID PROFILES; SUBCLINICAL HYPOTHYROIDISM; POPULATION; INFLAMMATION; EXPRESSION; PATHWAY; OBESITY; STRESS; LIVER	Subclinical hypothyroidism is known to be associated with increased serum cholesterol. Since thyroid-stimulating hormone (TSH) exerts an inductor effect on cholesterol biosynthesis, we aimed to investigate the relationship between TSH mRNA and cholesterol metabolism in human adipose tissue (AT). Cross-sectionally, AT TSH-beta (TSHB) mRNA was evaluated in 4 independent cohorts in association with serum total and LDL cholesterol, and AT lipidomics. Longitudinally, the effects of statins and of diet and exercise on AT TSHB mRNA were also examined. The bidirectional relationship between cholesterol and TSHB were studied in isolated human adipocytes. TSHB mRNA was consistently detected in AT from euthyroid subjects, and positively associated with serum total- and LDL-cholesterol, and with AT-specific cholesterol metabolism-associated lipids [arachidonoyl cholesteryl ester, C8-dihydroceramide, N-stearoyl-d-sphingosine, and GlcCer(18:0, 24:1)]. Reduction of cholesterol with statins and with diet and exercise interventions led to decreased TSHB mRNA in human AT, whereas excess cholesterol up-regulated TSHB mRNA in human adipocytes. In addition, recombinant human TSH alpha/beta administration resulted in increased HMGCR mRNA levels in human adipocytes. In mice, subcutaneous AT Tshb expression levels correlated directly with circulating cholesterol levels. In summary, current results provide novel evidence of TSHB as a paracrine factor that is modulated in parallel with cholesterol metabolism in human AT.-Moreno-Navarrete, J. M., Moreno, M., Ortega, F., Xifra, G., Hong, S., Asara, J. M., Serrano, J. C. E., Jove, M., Pissios, P., Bluher, M., Ricart, W., Portero-Otin, M., Fernandez-Real, J. M. TSHB mRNA is linked to cholesterol metabolism in adipose tissue.	[Maria Moreno-Navarrete, Jose; Moreno, Maria; Ortega, Francisco; Xifra, Gemma; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III ISCIII, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain; [Xifra, Gemma; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Univ Girona, Dept Med, Girona, Spain; [Hong, Shangyu; Pissios, Pavlos] Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Serrano, Jose C. E.; Jove, Mariona; Portero-Otin, Manuel] Univ Lleida, Nutr & Envelliment NUTREN Nutrigen, Cient & Tecnol Agroalimentari Lleida PCiTAL, Inst Recerca Biomed Lleida IRBLLEIDA, Lleida, Spain; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Leipzig University	Fernandez-Real, JM (corresponding author), Inst Salud Carlos III ISCIII, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain.; Fernandez-Real, JM (corresponding author), Hosp Girona Dr Josep Trueta, Sect Diabet Endocrinol & Nutr, Carretera Franca S-N, Girona 17007, Spain.	jmfreal@idibgi.org	Moreno-Navarrete, José María/H-9772-2015; Jové, Mariona/M-9104-2016; Serrano, Jose C. E./C-6557-2011; Fernández-Real, Jose Manuel/AGH-3599-2022; Portero-Otin, Manuel/B-7122-2009; Ortega, Francisco José J/F-3883-2016; Moreno-Navarrete, José María/ABG-5548-2021	Moreno-Navarrete, José María/0000-0002-2883-511X; Jové, Mariona/0000-0001-5577-6162; Serrano, Jose C. E./0000-0001-6714-6061; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Portero-Otin, Manuel/0000-0002-1823-0299; Ortega, Francisco José J/0000-0003-2111-769X; Moreno-Navarrete, José María/0000-0002-2883-511X	Instituto de Salud Carlos III from Spain [PI15/01934]; Fondo Europeo de Desarrollo Regional (FEDER); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK083694]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083694] Funding Source: NIH RePORTER	Instituto de Salud Carlos III from Spain(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank A. Casane (Institut de Recerca Biomedica de Lleida) and E. Loshuertos and O. Rovira [Endocrinology, Institut d'Investigacio Biomedicade Girona (IdIBGi)] for technical help. We are indebted to the IdiBGi Biobank, integrated in the Spanish National Biobank Network, for the sample and data procurement. This work was partially supported by research grant PI15/01934 from the Instituto de Salud Carlos III from Spain, and was also supported by Fondo Europeo de Desarrollo Regional (FEDER). Centro de Investigacion Biomedica en Red (CIBER), Fisiopatologia de la Obesidad y Nutricion (OBN) is an initiative of the Instituto de Salud Carlos III of Spain. This study was also partially funded by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK083694 (to P.P.). The authors declare no conflicts of interest.	Babenko NA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P912; Bakker SJL, 2001, J CLIN ENDOCR METAB, V86, P1206, DOI 10.1210/jc.86.3.1206; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Chon Seung Joo, 2016, J Menopausal Med, V22, P146, DOI 10.6118/jmm.2016.22.3.146; Chung S, 2014, ARTERIOSCL THROM VAS, V34, P1880, DOI 10.1161/ATVBAHA.114.303896; Delitala AP, 2017, EUR J INTERN MED, V38, P17, DOI 10.1016/j.ejim.2016.12.015; Draman MS, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00083; Gao N, 2013, ATHEROSCLEROSIS, V227, P18, DOI 10.1016/j.atherosclerosis.2012.10.070; Haluzik M, 2003, J CLIN ENDOCR METAB, V88, P5605, DOI 10.1210/jc.2003-030576; Ittermann T, 2016, EUR RADIOL, V26, P4490, DOI 10.1007/s00330-016-4316-4; Jove M, 2014, FASEB J, V28, P1071, DOI 10.1096/fj.13-234419; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; KOVANEN PT, 1975, J LIPID RES, V16, P211; Lambrinoudaki I, 2012, J HYPERTENS, V30, P592, DOI 10.1097/HJH.0b013e32834f5076; Liu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124951; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MIETTINEN TA, 1981, INT J OBESITY, V5, P613; Morton NM, 2016, NAT MED, V22, P771, DOI 10.1038/nm.4115; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Santos-Palacios S, 2013, CLIN ENDOCRINOL, V79, P874, DOI 10.1111/cen.12216; Song GH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30889; Tian LM, 2010, HEPATOLOGY, V52, P1401, DOI 10.1002/hep.23800; Wang FR, 2012, J CLIN ENDOCR METAB, V97, P2724, DOI 10.1210/jc.2012-1133; Wang Y, 2015, J IMMUNOL, V195, P126, DOI 10.4049/jimmunol.1403149; Witte T, 2015, J CLIN ENDOCR METAB, V100, P2090, DOI 10.1210/jc.2014-4466; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang J, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12369; Zhang XJ, 2015, J LIPID RES, V56, P963, DOI 10.1194/jlr.M047654; Zhao M, 2015, THYROID, V25, P485, DOI 10.1089/thy.2014.0219; Zhou LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31381	32	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4482	4491		10.1096/fj.201700161R	http://dx.doi.org/10.1096/fj.201700161R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646016	Green Published			2022-12-26	WOS:000413397400025
J	Huang, C; Alapa, M; Shu, P; Nagarajan, N; Wu, CG; Sadoshima, J; Kholodovych, V; Li, H; Beuve, A				Huang, Can; Alapa, Maryam; Shu, Ping; Nagarajan, Narayani; Wu, Changgong; Sadoshima, Junichi; Kholodovych, Vladyslav; Li, Hong; Beuve, Annie			Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; S-NITROSYLATION; CATALYTIC DOMAINS; BINDING-SITE; RECEPTOR; DESENSITIZATION; ACTIVATION; MECHANISM; STRESS; SYSTEM	Nitric oxide (NO) modulates many physiological events through production of cGMP from its receptor, the NO-sensitive guanylyl cyclase (GC1). NO also appears to function in a cGMP-independent manner, via S-nitrosation (SNO), a redox-based modification of cysteine thiols. Previously, we have shown that S-nitrosated GC1 (SNO-GC1) is desensitized to NO stimulation following prolonged NO exposure or under oxidative/nitrosative stress. In animal models of nitrate tolerance and angiotensin II-induced hypertension, decreased vasodilation in response to NO correlates with GC1 thiol oxidation, but the physiological mechanism that resensitizes GC1 to NO and restores basal activity is unknown. Because GC1 interacts with the oxidoreductase protein-disulfide isomerase, we hypothesized that thioredoxin-1 (Trx1), a cytosolic oxidoreductase, could be involved in restoring GC1 basal activity and NO sensitivity because the Trx/thioredoxin reductase (TrxR) system maintains thiol redox homeostasis. Here, by manipulating activity and levels of the Trx1/TrxR system and by using a Trx1-Trap assay, we demonstrate that Trx1 modulates cGMP synthesis through an association between Trx1 and GC1 via a mixed disulfide. A proximity ligation assay confirmed the endogenous Trx1-GC1 complex in cells. Mutational analysis suggested that Cys(609) in GC1 is involved in the Trx1-GC1 association and modulation of GC1 activity. Functionally, we established that Trx1 protects GC1 from S-nitrosocysteine-induced desensitization. A computational model of Trx1-GC1 interaction illustrates a possible mechanism for Trx1 to maintain basal GC1 activity and prevent/rescue GC1 desensitization to NO. The etiology of some oxidative vascular diseases may very well be explained by the dysfunction of the Trx1-GC1 association.	[Huang, Can; Alapa, Maryam; Shu, Ping; Beuve, Annie] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Nagarajan, Narayani; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Wu, Changgong; Li, Hong] Rutgers New Jersey Med Sch, Ctr Adv Prote Res, Dept Microbiol Biochem & Mol Genet, Ctr Canc, Newark, NJ 07103 USA; [Kholodovych, Vladyslav] Rutgers State Univ, Off Adv & Res Comp, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Beuve, A (corresponding author), Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, MSB, 185 S Orange Ave, Newark, NJ USA.	beuveav@njms.rutgers.edu	Huang, Can/HGB-4695-2022; Huang, Can/AAG-9168-2019; Li, Hong/K-8436-2013	Huang, Can/0000-0003-1734-0450; Li, Hong/0000-0001-5731-5335; Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [GM112415, GM067640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112415, R01GM067640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM112415 (to A. B. and H. L.) and GM067640 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baskaran P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026976; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591; Beuve A, 2016, J PROTEOMICS, V138, P40, DOI 10.1016/j.jprot.2016.02.009; Case D. A., 2017, AMBER 2017; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Choi H, 2011, J CARDIOVASC PHARM, V58, P522, DOI 10.1097/FJC.0b013e31822d80a5; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Crassous PA, 2012, AM J PHYSIOL-HEART C, V303, pH597, DOI 10.1152/ajpheart.00138.2012; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Heckler EJ, 2013, BIOCHEM J, V452, P161, DOI 10.1042/BJ20130298; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hobbs A., GUANYLYL CYCLASES GC; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kumar V, 2013, BIOCHEMISTRY-US, V52, P3601, DOI 10.1021/bi301657w; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Riego JA, 2009, FREE RADICAL BIO MED, V47, P269, DOI 10.1016/j.freeradbiomed.2009.04.027; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437	37	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14362	14370		10.1074/jbc.M117.787390	http://dx.doi.org/10.1074/jbc.M117.787390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28659344	Green Published, hybrid			2022-12-26	WOS:000408747500005
J	Gao, Y; Westfield, G; Erickson, JW; Cerione, RA; Skiniotis, G; Ramachandran, S				Gao, Yang; Westfield, Gerwin; Erickson, Jon W.; Cerione, Richard A.; Skiniotis, Georgios; Ramachandran, Sekar			Isolation and structure-function characterization of a signaling-active rhodopsin-G protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; G protein-coupled receptor (GPCR); rhodopsin; signal transduction; structural biology; EM; G-protein; SAXS; photo-transduction; transducin	SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; ALPHA-SUBUNIT; MONOMERIC RHODOPSIN; ADRENERGIC-RECEPTOR; ARRESTIN-1 BINDING; MEMBRANE-PROTEINS; HIGH-RESOLUTION; TRANSDUCIN	The visual photo-transduction cascade is a prototypical G protein-coupled receptor (GPCR) signaling system, in which light-activated rhodopsin (Rho*) is the GPCR catalyzing the exchange of GDP for GTP on the heterotrimeric G protein transducin (G(T)). This results in the dissociation of G(T) into its component (T)-GTP and (11) subunit complex. Structural information for the Rho*-G(T) complex will be essential for understanding the molecular mechanism of visual photo-transduction. Moreover, it will shed light on how GPCRs selectively couple to and activate their G protein signaling partners. Here, we report on the preparation of a stable detergent-solubilized complex between Rho* and a heterotrimer (G(T)*) comprising a G(T)/G(i1) chimera ((T)*) and (11). The complex was formed on native rod outer segment membranes upon light activation, solubilized in lauryl maltose neopentyl glycol, and purified with a combination of affinity and size-exclusion chromatography. We found that the complex is fully functional and that the stoichiometry of Rho* to G(T)* is 1:1. The molecular weight of the complex was calculated from small-angle X-ray scattering data and was in good agreement with a model consisting of one Rho* and one G(T)*. The complex was visualized by negative-stain electron microscopy, which revealed an architecture similar to that of the (2)-adrenergic receptor-G(S) complex, including a flexible (T)* helical domain. The stability and high yield of the purified complex should allow for further efforts toward obtaining a high-resolution structure of this important signaling complex.	[Gao, Yang; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Westfield, Gerwin; Skiniotis, Georgios] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Westfield, Gerwin; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Skiniotis, Georgios] Stanford Univ, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA	Cornell University; Cornell University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Cote, Rick H/G-3363-2013; Ramachandran, Sekar/AAP-2287-2020	Cote, Rick H/0000-0002-1573-6526; Ramachandran, Sekar/0000-0002-2243-1368; Westfield, Gerwin/0000-0001-9634-2336; Gao, Yang/0000-0002-8758-0954; Skiniotis, Georgios/0000-0003-0238-7846	National Institutes of Health Grant [GM103485]	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Cindy Westmiller for expert secretarial assistance. The MacCHESS facility was the recipient of National Institutes of Health Grant GM103485.	Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Ma P, 2002, NAT REV DRUG DISCOV, V1, P571, DOI 10.1038/nrd884; Maeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098714; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Perez J, 2015, ACTA CRYSTALLOGR D, V71, P86, DOI 10.1107/S1399004714016678; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; STRYER L, 1991, J BIOL CHEM, V266, P10711; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vishnivetskiy SA, 2013, CELL SIGNAL, V25, P2155, DOI 10.1016/j.cellsig.2013.07.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r; Xu S., 2007, P SOC PHOTO-OPT INS, V6665, P1; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	50	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14280	14289		10.1074/jbc.M117.797100	http://dx.doi.org/10.1074/jbc.M117.797100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28655769	Green Published, hybrid			2022-12-26	WOS:000408439800032
J	Li, SM; Zhou, J; Bu, JH; Ning, K; Zhang, LY; Li, J; Guo, YL; He, X; He, H; Cai, XX; Chen, YX; Reinach, PS; Liu, ZG; Li, W				Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Reinach, Peter Sol; Liu, Zuguo; Li, Wei			Ectodysplasin A protein promotes corneal epithelial cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; GROWTH-FACTOR RECEPTOR; INTERNATIONAL WORKSHOP; DRY EYE; KAPPA-B; INVOLVEMENT; EXPRESSION; EDAR; MICE; IDENTIFICATION	The EDA gene encodes ectodysplasin A (Eda), which if mutated causes X-linked hypohidrotic ectodermal dysplasia (XLHED) disease in humans. Ocular surface changes occur in XLHED patients whereas its underlying mechanism remains elusive. In this study, we found Eda was highly expressed in meibomian glands, and it was detected in human tears but not serum. Corneal epithelial integrity was defective and the thickness was reduced in the early postnatal stage of Eda mutant Tabby mice. Corneal epithelial cell proliferation decreased and the epithelial wound healing was delayed in Tabby mice, whereas it was restored by exogenous Eda. Eda exposure promoted mouse corneal epithelial wound healing during organ culture, whereas scratch wound assay showed that it did not affect human corneal epithelial cell line migration. Epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) were down-regulated in Tabby mice corneal epithelium. Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR, and p-ERK in human corneal epithelial cells in a dose-dependent manner. In conclusion, Eda protein can be secreted from meibomian glands and promotes corneal epithelial cell proliferation through regulation of the EGFR signaling pathway. Eda release into the tears plays an essential role in the maintenance of corneal epithelial homeostasis.	[Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Xiamen Univ, Eye Inst, 4th Floor,Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China; [Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Xiamen Univ, Med Coll, Xiamen 361102, Fujian, Peoples R China; [Liu, Zuguo; Li, Wei] Xiamen Univ, Xiamen Eye Ctr, Xiamen 361000, Fujian, Peoples R China; [Li, Sanming; Zhou, Jing; Bu, Jinghua; Ning, Ke; Zhang, Liying; Li, Juan; Guo, Yuli; He, Xin; He, Hui; Cai, Xiaoxin; Chen, Yongxiong; Liu, Zuguo; Li, Wei] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361102, Fujian, Peoples R China; [Reinach, Peter Sol] Wenzhou Med Univ, Wenzhou 325000, Zhejiang, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Wenzhou Medical University	Li, W (corresponding author), Xiamen Univ, Eye Inst, 4th Floor,Chengyi Bldg,Xiangan Campus, Xiamen 361102, Fujian, Peoples R China.	wei1018@xmu.edu.cn	Li, Wei/P-8985-2015; Reinach, Peter/AAI-3582-2021	Li, Wei/0000-0001-7458-2590; Bu, Jinghua/0000-0001-9815-9623; Zhou, Jing/0000-0002-8475-7179	Chinese National Key Scientific Research Project [2013CB967003]; National Natural Science Foundation of China (NSFC) [81270977, 81470602, 81330022]; Fundamental Research Funds for the Central Universities of China [2012121049, 20720150171]	Chinese National Key Scientific Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported in part by Chinese National Key Scientific Research Project Grant 2013CB967003 (to W. L.), National Natural Science Foundation of China (NSFC) Grants 81270977 and 81470602 (to W. L.), and 81330022 (to Z. L.), and Fundamental Research Funds for the Central Universities of China Grants 2012121049 and 20720150171 (to W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bron A J, 2004, Ocul Surf, V2, P149; Butovich IA, 2009, PROG RETIN EYE RES, V28, P483, DOI 10.1016/j.preteyeres.2009.07.002; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2005, AM J PATHOL, V167, P89, DOI 10.1016/S0002-9440(10)62956-2; Cui CY, 2002, HUM MOL GENET, V11, P1763, DOI 10.1093/hmg/11.15.1763; Dietz J, 2013, EUR J PEDIATR, V172, P1023, DOI 10.1007/s00431-013-1985-8; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jacob JT, 2008, OCUL SURF, V6, P175, DOI 10.1016/S1542-0124(12)70178-7; Kaercher T, 2004, GRAEF ARCH CLIN EXP, V242, P495, DOI 10.1007/s00417-004-0868-0; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Laurikkala J, 2002, DEVELOPMENT, V129, P2541; Lefebvre S, 2012, J INVEST DERMATOL, V132, P1094, DOI 10.1038/jid.2011.453; Melnick M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-32; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tanihara H, 2002, CORNEA, V21, pS62, DOI 10.1097/01.ico.0000263121.45898.d2; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Tyagi P., 2011, BMJ CASE REP; Vargas GA, 1996, J CLIN INVEST, V97, P2426, DOI 10.1172/JCI118689; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang YC, 2016, AM J PATHOL, V186, P32, DOI 10.1016/j.ajpath.2015.09.019; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	33	15	15	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13391	13401		10.1074/jbc.M117.803809	http://dx.doi.org/10.1074/jbc.M117.803809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28655773	hybrid, Green Published			2022-12-26	WOS:000407465300025
J	Humayun, MZ; Zhang, Z; Butcher, AM; Moshayedi, A; Saier, MH				Humayun, M. Zafri; Zhang, Zhongge; Butcher, Anna M.; Moshayedi, Aref; Saier, Milton H., Jr.			Hopping into a hot seat: Role of DNA structural features on IS5-mediated gene activation and inactivation under stress	PLOS ONE			English	Article							COLI-BGL OPERON; ESCHERICHIA-COLI; DUPLEX DESTABILIZATION; NUCLEOTIDE-SEQUENCE; BINDING PROTEINS; FUCPIK OPERON; TRANSPOSITION; EXPRESSION; FLHDC; TRANSCRIPTION	Insertion sequence elements (IS elements) are proposed to play major roles in shaping the genetic and phenotypic landscapes of prokaryotic cells. Recent evidence has raised the possibility that environmental stress conditions increase IS hopping into new sites, and often such hopping has the phenotypic effect of relieving the stress. Although stressinduced targeted mutations have been reported for a number of E. coli genes, the glpFK (glycerol utilization) and the cryptic bglGFB (beta-glucoside utilization) systems are among the best characterized where the effects of IS insertion-mediated gene activation are well-characterized at the molecular level. In the glpFK system, starvation of cells incapable of utilizing glycerol leads to an IS5 insertion event that activates the glpFK operon, and enables glycerol utilization. In the case of the cryptic bglGFB operon, insertion of IS5 (and other IS elements) into a specific region in the bglG upstream sequence has the effect of activating the operon in both growing cells, and in starving cells. However, a major unanswered question in the glpFK system, the bgl system, as well as other examples, has been why the insertion events are promoted at specific locations, and how the specific stress condition (glycerol starvation for example) can be mechanistically linked to enhanced insertion at a specific locus. In this paper, we show that a specific DNA structural feature (superhelical stressinduced duplex destabilization, SIDD) is associated with "stress-induced" IS5 insertion in the glpFK, bglGFB, flhDC, fucAO and nfsB systems. We propose a speculative mechanistic model that links specific environmental conditions to the unmasking of an insertional hotspot in the glpFK system. We demonstrate that experimentally altering the predicted stability of a SIDD element in the nfsB gene significantly impacts IS5 insertion at its hotspot.	[Humayun, M. Zafri] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Zhang, Zhongge; Butcher, Anna M.; Moshayedi, Aref; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego	Humayun, MZ (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.; Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	humayun@njms.rutgers.edu; msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017; Humayun, M. Zafri/0000-0001-5294-0852	National Institutes of Health [GM077402, GM109895]; NIH [GM077402, GM109895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402, R01GM109895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MZH wishes to acknowledge a sabbatical leave of absence from Rutgers University that enabled him to initiate this work. This work was supported by National Institutes of Health grants GM077402 and GM109895 to MHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MZH wishes to acknowledge a sabbatical leave of absence from Rutgers University that enabled him to initiate this work. This work was supported by NIH grants GM077402 and GM109895 to MHS.	Ak P, 2005, PLOS COMPUT BIOL, V1, P41, DOI 10.1371/journal.pcbi.0010007; Andersson DI, 2011, ECOSAL PLUS, V4; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; BARTLETT DH, 1989, J BACTERIOL, V171, P1763, DOI 10.1128/jb.171.3.1763-1766.1989; BAUER W, 1968, J MOL BIOL, V33, P141, DOI 10.1016/0022-2836(68)90286-6; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; BENHAM CJ, 1993, P NATL ACAD SCI USA, V90, P2999, DOI 10.1073/pnas.90.7.2999; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; CHEN YM, 1989, J BACTERIOL, V171, P6097, DOI 10.1128/jb.171.11.6097-6105.1989; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; CONN EE, 1991, PLANTA MED, V57, pS1, DOI 10.1055/s-2006-960222; Copeland MF, 2009, SOFT MATTER, V5, P1174, DOI 10.1039/b812146j; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deweese JE, 2009, BIOCHEM MOL BIOL EDU, V37, P2, DOI 10.1002/bmb.20244; Du XJ, 2013, NUCLEIC ACIDS RES, V41, P5965, DOI 10.1093/nar/gkt308; EZE MO, 1981, J GEN MICROBIOL, V124, P299; Fahrner KA, 2015, J BACTERIOL, V197, P3087, DOI 10.1128/JB.00455-15; Fricker AD, 2014, ANNU REV GENET, V48, P167, DOI 10.1146/annurev-genet-120213-092046; Gilbert N, 2014, CURR OPIN GENET DEV, V25, P15, DOI 10.1016/j.gde.2013.10.013; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Hall BG, 1999, J BACTERIOL, V181, P1149, DOI 10.1128/JB.181.4.1149-1155.1999; Hall BG, 1998, MOL BIOL EVOL, V15, P1; HALL BG, 1992, MOL BIOL EVOL, V9, P688; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Harshey RM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0007-2014; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Maisnier-Patin S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018176; Manna D, 2004, P NATL ACAD SCI USA, V101, P9780, DOI 10.1073/pnas.0400745101; MCCALLA DR, 1978, J BACTERIOL, V133, P10, DOI 10.1128/JB.133.1.10-16.1978; Navarre WW, 2016, ADV MICROB PHYSIOL, V69, P157, DOI 10.1016/bs.ampbs.2016.07.004; PARKER LL, 1990, GENETICS, V124, P473; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2014, TN7 MICROBIOL SPECTR, V2; Race PR, 2005, J BIOL CHEM, V280, P13256, DOI 10.1074/jbc.M409652200; REYNOLDS AE, 1981, NATURE, V293, P625, DOI 10.1038/293625a0; Saier MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00390; Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405; SCHNETZ K, 1992, P NATL ACAD SCI USA, V89, P1244, DOI 10.1073/pnas.89.4.1244; SCHNETZ K, 1995, EMBO J, V14, P2545, DOI 10.1002/j.1460-2075.1995.tb07252.x; Siguier P, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0030-2014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; SINGH J, 1995, MOL MICROBIOL, V17, P1085, DOI 10.1111/j.1365-2958.1995.mmi_17061085.x; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Staib L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01116; Swingle B, 2004, MOL MICROBIOL, V52, P1055, DOI 10.1111/j.1365-2958.2004.04051.x; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vandecraen J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00359; Venkatesh GR, 2010, J BACTERIOL, V192, P6456, DOI 10.1128/JB.00807-10; Wang HQ, 2004, GENOME RES, V14, P1575, DOI 10.1101/gr.2080004; Wang XX, 2011, ISME J, V5, P1517, DOI 10.1038/ismej.2011.27; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wiebe H, 2015, J BACTERIOL, V197, P2713, DOI 10.1128/JB.00263-15; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zhabinskaya D, 2015, BIOINFORMATICS, V31, P421, DOI 10.1093/bioinformatics/btu657; Zhang Z, 2017, MICROBIOLOGY; Zhang ZG, 2017, MICROBIOL-SGM, V163, P554, DOI 10.1099/mic.0.000426; Zhang ZG, 2016, MUTAT RES-FUND MOL M, V793, P22, DOI 10.1016/j.mrfmmm.2016.10.003; Zhang ZG, 2010, J BACTERIOL, V192, P2013, DOI 10.1128/JB.01085-09; Zhang ZG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000689; Zhang ZG, 2009, MOL MICROBIOL, V74, P29, DOI 10.1111/j.1365-2958.2009.06831.x	66	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180156	10.1371/journal.pone.0180156	http://dx.doi.org/10.1371/journal.pone.0180156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28666002	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608700066
J	Wang, P; Li, XP; Cao, LH; Huang, SH; Li, HY; Zhang, Y; Yang, T; Jiang, JR; Shi, DS				Wang, Ping; Li, Xiangping; Cao, Lihua; Huang, Shihai; Li, Haiyan; Zhang, Yan; Yang, Ting; Jiang, Jianrong; Shi, Deshun			MicroRNA-148a overexpression improves the early development of porcine somatic cell nuclear transfer embryos	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; CLONED EMBRYOS; METHYLATION PATTERNS; DONOR CELLS; IN-VITRO; 5-AZA-2'-DEOXYCYTIDINE; HYPOMETHYLATION; COMPETENCE; EXPRESSION; INHIBITOR	Incomplete epigenetic reprogramming of donor cell nuclei is one of the main contributors to the low efficiency of somatic cell nuclear transfer (SCNT). To improve the success of SCNT, somatic cell DNA methylation levels must be reduced to those levels found in totipotent embryonic cells. Recent studies have demonstrated that miR-148a can affect DNA methylation via DNMT1 modulation in various cancers. Therefore, the focus of this study was to examine the influence of miR-148a on DNA methylation in donor cells and in SCNT embryo development. Thus, a stable cell line overexpressing miR-148a was established and used to produce SCNT embryos. Upon examination, DNMT1 was found to be a miR-148a target in porcine fetal fibroblasts (PFF). Furthermore, miR-148a overexpression in PFFs significantly decreased DNMT1 expression and global DNA methylation levels (P < 0.05). Moreover, miRNA-148a expression levels in SCNT embryos were significantly lower at the 2-cell and 4-cell stages when compared to IVF and parthenogenetic embryos. The group overexpressing miRNA-148a also showed a significant increase in blastocyst formation and total cell numbers (P < 0.05). Additionally, miR-148a overexpression altered the immunofluorescence signal of 5-mC and H3K9ac, and enhanced pluripotent gene (Oct4 and Nanog) expression levels during embryo development. These results indicate that miR-148a overexpression enhances the developmental potential of SCNT embryos and modifies epigenetic status.	[Wang, Ping; Li, Xiangping; Cao, Lihua; Li, Haiyan; Zhang, Yan; Yang, Ting; Jiang, Jianrong; Shi, Deshun] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi Zhuang, Peoples R China; [Huang, Shihai] Guangxi Univ, Coll Life Sci & Technol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi University; Guangxi University	Li, XP; Shi, DS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi Zhuang, Peoples R China.	xiangpingli@163.com; adrsshi@gxu.edu.cn			National Transgenic Project [2014ZX08007-001]; National Natural Science funding [31560632]; Guangxi Natural Science funding [2016GXNSFDA380030, 2014GXNSFAA118084, 2014GXNSFAA118099]; Innovation Project of Guangxi Graduate Education [YCBZ2014013]	National Transgenic Project; National Natural Science funding(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science funding; Innovation Project of Guangxi Graduate Education	This work was supported by the National Transgenic Project (2014ZX08007-001). National Natural Science funding (31560632); Guangxi Natural Science funding (2016GXNSFDA380030, 2014GXNSFAA118084, 2014GXNSFAA118099) and the Innovation Project of Guangxi Graduate Education (YCBZ2014013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2005, MOL REPROD DEV, V72, P311, DOI 10.1002/mrd.20357; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chung YG, 2003, BIOL REPROD, V69, P146, DOI 10.1095/biolreprod.102.014076; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Gomez MC, 2012, REPROD DOMEST ANIM, V47, P130, DOI 10.1111/rda.12027; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Huan YJ, 2015, CELL REPROGRAM, V17, P191, DOI 10.1089/cell.2014.0103; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Ji Huili, 2014, Yichuan, V36, P1211, DOI 10.3724/SP.J.1005.2014.1211; Jones KL, 2001, MOL REPROD DEV, V60, P208, DOI 10.1002/mrd.1079; Kavalali ET, 2011, J NEURODEV DISORD, V3, P250, DOI 10.1007/s11689-011-9078-3; Kumar BM, 2006, CELL TISSUE RES, V325, P445, DOI 10.1007/s00441-006-0201-9; Lopez-Bertoni H, 2015, ONCOGENE, V34, P3994, DOI 10.1038/onc.2014.334; Meister G, 2004, MECHANISMS GENE SILE, V16, P431; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Sun HL, 2015, CELL REPROGRAM, V17, P404, DOI 10.1089/cell.2014.0084; Teng Y, 2016, CELL PHYSIOL BIOCHEM, V39, P2341, DOI 10.1159/000447926; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu Q., 2013, ADV METEOROL, V2013, P1, DOI DOI 10.1093/JMCB/MJS049; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhan Q, 2015, CANCER INVEST, V33, P267, DOI 10.3109/07357907.2015.1025794; Zhang XX, 2015, MOL MED REP, V12, P6672, DOI 10.3892/mmr.2015.4246; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x; Zhu A, 2012, MED ONCOL, V29, P2701, DOI 10.1007/s12032-011-0134-3; Zuo JB, 2013, MOL CELLS, V35, P313, DOI 10.1007/s10059-013-2314-9	35	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180535	10.1371/journal.pone.0180535	http://dx.doi.org/10.1371/journal.pone.0180535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665977	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608700015
J	Yang, DD; Zhang, ZF; Liang, SS; Yang, QK; Wang, YR; Qin, ZK				Yang, Dandan; Zhang, Zhifeng; Liang, Shaoshuai; Yang, Qiankun; Wang, Yingrui; Qin, Zhenkui			A novel role of Kruppel-like factor 4 in Zhikong scallop Chlamys farreri during spermatogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SEX DETERMINATION; GERM-CELL; EXPRESSION; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; GAMETOGENESIS; REVEALS; GONAD; FOXL2	Kruppel-like factor 4 (KLF4) is a kind of zinc finger transcription factor, which is involved in terminal differentiation of epithelial cells and reprogramming of somatic cells to induced pluripotent stem (iPS) cells in mammals. In the present study, we identified a full-length cDNA of Klf4 in Zhikong scallop Chamys farreri (Cf-Klf4) and found that Cf-Klf4 presented a sexual dimorphic expression characteristic in C. farreri gonads. Cf-Klf4 expression was significantly higher in testes than in ovaries from growing stage to mature stage detected by quantitative real-time PCR, and was located in male gametes, except for spermatozoa during spermatogenesis through in situ hybridization and immunohistochemistry, while no positive signal was visible in female gametes during oogenesis. Furthermore, the knockdown of Cf-Klf4 in testes by means of in vivo RNA interference led to an obviously developmental retardance, lower gonadosomatic index, less male gametes and more apoptotic spermatocytes. Interestingly, we found that two out of eight scallops showed a hermaphroditic phenotype characteristic of male-to-female sex reversal when the Klf4 mRNA and protein levels were knocked down in males. These results verified that Klf4 plays an important role in testis functional maintenance and is necessary in spermatogenesis of C. farreri.	[Yang, Dandan; Zhang, Zhifeng; Liang, Shaoshuai; Yang, Qiankun; Wang, Yingrui; Qin, Zhenkui] Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Zhang, Zhifeng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Qin, ZK (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	qinzk@ouc.edu.cn	YANG, Dan/HHD-2733-2022	Qin, Zhenkui/0000-0002-8717-1210	National Natural Science Foundation of China [31602139]; Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02]; National High Technology Research and Development Program of China [2012AA10A402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China received by ZQ (grant number: 31602139), http://www.nsfc.gov.cn/, the Scientific and Technological Innovation Project from Laboratory for Marine Fisheries and Aquaculture, Qingdao National Laboratory for Marine Science and Technology received by ZZ (grant number: 2015ASKJ02), http://www.qnlm.ac/ index, and the National High Technology Research and Development Program of China received by ZZ (grant number: 2012AA10A402), http//program. most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Behr R, 2007, MOL HUM REPROD, V13, P815, DOI 10.1093/molehr/gam064; Behr R, 2002, MECH DEVELOP, V115, P167, DOI 10.1016/S0925-4773(02)00127-2; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Dang T, 2000, BIOCH CELL BIOL, V32, P1103; Feng ZF, 2011, AQUACULTURE, V314, P202, DOI 10.1016/j.aquaculture.2011.02.017; [冯政夫 Feng Zhengfu], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P930; Godmann M, 2009, MOL HUM REPROD, V15, P479, DOI 10.1093/molehr/gap040; Godmann M, 2008, DEV BIOL, V315, P552, DOI 10.1016/j.ydbio.2007.12.018; Godmann M, 2009, MECH DEVELOP, V126, P650, DOI 10.1016/j.mod.2009.06.1081; Hodgkin J., 1985, TRENDS GENET, V1, P85; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115917; Li Y., 2016, COMP MATH MATH PHYS, V2016, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1109/TSG.2015.2508923; Liao C.Y., 1983, J FISH CHINA, V7, P1; Lin C, 2012, FASEB J, V26, P944; Liu J, 2014, CAN J ZOOL, V92, P195, DOI 10.1139/cjz-2013-0202; Liu JG, 2014, J STEROID BIOCHEM, V141, P77, DOI 10.1016/j.jsbmb.2014.01.008; Liu XL, 2012, DEV GENES EVOL, V222, P279, DOI 10.1007/s00427-012-0410-z; Ma YB, 2011, MAR BIOTECHNOL, V13, P93, DOI 10.1007/s10126-010-9273-3; Masuyama H, 2012, CHROMOSOME RES, V20, P163, DOI 10.1007/s10577-011-9264-x; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; [吴洪流 Wu Hongliu], 2002, [海洋科学, Marine Sciences], V26, P5; Yet F, 1998, BIOL CHEM, V273, P10747; Yu FF, 2011, J SHELLFISH RES, V30, P247, DOI 10.2983/035.030.0208; Yu T, 2015, CELL DEATH DIFFER; Zhang N, 2014, G3-GENES GENOM GENET, V4, P2207, DOI 10.1534/g3.114.013904; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002	40	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180351	10.1371/journal.pone.0180351	http://dx.doi.org/10.1371/journal.pone.0180351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665994	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608700087
J	Fenwick, EK; Xie, J; Man, REK; Sabanayagam, C; Lim, L; Rees, G; Wong, TY; Lamoureux, EL				Fenwick, Eva K.; Xie, Jing; Man, Ryan E. K.; Sabanayagam, Charumathi; Lim, Lyndell; Rees, Gwyn; Wong, Tien Y.; Lamoureux, Ecosse L.			Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; HEART-DISEASE; MANAGEMENT; METHODOLOGY; POPULATION; ADULTS; CARE; EYE	Purpose To examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema. Materials and methods In this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any diabetic retinopathy; 183 any diabetic macular edema) were examined. Diabetic retinopathy was assessed from fundus photographs; diabetic macular edema from Ocular Coherence Tomography scans; and HbA1c and serum lipid values from fasting blood samples. Poor glucose control was defined as HbA1c >= 7%; poor blood pressure control as SBP >= 130/DBP >= 80; and poor lipid control as total cholesterol: HDL ratio >= 4.0. The association of poor glucose control, poor blood pressure control and poor lipid control alone and in combination (poor glucose & blood pressure control; poor glucose & lipid control; poor blood pressure & lipid control; and poor glucose, blood pressure & lipid control) with diabetic retinopathy/diabetic macular edema was examined using multiple logistic regression models. Results Patients' mean +/- standard deviation age was 64.9 +/- 11.6 years (57% male). In adjusted models, compared to those with good control of all indicators (n = 99, 18.3%), the odds ratio (95% Confidence Interval) of having any diabetic retinopathy was 2.44 (1.34 +/- 4.46), 3.75 (1.75 +/- 8.07), 4.64 (2.13 +/- 10.12) and 2.28 (1.01 +/- 5.16) for poor glucose control only; poor glucose & blood pressure control; poor glucose & lipid control; and poor glucose, blood pressure & lipid control, respectively. Correspondingly for diabetic macular edema, they were 3.19 (1.55 +/- 6.59); 3.60 (1.58 +/- 8.22); 2.76 (1.18 +/- 6.44); and 3.01 (1.18 +/- 7.67), respectively. Odds were not significantly increased for other indicators. Discussion Compared to individual indicators of poor diabetes control, risk of diabetic retinopathy and diabetic macular edema increased three to fourfold with a combination of these indicators. Targeting combined diabetes control indicators is important to reduce risk of diabetic retinopathy/ diabetic macular edema.	[Fenwick, Eva K.; Xie, Jing; Lim, Lyndell; Rees, Gwyn; Lamoureux, Ecosse L.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Fenwick, Eva K.; Man, Ryan E. K.; Sabanayagam, Charumathi; Wong, Tien Y.; Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Fenwick, Eva K.; Sabanayagam, Charumathi; Wong, Tien Y.; Lamoureux, Ecosse L.] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; Singapore National Eye Center; National University of Singapore	Lamoureux, EL (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; Lamoureux, EL (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Lamoureux, EL (corresponding author), Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore.	ecosse.lamoureux@seri.com.sg	Sabanayagam, Charumathi/C-1294-2011; xie, jing/GRY-1689-2022; Wong, Tien Yin/AAC-9724-2020; Lamoureux, Ecosse/Z-5482-2019	Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; /0000-0001-6694-3587; Man, Ryan/0000-0001-5028-605X; Lamoureux, Ecosse/0000-0001-8674-5705; Lim, Lyndell/0000-0003-2491-685X	National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE) - Translational Clinical Research in Major Eye Diseases [529923]; CCRE Diabetes; Australian Research Council [LP0884108]; Royal Victorian Eye and Ear Hospital; Victorian Government; National Health and Medical Research Council Early Career Fellowship [1072987, 1109330, 1061801]	National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE) - Translational Clinical Research in Major Eye Diseases(National Health and Medical Research Council (NHMRC) of Australia); CCRE Diabetes; Australian Research Council(Australian Research Council); Royal Victorian Eye and Ear Hospital; Victorian Government; National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Financial support came from the National Health and Medical Research Council (www. nhmrc.gov.au) Centre for Clinical Research Excellence (CCRE) #529923-Translational Clinical Research in Major Eye Diseases; CCRE Diabetes; Australian Research Council (www.arc.gov.au) Grant LP0884108; Royal Victorian Eye and Ear Hospital (www.eyeandear.org.au); Operational Infrastructure Support from the Victorian Government. Dr Eva Fenwick is funded by National Health and Medical Research Council (www. nhmrc.gov.au) Early Career Fellowship (#1072987). A/Prof Lyndell Lim is funded by National Health and Medical Research Council (www.nhmrc.gov.au) Early Career Fellowship (#1109330). Dr Reesis funded by a National Health and Medical Research Council (www. nhmrc.gov.au) Career Development Award (#1061801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athyros VG, 2010, CURR VASC PHARMACOL, V8, P1; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Budescu D, 1993, PSYCHOL BULL; Buse J, 2007, CIRCULATION; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chew EY, 2014, OPHTHALMOLOGY, V121, P2443, DOI 10.1016/j.ophtha.2014.07.019; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Das R, 2015, OPHTHALMOLOGY, V122, P1820, DOI 10.1016/j.ophtha.2015.05.011; Elis A, 2008, QJM-INT J MED, V101, P275, DOI 10.1093/qjmed/hcm150; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; Foo V, 2016, J DIABETES; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gupta A, 2004, AM J OPHTHALMOL; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Huang OS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1185, DOI 10.1001/archophthalmol.2010.168; International Council of Ophthalmology, 2014, ICO GUID DIAB EYE CA; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Lamoureux E, 2015, ASS RES VIS OPHTH AR; Lamoureux EL, 2012, CLIN EXP OPHTHALMOL, V40, P73, DOI 10.1111/j.1442-9071.2011.02697.x; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Mitchell P., 2008, GUIDELINES MANAGEMEN; Mohamed Q, 2007, JAMA-J AM MED ASSOC; Raman R, 2010, OPHTHALMOLOGY; Raman R, 2012, CURR EYE RES, V37, P513, DOI 10.3109/02713683.2012.669005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Stratton I, 2001, DIABETOLOGIA, P44156; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wong T, 2008, EPIDEMIOLOGY DIABETE, P475, DOI DOI 10.1002/9780470779750.CH30; Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12; World Health Organization, 2005, PREV BLINDN DIAB MEL; World Health Organization, 2007, VIS 2020 RIGHT SIGHT; Yu TC, 2015, CLINICOECON OUTCOMES, P737; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	37	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180252	10.1371/journal.pone.0180252	http://dx.doi.org/10.1371/journal.pone.0180252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662119	Green Published, gold			2022-12-26	WOS:000404608300133
J	Hou, J; Brouwer, WP; Kreefft, K; Gama, L; Price, SL; Janssen, HLA; French, PJ; Vanwolleghem, T; Boonstra, A				Hou, Jun; Brouwer, Willem P.; Kreefft, Kim; Gama, Lucio; Price, Sarah L.; Janssen, Harry L. A.; French, Pim J.; Vanwolleghem, Thomas; Boonstra, Andre			Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DENDRITIC CELLS; PROGRESSION; MICROARRAY; MONOCYTES; LIVER; KIR	Chronic hepatitis B is a highly heterogeneous liver disease characterized by phases with fluctuations in viral replication and progressive liver damage in some, but not all infected individuals. Despite four decades of research, insight into host determinants underlying these distinct clinical phases-immunotolerant, immune active, inactive carrier, and HBeAg-negative hepatitis-remains elusive. We performed an in-depth transcriptome analysis of archived FFPE liver biopsies of each clinical phase to address host determinants associated with the natural history. Therefore, we determined, for the first time, intrahepatic global expression profiles of well-characterized chronic HBV patients at different clinical phases. Our data, obtained by microarray, demonstrate that B cells and NK/cytotoxic-related genes in the liver, including CD19, TNFRSF13C, GZMH, and KIR2DS3, were differentially expressed across the clinical HBV phases, which was confirmed by modular analysis and also Nanostring arrays in an independent cohort. Compared to the immunotolerant phase, 92 genes were differentially expressed in the liver during the immune active phase, 46 in the inactive carrier phase, and 71 in the HBeAg-negative phase. Furthermore, our study also revealed distinctive transcription of genes associated with cell cycle activity, NF B-K signaling, cytotoxic function and mitochondrial respiration between clinical phases. Our data define for the first time using microarray unique transcriptomes in the HBV-infected liver during consecutive clinical phases. We demonstrate that fluctuations of viral loads and liver damage coincide with fluctuations in the liver transcriptome and point to functional immune and non-immune- components contributing to the clinical phenotype in patients.	[Hou, Jun; Brouwer, Willem P.; Kreefft, Kim; Janssen, Harry L. A.; Vanwolleghem, Thomas; Boonstra, Andre] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Gama, Lucio; Price, Sarah L.] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Janssen, Harry L. A.] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [French, Pim J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Erasmus University Rotterdam; Erasmus MC	Boonstra, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	Brouwer, Willem Pieter/P-5444-2014; Vanwolleghem, Thomas/AAD-4094-2022; Hou, Jun/AGJ-0692-2022	Brouwer, Willem Pieter/0000-0001-8713-1481; Boonstra, Andre/0000-0001-8607-1616; French, Pim/0000-0002-0668-9529; Price, Sarah/0000-0002-4392-7506; Vanwolleghem, Thomas/0000-0002-0572-8741	Virgo consortium - Dutch government [FES0908]	Virgo consortium - Dutch government	This work was supported by the Virgo consortium, funded by the Dutch government project number FES0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Brouwer WP, 2015, LIVER INT, V35, P438, DOI 10.1111/liv.12695; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen XM, 2015, CANCER PREV RES, V8, P455, DOI 10.1158/1940-6207.CAPR-14-0384; Chin R, 2010, VIRUS RES, V147, P7, DOI 10.1016/j.virusres.2009.09.012; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hou J, 2014, ANTIVIR RES, V109, P116, DOI 10.1016/j.antiviral.2014.06.020; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Lebosse F, 2016, J HEPATOL; Marangon AV, 2011, HUM IMMUNOL, V72, P1074, DOI 10.1016/j.humimm.2011.08.017; Moretta A, 2009, CLIN EXP IMMUNOL, V157, P325, DOI 10.1111/j.1365-2249.2009.03983.x; Movita D, 2015, J VIROL, V89, P4809, DOI 10.1128/JVI.03733-14; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rueger S, 2014, GUT; Saxena N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111256; Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Garde MDB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166094; Vanwolleghem T, 2015, HEPATOLOGY, V62, P87, DOI 10.1002/hep.27805; Warita K, 2012, J TOXICOL SCI, V37, P287, DOI 10.2131/jts.37.287; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Zou LY, 2015, ONCOL REP, V33, P2461, DOI 10.3892/or.2015.3852	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179920	10.1371/journal.pone.0179920	http://dx.doi.org/10.1371/journal.pone.0179920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662087	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300071
J	Kong, P; McDowell, JM; Hong, CX				Kong, Ping; McDowell, John M.; Hong, Chuanxue			Zoospore exudates from Phytophthora nicotianae affect immune responses in Arabidopsis	PLOS ONE			English	Article							PLANT DEFENSIN GENE; SALICYLIC-ACID; SIGNALING PATHWAYS; PERONOSPORA-PARASITICA; MICROBE INTERACTIONS; NONHOST RESISTANCE; JASMONATE; THALIANA; EDS1; NPR1	Zoospore exudates play important roles in promoting zoospore communication, homing and germination during plant infection by Phytophthora. However, it is not clear whether exudates affect plant immunity. Zoospore-free fluid (ZFF) and zoospores of P. nicotianae were investigated comparatively for effects on resistance of Arabidopsis thaliana Col-0 and mutants that affect signaling mediated by salicylic acid (SA) and jasmonic acid (JA): eds16 ( enhanced disease susceptibility16), pad4 (phytoalexin deficient4), and npr1 (nonexpressor of pathogenesis-related genes1). Col-0 attracted more zoospores and had severe tissue damage when flooded with a zoospore suspension in ZFF. Mutants treated with ZFF alone developed disease symptoms similar to those inoculated with zoospores and requirements of EDS16 and PAD4 for plant responses to zoospores and the exudates was apparent. Zoospore and ZFFs also induced expression of the PR1 and PDF1.2 marker genes for defense regulated by SA and JA, respectively. However, ZFF affected more JA defense signaling, down regulating PR1 when SA signaling or synthesis is deficient, which may be responsible for Arabidopsis mutant plants more susceptible to infection by high concentration of P. nicotianae zoospores. These results suggest that zoospore exudates can function as virulence factors and inducers of plant immune responses during plant infection by Phytophthora.	[Kong, Ping; Hong, Chuanxue] Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA; [McDowell, John M.; Hong, Chuanxue] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Kong, P (corresponding author), Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA.	pkong@vt.edu		McDowell, John/0000-0002-9070-4874	Specialty Crop Research Initiative (SCRI) [201051181-21140]; United States USDA National Institute of Food and Agriculture; Virginia Agricultural Experiment Station	Specialty Crop Research Initiative (SCRI); United States USDA National Institute of Food and Agriculture; Virginia Agricultural Experiment Station	This study was supported in part by the Specialty Crop Research Initiative (SCRI, Agreement#: 201051181-21140) and the Hatch Program of the United States USDA National Institute of Food and Agriculture, and the Virginia Agricultural Experiment Station to CH. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Attard A, 2010, NEW PHYTOL, V187, P449, DOI 10.1111/j.1469-8137.2010.03272.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Eulgem T, 2004, PLANT PHYSIOL, V135, P1129, DOI 10.1104/pp.104.040444; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1997, GENETICS, V146, P381; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jiang H, 2014, PHYTOPATHOLOGY S3, V104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; Kamoun S, 2015, MOL PLANT PATHOL; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kemen E, 2014, CURR OPIN PLANT BIOL, V20, P75, DOI 10.1016/j.pbi.2014.04.005; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Kong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33239; Kong P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-313; Kong P, 2010, PHYTOPATHOLOGY, V100, P632, DOI 10.1094/PHYTO-100-7-0632; Kong P, 2010, FEMS MICROBIOL LETT, V303, P55, DOI 10.1111/j.1574-6968.2009.01861.x; McDowell JM, 2005, MOL PLANT MICROBE IN, V18, P1226, DOI 10.1094/MPMI-18-1226; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; McDowell JM, 2011, METHODS MOL BIOL, V712, P137, DOI 10.1007/978-1-61737-998-7_12; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Raftoyannis Y, 2006, MICROBIOL RES, V161, P1, DOI 10.1016/j.micres.2005.04.003; Rairdan GJ, 2002, GENETICS, V161, P803; Rairdan GJ, 2001, MOL PLANT MICROBE IN, V14, P1235, DOI 10.1094/MPMI.2001.14.10.1235; Robinson LH, 2003, AUSTRALAS PLANT PATH, V32, P53, DOI 10.1071/AP02064; Roetschi A, 2001, PLANT J, V28, P293, DOI 10.1046/j.1365-313X.2001.01148.x; Rookes JE, 2008, PHYSIOL MOL PLANT P, V72, P151, DOI 10.1016/j.pmpp.2008.08.005; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008	50	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							0180523	10.1371/journal.pone.0180523	http://dx.doi.org/10.1371/journal.pone.0180523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662148	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300163
J	Liu, ZH; Li, SY; Liu, YM; Guo, W; Bai, O				Liu, Zhihe; Li, Siyun; Liu, Yingmin; Guo, Wei; Bai, Ou			PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; PREVALENCE; TUMOR; RISK; PD-1	Objective The purpose of this study was to determine the association between PD1 expression and the clinical prognosis of diffuse large B-cell lymphoma (DLBCL) co-occurring with hepatitis B virus (HBV) infection. Methods A total of 165 patients presented with newly diagnosed and untreated DLBCL at the First Hospital of Jilin University, Changchun, China, between 2011.01 and 2014.12. Complete clinical information was available for 152 of these 165 patients. We retrospectively reviewed the results of HBV serum marker assays and the clinical information of these 152 DLBCL patients from our hospital database; eventually, only 51 patients were enrolled in this study, and these 51 patients received the PD1 test item. Results. (1) The incidence of HBsAg prevalence was 13.2% (20/152) in this study;. (2)The incidence of PD1 expression in the HBsAg(+) group was 4.3-fold higher than that in the HBsAg(-) group (40.0% vs 9.4%; P = 0.010);. (3) The clinical information, including sex, age, clinical stage, IPI, molecular subtype and chemotherapy status, was analyzed between the HBsAg(+) and HBsAg(-) groups, but there were no significant differences between the two groups;. (4) The median OS and PFS of the patients in the HBsAg(+) group were 36.5 months and 12 months, respectively; however, the median OS and PFS of patients in the HBsAg(+) group were not reached (P = 0.033) and 32 months (P = 0.049), respectively; and. (5) The median OS and PFS of PD1-positive patients in the HBsAg(+) group were the worst (24 months and 9 months, respectively), whereas the median OS and PFS of PD1-negative patients in the HBsAg(-) group were the best (not reached and 32 months, respectively). Conclusions Compared with patients in the HBsAg(-) group, the incidence of PD1 expression was significantly higher in the HBsAg(+) group, and the median OS and PFS times were the worst in PD1-positive patients in the HBsAg(+) group. These results indicated that the dismal	[Liu, Zhihe; Liu, Yingmin; Guo, Wei; Bai, Ou] Jilin Univ, Hosp 1, Dept Hematol, Changchun, Peoples R China; [Li, Siyun] Qingdao Univ, Sch Med, Affiliated Women & Children Hosp, Dept Pediat, Qingdao, Peoples R China	Jilin University; Qingdao University	Bai, O (corresponding author), Jilin Univ, Hosp 1, Dept Hematol, Changchun, Peoples R China.	oubai16@163.com	liu, zhihe/J-5319-2012	liu, zhihe/0000-0002-9264-094X	Jilin Province Science and Technology Department [20160101010JC]; Jilin Province Development; Reform Commission [2014Y090]	Jilin Province Science and Technology Department; Jilin Province Development; Reform Commission	This study was funded by Jilin Province Science and Technology Department (20160101010JC) and Jilin Province Development and Reform Commission (2014Y090). The owner of the two funding was OB.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chen X, 2015, PLOS ONE, V10; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Dalia S, 2013, LEUKEMIA RES, V37, P1107, DOI 10.1016/j.leukres.2013.06.007; Deng LJ, 2015, ONCOTARGET, V6, P25061, DOI 10.18632/oncotarget.4677; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Fwu CW, 2011, HEPATOLOGY, V53, P1217, DOI 10.1002/hep.24150; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Guo W, 2015, J NANOMATER, V2015, DOI 10.1155/2015/897142; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Ma SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005642; Muenst S, 2010, DIS MARKERS, V29, P47, DOI [10.1155/2010/404069, 10.3233/DMA-2010-0725]; Nath A, 2010, INTERN MED J, V40, P633, DOI 10.1111/j.1445-5994.2009.02060.x; Ott JJ, 2017, J HEPATOL, V66, P48, DOI 10.1016/j.jhep.2016.08.013; Routh JC, 2008, J UROLOGY, V179, P1954, DOI 10.1016/j.juro.2008.01.056; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Stein H, 2008, DIFFUSE LARGE B CELL, P233; Taborelli M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0073-x; Tajima K, 2016, J MED VIROL, V88, P2206, DOI 10.1002/jmv.24584; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang ZZ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.1	26	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180390	10.1371/journal.pone.0180390	http://dx.doi.org/10.1371/journal.pone.0180390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662185	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300149
J	Molladavoodi, S; Robichaud, M; Wulff, D; Gorbet, M				Molladavoodi, Sara; Robichaud, Matthew; Wulff, David; Gorbet, Maud			Corneal epithelial cells exposed to shear stress show altered cytoskeleton and migratory behaviour	PLOS ONE			English	Article							MEDIATED ENDOTHELIAL MECHANOTRANSDUCTION; ADHESION MOLECULE-1 ICAM-1; ACTIVATED PROTEIN-KINASES; NANOSCALE TOPOGRAPHY; SIGNALING PATHWAYS; ELECTRIC-FIELDS; ACTIN; EXPRESSION; MOVEMENT; RHO	Cells that form the corneal epithelium, the outermost layer of the cornea, are exposed to shear stress through blinking during waking hours. In this in vitro study, the effect of fluid shear stress on human corneal epithelial cells (HCECs) was investigated. Following exposure to shear stresses of 4 and 8 dyn/cm(2), HCECs showed cytoskeletal rearrangement with more prominent, organized and elongated filamentous actin. Cytoskeletal changes were time-dependent, and were most significant after 24 hours of shear stress. Higher rates of migration and proliferation, as evaluated by a scratch assay, were also observed following 24 hours of low shear stress exposure (4 dyn/cm(2)). This result contrasted the poor migration observed in samples scratched before shear exposure, indicating that shear-induced cytoskeletal changes played a key role in improved wound healing and must therefore precede any damage to the cell layer. HCEC cytoskeletal changes were accompanied by an upregulation in integrin beta(1) and downregulation of ICAM-1. These results demonstrate that HCECs respond favourably to flow-induced shear stress, impacting their proliferation and migration properties as well as phenotype.	[Molladavoodi, Sara; Robichaud, Matthew; Gorbet, Maud] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada; [Wulff, David] Univ Waterloo, Dept Chem Engn, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Gorbet, M (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada.	mgorbet@uwaterloo.ca	Wulff, David/ABC-9184-2020	Wulff, David/0000-0002-2873-1214	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funded by Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI 10.1517/17425247.5.5.567 ; Bin Geng, 2015, Biochem Biophys Res Commun, V466, P117, DOI 10.1016/j.bbrc.2015.08.117; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067675; Chiu JJ, 2004, J BIOMECH, V37, P531, DOI 10.1016/j.jbiomech.2003.08.012; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Chou SF, 2016, COLLOID SURFACE B, V142, P105, DOI 10.1016/j.colsurfb.2016.02.051; Dalton BA, 2001, EXP EYE RES, V73, P797, DOI 10.1006/exer.2001.1090; Danjo Y, 1998, J CELL SCI, V111, P3323; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Etienne S, 1998, J IMMUNOL, V161, P5755; Evans ND, 2009, EUR CELLS MATER, V18, P1; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fukuda S, 2000, CIRC RES, V86, pE13, DOI 10.1161/01.RES.86.1.e13; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020; Jilkova ZM, 2014, BIOL OPEN, V3, P1228, DOI 10.1242/bio.201410132; Jones MB, 2008, B MATH BIOL, V70, P323, DOI 10.1007/s11538-007-9252-7; Justine C., 2016, COAL OP C, P1; Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Koo S, 2014, ACTA BIOMATER, V10, P1975, DOI 10.1016/j.actbio.2014.01.015; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Leonard EK, 2012, BIOTECHNOL BIOENG, V109, P3189, DOI 10.1002/bit.24587; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; MATHERS WD, 1992, CURR EYE RES, V11, P517, DOI 10.3109/02713689209001807; Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Molladavoodi S, 2015, ACTA BIOMATER, V11, P324, DOI 10.1016/j.actbio.2014.10.005; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Petroll WM, 2015, J FUNCT BIOMATER, V6, P222, DOI 10.3390/jfb6020222; Pretor S, 2015, MOL PHARMACEUT, V12, P34, DOI 10.1021/mp500401t; Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015; Ren HW, 1997, ACTA OPHTHALMOL SCAN, V75, P383; Rennier Keith, 2015, BMC Res Notes, V8, P85, DOI 10.1186/s13104-015-1037-8; Rennier K, 2012, J CELL PHYSIOL, V227, P2398, DOI 10.1002/jcp.22975; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; Saha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084227; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Srinivas SP, 2002, ADV EXP MED BIOL, V506, P677; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Sugihara-Seki M, 2003, J BIOMECH ENG-T ASME, V125, P628, DOI 10.1115/1.1611515; Utsunomiya T, 2016, INVEST OPHTH VIS SCI, V57, P6382, DOI 10.1167/iovs.16-20638; Wang C, 2012, J BIOMECH, V45, P1212, DOI 10.1016/j.jbiomech.2012.01.045; Xia L, 2011, HUM CELL, V24, P127, DOI 10.1007/s13577-011-0031-2; Yamamoto K, 2002, CORNEA, V21, P85, DOI 10.1097/00003226-200201000-00018; Yannariello-Brown J, 1998, EXP EYE RES, V67, P383, DOI 10.1006/exer.1998.0514; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yin J, 2008, INVEST OPHTH VIS SCI, V49, P900, DOI 10.1167/iovs.07-1122; Zhao M, 1996, J CELL SCI, V109, P1405	69	29	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178981	10.1371/journal.pone.0178981	http://dx.doi.org/10.1371/journal.pone.0178981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662184	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300012
J	Aki, A; Nagasaki, M; Malynn, BA; Ma, A; Kagari, T				Aki, Anri; Nagasaki, Miyuki; Malynn, Barbara Ann; Ma, Averil; Kagari, Takashi			Hypomorphic A20 expression confers susceptibility to psoriasis	PLOS ONE			English	Article							NF-KAPPA-B; MODIFYING ENZYME A20; RESTRICTS UBIQUITINATION; INHIBITION; CELLS; PROTEIN; INTERLEUKIN-17; INFLAMMATION; REVEALS; ABSENCE	Psoriasis is a common inflammatory skin disease that affects approximately 1% of the population worldwide. Tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene polymorphisms have been strongly associated with psoriasis susceptibility. In this study, we investigate how TNFAIP3, also known as A20, may regulate psoriasis susceptibility. We found that haplo-insufficient A20(+/-) mice develop severe toll-like receptor (TLR)-induced skin inflammation compared to wild type mice owing to amplified production of interleukin (IL)-17 and IL-23. Examination of TNFAIP3 mRNA expression in skin biopsies from patients with psoriasis revealed reduced expression in both involved and uninvolved skin. Our results demonstrate the clinical importance of reduced dermal expression of A20 in psoriasis and suggest that A20 restriction of the IL-23/17 axis protects against psoriasis.	[Aki, Anri; Nagasaki, Miyuki; Kagari, Takashi] Daiichi Sankyo Co Ltd, R&D Div, Oncol Funct, Biol & Immunooncol Labs, Tokyo, Japan; [Malynn, Barbara Ann; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Daiichi Sankyo Company Limited; University of California System; University of California San Francisco	Kagari, T (corresponding author), Daiichi Sankyo Co Ltd, R&D Div, Oncol Funct, Biol & Immunooncol Labs, Tokyo, Japan.	kagari.takashi.z4@daiichisankyo.co.jp		Aki, Anri/0000-0002-2369-2770	National Institutes of Health; Daiichi Sankyo Co., Ltd.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AM). Daiichi Sankyo Co., Ltd. provided support in the form of salaries for AA, MN, and TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gisondi P, 2014, DERMATOLOGY THER, V4, P1, DOI 10.1007/s13555-014-0042-5; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Lonnberg AS, 2014, CLIN COSMET INVESTI, V7, P251, DOI 10.2147/CCID.S67534; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang S, 2016, GENES IMMUN, V17, P165, DOI 10.1038/gene.2016.4; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180481	10.1371/journal.pone.0180481	http://dx.doi.org/10.1371/journal.pone.0180481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658319	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900073
J	Laudy, AE; Rog, P; Smolinska-Krol, K; Cmiel, M; Sloczynska, A; Patzer, J; Dzierzanowska, D; Wolinowska, R; Starosciak, B; Tyski, S				Laudy, Agnieszka E.; Rog, Patrycja; Smolinska-Krol, Katarzyna; Cmiel, Milena; Sloczynska, Alicja; Patzer, Jan; Dzierzanowska, Danuta; Wolinowska, Renata; Starosciak, Bohdan; Tyski, Stefan			Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; FIELD GEL-ELECTROPHORESIS; RESISTANCE; MECHANISMS; BAUMANNII; BACTERIA; CLASS-1; VARIANT; STRAIN	Knowledge of the prevalence of ESBL enzymes among P. aeruginosa strains compared to the Enterobacteraiceae family is limited. The phenotypic tests recommended by EUCAST for the detection of ESBL-producing Enterobacteriaceae are not always suited for P. aeruginosa strains. This is mainly due to the presence of other families of ESBLs in P. aeruginosa isolates more often than in Enterobacteriaceae, production of natural AmpC cephalosporinase and its overexpression, and co-production of metallo-beta-lactamases. The aim of this study was to determine the occurrence of ESBLs in P. aeruginosa isolated from patients from hospitals in Warsaw, to evaluate the ESBL production of these isolates using currently available phenotypic tests, their modifications, multiplex PCR and molecular typing of ESBL-positive isolates by PFGE. Clinical isolates of P. aeruginosa were collected in 2000-2014 from four Warsaw hospitals. Based on the data obtained in this study, we suggest using three DDST methods with inhibitors, such as clavulanic acid, sulbactam and imipenem, to detect ESBL-producing P. aeruginosa strains. Depending on the appearance of the plates, we suggest a reduction in the distance between discs with antibiotics to 15 mm and the addition of boronic acid at 0.4 mg per disc. The analysed isolates carried genes encoding ESBL from the families VEB (69 isolates with VEB-9), GES (6 with GES-1, 1 GES-5, 5 GES-13 and 2 with GES-15), OXA-2 (12 with OXA-15, 1 OXA-141, 1 OXA-210, 1 OXA-543 and 1 with OXA-544) and OXA-10 (5 isolates with OXA-74 and one with OXA-142). The most important result of this study was the discovery of three new genes, bla(GES)-15, bla(OXA)-141 and bla(OXA)-142; their nucleotide sequences have been submitted to the NCBI GenBank. It is also very important to note that this is the first report on the epidemiological problem of VEB-9-producing bacterial strains, not only in Poland but also worldwide.	[Laudy, Agnieszka E.; Rog, Patrycja; Smolinska-Krol, Katarzyna; Cmiel, Milena; Sloczynska, Alicja; Wolinowska, Renata; Starosciak, Bohdan; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland; [Patzer, Jan; Dzierzanowska, Danuta] Childrens Mem Hlth Inst, Dept Clin Microbiol & Immunol, Warsaw, Poland; [Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Warsaw, Poland	Medical University of Warsaw; Children's Memorial Health Institute; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland.	alaudy@wp.pl	Wolinowska, Renata/V-6945-2018; Laudy, Agnieszka/M-4930-2018; Tyski, Stefan/W-5271-2018; Laudy, Agnieszka/AAC-1000-2022	Wolinowska, Renata/0000-0002-2338-556X; Laudy, Agnieszka/0000-0002-5989-4462; Tyski, Stefan/0000-0003-3352-038X; 	State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa" [2PO5D 018 30]; Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland [REGON:006220910, NIP:5262173856, KRS:0000195643]; Medical University of Warsaw	State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa"; Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland; Medical University of Warsaw	The study was funded partially by a grant from the State Committee for Scientific Research (KBN) "The presence of extended-spectrum beta-lactamases among the drug-resistant isolates of Pseudomonas aeruginosa" (grant no. 2PO5D 018 30), AEL, JP, DD, RW, BS, and Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland. REGON:006220910, NIP:5262173856, KRS:0000195643, AEL, ST, and Medical University of Warsaw, statutory funds, AEL, ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Bae IK, 2014, DIAGN MICR INFEC DIS, V79, P373, DOI 10.1016/j.diagmicrobio.2014.03.007; Celenza G, 2006, J ANTIMICROB CHEMOTH, V57, P975, DOI 10.1093/jac/dkl055; CLSI, 2016, M100S CLSI; Danel F, 1997, ANTIMICROB AGENTS CH, V41, P785, DOI 10.1128/AAC.41.4.785; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; EUCAST, 2013, EUCAST GUID DET RES; EUCAST, 2017, EUCAST DISK DIFF MET; Garza-Ramos U, 2015, DIAGN MICR INFEC DIS, V81, P135, DOI 10.1016/j.diagmicrobio.2014.09.029; Glupczynski Y, 2010, J ANTIMICROB CHEMOTH, V65, P866, DOI 10.1093/jac/dkq048; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jiang XF, 2006, ANTIMICROB AGENTS CH, V50, P2990, DOI 10.1128/AAC.01511-05; Juan C, 2013, J ANTIMICROB CHEMOTH, V68, P619, DOI 10.1093/jac/dks439; Kos VN, 2016, ANTIMICROB AGENTS CH, V60, P3856, DOI 10.1128/AAC.03113-15; Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P1331, DOI 10.1128/AAC.01561-09; Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P4864, DOI 10.1128/AAC.00771-10; Libisch B, 2008, FEMS IMMUNOL MED MIC, V54, P330, DOI 10.1111/j.1574-695X.2008.00483.x; Lin SP, 2012, J MICROBIOL IMMUNOL, V45, P200, DOI 10.1016/j.jmii.2011.11.015; Maurya AP, 2014, ANTIMICROB AGENTS CH, V58, P6966, DOI 10.1128/AAC.02365-14; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3743, DOI 10.1128/AAC.49.9.3743-3748.2005; Poirel L, 2001, EMERG INFECT DIS, V7, P468, DOI 10.3201/eid0703.017322; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sepehri S, 2014, CAN J INFECT DIS MED, V25, P229, DOI 10.1155/2014/657047; Singla P, 2014, J CLIN DIAGN RES, V8, pDC16, DOI 10.7860/JCDR/2014/8008.4289; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MIC; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P2710, DOI 10.1128/AAC.01660-10; Vatcheva-Dobrevska R, 2013, MICROB DRUG RESIST, V19, P355, DOI 10.1089/mdr.2013.0004; Weldhagen GF, 2003, ANTIMICROB AGENTS CH, V47, P2385, DOI 10.1128/AAC.47.8.2385-2392.2003; Woodford N, 2008, J ANTIMICROB CHEMOTH, V62, P1265, DOI 10.1093/jac/dkn400	38	50	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180121	10.1371/journal.pone.0180121	http://dx.doi.org/10.1371/journal.pone.0180121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658322	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900062
J	Nakajima, R; Sato, T; Ogawa, T; Okano, H; Noce, T				Nakajima, Ryusuke; Sato, Takuya; Ogawa, Takehiko; Okano, Hideyuki; Noce, Toshiaki			A noncoding RNA containing a SINE-B1 motif associates with meiotic metaphase chromatin and has an indispensable function during spermatogenesis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX; MOUSE; PROTEIN; EXPRESSION; GENE; B1; SPERMATOCYTES; TRANSCRIPTION; LOCALIZATION; CHROMOSOMES	A search for early response genes that are activated following germ cell induction from mouse embryonic stem cells in vitro led us to the isolation of a long noncoding RNA that contains a SINE (short interspersed element)-B1F motif that was named R53. In situ hybridization and northern blot analyses revealed that the R53 subfragment RNA bears a B1F motif, is processed from the primary transcript, is expressed in adult testis and is predominantly localized in meiotic metaphase chromatin during spermatogenesis. Recent studies of chromosome-associated RNAs have explored novel functions of noncoding RNAs. Specifically, chromosome-bound noncoding RNAs function not only as structural components of chromosome but also as scaffolds that recruit epigenetic modulators for transcriptional regulation, and they are dynamically rearranged during the cell cycle. However, few studies have explored meiotic chromatin; thus, R53 RNA appears to be the first long noncoding RNA to be tightly associated with the metaphase chromatin during spermatogenesis. Furthermore, R53 knockdown using a lentivirus-mediated RNAi injected into mouse testis and organ culture of the fragments revealed a remarkable reduction in postmeiotic cells and irregular up-regulation of several postmeiotic genes, which suggests the possibility that the SINE-B1-derived noncoding RNA R53 plays an indispensable role in the transcriptional regulation of key spermatogenesis genes.	[Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo, Japan; [Sato, Takuya; Ogawa, Takehiko] Yokohama City Univ Assoc Med Sci, Inst Mol Med & Life Sci, Lab Prote, Yokohama, Kanagawa, Japan	Keio University	Nakajima, R; Noce, T (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo, Japan.	rnakajima@a3.keio.jp; noce@z5.keio.jp	Sato, Takuya/X-9143-2019; Okano, Hideyuki/X-9131-2019; Sato, Takuya/F-8251-2017; Okano, Hideyuki/I-7584-2019	Sato, Takuya/0000-0002-6198-2234; Okano, Hideyuki/0000-0001-7482-5935; Sato, Takuya/0000-0002-6198-2234; 	Japan Society for the Challenging Research Exploratory [26650129]; Promotion of Science Research Fellowship Program [26-7577]	Japan Society for the Challenging Research Exploratory; Promotion of Science Research Fellowship Program	Grant-in-Aids from the Japan Society for the Challenging Research Exploratory (26650129) and the Promotion of Science Research Fellowship Program (26-7577). http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Ganesan G, 2008, RNA, V14, P1399, DOI 10.1261/rna.838308; Garcia-Lopez J, 2015, RNA, V21, P946, DOI 10.1261/rna.048215.114; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hernandez-Hernandez A, 2008, CHROMOSOMA, V117, P77, DOI 10.1007/s00412-007-0128-2; Ichiyanagi K, 2013, GENES GENET SYST, V88, P19, DOI 10.1266/ggs.88.19; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; McCarrey JR, 2006, GENESIS, V34, P257; Meng YC, 2016, NUCLEIC ACIDS RES, V44, P4934, DOI 10.1093/nar/gkw195; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Muslimov IA, 2002, J CELL SCI, V115, P1243; NOCE T, 1992, DEV BIOL, V153, P356, DOI 10.1016/0012-1606(92)90120-6; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Ohnishi Y, 2012, MOL BIOL REP, V39, P903, DOI 10.1007/s11033-011-0815-1; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; QUENTIN Y, 1989, J MOL EVOL, V28, P299, DOI 10.1007/BF02103425; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schmitz J, 2012, GENOME DYNAM, V7, P92, DOI 10.1159/000337117; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsunekawa N, 1999, J VET MED SCI, V61, P381, DOI 10.1292/jvms.61.381; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Werner MS, 2015, CELL REP, V12, P1089, DOI 10.1016/j.celrep.2015.07.033; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yoneda R, 2016, MOL REPROD DEV, V83, P541, DOI 10.1002/mrd.22650; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	45	8	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179585	10.1371/journal.pone.0179585	http://dx.doi.org/10.1371/journal.pone.0179585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658256	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900034
J	Veiga, AK; Saraiva, AM; Chapman, AD; Morris, PJ; Gendreau, C; Schigel, D; Robertson, TJ				Veiga, Allan Koch; Saraiva, Antonio Mauro; Chapman, Arthur David; Morris, Paul John; Gendreau, Christian; Schigel, Dmitry; Robertson, Tim James			A conceptual framework for quality assessment and management of biodiversity data	PLOS ONE			English	Article							INFORMATION QUALITY; DIMENSIONS; DATABASES; DIVERSITY; TAXONOMY; TRUST	The increasing availability of digitized biodiversity data worldwide, provided by an increasing number of institutions and researchers, and the growing use of those data for a variety of purposes have raised concerns related to the "fitness for use" of such data and the impact of data quality (DQ) on the outcomes of analyses, reports, and decisions. A consistent approach to assess and manage data quality is currently critical for biodiversity data users. However, achieving this goal has been particularly challenging because of idiosyncrasies inherent in the concept of quality. DQ assessment and management cannot be performed if we have not clearly established the quality needs from a data user's standpoint. This paper defines a formal conceptual framework to support the biodiversity informatics community allowing for the description of the meaning of "fitness for use" from a data user's perspective in a common and standardized manner. This proposed framework defines nine concepts organized into three classes: DQ Needs, DQ Solutions and DQ Report. The framework is intended to formalize human thinking into well-defined components to make it possible to share and reuse concepts of DQ needs, solutions and reports in a common way among user communities. With this framework, we establish a common ground for the collaborative development of solutions for DQ assessment and management based on data fitness for use principles. To validate the framework, we present a proof of concept based on a case study at the Museum of Comparative Zoology of Harvard University. In future work, we will use the framework to engage the biodiversity informatics community to formalize and share DQ profiles related to DQ needs across the community.	[Veiga, Allan Koch; Saraiva, Antonio Mauro] Univ Sao Paulo, Res Ctr Biodivers & Comp, Sao Paulo, Brazil; [Chapman, Arthur David] Australian Biodivers Informat Serv, Ballan, Vic, Australia; [Morris, Paul John] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Gendreau, Christian] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Schigel, Dmitry; Robertson, Tim James] Secretariat, Global Biodivers Informat Facil, Copenhagen, Denmark	Universidade de Sao Paulo; Harvard University; Universite de Montreal	Veiga, AK; Saraiva, AM (corresponding author), Univ Sao Paulo, Res Ctr Biodivers & Comp, Sao Paulo, Brazil.	allan.kv@gmail.com; saraiva@usp.br	Saraiva, Antonio M/B-6350-2011; Veiga, Allan/C-7476-2013	Saraiva, Antonio M/0000-0003-2283-1123; Gendreau, Christian/0000-0003-4898-4291; Chapman, Arthur/0000-0003-1700-6962; Veiga, Allan/0000-0003-2672-8115; Schigel, Dmitry/0000-0002-2919-1168; Morris, Paul/0000-0002-3673-444X	Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [233676/2014-7, 308326/2010-5, 311531/2014-8]; Research Centeron Biodiversity and Computing, BioComp [11.1.9359.1.2]; Sao Paulo Research Foundation, FAPESP [2015/241683]	Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Centeron Biodiversity and Computing, BioComp; Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study is part of the Doctorate Degree thesis of AKV, who was supported by a Brazilian Governmental National Research Agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES. In addition, the author AKV was granted an exchange scholarship by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grant #233676/2014-7). The author AMS is a profess or at Universidade de Sao Paulo,which supported the Research Centeron Biodiversity and Computing, BioComp (grant #11.1.9359.1.2). AMS was also supported by Conselho Nacionalde Desenvolvimento Cientifico e Tecnologico (grants #308326/2010-5 and #311531/2014-8), and by Sao Paulo Research Foundation, FAPESP, (grant #2015/241683).The funders had no role in study design, data collection and analysis, decisionto publish,or preparation of the manuscript.	ABRS, 2004, AUSTR FAUN DIR; ASC [Association of Systematics Collections], 1992, BIOL COLL DAT STAND; Askham N., 2013, 6 PRIMARY DIMENSION; BDQ Toolkit, 2017, BDQ TOOLK BDQ TOOLK; BDQIG, 2015, GBIF TDWG BIOD DAT Q; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Berndt DJ, 2001, COMPUTER, V34, P56, DOI 10.1109/2.970578; Bishop M., 2003, COMPUTER SECURITY AR; Busby JR, 1979, AUSTR BIOTAXONOMIC I, P25; Chapman AD, 1992, P SEM ORG COMM LAND; Chapman AD, 2005, PRINCIPLES METHODS D, P75; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chapman AD, 1991, AUSTRAL FL FAUNA SER, V12-15, P1; Chapman AD, 2005, PRINCIPLES DATA QUAL, P61; Chapman AD, 2004, APPENDIX 1 SISTEMA I; Chengalur-Smith IN, 1999, IEEE T KNOWL DATA EN, V11, P853, DOI 10.1109/69.824597; Chrisman NR, 1983, ROLE QUALITY INFORM, V2, P303; Conn BJ, 1996, HISPID3 HERBARIUM IN; Croft J. R., 1989, HISPID HERBARIUM INF; Dalcin E. C., 2005, THESIS; Dou L, 2012, PROCEDIA COMPUT SCI, V9, P1614, DOI 10.1016/j.procs.2012.04.177; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; Eppler M, 2006, MANAGING INFORM QUAL; FOX C, 1994, INFORM PROCESS MANAG, V30, P9, DOI 10.1016/0306-4573(94)90020-5; GBIF [Global Biodiversity Information Facility], 2015, DWCA VAL; GBIF [Global Biodiversity Information Facility], 2015, WHAT IS GBIF; Ge M, 2007, REV INFORM QUALITY R, P76; Huang KT, 1999, INFORM KNOWLEDGE MAN; JOHNSON JR, 1981, ACCOUNT REV, V56, P270; Kaplan D, 1998, COMMUN ACM, P72; KLOBAS JE, 1995, J INFORM SCI, V21, P95, DOI 10.1177/016555159502100204; Lee Y.W., 2006, JOURNEY DATA QUALITY; Lee YW, 2002, INFORM MANAGE-AMSTER, V40, P133, DOI 10.1016/S0378-7206(02)00043-5; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; McGilvray D, 2008, EXECUTING DATA QUALI; MVZ [Museum of Vertebrate Zoology Berkeley], 1996, MVZ COLL INF MOD; Nelson D, 2004, J BACTERIOL, V186, P7029, DOI 10.1128/JB.186.21.7029-7031.2004; Nicolaou AI, 2006, INFORM SYST RES, V17, P332, DOI 10.1287/isre.1060.0103; Noy N.F., WHAT IS ONTOLOGY WHY; Otegui J, 2016, BIOINFORMATICS; Otegui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055144; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Pipino L.L., 2002, COMMUN ACM, V45, P211, DOI DOI 10.1145/505248.506010; Research Data Alliance [RDA], 2016, ASS DAT FITN US RDA; ROSENBERG G, 1993, AM MALACOL BULL, V10, P257; SearchCIO, 2005, WHAT IS TOT QUAL MAN; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strong DM, 1997, COMMUN ACM, V40, P103, DOI 10.1145/253769.253804; Stvilia B, 2006, J AM SOC INFORM SCI; Sunderland ME, 2013, ENDEAVOUR, V37, P150, DOI 10.1016/j.endeavour.2013.04.001; TDWG [Biodiversity Information Standards], 2015, TASK GROUP CHART BDQ; TDWG [Biodiversity Information Standards], 2007, HISPID3 HERB INF STA; Teflian M., 1999, INFORM LIQUIDITY; Veiga AK, 2014, IEEE LAT AM T, V12, P683, DOI 10.1109/TLA.2014.6868870; Veiga AK, 2012, ICT AGR RURAL DEV EN; Wand Y, 1996, COMMUN ACM, V39, P86, DOI 10.1145/240455.240479; Wang R. Y., 1996, Journal of Management Information Systems, V12, P5; WANG RY, 1995, DECIS SUPPORT SYST, V13, P349, DOI 10.1016/0167-9236(93)E0050-N; Wang RY, 1998, COMMUNICATIONS A FEB, P58; Wang Y. Y. R., 2001, DATA QUALITY; Williams SM., 1979, DOCUMENTATION STANDA, Vvii, P48; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	64	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0178731	10.1371/journal.pone.0178731	http://dx.doi.org/10.1371/journal.pone.0178731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658288	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900008
J	Fomenkov, A; Sun, ZY; Dila, DK; Anton, BP; Roberts, RJ; Raleigh, EA				Fomenkov, Alexey; Sun, Zhiyi; Dila, Deborah K.; Anton, Brian P.; Roberts, Richard J.; Raleigh, Elisabeth A.			EcoBLMcrX, a classical modification-dependent restriction enzyme in Escherichia coli B: Characterization in vivo and in vitro with a new approach to cleavage site determination	PLOS ONE			English	Article							MCRA PROTEIN; DNA; GENOME; ENDONUCLEASES; EXPRESSION; SEQUENCES; CLONING; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; BACTERIOPHAGES	Here we characterize the modification-dependent restriction enzyme (MDE) EcoBLMcrX in vivo, in vitro and in its genomic environment. MDE cleavage of modified DNAs protects prokaryote populations from lethal infection by bacteriophage with highly modified DNA, and also stabilizes lineages by reducing gene import when sparse modification occurs in the wrong context. The function and distribution of MDE families are thus important. Here we describe the properties of EcoBLMcrX, an enzyme of the E. coli B lineage, in vivo and in vitro. Restriction in vivo and the genome location of its gene, ecoBLmcrX, were determined during construction and sequencing of a B/K-12 hybrid, ER2566. In classical restriction literature, this B system was named r(6) or rglA(B). Like many genome defense functions, ecoBLmcrX is found within a genomic island, where gene content is variable among natural E. coli isolates. In vitro, EcoBLMcrX was compared with two related enzymes, BceYI and NhoI. All three degrade fully cytosine-modified phage DNA, as expected for EcoBLMcrX from classical T4 genetic data. A new method of characterizing MDE specificity was developed to better understand action on fully-modified targets such as the phage that provide major evolutionary pressure for MDE maintenance. These enzymes also cleave plasmids with C-m5 in particular motifs, consistent with a role in lineage-stabilization. The recognition sites were characterized using a site-ranking approach that allows visualization of preferred cleavage sites when fully-modified substrates are digested. A technical constraint on the method is that ligation of one-nucleotide 5' extensions favors G:C over A:T approximately five-fold. Taking this bias into account, we conclude that EcoBLMcrX can cleave 3' to the modified base in the motif (RC)-C-m5 vertical bar. This is compatible with, but less specific than, the site reported by others. Highly-modified site contexts, such as those found in base-substituted virulent phages, are strongly preferred.	[Fomenkov, Alexey; Sun, Zhiyi; Dila, Deborah K.; Anton, Brian P.; Roberts, Richard J.; Raleigh, Elisabeth A.] New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA; [Dila, Deborah K.] Univ Wisconsin, Milwaukee, WI 53201 USA	New England Biolabs; University of Wisconsin System; University of Wisconsin Milwaukee	Raleigh, EA (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA.	raleigh@neb.com		Sun, Zhiyi/0000-0002-6106-5356	New England Biolabs	New England Biolabs	This work was supported by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Anton BP, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00230-16; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Bair CL, 2007, J MOL BIOL, V366, P779, DOI 10.1016/j.jmb.2006.11.049; Bujnicki JM, 2000, MOL MICROBIOL, V37, P1280, DOI 10.1046/j.1365-2958.2000.02010.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DEMEREC M, 1966, GENETICS, V54, P61; DHARMALINGAM K, 1976, NATURE, V260, P454, DOI 10.1038/260454a0; DHARMALINGAM K, 1979, VIROLOGY, V96, P404, DOI 10.1016/0042-6822(79)90098-9; Dixit PD, 2015, P NATL ACAD SCI USA, V112, P9070, DOI 10.1073/pnas.1510839112; GEORGOPOULOS CP, 1971, VIROLOGY, V44, P271, DOI 10.1016/0042-6822(71)90259-5; Gonchar D.A., 2016, BIOTECHNOLOGY-PAKIST, V12, P175; HIOM K, 1991, J BACTERIOL, V173, P7368, DOI 10.1128/jb.173.22.7368-7373.1991; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Iurlaro M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1001-5; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnston C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003178; Kamps-Hughes N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt257; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; LEUNG DW, 1979, NUCLEIC ACIDS RES, V6, P17, DOI 10.1093/nar/6.1.17; lida S, 1987, VIROLOGY, V157, P156; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Mulligan EA, 2008, PROTEIN EXPRES PURIF, V62, P98, DOI 10.1016/j.pep.2008.06.016; Mulligan EA, 2010, NUCLEIC ACIDS RES, V38, P1997, DOI 10.1093/nar/gkp1120; Nandi T, 2015, GENOME RES, V25, P129, DOI 10.1101/gr.177543.114; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; RALEIGH EA, 1989, GENETICS, V122, P279; RAMALINGAM R, 1992, J BIOSCIENCE, V17, P217, DOI 10.1007/BF02703150; Samuelson JC, 2004, NUCLEIC ACIDS RES, V32, P3661, DOI 10.1093/nar/gkh674; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stephanou AS, 2009, J MOL BIOL, V391, P565, DOI 10.1016/j.jmb.2009.06.020; Stucken K, 2013, BIOL RES, V46, P373, DOI 10.4067/S0716-97602013000400009; Sun ZY, 2015, MOL CELL, V57, P750, DOI 10.1016/j.molcel.2014.12.035; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; SZYBALSKI W, 1988, GENE, V74, P279; Tarasova GV, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-7; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Wang S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150130; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Xu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28579; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Yang HX, 2015, PLANT J, V81, P268, DOI 10.1111/tpj.12726	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179853	10.1371/journal.pone.0179853	http://dx.doi.org/10.1371/journal.pone.0179853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654677	gold, Green Published, Green Submitted			2022-12-26	WOS:000404541500037
J	Termini, JM; Silver, ZA; Connor, B; Antonopoulos, A; Haslam, SM; Dell, A; Desrosiers, RC				Termini, James M.; Silver, Zachary A.; Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne; Desrosiers, Ronald C.			HEK293T cell lines defective for O-linked glycosylation	PLOS ONE			English	Article							EPIMERASE-DEFICIENCY GALACTOSEMIA; MAMMALIAN-CELLS; LELOIR PATHWAY; MUTANTS; GLYCANS; ENZYMES; SYSTEMS; MOUSE	Here we describe derivatives of the HEK293T cell line that are defective in their ability to generate mucin-type O-linked glycosylation. Using CRISPR/Cas9 and a single-cell GFP-sorting procedure, the UDP-galactose-4-epimerase (GALE), galactokinase 1 (GALK1), and galactokinase 2 (GALK2) genes were knocked out individually and in combinations with greater than 90% of recovered clones having the desired mutations. Although HEK293T cells are tetraploid, we found this approach to be an efficient method to target and disrupt all 4 copies of the target gene. Deficient glycosylation in the GALE knockout cell line could be rescued by the addition of galactose and N-acetylgalactosamine (GalNAc) to the cell culture media. However, when key enzymes of the galactose/GalNAc salvage pathways were disrupted in tandem (GALE+GALK1 or GALE+GALK2), O-glycosylation was eliminated and could not be rescued by the addition of either galactose plus GalNAc or UDP-galactose plus UDP-GalNAc. GALK1 and GALK2 are key enzymes of the galactose/GalNAc salvage pathways. Mass spectrometry was performed on whole cell lysate of the knockout cell lines to verify the glycosylation phenotype. As expected, the GALE knockout was almost completely devoid of all O-glycosylation, with minimal glycosylation as a result of functional salvage pathways. However, the GALE+GALK1 and GALE+GALK2 knockout lines were devoid of all O-glycans. Mass spectrometry analysis revealed that the disruption of GALE, GALK1, and GALE+GALK2 had little effect on the N-glycome. But when GALE was knocked out in tandem with GALK1, N-glycans were exclusively of the high mannose type. Due to the well-characterized nature of these five knockout cell lines, they will likely prove useful for a wide variety of applications.	[Termini, James M.; Silver, Zachary A.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Connor, Bryony; Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London, England	University of Miami; Imperial College London	Desrosiers, RC (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	r.desrosiers@med.miami.edu		Desrosiers, Ronald/0000-0001-6851-3003; Dell, Anne/0000-0003-1380-2347	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI104523]; State of Florida contract CODMR; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104523] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of Florida contract CODMR; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) R01 AI104523. This study was also partially supported by State of Florida contract CODMR (http://hivaidsinstitute.med.miami.edu/) and grant BB/K016164/1 from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (to A.D., and S.M.H.). A.D. is a Wellcome Trust Senior Research Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch N, 2017, J BIOL CHEM, V292, P1068, DOI 10.1074/jbc.M116.743740; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cummings R.D., 2015, ESSENTIALS GLYCOBIOL, P435; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fridovich-Keil J, 1993, GENEREVIEWS R; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Lai K, 2009, IUBMB LIFE, V61, P1063, DOI 10.1002/iub.262; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Openo KK, 2006, AM J HUM GENET, V78, P89, DOI 10.1086/498985; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rehwinkel J, 2014, CELL MOL LIFE SCI, V71, P3749, DOI 10.1007/s00018-014-1646-8; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; Stansell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124784; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Timson DJ, 2006, IUBMB LIFE, V58, P83, DOI 10.1080/15216540600644846; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263	31	14	14	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179949	10.1371/journal.pone.0179949	http://dx.doi.org/10.1371/journal.pone.0179949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654657	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500040
J	Carvallo, L; Lopez, L; Fajardo, JE; Jaureguiberry-Bravo, M; Fiser, A; Berman, JW				Carvallo, Loreto; Lopez, Lillie; Fajardo, Jorge E.; Jaureguiberry-Bravo, Matias; Fiser, Andras; Berman, Joan W.			HIV-Tat regulates macrophage gene expression in the context of neuroAIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; CHROMATIN-REMODELING COMPLEX; BLOOD-BRAIN-BARRIER; RNA-POLYMERASE-II; NEUROCOGNITIVE DISORDERS; T-CELLS; TRANSCRIPTIONAL ACTIVITY; REPRESSES TRANSCRIPTION	Despite the success of cART, greater than 50% of HIV infected people develop cognitive and motor deficits termed HIV-associated neurocognitive disorders (HAND). Macrophages are the major cell type infected in the CNS. Unlike for T cells, the virus does not kill macrophages and these long-lived cells may become HIV reservoirs in the brain. They produce cytokines/chemokines and viral proteins that promote inflammation and neuronal damage, playing a key role in HIV neuropathogenesis. HIV Tat is the transactivator of transcription that is essential for replication and transcriptional regulation of the virus and is the first protein to be produced after HIV infection. Even with successful cART, Tat is produced by infected cells. In this study we examined the role of the HIV Tat protein in the regulation of gene expression in human macrophages. Using THP-1 cells, a human monocyte/macrophage cell line, and their infection with lentivirus, we generated stable cell lines that express Tat-Flag. We performed ChIP-seq analysis of these cells and found 66 association sites of Tat in promoter or coding regions. Among these are C5, CRLF2/TSLPR, BDNF, and APBA1/Mint1, genes associated with inflammation/damage. We confirmed the association of Tat with these sequences by ChIP assay and expression of these genes in our THP-1 cell lines by qRT-PCR. We found that HIV Tat increased expression of C5, APBA1, and BDNF, and decreased CRLF2. The K50A Tat-mutation dysregulated expression of these genes without affecting the binding of the Tat complex to their gene sequences. Our data suggest that HIV Tat, produced by macrophage HIV reservoirs in the brain despite successful cART, contributes to neuropathogenesis in HIV-infected people.	[Carvallo, Loreto; Lopez, Lillie; Jaureguiberry-Bravo, Matias; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Fajardo, Jorge E.; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	joan.berman@einstein.yu.edu	Carvallo, Loreto/C-2237-2019	Carvallo, Loreto/0000-0001-9943-1342; Fajardo, Jorge/0000-0001-9701-8546; Jaureguiberry, Matias/0000-0001-9937-7008	National Institutes of Health Grants [R01MH075679, R01MH090958, R01MH077542, R21MH102113]; Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075679] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01MH075679, R01MH090958, R01MH077542 (JWB), R21MH102113 (JWB, LC), and Pilot Funding from Einstein (Epigenomics Shared Facility for massively-parallel sequencing assays to JWB, LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578; Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Albrecht D, 2006, AIDS RES HUM RETROV, V22, P248, DOI 10.1089/aid.2006.22.248; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Andras IE, 2008, MOL PHARMACOL, V73, P1424, DOI 10.1124/mol.107.042028; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Bachani M, 2013, J NEUROVIROL, V19, P82, DOI 10.1007/s13365-012-0144-8; Bachis A, 2012, J NEUROSCI, V32, P9477, DOI 10.1523/JNEUROSCI.0865-12.2012; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Bouwman RD, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-53; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Buckner CM, 2006, J NEUROIMMUNE PHARM, V1, P160, DOI 10.1007/s11481-006-9017-3; Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Caldwell RL, 2006, J LEUKOCYTE BIOL, V79, P192, DOI 10.1189/jlb.0405194; Caldwell RL, 2000, J IMMUNOL, V165, P7035, DOI 10.4049/jimmunol.165.12.7035; Carroll IR, 1998, MOL IMMUNOL, V35, P1171, DOI 10.1016/S0161-5890(98)00107-2; Carvallo L, 2008, J CELL PHYSIOL, V214, P740, DOI 10.1002/jcp.21267; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Colten H R, 1979, Ann N Y Acad Sci, V332, P482, DOI 10.1111/j.1749-6632.1979.tb47142.x; Dadachova E, 2015, NAT METHODS, V12, P399, DOI 10.1038/nmeth.3373; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fields J, 2014, J NEUROIMMUNE PHARM, V9, P102, DOI 10.1007/s11481-013-9520-2; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gatignol A, 2007, ADV PHARMACOL, V55, P137, DOI 10.1016/S1054-3589(07)55004-0; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; HARTUNG HP, 1983, SPRINGER SEMIN IMMUN, V6, P283, DOI 10.1007/BF02116277; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hidalgo-Estevez AM, 2006, J GEN VIROL, V87, P1603, DOI 10.1099/vir.0.81637-0; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Jongen PJH, 2000, ACTA NEUROL SCAND, V101, P116, DOI 10.1034/j.1600-0404.2000.101002116.x; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lambotte O, 2003, BRAIN PATHOL, V13, P95, DOI 10.1111/j.1750-3639.2003.tb00010.x; Lin CW, 2012, J DRUG TARGET, V20, P515, DOI 10.3109/1061186X.2012.693496; LONGO F, 1995, BIOCHEM BIOPH RES CO, V206, P326, DOI 10.1006/bbrc.1995.1045; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; MARDER SR, 1985, J IMMUNOL, V134, P3325; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mavankal G, 1996, P NATL ACAD SCI USA, V93, P2089, DOI 10.1073/pnas.93.5.2089; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2015, J NEUROVIROL, V21, P227, DOI 10.1007/s13365-014-0291-1; Nath S, 2012, J NEUROVIROL, V18, P445, DOI 10.1007/s13365-012-0122-1; OOI YM, 1979, J IMMUNOL, V123, P2494; OOI YM, 1980, J IMMUNOL, V124, P2077; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Parisiadou L, 2007, NEUROBIOL AGING, V28, P377, DOI 10.1016/j.neurobiolaging.2005.12.015; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rackstraw S, 2011, PSYCHOL HEALTH MED, V16, P548, DOI 10.1080/13548506.2011.579992; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Rappaport J, 2015, J NEUROVIROL, V21, P235, DOI 10.1007/s13365-015-0346-y; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Reeder JE, 2015, ELIFE, V4, DOI 10.7554/eLife.08955; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Soederholm A, 2007, EUR J IMMUNOL, V37, P2156, DOI 10.1002/eji.200636820; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Speth C, 2001, J VIROL, V75, P2604, DOI 10.1128/JVI.75.6.2604-2516.2001; Stoiber H, 1997, ANNU REV IMMUNOL, V15, P649, DOI 10.1146/annurev.immunol.15.1.649; Sullivan SE, 2014, J BIOL CHEM, V289, P15374, DOI 10.1074/jbc.M113.541003; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tong J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082030; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; VESCHAMBRE P, 1995, J MOL BIOL, V250, P169, DOI 10.1006/jmbi.1995.0368; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Woollard SM, 2014, J CEREBR BLOOD F MET, V34, P1047, DOI 10.1038/jcbfm.2014.54; Wu DT, 2000, J NEUROVIROL, V6, pS82; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xing HQ, 2009, NEUROPATHOLOGY, V29, P433, DOI 10.1111/j.1440-1789.2008.00996.x; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007	125	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179882	10.1371/journal.pone.0179882	http://dx.doi.org/10.1371/journal.pone.0179882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640909	gold, Green Submitted, Green Published			2022-12-26	WOS:000404135800077
J	Vernon, RM; Chong, PA; Lin, H; Yang, ZR; Zhou, QX; Aleksandrov, AA; Dawson, JE; Riordan, JR; Brouillette, CG; Thibodeau, PH; Forman-Kay, JD				Vernon, Robert M.; Chong, P. Andrew; Lin, Hong; Yang, Zhengrong; Zhou, Qingxian; Aleksandrov, Andrei A.; Dawson, Jennifer E.; Riordan, John R.; Brouillette, Christie G.; Thibodeau, Patrick H.; Forman-Kay, Julie D.			Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; cystic fibrosis transmembrane conductance regulator (CFTR); protein engineering; protein misfolding; protein stability	ATP-BINDING; DELTA-F508 CFTR; R-DOMAIN; MULTIDRUG-RESISTANCE; PROTEIN STABILITY; CHLORIDE CHANNEL; ABC TRANSPORTER; SEQUENCE; DESIGN; EVOLUTION	Characterization of the second nucleotide-binding domain (NBD2) of the cystic fibrosis transmembrane conductance regulator (CFTR) has lagged behind research into the NBD1 domain, in part because NBD1 contains the F508del mutation, which is the dominant cause of cystic fibrosis. Research on NBD2 has also been hampered by the overall instability of the domain and the difficulty of producing reagents. Nonetheless, multiple disease-causing mutations reside in NBD2, and the domain is critical for CFTR function, because channel gating involves NBD1/NBD2 dimerization, and NBD2 contains the catalytically active ATPase site in CFTR. Recognizing the paucity of structural and biophysical data on NBD2, here we have defined a bioinformatics-based method for manually identifying stabilizing substitutions in NBD2, and we used an iterative process of screening single substitutions against thermal melting points to both produce minimally mutated stable constructs and individually characterize mutations. We present a range of stable constructs with minimal mutations to help inform further research on NBD2. We have used this stabilized background to study the effects of NBD2 mutations identified in cystic fibrosis (CF) patients, demonstrating that mutants such as N1303K and G1349D are characterized by lower stability, as shown previously for some NBD1 mutations, suggesting a potential role for NBD2 instability in the pathology of CF.	[Vernon, Robert M.; Chong, P. Andrew; Lin, Hong; Dawson, Jennifer E.; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Yang, Zhengrong; Zhou, Qingxian; Brouillette, Christie G.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL 35294 USA; [Yang, Zhengrong; Zhou, Qingxian; Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Thibodeau, Patrick H.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Aleksandrov, Andrei A.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Cyst Fibrosis Treatment & Res Ctr, Chapel Hill, NC 27599 USA; [Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Med, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.	forman@sickkids.ca		Dawson, Jennifer Erin/0000-0002-8387-6109; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Canada; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R01DK051870] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Cystic Fibrosis Foundation Therapeutics (to J. D. F.-K., P. H. T., C. G. B., and J. R. R.), from Cystic Fibrosis Canada (to J. D. F.-K.), and from the National Institutes of Health (to P. H. T. and J. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Chong PA, 2015, J BIOL CHEM, V290, P22862, DOI 10.1074/jbc.M115.641134; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Da Paula AC, 2010, J BIOL CHEM, V285, P27033, DOI 10.1074/jbc.M110.120352; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FERSHT A, 1998, STRUCTURE MECH PROTE, P508; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Goldstein RA, 2011, PROTEINS, V79, P1396, DOI 10.1002/prot.22964; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lehmann M, 2000, PROTEIN ENG, V13, P49, DOI 10.1093/protein/13.1.49; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ramalho AS, 2016, J CYST FIBROS, V15, P21, DOI 10.1016/j.jcf.2015.02.002; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Tian JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-370; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wainreb G, 2011, BIOINFORMATICS, V27, P3286, DOI 10.1093/bioinformatics/btr576; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhao X., 2008, PEDIAT PULMONARY, V43, P205	66	14	14	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14147	14164		10.1074/jbc.M116.772335	http://dx.doi.org/10.1074/jbc.M116.772335			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28655774	Green Published, hybrid			2022-12-26	WOS:000408439800020
J	Dorn, ES; Tress, B; Suchodolski, JS; Nisar, T; Ravindran, P; Weber, K; Hartmann, K; Schulz, BS				Dorn, Elisabeth S.; Tress, Barbara; Suchodolski, Jan S.; Nisar, Tariq; Ravindran, Prajesh; Weber, Karin; Hartmann, Katrin; Schulz, Bianka S.			Bacterial microbiome in the nose of healthy cats and in cats with nasal disease	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; NASOPHARYNGEAL MICROBIOTA; BRADYRHIZOBIUM-ENTERICA; PATHOGENIC BACTERIA; INCREASED RISK; EARLY-LIFE; COMMUNITIES; ASTHMA; INFECTION; COLITIS	Background Traditionally, changes in the microbial population of the nose have been assessed using conventional culture techniques. Sequencing of bacterial 16S rRNA genes demonstrated that the human nose is inhabited by a rich and diverse bacterial microbiome that cannot be detected using culture-based methods. The goal of this study was to describe the nasal microbiome of healthy cats, cats with nasal neoplasia, and cats with feline upper respiratory tract disease (FURTD). Methodology/Principal findings DNA was extracted from nasal swabs of healthy cats (n = 28), cats with nasal neoplasia (n = 16), and cats with FURTD (n = 15), and 16S rRNA genes were sequenced. High species richness was observed in all samples. Rarefaction analysis revealed that healthy cats living indoors had greater species richness (observed species p = 0.042) and Shannon diversity (p = 0.003) compared with healthy cats living outdoors. Higher species richness (observed species p = 0.001) and Shannon diversity (p<0.001) were found in middle-aged cats in comparison to healthy cats in different age groups. Principal coordinate analysis revealed separate clustering based on similarities in bacterial molecular phylogenetic trees of 16S rRNA genes for indoor and outdoor cats. In all groups examined, the most abundant phyla identified were Proteobacteria, Firmicutes, and Bacteroidetes. At the genus level, 375 operational taxonomic units (OTUs) were identified. In healthy cats and cats with FURTD, Moraxella spp. was the most common genus, while it was unclassified Bradyrhizobiaceae in cats with nasal neoplasia. High individual variability was observed. Conclusion This study demonstrates that the nose of cats is inhabited by much more variable and diverse microbial communities than previously shown. Future research in this field might help to develop new diagnostic tools to easily identify nasal microbial changes, relate them to certain disease processes, and help clinicians in the decision process of antibiotic selection for individual patients.	[Dorn, Elisabeth S.; Tress, Barbara; Weber, Karin; Hartmann, Katrin; Schulz, Bianka S.] LMU Univ Munich, Clin Small Anim Med, Munich, Germany; [Suchodolski, Jan S.; Nisar, Tariq; Ravindran, Prajesh] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, Dept Small Anim Clin Sci, College Stn, TX USA	University of Munich; Texas A&M University System; Texas A&M University College Station	Schulz, BS (corresponding author), LMU Univ Munich, Clin Small Anim Med, Munich, Germany.	B.Schulz@medizinische-kleintierklinik.de	Weber, Karin/A-6034-2016	Weber, Karin/0000-0002-0541-4355; Dorn, Elisabeth/0000-0002-8052-7026	sdw-Stiftung der Deutschen Wirtschaft	sdw-Stiftung der Deutschen Wirtschaft	This work was supported by sdw-Stiftung der Deutschen Wirtschaft (30,000 epsilon, https://www.sdw.org/home) (ESD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Alho OP, 2003, ALLERGY, V58, P767, DOI 10.1034/j.1398-9995.2003.00252.x; Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Autio TJ, 2015, LARYNGOSCOPE, V125, pE1, DOI 10.1002/lary.24862; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Berger A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0595-2; Bhatt AS, 2013, NEW ENGL J MED, V369, P1867, DOI 10.1056/NEJMc1311318; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Biswas K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00134; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Boutin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116029; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Choi CH, 2014, AM J RHINOL ALLERGY, V28, P281, DOI 10.2500/ajra.2014.28.4050; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Dickey AM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0316-2; Dolieslager SMJ, 2011, VET MICROBIOL, V148, P93, DOI 10.1016/j.vetmic.2010.08.002; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Feazel LM, 2011, INT FORUM ALLERGY RH, V1, P451, DOI 10.1002/alr.20071; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Goldstein EJC, 2012, ANTIMICROB AGENTS CH, V56, P6319, DOI 10.1128/AAC.01794-12; Gourkow N, 2013, CAN VET J, V54, P132; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hariharan H, 2011, COMP IMMUNOL MICROB, V34, P129, DOI 10.1016/j.cimid.2010.05.001; Harris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136986; Hasegawa K, 2015, EXPERT REV CLIN IMMU, V11, P789, DOI 10.1586/1744666X.2015.1045417; Hauser LJ, 2016, INT FORUM ALLERGY RH, V6, P34, DOI 10.1002/alr.21630; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Holst BS, 2010, J FELINE MED SURG, V12, P783, DOI 10.1016/j.jfms.2010.06.002; Johnson LR, 2009, J FELINE MED SURG, V11, P645, DOI 10.1016/j.jfms.2008.12.004; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kil DY, 2011, J ANIM SCI, V89, P1498, DOI 10.2527/jas.2010-3498; Kim RJT, 2015, INT FORUM ALLERGY RH, V5, P877, DOI 10.1002/alr.21600; Kizilova A K, 2014, Mikrobiologiia, V83, P366; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Liu C M, 1992, J Formos Med Assoc, V91, P252; Lo SC, 2015, INT J CLIN EXP PATHO, V8, P13834; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; McDonald R, 2015, ISME J, V9, P2712, DOI 10.1038/ismej.2015.65; McManus CM, 2014, VET J, V201, P196, DOI 10.1016/j.tvjl.2014.05.015; Mika M, 2015, J ALLERGY CLIN IMMUN, V135, P905, DOI 10.1016/j.jaci.2014.12.1909; Mizgerd JP, 2014, AM J RESP CRIT CARE, V190, P1206, DOI 10.1164/rccm.201410-1919ED; NIH Human Microbiome Project, 2011, COR MICR SAMPL PROT; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peterson SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152493; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; PUGH GW, 1986, AM J VET RES, V47, P2343; Redinbo MR, 2014, J MOL BIOL, V426, P3877, DOI 10.1016/j.jmb.2014.09.011; Rutten NBMM, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0519-0; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Schulz BS, 2014, J FELINE MED SURG, V16, P943, DOI 10.1177/1098612X14524969; Schulz BS, 2006, VET REC, V158, P269, DOI 10.1136/vr.158.8.269; Schulz C, 2015, J FELINE MED SURG; Sellart-Altisent Maite, 2007, Revista Iberoamericana de Micologia, V24, P125; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; Sturgeon A, 2014, VET J, V201, P223, DOI 10.1016/j.tvjl.2014.01.024; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ungaro R, 2014, AM J GASTROENTEROL, V109, P1728, DOI 10.1038/ajg.2014.246; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Vazquez-Baeza Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.177, 10.1038/nmicrobiol.2016.177]; Veir JK, 2008, J FELINE MED SURG, V10, P551, DOI 10.1016/j.jfms.2008.04.002; Vientos-Plotts AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173818; Vingataramin L, 2015, BIOTECHNIQUES, V58, P120, DOI 10.2144/000114263; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Wanke I, 2011, J INVEST DERMATOL, V131, P382, DOI 10.1038/jid.2010.328; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; Wilson MT, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0485-x; Wu SG, 2012, WORLD J MICROB BIOT, V28, P2165, DOI 10.1007/s11274-012-1022-5; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zariwala M. A., 2007, GENEREVIEWS	89	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180299	10.1371/journal.pone.0180299	http://dx.doi.org/10.1371/journal.pone.0180299			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662139	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300139
J	Jang, HD; Hong, JY; Han, K; Lee, JC; Shin, BJ; Choi, SW; Suh, SW; Yang, JH; Park, SY; Bang, C				Jang, Hae-Dong; Hong, Jae-Young; Han, Kyungdo; Lee, Jae Chul; Shin, Byung-Joon; Choi, Sung-Woo; Suh, Seung-Woo; Yang, Jae-Hyuk; Park, Si-Young; Bang, Chungwon			Relationship between bone mineral density and alcohol intake: A nationwide health survey analysis of postmenopausal women	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; NUTRITION EXAMINATION SURVEY; MEN; ASSOCIATION; CONSUMPTION; METABOLISM; TOOL	Objectives Among a variety of relevant factors of osteoporosis, the association between alcohol intake and postmenopausal women's bone mineral density (BMD) by using data from the Korean National Health and Nutrition Examination Survey was evaluated in this study. Materials and methods Among a total of 31,596 subjects, males, premenopausal women, participants without BMD data were excluded. Finally, a total number of subjects in the study was 3,312. The frequency and amount of alcohol intake were determined by self-reported questionnaires, and BMD was measured by dual-energy x-ray absorptiometry. Results Mean femoral BMD for light drinkers was statistically significantly greater than that for heavy drinkers and non-drinkers. We observed the characteristic trends for BMD by drinking frequency; the mean BMD gradually increased from non-drinkers to the participants who drank 2-3 times per week; these participants exhibited the highest BMD. Participants who drank alcohol greater than 4 times per week showed a lower BMD. In the risk factor analysis, the adjusted odds ratio for osteoporosis (at femoral neck) was 1.68 in non-drinkers and 1.70 in heavy drinkers compared with light drinkers. Conclusions Light alcohol intake (2-3 times per week and 1-2 or 5-6 glasses per occasion) in South Korean postmenopausal women was related to high femoral BMD. Non-drinkers and heavy drinkers had approximately a 1.7-times greater risk for osteoporosis than light drinkers.	[Jang, Hae-Dong; Lee, Jae Chul; Shin, Byung-Joon; Choi, Sung-Woo] Soonchunhyang Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Hong, Jae-Young] Univ Korea Hosp, Dept Orthoped, Ansan, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Suh, Seung-Woo; Yang, Jae-Hyuk] Korea Univ, Coll Med, Guro Hosp, Scoliosis Res Inst,Dept Orthoped, Seoul, South Korea; [Park, Si-Young] Korea Univ, Coll Med, Anam Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Bang, Chungwon] Soonchunhyang Univ, Cheonan Hosp, Dept Orthopaed Surg, Chungcheongnam Do, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University	Hong, JY (corresponding author), Univ Korea Hosp, Dept Orthoped, Ansan, South Korea.	osspine@korea.ac.kr						Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; Adewuya AO, 2005, ALCOHOL ALCOHOLISM, V40, P575, DOI 10.1093/alcalc/agh197; Al-Saeed O, 2013, ASIAN SPINE J, V7, P104, DOI 10.4184/asj.2013.7.2.104; Cousins JM, 2010, BONE, V47, P205, DOI 10.1016/j.bone.2010.05.003; de Jonge E.A., 2016, EUR J NUTR; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Ganry O, 2000, AM J EPIDEMIOL, V151, P773, DOI 10.1093/oxfordjournals.aje.a010277; Gong GM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8076796; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hirata H, 2016, TOHOKU J EXP MED, V239, P95, DOI 10.1620/tjem.239.95; Hyeon JH, 2016, ASIA PAC J CLIN NUTR, V25, P308, DOI 10.6133/apjcn.2016.25.2.17; Jugdaohsingh R, 2006, P NUTR SOC, V65, P291, DOI 10.1079/PNS2006508; Kim BH, 2009, ASIAN SPINE J, V3, P1, DOI 10.4184/asj.2009.3.1.1; Kim Mi Jin, 2003, Korean J Intern Med, V18, P174; Kizilgul M, 2016, INDIAN J GASTROENTER, V35, P253, DOI 10.1007/s12664-016-0652-1; LAITINEN K, 1991, BONE MINER, V13, P139, DOI 10.1016/0169-6009(91)90081-A; Lee J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3514-5; Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Rapuri PB, 2000, AM J CLIN NUTR, V72, P1206; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seo S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007914; Tucker KL, 2009, AM J CLIN NUTR, V89, P1188, DOI 10.3945/ajcn.2008.26765; Ulhoi MP, 2017, J FORENSIC SCI, V62, P131, DOI 10.1111/1556-4029.13256; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wosje KS, 2007, OSTEOPOROSIS INT, V18, P391, DOI 10.1007/s00198-006-0249-0	27	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180132	10.1371/journal.pone.0180132	http://dx.doi.org/10.1371/journal.pone.0180132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662191	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300110
J	Matusu, R; Senol, B; Pekar, L				Matusu, Radek; Senol, Bilal; Pekar, Libor			Robust stability of fractional order polynomials with complicated uncertainty structure	PLOS ONE			English	Article							CONTROLLER-DESIGN; SYSTEMS; STABILIZATION; BOUNDS	The main aim of this article is to present a graphical approach to robust stability analysis for families of fractional order (quasi-) polynomials with complicated uncertainty structure. More specifically, the work emphasizes the multilinear, polynomial and general structures of uncertainty and, moreover, the retarded quasi-polynomials with parametric uncertainty are studied. Since the families with these complex uncertainty structures suffer from the lack of analytical tools, their robust stability is investigated by numerical calculation and depiction of the value sets and subsequent application of the zero exclusion condition.	[Matusu, Radek] Tomas Bata Univ Zlin, Fac Appl Informat, Ctr Secur Informat & Adv Technol CEBIA Tech, Zlin, Czech Republic; [Senol, Bilal] Inonu Univ, Dept Comp Engn, Fac Engn, Malatya, Turkey; [Pekar, Libor] Tomas Bata Univ Zlin, Fac Appl Informat, Dept Automat & Control Engn, Zlin, Czech Republic	Tomas Bata University Zlin; Inonu University; Tomas Bata University Zlin	Matusu, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, Ctr Secur Informat & Adv Technol CEBIA Tech, Zlin, Czech Republic.	rmatusu@fai.utb.cz	SENOL, Bilal/Y-5328-2018; Pekar, Libor/H-6373-2012; Matušů, Radek/H-6355-2012	SENOL, Bilal/0000-0002-3734-8807; Pekar, Libor/0000-0002-2401-5886; 	European Regional Development Fund under the project CEBIA-Tech Instrumentation [CZ.1.05/ 2.1.00/19.0376]; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme [LO1303, MSMT-7778/2014]	European Regional Development Fund under the project CEBIA-Tech Instrumentation; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme	This work was supported by the European Regional Development Fund under the project CEBIA-Tech Instrumentation No. CZ.1.05/ 2.1.00/19.0376 and by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project No. LO1303 (MSMT-7778/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson K, 2005, MECH TIME-DEPEND MAT, V9, P15, DOI 10.1007/s11043-005-3442-1; Ahmed BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166150; Ahn HS, 2007, APPL MATH COMPUT, V187, P27, DOI 10.1016/j.amc.2006.08.099; Ahn HS, 2008, AUTOMATICA, V44, P2985, DOI 10.1016/j.automatica.2008.07.003; [Anonymous], 2004, UNSOLVED PROBLEMS MA; [Anonymous], 1974, MATH SCI ENG; [Anonymous], IEEE INT C EM TECHN; Atangana A, 2016, CHAOS SOLITON FRACT, V89, P447, DOI 10.1016/j.chaos.2016.02.012; Barmish BR, 1994, NEW TOOLS ROBUSTNESS; Bhattacharyya SP, 2009, AUTOM CONTROL ENG SE, V33, pXVII; Bhattacharyya SP., 1995, ROBUST CONTROL PARAM; Chang XH, 2016, APPL MATH COMPUT, V291, P213, DOI 10.1016/j.amc.2016.07.001; Chen Y, 2009, P 2009 AM CONTR C ST; Chen Y., 2005, P IEEE INT C MECH AU; Das S, 2012, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-642-23117-9; Delavari H, 2013, ASIAN J CONTROL, V15, P783, DOI 10.1002/asjc.677; Dorcak L, 2007, ACTA MONTAN SLOVACA, V12, P231; Doyle JC, 1992, FEEDBACK CONTROL THE; Dzielinski A, 2010, B POL ACAD SCI-TECH, V58, P583, DOI 10.2478/v10175-010-0059-6; Gu K., 2003, STABILITY TIME DELAY; Gutierrez RE, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/375858; Heymans N, 2008, J VIB CONTROL, V14, P1587, DOI 10.1177/1077546307087428; Hilfer R., 2000, APPL FRACTIONAL CALC; Jiao Z, 2012, COMPUT MATH APPL, V64, P3258, DOI 10.1016/j.camwa.2012.03.011; Kasnakoglu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165017; Krishna BT, 2008, ACT PASSIV ELECTRON, V2008, DOI 10.1155/2008/369421; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li C, 2012, J FRANKLIN I, V349, P2406, DOI 10.1016/j.jfranklin.2012.05.006; Liao Z, 2011, J FRANKLIN I, V348, P1101, DOI 10.1016/j.jfranklin.2011.04.012; Lima MFM, 2007, J ADV COMPUT INTELL, V11, P1079, DOI 10.20965/jaciii.2007.p1079; Liu S, 2016, APPL MATH LETT, V51, P13, DOI 10.1016/j.aml.2015.06.018; Lu JG, 2013, FRACT CALC APPL ANAL, V16, P142, DOI 10.2478/s13540-013-0010-2; Lu JG, 2010, IEEE T AUTOMAT CONTR, V55, P152, DOI 10.1109/TAC.2009.2033738; Lu JG, 2009, IEEE T AUTOMAT CONTR, V54, P1294, DOI 10.1109/TAC.2009.2013056; Lu JG, 2013, J FRANKLIN I, V350, P3365, DOI 10.1016/j.jfranklin.2013.07.014; Luo Y, 2012, AUTOMATICA, V48, P2159, DOI 10.1016/j.automatica.2012.05.072; Ma YD, 2014, FRACT CALC APPL ANAL, V17, P136, DOI 10.2478/s13540-014-0159-3; Machado JT, 2011, COMMUN NONLINEAR SCI, V16, P1140, DOI 10.1016/j.cnsns.2010.05.027; Magin RL, 2008, J VIB CONTROL, V14, P1431, DOI 10.1177/1077546307087439; Magin R.-L., 2006, FRACTIONAL CALCULUS; Magin RL, 2012, P 13 INT CARP CONTR; Matuat R, 2015, MATH PROBLEMS ENG; Matusu Radek, 2016, International Journal of Circuits, Systems and Signal Processing, V10, P326; Matusu R, 2017, APPL THERMAL E UNPUB; Matusu R, 2011, T I MEAS CONTROL, V33, P274, DOI 10.1177/0142331210361409; Matuu R., 2013, INT J CIRCUITS SYSTE, V7, P26; Miller K.S., 1993, INTRO FRACTIONAL CAL; Moornani KA, 2010, IET CONTROL THEORY A, V4, P2097, DOI 10.1049/iet-cta.2009.0485; Ostalczyk P, 2009, IFAC P VOLUMES, V42, P268; Perdikaris P, 2014, ANN BIOMED ENG, V42, P1012, DOI 10.1007/s10439-014-0970-3; Petras I., 2009, FRACT CALC APPL ANAL, V12, P269; Petras I, 2002, P INT CARP CONTR C M; Petras I, 2005, P INT C COMP CYB VIE; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Podlubny I., 1999, FRACTIONAL DIFFERENT; Radwan AG, 2014, J ADV RES, V5, P125, DOI 10.1016/j.jare.2013.01.003; Sabatier J., 2007, ADV FRACTIONAL CALCU; Senol B, 2012, P 5 IFAC WORKSH FRAC; Senol B., 2012, P 2012 IEEE INT C CO; Senol B, 2014, ISA T, V53, P189, DOI 10.1016/j.isatra.2013.09.004; Senol B, 2013, J FRANKLIN I, V350, P1908, DOI 10.1016/j.jfranklin.2013.05.010; Sheng H, 2012, FRACTIONAL PROCESSES AND FRACTIONAL-ORDER SIGNAL PROCESSING: TECHNIQUES AND APPLICATIONS, P1, DOI 10.1007/978-1-4471-2233-3; Silva MF, 2004, NONLINEAR DYNAM, V38, P417, DOI 10.1007/s11071-004-3770-8; Skogestad S., 2005, MULTIVARIABLE FEEDBA; Tan N, 2009, ISA T, V48, P166, DOI 10.1016/j.isatra.2009.01.002; Yeroglu C, 2013, SYST CONTROL LETT, V62, P845, DOI 10.1016/j.sysconle.2013.06.005; Yeroglu C, 2011, ISA T, V50, P461, DOI 10.1016/j.isatra.2011.03.004; Yeroglu C, 2010, INT J CONTROL AUTOM, V8, P1009, DOI 10.1007/s12555-010-0510-3; Yin C, 2015, APPL MATH COMPUT, V269, P351, DOI 10.1016/j.amc.2015.07.059; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066	70	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180274	10.1371/journal.pone.0180274	http://dx.doi.org/10.1371/journal.pone.0180274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662173	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300136
J	Men, QL; Xue, GX; Mu, D; Hu, QL; Huang, MY				Men, Qiulei; Xue, Guoxi; Mu, Dan; Hu, Qingling; Huang, Minyi			Mitochondrial DNA markers reveal high genetic diversity and strong genetic differentiation in populations of Dendrolimus kikuchii Matsumura (Lepidoptera: Lasiocampidae)	PLOS ONE			English	Article							MOTH LEPIDOPTERA; CODLING MOTH; TORTRICIDAE; FLOW; L.; APPLE; RATES	Dendrolimus kikuchii Matsumura, 1927 is a serious forest pest causing great damage to coniferous trees in China. Despite its economic importance, the population genetics of this pest are poorly known. We used three mitochondrial genes (COI, COII and Cytb) to investigate the genetic diversity and genetic differentiation of 15 populations collected from the main distribution regions of D. kikuchii in China. Populations show high haplotype and nucleotide diversity. Haplotype network and phylogenetic analysis divides the populations into three major clades, the central and southeastern China (CC+SEC) clade, the eastern China (EC) clade, and the southwestern China (SWC) clade. Populations collected from adjacent localities share the same clade, which is consistent with the strong relationship of isolation by distance (r = 0.74824, P = 0.00001). AMOVA analysis indicated that the major portion of this molecular genetic variation is found among the three groups of CC+ SEC, EC and SWC (61.26%). Of 105 pairwise FST comparisons, 93 show high genetic differentiation. Populations of Puer (PE), Yangshuo (YS) and Leishan (LS) are separated from other populations by a larger genetic distance. Distributions of pairwise differences obtained with single and combined gene data from the overall populations are multimodal, suggesting these populations had no prior population expansion in southern China. The nonsignificant neutral test on the basis of Tajima' D and Fu's Fs, and the lack of a star-shaped haplotype network together with the multiple haplotypes support this hypothesis. Pleistocene climatic fluctuations, combined with the host specificity to Pinus species, made these regions of south China into a refuge for D. kikuchii. The high level of population genetic structuring is related to their weak flight capacity, their variations of life history and the geographic distance among populations.	[Men, Qiulei; Mu, Dan; Huang, Minyi] Anqing Normal Univ, Sch Life Sci, Res Ctr Aquat Organism Conservat & Water Ecosyst, Prov Key Lab Biodivers Study & Ecol Conservat Sou, Anqing, Anhui, Peoples R China; [Xue, Guoxi] Zhengzhou Univ Light Ind, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China; [Hu, Qingling] Weinan Normal Univ, Sch Chem & Environm, Weinan, Shaanxi, Peoples R China	Anqing Normal University; Zhengzhou University of Light Industry; Weinan Normal University	Men, QL (corresponding author), Anqing Normal Univ, Sch Life Sci, Res Ctr Aquat Organism Conservat & Water Ecosyst, Prov Key Lab Biodivers Study & Ecol Conservat Sou, Anqing, Anhui, Peoples R China.	menqiulei888@126.com		Mu, Dan/0000-0001-5416-9723; Qu, Yi/0000-0002-9993-8810	National Natural Science Foundation of China [31300551]; Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province [20160235]; Special Fondation for Young Scientist of Weinan Normal University [15ZRRC03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province; Special Fondation for Young Scientist of Weinan Normal University	Funded by agrant from the National Natural Science Foundation of China (31300551), the Young Talent Support Program from the Association for Science and Technology of Colleges in Shaanxi Province (20160235), and the Special Fondation for Young Scientist of Weinan Normal University (15ZRRC03).	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Boivin T, 2004, BIOL J LINN SOC, V83, P341, DOI 10.1111/j.1095-8312.2004.00392.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; Calcagno V, 2007, J EVOLUTION BIOL, V20, P1720, DOI 10.1111/j.1420-9101.2007.01391.x; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Chen MH, 2010, B ENTOMOL RES, V100, P75, DOI 10.1017/S0007485309006786; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Du YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157609; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089873; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hou T., 1987, PINE CATERPILLARS CH; Huang QB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067294; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Li Y, 2015, B ENTOMOL RES, V105, P485, DOI 10.1017/S0007485315000334; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Men QL, 2013, BIOL INVASIONS, V15, P447, DOI 10.1007/s10530-012-0299-5; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; Myers CT, 2006, J ECON ENTOMOL, V99, P1299, DOI 10.1603/0022-0493-99.4.1299; Nason JD, 2002, EVOLUTION, V56, P1475, DOI 10.1111/j.0014-3820.2002.tb01459.x; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosetti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040807; Shen L, 2002, ACTA ECOLOGY SINICA, V22, P1985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timm AE, 2006, J ECON ENTOMOL, V99, P341, DOI 10.1603/0022-0493-99.2.341; Tong Q, 2009, J ANHUI AGR SCI, V37, P13122; Wang J, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev063; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weng HongBiao, 2008, Scientia Silvae Sinicae, V44, P164; WRIGHT S, 1978, P580; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang AB, 2004, CHINESE BULL ENTOMOL, V2, P146, DOI DOI 10.3969/j.issn.0452-8255.2004.02.011; Zheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078476	47	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179706	10.1371/journal.pone.0179706	http://dx.doi.org/10.1371/journal.pone.0179706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662066	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300043
J	Weng, SL; Kao, HJ; Huang, CH; Lee, TY				Weng, Shun-Long; Kao, Hui-Ju; Huang, Chien-Hsun; Lee, Tzong-Yi			MDD-Palm: Identification of protein S-palmitoylation sites with substrate motifs based on maximal dependence decomposition	PLOS ONE			English	Article							PHOSPHORYLATION SITES; SECONDARY STRUCTURE; WEB SERVER; CSS-PALM; PREDICTION; RESOURCE; TRAFFICKING; ASSOCIATION; STABILITY; STRATEGY	S-palmitoylation, the covalent attachment of 16-carbon palmitic acids to a cysteine residue via a thioester linkage, is an important reversible lipid modification that plays a regulatory role in a variety of physiological and biological processes. As the number of experimentally identified S-palmitoylated peptides increases, it is imperative to investigate substrate motifs to facilitate the study of protein S-palmitoylation. Based on 710 non homologous S-palmitoylation sites obtained from published databases and the literature, we carried out a bioinformatics investigation of S-palmitoylation sites based on amino acid composition. Two Sample Logo indicates that positively charged and polar amino acids surrounding S-palmitoylated sites may be associated with the substrate site specificity of protein S-palmitoylation. Additionally, maximal dependence decomposition (MDD) was applied to explore the motif signatures of S-palmitoylation sites by categorizing a large-scale dataset into subgroups with statistically significant conservation of amino acids. Single features such as amino acid composition (AAC), amino acid pair composition (AAPC), position specific scoring matrix (PSSM), position weight matrix (PWM), amino acid substitution matrix (BLOSUM62), and accessible surface area (ASA) were considered, along with the effectiveness of incorporating MDD-identified substrate motifs into a two-layered prediction model. Evaluation by five-fold cross-validation showed that a hybrid of AAC and PSSM performs best at discriminating between S-palmitoylation and non-S-palmitoylation sites, according to the support vector machine (SVM). The two-layered SVM model integrating MDD-identified substrate motifs performed well, with a sensitivity of 0.79, specificity of 0.80, accuracy of 0.80, and Matthews Correlation Coefficient (MCC) value of 0.45. Using an independent testing dataset (613 S-palmitoylated and 5412 non-S-palmitoylated sites) obtained from the literature, we demonstrated that the two-layered SVM model could outperform other prediction tools, yielding a balanced sensitivity and specificity of 0.690 and 0.694, respectively. This two-layered SVM model has been implemented as a web-based system (MDD-Palm), which is now freely available at	[Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Weng, Shun-Long] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Kao, Hui-Ju; Huang, Chien-Hsun; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan; [Huang, Chien-Hsun] Tao Yuan Hosp, Minist Hlth & Welf, Taoyuan, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Yuan Ze University; Yuan Ze University	Huang, CH; Lee, TY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan.; Huang, CH (corresponding author), Tao Yuan Hosp, Minist Hlth & Welf, Taoyuan, Taiwan.; Lee, TY (corresponding author), Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan.	lithsunh@gmail.com; francis@saturn.yzu.edu.tw			Ministry of Science and Technology (MOST) of Taiwan [103-2221-E-155-020-MY3, MOST 104-2221-E-155-036-MY2]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology (MOST) of Taiwan under the contract numbers of 103-2221-E-155-020-MY3 and MOST 104-2221-E-155-036-MY2 to TYL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berchtold LA, 2011, P NATL ACAD SCI USA, V108, pE681, DOI 10.1073/pnas.1104384108; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bretana NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040694; Bui VM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2299-1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Chen YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118752; Chen YJ, 2015, NUCLEIC ACIDS RES, V43, pD503, DOI 10.1093/nar/gku1176; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hsu JBK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027567; Hu LL, 2011, BIOCHIMIE, V93, P489, DOI 10.1016/j.biochi.2010.10.022; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang KY, 2016, NUCLEIC ACIDS RES, V44, pD435, DOI 10.1093/nar/gkv1240; Huang KY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S10; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021849; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Li SY, 2015, J CHEM INF MODEL, V55, P2015, DOI 10.1021/acs.jcim.5b00276; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lu CT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/528650; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Shi SP, 2013, J MOL GRAPH MODEL, V40, P125, DOI 10.1016/j.jmgm.2012.12.006; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Bui VM, 2016, BIOINFORMATICS, V32, P165, DOI 10.1093/bioinformatics/btv558; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu HY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S1; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	62	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179529	10.1371/journal.pone.0179529	http://dx.doi.org/10.1371/journal.pone.0179529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662047	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300030
J	Yu, CF; Li, HF; Zhang, QN; He, HY; Chen, XH; Hua, ZY				Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu			Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011	PLOS ONE			English	Article							WEIGHT-LOSS; NEONATAL HYPERBILIRUBINEMIA; EXTREME HYPERBILIRUBINEMIA; BREAST	Objectives This study was intended to explore the etiology and risk factors of severe neonatal hyperbilirubinemia and to analyze the adverse events associated with ECT (Exchange Transfusion), as well as to identify the factors related to the poor prognosis. Methods All of the full-term neonates who had undergone ECT for hyperbilirubinemia at Children's Hospital of Chongqing Medical University from January 2001 to December 2011 were enrolled in this study. General demographic characteristics, comorbidities, pre- and post-exchange TSB(Total Serum Bilirubin) levels, duration and frequency of ECT, and clinical outcomes were recorded and analyzed anonymously. Results Of 614 total infants, 368 patients (59.9%) with ABO incompatibility were identified, of whom 197 (53.5%) developed acute bilirubin encephalopathy (ABE) and 16 (4.3%) suffered a poor prognosis. The etiology was unidentified in 103 patients (16.8%), of whom 62 (60.1%) developed ABE and 9 (8.7%) had a poor prognosis. Identified adverse events secondary to ECT included thrombocytopenia (54.6%), hyperglycemia (42.8%), apnea (3.3%) and necrotizing enterocolitis (NEC) (1.3%). No ECT-related mortality was documented in this study. Conclusions The etiology, peak TSB level before ECT, and time of ECT had a significant impact on the outcome of severe neonatal hyperbilirubinemia. ABO incompatibility was the most common cause of extreme neonatal hyperbilirubinemia. Pathological weight loss could be involved in the development of extreme hyperbilirubinemia with an unidentified cause.	[Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Yu, Canfeng; Li, Huifan; Zhang, Qiannan; He, Huayun; Chen, Xinhong; Hua, Ziyu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Yu, Canfeng] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Li, Huifan; Hua, Ziyu] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China.	h_ziyu@126.com		zhang, qiannan/0000-0002-6583-0430	National Key Clinical Specialist Construction Programs of China-Neonatology [2011873]; Chongqing Science and Technology Commission [cstc2013jcyjA10020]	National Key Clinical Specialist Construction Programs of China-Neonatology; Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC)	This research is supported by the grant from National Key Clinical Specialist Construction Programs of China-Neonatology (GrantNo. 2011873) and Chongqing Science and Technology Commission (Grant No. cstc2013jcyjA10020)	American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Babu TA, 2012, INDIAN J PEDIATR, V79, P202, DOI 10.1007/s12098-011-0501-2; Campistol J, 2012, NEUROLOGIA, V27, P202, DOI 10.1016/j.nrl.2010.03.013; Chang RJ, 2012, PEDIATR NEONATOL, V53, P41, DOI 10.1016/j.pedneo.2011.11.008; Chen HN, 2008, PEDIATRICS, V122, pE905, DOI 10.1542/peds.2008-0249; Cheng Shao-Wen, 2012, Chang Gung Med J, V35, P148; Christensen RD, 2013, BLOOD CELL MOL DIS, V50, P105, DOI 10.1016/j.bcmd.2012.10.004; Davutoglu M, 2010, TURKISH J PEDIATR, V52, P163; Ding GF, 2000, CHIN J PEDIAT, V38, P624; Du CS, 2000, CHIN J HEMATOL, V21, P174; Duman N, 2004, ACTA PAEDIATR, V93, P361, DOI 10.1080/08035250310007475; Ebbesen F, 2005, ACTA PAEDIATR, V94, P59, DOI 10.1080/08035250410022170; Flaherman VJ, 2013, ARCH DIS CHILD-FETAL, V98, pF488, DOI 10.1136/archdischild-2012-303076; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; Katar S, 2008, J CHILD NEUROL, V23, P415, DOI 10.1177/0883073807309780; Lam S T, 2002, SE ASIAN J TROP MED, V34, P73; Li QP, 2006, J APPL CLIN PEDIAT, V21, P958; Macdonald PD, 2003, ARCH DIS CHILD-FETAL, V88, pF472, DOI 10.1136/fn.88.6.F472; PALMER DC, 1983, AUST PAEDIATR J, V19, P86; Sakha SH, 2010, TURKISH J PEDIATR, V52, P367; Saluja S, 2010, INT J PEDIATR OTORHI, V74, P1292, DOI 10.1016/j.ijporl.2010.08.007; Sgro M, 2011, J PERINATOL, V31, P392, DOI 10.1038/jp.2010.137; Subspecialty Group of Neonatology Society of Pediatrics Chinese Medical Association, 2012, Zhonghua Er Ke Za Zhi, V50, P331; Wang X. M., 2016, INT J CHEM ENG, V2016, P1, DOI DOI 10.3852/16-100; Xiao M, 2011, PRACTICAL NEONATOLOG, P296; Zhuang Yan, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P332	26	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179550	10.1371/journal.pone.0179550	http://dx.doi.org/10.1371/journal.pone.0179550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662083	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300033
J	Suarez, SE; Brookfield, ME; Catlos, EJ; Stockil, DF				Suarez, Stephanie E.; Brookfield, Michael E.; Catlos, Elizabeth J.; Stockil, Daniel F.			A U-Pb zircon age constraint on the oldest recorded air-breathing land animal	PLOS ONE			English	Article							MIDLAND VALLEY	The oldest-known air-breathing land animal is the millipede Pneumodesmus newmani, found in the Cowie Harbour Fish Bed at Stonehaven, Scotland. Here we report the youngest, most concordant U-238- -Pb-206 zircon age from ash below the fish bed of 413.7 +/- 4.4 Ma (+/- 2 sigma), whereas the youngest age from a tuffaceous sandstone above the fish bed is statistically indistinguishable at 414.3 +/- 7.1 Ma. The Cowie Harbour Fish Bed thus appears to be lowermost Devonian (Lochkovian), contrary to the previously accepted mid-Silurian age based on palynomorphs from adjacent exposures. This has implications for the evolutionary timetable of land colonization, as the Cowie ages overlap late Lochkovian zircon ages reported elsewhere for andesite below the nearby (similar to 50 ml) Rhynie Chert, which has more advanced terrestrial biota. The results postdate the possible late Silurian Ludford Lane locality in Shropshire, England. Pneumodesmus newmani is thus not the earliest air-breathing land animal, unless the Ludford Lane locality is younger than presently assigned.	[Suarez, Stephanie E.; Catlos, Elizabeth J.; Stockil, Daniel F.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA; [Brookfield, Michael E.] Univ Massachusetts, Environm Earth & Ocean Sci, Boston, MA 02125 USA	University of Texas System; University of Texas Austin; University of Massachusetts System; University of Massachusetts Boston	Catlos, EJ (corresponding author), Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA.	ejcatlos@jsg.utexas.edu	Catlos, Elizabeth/AAA-7884-2021	Catlos, Elizabeth/0000-0001-6043-3498; Suarez, Stephanie/0000-0002-1647-0221	Geological Society of America South Central Section	Geological Society of America South Central Section	Funding was provided to Stephanie Suarez from the Geological Society of America South Central Section. This was an undergraduate research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SCOTT OUTD ACC COS; Bowring S. A., 2006, PALEONTOLOGICAL SOC, V11, P23; Browne MAE, 2002, BRIT GEOLOGICAL SURV, V67, P1; Cohen KM, 2004, ICS INT CHRONOSTRATI, V36, P199; Davies NS, 2005, NORW J GEOL, V85, P193; DINELEY DL, 1999, FOSSIL FISHES GREAT; Guillong M, 2014, J ANAL ATOM SPECTROM, V29, P963, DOI 10.1039/c4ja00009a; HALLERMEIER RJ, 1981, SEDIMENTOLOGY, V28, P859, DOI 10.1111/j.1365-3091.1981.tb01948.x; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; JERAM AJ, 1990, SCIENCE, V250, P658, DOI 10.1126/science.250.4981.658; Kirkland CL, 2015, LITHOS, V212, P397, DOI 10.1016/j.lithos.2014.11.021; Lavender K, 2002, REV PALAEOBOT PALYNO, V118, P157, DOI 10.1016/S0034-6667(01)00112-9; MARSHALL JEA, 1991, GEOL MAG, V128, P283, DOI 10.1017/S0016756800022135; MARSHALL JEA, 1994, J GEOL SOC LONDON, V151, P425, DOI 10.1144/gsjgs.151.3.0425; Parry SF, 2011, J GEOL SOC LONDON, V168, P863, DOI 10.1144/0016-76492010-043; Scottish Earth Science Education Forum, 2009, EARTH SCI OUTD TEACH; Selden Paul, 2008, Bulletin of the British Myriapod and Isopod Group, V23, P36; Shear W. A., 1998, AM MUS NOVIT, V3231, P1; Slama J, 2008, CHEM GEOL, V249, P1, DOI 10.1016/j.chemgeo.2007.11.005; Smith AG, 2015, GEOL SOC SPEC PUBL, V404, P37, DOI 10.1144/SP404.8; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Suzuki Y., 2013, EARTH PLANETS SPACE, P65, DOI DOI 10.5047/EPS.2013.03.009; Wellman C.H., 1993, J MICROPALAEONTOL, V12, P47, DOI [10.1144/jm.12.1.47, DOI 10.1144/JM.12.1.47]; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2	24	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179262	10.1371/journal.pone.0179262	http://dx.doi.org/10.1371/journal.pone.0179262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658320	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900018
J	Wong, YQ; Tan, LK; Seow, P; Tan, MP; Abd Kadir, KA; Vijayananthan, A; Ramli, N				Wong, Yoke Queen; Tan, Li Kuo; Seow, Pohchoo; Tan, Maw Pin; Abd Kadir, Khairul Azmi; Vijayananthan, Anushya; Ramli, Norlisah			Microstructural integrity of white matter tracts amongst older fallers: A DTI study	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; BLOOD-PRESSURE; GAIT; AGE; BRAIN; HYPERINTENSITIES; ABNORMALITIES; DISORDERS	Objectives This study assesses the whole brain microstructural integrity of white matter tracts (WMT) among older individuals with a history of falls compared to non-fallers. Methods 85 participants (43 fallers, 42 non-fallers) were evaluated with conventional MRI and diffusion tensor imaging (DTI) sequences of the brain. DTI metrics were obtained from selected WMT using tract-based spatial statistics (TBSS) method. This was followed by binary logistic regression to investigate the clinical variables that could act as confounding elements on the outcomes. The TBSS analysis was then repeated, but this time including all significant predictor variables from the regression analysis as TBSS covariates. Results The mean diffusivity (MD) and axial diffusivity (AD) and to a lesser extent radial diffusivity (RD) values of the projection fibers and commissural bundles were significantly different in fallers (p < 0.05) compared to non-fallers. However, the final logistic regression model obtained showed that only functional reach, white matter lesion volume, hypertension and orthostatic hypotension demonstrated statistical significant differences between fallers and non-fallers. No significant differences were found in the DTI metrics when taking into account age and the four variables as covariates in the repeated analysis. Conclusion This DTI study of 85 subjects, do not support DTI metrics as a singular factor that contributes independently to the fall outcomes. Other clinical and imaging factors have to be taken into account.	[Wong, Yoke Queen; Tan, Li Kuo; Seow, Pohchoo; Abd Kadir, Khairul Azmi; Vijayananthan, Anushya; Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Dept Biomed Imaging, Fac Med, Kuala Lumpur, Malaysia; [Wong, Yoke Queen] Hosp Selayang, Dept Diagnost Imaging, Batu Caves, Selangor, Malaysia; [Tan, Maw Pin] Univ Malaya, Med Ctr, Dept Geriatr Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ramli, N (corresponding author), Univ Malaya, Res Imaging Ctr, Dept Biomed Imaging, Fac Med, Kuala Lumpur, Malaysia.	norlisahramli@gmail.com	RAMLI, NORLISAH MOHD/G-5209-2010; Vijayananthan, Anushya/C-8025-2014; Seow, Pohchoo/AAP-6940-2020; ABD KADIR, KHAIRUL AZMI/AAC-7007-2022; Tan, Li Kuo/B-5494-2010; Tan, Maw Pin/G-6917-2011	RAMLI, NORLISAH MOHD/0000-0001-7497-8093; Vijayananthan, Anushya/0000-0001-6341-329X; Tan, Li Kuo/0000-0002-6912-172X; Tan, Maw Pin/0000-0002-3400-8540	UNIVERSITY OF MALAYARESEARCH GRANT (UMRG) [RP008A-13HTM]	UNIVERSITY OF MALAYARESEARCH GRANT (UMRG)	This study was made possible with financial assistance from the UNIVERSITY OF MALAYARESEARCH GRANT (UMRG), grant reference number RP008A-13HTM. The URLs of the funders: https://umresearch.um.edu.my/ download/research-grants/internal-grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alves GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/291658; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Axer H, 2010, CLIN NEUROL NEUROSUR, V112, P265, DOI 10.1016/j.clineuro.2009.12.015; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Ballard C, 2000, ANN NY ACAD SCI, V903, P442, DOI 10.1111/j.1749-6632.2000.tb06396.x; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Bloem BR, 2003, CURR OPIN NEUROL, V16, P15, DOI 10.1097/00019052-200302000-00003; Bruijn SM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00104; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Colloby SJ, 2011, BRIT J PSYCHIAT, V199, P404, DOI 10.1192/bjp.bp.110.090423; de Laat KF, 2011, STROKE, V42, P373, DOI 10.1161/STROKEAHA.110.596502; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Englander F, 1996, J FORENSIC SCI, V41, P733; Gaser's C., STRUCT BRAIN MAPP GR; Griebe M, 2011, J NEUROL, V258, P1451, DOI 10.1007/s00415-011-5956-6; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Iseki Kazumi, 2015, J Clin Mov Disord, V2, P1, DOI 10.1186/s40734-014-0011-2; Kafri M, 2012, J NEUROIMAGING, P39; Koo BB, 2012, ARCH NEUROL-CHICAGO, V69, P733, DOI 10.1001/archneurol.2011.2272; Lee SJ, 2009, ARCH GERONTOL GERIAT, V49, P255, DOI 10.1016/j.archger.2008.09.005; Lesion Segmentation Toolbox (LST), STRUCT BRAIN MAPP GR; Lord SR, 2007, FALLS IN OLDER PEOPLE: RISK FACTORS AND STRATEGIES FOR PREVENTION, 2ND EDITION, P1, DOI 10.1017/CBO9780511722233; Maldjian JA, 2013, AM J NEURORADIOL, V34, P2265, DOI 10.3174/ajnr.A3590; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Oh YS, 2013, J MOV DISORD, V6, P23, DOI 10.14802/jmd.13006; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tan MP, 2016, GERIATR GERONTOL INT, V16, P111, DOI 10.1111/ggi.12446; Tan PJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-78; TBSS, FMRIB SOFTW LIB V5 0; Veeramuthu V, 2015, J NEUROTRAUM, V13, P1; Vercruysse S, 2015, MOVEMENT DISORD, V30, P567, DOI 10.1002/mds.26130; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Zia A, 2015, POSTGRAD MED, V127, P186, DOI 10.1080/00325481.2015.996505	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179895	10.1371/journal.pone.0179895	http://dx.doi.org/10.1371/journal.pone.0179895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658309	gold, Green Published, Green Submitted			2022-12-26	WOS:000404607900046
J	Wu, MY; Mead, ME; Kim, SC; Rokas, A; Yu, JH				Wu, Ming-Yueh; Mead, Matthew E.; Kim, Sun-Chang; Rokas, Antonis; Yu, Jae-Hyuk			WetA bridges cellular and chemical development in Aspergillus flavus	PLOS ONE			English	Article							ASEXUAL SPORULATION; GENE ONTOLOGY; SECONDARY METABOLISM; PROTEIN FAMILIES; DISTINCT STAGES; BLUE-LIGHT; NIDULANS; ABAA; BRLA; CONIDIOGENESIS	Bridging cellular reproduction and survival is essential for all life forms. Aspergillus fungi primarily reproduce by forming asexual spores called conidia, whose formation and maturation is governed by the central genetic regulatory circuit BrlA -> AbaA -> WetA. Here, we report that WetA is a multi-functional regulator that couples spore differentiation and survival, and governs proper chemical development in Aspergillus flavus. The deletion of wetA results in the formation of conidia with defective cell walls and no intra-cellular trehalose, leading to reduced stress tolerance, a rapid loss of viability, and disintegration of spores. WetA is also required for normal vegetative growth, hyphal branching, and production of aflatoxins. Targeted and genome-wide expression analyses reveal that WetA exerts feedback control of brlA and that 5,700 genes show altered mRNA levels in the mutant conidia. Functional category analyses of differentially expressed genes in Delta wetA RNA-seq data indicate that WetA contributes to spore integrity and maturity by properly regulating the metabolic pathways of trehalose, chitin, alpha-(1,3)-glucan, beta-(1,3)-glucan, melanin, hydrophobins, and secondary metabolism more generally. Moreover, 160 genes predicted to encode transcription factors are differentially expressed by the absence of wetA, suggesting that WetA may play a global regulatory role in conidial development. Collectively, we present a comprehensive model for developmental control that bridges spore differentiation and survival in A. flavus.	[Wu, Ming-Yueh; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Wu, Ming-Yueh; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Mead, Matthew E.; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022; Rokas, Antonis/A-9775-2008; Wu, Ming-Yueh/J-7199-2019; Yu, Jae-Hyuk/A-2343-2008	Rokas, Antonis/0000-0002-7248-6551; Wu, Ming-Yueh/0000-0002-2479-3709; Yu, Jae-Hyuk/0000-0002-6530-8407; Mead, Matthew/0000-0001-9195-7585	Hatch [WIS01665, WIS01889]; Intelligent Synthetic Biology Center of Global Frontier Projects [2015M3A6A8065838]	Hatch(United States Department of Agriculture (USDA)); Intelligent Synthetic Biology Center of Global Frontier Projects	This work was supported by Hatch (WIS01665 and WIS01889) to JHY and the Intelligent Synthetic Biology Center of Global Frontier Projects (2015M3A6A8065838) to SCK and JHY. The sponsors or funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Affeldt KJ, 2014, MBIO, V5, DOI 10.1128/mBio.01501-14; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Bieszke JA, 2007, CURR GENET, V52, P149, DOI 10.1007/s00294-007-0148-8; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CHANG YC, 1993, GENETICS, V133, P29; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Ebbole DJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P577; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Grice CM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00026; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klich MA, 1988, LAB GUIDE COMMON ASP; Li F, 2015, APPL MICROBIOL BIOT, V99, P827, DOI 10.1007/s00253-014-6124-6; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; LILLEHOJ EB, 1967, EXPERIENTIA, V23, P187, DOI 10.1007/BF02136277; Lind AL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005096; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MARTINELLI SD, 1971, J GEN MICROBIOL, V69, P261, DOI 10.1099/00221287-69-2-261; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ogawa M, 2010, FUNGAL GENET BIOL, V47, P10, DOI 10.1016/j.fgb.2009.10.004; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Payne G.A., 1998, MYCOTOXINS AGR FOOD, P279; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; PRADE RA, 1994, MOL GEN GENET, V244, P539, DOI 10.1007/BF00583905; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; SEWALL TC, 1994, CAN J MICROBIOL, V40, P1035, DOI 10.1139/m94-164; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin KS, 2015, BIOCHEM BIOPH RES CO, V463, P428, DOI 10.1016/j.bbrc.2015.05.090; Son H, 2014, EUKARYOT CELL, V13, P87, DOI 10.1128/EC.00220-13; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TIMBERLAKE WE, 1993, PLANT CELL, V5, P1453; TIMBERLAKE WE, 1987, A VAN LEEUW J MICROB, V53, P317, DOI 10.1007/BF00400554; TIMBERLAKE WE, 1990, ANNU REV GENET, V24, P5, DOI 10.1146/annurev.ge.24.120190.000253; Udomkun P, 2017, FOOD CONTROL, V76, P127, DOI 10.1016/j.foodcont.2017.01.008; Wang MS, 2015, RES MICROBIOL, V166, P56, DOI 10.1016/j.resmic.2014.12.003; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	68	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179571	10.1371/journal.pone.0179571	http://dx.doi.org/10.1371/journal.pone.0179571			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658268	gold, Green Submitted, Green Published			2022-12-26	WOS:000404607900032
J	Mandage, R; Telford, M; Rodriguez, JA; Farre, X; Layouni, H; Marigorta, UM; Cundiff, C; Heredia-Genestar, JM; Navarro, A; Santpere, G				Mandage, Rajendra; Telford, Marco; Antonio Rodriguez, Juan; Farre, Xavier; Layouni, Hafid; Marigorta, Urko M.; Cundiff, Caitlin; Maria Heredia-Genestar, Jose; Navarro, Arcadi; Santpere, Gabriel			Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; DICKKOPF FAMILY; RISK-FACTORS; ASSOCIATION; DNA; SUSCEPTIBILITY; VISUALIZATION; DETERMINANTS; NEUREGULIN-1	Epstein-Barr virus (EBV), human herpes virus 4, has been classically associated with infectious mononucleosis, multiple sclerosis and several types of cancers. Many of these diseases show marked geographical differences in prevalence, which points to underlying genetic and/or environmental factors. Those factors may include a different susceptibility to EBV infection and viral copy number among human populations. Since EBV is commonly used to transform B-cells into lymphoblastoid cell lines (LCLs) we hypothesize that differences in EBV copy number among individual LCLs may reflect differential susceptibility to EBV infection. To test this hypothesis, we retrieved whole-genome sequenced EBV-mapping reads from 1,753 LCL samples derived from 19 populations worldwide that were sequenced within the context of the 1000 Genomes Project. An in silico methodology was developed to estimate the number of EBV copy number in LCLs and validated these estimations by real-time PCR. After experimentally confirming that EBV relative copy number remains stable over cell passages, we performed a genome wide association analysis (GWAS) to try detecting genetic variants of the host that may be associated with EBV copy number. Our GWAS has yielded several genomic regions suggestively associated with the number of EBV genomes per cell in LCLs, unraveling promising candidate genes such as CAND1, a known inhibitor of EBV replication. While this GWAS does not unequivocally establish the degree to which genetic makeup of individuals determine viral levels within their derived LCLs, for which a larger sample size will be needed, it potentially highlighted human genes affecting EBV-related processes, which constitute interesting candidates to follow up in the context of EBV related pathologies.	[Mandage, Rajendra; Telford, Marco; Antonio Rodriguez, Juan; Farre, Xavier; Layouni, Hafid; Marigorta, Urko M.; Maria Heredia-Genestar, Jose; Navarro, Arcadi; Santpere, Gabriel] Univ Pompeu Fabra, PRBB, Dept Ciencies Expt & Salut, Inst Evolutionary Biol UPF CSIC, Barcelona, Catalonia, Spain; [Layouni, Hafid] ESCI UPF, Bioinformat Studies, Pg Pujades 1, Barcelona, Spain; [Marigorta, Urko M.; Cundiff, Caitlin] Georgia Inst Technol, Dept Biol, Atlanta, GA 30332 USA; [Navarro, Arcadi] Natl Inst Bioinformat INB, PRBB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] ICREA, PRBB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] CRG, PRBB, Barcelona, Catalonia, Spain; [Santpere, Gabriel] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University System of Georgia; Georgia Institute of Technology; Pompeu Fabra University; ICREA; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Yale University	Navarro, A; Santpere, G (corresponding author), Univ Pompeu Fabra, PRBB, Dept Ciencies Expt & Salut, Inst Evolutionary Biol UPF CSIC, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), Natl Inst Bioinformat INB, PRBB, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), ICREA, PRBB, Barcelona, Catalonia, Spain.; Navarro, A (corresponding author), CRG, PRBB, Barcelona, Catalonia, Spain.; Santpere, G (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.	arcadi.navarro@upf.edu; gabrielsantperebaro@gmail.com	Ramon, Xavier Farre/AAH-7226-2019; Santpere, Gabriel/I-9437-2014; Rodriguez, Juan Antonio/GQP-1484-2022; Marigorta, Urko M/L-9512-2014	Santpere, Gabriel/0000-0001-5909-8637; Rodriguez, Juan Antonio/0000-0001-5195-315X; Farre Ramon, Xavier/0000-0001-6838-9479; Marigorta, Urko M/0000-0002-9087-6609; Heredia-Genestar, Jose Maria/0000-0002-7970-5016	Institute de Salud Carlos III [RD07/0060, F13/0001/0026]; Spanish Government [BFU2012-38236]; Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya [2014SGR1311]; FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo)	Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish Government(Spanish GovernmentEuropean Commission); Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya(Generalitat de Catalunya); FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo)	This work was supported by Institute de Salud Carlos III (ES) (RD07/0060); Spanish Government Grants (BFU2012-38236); Departament d'Innovacio, Universitats I Empresa, Generalitat de Catalunya (2014SGR1311); Institute de Salud Carlos III (F13/0001/0026); FEDER (Fondo Europeo de Desarrollo Regional)/FSE (Fondo Social Europeo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Caliskan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107166; Carter CJ, 2012, IMMUNOPHARM IMMUNOT, V34, P21, DOI 10.3109/08923973.2011.572262; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gastaldello S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003664; Gastaldello S, 2012, J MOL CELL BIOL, V4, P242, DOI 10.1093/jmcb/mjs012; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Hjalgrim H., 2007, EPIDEMIOLOGY EBV ITS; Hohaus S, 2011, CLIN CANCER RES, V17, P2885, DOI 10.1158/1078-0432.CCR-10-3327; Houldcroft CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108384; Houldcroft CJ, 2014, REV MED VIROLOGY; Hu N, GENOMIC LANDSCAPE SO, DOI [10.1158/0008-5472.CAN-15-0338, DOI 10.1158/0008-5472.CAN-15-0338]; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Jarrett RF, 2003, LEUKEMIA LYMPHOMA, V44, pS27, DOI 10.1080/10428190310001623801; Jha HC, 2016, PATHOGENS, P5; Kanakry JA, 2013, BLOOD, V121, P3547, DOI 10.1182/blood-2012-09-454694; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korzeniewski N, 2012, NEOPLASIA, V14, P799, DOI 10.1593/neo.12580; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Maurmann S, 2003, J CLIN MICROBIOL, V41, P5419, DOI 10.1128/JCM.41.12.5419-5428.2003; Mishra A, 2014, TWIN RES HUM GENET, V18, P1; Morris MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19533; Neparidze Natalia, 2014, Clin Adv Hematol Oncol, V12, P358; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Polakis P, 2000, GENE DEV, V14, P1837; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Gent M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003960; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wang T, 2010, BIOCH BIOPHYSICAL RE; Xiao JQ, 2008, VIROLOGY, V370, P430, DOI 10.1016/j.virol.2007.09.012; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yap LF, 2014, INT J ONCOL, V44, P1774, DOI 10.3892/ijo.2014.2342; Yuan Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07960; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu J, 2012, CARCINOGENESIS, V33, P2334, DOI 10.1093/carcin/bgs278	64	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179446	10.1371/journal.pone.0179446	http://dx.doi.org/10.1371/journal.pone.0179446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654678	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500013
J	Heermann, L; DeAngelis, DL; Borcherding, J				Heermann, Lisa; DeAngelis, Donald L.; Borcherding, Jost			A new mechanistic approach for the further development of a population with established size bimodality	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; THE-YEAR PERCH; ONTOGENIC NICHE SHIFTS; INTRASPECIFIC COMPETITION; PHENOTYPIC PLASTICITY; LARGEMOUTH BASS; FOOD RESOURCES; LIFE-HISTORY; MICROPTERUS-SALMOIDES; GROWTH TRAJECTORIES	Usually, the origin of a within-cohort bimodal size distribution is assumed to be caused by initial size differences or by one discrete period of accelerated growth for one part of the population. The aim of this study was to determine if more continuous pathways exist allowing shifts from the small to the large fraction within a bimodal age-cohort. Therefore, a Eurasian perch population, which had already developed a bimodal size-distribution and had differential resource use of the two size-cohorts, was examined. Results revealed that formation of a bimodal size-distribution can be a continuous process. Perch from the small size-cohort were able to grow into the large size-cohort by feeding on macroinvertebrates not used by their conspecifics. The diet shifts were accompanied by morphological shape changes. Intra-specific competition seemed to trigger the development towards an increasing number of large individuals. A stage-structured matrix model confirmed these assumptions. The fact that bimodality can be a continuous process is important to consider for the understanding of ecological processes and links within ecosystems.	[Heermann, Lisa; Borcherding, Jost] Univ Cologne, Inst Zool, Dept Gen Ecol, Cologne, Germany; [DeAngelis, Donald L.] US Geol Survey, Wetlands & Aquat Res Ctr, Gainesville, FL USA	University of Cologne; United States Department of the Interior; United States Geological Survey	Heermann, L (corresponding author), Univ Cologne, Inst Zool, Dept Gen Ecol, Cologne, Germany.	lisa.heermann@uni-koeln.de	Borcherding, Jost/A-1142-2011	Borcherding, Jost/0000-0003-3411-5861; Heermann, Lisa/0000-0003-4620-4087	German Research Foundation [DFG BO 1507/5-1, DFG BO 1507/5-2]; U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program [KA30CTF]; Greater Everglades Priority Ecosystem Science program	German Research Foundation(German Research Foundation (DFG)); U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program; Greater Everglades Priority Ecosystem Science program	The study was financially supported by the German Research Foundation (http://www.dfg.de) to JB (DFG BO 1507/5-1, 5-2) and by the U.S. Geological Survey's Greater Everglades Priority Ecosystems Science program (http://www.usgs.gov < http://www.usgs.gov >) to DLD (KA30CTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all helping hands in the field, and comments of Donald Schoolmaster of USGS. DLD was supported by the Greater Everglades Priority Ecosystem Science program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We also thank two anonymous reviewers for comments to an earlier version of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Beeck P, 2002, FRESHWATER BIOL, V47, P2359, DOI 10.1046/j.1365-2427.2002.01004.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcherding J, 2007, ECOL FRESHW FISH, V16, P198, DOI 10.1111/j.1600-0633.2006.00212.x; Borcherding J, 2010, J ANIM ECOL, V79, P1101, DOI 10.1111/j.1365-2656.2010.01704.x; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CRAIG JF, 1979, J ANIM ECOL, V48, P315, DOI 10.2307/4116; DEANGELIS DL, 1982, T AM FISH SOC, V111, P384, DOI 10.1577/1548-8659(1982)111<384:GOBSDI>2.0.CO;2; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Estlander S, 2017, ECOL EVOL, V7, P665, DOI 10.1002/ece3.2658; Garcia-Berthou E, 2002, INT REV HYDROBIOL, V87, P353, DOI 10.1002/1522-2632(200207)87:4<353::AID-IROH353>3.0.CO;2-N; Heermann L, 2007, J FISH BIOL, V70, P1365, DOI 10.1111/j.1095-8649.2007.01417.x; Heermann L, 2013, J APPL ICHTHYOL, V29, P549, DOI 10.1111/jai.12044; Heermann L, 2013, FISHERIES MANAG ECOL, V20, P187, DOI 10.1111/fme.12000; Heermann L, 2009, ECOL FRESHW FISH, V18, P560, DOI 10.1111/j.1600-0633.2009.00371.x; Heermann L, 2014, ECOL FRESHW FISH, V23, P129, DOI 10.1111/eff.12060; Heibo E, 2005, ECOL FRESHW FISH, V14, P344, DOI 10.1111/j.1600-0633.2005.00108.x; Hjelm J, 2000, OECOLOGIA, V122, P190, DOI 10.1007/PL00008846; Huss M, 2008, OECOLOGIA, V158, P249, DOI 10.1007/s00442-008-1140-9; Huss M, 2013, FRESHWATER BIOL, V58, P1416, DOI 10.1111/fwb.12138; Huss M, 2010, OIKOS, V119, P2000, DOI 10.1111/j.1600-0706.2010.18454.x; HUSTON MA, 1987, AM NAT, V129, P678, DOI 10.1086/284666; JUANES F, 1994, J FISH BIOL, V45, P41, DOI 10.1111/j.1095-8649.1994.tb01083.x; Klemetsen A, 2002, ENVIRON BIOL FISH, V64, P39, DOI 10.1023/A:1016062421601; Knudsen R, 2016, HYDROBIOLOGIA, V783, P1, DOI 10.1007/s10750-016-2999-9; Melard C, 1996, J APPL ICHTHYOL, V12, P175, DOI 10.1111/j.1439-0426.1996.tb00085.x; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; Olsson J, 2005, EVOL ECOL RES, V7, P1109; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; Persson L., 1988, P203; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; Pfister CA, 2002, ECOLOGY, V83, P59; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Rennie MD, 2008, J ANIM ECOL, V77, P916, DOI 10.1111/j.1365-2656.2008.01412.x; Scharf WR, 2009, FISH RES, V96, P77, DOI 10.1016/j.fishres.2008.09.008; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tatrai I, 1997, HYDROBIOLOGIA, V345, P117, DOI 10.1023/A:1002919305978; Van Densen WLT, 1985, J APPL ICHTHYOL, V3, P119; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wintzer AP, 2005, ECOL FRESHW FISH, V14, P311, DOI 10.1111/j.1600-0633.2005.00105.x; Ziemba RE, 1999, OECOLOGIA, V120, P524, DOI 10.1007/s004420050886	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179339	10.1371/journal.pone.0179339	http://dx.doi.org/10.1371/journal.pone.0179339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650963	gold, Green Submitted, Green Published			2022-12-26	WOS:000404537300005
J	Hsueh, PT; Wang, HH; Liu, CL; Ni, WF; Chen, YL; Liu, JK				Hsueh, Pei-Tan; Wang, Hsuan-Han; Liu, Chiu-Lin; Ni, Wei-Fen; Chen, Ya-Lei; Liu, Jong-Kang			Expression of cerebral serotonin related to anxiety-like behaviors in C57BL/6 offspring induced by repeated subcutaneous prenatal exposure to low-dose lipopolysaccharide	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; BRAIN-DEVELOPMENT; DOPAMINE; MODEL; INFLAMMATION; SYSTEM; MODULATION; DISORDER; EPILEPSY; STRESS	Prenatal exposure to lipopolysaccharide (LPS), which likely occurs due to infection or contact with environmental allergens during pregnancy, is a proposed risk factor that induces anxiety-and autism spectrum disorder-like behaviors in offspring. However, the molecular and behavioral changes in offspring after maternal immune activation have not been completely identified. We hypothesized that a subcutaneous injection of LPS in a pregnant mouse would induce changes in cerebral serotonin (5-HT) in parallel to the appearance of anxiety-like behaviors in the dam's offspring. After LPS injections (total, 100 mu g/Kg), the time spent in the central region during the open field test and the number of times that the mice moved between the light and dark boxes and between the open and closed arms on the elevated plus maze test revealed anxiety-like behaviors in offspring at 5, 6 and 9 weeks of age. The mRNA expression levels of tph2 (5-HT synthesizing enzyme) and slc6a4 (5-HT transporter) were down-regulated in both adolescent (5 weeks of age) and adult (8 weeks of age) brains. Immunohistochemistry revealed that the numbers and sizes of tph2-expressing cells were notably decreased in the raphe nuclei of the midbrain of adults. Moreover, compared with controls (phosphate-buffered saline-treated offspring), the cerebral 5-HT concentration at adolescence and adulthood in LPS-induced offspring was significantly decreased. We concluded that maternal immune activation induced by exposure to a low dose of LPS decreased cerebral 5-HT levels in parallel to the down-regulation of the tph2 and slc6a4 genes and in conjunction with anxiety-like behaviors in offspring.	[Hsueh, Pei-Tan; Liu, Jong-Kang] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wang, Hsuan-Han; Liu, Chiu-Lin; Ni, Wei-Fen; Chen, Ya-Lei] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan	National Sun Yat Sen University; National Kaohsiung Normal University	Liu, JK (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Chen, YL (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	dan1001@nknu.edu.tw; jkliu@mail.nsysu.edu.tw			Ministry of Science and Technology (Taiwan) [NSC102-2628-B-017-001-MY3, MOST105-2320-B-017-003-MY3, MOST105-2320-B-017-001]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology (Taiwan); https://www.most.gov.tn; grant number NSC102-2628-B-017-001-MY3; MOST105-2320-B-017-003-MY3; and MOST105-2320-B-017-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Accardo JA, 2015, EPILEPSY BEHAV, V47, P202, DOI 10.1016/j.yebeh.2014.09.081; Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Altieri SC, 2015, NEUROPSYCHOPHARMACOL, V40, P1456, DOI 10.1038/npp.2014.331; Amrein I, 2011, EUR J NEUROSCI, V34, P978, DOI 10.1111/j.1460-9568.2011.07804.x; Arreola R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3160486; Babri S, 2014, BRAIN BEHAV IMMUN, V37, P164, DOI 10.1016/j.bbi.2013.12.003; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Bogdanik LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030217; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; Castillo A, 2014, EUR J MED GENET, V57, P654, DOI 10.1016/j.ejmg.2014.08.009; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chen Y., 2016, P IEEE INT C VER LAR, P1, DOI DOI 10.1109/VLSIT.2016.7573429; Claustrat B, 2015, NEUROCHIRURGIE, V61, P77, DOI 10.1016/j.neuchi.2015.03.002; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; CSORDAS T, 1978, GYNECOL OBSTET INVES, V9, P57, DOI 10.1159/000300971; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Depino AM, 2015, NEUROSCIENCE, V299, P56, DOI 10.1016/j.neuroscience.2015.04.065; Dutkiewicz J, 2015, ANN AGR ENV MED, V22, P576, DOI 10.5604/12321966.1185757; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Gentile MT, 2012, J NEUROCHEM, V123, P963, DOI 10.1111/jnc.12004; Gu F., 2017, J NEUROSCIENCE RES; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Hong H, 2016, INT NEUROUROL J, V20, pS2, DOI 10.5213/inj.1632604.302; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Hsueh PT, 2016, MICROBIOL IMMUNOL, V60, P725, DOI 10.1111/1348-0421.12450; Jaunarajs KLE, 2012, NEUROSCIENCE, V218, P243, DOI 10.1016/j.neuroscience.2012.05.052; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Kerns CM, 2014, J AUTISM DEV DISORD, V44, P2851, DOI 10.1007/s10803-014-2141-7; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Krishna S, 2016, BEHAV BRAIN RES, V302, P279, DOI 10.1016/j.bbr.2016.01.038; Kubesova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115439; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu B, 2004, BIOL PHARM BULL, V27, P1245, DOI 10.1248/bpb.27.1245; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Matson JL, 2013, RES DEV DISABIL, V34, P2475, DOI 10.1016/j.ridd.2013.05.021; Money KM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00260; Ornoy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00316; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Rath MF, 2016, ENDOCRINOLOGY, V157, P2028, DOI 10.1210/en.2015-1888; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; Sens J, 2017, PHARMACOL BIOCHEM BE, V153, P168, DOI 10.1016/j.pbb.2016.12.016; Simic G, 2017, PROG NEUROBIOL, V151, P101, DOI 10.1016/j.pneurobio.2016.04.001; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stansley BJ, 2013, NEUROPHARMACOLOGY, V67, P243, DOI 10.1016/j.neuropharm.2012.11.010; Takeshima M, 2016, J CLIN BIOCHEM NUTR, V59, P93, DOI 10.3164/jcbn.16-15; Valentini V, 2013, NEUROPHARMACOLOGY, V65, P58, DOI 10.1016/j.neuropharm.2012.08.025; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vasilache AM, 2013, J NEUROENDOCRINOL, V25, P635, DOI 10.1111/jne.12044; Vasudeva RK, 2011, J CHEM NEUROANAT, V41, P281, DOI 10.1016/j.jchemneu.2011.05.008; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Voineagu I, 2013, DIS MARKERS, V2013, P55, DOI 10.1155/2013/476276; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Yan QS, 2001, EUR J PHARMACOL, V418, P55, DOI 10.1016/S0014-2999(01)00913-X; Zager A, 2015, BRAIN BEHAV IMMUN, V43, P159, DOI 10.1016/j.bbi.2014.07.021; Zarrindast MR, 2015, ARCH IRAN MED, V18, P591, DOI 0151809/AIM.009	65	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179970	10.1371/journal.pone.0179970	http://dx.doi.org/10.1371/journal.pone.0179970			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650979	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300035
J	Ostensson, E; Silfverschiold, M; Greiff, L; Asciutto, C; Wennerberg, J; Lydryp, ML; Hakansson, U; Sparen, P; Borgfeldt, C				Ostensson, Ellinor; Silfverschiold, Maria; Greiff, Lennart; Asciutto, Christine; Wennerberg, Johan; Lydryp, Marie-Louise; Hakansson, Ulf; Sparen, Par; Borgfeldt, Christer			The economic burden of human papillomavirus-related precancers and cancers in Sweden	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VAGINAL INTRAEPITHELIAL NEOPLASIA; COMPARATIVE GENOMIC HYBRIDIZATION; QUADRIVALENT HPV VACCINE; COST-EFFECTIVENESS; POSITIVE TONSILLAR; PROGNOSTIC-FACTOR; DNA DETECTION; VULVAR; LESIONS	Background High-risk (HR) human papillomavirus (HPV) infection is an established cause of malignant disease. We used a societal perspective to estimate the cost of HR HPV-related cervical, vulvar, vaginal, anal, and penile precancer and cancer, and oropharyngeal cancer in Sweden in 2006, 1 year before HPV vaccination became available in the country. Materials and methods This prevalence-based cost-of-illness study used diagnosis-specific data from national registries to determine the number of HR HPV-related precancers and cancers. The HR HPV-attributable fractions of these diseases were derived from a literature review and applied to the total burden to estimate HR HPV-attributable costs. Direct costs were based on health care utilization and indirect costs on loss of productivity due to morbidity (i.e., sick leave and early retirement) and premature mortality. Results The total annual cost of all HR HPV-attributable precancers and cancers was (sic)94 million ((sic)10.3/inhabitant). Direct costs accounted for (sic)31.3 million ((sic)3.4/inhabitant) of the total annual cost, and inpatient care amounted to (sic)20.7 million of direct costs. Indirect costs made up (sic)62.6 million ((sic)6.9/inhabitant) of the total annual cost, and premature mortality amounted to _ 36 million of indirect costs. Cervical precancer and cancer was most costly (total annual cost (sic)58.4 million). Among cancers affecting both genders, anal precancer and cancer, and oropharyngeal cancer were the most costly ((sic)11.2 million and (sic)11.9 million, respectively). For oropharyngeal cancer, males had the highest health care utilization and represented 71% of the total annual cost. Penile precancer and cancer was least costly ((sic)2.6 million). Conclusion The economic burden of HR HPV-related precancers and cancers is substantial. The disease-related management and treatment costs we report are relevant as a point of reference for future economic evaluations investigating the overall benefits of HPV vaccination in females and males in Sweden.	[Ostensson, Ellinor; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Silfverschiold, Maria; Greiff, Lennart; Wennerberg, Johan] Lund Univ, Skanes Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Asciutto, Christine; Borgfeldt, Christer] Lund Univ, Skanes Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Lydryp, Marie-Louise] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Hakansson, Ulf] Lund Univ, Skanes Univ Hosp, Dept Urol, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Lund University; Lund University; Lund University	Ostensson, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.; Ostensson, E (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden.	ellinor.ostensson@ki.se		Borgfeldt, Christer/0000-0003-2267-8325; Sparen, Par/0000-0002-5184-8971; Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [C8 30305153]	Swedish Cancer Foundation	This work was supported by the Swedish Cancer Foundation (C8 30305153), URL: www.cancerfonden.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2002, BRIT J CANCER, V86, P924, DOI 10.1038/sj.bjc.6600112; Anayannis NVJ, 2015, ARCH PATHOL LAB MED, V139, P1373, DOI 10.5858/arpa.2014-0554-RA; Andersson S, 2005, BRIT J CANCER, V92, P2195, DOI 10.1038/sj.bjc.6602648; Andersson S, 2004, CANCER DETECT PREV, V29, P37, DOI 10.1016/j.cdp.2004.11.003; Andersson S, 2003, ACTA OBSTET GYN SCAN, V82, P960, DOI 10.1034/j.1600-0412.2003.00263.x; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Andersson S, 2013, ONCOL LETT, V6, P215, DOI 10.3892/ol.2013.1350; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Blomqvist P, 2000, J NEUROL NEUROSUR PS, V69, P792, DOI 10.1136/jnnp.69.6.792; Bogaards JA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2016; Bryndorf T, 2004, CYTOGENET GENOME RES, V106, P43, DOI 10.1159/000078559; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Dahlgren L, 2004, INT J CANCER, V112, P1015, DOI 10.1002/ijc.20490; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Drummond M, 2005, METH EC EV HLTH CARE; Du J, 2011, ACTA ONCOL, V50, P1215, DOI 10.3109/0284186X.2011.584556; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira M, 2008, MODERN PATHOL, V21, P968, DOI 10.1038/modpathol.2008.91; Fox PA, 2005, SEX TRANSM INFECT, V81, P142, DOI 10.1136/sti.2003.008318; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gold M, 1996, MED CARE, V34, pDS197; Graflund M, 2004, INT J GYNECOL CANCER, V14, P896, DOI 10.1111/j.1048-891X.2004.014527.x; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Hampl M, 2006, OBSTET GYNECOL, V108, P1361, DOI 10.1097/01.AOG.0000245786.86267.80; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Henriksson F, 1998, PHARMACOECONOMICS, V13, P597, DOI 10.2165/00019053-199813050-00012; Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kirrander P, 2011, BJU INT, V108, P355, DOI 10.1111/j.1464-410X.2010.09770.x; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Krustrup D, 2009, INT J EXP PATHOL, V90, P182, DOI 10.1111/j.1365-2613.2008.00636.x; Kulasingam S, 2007, SEX HEALTH, V4, P165, DOI 10.1071/SH07043; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Larsson GL, 2012, INT J GYNECOL CANCER, V22, P1413, DOI 10.1097/IGC.0b013e31826a0471; Laytragoon-Lewin N, 2007, ANTICANCER RES, V27, P4473; Lidgren M, 2007, EUR J HEALTH ECON, V8, P5, DOI 10.1007/s10198-006-0003-8; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Lindell G, 2010, GYNECOL ONCOL, V117, P312, DOI 10.1016/j.ygyno.2009.12.031; Lindquist D, 2012, ANTICANCER RES, V32, P153; Logani S, 2003, MODERN PATHOL, V16, P735, DOI 10.1097/01.MP.0000081051.55284.2A; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Madsen BS, 2008, INT J CANCER, V122, P2827, DOI 10.1002/ijc.23446; Mallen-St Clair J, 2016, BBA-REV CANCER, V1866, P141, DOI 10.1016/j.bbcan.2016.07.005; Menczer J, 2000, EUR J GYNAECOL ONCOL, V21, P30; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Nasman A, 2015, EUR J CANCER, V51, P55, DOI 10.1016/j.ejca.2014.10.016; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; OSTENSSON E, 2015, PLOS ONE, V10; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Pinto LA, 2016, J INFECT DIS, V214, P1276, DOI 10.1093/infdis/jiw359; Rice DP, 1996, HLTH EC SERIES, V6; Skapa P, 2007, AM J SURG PATHOL, V31, P1834, DOI 10.1097/PAS.0b013e3180686d10; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Soderlund-Strand A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.056; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; Statens beredning for medicinsk utvardering SBU, 2008, 20081 SBU; Stockholm County Council, 2003, COST PAT PRIM CAR RE; Sutton BC, 2008, MODERN PATHOL, V21, P345, DOI 10.1038/modpathol.3801010; Swedish Association of Local Authorities and Regions, 2014, 5813 SWED ASS LOC AU; The Dental and Pharmaceutical Benefits Agency (TLV), 2003, GEN GUID EC EV PHARM; Varnai AD, 2006, INT J COLORECTAL DIS, V21, P135, DOI 10.1007/s00384-005-0777-7; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Westra WH, 2012, HEAD NECK PATHOL, V6, pS48, DOI 10.1007/s12105-012-0371-6; Wikstrom A, 2012, J EUR ACAD DERMATOL, V26, P325, DOI 10.1111/j.1468-3083.2011.04069.x; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c; Youk EG, 2001, DIS COLON RECTUM, V44, P236, DOI 10.1007/BF02234299	77	13	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179520	10.1371/journal.pone.0179520	http://dx.doi.org/10.1371/journal.pone.0179520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651012	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300010
J	Biesbroek, PS; Amier, RP; Teunissen, PFA; Hofman, MBM; Robbers, LFHJ; van de Ven, PM; Beek, AM; van Rossum, AC; van Royen, N; Nijveldt, R				Biesbroek, P. Stefan; Amier, Raquel P.; Teunissen, Paul. F. A.; Hofman, Mark B. M.; Robbers, Lourens F. H. J.; van de Ven, Peter M.; Beek, Aernout M.; van Rossum, Albert C.; van Royen, Niels; Nijveldt, Robin			Changes in remote myocardial tissue after acute myocardial infarction and its relation to cardiac remodeling: A CMR T1 mapping study	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME QUANTIFICATION; QUANTITATIVE T2; RAT-HEART; EDEMA; INFLAMMATION; REPERFUSION; FIBROSIS; CORONARY; INJURY	Objectives To characterize the temporal alterations in native T1 and extracellular volume (ECV) of remote myocardium after acute myocardial infarction (AMI), and to explore their relation to left ventricular (LV) remodeling. Methods Forty-two patients with AMI successfully treated with primary PCI underwent cardiovascular magnetic resonance after 4-6 days and 3 months. Cine imaging, late gadolinium enhancement, and T1-mapping (MOLLI) was performed at 1.5T. T1 values were measured in the myocardial tissue opposite of the infarct area. Myocardial ECV was calculated from native-and post-contrast T1 values in 35 patients, using a correction for synthetic hematocrit. Results Native T1 of remote myocardium significantly decreased between baseline and follow-up (1002 +/- 39 to 985 +/- 30ms, p<0.01). High remote native T1 at baseline was independently associated with a high C-reactive protein level (standardized Beta 0.32, p = 0.04) and the presence of microvascular injury (standardized Beta 0.34, p = 0.03). ECV of remote myocardium significantly decreased over time in patients with no LV dilatation (29 +/- 3.8 to 27 +/- 2.3%, p<0.01). In patients with LV dilatation, remote ECV remained similar over time, and was significantly higher at follow-up compared to patients without LV dilatation (30 +/- 2.0 versus 27 +/- 2.3%, p = 0.03). Conclusions In reperfused first-time AMI patients, native T1 of remote myocardium decreased from baseline to follow-up. ECV of remote myocardium decreased over time in patients with no LV	[Biesbroek, P. Stefan; Amier, Raquel P.; Teunissen, Paul. F. A.; Robbers, Lourens F. H. J.; Beek, Aernout M.; van Rossum, Albert C.; van Royen, Niels; Nijveldt, Robin] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Biesbroek, P. Stefan] Netherlands Heart Inst, Utrecht, Netherlands; [Hofman, Mark B. M.] Vrije Univ Amsterdam, Med Ctr, Phys & Med Technol, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam, Med Ctr, Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Nijveldt, R (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands.	Robin@Nijveldt.net	Teunissen, Paul/AAC-2908-2020; van Royen, Niels/Q-1097-2017; Nijveldt, Robin/N-8683-2017	Nijveldt, Robin/0000-0003-1530-6363; van Rossum, Albert C./0000-0003-1714-4652; Robbers, Lourens/0000-0002-8826-7628; Teunissen, Paul/0000-0001-7574-9698	Volcano Corporation	Volcano Corporation	This work was supported in part by unrestricted research grants from Volcano Corporation (http//www.volcanocorp.corn/) and Biotronik (https://www.biotronik.com/en-us)(NR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, HEART, V94, P737, DOI 10.1136/hrt.2007.115329; Ambale-Venkatesh B, 2015, NAT REV CARDIOL, V12, P18, DOI 10.1038/nrcardio.2014.159; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Brouwer WP, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-28; Bulluck H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003555; Carberry J, 2016, HYPERTENSION, V68, P385, DOI 10.1161/HYPERTENSIONAHA.116.07222; Carrick D, 2015, JACC CARDIOVASC IMAG; CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V65, P315, DOI 10.1016/j.jacc.2014.11.004; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Ghugre NR, 2013, MAGN RESON MED, V70, P1095, DOI 10.1002/mrm.24531; Goebel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155591; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; Park CH, 2013, INT J CARDIOVAS IMAG, V29, P65, DOI 10.1007/s10554-013-0256-0; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Pokorney Sean D, 2012, J Cardiovasc Magn Reson, V14, P62, DOI 10.1186/1532-429X-14-62; Puri KS, 2009, J POSTGRAD MED, V55, P131, DOI 10.4103/0022-3859.52846; Ruparelia N, 2013, INFLAMM RES, V62, P515, DOI 10.1007/s00011-013-0605-4; Schelbert EB, 2010, CIRC-CARDIOVASC IMAG, V3, P743, DOI 10.1161/CIRCIMAGING.108.835793; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Teunissen PFA, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001786; Treibel TA, 2016, JACC-CARDIOVASC IMAG, V9, P54, DOI 10.1016/j.jcmg.2015.11.008; Tsuda T, 2003, CARDIOVASC RES, V59, P926, DOI 10.1016/S0008-6363(03)00519-4; Ugander M, 2012, JACC-CARDIOVASC IMAG, V5, P596, DOI 10.1016/j.jcmg.2012.01.016; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; WILLIAMS ES, 1980, J NUCL MED, V21, P449; Zia MI, 2012, CIRC-CARDIOVASC IMAG, V5, P566, DOI 10.1161/CIRCIMAGING.112.973222	35	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180115	10.1371/journal.pone.0180115	http://dx.doi.org/10.1371/journal.pone.0180115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644903	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100064
J	Schicho, A; Luerken, L; Stroszczynski, C; Meier, R; Schreyer, AG; Dendl, LM; Schleder, S				Schicho, Andreas; Luerken, Lukas; Stroszczynski, Christian; Meier, Ramona; Schreyer, Andreas G.; Dendl, Lena-Marie; Schleder, Stephan			Vascular geometry as a risk factor for non-penetrating traumatic injuries of the aortic	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES	Purpose To assess biomechanical factors in aortic arch geometry contributing to the development of non-penetrating aortic arch injury (NAAI) in multiply injured patients with an Injury Severity Score (ISS) >= 16. Material and methods 230 consecutive multiply injured trauma patients with an ISS >= 16 admitted to our Level-I trauma center during a consecutive 24-month period were prospectively included of whom 13 presented with NAAI (5.7%). Standardized whole-body CT in a 2x128-detector-row scanner included a head-and-neck CTA. Aortic arch diameters, width, height, angles and thoracic width and height were measured in individuals with NAAI and ISS-, sex-, age-, and trauma mechanism-matched controls. Results There was no difference between groups regarding sex, age, ISS, and aortic diameters. The aortic arch angle in individuals with NAAI (71.3 degrees +/- 14.9 degrees) was larger than in healthy control (60.7 degrees +/- 8.6 degrees; p*<0.05). In patients with NAAI, the distance between ascendent and descendent aorta was larger (5.2 cm +/- 1.9 cm) than in control (2.8 +/- 0.5 cm; ***p<0.001). The aortic arch is higher above tracheal bifurcation in NAAI (3.6 cm +/- 0.6 cm) than in matched control (2.4 cm +/- 0.3 cm; ***p<0.001). Accordingly, the area under the aortic arch, calculated as half of an eliptic shape, is significantly larger in patients with NAAI (15.0 cm2 +/- 6.5 cm2) when compared to age- and sex- matched controls without NAAI (5.5 cm2 +/- 1.3 cm2; ***p<0.001). Conclusion Besides the magnitude of deceleration and direction of impact, width and height of the aortic arch are the 3rd and 4th factor directly contributing to the risk of developing traumatic NAAI in severely injured patients.	[Schicho, Andreas; Luerken, Lukas; Stroszczynski, Christian; Meier, Ramona; Schreyer, Andreas G.; Dendl, Lena-Marie; Schleder, Stephan] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany	University of Regensburg	Schicho, A (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	andreas.schicho@ukr.de	Luerken, Lukas/X-6622-2019; Schreye, Andreas/ABC-3197-2020	Schreyer, Andreas/0000-0002-2539-059X; Schleder, Stephan/0000-0002-7785-3015				Bertrand S, 2008, TRAFFIC INJ PREV, V9, P153, DOI 10.1080/15389580701775777; Dehner Christoph, 2013, Glob J Health Sci, V5, P115, DOI 10.5539/gjhs.v5n3p115; Erbel R, 2006, HEART, V92, P137, DOI 10.1136/hrt.2004.055111; Ernstberger A, 2015, INJURY, V46, pS135, DOI 10.1016/S0020-1383(15)30033-4; Fitzharris M, 2004, J TRAUMA, V57, P582, DOI 10.1097/01.TA.0000088015.83951.D0; Frydrychowicz A, 2012, EUR RADIOL, V22, P1122, DOI 10.1007/s00330-011-2353-6; Martin G, 2016, BRAIN INJURY, V30, P1517, DOI 10.1080/02699052.2016.1192683; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; O'Connor JV, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-42; Schicho A., 2017, VASCULAR GEOMETRY RI; Warwick R, 2013, MED HYPOTHESES, V80, P271, DOI 10.1016/j.mehy.2012.12.002; Wojciechowski J, 2016, SURG TODAY, P1	12	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180066	10.1371/journal.pone.0180066	http://dx.doi.org/10.1371/journal.pone.0180066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644901	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100061
J	Anunciado-Koza, RP; Manuel, J; Mynatt, RL; Zhang, JY; Kozak, LP; Koza, RA				Anunciado-Koza, Rea P.; Manuel, Justin; Mynatt, Randall L.; Zhang, Jingying; Kozak, Leslie P.; Koza, Robert A.			Diet-induced adipose tissue expansion is mitigated in mice with a targeted inactivation of mesoderm specific transcript (Mest)	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; ACTIVATED-RECEPTOR-ALPHA; MESENCHYMAL STEM-CELLS; FAT MASS EXPANSION; GENE-EXPRESSION; EPOXYEICOSATRIENOIC ACIDS; GLUCOSE-HOMEOSTASIS; IMPRINTED GENE; IN-VIVO; ADIPOCYTE DIFFERENTIATION	Interindividual variation of white adipose tissue (WAT) expression of mesoderm specific transcript (Mest), a paternally-expressed imprinted gene belonging to the alpha/beta-hydrolase fold protein family, becomes apparent among genetically inbred mice fed high fat diet (HFD) and is positively associated with adipose tissue expansion (ATE). To elucidate a role for MEST in ATE, mice were developed with global and adipose tissue inactivation of Mest. Mice with homozygous (Mest(gKO)) and paternal allelic (Mest(pKO)) inactivation of Mest were born at expected Mendelian frequencies, showed no behavioral or physical abnormalities, and did not perturb expression of the Mest locus-derived microRNA miR-335. Mest(pKO) mice fed HFD showed reduced ATE and adipocyte hypertrophy, improved glucose tolerance, and reduced WAT expression of genes associated with hypoxia and inflammation compared to littermate controls. Remarkably, caloric intake and energy expenditure were unchanged between genotypes. Mice with adipose tissue inactivation of Mest were phenotypically similar to Mest(pKO), supporting a role for WAT MEST in ATE. Global profiling of WAT gene expression of HFD-fed control and Mest(pKO) mice detected few differences between genotypes; nevertheless, genes with reduced expression in Mest(pKO) mice were associated with immune processes and consistent with improved glucose homeostasis. Ear-derived mesenchymal stem cells (EMSC) from Mest(gKO) mice showed no differences in adipogenic differentiation compared to control cells unless challenged by shRNA knockdown of Gpat4, an enzyme that mediates lipid accumulation in adipocytes. Reduced adipogenic capacity of EMSC from Mest(gKO) after Gpat4 knockdown suggests that MEST facilitates lipid accumulation in adipocytes. Our data suggests that reduced diet-induced ATE in MEST-deficient mice diminishes hypoxia and inflammation in WAT leading to improved glucose tolerance and insulin sensitivity. Since inactivation of Mest in mice has minimal additional effects aside from reduction of ATE, an intervention that mitigates MEST function in adipocytes is a plausible strategy to obviate obesity and type-2-diabetes.	[Anunciado-Koza, Rea P.; Manuel, Justin; Koza, Robert A.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04070 USA; [Mynatt, Randall L.; Zhang, Jingying] LSU Syst, Pennington Biomed Res Ctr, Transgen Core Facil, Baton Rouge, LA USA; [Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland	Maine Medical Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Koza, RA (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04070 USA.	rkoza@mmc.org	zhang, jingying R/R-4262-2018; Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019; Koza, Robert/0000-0001-6994-7268	NIDDK [RO1DK090361]; Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute - COBRE [NIGMS P30GM106391]; Viral Vector Core at Maine Medical Center Research Institute - COBRE [NIGMS P30GM103392]; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - COBRE [NIGMS P20GM103528]; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - NORC [NIDDK P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090361, P30DK072476] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute - COBRE; Viral Vector Core at Maine Medical Center Research Institute - COBRE; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - COBRE; Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center - NORC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Studies were funded by NIDDK RO1DK090361 (R.A.K). Support was also provided by the Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM106391), the Viral Vector Core at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM103392), and the Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center funded in part by COBRE (NIGMS P20GM103528) and NORC (NIDDK P30DK072476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza RP, 2016, ANN NY ACAD SCI, V1363, P50, DOI 10.1111/nyas.12958; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Barbagallo I, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00309; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouchard C, 2010, AM J CLIN NUTR, V91, P5, DOI 10.3945/ajcn.2009.28933; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Chu DT, 2014, J BIOL CHEM, V289, P18478, DOI 10.1074/jbc.M114.555821; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fang X, 2005, J PHARMACOL EXP THER, V314, P260, DOI 10.1124/jpet.105.085605; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Hiramuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130436; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Ineson J, 2012, J REPROD DEVELOP, V58, P490, DOI 10.1262/jrd.11-115A; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jung H, 2011, BIOCHEM J, V436, P263, DOI 10.1042/BJ20101512; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kamei Y, 2007, FEBS LETT, V581, P91, DOI 10.1016/j.febslet.2006.12.002; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kanwar YS, 2002, AM J PHYSIOL-RENAL, V282, pF953, DOI 10.1152/ajprenal.00200.2001; Karbiener M, 2015, INT J OBESITY, V39, P1733, DOI 10.1038/ijo.2015.121; Kim DH, 2010, STEM CELLS DEV, V19, P1863, DOI 10.1089/scd.2010.0098; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Koza RA, 2004, METABOLISM, V53, P799, DOI 10.1016/j.metabol.2003.12.024; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kumar RA, 2004, GENESIS, V38, P51, DOI 10.1002/gene.20001; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lin X, 2014, J BONE MINER RES, V29, P1575, DOI 10.1002/jbmr.2163; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marchot P, 2012, PROTEIN PEPTIDE LETT, V19, P132, DOI 10.2174/092986612799080284; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Pires RC, 2014, APPL PHYSIOL NUTR ME, V39, P895, DOI 10.1139/apnm-2013-0520; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Soukas A, 2000, GENE DEV, V14, P963; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Voigt A, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0477-z; Waldman M, 2016, STEM CELLS DEV, V25, P1084, DOI 10.1089/scd.2016.0072; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199; Zhu L, 2014, CELL BIOCHEM BIOPHYS, V68, P283, DOI 10.1007/s12013-013-9708-3; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	83	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179879	10.1371/journal.pone.0179879	http://dx.doi.org/10.1371/journal.pone.0179879			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640866	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800076
J	Delobel, JB; Gnep, K; Ospina, JD; Beckendorf, V; Chira, C; Zhu, J; Bossi, A; Messai, T; Acosta, O; Castelli, J; de Crevoisier, R				Delobel, Jean-Bernard; Gnep, Khemara; David Ospina, Juan; Beckendorf, Veronique; Chira, Ciprian; Zhu, Jian; Bossi, Alberto; Messai, Taha; Acosta, Oscar; Castelli, Joel; de Crevoisier, Renaud			Nomogram to predict rectal toxicity following prostate cancer radiotherapy	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; CONVENTIONALLY FRACTIONATED RADIOTHERAPY; DOSE-ESCALATION TRIAL; CONFORMAL RADIOTHERAPY; RANDOMIZED-TRIAL; INCREASED RISK; 68 GY; ASSOCIATION; MULTICENTER; FAILURE	Background To identify predictors of acute and late rectal toxicity following prostate cancer radiotherapy (RT), while integrating the potential impact of RT technique, dose escalation, and moderate hypofractionation, thus enabling us to generate a nomogram for individual prediction. Methods In total, 972 patients underwent RT for localized prostate cancer, to a total dose of 70 Gy or 80 Gy, using two different fractionations (2 Gy or 2.5 Gy/day), by means of several RT techniques (3D conformal RT [3DCRT], intensity-modulated RT [IMRT], or image-guided RT [IGRT]). Multivariate analyses were performed to identify predictors of acute and late rectal toxicity. A nomogram was generated based on the logistic regression model used to predict the 3-year rectal toxicity risk, with its accuracy assessed by dividing the cohort into training and validation subgroups. Results Mean follow-up for the entire cohort was 62 months, ranging from 6 to 235. The rate of acute Grade >= 2 rectal toxicity was 22.2%, decreasing when combining IMRT and IGRT, compared to 3DCRT (RR = 0.4, 95% CI: 0.3-0.6, p< 0.01). The 5-year Grade >= 2 risks for rectal bleeding, urgency/tenesmus, diarrhea, and fecal incontinence were 9.9%, 4.5%, 2.8%, and 0.4%, respectively. The 3-year Grade >= 2 risk for overall rectal toxicity increased with total dose (p< 0.01, RR = 1.1, 95% CI: 1.0-1.1) and dose per fraction (2Gy vs. 2.5Gy) (p = 0.03, RR = 3.3, 95% CI: 1.1-10.0), and decreased when combining IMRT and IGRT (RR = 0.50, 95% CI: 0.3-0.8, p< 0.01). Based on these three parameters, a nomogram was generated. Conclusions Dose escalation and moderate hypofractionation increase late rectal toxicity. IMRT combined with IGRT markedly decreases acute and late rectal toxicity. Performing combined IMRT and IGRT can thus be envisaged for dose escalation and moderate hypofractionation. Our nomogram predicts the 3-year rectal toxicity risk by integrating total dose, fraction dose, and RT technique.	[Delobel, Jean-Bernard] Ctr Hosp Univ Pontchaillou, Dept Gastroenterol, Rennes, France; [Gnep, Khemara; David Ospina, Juan; Zhu, Jian; Acosta, Oscar; Castelli, Joel; de Crevoisier, Renaud] Univ Rennes 1, INSERM, U1099, LTSI, Rennes, France; [Gnep, Khemara; Castelli, Joel; de Crevoisier, Renaud] Ctr Eugene Marquis, Rennes, France; [David Ospina, Juan] Univ Nacl Colombia, Escuela Estadist, Medellin, Colombia; [Beckendorf, Veronique; Chira, Ciprian] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France; [Bossi, Alberto; Messai, Taha] Inst Gustave Roussy, Villejuif, France; [Zhu, Jian] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jian; de Crevoisier, Renaud] CRIBs, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UNICANCER; Centre Eugene Marquis; Universidad Nacional de Colombia; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Gustave Roussy; Southeast University - China	Gnep, K (corresponding author), Univ Rennes 1, INSERM, U1099, LTSI, Rennes, France.; Gnep, K (corresponding author), Ctr Eugene Marquis, Rennes, France.	khemara.gnep@gmail.com	de Crevoisier, Renaud/ABD-7321-2020; CASTELLI, joël/P-6142-2018	CASTELLI, joël/0000-0001-6128-1836; Acosta, Oscar/0000-0002-5447-1479				Aluwini S, 2016, LANCET ONCOL, V17, P464, DOI 10.1016/S1470-2045(15)00567-7; Arcangeli S, 2012, INT J RADIAT ONCOL, V84, P1172, DOI 10.1016/j.ijrobp.2012.02.049; Beckendorf V, 2011, INT J RADIAT ONCOL, V80, P1056, DOI 10.1016/j.ijrobp.2010.03.049; Burri RJ, 2008, RADIAT RES, V170, P49, DOI 10.1667/RR1219.1; Cahlon O, 2008, SEMIN RADIAT ONCOL, V18, P48, DOI 10.1016/j.semradonc.2007.09.007; Coates J, 2015, RADIOTHER ONCOL, V115, P107, DOI 10.1016/j.radonc.2015.03.005; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; DCTD N NIH, 2006, CANC THER EV PROG CO; De Crevoisier R, 2005, INT J RADIAT ONCOL, V62, P965, DOI 10.1016/j.ijrobp.2004.11.032; Dearnaley D, 2012, LANCET ONCOL, V13, P43, DOI 10.1016/S1470-2045(11)70293-5; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Drean G, 2016, RADIOTHER ONCOL; Engels B, 2009, INT J RADIAT ONCOL, V74, P388, DOI 10.1016/j.ijrobp.2008.08.007; Fiorino C, 2012, INT J RADIAT ONCOL, V83, P38, DOI 10.1016/j.ijrobp.2011.06.1953; Fiorino C, 2009, RADIOTHER ONCOL, V93, P153, DOI 10.1016/j.radonc.2009.08.004; Gami B, 2003, ALIMENT PHARM THER, V18, P987, DOI 10.1046/j.1365-2036.2003.01760.x; Heemsbergen WD, 2007, INT J RADIAT ONCOL, V67, P1418, DOI 10.1016/j.ijrobp.2006.11.014; Hoffman KE, 2014, INT J RADIAT ONCOL, V88, P1074, DOI 10.1016/j.ijrobp.2014.01.015; Incrocci L, 2016, LANCET ONCOL, V17, P1061, DOI 10.1016/S1470-2045(16)30070-5; Kok D, 2013, RADIOTHER ONCOL, V107, P140, DOI 10.1016/j.radonc.2013.04.007; Kuban DA, 2010, INT J RADIAT ONCOL, V78, pS58, DOI 10.1016/j.ijrobp.2010.07.170; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Landoni V, 2016, PHYS MEDICA, V32, P521, DOI 10.1016/j.ejmp.2016.03.003; Lee WR, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.1; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Marzi S, 2009, J EXP CLIN CANC RES, V28, P1; Ospina JD, 2014, INT J RADIAT ONCOL, V89, P1024, DOI 10.1016/j.ijrobp.2014.04.027; Peeters STK, 2005, INT J RADIAT ONCOL, V61, P1019, DOI 10.1016/j.ijrobp.2004.07.715; Pergolizzi S, 2013, DIGEST LIVER DIS, V45, P933, DOI 10.1016/j.dld.2013.04.012; Perrier L, 2013, RADIOTHER ONCOL, V106, P50, DOI 10.1016/j.radonc.2012.11.011; Pollack A, 2013, J CLIN ONCOL, V31, P3860, DOI 10.1200/JCO.2013.51.1972; RUBIN P, 1995, INT J RADIAT ONCOL, V31, P1041, DOI 10.1016/0360-3016(95)00057-6; Someya M, 2015, RADIOTHER ONCOL, V115, P235, DOI 10.1016/j.radonc.2015.04.008; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Stenmark MH, 2014, RADIOTHER ONCOL, V110, P291, DOI 10.1016/j.radonc.2014.01.007; Sveistrup J, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-44; Thurner EM, 2014, STRAHLENTHER ONKOL, V190, P304, DOI 10.1007/s00066-013-0485-0; Tucker SL, 2011, INT J RADIAT ONCOL, V81, P600, DOI 10.1016/j.ijrobp.2010.11.080; Valdagni R, 2012, INT J RADIAT ONCOL, V82, P1957, DOI 10.1016/j.ijrobp.2011.03.028; Valdagni R, 2009, INT J RADIAT ONCOL, V74, P1431, DOI 10.1016/j.ijrobp.2008.10.021; Valeriani M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-137; Varela E, 2009, ALIMENT PHARM THER, V30, P175, DOI 10.1111/j.1365-2036.2009.04019.x; Viani GA, 2009, INT J RADIAT ONCOL, V74, P1405, DOI 10.1016/j.ijrobp.2008.10.091; Wachter S, 2000, RADIOTHER ONCOL, V54, P11, DOI 10.1016/S0167-8140(99)00173-5; Wedlake L, 2008, ALIMENT PHARM THER, V27, P980, DOI 10.1111/j.1365-2036.2008.03663.x; Wortel RC, 2015, INT J RADIAT ONCOL, V91, P737, DOI 10.1016/j.ijrobp.2014.12.017; Yeoh EE, 2011, INT J RADIAT ONCOL, V81, P1271, DOI 10.1016/j.ijrobp.2010.07.1984; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047	50	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179845	10.1371/journal.pone.0179845	http://dx.doi.org/10.1371/journal.pone.0179845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640871	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800072
J	Jing, H; Liao, L; Su, XX; Shuai, Y; Zhang, XJ; Deng, ZH; Jin, Y				Jing, Huan; Liao, Li; Su, Xiaoxia; Shuai, Yi; Zhang, Xinjing; Deng, Zhihong; Jin, Yan			Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis	FASEB JOURNAL			English	Article						mesenchymal stem cell; Kat2a; vascular formation; bone mass loss	MESENCHYMAL STEM-CELLS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; VESSEL; REGENERATION; ACETYLATION; EXPRESSION; PROMOTER; MODEL; AGE	Angiogenesis is disrupted in age-related and postmenopausal osteoporosis. However, the mechanisms of the disorder remain elusive. We confirmed in this study that, in accordance with the decrease of H-type vessels, the proangiogenic potential of bone marrow-derived mesenchymal stem cells (BMSCs) declined during osteoporosis. Screening of the histone acetyltransferase family revealed that GCN5 decreased in BMSCs derived from osteoporotic femur. Further analysis identified that GCN5 plays important roles in regulating the proangiogenic potential of BMSCs. GCN5 promoted BMSC-mediated angiogenesis by enhancing H3K9ac levels on the promoter of Vegf. The decrease of GCN5 in osteoporotic BMSCs led to the decline of proangiogenic capacity. Accordingly, overexpression of GCN5 enhanced the proangiogenic potency of osteoporotic BMSCs. Furthermore, recovering GCN5 expression in vivo by lentiviral expression vector significantly attenuated the loss of angiogenesis in ovariectomized mouse femurs. Our study results revealed an epigenetic mechanism controlling BMSC-mediated angiogenesis and provided a novel therapeutic target for osteoporosis treatment.-Jing, H., Liao, L., Su, X., Shuai, Y. Zhang, X., Deng, Z., Jin, Y. Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis.	[Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, Shaanxi Int Joint Res Ctr Oral Dis, Ctr Tissue Engn, Xian, Peoples R China; [Deng, Zhihong] Fourth Mil Med Univ, Dept Otolaryngol, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Zhang, Xinjing] Chongqing Med Univ, Dept Prothodont, Stomatol Hosp, Chongqing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Chongqing Medical University	Jin, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.; Deng, ZH (corresponding author), Fourth Mil Med Univ, Dept Otolaryngol, Xijing Hosp, Xian, Shaanxi, Peoples R China.	dengzh@fmmu.edu.cn; yanjin@fmmu.edu.cn	Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009	Nature Science Foundation of China [81470710, 81670915, 81470679, 31601113, 31670995]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Nature Science Foundation of China Grants 81470710, 81670915, 81470679, 31601113, and 31670995. The authors declare no conflict of interest.	Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Bischoff DS, 2008, J CELL BIOCHEM, V103, P812, DOI 10.1002/jcb.21450; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911; Ding WG, 2012, J BONE MINER METAB, V30, P400, DOI 10.1007/s00774-011-0328-y; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gennari L, 2016, EXPERT OPIN PHARMACO, V17, P1141, DOI 10.1080/14656566.2016.1176147; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Iordache F, 2012, INT J MOL SCI, V13, P15074, DOI 10.3390/ijms131115074; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048; Ko JY, 2015, BONE, V81, P80, DOI 10.1016/j.bone.2015.06.022; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laroche M, 2002, JOINT BONE SPINE, V69, P262, DOI 10.1016/S1297-319X(02)00391-3; Li BX, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-015-0512-4; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Liu K, 2015, INT J MOL SCI, V16, P21897, DOI 10.3390/ijms160921897; Liu WJ, 2015, AGING-US, V7, P205, DOI 10.18632/aging.100728; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Majaz S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0114-6; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yin YW, 2015, GENE EXPRESSION, V16, P187, DOI 10.3727/105221615X14399878166230; Zhang P, 2016, J BONE MINER RES, V31, P391, DOI 10.1002/jbmr.2704; Zhang YX, 2015, J BIOCHEM, V158, P445, DOI 10.1093/jb/mvv059; Zhao QH, 2013, FEBS J, V280, P5801, DOI 10.1111/febs.12500	38	31	35	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4422	4433		10.1096/fj.201700118R	http://dx.doi.org/10.1096/fj.201700118R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28642327				2022-12-26	WOS:000413397400020
J	Nathan, DG				Nathan, David G.			Cholesterol: the debate should be terminated	FASEB JOURNAL			English	Article						heart disease; coronary disease; statin	STATINS	Here, I offer personalperspectives on cholesterol homeostasis that reflectmy belief that certain aspects of the debate have been overstated.-Nathan, D.G. Cholesterol: the debate should be terminated.	[Nathan, David G.] Boston Childrens Hosp, Dana Farber Canc Inst, Pediat Blood & Canc Ctr, Boston, MA USA; [Nathan, David G.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nathan, DG (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	david_nathan@dfci.harvard.edu						Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Fye W. B., 1996, ATHEROTHROMBOSIS COR; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Levine SA, 1929, J CLIN ENDOCRINOL, V8, P245; Levy D., 2005, A CHANGE OF HEART; Steinberg D., 2007, THE CHOLESTEROL WARS; Steinberg D, 2013, J LIPID RES, V54, P2946, DOI 10.1194/jlr.R043414	7	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2722	2728		10.1096/fj.201700385R	http://dx.doi.org/10.1096/fj.201700385R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28663517				2022-12-26	WOS:000405931000002
J	Ahmadi, S; Davami, F; Davoudi, N; Nematpour, F; Ahmadi, M; Ebadat, S; Azadmanesh, K; Barkhordari, F; Mahboudi, F				Ahmadi, Samira; Davami, Fatemeh; Davoudi, Noushin; Nematpour, Fatemeh; Ahmadi, Maryam; Ebadat, Saeedeh; Azadmanesh, Kayhan; Barkhordari, Farzaneh; Mahboudi, Fereidoun			Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design	PLOS ONE			English	Article							PROTEIN-PRODUCTION; HIGHLY EFFICIENT; RECOMBINANT; GENERATION; SEQUENCE; IMPACT; LINES	Establishing stable Chinese Hamster Ovary (CHO) cells producing monoclonal antibodies (mAbs) usually pass through the random integration of vectors to the cell genome, which is sensitive to gene silencing. One approach to overcome this issue is to target a highly transcribed region in the genome. Transposons are useful devices to target active parts of genomes, and PiggyBac (PB) transposon can be considered as a good option. In the present study, three PB transposon donor vectors containing both heavy and light chains were constructed, one contained independent expression cassettes while the others utilized either an Internal Ribosome Entry Site (IRES) or 2A element to express mAb. Conventional cell pools were created by transferring donor vectors into the CHO cells, whereas transposon-based cells were generated by transfecting the cells with donor vectors with a companion of a transposase-encoding helper vector, with 1:2.5 helper/donor vectors ratio. To evaluate the influence of helper/donor vectors ratio on expression, the second transposon-based cell pools were generated with 1:5 helper/donor ratio. Expression levels in the transposon-based cells were two to five-folds more than those created by conventional method except for the IRES-mediated ones, in which the observed difference increased more than 100-fold. The results were dependent on both donor vector design and vectors ratios.	[Ahmadi, Samira; Davami, Fatemeh; Davoudi, Noushin; Nematpour, Fatemeh; Ebadat, Saeedeh; Barkhordari, Farzaneh; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran; [Ahmadi, Maryam] Semnan Univ Med Sci, Med Biotechnol Dept, Semnan, Iran; [Azadmanesh, Kayhan] Pasteur Inst Iran, Dept Virol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Semnan University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mahboudi, F (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran.	mahboudi@pasteur.ac.ir	barkhordari, farzaneh/AAB-3783-2020; barkhordari, farzaneh/AAE-1137-2020; Azadmanesh, kayhan/W-2445-2017	barkhordari, farzaneh/0000-0003-0500-1726; Azadmanesh, kayhan/0000-0002-7165-9043	Pasteur Institute of Iran	Pasteur Institute of Iran	This work was supported by Pasteur Institute of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no conflict of interest. Also, the authors wish to thank Dr. Ahmad Adeli and Reza Moazzami for their technical supports. The current study was supported by a grant from the Pasteur Institute of Iran.	Ahmadi M, 2016, BIOTECHNOLOGY PROGR; Alattia JR, 2013, BIOTECHNOL BIOENG, V110, P1995, DOI 10.1002/bit.24851; Balasubramanian S, 2016, BIOTECHNOL BIOENG, V113, P1234, DOI 10.1002/bit.25888; Balasubramanian S, 2015, J BIOTECHNOL, V200, P61, DOI 10.1016/j.jbiotec.2015.03.001; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Cacciatore JJ, 2010, BIOTECHNOL ADV, V28, P673, DOI 10.1016/j.biotechadv.2010.04.003; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; Davies SL, 2011, BIOTECHNOL PROGR, V27, P1689, DOI 10.1002/btpr.692; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Frye C. C., 2013, J BIOTECHNOL, V168, P4, DOI DOI 10.1016/J.JBI0TEC.2013.08.021; Haryadi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116878; Ho S.-H., 2015, INT J MARKETING STUD, V7, DOI [10.5539/ijms.v7n2p10, DOI 10.5539/IJMS.V7N2P10]; Ho SCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063247; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Inada E, 2015, INT J ORAL SCI, V7, P144, DOI 10.1038/ijos.2015.18; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; Kim JY, 2011, APPL MICROBIOL BIOT, V89, P1917, DOI 10.1007/s00253-011-3106-9; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Li M, 2012, MOL THER, V20, P46, DOI 10.1038/mt.2011.197; Liu JM, 2014, PROTEIN J, V33, P174, DOI 10.1007/s10930-014-9550-5; Mason M, 2012, BIOTECHNOL PROGR, V28, P846, DOI 10.1002/btpr.1542; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Meir YJJ, 2013, FASEB J, V27, P4429, DOI 10.1096/fj.12-223586; Mossine VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085494; Nematpour F, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0330-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajendra Y, 2016, BIOTECHNOLOGY PROGR; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Ye JX, 2010, BIOTECHNOL PROGR, V26, P1431, DOI 10.1002/btpr.469; Zhao S, 2016, TRANSL LUNG CANCER R, V5, P120, DOI 10.3978/j.issn.2218-6751.2016.01.05	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179902	10.1371/journal.pone.0179902	http://dx.doi.org/10.1371/journal.pone.0179902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662065	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300068
J	Trucco, LD; Roselli, E; Araya, P; Nunez, NG; Mena, HA; Bocco, JL; Negrotto, S; Maccioni, M				Daniel Trucco, Lucas; Roselli, Emiliano; Araya, Paula; Gonzalo Nunez, Nicolas; Agustina Mena, Hebe; Luis Bocco, Jose; Negrotto, Soledad; Maccioni, Mariana			Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; TUMOR-GROWTH; CANCER; CELLS; INFLAMMATION; ACTIVATION; EXPRESSION; HYPOXIA; METASTASIS	The mechanisms that link inflammatory responses to cancer development remain a subject of intense investigation, emphasizing the need to better understand the cellular and molecular pathways that create a tumor promoting microenvironment. The myeloid differentiation primary response protein MyD88 acts as a main adaptor molecule for the signaling cascades initiated from Toll-like receptors (TLRs) and the interleukin 1 receptor (IL-1R). MyD88 has been shown to contribute to tumorigenesis in many inflammation-associated cancer models. In this study, we sought to better define the role of MyD88 in neoplastic cells using a murine melanoma model. Herein, we have demonstrated that MyD88 expression is required to maintain the angiogenic switch that supports B16 melanoma growth. By knocking down MyD88 we reduced TLR-mediated NF-B-K activation with no evident effects over cell proliferation and survival. In addition, MyD88 downregulation was associated with a decrease of HIF1 alpha levels and its target gene VEGF, in correlation with an impaired capability to induce capillary sprouting and tube formation of endothelial cells. Melanomas developed from cells lacking MyD88 showed an enhanced secretion of chemoattractant ligands such as CCL2, CXCL10 and CXCL1 and have an improved infiltration of macrophages to the tumor site. Our results imply that cell-autonomous signaling through MyD88 is required to sustain tumor growth and underscore its function as an important positive modulator of tumor angiogenesis.	[Daniel Trucco, Lucas; Roselli, Emiliano; Araya, Paula; Luis Bocco, Jose; Maccioni, Mariana] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol CIBICI, Consejo Nacl Invest Cient & Tecn CONICET,Dept Bio, Cordoba, Argentina; [Gonzalo Nunez, Nicolas] Inst Curie, INSERM, U932, Lab Transfert,Lab Immunol, Paris, France; [Agustina Mena, Hebe; Negrotto, Soledad] Acad Nacl Med Buenos Aires, Lab Trombosis Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Buenos Aires National Academy of Medicine	Maccioni, M (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol CIBICI, Consejo Nacl Invest Cient & Tecn CONICET,Dept Bio, Cordoba, Argentina.	mmaccioni@fcq.unc.edu.ar	Araya, Paula/AAC-3641-2021	Araya, Paula/0000-0002-0340-5359; Roselli, Emiliano/0000-0001-6048-7170; Mena, Hebe Agustina/0000-0003-1724-8582	Fondo Nacional de Ciencia y Tecnologia-Prestamo [BID PICT 2011 2657/PICT 2013 1068, PIP CONICET 2012/2014 11220110100921]; Institute Nacional del Cancer Convocatoria [SECyT-UNC 366/16]	Fondo Nacional de Ciencia y Tecnologia-Prestamo; Institute Nacional del Cancer Convocatoria	This study was funded by Fondo Nacional de Ciencia y Tecnologia-Prestamo BID PICT 2011 2657/PICT 2013 1068 to MM, PIP CONICET 2012/2014 11220110100921, Institute Nacional del Cancer Convocatoria 2015 to MM, SECyT-UNC 366/16 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Banerjee A, 2014, INFECT IMMUN, V82, P356, DOI 10.1128/IAI.01344-13; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Gatti G, 2009, PROSTATE, V69, P1387, DOI 10.1002/pros.20984; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Je EM, 2012, TUMORI, V98, P663, DOI 10.1700/1190.13209; Jia RJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.71; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kfoury A, 2013, JNCI-J NATL CANCER I, V105, P937, DOI 10.1093/jnci/djt120; Liang BB, 2013, CLIN CANCER RES, V19, P2905, DOI 10.1158/1078-0432.CCR-12-1245; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Trucco LD, 2014, FASEB J; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhu Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-77	46	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179897	10.1371/journal.pone.0179897	http://dx.doi.org/10.1371/journal.pone.0179897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662055	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300066
J	Lee, JC; Chuang, KS; Chen, YW; Hsu, FY; Chou, FI; Yen, SH; Wu, YH				Lee, Jia-Cheng; Chuang, Keh-Shih; Chen, Yi-Wei; Hsu, Fang-Yuh; Chou, Fong-In; Yen, Sang-Hue; Wu, Yuan-Hung			Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy	PLOS ONE			English	Article							BNCT; BEAM; THOR; RADIATION; CHILDREN; TRIAL	Diffuse intrinsic pontine glioma is a very frustrating disease. Since the tumor infiltrates the brain stem, surgical removal is often impossible. For conventional radiotherapy, the dose constraint of the brain stem impedes attempts at further dose escalation. Boron neutron capture therapy (BNCT), a targeted radiotherapy, carries the potential to selectively irradiate tumors with an adequate dose while sparing adjacent normal tissue. In this study, 12 consecutive patients treated with conventional radiotherapy in our institute were reviewed to evaluate the feasibility of BNCT. NCTPIan Ver. 1.1.44 was used for dose calculations. Compared with two and three fields, the average maximal dose to the normal brain may be lowered to 7.35 +/- 0.72 Gy-Eq by four-field irradiation. The mean ratio of minimal dose to clinical target volume and maximal dose to normal tissue was 2.41 +/- 0.26 by four-field irradiation. A therapeutic benefit may be expected with multi-field boron neutron capture therapy to treat diffuse intrinsic pontine glioma without craniotomy, while the maximal dose to the normal brain would be minimized by using the four-field setting.	[Lee, Jia-Cheng; Chen, Yi-Wei; Yen, Sang-Hue; Wu, Yuan-Hung] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Lee, Jia-Cheng; Chuang, Keh-Shih] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chen, Yi-Wei; Wu, Yuan-Hung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Fang-Yuh; Chou, Fong-In] Natl Tsing Hua Univ, Nucl Sci & Technol Dev Ctr, Hsinchu, Taiwan; [Wu, Yuan-Hung] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Wu, Yuan-Hung] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan	Taipei Veterans General Hospital; National Tsing Hua University; National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wu, YH (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Wu, YH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.	yuanhung@gmail.com	Chen, Yi/HIR-2608-2022	wu, yuanhung/0000-0003-2908-7704	Taipei Veterans General Hospital [V105A-046, V105A-013, V106A-007, V106A-016]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the Taipei Veterans General Hospital (www.vghtpe.gov,tw) No: V105A-046(JCL), V105A-013(YHW), V106A-007(YHW), V106A-016 (JCL), Taipei Veterans General Hospital-National Yang Ming University Excellent Physician Scientists Cultivation Program (www.vghtpe.gov.tw) No. 105-V-B-107(YHW). The funders had no role in study design, data collection	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aoyama H, 2006, INT J RADIAT ONCOL, V64, P962, DOI 10.1016/j.ijrobp.2005.11.005; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Gonzalez S, 2003, NCTPLAN NEW PC VERSI; Hsu FY, 2009, APPL RADIAT ISOTOPES, V67, pS130, DOI 10.1016/j.apradiso.2009.03.033; ICRU, 1992, PHOT EL PROT NEUTR I; Kawabata S, 2011, APPL RADIAT ISOTOPES, V69, P1796, DOI 10.1016/j.apradiso.2011.03.014; Kiger W III, 2002, VERIFICATION VALIDAT, P613; Liu YH, 2009, APPL RADIAT ISOTOPES, V67, pS137, DOI 10.1016/j.apradiso.2009.03.088; Marcus KJ, 2003, INT J RADIAT ONCOL, V55, P1182, DOI 10.1016/S0360-3016(02)04391-2; Morgan-Fletcher S.L., 2001, BRIT J RADIOL, V74, P294, DOI [10.1259/bjr.74.879.740294, DOI 10.1259/bjr.74.879.740294, DOI 10.1259/BJR.74.879.740294]; Nakagawa Y, 2009, APPL RADIAT ISOTOPES, V67, pS27, DOI 10.1016/j.apradiso.2009.03.090; Pelowitz D.B., 2011, 0LACP1100438 LOS AL; Rasband W., 2006, IMAGEJ; ROGUS RD, 1994, MED PHYS, V21, P1611, DOI 10.1118/1.597267; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenenko VA, 2008, MED PHYS, V35, P5851, DOI 10.1118/1.3013556; Skold K, 2014, BRIT J RADIOLOGY; Tung CJ, 2004, APPL RADIAT ISOTOPES, V61, P861, DOI 10.1016/j.apradiso.2004.05.066; Wang LW, 2016, INT J RADIAT ONCOL, V95, P396, DOI 10.1016/j.ijrobp.2016.02.028; Wang LW, 2014, APPL RADIAT ISOTOPES, V88, P23, DOI 10.1016/j.apradiso.2013.11.134; Zamenhof R., 2001, NEUTRON CAPTURE THER, P216	22	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180461	10.1371/journal.pone.0180461	http://dx.doi.org/10.1371/journal.pone.0180461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662135	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300158
J	Liao, K; Chen, WB; Zhang, RT; Zhou, HB; Xu, JL; Zhou, CX; Yan, XJ				Liao, Kai; Chen, Wenbi; Zhang, Runtao; Zhou, Haibo; Xu, Jilin; Zhou, Chengxu; Yan, Xiaojun			qPCR analysis of bivalve larvae feeding preferences when grazing on mixed microalgal diets	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; SCALLOP PLACOPECTEN-MAGELLANICUS; PARTICLE SELECTION; RAZOR CLAM; SURFACE-PROPERTIES; GROWTH; SURVIVAL; ABSORPTION; SUSPENSION; SEA	Characterization of the feeding preferences of bivalve larvae would help improving the bivalve aquaculture and hatchery by providing appropriate microalgal diets. However, inaccurate and laborious identification and counting of microalgal species have challenged the selective feeding of bivalves. In the present study, we developed a highly specific and sensitive assay using quantitative polymerase chain reaction (qPCR) to assess the selective feeding of bivalve larvae based on species-specific primers targeting to microalgal 18S rDNA sequences. The assay exhibited good specificity. The detection limits of the qPCR assay were 769, 71, 781 and 21 18S rDNA copies for Chaetoceros calcitrans, Isochrysis galbana, Platymonas helgolandica and Nannochloropsis oculata, respectively. Using such assay, we found that C. calcitrans and I. galbana were preferentially ingested, whereas N. oculata was preferentially rejected in biodeposits of four bivalve species, Tegillarca gransa, Cyclina sinensis, Scapharca subcrenata and Sinonovacula constricta. Furthermore, our growth experiments revealed that C. calcitrans and I. galbana could significantly promote the shell growth, whereas feeding of N. oculata resulted in poorer growth of four bivalve species. These data indicated that qPCR might be useful in screening of efficient and reliable microalgal species for each bivalve species, leading to improved bivalve aquaculture and hatchery.	[Liao, Kai; Zhang, Runtao; Zhou, Haibo; Xu, Jilin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Chinese Minist Educ, Ningbo, Zhejiang, Peoples R China; [Chen, Wenbi; Zhou, Chengxu; Yan, Xiaojun] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Xu, JL (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Chinese Minist Educ, Ningbo, Zhejiang, Peoples R China.; Yan, XJ (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	xujilin@nbu.edu.cn; yanxiaojun@nbu.edu.cn	ZHOU, Haibo/M-7373-2017	Yan, Xiaojun/0000-0003-0257-0157	Zhejiang Natural Science Foundation, China [LY15C190004]; Project of Ministry of Education, China [20133305130001]; Ningbo Science and Technology Research Projects, China [2017C110003]; Ningbo Marine Algae Biotechnology Team, China [2011B81007]; Earmarked Fund for Modern Agro-industry Technology Research System, China [CARS-48]; Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K.C. Wong Magna Fund in Ningbo University; Fujian Baozhi Aquatic Science and Technology Ltd.	Zhejiang Natural Science Foundation, China(Natural Science Foundation of Zhejiang Province); Project of Ministry of Education, China(Ministry of Education, China); Ningbo Science and Technology Research Projects, China; Ningbo Marine Algae Biotechnology Team, China; Earmarked Fund for Modern Agro-industry Technology Research System, China; Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K.C. Wong Magna Fund in Ningbo University; Fujian Baozhi Aquatic Science and Technology Ltd.	This research was supported by Zhejiang Natural Science Foundation, China (LY15C190004); Project of Ministry of Education, China (20133305130001); Ningbo Science and Technology Research Projects, China (2017C110003); Ningbo Marine Algae Biotechnology Team, China (2011B81007); the Earmarked Fund for Modern Agro-industry Technology Research System, China (CARS-48); Li DakSum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; and partly sponsored by K.C. Wong Magna Fund in Ningbo University. HZ received support in the form of salary from Fujian Baozhi Aquatic Science and Technology Ltd. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript .The specific roles of these authors are articulated in the 'author contributions' section	[Anonymous], 1916, SCIENCE, V44, P178, DOI 10.1126/science.44.1127.178; Bernardo V, 2013, ANAL BIOCHEM, V432, P131, DOI 10.1016/j.ab.2012.09.029; Brillant MGS, 2002, MAR BIOL, V141, P457, DOI 10.1007/s00227-002-0845-2; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; China Fishery Statistical Yearbook, 2015, CHI FISH STAT YB; Dunphy BJ, 2006, AQUACULTURE, V261, P594, DOI 10.1016/j.aquaculture.2006.08.015; Durbin EG, 2008, MAR BIOL, V153, P699, DOI 10.1007/s00227-007-0843-5; Durbin EG, 2012, J PLANKTON RES, V34, P72, DOI 10.1093/plankt/fbr082; Espinosa E. P., 2016, MAR BIOL, V163, P1; Espinosa EP, 2008, ESTUAR COAST SHELF S, V79, P1, DOI 10.1016/j.ecss.2008.02.022; Gouda R, 2006, AQUACULTURE, V259, P169, DOI 10.1016/j.aquaculture.2006.03.050; HAVEN DS, 1970, BIOL BULL, V139, P248, DOI 10.2307/1540081; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; MAMAT NZ, 2014, INT AQUAT RES, V6, pNIL33, DOI DOI 10.1007/s40071-014-0057-7; Marshall R, 2010, REV AQUACULT, V2, P33, DOI 10.1111/j.1753-5131.2010.01022.x; Martinez-Fernandez E, 2006, AQUACULTURE, V257, P491, DOI 10.1016/j.aquaculture.2006.03.022; Navarro E, 2016, MAR ENVIRON RES, V120, P111, DOI 10.1016/j.marenvres.2016.07.013; Nejstgaard JC, 2003, LIMNOL OCEANOGR-METH, V1, P29, DOI 10.4319/lom.2003.1.29; Rosa M, 2017, J EXP MAR BIOL ECOL, V486, P59, DOI 10.1016/j.jembe.2016.09.007; Rosa M, 2013, J EXP MAR BIOL ECOL, V446, P320, DOI 10.1016/j.jembe.2013.05.011; Sanchez-Lazo C, 2014, AQUACULTURE, V426, P138, DOI 10.1016/j.aquaculture.2014.01.032; Shen HD, 2013, AQUAC RES, V44, P1524, DOI 10.1111/j.1365-2109.2012.03159.x; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SIERSZEN ME, 1992, ARCH HYDROBIOL, V123, P257; Velasco LA, 2007, AQUACULTURE, V270, P299, DOI 10.1016/j.aquaculture.2007.04.005; Villanueva PA, 2016, MAR FRESHW BEHAV PHY, V49, P291, DOI 10.1080/10236244.2016.1193952; Wang Hui, 2008, Marine Fisheries, V30, P92; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; Xu JL, 2012, J AGR FOOD CHEM, V60, P3973, DOI 10.1021/jf300620e; Yang F, 2016, AQUACULT NUTR, V22, P846, DOI 10.1111/anu.12310	30	7	7	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180730	10.1371/journal.pone.0180730	http://dx.doi.org/10.1371/journal.pone.0180730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662212	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300174
J	Ogawa, C; Tsuchiya, K; Tomosugi, N; Kanda, F; Maeda, K; Maeda, T				Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Kanda, Fumiyoshi; Maeda, Kunimi; Maeda, Teiryo			Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEPCIDIN LEVELS; THERAPY; MANAGEMENT; RISK; ERYTHROPOIETIN; INFLAMMATION; DIALYSIS	Background Optimal iron levels in patients on hemodialysis are currently unknown, and a higher level than that for the healthy population is usually set for such patients considering the use of erythropoiesis-stimulating agents or the occurrence of chronic inflammation. However, excessive iron causes oxidative stress and impairment of its utilization by cells. Therefore we investigated the relationship between hemoglobin (Hb) level and iron status in hemodialysis patients to identify the optimal iron levels for patients undergoing hemodialysis. Methods A total of 208 outpatients on maintenance hemodialysis were followed up between July 2006 and June 2007. Men accounted for 64.9% cases [mean age, 59.3 +/- 13.1 years and median dialysis history, 7.7 (3.6-13.2) years], and diabetic nephropathy accounted for 25.0% cases. Hemoglobin level was measured twice a month and serum ferritin, serum iron, and total iron-binding capacity were measured once a month. The doses of recombinant human erythropoietin and low-dose iron supplement were adjusted to maintain a hemoglobin level of 10-11 g/dL, according to the guidelines of the Japanese Society for Dialysis Therapy. Hepcidin was measured at baseline. Using the mean values for 1-year period, the relationships among hemoglobin, serum ferritin levels, and transferrin saturation levels were investigated based on a receiver operating characteristic curve and a logistic regression model. In addition, the correlations among serum ferritin, transferrin saturation, and hepcidin levels were analyzed by Pearson product-moment correlation coefficient and linear regression model. Results By receiver operating characteristic curve, the cutoff point of serum ferritin and transferrin saturation levels with a hemoglobin >= 10 g/dL showed <90 ng/mL (sensitivity: 69.1%, specificity: 72.1%, p < 0.001) and >= 20% (sensitivity: 77.6%, specificity: 48.8%, p = 0.302). Upon logistic regression model analysis with a hemoglobin >= 10 g/dL as the endpoint, the analysis of odds ratios relative to a group with serum ferritin >= 90 ng/mL and transferrin saturation <20% revealed that the group with serum ferritin <90 ng/mL and transferrin saturation >= 20% had the highest ratio: 46.75 (95% confidence interval: 10.89-200.70, p < 0.001). In Pearson product-moment correlation coefficient, hepcidin showed a strong positive correlation with serum ferritin [r = 0.78 (95% confidence interval: 0.72-0.83, p < 0.001)] and a weak positive correlation with transferrin saturation [r = 0.18 (95% confidence interval: 0.04-0.31, p = 0.010)]. In the multivariable analyses of the linear regression model, a positive relationship was shown between hepcidin and serum ferritin [beta-coefficient of 0.30 (95% confidence interval: 0.27-0.34, p < 0.001)]; however, no relationship was shown with transferrin saturation [beta-coefficient of 0.09 (95% confidence interval: -0.31-0.49, p = 0.660)]. Conclusions In this study, the iron status of serum ferritin <90 ng/mL and transferrin saturation >= 20% was optimal in hemodialysis patients receiving recombinant human erythropoietin for anemia therapy. This result indicates that the threshold values for the optimal iron status may be lower than those currently recommended in iron-level management guideline.	[Ogawa, Chie; Kanda, Fumiyoshi; Maeda, Kunimi; Maeda, Teiryo] Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan; [Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Maeda, Kunimi; Maeda, Teiryo] INC, Biomarker Soc, Kawasaki, Kanagawa, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Project Res Ctr, Div Syst Biosci Drug Discovery, Uchinada, Ishikawa, Japan	Tokyo Women's Medical University; Kanazawa Medical University	Ogawa, C (corresponding author), Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan.; Ogawa, C (corresponding author), INC, Biomarker Soc, Kawasaki, Kanagawa, Japan.	tato.ogawa@gmail.com						Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; ALI MAM, 1978, CAN MED ASSOC J, V118, P945; [Anonymous], 2011, KIDNEY INT S, V4, P292; [Anonymous], 2006, AM J KIDNEY DIS S, V47, pS11; Anraku M, 2008, CLIN BIOCHEM, V41, P1168, DOI 10.1016/j.clinbiochem.2008.07.007; Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Cristol JP, 1997, NEPHROL DIAL TRANSPL, V12, P2312, DOI 10.1093/ndt/12.11.2312; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; ESCHBACH JW, 1977, ANN INTERN MED, V87, P710, DOI 10.7326/0003-4819-87-6-710; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Hamano T, 2015, KIDNEY INT SUPPL, V5, P23, DOI 10.1038/kisup.2015.6; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Kiechl S, 1997, CIRCULATION, V96, P3300; Kliger SA, AM J KIDNEY DIS, V62, P849; Kuragano T, 2010, AM J NEPHROL, V31, P534, DOI 10.1159/000312381; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Maruyama Y, 2007, NEPHROL DIAL TRANSPL, V22, P1407, DOI 10.1093/ndt/gfl789; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Nakanishi T, 2010, AM J NEPHROL, V32, P439, DOI 10.1159/000320733; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pasricha SRS, 2010, MED J AUSTRALIA, V193, P525, DOI 10.5694/j.1326-5377.2010.tb04038.x; Reis KA, 2005, INT HEART J, V46, P255, DOI 10.1536/ihj.46.255; Rubab Z, 2015, SAUDI J KIDNEY DIS T, V26, P19; Sargent JA, 2004, BLOOD PURIFICAT, V22, P112, DOI 10.1159/000074931; Takasawa K, 2015, NUTRIENTS, V7, P103, DOI 10.3390/nu7010103; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Tsukamoto T, 2016, AM J NEPHROL, V43, P32, DOI 10.1159/000444335; Turenne MN, 2015, J AM SOC NEPHROL, V26, P754, DOI 10.1681/ASN.2013111232; Usberti M, 2002, J NEPHROL, V15, P558; Weiss G, 2009, EUR J CLIN INVEST, V39, P883, DOI 10.1111/j.1365-2362.2009.02182.x; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179608	10.1371/journal.pone.0179608	http://dx.doi.org/10.1371/journal.pone.0179608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662118	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300038
J	Phillips, JS; Pilling, GM; Leroy, B; Evans, K; Usu, T; Lam, CH; Schaefer, KM; Nicol, S				Phillips, Joe Scutt; Pilling, Graham M.; Leroy, Bruno; Evans, Karen; Usu, Thomas; Lam, Chi Hin; Schaefer, Kurt M.; Nicol, Simon			Revisiting the vulnerability of juvenile bigeye (Thunnus obesus) and yellowfin (T-albacares) tuna caught by purse-seine fisheries while associating with surface waters and floating objects	PLOS ONE			English	Article							FISH-AGGREGATING DEVICES; SKIPJACK KATSUWONUS-PELAMIS; EASTERN PACIFIC-OCEAN; TROPICAL TUNA; HABITAT UTILIZATION; VERTICAL MOVEMENTS; SPECIES COMPOSITION; ECOLOGICAL TRAP; BEHAVIOR; CATCHES	Tuna fisheries catch over three million tonnes of skipjack tuna (Katsuwonus pelamis) each year, the majority of which come from purse-seine vessels targeting fish associated with man-made fish aggregating devices (FADs). A significant challenge for fisheries management is to maximize the efficiency of skipjack tuna catches whilst minimizing the bycatch of small and immature bigeye (Thunnus obesus) and yellowfin (T. albacares) tuna, for which long-term sustainability is uncertain in 75% of the world's stocks. To better manage the issues common with this fishing method, an improved understanding of tuna behaviour around FADs is necessary. We probabilistically classified the vertical behavioural patterns of 50 bigeye and 35 yellowfin tuna (mean fork length 72cm and 70cm, respectively) electronically tagged throughout the western and central Pacific Ocean into shallow and deep states, using a state-space modelling approach. The occurrence of surface-association behaviours, defined as an individual remaining in a shallow state for 24-hours, was examined in relation to known capture events and FAD density. In general, surface-association events for both species were short and lasted on average less than three days, although events as long as 28 days were observed, and were more common in yellowfin when in archipelagic waters. Events were longest immediately following tagging in 62% and 17% of bigeye and yellowfin, respectively. Surface-association behaviour was not generally estimated just prior to recapture, being either non-existent or shorter than two days for 85% of bigeye and 74% of yellowfin. Current management measures in purse-seine tuna fisheries involve periodic or spatial closures for FAD use. If the chief benefit to purse-seine fishers of surface-association around floating objects is in locating schools in horizontal space at short-term time-scales, rather than holding fish near the surface for extended periods, controlling the number of sets made on FADs should be explored further as an additional management tool.	[Phillips, Joe Scutt] Univ New South Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Pilling, Graham M.; Leroy, Bruno] Pacific Community SPC, Ocean Fisheries Programme, Noumes, New Caledonia; [Evans, Karen] CSIRO, Marine & Atmosphere Res, Hobart, Tas, Australia; [Usu, Thomas] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Lam, Chi Hin] Univ Massachusetts, Large Pelag Res Ctr, Gloucester, MA USA; [Schaefer, Kurt M.] Interamer Trop Tuna Commiss, La Jolla, CA USA; [Nicol, Simon] Australian Bur Agr & Resource Econ & Sci, Canberra, ACT, Australia	University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Massachusetts System	Phillips, JS (corresponding author), Univ New South Wales, Climate Change Res Ctr, Sydney, NSW, Australia.	j.scuttphillips@unsw.edu.au	evans, karen/D-7110-2012	Nicol, Simon/0000-0001-8193-8719; Evans, Karen/0000-0003-2205-4264	Engineering and Physical Sciences Research Council [EP/G03690X/1JSP]; Lenfest Ocean Program JSP; Australian Research Council [LP140100327]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Lenfest Ocean Program JSP; Australian Research Council(Australian Research Council)	Funded by Engineering and Physical Sciences Research Council EP/G03690X/1JSP, Lenfest Ocean Program JSP, Australian Research Council LP140100327.	Albert JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115386; Allain V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036701; Bromhead D., 2003, REV IMPACTS FISH AGG; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; Dagorn L, 2000, AQUAT LIVING RESOUR, V13, P203, DOI 10.1016/S0990-7440(00)01065-2; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2010, FISH RES, V106, P60, DOI 10.1016/j.fishres.2010.07.002; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Evans K, 2015, MAR POLICY, V59, P94, DOI 10.1016/j.marpol.2015.05.003; Evans K, 2013, DEEP-SEA RES PT II, V88-89, P1, DOI 10.1016/j.dsr2.2012.10.005; Evans K, 2008, CAN J FISH AQUAT SCI, V65, P2427, DOI 10.1139/F08-148; Fernandez E, 2010, SPC FISHERIES NEWSLE, V133, P35; Fonteneau A, 2000, AQUAT LIVING RESOUR, V13, P253, DOI 10.1016/S0990-7440(00)01054-8; Fonteneau A, 1999, WORLDWIDE REV PURSE; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Fuller DW, 2015, FISH RES, V172, P57, DOI 10.1016/j.fishres.2015.06.024; Fuller DW, 2014, ICES J MAR SCI, V71, P1774, DOI 10.1093/icesjms/fsu012; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Guillotreau P, 2011, FISH RES; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Hampton J, 1992, P INT WORKSH EC FISH, P222; Hampton J., 2010, TUNA FISHERIES STATU; Hare SR, 2015, FISH RES, V172, P361, DOI 10.1016/j.fishres.2015.08.004; Holland K., 1996, SPC FISH AGGREGATING, V2, P2; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; IATTC, 2013, MULT PROGR CONV TUN; IATTC, 2015, TUN BILLF OTH PEL SP; ISSF, 2016, 201605 ISSF; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Leroy BM, 2010, VERTICAL BEHAV OBSER, P21, DOI [10.1007/978-1-4020-9640-210, DOI 10.1007/978-1-4020-9640-210]; Leroy B, 2015, FISH RES, V163, P23, DOI 10.1016/j.fishres.2013.09.001; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Magnuson J., 1973, FISH B B, V71; Marsac F, 1999, DRIFTING FADS USED T; Matsumoto T, 2013, FISH OCEANOGR, V22, P234, DOI 10.1111/fog.12017; Maufroy A, 2017, ICES J MAR SCI, V74, P215, DOI 10.1093/icesjms/fsw175; Miyake M., 2010, RECENT DEV TUNA IND; Moreno G, 2016, FISH RES, V178, P122, DOI 10.1016/j.fishres.2015.09.021; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Ohta I, 2005, MAR BIOL, V146, P581, DOI 10.1007/s00227-004-1456-x; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Phillips JS, 2015, ECOL APPL, V25, P1244, DOI 10.1890/14-0862.1; Pilling G, 2013, 9 REGUL SESS, P1; Pilling GM, 2014, PURSE SEINE CPUE SKI; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Robert M, 2013, MAR ECOL PROG SER, V484, P239, DOI 10.3354/meps10303; Robert M, 2012, MAR BIOL, V159, P907, DOI 10.1007/s00227-011-1868-3; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schaefer KM, 2005, MAR BIOL, V146, P781, DOI 10.1007/s00227-004-1480-x; Schaefer K, 2015, FISH RES, V161, P336, DOI 10.1016/j.fishres.2014.08.018; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2014, FISH OCEANOGR, V23, P65, DOI 10.1111/fog.12047; Schaefer KM, 2013, MAR BIOL, V160, P3005, DOI 10.1007/s00227-013-2290-9; Schaefer KM, 2010, MAR BIOL, V157, P2625, DOI 10.1007/s00227-010-1524-3; Schaefer Kurt M., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V57, P67; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Sempo G, 2013, J APPL ECOL, V50, P1081, DOI 10.1111/1365-2664.12140; Sippel T, 2014, FISH RES; Trygonis V, 2016, FISH RES, V177, P39, DOI 10.1016/j.fishres.2016.01.013; WCPFC, 2014, FAD MARK MAN DISC PA; Williams P, 2012, OVERVIEW TUNA FISHER; Williams P, 2016, OVERVIEW TUNA FISHER	65	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179045	10.1371/journal.pone.0179045	http://dx.doi.org/10.1371/journal.pone.0179045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662091	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300015
J	Wasser, SK; Lundin, JI; Ayres, K; Seely, E; Giles, D; Balcomb, K; Hempelmann, J; Parsons, K; Booth, R				Wasser, Samuel K.; Lundin, Jessica I.; Ayres, Katherine; Seely, Elizabeth; Giles, Deborah; Balcomb, Kenneth; Hempelmann, Jennifer; Parsons, Kim; Booth, Rebecca			Population growth is limited by nutritional impacts on pregnancy success in endangered Southern Resident killer whales (Orcinus orca)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PAPIO-CYNOCEPHALUS-CYNOCEPHALUS; THYROID-HORMONE; TURSIOPS-TRUNCATUS; POLYCHLORINATED-BIPHENYLS; EUBALAENA-GLACIALIS; REPRODUCTIVE STATUS; MARINE MAMMALS; DETECTION DOGS; DIVERSE ARRAY	The Southern Resident killer whale population (Orcinus orca) was listed as endangered in 2005 and shows little sign of recovery. These fish eating whales feed primarily on endangered Chinook salmon. Population growth is constrained by low offspring production for the number of reproductive females in the population. Lack of prey, increased toxins and vessel disturbance have been listed as potential causes of the whale's decline, but partitioning these pressures has been difficult. We validated and applied temporal measures of progesterone and testosterone metabolites to assess occurrence, stage and health of pregnancy from genotyped killer whale feces collected using detection dogs. Thyroid and glucocorticoid hormone metabolites were measured from these same samples to assess physiological stress. These methods enabled us to assess pregnancy occurrence and failure as well as how pregnancy success was temporally impacted by nutritional and other stressors, between 2008 and 2014. Up to 69% of all detectable pregnancies were unsuccessful; of these, up to 33% failed relatively late in gestation or immediately post-partum, when the cost is especially high. Low availability of Chinook salmon appears to be an important stressor among these fish-eating whales as well as a significant cause of late pregnancy failure, including unobserved perinatal loss. However, release of lipophilic toxicants during fat metabolism in the nutritionally deprived animals may also provide a contributor to these cumulative effects. Results point to the importance of promoting Chinook salmon recovery to enhance population growth of Southern Resident killer whales. The physiological measures used in this study can also be used to monitor the success of actions aimed at promoting adaptive management of this important apex predator to the Pacific Northwest.	[Wasser, Samuel K.; Lundin, Jessica I.; Ayres, Katherine; Seely, Elizabeth; Booth, Rebecca] Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA; [Giles, Deborah; Balcomb, Kenneth] Ctr Whale Res, Friday Harbor, WA USA; [Hempelmann, Jennifer; Parsons, Kim] Natl Ocean & Atmospher Adm Fisheries, Northwest Fisheries Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Wasser, SK (corresponding author), Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA.	wassers@uw.edu	Wasser, Samuel K/I-5542-2015		National Oceanic and Atmospheric Administration (NOAA) [NA10OAR417005]; U.S. Environmental Protection Agency STAR Fellowship Assistance [91735201]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency STAR Fellowship Assistance	This work was supported by the National Oceanic and Atmospheric Administration (NOAA), award no. NA10OAR417005. No role played by funder. U.S. Environmental Protection Agency STAR Fellowship Assistance Agreement no. 91735201 also supported this work. No role played by funder.	Alava JJ, 2012, ENVIRON SCI TECHNOL, V46, P12655, DOI 10.1021/es303062q; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Baird RW, 2001, CAN FIELD NAT, V115, P676; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; BONGAARTS J, 1980, SCIENCE, V208, P564, DOI 10.1126/science.7367878; BOON JP, 1994, EUR J PHARM-ENVIRON, V270, P237, DOI 10.1016/0926-6917(94)90068-X; Brent LJN, 2015, CURR BIOL, V25, P746, DOI 10.1016/j.cub.2015.01.037; Brett J.R., 1995, P3; Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59, DOI 10.1177/074823379801400107; Canadian Press, 2013, 1 NAT EXP POLL CHEM; Chinook Albion, 2014, FISHERIES OCEANS CAN; Costa Lucio G, 2008, Acta Biomed, V79, P172; Cullon DL, 2009, ENVIRON TOXICOL CHEM, V28, P148, DOI 10.1897/08-125.1; deSwart RL, 1996, ENVIRON HEALTH PERSP, V104, P823, DOI 10.2307/3432713; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; du Dot TJ, 2009, PHYSIOL BIOCHEM ZOOL, V82, P516, DOI 10.1086/603637; Ford JKB, 200542 CAN SCI ADV S; Ford MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144956; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Hanson MB, 2013, J ACOUST SOC AM, V134, P3486, DOI 10.1121/1.4821206; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hayward LS, 2010, GEN COMP ENDOCR, V169, P117, DOI 10.1016/j.ygcen.2010.08.004; Hilborn R., 2012, EFFECTS SALMON FISHE; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; LAHVIS GP, 1995, ENVIRON HEALTH PERSP, V103, P67, DOI 10.2307/3432414; Lee D, 2014, FASEB J S, V28; Lundin JI, 2016, ENVIRON SCI TECHNOL, V50, P6506, DOI 10.1021/acs.est.6b00825; Lundin JI, 2015, ARCH ENV CONTAM TOXI; Mesa MG, 2006, RIVER RES APPL, V22, P1085, DOI 10.1002/rra.955; Mongillo TM, 2012, MAR ECOL PROG SER, V453, P263, DOI 10.3354/meps09658; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; National Oceanic and Atmospheric Administration (NOAA), PRIOR ACT 2016 2020; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Reddy ML, 2001, SCI TOTAL ENVIRON, V274, P171, DOI 10.1016/S0048-9697(01)00741-0; Robeck TR, 2016, GEN COMP ENDOCR, V236, P83, DOI 10.1016/j.ygcen.2016.07.010; Robeck TR, 2015, J MAMMAL, V96, P1055, DOI 10.1093/jmammal/gyv113; Robeck TR, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P193; Robeck TR, 2016, GEN COMP ENDOCRINOLO; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Shukovsky P., 1999, TRIBE SOUNDS ALARM F, pA1; Sinha N, 2014, CASE REPORTS CRITICA; SMITH CA, 1947, AM J OBSTET GYNECOL, V53, P599, DOI 10.1016/0002-9378(47)90277-9; Stetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055967; Velloso AL, 1998, GEN COMP ENDOCR, V112, P96, DOI 10.1006/gcen.1998.7147; Ward E, 2013, NMFSNWFSC123 NOAA; Ward EJ, ECOSPHERE, V7; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; WASSER SK, 1994, J REPROD FERTIL, V101, P213; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2001, FOUND HUM B, P137; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; West KL, 2014, GEN COMP ENDOCR, V197, P73, DOI 10.1016/j.ygcen.2013.11.021; Wiles G.J., 2016, PERIODIC STATUS REV; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wunderink YS, 2012, COMP BIOCHEM PHYS A, V162, P317, DOI 10.1016/j.cbpa.2012.03.023	62	75	77	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179824	10.1371/journal.pone.0179824	http://dx.doi.org/10.1371/journal.pone.0179824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662095	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300052
J	Yamasaki, K; Hyodo, S; Taguchi, K; Nishi, K; Yamaotsu, N; Hirono, S; Chuang, VTG; Seo, H; Maruyama, T; Otagiri, M				Yamasaki, Keishi; Hyodo, Saya; Taguchi, Kazuaki; Nishi, Koji; Yamaotsu, Noriyuki; Hirono, Shuichi; Chuang, Victor Tuan Giam; Seo, Hakaru; Maruyama, Toru; Otagiri, Masaki			Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin	PLOS ONE			English	Article							N-B TRANSITION; NUCLEAR-MAGNETIC-RESONANCE; TO-BASE TRANSITION; PROTEIN COMPLEXES; WARFARIN-BINDING; CRYSTALLOGRAPHIC ANALYSIS; CIRCULAR-DICHROISM; FLUFENAMIC ACID; DIAZEPAM; PLASMA	A wide variety of drugs bind to human serum albumin (HSA) at its two principal sites, namely site I and site II. A number of reports indicate that drug binding to these two binding sites are not completely independent, and that interactions between ligands of these two discrete sites can play a role. In this study, the effect of the binding of long-chain fatty acids on the interactive binding between dansyl-L-asparagine (DNSA; site I ligand) and ibuprofen (site II ligand) at pH6.5 was examined. Binding experiments showed that the binding of sodium oleate (Ole) to HSA induces conformational changes in the molecule, which, in turn, changes the individual binding of DNSA and ibuprofen, as well as the mode of interaction between these two ligands from a 'competitive-like' allosteric interaction in the case of the defatted HSA conformer to a 'nearly independent' binding in the case of non-defatted HSA conformer. Circular dichroism measurements indicated that ibuprofen and Ole are likely to modify the spatial orientation of DNSA at its binding site. Docking simulations suggest that the long-distance electric repulsion between DNSA and ibuprofen on defatted HSA contributes to a 'competitive-like' allosteric interaction, whereas extending the distance between ligands and/or increasing the flexibility or size of the DNSA binding site in fatted HSA evokes a change in the interaction mode to 'nearly independent' binding. The present findings provide further insights into the structural dynamics of HSA upon the binding of fatty acids, and its effects on drug binding and drug-drug interactions that occur on HSA.	[Yamasaki, Keishi; Hyodo, Saya; Taguchi, Kazuaki; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan; [Nishi, Koji] Yokohama Univ Pharm, Dept Clin Pharm, Yokohama, Kanagawa, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Sch Pharm, Fac Hlth Sci, Perth, WA, Australia; [Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan	Sojo University; Sojo University; Kitasato University; Curtin University; Kumamoto University	Yamasaki, K; Otagiri, M (corresponding author), Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan.; Yamasaki, K; Otagiri, M (corresponding author), Sojo Univ, DDS Res Inst, Kumamoto, Japan.	kcyama@ph.sojo-u.ac.jp; otagirim@ph.sojo-u.ac.jp	Chuang, Victor/A-3644-2011; Yamaotsu, Noriyuki/AAW-2545-2020	Chuang, Victor/0000-0002-2141-630X; Yamaotsu, Noriyuki/0000-0002-4302-1085; Yamasaki, Keishi/0000-0003-0537-2367	Japan Society for the Promotion of Science (JSPS) [KAKENHI 21590054]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI 21590054 to KY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour N, 2016, EUR J DRUG METAB PH, V41, P705, DOI 10.1007/s13318-015-0297-y; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; BAHR R, 1991, ACTA PHYSIOL SCAND, V143, P105, DOI 10.1111/j.1748-1716.1991.tb09205.x; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; BOS OJM, 1989, J BIOL CHEM, V264, P953; BREE F, 1990, EUR J DRUG METAB PH, V15, P303, DOI 10.1007/BF03190219; BREE F, 1993, J PHARM PHARMACOL, V45, P1050, DOI 10.1111/j.2042-7158.1993.tb07179.x; BRODERSEN R, 1990, EUR J BIOCHEM, V189, P343, DOI 10.1111/j.1432-1033.1990.tb15495.x; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHAKRABARTI SK, 1978, BIOCHEM PHARMACOL, V27, P739, DOI 10.1016/0006-2952(78)90513-0; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P455; CHIGNELL CF, 1971, MOL PHARMACOL, V7, P229; CHIGNELL CF, 1970, MOL PHARMACOL, V6, P1; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P244; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; DROGE JHM, 1985, BIOCHIM BIOPHYS ACTA, V827, P396, DOI 10.1016/0167-4838(85)90224-9; DROGE JHM, 1982, BIOCHEM PHARMACOL, V31, P3781, DOI 10.1016/0006-2952(82)90293-3; ERA S, 1990, INT J PEPT PROT RES, V35, P1; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FREDRICKSON DS, 1958, J CLIN INVEST, V37, P1504, DOI 10.1172/JCI103742; GIACOMINI KM, 1984, PHARMACEUT RES, P179, DOI 10.1023/A:1016352725805; KASAIMORITA S, 1987, BIOCHIM BIOPHYS ACTA, V915, P277, DOI 10.1016/0167-4838(87)90310-4; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KRAGHHANSEN U, 1988, MOL PHARMACOL, V34, P160; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KURIEN V A, 1971, Progress in Cardiovascular Diseases, V13, P361, DOI 10.1016/S0033-0620(71)80012-9; MANGROO D, 1995, BIOCHEM CELL BIOL, V73, P223, DOI 10.1139/o95-027; MCNAMARA PJ, 1990, BIOCHEM PHARMACOL, V40, P1247, DOI 10.1016/0006-2952(90)90390-7; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Moosavi-Movahedi Z, 2006, PROTEIN J, V25, P193, DOI 10.1007/s10930-006-9002-y; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Ryan AJ, 2011, J STRUCT BIOL, V174, P84, DOI 10.1016/j.jsb.2010.10.004; Sakai T, 2001, PHARMACEUT RES, V18, P520, DOI 10.1023/A:1011014629551; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SJODIN T, 1977, BIOCHEM PHARMACOL, V26, P2157, DOI 10.1016/0006-2952(77)90268-4; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; WANWIMOLRUK S, 1982, BIOCHIM BIOPHYS ACTA, V709, P247, DOI 10.1016/0167-4838(82)90467-8; WILDING G, 1977, BIOCHEM PHARMACOL, V26, P1143, DOI 10.1016/0006-2952(77)90058-2; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	52	34	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180404	10.1371/journal.pone.0180404	http://dx.doi.org/10.1371/journal.pone.0180404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662200	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300152
J	Amat, SB; Rowan, MJM; Gaffield, MA; Bonnan, A; Kikuchi, C; Taniguchi, H; Christie, JM				Amat, Samantha B.; Rowan, Matthew J. M.; Gaffield, Michael A.; Bonnan, Audrey; Kikuchi, Chikako; Taniguchi, Hiroki; Christie, Jason M.			Using c-kit to genetically target cerebellar molecular layer interneurons in adult mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MOUSE CEREBELLUM; PURKINJE-CELLS; GRANULE CELLS; INHIBITORY INTERNEURONS; CORTICAL-NEURONS; NEURAL CIRCUITS; RAT CEREBELLUM; MAST-CELLS; IN-VIVO	The cerebellar system helps modulate and fine-tune motor action. Purkinje cells (PCs) provide the sole output of the cerebellar cortex, therefore, any cerebellar involvement in motor activity must be driven by changes in PC firing rates. Several different cell types influence PC activity including excitatory input from parallel fibers and inhibition from molecular layer interneurons (MLIs). Similar to PCs, MLI activity is driven by parallel fibers, therefore, MLIs provide feed-forward inhibition onto PCs. To aid in the experimental assessment of how molecular layer inhibition contributes to cerebellar function and motor behavior, we characterized a new knock-in mouse line with Cre recombinase expression under control of endogenous c-kit transcriptional machinery. Using these engineered c-Kit mice, we were able to obtain high levels of conditional MLI transduction in adult mice using Cre-dependent viral vectors without any PC or granule cell labeling. We then used the mouse line to target MLIs for activity perturbation in vitro using opto-and chemogenetics.	[Amat, Samantha B.; Rowan, Matthew J. M.; Gaffield, Michael A.; Bonnan, Audrey; Kikuchi, Chikako; Taniguchi, Hiroki; Christie, Jason M.] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA	Max Planck Society	Christie, JM (corresponding author), Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA.	jason.christie@mpfi.org	Core, Vector/CAF-4832-2022		Max Planck Society; Max Planck Florida Institute for Neuroscience; National Institutes of Health [NS083984, NS083127]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS083127, R01NS083894] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Max Planck Florida Institute for Neuroscience; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Max Planck Society (Max Planck Gesellschaft; H.T and J.M.C., https://www.mpg.de/en), the Max Planck Florida Institute for Neuroscience (H.T. and J.M.C., https://www.maxplanckflorida.org), the National Institutes of Health Grants (NS083984 [J.M.C.] and NS083127 [M.J.M.R.], https://www.nih.gov/), and the Japan Science and Technology Agency (JSTP RESTO; H.T., http://www.jst.go.jp/EN/)	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Astorga G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00275; Berrozpe G, 2006, MOL CELL BIOL, V26, P5850, DOI 10.1128/MCB.01854-05; Besser S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129934; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; D'Angelo E, 2008, FRONT NEUROSCI-SWITZ, V2, P35, DOI 10.3389/neuro.01.008.2008; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; DETALAMONI NT, 1993, P NATL ACAD SCI USA, V90, P11949, DOI 10.1073/pnas.90.24.11949; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Eccles JC, 1967, CEREBELLUM NEURONAL; Eriksson B, 2000, FEBS LETT, V479, P106, DOI 10.1016/S0014-5793(00)01893-7; Gaffield MA, 2017, J NEUROSCI, V37, P4751, DOI 10.1523/JNEUROSCI.0534-17.2017; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Grimaldi P, 2009, DEV BIOL, V328, P422, DOI 10.1016/j.ydbio.2009.02.008; He M, 2016, NEURON; Heger K, 2014, EUR J IMMUNOL, V44, P296, DOI 10.1002/eji.201343731; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Huang Z Josh, 2014, Cold Spring Harb Protoc, V2014, P150, DOI 10.1101/pdb.top080374; Jelitai M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13722; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Kim J, 2014, CELL REP, V7, P1601, DOI 10.1016/j.celrep.2014.04.047; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Kuhn B, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00049; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MANOVA K, 1992, J NEUROSCI, V12, P4663; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Mauk MD, 2000, CURR BIOL, V10, pR522, DOI 10.1016/S0960-9822(00)00584-4; Medina JF, 2011, CURR OPIN NEUROBIOL, V21, P616, DOI 10.1016/j.conb.2011.05.025; MORII E, 1992, DEV BRAIN RES, V65, P123, DOI 10.1016/0165-3806(92)90016-P; Nadal-Ginard B, 2014, CIRC RES, V115, P415, DOI 10.1161/CIRCRESAHA.114.304676; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; Palay S. L., 1974, CEREBELLAR CORTEX CY; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Rodrigo J, 2001, BRAIN RES, V909, P20, DOI 10.1016/S0006-8993(01)02613-0; Schilling K, 2009, CEREBELLUM, V8, P477, DOI 10.1007/s12311-009-0124-6; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011; Sultan F, 1998, J COMP NEUROL, V393, P353; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; TAKEDA H, 1992, DIFFERENTIATION, V51, P121, DOI 10.1111/j.1432-0436.1992.tb00688.x; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4	58	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179347	10.1371/journal.pone.0179347	http://dx.doi.org/10.1371/journal.pone.0179347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658323	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900021
J	Harmsen, BJ; Foster, RJ; Sanchez, E; Gutierrez-Gonzalez, CE; Silver, SC; Ostro, LET; Kelly, MJ; Kay, E; Quigley, H				Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Gutierrez-Gonzalez, Carmina E.; Silver, Scott C.; Ostro, Linde E. T.; Kelly, Marcella J.; Kay, Elma; Quigley, Howard			Long term monitoring of jaguars in the Cockscomb Basin Wildlife Sanctuary, Belize; Implications for camera trap studies of carnivores	PLOS ONE			English	Article							PANTHERA-ONCA; POPULATION VIABILITY; SYMPATRIC JAGUARS; HABITAT USE; CONSERVATION; PUMAS; VARIANCE; DYNAMICS; BEHAVIOR; DENSITY	In this study, we estimate life history parameters and abundance for a protected jaguar population using camera-trap data from a 14-year monitoring program (2002 - 2015) in Belize, Central America. We investigated the dynamics of this jaguar population using 3,075 detection events of 105 individual adult jaguars. Using robust design open population models, we estimated apparent survival and temporary emigration and investigated individual heterogeneity in detection rates across years. Survival probability was high and constant among the years for both sexes (phi = 0.78), and the maximum (conservative) age recorded was 14 years. Temporary emigration rate for the population was random, but constant through time at 0.20 per year. Detection probability varied between sexes, and among years and individuals. Heterogeneity in detection took the form of a dichotomy for males: those with consistently high detection rates, and those with low, sporadic detection rates, suggesting a relatively stable population of 'residents' consistently present and a fluctuating layer of 'transients'. Female detection was always low and sporadic. On average, twice as many males than females were detected per survey, and individual detection rates were significantly higher for males. We attribute sex-based differences in detection to biases resulting from social variation in trail-walking behaviour. The number of individual females detected increased when the survey period was extended from 3 months to a full year. Due to the low detection rates of females and the variable 'transient' male subpopulation, annual abundance estimates based on 3-month surveys had low precision. To estimate survival and monitor population changes in elusive, wide-ranging, low-density species, we recommend repeated surveys over multiple years; and suggest that continuous monitoring over multiple years yields even further insight into population dynamics of elusive predator populations.	[Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Kay, Elma] Univ Belize, Environm Res Inst, Belmopan, Belize; [Harmsen, Bart J.; Foster, Rebecca J.; Sanchez, Emma; Quigley, Howard] Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA; [Gutierrez-Gonzalez, Carmina E.] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Mexico; [Silver, Scott C.] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY USA; [Ostro, Linde E. T.] New York Acad Sci, World Trade Ctr 7, New York, NY USA; [Kelly, Marcella J.] Virginia Tech, Dept Fisheries & Wildlife Sci, Blacksburg, VA USA	Universidad Autonoma de Queretaro; Wildlife Conservation Society; Virginia Polytechnic Institute & State University	Harmsen, BJ (corresponding author), Univ Belize, Environm Res Inst, Belmopan, Belize.; Harmsen, BJ (corresponding author), Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA.	bharmsen@panthera.org	Kelly, Marcella/B-4891-2011; Foster, Rebecca/GSM-6886-2022	Kelly, Marcella/0000-0001-9044-3873; FOSTER, REBECCA/0000-0002-6055-422X	Panthera; Wildlife Conservation Society; Natural Environment Research Council; Liz Claiborne Art Ortenberg Foundation; North of England Zoological Society; Brevard Zoo; Woodland Park Zoo; Virginia Tech University; Summerlee Foundation	Panthera; Wildlife Conservation Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Liz Claiborne Art Ortenberg Foundation; North of England Zoological Society; Brevard Zoo; Woodland Park Zoo; Virginia Tech University; Summerlee Foundation	This research was funded by Panthera (www.panthera.org) to BJH RJF ESEK, the Wildlife Conservation Society (www.wcs.org) to BJH RJF SCS LETO, the Natural Environment Research Council (UK; www.nerc.ac.uk) to BJH RJF, the Liz Claiborne Art Ortenberg Foundation (www.lcaof.org) to BJH RJF, the North of England Zoological Society (www.chesterzoo.org/global/north-ofengland-zoological-society) to BJH RJF, the Brevard Zoo (https://brevardzoo.org/) to BJH RJF,the Woodland Park Zoo (http://www.zoo.org/)to BJH RJF, Virginia Tech University (http ://www.vt.edu/) to MJK, and the Summerlee Foundation (http://summerlee.org/) to BJH ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IUCN RED LIST THREAT; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G.A., 2004, ECOL J, V6, P1; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Barlow ACD, 2009, J MAMMAL, V90, P472, DOI 10.1644/07-MAMM-A-415.1; Ceballos, 2016, JAGUAR SIGLO 21 PERS, P112; Ceballos G, 2011, TROPICAL CONSERVATIO, V17, P273; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Connell AF, 2011, CAMERA TRAPS ANIMAL; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Crooks KR, 1998, CONSERV BIOL, V12, P889, DOI 10.1046/j.1523-1739.1998.97054.x; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; de la Torre JA, 2017, ORYX; De Paula RC, 2010, PLANO AC CONSERVAC A; Ecotourism Greve S., 2014, ISCONTOUR TOURISM RE; Fay MP, 2010, J STAT SOFTW, V36, P1; Figueroa O. A., 2013, THESIS U FLORIDA; Figueroa OA, 2016, JAGUAR SIGLO 21 PERS, P112; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Foster RJ, 2008, THESIS; Gilbert M, 2014, PLOS ONE, V9, P1; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Gutierrez-Gonzalez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137541; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; Harmsen Bart J., 2010, P403; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Harmsen BJ, 2006, THESIS; Harmsen BJ, 2016, CAT NEWS, P64; Henschel P, 2003, LEOPARDS AFRICAN RAI; Horev A, 2012, BIOL CONSERV, V147, P22, DOI 10.1016/j.biocon.2012.01.012; Hunter L, 2011, CARNIVORES WORLD; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth UK, 2002, MONITORING TIGERS TH, P111; Kendall WL, 1997, ECOLOGY, V78, P563; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LaRue MA, 2016, ECOL MODEL, V321, P121, DOI 10.1016/j.ecolmodel.2015.09.026; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Miquelle DG, 2015, INTEGR ZOOL; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Paviolo A, 2016, NATURE; Payan E, 2006, CAT NEWS, P25; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; ROSS PI, 1992, J WILDLIFE MANAGE, V56, P417, DOI 10.2307/3808853; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sharma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101319; Silver S, 2004, ASSESSING JAGUAR ABU; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollman R, 2008, CAT NEWS, P15; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Steinberg MK, 2016, CONSERV SOC, V14, P13, DOI 10.4103/0972-4923.182801; Sunquist ME, 2002, WILD CATS WORLD; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Tian Y, 2014, LANDSCAPE ECOL, V29, P621, DOI 10.1007/s10980-014-0009-z; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Watkins A, 2015, ECOL MODEL, V306, P268, DOI 10.1016/j.ecolmodel.2014.10.038; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zanin M, 2015, J NAT CONSERV, V23, P90, DOI 10.1016/j.jnc.2014.06.003	69	25	29	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179505	10.1371/journal.pone.0179505	http://dx.doi.org/10.1371/journal.pone.0179505			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658274	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900028
J	Kringel, D; Sisignano, M; Zinn, S; Lotsch, J				Kringel, Dario; Sisignano, Marco; Zinn, Sebastian; Loetsch, Joern			Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq (TM) panel	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; ROOT GANGLION NEURONS; ION-CHANNEL; CAPSAICIN RECEPTOR; PAIN SENSITIVITY; BRONCHIAL-ASTHMA; DNA; POLYMORPHISMS; VARIANTS; MUTATION	Background Transient receptor potential cation channel subfamily V member 1 (TRPV1) are sensitive to heat, capsaicin, pungent chemicals and other noxious stimuli. They play important roles in the pain pathway where in concert with proinflammatory factors such as leukotrienes they mediate sensitization and hyperalgesia. TRPV1 is the target of several novel analgesics drugs under development and therefore, TRPV1 genetic variants might represent promising candidates for pharmacogenetic modulators of drug effects. Methods A next-generation sequencing (NGS) panel was created for the human TRPV1 gene and in addition, for the leukotriene receptors BLT1 and BLT2 recently described to modulate TRPV1 mediated sensitisation processes rendering the coding genes LTB4R and LTB4R2 important co-players in pharmacogenetic approaches involving TRPV1. The NGS workflow was based on a custom AmpliSeq (TM) panel and designed for sequencing of human genes on an Ion PGM (TM) Sequencer. A cohort of 80 healthy subjects of Western European descent was screened to evaluate and validate the detection of exomic sequences of the coding genes with 25 base pair exon padding. Results The amplicons covered approximately 97% of the target sequence. A median of 2.81 x 10(6) reads per run was obtained. This identified approximately 140 chromosome loci where nucleotides deviated from the reference sequence GRCh37 hg19 comprising the three genes TRPV1, LTB4R and LTB4R2. Correspondence between NGS and Sanger derived nucleotide sequences was 100%. Conclusions Results suggested that the NGS approach based on AmpliSeq (TM) libraries and Ion Personal Genome Machine (PGM) sequencing is a highly efficient mutation detection method. It is suitable for large-scale sequencing of TRPV1 and functionally related genes. The method adds a large amount of genetic information as a basis for complete analysis of TRPV1 ion channel genetics and its functional consequences.	[Kringel, Dario; Sisignano, Marco; Zinn, Sebastian; Loetsch, Joern] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [Loetsch, Joern] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft	Lotsch, J (corresponding author), Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany.; Lotsch, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	European Union Seventh Framework Programme (FP7) [602919]; Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation - Pharma (TRIP,JL)	European Union Seventh Framework Programme (FP7); Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation - Pharma (TRIP,JL)	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602919 ("GLORIA", JL). Support of the laboratory equipment was gained from the Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE), LOEWE-Zentrum fur Translationale Medizinund Pharmakologie (JL) and personnel support was received from the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation - Pharma (TRIP,JL). The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boukalova S, 2014, PHYSIOL RES, V63, pS205, DOI 10.33549/physiolres.932658; Brito R, 2014, CELLS-BASEL, V3, P517, DOI 10.3390/cells3020517; Carreno O, 2012, AM J MED GENET B, V159B, P94, DOI 10.1002/ajmg.b.32007; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen CL, 2015, ALLERGY ASTHMA PROC, V36, pE29, DOI 10.2500/aap.2015.36.3828; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2012, J BIOL CHEM, V287, P7279, DOI 10.1074/jbc.M111.305045; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Concolino P, 2014, CLIN CHIM ACTA, V437, P72, DOI 10.1016/j.cca.2014.06.026; Craib SJ, 2001, BRIT J PHARMACOL, V134, P30, DOI 10.1038/sj.bjp.0704223; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Leng WWJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149405; Dias AG, 2013, CHEM SENSES, V38, P137, DOI 10.1093/chemse/bjs090; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frank M, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-29; Glotov AS, 2015, CLIN CHIM ACTA, V446, P132, DOI 10.1016/j.cca.2015.04.014; Guimaraes Marilia Z. P., 2007, P151; Gulsuner S, 2011, GENOME RES, V21, P1995, DOI 10.1101/gr.126110.111; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Hwang SW, 2002, CURR OPIN PHARMACOL, V2, P235, DOI 10.1016/S1471-4892(02)00149-2; Jhun EH, 2015, PHARMACOGENOMICS, V16, P1795, DOI 10.2217/pgs.15.126; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; Lohmann K, 2014, NEUROTHERAPEUTICS, V11, P699, DOI 10.1007/s13311-014-0288-8; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Millat G, 2014, CLIN CHIM ACTA, V433, P266, DOI 10.1016/j.cca.2014.03.032; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Norton N, 2012, CURR OPIN CARDIOL, V27, P214, DOI 10.1097/HCO.0b013e328352207e; Park JJ, 2007, NEUROSCI LETT, V411, P87, DOI 10.1016/j.neulet.2006.10.046; Park S, 2016, J NUTRIGENET NUTRIGE, V9, P47, DOI 10.1159/000446499; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Portier BP, 2014, AM J CLIN PATHOL, V141, P559, DOI 10.1309/AJCP1JUGQMW7ZNTL; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Ren YF, 2015, PEDIATR RES, V77, P506, DOI 10.1038/pr.2015.11; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 1999, BRIT J PHARMACOL, V126, P1351, DOI 10.1038/sj.bjp.0702440; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tarabeux J, 2014, STREAMLINED ION TORR, P1476; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Triantafyllou K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12913; Tulah AS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-110; Tulah AS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-173; Valdes AM, 2011, ANN RHEUM DIS, V70, P1556, DOI 10.1136/ard.2010.148122; Vigna SR, 2011, PANCREAS, V40, P708, DOI 10.1097/MPA.0b013e318214c8df; Vrabec JT, 2008, OTOL NEUROTOL, V29, P561, DOI 10.1097/MAO.0b013e318168d23b; Wang MY, 2010, J NEUROSURG-SPINE, V12, P694, DOI 10.3171/2009.12.SPINE09621; Wang Qiang, 2009, Wei Sheng Yan Jiu, V38, P516; Wang S, 2016, PAIN, V157, P1515, DOI 10.1097/j.pain.0000000000000556; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zinn S, 2017, J BIOL CHEM, V292, P6123, DOI 10.1074/jbc.M116.769125	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180116	10.1371/journal.pone.0180116	http://dx.doi.org/10.1371/journal.pone.0180116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658281	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900061
J	Li, ML; Dai, YB; Lei, J; Tang, J; Zhou, YH; Xia, B; Xia, Y; Yin, GM				Li, Mingliang; Dai, Yingbo; Lei, Jun; Tang, Jin; Zhou, Yihong; Xia, Bing; Xia, Yang; Yin, Guangming			Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat	PLOS ONE			English	Article							TISSUE-DAMAGE; RECEPTORS; FIBROBLASTS; METABOLISM; ACTIVATION; PRIAPISM; HYPOXIA; SYSTEM	Aims Chronic allograft nephropathy is a worldwide issue with the major feature of progressive allograft fibrosis, eventually ending with graft loss. Adenosine has been demonstrated to play an important role in process of fibrosis. Our study aimed to investigate the relationship between adenosine and fibrosis in renal allograft acute rejection in rat. Materials and methods Wistar rats and SD rats were selected as experimental animals. Our study designed two groups. In the allograft transplantation group, kidneys of Wistar rats were orthotopically transplanted into SD rat recipients, the same species but not genetically identical, to induce acute rejection. Kidney transplantations of SD rats to SD rats which were genetically identical were served as the control. We established rat models and detected a series of indicators. All data were analyzed statistically. P<0.05 was considered statistically significant. Results Compared with the control group, levels of adenosine increased significantly in the allograft transplantation group, in which acute rejection was induced (P<0.05). Progressive allograft fibrosis as well as collagen deposition were observed. Conclusions These findings suggested that level of adenosine was upregulated in acute rejection after kidney allograft transplantation in rat. Acute rejection may promote renal allograft fibrosis via the adenosine signaling pathways.	[Li, Mingliang; Dai, Yingbo; Lei, Jun; Tang, Jin; Zhou, Yihong; Xia, Bing; Yin, Guangming] Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Li, Mingliang] First Peoples Hosp Xiangtan City, Dept Urol, Xiangtan, Peoples R China; [Xia, Yang] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA	Central South University; University of Texas System; University of Texas Health Science Center Houston	Yin, GM (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China.	yingm75@126.com		li, ming liang/0000-0002-5200-5415	Science and Technology Project of Hunan Province, China [2010FJ4088]	Science and Technology Project of Hunan Province, China	This work was supported by the Science and Technology Project of Hunan Province, China (NO. 2010FJ4088). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Chan ESL, 2010, MOD RHEUMATOL, V20, P114, DOI 10.1007/s10165-009-0251-4; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077278; Chen JB, 2012, BRIT J PHARMACOL, V166, P1140, DOI 10.1111/j.1476-5381.2012.01831.x; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Dai YB, 2009, J SEX MED, V6, P292, DOI 10.1111/j.1743-6109.2008.01187.x; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Fadili Wafaa, 2013, Arab J Nephrol Transplant, V6, P45; Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13; Ferenbach DA, 2011, KIDNEY INT, V80, P329, DOI 10.1038/ki.2011.167; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Lazzerini PE, 2012, J MOL MED, V90, P331, DOI 10.1007/s00109-011-0824-5; Liao YJ, 2012, WORLD J GASTROENTERO, V18, P5260, DOI 10.3748/wjg.v18.i37.5260; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; Nangaku M, 2008, HYPERTENS RES, V31, P175, DOI 10.1291/hypres.31.175; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Tang J, 2015, EXP THER MED, V9, P737, DOI 10.3892/etm.2015.2177; Textor SC, 2004, J AM SOC NEPHROL, V15, P1974, DOI 10.1097/01.ASN.0000133699.97353.24; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	22	1	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0180211	10.1371/journal.pone.0180211	http://dx.doi.org/10.1371/journal.pone.0180211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651015	Green Submitted, Green Published, gold			2022-12-26	WOS:000404537300042
J	Bamba, S; Sasaki, M; Takaoka, A; Takahashi, K; Imaeda, H; Nishida, A; Inatomi, O; Sugimoto, M; Andoh, A				Bamba, Shigeki; Sasaki, Masaya; Takaoka, Azusa; Takahashi, Kenichiro; Imaeda, Hirotsugu; Nishida, Atsushi; Inatomi, Osamu; Sugimoto, Mitsushige; Andoh, Akira			Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease	PLOS ONE			English	Article							MODERATE ULCERATIVE-COLITIS; INFLAMMATORY-BOWEL-DISEASE; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; JAPANESE PATIENTS; COMPUTED-TOMOGRAPHY; NUTRITIONAL-STATUS; METABOLISM; REMISSION; CONSENSUS	The relationship between skeletal muscle volume and the prognosis of patients with inflammatory bowel disease (IBD) remains undetermined. We conducted a retrospective study of 72 IBD patients who were admitted to the hospital due to disease exacerbation. We enrolled IBD patients who had undergone abdominal computed tomography and assessed the nutritional indices, such as the Onodera's prognostic nutritional index (O-PNI) and the controlling nutritional status (CONUT) index. The L3 skeletal muscle index (SMI), which is the ratio of the cross-sectional area of skeletal muscles at the level of the third lumbar (L3) vertebra to the height squared, was used to identify sarcopenia. Sarcopenia, defined as a low SMI, was observed in 42% of all IBD patients (37% with Crohn's disease (CD) and 48% with ulcerative colitis (UC)). In UC patients, the O-PNI and CONUT values, height, and albumin levels were significantly lower than in CD patients. The SMI strongly correlated with sex, body weight, albumin level, and O-PNI in IBD patients. Multivariate analysis using the Cox regression model demonstrated that the presence of sarcopenia (P = 0.015) and disease type (CD or UC) (P = 0.007) were significant factors predicting intestinal resection. The cumulative operation-free survival rate was significantly lower for sarcopenic patients than in all IBD patients (P = 0.003) and a stratified analysis of CD patients (P = 0.001) using the Kaplan-Meier method and log-rank test. The L3 skeletal muscle area is a prognostic factor for intestinal resection in patients with CD.	[Bamba, Shigeki; Takahashi, Kenichiro; Imaeda, Hirotsugu; Nishida, Atsushi; Inatomi, Osamu; Sugimoto, Mitsushige; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Sasaki, Masaya; Takaoka, Azusa] Shiga Univ Med Sci, Div Clin Nutr, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Bamba, S (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	sb@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Bamba, Shigeki/0000-0002-4108-5894; Inatomi, Osamu/0000-0002-5837-6575	Grants-in-Aid for Scientific Research [15K08948] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Al-Jaouni R, 2002, AM J GASTROENTEROL, V97, P2843; Ban H, 2016, EXP THER MED, V12, P829, DOI 10.3892/etm.2016.3341; Bryant RV, 2013, ALIMENT PHARM THER, V38, P213, DOI 10.1111/apt.12372; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Elia M., 2003, DEV USE MALNUTRITION; GASSULL MA, 1986, GUT, V27, P76, DOI 10.1136/gut.27.Suppl_1.76; Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x; Holt DQ, 2017, ALIMENT PHARM THER, V45, P1255, DOI 10.1111/apt.14018; Hoshikawa Y, 2012, EUR J APPL PHYSIOL, V112, P3487, DOI 10.1007/s00421-012-2335-7; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Inoue M, 2015, J CLIN BIOCHEM NUTR, V56, P215, DOI 10.3164/jcbn.14-100; Iritani S, 2015, J GASTROENTEROL, V50, P323, DOI 10.1007/s00535-014-0964-9; Itoh S, 2016, HEPATOL RES, V46, P292, DOI 10.1111/hepr.12537; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Krok KL, 2003, CURR OPIN GASTROEN, V19, P148, DOI 10.1097/00001574-200303000-00009; Mitsiopoulos N., 1985, J APPL PHYSIOL, V1998, P115; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Nishida N, 2013, J CLIN BIOCHEM NUTR, V53, P122, DOI 10.3164/jcbn.13-18; Nishikawa H, 2016, HEPATOL RES; Okamoto H, 2011, J CLIN BIOCHEM NUTR, V49, P169, DOI 10.3164/jcbn.11-13; Okumura S, 2016, SURGERY, V159, P821, DOI 10.1016/j.surg.2015.08.047; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; RIGAUD D, 1994, AM J CLIN NUTR, V60, P775, DOI 10.1093/ajcn/60.5.775; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Sasaki M, 2011, J CLIN BIOCHEM NUTR, V48, P183, DOI 10.3164/jcbn.10-83; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V47, P32, DOI 10.3164/jcbn.10-07; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V46, P68, DOI 10.3164/jcbn.09-55; Schneider SM, 2008, INFLAMM BOWEL DIS, V14, P1562, DOI 10.1002/ibd.20504; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Subramaniam K, 2015, ALIMENT PHARM THER, V41, P419, DOI 10.1111/apt.13058; Valentini L, 2008, NUTRITION, V24, P694, DOI 10.1016/j.nut.2008.03.018; van Langenberg DR, 2014, J CROHNS COLITIS, V8, P626, DOI 10.1016/j.crohns.2013.11.024; Zhang T, 2016, CLIN NUTR; Zhang TH, 2017, JPEN-PARENTER ENTER, V41, P592, DOI 10.1177/0148607115612054; Zhuang CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003164	43	66	66	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0180036	10.1371/journal.pone.0180036	http://dx.doi.org/10.1371/journal.pone.0180036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644887	Green Submitted, gold, Green Published			2022-12-26	WOS:000404145100059
J	Lan, Y; Zhang, XH; Liu, ZM; Zhou, L; Shen, RH; Zhong, XP; Cui, WJ; Zhou, ZM				Lan, Yao; Zhang, Xiaohuan; Liu, Zhongmei; Zhou, Li; Shen, Ruihua; Zhong, Xianping; Cui, Wenjing; Zhou, Zhemin			Overexpression and characterization of two types of nitrile hydratases from Rhodococcus rhodochrous J1	PLOS ONE			English	Article							RIBOSOME BINDING-SITES; ESCHERICHIA-COLI; PROTEIN; EXPRESSION; MATURATION; STABILITY; MECHANISM; PRODUCT	Nitrile hydratase (NHase) from Rhodococcus rhodochrous J1 is widely used for industrial production of acrylamide and nicotinamide. However, the two types of NHases (L-NHase and H-NHase) from R. rhodochrous J1 were only slightly expressed in E. coli by routine methods, which limits the comprehensive and systematic characterization of the enzyme properties. We successfully expressed the two types of recombinant NHases in E. coli by codon-optimization, engineering of Ribosome Binding Site (RBS) and spacer sequences. The specific activity of the purified L-NHase and H-NHase were 400 U/mg and 234 U/mg, respectively. The molecular mass of L-NHase and H-NHase was identified to be 94 kDa and 504 kDa, respectively, indicating that the quaternary structure of the two types of NHases was the same as those in R. rhodochrous J1. H-NHase exhibited higher substrate and product tolerance than L-NHase. Moreover, higher activity and shorter culture time were achieved in recombinant E. coli, and the whole cell catalyst of recombinant E. coli harboring H-NHase has equivalent efficiency in tolerance to the high-concentration product relative to that in R. rhodochrous J1. These results indicate that biotransformation of nitrile by R. rhodochrous J1 represents a potential alternative to NHase-producing E. coli.	[Lan, Yao; Liu, Zhongmei; Zhou, Li; Cui, Wenjing; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zhang, Xiaohuan] ENNova Hlth Sci Technol Co Ltd, ENN Grp, Langfang, Hebei, Peoples R China; [Shen, Ruihua; Zhong, Xianping] Rudong Nantian Nongke Chem Engn Co Ltd, Yangkou Port Econ Dev Zone, Changsha Town, Rudong, Peoples R China	Jiangnan University	Cui, WJ; Zhou, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	wjcui@jiangnan.edu.cn; zhmzhou@jiangnan.edu.cn	Cui, Wenjing/HIR-1471-2022	Zhou, Li/0000-0001-8448-2040	National natural science foundation of China [31400058, 31400078]; Priority Academic Program Development of Jiangsu Higher Education Institutions [111-2-06]; International S&T Innovation Cooperation Key Project [2016YFE0127400]	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; International S&T Innovation Cooperation Key Project	National natural science foundation of China, 31400058, www.nsfc.gov.cn/, WC. National natural science foundation of China, 31400078, www.nsfc.gov.cn/, ZL. Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, ZZ. 111 Project, 111-2-06, http://www.dost.moe.edu.cn ZZ. Jiangsu province "Collaborative Innovation Center for Advanced Industrial Fermentation "industry development program ZZ. International S&T Innovation Cooperation Key Project, 2016YFE0127400, www.most.gov.cn/ ZL. Fundamental Research Funds for the Central Universities JUSRP51713B www.moe.gov.cn/ WC. The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company Rudong Nantian Nongke Chemical Engineering Co. Ltd and ENNova Health Science Technology Co., Ltd., ENN Group participated in the data analysis and a part of fermentation experiment.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Arakawa T, 2009, J AM CHEM SOC, V131, P14838, DOI 10.1021/ja903979s; Cui YT, 2014, BIOCHEM BIOPH RES CO, V450, P401, DOI 10.1016/j.bbrc.2014.05.127; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Icev A, 2003, P 3 ACM SIGKDD WORKS, V10, P34; KOBAYASHI M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P23, DOI 10.1016/0167-4781(91)90208-4; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; KURIKI Y, 1989, J BACTERIOL, V171, P5452, DOI 10.1128/jb.171.10.5452-5457.1989; Liu Y, 2014, J BIOSCI BIOENG, V118, P249, DOI 10.1016/j.jbiosc.2014.02.015; Liu Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-48; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; NAGASAWA T, 1991, EUR J BIOCHEM, V196, P581, DOI 10.1111/j.1432-1033.1991.tb15853.x; Nagasawa T, 1990, APPL MICROBIOL BIOT, V34, P783; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Yukl ET, 2012, CURR OPIN CHEM BIOL, V16, P54, DOI 10.1016/j.cbpa.2012.02.010; Zhou ZM, 2010, BIOCHEMISTRY-US, V49, P9638, DOI 10.1021/bi100651v; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	26	15	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179833	10.1371/journal.pone.0179833	http://dx.doi.org/10.1371/journal.pone.0179833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644864	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100043
J	Listl, D; Poschlod, P; Reisch, C				Listl, Daniela; Poschlod, Peter; Reisch, Christoph			Phylogeography of a tough rock survivor in European dry grasslands	PLOS ONE			English	Article							WILD EDIBLE PLANTS; CHLOROPLAST DNA PHYLOGEOGRAPHY; CRYPTIC NORTHERN REFUGIA; GENETIC-VARIATION; GLACIAL REFUGIA; HYBRID ZONE; POSTGLACIAL RECOLONIZATION; PHYLOGENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; GEOGRAPHIC PATTERN	Phylogeographic analyses of plants in Europe have revealed common glacial refugia and migration routes for several trees and herbs with arctic-alpine distributions. The postglacial histories of dry grassland species in central Europe have rarely been analyzed, even though the extremely species-rich habitat is threatened. Sedum album (Crassulaceae) is a common inhabitant of rocky sites in central European dry grasslands. We inferred the phylogeographic history of S. album over its distribution range in Europe. Genetic diversity within and differentiation between 34 S. album populations was examined using AFLP markers. Population isolation was indicated based on the rarity of the fragments and by isolation-by-distance effects. We sequenced the trnL-trnF region in 32 populations and used chloroplast microsatellites to analyze chloroplast haplotype distributions. Two distinct S. album lineages were detected. One lineage was comprised of populations from eastern and central parts of central Europe, and the Apennine Peninsula. A second lineage was comprised of populations from the Iberian Peninsula and western and northern parts of central Europe. Glacial refugia were identified based on the accumulation of ancient chloroplast haplotypes, high diversity of AFLP fragments within populations, and high levels of rare fragments in Liguria, Serbia, the Apennine and Iberian peninsulas. Cryptic refugia were detected in the Czech Republic and Slovakia. Isolation by distance was present all over the distribution range, and it was separately detected in southwestern and central Europe. In western Europe, where a contact zone between the two lineages can be expected, no isolation by distance was detected. Our results suggest migration routes of S. album northeastward from glacial refugia in southern Iberia, northward from the Apennine Peninsula, and northward and westward from the southeastern parts of central Europe. Therefore, central European grasslands were recently colonized by northern cryptic populations and source populations originating in the east and the Apennine Peninsula.	[Listl, Daniela; Poschlod, Peter; Reisch, Christoph] Univ Regensburg, Inst Plant Sci, Regensburg, Germany	University of Regensburg	Listl, D (corresponding author), Univ Regensburg, Inst Plant Sci, Regensburg, Germany.	daniela.listl@ur.de	Poschlod, Peter/AAF-7902-2019					Abbott RJ, 2004, NEW PHYTOL, V161, P211, DOI 10.1046/j.1469-8137.2003.00953.x; Albers F, 1998, STANDARDLISTE FARN B; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonn S, 1998, AUSBREITUNGSBIOLOGIE; Brandes Dietmar, 1995, P49; Bylebyl K, 2008, MOL ECOL, V17, P3379, DOI 10.1111/j.1365-294X.2008.03836.x; Cakilcioglu U, 2010, J ETHNOPHARMACOL, V132, P165, DOI 10.1016/j.jep.2010.08.017; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cottrell JE, 2005, FOREST ECOL MANAG, V206, P71, DOI 10.1016/j.foreco.2004.10.052; Daneck H, 2016, BIOL J LINN SOC, V119, P704, DOI 10.1111/bij.12619; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; di Castri F., 1989, SCOPE, V37, P1; Dobes C., 2000, DOCUMENTED CHROMOSOM; DumolinLapegue S, 1997, GENETICS, V146, P1475; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellenberg H, 1996, VEGETATION MITTELEUR; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Ferris C, 1998, HEREDITY, V80, P584, DOI 10.1046/j.1365-2540.1998.00342.x; Fischer M, 1998, AM J BOT, V85, P811, DOI 10.2307/2446416; Flanagan NS, 1999, J EVOLUTION BIOL, V12, P577, DOI 10.1046/j.1420-9101.1999.00049.x; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; Grivet D, 2003, CONSERV GENET, V4, P47, DOI 10.1023/A:1021804009832; Grivet D, 2002, MOL ECOL, V11, P1351, DOI 10.1046/j.1365-294X.2002.01522.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hart H., 1991, Flora Mediterranea, V1, P31; Hedren M, 1997, PLANT SYST EVOL, V204, P21, DOI 10.1007/BF00982529; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HEWITT GM, 1975, HEREDITY, V35, P375, DOI 10.1038/hdy.1975.108; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kajtoch L, 2016, BIODIVERS CONSERV, V25, P2309, DOI 10.1007/s10531-016-1065-2; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Koch M, 2004, AM J BOT, V91, P115, DOI 10.3732/ajb.91.1.115; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; Kropf M, 2002, MOL ECOL, V11, P447, DOI 10.1046/j.1365-294X.2002.01446.x; Kropf M, 2008, TAXON, V57, P511, DOI 10.2307/25066019; Leipold M, 2017, ECOL EVOL, V7, P1919, DOI 10.1002/ece3.2811; Lugon-Moulin N, 1999, MOL ECOL, V8, P419, DOI 10.1046/j.1365-294X.1999.00595.x; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; MANTEL N, 1967, CANCER RES, V27, P209; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Meindl C, 2012, THESIS; Meindl C, 2016, PLANT SYST EVOL, P1; Meusel H., 1965, VERGLEICHENDE CHOROL, VVolume 1; Mithen S., 2006, ICE GLOBAL HUMAN HIS, V1st ed.; Negrini R, 2007, ANIM GENET, V38, P60, DOI 10.1111/j.1365-2052.2007.01554.x; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Ozgen U, 2004, ECON BOT, V58, P691, DOI 10.1663/0013-0001(2004)058[0691:ESITVO]2.0.CO;2; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Peakall R., 2001, GENALEX GENETIC ANAL; Perez-Collazos E, 2009, MOL ECOL, V18, P848, DOI 10.1111/j.1365-294X.2008.04060.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Polunin O., 1980, FLOWERS GREECE BALKA; Poschlod P, 1998, ACTA BOT NEERL, V47, P27; Poschlod P., 2015, GESCH KULTURLANDSCHA; Poschlod P., 2013, VEGETATION ECOLOGY, P164, DOI [DOI 10.1002/9781118452592.CH6, 10.1002/9781118452592.ch6]; Pritchard JK, 2000, GENETICS, V155, P945; Redzic SJ, 2006, ECOL FOOD NUTR, V45, P189, DOI 10.1080/03670240600648963; Reisch C, 2003, HEREDITY, V91, P519, DOI 10.1038/sj.hdy.6800350; Reisch C, 2003, BIOL J LINN SOC, V80, P11, DOI 10.1046/j.1095-8312.2003.00215.x; Reisch C, 2008, BIOL J LINN SOC, V93, P385, DOI 10.1111/j.1095-8312.2007.00933.x; Rendell S, 2003, MOL ECOL, V12, P2681, DOI 10.1046/j.1365-294X.2003.01934.x; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Ronikier M, 2008, J BIOGEOGR, V35, P1650, DOI 10.1111/j.1365-2699.2008.01907.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanz M, 2014, BOT J LINN SOC, V174, P214, DOI 10.1111/boj.12132; Schonswetter P, 2006, MOL ECOL, V15, P709, DOI 10.1111/j.1365-294X.2006.02821.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simkova K, 2015, J APPL BOT FOOD QUAL, V88, P49, DOI 10.5073/JABFQ.2015.088.009; Skrede I, 2006, MOL ECOL, V15, P1827, DOI 10.1111/j.1365-294X.2006.02908.x; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Smith G.F., 2010, CACTUS SUCCULENT J U, V82, P41; Soubani E., 2010, THESIS; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tardio J, 2006, BOT J LINN SOC, V152, P27, DOI 10.1111/j.1095-8339.2006.00549.x; Tausch S, 2017, PLANT BIOL IN PRESS; Tutin TG, 1993, FLORA EUROPAEA; Van Ham RCHJ, 1998, AM J BOT, V85, P123, DOI 10.2307/2446561; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vernesi C, 2002, MOL ECOL, V11, P1285, DOI 10.1046/j.1365-294X.2002.01534.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walter R, 2005, AM J BOT, V92, P92, DOI 10.3732/ajb.92.1.92; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wittig Ruediger, 2004, Urban Ecosystems, V7, P323, DOI 10.1007/s11252-005-6833-9; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	107	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179961	10.1371/journal.pone.0179961	http://dx.doi.org/10.1371/journal.pone.0179961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640885	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800087
J	Mazzoni, E; D'Agostino, A; Manfrini, M; Maniero, S; Puozzo, A; Bassi, E; Marsico, S; Fortini, C; Trevisiol, L; Patergnani, S; Tognon, M				Mazzoni, Elisa; D'Agostino, Antonio; Manfrini, Marco; Maniero, Stefania; Puozzo, Andrea; Bassi, Elena; Marsico, Stefano; Fortini, Cinzia; Trevisiol, Lorenzo; Patergnani, Simone; Tognon, Mauro			Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold	FASEB JOURNAL			English	Article						genes; matrix; adhesion; bone; biomaterial	MESENCHYMAL STROMAL CELLS; BONE; TETRANECTIN; EXPRESSION; MARKERS	Novel biomaterials are of paramount importance for bone regrowth. In this study, we investigated human adipose stem cells (hASCs) for osteogenic, osteoconductivity, and osteoinductivity effects of an innovative collagen/hydroxylapatite hybrid scaffold. In hASCs that were grown on this scaffold, osteogenic genes were analyzed for their expression profiles, together with adhesion and extracellular matrix genes. In hASC integrins, basement membrane constituents and collagens were up-regulated, together with cell proliferation. In addition, expression of osteopontin and activated focal adhesion kinase was studied at the protein level. Our in vitro data indicate that hASCs, together with hybrid biomaterial, is an important model of study to investigate in vitro bone induction.-Mazzoni, E., D'Agostino, A., Manfrini, M., Maniero, S., Puozzo, A., Bassi, E., Marsico, S., Fortini, C., Trevisiol, L., Patergnani, S., Tognon, M. Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold.	[Mazzoni, Elisa; Manfrini, Marco; Maniero, Stefania; Puozzo, Andrea; Bassi, Elena; Marsico, Stefano; Patergnani, Simone; Tognon, Mauro] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Fortini, Cinzia] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Mazzoni, Elisa; D'Agostino, Antonio; Trevisiol, Lorenzo] Univ Verona, Dept Surg, Verona, Italy; [Manfrini, Marco] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Bassi, Elena] Univ Parma, Sect Anat Pathol, Parma, Italy	University of Ferrara; University of Ferrara; University of Verona; University of Bologna; University of Parma	Tognon, M (corresponding author), Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, 64-B Fossato Mortara St, I-44121 Ferrara, Italy.	tgm@unife.it	Trevisiol, Lorenzo/ABD-6737-2020; Patergnani, Simone/AAC-3969-2021; Patergnani, Simone/AAK-2929-2021; Mazzoni, Elisa/K-6313-2016	Trevisiol, Lorenzo/0000-0002-2732-238X; Patergnani, Simone/0000-0001-7951-9267; Manfrini, Marco/0000-0003-3154-9269; Mazzoni, Elisa/0000-0001-6829-8569	Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR); University of Verona, Fondo Universitario per la Ricerca (FUR); Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM) [CFR/2015/2016]	Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR); University of Verona, Fondo Universitario per la Ricerca (FUR); Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM)	This work was supported, in part, by grants from Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR) Projects; University of Verona, Fondo Universitario per la Ricerca (FUR) Projects; Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM), Grant CFR/2015/2016. E.M. is a Research Associate in the Department of Surgery, School of Medicine, University of Verona. The authors declare no conflicts of interest.	Bononi I, 2012, J CELL PHYSIOL, V227, P3787, DOI 10.1002/jcp.24088; Brodano GB, 2012, EUR SPINE J, V21, pS3, DOI 10.1007/s00586-012-2233-z; Capulli M, 2014, J BONE MINER RES, V29, P1833, DOI 10.1002/jbmr.2206; D'Agostino A., 2016, J ORAL MAXILLOFAC SU, V74, P1238, DOI DOI 10.1016/J.J0MS.2016.01.052; Docheva D, 2014, BIRTH DEFECTS RES C, V102, P13, DOI 10.1002/bdrc.21059; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fuchigami S, 2016, EUR J ORAL SCI, V124, P151, DOI 10.1111/eos.12249; Gothard D, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414551763; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Iba K, 2013, J BONE MINER METAB, V31, P399, DOI 10.1007/s00774-013-0436-y; Izu Y, 2016, CELL TISSUE RES, V364, P623, DOI 10.1007/s00441-015-2345-y; Jiang PL, 2015, ACS APPL MATER INTER, V7, P14384, DOI 10.1021/acsami.5b03172; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Kobayashi A, 2007, ARCH PATHOL LAB MED, V131, P563; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276; Manfrini M, 2015, CELL BIOCHEM BIOPHYS, V71, P1509, DOI 10.1007/s12013-014-0374-x; Marques C, 2014, INT J NANOMED, V9, P2713, DOI 10.2147/IJN.S55943; Mazzoni E, 2012, EXP HEMATOL, V40, P466, DOI 10.1016/j.exphem.2012.02.008; Mendelson BC, 2010, AESTHET PLAST SURG, V34, P455, DOI 10.1007/s00266-010-9473-2; Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93; Rakow A, 2016, BIOMATERIALS, V98, P31, DOI 10.1016/j.biomaterials.2016.04.023; Ram VS, 2015, J CLIN DIAGN RES, V9, pZE7, DOI 10.7860/JCDR/2015/11268.5438; Ripoll CB, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-3; Rosset EM, 2016, MATRIX BIOL, V52-54, P78, DOI 10.1016/j.matbio.2016.02.001; Srouji S, 2013, CLIN ORAL IMPLAN RES, V24, P1288, DOI 10.1111/j.1600-0501.2012.02571.x; Stockl S, 2013, CELL PHYSIOL BIOCHEM, V31, P703, DOI 10.1159/000350089; Sun Z, 2013, J ORTHOP RES, V31, P1804, DOI 10.1002/jor.22439; Thangavelu M, 2016, COLLOID SURFACE B, V143, P15, DOI 10.1016/j.colsurfb.2016.03.021; Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Yang W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0826-y	34	20	21	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4555	4565		10.1096/fj.201601384R	http://dx.doi.org/10.1096/fj.201601384R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28659417	Green Submitted			2022-12-26	WOS:000413397400031
J	Ingelbeen, B; Bah, EI; Decroo, T; Balde, I; Nordenstedt, H; van Griensven, J; De Weggheleire, A				Ingelbeen, Brecht; Bah, Elhadj Ibrahima; Decroo, Tom; Balde, Idrissa; Nordenstedt, Helena; van Griensven, Johan; De Weggheleire, Anja			Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study	PLOS ONE			English	Article							VIRUS DISEASE; SIERRA-LEONE	Non-cases are suspect Ebola Virus Disease (EVD) cases testing negative by EVD RT-PCR after admission to an Ebola Treatment Centre (ETC). Admitting non-cases to an ETC prompts concerns on case-and workload in the ETC, risk for nosocomial EVD infection, and delays in diagnosis and disease-specific treatment. We retrospectively analysed characteristics, outcomes and determinants of death of EVD cases and non-cases admitted to the Conakry ETC in Guinea between 03/2014 and 09/2015. Of the 2362 admitted suspects who underwent full confirmatory PCR testing, 1540 (65.2%) were non-cases; among them 727 needed repeated confirmatory PCR testing resulting in 2.5 days (average) in the ETC isolation ward. Twenty-one patients tested positive on the repeat test, most in a period of flawed sampling for the initial test and none after introduction of PCR confirmation with geneXpert. No readmissions following nosocomial EVD infection were recorded. No combination of symptoms yielded acceptable sensitivity and specificity to allow differentiating confirmed from non-cases. Symptoms as ocular bleeding/redness have high specificity, but limited usefulness as not common. Admission delay and age distribution were not different for both groups. In total, 98 (20.6%) of 475 deaths in the ETC were non-cases. Most died within 24 hours after admission. Living in Conakry (aOR 1.78 (1.08-2.96)) was the strongest risk factor for death. Weeks with higher admission load had lower case fatality among non-cases, probably because more acute (and treatable) illnesses of contacts of known cases were admitted. These findings show high numbers of potentially critically ill non-cases need to be considered when setting up triage and referral of EVD suspect cases. Symptoms and risk factors alone do not allow differentiating the non-cases. Integration of highly-sensitive EVD diagnostic methods with short turnaround time in the triage of peripheral hospitals and dropping the systematic 2nd PCR for symptomatic early presenters could limit delays in access to adapted care of cases and seriously ill non-cases. Whether feasible without compromising outbreak control, and under which conditions, should be further assessed.	[Ingelbeen, Brecht; Bah, Elhadj Ibrahima; Balde, Idrissa; Nordenstedt, Helena] Operat Ctr Brussels, Med Sans Frontieres, Conakry, Guinea; [Bah, Elhadj Ibrahima; Balde, Idrissa] Ctr Hosp Univ Donka, Conakry, Guinea; [Decroo, Tom] Operat Ctr Brussels, Operat Res Unit, Med Sans Frontieres, Brussels, Belgium; [Nordenstedt, Helena] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [van Griensven, Johan; De Weggheleire, Anja] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium	Doctors Without Borders; Karolinska Institutet; Institute of Tropical Medicine (ITM)	Ingelbeen, B (corresponding author), Operat Ctr Brussels, Med Sans Frontieres, Conakry, Guinea.	brechtingelbeen@gmail.com	Decroo, Tom/AAV-7208-2020; De Weggheleire, Anja/C-7345-2018	Decroo, Tom/0000-0002-1205-1484; De Weggheleire, Anja/0000-0001-9377-4766; Ingelbeen, Brecht/0000-0002-2214-6858	Medecins Sans Frontieres. Medecins Sans Frontieres	Medecins Sans Frontieres. Medecins Sans Frontieres	This research received no specific funding. It was carried out during and following patient management at the Conakry Ebola treatment centre supported by Medecins Sans Frontieres. Medecins Sans Frontieres provided funding for the publication fee.	Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Brolin Ribacke KJ, 2016, FRONT PUBLIC HEAL, V4, P1; Cheng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145422; Edwards Justin D., 2015, INTRO TECHNOLOGIES G, P1; Farge E., 2014, EXCLUSIVE GUINEA SAY; Fitzpatrick G, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.40.20924; Fitzpatrick G, 2015, J INFECT DIS; Lado M, 2015, LANCET INFECT DIS, V15, P1024, DOI 10.1016/S1473-3099(15)00137-1; Levine AC, 2015, ANN EMERG MED, V66, P285, DOI 10.1016/j.annemergmed.2015.03.011; Li WG, 2016, ONCOTARGET, V7, P27910, DOI 10.18632/oncotarget.8558; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Semper AE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001980; Van den Bergh R, 2016, EMERG INFECT DIS J, V22; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; van Vuren PJ, 2016, J CLIN MICROBIOL, V54, P359, DOI 10.1128/JCM.02724-15; WHO CDC, 2014, TECHN GUID INT DIS S; World Health Organization, 2016, SIT EP MIOL HEBD EP	17	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180070	10.1371/journal.pone.0180070	http://dx.doi.org/10.1371/journal.pone.0180070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665950	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700059
J	Talsma, DT; Katta, K; Boersema, M; Adepu, S; Naggi, A; Torri, G; Stegeman, C; Navis, G; van Goor, H; Hillebrands, JL; Yazdani, S; van den Born, J				Talsma, Ditmer T.; Katta, Kirankumar; Boersema, Miriam; Adepu, Saritha; Naggi, Annamaria; Torri, Giangiacomo; Stegeman, Coen; Navis, Gerjan; van Goor, Harry; Hillebrands, Jan-Luuk; Yazdani, Saleh; van den Born, Jacob			Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin	PLOS ONE			English	Article							DENDRITIC CELLS; ALLOGRAFT-REJECTION; ENDOTHELIAL-CELLS; INFLAMMATION; LYMPHANGIOGENESIS; SULFATE; SKIN; RAT; DIFFERENTIATION; PROTEOGLYCANS	Background Chronic renal transplant dysfunction is characterized by loss of renal function and tissue remodeling, including chronic inflammation and lymph vessel formation. Proteoglycans are known for their chemokine presenting capacity. We hypothesize that interruption of the lymphatic chemokine-proteoglycan interaction interferes with the lymphatic outflow of leukocytes from the renal graft and might decrease the anti-graft allo-immune response. Methods In a rat renal chronic transplant dysfunction model (female Dark-Agouti to male Wistar Furth), chemokines were profiled by qRT-PCR in microdissected tubulo-interstitial tissue. Disruption of lymphatic chemokine-proteoglycan interaction was studied by (non-anticoagulant) heparin-derived polysaccharides in vitro and in renal allografts. The renal allograft function was assessed by rise in plasma creatinine and urea. Results Within newly-formed lymph vessels of transplanted kidneys, numerous CD45(+) leukocytes were found, mainly MHCII+, ED-1(-), IDO-, HIS14(-), CD103(-) antigen presenting cells, most likely representing a subset of dendritic cells. Treatment of transplanted rats with regular heparin and two different (non-)anticoagulant heparin derivatives revealed worsening of kidney function only in the glycol-split heparin treated group despite a two-fold reduction of tubulo-interstitial leukocytes (p<0.02). Quantitative digital image analysis however revealed increased numbers of intra-lymphatic antigen-presenting cells only in the glycol-split heparin group (p<0.01). The number of intra-lymphatic leukocytes significantly correlates with plasma creatinine and urea, and inversely with creatinine clearance. Conclusions Treatment of transplanted rats with glycol-split heparin significantly increases the number of intra-lymphatic antigen presenting cells, by increased renal diffusion of lymphatic chemokines, thereby increasing the activation and recruitment of antigen presenting cells towards the lymph vessel. This effect is unwanted in the transplantation setting, but might be advantageous in e.g., dendritic cell vaccination.	[Talsma, Ditmer T.; Katta, Kirankumar; Adepu, Saritha; Stegeman, Coen; Navis, Gerjan; Yazdani, Saleh; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Boersema, Miriam; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Naggi, Annamaria; Torri, Giangiacomo] Ronzoni Inst, Milan, Italy	University of Groningen; University of Groningen	Talsma, DT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	d.t.talsma@umcg.nl	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577; Stegeman, Coen/0000-0002-0224-0927; Torri, Giangiacomo/0000-0002-2077-1203; Adepu, Saritha/0000-0002-8617-9421; Hillebrands, Jan-Luuk/0000-0003-3135-3274	graduate school of Medical Sciences of the University Medical Center of Groningen	graduate school of Medical Sciences of the University Medical Center of Groningen	The graduate school of Medical Sciences of the University Medical Center of Groningen provided financial support to DT, KK, MB, SA, SY in the form of PhD stipends. The authors received no specific funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was financially supported by the graduate school of Medical Sciences of the University Medical Center of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Pramod Agarwal, Peter Zwiers, Marian Bulthuis, Andre A Zandvoort, Michel Weij, Annemieke Smit-van Oosten and Melinda Sammary for their excellent technical assistance.	Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Asgeirsdottir SA, 2002, ANN NY ACAD SCI, V973, P586, DOI 10.1111/j.1749-6632.2002.tb04704.x; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Boersema M, 2012, AM J TRANSPLANT, V12, P1429, DOI 10.1111/j.1600-6143.2012.04001.x; Braun C, 2001, TRANSPLANTATION, V72, P209, DOI 10.1097/00007890-200107270-00007; Casu B, 2004, J MED CHEM, V47, P838, DOI 10.1021/jm030893g; Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Cui Y, 2015, J CLIN INVEST, V125, P4255, DOI 10.1172/JCI79693; Dias-Baruffi M, 1998, GLYCOCONJUGATE J, V15, P523, DOI 10.1023/A:1006995222189; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Frank RD, 2005, J THROMB HAEMOST, V3, P531, DOI 10.1111/j.1538-7836.2005.01188.x; Frank RD, 2006, THROMB HAEMOSTASIS, V96, P802, DOI 10.1160/TH06-07-0418; Gottmann U, 2007, TRANSPL INT, V20, P542, DOI 10.1111/j.1432-2277.2007.00471.x; Hansson M, 2006, MICROBES INFECT, V8, P841, DOI 10.1016/j.micinf.2005.10.007; Huber S, 2007, KIDNEY INT, V71, P771, DOI 10.1038/sj.ki.5002112; Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x; Johns SC, 2016, CIRC RES, V119, P210, DOI 10.1161/CIRCRESAHA.116.308504; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; KROESE FGM, 1987, EUR J IMMUNOL, V17, P921, DOI 10.1002/eji.1830170705; Kusyk T, 2005, TRANSPL P, V37, P1026, DOI 10.1016/j.transproceed.2005.02.018; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Saeki H, 1999, J IMMUNOL, V162, P2472; Shapira OM, 1999, J SURG RES, V85, P83, DOI 10.1006/jsre.1999.5667; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P2834, DOI 10.1111/j.1600-6143.2007.02001.x; Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024; Tan SM, 2013, CYTOTHERAPY, V15, P492, DOI 10.1016/j.jcyt.2012.12.002; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Yazdani S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.18; Yin X, 2014, J IMMUNOL, V192, P2133, DOI 10.4049/jimmunol.1301286; Zheng YX, 2011, MOL VIS, V17, P1694	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180206	10.1371/journal.pone.0180206	http://dx.doi.org/10.1371/journal.pone.0180206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665959	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700071
J	Treves, A; Rabenhorst, MF				Treves, Adrian; Rabenhorst, Mark F.			Risk map for wolf threats to livestock still predictive 5 years after construction	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; SPATIAL MODEL; PREDATION	Risk maps are spatial models of environmental hazards such as predation on livestock. We tested the long-term validity of a published risk map built from locations where Wisconsin wolves attacked livestock from 1999-2006. Using data collected after model construction, we verified the predictive accuracy of the risk map exceeded 91% for the period 2007-2011. Predictive power lasting 5 years or more substantiates the claim that risk maps are both valid and verified tools for anticipating spatial hazards. Classification errors coincided with verifier uncertainty about which wolves might be responsible. Perceived threats by wolves to domestic animals were not as well predicted (82%) as verified attacks had been and errors in classification coincided with incidents involved domestic animals other than bovids and verifier uncertainty about which wolves were involved. We recommend risk maps be used to target interventions selectively at high-risk sites.	[Treves, Adrian] Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Rabenhorst, Mark F.] Carnivore Coexistence Lab, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Treves, A (corresponding author), Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA.	atreves@wisc.edu	Treves, Adrian/P-3707-2018	Treves, Adrian/0000-0002-3052-4708				Edge JL, 2011, WILDLIFE BIOL, V17, P1, DOI 10.2981/10-043; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; Miller JRB, 2015, BIODIVERS CONSERV, V24, P2887, DOI 10.1007/s10531-015-0993-6; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2002, WILDLIFE SOC B, V30, P231; Treves A., 2015, DATA ARCH; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5	10	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180043	10.1371/journal.pone.0180043	http://dx.doi.org/10.1371/journal.pone.0180043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665979	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608700057
J	Abade, E; Sampaio, J; Goncalves, B; Baptista, J; Alves, A; Viana, J				Abade, Eduardo; Sampaio, Jaime; Goncalves, Bruno; Baptista, Jorge; Alves, Alberto; Viana, Joao			Effects of different re-warm up activities in football players' performance	PLOS ONE			English	Article							POST-ACTIVATION POTENTIATION; POSTACTIVATION POTENTIATION; SOCCER PLAYERS; PLYOMETRIC EXERCISE; ECCENTRIC EXERCISE; INJURY PREVENTION; SPORTS-MEDICINE; REPEATED-SPRINT; UP STRATEGIES; VERTICAL JUMP	Warm up routines are commonly used to optimize football performance and prevent injuries. Yet, official pre-match protocols may require players to passively rest for approximately 10 to 15 minutes between the warm up and the beginning of the match. Therefore, the aim of this study was to explore the effect of different re-warm up activities on the physical performance of football players. Twenty-Two Portuguese elite under-19 football players participated in the study conducted during the competitive season. Different re-warm up protocols were performed 6 minutes after the same standardized warm up in 4 consecutive days in a crossover controlled approach: without, eccentric, plyometric and repeated changes of direction. Vertical jump and Sprint performances were tested immediately after warm up and 12 minutes after warm up. Results showed that repeated changes of direction and plyometrics presented beneficial effects to jump and sprint. Different practical implications may be taken from the eccentric protocol since a vertical jump impairment was observed, suggesting a possibly harmful effect. The absence of re-warm up activities may be detrimental to players' physical performance. However, the inclusion of re-warm up prior to match is a complex issue, since the manipulation of volume, intensity and recovery may positively or negatively affect the subsequent performance. In fact, this exploratory study shows that eccentric exercise may be harmful for physical performance when performed prior a football match. However, plyometric and repeated changes of direction exercises seem to be simple, quick and efficient activities to attenuate losses in vertical jump and sprint capacity after warm up. Coaches should aim to develop individual optimal exercise modes in order to optimize physical performance after re warm activities.	[Abade, Eduardo; Sampaio, Jaime; Goncalves, Bruno; Baptista, Jorge; Alves, Alberto; Viana, Joao] Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Evora, Portugal; [Abade, Eduardo; Baptista, Jorge; Alves, Alberto; Viana, Joao] Univ Inst Maia, ISMAI, Maia, Portugal; [Sampaio, Jaime; Goncalves, Bruno] Univ Tras Os Montes & Alto Douro, UTAD, Vila Real, Portugal	Instituto Universitario da Maia (ISMAI); University of Tras-os-Montes & Alto Douro	Abade, E (corresponding author), Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Evora, Portugal.; Abade, E (corresponding author), Univ Inst Maia, ISMAI, Maia, Portugal.	eduardoabade@gmail.com	Sampaio, Jaime/B-7392-2008; Viana, João L/V-8946-2017; Gonçalves, Bruno/M-5361-2013	Sampaio, Jaime/0000-0003-2335-9991; Viana, João L/0000-0002-9147-7781; Gonçalves, Bruno/0000-0001-7874-4104; Alves, Alberto/0000-0001-9484-7349; Abade, Eduardo Andre de Azevedo/0000-0002-4766-896X	Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Regional Development Fund, through COMPETE 2020 [POCI-01-0145-FEDER-006969]; European Regional Development Fund [NORTE-01-0145-FEDER-000016]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Regional Development Fund, through COMPETE 2020; European Regional Development Fund(European Commission)	CIDESD is a research unit supported by the Portuguese Foundation for Science and Technology, (UID/DTP/04045/2013) and by the European Regional Development Fund, through COMPETE 2020 (POCI-01-0145-FEDER-006969). This research is part of NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, funded by the European Regional Development Fund, through NORTE 2020 (NORTE-01-0145-FEDER-000016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banister EW, 1999, EUR J APPL PHYSIOL O, V79, P182, DOI 10.1007/s004210050493; Barengo NC, 2014, INT J ENV RES PUB HE, V11, P11986, DOI 10.3390/ijerph111111986; Bishop D, 2003, SPORTS MED, V33, P483, DOI 10.2165/00007256-200333070-00002; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brandenburg JP, 2005, J STRENGTH COND RES, V19, P427; Brockett CL, 2001, MED SCI SPORT EXER, V33, P783; Byrne PJ, 2014, J STRENGTH COND RES, V28, P610, DOI 10.1519/JSC.0b013e3182a0d8c1; Chiu LZF, 2003, J STRENGTH COND RES, V17, P671, DOI 10.1519/1533-4287(2003)017<0671:PPRIAA>2.0.CO;2; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; Dello Iacono A, 2016, J STRENGTH COND RES, V30, P3122, DOI 10.1519/JSC.0000000000001393; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Edholm P, 2015, SCAND J MED SCI SPOR, V25, pE40, DOI 10.1111/sms.12236; Fatouros IG, 2000, J STRENGTH COND RES, V14, P470; Fauth ML, 2010, J STRENGTH COND RES, V24, P1131, DOI 10.1519/JSC.0b013e3181cc2353; Fredrick GA, 2001, STRENGTH COND J, V23, P21, DOI 10.1519/1533-4295(2001)023<0021:BPIDF>2.0.CO;2; Hader K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149839; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kilduff LP, 2013, J SCI MED SPORT, V16, P482, DOI 10.1016/j.jsams.2012.11.889; Masamoto N, 2003, J STRENGTH COND RES, V17, P68; McGowan CJ, 2015, SPORTS MED, V45, P1523, DOI 10.1007/s40279-015-0376-x; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Proske U, 2005, EXERC SPORT SCI REV, V33, P98, DOI 10.1097/00003677-200504000-00007; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Quagliarella L, 2010, J STRENGTH COND RES, V24, P1229, DOI 10.1519/JSC.0b013e3181cb281a; Russell M, 2015, SPORTS MED, V45, P353, DOI 10.1007/s40279-014-0297-0; Sale D, 2004, BRIT J SPORT MED, V38, P386, DOI 10.1136/bjsm.2002.003392; SARGEANT AJ, 1987, EUR J APPL PHYSIOL, V56, P693, DOI 10.1007/BF00424812; Sayers A, 2008, STRENGTH COND J, V30, P56, DOI 10.1519/SSC.0b013e31817f985d; SCHOT P, 1995, J ORTHOP SPORT PHYS, V22, P254, DOI 10.2519/jospt.1995.22.6.254; Sotiropoulos K, 2010, J SPORT SCI MED, V9, P326; Stolen T, 2005, SPORTS MED, V35, P501; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; Wilson JM, 2013, J STRENGTH COND RES, V27, P854, DOI 10.1519/JSC.0b013e31825c2bdb; Wong DP, 2012, J STRENGTH COND RES, V26, P2324, DOI 10.1519/JSC.0b013e31823daeab	40	8	8	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180152	10.1371/journal.pone.0180152	http://dx.doi.org/10.1371/journal.pone.0180152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662123	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300113
J	Kang, HM; Kim, GH; Jeon, HK; Kim, DH; Jeon, TY; Park, DY; Jeong, H; Chun, WJ; Kim, MH; Park, J; Lim, M; Kim, TH; Cho, YK				Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Kim, Dae Hwan; Jeon, Tae Yong; Park, Do Youn; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun; Park, Juhee; Lim, Minji; Kim, Tae-Hyeong; Cho, Yoon-Kyung			Circulating tumor cells detected by lab-on-adisc: Role in early diagnosis of gastric cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MICROFLUIDIC DEVICE; PERIPHERAL-BLOOD; CLINICAL-SIGNIFICANCE; MOLECULAR-DETECTION; MUCIN EXPRESSION; HIGH-PURITY; ENRICHMENT; METASTASIS; CARCINOMAS	Background The use of circulating tumor cells (CTCs) as an early diagnostic biomarker and prognostic indicator after surgery or chemotherapy has been suggested for various cancers. This study aimed to evaluate CTCs in patients who underwent gastrectomy for gastric cancer and to explore their clinical usefulness in the early diagnosis of gastric cancer. Methods A total of 116 patients with gastric cancer who underwent gastrectomy and 31 healthy volunteers were prospectively included between 2014 and 2015. Peripheral blood samples were collected before gastrectomy, and CTCs were examined using a centrifugal microfluidic system with a new fluid-assisted separation technique. Results After creating a receiver operating characteristic curve to identify the discriminative CTC value needed differentiate patients with gastric cancer from healthy volunteers, sensitivity and specificity were nearly optimized at a CTC threshold of 2 per 7.5 mL of blood. Of the 102 persons with a CTC level >= 2 per 7.5 mL of blood, 99 (97.1%) had gastric cancer, and of the 45 persons with a CTC level <2 per 7.5 mL of blood, 28 (62.2%) were healthy controls. Accordingly, the sensitivity and specificity for the differentiation of patients with gastric cancer from healthy controls were 85.3% and 90.3%, respectively. However, the presence of CTCs was not associated with any clinicopathologic features such as staging, histologic type, or mucin phenotype. Conclusion Although we could not prove the clinical feasibility of CTCs for gastric cancer staging, our results suggest a potential role of CTCs as an early diagnostic biomarker of gastric cancer.	[Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Kang, Hwa Mi; Kim, Gwang Ha; Jeon, Hye Kyung; Jeong, Hyunjin; Chun, Won Joo; Kim, Mi-Hyun] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Dae Hwan; Jeon, Tae Yong] Pusan Natl Univ, Dept Surg, Sch Med, Busan, South Korea; [Park, Do Youn] Pusan Natl Univ, Dept Pathol, Sch Med, Busan, South Korea; [Park, Juhee; Kim, Tae-Hyeong; Cho, Yoon-Kyung] IBS, Ctr Soft & Living Matter, Ulsan, South Korea; [Lim, Minji; Cho, Yoon-Kyung] UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Kim, GH (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Kim, GH (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	doc0224@pusan.ac.kr	Kim, Gwang Ha/ABF-3932-2021; Kim, Tae-Hyeong/X-8784-2019; Kim, Tae-Hyeong/AAO-8275-2020; Cho, Yoon-Kyoung/E-9082-2010; Cho, Yoon-Kyoung/ABF-9355-2021; Park, Juhee/P-5219-2017	Kim, Gwang Ha/0000-0001-9721-5734; Kim, Tae-Hyeong/0000-0002-1959-4705; Kim, Tae-Hyeong/0000-0002-1959-4705; Cho, Yoon-Kyoung/0000-0001-6423-1834; Cho, Yoon-Kyoung/0000-0001-6423-1834; Park, Juhee/0000-0002-8109-6387	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C1845]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C1845). The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Beeharry MK, 2016, WORLD J GASTROENTERO, V22, P1202, DOI 10.3748/wjg.v22.i3.1202; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Correia M, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00696.x; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Digklia A, 2016, WORLD J GASTROENTERO, V22, P2403, DOI 10.3748/wjg.v22.i8.2403; Edge S, 2010, AJCC CANC STAGING HD; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Hiraiwa K, 2008, ANN SURG ONCOL, V15, P3092, DOI 10.1245/s10434-008-0122-9; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; Huang XZ, 2015, INT J CANCER, V136, P21, DOI 10.1002/ijc.28954; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Kim DH, 2013, ARCH PATHOL LAB MED, V137, P1047, DOI 10.5858/arpa.2012-0193-OA; Kim GH, 2006, SCAND J GASTROENTERO, V41, P880, DOI 10.1080/00365520500497140; Kim TH, 2017, ANAL CHEM, V89, P1155, DOI 10.1021/acs.analchem.6b03534; Kubisch I, 2015, ONCOLOGY-BASEL, V89, P294, DOI 10.1159/000437373; Lee A, 2014, ANAL CHEM, V86, P11349, DOI 10.1021/ac5035049; Lee HJ, 2015, WORLD J GASTROENTERO, V21, P3944, DOI 10.3748/wjg.v21.i13.3944; Li M, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/981261; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Park DY, 2008, AM J SURG PATHOL, V32, P524, DOI 10.1097/PAS.0b013e31815b890e; Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/NMETH.3404, 10.1038/nmeth.3404]; Tang YD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06052; Uenosono Y, 2013, CANCER-AM CANCER SOC, V119, P3984, DOI 10.1002/cncr.28309; Witzig TE, 2002, CLIN CANCER RES, V8, P1085; Wu CH, 2006, DIS MARKERS, V22, P103, DOI 10.1155/2006/281315; Yeh KH, 1998, ANTICANCER RES, V18, P1283; Zhou MD, 2014, SCI REP-UK, V4, DOI 10.1038/srep07392	35	39	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180251	10.1371/journal.pone.0180251	http://dx.doi.org/10.1371/journal.pone.0180251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662130	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300132
J	Liang, B; Zhao, JY; Wang, X				Liang, Bin; Zhao, Jianying; Wang, Xuan			A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis	PLOS ONE			English	Article							MICRORNA EXPRESSION SIGNATURES; CARCINOMA-CELLS; BLADDER-CANCER; PROLIFERATION; INVASION; APOPTOSIS; SURVIVAL; TUMORIGENESIS; METASTASIS; MIGRATION	Accumulating evidence has demonstrated that some specific miRNAs were aberrantly expressed in renal clear cell carcinoma and participated in many biological processes. The aim of this study was to investigate a panel of miRNA signature for diagnosis and prognosis of renal clear cell carcinoma (KIRC). Here, we performed a comprehensive analysis for miRNA expression profiles and corresponding clinical information of 516 KIRC patients from The Cancer Genome Atlas (TCGA). In the study, a total of 63 differentially expressed miRNAs were identified, of which 34 were up-regulated and 29 were down-regulated. We constructed a panel of three-miRNA that were significantly associated with KIRC diagnosis and KIRC patients' prognosis. The three-miRNA signature reached a sensitivity of 98.3% and a specificity of 97.2% in the diagnosis of KIRC. Using the three-miRNA signature, we classified the KIRC patients into high-risk group and low-risk group. The Kaplan-Meier curves showed that KIRC patients with high risk scores had significantly worsen overall survival (OS) and disease free survival (DFS) than KIRC patients with low risk scores. In the univariate and multivariate Cox regression analysis, three-miRNA signature was an independent prognostic factor in OS. In conclusion, the three-miRNA signature could be used as a diagnostic and prognostic biomarker in KIRC, and therefore, may help to provide significant clinical implication for the treatment of KIRC.	[Liang, Bin] China Med Univ, Dept Bioinformat, Key Lab Cell Biol, Minist Publ Hlth,Coll Basic Med Sci, Shenyang, Peoples R China; [Liang, Bin] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Coll Basic Med Sci, Shenyang, Peoples R China; [Zhao, Jianying] PLA, Dept Clin Lab, Hosp 202, Shenyang, Peoples R China; [Zhao, Jianying] Jinzhou Med Univ, Grad Sch, Jinzhou, Peoples R China; [Wang, Xuan] Dalian Med Univ, Grad Sch, Dalian, Peoples R China	China Medical University; China Medical University; Jinzhou Medical University; Dalian Medical University	Liang, B (corresponding author), China Med Univ, Dept Bioinformat, Key Lab Cell Biol, Minist Publ Hlth,Coll Basic Med Sci, Shenyang, Peoples R China.; Liang, B (corresponding author), China Med Univ, Key Lab Med Cell Biol, Minist Educ, Coll Basic Med Sci, Shenyang, Peoples R China.	bliang@cmu.edu.cn						Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Chen JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-169; Christinat Y, 2015, ONCOTARGET, V6, P10521, DOI 10.18632/oncotarget.3294; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Feng YH, 2016, BIOMED REP, V5, P395, DOI 10.3892/br.2016.747; Gao Y, 2016, ONCOTARGET, V7, P20324, DOI 10.18632/oncotarget.7951; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; He HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125672; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Ji S., 2012, ADV DIFFER EQU, V2012, P1, DOI DOI 10.1016/J.CAGE0.2012.01.004; Kaucsar T, 2010, ADV DRUG DELIVER REV, V62, P1390, DOI 10.1016/j.addr.2010.10.003; Kong W, 2016, J BIOL CHEM, V291, P22855, DOI 10.1074/jbc.A110.101055; Kurozumi A, 2017, J HUM GENET, V62, P49, DOI 10.1038/jhg.2016.84; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Li YF, 2016, MOL MED REP, V14, P560, DOI 10.3892/mmr.2016.5251; Liang T, 2016, ONCOL RES, V24, P371, DOI 10.3727/096504016X14685034103356; Liao LL, 2015, CANCER GENET-NY, V208, P206, DOI 10.1016/j.cancergen.2015.02.008; Liep J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157801; Liu F, 2016, BIOCHEM BIOPH RES CO, V480, P87, DOI 10.1016/j.bbrc.2016.10.004; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma Q, 2016, INT J ONCOL, V49, P2589, DOI 10.3892/ijo.2016.3746; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mlcochova H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31852; Ramanathan R, 2017, BREAST CANC RES TREA; Schmidt LS, 2016, SEMIN ONCOL, V43, P566, DOI 10.1053/j.seminoncol.2016.09.001; Shinmei S, 2013, INT J UROL, V20, P468, DOI 10.1111/j.1442-2042.2012.03182.x; Shu X, 2017, BRIT J CANCER, V116, P77, DOI 10.1038/bjc.2016.392; Sohn W, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.68; Szabo Z, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.06.011; Trevisani F, 2016, BRIT J CANCER, V115, P1343, DOI 10.1038/bjc.2016.329; Tusong H, 2016, CANC BIOMARK; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Velazquez KT, 2016, AM J PHYSIOL-GASTR L, V310, pG347, DOI 10.1152/ajpgi.00326.2015; Wang H, 2015, LABMEDICINE, V46, P118, DOI 10.1309/LMWR9CEA2K2XVSOX; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zeng FC, 2016, ONCOTARGETS THER, V9, P2131, DOI 10.2147/OTT.S98002; Zhao JJ, 2016, ARCH MED SCI, V12, P473, DOI 10.5114/aoms.2016.59918; ZHU J, 2016, TUMOUR BIOL	42	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180660	10.1371/journal.pone.0180660	http://dx.doi.org/10.1371/journal.pone.0180660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662155	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300173
J	Paul, AL; Sng, NJ; Zupanska, AK; Krishnamurthy, A; Schultz, ER; Ferl, RJ				Paul, Anna-Lisa; Sng, Natasha J.; Zupanska, Agata K.; Krishnamurthy, Aparna; Schultz, Eric R.; Ferl, Robert J.			Genetic dissection of the Arabidopsis spaceflight transcriptome: Are some responses dispensable for the physiological adaptation of plants to spaceflight?	PLOS ONE			English	Article							EXPRESSION ANALYSIS; PHYTOCHROME D; SPACE; THALIANA; ROOTS; GRAVITY; GROWTH; HEAT; GRAVITROPISM; TOLERANCE	Experimentation on the International Space Station has reached the stage where repeated and nuanced transcriptome studies are beginning to illuminate the structural and metabolic differences between plants grown in space compared to plants on the Earth. Genes that are important in establishing the spaceflight responses are being identified, their roles in spaceflight physiological adaptation are increasingly understood, and the fact that different genotypes adapt differently is recognized. However, the basic question of whether these spaceflight responses are actually required for survival has yet to be posed, and the fundamental notion that spaceflight responses may be non-adaptive has yet to be explored. Therefore the experiments presented here were designed to ask if portions of the plant spaceflight response can be genetically removed without causing loss of spaceflight survival and without causing increased stress responses. The CARA experiment compared the spaceflight transcriptome responses in the root tips of two Arabidopsis ecotypes, Col-0 and WS, as well as that of a PhyD mutant of Col-0. When grown with the ambient light of the ISS, phyD plants displayed a significantly reduced spaceflight transcriptome response compared to Col-0, suggesting that altering the activity of a single gene can actually improve spaceflight adaptation by reducing the transcriptome cost of physiological adaptation. The WS genotype showed an even simpler spaceflight transcriptome response in the ambient light of the ISS, more broadly indicating that the plant genotype can be manipulated to reduce the cost of spaceflight adaptation, as measured by transcriptional response. These differential genotypic responses suggest that genetic manipulation could further reduce, or perhaps eliminate the metabolic cost of spaceflight adaptation. When plants were germinated and then left in the dark on the ISS, the WS genotype actually mounted a larger transcriptome response than Col-0, suggesting that the in-space light environment affects physiological adaptation, which implies that manipulating the local habitat can also substantially impact the metabolic cost of spaceflight adaptation.	[Paul, Anna-Lisa; Sng, Natasha J.; Zupanska, Agata K.; Krishnamurthy, Aparna; Schultz, Eric R.; Ferl, Robert J.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Ferl, Robert J.] Univ Florida, Interdisciplinary Ctr Biotechnol & Res, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ferl, RJ (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.; Ferl, RJ (corresponding author), Univ Florida, Interdisciplinary Ctr Biotechnol & Res, Gainesville, FL 32611 USA.	robferl@ufl.edu	Zupanska, Agata/AAE-6817-2020	Ferl, Robert/0000-0003-4178-764X; Haveman, Natasha/0000-0001-7083-5925; Paul, Anna-Lisa/0000-0003-2211-2604	Center for Advancement of Science in Space (CASIS) [GA-2013-104]	Center for Advancement of Science in Space (CASIS)	The work was supported by grant number GA-2013-104, Center for Advancement of Science in Space (CASIS), URL:http://www.isscasis.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; [Anonymous], 2015, PROTEOMICS TRANSCRIP; [Anonymous], 2015, COMP SPACEFLIGHT TRA; Aoki Y, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv165; Aubert Y, 2010, PLANT CELL PHYSIOL, V51, P1975, DOI 10.1093/pcp/pcq155; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Chan ZL, 2013, PLANT PHYSIOL BIOCH, V73, P189, DOI 10.1016/j.plaphy.2013.09.013; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Des Marais DL, 2012, PLANT CELL, V24, P893, DOI 10.1105/tpc.112.096180; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fengler S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/547495; Ferl RJ, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2015.23; Ferl RJ, 2015, ASTROBIOLOGY, V15, P32, DOI 10.1089/ast.2014.1210; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Guo M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00114; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Kiss JZ, 2015, METHODS MOL BIOL, V1309, P255, DOI 10.1007/978-1-4939-2697-8_19; Kiss JZ, 2012, PLANTA, V236, P635, DOI 10.1007/s00425-012-1633-y; Kittang AI, 2014, PLANT BIOLOGY, V16, P528, DOI 10.1111/plb.12132; Klingseisen B, 2013, PREV VET MED, V110, P159, DOI 10.1016/j.prevetmed.2012.12.001; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kwon T, 2015, AM J BOT, V102, P21, DOI 10.3732/ajb.1400458; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Mazars C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29637; Mazars C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091814; Millar KDL, 2011, ASTROBIOLOGY, V11, P787, DOI 10.1089/ast.2011.0699; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Nakashima J, 2014, PLANT BIOLOGY, V16, P142, DOI 10.1111/plb.12062; Nakashima J, 2014, PLANT BIOL, V16; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Oliva M, 2007, NEW PHYTOL, V176, P37, DOI 10.1111/j.1469-8137.2007.02184.x; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Passardi F, 2007, J PLANT PHYSIOL, V164, P980, DOI 10.1016/j.jplph.2006.06.008; Paul AL, 2005, ADV SPACE RES-SERIES, V36, P1175, DOI 10.1016/j.asr.2005.03.066; Paul AL, 2015, METHODS MOL BIOL, V1309, P285, DOI 10.1007/978-1-4939-2697-8_20; Paul AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-112; Paul AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-232; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Poulet L, 2016, BOT LETT, V163, P337, DOI 10.1080/23818107.2016.1194228; Ruyters G, 2014, PLANT BIOLOGY, V16, P4, DOI 10.1111/plb.12127; Salmi ML, 2008, PLANTA, V229, P151, DOI 10.1007/s00425-008-0817-y; Sato EM, 2015, J EXP BOT, V66, P2155, DOI [10.1093/jxb/eru515, 10.1093/jxb/er]; Schuler O, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01776, 10.3389/fpls.2015.01176]; Schultz ER, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0975-9; Schultz ER, 2016, MICROGRAVITY SCI TEC, V28, P621, DOI 10.1007/s12217-016-9514-9; Sng N, 2014, GRAVITATIONAL SPACE, V2, P81; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Sugimoto M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-4; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Thatcher LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126978; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vandenbrink JP, 2016, PLANTA, V244, P1201, DOI 10.1007/s00425-016-2581-8; Vandenbrink JP, 2016, PLANT SCI, V243, P115, DOI 10.1016/j.plantsci.2015.11.004; Vandenbrink JP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00563; Vanholme B, 2014, PLANT PHYSIOL, V165, P290, DOI 10.1104/pp.113.233742; Yong WD, 2005, PLANTA, V221, P747, DOI 10.1007/s00425-005-1563-z; Zhang Y, 2015, PLANTA, V241, P475, DOI 10.1007/s00425-014-2196-x; Zupanska AK, 2013, AM J BOT, V100, P235, DOI 10.3732/ajb.1200343	68	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180186	10.1371/journal.pone.0180186	http://dx.doi.org/10.1371/journal.pone.0180186			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662188	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300120
J	Piotrowska, I; Isalan, M; Mielcarek, M				Piotrowska, Izabela; Isalan, Mark; Mielcarek, Michal			Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy	PLOS ONE			English	Article							INDUCED HEART-FAILURE; CARDIAC-HYPERTROPHY; ANTHRACYCLINE CARDIOTOXICITY; MOLECULAR-MECHANISMS; HDAC INHIBITION; MICE; REPRESSION; INFUSION; THERAPY; DISEASE	Doxorubicin is a potent chemotherapeutic agent that is widely-used to treat a variety of cancers but causes acute and chronic cardiac injury, severely limiting its use. Clinically, the acute side effects of doxorubicin are mostly manageable, whereas the delayed consequences can lead to life-threatening heart failure, even decades after cancer treatment. The cardiotoxicity of doxorubicin is subject to a critical cumulative dose and so dosage limitation is considered to be the best way to reduce these effects. Hence, a number of studies have defined a "safe dose" of the drug, both in animal models and clinical settings, with the aim of avoiding long-term cardiac effects. Here we show that a dose generally considered as safe in a mouse model can induce harmful changes in the myocardium, as early as 2 weeks after infusion. The adverse changes include the development of fibrotic lesions, disarray of cardiomyocytes and a major transcription dysregulation. Importantly, low-dose doxorubicin caused specific changes in the transcriptional profile of several histone deacetylases (HDACs) which are epigenetic regulators of cardiac remodelling. This suggests that cardioprotective therapies, aimed at modulating HDACs during doxorubicin treatment, deserve further exploration.	[Piotrowska, Izabela] UCL, Hatter Cardiovasc Inst, London, England; [Isalan, Mark; Mielcarek, Michal] Imperial Coll London, Dept Life Sci, London, England; [Mielcarek, Michal] Univ Med Sci, Dept Epidemiol Rare Dis & Neuroepidemiol, Poznan, Poland	University of London; University College London; Imperial College London	Mielcarek, M (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Mielcarek, M (corresponding author), Univ Med Sci, Dept Epidemiol Rare Dis & Neuroepidemiol, Poznan, Poland.	m.mielcarek@imperial.ac.uk	Mielcarek, Michal/M-6302-2018	Mielcarek, Michal/0000-0002-9874-6753; Isalan, Mark/0000-0002-4652-0365	European Research Council [H2020E-RC-2014-PoC641232-Fingers4Cure]; MRC [MC_PC_15028] Funding Source: UKRI; Medical Research Council [MC_PC_15028] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the funding from European Research Council grant H2020E-RC-2014-PoC641232-Fingers4Cure. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustin-Pavon C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0128-x; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Berry JM, 2008, EXPERT OPIN DRUG SAF, V7, P53, DOI [10.1517/14740338.7.1.53, 10.1517/14740338.7.1.53 ]; Bush EW, 2009, EXPERT OPIN THER TAR, V13, P767, DOI 10.1517/14728220902939161; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen MC, 2011, HEPATOLOGY, V53, P148, DOI 10.1002/hep.23964; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Desai VG, 2013, TOXICOL APPL PHARM, V266, P109, DOI 10.1016/j.taap.2012.10.025; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Fulgenzi G, 2015, J CELL BIOL, V210, P1003, DOI 10.1083/jcb.201502100; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Horan PG, 2006, EUR HEART J, V27, P1137, DOI 10.1093/eurheartj/ehi702; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Lehmann LH, 2014, CELL MOL LIFE SCI, V71, P1673, DOI 10.1007/s00018-013-1516-9; Lipshultz SE, 2012, PEDIATRICS, V130, P1003, DOI 10.1542/peds.2012-0727; Liu XJ, 2012, ACTA CARDIOL SIN, V28, P236; Lotrionte M, 2013, AM J CARDIOL, V112, P1980, DOI 10.1016/j.amjcard.2013.08.026; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McGowan JV, 2017, CARDIOVASC DRUG THER, V31, P63, DOI 10.1007/s10557-016-6711-0; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; McLendon PM, 2014, P NATL ACAD SCI USA, V111, pE5178, DOI 10.1073/pnas.1415589111; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Mielcarek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108961; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mitry MA, 2016, IJC HEART VASC, V10, P17, DOI 10.1016/j.ijcha.2015.11.004; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Rafehi H, 2014, GENOME RES, V24, P1271, DOI 10.1101/gr.168781.113; Rahman AM, 2007, INT J NANOMED, V2, P567; Raj Shashi, 2014, Curr Treat Options Cardiovasc Med, V16, P315, DOI 10.1007/s11936-014-0315-4; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	44	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180571	10.1371/journal.pone.0180571	http://dx.doi.org/10.1371/journal.pone.0180571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662206	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300167
J	Exposito-Granados, M; Parejo, D; Martinez, JG; Sanchez-Tojar, A; Precioso, M; Molina-Morales, M; Aviles, JM				Exposito-Granados, Monica; Parejo, Deseada; Martinez, Juan Gabriel; Sanchez-Tojar, Alfredo; Precioso, Marta; Molina-Morales, Mercedes; Aviles, Jesus M.			An experimental test of host's life history traits modulation in response to cuckoo parasitism risk	PLOS ONE			English	Article							GREAT SPOTTED CUCKOO; EXPERIMENTAL BROOD PARASITISM; REED WARBLERS; PHENOTYPIC PLASTICITY; RECOGNITION ERRORS; PLANT TOLERANCE; PREDATION RISK; MAGPIE HOSTS; NEST DEFENSE; CLUTCH SIZE	Hosts can counteract parasites through defences based on resistance and/or tolerance. The mechanistic basis of tolerance, which involve defensive mechanisms minimizing parasite damage after a successful parasitic attack, remains poorly explored in the study of cuckoo-host interactions. Here, we experimentally explore the possibility that the risk of great spotted cuckoo Clamator glandarius parasitism may induce tolerance defences in magpie Pica pica hosts through plasticity in life-history traits. We predict that magpies exposed to auditory cues indicating high parasitism risk will more likely exhibit resistance and/or modify their life-history traits to minimize parasitism costs (i.e. tolerance) compared to magpies under low parasitism risk. We found that manipulating the perceived parasitism risk did not affect host resistance (i.e. rejection of parasitic eggs) nor host life-history traits. Unexpectedly, host's egg volume increased over the season in nests exposed to auditory cues of control non-harmful hoopoes Upupa epops. Our results do not provide support for inducible defences (either based on resistance or tolerance) in response to risk of parasitism in magpie hosts. Even so, we encourage studying plastic expression of breeding strategies in response to risk of cuckoo parasitism to achieve a better understanding of the mechanistic basis of tolerance defences.	[Exposito-Granados, Monica; Parejo, Deseada; Aviles, Jesus M.] EEZA CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain; [Parejo, Deseada] Univ Extremadura, Dept Zool, Badajoz, Spain; [Martinez, Juan Gabriel; Sanchez-Tojar, Alfredo; Precioso, Marta; Molina-Morales, Mercedes] Univ Granada, Dept Zool, Granada, Spain; [Sanchez-Tojar, Alfredo] Max Planck Inst Ornithol, Evolutionary Biol Grp, Seewiesen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Extremadura; University of Granada; Max Planck Society	Exposito-Granados, M (corresponding author), EEZA CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain.	moexposit@eeza.csic.es	Martinez, Juan/GXM-4393-2022; Expósito-Granados, Mónica/K-1863-2019; Parejo, Deseada/L-3953-2014; Avilés, Jesús/K-3332-2014; Sánchez-Tójar, Alfredo/H-3619-2019; Molina-Morales, Mercedes/I-8397-2019; Martínez, Juan Gabriel/L-9471-2014	Expósito-Granados, Mónica/0000-0002-7996-2469; Parejo, Deseada/0000-0002-7368-2378; Avilés, Jesús/0000-0002-1463-8393; Sánchez-Tójar, Alfredo/0000-0002-2886-0649; Martínez, Juan Gabriel/0000-0001-5277-4620; Molina Morales, Mercedes/0000-0001-8669-6624; Precioso, Marta/0000-0002-2030-5966	Spanish Ministry of Education and Science/FEDER [CGL2011-27561/BOS, CGL2014-56769-P]; Government of Extremadura [TA13002]; Spanish Ministry of Economy and Competitiveness [BES-2012-051898]	Spanish Ministry of Education and Science/FEDER(Spanish Government); Government of Extremadura; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Education and Science/FEDER (Projects CGL2011-27561/BOS and CGL2014-56769-P to D. P. and J.M.A.). D.P. was supported by the Government of Extremadura while writing (contract number TA13002). M.E.G. was supported by the Spanish Ministry of Economy and Competitiveness (grant number BES-2012-051898).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2013, EMU, V113, P187, DOI 10.1071/MU12086; Arias-de-Reyna L, 1998, OX ORN SER, V9, P129; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; Bartol I, 2002, J AVIAN BIOL, V33, P420, DOI 10.1034/j.1600-048X.2002.02945.x; Birkhead T. R., 1991, MAGPIES ECOLOGY BEHA; Brooker M, 1996, BEHAV ECOL, V7, P395, DOI 10.1093/beheco/7.4.395; Campobello D, 2011, ANIM BEHAV, V82, P885, DOI 10.1016/j.anbehav.2011.07.028; Capek M, 2010, CONDOR, V112, P763, DOI 10.1525/cond.2010.100063; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Cunningham EJA, 2006, BEHAV ECOL, V17, P126, DOI 10.1093/beheco/arj006; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Feeney WE, 2015, AUK, V132, P359, DOI 10.1642/AUK-14-218.1; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Forsman JT, 2009, OIKOS, V118, P464, DOI 10.1111/j.1600-0706.2008.17000.x; Grim T, 2005, AUK, V122, P530, DOI 10.1642/0004-8038(2005)122[0530:HROBPI]2.0.CO;2; Hauber ME, 2003, EVOL ECOL RES, V5, P559; Hoover JP, 2007, P NATL ACAD SCI USA, V104, P4479, DOI 10.1073/pnas.0609710104; HOYT DF, 1979, AUK, V96, P73; Hua FY, 2014, BEHAV ECOL, V25, P509, DOI 10.1093/beheco/aru017; Kleindorfer S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-30; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; LaManna JA, 2016, ECOL LETT, V19, P403, DOI 10.1111/ele.12573; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lindholm AK, 2000, BEHAVIOUR, V137, P43, DOI 10.1163/156853900501863; Llimosa F., 1999, GUIA SONORA AVES ESP; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; Medina I, 2016, BIOL REV, V91, P569, DOI 10.1111/brv.12181; Aviles JM, 2014, BEHAV ECOL SOCIOBIOL, V68, P1287, DOI 10.1007/s00265-014-1739-2; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; MOKSNES A, 1993, BEHAV ECOL, V4, P120, DOI 10.1093/beheco/4.2.120; Molina-Morales M, 2016, BEHAV ECOL, V27, P1441, DOI 10.1093/beheco/arw066; Molina-Morales M, 2014, EVOLUTION, V68, P3020, DOI 10.1111/evo.12471; Molina-Morales M, 2013, J ANIM ECOL, V82, P389, DOI 10.1111/1365-2656.12022; Molina-Morales M, 2012, ANIM BEHAV, V83, P671, DOI 10.1016/j.anbehav.2011.12.011; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Parejo D, 2012, BEHAV ECOL SOCIOBIOL, V66, P1097, DOI 10.1007/s00265-012-1360-1; Parejo D, 2012, P ROY SOC B-BIOL SCI, V279, P2135, DOI 10.1098/rspb.2011.2601; PAYNE RB, 1977, ANNU REV ECOL SYST, V8, P1, DOI 10.1146/annurev.es.08.110177.000245; Price P. W., 1980, EVOLUTIONARY BIOL PA; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Saino N, 2010, BEHAV ECOL SOCIOBIOL, V64, P1813, DOI 10.1007/s00265-010-0993-1; Saino N, 2010, P ROY SOC B-BIOL SCI, V277, P1203, DOI 10.1098/rspb.2009.2012; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Soler JJ, 2016, ENCICLOPEDIA VIRTUAL; Soler JJ, 2010, P R SOC LOND B; Soler M, 2000, BEHAVIOUR, V137, P213, DOI 10.1163/156853900502033; SOLER M, 1995, EVOLUTION, V49, P770, DOI 10.1111/j.1558-5646.1995.tb02312.x; SOLER M, 1990, NATURE, V343, P748, DOI 10.1038/343748a0; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler Manuel, 1996, Ardeola, V43, P87; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Svensson EI, 2010, TRENDS ECOL EVOL, V25, P267, DOI 10.1016/j.tree.2009.12.005; Thorogood R, 2013, EVOLUTION, V67, P3545, DOI 10.1111/evo.12213; Welbergen JA, 2012, BEHAV ECOL, V23, P783, DOI 10.1093/beheco/ars031; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041	73	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179206	10.1371/journal.pone.0179206	http://dx.doi.org/10.1371/journal.pone.0179206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658287	Green Published, Green Submitted, gold			2022-12-26	WOS:000404607900016
J	Tariku, A; Alemu, K; Gizaw, Z; Muchie, KF; Derso, T; Abebe, SM; Yitayal, M; Fekadu, A; Ayele, TA; Alemayehu, GA; Tsegaye, AT; Shimeka, A; Biks, GA				Tariku, Amare; Alemu, Kassahun; Gizaw, Zemichael; Muchie, Kindie Fentahun; Derso, Terefe; Abebe, Solomon Mekonnen; Yitayal, Mezgebu; Fekadu, Abel; Ayele, Tadesse Awoke; Alemayehu, Geta Asrade; Tsegaye, Adino Tesfahun; Shimeka, Alemayehu; Biks, Gashaw Andargie			Mothers' education and ANC visit improved exclusive breastfeeding in Dabat Health and Demographic Surveillance System Site, northwest Ethiopia	PLOS ONE			English	Article							CHILD NUTRITION; RISK; ASSOCIATION; OUTCOMES	Introduction Despite its proven benefit in reducing child mortality and morbidity, the coverage of exclusive breastfeeding (EBF) remains sub-optimal. In Ethiopia, about 52% of infants under six months of age were exclusively breastfed, implying the need for further identification of the barriers to optimal EBF practice. Therefore, this study aimed to investigate EBF and its determinants in the predominantly rural northwest Ethiopia. Methods The study was conducted at the Dabat Health and Demographic Surveillance System (HDSS) site, which is located in Dabat District, northwest Ethiopia. A total of 5,227 mothers with children under five years of age were included for analysis. Multivariable binary logistic regression analysis was employed to identify factors associated with EBF. The Adjusted Odds Ratio (AOR) with a 95% Confidence Interval (CI) was estimated to show the strength of association. A P-value of <0.05 was used to declare statistical significance. Results About 54.5% [95% CI: 51.9, 57.1] of the mothers practiced EBF. Mothers' education [AOR = 2.10; 95% CI: 1.63, 2.71], age (20-35 years) [AOR = 1.39; CI: 1.07, 1.80], urban residence [AOR = 1.28; 95% CI: 1.07, 1.54], at least one ANC visit [AOR = 1.41; 95% CI: 1.23,1.61], initiation of breastfeeding within one hour of birth [AOR = 1.32; 95% CI: 1.15,1.50], richer household [AOR = 1.34; 95% CI: 1.07, 1.65], and withholding prelacteal feeds [AOR = 1.34; 95% CI: 1.17, 1.53] were found important determinants of EBF. Conclusion In this study area, the prevalence of EBF is lower than the national as well as the global recommendation for universal coverage of EBF. Therefore, strengthening the implementation of Infant and Young Child Feeding strategy (IYCF) and maternal health care utilization are essential for stepping up EBF coverage. Moreover, attention should be given to uneducated, rural resident, and adolescent mothers.	[Tariku, Amare; Derso, Terefe; Abebe, Solomon Mekonnen] Univ Gondar, Dept Human Nutr, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tariku, Amare; Alemu, Kassahun; Muchie, Kindie Fentahun; Abebe, Solomon Mekonnen; Yitayal, Mezgebu; Ayele, Tadesse Awoke; Alemayehu, Geta Asrade; Tsegaye, Adino Tesfahun; Biks, Gashaw Andargie] Univ Gondar, Dabat Res Ctr Hlth & Demog Surveillance Syst, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alemu, Kassahun; Muchie, Kindie Fentahun; Fekadu, Abel; Ayele, Tadesse Awoke; Tsegaye, Adino Tesfahun; Shimeka, Alemayehu] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Gizaw, Zemichael] Univ Gondar, Dept Environm & Occupat Hlth & Safety, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yitayal, Mezgebu; Alemayehu, Geta Asrade; Biks, Gashaw Andargie] Univ Gondar, Dept Hlth Serv Management & Hlth Econ, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Tariku, A (corresponding author), Univ Gondar, Dept Human Nutr, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.; Tariku, A (corresponding author), Univ Gondar, Dabat Res Ctr Hlth & Demog Surveillance Syst, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	amaretariku15@yahoo.com	Gizaw, Zemichael/CAF-1126-2022; Dadi, Abel Fekadu/AAU-3433-2020; Workneh, Zemichael Gizaw/M-1774-2019	Gizaw, Zemichael/0000-0002-6713-1975; Dadi, Abel Fekadu/0000-0001-9967-7713; Yitayal, Mezgebu/0000-0002-9206-9528	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA); EPHA-CDC Cooperative Agreement [NU22GGH001039-04-00]; University of Gondar	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EPHA-CDC Cooperative Agreement; University of Gondar	This work was supported by the Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA) in accordance with the EPHA-CDC Cooperative Agreement No. NU22GGH001039-04-00 and University of Gondar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Aidam BA, 2005, EUR J CLIN NUTR, V59, P789, DOI 10.1038/sj.ejcn.1602144; Alemayehu T, 2009, ETHIOPIAN J HLTH DEV, V23; Arora S, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e67; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biks GA, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0055-4; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Central Statistical Authority, 2011, ETH DEM HLTH SURV; Central Statistical Authority [Ethiopia] and ORC Macro, 2005, DEM HLTH SUR; Coutsoudis A, 2015, IAEA B; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Egata G, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-8; Federal Democratic Republic of Ethiopa, HLTH SECT DEV PROGR; Federal Ministry of Health, 2004, FAM HLTH DEP ETH NAT; Ghwass MMEA, 2011, BREASTFEEDING MED, V6; Greiner T, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-18; Hackett KM, 2015, MATERN CHILD NUTR, V11, P173, DOI 10.1111/mcn.12007; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Himani BK, 2011, NURSING MIDWIFERY RE, V7; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Jedrychowski W, 2012, EUR J PEDIATR, V171, P151, DOI 10.1007/s00431-011-1507-5; Jessri M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-77; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Jones JR, 2011, FACTORS ASSOCIATED E; Jorgensen MH, 2001, J PEDIATR GASTR NUTR, V32, P293, DOI 10.1097/00005176-200103000-00011; Khanal V, 2014, NUTRIENTS, V6, P1691, DOI 10.3390/nu6041691; Knip M, 2005, ADV EXP MED BIOL, V569, P142; Kushwaha KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109181; Lakati A, 2010, E AFRICAN J PUBLIC H, V7; Lamberti LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S18; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; Li RW, 2014, PEDIATRICS, V134, pS13, DOI 10.1542/peds.2014-0646D; Lin SS, 2008, J CLIN NURS, V17, P296, DOI 10.1111/j.1365-2702.2006.01927.x; Mannion CA, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-4; Mgongo M, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-12; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Parizoto GM, 2009, J PEDIAT-BRAZIL, V85, P201, DOI [10.2223/JPED.1888, 10.1590/S0021-75572009000300004]; PerezEscamilla R, 1996, J NUTR, V126, P2765; Pisacane A, 2005, PEDIATRICS, V116, pE494, DOI 10.1542/peds.2005-0479; Quinn PJ, 2001, J PAEDIATR CHILD H, V37, P465, DOI 10.1046/j.1440-1754.2001.00702.x; Reynolds A, 2001, PEDIATR CLIN N AM, V48, P159, DOI 10.1016/S0031-3955(05)70291-1; Rundall P, 2007, ORG BM; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; Seid AM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-14; Seifu W., 2014, J PEDIAT NEONATAL CA, V1; Sonko A, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0098-4; Su L-L, 2007, BMJ; Tan KL, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-2; Tariku A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0074-9; Vieira TO, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-175; Wassie MM, 2015, BMC NUTR, V1, P1, DOI DOI 10.1186/S40795-015-0015-9; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Yeneabat T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-262; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	57	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179056	10.1371/journal.pone.0179056	http://dx.doi.org/10.1371/journal.pone.0179056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658257	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900012
J	Contreras-Aguilar, MD; Escribano, D; Martinez-Subiela, S; Martinez-Miro, S; Rubio, M; Tvarijonaviciute, A; Tecles, F; Ceron, JJ				Contreras-Aguilar, Maria Dolores; Escribano, Damian; Martinez-Subiela, Silvia; Martinez-Miro, Silvia; Rubio, Monica; Tvarijonaviciute, Asta; Tecles, Fernando; Ceron, Jose J.			Influence of the way of reporting alpha-Amylase values in saliva in different naturalistic situations: A pilot study	PLOS ONE			English	Article							STRESS-RESPONSE; METHODOLOGICAL CONSIDERATIONS; ANTIMICROBIAL PROTEINS; VETERINARY STUDENTS; PSYCHOSOCIAL STRESS; EXERCISE; DETERMINANTS; BIOMARKERS; INTENSITY; CORTISOL	The objective of this pilot study was to compare the different ways of measuring salivary alpha-amylase (sAA, enzymatic vs. concentration) and to evaluate the influence that the different ways of reporting the results can have in sAA interpretation. For this purpose, sAA was measured by direct quantification and also by an enzymatic assay in three different naturalistic situations, a physical stressor (situation 1) and two mental stressors of different intensity (situations 2 and 3). The results were expressed in three different ways (without correction, multiplied by flow rate and divided by protein concentration). sAA concentration and activity increased just after situations 1 and 3. When values were multiplied by the flow rate, significant changes after situation 1 were detected only for sAA activity but not for sAA concentration, being these changes of lower significance and magnitude that those observed for sAA activity without any correction. In addition, a significant increase in sAA activity was found at T+15 in situation 2. In situation 3 the significant decrease in sAA at T+15 disappeared. When values were divided by protein concentration, there were no significant changes in situations 1 or 3, but a decrease in situation 2 at T+0 and an increase at T+15. sAA activity and concentration showed a significant correlation in all situations. This pilot study points out that the way of expressing sAA can influence the results obtained in different stress models and also their interpretation. Therefore, how sAA is reported and the factors involved in the different ways of expressing sAA, should be taken into consideration for an objective interpretation of sAA values.	[Contreras-Aguilar, Maria Dolores; Escribano, Damian; Martinez-Subiela, Silvia; Tvarijonaviciute, Asta; Tecles, Fernando; Ceron, Jose J.] Clin Anal Interdisciplinary Lab Interlab UMU, Campus Excellence Mare Nostrum, Murcia, Spain; [Martinez-Miro, Silvia] Vet Sch, Dept Anim Prod, Campus Excellence Mare Nostrum, Murcia, Spain; [Rubio, Monica] Univ CEU Cardenal Herrera, Vet Sch, Dept Med & Anim Surgey, Valencia, Spain; [Escribano, Damian] Univ Autonoma Barcelona, Vet Sci, Dept Anim & Food Sci, Barcelona, Spain	University of Murcia; Universidad CEU Cardenal Herrera; Autonomous University of Barcelona	Tecles, F (corresponding author), Clin Anal Interdisciplinary Lab Interlab UMU, Campus Excellence Mare Nostrum, Murcia, Spain.	ftecles@um.es	Martínez, Silvia/I-3194-2015; Tecles, Fernando/Z-4602-2019; Ceron, Jose J/H-9043-2015; Tortosa, Damian Escribano/AAG-1780-2019; Contreras-Aguilar, María Dolores/AAG-6239-2019; Martinez-Subiela, Silvia/H-5719-2015; Tortosa, Damian Escribano/L-6138-2017; Tvarijonaviciute, Asta/U-4303-2017	Martínez, Silvia/0000-0002-1350-0886; Ceron, Jose J/0000-0002-8654-1793; Tortosa, Damian Escribano/0000-0001-9439-6779; Contreras-Aguilar, María Dolores/0000-0003-2898-0410; Martinez-Subiela, Silvia/0000-0002-1524-1558; Tortosa, Damian Escribano/0000-0001-9439-6779; Tvarijonaviciute, Asta/0000-0002-5323-5001; Tecles, Fernando/0000-0002-7635-533X; RUBIO, MONICA/0000-0002-2689-8862	Seneca Foundation of Murcia Region [19894/GERM/15]; 'FPU' of University of Murcia [R.-605/2016]; 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad'; 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute	Seneca Foundation of Murcia Region(Fundacion Seneca); 'FPU' of University of Murcia; 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad'; 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute	This work was supported by the Seneca Foundation of Murcia Region (19894/GERM/15, https://www).fseneca.es/node/7667). Predoctoral contract 'FPU' of University of Murcia (R.-605/2016) which recipient is Maria Dolores Contreras-Aguilar; the postdoctoral program 'Juan de la Cierva' of the 'Ministerio de Economia y Competitividad' which recipient is Damian Escribano; and the postdoctoral program 'Juan de la Cierva incorporacion' of the 'Ministerio de Economia y Competitividad' which recipient is Asta Tvarijonaviciute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgrove JE, 2014, SCAND J MED SCI SPOR, V24, P649, DOI 10.1111/sms.12056; Allgrove JE, 2008, J SPORT SCI, V26, P653, DOI 10.1080/02640410701716790; Allgrove JE, 2012, J REHABIL RES DEV, V49, P925, DOI 10.1682/JRRD.2011.06.0105; BARDO JW, 1978, PERCEPT MOTOR SKILL, V46, P308, DOI 10.2466/pms.1978.46.1.308; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; de Oliveira VN, 2010, INT J SPORTS MED, V31, P377, DOI 10.1055/s-0030-1248332; DeCaro JA, 2008, AM J HUM BIOL, V20, P617, DOI 10.1002/ajhb.20795; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fortes MB, 2011, CELL STRESS CHAPERON, V16, P345, DOI 10.1007/s12192-010-0244-4; Fuentes-Rubio M, 2015, J VET BEHAV, V10, P122, DOI 10.1016/j.jveb.2014.12.008; Gallina S, 2011, CLIN ENDOCRINOL, V75, P747, DOI 10.1111/j.1365-2265.2011.04143.x; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Hafen M, 2008, J VET MED EDUC, V35, P102, DOI 10.3138/jvme.35.1.102; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Koibuchi E, 2014, EXP THER MED, V7, P773, DOI 10.3892/etm.2014.1497; MACKINNON LT, 1993, MED SCI SPORT EXER, V25, P678; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mirzaii-Dizgah I, 2011, ORAL DIS, V17, P597, DOI 10.1111/j.1601-0825.2011.01817.x; Nagel C, 2015, REPROD DOMEST ANIM, V50, P866, DOI 10.1111/rda.12600; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Paszynska E, 2016, WORLD J BIOL PSYCHIA, V17, P266, DOI 10.3109/15622975.2016.1163419; Polo A., 2016, REV ANSIEDAD ESTRES, V2, P159; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; STOREY K, 1993, AM J MENT RETARD, V98, P437; Tecles F, 2016, SCAND J CLIN LAB INV, P1; Tecles F, 2014, J VET MED EDUC, V41, P37, DOI 10.3138/jvme.0513-073R1; TOMASI TB, 1982, J CLIN IMMUNOL, V2, P173, DOI 10.1007/BF00915219; van der Heiden C, 1999, CLIN CHIM ACTA, V281, pS5; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Walsh NP, 1999, J SPORT SCI, V17, P129, DOI 10.1080/026404199366226	36	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180100	10.1371/journal.pone.0180100	http://dx.doi.org/10.1371/journal.pone.0180100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654668	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500055
J	Vu, NX; Pruksametanan, N; Srila, W; Yuttavanichakul, W; Teamtisong, K; Teaumroong, N; Boonkerd, N; Tittabutr, P; Yamabhai, M				Nguyen Xuan Vu; Pruksametanan, Natcha; Srila, Witsanu; Yuttavanichakul, Watcharin; Teamtisong, Kamonluck; Teaumroong, Neung; Boonkerd, Nantakorn; Tittabutr, Panlada; Yamabhai, Montarop			Generation of a rabbit single-chain fragment variable (scFv) antibody for specific detection of Bradyrhizobiumsp. DOA9 in both free-living and bacteroid forms	PLOS ONE			English	Article							LEGUMINOSARUM STRAIN 3841; MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; POLYCLONAL ANTISERA; FUSION PROTEINS; ANTIGENS; IDENTIFICATION; SELECTION; LIPOPOLYSACCHARIDES; RHIZOBIA	A simple and reliable method for the detection of specific nitrogen-fixing bacteria in both free-living and bacteroid forms is essential for the development and application of biofertilizer. Traditionally, a polyclonal antibody generated from an immunized rabbit was used for detection. However, the disadvantages of using a polyclonal antibody include limited supply and cross-reactivity to related bacterial strains. This is the first report on the application of phage display technology for the generation of a rabbit recombinant monoclonal antibody for specific detection and monitoring of nitrogen-fixing bacteria in both free-living form and in plant nodules. Bradyrhizobium sp. DOA9, a broad host range soil bacteria, originally isolated from the root nodules of Aeschynomene americana in Thailand was used as a model in this study. A recombinant single-chain fragment variable (scFv) antibody library was constructed from the spleen of a rabbit immunized with DOA9. After three rounds of biopanning, one specific phage-displayed scFv antibody, designated bDOA9rb8, was identified. Specific binding of this antibody was confirmed by phage enzyme-linked immunosorbent assay (phage ELISA). The phage antibody could bind specifically to DOA9 in both free-living cells (pure culture) and bacteroids inside plant nodules. In addition to phage ELISA, specific and robust immunofluorescence staining of both free-living and bacteroid forms could also be observed by confocal-immunofluorescence imaging, without cross-reactivity with other tested bradyrhizobial strains. Moreover, specific binding of free scFv to DOA9 was also demonstrated by ELISA. This recombinant antibody can also be used for the study of the molecular mechanism of plant-microbe interactions in the future.	[Nguyen Xuan Vu; Pruksametanan, Natcha; Srila, Witsanu; Yamabhai, Montarop] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand; [Nguyen Xuan Vu; Yuttavanichakul, Watcharin; Teaumroong, Neung; Boonkerd, Nantakorn; Tittabutr, Panlada] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Biofertilizer & Plant Microbe Interact Res Unit, Nakhon Ratchasima, Thailand; [Teamtisong, Kamonluck] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima, Thailand; [Nguyen Xuan Vu] Thai Nguyen Univ Agr & Forestry, Fac Biotechnol & Food Technol, Thai Nguyen City, Thai Nguyen Pro, Vietnam	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology; Thai Nguyen University	Yamabhai, M (corresponding author), Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Mol Biotechnol Lab, Nakhon Ratchasima, Thailand.; Tittabutr, P (corresponding author), Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Biofertilizer & Plant Microbe Interact Res Unit, Nakhon Ratchasima, Thailand.	panlada@sut.ac.th; montarop@g.sut.ac.th	Yamabhai, Montarop/AFM-1335-2022; Yamabhai, Montarop/AAX-8731-2021	Srila, Witsanu/0000-0001-9522-5437; Yuttavanichakul, watcharin/0000-0002-3786-0405; Yamabhai, Montarop/0000-0003-2674-2419	Suranaree University of Technology; Office of the Higher Education Commission under the NRU project of Thailand; National Research Council of Thailand; Agricultural Research Development Agency (Public Organization), Thailand [CRP5507010890]; SUT-PhD Scholarship Program for ASEAN	Suranaree University of Technology; Office of the Higher Education Commission under the NRU project of Thailand; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Agricultural Research Development Agency (Public Organization), Thailand; SUT-PhD Scholarship Program for ASEAN	This work was supported by Suranaree University of Technology, the SUT-PhD Scholarship Program for ASEAN, and by the Office of the Higher Education Commission under the NRU project of Thailand. It was also supported by the National Research Council of Thailand and by the Agricultural Research Development Agency (Public Organization), Thailand CRP5507010890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSON RW, 1984, J BACTERIOL, V158, P1012, DOI 10.1128/JB.158.3.1012-1017.1984; Ducancel F, 2012, MABS-AUSTIN, V4, P445, DOI 10.4161/mabs.20776; Filpula D, 2007, BIOMOL ENG, V24, P201, DOI 10.1016/j.bioeng.2007.03.004; FUHRMANN J, 1985, APPL ENVIRON MICROB, V49, P1010, DOI 10.1128/AEM.49.4.1010-1013.1985; Griffiths AD, 1998, CURR OPIN BIOTECH, V9, P102, DOI 10.1016/S0958-1669(98)80092-X; HOBEN HJ, 1994, WORLD J MICROB BIOT, V10, P538, DOI 10.1007/BF00367662; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Jayaraman V, 1998, BIOCHEM MOL BIOL INT, V44, P777; Ji ZJ, 2017, SYST APPL MICROBIOL, V40, P114, DOI 10.1016/j.syapm.2016.12.003; KANNENBERG EL, 1992, MOL MICROBIOL, V6, P2477, DOI 10.1111/j.1365-2958.1992.tb01424.x; Kay B. K, 1996, PHAGE DISPLAY PEPTID; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kontermann R, 2010, ANTIBODY ENG; Lei L, 2014, PLANT PHYSIOL, V164, P1045, DOI 10.1104/pp.113.232637; Lucas MM, 1996, J BACTERIOL, V178, P2727, DOI 10.1128/jb.178.10.2727-2733.1996; Noisangiam R, 2012, APPL ENVIRON MICROB, V78, P6236, DOI 10.1128/AEM.00897-12; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; OLSEN PE, 1989, APPL ENVIRON MICROB, V55, P520, DOI 10.1128/AEM.55.2.520-522.1989; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Payakapong W, 2003, WORLD J MICROB BIOT, V19, P981, DOI 10.1023/B:WIBI.0000007416.10475.d9; Rangnoi K, 2011, MOL BIOTECHNOL, V49, P240, DOI 10.1007/s12033-011-9398-2; Rohrbach P, 2003, BIOTECHNOL GENET ENG, V20, P137, DOI 10.1080/02648725.2003.10648041; Rosander A, 2002, J MICROBIOL METH, V51, P43, DOI 10.1016/S0167-7012(02)00052-0; SCHLOTER M, 1995, BIOTECHNOL ADV, V13, P75, DOI 10.1016/0734-9750(94)00023-6; Schloter M, 1997, APPL ENVIRON MICROB, V63, P2038, DOI 10.1128/AEM.63.5.2038-2046.1997; SCHMIDT EL, 1968, J BACTERIOL, V95, P1987, DOI 10.1128/JB.95.6.1987-1992.1968; Sidhu S. S., 2005, PHAGE DISPLAY BIOTEC, V2nd; Sidhu SS, 2001, TRENDS MICROBIOL, V9, P565, DOI [10.1016/S0966-842X(01)02206-5, DOI 10.1016/S0966-842X(01)02206-5]; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Spadiut O, 2014, TRENDS BIOTECHNOL, V32, P54, DOI 10.1016/j.tibtech.2013.10.002; Teamtisong K, 2014, MICROBES ENVIRON, V29, P370, DOI 10.1264/jsme2.ME14065; Teillaud JL, 2005, EXPERT OPIN BIOL TH, V5, pS15, DOI 10.1517/14712598.5.1.S15; WRIGHT SF, 1986, APPL ENVIRON MICROB, V52, P119, DOI 10.1128/AEM.52.1.119-123.1986	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179983	10.1371/journal.pone.0179983	http://dx.doi.org/10.1371/journal.pone.0179983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654662	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500045
J	Uematsu, H; Yamashita, K; Kunisawa, S; Fushimi, K; Imanaka, Y				Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Fushimi, Kiyohide; Imanaka, Yuichi			Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals	PLOS ONE			English	Article							INFECTION; HEALTH; IMPACT; CARE; OUTCOMES; QUALITY; COSTS	Objectives The nationwide impact of antimicrobial-resistant infections on healthcare facilities throughout Japan has yet to be examined. This study aimed to estimate the disease burden of methicillin-resistant Staphylococcus aureus (MRSA) infections in Japanese hospitals. Design Retrospective analysis of inpatients comparing outcomes between subjects with and without MRSA infection. Data source A nationwide administrative claims database. Setting 1133 acute care hospitals throughout Japan. Participants All surgical and non-surgical inpatients who were discharged between April 1, 2014 and March 31, 2015. Main outcome measures Disease burden was assessed using hospitalization costs, length of stay, and in-hospital mortality. Using a unique method of infection identification, we categorized patients into an anti-MRSA drug group and a control group based on anti-MRSA drug utilization. To estimate the burden of MRSA infections, we calculated the differences in outcome measures between these two groups. The estimates were extrapolated to all 1584 acute care hospitals in Japan that have adopted a prospective payment system. Results We categorized 93 838 patients into the anti-MRSA drug group and 2 181 827 patients into the control group. The mean hospitalization costs, length of stay, and in-hospital mortality of the anti-MRSA drug group were US$ 33 548, 75.7 days, and 22.9%, respectively; these values were 3.43, 2.95, and 3.66 times that of the control group, respectively. When extrapolated to the 1584 hospitals, the total incremental burden of MRSA was estimated to be US $ 2 billion (3.41% of total hospitalization costs), 4.34 million days (3.02% of total length of stay), and 14.3 thousand deaths (3.62% of total mortality). Conclusions This study quantified the approximate disease burden of MRSA infections in Japan. These findings can inform policymakers on the burden of antimicrobial-resistant infections and support the application of infection prevention programs.	[Uematsu, Hironori; Yamashita, Kazuto; Kunisawa, Susumu; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU)	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022		Ministry of Health, Labour and Welfare of Japan [H27-shinkogyosei-shitei-005, H27-seisaku-shitei-009]; Japan Society for the Promotion of Science [[A]25253033]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (H27-shinkogyosei-shitei-005, H27-seisaku-shitei-009; http://www.mhlw.go.jp/), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. ([A]25253033; https://www.jsps.go.jp/index.html) to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa N, 2013, J INFECT CHEMOTHER, V19, P447, DOI 10.1007/s10156-012-0501-9; Anderson Gerard F, 2010, Issue Brief (Commonw Fund), V90, P1; [Anonymous], 2015, DISCHARGE SURVEY 201; [Anonymous], 2016, JAP NOS INF SURV 201; [Anonymous], 2014, REV ANTIMICROBIAL RE; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Centres for Disease Control and Prevention (US), 2013, ANT RES THREATS US; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hamada H, 2012, HEALTH POLICY, V107, P194, DOI 10.1016/j.healthpol.2012.01.002; Lee J, 2011, J HOSP INFECT, V77, P316, DOI 10.1016/j.jhin.2010.11.013; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Park S, 2013, HEALTH POLICY, V111, P264, DOI 10.1016/j.healthpol.2013.05.015; PPP. OECD, 2016, PURCH POW PART PPP I, DOI 10.1787/1290ee5a-en; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sasaki T, 2015, NEUROL MED-CHIR, V55, P267, DOI 10.2176/nmc.ra.2014-0317; Sekimoto M, 2010, VOX SANG, V98, P538, DOI 10.1111/j.1423-0410.2009.01290.x; Shih T, 2014, ANONYMOUS SUCCESS AC, P153; Uematsu H, 2016, RESPIROLOGY; Uematsu H, 2016, AM J INFECT CONTROL; Uematsu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125284; Uematsu H, 2014, INT J QUAL HEALTH C, V26, P100, DOI 10.1093/intqhc/mzt078; World Health Organization, 2014, ANT RES GLOB REP SUR	26	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179767	10.1371/journal.pone.0179767	http://dx.doi.org/10.1371/journal.pone.0179767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654675	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500032
J	Yan, H; Ajuwon, KM				Yan, Hui; Ajuwon, Kolapo M.			Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway	PLOS ONE			English	Article							EPITHELIAL-CELLS; PERMEABILITY; EXPRESSION; GUT; LIPOPOLYSACCHARIDE; DISEASE; KINASE; LPS; INFLAMMATION; PERFORMANCE	The intestinal epithelial barrier, composed of epithelial cells, tight junction proteins and intestinal secretions, prevents passage of luminal substances and antigens through the paracellular space. Dysfunction of the intestinal barrier integrity induced by toxins and pathogens is associated with a variety of gastrointestinal disorders and diseases. Although butyrate is known to enhance intestinal health, its role in the protection of intestinal barrier function is poorly characterized. Therefore, we investigated the effect of butyrate on intestinal epithelial integrity and tight junction permeability in a model of LPS-induced inflammation in IPEC-J2 cells. Butyrate dose-dependently reduced LPS impairment of intestinal barrier integrity and tight junction permeability, measured by trans-epithelial electrical resistance (TEER) and paracellular uptake of fluorescein isothiocyanate-dextran (FITC-dextran). Additionally, butyrate increased both mRNA expression and protein abundance of claudins-3 and 4, and influenced intracellular ATP concentration in a dose-dependent manner. Furthermore, butyrate prevented the downregulation of Akt and 4E-BP1 phosphorylation by LPS, indicating that butyrate might enhance tight junction protein abundance through mechanisms that included activation of Akt/mTOR mediated protein synthesis. The regulation of AMPK activity and intracellular ATP level by butyrate indicates that butyrate might regulate energy status of the cell, perhaps by serving as a nutrient substrate for ATP synthesis, to support intestinal epithelial barrier tight junction protein abundance. Our findings suggest that butyrate might protect epithelial cells from LPS-induced impairment of barrier integrity through an increase in the synthesis of tight junction proteins, and perhaps regulation of energy homeostasis.	[Yan, Hui; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu			Purdue Research Foundation	Purdue Research Foundation	HY was supported by a fellowship from the Purdue Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Ahdieh M, 2001, AM J PHYSIOL-CELL PH, V281, pC2029, DOI 10.1152/ajpcell.2001.281.6.C2029; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Awad WA, 2012, POULTRY SCI, V91, P2949, DOI 10.3382/ps.2012-02448; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Brandtzaeg P, 2011, EUR J PHARMACOL, V668, pS16, DOI 10.1016/j.ejphar.2011.07.006; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Fusunyan RD, 1998, PEDIATR RES, V43, P84, DOI 10.1203/00006450-199801000-00013; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo SH, 2015, J IMMUNOL, V195, P4999, DOI 10.4049/jimmunol.1402598; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hammer AM, 2015, ALCOHOL RES-CURR REV, V37, P209; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu CH, 2012, ANIM FEED SCI TECH, V177, P108, DOI 10.1016/j.anifeedsci.2012.07.028; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marette A, 2002, CURR OPIN CLIN NUTR, V5, P377, DOI 10.1097/00075197-200207000-00005; Murugesan GR, 2015, POULTRY SCI, V94, P1298, DOI 10.3382/ps/pev075; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Neunlist M, 2013, NAT REV GASTRO HEPAT, V10, P90, DOI 10.1038/nrgastro.2012.221; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schlegel N, 2012, HISTOCHEM CELL BIOL, V138, P627, DOI 10.1007/s00418-012-0983-7; Song ZH, 2015, J ANIM SCI, V93, P1599, DOI 10.2527/jas.2014-8580; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaarala O, 2008, CURR OPIN GASTROEN, V24, P701, DOI 10.1097/MOG.0b013e32830e6d98; Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926; VELLENGA L, 1992, AM J VET RES, V53, P1180; Vergauwen H., 2015, IMPACT FOOD BIOACTIV, P125; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang H, 2015, J NUTR, V145, P1156, DOI 10.3945/jn.114.209817; Weber P, 2003, CLIN EXP RHEUMATOL, V21, P657; Yan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145940; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yang FJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0372-1; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	61	172	191	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e017958	10.1371/journal.pone.0179586	http://dx.doi.org/10.1371/journal.pone.0179586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654658	Green Published, Green Submitted, gold			2022-12-26	WOS:000404541500018
J	Zhao, J; Brown, K; Liem, RKH				Zhao, Jian; Brown, Kristy; Liem, Ronald K. H.			Abnormal neurofilament inclusions and segregations in dorsal root ganglia of a Charcot-Marie-Tooth type 2E mouse model	PLOS ONE			English	Article							SLOW AXONAL-TRANSPORT; TRANSGENIC MICE; LIGHT GENE; N98S MUTATION; DISEASE; NEUROPATHY; SUBUNIT; PHENOTYPE; BETA,BETA'-IMINODIPROPIONITRILE; CYTOSKELETON	Charcot-Marie-Tooth (CMT) disease or hereditary motor and sensory neuropathy is the most prevalent inherited peripheral neuropathy and is associated with over 90 causative genes. Mutations in neurofilament light polypeptide gene, NEFL cause CMT2E, an axonal form of CMT that results in abnormal structures and/or functions of peripheral axons in spinal cord motor neurons and dorsal root ganglion neurons. We have previously generated and characterized a knock-in mouse model of CMT2E with the N98S mutation in Nefl that presented with multiple inclusions in spinal cord neurons. In this report, we conduct immunofluorescence studies of cultured dorsal root ganglia (DRG) from Nefl N98S/+ mice, and show that inclusions found in DRG neurites can occur in embryonic stages. Ultrastructural analyses reveal that the inclusions are disordered neurofilaments packed in high density, segregated from other organelles. Immunochemical studies show decreased NFL protein levels in DRG, cerebellum and spinal cord in Nefl N98S/+ mice, and total NFL protein pool is shifted toward the triton-insoluble fraction. Our findings reveal the nature of the inclusions in Nefl N98S/+ mice, provide useful information to understand mechanisms of CMT2E disease, and identify DRG from Nefl N98S/+ mice as a useful cell line model for therapeutic discoveries.	[Zhao, Jian; Brown, Kristy; Liem, Ronald K. H.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA; [Liem, Ronald K. H.] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA	Columbia University; Columbia University	Liem, RKH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA.; Liem, RKH (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	rkl2@cumc.columbia.edu			Muscular Dystrophy Association [MDA2550838]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported by the Muscular Dystrophy Association, Grant # MDA2550838 (https://www.mda.org/) to RKHL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Adebola AA, 2015, HUM MOL GENET, V24, P2163, DOI 10.1093/hmg/ddu736; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Berciano J, 2016, J NEUROL, V263, P361, DOI 10.1007/s00415-015-7985-z; BIZZI A, 1984, J NEUROSCI, V4, P722; Ching GY, 1999, J NEUROSCI, V19, P2974; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; DONAGHY M, 1988, J NEUROCYTOL, V17, P197, DOI 10.1007/BF01674207; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Fabrizi GM, 2004, NEUROLOGY, V62, P1429, DOI 10.1212/01.WNL.0000120664.07186.3C; GILBERT MR, 1992, J NEUROSCI, V12, P1763; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; GRIFFIN JW, 1983, J NEUROSCI, V3, P557; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; KAPLAN MP, 1991, J NEUROSCI RES, V30, P545, DOI 10.1002/jnr.490300312; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; PACHTER JS, 1984, DEV BIOL, V103, P200, DOI 10.1016/0012-1606(84)90021-6; Perez-Olle R, 2004, HUM MOL GENET, V13, P2207, DOI 10.1093/hmg/ddh236; SPENCER PS, 1975, J NEUROL NEUROSUR PS, V38, P771, DOI 10.1136/jnnp.38.8.771; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; VICKERS JC, 1994, J NEUROSCI, V14, P5603; Xue C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004406; Yoshihara T, 2002, J PERIPHER NERV SYST, V7, P221, DOI 10.1046/j.1529-8027.2002.02028.x; Yum SW, 2009, ANN NEUROL, V66, P759, DOI 10.1002/ana.21728; Zuchner S, 2004, NEUROMUSCULAR DISORD, V14, P147, DOI 10.1016/j.nmd.2003.10.003	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180038	10.1371/journal.pone.0180038	http://dx.doi.org/10.1371/journal.pone.0180038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654681	Green Submitted, Green Published, gold			2022-12-26	WOS:000404541500049
J	Poleo, ABS; Schjolden, J; Sorensen, J; Nilsson, GE				Poleo, Antonio B. S.; Schjolden, Joachim; Sorensen, Jorgen; Nilsson, Goran E.			The high tolerance to aluminium in crucian carp (Carassius carassius) is associated with its ability to avoid hypoxia	PLOS ONE			English	Article							TROUT SALVELINUS-FONTINALIS; ACID-MINE DRAINAGE; SALMON SALMO-SALAR; LOW PH; RAINBOW-TROUT; AQUEOUS ALUMINUM; MIXING ZONES; BROOK TROUT; PHYSIOLOGICAL DISTURBANCES; SCANNING ELECTRON	It is well known that aluminium is the principle toxicant killing fish in acidified freshwater systems, and it has been shown that crucian carp (Carassius carassius) can survive exposures to aqueous aluminium levels toxic to most other freshwater fish species. The crucian carp has a remarkable ability to survive anoxic conditions, and the aim of the present study was to reveal if the tolerance to aluminium can be associated with the ability to survive prolonged anoxia. Crucian carps were exposed to either acidic Al-rich water (pH 5.8; 960 mu g Al/l), acidic Al-poor water (pH 5.8; 50 mu g Al/l) or untreated control water (pH 6.5; 50 mu g Al/l). Blood, muscle and gill samples were collected from exposed fish, and closed respirometry was performed to measure critical O-2-tension an normoxic O-2-consumption. The results show an increased gill surface area in Al-exposed fish, while the critical O-2-tension did not change. The normoxic O-2-consumption was lower in Al-exposed fish and might be due to a reduced metabolic rate. The results suggest that crucian carp exposed to aluminium do not become hypoxic, since haematocrit, plasma lactate and blood ethanol did not differ from that of control fish after 14 days of exposure. We also observed an initial loss of plasma chloride and sodium, followed by a stabilisation of these ions at a lower level than in control fish. The decrease in plasma ions caused a transient increase in haematocrit and water content in muscle tissue, returning to control levels when the ion concentrations stabilised, suggesting that the water balance was restored. We conclude that the high tolerance to aluminium in crucian carp is associated with its ability to avoid hypoxia as well as an ability to counteract a continuous loss of plasma ions.	[Poleo, Antonio B. S.] Inland Norway Univ Appl Sci, Campus Evenstad, Evenstad, Norway; [Schjolden, Joachim] Norwegian Natl Author Invest & Prosecut Econ & En, Oslo, Norway; [Sorensen, Jorgen] Fresenius Kabi Norge AS, Halden, Norway; [Nilsson, Goran E.] Univ Oslo, Dept Biosci, Oslo, Norway	Inland Norway University of Applied Sciences; University of Oslo	Poleo, ABS (corresponding author), Inland Norway Univ Appl Sci, Campus Evenstad, Evenstad, Norway.	antonio.poleo@inn.no	Nilsson, Göran Erik/Q-6129-2019					BAKER JP, 1982, WATER AIR SOIL POLL, V18, P289, DOI 10.1007/BF02419419; BARNES RB, 1975, CHEM GEOL, V15, P177, DOI 10.1016/0009-2541(75)90018-2; DALZIEL TRK, 1987, ANN SOC ROY ZOOL BEL, V117, P421; DICKSON W, 1978, VERH INT VEREIN THEO, V20, P851; DIETRICH D, 1989, AQUAT TOXICOL, V15, P197, DOI 10.1016/0166-445X(89)90036-2; DRISCOLL CT, 1980, NATURE, V284, P161, DOI 10.1038/284161a0; DRISCOLL CT, 1984, INT J ENVIRON AN CH, V16, P267, DOI 10.1080/03067318408076957; Exley C, 1996, J THEOR BIOL, V179, P25, DOI 10.1006/jtbi.1996.0044; Gensemer RW, 1999, CRIT REV ENV SCI TEC, V29, P315, DOI 10.1080/10643389991259245; Hem J.D., 1967, GEOLOGICAL SURVEY A; Henry TB, 2001, ENVIRON TOXICOL CHEM, V20, P1304, DOI 10.1002/etc.5620200619; Hochachka P. W., 1980, LIVING OXYGEN CLOSED; Howells G., 1994, Environmental Topics, V6, P55; Howells G, 1990, CHEM ECOL, V4, P117, DOI DOI 10.1080/02757549008035972; HUGHES GM, 1979, J ZOOL, V187, P443; LEWIS SV, 1976, MICRON, V7, P205, DOI 10.1016/0047-7206(76)90004-2; LYDERSEN E, 1990, NORD HYDROL, V21, P195; Lydersen E, 1994, J ECOL CHEM, V3, P357; MCDONALD DG, 1988, CAN J FISH AQUAT SCI, V45, P1606, DOI 10.1139/f88-190; Muniz IP, 1980, P INT C ECOLOGICAL I, P84; NEVILLE CM, 1985, CAN J FISH AQUAT SCI, V42, P2004, DOI 10.1139/f85-248; NILSSON GE, 1993, J EXP BIOL, V180, P153; NILSSON GE, 1990, J EXP BIOL, V150, P295; NILSSON GE, 1992, J EXP BIOL, V164, P243; Nilsson GE, 2012, RESP PHYSIOL NEUROBI, V184, P214, DOI 10.1016/j.resp.2012.07.012; OUGHTON DH, 1992, ANALYST, V117, P619, DOI 10.1039/an9921700619; PIIRONEN J, 1986, ANN ZOOL FENN, V23, P335; PLAYLE RC, 1989, CAN J ZOOL, V67, P314, DOI 10.1139/z89-046; Poleo A, 2000, CAN J FISH AQUAT SCI, V57, P1423, DOI 10.1139/cjfas-57-7-1423; Poleo ABS, 2003, J INORG BIOCHEM, V97, P89, DOI 10.1016/S0162-0134(03)00261-7; POLEO ABS, 1994, WATER AIR SOIL POLL, V75, P339, DOI 10.1007/BF00482945; Poleo ABS, 1995, AQUAT SCI, V57, P350, DOI 10.1007/BF00878398; Poleo ABS, 1997, ENVIRON POLLUT, V96, P129, DOI 10.1016/S0269-7491(97)00033-X; POLEO ABS, 1995, AQUAT TOXICOL, V31, P347, DOI 10.1016/0166-445X(94)00083-3; RAJBANSHI VK, 1977, J FISH BIOL, V10, P325, DOI 10.1111/j.1095-8649.1977.tb04066.x; ROSSELAND BO, 1992, ENVIRON POLLUT, V78, P3, DOI 10.1016/0269-7491(92)90003-S; Schjolden J, 2007, SCI TOTAL ENVIRON, V384, P239, DOI 10.1016/j.scitotenv.2007.06.009; Schofield C. L., 1980, POLLUTED RAIN, P341; SMITH TR, 1995, ENVIRON POLLUT, V90, P33, DOI 10.1016/0269-7491(94)00094-T; Sollid J, 2003, J EXP BIOL, V206, P3667, DOI 10.1242/jeb.00594; Sparling DW, 1996, REV ENVIRON CONTAM T, V145, P1; Sprague J.B., 1973, ASTMSTP528 AM SOC TE, P6; STAURNES M, 1984, EXPERIENTIA, V40, P226, DOI 10.1007/BF01963613; TIETGE JE, 1988, CAN J FISH AQUAT SCI, V45, P1643, DOI 10.1139/f88-194; ULTSCH GR, 1979, COMP BIOCHEM PHYS A, V62, P685, DOI 10.1016/0300-9629(79)90125-7; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; Waters AS, 2016, MINE WATER ENVIRON, V35, P235, DOI 10.1007/s10230-016-0387-3; Waters AS, 2013, WATER SCI TECHNOL, V67, P1764, DOI 10.2166/wst.2013.051; WEATHERLEY NS, 1991, WATER AIR SOIL POLL, V55, P345; Witters HE, 1996, ENVIRON TOXICOL CHEM, V15, P986, DOI 10.1002/etc.5620150622; WOOD CM, 1987, ANN SOC ROY ZOOL BEL, V117, P399	51	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179519	10.1371/journal.pone.0179519	http://dx.doi.org/10.1371/journal.pone.0179519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644866	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100021
J	Prashek, J; Bouyain, S; Fu, MG; Li, Y; Berkes, D; Yao, XL				Prashek, Jennifer; Bouyain, Samuel; Fu, Mingui; Li, Yong; Berkes, Dusan; Yao, Xiaolan			Interaction between the PH and START domains of ceramide transfer protein competes with phosphatidylinositol 4-phosphate binding by the PH domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; fluorescence resonance energy transfer (FRET); isothermal titration calorimetry (ITC); lipid transport; phosphatidylinositol; sphingolipid; X-ray crystallography; AlphaScreen; ceramide transfer protein	PLECKSTRIN HOMOLOGY DOMAIN; ENDOPLASMIC-RETICULUM; NONVESICULAR TRAFFICKING; STRUCTURAL BASIS; TRANSPORT; CERT; PHOSPHORYLATION; ASSOCIATION; REFINEMENT; MECHANISM	De novo synthesis of the sphingolipid sphingomyelin requires non-vesicular transport of ceramide from the endoplasmic reticulum to the Golgi by the multidomain protein ceramide transfer protein (CERT). CERT's N-terminal pleckstrin homology (PH) domain targets it to the Golgi by binding to phosphatidylinositol 4-phosphate (PtdIns(4)P) in the Golgi membrane, whereas its C-terminal StAR-related lipid transfer domain (START) carries out ceramide transfer. Hyperphosphorylation of a serine-rich motif immediately after the PH domain decreases both PtdIns(4)P binding and ceramide transfer by CERT. This down-regulation requires both the PH and START domains, suggesting a possible inhibitory interaction between the two domains. In this study we show that isolated PH and START domains interact with each other. The crystal structure of a PH-START complex revealed that the START domain binds to the PH domain at the same site for PtdIns(4)P-binding, suggesting that the START domain competes with PtdIns(4)P for association with the PH domain. We further report that mutations disrupting the PH-START interaction increase both PtdIns(4)P-binding affinity and ceramide transfer activity of a CERT-serine-rich phosphorylation mimic. We also found that these mutations increase the Golgi localization of CERT inside the cell, consistent with enhanced PtdIns(4)P binding of the mutant. Collectively, our structural, biochemical, and cellular investigations provide important structural insight into the regulation of CERT function and localization.	[Prashek, Jennifer; Bouyain, Samuel; Yao, Xiaolan] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Fu, Mingui; Li, Yong] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Berkes, Dusan] Slovak Univ Technol Bratislava, Dept Organ Chem, Radlinskeho 9, Bratislava 81237, Slovakia	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Slovak University of Technology Bratislava	Yao, XL (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	yaoxia@umkc.edu	Berkes, Dusan/G-1741-2010	Berkes, Dusan/0000-0002-5717-5763; Yao, Xiaolan/0000-0002-6570-3730	National Institutes of Health [R15GM113200-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15GM113200-0. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACHARI A, 1992, BIOCHEMISTRY-US, V31, P10449, DOI 10.1021/bi00158a006; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; DeLano WL, 2002, PYMOL MOLECULAR GRAP; Duris A, 2011, ORG LETT, V13, P1642, DOI 10.1021/ol2001057; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; GALLAGHER T, 1994, BIOCHEMISTRY-US, V33, P4721, DOI 10.1021/bi00181a032; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2003, J MED CHEM, V46, P3688, DOI 10.1021/jm0300779; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prashek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079590; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Tuuf J, 2011, BBA-BIOMEMBRANES, V1808, P229, DOI 10.1016/j.bbamem.2010.09.011; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200	47	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14217	14228		10.1074/jbc.M117.780007	http://dx.doi.org/10.1074/jbc.M117.780007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28652409	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000408439800025
J	Mitrofan, CG; Appleby, SL; Nash, GB; Mallat, Z; Chilvers, ER; Upton, PD; Morrell, NW				Mitrofan, Claudia-Gabriela; Appleby, Sarah L.; Nash, Gerard B.; Mallat, Ziad; Chilvers, Edwin R.; Upton, Paul D.; Morrell, Nicholas W.			Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-alpha-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; LEUKOCYTE RECRUITMENT; EXPRESSION; INHIBITION; GENE; CALCIFICATION; ADHESION; ALK1; HYPERTENSION; INFLAMMATION	Bone morphogenetic proteins 9 and 10 (BMP9/BMP10) are circulating cytokines with important roles in endothelial homeostasis. The aim of this study was to investigate the roles of BMP9 and BMP10 in mediating monocyte-endothelial interactions using an in vitro flow adhesion assay. Herein, we report that whereas BMP9/BMP10 alone had no effect on monocyte recruitment, at higher concentrations both cytokines synergized with tumor necrosis factor-alpha (TNF alpha) to increase recruitment to the vascular endothelium. The BMP9/BMP10-mediated increase in monocyte recruitment in the presence of TNF alpha was associated with up-regulated expression levels of E-selectin, vascular cell adhesion molecule (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) on endothelial cells. Using siRNAs to type I and II BMP receptors and the signaling intermediaries (Smads), we demonstrated a key role for ALK2 in the BMP9/BMP10-induced surface expression of E-selectin, and both ALK1 and ALK2 in the up-regulation of VCAM-1 and ICAM-1. The type II receptors, BMPR-II and ACTR-IIA were both required for this response, as was Smad1/5. The up-regulation of cell surface adhesion molecules by BMP9/10 in the presence of TNF alpha was inhibited by LDN193189, which inhibits ALK2 but not ALK1. Furthermore, LDN193189 inhibited monocyte recruitment induced by TNF alpha and BMP9/10. BMP9/10 increased basal I kappa B alpha protein expression, but did not alter p65/RelA levels. Our findings suggest that higher concentrations of BMP9/BMP10 synergize with TNF alpha to induce the up-regulation of endothelial selectins and adhesion molecules, ultimately resulting in increased monocyte recruitment to the vascular endothelium. This process is mediated mainly via the ALK2 type I receptor, BMPR-II/ACTR-IIA type II receptors, and downstream Smad1/5 signaling.	[Mitrofan, Claudia-Gabriela; Appleby, Sarah L.; Mallat, Ziad; Chilvers, Edwin R.; Upton, Paul D.; Morrell, Nicholas W.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England; [Nash, Gerard B.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Cambridge; University of Birmingham	Morrell, NW (corresponding author), Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk	Nash, Gerard B/E-4182-2010; Mallat, Ziad/D-4041-2012; wei, wei/HHR-8613-2022	Nash, Gerard B/0000-0002-5935-2831; Mallat, Ziad/0000-0003-0443-7878; Morrell, Nicholas/0000-0001-5700-9792; Chilvers, Edwin/0000-0002-4230-9677	Wellcome Trust [099824/Z/12/Z]; British Heart Foundation [RG/13/4/30107]; Medical Research Council Experimental Challenge Award [MR/KR020919/1]; Medical Research Council [MR/K020919/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10086] Funding Source: researchfish; MRC [MR/K020919/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Medical Research Council Experimental Challenge Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Ph.D. fellowship from the Wellcome Trust Grant 099824/Z/12/Z (to C.-G. M.), British Heart Foundation Programme Grant RG/13/4/30107 (to N. W. M.), and Medical Research Council Experimental Challenge Award MR/KR020919/1 (to N. W. M.). N. W. M. is a founder and director of Morphogen-IX. P. D. U. is a founder of Morphogen-IX.	Appleby SL, 2016, J IMMUNOL, V197, P3302, DOI 10.4049/jimmunol.1601219; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Butler LM, 2011, J VIROL, V85, P7321, DOI 10.1128/JVI.00021-11; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Christian F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010012; Csiszar A, 2006, AM J PATHOL, V168, P629, DOI 10.2353/ajpath.2006.050284; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH569, DOI 10.1152/ajpheart.00180.2008; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; D'Alessio P, 1998, FREE RADICAL BIO MED, V24, P979, DOI 10.1016/S0891-5849(97)00396-1; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herrera B, 2014, INT J MOL SCI, V15, P5199, DOI 10.3390/ijms15045199; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Horbelt D, 2015, J BIOL CHEM, V290, P3390, DOI 10.1074/jbc.M114.604397; Hurst LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14079; Jiang J, 2010, CARDIOVASC RES, V87, P366, DOI 10.1093/cvr/cvq013; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kim CW, 2013, ARTERIOSCL THROM VAS, V33, P1350, DOI 10.1161/ATVBAHA.112.300287; Kraehling JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13516; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Levet S, 2015, P NATL ACAD SCI USA, V112, pE3207, DOI 10.1073/pnas.1508386112; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; MATSUMORI A, 1994, BRIT HEART J, V72, P561; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Pachori AS, 2010, J MOL CELL CARDIOL, V48, P1255, DOI 10.1016/j.yjmcc.2010.01.010; POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P245, DOI 10.1002/path.1700750202; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Toshner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091334; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Venkatesh D, 2013, IMMUNITY, V38, P1025, DOI 10.1016/j.immuni.2013.01.012; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wolle J, 1996, ARTERIOSCL THROM VAS, V16, P1501, DOI 10.1161/01.ATV.16.12.1501; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Yao YC, 2008, ARTERIOSCL THROM VAS, V28, P2266, DOI 10.1161/ATVBAHA.108.176958; Yoshimatsu Y, 2013, P NATL ACAD SCI USA, V110, P18940, DOI 10.1073/pnas.1310479110; Yung LM, 2015, CARDIOVASC RES, V108, P278, DOI 10.1093/cvr/cvv221; Zhang F, 2002, ATHEROSCLEROSIS, V161, P381, DOI 10.1016/S0021-9150(01)00672-4; Zhang M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0214-3	67	33	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13714	13726		10.1074/jbc.M117.778506	http://dx.doi.org/10.1074/jbc.M117.778506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28646109	hybrid, Green Published			2022-12-26	WOS:000407942400019
J	Broussard, MA; Mas, F; Howlett, B; Pattemore, D; Tylianakis, JM				Broussard, Melissa Ann; Mas, Flore; Howlett, Brad; Pattemore, David; Tylianakis, Jason M.			Possible mechanisms of pollination failure in hybrid carrot seed and implications for industry in a changing climate	PLOS ONE			English	Article							POLLEN VIABILITY; TEMPERATURE STRESS; APIS-MELLIFERA; BRASSICA-NAPUS; FRUIT-SET; WILD; YIELD; OLIGOSACCHARIDES; PERFORMANCE; NECTAR	Approximately one-third of our food globally comes from insect-pollinated crops. The dependence on pollinators has been linked to yield instability, which could potentially become worse in a changing climate. Insect-pollinated crops produced via hybrid breeding (20% of fruit and vegetable production globally) are especially at risk as they are even more reliant on pollinators than open-pollinated plants. We already observe a wide range of fruit and seed yields between different cultivars of the same crop species, and it is unknown how existing variation will be affected in a changing climate. In this study, we examined how three hybrid carrot varieties with differential performance in the field responded to three temperature regimes (cooler than the historical average, average, and warmer that the historical average). We tested how temperature affected the plants' ability to set seed (seed set, pollen viability) as well as attract pollinators (nectar composition, floral volatiles). We found that there were significant intrinsic differences in nectar phenolics, pollen viability, and seed set between the carrot varieties, and that higher temperatures did not exaggerate those differences. However, elevated temperature did negatively affect several characteristics relating to the attraction and reward of pollinators (lower volatile production and higher nectar sugar concentration) across all varieties, which may decrease the attractiveness of this already pollinator-limited crop. Given existing predictions of lower pollinator populations in a warmer climate, reduced attractiveness would add yet another challenge to future food production.	[Broussard, Melissa Ann; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Mas, Flore; Howlett, Brad] Christchurch Mail Ctr, New Zealand Inst Plant & Food Res, Christchurch, New Zealand; [Pattemore, David] Waikato Mail Ctr, New Zealand Inst Plant & Food Res, Hamilton, New Zealand; [Tylianakis, Jason M.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	University of Canterbury; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Imperial College London	Broussard, MA (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	melissa.a.broussard@gmail.com	Broussard, Melissa/F-5357-2018; Mas, Flore/N-6656-2019; Pattemore, David/G-1269-2018; Howlett, Brad/F-1150-2018	Broussard, Melissa/0000-0002-0177-3393; Mas, Flore/0000-0002-0348-2936; Pattemore, David/0000-0003-4609-2660; Howlett, Brad/0000-0002-0694-135X	New Zealand Ministry for Business, Employment & Innovation under "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems" [C11X1309]	New Zealand Ministry for Business, Employment & Innovation under "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems"	This project was funded by the New Zealand Ministry for Business, Employment & Innovation (www.mbie.govt.nz/) under grant no. C11X1309, "Bee minus to Bee plus and Beyond: Higher Yields from Smarter, Growth-focused Pollination Systems". The granting agency had no role in the research process apart from approving the initial proposal and granting funding.	ABDULBAKI AA, 1995, HORTSCIENCE, V30, P115, DOI 10.21273/HORTSCI.30.1.115; AHMAD M, 2002, J RES SCI, V13, P31; [Anonymous], 2010, PRINCIPLES PRACTICES; ARNASON JT, 1992, J STORED PROD RES, V28, P119, DOI 10.1016/0022-474X(92)90019-M; Barton K., 2014, MUMIN MULTIMODEL INT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohart GE, 1960, INSECT POLLINATORS C; Bolker B, 2014, GETTING STARTED GLMM; Bradeen JM, 2002, J AM SOC HORTIC SCI, V127, P383, DOI 10.21273/JASHS.127.3.383; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Burnham K. P., 1998, MODEL SELECTION INFE; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; Cao YH, 2004, CHROMATOGRAPHIA, V59, P135, DOI 10.1365/s10337-003-0138-z; Davidson MM, 2010, NEW ZEAL J CROP HORT, V38, P113, DOI 10.1080/01140671003781736; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; DOWKER BD, 1981, J AGR SCI, V97, P25, DOI 10.1017/S0021859600035802; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Erickson E, 1979, JOURNAL; FAOSTAT F, 2009, STAT DAT; Gaffney A., 2011, THESIS; Galuszka H., 1989, Biuletyn Warzywniczy, V33, P35; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Geard A, 2006, 27 INT HORT C EXH, P42; GONZALEZ JL, 1994, AGRON J, V86, P1070, DOI 10.2134/agronj1994.00021962008600060070x; Goodwin M., 2012, POLLINATION CROPS AU; Gracie A., 2011, IMPROVING RELIABILIT; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; HAGLER JR, 1990, ENVIRON ENTOMOL, V19, P327, DOI 10.1093/ee/19.2.327; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; Hampton J. G., 2012, Agronomy New Zealand, V42, P129; Hanna WW, 1995, PLANT BREEDING REV, V13, P179; Hart JM, 2004, HYBRID SEED CARROT C; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; HAWTHORN L. R., 1956, PROC AMER SOC HORT SCI, V67, P384; Hedhly A, 2011, ENVIRON EXP BOT, V74, P9, DOI 10.1016/j.envexpbot.2011.03.016; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; &HLARR, 1985, CRYOPRESERVATION PLA, P171; Holzschuh A, 2011, P ROY SOC B-BIOL SCI, V278, P3444, DOI 10.1098/rspb.2011.0268; Howlett B, 2013, IMPACT CLIMATE CHANG; Howlett B. G., 2015, New Zealand Plant Protection, V68, P373; Howlett BG, 2012, J APPL ENTOMOL, V136, P421, DOI 10.1111/j.1439-0418.2011.01665.x; Howlett B. G., 2011, New Zealand Plant Protection, V64, P25; Juroszek P, 2011, PLANT PATHOL, V60, P100, DOI 10.1111/j.1365-3059.2010.02410.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KNUDSEN IM, 1986, J SCI FOOD AGR, V37, P560, DOI 10.1002/jsfa.2740370609; KNUDSEN KEB, 1991, J AGR FOOD CHEM, V39, P689, DOI 10.1021/jf00004a013; KOUL P, 1989, NEW PHYTOL, V112, P437, DOI 10.1111/j.1469-8137.1989.tb00335.x; Krontal Y, 2000, J HORTIC SCI BIOTECH, V75, P35, DOI 10.1080/14620316.2000.11511197; Kuznetsova A, 2020, PACKAGE IMERTEST; Mahli SS, 2007, CAN J PLANT SCI, V87, P449, DOI 10.4141/P05-180; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Niemela T, 2006, CAN J PLANT SCI, V86, P693, DOI 10.4141/P05-189; OCKENDON DJ, 1976, NEW PHYTOL, V76, P511, DOI 10.1111/j.1469-8137.1976.tb01487.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; PARKER FD, 1982, J KANSAS ENTOMOL SOC, V55, P171; PATTERSON DT, 1995, WEED SCI, V43, P685, DOI 10.1017/S0043174500081832; Perez-Banon C, 2007, PLANT ECOL, V192, P133, DOI 10.1007/s11258-006-9233-1; Petanidou T, 1996, NEW PHYTOL, V133, P513, DOI 10.1111/j.1469-8137.1996.tb01919.x; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Proctor M., 1996, The natural history of pollination.; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers MA, 2012, HORTTECHNOLOGY, V22, P452, DOI 10.21273/HORTTECH.22.4.452; Rubatzky V.E., 1999, CARROTS RELATED VEGE; Ruperez P, 1998, Z LEBENSM UNTERS F A, V206, P130, DOI 10.1007/s002170050228; Sagae M, 2008, BIOSCI BIOTECH BIOCH, V72, P110, DOI 10.1271/bbb.70490; SMALL E, 1984, PLANT BIOSYSTEMATICS, P195; Song H-x, 2010, J SHANXI AGR SCI, V4; Spurr C., 2003, THESIS U TASMANIA; Steffan-Dewenter I, 2003, APIDOLOGIE, V34, P227, DOI [10.1051/apdio:2003015, 10.1051/apido:2003015]; STEIN M, 1995, PLANT BREEDING, V114, P1, DOI 10.1111/j.1439-0523.1995.tb00750.x; Sugimoto A, 2012, PLANT GENETIC RESOUR, V11; Tay D., 2002, P INT SEED SEM TRAD, P128; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Verdial M. F., 2001, Scientia Agricola, V58, P533, DOI 10.1590/S0103-90162001000300015; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Willis J. C., 1895, Ann Botany, Vxxxiv, P227; Willis JC, 1903, ANN BOT-LONDON, V17, P313, DOI 10.1093/oxfordjournals.aob.a088919; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wolf S, 1999, HORTSCIENCE, V34, P860, DOI 10.21273/HORTSCI.34.5.860; Wood S, 2009, GAMM4 GENERALIZED AD; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Ziska LH, 2004, WEED SCI, V52, P584, DOI 10.1614/WS-03-161R; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P159; Zuur Alain F., 2009, P1	89	15	15	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180215	10.1371/journal.pone.0180215	http://dx.doi.org/10.1371/journal.pone.0180215			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665949	Green Published, gold			2022-12-26	WOS:000404608700073
J	Cebron, D; Viroulet, S; Vidal, J; Masson, JP; Viroulet, P				Cebron, David; Viroulet, Sylvain; Vidal, Jeremie; Masson, Jean-Paul; Viroulet, Philippe			Experimental and theoretical study of magnetohydrodynamic ship models	PLOS ONE			English	Article							PROPULSION; MHD; SEAWATER; FLOW; MAGNET; FORCE	Magnetohydrodynamic (MHD) ships represent a clear demonstration of the Lorentz force in fluids, which explains the number of students practicals or exercises described on the web. However, the related literature is rather specific and no complete comparison between theory and typical small scale experiments is currently available. This work provides, in a self-consistent framework, a detailed presentation of the relevant theoretical equations for small MHD ships and experimental measurements for future benchmarks. Theoretical results of the literature are adapted to these simple battery/magnets powered ships moving on salt water. Comparison between theory and experiments are performed to validate each theoretical step such as the Tafel and the Kohlrausch laws, or the predicted ship speed. A successful agreement is obtained without any adjustable parameter. Finally, based on these results, an optimal design is then deduced from the theory. Therefore this work provides a solid theoretical and experimental ground for small scale MHD ships, by presenting in detail several approximations and how they affect the boat efficiency. Moreover, the theory is general enough to be adapted to other contexts, such as large scale ships or industrial flow measurement techniques.	[Cebron, David; Vidal, Jeremie; Masson, Jean-Paul] Univ Grenoble Alpes, CNRS, ISTerre, F-38000 Grenoble, France; [Viroulet, Sylvain] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Viroulet, Sylvain] Univ Manchester, Manchester Ctr Nonlinear Dynam, Manchester M13 9PL, Lancs, England	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Manchester; University of Manchester	Cebron, D (corresponding author), Univ Grenoble Alpes, CNRS, ISTerre, F-38000 Grenoble, France.	david.cebron@univ-grenoble-alpes.fr	Viroulet, Sylvain/M-2408-2017; Cebron, David/A-9625-2014; Vidal, Jérémie/M-6382-2019	Viroulet, Sylvain/0000-0002-8204-1425; Cebron, David/0000-0002-3579-8281; Vidal, Jérémie/0000-0002-3654-6633				BAUMGARTL J, 1993, PHYS FLUIDS A-FLUID, V5, P3280, DOI 10.1063/1.858685; Bennett JE, 1978, AICHE S SERIES, V74; Boissonneau P, 1999, ENERG CONVERS MANAGE, V40, P1783, DOI 10.1016/S0196-8904(99)00072-2; Boissonneau P, 1999, J PHYS D APPL PHYS, V32, P2387, DOI 10.1088/0022-3727/32/18/310; Brown SH, 1990, PROPULSIVE EFFICIENC; Camacho J. M., 2013, Rev. mex. fís. E, V59, P8; Clancy T., 1998, HUNT RED OCOTBER; Convert D., 1995, Magnetohydrodynamics, V31, P290; Convert D., 1995, PROPULSION MAGNETOHY; Davidson PA, 1992, ROLE PRESSURE FORCES, V104, P39; Doragh RA., 1963, SNAME T, V71, P370; DOSS E, 1991, J PROPUL POWER, V7, P635, DOI 10.2514/3.23372; Doss E, 1990, NEED SUPERCONDUCTING; Doss ED, 1992, SAE TECHNICAL PAPER; Engel-Herbert R, 2005, J APPL PHYS, V97, DOI 10.1063/1.1883308; Font GI, 2004, PHYS TEACH, V42, P410; Friauf JB., 1961, J AM SOC NAVAL ENG, V73, P139; Gilbert JB, 1991, STUDIES MHD PROPULSI; Han J, 2002, 17 INT C MAGN LEV SY; Hoerner S. F, 1965, FLUID DYNAMIC DRAG; Huebscher R.G., 1948, ASHVE T, V54, P101; Iwata A, 1980, P ICEC 8 GEN, V8, P775; Khonichev V. I., 1980, Journal of Applied Mechanics and Technical Physics, V21, P77, DOI 10.1007/BF00910143; Khonichev V. I., 1978, Journal of Applied Mechanics and Technical Physics, V19, P760, DOI 10.1007/BF01201553; Khonichev VI, 1981, PMTF ZH PRIKLADNOI M, V21, P109; Leroy R, 1978, P S WAT EL, V78, P4; Leus V., 2004, ETR20042 TECHN ISR I; LIN TF, 1995, J PROPUL POWER, V11, P1349, DOI 10.2514/3.23978; LIN TF, 1991, J PROPUL POWER, V7, P1081, DOI 10.2514/3.23433; Mitchell D. L., 1988, Journal of Superconductivity, V1, P349, DOI 10.1007/BF00618593; Motora S, 1994, INT C EN TRANSF MHD, P501; Muller U, 2002, CISM COUR L, P1; Nishigaki K, 2000, CRYOGENICS, V40, P353, DOI 10.1016/S0011-2275(00)00049-7; Paula J.D., 2006, ATKINS PHYS CHEM, P77; Petrick M, 1992, RESULTS LARGE SCALE; Phillips O.M., 1962, J SHIP RES, V43, P43; POHJAVIRTA A, 1991, IEEE T MAGN, V27, P3735, DOI 10.1109/20.102945; Priede J, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/5/055402; Rice WA, 1961, PROPULSION SYSTEM; Robinson RA, 1937, J CHEM SOC, P574, DOI 10.1039/jr9370000574; Saji Y, 1988, REV KOBE U MERCANT 2, V36; Saji Y, 1978, ADV CRYO ENG, P159; Sasakawa Y, 1995, SUPERCONDUCTING MHD; Schlichting H., 1968, BOUNDARY LAYER THEOR; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shatrov V. I., 1985, Journal of Applied Mechanics and Technical Physics, V26, P19, DOI 10.1007/BF00919618; Shatrov V. I., 1981, Journal of Applied Mechanics and Technical Physics, V22, P817, DOI 10.1007/BF00906112; SWALLOM DW, 1991, NAV ENG J, V103, P141, DOI 10.1111/j.1559-3584.1991.tb00945.x; Takezawa S, 1995, B MESJ, V23, P46; Tempelmeyer KE, 1990, DTIC DOCUMENT; Thess A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.164501; Thibault J., 1994, 2 INT C EN TRANSF MH; TUCK EO, 1966, J FLUID MECH, V26, P81, DOI 10.1017/S0022112066001101; Tuck EO, 2002, 24 S NAV HYDR FUK JA, V813; Van den Berg Thomas H, 2005, PHYS REV LETT, V94; Way S., 1968, ELECTROMAGNETIC PROP, V2, P49; Weier T, 2007, FLUID MECH APPL, V80, P295; Wright M.R., 2007, INTRO AQUEOUS ELECTR; Yakovlev V. I., 1980, Journal of Applied Mechanics and Technical Physics, V21, P376, DOI 10.1007/BF00920776; Yan LG, 2000, IEEE T APPL SUPERCON, V10, P955, DOI 10.1109/77.828390; Yan LG, 2000, IEEE T APPL SUPERCON, V10, P951, DOI 10.1109/77.828389; YANG ZJ, 1990, SUPERCOND SCI TECH, V3, P591, DOI 10.1088/0953-2048/3/12/004	62	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0178599	10.1371/journal.pone.0178599	http://dx.doi.org/10.1371/journal.pone.0178599			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665941	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608700027
J	Ferrara, S; Falcone, M; Macchi, R; Bragonzi, A; Girelli, D; Cariani, L; Cigana, C; Bertoni, G				Ferrara, Silvia; Falcone, Marilena; Macchi, Raffaella; Bragonzi, Alessandra; Girelli, Daniela; Cariani, Lisa; Cigana, Cristina; Bertoni, Giovanni			The PAPI-1 pathogenicity island-encoded small RNA PesA influences Pseudomonas aeruginosa virulence and modulates pyocin S3 production	PLOS ONE			English	Article							FIBROSIS LUNG INFECTION; FUNCTIONAL-ANALYSIS; IDENTIFICATION; GENES; PAO1; BACTERIA; RECEPTOR; TARGETS; STRAIN; GROWTH	Small non-coding RNAs (sRNAs) are post-transcriptional regulators of gene expression that have been recognized as key contributors to bacterial virulence and pathogenic mechanisms. In this study, we characterized the sRNA PesA of the opportunistic human pathogen Pseudomonas aeruginosa. We show that PesA, which is transcribed within the pathogenicity island PAPI-1 of P. aeruginosa strain PA14, contributes to P. aeruginosa PA14 virulence. In fact, pesA gene deletion resulted in a less pathogenic strain, showing higher survival of cystic fibrosis human bronchial epithelial cells after infection. Moreover, we show that PesA influences positively the expression of pyocin S3 whose genetic locus comprises two structural genes, pyoS3A and pyoS3I, encoding the killing S3A and the immunity S3I proteins, respectively. Interestingly, the deletion of pesA gene results in increased sensitivity to UV irradiation and to the fluoroquinolone antibiotic ciprofloxacin. The degree of UV sensitivity displayed by the PA14 strain lacking PesA is comparable to that of a strain deleted for pyoS3A-I. These results suggest an involvement of pyocin S3 in DNA damage repair and a regulatory role of PesA on this function.	[Ferrara, Silvia; Falcone, Marilena; Macchi, Raffaella; Bertoni, Giovanni] Univ Milan, Dept Biosci, Milan, Italy; [Bragonzi, Alessandra; Cigana, Cristina] IRCCS San Raffaele Sci Inst, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Girelli, Daniela; Cariani, Lisa] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Cyst Fibrosis Microbiol Lab, Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico	Ferrara, S; Bertoni, G (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	silvia.ferrara@unimi.it; giovanni.bertoni@unimi.it	BERTONI, GIOVANNI/J-3437-2012; FERRARA, SILVIA/ABB-8803-2020; Bragonzi, Alessandra/AAC-6751-2022; Ferrara, Silvia/AAR-4497-2020; Cigana, Cristina/D-2883-2016	BERTONI, GIOVANNI/0000-0001-5761-9494; FERRARA, SILVIA/0000-0002-8024-7147; Cigana, Cristina/0000-0003-0436-9721; Falcone, Marilena/0000-0001-7838-7258	European Commission [NABATIVI-223670]; Italian Cystic Fibrosis Research Foundation (FFC) [13/2015]; Universita degli Studi di Milano	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Universita degli Studi di Milano	This work has been supported by the following grants to GB: European Commission (NABATIVI-223670, EU-FP7-HEALTH-2007-B) and Italian Cystic Fibrosis Research Foundation (FFC#13/2015) with the contribution of Gruppo di Sostegno FFC di Sassari Castelsardo and Delegazione FFC di Boschi Sant'Anna Minerbe and (FFC#14/2016) with the contribution of Delegazione FFC di Reggio Calabria and Gruppo di Sostegno FFC di Vigevano. SF was the recipient of a Postdoctoral Fellowship of the Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi-Ali A, 2004, CAN J MICROBIOL, V50, P375, DOI 10.1139/W04-019; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Baysse C, 1999, J BACTERIOL, V181, P3849, DOI 10.1128/JB.181.12.3849-3851.1999; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Caldelari I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010298; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Cigana C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21465; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Delvillani F, 2014, RNA, V20, P1963, DOI 10.1261/rna.044354.114; Dingemans J, 2016, MICROBIOLOGYOPEN, V5, P413, DOI 10.1002/mbo3.339; DUPORT C, 1995, J BIOL CHEM, V270, P8920, DOI 10.1074/jbc.270.15.8920; Elfarash A, 2012, MICROBIOLOGYOPEN, V1, P268, DOI 10.1002/mbo3.27; Ferrara S, 2015, ENVIRON MICROBIOL, V17, P199, DOI 10.1111/1462-2920.12590; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Ling H, 2010, FEBS LETT, V584, P3354, DOI 10.1016/j.febslet.2010.06.021; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SANO Y, 1993, J BACTERIOL, V175, P2907, DOI 10.1128/JB.175.10.2907-2916.1993; SANO Y, 1993, MOL GEN GENET, V237, P161, DOI 10.1007/BF00282797; SANO Y, 1993, J BACTERIOL, V175, P6179, DOI 10.1128/JB.175.19.6179-6185.1993; SEO YH, 1990, BIOCHEM BIOPH RES CO, V172, P455, DOI 10.1016/0006-291X(90)90694-I; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tjaden B., 2008, NUCLEIC ACIDS RES, P36; Wagner Victoria E., 2008, P129; Wenner N, 2014, ENVIRON MICROBIOL, V16, P1053, DOI 10.1111/1462-2920.12272; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wright PR, 2014, NUCLEIC ACIDS RES, P42; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945	46	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180386	10.1371/journal.pone.0180386	http://dx.doi.org/10.1371/journal.pone.0180386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665976	Green Published, gold			2022-12-26	WOS:000404608700004
J	Ghazanfar, S; Vuocolo, T; Morrison, JL; Nicholas, LM; McMillen, IC; Yang, JYH; Buckley, MJ; Tellam, RL				Ghazanfar, Shila; Vuocolo, Tony; Morrison, Janna L.; Nicholas, Lisa M.; McMillen, Isabella C.; Yang, Jean Y. H.; Buckley, Michael J.; Tellam, Ross L.			Gene expression allelic imbalance in ovine brown adipose tissue impacts energy homeostasis	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; EARLY-LIFE; DISCOVERY; DIVERGENCE; FRAMEWORK; POWERFUL; DATABASE; PROGRESS; REVEALS; TOOL	Heritable trait variation within a population of organisms is largely governed by DNA variations that impact gene transcription and protein function. Identifying genetic variants that affect complex functional traits is a primary aim of population genetics studies, especially in the context of human disease and agricultural production traits. The identification of alleles directly altering mRNA expression and thereby biological function is challenging due to difficulty in isolating direct effects of cis-acting genetic variations from indirect trans-acting genetic effects. Allele specific gene expression or allelic imbalance in gene expression (AI) occurring at heterozygous loci provides an opportunity to identify genes directly impacted by cis-acting genetic variants as indirect trans-acting effects equally impact the expression of both alleles. However, the identification of genes showing AI in the context of the expression of all genes remains a challenge due to a variety of technical and statistical issues. The current study focuses on the discovery of genes showing AI using single nucleotide polymorphisms as allelic reporters. By developing a computational and statistical process that addressed multiple analytical challenges, we ranked 5,809 genes for evidence of AI using RNA-Seq data derived from brown adipose tissue samples from a cohort of late gestation fetal lambs and then identified a conservative subgroup of 1,293 genes. Thus, AI was extensive, representing approximately 25% of the tested genes. Genes associated with AI were enriched for multiple Gene Ontology (GO) terms relating to lipid metabolism, mitochondrial function and the extracellular matrix. These functions suggest that cis-acting genetic variations causing AI in the population are preferentially impacting genes involved in energy homeostasis and tissue remodelling. These functions may contribute to production traits likely to be under genetic selection in the population.	[Ghazanfar, Shila; Buckley, Michael J.] CSIRO, Data61, N Ryde, NSW, Australia; [Ghazanfar, Shila; Yang, Jean Y. H.] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Vuocolo, Tony; Tellam, Ross L.] CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Morrison, Janna L.; Nicholas, Lisa M.; McMillen, Isabella C.] Univ South Australia, Early Origins Adult Hlth Res Grp, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of South Australia	Ghazanfar, S (corresponding author), CSIRO, Data61, N Ryde, NSW, Australia.; Ghazanfar, S (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.; Tellam, RL (corresponding author), CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia.	shila.ghazanfar@sydney.edu.au; Ross.Tellam@gmail.com	McMillen, Isabella Caroline/N-5540-2019; Morrison, Janna/B-8308-2009; Tellam, Ross/T-2423-2019; Yang, Jean YH/D-2920-2015; Tellam, Ross/H-2798-2013	Morrison, Janna/0000-0002-8602-8519; Yang, Jean YH/0000-0002-5271-2603; Tellam, Ross/0000-0003-2353-1640; Ghazanfar, Shila/0000-0001-7861-6997	CSIRO OCE Top-Up Scholarship; Australian Postgraduate Award; Science and Industry Endowment Fund [RP03-064]; Australian Research Council Future Fellowship Grant [FT0991918]; Australian Research Council DP Grant [130100488]; National Health and Medical Research Council [APP1066916]	CSIRO OCE Top-Up Scholarship; Australian Postgraduate Award(Australian Government); Science and Industry Endowment Fund; Australian Research Council Future Fellowship Grant(Australian Research Council); Australian Research Council DP Grant(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funded by SG: CSIRO OCE Top-Up Scholarship, SG: Australian Postgraduate Award, RT, MJB, JLM, ICM: Science and Industry Endowment Fund (RP03-064), JYHY: Australian Research Council Future Fellowship Grant (FT0991918), JYHY: Australian Research Council DP Grant (130100488), JLM: National Health and Medical Research Council (APP1066916). Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Aldermann G, 1975, FISHERIES FOOD TECHN, P33; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Asada R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16580; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Chamberlain AJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2174-0; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ENCODE, GUID EXP; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutter B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-116; Iizuka K, 2013, ENDOCR J, V60, P1145, DOI 10.1507/endocrj.EJ13-0079; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nag A, 2015, G3-GENES GENOM GENET, V5, P1713, DOI 10.1534/g3.115.018853; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/305763; Symonds ME, 2012, P NUTR SOC, V71, P363, DOI 10.1017/S0029665112000584; Symonds ME, 2011, PROG BIOPHYS MOL BIO, V106, P300, DOI 10.1016/j.pbiomolbio.2010.11.008; Verdeguer F, 2016, MOL CELL BIOL, V36, P184, DOI 10.1128/MCB.00722-15; Yao X, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-35; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180378	10.1371/journal.pone.0180378	http://dx.doi.org/10.1371/journal.pone.0180378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665992	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000404608700003
J	Burgerhout, E; Mommens, M; Johnsen, H; Aunsmo, A; Santi, N; Andersen, O				Burgerhout, Erik; Mommens, Maren; Johnsen, Hanne; Aunsmo, Arnfinn; Santi, Nina; Andersen, Oivind			Genetic background and embryonic temperature affect DNA methylation and expression of myogenin and muscle development in Atlantic salmon (Salmo solar)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; SKELETAL-MUSCLE; SALAR L; INCUBATION-TEMPERATURE; EPIGENETIC CONTROL; TELEOST FISH; GROWTH; CELLULARITY; CELLS	The development of ectothermic embryos is strongly affected by incubation temperature, and thermal imprinting of body growth and muscle phenotype has been reported in various teleost fishes. The complex epigenetic regulation of muscle development in vertebrates involves DNA methylation of the myogenin promoter. Body growth is a heritable and highly variable trait among fish populations that allows for local adaptations, but also for selective breeding. Here we studied the epigenetic effects of embryonic temperature and genetic background on body growth, muscle cellularity and myogenin expression in farmed Atlantic salmon (Salmo salar). Eggs from salmon families with either high or low estimated breeding values for body growth, referred to as Fast and Slow genotypes, were incubated at 8(circle)C or 4(circle)C until the embryonic 'eyed-stage' followed by rearing at the production temperature of 8(circle)C. Rearing temperature strongly affected the growth rates, and the 8(circle)C fish were about twice as heavy as the 4(circle)C fish in the order Fast8>Slow8>Fast4>Slow4 prior to seawater transfer. Fast8 was the largest fish also at harvest despite strong growth compensation in the low temperature groups. Larval myogenin expression was approximately 4-6 fold higher in the Fast8 group than in the other groups and was associated with relative low DNA methylation levels, but was positively correlated with the expression levels of the DNA methyltransferase genes dnmt1, dnmt3a and dnmt3b. Juvenile Fast8 fish displayed thicker white muscle fibres than Fast4 fish, while Slow 8 and Slow 4 showed no difference in muscle cellularity. The impact of genetic background on the thermal imprinting of body growth and muscle development in Atlantic salmon suggests that epigenetic variation might play a significant role in the local adaptation to fluctuating temperatures over short evolutionary time.	[Burgerhout, Erik; Johnsen, Hanne] Nofima AS, Tromso, Norway; [Mommens, Maren; Aunsmo, Arnfinn; Santi, Nina] AquaGen AS, Trondheim, Norway; [Andersen, Oivind] Nofima AS, As, Norway; [Andersen, Oivind] Norwegian Univ Life Sci, Dept Anim & Aquaculture Sci, As, Norway	Nofima; Nofima; Norwegian University of Life Sciences	Andersen, O (corresponding author), Nofima AS, As, Norway.; Andersen, O (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquaculture Sci, As, Norway.	oivind.andersen@nofima.no	Burgerhout, Erik/AAI-4527-2020		Norwegian Research Council Project [221734/030]	Norwegian Research Council Project(Research Council of Norway)	The authors received funding from Norwegian Research Council Project No. 221734/030. Nofima AS provided support in the form of salaries for authors [EB, HJ, OA] and AquaGen AS provided support in the form of salaries for authors [MM, AA, NS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albokhadaim I, 2007, J EXP BIOL, V210, P1735, DOI 10.1242/jeb.003194; Aunsmo A, 2014, AQUACULTURE, P249; Aunsmo A, 2008, AQUACULTURE, V284, P19, DOI 10.1016/j.aquaculture.2008.07.028; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bizuayehu TT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1503-7; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Campos C, 2013, EPIGENETICS-US, V8, P389, DOI 10.4161/epi.24178; CHO CY, 1992, AQUACULTURE, V100, P107, DOI 10.1016/0044-8486(92)90353-M; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Harvey AC, 2016, EVOL APPL, V9, P435, DOI 10.1111/eva.12346; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Jimenez AG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3150; Johansen KA, 2005, MAR BIOTECHNOL, V7, P576, DOI 10.1007/s10126-004-5133-3; Johnston IA, 1997, CAN J ZOOL, V75, P64, DOI 10.1139/z97-008; Johnston IA, 2000, J EXP BIOL, V203, P2539; Johnston IA, 2001, MAR ECOL PROG SER, V213, P285, DOI 10.3354/meps213285; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Johnston IA, 2012, P ROY SOC B-BIOL SCI, V279, P2255, DOI 10.1098/rspb.2011.2536; Julin K, 2009, J VIROL METHODS, V162, P30, DOI 10.1016/j.jviromet.2009.07.003; Laker RC, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5725927; Lighten J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160299; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Macqueen DJ, 2007, J EXP BIOL, V210, P2781, DOI 10.1242/jeb.006981; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MATSCHAK TW, 1995, EXPERIENTIA, V51, P260, DOI 10.1007/BF01931109; Moresi V, 2015, BBA-GENE REGUL MECH, V1849, P309, DOI 10.1016/j.bbagrm.2015.01.002; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nakatsuka R, 2010, ARCH ORAL BIOL, V55, P350, DOI 10.1016/j.archoralbio.2010.03.003; NATHANAILIDES C, 1995, CAN J FISH AQUAT SCI, V52, P675, DOI 10.1139/f95-068; O'Steen S, 1998, J EXP BIOL, V201, P439; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rescan PY, 2005, GEN COMP ENDOCR, V142, P111, DOI 10.1016/j.ygcen.2004.12.016; Schnurr ME, 2014, J EXP BIOL, V217, P1370, DOI 10.1242/jeb.094037; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Seiliez I, 2015, CELL TISSUE RES, V359, P715, DOI 10.1007/s00441-014-2060-0; Shima A, 2008, ZOOL SCI, V25, P1066, DOI 10.2108/zsj.25.1066; Skinner MK, 2014, GENOME BIOL EVOL, V6, P1972, DOI 10.1093/gbe/evu158; Steinbacher P, 2006, DEV DYNAM, V235, P3132, DOI 10.1002/dvdy.20950; Steinbacher P, 2011, J EXP BIOL, V214, P1791, DOI 10.1242/jeb.050096; STICKLAND NC, 1988, ANAT EMBRYOL, V178, P253, DOI 10.1007/BF00318228; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tsai HY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0215-y; USHER ML, 1994, J FISH BIOL, V44, P953, DOI 10.1006/jfbi.1994.1088; Valente LMP, 1999, J FISH BIOL, V55, P675, DOI 10.1111/j.1095-8649.1999.tb00710.x; VEGGETTI A, 1993, ANAT EMBRYOL, V187, P353; Watkins TB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P140, DOI 10.1086/498182; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Wilkes D, 2001, J EXP BIOL, V204, P2763; Xie SQ, 2001, DIFFERENTIATION, V68, P106, DOI 10.1046/j.1432-0436.2001.680204.x	59	42	43	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179918	10.1371/journal.pone.0179918	http://dx.doi.org/10.1371/journal.pone.0179918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662198	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000404608300070
J	Dugovich, BS; Peel, MJ; Palmer, AL; Zielke, RA; Sikora, AE; Beechler, BR; Jolles, AE; Epps, CW; Dolan, BP				Dugovich, Brian S.; Peel, Melanie J.; Palmer, Amy L.; Zielke, Ryszard A.; Sikora, Aleksandra E.; Beechler, Brianna R.; Jolles, Anna E.; Epps, Clinton W.; Dolan, Brian P.			Detection of bacterial-reactive natural IgM antibodies in desert bighorn sheep populations	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; VIBRIO-CORALLIILYTICUS; INFLUENZA-VIRUS; MOUNTAIN SHEEP; CELLS; PATHOGEN; DISEASE; INHIBITION; DIVERSITY; IMMUNITY	Ecoimmunology is a burgeoning field of ecology which studies immune responses in wildlife by utilizing general immune assays such as the detection of natural antibody. Unlike adaptive antibodies, natural antibodies are important in innate immune responses and often recognized conserved epitopes present in pathogens. Here, we describe a procedure for measuring natural antibodies reactive to bacterial antigens that may be applicable to a variety of organisms. IgM from desert bighorn sheep plasma samples was tested for reactivity to outer membrane proteins from Vibrio coralliilyticus, a marine bacterium to which sheep would have not been exposed. Immunoblotting demonstrated bighorn sheep IgM could bind to a variety of bacterial cell envelope proteins while ELISA analysis allowed for rapid determination of natural antibody levels in hundreds of individual animals. Natural antibody levels were correlated with the ability of plasma to kill laboratory strains of E. coli bacteria. Finally, we demonstrate that natural antibody levels varied in two distinct populations of desert bighorn sheep. These data demonstrate a novel and specific measure of natural antibody function and show that this varies in ecologically relevant ways.	[Dugovich, Brian S.; Peel, Melanie J.; Palmer, Amy L.; Beechler, Brianna R.; Jolles, Anna E.; Dolan, Brian P.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Zielke, Ryszard A.; Sikora, Aleksandra E.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Epps, Clinton W.] Oregon State Univ, Dept Fisheries & Wildlife, Coll Agr Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Dolan, BP (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Brian.Dolan@oregonstate.edu	Sikora, Aleksandra E/HGD-6641-2022; Beechler, Brianna R/H-7972-2019; Epps, Clinton/AAX-3971-2021	Beechler, Brianna R/0000-0002-9711-4340; Epps, Clinton/0000-0001-6577-1840; Jolles, Anna/0000-0003-3074-9912	California Department of Fish and Wildlife (CDFW); National Park Service (NPS); California Chapter of the Wild Sheep Foundation; Oregon State University; NPS	California Department of Fish and Wildlife (CDFW); National Park Service (NPS); California Chapter of the Wild Sheep Foundation; Oregon State University; NPS	Bighorn samples were provided from research funded by the California Department of Fish and Wildlife (CDFW), the National Park Service (NPS), and the California Chapter of the Wild Sheep Foundation. Funding for analyses was provided by Oregon State University and NPS. Bighorn sheep captures within the Mojave National Preserve were conducted under NPS research permit MOJA-2013-SCI-0030. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brock PM, 2014, INTEGR COMP BIOL, V54, P353, DOI 10.1093/icb/icu046; Buchalski MR, 2016, J MAMMAL, V97, P823, DOI 10.1093/jmammal/gyw011; BUDZKO DB, 1981, J CLIN MICROBIOL, V13, P818, DOI 10.1128/JCM.13.5.818-823.1981; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; COWAN IAN McTAGGART, 1940, AMER MIDLAND NAT, V24, P505, DOI 10.2307/2420858; Creech TG, 2016, J ARID ENVIRON, V127, P160, DOI 10.1016/j.jaridenv.2015.11.011; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; ELLIOT LF, 1994, J WILDLIFE DIS, V30, P315, DOI 10.7589/0090-3558-30.3.315; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Epps CW, 2006, MOL ECOL, V15, P4295, DOI 10.1111/j.1365-294X.2006.03103.x; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Epps CW, 2016, MOJAVE NATL PRESERVE, V2016, P1; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; Herget S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-35; Hunter KW, 2008, J MICROBIOL METH, V75, P464, DOI 10.1016/j.mimet.2008.07.022; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jessup DA, 1985, T DESERT BIGHORN COU, V29, P29; Kantor AB, 1997, J IMMUNOL, V158, P1175; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Lobo PI, 2008, J IMMUNOL, V180, P1769, DOI 10.4049/jimmunol.180.3.1769; LUDEWIG S, 1949, J BIOL CHEM, V179, P271; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin LB, 2007, AM J PHYSIOL-REG I, V292, pR316, DOI 10.1152/ajpregu.00386.2006; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mayasari N, 2016, PREV VET MED, V127, P1, DOI 10.1016/j.prevetmed.2016.03.001; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Nguyen TTT, 2015, J IMMUNOL, V194, P1489, DOI 10.4049/jimmunol.1401880; Notley CA, 2011, J IMMUNOL, V186, P4967, DOI 10.4049/jimmunol.1003021; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Quartier P, 2005, EUR J IMMUNOL, V35, P252, DOI 10.1002/eji.200425497; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Sandmeier FC, 2012, BIOL OPEN, V1, P1078, DOI 10.1242/bio.20122527; Savage HP, 2015, ANN NY ACAD SCI, V1362, P132, DOI 10.1111/nyas.12799; SEITANID.B, 1969, J CLIN PATHOL, V22, P321, DOI 10.1136/jcp.22.3.321; van der Klein SAS, 2015, POULTRY SCI, V94, P875, DOI 10.3382/ps/pev052; van Knegsel ATM, 2007, J DAIRY SCI, V90, P5490, DOI 10.3168/jds.2007-0289; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; Wehausen J. D., 1993, DESERT BIGHORN COUNC, V37, P1; Wehausen JD, 2011, CALIF FISH GAME, V97, P7; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Zielke RA, 2014, CURR PROTOC MICROBIO, V34	53	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180415	10.1371/journal.pone.0180415	http://dx.doi.org/10.1371/journal.pone.0180415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662203	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300153
J	Jiang, JW; Min, Y; Chang, J; Ge, Y				Jiang, Jinwei; Min, Yong; Chang, Jie; Ge, Ying			Biological interactions and cooperative management of multiple species	PLOS ONE			English	Article							ECOLOGICAL SYSTEMS; FISHERIES; MODEL; CAPABILITIES; RESOURCES; DYNAMICS; ECOPATH; ECOSIM	Coordinated decision making and actions have become the primary solution for the overexploitation of interacting resources within ecosystems. However, the success of coordinated management is highly sensitive to biological, economic, and social conditions. Here, using a game theoretic framework and a 2-species model that considers various biological relationships (competition, predation, and mutualism), we compute cooperative (or joint) and noncooperative (or separate) management equilibrium outcomes of the model and investigate the effects of the type and strength of the relationships. We find that cooperation does not always show superiority to non-cooperation in all biological interactions: (1) if and only if resources are involved in high-intensity predation relationships, cooperation can achieve a win-win scenario for ecosystem services and resource diversity; (2) for competitive resources, cooperation realizes higher ecosystem services by sacrificing resource diversity; and (3) for mutual resources, cooperation has no obvious advantage for either ecosystem services or resource evenness but can slightly improve resource abundance. Furthermore, by using a fishery model of the North California Current Marine Ecosystem with 63 species and seven fleets, we demonstrate that the theoretical results can be reproduced in real ecosystems. Therefore, effective ecosystem management should consider the interconnection between stakeholders' social relationship and resources' biological relationships.	[Jiang, Jinwei; Min, Yong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Min, Yong; Chang, Jie; Ge, Ying] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Min, Yong] Univ Quebec Montreal, Dept Biol Sci, Inst Environm Sci, Montreal, PQ, Canada	Zhejiang University of Technology; Zhejiang University; University of Quebec; University of Quebec Montreal	Min, Y (corresponding author), Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China.; Min, Y (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Min, Y (corresponding author), Univ Quebec Montreal, Dept Biol Sci, Inst Environm Sci, Montreal, PQ, Canada.	myong@zjut.edu.cn			The National Natural Science Foundation of China [71303217, 31370354, 31470463]; Zhejiang Provincial Natural Science Foundation of China [LY17G030030]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The National Natural Science Foundation of China (Grant Nos. 71303217, 31370354 and 31470463) and the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY17G030030).	ANDERSON LG, 1975, J FISH RES BOARD CAN, V32, P1825, DOI 10.1139/f75-217; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Chen XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04161; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Field JC, 2004, APPL ECOSYSTEM BASED, P408; Garcia-Algarra J, 2014, J THEOR BIOL, V363, P332, DOI 10.1016/j.jtbi.2014.08.039; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HANNESSON R, 1983, J ENVIRON ECON MANAG, V10, P329, DOI 10.1016/0095-0696(83)90003-7; Hannesson R, 2011, ANNU REV RESOUR ECON, V3, P181, DOI 10.1146/annurev-resource-083110-120107; LIDICKER WZ, 1979, BIOSCIENCE, V29, P475, DOI 10.2307/1307540; May R., 2007, THEORETICAL ECOLOGY, V3rd; MAY RM, 1979, SCIENCE, V205, P267, DOI 10.1126/science.205.4403.267; Min Y, 2011, ECOL MODEL, V222, P3277, DOI 10.1016/j.ecolmodel.2011.06.013; MUNRO GR, 1979, CAN J ECON, V12, P355, DOI 10.2307/134727; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Steenbeek J, 2016, ECOL MODEL, V319, P178, DOI 10.1016/j.ecolmodel.2015.06.031; Sumaila U.R., 2013, GAME THEORY FISHERIE; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Weitz JS, 2016, P NATL ACAD SCI USA, V113, pE7518, DOI 10.1073/pnas.1604096113; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x; White C, 2012, ECOL LETT, V15, P509, DOI 10.1111/j.1461-0248.2012.01773.x; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003; Yang W, 2013, P NATL ACAD SCI USA, V110, P10916, DOI 10.1073/pnas.1301733110	28	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180189	10.1371/journal.pone.0180189	http://dx.doi.org/10.1371/journal.pone.0180189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662140	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300123
J	Murphy, C; Rettedal, E; Lehouritis, P; Devoy, C; Tangney, M				Murphy, Carola; Rettedal, Elizabeth; Lehouritis, Panos; Devoy, Ciaran; Tangney, Mark			Intratumoural production of TNF alpha by bacteria mediates cancer therapy	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-THERAPY; IONIZING-RADIATION; DNA DELIVERY; TUMOR-GROWTH; SALMONELLA; TRANSCRIPTION; MELANOMA; VECTOR; SYSTEM	Systemic administration of the highly potent anticancer therapeutic, tumour necrosis factor alpha (TNF alpha) induces high levels of toxicity and is responsible for serious side effects. Consequently, tumour targeting is required in order to confine this toxicity within the locality of the tumour. Bacteria have a natural capacity to grow within tumours and deliver therapeutic molecules in a controlled fashion. The non-pathogenic E. co/istrain MG1655 was investigated as a tumour targeting system in order to produce TNF alpha specifically within murine tumours. In vivo bioluminescence imaging studies and ex vivo immunofluorescence analysis demonstrated rapid targeting dynamics and prolonged survival, replication and spread of this bacterial platform within tumours. An engineered TNF alpha producing construct deployed in mouse models via either intra-tumoural (i.t.) or intravenous (i.v.) administration facilitated robust TNF alpha production, as evidenced by ELISA of tumour extracts. Tumour growth was impeded in three subcutaneous murine tumour models (CT26 colon, RENCA renal, and TRAMP prostate) as evidenced by tumour volume and survival analyses. A pattern of pro inflammatory cytokine induction was observed in tumours of treated mice vs. controls. Mice remained healthy throughout experiments. This study indicates the therapeutic efficacy and safety of TNF alpha expressing bacteria in vivo, highlighting the potential of non-pathogenic bacteria as a platform for restricting the activity of highly potent cancer agents to tumours.	[Murphy, Carola; Rettedal, Elizabeth; Lehouritis, Panos; Devoy, Ciaran; Tangney, Mark] Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland; [Devoy, Ciaran; Tangney, Mark] Univ Coll Cork, SynBioCtr, Cork, Ireland; [Tangney, Mark] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland	University College Cork; University College Cork; University College Cork	Tangney, M (corresponding author), Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland.; Tangney, M (corresponding author), Univ Coll Cork, SynBioCtr, Cork, Ireland.; Tangney, M (corresponding author), Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	m.tangney@ucc.ie		Tangney, Mark/0000-0002-6314-1260; Rettedal, Elizabeth/0000-0001-5586-0508	Irish Cancer Society [PCI12TAN]; European Commission Seventh Framework Program [PIAPGA-2013-612219-VIP]; Breakthrough Cancer Research	Irish Cancer Society; European Commission Seventh Framework Program; Breakthrough Cancer Research	The authors wish to acknowledge support relevant to this manuscript to MT, from the Irish Cancer Society (PCI12TAN), the European Commission Seventh Framework Program (PIAPGA-2013-612219-VIP) and Breakthrough Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio C, 2007, J GENE MED, V9, P416, DOI 10.1002/jgm.1023; Ahmad S, 2009, MOL THER, V17, P1101, DOI 10.1038/mt.2009.66; Baban CK, 2012, JOVE-J VIS EXP, DOI 10.3791/4318; Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Barbe S, 2005, FEMS MICROBIOL LETT, V246, P67, DOI 10.1016/j.femsle.2005.03.037; Byrne WL, 2014, J CONTROL RELEASE, V196, P384, DOI 10.1016/j.jconrel.2014.10.030; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen JX, 2012, CANCER SCI, V103, P325, DOI 10.1111/j.1349-7006.2011.02147.x; Cronin M, 2014, MOL THER, V22, P1188, DOI 10.1038/mt.2014.23; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Feng KK, 2005, CANCER LETT, V221, P41, DOI 10.1016/j.canlet.2004.09.030; Flores Bueso Y, 2017, TRENDS BIOTECHNOLOGY; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; HALLAHAN DE, 1991, P NATL ACAD SCI USA, V88, P2156, DOI 10.1073/pnas.88.6.2156; Herman JM, 2013, J CLIN ONCOL, V31, P886, DOI 10.1200/JCO.2012.44.7516; Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005; Loeffler M, 2008, CANCER GENE THER, V15, P787, DOI 10.1038/cgt.2008.48; Loeffler M, 2008, J NATL CANCER I, V100, P1113, DOI 10.1093/jnci/djn205; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Murphy CT, 2010, J LEUKOCYTE BIOL, V88, P1271, DOI 10.1189/jlb.0909627; Nuyts S, 2001, GENE THER, V8, P1197, DOI 10.1038/sj.gt.3301499; O'Brien MER, 2000, BRIT J CANCER, V83, P853, DOI 10.1054/bjoc.2000.1401; Stanton M, 2015, CURR GENE THER, V15, P277, DOI 10.2174/1566523215666150126122712; Tangney M, 2010, DISCOV MED, V10, P195; Theys J, 1999, APPL ENVIRON MICROB, V65, P4295; van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022; Yuan Z, 2013, CANCER GENE THER, V20, P46, DOI 10.1038/cgt.2012.83	33	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180034	10.1371/journal.pone.0180034	http://dx.doi.org/10.1371/journal.pone.0180034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662099	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300090
J	Kar, R; Nangpal, P; Mathur, S; Singh, S; Tyagi, AK				Kar, Ritika; Nangpal, Prachi; Mathur, Shubhita; Singh, Swati; Tyagi, Anil K.			bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs	PLOS ONE			English	Article							7,8-DIAMINOPELARGONIC ACID AMINOTRANSFERASE; EXPERIMENTAL AIRBORNE TUBERCULOSIS; PULMONARY TUBERCULOSIS; PANTOTHENATE AUXOTROPH; BIOTIN BIOSYNTHESIS; CLINICAL DEVELOPMENT; BCG; VACCINE; MODEL; MICE	Owing to the devastation caused by tuberculosis along with the unsatisfactory performance of the Bacillus Calmette-Guerin (BCG) vaccine, a more efficient vaccine than BCG is required for the global control of tuberculosis. A number of studies have demonstrated an essential role of biotin biosynthesis in the growth and survival of several microorganisms, including mycobacteria, through deletion of the genes involved in de novo biotin biosynthesis. In this study, we demonstrate that a bioA mutant of Mycobacterium tuberculosis (Mtb Delta bioA) is highly attenuated in the guinea pig model of tuberculosis when administered aerogenically as well as intradermally. Immunization with Mtb Delta bioA conferred significant protection in guinea pigs against an aerosol challenge with virulent M. tuberculosis, when compared with the unvaccinated animals. Booster immunization with Mtb Delta bioA offered no advantage over a single immunization. These experiments demonstrate the vaccinogenic potential of the attenuated M. tuberculosis bioA mutant against tuberculosis.	[Kar, Ritika; Nangpal, Prachi; Mathur, Shubhita; Singh, Swati; Tyagi, Anil K.] Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi, India; [Tyagi, Anil K.] Guru Gobind Singh Indraprastha Univ, New Delhi, India	University of Delhi; GGS Indraprastha University	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi, India.; Tyagi, AK (corresponding author), Guru Gobind Singh Indraprastha Univ, New Delhi, India.	aniltyagi@south.du.ac.in		Kar, Ritika/0000-0003-3953-4897	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/COE/05/06-II]; Council of Scientific and Industrial Research (CSIR), India; Department of Biotechnology, Government of India; Indian Council of Medical Research (ICMR), India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was supported by financial grant from Department of Biotechnology, Ministry of Science and Technology, Government of India (Grant Number-BT/01/COE/05/06-II). RK and PN are grateful to Council of Scientific and Industrial Research (CSIR), India, for research fellowships. SM is grateful to Department of Biotechnology, Government of India for research fellowship. SS is grateful to Indian Council of Medical Research (ICMR), India for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Aguilo N, 2016, TUBERCULOSIS, V96, P71, DOI 10.1016/j.tube.2015.10.010; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051; ARONSON JD, 1958, ARCH INTERN MED, V101, P881, DOI 10.1001/archinte.1958.00260170037006; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dai R, 2014, CHEMBIOCHEM, V15, P575, DOI 10.1002/cbic.201300748; Dascher CC, 1999, J IMMUNOL, V163, P5478; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Dey S, 2010, BIOCHEMISTRY-US, V49, P6746, DOI 10.1021/bi902097j; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Geldmacher C, 2015, LANCET RESP MED, V3, P906, DOI 10.1016/S2213-2600(15)00474-9; Ginsberg AM, 2016, TUBERCULOSIS, V99, pS16, DOI 10.1016/j.tube.2016.05.013; Gupta UD, 2005, TUBERCULOSIS, V85, P277, DOI 10.1016/j.tube.2005.08.008; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Keer J, 2000, MICROBIOL-SGM, V146, P2209, DOI 10.1099/00221287-146-9-2209; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Koch R, 1891, Br Med J, V1, P125; Lasco TM, 2005, TUBERCULOSIS, V85, P245, DOI 10.1016/j.tube.2005.01.001; Lee S, 2006, INFECT IMMUN, V74, P6491, DOI 10.1128/IAI.00531-06; Mann S, 2005, BIOCHEM SOC T, V33, P802, DOI 10.1042/BST0330802; Mann S, 2009, BIOCHIMIE, V91, P826, DOI 10.1016/j.biochi.2009.03.019; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Moreira AL, 2002, INFECT IMMUN, V70, P2100, DOI 10.1128/IAI.70.4.2100-2107.2002; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Said HM, 2009, J NUTR, V139, P158, DOI 10.3945/jn.108.092023; Salaemae W, 2011, PROTEIN CELL, V2, P691, DOI 10.1007/s13238-011-1100-8; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schneider G, 2001, FEBS LETT, V495, P7, DOI 10.1016/S0014-5793(01)02325-0; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; SMITH DW, 1977, AM J PATHOL, V89, P273; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Spertini F, 2015, LANCET RESP MED, V3, P953, DOI 10.1016/S2213-2600(15)00435-X; STONER GL, 1975, J BIOL CHEM, V250, P4029; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Williams A, 2009, TUBERCULOSIS, V89, P389, DOI 10.1016/j.tube.2009.08.004; Yu J, 2011, MICROBES INFECT, V13, P33, DOI 10.1016/j.micinf.2010.08.010; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071243	68	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179513	10.1371/journal.pone.0179513	http://dx.doi.org/10.1371/journal.pone.0179513			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658275	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900029
J	Wang, ZM; Qiu, ZW; Gao, CX; Sun, YJ; Dong, W; Zhang, Y; Chen, RL; Qi, Y; Li, SY; Guo, YJ; Piao, YJ; Li, S; Piao, FY				Wang, Zhemin; Qiu, Zewen; Gao, Chenxue; Sun, Yijie; Dong, Wei; Zhang, Yan; Chen, Ruolin; Qi, Yuan; Li, Shuangyue; Guo, Yanjie; Piao, Yongjun; Li, Sheng; Piao, Fengyuan			2,5-hexanedione downregulates nerve growth factor and induces neuron apoptosis in the spinal cord of rats via inhibition of the PI3K/Akt signaling pathway	PLOS ONE			English	Article							NORMAL-HEXANE; CELL-DEATH; IN-VITRO; BAD; BCL-2; NGF; EXPRESSION; NEUROPATHY; CASPASE-3; SURVIVAL	2,5-hexanedione (2,5-HD) is the main active metabolite of n-hexane and induces apoptosis in nerve tissue, however, the mechanism of which remains unclear. In the present study, neuropathic animal models were successfully constructed in rats by injecting 100, 200 and 400 mg/kg 2,5-HD intraperitoneally for 5 weeks. Rats exposed to 2,5-HD exhibited progressive gait abnormalities and slower motor neural response in a dose-dependent manner. TUNEL analysis and immunofluorescence dual labeling revealed that the spinal cord of the 2,5-HD treated rats underwent significantly more apoptosis in the cells of spinal cord than that of the control group. The neuron apoptosis index in spinal cord was 4.1%, 6.7%, 9.8% respectively in rats exposed to 100, 200 and 400 mg/kg 2,5-HD, compared with 1.1% in the control group (p < 0.05). Biochemical analysis showed that 2,5-HD exposure downregulated NGF expression in the spinal cord of the intoxicated rats; inhibited the phosphorylation of Akt and Bad, two key players in PI3K/Akt pathway downstream of NGF; increased the dimerization of Bad with Bcl-xL in the mitochondrial fraction, followed by the release of cytochrome c and activation of caspase-3 in the spinal cord of rats. In vitro study showed that the NGF expression decreased significantly in VSC4.1 cells dosed with 5.0, 10.0 mM 2,5HD in comparison with the control group. It was also found that NGF supplement repressed the induced apoptosis, and increased p-Akt and p-Bad level in 2,5-HD treated VSC4.1 cells, which could be antagonized by PI3K kinase (the upstream member of Akt) inhibitor LY294002. Taken together, our experimental results indicate that 2,5-HD may induce apoptosis in the spinal cord of rats via downregulating NGF expression and subsequently repressing PI3K/Akt signaling pathway.	[Wang, Zhemin; Gao, Chenxue; Sun, Yijie; Dong, Wei; Zhang, Yan; Qi, Yuan; Li, Shuangyue; Piao, Fengyuan] Dalian Med Univ, Dept Occupat & Environm Hlth, Dalian, Liaoning, Peoples R China; [Qiu, Zewen] Dalian Med Univ, Lab Anim Ctr, Dalian, Liaoning, Peoples R China; [Chen, Ruolin] Heping Ctr Dis Control & Prevent Tianjin, Dept Sexually Transmitted Dis, Tianjin, Peoples R China; [Guo, Yanjie; Li, Sheng] Dalian Med Univ, Dept Biochem, Dalian, Liaoning, Peoples R China; [Piao, Yongjun] Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Wang, Zhemin] Baotou Med Coll, Affiliated Hosp 2, Dept Prevent & Hlth Care, Baotou, Inner Mongolia, Peoples R China	Dalian Medical University; Dalian Medical University; Tianjin Center for Disease Control & Prevention; Dalian Medical University; Dalian Medical University; Baotou Medical College	Piao, FY (corresponding author), Dalian Med Univ, Dept Occupat & Environm Hlth, Dalian, Liaoning, Peoples R China.; Li, S (corresponding author), Dalian Med Univ, Dept Biochem, Dalian, Liaoning, Peoples R China.	lisheng_1996@163.com; piaofengyuan353@163.com			National Natural Science Foundation of China [81273038, 81102160]; Dalian Municipal Science and Technology Plan Project [2013E15SF163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dalian Municipal Science and Technology Plan Project	This work was supported by National Natural Science Foundation of China (grant numbers 81273038 and 81102160) and Dalian Municipal Science and Technology Plan Project (grant number 2013E15SF163).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Angelucci F, 2007, EUR NEUROPSYCHOPHARM, V17, P756, DOI 10.1016/j.euroneuro.2007.03.002; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bottger D, 2010, BRAIN RES, V1312, P108, DOI 10.1016/j.brainres.2009.11.062; Chang AP, 1998, MUSCLE NERVE, V21, P964, DOI 10.1002/(SICI)1097-4598(199807)21:7<964::AID-MUS21>3.3.CO;2-I; CHANG YC, 1991, BRIT J IND MED, V48, P12; CHANG YC, 1990, BRIT J IND MED, V47, P485; Chen RL, 2015, IND HEALTH, V53, P222, DOI 10.2486/indhealth.2014-0182; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Cui N, 2007, NEUROCHEM RES, V32, P1566, DOI 10.1007/s11064-007-9359-0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; GILBERT SG, 1982, J TOXICOL ENV HEALTH, V10, P31, DOI 10.1080/15287398209530228; GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Huang Chin-Chang, 2008, Acta Neurol Taiwan, V17, P3; Koh PO, 2011, NEUROSCI LETT, V498, P105, DOI 10.1016/j.neulet.2011.05.003; Kristiansen M, 2014, CELL DEATH DIFFER, V21, P1025, DOI 10.1038/cdd.2014.47; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; Li Y, 2013, J BIOMED RES, V27, P43, DOI 10.7555/JBR.27.20120051; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Liu Qiang, 2005, Wei Sheng Yan Jiu, V34, P271; LoPachin RM, 2004, TOXICOL APPL PHARM, V198, P61, DOI 10.1016/j.taap.2004.03.002; LoPachin RM, 2003, TOXICOL APPL PHARM, V193, P29, DOI 10.1016/j.taap.2003.07.005; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Ogawa Y, 1996, INT ARCH OCC ENV HEA, V68, P495, DOI 10.1007/s004200050099; OGE AE, 1994, MUSCLE NERVE, V17, P1416, DOI 10.1002/mus.880171211; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shimoke K, 2005, NEUROSCI LETT, V389, P124, DOI 10.1016/j.neulet.2005.07.030; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; SPENCER PS, 1975, J NEUROL NEUROSUR PS, V38, P771, DOI 10.1136/jnnp.38.8.771; STRANGE P, 1991, NEUROTOXICOL TERATOL, V13, P401, DOI 10.1016/0892-0362(91)90088-E; Sun Y, 2012, ARCH TOXICOL, V86, P205, DOI 10.1007/s00204-011-0745-7; TAKEUCHI Y, 1983, BRIT J IND MED, V40, P199; Torres ME, 2014, ENVIRON TOXICOL PHAR, V38, P807, DOI 10.1016/j.etap.2014.09.008; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang QS, 2007, TOXICOLOGY, V231, P58, DOI 10.1016/j.tox.2006.11.071; Wang T, 2010, ACTA PHARMACOL SIN, V31, P765, DOI 10.1038/aps.2010.69; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yin HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076011; Zassler B, 2006, EXP NEUROL, V198, P391, DOI 10.1016/j.expneurol.2005.12.009; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhang WC, 2013, J APPL TOXICOL, V33, P661, DOI 10.1002/jat.2714; Zhang X., 2010, MODERN PRIMARY SECON, V4, P5; Zhang Yanshu, 2007, Wei Sheng Yan Jiu, V36, P263; Zhao L, 2011, BIOMED ENVIRON SCI, V24, P374, DOI 10.3967/0895-3988.2011.04.008; Zilz TR, 2007, TOXICOLOGY, V231, P210, DOI 10.1016/j.tox.2006.12.002	49	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179388	10.1371/journal.pone.0179388	http://dx.doi.org/10.1371/journal.pone.0179388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654704	gold, Green Published, Green Submitted			2022-12-26	WOS:000404541500061
J	Wang, FM; King, JDM; Rose, T; Kretzschmar, T; Wissuwa, M				Wang, Fanmiao; King, James Douglas Morrison; Rose, Terry; Kretzschmar, Tobias; Wissuwa, Matthias			Can natural variation in grain P concentrations be exploited in rice breeding to lower fertilizer requirements?	PLOS ONE			English	Article							SEED PHYTATE; PHOSPHORUS; EFFICIENCY; REDISTRIBUTION; IMPROVE; YIELD	Agricultural usage of phosphorus (P) is largely driven by the amount of P removed from fields in harvested plant matter as offtake needs to be balanced by P fertilizer application. Reducing P concentration in grains is a way to decrease P offtake and reduce P fertilizer requirements or soil P mining where insufficient P is applied. Our objective was to assesses the genotypic variation for grain P concentration present within the rice gene pool and resolve to what extent it is affected by environment (P supply) or associated with genetic factors. About 2-fold variation in grain P concentrations were detected in two rice diversity panels, however, environmental effects were stronger than genotype effects. Genome wide association studies identified several putative loci associated with grain P concentrations. In most cases this was caused by minor haplotype associations with high grain P concentrations while associations with reduced P concentrations were identified on chromosomes 1, 6, 8, 11 and 12. Only the latter type of locus is of interest in breeding for reduced P concentrations and the most promising locus was at 20.7 Mb on chromosome 8, where a rare haplotype that was absent from all modern varieties studied reduced grain P concentration by 9.3%. This and all other loci were not consistently detected across environments or association panels, confirming that genetic effects were small compared to effects of environment. We conclude that the genetic effects detected were not sufficiently large or consistent to be of utility in plant breeding. Instead breeding efforts may have to rely on small to medium effect mutants already identified and attempt to achieve a more pronounced reduction in grain P concentration through the introgression of these mutants into a single genetic background.	[Wang, Fanmiao; King, James Douglas Morrison; Wissuwa, Matthias] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan; [Wang, Fanmiao; King, James Douglas Morrison; Wissuwa, Matthias] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, 1-1 Ohwashi, Tsukuba, Ibaraki, Japan; [Wang, Fanmiao; Kretzschmar, Tobias] IRRI, Los Banos, Laguna, Philippines; [Rose, Terry] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	University of Tokyo; Japan International Research Center for Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI); Southern Cross University	Wissuwa, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.; Wissuwa, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, 1-1 Ohwashi, Tsukuba, Ibaraki, Japan.	wissuwa@affrc.go.jp	kretzschmar, tobias/AAH-3739-2021	Wissuwa, Matthias/0000-0003-3505-9398; kretzschmar, tobias/0000-0002-8227-0746; Rose, Terry/0000-0001-5386-6818	Global Rice Science Partnership (GRISP) New Frontiers Research Project [DRPC2012-46]	Global Rice Science Partnership (GRISP) New Frontiers Research Project	Financial support in the form of Global Rice Science Partnership (GRISP) New Frontiers Research Project (DRPC2012-46) to MW is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair MW, 2009, CROP SCI, V49, P237, DOI 10.2135/cropsci2008.05.0246; Dobermann A, 1996, NUTR CYCL AGROECOSYS, V46, P111, DOI 10.1007/BF00704311; Fageria NK, 2013, J PLANT NUTR, V36, P1841, DOI 10.1080/01904167.2013.816727; Fairhurst T., 2000, NUTRIENT DISORDERS N, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; HOCKING PJ, 1994, J PLANT NUTR, V17, P1289, DOI 10.1080/01904169409364807; Jeong K, 2017, PLANT BIOTECHNOL J, V15, P15, DOI 10.1111/pbi.12586; Julia C, 2016, ANN BOT-LONDON, V118, P1151, DOI 10.1093/aob/mcw164; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Pariasca-Tanaka J, 2015, PLANT SOIL, V392, P253, DOI 10.1007/s11104-015-2460-2; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Raboy V, 2014, J HERED, V105, P656, DOI 10.1093/jhered/esu044; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Rose TJ, 2010, FIELD CROP RES, V119, P154, DOI 10.1016/j.fcr.2010.07.004; Sattari SZ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054003; Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1; Spindel JE, 2016, NEW PHYTOL, V212, P814, DOI 10.1111/nph.14174; Van Kauwenbergh SJ, 2010, WORLD PHOSPHATE ROCK, V75, P58; Vandamme E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01435; Vandamme E, 2016, NUTR CYCL AGROECOSYS, V104, P413, DOI 10.1007/s10705-015-9716-3; Vandamme E, 2016, FIELD CROP RES, V186, P10, DOI 10.1016/j.fcr.2015.11.003; Wang FM, 2016, J EXP BOT, V67, P1221, DOI 10.1093/jxb/erv517; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Yamaji N, 2017, NATURE, V541, P92, DOI 10.1038/nature20610; Ye YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101776; Zhao HJ, 2016, NEW PHYTOL, V211, P926, DOI 10.1111/nph.13969; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	32	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179484	10.1371/journal.pone.0179484	http://dx.doi.org/10.1371/journal.pone.0179484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651022	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300009
J	Mellem, D; Sattler, M; Pagel-Wolff, S; Jaspers, S; Wenck, H; Rubhausen, MA; Fischer, F				Mellem, Daniel; Sattler, Martin; Pagel-Wolff, Sonja; Jaspers, Soeren; Wenck, Horst; Ruebhausen, Michael Alexander; Fischer, Frank			Fragmentation of the mitochondria! network in skin in vivo	PLOS ONE			English	Article							NADH FLUORESCENCE; OXIDATIVE STRESS; DIFFERENTIATION; AUTOPHAGY; CELLS; KERATINOCYTES; HEPATOCYTES; HYPERFUSION; MORPHOLOGY; FISSION	Mitochondria form dynamic networks which adapt to the environmental requirements of the cell. We investigated the aging process of these networks in human skin cells in vivo by multiphoton microscopy. A study on the age-dependency of the mitochondrial network in young and old volunteers revealed that keratinocytes in old skin establish a significantly more fragmented network with smaller and more compact mitochondrial clusters than keratinocytes in young skin. Furthermore, we investigated the mitochondrial network during differentiation processes of keratinocytes within the epidermis of volunteers. We observe a fragmentation similar to the age-dependent study in almost all parameters. These parallels raise questions about the dynamics of biophysical network structures during aging processes.	[Mellem, Daniel; Ruebhausen, Michael Alexander] Univ Hamburg, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Mellem, Daniel; Sattler, Martin; Pagel-Wolff, Sonja; Jaspers, Soeren; Wenck, Horst; Fischer, Frank] Beiersdorf AG, Appl Biophys, Hamburg, Germany	University of Hamburg; Beiersdorf AG	Fischer, F (corresponding author), Beiersdorf AG, Appl Biophys, Hamburg, Germany.	frank.fischer@beiersdorf.com	Fischer, Frank/AFO-7637-2022	Fischer, Frank/0000-0002-7932-7174	Foundation of German Business; DFG [773/6-2]; Germany Economy Foundation	Foundation of German Business; DFG(German Research Foundation (DFG)); Germany Economy Foundation	This work was supported by Foundation of German Business: DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beiersdorf AG and DFG by Ru 773/6-2 provided support in the form of salaries for authors DM, MS, SPJ, SJ, HW and FF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. DM acknowledges financial support by the Germany Economy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert-Blaise C, 2003, CELL DEATH DIFFER, V10, P850, DOI 10.1038/sj.cdd.4401245; AVIDOR Y, 1962, J BIOL CHEM, V237, P2377; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Balu M, 2013, BIOPHYS J, V104, P258, DOI 10.1016/j.bpj.2012.11.3809; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Fitzpatrick TB, 1975, J MED ESTHETIQUE, V2, P2; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hamanaka R.B., 2013, CELL LOGIST, V3, DOI [10.4161/cl.25456, DOI 10.4161/CL.25456]; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Mellem D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146973; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prahl S, 2008, BIOFACTORS, V32, P245, DOI 10.1002/biof.5520320129; Puschmann S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036005; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van der Bliek AM, 2013, COLD SPRING HARB PER, V5; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	34	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0174469	10.1371/journal.pone.0174469	http://dx.doi.org/10.1371/journal.pone.0174469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644888	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100001
J	Grapow, M; Haug, M; Tschung, C; Winkler, B; Banerjee, P; Heinisch, PP; Fassl, J; Reuthebuch, O; Eckstein, F				Grapow, Martin; Haug, Martin; Tschung, Chistopher; Winkler, Bernhard; Banerjee, Prerana; Heinisch, Paul Philipp; Fassl, Jens; Reuthebuch, Oliver; Eckstein, Friedrich			Therapy options in deep sternal wound infection: Sternal plating versus muscle flap	PLOS ONE			English	Article							RISK-FACTOR-ANALYSIS; OPEN-HEART-SURGERY; CARDIAC-SURGERY; MEDIASTINITIS; MANAGEMENT; FIXATION; CLOSURE; EXPERIENCE; RECONSTRUCTION; PREVALENCE	Background Management of deep sternal wound infection (DSWI) in cardiac surgical patients still remains challenging. A variety of treatment strategies has been described. Aim of this cohort study was to analyse two different treatment strategies for DSWI: titanium sternal plating system (TSFS) and muscle flap coverage (MFC). Methods Between January 2007 and December 2011, from 3122 patients undergoing cardiac surgery 42 were identified with DSWI and treated with one of the above mentioned strategies. In-hospital data were collected, follow-up performed by telephone and assessment of Quality of Life (QoL) using the SF-12 Health Survey Questionnaire. Results 20 patients with deep sternal wound infection were stabilized with TSFS and 22 patients treated with MFC. Preoperative demographics and risk factors did not reveal any significant differences. Patients treated with TSFS had a significantly shorter operation time (p<0.05) and shorter hospitalization (p<0.05). A tendency towards lower mortality rate (p = n.s.) and less re-interventions were also noted (plating 0.6 vs. flap 1.17 per patient, n.s.). Quality of Life in the TSFS group for the physical-summary-score was significantly elevated compared to the MFC group (p<0.05). Relating to chest stability and cosmetic result the treatment with TSFS showed superior results, but the usage of MFC gave the patients more freedom in breathing and less chest pain. Conclusion Our results demonstrate that the use of TSFS is a feasible and safe alternative in DSWI. However, MFC remains an absolutely essential option for complicated DSWI since the amount of perfused tissue can be the key for infection control.	[Grapow, Martin; Tschung, Chistopher; Winkler, Bernhard; Banerjee, Prerana; Reuthebuch, Oliver; Eckstein, Friedrich] Univ Hosp, Dept Cardiac Surg, Basel, Switzerland; [Haug, Martin] Univ Hosp, Dept Plast Reconstruct Aesthet & Hand Surg, Basel, Switzerland; [Winkler, Bernhard; Heinisch, Paul Philipp] Univ Hosp, Dept Cardiovasc Surg, Inselspital, Bern, Switzerland; [Fassl, Jens] Univ Hosp, Dept Anaesthesiol, Basel, Switzerland	University of Bern; University Hospital of Bern	Winkler, B (corresponding author), Univ Hosp, Dept Cardiac Surg, Basel, Switzerland.; Winkler, B (corresponding author), Univ Hosp, Dept Cardiovasc Surg, Inselspital, Bern, Switzerland.	publications.medic@gmail.com	Fassl, Jens/P-7901-2018; Reuthebuch, Oliver/AAC-3164-2022; ECKSTEIN, FRIEDRICH/AAB-5232-2022	Reuthebuch, Oliver/0000-0003-1386-0686; , Paul/0000-0003-2606-0557				Ariyaratnam P, 2010, INTERACT CARDIOV TH, V11, P543, DOI 10.1510/icvts.2010.237883; Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023; Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; Bitkover CY, 1998, ANN THORAC SURG, V65, P36, DOI 10.1016/S0003-4975(97)01003-5; Braxton John H, 2004, Semin Thorac Cardiovasc Surg, V16, P70; Centofanti P, 2007, J CARDIOVASC SURG, V48, P641; Cicilioni OJ, 2005, PLAST RECONSTR SURG, V115, P1297, DOI 10.1097/01.PRS.0000156918.15595.85; Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005; Dalton ML, 1992, JULIANS REINTRODUCTI, V53; Ennker IC, 2009, J PLAST RECONSTR AES, V62, P1479, DOI 10.1016/j.bjps.2008.05.017; Fawzy H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-63; Floros P, 2011, HEART LUNG CIRC, V20, P712, DOI 10.1016/j.hlc.2011.08.001; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gaudreau G, 2010, EUR J CARDIO-THORAC, V37, P888, DOI 10.1016/j.ejcts.2009.07.043; Graeber G M, 1999, Semin Thorac Cardiovasc Surg, V11, P251; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Hallock GG, 2007, ANN PLAS SURG, V59, P655, DOI 10.1097/SAP.0b013e318049e6d5; Jones G, 1997, ANN SURG, V225, P766, DOI 10.1097/00000658-199706000-00014; Jonkers D, 2003, EUR J CARDIO-THORAC, V23, P97, DOI 10.1016/S1010-7940(02)00662-0; Juhl AA, 2012, SCAND CARDIOVASC J, V46, P254, DOI 10.3109/14017431.2012.674549; JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012; Karra R, 2006, J THORAC CARDIOV SUR, V132, P537, DOI 10.1016/j.jtcvs.2006.04.037; Lee JC, 2010, PLAST RECONSTR SURG, V125, P1720, DOI 10.1097/PRS.0b013e3181d51292; Li EN, 2004, ANN PLAS SURG, V53, P334, DOI 10.1097/01.sap.0000120684.64559.49; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mauermann WJ, 2008, BEST PRACT RES-CLIN, V22, P423, DOI 10.1016/j.bpa.2008.04.003; MILANO CA, 1995, CIRCULATION, V92, P2245, DOI 10.1161/01.CIR.92.8.2245; Plass A, 2011, THORAC CARDIOV SURG, V59, P30, DOI 10.1055/s-0030-1250390; Raja Shahzad G, 2007, Interact Cardiovasc Thorac Surg, V6, P523, DOI 10.1510/icvts.2007.157370; ROBICSEK F, 1977, J THORAC CARDIOV SUR, V73, P267; Schols RM, 2011, EUR J PLAST SURG, V34, P487, DOI 10.1007/s00238-011-0573-2; Singh Kimberly, 2011, Semin Plast Surg, V25, P25, DOI 10.1055/s-0031-1275168; Upton Arlo, 2005, N Z Med J, V118, pU1316; van Wingerden JJ, 2011, INTERACT CARDIOV TH, V13, P179, DOI 10.1510/icvts.2011.270652; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180024	10.1371/journal.pone.0180024	http://dx.doi.org/10.1371/journal.pone.0180024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665964	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608700055
J	Hao, M; Zhang, PP; Li, BS; Liu, X; Zhao, Y; Tan, HL; Sun, CY; Wang, XC; Wang, XR; Qiu, HY; Wang, DC; Diao, BW; Jing, HQ; Yang, RF; Kan, BA; Zhou, L				Hao, Min; Zhang, Pingping; Li, Baisheng; Liu, Xiao; Zhao, Yong; Tan, Hailing; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Qiu, Haiyan; Wang, Duochun; Diao, Baowei; Jing, Huaiqi; Yang, Ruifu; Kan, Biao; Zhou, Lei			Development and evaluation of an up-converting phosphor technology-based lateral flow assay for the rapid, simultaneous detection of Vibrio cholerae serogroups 01 and 0139	PLOS ONE			English	Article							ENVIRONMENTAL WATER SAMPLES; GOLD NANOPARTICLE; YERSINIA-PESTIS; O139 BENGAL; BANGLADESH; EPIDEMIC; PCR; COAGGLUTINATION; BIOSENSOR; SEAFOOD	Vibrio cholerae serogroups 01 and 0139 are etiological agents of cholera, a serious and acute diarrheal disease, and rapid detection of V. cholerae is a key method for preventing and controlling cholera epidemics. Here, a point of care testing (POCT) method called Vch-UPT-LF, which is an up-converting phosphor technology-based lateral flow (UPT-LF) assay with a dual-target detection mode, was developed to detect V. cholerae 01 and 0139 simultaneously from one sample loading. Although applying an independent reaction pair made both detection results for the two Vch-UPT-LF detection channels more stable, the sensitivity slightly declined from 10(4) to 10(5) colony-forming units (CFU) mL(-1) compared with that of the single-target assay, while the quantification ranges covering four orders of magnitude were maintained. The strip showed excellent specificity for seven Vibrio species that are highly related genetically, and nine food-borne species whose transmission routes are similar to those of V. cholerae. The legitimate arrangement of the two adjacent test lines lessened the mutual impact of the quantitation results between the two targets, and the quantification values did not differ by more than one order of magnitude when the samples contained high concentrations of both V. cholerae 01 and 0139. Under pre-incubation conditions, 1x10(1) CFU mL(-1) of V. cholerae 01 or 0139 could be detected in fewer than 7 h, while the Vch-UPT-LF assay exhibited sensitivity as high as a real-time fluorescent polymerase chain reaction with fewer false-positive results. Therefore, successful development of Vch-UPT-LF as a dual-target assay for quantitative detection makes this assay a good candidate POCT method for the detection and surveillance of epidemic cholera.	[Hao, Min; Qiu, Haiyan; Wang, Duochun; Diao, Baowei; Jing, Huaiqi; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Hao, Min] Beijing Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Pingping; Liu, Xiao; Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China; [Zhang, Pingping; Liu, Xiao; Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing, Peoples R China; [Li, Baisheng; Tan, Hailing] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Liu, Xiao] Chongqing Entry Exit Inspect & Quarantine Bur, Chongqing, Peoples R China; [Sun, Chongyun] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wang, Xiaochen] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Xinrui] Inst Plague Prevent & Control Hebei Prov, Zhangjiakou, Hebei, Peoples R China; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhou, Lei] Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China; [Zhou, Lei] Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shanxi, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese People's Liberation Army General Hospital; Jilin Agricultural University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Northwest University Xi'an; Northwest University Xi'an	Kan, BA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Yang, RF; Zhou, L (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China.; Yang, RF; Zhou, L (corresponding author), Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing, Peoples R China.; Kan, BA (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Zhou, L (corresponding author), Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China.; Zhou, L (corresponding author), Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shanxi, Peoples R China.	ruifuyang@gmail.com; Kanbiao@icdc.cn; ammszhoulei@aliyun.com			National High Technology Research and Development Program of China [2013AA032205]; Beijing Nova Program [Z151100000315086]; National Key Research and Development Program [2016YFC1202502]; Science and Technology Program of Guangzhou, China [2014Y2-00090]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Key Research and Development Program; Science and Technology Program of Guangzhou, China	This study was supported by the National High Technology Research and Development Program of China (grant no. 2013AA032205), the Beijing Nova Program (grant no. Z151100000315086), National Key Research and Development Program (grant no. 2016YFC1202502), and Science and Technology Program of Guangzhou, China (2014Y2-00090). The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	AGARWAL V, 1995, INDIAN J MED RES, V101, P55; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; ARYA SC, 1995, J CLIN MICROBIOL, V33, P509, DOI 10.1128/JCM.33.2.509-510.1995; Bhattacharya T, 2006, ENVIRON MICROBIOL, V8, P526, DOI 10.1111/j.1462-2920.2005.00932.x; Chomvarin C, 2007, J GEN APPL MICROBIOL, V53, P229, DOI 10.2323/jgam.53.229; COLWELL RR, 1992, FEMS MICROBIOL LETT, V97, P215, DOI 10.1016/0378-1097(92)90339-P; Durrheim D, 2004, LANCET, V363, P897, DOI 10.1016/S0140-6736(04)15748-6; Faruque SM, 2003, EMERG INFECT DIS, V9, P1116; FINELLI L, 1992, J INFECT DIS, V166, P1433, DOI 10.1093/infdis/166.6.1433; Fykse EM, 2012, MAR POLLUT BULL, V64, P200, DOI 10.1016/j.marpolbul.2011.12.007; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Hill VR, 2011, EMERG INFECT DIS, V17, P2147, DOI 10.3201/eid1711.110748; Hong WY, 2010, J MICROBIOL METH, V83, P133, DOI 10.1016/j.mimet.2010.08.005; Hua F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17178; HUQ A, 1995, LANCET, V345, P1249, DOI 10.1016/S0140-6736(95)92038-2; Huq A, 2012, CURR PROTOC MICROBIO; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kumar P, 2010, VISUAL INFORMATION COMMUNICATION, P41, DOI 10.1007/978-1-4419-0312-9_3; Maggi P, 1997, EUR J EPIDEMIOL, V13, P95, DOI 10.1023/A:1007329700125; Pengsuk C, 2013, BIOSENS BIOELECTRON, V42, P229, DOI 10.1016/j.bios.2012.10.011; Rawlings TK, 2007, APPL ENVIRON MICROB, V73, P7926, DOI 10.1128/AEM.01238-07; REHNSTAM AS, 1989, APPL ENVIRON MICROB, V55, P1907, DOI 10.1128/AEM.55.8.1907-1910.1989; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SRIVASTAVA R, 1985, GENE, V40, P267, DOI 10.1016/0378-1119(85)90049-6; Theron J, 2000, J APPL MICROBIOL, V89, P539, DOI 10.1046/j.1365-2672.2000.01140.x; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Wang DC, 2010, APPL ENVIRON MICROB, V76, P5520, DOI 10.1128/AEM.02559-09; Wang Xiao-Mei, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P768; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Yang L, 2008, BIOTECHNOL ADV, V26, P135, DOI 10.1016/j.biotechadv.2007.10.003; Yu CY, 2011, J MICROBIOL METH, V86, P277, DOI 10.1016/j.mimet.2011.04.020; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105305; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21342	33	16	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179937	10.1371/journal.pone.0179937	http://dx.doi.org/10.1371/journal.pone.0179937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662147	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300074
J	Hsu, TH; Gwo, JC				Hsu, Te-Hua; Gwo, Jin-Chywan			Genetic diversity and stock identification of small abalone (Haliotis diversicolor) in Taiwan and Japan	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; FRAGMENT-LENGTH POLYMORPHISM; POPULATION-STRUCTURE; SPECIES DELIMITATION; MITOCHONDRIAL-DNA; TIDELAND SNAILS; SAGAMI BAY; SUPERTEXTA; DISCUS; SURVIVAL	Small abalone (Haliotis diversicolor) is a commercially valuable species for both fisheries and aquaculture. The production of annual farmed small abalone in Taiwan, once the highest in the world, has dramatically decreased in the past 15 years, and currently, the industry is close to collapse. Understanding the genetic diversity of small abalone and developing stock identification methods will be useful for genetic breeding, restoring collapsed stocks, managing stocks, and preventing illegal trade. We investigated 307 cultured and wild individuals from Taiwan, Japan, and Bali Island (Indonesia) by using the mitochondrial cytochrome c oxidase subunit I (COI) gene. Network analysis of mtDNA COI gene sequences revealed that the individuals collected from Taiwan, Japan, and Indonesia could be identified, and showed significant genetic divergence. In addition, the Indonesian population (Haliotis diversicolor squamata) was significantly different from the other populations and might need to be considered a separate species. We discovered a single nucleotide polymorphism marker in the mtDNA COI gene that can be used to distinguish the Taiwan population from the Japan population. We also developed a polymerase chain reactionrestriction fragment length polymorphism method for rapid detection. Furthermore, we could identify the cultured stocks, wild population, and hybrid stocks by using 6 microsatellites and amplified fragment length polymorphism. This study contributes useful tools for stock identification and the production of high-disease resistant small abalone strains (Japan x Taiwan or Taiwan x Japan). Efforts should be made to avoid unintentional random genetic mixing of the Taiwan population with the Japan population and subsequent breakdown of population differentiation, which impair local adaptation of the Taiwan wild population. Molecular markers revealed a split between the Taiwan and Japan populations, and the existence of a possible barrier to the free dispersal of small abalone is discussed.	[Hsu, Te-Hua] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Gwo, Jin-Chywan] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Gwo, JC (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.	gwojc@hotmail.com	HSU, Te-Hua/A-8294-2011	HSU, Te-Hua/0000-0001-7819-4122	Ministry of Science and Technology, Taiwan (MST) [98-2311-B-019-003-MY3]	Ministry of Science and Technology, Taiwan (MST)	This work was funded by the Ministry of Science and Technology, Taiwan (MST) under project number 98-2311-B-019-003-MY3 to J.-C. Gwo.	An HS, 2013, GENET MOL RES, V12, P6309, DOI 10.4238/2013.December.4.18; An HS, 2005, MAR BIOTECHNOL, V7, P373, DOI 10.1007/s10126-004-4405-2; An HS, 2013, BIOCHEM SYST ECOL, V48, P76, DOI 10.1016/j.bse.2012.11.010; An HS, 2012, INT J MOL SCI, V13, P10750, DOI 10.3390/ijms130910750; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chang PH, 2005, DIS AQUAT ORGAN, V65, P23, DOI 10.3354/dao065023; CHEN HC, 1984, AQUACULTURE, V39, P11, DOI 10.1016/0044-8486(84)90256-4; Cook PA., 2014, MOD EC, V5, P1181, DOI DOI 10.4236/ME.2014.513110; Degnan SA, 2006, MOL PHYLOGENET EVOL, V41, P249, DOI 10.1016/j.ympev.2006.06.023; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estes JA, 2005, PALEOBIOLOGY, V31, P591, DOI 10.1666/04059.1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans B, 2004, AQUACULTURE, V233, P109, DOI 10.1016/j.aquaculture.2003.09.037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; *FAO, 2000, FISHSTAT PLUS UN SOF; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; Geiger DL, 2000, B MALACOLOGICO, V35, P57; Gonzalez EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125743; Gwo JC, 2002, THERIOGENOLOGY, V58, P1563, DOI 10.1016/S0093-691X(02)01055-5; Hamasaki K, 2008, FISH FISH, V9, P243, DOI 10.1111/j.1467-2979.2008.00280.x; Hara M, 2007, MAR BIOTECHNOL, V9, P74, DOI 10.1007/s10126-006-6060-2; Hsu TH, 2010, AQUAC RES, V41, pe316, DOI 10.1111/j.1365-2109.2010.02533.x; Hsu TeHua, 2015, Endangered Species Research, V27, P277; Hsu TH, 2011, J NAT TAIWAN MUSEUM, V65, P29; Huang CY, 2001, Z NATURFORSCH C, V56, P898; Huang WB, 2010, FISHERIES SCI, V76, P131, DOI 10.1007/s12562-009-0190-1; Jiang L, 1995, MOL MAR BIOL BIOTECH, V4, P353; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Kojima S, 2006, MAR BIOL, V149, P525, DOI 10.1007/s00227-005-0183-2; Kojima S, 2003, ZOOL SCI, V20, P1423, DOI 10.2108/zsj.20.1423; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; de la Cruz FL, 2011, REV AQUACULT, V3, P74, DOI 10.1111/j.1753-5131.2011.01045.x; Launey S, 2001, GENETICS, V159, P255; Lemay MA, 2009, AQUACULTURE, V295, P22, DOI 10.1016/j.aquaculture.2009.06.029; Li Q, 2004, AQUACULTURE, V235, P207, DOI 10.1016/j.aquaculture.2003.12.018; Liang WD, 2003, DEEP-SEA RES PT II, V50, P1085, DOI 10.1016/S0967-0645(03)00011-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindberg DR, 1992, ABALONE OF THE WORLD, P318; Liu JY, 2011, AFR J BIOTECHNOL, V10, P19267, DOI 10.5897/AJB10.2344; Luo XA, 2010, AQUAC RES, V41, P1827, DOI 10.1111/j.1365-2109.2010.02568.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Nie ZQ, 2004, J SHELLFISH RES, V23, P941; Onitsuka T, 2008, J SHELLFISH RES, V27, P843, DOI 10.2983/0730-8000(2008)27[843:SGAROA]2.0.CO;2; Onitsuka T, 2007, MAR ECOL PROG SER, V351, P129, DOI 10.3354/meps07150; Onitsuka T, 2007, FISHERIES SCI, V73, P995, DOI 10.1111/j.1444-2906.2007.01428.x; Onitsuka T, 2007, FISHERIES SCI, V73, P295, DOI 10.1111/j.1444-2906.2007.01335.x; Park CJ, 2012, BIOCHEM SYST ECOL, V44, P86, DOI 10.1016/j.bse.2012.04.006; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A., 2007, TRACER V1 4; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Ren P, 2008, MOL ECOL RESOUR, V8, P1390, DOI 10.1111/j.1755-0998.2008.02329.x; Ren P, 2016, AQUACULTURE, V454, P163, DOI 10.1016/j.aquaculture.2015.12.026; Roodt-Wilding R, 2007, AQUAC RES, V38, P1229, DOI 10.1111/j.1365-2109.2007.01801.x; Somarakis S, 2013, AQUACULT ENV INTERAC, V3, P135, DOI 10.3354/aei00057; Takeshima H, 2016, MOL ECOL, V25, P3048, DOI 10.1111/mec.13650; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ting YY, 2003, SEEDLING PRODUCTION; Tomiyama T, 1980, FISHERIES JAPAN ABAL; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang ZY, 2004, J SHELLFISH RES, V23, P1143; Will M, 2015, GENETICA, V143, P487, DOI 10.1007/s10709-015-9847-0; Will M, 2011, MAR BIOL, V158, P1417, DOI 10.1007/s00227-011-1659-x; Yang H.-S., 1986, Bulletin of Taiwan Fisheries Research Institute, P195; Yang HS, 1989, LAND BASED CULTURE S; You Wei-wei, 2005, Journal of Xiamen University Natural Science, V44, P701; You WW, 2009, AQUAC RES, V40, P1474, DOI 10.1111/j.1365-2109.2009.02247.x; Zhan X, 2009, CONSERV GENET, V10, P1185, DOI 10.1007/s10592-008-9740-9; Zhang GF, 2004, J SHELLFISH RES, V23, P947; [周晶 ZHOU Jing], 2006, [海洋湖沼通报, Transactions of Oceanology and Limnology], V0, P54	71	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179818	10.1371/journal.pone.0179818	http://dx.doi.org/10.1371/journal.pone.0179818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662122	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300051
J	Manceur, AP; Zou, W; Marcil, A; Paquet, E; Gadoury, C; Jaentschke, B; Li, XG; Petiot, E; Durocher, Y; Baardsnes, J; Rosa-Calatrava, M; Ansorge, S; Kamen, AA				Manceur, Aziza P.; Zou, Wei; Marcil, Anne; Paquet, Eric; Gadoury, Christine; Jaentschke, Bozena; Li, Xuguang; Petiot, Emma; Durocher, Yves; Baardsnes, Jason; Rosa-Calatrava, Manuel; Ansorge, Sven; Kamen, Amine A.			Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza	PLOS ONE			English	Article							A VIRAL HEMAGGLUTININS; VIRUS-LIKE PARTICLES; NEUTRALIZING EPITOPE; UNIVERSAL ANTIBODIES; MDCK CELLS; VACCINES; CULTURE; CANDIDATE; SUBTYPES; GROWTH	Vaccination is the most effective course of action to prevent influenza. About 150 million doses of influenza vaccines were distributed for the 2015-2016 season in the USA alone according to the Centers for Disease Control and Prevention. Vaccine dosage is calculated based on the concentration of hemagglutinin (HA), the main surface glycoprotein expressed by influenza which varies from strain to strain. Therefore yearly-updated strain-specific antibodies and calibrating antigens are required. Preparing these quantification reagents can take up to three months and significantly slows down the release of new vaccine lots. Therefore, to circumvent the need for strain-specific sera, two anti-HA monoclonal antibodies (mAbs) against a highly conserved sequence have been produced by immunizing mice with a novel peptide-conjugate. Immunoblots demonstrate that 40 strains of influenza encompassing HA subtypes H1 to H13, as well as B strains from the Yamagata and Victoria lineage were detected when the two mAbs are combined to from a pan-HA mAb cocktail. Quantification using this pan-HA mAbs cocktail was achieved in a dot blot assay and results correlated with concentrations measured in a hemagglutination assay with a coefficient of correlation of 0.80. A competitive ELISA was also optimised with purified viral-like particles. Regardless of the quantification method used, pan-HA antibodies can be employed to accelerate process development when strain-specific antibodies are not available, and represent a valuable tool in case of pandemics. These antibodies were also expressed in CHO cells to facilitate large-scale production using bioreactor technologies which might be required to meet industrial needs for quantification reagents. Finally, a simulation model was created to predict the binding affinity of the two anti-HA antibodies to the amino acids composing the highly conserved epitope; different probabilities of interaction between a given amino acid and the antibodies might explain the affinity of each antibody against different influenza strains.	[Manceur, Aziza P.; Zou, Wei; Marcil, Anne; Paquet, Eric; Gadoury, Christine; Durocher, Yves; Baardsnes, Jason; Ansorge, Sven; Kamen, Amine A.] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada; [Jaentschke, Bozena; Li, Xuguang] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada; [Petiot, Emma; Rosa-Calatrava, Manuel] Univ Claude Bernard Lyon 1, Lab Virol & Pathol Humaine, Int Ctr Infect Dis Res, VirPath Team,ENS Lyon,CNRS,UMR5308,Inserm,U1111, Villeurbanne, France; [Kamen, Amine A.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	National Research Council Canada; Health Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University	Manceur, AP (corresponding author), Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada.	Aziza.Manceur@cnrc-nrc.gc.ca	Durocher, Yves/K-8709-2019	Marcil, Anne/0000-0002-4111-1781; Rosa-calatrava, Manuel/0000-0002-7559-9527; PETIOT, Emma/0000-0002-1989-4695	National Research Council Canada	National Research Council Canada	Funded by the National Research Council Canada.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Chon JH, 2011, NEW BIOTECHNOL, V28, P458, DOI 10.1016/j.nbt.2011.03.015; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Gaillet B, 2010, BIOTECHNOL BIOENG, V106, P203, DOI 10.1002/bit.22698; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Gorr TA, 2015, PROTEOM CLIN APPL, V9, P396, DOI 10.1002/prca.201400118; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V96, P932, DOI 10.1002/bit.21109; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Le Mauff F, 2014, PLANT BIOTECHNOL J, DOI 10.1111/pbi.12301; Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Li GL, 2012, P NATL ACAD SCI USA, V109, P20774, DOI 10.1073/pnas.1219604110; Maiti R, 2005, NUCLEIC ACIDS RES, V33, pW358, DOI 10.1093/nar/gki485; Manceur AP, 2015, VACCINE, V33, P5913, DOI 10.1016/j.vaccine.2015.07.104; Milian E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504831; Montomoli E, 2012, EXPERT REV VACCINES, V11, P587, DOI [10.1586/ERV.12.24, 10.1586/erv.12.24]; Moules V, 2011, VIROLOGY, V414, P51, DOI 10.1016/j.virol.2011.03.011; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Reperant Leslie A, 2014, F1000Prime Rep, V6, P47, DOI 10.12703/P6-47; Rose PW, NUCL ACIDS RES, V43, pD345; Schuind A, 2015, J INFECT DIS; Shriver Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00315; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun Y, MBIO, V7; Thompson CM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-141; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Venereo-Sanchez A, 2016, VACCINE, V34, P3371, DOI 10.1016/j.vaccine.2016.04.089; Voeten JTM, 1999, VACCINE, V17, P1942, DOI 10.1016/S0264-410X(98)00464-2; Wen YX, 2016, VACCINE, V34, P3388, DOI 10.1016/j.vaccine.2016.04.091; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Yagami H, 2013, PHARM PAT ANAL, V2, P249, DOI [10.4155/PPA.13.2, 10.4155/ppa.13.2]; Ye J, BIOTECHNOL PROG, V26, P1431; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yusibov V., 2014, EXPERT REV VACCINES, V9, P1; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	44	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180317	10.1371/journal.pone.0180314	http://dx.doi.org/10.1371/journal.pone.0180314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662134	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300141
J	Mills, AJ; Milewski, AV; Snyman, D; Jordaan, JJ				Mills, Anthony J.; Milewski, Antoni V.; Snyman, Dirk; Jordaan, Jorrie J.			Effects of anabolic and catabolic nutrients on woody plant encroachment after long-term experimental fertilization in a South African savanna	PLOS ONE			English	Article							SHRUB ENCROACHMENT; PHOTOSYSTEM-II; SOIL PHOSPHATE; VEGETATION; BORON; GRASSLAND; NITROGEN; TREES; CARBON; WATER	The causes of the worldwide problem of encroachment of woody plants into grassy vegetation are elusive. The effects of soil nutrients on competition between herbaceous and woody plants in various landscapes are particularly poorly understood. A long-term experiment of 60 plots in a South African savanna, comprising annual applications of ammonium sulphate (146 +/- 1166 kg ha(-1) yr(-1)) and superphosphate (233 +/- 466 kg ha(-1) yr(-1)) over three decades, and subsequent passive protection over another three decades, during which indigenous trees encroached on different plots to extremely variable degrees, provided an opportunity to investigate relationships between soil properties and woody encroachment. All topsoils were analysed for pH, acidity, EC, water-dispersible clay, Na, Mg, K, Ca, P, S, C, N, NH4, NO3, B, Mn, Cu and Zn. Applications of ammonium sulphate (AS), but not superphosphate (SP), greatly constrained tree abundance relative to control plots. Differences between control plots and plots that had received maximal AS application were particularly marked (16.3 +/- 5.7 versus 1.2 +/- 0.8 trees per plot). Soil properties most affected by AS applications included pH (H2O) (control to maximal AS application: 6.4 +/- 0.1 to 5.1 +/- 0.2), pH (KCl) (5.5 +/- 0.2 to 4.0 +/- 0.1), acidity (0.7 +/- 0.1 to 2.6 +/- 0.3 cmol kg(-1)), acid saturation (8 +/- 2 to 40 +/- 5%), Mg (386 +/- 25 to 143 +/- 15 mg kg(-1)), Ca (1022 +/- 180 to 322 +/- 14 mg kg(-1)), Mn (314 +/- 11 to 118 +/- 9 mg kg(-1)), Cu (3.6 +/- 0.3 to 2.3 +/- 0.2 mg kg(-1)) and Zn (6.6 +/- 0.4 to 3.7 +/- 0.4 mg kg(-1)). Magnesium, B, Mn and Cu were identified using principal component analysis, boundary line analysis and Kruskal-Wallis rank sum tests as the nutrients most likely to be affecting tree abundance. The ratio Mn/Cu was most related to tree abundance across the experiment, supporting the hypothesis that competition between herbaceous and woody plants depends on the availability of anabolic relative to catabolic nutrients. These findings, based on more than six decades of experimentation, may have global significance for the theoretical understanding of changes in vegetation structure and thus the practical control of invasive woody plants.	[Mills, Anthony J.] Stellenbosch Univ, Dept Soil Sci, Stellenbosch, South Africa; [Milewski, Antoni V.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Rondebosch, South Africa; [Snyman, Dirk] C4 EcoSolut, Tokai, Ibaraki, South Africa; [Jordaan, Jorrie J.] Univ Limpopo, Sovenga, South Africa	Stellenbosch University; National Research Foundation - South Africa; University of Cape Town; University of Limpopo	Mills, AJ (corresponding author), Stellenbosch Univ, Dept Soil Sci, Stellenbosch, South Africa.	mills@sun.ac.za	Mills, Anthony J/W-9228-2019; Mills, Anthony/AAY-6268-2021	Mills, Anthony J/0000-0001-5676-2440; 	South African Government's Department of Environmental Affairs; Natural Resources Management Programme; National Research Foundation [FA2005040700027]	South African Government's Department of Environmental Affairs; Natural Resources Management Programme; National Research Foundation	We gratefully acknowledge the South African Government's Department of Environmental Affairs, Natural Resources Management Programme, and the National Research Foundation (grant number FA2005040700027) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; Barker A. V., 2015, Handbook of plant nutrition; BEADLE NCW, 1954, ECOLOGY, V35, P370, DOI 10.2307/1930100; BEADLE NCW, 1966, ECOLOGY, V47, P992, DOI 10.2307/1935647; BEATON J. D., 1968, Technical Bulletin. Sulphur Institute; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Ben-Gal A, 2003, PLANT SOIL, V256, P179, DOI 10.1023/A:1026229612263; BEYERS C P D L, 1971, Agrochemophysica, V3, P49; Bingham FT, 1982, METHODS SOIL ANAL; Blanco-Macías F., 2009, Rev. Chapingo Ser.Hortic, V15, P217; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2010, PLANT SOIL, V334, P47, DOI 10.1007/s11104-010-0440-0; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman D.M, 2000, AUSTR RAINFORESTS IS, DOI DOI 10.1017/CBO9780511583490; Bowman RA, 1998, SOIL SCI, V163, P241, DOI 10.1097/00010694-199803000-00009; Brady NC, 2013, ELEMENTS NATURE PROP; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Cole M. M., 1986, The savannas, biogeography and geobotany.; COWLING RM, 1980, VEGETATIO, V43, P191, DOI 10.1007/BF00158749; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Division of Chemical Services, 1956, ANAL METHODS; Dodd JR, 2005, SOIL SCI SOC AM J, V69, P1118, DOI 10.2136/sssaj2004.0279; Donaldson C. H., 1984, Journal of the Grassland Society of Southern Africa, V1, P27; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Du Plessis SF, 1964, S AFR J AGR SCI, V8, P1113; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Eaton T.E., 2015, HDB PLANT NUTR, P427; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fageria NK, 2010, COMMUN SOIL SCI PLAN, V41, P1565, DOI 10.1080/00103624.2010.485237; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Fey MV., 2010, SOILS S AFRICA; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Garrison VH, 2003, BIOSCIENCE, V53, P469, DOI 10.1641/0006-3568(2003)053[0469:AAADFD]2.0.CO;2; Gibbens RP, 2005, J ARID ENVIRON, V61, P651, DOI 10.1016/j.jaridenv.2004.10.001; GOODLAND R, 1973, J ECOL, V61, P219, DOI 10.2307/2258929; Goussias C, 2002, PHILOS T R SOC B, V357, P1369, DOI 10.1098/rstb.2002.1134; GRAHAM RD, 1980, Z PFLANZ BODENKUNDE, V143, P161, DOI 10.1002/jpln.19801430205; Grzebisz W., 2015, HDB PLANT NUTR, P199; Gupta U. C., 1979, Journal of Agronomy, V31, P273; HARIDASAN M, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P171; Havlin J, 2005, SOIL FERTILITY SOIL; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Jordaan JJ, 2010, AFR J RANGE FOR SCI, V27, P105, DOI 10.2989/10220119.2010.502650; KELLMAN M, 1979, J ECOL, V67, P565, DOI 10.2307/2259112; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kramer U, 2006, MOL BIOL METAL HOMEO, P216; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane N., 2010, LIFE ASCENDING 10 GR, VReprint; Lane N., 2010, WHY ARE CELLS POWERE; Lee D, 1996, COMMUN SOIL SCI PLAN, V27, P783, DOI 10.1080/00103629609369595; Lloyd J, 2008, TREE PHYSIOL, V28, P451, DOI 10.1093/treephys/28.3.451; LOUW A. J., 1966, S AFRICAN J AGR SCI, V9, P173; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Marschner H., 2012, MINERAL NUTR HIGHER, P226; MCLEAN EO, 1983, AGRON J, V75, P635, DOI 10.2134/agronj1983.00021962007500040014x; Milewski AV, 2015, S AFR J BOT; Mills AJ, 2004, GEODERMA, V121, P45, DOI 10.1016/j.geoderma.2003.10.004; Mills AJ, 2006, BIOSCIENCE, V56, P579, DOI 10.1641/0006-3568(2006)56[579:AFFETD]2.0.CO;2; Mills AJ, 2016, AUSTRAL ECOL, V41, P927, DOI 10.1111/aec.12385; Mills AJ, 2012, GEODERMA, V189, P124, DOI 10.1016/j.geoderma.2012.05.006; Milne AE, 2006, ANN APPL BIOL, V149, P223, DOI 10.1111/j.1744-7348.2006.00086.x; Mortvedt J. J., 2000, HDB SOIL SCI, pD71; Mucina L., 2006, VEGETATION S AFRICA; Murovhi R. N., 2006, Southern African Forestry Journal, P23; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Noble J.C., 1998, DELICATE NOXIOUS SCR; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Pilbeam DJ., 2015, HDB PLANT NUTR, P305, DOI DOI 10.1201/B18458-11; R Core Team, 2021, R LANGUAGE ENV STAT; Rerkasem B, 2004, FIELD CROP RES, V89, P173, DOI 10.1016/j.fcr.2004.01.022; SANBI (South African National Biodiversity Institute), 2016, VEG MAP S AFR LES SW; Scholes RJ, 2015, NPP GRASSLAND NPP GR; Scholes RJ, 1993, NYLSVLEY STUDY AFRIC; SETA AK, 1996, GEODERMA, V74, P255; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Sims JT, 2000, HDB SOIL SCI, pD; Soil Classification Working Group, 1991, MEM AGR NAT RESOUR S, V15, P1; Specht R.L., 1979, P1; SPECHT RL, 1983, ECOL STUD, V43, P41; Sprengel C., 1828, J TECHNISCHE OKONOMI, V2, P423; Sumner M.E., 2000, HDB SOIL SCI; The Non-Affiliated Soil Analysis Work Committee, 1990, HDB STAND SOIL TEST; TRIERWEILER JF, 1969, SOIL SCI SOC AM PRO, V33, P49, DOI 10.2136/sssaj1969.03615995003300010017x; Trotter M, 2014, CROP PASTURE SCI, V65, P817, DOI 10.1071/CP13449; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Oudtshoorn FV., 1999, GUIDE GRASSES SO AFR; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; von Liebig J., 1855, RELATIONS CHEM AGR A; Wakeling JL, 2010, PLANT SOIL, V336, P173, DOI 10.1007/s11104-010-0457-4; Walkley A, 1935, J AGR SCI, V25, P598, DOI 10.1017/S0021859600019687; Ward D, 2010, PLANT ECOL, V209, P147, DOI 10.1007/s11258-010-9731-z; WEBB LJ, 1969, J ECOL, V57, P817, DOI 10.2307/2258502; WESTOBY M, 1988, BIOSCIENCE, V38, P549, DOI 10.2307/1310763; WHITTAKER R H, 1975, P385; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; YEOMANS JC, 1991, COMMUN SOIL SCI PLAN, V22, P843, DOI 10.1080/00103629109368458; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	108	6	6	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179848	10.1371/journal.pone.0179848	http://dx.doi.org/10.1371/journal.pone.0179848			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662068	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300058
J	Read, SA; Alonso-Caneiro, D; Vincent, SJ				Read, Scott A.; Alonso-Caneiro, David; Vincent, Stephen J.			Longitudinal changes in macular retinal layer thickness in pediatric populations: Myopic vs non-myopic eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; HUMAN FOVEAL DEVELOPMENT; CHOROIDAL THICKNESS; CHILDREN; CHILDHOOD; RETINOBLASTOMA; TOPOGRAPHY; MORPHOLOGY; ETIOLOGY	Knowledge of the normal in vivo thickness of the retina, and its individual layers in pediatric populations is important for diagnosing and monitoring retinal disorders, and for understanding the eye's normal development and the impact of eye growth and refractive error such as myopia (short-sightedness) upon retinal morphology. In this prospective, observational longitudinal study, total retinal thickness (and individual retinal layer thickness) and the changes in retinal morphology occurring over an 18-month period were examined in 101 children with a range of refractive errors. In childhood, the presence of myopia was associated with subtle but statistically significant (p<0.05) changes in the topographical thickness distribution of macular retinal thickness (and retinal layer thickness), characterised by a thinning of the parafoveal retina (and parafoveal or perifoveal thinning in most outer and inner retinal layers). The parafoveal retina was on average 6 pm thinner in myopic children. However, over 18 months, longitudinal changes in retinal thickness and individual layers were of small magnitude (average changes of less than 2 pm over 18 months), indicative of a high degree of stability in retinal morphology in healthy adolescent eyes, despite significant eye growth over this same period of time. This provides the first detailed longitudinal assessment of macula retinal layer morphology in adolescence, and delivers new normative data on expected changes in retinal structure over time and associated with myopia during this period of childhood development.	[Read, Scott A.; Alonso-Caneiro, David; Vincent, Stephen J.] Queensland Univ Technol, Contact Lens & Visual Opt Lab, Sch Optometry & Vis Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Read, SA (corresponding author), Queensland Univ Technol, Contact Lens & Visual Opt Lab, Sch Optometry & Vis Sci, Brisbane, Qld, Australia.	sa.read@qut.edu.au	Vincent, Stephen J/H-6548-2019	Vincent, Stephen J/0000-0002-5998-1320; Read, Scott/0000-0002-1595-673X; Alonso-Caneiro, David/0000-0002-7754-6592	Australian Research Council Discovery Early Career Research Award [DE120101434]	Australian Research Council Discovery Early Career Research Award(Australian Research Council)	This work was funded by an Australian Research Council Discovery Early Career Research Award (DE120101434) to SAR. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrio-Barrio J, 2013, ACTA OPHTHALMOL, V91, pe56, DOI 10.1111/j.1755-3768.2012.02562.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cao C, 2014, J PEDIAT OPHTH STRAB, V51, P230, DOI 10.3928/01913913-20140603-01; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Chen S, 2014, INVEST OPHTH VIS SCI, V55, P7410, DOI 10.1167/iovs.14-13894; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dubis AM, 2012, ARCH OPHTHALMOL-CHIC, V130, P1291, DOI 10.1001/archophthalmol.2012.2270; FitzGibbon T, 1996, J COMP NEUROL, V375, P238; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Gerth C, 2008, ARCH OPHTHALMOL-CHIC, V126, P807, DOI 10.1001/archopht.126.6.807; Harb E, 2012, OPTOMETRY VISION SCI, V89, P620, DOI 10.1097/OPX.0b013e318251293a; Henry CR, 2015, J AAPOS, V19, P541, DOI 10.1016/j.jaapos.2015.09.006; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Jin PY, 2016, AM J OPHTHALMOL, V168, P164, DOI 10.1016/j.ajo.2016.05.008; Lee H, 2016, INVEST OPHTH VIS SCI, V57, pOCT69, DOI 10.1167/iovs.15-18825; Lee H, 2015, OPHTHALMOLOGY, V122, P2145, DOI 10.1016/j.ophtha.2015.03.033; Lee H, 2015, INVEST OPHTH VIS SCI, V56, P4537, DOI 10.1167/iovs.15-16542; Li T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158948; Liu XT, 2015, AM J OPHTHALMOL, V160, P53, DOI 10.1016/j.ajo.2015.03.012; Maldonado RS, 2013, CLIN PERINATOL, V40, P271, DOI 10.1016/j.clp.2013.02.007; Maldonado RS, 2011, OPHTHALMOLOGY, V118, P2315, DOI 10.1016/j.ophtha.2011.05.028; McCafferty BK, 2015, J PEDIAT OPHTH STRAB, V52, P167, DOI 10.3928/01913913-20150427-06; Park S, 2013, DOC OPHTHALMOL, V126, P199, DOI 10.1007/s10633-013-9375-0; Park SY, 2013, AM J OPHTHALMOL, V156, P557, DOI 10.1016/j.ajo.2013.04.027; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P6779, DOI 10.1167/iovs.14-15978; Read SA, 2015, RETINA-J RET VIT DIS, V35, P1223, DOI 10.1097/IAE.0000000000000464; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P7578, DOI 10.1167/iovs.13-12772; Read SA, 2012, OPTOMETRY VISION SCI, V89, P611, DOI 10.1097/OPX.0b013e3182501917; Rudnicka AR, 2016, BRIT J OPHTHALMOL, V100, P882, DOI 10.1136/bjophthalmol-2015-307724; Samara WA, 2015, J AAPOS, V19, P368, DOI 10.1016/j.jaapos.2015.02.019; Shen L, 2016, OPHTHALMOLOGY, V123, P92, DOI 10.1016/j.ophtha.2015.07.002; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Turk A, 2012, AM J OPHTHALMOL, V153, P552, DOI 10.1016/j.ajo.2011.08.026; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yanni SE, 2013, AM J OPHTHALMOL, V155, P354, DOI 10.1016/j.ajo.2012.08.010	40	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180462	10.1371/journal.pone.0180462	http://dx.doi.org/10.1371/journal.pone.0180462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662138	gold, Green Submitted, Green Published			2022-12-26	WOS:000404608300159
J	Ruiz-Rodriguez, M; Moller, AP; Mousseau, TA; Soler, JJ				Ruiz-Rodriguez, Magdalena; Moller, Anders P.; Mousseau, Timothy A.; Soler, Juan J.			Capacity of blood plasma is higher in birds breeding in radioactively contaminated areas	PLOS ONE			English	Article							LOW-DOSE RADIATION; BARN SWALLOWS; NATURAL ANTIBODIES; IONIZING-RADIATION; CHERNOBYL; CONSEQUENCES; COMPLEMENT; VIRULENCE; POLLUTION; EXPOSURE	Background Environmental pollution in general, and radioactive contamination in particular, may deeply affect host-parasite relationships and their consequences for the evolution of organisms. The nuclear accident that occurred more than 30 years ago in Chernobyl resulted in significant changes in diversity and richness of microbial communities that could influence characteristics of animal-bacteria interactions, including host immune responses and competitive interference by bacteria. Given the high mortality rate of birds breeding in radioactively contaminated zones, those with stronger defences against infections should experience significant fitness advantages. Methodology/Principal Findings Here we characterized antimicrobial capacity of barn swallows (Hirundo rustica) from different Ukrainian populations (subject to a gradient of ionizing radiation) against 12 bacterial species. We also quantified constitutive innate immunity, which is the non-specific first barrier of protection of hosts against microbial parasites. We found a positive association between specific antimicrobial capacity of individual hosts and radiation levels in breeding habitats even after controlling for other confounding variables such as sex and age. However, no significant relationship was found between immunocompetence (non-specific response) and background radiation. Conclusions/Significance These results suggest that radiation selects for broad antimicrobial spectra of barn swallows, although not for all bacterial strains. We discuss these results in the framework of host-parasite evolution under extreme environmental conditions.	[Ruiz-Rodriguez, Magdalena; Soler, Juan J.] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, La Canada De San Urbano, Almeria, Spain; [Ruiz-Rodriguez, Magdalena; Moller, Anders P.] Univ Paris Saclay, AgroParisTech, Univ Paris Sud, Ecol Syst Evolut,CNRS, Orsay, France; [Mousseau, Timothy A.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina System; University of South Carolina Columbia	Ruiz-Rodriguez, M (corresponding author), CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, La Canada De San Urbano, Almeria, Spain.; Ruiz-Rodriguez, M (corresponding author), Univ Paris Saclay, AgroParisTech, Univ Paris Sud, Ecol Syst Evolut,CNRS, Orsay, France.	magda@eeza.csic.es	Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Ruiz-Rodríguez, Magdalena/D-4226-2014; Mousseau, Timothy A/A-1253-2011; Moller, Anders/O-6665-2016; Soler, J. J./H-2363-2011	Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Moller, Anders/0000-0003-3739-4675; Soler, J. J./0000-0003-2990-1489; Mousseau, Timothy/0000-0002-2235-4868	Samuel Freeman Charitable Trust; US Fulbright Program; CNRS (France); American Council of Learned Societies; University of South Carolina College of Arts and Sciences; Spanish Ministerio de Economia y Competitividad European funds (FEDER) [CGL2013-48193-C3-1-P]; program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia)	Samuel Freeman Charitable Trust; US Fulbright Program; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); American Council of Learned Societies; University of South Carolina College of Arts and Sciences; Spanish Ministerio de Economia y Competitividad European funds (FEDER); program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia)(Junta de Andalucia)	M.Ruiz-Rodriguez had a postdoc stipend from the program "AndalucoAaTalentHub" (Agencia Andaluzadel Conocimiento, Junta de Andalucia). Funding was provided in part by the Samuel Freeman Charitable Trust, the US Fulbright Program, the CNRS (France), the American Council of Learned Societies, the University of South Carolina College of Arts and Sciences, and the Spanish Ministerio de Economia y Competitividad European funds (FEDER)) (CGL2013-48193-C3-1-P).	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Balbontin J, 2015, ECOLOGY, V96, P948, DOI 10.1890/14-1274.1; Benyacoub J, 2014, BENEF MICROBES, V5, P129, DOI 10.3920/BM2013.0014; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS C, V151, P271, DOI 10.1016/j.cbpc.2009.11.006; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Camplani A, 1999, P ROY SOC B-BIOL SCI, V266, P1111, DOI 10.1098/rspb.1999.0751; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Copplestone D, 2004, J ENVIRON RADIOACTIV, V74, P31, DOI 10.1016/j.jenvrad.2004.01.020; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Eeva T, 2013, PARASITOLOGY, V140, P1384, DOI 10.1017/S0031182013000796; Ferreira M, 2016, FOOD REV INT, V32, P377, DOI 10.1080/87559129.2015.1094816; Flannagan RS, 2015, PATHOGENS, V4, P826, DOI 10.3390/pathogens4040826; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; HAMMOND CW, 1960, P SOC EXP BIOL MED, V104, P261; Hammond CW, 1959, RADIAT RES, V11, P242; Hu QH, 2010, J ENVIRON RADIOACTIV, V101, P426, DOI 10.1016/j.jenvrad.2008.08.004; Jaakohuhta S, 2007, INT J FOOD MICROBIOL, V114, P288, DOI 10.1016/j.ijfoodmicro.2006.09.025; Ksiazek A, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0684; Larsson CM, 2008, J ENVIRON RADIOACTIV, V99, P1364, DOI 10.1016/j.jenvrad.2007.11.019; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; McGarigal K., 2000, MULTIVARIATE STAT WI; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2013, BIOL REV, V88, P226, DOI 10.1111/j.1469-185X.2012.00249.x; Moller AP, 2007, FUNCT ECOL, V21, P363, DOI 10.1111/j.1365-2435.2006.01215.x; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Moller AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035223; Moller AP, 2006, TRENDS ECOL EVOL, V21, P200, DOI 10.1016/j.tree.2006.01.008; Moller AP, 2005, J ANIM ECOL, V74, P1102, DOI 10.1111/j.1365-2656.2005.01009.x; Moller AP., 1994, SEXUAL SELECTION BAR; Mollert AP, 2016, TRENDS ECOL EVOL, V31, P281, DOI 10.1016/j.tree.2016.01.005; Morley NJ, 2012, J ENVIRON RADIOACTIV, V106, P81, DOI 10.1016/j.jenvrad.2011.12.019; Mousseau TA, 2014, J HERED, V105, P704, DOI 10.1093/jhered/esu040; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Porcheron G, 2015, VET MICROBIOL, V179, P2, DOI 10.1016/j.vetmic.2015.03.024; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Quillfeldt P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-26; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Romanovskaya VA, 1998, MICROBIOLOGY+, V67, P226; Rozalski A, 1997, MICROBIOL MOL BIOL R, V61, P65; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Ruiz-Rodriguez M, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1397-5; Saino N, 2003, J EVOLUTION BIOL, V16, P1127, DOI 10.1046/j.1420-9101.2003.00616.x; Simkova A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0438-6; Skrypnyk A., 2008, P 18 EUR C CLIN MICR; Smith J.T., 2005, CHERNOBYL CATASTROPH; Statsoft Inc, 2005, STATISTICA DAT AN SO; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Weis JS, 2011, BIOSCIENCE, V61, P375, DOI 10.1525/bio.2011.61.5.6; Weller R, 2009, VET ITAL, V45, P225; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P237, DOI [10.1111/j.1749-6632.2009.04832.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P58, DOI 10.1111/j.1749-6632.2009.04822.x; Yuen GJ, 2014, J MICROBIOL, V52, P200, DOI 10.1007/s12275-014-4011-6; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	64	1	1	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179209	10.1371/journal.pone.0179209	http://dx.doi.org/10.1371/journal.pone.0179209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662048	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300017
J	Urvanegia, AC; Braga, JCT; Shitara, D; Fregnani, JH; Neves, JI; Pinto, CA; Marghoob, AA; Duprat, JP; Rezze, GG				Urvanegia, Ana Claudia; Tavoloni Braga, Juliana Casagrande; Shitara, Danielle; Fregnani, Jose Humberto; Neves, Jose Ivanildo; Pinto, Clovis Antonio; Marghoob, Ashfaq A.; Duprat, Joao Pedreira; Rezze, Gisele Gargantini			Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry	PLOS ONE			English	Article							METASTATIC MELANOMA; DIAGNOSTIC-ACCURACY; MELANOCYTIC NEVI; DERMOSCOPY; PATHWAYS; CELLS	The classification of melanoma into four histological subtypes has been questioned regarding its clinical validity in providing relevant information for treatment for metastatic tumors. Specific genetic alterations are associated with particular clinical and histopathological features, suggesting that these could be helpful in refining existing melanoma classification schemes. We analyzed BRAF V600E mutated melanomas to explore the Reflectance confocal microscopy (RCM) utility as a screening aid in the evaluation of the most appropriate patients for genetic testing. Thus, 32 melanomas were assessed regarding their BRAF V600E mutational status. Experts blinded to dermoscopic images and V600E immunohistochemistry results evaluated RCM images regarding previously described melanoma features. BRAF positive melanomas were related to younger age (p = 0.035), invasive melanomas (p = 0.03) and to the presence of hiporreflective cells (p = 0.02), epidermal nests (p = 0.02), dermal-epidermal junction nests (p = 0.05), edged papillae (p = 0.05), and bright dots (p = 0.05), and to absence of junctional thickening due to isolated cells (p = 0.01) and meshwork (p = 0.02). This study can not characterize other mutations in the BRAF, because the immunohistochemistry is specific to the type V600E. The findings should encourage the genetic evaluation of BRAF mutation. This study highlights the potential of RCM as a supplementary tool in the screening of BRAF-mutated melanomas.	[Urvanegia, Ana Claudia; Tavoloni Braga, Juliana Casagrande; Duprat, Joao Pedreira; Rezze, Gisele Gargantini] AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil; [Tavoloni Braga, Juliana Casagrande; Shitara, Danielle; Rezze, Gisele Gargantini] Dermaimage Med Associates, Sao Paulo, Brazil; [Fregnani, Jose Humberto] Barretos Canc Hosp, Teaching & Res Inst, Sao Paulo, Brazil; [Neves, Jose Ivanildo; Pinto, Clovis Antonio] AC Camargo Canc Ctr, Anat Pathol Dept, Sao Paulo, Brazil; [Marghoob, Ashfaq A.] Mem Sloan Kettering Skin Canc Ctr, Dermatol Serv, New York, NY USA	A.C.Camargo Cancer Center; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; Memorial Sloan Kettering Cancer Center	Rezze, GG (corresponding author), AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil.; Rezze, GG (corresponding author), Dermaimage Med Associates, Sao Paulo, Brazil.	ggrezze@hotmail.com	Fregnani, José H/H-4238-2012; Braga, Juliana/M-2997-2014; Duprat, Joao P/I-4198-2015	Fregnani, José H/0000-0002-5235-6469; Braga, Juliana/0000-0002-1378-6992; Duprat, Joao P/0000-0001-8968-4506; Machado Urvanegia, Ana Claudia/0000-0002-8987-8156	FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/13090-5]	FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by Grants from FAPESP (Sao Paulo Research Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) process number 2012/13090-5,URL:http://WWW.fapesp.br/, to JPD	Benati E, 2015, BRIT J DERMATOL, V173, P1232, DOI 10.1111/bjd.14049; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2011, CLIN CANCER RES, V17, P4922, DOI 10.1158/1078-0432.CCR-10-2612; Gill M, 2005, J AM ACAD DERMATOL, V53, P108, DOI 10.1016/j.jaad.2005.04.013; Giovanni P, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/671283; Langley RGB, 2007, DERMATOLOGY, V215, P365, DOI 10.1159/000109087; Long E, 2015, J EUR ACAD DERMATOL, V29, P2436, DOI 10.1111/jdv.13332; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Longo C, 2011, J AM ACAD DERMATOL, V65, P604, DOI 10.1016/j.jaad.2010.10.035; Losi A, 2014, BRIT J DERMATOL, V171, P48, DOI 10.1111/bjd.12781; Marchetti MA, 2014, BRIT J DERMATOL, V171, P1060, DOI 10.1111/bjd.13260; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Pan Zhan-Yan, 2012, J Am Acad Dermatol, V66, pe47, DOI 10.1016/j.jaad.2010.09.722; Pellacani G, 2005, BRIT J DERMATOL, V152, P384, DOI 10.1111/j.1365-2133.2005.06348.x; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellacani G, 2014, EXP DERMATOL, V23, P414, DOI 10.1111/exd.12417; Pellacani G, 2012, J AM ACAD DERMATOL, V66, pE109, DOI 10.1016/j.jaad.2011.05.017; Ponti G, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/246751; Pozzobon FC, 2014, BRIT J DERMATOL, V171, P754, DOI 10.1111/bjd.13069; Rezze GG, 2015, ATLAS MICROSCOPIA CO; Ruini C, 2015, MELANOMA RES, V25, P367, DOI 10.1097/CMR.0000000000000147; Shitara D, 2015, BRIT J DERMATOL, V173, P671, DOI 10.1111/bjd.13829; Singh M, 2008, BRIT J DERMATOL, V158, P15, DOI 10.1111/j.1365-2133.2007.08316.x; Braga JCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081205; Tschandl P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069639; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Zalaudek I, 2008, AM J DERMATOPATH, V30, P402, DOI 10.1097/DAD.0b013e3181734e9a; Zalaudek I, 2011, J INVEST DERMATOL, V131, P542, DOI 10.1038/jid.2010.332	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179745	10.1371/journal.pone.0179745	http://dx.doi.org/10.1371/journal.pone.0179745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662062	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300045
J	Zhong, NF; Dai, QF; Liang, RS; Li, XP; Tan, XP; Zhang, XM; Wei, ZC; Wang, FQ; Liu, HZ; Meng, HY				Zhong, Nianfa; Dai, Qiaofeng; Liang, Ruisheng; Li, Xianping; Tan, Xiaopei; Zhang, Xiaomeng; Wei, Zhongchao; Wang, Faqiang; Liu, Hongzhan; Meng, Hongyun			Analogue of electromagnetically induced absorption with double absorption windows in a plasmonic system	PLOS ONE			English	Article							INDUCED TRANSPARENCY	We report the observation of an analog of double electromagnetically induced absorption (EIA) in a plasmonic system consisting of two disk resonators side-coupled to a discrete metal-insulator-metal (MIM) waveguide. The finite-difference time-domain (FDTD) simulation calculations show that two absorption windows are obtained and can be easily tuned by adjusting the parameters of the two resonance cavities. The consistence between the coupled-model theory and FDTD simulation results verify the feasibility of the proposed system. Since the scheme is easy to be fabricated, our proposed configuration may thus be applied to narrow-band filtering, absorptive switching, and absorber applications.	[Zhong, Nianfa; Dai, Qiaofeng; Liang, Ruisheng; Li, Xianping; Tan, Xiaopei; Zhang, Xiaomeng; Wei, Zhongchao; Wang, Faqiang; Liu, Hongzhan; Meng, Hongyun] South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou Key Lab Special Fiber Photon Devices, Guangzhou, Guangdong, Peoples R China	South China Normal University	Dai, QF; Wei, ZC (corresponding author), South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou Key Lab Special Fiber Photon Devices, Guangzhou, Guangdong, Peoples R China.	daiqf@scnu.edu.cn; wzc@scnu.edu.cn	Wei, Zhongchao/V-7626-2017	Wei, Zhongchao/0000-0003-3586-2180	National Natural Science Foundation of China (NSFC) [61275059, 11374107, 61475049, 11674109]; Natural Science Foundation of Guangdong Province, China [2016A030313851, 2016A030313443]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. 61275059, 11374107, 61475049, 11674109 and the Natural Science Foundation of Guangdong Province, China under Grant Nos. 2016A030313851, 2016A030313443	Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Cao GT, 2014, OPT LETT, V39, P216, DOI 10.1364/OL.39.000216; Guo J, 2014, APPL OPTICS, V53, P1604, DOI 10.1364/AO.53.001604; Han ZH, 2011, OPT EXPRESS, V19, P3251, DOI 10.1364/OE.19.003251; HAUS HA, 1991, P IEEE, V79, P1505, DOI 10.1109/5.104225; He JN, 2015, OPT EXPRESS, V23, P6083, DOI 10.1364/OE.23.006083; Huang Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647951; Lai G, 2015, OPT EXPRESS, V23, P6554, DOI 10.1364/OE.23.006554; Lezama A, 1999, PHYS REV A, V59, P4732, DOI 10.1103/PhysRevA.59.4732; Li G.-Z., 2015, EVIDENCE BASED COMPL, V2015, P1, DOI DOI 10.1155/2015/720706; Li H-J, 2016, APPL PHYS EXPRESS, V9, DOI DOI 10.7567/APEX.9.012001; Liu DD, 2016, AIP ADV, V6, DOI 10.1063/1.4942937; Lu H, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053803; Okamoto K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36165; Piao X, 2012, OPT EXPRESS, V20, P18994, DOI 10.1364/OE.20.018994; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Shi SS, 2015, J APPL PHYS, V118, DOI 10.1063/1.4932668; Taubert R, 2012, NANO LETT, V12, P1367, DOI 10.1021/nl2039748; Wei ZC, 2017, PLASMONICS, V12, P641, DOI 10.1007/s11468-016-0309-z; Yu DM, 2016, APPL PHYS EXPRESS, V9, DOI 10.7567/APEX.9.054301; Yun BF, 2014, OPT EXPRESS, V22, P28662, DOI 10.1364/OE.22.028662; Zhang S, 2008, PHYS REV LETT; Zhang X, 2016, PLASMONICS; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]	24	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0179609	10.1371/journal.pone.0179609	http://dx.doi.org/10.1371/journal.pone.0179609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662059	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300039
J	Beaujean, O; Locri, F; Aronsson, M; Kvanta, A; Andre, H				Beaujean, Ophelie; Locri, Filippo; Aronsson, Monica; Kvanta, Anders; Andre, Helder			A novel in vivo model of puncture-induced iris neovascularization	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; ANGIOGENESIS; RETINOPATHY; MOUSE; CELLS; EYE	Purpose To assess iris neovascularization by uveal puncture of the mouse eye and determine the role of angiogenic factors during iris neovascularization. Methods Uveal punctures were performed on BalbC mouse eyes to induce iris angiogenesis. VEGF-blockage was used as an anti-angiogenic treatment, while normoxia-and hypoxia-conditioned media from retinal pigment epithelium (RPE) cells was used as an angiogenic-inducer in this model. Iris vasculature was determined in vivo by noninvasive methods. Iris blood vessels were stained for platelet endothelial cell adhesion molecule-1 and vascular sprouts were counted as markers of angiogenesis. Expression of angiogenic and inflammatory factors in the puncture-induced model were determined by qPCR and western blot. Results Punctures led to increased neovascularization and sprouting of the iris. qPCR and protein analysis showed an increase of angiogenic factors, particularly in the plasminogen-activating receptor and inflammatory systems. VEGF-blockage partly reduced iris neovascularization, and treatment with hypoxia-conditioned RPE medium led to a statistically significant increase in iris neovascularization. Conclusions This study presents the first evidence of a puncture-induced iris angiogenesis model in the mouse. In a broader context, this novel in vivo model of neovascularization has the potential for noninvasive evaluation of angiogenesis modulating substances.	[Beaujean, Ophelie; Locri, Filippo; Aronsson, Monica; Kvanta, Anders; Andre, Helder] Karolinska Inst, St Erik Eye Hosp, Sect Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Andre, H (corresponding author), Karolinska Inst, St Erik Eye Hosp, Sect Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden.	helder.andre@ki.se	Andre, Helder/AAC-5220-2019	Andre, Helder/0000-0002-2926-2376	Regne Ars Foundation for Research in Eye Diseases; Swedish Eye Foundation; Cronqvist Foundation; Karolinska Institutet; Erasmus Trainee scholarship	Regne Ars Foundation for Research in Eye Diseases; Swedish Eye Foundation; Cronqvist Foundation; Karolinska Institutet(Karolinska Institutet); Erasmus Trainee scholarship	The presented work was supported by grants from the Regne Ars Foundation for Research in Eye Diseases, the Swedish Eye Foundation, the Cronqvist Foundation, and the Karolinska Institutet; Ophelie Beauhean was partly supported by an Erasmus Trainee scholarship.	Adair T.H, 2010, ANGIOGENESIS C SERIE, P1; Andre H, 2015, INVEST OPHTH VIS SCI, V56, P6591, DOI 10.1167/iovs.15-16476; Baldock R, 2015, KAUFMANS ATLAS MOU S; Besharse J., 2010, ENCY EYE; Cammalleri M, 2016, INVEST OPHTH VIS SCI, V57, P2586; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Forooghian F, AM J OPHTHALMOL; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; ISHIBASHI T, 1995, ARCH OPHTHALMOL-CHIC, V113, P227, DOI 10.1001/archopht.1995.01100020111041; Jeong YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160662; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Kvanta A, 2006, ACTA OPHTHALMOL SCAN, V84, P282, DOI 10.1111/j.1600-0420.2006.00659.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Salman AG, 2013, OPHTHALMIC RES, V49, P20, DOI 10.1159/000341734; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Takei A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42546; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Uhrin P, 2013, CELL ADHES MIGR, V7, P23, DOI 10.4161/cam.22124; Yang HF, 2015, EXP EYE RES, V140, P106, DOI 10.1016/j.exer.2015.08.025	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180235	10.1371/journal.pone.0180235	http://dx.doi.org/10.1371/journal.pone.0180235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658313	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900068
J	Duncan, C; Jamieson, FB; Troudt, J; Izzo, L; Bielefeldt-Ohmann, H; Izzo, A; Mehaffy, C				Duncan, Carla; Jamieson, Frances B.; Troudt, JoLynn; Izzo, Linda; Bielefeldt-Ohmann, Helle; Izzo, Angelo; Mehaffy, Carolina			Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion	PLOS ONE			English	Article							ALTERNATE SIGMA-FACTOR; GUINEA-PIG MODEL; MYCOBACTERIUM-TUBERCULOSIS; 2-COMPONENT SYSTEM; MOLYBDOPTERIN BIOSYNTHESIS; STRINGENT RESPONSE; MASS-SPECTROMETRY; HYPOXIC RESPONSE; BEIJING LINEAGE; MUTANT LACKING	Tuberculosis remains one of the most difficult to control infectious diseases in the world. Many different factors contribute to the complexity of this disease. These include the ability of the host to control the infection which may directly relate to nutritional status, presence of co-morbidities and genetic predisposition. Pathogen factors, in particular the ability of different Mycobacterium tuberculosis strains to respond to the harsh environment of the host granuloma, which includes low oxygen and nutrient availability and the presence of damaging radical oxygen and nitrogen species, also play an important role in the success of different strains to cause disease. In this study we evaluated the impact of a naturally occurring 12 gene 15 Kb genomic deletion on the physiology and virulence of M. tuberculosis. The strains denominated ON-A WT (wild type) and ON-A NM (natural mutant) were isolated from a previously reported TB outbreak in an inner city under-housed population in Toronto, Canada. Here we subjected these isogenic strains to transcriptomic (via RNA-seq) and proteomic analyses and identified several gene clusters with differential expression in the natural mutant, including the DosR regulon and the molybdenum cofactor biosynthesis genes, both of which were found in lower abundance in the natural mutant. We also demonstrated lesser virulence of the natural mutant in the guinea pig animal model. Overall, our findings suggest that the ON-A natural mutant is less fit to cause disease, but nevertheless has the potential to cause extended transmission in at-risk populations.	[Duncan, Carla; Jamieson, Frances B.; Mehaffy, Carolina] Publ Hlth Ontario, Toronto, ON, Canada; [Jamieson, Frances B.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Troudt, JoLynn; Izzo, Linda; Izzo, Angelo; Mehaffy, Carolina] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Toronto; Colorado State University; University of Queensland; University of Queensland; University of Queensland	Mehaffy, C (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Mehaffy, C (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Carolina.Mehaffy@colostate.edu			Lung Association/Ontario Thoracic Society; NIH/NIAID IDIQ [HHSN2722010000091, HHSN27200004]; Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models"	Lung Association/Ontario Thoracic Society; NIH/NIAID IDIQ; Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models"	This study was supported by a grant-in-aid from The Lung Association/Ontario Thoracic Society (http://www.on.lung.ca) (CM, FBJ). Guinea Pig infections were supported by NIH/NIAID IDIQ Contract No. HHSN2722010000091 Task Order HHSN27200004, Task A58, entitled "Testing of mutant mycobacteria in established advanced small animal models" (Al). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Banuls AL, 2015, J MED MICROBIOL, V64, P1261, DOI 10.1099/jmm.0.000171; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; Bhattacharya M, 2011, BIOCHEM BIOPH RES CO, V415, P17, DOI 10.1016/j.bbrc.2011.09.143; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Espinosa-Cueto P, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0102-3; Feske ML, 2013, AM J PUBLIC HEALTH, V103, P839, DOI 10.2105/AJPH.2012.300973; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Grover A, 2012, TUBERCULOSIS, V92, P105, DOI 10.1016/j.tube.2011.09.003; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Haddad MB, 2005, JAMA-J AM MED ASSOC, V293, P2762, DOI 10.1001/jama.293.22.2762; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 1999, J BACTERIOL, V181, P1380, DOI 10.1128/JB.181.5.1380-1387.1999; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kettman JR, 2001, BIOMOL ENG, V18, P207, DOI 10.1016/S1389-0344(01)00096-X; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Kirksey MA, 2011, INFECT IMMUN, V79, P2829, DOI 10.1128/IAI.00097-11; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Lopez PM, 2010, MICROBIOL-SGM, V156, P2112, DOI 10.1099/mic.0.037200-0; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Organization W. H., 2015, GLOB TUB REP; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; Shi TY, 2011, J CELL BIOCHEM, V112, P2721, DOI 10.1002/jcb.23233; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAKAYAMA K, 1975, J LIPID RES, V16, P308; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Voss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028170; Wieczorek AE, 2014, PATHOG DIS, V71, P315, DOI 10.1111/2049-632X.12147; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10	71	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179996	10.1371/journal.pone.0179996	http://dx.doi.org/10.1371/journal.pone.0179996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650996	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300036
J	Malachin, G; Reiten, MR; Salvesen, O; Aanes, H; Kamstra, JH; Skovgaard, K; Heegaard, PMH; Ersdal, C; Espenes, A; Tranulis, MA; Bakkebo, MK				Malachin, Giulia; Reiten, Malin R.; Salvesen, Oyvind; Aanes, Havard; Kamstra, Jorke H.; Skovgaard, Kerstin; Heegaard, Peter M. H.; Ersdal, Cecilie; Espenes, Arild; Tranulis, Michael A.; Bakkebo, Maren K.			Loss of prion protein induces a primed state of type I interferon-responsive genes	PLOS ONE			English	Article							UP-REGULATED GENES; DIFFERENTIAL EXPRESSION; MICE LACKING; PRP; MOUSE; REVEALS; PROFILE	The cellular prion protein (PrPC) has been extensively studied because of its pivotal role in prion diseases; however, its functions remain incompletely understood. A unique line of goats has been identified that carries a nonsense mutation that abolishes synthesis of PrPC. In these animals, the PrP-encoding mRNA is rapidly degraded. Goats without PrPC are valuable in re-addressing loss-of-function phenotypes observed in Prnp knockout mice. As PrPC has been ascribed various roles in immune cells, we analyzed transcriptomic responses to loss of PrPC in peripheral blood mononuclear cells (PBMCs) from normal goat kids (n = 8, PRNP (+/+)) and goat kids without PrPC (n = 8, PRNPTer/Ter) by mRNA sequencing. PBMCs normally express moderate levels of PrPC. The vast majority of genes were similarly expressed in the two groups. However, a curated list of 86 differentially expressed genes delineated the two genotypes. About 70% of these were classified as interferon-responsive genes. In goats without PrPC, the majority of type I interferon-responsive genes were in a primed, modestly upregulated state, with fold changes ranging from 1.4 to 3.7. Among these were ISG15, DDX58 (RIG-1), MX1, MX2, OAS1, OAS2 and DRAM1, all of which have important roles in pathogen defense, cell proliferation, apoptosis, immunomodulation and DNA damage response. Our data suggest that PrPC contributes to the fine-tuning of resting state PBMCs expression level of type I interferon-responsive genes. The molecular mechanism by which this is achieved will be an important topic for further research into PrPC physiology.	[Malachin, Giulia; Reiten, Malin R.; Salvesen, Oyvind; Kamstra, Jorke H.; Ersdal, Cecilie; Espenes, Arild; Tranulis, Michael A.; Bakkebo, Maren K.] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Aanes, Havard] Oslo Univ Hosp, Rikshosp, Inst Clin Med, Dept Microbiol,Div Diagnost & Intervent, Oslo, Norway; [Skovgaard, Kerstin; Heegaard, Peter M. H.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Innate Immunol Grp, Lyngby, Denmark	Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; Technical University of Denmark	Tranulis, MA (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway.	Michael.Tranulis@nmbu.no	Heegaard, Peter/E-9794-2015	Heegaard, Peter/0000-0003-4506-4932; skovgaard, kerstin/0000-0001-5663-4879; Malachin, Giulia/0000-0003-1888-6850; Kamstra, Jorke/0000-0001-7984-0229; Salvesen, Oyvind/0000-0003-2480-1294	Norwegian Research Council [227386/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	MAT received funding from the Norwegian Research Council, Grant number 227386/E40 (http://www.forskningsradet.no/no/Forsiden/1173185591033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Benvegnu S, 2011, PHYSIOL GENOMICS, V43, P711, DOI 10.1152/physiolgenomics.00205.2010; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carroll JA, 2015, J VIROL, V89, P2388, DOI 10.1128/JVI.02952-14; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Herrmann US, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004662; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Isaacs JD, 2008, IMMUNOLOGY, V125, P313, DOI 10.1111/j.1365-2567.2008.02853.x; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Peralta OA, 2012, MOL REPROD DEV, V79, P488, DOI 10.1002/mrd.22057; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ramljak S, 2008, J PROTEOME RES, V7, P2681, DOI 10.1021/pr7007187; Reiten MR, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00044; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Salvesen O, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0879-5; Salvesen O, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0870-x; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Stobart MJ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-5; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhou RY, 2008, J HERED, V99, P647, DOI 10.1093/jhered/esn073	50	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179881	10.1371/journal.pone.0179881	http://dx.doi.org/10.1371/journal.pone.0179881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651013	Green Published, gold			2022-12-26	WOS:000404537300027
J	Afiune, LAF; Leal-Silva, T; Sinzato, YK; Moraes-Souza, RQ; Soares, TS; Campos, KE; Fujiwara, RT; Herrera, E; Damasceno, DC; Volpato, GT				Freitas Afiune, Luana Alves; Leal-Silva, Thais; Sinzato, Yuri Karen; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Campos, Kleber Eduardo; Fujiwara, Ricardo Toshio; Herrera, Emilio; Damasceno, Debora Cristina; Volpato, Gustavo Tadeu			Beneficial effects of Hibiscus rosa-sinensis L. flower aqueous extract in pregnant rats with diabetes	PLOS ONE			English	Article							OXIDATIVE STRESS STATUS; ANTIFERTILITY ACTIVITY; BENZENE EXTRACT; LIPID PROFILE; CHOLESTEROL; HDL; SUPPLEMENTATION; ANTIOXIDANT; METABOLISM; MECHANISMS	Purpose The Hibiscus rosa-sinensis flower is widely used in Brazilian traditional medicine for the treatment of diabetes and has shown antifertility activity in female Wistar rats. However, there is no scientific confirmation of its effect on diabetes and pregnancy. The aim of this study was evaluate the effect of aqueous extract of H. rosa-sinensis flowers on maternalfetal outcome in pregnant rats with diabetes. Methods Diabetes was induced by streptozotocin (STZ, 40 mg/kg) in virgin, adult, female Wistar rats. After diabetes induction, the rats were mated. The pregnant rats were distributed into four groups (n minimum = 11 animals/group): non-diabetic, non-diabetic treated, diabetic, and diabetic treated. Oral aqueous extract of Hibiscus rosa-sinensis was administered to rats in the treatment groups during pregnancy. At term pregnancy, maternal reproductive outcomes, fetal parameters, and biochemical parameters were analyzed. Results The non-diabetic treated group showed decreased high density lipoprotein cholesterol, increased atherogenic index (AI) and coronary artery risk index (CRI), and increased preimplantation loss rate compared to the non-diabetic group. Although treatment with H. rosasinensis led to no toxicity, it showed deleterious effects on cardiac and reproductive functions. However, the diabetic treated group showed increased maternal and fetal weights, reduced AI and CRI, and reduced preimplantation loss rate compared to the untreated diabetic group. Conclusion Our results demonstrate beneficial effects of this flower only in pregnant rats with diabetes and their offspring. Although these findings cannot be extrapolated to human clinical use, they show that the indiscriminate intake of H. rosa-sinensis may be harmful to healthy individuals and its use should be completely avoided in pregnancy.	[Freitas Afiune, Luana Alves; Leal-Silva, Thais; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Campos, Kleber Eduardo; Volpato, Gustavo Tadeu] Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, Mato Grosso Sta, Brazil; [Sinzato, Yuri Karen; Moraes-Souza, Rafaianne Queiroz; Soares, Thaigra Sousa; Damasceno, Debora Cristina; Volpato, Gustavo Tadeu] Univ Estadual Paulista Unesp, Botucatu Med Sch, Lab Expt Res Gynecol & Obstet, Gynecol Obstet & Mastol Grad Course, Botucatu, SP, Brazil; [Fujiwara, Ricardo Toshio] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil; [Herrera, Emilio] Univ CEU San Pablo, Dept Biochem & Mol Biol, Madrid, Spain	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; San Pablo CEU University	Volpato, GT (corresponding author), Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, Mato Grosso Sta, Brazil.; Volpato, GT (corresponding author), Univ Estadual Paulista Unesp, Botucatu Med Sch, Lab Expt Res Gynecol & Obstet, Gynecol Obstet & Mastol Grad Course, Botucatu, SP, Brazil.	gtvolpato@yahoo.com	Volpato, Gustavo Tadeu/A-5350-2013; Sinzato, Yuri K/E-8626-2019; Herrera-Castillon, Emilio/D-9143-2012; Volpato, Gustavo Tadeu/ABC-4863-2020; Damasceno, Débora C/C-7234-2012; Fujiwara, Ricardo Toshio/J-7579-2012; Afiune, Luana Alves de Freitas/F-1166-2018	Volpato, Gustavo Tadeu/0000-0002-4753-3264; Sinzato, Yuri K/0000-0002-2973-1099; Herrera-Castillon, Emilio/0000-0002-8152-787X; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Damasceno, Débora C/0000-0002-7003-9643; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Moraes-Souza, Rafaianne/0000-0002-3639-5740; Afiune, Luana Alves de Freitas/0000-0001-7702-2548; Sousa Soares, Thaigra/0000-0003-4402-0241	Conselho Nacional de Desenvolvimento Ciento e Tecnologico	Conselho Nacional de Desenvolvimento Ciento e Tecnologico	Ricardo T. Fujiwara and Debora C. Damasceno received support from Conselho Nacional de Desenvolvimento Ciento e Tecnologico.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ajiboye TO, 2011, DRUG CHEM TOXICOL, V34, P109, DOI 10.3109/01480545.2010.536767; Anusha Bhaskar, 2011, Annals of Biological Research, V2, P653; Bhaskar A, 2012, INDIAN J PHARMACOL, V44, P694, DOI 10.4103/0253-7613.103252; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Consonni M, 2012, BRAZ ARCH BIOL TECHN, V55, P695, DOI 10.1590/S1516-89132012000500008; Da-Costa-Rocha I, 2014, FOOD CHEM, V165, P424, DOI 10.1016/j.foodchem.2014.05.002; Damasceno D. C., 2008, Botanical medicine in clinical practice, P547, DOI 10.1079/9781845934132.0547; Damasceno DC, 2002, ANIM REPROD SCI, V72, P235, DOI 10.1016/S0378-4320(02)00094-5; Damasceno DC, 2008, ANOMALIAS CONGENITAS; Damasceno DC, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-20; Damasceno DC, 2013, REPROD SCI, V20, P730, DOI 10.1177/1933719112461186; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Eriksson UJ, 2003, REV ENDOCR METAB DIS, V4, P79, DOI 10.1023/A:1021879504372; Fernandez-Arroyo S, 2011, FOOD RES INT, V44, P1490, DOI 10.1016/j.foodres.2011.03.040; Gauthaman K. K., 2006, BMC Complementary and Alternative Medicine, V6; Guerin M, 2001, ARTERIOSCL THROM VAS, V21, P282, DOI 10.1161/01.ATV.21.2.282; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kahn CR, 2004, JOSLINS DIABETES MEL; Khalid L, 2014, PAK J PHARM SCI, V27, P1327; KHOLKUTE SD, 1976, PLANTA MED, V29, P321, DOI 10.1055/s-0028-1097671; Knopfholz J, 2014, CHOLESTEROL, V2014, P261; Liu Chiu-Shong, 1999, Acta Paediatrica Sinica, V40, P319; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Mak Yin Wei, 2013, Journal of King Saud University Science, V25, P275, DOI 10.1016/j.jksus.2012.12.003; MASAKI H, 1995, BIOL PHARM BULL, V18, P162, DOI 10.1248/bpb.18.162; Moqbel FS, 2011, INDIAN J EXP BIOL, V49, P24; MURAKAMI T, 1995, ARTERIOSCL THROM VAS, V15, P1819, DOI 10.1161/01.ATV.15.11.1819; Murthy DRK, 1997, BIOL PHARM BULL, V20, P756, DOI 10.1248/bpb.20.756; Nayak D, 2015, IET NANOBIOTECHNOL, V9, P288, DOI 10.1049/iet-nbt.2014.0047; PAL AK, 1985, CONTRACEPTION, V32, P517, DOI 10.1016/0010-7824(85)90021-6; Pillai SS, 2016, PLANT FOOD HUM NUTR, V71, P42, DOI 10.1007/s11130-015-0521-6; Pinheiro MS, 2017, AN ACAD BRAS CIENC, V89, P263, DOI 10.1590/0001-3765201720160050; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Ruban P., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P399, DOI 10.1016/S2221-1691(12)60064-1; Sachdewa A, 2003, J ETHNOPHARMACOL, V89, P61, DOI 10.1016/S0378-8741(03)00230-7; Sachdewa Archana, 2001, Indian Journal of Experimental Biology, V39, P284; SALEWSKL E., 1964, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMEEDEBERGS], V247, P367; Shewale PB, 2012, INDIAN J PHARMACOL, V44, P454, DOI 10.4103/0253-7613.99303; Shivananda Nayak B, 2007, Int J Low Extrem Wounds, V6, P76; SINGH MP, 1982, PLANTA MED, V44, P171, DOI 10.1055/s-2007-971433; Sinzato Yuri Karen, 2012, Exp Diabetes Res, V2012, P108163, DOI 10.1155/2012/108163; STAPLES RE, 1964, STAIN TECHNOL, V39, P61; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Vasudeva N, 2008, EVID-BASED COMPL ALT, V5, P91, DOI 10.1093/ecam/nem003; Venkatesh S, 2008, FITOTERAPIA, V79, P79, DOI 10.1016/j.fitote.2007.06.015; Volpato GT, 2008, J ETHNOPHARMACOL, V116, P131, DOI 10.1016/j.jep.2007.11.013; Volpato GT, 2011, J ETHNOPHARMACOL, V138, P691, DOI 10.1016/j.jep.2011.09.044; Volpato GT, 2017, CURR MED CHEM, V24, P404, DOI 10.2174/0929867323666161003122914; Volpato GT, 2015, REPROD SCI, V22, P602, DOI 10.1177/1933719114556485; Wilson JG, 1965, TERATOLOGY PRINCIPLE, P47; Young D, 2000, EFFECTS DRUGS CLIN L; Zhu YN, 2014, J CLIN ENDOCR METAB, V99, P561, DOI 10.1210/jc.2013-2845	55	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179785	10.1371/journal.pone.0179785	http://dx.doi.org/10.1371/journal.pone.0179785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644857	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100037
J	Herath, H; Herath, R; Wickremasinghe, R				Herath, Himali; Herath, Rasika; Wickremasinghe, Rajitha			Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women-A community based retrospective cohort study	PLOS ONE			English	Article							FOLLOW-UP	Background Women with a history of gestational diabetes mellitus (GDM) have an increased risk of type 2 diabetes mellitus (T2DM) later in life compared to women with no GDM. This study was aimed to determine the risk of developing T2DM 10 years after GDM in Sri Lankan women. Methods A retrospective cohort study was conducted in the Colombo district, Sri Lanka. 7205 women who delivered a child in 2005 were identified through Public Health Midwives in the field. Women with antenatal records were interviewed and relevant data were extracted from medical records to identify potential participants. One hundred and nineteen women who had GDM and 240 women who did not have GDM were recruited. Current diagnosis of diabetes was based on history, relevant medical records and blood reports within the past 1 year. Results The mean duration of follow up was 10.9 (SD = 0.35) years in the GDM group and 10.8 (SD = 0.31) years in the non-GDM group. The incidence density of diabetes in the GDM group was 56.3 per 1000 person years compared to 5.4 per 1000 person years in non GDM group giving a rate ratio of 10.42 (95% CI: 6.01-19.12). A woman having GDM in the index pregnancy was 10.6 times more likely to develop diabetes within 10 years compared to women with no GDM after controlling for other confounding variables. Delivering a child after 30 years, being treated with insulin during the pregnancy and delivering a baby weighing more than 3.5 Kg were significant predictors of development of T2DM after controlling for family history of diabetes mellitus (DM), GDM in previous pregnancies, parity and gestational age at delivery. Conclusions Women with GDM had a 10-fold higher risk of developing T2DM during a 10-year follow up period as compared to women with no GDM after controlling for other confounding variables.	[Herath, Himali] Med Res Inst, Dept Nutr, Colombo, Sri Lanka; [Herath, Rasika] Univ Kelaniya, Dept Obstet & Gynaecol, Fac Med, Ragama, Sri Lanka; [Wickremasinghe, Rajitha] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka	Medical Research Institute Sri Lanka (MRI); University Kelaniya; University Kelaniya	Herath, H (corresponding author), Med Res Inst, Dept Nutr, Colombo, Sri Lanka.	himalides@yahoo.com		Herath, Himali/0000-0003-3316-2463; Herath, Rasika/0000-0001-7209-2512	National Research Council SriLanka [15-045]	National Research Council SriLanka	This work was supported by the National Research Council SriLanka (http://www.nrc.gov.lk/) Grant Number 15-045 to RH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2016, DIABETES CARE, V39, P536; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Barden A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.15; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bentley-Lewis R, 2009, LANCET, V373, P1738, DOI 10.1016/S0140-6736(09)60958-2; Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005; Chyad Al-Noaemi M, 2011, GESTATIONAL DIABETES, P91; Dahanayaka NJ, 2012, CEYLON MED J, V57, P5, DOI 10.4038/cmj.v57i1.4193; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Eades CE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0457-8; Family Health Bureau Ministry of Health SL, 2005, ANN REP FAM HLTH 200; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Ginige S., 2004, J COLL COMMUNITY PHY, V9, P40, DOI [10.4038/JCCPSL.V9I1.8278, DOI 10.4038/JCCPSL.V9I1.8278]; Gunderson EP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000490; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS16, DOI 10.1016/j.ijgo.2015.02.010; Internal Medicine Milestone Group. Accreditation Council for graduate medical education (ACGME) and American board of internal medicine (ABIM), 2015, IPC ANN REP 2015, P1; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Krishnaveni GV, 2007, DIABETES RES CLIN PR, V78, P398, DOI 10.1016/j.diabres.2007.06.002; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227; Mahalakshmi Manni Mohanraj, 2014, Indian J Endocrinol Metab, V18, P400, DOI 10.4103/2230-8210.131205; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; O'Reilly SL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002092; Oldfield MD, 2007, POSTGRAD MED J, V83, P426, DOI 10.1136/pgmj.2006.056267; Peacock AS, 2014, WOMEN BIRTH, V27, pE7, DOI 10.1016/j.wombi.2014.09.002; Rayanagoudar G, 2016, DIABETOLOGIA, V59, P1403, DOI 10.1007/s00125-016-3927-2; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P89, DOI 10.5830/CVJA-2016-021; World Health Organization, 1999, WHONCDNCS992PDF	30	72	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179647	10.1371/journal.pone.0179647	http://dx.doi.org/10.1371/journal.pone.0179647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644881	Green Submitted, Green Published, gold			2022-12-26	WOS:000404145100028
J	Kieh, MD; Cho, EM; Myles, IA				Kieh, Mark D.; Cho, Elim M.; Myles, Ian A.			Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak	PLOS ONE			English	Article							EMERGENCY RISK COMMUNICATION; BLOOD-CONTAINING AEROSOLS; HEMORRHAGIC-FEVER; SOCIAL MEDIA; WEST-AFRICA; TRANSMISSION; MANAGEMENT; EPIDEMIC; VACCINES; LESSONS	Under a traditional paradigm, only those with the expected background knowledge consume academic literature. The lay press, as well as government and non-government agencies, play a complementary role of extracting findings of high interest or importance and translating them for general viewing. The need for accurate reporting and public advising is paramount when attempting to tackle epidemic outbreaks through behavior change. Yet, public trust in media outlets is at a historic low. The Crisis and Emergency Risk Communication (CERC) model for media reporting on public health emergencies was established in 2005 and has subsequently been used to analyze media reporting on outbreaks of influenza and measles as well as smoking habits and medication compliance. However, no media analysis had yet been performed on the 2013-2016 Ebola Virus Disease (EVD) outbreak. This study compared the EVD information relayed by lay press sources with general review articles in the academic literature through a mixed-methods analysis. These findings suggest that comprehensive review articles could not serve as a source to clarify and contextualize the uncertainties around the EVD outbreak, perhaps due to adherence to technical accuracy at the expense of clarity within the context of outbreak conditions. This finding does not imply inferiority of the academic literature, nor does it draw direct causation between confusion in review articles and public misunderstanding. Given the erosion of the barriers siloing academia, combined with the demands of today's fast-paced media environment, contemporary researchers should realize that no study is outside the public forum and to therefore consider shifting the paradigm to take personal responsibility in the process of accurately translating their scientific words into public policy actions to best serve as a source of clarity.	[Kieh, Mark D.; Cho, Elim M.; Myles, Ian A.] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Myles, Ian A.] George Washington Sch Publ Hlth, MPH Program, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Myles, IA (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Myles, IA (corresponding author), George Washington Sch Publ Hlth, MPH Program, Washington, DC 20052 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703				Abdullah S, 2015, EUR REV MED PHARMACO, V19, P2983; Afshordi N, 2017, ARXIV201717030538, P1703; Afshordi N, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.041301; Anderson G, 2015, J MED VIROL, V87, P537, DOI 10.1002/jmv.24130; Baize S, 2015, CURR OPIN VIROL, V10, P70, DOI 10.1016/j.coviro.2015.01.008; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; Bastug A, 2015, TURK J MED SCI, V45, P1, DOI 10.3906/sag-1411-37; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bebell LM, 2015, OBSTET GYNECOL, V125, P1293, DOI 10.1097/AOG.0000000000000853; Beeching NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7348; Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227; Bociaga-Jasik Monika, 2014, Folia Med Cracov, V54, P49; Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6; Bousso R, 2002, REV MOD PHYS, V74, P825, DOI 10.1103/RevModPhys.74.825; Burd EM, 2015, J CLIN MICROBIOL, V53, P4, DOI 10.1128/JCM.03115-14; Burnouf T, 2014, TRANSFUS APHER SCI, V51, P120, DOI 10.1016/j.transci.2014.10.003; Butler D, 2013, NATURE, V495, P433, DOI 10.1038/495433a; Camacho A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009346; Cardile Anthony P, 2014, Recent Pat Antiinfect Drug Discov, V9, P97; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Casadevall A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004717; Centers for Disease Control and Prevention, 2017, OUTBR CHRON EB VIR D; Chiappelli F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0362-3; Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Davis J., 2002, OCCASIONAL PAPERS S, V1, P1; De Clercq E, 2015, BIOCHEM PHARMACOL, V93, P1, DOI 10.1016/j.bcp.2014.11.008; de La Vega MA, 2015, VIRAL IMMUNOL, V28, P3, DOI 10.1089/vim.2014.0068; Dhama K, 2015, J INFECT DEV COUNTR, V9, P441, DOI 10.3855/jidc.6197; Durojaiye ET, 2015, AFR J REPROD HEALTH, V19, P18; Eisa-Beygi S, 2015, ANTIVIR RES, V114, P53, DOI 10.1016/j.antiviral.2014.12.005; Elshabrawy HA, 2015, REV MED VIROL, V25, P241, DOI 10.1002/rmv.1841; Eriksson CO, 2015, PEDIATR CRIT CARE ME, V16, P97, DOI 10.1097/PCC.0000000000000358; Falasca L, 2015, CELL DEATH DIFFER, V22, P1250, DOI 10.1038/cdd.2015.67; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Formenty P, 2006, CLIN INFECT DIS, V42, P1521, DOI 10.1086/503836; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011; Funk DJ, 2015, CAN J ANESTH, V62, P80, DOI 10.1007/s12630-014-0257-z; Galas Aleksander, 2014, Folia Med Cracov, V54, P17; Galas Aleksander, 2014, Folia Med Cracov, V54, P27; Galvin Sheila, 2015, J Ir Dent Assoc, V61, P141; Gao JJ, 2014, DRUG DISCOV THER, V8, P229, DOI 10.5582/ddt.2014.01040; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Glisic S, 2015, EXPERT OPIN DRUG DIS, V10, P1025, DOI 10.1517/17460441.2015.1062872; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Goodfellow NA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-909; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4336; Gumusova S, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0089-x; Gut Wlodzimierz, 2015, Przegl Epidemiol, V69, P15; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; HEINSOHN P, 1993, AM IND HYG ASSOC J, V54, P446, DOI 10.1080/15298669391354946; Hellman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005088; Hewlett AL, 2015, CURR OPIN INFECT DIS, V28, P343, DOI 10.1097/QCO.0000000000000176; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Hilton S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1116; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Jadav Surender Singh, 2015, Infectious Disorders - Drug Targets, V15, P20; Jensen JD, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S3-S4; Judson S, 2015, VIRUSES-BASEL, V7, P511, DOI 10.3390/v7020511; Katz LM, 2014, TRANSFUSION, V54, P3247, DOI 10.1111/trf.12913; Kekule AS, 2015, VIRUSES-BASEL, V7, P3789, DOI 10.3390/v7072797; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011386.pub2; Kilgore PE, 2015, PHARMACOTHERAPY, V35, P43, DOI 10.1002/phar.1545; Kite J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162765; Knipe DM, 2015, J VIROL, V89, P7446, DOI 10.1128/JVI.01251-15; Knust B, 2012, J INFECT DIS S2, V2, pS119; Krause PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8202; Laakso M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-124; Lanini S, 2015, LANCET INFECT DIS, V15, P738, DOI 10.1016/S1473-3099(15)70106-4; Leroy EM, 2011, CLIN MICROBIOL INFEC, V17, P964, DOI 10.1111/j.1469-0691.2011.03535.x; Li HY, 2015, MICROBES INFECT, V17, P109, DOI 10.1016/j.micinf.2014.11.012; Li J, 2016, INT J INFECT DIS, V42, P34, DOI 10.1016/j.ijid.2015.10.021; Lindblad R, 2015, J ALLERGY CLIN IMMUN, V135, P868, DOI 10.1016/j.jaci.2014.12.012; Madariaga MG, 2015, AM J MED, V128, P682, DOI 10.1016/j.amjmed.2015.01.035; Marcinkiewicz Janusz, 2014, Folia Med Cracov, V54, P39; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; McCoy CE, 2014, WEST J EMERG MED, V15, P723, DOI 10.5811/westjem.2014.10.24155; McElroy Anita, 2015, Clin Adv Hematol Oncol, V13, P29; Meir L., EBOLA PANIC BOOSTS S; Meyers L, 2015, ANN EMERG MED, V65, P101, DOI 10.1016/j.annemergmed.2014.10.009; MILLER RL, 1995, AM IND HYG ASSOC J, V56, P670, DOI 10.1202/0002-8894(1995)056<0670:COBAGB>2.0.CO;2; Mirazimi A, 2015, J INTERN MED, V278, P227, DOI 10.1111/joim.12386; Mishra B, 2014, INDIAN J MED MICROBI, V32, P364, DOI 10.4103/0255-0857.142230; Missair A, 2015, ANESTH ANALG, V121, P810, DOI 10.1213/ANE.0000000000000573; Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863; Moller-Tank S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004731; Moore LSP, 2014, BRIT J HOSP MED, V75, P515, DOI 10.12968/hmed.2014.75.9.515; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; Mrozek-Budzyn Dorota, 2014, Folia Med Cracov, V54, P33; Murray MJ, 2015, ANESTH ANALG, V121, P798, DOI 10.1213/ANE.0000000000000866; Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451; Oliphant E, 2014, GENET TEST MOL BIOMA, V18, P715, DOI 10.1089/gtmb.2014.1560; Olszanecki Rafal, 2014, Folia Med Cracov, V54, P67; Olupot-Olupot P, 2015, PEDIATR INFECT DIS J, V34, P314, DOI 10.1097/INF.0000000000000638; Osterholm M. T., 2015, MBIO, V6; Osungbade K O, 2014, Afr J Med Med Sci, V43, P87; Parkes-Ratanshi R, 2014, INTENS CARE MED, V40, P1742, DOI 10.1007/s00134-014-3497-z; Patane S, 2014, INT J CARDIOL, V177, P524, DOI 10.1016/j.ijcard.2014.08.114; Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036; Picazo E, 2015, DRUG DISCOV TODAY, V20, P277, DOI 10.1016/j.drudis.2014.12.010; Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571; Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267; Richardson KJ, 2015, ADV EMERG NURS J, V37, P102, DOI 10.1097/TME.0000000000000063; Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5; Riffkin R., 2015, GALLUP; Roca A, 2015, J ALLERGY CLIN IMMUN, V135, P856, DOI 10.1016/j.jaci.2015.02.015; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Schirrmacher V, 2015, INT J MOL MED, V36, P3, DOI 10.3892/ijmm.2015.2213; Sharma N, 2015, DIGEST DIS SCI, V60, P2590, DOI 10.1007/s10620-015-3691-z; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Silver S, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu008; Smith MJ, 2015, MONASH BIOETH REV, V33, P130, DOI 10.1007/s40592-015-0038-7; Snow CE, 2016, NATL ACAD COLLECTION; Somerville RCJ, 2011, PHYS TODAY, V64, P48, DOI 10.1063/PT.3.1296; Sordillo PP, 2015, IN VIVO, V29, P1; Starbird K., 2017, EXAMINING ALTERNATIV; Suwantarat N, 2015, CURR OPIN INFECT DIS, V28, P349, DOI 10.1097/QCO.0000000000000183; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Tan DX, 2014, J PINEAL RES, V57, P381, DOI 10.1111/jpi.12186; Tattevin P, 2014, INTENS CARE MED, V40, P1738, DOI 10.1007/s00134-014-3473-7; Timen A, 2015, EUR J PUBLIC HEALTH, V25, P187, DOI 10.1093/eurpub/cku236; Timsit JF, 2015, INTENS CARE MED, V41, P575, DOI 10.1007/s00134-015-3755-8; To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007; Toner E, 2015, DISASTER MED PUBLIC, V9, P33, DOI 10.1017/dmp.2014.115; Torres Mercedes, 2015, Emerg Med Clin North Am, V33, pe1; Tosh PK, 2014, MAYO CLIN PROC, V89, P1710, DOI 10.1016/j.mayocp.2014.10.010; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Tully CM, 2015, LANCET INFECT DIS, V15, P356, DOI 10.1016/S1473-3099(14)71071-0; Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495; Wadman MC, 2015, ANN EMERG MED, V66, P306, DOI 10.1016/j.annemergmed.2015.04.020; Waters A, 2015, J HOSP MED, V10, P50, DOI 10.1002/jhm.2298; Weingartl HM, 2013, DEV BIOLOGICALS, V135, P211, DOI 10.1159/000178495; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; West T Eoin, 2014, Ann Am Thorac Soc, V11, P1341, DOI 10.1513/AnnalsATS.201410-481PS; WOLLINA U, 1989, ACTA HISTOCHEM, V87, P87, DOI 10.1016/S0065-1281(89)80005-4; Wong G, 2015, EXPERT OPIN INV DRUG, V24, P999, DOI 10.1517/13543784.2015.1052403; Wong G, 2015, CLIN MICROBIOL REV, V28, P593, DOI 10.1128/CMR.00014-15; Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705; Wozniak-Kosek A, 2015, ADV EXP MED BIOL, V857, P19, DOI 10.1007/5584_2015_123; Yang Y, 2008, ANN APPL STAT, V2, P1409, DOI 10.1214/08-AOAS193; Ye L, 2015, MICROBES INFECT, V17, P98, DOI 10.1016/j.micinf.2014.12.004; Zawilinska Barbara, 2014, Folia Med Cracov, V54, P57	150	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179356	10.1371/journal.pone.0179356	http://dx.doi.org/10.1371/journal.pone.0179356			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640889	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800030
J	Kim, SY; Kim, HJ; Park, EK; Joe, J; Sim, S; Choi, HG				Kim, So Young; Kim, Hyung-Jong; Park, Eun-Kyu; Joe, Jiwon; Sim, Songyong; Choi, Hyo Geun			Severe hearing impairment and risk of depression: A national cohort study	PLOS ONE			English	Article							OLDER-ADULTS; COCHLEAR IMPLANTS; HEALTH; ASSOCIATION; DIFFICULTIES; ADOLESCENTS; PREVALENCE; SYMPTOMS; CHILDREN	Objective Hearing impairment is suggested to be associated with depression in the elderly. The present study evaluated the risk of depression after hearing impairment in all age groups matched by age, sex, income, and region of residence. Methods The Korean Health Insurance Review and Assessment Service-National Patient Samples were collected for a period from 2002 to 2013. Hearing impairment was defined as a hearing threshold >= 60 dB in both ears or as >= 80 dB in one ear and >= 40 dB in one ear. Hearing-impaired participants performed a pure tone audiometry test 3 times and an auditory brainstem response threshold test once. The 6,136 hearing-impaired participants were matched 1: 4 with 24,544 controls with no reported hearing impairment for age, sex, income, and region of residence. Depression was investigated based on the International Classification of Disease-10 codes F31 (bipolar affective disorder) through F39 (unspecified mood disorder) by a psychiatrist from 2002 through 2013. The crude (simple) and adjusted (age, sex, income, region of residence, dementia, hypertension, diabetes, and dyslipidemia) hazard ratio (HR) of hearing impairment on depression were analyzed using Cox-proportional hazard model. Results The rate of depression was significantly higher in the severe hearing-impaired group than in the control group (7.9% vs. 5.7%, P < 0.001). Severe hearing impairment increased the risk of depression (adjusted HR = 1.37, 95% confidence interval [CI] = 1.24-1.52, P < 0.001). In a subgroup analysis, young (0-29 years old), middle-aged (30-59 years old), and old (>= 60 years old) severe hearing-impaired groups showed significantly increased risk of depression compared to controls with no reported hearing impairment. In accordance with income level, severe hearing impairment elevated depression in the low and high income groups, but not in the middle income group. Conclusion Severe hearing impairment increased the risk of depression independently of age, sex, region, past medical histories, and income (in low and high income persons but not in middle income persons).	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Hyung-Jong; Park, Eun-Kyu; Joe, Jiwon; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2016M3A9E8941669]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2016M3A9E8941669) from the National Research Foundation (NRF) of Korea and a research grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2016, JAMA OTOLARYNGOL, V142, P652, DOI 10.1001/jamaoto.2016.0700; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; dos Santos FD, 2015, INT ARCH OTORHINOLAR, V19, P229, DOI 10.1055/s-0034-1396792; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Harada S, 2008, PREV MED, V47, P433, DOI 10.1016/j.ypmed.2008.06.011; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Huber M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00953; Jeddi Zahra, 2012, Iran J Otorhinolaryngol, V24, P7; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Jun HJ, 2015, LARYNGOSCOPE, V125, P690, DOI 10.1002/lary.24913; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Lin CS, 2016, J LARYNGOL OTOL, V130, P42, DOI 10.1017/S0022215115002960; Mick P, 2016, EAR HEARING, V37, pE194, DOI 10.1097/AUD.0000000000000267; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Park JW, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0140-1; Pronk M, 2013, AM J AUDIOL, V22, P316, DOI 10.1044/1059-0889(2013/12-0069); Schmitt C, 2000, Int Tinnitus J, V6, P41; Stevenson J, 2015, EUR CHILD ADOLES PSY, V24, P477, DOI 10.1007/s00787-015-0697-1; Theunissen SCPM, 2011, INT J PEDIATR OTORHI, V75, P1313, DOI 10.1016/j.ijporl.2011.07.023; Tremblay KL, 2015, EAR HEARING, V36, pE290, DOI 10.1097/AUD.0000000000000195; Tseng CC, 2016, J AFFECT DISORDERS, V197, P94, DOI 10.1016/j.jad.2016.03.020	23	45	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179973	10.1371/journal.pone.0179973	http://dx.doi.org/10.1371/journal.pone.0179973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640916	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800088
J	Udo, EE; Al-Sweih, N				Udo, Edet E.; Al-Sweih, Noura			Dominance of community-associated methicillin-resistant Staphylococcus aureus clones in a maternity hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NEONATAL UNIT; SAUDI-ARABIA; CHROMOSOME; EPIDEMIOLOGY; INFECTIONS; DIVERSITY; MRSA; SURVEILLANCE; EMRSA-15	Background Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing healthcare-and community-acquired infections. The purpose of this study was to characterize MRSA isolated at the Maternity Hospital between 2006 and 2011 for their genetic relatedness. Materials and methods The MRSA isolates were investigated using a combination of antibiogram, Staphylococcal chromosome cassette mec (SCCmec) and spa typing to determine their relatedness to MRSA isolated in other Kuwait hospitals. The isolates were also investigated for the carriage of genes for Pantone valentine Leukocidin (PVL). Results A total of 103 MRSA obtained from 64 neonates, 17 adult patients and 12 healthcare workers. The isolates were resistant to Kanamycin (46.6%), gentamicin (40.8%), trimethoprim (32%), ciprofloxacin (22.3%), fusidic acid (16.5%), tetracycline (19.4%), erythromycin (15.5%), clindamycin (15.5%), streptomycin (11.6%) high-level mupirocin (2.9%) and chloramphenicol (0.9%). Twenty (19.4%) of the isolates were multiresistant. Thirty-one (30.0%) isolates were positive for PVL. Molecular typing revealed the presence of 11 clonal complexes and 23 clones with ST5-V-t002, (N = 22), ST22-IV-t223 (N = 18), ST22-IV-t852 (N = 10), ST80-IV-t044 (N = 7), ST5-V-t688 (N = 5), ST772-V-t657 (N = 5) and ST239-III-t860 (N = 4) constituting 66.9% of the isolates. Other clones were isolated sporadically. The number of MRSA isolates increased from two in 2006 to 22 in 2011 with a peak of 43 in 2008. Conclusion The study revealed a high prevalence of community-associated MRSA Maternity hospital. The MRSA population consisted of known strains, such as ST239-III-t680, ST22-IV-t223/t852 and ST80-IV-t044, that were reported previously in Kuwait and novel strains such as	[Udo, Edet E.; Al-Sweih, Noura] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University [MI 01/11]	Kuwait University	This study was funded by Research Sector, Kuwait University, grant MI 01/11.	Abou Shady HM, 2015, BRAZ J INFECT DIS, V19, P68, DOI 10.1016/j.bjid.2014.09.005; Al-Haddad AM, 2001, J MED MICROBIOL, V50, P558, DOI 10.1099/0022-1317-50-6-558; Machuca MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073434; Ali H, 2012, J HOSP INFECT, V80, P293, DOI 10.1016/j.jhin.2011.12.019; Alsubaie S, 2012, PEDIATR INT, V54, P786, DOI 10.1111/j.1442-200X.2012.03673.x; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; BSAC, 2010, BSAC METH SUSC TEST; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chung M, 2004, J CLIN MICROBIOL, V42, P542, DOI 10.1128/JCM.42.2.542-547.2004; Clinical and Laboratory Standard Institute, 2012, M100S22 CLSI; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Creech CB, 2010, AM J INFECT CONTROL, V38, P72, DOI 10.1016/j.ajic.2009.06.015; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Djoudi F, 2013, NEW MICROBIOL, V36, P49; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garcia CP, 2014, PEDIATR INFECT DIS J, V33, pE252, DOI 10.1097/INF.0000000000000435; Geraci DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087760; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kamath S, 2010, INDIAN J PEDIATR, V77, P37, DOI 10.1007/s12098-010-0005-5; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Maltezou HC, 2006, INT J ANTIMICROB AG, V27, P87, DOI 10.1016/j.ijantimicag.2005.11.004; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, pO390, DOI 10.1111/1469-0691.12417; Schuenck RP, 2009, DIAGN MICR INFEC DIS, V64, P434, DOI 10.1016/j.diagmicrobio.2009.04.007; Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3; Senok A, 2016, INT J INFECT DIS, V51, P31, DOI 10.1016/j.ijid.2016.08.016; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Takei Y, 2010, BIOCONTROL SCI, V15, P129, DOI 10.4265/bio.15.129; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2008, MED PRIN PRACT, V17, P71, DOI 10.1159/000109594; Udo E. E., 2016, New Microbes and New Infections, V12, P24, DOI 10.1016/j.nmni.2016.03.008; Udo EE, 2013, MED PRIN PRACT, V22, P535, DOI 10.1159/000350526; Udo EE, 2011, J MED MICROBIOL, V60, P600, DOI 10.1099/jmm.0.028381-0; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; Williams K, 2014, J HOSP INFECT, V88, P149, DOI 10.1016/j.jhin.2014.06.012; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179563	10.1371/journal.pone.0179563	http://dx.doi.org/10.1371/journal.pone.0179563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640870	gold, Green Submitted, Green Published			2022-12-26	WOS:000404135800038
J	Houot, L; Navarro, R; Nouailler, M; Duche, D; Guerlesquin, F; Lloubes, R				Houot, Laetitia; Navarro, Romain; Nouailler, Matthieu; Duche, Denis; Guerlesquin, Francoise; Lloubes, Roland			Electrostatic interactions between the CTX phage minor coat protein and the bacterial host receptor TolA drive the pathogenic conversion of Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; OUTER-MEMBRANE INTEGRITY; COLI CELL-ENVELOPE; ESCHERICHIA-COLI; FILAMENTOUS PHAGE; 2-HYBRID SYSTEM; PAL COMPLEX; PSEUDOMONAS-AERUGINOSA; POLAR LOCALIZATION; ANALYSIS WORKBENCH	Vibrio cholerae is a natural inhabitant of aquatic environments and converts to a pathogen upon infection by a filamentous phage, CTX Phi, that transmits the cholera toxin-encoding genes. This toxigenic conversion of V. cholerae has evident implication in both genome plasticity and epidemic risk, but the early stages of the infection have not been thoroughly studied. CTX Phi transit across the bacterial periplasm requires binding between the minor coat protein named pIII and a bacterial inner-membrane receptor, TolA, which is part of the conserved Tol-Pal molecular motor. To gain insight into the TolA-pIII complex, we developed a bacterial two-hybrid approach, named Oxi-BTH, suited for studying the interactions between disulfide bond-folded proteins in the bacterial cytoplasm of an Escherichia coli reporter strain. We found that two of the four disulfide bonds of pIII are required for its interaction with TolA. By combining Oxi-BTH assays, NMR, and genetic studies, we also demonstrate that two intermolecular salt bridges between TolA and pIII provide the driving forces of the complex interaction. Moreover, we show that TolA residue Arg-325 involved in one of the two salt bridges is critical for proper functioning of the Tol-Pal system. Our results imply that to prevent host evasion, CTX Phi uses an infection strategy that targets a highly conserved protein of Gram-negative bacteria essential for the fitness of V. cholerae in its natural environment.	[Houot, Laetitia; Navarro, Romain; Nouailler, Matthieu; Duche, Denis; Guerlesquin, Francoise; Lloubes, Roland] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol,UMR7255, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Houot, L (corresponding author), Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol,UMR7255, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	lhouot@imm.cnrs.fr		LLOUBES, Roland/0000-0002-9520-1053; Duche, Denis/0000-0002-4208-6661	CNRS; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-14-CE09-0023]; Fondation pour la Recherche Medicale [SPF20100518724]; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported in part by CNRS and the Aix-Marseille Universite (to the R. L. and W. G. Laboratories) and Agence Nationale de la Recherche Grant ANR-14-CE09-0023 (to the R. L. research team). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctoral Fellowship FRM, SPF20100518724 from Fondation pour la Recherche Medicale. To whom correspondence should be addressed. Tel.: 33-491-164-663; Fax: 33-491-712-124; E-mail: E-mail: lhouot@imm.cnrs.fr.; Supported by a Ph.D. fellowship from the French Ministry of Research.	Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Basse MJ, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw007; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bennett NJ, 2006, J MOL BIOL, V356, P266, DOI 10.1016/j.jmb.2005.11.069; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Ceccarelli D, 2015, APPL ENVIRON MICROB, V81, P1909, DOI 10.1128/AEM.03540-14; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Deng LW, 2002, J MOL BIOL, V319, P603, DOI 10.1016/S0022-2836(02)00260-7; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; Derouiche R, 1997, MICROBIOL-UK, V143, P3185, DOI 10.1099/00221287-143-10-3185; Faruque SM, 1998, INFECT IMMUN, V66, P5819, DOI 10.1128/IAI.66.12.5819-5825.1998; Fengler VHI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047756; Ford CG, 2012, J BIOL CHEM, V287, P36258, DOI 10.1074/jbc.M112.403386; Gao Y, 2016, J BACTERIOL, V198, P2818, DOI 10.1128/JB.00309-16; Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; Goforth JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060765; Gonzalez MD, 2002, J BACTERIOL, V184, P6050, DOI 10.1128/JB.184.21.6050-6055.2002; Gray AN, 2015, ELIFE, V4, DOI 10.7554/eLife.07118; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Hasan NA, 2013, APPL ENVIRON MICROB, V79, P5782, DOI 10.1128/AEM.01113-13; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Heilpern AJ, 2003, J BACTERIOL, V185, P1037, DOI 10.1128/JB.185.3.1037-1044.2003; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jiang S, 2003, APPL ENVIRON MICROB, V69, P7541, DOI 10.1128/AEM.69.12.7541-7544.2003; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Li C, 2012, J BIOL CHEM, V287, P19048, DOI 10.1074/jbc.M112.342246; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Mai-Prochnow A, 2015, FEMS MICROBIOL REV, V39, P465, DOI 10.1093/femsre/fuu007; Martin A, 2003, J MOL BIOL, V329, P599, DOI 10.1016/S0022-2836(03)00433-9; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Meury J, 1999, BIOL CELL, V91, P67, DOI 10.1016/S0248-4900(99)80032-X; Morgan SJ, 2016, J BACTERIOL, V198, P498, DOI 10.1128/JB.00338-15; Ng D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006109; Ouellette SP, 2014, ENV MICROBIOL REP, V6, P259, DOI 10.1111/1758-2229.12123; Pommier S, 2005, J BACTERIOL, V187, P7526, DOI 10.1128/JB.187.21.7526-7534.2005; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Santos TMA, 2014, MOL MICROBIOL, V92, P985, DOI 10.1111/mmi.12609; Sarkar A, 2002, INFECT IMMUN, V70, P4735, DOI 10.1128/IAI.70.8.4735-4742.2002; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; TOMASI M, 1979, EUR J BIOCHEM, V93, P621, DOI 10.1111/j.1432-1033.1979.tb12862.x; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	73	7	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13584	13598		10.1074/jbc.M117.786061	http://dx.doi.org/10.1074/jbc.M117.786061			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28642371	Green Published, hybrid			2022-12-26	WOS:000407942400010
J	An, JY; Park, BB; Chun, JH; Osawa, A				An, Ji Young; Park, Byung Bae; Chun, Jung Hwa; Osawa, Akira			Litterfall production and fine root dynamics in cool-temperate forests	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; GROUND CARBON ALLOCATION; SCOTS PINE STANDS; NORTHERN HARDWOOD; NITROGEN AVAILABILITY; DOUGLAS-FIR; BIOMASS; TURNOVER; SOIL; ECOSYSTEMS	Current understanding of litterfall and fine root dynamics in temperate forests is limited, even though these are the major contributors to carbon and nutrient cycling in the ecosystems. In this study, we investigated litterfall and fine root biomass and production in five deciduous and four coniferous forests at the Gwangneung Experimental Forest in Korea. We used ingrowth cores to measure fine root production and root turnover rate. The litterfall was separated into leaves, twigs, and others, and then leaves were further separated according to species. Annual litterfall mass was not significantly different between the years, 360 to 651 g m(-2) in 2011 and 300 to 656 g m(-2) in 2012. Annual fine root (<5 mm) production was significantly higher in 2012 (421 to 1342 g m(-2)) than in 2011 (99 to 872 g m(-2)). Annual litterfall mass was significantly different among the stands, while fine root production did not statistically differ among the stands. The average fine root turnover rate, calculated by dividing the annual fine root production by the maximum standing fine root biomass, was 1.65 for deciduous forests and 1.97 for coniferous forests. Fine root production constituted 18-44% of NPP, where NPP was the sum of woody biomass production, litterfall production, and fine root production. Belowground production was a greater fraction of NPP in more productive forests suggesting their greater carbon allocation belowground.	[An, Ji Young; Park, Byung Bae; Chun, Jung Hwa] Korea Forest Res Inst, Div Forest Ecol, Seoul, South Korea; [An, Ji Young; Osawa, Akira] Kyoto Univ, Div Forest & Biomat Sci, Kyoto, Japan; [Park, Byung Bae] Chungnam Natl Univ, Dept Environm & Forest Resources, Daejeon, South Korea	Korea Forest Research Institute (KFRI); Kyoto University; Chungnam National University	Park, BB (corresponding author), Korea Forest Res Inst, Div Forest Ecol, Seoul, South Korea.; Park, BB (corresponding author), Chungnam Natl Univ, Dept Environm & Forest Resources, Daejeon, South Korea.	bbpark@cnu.ac.kr		Park, Byung Bae/0000-0002-0620-7374; An, Ji Young/0000-0001-8573-0456	'R&D Program for Forest Science Technology [FTIS2014068E10-1719-AA01]; Korea Forest Service (Korea Forestry Promotion Institute)	'R&D Program for Forest Science Technology; Korea Forest Service (Korea Forestry Promotion Institute)(Korea Forest ServiceKorea Forestry Promotion Institute (KOFPI))	This study was partially carried out with the support of 'R&D Program for Forest Science Technology (Project No. FTIS2014068E10-1719-AA01)' provided by Korea Forest Service (Korea Forestry Promotion Institute), http://english.forest.go.kr/newkfsweb/eng/idx/Index.do?mn=ENG_01.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; Alvarez-Uria P, 2007, FUNCT ECOL, V21, P211, DOI 10.1111/j.1365-2435.2007.01231.x; [Anonymous], THESIS; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; BURKE MK, 1994, PLANT SOIL, V162, P135, DOI 10.1007/BF01416099; Chae N, 2011, J PLANT BIOL, V54, P101, DOI 10.1007/s12374-011-9148-9; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; Cho YC, 2007, J PLANT BIOL, V50, P615, DOI 10.1007/BF03030604; Chun Jung Hwa, 2007, Journal of Korean Forestry Society, V96, P591; Cox MS, 2001, SOIL SCI, V166, P484, DOI 10.1097/00010694-200107000-00006; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Fairley R. I., 1985, Ecological interactions in soil: plants, microbes and animals, P37; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; GOWER ST, 1987, BIOTROPICA, V19, P171, DOI 10.2307/2388741; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; HENDRICK RL, 1993, CAN J FOREST RES, V23, P2507, DOI 10.1139/x93-312; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hishi T., 2015, Plant Root, V9, P85, DOI 10.3117/plantroot.9.85; Hwang J, 2007, J PLANT NUTR, V30, P1821, DOI 10.1080/01904160701628940; Im J-N, 2000, METHODS SOIL PLANT, P1; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Janssens IA, 2002, FOREST ECOL MANAG, V168, P231, DOI 10.1016/S0378-1127(01)00755-1; KEYES MR, 1981, CAN J FOREST RES, V11, P599, DOI 10.1139/x81-082; Kim J, 2006, ECOL RES, V21, P881, DOI 10.1007/s11284-006-0055-3; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lee Dongho, 2007, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V9, P149; Leppalammi-Kujansuu J, 2014, FOREST ECOL MANAG, V326, P79, DOI 10.1016/j.foreco.2014.03.039; Li Z, 2003, CAN J FOREST RES, V33, P126, DOI 10.1139/X02-165; Lim J. H., 2003, KOREAN J AGR FOREST, V5, P101; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Makkonen K, 1999, PLANT SOIL, V210, P43, DOI 10.1023/A:1004629212604; McCormack ML, 2015, ECOL MODEL, V297, P107, DOI 10.1016/j.ecolmodel.2014.11.013; McCormack ML, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00205; Messier C., 1993, Silva Fennica, V27, P209; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; NADELHOFFER KJ, 1985, ECOLOGY, V66, P1377, DOI 10.2307/1939190; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Newman GS, 2006, ECOSYSTEMS, V9, P317, DOI 10.1007/s10021-006-0015-3; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Park BB, 2008, ECOSYSTEMS, V11, P325, DOI 10.1007/s10021-008-9126-3; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; SANTANTONIO D, 1987, CAN J FOREST RES, V17, P900, DOI 10.1139/x87-141; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sierra CA, 2003, J TROP ECOL, V19, P599, DOI 10.1017/S0266467403003663; Smithwick EAH, 2014, ECOL MODEL, V291, P193, DOI 10.1016/j.ecolmodel.2014.07.023; Son Y, 2003, ECOL RES, V18, P339, DOI 10.1046/j.1440-1703.2003.00559.x; Sparks DL, 1996, SSSA BOOK SER; Steele SJ, 1997, TREE PHYSIOL, V17, P577; Sumner M. E., 1996, Methods of soil analysis. Part 3 - chemical methods., P1201; Tateno R, 2004, FOREST ECOL MANAG, V193, P297, DOI 10.1016/j.foreco.2003.11.011; Van Do T, 2015, ECOL RES, V30, P921, DOI 10.1007/s11284-015-1295-x; Trumbore SE, 2003, SCIENCE, V302, P1344, DOI 10.1126/science.1091841; VanDo T, 2015, TREES; VOGT K, 1991, TREE PHYSIOL, V9, P69, DOI 10.1093/treephys/9.1-2.69; Vogt K.A., 1991, TECHNIQUES APPROACHE, P477; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; Vogt KA, 1998, DEV PLANT SOIL SCI, V82, P687; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; YIN XW, 1989, FOREST ECOL MANAG, V27, P159, DOI 10.1016/0378-1127(89)90105-9; Yuan ZY, 2013, ACTA OECOL, V48, P54, DOI 10.1016/j.actao.2013.01.009; Zak DR, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P372; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhou Y, 2014, PLANT SOIL, V374, P19, DOI 10.1007/s11104-013-1816-8	69	14	15	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180126	10.1371/journal.pone.0180126	http://dx.doi.org/10.1371/journal.pone.0180126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662215	Green Submitted, Green Published, gold			2022-12-26	WOS:000404608300108
J	Bose, U; Kruangkum, T; Wang, TF; Zhao, M; Ventura, T; Mitu, SA; Hodson, MP; Shaw, PN; Sobhon, P; Cummins, SF				Bose, Utpal; Kruangkum, Thanapong; Wang, Tianfang; Zhao, Min; Ventura, Tomer; Mitu, Shahida Akter; Hodson, Mark P.; Shaw, Paul N.; Sobhon, Prasert; Cummins, Scott F.			Biomolecular changes that occur in the antennal gland of the giant freshwater prawn (Machrobrachium rosenbergii)	PLOS ONE			English	Article							CHINESE MITTEN CRAB; JUVENILE-HORMONE; ANDROGENIC GLAND; SPINY LOBSTER; URIC-ACID; IDENTIFICATION; PHEROMONE; SEQUENCE; RELEASE; CRUSTACEANS	In decapod crustaceans, the antennal gland (AnG) is a major primary source of externally secreted biomolecules, and some may act as pheromones that play a major role in aquatic animal communication. In aquatic crustaceans, sex pheromones regulate reproductive behaviours, yet they remain largely unidentified besides the N-acetylglucosamine-1,5-lactone (NAGL) that stimulates male to female attraction. In this study, we used an AnG transcriptome of the female giant freshwater prawn (Macrobrachium rosenbergii) to predict the secretion of 226 proteins, including the most abundantly expressed transcripts encoding the Spaetzle protein, a serine protease inhibitor, and an arthropodial cuticle protein AMP 8.1. A quantitative proteome analysis of the female AnG at intermolt, premolt and postmolt, identified numerous proteins of different abundances, such as the hemocyanin subunit 1 that is most abundant at intermolt. We also show that hemocyanin subunit 1 is present within water surrounding females. Of those metabolites identified, we demonstrate that the NAGL and Nacetylglucosamine (NAG) can bind with high affinity to hemocyanin subunit 1. In summary, this study has revealed components of the female giant freshwater prawn AnG that are released and contribute to further research towards understanding crustacean conspecific signalling.	[Bose, Utpal; Wang, Tianfang; Zhao, Min; Ventura, Tomer; Mitu, Shahida Akter; Cummins, Scott F.] Univ Sunshine Coast, Genet Ecol & Physiol Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia; [Bose, Utpal; Hodson, Mark P.] Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Kruangkum, Thanapong] Mahidol Univ, Dept Anat, Fac Sci, Bangkok, Thailand; [Kruangkum, Thanapong; Sobhon, Prasert] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Fac Sci, Bangkok, Thailand; [Hodson, Mark P.; Shaw, Paul N.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Sobhon, Prasert] Burapha Univ, Fac Allied Hlth Sci, Chon Buri, Thailand	University of the Sunshine Coast; University of Queensland; Mahidol University; Mahidol University; University of Queensland; Burapha University	Cummins, SF (corresponding author), Univ Sunshine Coast, Genet Ecol & Physiol Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	scummins@usc.edu.au	Wang, Tianfang/GRO-0844-2022; Shaw, Paul/Q-8454-2019; Ventura, T./H-9832-2019; Shaw, Paul N/G-4418-2010; Wang, Tianfang/L-5192-2016; Zhao, Min/J-6588-2019; Bose, Utpal/AAU-5241-2020; Bose, Utpal/A-1785-2019; Wang, Tianfang/AAG-4290-2020; Hodson, Mark/J-7609-2013; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Shaw, Paul/0000-0001-7154-592X; Ventura, T./0000-0002-0777-2367; Shaw, Paul N/0000-0001-7154-592X; Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Bose, Utpal/0000-0003-1156-6504; Bose, Utpal/0000-0003-1156-6504; Wang, Tianfang/0000-0002-4876-7767; Hodson, Mark/0000-0002-5436-1886; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [FT110100990]; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council (Future Fellowship, FT110100990 to SFC). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohsen I, 2009, THESIS; ATEMA J, 1986, J CHEM ECOL, V12, P2065, DOI 10.1007/BF01041997; Bamber SD, 1997, ESTUAR COAST SHELF S, V44, P195, DOI 10.1006/ecss.1996.0211; BARKER DL, 1979, BRAIN RES, V161, P99, DOI 10.1016/0006-8993(79)90198-7; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bhavan P. S., 2010, International Journal of Biology, V2, P107; BINNS R, 1969, BIOL BULL, V136, P147, DOI 10.2307/1539809; Bose U, 2016, COMP BIOCHEM PHYS D, V19, P25, DOI 10.1016/j.cbd.2016.05.004; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Case D.A., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chandler JC, 2015, SEX DEV, V9, P338, DOI 10.1159/000443943; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eriksson L., 2001, MULTI MEGAVARIATE DA; Felgenhauer B.E., 1992, P45; FINGERMAN M, 1994, J CRUSTACEAN BIOL, V14, P413, DOI 10.2307/1548990; Fingerman M, 1997, INVERTEBR REPROD DEV, V31, P47, DOI 10.1080/07924259.1997.9672562; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Gao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144350; Giraud-Billoud M, 2011, COMP BIOCHEM PHYS A, V158, P506, DOI 10.1016/j.cbpa.2010.12.012; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Guo YR, 2014, FISHERIES SCI, V80, P621, DOI 10.1007/s12562-014-0738-6; Hardege JD, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P373, DOI 10.1007/978-0-387-77101-4_19; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamio M, 2005, BIOL BULL-US, V208, P12, DOI 10.2307/3593096; Kamio M, 2014, J EXP BIOL, V217, P1286, DOI 10.1242/jeb.099051; KEEN JN, 1991, EUR J BIOCHEM, V197, P407, DOI 10.1111/j.1432-1033.1991.tb15925.x; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kruangkum T, 2015, ANIM REPROD SCI, V161, P129, DOI 10.1016/j.anireprosci.2015.08.015; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levesque B, 1999, PHARMACOGENETICS, V9, P207; Li X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059064, 10.1371/journal.pone.0067880, 10.1371/journal.pone.0063227, 10.1371/journal.pone.0080399]; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MANGUM CP, 1980, AM ZOOL, V20, P19; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Nor Faadila M, 2012, INT FOOD RES J, V20, P751; PETERSON DR, 1974, J EXP ZOOL, V189, P85, DOI 10.1002/jez.1401890108; Pinnow P, 2016, J COMP PHYSIOL B, V186, P161, DOI 10.1007/s00360-015-0943-3; Rittschof D, 2004, PEPTIDES, V25, P1503, DOI 10.1016/j.peptides.2003.10.024; RYAN EP, 1966, SCIENCE, V151, P340, DOI 10.1126/science.151.3708.340; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SPENCER M, 1986, J COMP PHYSIOL A, V158, P59, DOI 10.1007/BF00614520; Suwansa-ard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123848; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian ZH, 2012, FISHERIES SCI, V78, P67, DOI 10.1007/s12562-011-0426-8; Vasudevan Sugumar, 2013, Journal of Marine Animals and their Ecology, V6, P12; Ventura T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13537; Ventura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055322; Ventura T, 2012, BIOTECHNOL ADV, V30, P1543, DOI 10.1016/j.biotechadv.2012.04.008; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Zeeck E, 1998, J CHEM ECOL, V24, P13, DOI 10.1023/A:1022328610423	62	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0177064	10.1371/journal.pone.0177064	http://dx.doi.org/10.1371/journal.pone.0177064			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662025	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300002
J	Jeong, J; Park, S; An, HT; Kang, M; Ko, J				Jeong, Juyeon; Park, Sodam; An, Hyoung-Tae; Kang, Minsoo; Ko, Jesang			Small leucine zipper protein functions as a negative regulator of estrogen receptor a in breast cancer	PLOS ONE			English	Article							NUCLEAR RECEPTOR; CO-REPRESSOR; SUPERFAMILY; BINDING; SLZIP; GENE; TRANSCRIPTION; COACTIVATORS; COREGULATORS; INVOLVEMENT	The nuclear transcription factor estrogen receptor alpha (ER alpha) plays a critical role in breast cancer progression. ER alpha acts as an important growth stimulatory protein in breast cancer and the expression level of ER alpha is tightly related to the prognosis and treatment of patients. Small leucine zipper protein (sLZIP) functions as a transcriptional cofactor by binding to various nuclear receptors, including glucocorticoid receptor, androgen receptor, and peroxisome proliferator-activated receptor gamma. However, the role of sLZIP in the regulation of ER alpha and its involvement in breast cancer progression is unknown. We found that sLZIP binds to ER alpha and represses the transcriptional activity of ERa in ER alpha-positive breast cancer cells. sLZIP also suppressed the expression of ER alpha target genes. sLZIP disrupted the binding of ER alpha to the estrogen response element of the target gene promoter, resulting in suppression of cell proliferation. sLZIP is a novel co-repressor of ER alpha, and plays a negative role in ER alpha-mediated cell proliferation in breast cancer.	[Jeong, Juyeon; Park, Sodam; An, Hyoung-Tae; Kang, Minsoo; Ko, Jesang] Korea Univ, Div Life Sci, Seoul, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, Seoul, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Tunneling Nanotube Research Center through National Research Foundation of Korea (NRF) [NRF-2015R1A5A1009024]; Korea government (MSIP)	Tunneling Nanotube Research Center through National Research Foundation of Korea (NRF); Korea government (MSIP)	This work was supported by Tunneling Nanotube Research Center (NRF-2015R1A5A1009024) through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP).	CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Giguere V, 1998, STEROIDS, V63, P335, DOI 10.1016/S0039-128X(98)00024-5; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HENDERSON BE, 1988, CANCER RES, V48, P246; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; Kim J, 2014, FASEB J, V28, P5010, DOI 10.1096/fj.14-259218; Kim Y, 2015, ONCOGENE, V34, P226, DOI 10.1038/onc.2013.538; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Lu DS, 2001, CANCER RES, V61, P6755; Luciano RL, 2000, P NATL ACAD SCI USA, V97, P10757, DOI 10.1073/pnas.190062797; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Xue H, 2016, INT J ONCOL, V49, P519, DOI 10.3892/ijo.2016.3576	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180197	10.1371/journal.pone.0180197	http://dx.doi.org/10.1371/journal.pone.0180197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662179	Green Submitted, gold, Green Published			2022-12-26	WOS:000404608300124
J	Liu, YL; Lardi, M; Pedrioli, A; Eberl, L; Pessi, G				Liu, Yilei; Lardi, Martina; Pedrioli, Alessandro; Eberl, Leo; Pessi, Gabriella			NtrC-dependent control of exopolysaccharide synthesis and motility in Burkholderia cenocepacia H111	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; SWARMING MOTILITY; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; SIGMA-FACTOR; NITROGEN ASSIMILATION; BIOSYNTHESIS; SYSTEM	Burkholderia cenocepacia is a versatile opportunistic pathogen that survives in a wide variety of environments, which can be limited in nutrients such as nitrogen. We have previously shown that the sigma factor sigma(54) is involved in the control of nitrogen assimilation and virulence in B. cenocepacia H111. In this work, we investigated the role of the sigma(54) enhancer binding protein NtrC in response to nitrogen limitation and in the pathogenicity of H111. Of 95 alternative nitrogen sources tested the ntrC showed defects in the utilisation of nitrate, urea, L-citrulline, acetamide, DL-lactamide, allantoin and parabanic acid. RNA-Seq and phenotypic analyses of an ntrC mutant strain showed that NtrC positively regulates two important phenotypic traits: exopolysaccharide (EPS) production and motility. However, the ntrC mutant was not attenuated in C. elegans virulence.	[Liu, Yilei; Lardi, Martina; Pedrioli, Alessandro; Eberl, Leo; Pessi, Gabriella] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland	University of Zurich	Eberl, L; Pessi, G (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland.	leberl@botinst.uzh.ch; gabriella.pessi@botinst.uzh.ch	Eberl, Leo/AAE-8165-2019; Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/A-8380-2012	Eberl, Leo/0000-0002-7241-0864; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation [31003A-169307/1, LEand31003A_153374]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (31003A-169307/1 to LEand31003A_153374 to GP).	Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Ahn SJ, 2016, APPL ENVIRON MICROB, V82, P6189, DOI 10.1128/AEM.01499-16; AMES GFL, 1985, EMBO J, V4, P539, DOI 10.1002/j.1460-2075.1985.tb03662.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker AE, 2016, J BACTERIOL, V198, P1837, DOI 10.1128/JB.00196-16; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Carlier A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00298-14; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cuzzi B, 2012, INNATE IMMUN-LONDON, V18, P661, DOI 10.1177/1753425911435954; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109; Eberl L, 1996, J BACTERIOL, V178, P554, DOI 10.1128/jb.178.2.554-559.1996; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; Francke C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-385; Hervas AB, 2008, J BACTERIOL, V190, P416, DOI 10.1128/JB.01230-07; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; HIRSCHMAN J, 1985, P NATL ACAD SCI USA, V82, P7525, DOI 10.1073/pnas.82.22.7525; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Kim HS, 2009, MOL MICROBIOL, V74, P436, DOI 10.1111/j.1365-2958.2009.06875.x; Kuchma SL, 2015, J BACTERIOL, V197, P420, DOI 10.1128/JB.02130-14; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lardi M, 2015, APPL ENVIRON MICROB, V81, P4077, DOI 10.1128/AEM.00694-15; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118; MORETT E, 1989, J MOL BIOL, V210, P65, DOI 10.1016/0022-2836(89)90291-X; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Nickzad A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01215; Nickzad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128509; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pioszak AA, 2000, BIOCHEMISTRY-US, V39, P13450, DOI 10.1021/bi000795m; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Shastri S, 2017, PLASMID, V89, P49, DOI 10.1016/j.plasmid.2016.11.002; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wang D, 2013, APPL ENVIRON MICROB, V79, P7150, DOI 10.1128/AEM.02225-13; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yang Y, 2015, SCIENCE, V349, P882, DOI 10.1126/science.aab1478; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	63	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180362	10.1371/journal.pone.0180362	http://dx.doi.org/10.1371/journal.pone.0180362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662146	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300145
J	Liu, YZ; Sharp, JS; Do, DHT; Kahn, RA; Schwalbe, H; Buhr, F; Prestegard, JH				Liu, Yizhou; Sharp, Joshua S.; Do, Duc H-T.; Kahn, Richard A.; Schwalbe, Harald; Buhr, Florian; Prestegard, James H.			Mistakes in translation: Reflections on mechanism	PLOS ONE			English	Article							RARE ARGININE CODON; ESCHERICHIA-COLI; MESSENGER-RNA; ACID MISINCORPORATION; PROTEIN EXPRESSION; RIBOSOME; CONTEXT; LEVEL; GENE; DYNAMICS	Mistakes in translation of messenger RNA into protein are clearly a detriment to the recombinant production of pure proteins for biophysical study or the biopharmaceutical market. However, they may also provide insight into mechanistic details of the translation process. Mistakes often involve the substitution of an amino acid having an abundant codon for one having a rare codon, differing by substitution of a G base by an A base, as in the case of substitution of a lysine (AAA) for arginine (AGA). In these cases one expects the substitution frequency to depend on the relative abundances of the respective tRNAs, and thus, one might expect frequencies to be similar for all sites having the same rare codon. Here we demonstrate that, for the ADP-ribosylation factor from yeast expressed in E. coli, lysine for arginine substitutions frequencies are not the same at the 9 sites containing a rare arginine codon; mis-incorporation frequencies instead vary from less than 1 to 16%. We suggest that the context in which the codons occur (clustering of rare sites) may be responsible for the variation. The method employed to determine the frequency of mis-incorporation involves a novel mass spectrometric analysis of the products from the parallel expression of wild type and codon-optimized genes in N-15 and N-14 enriched media, respectively. The high sensitivity and low material requirements of the method make this a promising technology for the collection of data relevant to other mis-incorporations. The additional data could be of value in refining models for the ribosomal translation elongation process.	[Liu, Yizhou; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Sharp, Joshua S.] Univ Mississippi, Dept BioMol Sci, Oxford, MS USA; [Do, Duc H-T.] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Schwalbe, Harald; Buhr, Florian] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [Liu, Yizhou] Merck & Co Inc, Proc & Analyt Res & Dev, NMR Struct Elucidat Grp, Rahway, NJ 07065 USA; [Buhr, Florian] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge, England	University System of Georgia; University of Georgia; University of Mississippi; University System of Georgia; University of Georgia; Emory University; Goethe University Frankfurt; Merck & Company; University of Cambridge	Prestegard, JH (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu	Kahn, Richard/ABD-2666-2020; Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Kahn, Richard/0000-0002-0259-0601; Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Prestegard, James/0000-0002-1602-4790	National Institute of General Medical Sciences [GM061268]; EU; state of Hesse, Germany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122568] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EU(European Commission); state of Hesse, Germany; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially funded by a grant from the National Institute of General Medical Sciences to JHP, GM061268. FB was funded by EU Programme iNEXT. Work supervised by HS was funded by the state of Hesse, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Chen J, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000056; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Forman MD, 1998, PROTEIN SCI, V7, P500; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Harris RP, 2014, CURR OPIN BIOTECH, V30, P45, DOI 10.1016/j.copbio.2014.05.003; Huang YP, 2012, PROTEIN SCI, V21, P625, DOI 10.1002/pro.2046; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Kerrigan JJ, 2008, PROTEIN EXPRES PURIF, V60, P110, DOI 10.1016/j.pep.2008.02.016; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ogle JM, ANN REV BIOCH, P129; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pasa-Tolic L, 1999, J AM CHEM SOC, V121, P7949, DOI 10.1021/ja991063o; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Rodnina MV, 2016, PROTEIN SCI, V25, P1390, DOI 10.1002/pro.2950; Rudorf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134994; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; SIEMION IZ, 1994, BIOSYSTEMS, V33, P139, DOI 10.1016/0303-2647(94)90053-1; Vieira JP, 2016, BIOPHYS J, V110, P2120, DOI 10.1016/j.bpj.2016.04.004; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wilson DN, 2016, CURR OPIN STRUC BIOL, V37, P123, DOI 10.1016/j.sbi.2016.01.008; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Xie T, 1998, FEBS LETT, V434, P93; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128	35	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180566	10.1371/journal.pone.0180566	http://dx.doi.org/10.1371/journal.pone.0180566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662217	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608300166
J	Loiselle, JJ; Roy, JG; Sutherland, LC				Loiselle, Julie J.; Roy, Justin G.; Sutherland, Leslie C.			RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR GENE; OXIDATIVE-PHOSPHORYLATION; DIFFERENTIAL EXPRESSION; SPLICING REGULATION; PARKINSONS-DISEASE; BREAST-CANCER; SIGNATURES; 3P21.3; ADENOCARCINOMA	Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need for more effective SCLC screening and treatment options. Interestingly, the earliest and most frequent genetic alteration associated with lung cancers involves a lesion in the region to which the RNA binding protein RBM5 maps. We have recently shown that a decrease in RBM5 expression may be a key step in SCLC development, as RBM5 regulated many transformation-associated processes in SCLC cells. RBM5 is structurally and functionally similar to another RNA binding protein, RBM10. Both proteins have tumor-suppressor properties in a variety of cancer cell lines, and it has been suggested that RBM5 expression can influence RBM10. Due to their similarities, and the recent evidence that RBM10 is mutated in up to 21% of lung cancers, we hypothesized that RBM10 would share RBM5' s tumor-suppressor properties in SCLC. Using transcriptome analysis and functional assays, we show, however, that RBM10' s function was opposite to what we hypothesized; in the endogenously RBM5-null GLC20 SCLC cell line, RBM10 actually promoted cell proliferation and other transformation-associated processes. Using RNA immunoprecipitation followed by next generation sequencing (RIP-Seq) and Western blotting, we demonstrate that RBM5 post-transcriptionally regulated RBM10 expression via direct interaction with specific RBM10 splice variants. We propose a working model describing the impact of this interaction on cellular processes. Our results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value.	[Loiselle, Julie J.; Sutherland, Leslie C.] Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada; [Roy, Justin G.; Sutherland, Leslie C.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada; [Sutherland, Leslie C.] HSNRI, Sudbury, ON, Canada	Laurentian University; Laurentian University; Health Sciences North	Loiselle, JJ (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada.	jloiselle@hsnri.ca			Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council of Canada (NSERC) [9043429]	Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) (JJL) (http://www.nserc-crsng.gc.ca/Students- Etudiants/PG-CS/BellandPostgradB elletSuperieures_eng.asp). Discovery Grant #9043429 from the Natural Sciences and Engineering Research Council of Canada (NSERC) (LCS) (http://www.nserc-crsng.gc.ca/ProfessorsP rofesseurs/Grants-Subs/DGIGP-PSIGP_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Biffi A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.141; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chute JP, 1999, J CLIN ONCOL, V17, P1794, DOI 10.1200/JCO.1999.17.6.1794; D'Andrea D, 2013, NUCLEIC ACIDS RES, V41, pW84, DOI 10.1093/nar/gkt516; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Del Fabbro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085024; Dey D, 2013, LUPUS, V22, P919, DOI 10.1177/0961203313497118; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finsterer J, 2001, NEURORADIOLOGY, V43, P997, DOI 10.1007/s002340100618; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Garrisi VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112025; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GORLIN RJ, 1970, AM J DIS CHILD, V119, P176, DOI 10.1001/archpedi.1970.02100050178020; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Hernandez J, 2016, RNA BIOL, V13, P466, DOI 10.1080/15476286.2016.1144004; HUNG J, 1995, JAMA-J AM MED ASSOC, V273, P1908; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue A, 2014, FEBS LETT, V588, P942, DOI 10.1016/j.febslet.2014.01.052; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jackson TC, 2015, J CEREBR BLOOD F MET, V35, P655, DOI 10.1038/jcbfm.2014.242; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-576; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kurpinski KT, 2003, AM J MED GENET A, V120A, P1, DOI 10.1002/ajmg.a.10201; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lerman MI, 2000, CANCER RES, V60, P6116; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loiselle JJ, 2015, IN VITRO CELL DEV BI; Loiselle JJ, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00204; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Martinez-Arribas F, 2006, J CELL BIOCHEM, V97, P1275, DOI 10.1002/jcb.20725; Miller G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-62; Mueller CFH, 2009, ARCH BIOCHEM BIOPHYS, V488, P76, DOI 10.1016/j.abb.2009.06.002; Oh JJ, 2002, CANCER RES, V62, P3207; Ozuemba B, 2016, GENE, V580, P26, DOI 10.1016/j.gene.2015.12.070; Peng J, 2013, ONCOL LETT, V5, P1000, DOI 10.3892/ol.2012.1080; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/jcp.1041180311; Rodor J, 2017, RNA BIOL, V14, P45, DOI 10.1080/15476286.2016.1247148; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SMIT EF, 1992, INT J CANCER, V51, P72, DOI 10.1002/ijc.2910510115; Smith KS, 2015, NUCLEIC ACIDS RES, V43, P5307, DOI 10.1093/nar/gkv419; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tessier Sarah J, 2015, BMC Res Notes, V8, P46, DOI 10.1186/s13104-015-0983-5; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vinayanuwattikun C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31628; Wang Ke, 2012, J Cell Death, V5, P1, DOI 10.4137/JCD.S9073; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Wistuba II, 2000, CANCER RES, V60, P1949; Xiong Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06347; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146593; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhao JW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40488; Zhao LJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-247; Zheng SK, 2013, GENOME RES, V23, P998, DOI 10.1101/gr.147546.112; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	76	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180258	10.1371/journal.pone.0180258	http://dx.doi.org/10.1371/journal.pone.0180258			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662214	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300134
J	Curran, MM; Sandman, CA; Davis, EP; Glynn, LM; Baram, TZ				Curran, Megan M.; Sandman, Curt A.; Davis, Elysia Poggi; Glynn, Laura M.; Baram, Tallie Z.			Abnormal dendritic maturation of developing cortical neurons exposed to corticotropin releasing hormone (CRH): Insights into effects of prenatal adversity?	PLOS ONE			English	Article							HUMAN-PREGNANCY; ALZHEIMERS-DISEASE; PLACENTAL CLOCK; MESSENGER-RNA; STRESS; EXPRESSION; BRAIN; FETAL; HIPPOCAMPUS; RECEPTORS	Corticotropin releasing hormone (CRH) produced by the hypothalamus initiates the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the body's stress response. CRH levels typically are undetectable in human plasma, but during pregnancy the primate placenta synthesizes and releases large amounts of CRH into both maternal and fetal circulations. Notably, placental CRH synthesis increases in response to maternal stress signals. There is evidence that human fetal exposure to high concentrations of placental CRH is associated with behavioral consequences during infancy and into childhood, however the direct effects on of the peptide on the human brain are unknown. In this study, we used a rodent model to test the plausibility that CRH has direct effects on the developing cortex. Because chronic exposure to CRH reduces dendritic branching in hippocampal neurons, we tested the hypothesis that exposure to CRH would provoke impoverishment of dendritic trees in cortical neurons. This might be reflected in humans as cortical thinning. We grew developing cortical neurons in primary cultures in the presence of graded concentrations of CRH. We then employed Sholl analyses to measure dendritic branching and total dendritic length of treated cells. A seven-day exposure to increasing levels of CRH led to a significant, dose-dependent impoverishment of the branching of pyramidal-like cortical neurons. These results are consistent with the hypothesis that, rather than merely being a marker of prenatal stress, CRH directly decreases dendritic branching. Because dendrites comprise a large portion of cortical volume these findings might underlie reduced cortical thickness and could contribute to the behavioral consequences observed in children exposed to high levels of CRH in utero.	[Curran, Megan M.; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Sandman, Curt A.; Davis, Elysia Poggi] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Davis, Elysia Poggi] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Glynn, Laura M.] Chapman Univ, Dept Psychol, Orange, CA USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Denver; Chapman University System; Chapman University; University of California System; University of California Irvine; University of California System; University of California Irvine	Baram, TZ (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.; Baram, TZ (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.; Baram, TZ (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	tallie@uci.edu	Baram, Tallie Z/AGV-2524-2022	Baram, Tallie Z/0000-0003-0771-8616; Davis, Elysia/0000-0001-6345-9271; Garcia-Curran, Megan/0000-0003-3240-8310	National Institute of Health awards [P50 MH096889]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD51852, HD28413, HD50662, HD065823, HD40967]; National Institute of Neurological Disorders and Stroke [NS41298, T32 NS045540, NS28912]; National Institute of General Medical Sciences [T32GM08620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065823] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040967, R01HD050662, R01HD051852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073136, P50MH096889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045540, R01NS028912, R01NS041298] Funding Source: NIH RePORTER	National Institute of Health awards; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Health awards P50 MH096889 (TZB, LMG, EPD). Eunice Kennedy Shriver National Institute of Child Health and Human Development through HD51852 and HD28413 (CAS); HD50662 and HD065823 (EPD); HD40967 (LMG), National Institute of Neurological Disorders and Stroke through NS41298 (CAS) T32 NS045540 (TZB/MMC), NS28912 (TZB). National Institute of General Medical Sciences through T32GM08620 (MMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BARAM TZ, 1991, INT J DEV NEUROSCI, V9, P473, DOI 10.1016/0736-5748(91)90033-I; BARAM TZ, 1992, ANN NEUROL, V31, P488, DOI 10.1002/ana.410310505; BARAM TZ, 1995, NEUROREPORT, V6, P277, DOI 10.1097/00001756-199501000-00013; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; BEHAN DP, 1995, NATURE, V378, P284, DOI 10.1038/378284a0; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brunson KL, 2001, P NATL ACAD SCI USA, V98, P8856, DOI 10.1073/pnas.151224898; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; Chen YC, 2004, P NATL ACAD SCI USA, V101, P15782, DOI 10.1073/pnas.0403975101; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Class Quetzal A, 2008, Dev Neurosci, V30, P419, DOI 10.1159/000191213; Curran M, PROTOCOL PRIMARY NEU; Davis EP, 2005, DEV NEUROSCI-BASEL, V27, P299, DOI 10.1159/000086709; Deussing J, 2017, CURR MOL PHARMACOL, V10, P1; DORR HG, 1989, J CLIN ENDOCR METAB, V68, P863; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Gitau R, 2004, ARCH DIS CHILD-FETAL, V89, pF29, DOI 10.1136/fn.89.1.F29; GOLAND RS, 1986, J CLIN ENDOCR METAB, V63, P1199, DOI 10.1210/jcem-63-5-1199; GRINO M, 1989, ENDOCRINOLOGY, V124, P60, DOI 10.1210/endo-124-1-60; Gunn BG, 2008, J NEUROSCI, V28, P2903; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Howland MA, 2016, PSYCHONEUROENDOCRINO, V67, P10, DOI 10.1016/j.psyneuen.2016.01.023; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Karteris E, 2001, MOL GENET METAB, V72, P287, DOI 10.1006/mgme.2001.3159; Kastin AJ, 2002, NEUROENDOCRINOLOGY, V75, P367, DOI 10.1159/000059433; KEEGAN CE, 1994, ENDOCRINOLOGY, V134, P2547, DOI 10.1210/en.134.6.2547; Khan S, 2004, BRAIN RES, V1016, P48, DOI 10.1016/j.brainres.2004.04.062; Korosi A, 2008, EUR J PHARMACOL, V583, P204, DOI 10.1016/j.ejphar.2007.11.066; Kostich WA, 2004, J COMP NEUROL, V478, P111, DOI 10.1002/cne.20271; Koutmani Y, 2013, MOL PSYCHIATR, V18, P300, DOI 10.1038/mp.2012.198; Liu XJ, 2016, J NEUROSCI, V36, P4802, DOI 10.1523/JNEUROSCI.3186-15.2016; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Paus T., 2009, HDB ADOLESCENT PSYCH, V1, P95, DOI DOI 10.1002/9780470479193; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Regev L, 2014, FRONT NEUROENDOCRIN, V35, P171, DOI 10.1016/j.yfrne.2013.10.001; Rissman RA, 2012, P NATL ACAD SCI USA, V109, P6277, DOI 10.1073/pnas.1203140109; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; ROBINSON BG, 1989, MOL CELL ENDOCRINOL, V62, P337, DOI 10.1016/0303-7207(89)90022-1; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Sandman CA, 1999, ANN NY ACAD SCI, V897, P66, DOI 10.1111/j.1749-6632.1999.tb07879.x; Sandman CA, 2006, PEPTIDES, V27, P1457, DOI 10.1016/j.peptides.2005.10.002; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Yan XX, 1998, HIPPOCAMPUS, V8, P231, DOI 10.1002/(SICI)1098-1063(1998)8:3<231::AID-HIPO6>3.0.CO;2-M; Zhang C, 2016, ALZHEIMERS DEMENT, V12, P527, DOI 10.1016/j.jalz.2015.09.007	56	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180311	10.1371/journal.pone.0180311	http://dx.doi.org/10.1371/journal.pone.0180311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658297	Green Published, gold			2022-12-26	WOS:000404607900071
J	Luz, C; Rodrigues, LP; de Meester, A; Cordovil, R				Luz, Carlos; Rodrigues, Luis P.; de Meester, An; Cordovil, Rita			The relationship between motor competence and health-related fitness in children and adolescents	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; PHYSICAL-ACTIVITY; COORDINATION; PROFICIENCY; CHILDHOOD; YOUTH; ASSOCIATIONS; STRENGTH; OBESITY	Background and aims In the last twenty years, there has been increasing evidence that Motor Competence (MC) is vital for developing an active and healthy lifestyle. This study analyses the associations between motor competence and its components, with health-related fitness (HRF). Methods A random sample of 546 children (278 males, mean = 10.77 years) divided into four age groups (7-8; 9-10; 11-12; 13-14 years old) was evaluated. A quantitative MC instrument (evaluating stability, locomotor and manipulative skills), a maximal multistage 20-m shuttle-run test and the handgrip test, height and BMI were used in the analyses. Pearson correlations and standard regression modelling were performed to explore the associations between variables. Results Moderate to strong significant correlations (0.49 < r < 0.73) were found between MC and HRF, for both sexes, and correlation values were stable across the age groups. The MC model explained 74% of the HRF variance, with the locomotor component being the highest predictor for the entire sample (beta =.302; p < .001). Gender-related differences were found when boys and girls were analysed at each age group. Locomotor MC for girls was the most consistent significant predictor of HRF across all age groups (0.47 < beta < 0.65; all p <=.001). For boys, significant predictors were locomotor and manipulative MC (0.21 <beta< 0.49; all p < .05) in the two younger age groups (7-8 and 9-10 years) and stability (0.50 <beta< 0.54; all p <=.001) for the older two age groups (11-12 and 13-14 years). Conclusion These results support the idea that: (1) the relationship between overall MC and HRF is strong and stable across childhood and early adolescence; (2) when accounting for the different MC components, boys and girls show different relationship patterns with HFR across age.	[Luz, Carlos] Inst Politecn Lisboa, Escola Super Educ Lisboa, Lisbon, Portugal; [Luz, Carlos] Univ Lisbon, Fac Motricidade Humana, Lisbon, Portugal; [Rodrigues, Luis P.] Res Ctr Sports Hlth & Human Dev CIDESD, Vila Real, Portugal; [Rodrigues, Luis P.] Inst Politecn Viana do Castelo, Escola Super Desporto & Lazer Melgaco, Melgaco, Portugal; [de Meester, An] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Cordovil, Rita] Univ Lisbon, CIPER, Fac Motricidade Humana, Lisbon, Portugal	Polytechnic Institute of Lisbon; Universidade de Lisboa; Polytechnic Institute of Viana do Castelo; Ghent University; Universidade de Lisboa	Luz, C (corresponding author), Inst Politecn Lisboa, Escola Super Educ Lisboa, Lisbon, Portugal.; Luz, C (corresponding author), Univ Lisbon, Fac Motricidade Humana, Lisbon, Portugal.	carlosmiguelluz@gmail.com	Rodrigues, Luis P./W-1962-2018; da Luz, Carlos miguel nunes/U-3940-2019; Cordovil, Rita/E-7593-2012; De Meester, An/H-5410-2019	Rodrigues, Luis P./0000-0002-6804-3600; Cordovil, Rita/0000-0002-4907-7186; De Meester, An/0000-0003-2270-719X; Luz, Carlos/0000-0002-9126-5375	Foundation for Science and Technology (Portugal) [I&D472 (UID/DTP/00447/2013)]	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology)	This research was funded by the Foundation for Science and Technology (Portugal) I&D472 (UID/DTP/00447/2013).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FITNESSGRAM ACTIVITY; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; Castelli DM, 2007, J TEACH PHYS EDUC, V26, P358, DOI 10.1123/jtpe.26.4.358; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; Cohen DD, 2010, ACTA PAEDIATR, V99, P1065, DOI 10.1111/j.1651-2227.2010.01723.x; D'Hondt E, 2014, OBESITY, V22, P1505, DOI 10.1002/oby.20723; D'hondt E, 2011, INT J PEDIATR OBES, V6, pE556, DOI 10.3109/17477166.2010.500388; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Erwin HE, 2008, RES Q EXERCISE SPORT, V79, P495, DOI 10.1080/02701367.2008.10599516; Fransen J, 2014, RES DEV DISABIL, V35, P1375, DOI 10.1016/j.ridd.2014.03.011; Gallahue DL., 2012, UNDERSTANDING MOTOR; Gisladottir P, 2014, PEDIATR PHYS THER, V26, P69, DOI 10.1097/PEP.0000000000000006; Haga M, 2008, CHILD CARE HLTH DEV, V34, P329, DOI 10.1111/j.1365-2214.2008.00814.x; Haga M, 2015, PERCEPT MOTOR SKILL, V121, P900, DOI 10.2466/10.PMS.121c24x2; Hands B, 2009, SCAND J MED SCI SPOR, V19, P655, DOI 10.1111/j.1600-0838.2008.00847.x; Hardy LL, 2013, MED SCI SPORT EXER, V45, P1965, DOI 10.1249/MSS.0b013e318295a9fc; Hills AP, 2007, SPORTS MED, V37, P533, DOI 10.2165/00007256-200737060-00006; Holfelder B, 2014, PSYCHOL SPORT EXERC, V15, P382, DOI 10.1016/j.psychsport.2014.03.005; Laukkanen A, 2014, SCAND J MED SCI SPOR, V24, pE102, DOI 10.1111/sms.12116; Lopes L, 2013, HUM MOVEMENT SCI, V32, P9, DOI 10.1016/j.humov.2012.05.005; Lopes L, 2012, AM J HUM BIOL, V24, P746, DOI 10.1002/ajhb.22310; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Lopes VP, 2012, J SCI MED SPORT, V15, P38, DOI 10.1016/j.jsams.2011.07.005; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Luz C, 2016, J SCI MED SPORT, V19, P568, DOI 10.1016/j.jsams.2015.07.005; Milliken LA, 2008, J STRENGTH COND RES, V22, P1339, DOI 10.1519/JSC.0b013e31817393b1; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Robinson LE, 2015, SPORTS MED, V45, P1273, DOI 10.1007/s40279-015-0351-6; Ross WD, 1991, PHYSL TESTING ELITEA, P223; Stodden D, 2009, RES Q EXERCISE SPORT, V80, P223; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Stodden DF, 2014, PEDIATR EXERC SCI, V26, P231, DOI 10.1123/pes.2013-0027; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Vandorpe B, 2011, SCAND J MED SCI SPOR, V21, P378, DOI 10.1111/j.1600-0838.2009.01067.x; Vedul-Kjelsas V, 2012, CHILD CARE HLTH DEV, V38, P394, DOI 10.1111/j.1365-2214.2011.01275.x; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742	38	29	33	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0179993	10.1371/journal.pone.0179993	http://dx.doi.org/10.1371/journal.pone.0179993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JT	28658292	Green Submitted, Green Published, gold			2022-12-26	WOS:000404607900048
J	Hover, SS; Bertke, AS				Hover, Shantal S.; Bertke, Andrea S.			Herpes simplex virus 1 and 2 educational assessment of young adults in rural southwest Virginia	PLOS ONE			English	Article							GENITAL HERPES; SEXUAL HEALTH; KNOWLEDGE; INTERNET; FEMALE	Purpose Herpes simplex virus 2 (HSV-2) causes genital herpes, one of the most common sexually transmitted infections (STIs) in the U.S. HSV-1, commonly associated with cold sores, is increasing as a cause of genital herpes. Abstinence-only sexual health classes, commonly taught in Virginia, generate young adults who are under-educated in sexual health, increasing STI risks. College students in southwest Virginia were surveyed to assess comprehensiveness of high school health education regarding HSV-1 and HSV-2 and to identify students' preferred methods for STI education. Methods To obtain data on knowledge of HSV, comprehensiveness of sexual health education in high school, and preferred learning methods, 237 college students participated in an online questionnaire and 28 students were interviewed using structured interviews. Results Questionnaire and interview data indicated that Family Life Education classes need to include more comprehensive information on prevention, viral transmission, and differences between HSV-1 and HSV-2. The majority of total respondents (both the questionnaire and interview) (65%) reported non-comprehensive high school sexual health education. The majority of interview (79%) and questionnaire (55%) respondents wished they had learned more about herpes and other STIs in high school. Education preferences of both interviewed and surveyed respondents included interactive internet programs or games, more realistic lectures, and learning about STIs later in high school when students reported greater sexual activity. Conclusion Our results indicate that more comprehensive sexual health education is needed and wanted by students in southwest Virginia. More relevant educational programs should be implemented for VA high school students utilizing technology and interactive methods to improve student engagement in sexual health education.	[Hover, Shantal S.; Bertke, Andrea S.] Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA; [Hover, Shantal S.] Santa Barbara Publ Hlth Dept, Santa Barbara, CA USA	Virginia Polytechnic Institute & State University	Bertke, AS (corresponding author), Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA.	asbertke@vt.edu		Bertke, Andrea/0000-0002-8941-8010	Virginia Maryland College of Veterinary Medicine (ASB Startup)	Virginia Maryland College of Veterinary Medicine (ASB Startup)	Funding was provided by Virginia Maryland College of Veterinary Medicine (ASB Startup). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern NR, 2006, FAM COMMUNITY HEALTH, V29, P299, DOI 10.1097/00003727-200610000-00008; Aral SO, 2006, SPECIAL ISSUE SEXUAL, pS1; Batalden K, 2007, J PEDIATR ADOL GYNEC, V20, P319, DOI 10.1016/j.jpag.2007.04.004; Bull S, 2009, AIDS BEHAV, V13, P474, DOI 10.1007/s10461-008-9487-9; CDC Fact Sheet, 2013, INC PREV COST SEX TR; Chong A, 2012, EFFECTIVENESS SPILLO; Donovan P., 1998, 4 GUTTM I; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Heymann DL, 2008, CONTROL COMMUNICABLE; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Lewis LM, 1999, INT J STD AIDS, V10, P703, DOI 10.1258/0956462991913376; Lou CH, 2006, J ADOLESCENT HEALTH, V39, P720, DOI 10.1016/j.jadohealth.2006.04.003; Merin A, 2011, J HEALTH PSYCHOL, V16, P80, DOI 10.1177/1359105310367528; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Murray PR, 2009, MED MICROBIOLOGY, V6th, P361; NARAL, 2014, COMPR SEX ED; Peskin MF, 2015, J ADOLESCENT HEALTH, V56, P515, DOI 10.1016/j.jadohealth.2015.01.001; Rana RK, 2005, SEX TRANSM DIS, V32, P308, DOI 10.1097/01.olq.0000162363.82005.fe; Ratnam S, 2007, CAN J INFECT DIS MED, V18, P233, DOI 10.1155/2007/505364; Royer HR, 2013, J PEDIATR ADOL GYNEC, V26, P109, DOI 10.1016/j.jpag.2012.11.007; Tortolero SR, 2010, J ADOLESCENT HEALTH, V46, P169, DOI 10.1016/j.jadohealth.2009.06.008; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	22	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179969	10.1371/journal.pone.0179969	http://dx.doi.org/10.1371/journal.pone.0179969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ2LT	28654651	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500043
J	Uemura, A; Nakata, M; Goya, S; Fukayama, T; Tanaka, R				Uemura, Akiko; Nakata, Mary; Goya, Seijirow; Fukayama, Toshiharu; Tanaka, Ryou			Effective new membrane for preventing postthoracotomy pleural adhesion by surface water induction technology	PLOS ONE			English	Article							SEPRAFILM(R); RATS	Background After thoracic surgery, adhesions between the pleura can cause substantial complications. This study investigated the effectiveness of a novel membrane utilizing surface water induction technology to prevent adhesions. Methods Eight beagles were divided into an experimental group (five males) and a control group (three females). The experimental group underwent thoracotomy on both the left and right sides of the chest. Both sides received the membrane, and the membrane on one side was glued to the pleura using tissue adhesive. The control group underwent thoracotomy only on the left side. Two weeks postoperatively, all dogs were sacrificed and adhesions were evaluated macroscopically and microscopically. Results Severe adhesion was seen between the parietal and visceral pleura in all control dogs, whereas the experimental group showed minor adhesion in only one dog on one side. Conclusions Our novel anti-adhesive membrane appeared highly effective in preventing postthoracotomy pleural adhesions.	[Uemura, Akiko; Nakata, Mary; Goya, Seijirow; Tanaka, Ryou] Tokyo Univ Agr & Technol, Anim Med Ctr, Fuchu, Tokyo, Japan; [Fukayama, Toshiharu] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Tokyo University of Agriculture & Technology; National Cerebral & Cardiovascular Center - Japan	Uemura, A; Tanaka, R (corresponding author), Tokyo Univ Agr & Technol, Anim Med Ctr, Fuchu, Tokyo, Japan.	anco@vet.ne.jp; ryo@vet.ne.jp	uemura, akiko/T-1481-2019; Tanaka, Ryo S/C-8376-2013; Tanaka, Ryou/M-3078-2019	uemura, akiko/0000-0003-2671-5074; Tanaka, Ryo S/0000-0001-9948-6490; Tanaka, Ryou/0000-0001-9948-6490	Japan Science and Technology Agency (National Research and Development Agency)	Japan Science and Technology Agency (National Research and Development Agency)	This research was funded by the Japan Science and Technology Agency (National Research and Development Agency); however, the sponsor played no role in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the article for publication. Therefore, the authors have declared that no competing interests exist.	Barmparas G, 2010, J GASTROINTEST SURG, V14, P1619, DOI 10.1007/s11605-010-1189-8; Buyukkale S, 2015, INT J CLIN EXP MED, V8, P11544; Diamond MP, 2012, GYNECOL SURG, V9, P237, DOI 10.1007/s10397-012-0741-9; Diamond MP, 2012, GYNECOL SURG, V9, P247, DOI 10.1007/s10397-012-0742-8; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Gataullin N G, 1968, Sov Med, V31, P43; Getman Vladyslav, 2006, Interact Cardiovasc Thorac Surg, V5, P243, DOI 10.1510/icvts.2005.121129; Gonzalez-Quintero Victor Hugo, 2009, Rev Obstet Gynecol, V2, P38; Izumi Y, 2012, EUR SURG RES, V48, P93, DOI 10.1159/000337033; Karacam V, 2011, INT J MED SCI, V8, P380, DOI 10.7150/ijms.8.380; Kim JH, 2015, ANN DERMATOL, V27, P224, DOI 10.5021/ad.2015.27.2.224; Lefort B, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0257-2; Luijendijk RW, 1996, ANN SURG, V223, P242, DOI 10.1097/00000658-199603000-00003; Masuda M, 2015, GEN THORAC CARDIOVAS, V63, P670, DOI 10.1007/s11748-015-0590-3; Noishiki Y, 2010, ARTIF ORGANS, V34, P224, DOI 10.1111/j.1525-1594.2009.00787.x; Oizumi H, 1990, Nihon Kyobu Geka Gakkai Zasshi, V38, P72; SANDEN C, 1959, Munch Med Wochenschr, V101, P1970; Satoh H, 2013, TUBERK TORAK, V61, P357, DOI 10.5578/tt.6268; STANGEL JJ, 1984, J REPROD MED, V29, P143; Sulaiman H, 2001, ANN SURG, V234, P256, DOI 10.1097/00000658-200108000-00016; Takagi K, 2013, J SURG RES, V179, pE13, DOI 10.1016/j.jss.2012.01.056; Yim APC, 1998, ANN THORAC SURG, V65, P328, DOI 10.1016/S0003-4975(97)01341-6	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0179815	10.1371/journal.pone.0179815	http://dx.doi.org/10.1371/journal.pone.0179815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654705	Green Published, gold, Green Submitted			2022-12-26	WOS:000404541500033
J	Elsohaby, I; Burns, JB; Riley, CB; Shaw, RA; McClure, JT				Elsohaby, Ibrahim; Burns, Jennifer B.; Riley, Christopher B.; Shaw, R. Anthony; McClure, J. Trenton			Application of laboratory and portable attenuated total reflectance infrared spectroscopic approaches for rapid quantification of alpaca serum immunoglobulin G	PLOS ONE			English	Article							PASSIVE TRANSFER STATUS; NEONATAL LLAMAS; HAND-HELD; IMMUNITY; FAILURE; AUTHENTICATION; SPECTROMETERS; QUANTITATION; DIAGNOSIS; CAMELIDS	The objective of this study was to develop and compare the performance of laboratory grade and portable attenuated total reflectance infrared (ATR-IR) spectroscopic approaches in combination with partial least squares regression (PLSR) for the rapid quantification of alpaca serum IgG concentration, and the identification of low IgG (< 1000 mg/dL), which is consistent with the diagnosis of failure of transfer of passive immunity (FTPI) in neonates. Serum samples (n = 175) collected from privately owned, healthy alpacas were tested by the reference method of radial immunodiffusion (RID) assay, and laboratory grade and portable ATR-IR spectrometers. Various pre-processing strategies were applied to the ATR-IR spectra that were linked to corresponding RID-IgG concentrations, and then randomly split into two sets: calibration (training) and test sets. PLSR was applied to the calibration set and calibration models were developed, and the test set was used to assess the accuracy of the analytical method. For the test set, the Pearson correlation coefficients between the IgG measured by RID and predicted by both laboratory grade and portable ATR-IR spectrometers was 0.91. The average differences between reference serum IgG concentrations and the two IR-based methods were 120.5 mg/dL and 71 mg/dL for the laboratory and portable ATR-IR-based assays, respectively. Adopting an IgG concentration < 1000 mg/dL as the cut-point for FTPI cases, the sensitivity, specificity, and accuracy for identifying serum samples below this cut point by laboratory ATR-IR assay were 86, 100 and 98%, respectively (within the entire data set). Corresponding values for the portable ATR-IR assay were 95, 99 and 99%, respectively. These results suggest that the two different ATR-IR assays performed similarly for rapid qualitative evaluation of alpaca serum IgG and for diagnosis of IgG <1000 mg/dL, the portable ATR-IR spectrometer performed slightly better, and provides more flexibility for potential application in the field.	[Elsohaby, Ibrahim; Burns, Jennifer B.; Riley, Christopher B.; McClure, J. Trenton] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Elsohaby, Ibrahim] Zagazig Univ, Fac Vet Med, Dept Anim Med, Div Infect Dis, Zagazig, Sharkia Provinc, Egypt; [Riley, Christopher B.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Shaw, R. Anthony] Natl Res Council Canada, Med Devices Portfolio, Winnipeg, MB, Canada	University of Prince Edward Island; Egyptian Knowledge Bank (EKB); Zagazig University; Massey University; National Research Council Canada	Elsohaby, I (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada.; Elsohaby, I (corresponding author), Zagazig Univ, Fac Vet Med, Dept Anim Med, Div Infect Dis, Zagazig, Sharkia Provinc, Egypt.	ielsohaby@upei.ca	Elsohaby, Ibrahim/L-4214-2014; Elsohaby, Ibrahim/GQQ-4026-2022	Elsohaby, Ibrahim/0000-0003-2533-988X; Riley, Christopher/0000-0001-8679-7986	Atlantic Canada Opportunities Agency	Atlantic Canada Opportunities Agency	This research was funded by the Atlantic Canada Opportunities Agency.; The authors thank Cynthia Mitchell for her technical assistance. The authors also thank Professor Michael Reichel (University of Adelaide, Australia) and Dr. Nicole Jewett (New Brunswick, Canada) for providing the samples used in this study. Also, we would like to thank the anonymous reviewers for their helpful comments in the preparation of this article. This study was partially supported by the Atlantic Canada Opportunities Agency.	ADAMS R, 1994, VET CLIN N AM-FOOD A, V10, P209, DOI 10.1016/S0749-0720(15)30556-9; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Ayvaz H, 2015, FOOD CHEM, V174, P154, DOI 10.1016/j.foodchem.2014.11.001; Barnes R, 2004, J NEAR INFRARED SPEC, V1, P185; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; BLAND JM, 1995, INT J EPIDEMIOL, V24, pS7, DOI 10.1093/ije/24.Supplement_1.S7; Burns J, 2014, J VET INTERN MED, V28, P639, DOI 10.1111/jvim.12258; Chappuis G, 1998, VACCINE, V16, P1468, DOI 10.1016/S0264-410X(98)00110-8; De Marchi M, 2014, J DAIRY SCI, V97, P1171, DOI 10.3168/jds.2013-6799; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Dolente BA, 2007, J VET INTERN MED, V21, P519, DOI 10.1892/0891-6640(2007)21[519:CSINCC]2.0.CO;2; Elsohaby I, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0539-x; Elsohaby I, 2014, VET J, V202, P510, DOI 10.1016/j.tvjl.2014.09.014; Fowler ME, 2010, MEDICINE AND SURGERY OF CAMELIDS, 3RD EDITION, P17; GARMENDIA AE, 1987, AM J VET RES, V48, P1472; Hou S, 2016, CHEMOMETR INTELL LAB, V156, P108, DOI 10.1016/j.chemolab.2016.05.020; HUTCHISON JM, 1995, J VET DIAGN INVEST, V7, P515, DOI 10.1177/104063879500700416; Johnston NA, 1997, J AM VET MED ASSOC, V211, P1165; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pinn TL, 2013, J VET DIAGN INVEST, V25, P91, DOI 10.1177/1040638712472182; Rehman Saif, 2003, J Intensive Care Med, V18, P261, DOI 10.1177/0885066603255905; Reid LM, 2006, TRENDS FOOD SCI TECH, V17, P344, DOI 10.1016/j.tifs.2006.01.006; Riley CB, 2007, J VET INTERN MED, V21, P828, DOI 10.1892/0891-6640(2007)21[828:UOFISF]2.0.CO;2; Rodriguez-Saona LE, 2011, ANNU REV FOOD SCI T, V2, P467, DOI 10.1146/annurev-food-022510-133750; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shaw RA, 1998, ANN CLIN BIOCHEM, V35, P624, DOI 10.1177/000456329803500505; Shaw RA, 2000, ENCY ANAL CHEM, P83; Shaw RA M H, 2008, ENCY ANAL CHEM APPL, P83; SMITH B. C., 2011, FUNDAMENTALS FOURIER; Sorak D, 2012, APPL SPECTROSC REV, V47, P83, DOI 10.1080/05704928.2011.625748; Sun DW, 2009, INFRARED SPECTROSCOPY FOR FOOD QUALITY ANALYSIS AND CONTROL, P1; Walker P, 1999, J CAMEL PRACT RES, V6, P255; Wang T, 2015, J FOOD SCI, V80, pC2111, DOI 10.1111/1750-3841.13006; Weaver DM, 2000, AM J VET RES, V61, P738, DOI 10.2460/ajvr.2000.61.738; Weaver DM, 2000, J AM VET MED ASSOC, V216, P559, DOI 10.2460/javma.2000.216.559; Wernery U, 2001, J VET MED B, V48, P561, DOI 10.1046/j.1439-0450.2001.00478.x; Whitehead CE, 2009, VET CLIN N AM-FOOD A, V25, P353, DOI 10.1016/j.cvfa.2009.03.006; Williams PC, 1996, NEAR INFRARED SPECTR, P185; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179644	10.1371/journal.pone.0179644	http://dx.doi.org/10.1371/journal.pone.0179644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651006	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300012
J	Izuogu, AO; McNally, KL; Harris, SE; Youseff, BH; Presloid, JB; Burlak, C; Munshi-South, J; Best, SM; Taylor, RT				Izuogu, Adaeze O.; McNally, Kristin L.; Harris, Stephen E.; Youseff, Brian H.; Presloid, John B.; Burlak, Christopher; Munshi-South, Jason; Best, Sonja M.; Taylor, R. Travis			Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses	PLOS ONE			English	Article							WHITE-FOOTED MOUSE; HOST IMMUNE-RESPONSES; ENCEPHALITIS-VIRUS; BORRELIA-BURGDORFERI; STIMULATED GENES; INFECTION; HANTAVIRUS; NS5; IDENTIFICATION; DETERMINANTS	Tick-borne flaviviruses (TBFVs), including Powassan virus and tick-borne encephalitis virus cause encephalitis or hemorrhagic fevers in humans with case-fatality rates ranging from 1-30%. Despite severe disease in humans, TBFV infection of natural rodent hosts has little noticeable effect. Currently, the basis for resistance to disease is not known. We hypothesize that the coevolution of flaviviruses with their respective hosts has shaped the evolution of potent antiviral factors that suppress virus replication and protect the host from lethal infection. In the current study, we compared virus infection between reservoir host cells and related susceptible species. Infection of primary fibroblasts from the white-footed mouse (Peromyscus leucopus, a representative host) with a panel of vector-borne flaviviruses showed up to a 10,000-fold reduction in virus titer compared to control Mus musculus cells. Replication of vesicular stomatitis virus was equivalent in P. leucopus and M. musculus cells suggesting that restriction was flavivirus-specific. Step-wise comparison of the virus infection cycle revealed a significant block to viral RNA replication, but not virus entry, in P. leucopus cells. To understand the role of the type I interferon (IFN) response in virus restriction, we knocked down signal transducer and activator of transcription 1 (STAT1) or the type I IFN receptor (IFNAR1) by RNA interference. Loss of IFNAR1 or STAT1 significantly relieved the block in virus replication in P. leucopus cells. The major IFN antagonist encoded by TBFV, nonstructural protein 5, was functional in P. leucopus cells, thus ruling out ineffective viral antagonism of the host IFN response. Collectively, this work demonstrates that the IFN response of P. leucopus imparts a strong and virus-specific barrier to flavivirus replication. Future identification of the IFN-stimulated genes responsible for virus restriction specifically in P. leucopus will yield mechanistic insight into efficient control of virus replication and may inform the development of antiviral therapeutics.	[Izuogu, Adaeze O.; Youseff, Brian H.; Presloid, John B.; Taylor, R. Travis] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [McNally, Kristin L.; Best, Sonja M.] NIAID, Innate Immun & Pathogenesis Unit, Lab Virol, Rocky Mt Labs,DIR,NIH, Hamilton, MT USA; [Harris, Stephen E.] CUNY, Grad Ctr, New York, NY 10021 USA; [Burlak, Christopher] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Munshi-South, Jason] Fordham Univ, Louis Calder Ctr, Biol Field Stn, Armonk, NY USA	University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); City University of New York (CUNY) System; University of Minnesota System; University of Minnesota Twin Cities; Fordham University	Taylor, RT (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	travis.taylor@utoledo.edu	Presloid, John B/G-2447-2015	Munshi-South, Jason/0000-0002-8067-4341	Lyme Disease Association, Inc. [N12484701]; National Institutes of Health, National Institutes of Allergy and Infectious Diseases [ZIA-AI001125]; National Institute of General Medical Sciences of the National Institutes of Health [R15GM099055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	Lyme Disease Association, Inc.; National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by a pilot grant from the Lyme Disease Association, Inc., N12484701 to RTT. This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases. ZIA-AI001125 to SMB. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health. R15GM099055 to JMS. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, VECTOR-BORNE ZOONOT; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; [Anonymous], 2014, INNATE IMMUNITY DENG, V426, P1148; Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Barbour AG, 2016, SEMIN CELL DEV BIOL, P1; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Belikov SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094946; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Brinton M, 2003, ADV VIRUS RES, P1; BROWN RN, 1994, J WILDLIFE DIS, V30, P389, DOI 10.7589/0090-3558-30.3.389; D'Agostino PM, 2012, P NATL ACAD SCI USA, V109, P6175, DOI 10.1073/pnas.1203941109; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Egyed L, 2015, INTERVIROLOGY, V58, P369, DOI 10.1159/000443833; El Khoury MY, 2013, EMERG INFECT DIS, V19, P1926, DOI 10.3201/eid1912.130903; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077; Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629; Imhoff M, 2015, TICKS TICK-BORNE DIS, V6, P592, DOI 10.1016/j.ttbdis.2015.05.001; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Korenberg EI, 2001, EMERG INFECT DIS, V7, P459, DOI 10.3201/eid0703.017319; Lani R, 2014, TICKS TICK-BORNE DIS, V5, P457, DOI 10.1016/j.ttbdis.2014.04.001; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Luong LT, 2011, VECTOR-BORNE ZOONOT, V11, P1459, DOI 10.1089/vbz.2010.0255; Machida M, 2014, BRAIN BEHAV IMMUN, V35, P125, DOI 10.1016/j.bbi.2013.09.006; Maffioli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044703; Mandl JN, 2015, CELL, V160, P20, DOI 10.1016/j.cell.2014.12.003; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Mitzel DN, 2008, VIROLOGY, V381, P268, DOI 10.1016/j.virol.2008.08.030; Mitzel DN, 2007, VIROLOGY, V365, P410, DOI 10.1016/j.virol.2007.03.057; Mlera L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005346; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Munshi-South J, 2016, EVOL APPL, V9, P546, DOI 10.1111/eva.12357; Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Santos RI, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080220; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; SCHOGGINS JW, 2011, NATURE; Schountz T, 2014, VIRUSES-BASEL, V6, P1317, DOI 10.3390/v6031317; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; SONG JW, 1994, LANCET, V344, P1637, DOI 10.1016/S0140-6736(94)90430-8; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suss J, 2010, WIEN MED WOCHENSCHR, V160, P94, DOI 10.1007/s10354-010-0756-7; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Suss J, 2008, EUROSURVEILLANCE, V13, P1; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; WRIGHT SD, 1990, AM J VET RES, V51, P1980; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015; Zoldi V, 2014, NFECTIOUS DIS, V47, P178; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	68	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179781	10.1371/journal.pone.0179781	http://dx.doi.org/10.1371/journal.pone.0179781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650973	gold, Green Submitted, Green Published			2022-12-26	WOS:000404537300022
J	Cheng, J; Huang, J; Yuan, SZ; Zhou, S; Yan, W; Shen, W; Chen, Y; Xia, X; Luo, AY; Zhu, D; Wang, SX				Cheng, Jing; Huang, Jia; Yuan, Suzhen; Zhou, Su; Yan, Wei; Shen, Wei; Chen, Yun; Xia, Xi; Luo, Aiyue; Zhu, Da; Wang, Shixuan			Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; HUMAN CUMULUS CELLS; FOLLICULAR-FLUID; GENE-EXPRESSION; OVARIAN RESERVE; CLINICAL-IMPLICATIONS; AGE; OOCYTE; BIOMARKER; WOMEN	Circular RNAs (circRNAs) are a unique class of endogenous RNAs which could be used as potential diagnostic and prognostic biomarkers of many diseases. Our study aimed to investigate circRNA profiles in human granulosa cells (GCs) during maternal aging and to uncover age-related circRNA variations that potentially reflect decreased oocyte competence. CircRNAs in GCs from in vitro fertilization (IVF) patients with young age (YA, <= 30 years) and advanced age (AA, >= 38 years) were profiled by microarray, and validated in 20 paired samples. The correlation between circRNAs expression and clinical characteristics was analyzed in additional 80 samples. Chip-based analysis revealed 46 up-regulated and 11 down-regulated circRNAs in AA samples (fold change > 2.0). Specifically, circRNA_103829, circRNA_103827 and circRNA_104816 were validated to be up regulated, while circRNA_101889 was down-regulated in AA samples. After adjustment for gonadotropin treatment, only circRNA_103827 and circRNA_104816 levels were positively associated with maternal age (partial r = 0.332, P = 0.045; partial r = 0.473, P = 0.003; respectively). Moreover, circRNA_103827 and circRNA_104816 expressions in GCs were negatively correlated with the number of top quality embryos (r = -0.235, P = 0.036; r = -0.221, P = 0.049; respectively). Receiver operating characteristic (ROC) curve analysis indicated that the performance of circRNA_103827 for live birth prediction reached 0.698 [0.570-0.825], with 77.2% sensitivity and 60.9% specificity (P = 0.006), and that of circRNA_104816 was 0.645 [0.507-0.783] (P = 0.043). Bioinformatics analysis revealed that both circRNAs were potentially involved in glucose metabolism, mitotic cell cycle, and ovarian steroidogenesis. Therefore, age-related up-regulation of circRNA_103827 and circRNA_104816 might be potential indicators of compromised follicular micro-environment which could be used to predict IVF prognosis, and improve female infertility management.	[Cheng, Jing; Huang, Jia; Yuan, Suzhen; Zhou, Su; Yan, Wei; Shen, Wei; Luo, Aiyue; Zhu, Da; Wang, Shixuan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Chen, Yun] Peking Univ, Ultrason Dept, Shenzhen Hosp, Shenzhen, Peoples R China; [Xia, Xi] Peking Univ, Reprod Ctr, Shenzhen Hosp, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Peking University; Peking University	Wang, SX (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	sxwang2012@hotmail.com			National Natural Science Foundation of China [81370469, 81300453, 81502253, 81501227, 81471508]; International Science and Technology Corporation Program of China [2013DFA31400]; Guang Dong Natural Scientific Foundation [2015A030313889, 2014A030313797]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Corporation Program of China; Guang Dong Natural Scientific Foundation	This work was financially supported by the National Natural Science Foundation of China (No. 81370469; 81300453; 81502253; 81501227; 81471508), International Science and Technology Corporation Program of China (No. 2013DFA31400) and Guang Dong Natural Scientific Foundation (2015A030313889; 2014A030313797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2003, REPRODUCTION, P49; [American Society for Reproductive Medicine and Society for Assisted Reproductive Technology Centers for Disease Control and Prevention], 2011, 2011 ASS REPR TECHN, P24; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Du XF, 2016, REPROD SCI, V23, P1019, DOI 10.1177/1933719115625843; Dumesic DA, 2015, FERTIL STERIL, V103, P303, DOI 10.1016/j.fertnstert.2014.11.015; Ferrero H, 2012, HUM REPROD, V27, P1781, DOI 10.1093/humrep/des096; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Fragouli E, 2012, HUM REPROD, V27, P2559, DOI 10.1093/humrep/des170; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gatta V, 2013, FERTIL STERIL, V99, P2000, DOI 10.1016/j.fertnstert.2013.01.150; Grondahl ML, 2009, FERTIL STERIL, V91, P1820, DOI 10.1016/j.fertnstert.2008.02.137; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kanduri C, 2011, SEMIN CELL DEV BIOL, V22, P343, DOI 10.1016/j.semcdb.2011.02.020; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Moreno JM, 2015, FERTIL STERIL, V104, P1037, DOI 10.1016/j.fertnstert.2015.07.001; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; McReynolds S, 2012, FERTIL STERIL, V98, P1574, DOI 10.1016/j.fertnstert.2012.08.012; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Pacella L, 2012, FERTIL STERIL, V98, P986, DOI 10.1016/j.fertnstert.2012.06.025; Panda AC, 2016, NUCL ACIDS RES; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Sauer MV, 2015, FERTIL STERIL, V103, P1136, DOI 10.1016/j.fertnstert.2015.03.004; Scalici E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24976; Shang XC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003811; Tab R, 2015, FERTIL STERIL, V103; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Tremellen K, 2014, HUM REPROD, V29, P2606, DOI 10.1093/humrep/deu265; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; Wainer-Katsir K, 2015, FERTIL STERIL, V103, P1117, DOI 10.1016/j.fertnstert.2015.02.008; Yang W, 2016, EUROPEAN HEART J; Yu B, 2015, ONCOTARGET, V6, P3627, DOI 10.18632/oncotarget.2875; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zhang Y, 2016, METHODS MOL BIOL, V1402, P215, DOI 10.1007/978-1-4939-3378-5_17; Zhang YG, 2016, BJOG INT J OBSTET GY; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918	52	49	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0177888	10.1371/Journal.pone.0177888	http://dx.doi.org/10.1371/Journal.pone.0177888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644873	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100002
J	Yang, GD; Agapow, PM; Yedid, G				Yang, Guan-Dong; Agapow, Paul-Michael; Yedid, Gabriel			The tree balance signature of mass extinction is erased by continued evolution in clades of constrained size with trait-dependent speciation	PLOS ONE			English	Article							PERMIAN-TRIASSIC BOUNDARY; PHYLOGENETIC TREE; MOLECULAR PHYLOGENIES; FOSSIL RECORD; ORGANISMAL DIVERSITY; STATISTICAL-ANALYSIS; ECOLOGICAL LIMITS; NULL MODEL; DIVERSIFICATION; PATTERNS	The kind and duration of phylogenetic topological "signatures" left in the wake of macroevolutionary events remain poorly understood. To this end, we examined a broad range of simulated phylogenies generated using trait-biased, heritable speciation probabilities and mass extinction that could be either random or selective on trait value, but also using background extinction and diversity-dependence to constrain clade sizes. In keeping with prior results, random mass extinction increased imbalance of clades that recovered to pre-extinction size, but was a relatively weak effect. Mass extinction that was selective on trait values tended to produce clades of similar or greater balance compared to random extinction or controls. Allowing evolution to continue past the point of clade-size recovery resulted in erosion and eventual erasure of this signal, with all treatments converging on similar values of imbalance, except for very intense extinction regimes targeted at taxa with high speciation rates. Return to a more balanced state with extended post-extinction evolution was also associated with loss of the previous phylogenetic root in most treatments. These results further demonstrate that while a mass extinction event can produce a recognizable phylogenetic signal, its effects become increasingly obscured the further an evolving clade gets from that event, with any sharp imbalance due to unrelated evolutionary factors.	[Yang, Guan-Dong; Yedid, Gabriel] Nanjing Agr Univ, Dept Zool, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Agapow, Paul-Michael] Imperial Coll, Data Sci Inst, William Penney Lab, London, England; [Yang, Guan-Dong] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Nanjing Agricultural University; Imperial College London; Emory University; Rollins School Public Health	Yedid, G (corresponding author), Nanjing Agr Univ, Dept Zool, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	gyedid02@gmail.com			Chinese Ministry of Education [KYRC201301]; National Natural Science Foundation of China [680600529]	Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants #KYRC201301 from Chinese Ministry of Education (http://www.moe.edu.cn) and #680600529 from National Natural Science Foundation of China (http://www.nsfc.gov.cn) to GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alroy John, 2009, P301; Barraclough TG, 2003, EVOLUTION, V57, P2166; Beerling DJ, 2001, J GEOL SOC LONDON, V158, P737, DOI 10.1144/jgs.158.5.737; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Carlson SJ, 2008, FOSS STRATA, P167; Chan KMA, 1999, AM NAT, V153, P332, DOI 10.1086/303173; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Duchene D, 2015, MOL ECOL RESOUR, V15, P785, DOI 10.1111/1755-0998.12352; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Erwin D, 2000, NATURE, V404, P129, DOI 10.1038/35004679; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; Friedman M, 2011, P R SOC B, V277, P1675; Hagen O, 2015, SYST BIOL, V64, P432, DOI 10.1093/sysbio/syv001; Halliday TJD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3026; Harcourt-Brown KG, 2002, SYST BIOL, V51, P908, DOI 10.1080/10635150290155962; Harcourt-Brown KG, 2001, PALEOBIOLOGY, V27, P188, DOI 10.1666/0094-8373(2001)027<0188:TIOPT>2.0.CO;2; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Harmon LJ, 2007, RECONSTRUCTING EVOLU, P149; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 2002, SYST BIOL, V51, P889, DOI 10.1080/10635150290155917; Heard SB, 2007, AM NAT, V169, pE107, DOI 10.1086/512690; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; Holman EW, 2005, SYSTEMATIC BIOL, V54, P895, DOI 10.1080/10635150500354696; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Lau KV, 2016, P NAT ACAD SCI, V113, P2; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Looy CV, 1999, P NATL ACAD SCI USA, V96, P13857, DOI 10.1073/pnas.96.24.13857; LOSOS JB, 1995, AM NAT, V145, P329, DOI 10.1086/285743; McGowan AJ, 2004, PALEOBIOLOGY, V30, P369, DOI 10.1666/0094-8373(2004)030<0369:TEOTPB>2.0.CO;2; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mir A, 2013, MATH BIOSCI, V241, P125, DOI 10.1016/j.mbs.2012.10.005; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Mooers AO, 2004, SYST BIOL, V53, P809, DOI 10.1080/10635150490502595; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Purvis Andy, 1996, P153; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Rabosky DL, 2015, AM NAT, V185, P572, DOI 10.1086/680850; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ruber L, 2005, EVOLUTION, V59, P1119; Ruta M, 2007, P ROY SOC B-BIOL SCI, V274, P3087, DOI 10.1098/rspb.2007.1250; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SAVAGE HM, 1983, BIOL J LINN SOC, V20, P225, DOI 10.1111/j.1095-8312.1983.tb01874.x; Schaal EK, 2016, PALEOBIOLOGY, V42, P127, DOI 10.1017/pab.2015.36; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Sepulveda J, 2009, SCIENCE, V326, P129, DOI 10.1126/science.1176233; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Stam E, 2002, EVOLUTION, V56, P1292; Tarver JE, 2011, SYST BIOL, V60, P700, DOI 10.1093/sysbio/syr018; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Wei HY, 2015, EARTH-SCI REV, V149, P108, DOI 10.1016/j.earscirev.2014.10.007; Weir JT, 2006, EVOLUTION, V60, P842; WELLBORN GA, 1994, ECOLOGY, V75, P2104, DOI 10.2307/1941614; Wellborn GA, 2008, MOL ECOL, V17, P2927, DOI 10.1111/j.1365-294X.2008.03805.x; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; Yedid G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037233; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228; Yin HF, 2007, GLOBAL PLANET CHANGE, V55, P1, DOI 10.1016/j.gloplacha.2006.06.005; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	85	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179553	10.1371/journal.pone.0179553	http://dx.doi.org/10.1371/journal.pone.0179553			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644846	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100023
J	Shi, XY; Li, QB; Wang, T; Lackner, KS				Shi, Xiaoyang; Li, Qibin; Wang, Tao; Lackner, Klaus S.			Kinetic analysis of an anion exchange absorbent for CO2 capture from ambient air	PLOS ONE			English	Article							CARBON-DIOXIDE CAPTURE; MOISTURE	This study reports a preparation method of a new moisture swing sorbent for CO2 capture from air. The new sorbent components include ion exchange resin (IER) and polyvinyl chloride (PVC) as a binder. The IER can absorb CO2 when surrounding is dry and release CO2 when surrounding is wet. The manuscript presents the studies of membrane structure, kinetic model of absorption process, performance of desorption process and the diffusivity of water molecules in the CO2 absorbent. It has been proved that the kinetic performance of CO2 absorption/desorption can be improved by using thin binder and hot water treatment. The fast kinetics of P-100-90C absorbent is due to the thin PVC binder, and high diffusion rate of H2O molecules in the sample. The impressive is this new CO2 absorbent has the fastest CO2 absorption rate among all absorbents which have been reported by other up-todate literatures.	[Shi, Xiaoyang] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Li, Qibin] Chongqing Univ, Coll Aerosp Engn, Chongqing, Peoples R China; [Wang, Tao] Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou, Zhejiang, Peoples R China; [Lackner, Klaus S.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA	Columbia University; Chongqing University; Zhejiang University; Arizona State University; Arizona State University-Tempe	Wang, T (corresponding author), Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou, Zhejiang, Peoples R China.; Lackner, KS (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA.	oatgnaw@zju.edu.cn; Klaus.Lackner@asu.edu	li, qibin/O-2013-2019	li, qibin/0000-0001-9365-3788	National Natural Science Foundation of China [51676169]; Office of Naval Research [ONR BAA 14-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Office of Naval Research(Office of Naval Research)	This work was partly supported by the National Natural Science Foundation of China (No. 51676169), and partly supported by a grant from the Office of Naval Research (ONR BAA 14-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi S, 2011, CHEMSUSCHEM, V4, P628, DOI 10.1002/cssc.201000355; Choi S, 2011, ENVIRON SCI TECHNOL, V45, P2420, DOI 10.1021/es102797w; Drese JH, 2009, ADV FUNCT MATER, V19, P3821, DOI 10.1002/adfm.200901461; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Keith DW, 2009, SCIENCE, V325, P1654, DOI 10.1126/science.1175680; Lackner KS, 2009, EUR PHYS J-SPEC TOP, V176, P93, DOI 10.1140/epjst/e2009-01150-3; Lackner KS, 2016, SCIENCE, V354, P714, DOI 10.1126/science.aal2432; Lackner KS, 2012, P NATL ACAD SCI USA, V109, P13156, DOI 10.1073/pnas.1108765109; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Li QB, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501854; Lin YC, 2005, CHEM PHYS LETT, V412, P322, DOI 10.1016/j.cplett.2005.07.022; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Shi X., 2017, ARXIV170200388; Shi X., 2017, ARXIV PREPRINT ARXIV; Shi X., 2016, ANGEW CHEM, V128, P4094, DOI DOI 10.1002/ANGE.201507846; Shi XY, 2016, CHEM-EUR J, V22, P18326, DOI 10.1002/chem.201603701; Shi XY, 2016, ANGEW CHEM INT EDIT, V55, P4026, DOI 10.1002/anie.201507846; Socolow R., 2011, DIRECT AIR CAPTURE C; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Springer George S., 1988, ENV EFFECTS COMPOSIT, V3; Vyas PV, 2001, J MEMBRANE SCI, V187, P39, DOI 10.1016/S0376-7388(00)00613-X; Wang T, 2015, GREENH GASES; Wang T, 2016, PHYS CHEM CHEM PHYS, V18, P13084, DOI 10.1039/c5cp07229h; Wang T, 2013, PHYS CHEM CHEM PHYS, V15, P504, DOI 10.1039/c2cp43124f; Wang T, 2011, ENVIRON SCI TECHNOL, V45, P6670, DOI 10.1021/es201180v; Xiao H, 2017, ARXIV170203036	27	30	34	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179828	10.1371/journal.pone.0179828	http://dx.doi.org/10.1371/journal.pone.0179828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640914	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800071
J	Suzuki, K; Yamada, K; Fukuhara, Y; Tsuji, A; Shibata, K; Wakamatsu, N				Suzuki, Kaoru; Yamada, Kenichiro; Fukuhara, Yayoi; Tsuji, Ai; Shibata, Katsumi; Wakamatsu, Nobuaki			High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice	PLOS ONE			English	Article							BASAL GANGLIA DISEASE; EXPERIMENTAL WERNICKES ENCEPHALOPATHY; EXOME SEQUENCING REVEALS; EXTRACELLULAR GLUTAMATE; OXIDATIVE-METABOLISM; SLC19A3 MUTATIONS; PHOSPHATE-ESTERS; DEFICIENCY; MOUSE; PYRITHIAMINE	SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease.	[Suzuki, Kaoru; Yamada, Kenichiro; Fukuhara, Yayoi; Wakamatsu, Nobuaki] Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Kasugai, Aichi, Japan; [Tsuji, Ai; Shibata, Katsumi] Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Hikone, Shiga, Japan	University Shiga Prefecture	Wakamatsu, N (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Kasugai, Aichi, Japan.	nwaka@inst-hsc.jp	Suzuki, Kaoru/AHC-0437-2022	Tsuji, Ai/0000-0003-1619-7592; Nobuaki, Wakamatsu/0000-0003-1956-8977; Yamada, Kenichiro/0000-0003-0486-284X; Suzuki, Kaoru/0000-0002-5168-9018; Wakamatsu, Nobuaki/0000-0001-5693-2227	Takeda Science Foundation [10]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462225, 15K09610]; Grants-in-Aid for Scientific Research [15K09610] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Takeda Science Foundation (No.10 in 2009, to NW), http://www.takeda-sci.or.jp; Ministry of Education, Culture, Sports, Science and Technology of Japan (26462225 to NW, 15K09610 to KY, http://www.mext.go.jp.	Abdou E, 2015, NEUROCHEM RES, V40, P353, DOI 10.1007/s11064-014-1430-z; Allen PG., 2006, ALLEN BRAIN ATLAS; ANDERSON SH, 1986, LANCET, V2, P85; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Berdanier CD., 1998, ADV NUTR MICRONUTRIE, P73; BETTENDORFF L, 1994, BBA-MOL CELL RES, V1222, P7, DOI 10.1016/0167-4889(94)90019-1; BETTENDORFF L, 1993, J NEUROCHEM, V60, P423, DOI 10.1111/j.1471-4159.1993.tb03168.x; CALINGASAN NY, 1995, EXP NEUROL, V134, P64, DOI 10.1006/exnr.1995.1037; Calingasan NY, 2000, J NEUROPATH EXP NEUR, V59, P207, DOI 10.1093/jnen/59.3.207; Debs R, 2010, ARCH NEUROL-CHICAGO, V67, P126, DOI 10.1001/archneurol.2009.293; Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013; GIBSON GE, 1984, NEUROCHEM RES, V9, P803, DOI 10.1007/BF00965667; HARATA N, 1995, METAB BRAIN DIS, V10, P159, DOI 10.1007/BF01991863; HAYASHI K, 1981, BIOCHIM BIOPHYS ACTA, V641, P106, DOI 10.1016/0005-2736(81)90573-3; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; HAZELL AS, 1993, J NEUROCHEM, V61, P1155, DOI 10.1111/j.1471-4159.1993.tb03635.x; Hazell AS, 1998, METAB BRAIN DIS, V13, P97, DOI 10.1023/A:1020657129593; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; HEROUX M, 1995, NEUROCHEM RES, V20, P87, DOI 10.1007/BF00995157; IWATA H, 1988, J CHROMATOGR, V450, P317, DOI 10.1016/S0021-9673(01)83586-X; Kato K, 2014, PHARM RES-DORDR, V31, P136, DOI 10.1007/s11095-013-1144-y; Ke ZJ, 2005, NEUROCHEM INT, V47, P204, DOI 10.1016/j.neuint.2005.03.002; Ke ZJ, 2003, J NEUROPATH EXP NEUR, V62, P195, DOI 10.1093/jnen/62.2.195; Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Kono S, 2009, NEW ENGL J MED, V360, P1792, DOI 10.1056/NEJMc0809100; LANGLAIS PJ, 1993, J NEUROCHEM, V61, P2175, DOI 10.1111/j.1471-4159.1993.tb07457.x; Losa R, 2005, J PHARMACEUT BIOMED, V37, P1025, DOI 10.1016/j.jpba.2004.08.038; McCormick DB, 1988, MODERN NUTRITION HLT, P355; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Nosaka K, 2001, BBA-GENE STRUCT EXPR, V1517, P293, DOI 10.1016/S0167-4781(00)00247-5; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; RINDI G, 1961, BIOCHEM J, V80, P214, DOI 10.1042/bj0800214; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Said HM, 1999, AM J PHYSIOL-CELL PH, V277, pC645, DOI 10.1152/ajpcell.1999.277.4.C645; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; Schmuck G, 2009, ARCH TOXICOL, V83, P397, DOI 10.1007/s00204-008-0360-4; Tabarki B, 2015, EUR J PAEDIATR NEURO, V19, P547, DOI 10.1016/j.ejpn.2015.05.008; TALLAKSEN CME, 1993, ALCOHOL CLIN EXP RES, V17, P712, DOI 10.1111/j.1530-0277.1993.tb00825.x; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; WATANABE I, 1978, EXP MOL PATHOL, V28, P381, DOI 10.1016/0014-4800(78)90012-6; WOOLLEY DW, 1951, J BIOL CHEM, V191, P43; Yamada K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-171; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216; ZHANG SX, 1995, J NEUROPATH EXP NEUR, V54, P255, DOI 10.1097/00005072-199503000-00012; Zhao RB, 2001, BBA-GENE STRUCT EXPR, V1517, P320, DOI 10.1016/S0167-4781(00)00264-5; Zhao RB, 2013, MOL ASPECTS MED, V34, P373, DOI 10.1016/j.mam.2012.07.006	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2017	12	6							e0180279	10.1371/journal.pone.0180279	http://dx.doi.org/10.1371/journal.pone.0180279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3KB	28665968	gold, Green Published, Green Submitted			2022-12-26	WOS:000404608700080
J	Fett, D; Trompeter, K; Platen, P				Fett, Daniela; Trompeter, Katharina; Platen, Petra			Back pain in elite sports: A cross-sectional study on 1114 athletes	PLOS ONE			English	Article							INTERVERTEBRAL-DISK DEGENERATION; PHYSICAL-ACTIVITY; COUNTRY SKIERS; OVERUSE INJURIES; SPINAL POSTURE; RISK-FACTORS; NECK PAIN; PREVALENCE; ADOLESCENTS; STRENGTH	Objectives To establish the prevalence of back pain in German elite athletes; examine the influence of age, sex, sports discipline and training volume; and compare elite athletes with a physically active control group. Methods A standardized and validated online back pain questionnaire was sent by the German Olympic Sports Confederation to approximately 4,000 German national and international elite athletes, and a control group of 253 physically active but non-elite sports students. Results We received responses from 1,114 elite athletes (46.5% male and 53.1% female, mean age 20.9 years +/- 4.8 years, mean height 176.5 +/- 11.5 cm, mean weight 71.0 +/- 10.3 kg) and 166 physically active sports students (74.7% male and 24.1 female, mean age 21.2 +/- 2.0 years, mean height 180.0 +/- 8.0 cm, mean weight 74.0 +/- 14.5 kg). In elite athletes, the lifetime prevalence of back pain was 88.5%, the 12-month prevalence was 81.1%, the 3-month prevalence was 68.3% and the point prevalence was 49.0%, compared with 80.7%, 69.9%, 59.0% and 42.8%, respectively in the control group. The lifetime, 12-month and 3-month prevalences in elite athletes were significantly higher than in the control group. Regarding the individual sports disciplines, the prevalence of back pain was significantly higher in elite rowers, dancers, fencers, gymnasts, track and field athletes, figure skaters and marksmen, and those who play underwater rugby, water polo, basketball, hockey and ice hockey compared with the control group. The prevalence of back pain was significantly lower in elite triathletes. Conclusions Back pain is a common complaint in German elite athletes. Low back pain seems to be a problem in both elite athletes and physically active controls. A high training volume in elite athletes and a low training volume in physically active individuals might increase prevalence rates. Our findings indicate the necessity for specific prevention programs, especially in high-risk sports. Further research should investigate the optimal dose-effect relationship of sporting activity for the general population to prevent back pain.	[Fett, Daniela; Trompeter, Katharina; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany	Ruhr University Bochum	Fett, D; Trompeter, K (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.	daniela.fett@rub.de; katharina.trompeter@rub.de		Platen, Petra/0000-0002-3440-8245	German Federal Institute of Sport Science; project RAN Rucken [ZMVI1-080102N11-18]	German Federal Institute of Sport Science; project RAN Rucken	The present study was funded by the German Federal Institute of Sport Science (http://www.bisp.de). The research was realized within the project RAN Rucken (ZMVI1-080102N11-18). Funding were received by PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alricsson M, 2005, J SPORT MED PHYS FIT, V45, P547; Bahr R, 2004, SPINE, V29, P449, DOI 10.1097/01.BRS.0000096176.92881.37; Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Belavy DL, 2016, SPORTS MED, V46, P473, DOI 10.1007/s40279-015-0444-2; Bergstrom KA, 2004, KNEE SURG SPORT TR A, V12, P80, DOI 10.1007/s00167-003-0389-0; Burnett AF, 2004, MANUAL THER, V9, P211, DOI 10.1016/j.math.2004.06.002; Cabri J, 2003, SPORTVERLETZ SPORTSC, V17, P61; Campello M, 1996, SCAND J MED SCI SPOR, V6, P63, DOI 10.1111/j.1600-0838.1996.tb00073.x; Cholewicki J, 2005, SPINE, V30, P2614, DOI 10.1097/01.brs.0000188273.27463.bc; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Close C, 2016, MIDWIFERY, V37, P1, DOI 10.1016/j.midw.2016.03.013; Dalichau S, 2002, DEUT Z SPORTMED, V53, P12; Dankaerts W, 2006, SPINE, V31, P2017, DOI 10.1097/01.brs.0000228728.11076.82; Dubravcic-Simunjak S, 2003, AM J SPORT MED, V31, P511, DOI 10.1177/03635465030310040601; Eriksson K, 1996, SCAND J MED SCI SPOR, V6, P31; Filler TJ, 2004, TRAUMATOLOGY, V20, P13; Greene HS, 2001, AM J SPORT MED, V29, P795, DOI 10.1177/03635465010290062001; Hangai M, 2009, AM J SPORT MED, V37, P149, DOI 10.1177/0363546508323252; Haydt R, 2012, INT J SPORTS PHYS TH, V7, P296; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; HOWELL DW, 1984, AM J SPORT MED, V12, P278, DOI 10.1177/036354658401200407; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hutchinson MR, 1999, MED SCI SPORT EXER, V31, P1686, DOI 10.1097/00005768-199911000-00027; Iwamoto J, 2005, SCAND J MED SCI SPOR, V15, P163, DOI 10.1111/j.1600-0838.2004.00414.x; Kaneoka K, 2007, AM J SPORT MED, V35, P1341, DOI 10.1177/0363546507300259; Kernahan M, 1979, NOVA SCOTIA MED B, V58, P167; Kujala UM, 1997, AM J SPORT MED, V25, P363, DOI 10.1177/036354659702500316; Kujala UM, 1996, MED SCI SPORT EXER, V28, P165, DOI 10.1097/00005768-199602000-00002; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Ng L, 2014, J SCI MED SPORT, V17, P266, DOI 10.1016/j.jsams.2013.08.003; Lindgren S, 1988, Aust J Physiother, V34, P123, DOI 10.1016/S0004-9514(14)60604-8; Lively Mathew W, 2002, W V Med J, V98, P202; Manninen JSO, 1996, BRIT J SPORT MED, V30, P134, DOI 10.1136/bjsm.30.2.134; Mikkelsson LO, 2006, BRIT J SPORT MED, V40, P107, DOI 10.1136/bjsm.2004.017350; Mitchell T, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-152; Mortazavi J, 2015, ASIAN J SPORTS MED; Muller J, 2016, SCAND J MED SCI SPOR; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; Newcomer K, 1996, ACTA PAEDIATR, V85, P1433, DOI 10.1111/j.1651-2227.1996.tb13948.x; Newlands C, 2015, BR J SPORTS MED; Noll M, 2016, PLOS ONE; Oksuz E, 2006, SPINE, V31, pE968, DOI 10.1097/01.brs.0000247787.25382.3c; Perich D, 2011, KNEE SURG SPORT TR A, V19, P20, DOI 10.1007/s00167-010-1173-6; Rees CS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-382; ROY SH, 1990, MED SCI SPORT EXER, V22, P463; SALMINEN JJ, 1993, INT J SPORTS MED, V14, P406, DOI 10.1055/s-2007-1021200; Sato T, 2011, EUR SPINE J, V20, P94, DOI 10.1007/s00586-010-1485-8; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Shakeri H, 2013, J CHIROPR MED, V12, P160, DOI 10.1016/j.jcm.2013.08.005; Shan Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078109; Shehab DK, 2005, J ADOLESCENT HEALTH, V36, P32, DOI 10.1016/j.jadohealth.2003.12.011; Sitthipornvorakul E, 2011, EUR SPINE J, V20, P677, DOI 10.1007/s00586-010-1630-4; SWARD L, 1990, SPINE, V15, P124; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; Triki M, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.26802; Trompeter K, 2016, SPORTS MED IN PRESS; Tunas P, 2014, KNEE SURG SPORTS TRA; Villavicencio Alan T, 2006, Neurosurg Focus, V21, pE7; Villavicencio AT, 2007, J NEUROSURG-SPINE, V7, P408, DOI 10.3171/SPI-07/10/408; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vuori IM, 2001, MED SCI SPORT EXER, V33, pS551, DOI 10.1097/00005768-200106001-00026; Wade M, 2012, J APPL BIOMECH, V28, P677, DOI 10.1123/jab.28.6.677; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003	66	67	67	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180130	10.1371/journal.pone.0180130	http://dx.doi.org/10.1371/journal.pone.0180130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662110	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300109
J	Kolb, M; Kurz, S; Schafer, A; Huse, K; Dietz, A; Wichmann, G; Birkenmeier, G				Kolb, Marlen; Kurz, Susanne; Schaefer, Angelika; Huse, Klaus; Dietz, Andreas; Wichmann, Gunnar; Birkenmeier, Gerd			Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant	PLOS ONE			English	Article							PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER; NECK-CANCER; IDENTIFICATION; LRP; HYPERCHOLESTEROLEMIA; POLYMORPHISMS; PREDICTION; BIOMARKER	Background Low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is a ubiquitously expressed multi-ligand endocytosis receptor implicated in a wide range of signalling, among others in tumour biology. Tumour-associated genomic mutations of the LRP1 gene are described, but nothing is known about cancer-associated expression of LRP1 splice variants Therefore, the focus of this study was on an annotated truncated LRP1 splice variant (BC072015.1; NCBI GenBank), referred to as smLRP1, which was initially identified in prostate and lung carcinoma. Methods Using PCR and quantitative PCR, the expression of LRP1 and smLRP1 in different human tissues and tumour cell lines was screened and compared on tumour biopsies of head and neck squamous cell carcinoma (HNSCC). Using a recently developed anti-smLRP1 antibody, the expression of the putative LRP1 protein isoform in tumour cell lines in Western blot and immunofluorescence staining was further investigated. Results The alternative transcript smLRP1 is ubiquitously expressed in 12 human cell lines of different origin and 22 tissues which is similar to LRP1. A shift in expression of smLRP1 relative to LRP1 towards smLRP1 was observed in most tumour cell lines compared to healthy tissue. The expression of LRP1 as well as smLRP1 is decreased in HNSCC cell lines in comparison to healthy mucosa. In vitro results were checked using primary HNSCC. Furthermore, the expression of the protein isoform smLRP1 (32 kDa) was confirmed in human tumour cell lines. Conclusions Similar to LRP1, the truncated splice variant smLRP1 is ubiquitously expressed in healthy human tissues, but altered in tumours pointing to a potential role of smLRP1 in cancer. Comparative results suggest a shift in expression in favour of smLRP1 in tumour cells that warrant further evaluation. The protein isoform is suggested to be secreted.	[Kolb, Marlen; Dietz, Andreas; Wichmann, Gunnar] Univ Hosp Leipzig, Clin Otorhinolaryngol Head & Neck Surg, Leipzig, Germany; [Kurz, Susanne] Fraunhofer Inst Ceram Technol & Syst IKTS, Bio & Nanotechnol, Leipzig, Germany; [Schaefer, Angelika; Birkenmeier, Gerd] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Leipzig, Germany; [Huse, Klaus] FLI, Leibniz Inst Aging, Jena, Germany	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kolb, M (corresponding author), Univ Hosp Leipzig, Clin Otorhinolaryngol Head & Neck Surg, Leipzig, Germany.	marlen.kolb@medizin.uni-leipzig.de	Wichmann, Gunnar/AGW-9592-2022	Wichmann, Gunnar/0000-0001-6191-2095; Kolb, Marlen/0000-0002-8397-8295	European Social Fund [100098250]; GB; German Research Foundation (DFG) and University of Leipzig	European Social Fund(European Social Fund (ESF)); GB; German Research Foundation (DFG) and University of Leipzig	This work was supported by the European Social Fund (URLhttp://www.esf.de/ portal/DE/Startseite/inhalt.html); grant number 100098250. Funding was granted to GB.We also acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing.The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Aledo R, 2012, REV ESP CARDIOL, V65, P807, DOI [10.1016/j.recesp.2012.03.013, 10.1016/j.rec.2012.03.012]; Andl T, 1998, CANCER RES, V58, P5; [Anonymous], 2004, PREDICTION N GLYCOSY; Baum L, 1998, NEUROSCI LETT, V256, P5, DOI 10.1016/S0304-3940(98)00734-4; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benes P, 2003, BREAST CANCER RES, V5, pR77, DOI 10.1186/bcr591; BIRKENMEIER G, 1993, J IMMUNOL METHODS, V162, P59, DOI 10.1016/0022-1759(93)90407-X; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Cheng C-F, MOL CELLULAR BIOL, V28, P3344; de Gonzalo-Calvo D, 2015, INT J CARDIOL, V201, P20, DOI 10.1016/j.ijcard.2015.07.085; Gatta G, 2015, EUROPEAN J CANC; Gilardoni MB, 2003, J HISTOCHEM CYTOCHEM, V51, P1575, DOI 10.1177/002215540305101201; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gopal U, PLOS ONE, V6; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Jang JH, 2002, BIOCHEM BIOPH RES CO, V292, P378, DOI 10.1006/bbrc.2002.6668; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Jung- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/ng.3414; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Laskowski RA, NUCL ACIDS RES, V33, pW89; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li YH, 1998, ANTICANCER RES, V18, P1197; Li Yonghe, 1998, Invasion and Metastasis, V18, P240, DOI 10.1159/000024517; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; Martinez-Ledesma E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11966; Martinez-Poveda B, 2013, BIOPROTOCOL, V3; Meng H, 2011, CLIN CANCER RES, V17, P2426, DOI 10.1158/1078-0432.CCR-10-2385; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermeyer K, 2007, ONCOL REP, V17, P361; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Sobin L, 2009, TNM CLASSIFICATION M; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Van Leuven F, 1998, GENOMICS, V52, P138, DOI 10.1006/geno.1998.5408; VANLEUVEN F, 1994, GENOMICS, V24, P78, DOI 10.1006/geno.1994.1584; Wichmann G, 2015, INT J CANCER, V137, P2846, DOI 10.1002/ijc.29649; Xing P, 2016, CHIN J CANCER, V35, P4119	55	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180354	10.1371/journal.pone.0180354	http://dx.doi.org/10.1371/journal.pone.0180354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662213	Green Published, gold			2022-12-26	WOS:000404608300143
J	Masood, M; Reidpath, DD				Masood, Mohd; Reidpath, Daniel D.			Effect of national wealth on BMI: An analysis of 206,266 individuals in 70 low-, middle- and high-income countries	PLOS ONE			English	Article							BODY-MASS-INDEX; MULTILEVEL ANALYSIS; UNITED-STATES; WEIGHT-GAIN; OBESITY; INEQUALITY; HEALTH; ASSOCIATIONS; GENDER; ADULTS	Background This study explores the relationship between BMI and national-wealth and the cross-level interaction effect of national-wealth and individual household-wealth using multilevel analysis. Methods Data from the World Health Survey conducted in 2002-2004, across 70 low-, middle-and high-income countries was used. Participants aged 18 years and over were selected using multistage, stratified cluster sampling. BMI was used as outcome variable. The potential determinants of individual-level BMI were participants' sex, age, marital-status, education, occupation, household-wealth and location(rural/urban) at the individual-level. The country-level factors used were average national income (GNI-PPP) and income inequality (Giniindex). A two-level random-intercepts and fixed-slopes model structure with individuals nested within countries was fitted, treating BMI as a continuous outcome. Results The weighted mean BMI and standard-error of the 206,266 people from 70-countries was 23.90 (4.84). All the low-income countries were below the 25.0 mean BMI level and most of the high-income countries were above. All wealthier quintiles of household-wealth had higher scores in BMI than lowest quintile. Each USD10000 increase in GNI-PPP was associated with a 0.4 unit increase in BMI. The Gini-index was not associated with BMI. All these variables explained 28.1% of country-level, 4.9% of individual-level and 7.7% of total variance in BMI. The cross-level interaction effect between GNI-PPP and household-wealth was significant. BMI increased as the GNI-PPP increased in first four quintiles of householdwealth. However, the BMI of the wealthiest people decreased as the GNI-PPP increased. Conclusion Both individual-level and country-level factors made an independent contribution to the BMI of the people. Household-wealth and national-income had significant interaction effects.	[Masood, Mohd] La Trobe Univ, La Trobe Rural Hlth Sch, Dept Dent & Oral Hlth, Bendigo, Australia; [Masood, Mohd; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Global Publ Hlth, Bandar Sunway, Malaysia	La Trobe University; Monash University; Monash University Sunway	Masood, M (corresponding author), La Trobe Univ, La Trobe Rural Hlth Sch, Dept Dent & Oral Hlth, Bendigo, Australia.; Masood, M (corresponding author), Monash Univ, Sch Med & Hlth Sci, Global Publ Hlth, Bandar Sunway, Malaysia.	m.masood@latrobe.edu.au						Bates Douglas, 2014, J STAT SOFT IN PRESS; Chamieh MCa, 2013, THESIS; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Cowell F., 2011, MEASURING INEQUALITY, P7; Dean JA, 2012, J URBAN HEALTH, V89, P196, DOI 10.1007/s11524-011-9620-3; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Goldthorpe John H., 1987, SOCIAL MOBILITY CLAS; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Islam MK, 2010, HEALTH ECON, V19, P334, DOI 10.1002/hec.1479; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Katan MB, 2009, EUR J CLIN NUTR, V63, P2, DOI 10.1038/sj.ejcn.1602923; Kopelman P, 2007, OBES REV, V8, pVI; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Mellor JM, 2003, HEALTH SERV RES, V38, P137, DOI 10.1111/1475-6773.00109; Nandi A, 2014, AM J PUBLIC HEALTH, V104, pE162, DOI 10.2105/AJPH.2013.301392; Neuman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099327; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Philipson T. J., 1999, LONG RUN GROWTH OBES; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; [R-Team Computing RFfS], 2012, COMP RFFS; Robert SA, 2004, SOC SCI MED, V59, P2421, DOI 10.1016/j.socscimed.2004.03.034; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Su DJ, 2012, J BIOSOC SCI, V44, P417, DOI 10.1017/S002193201100071X; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P830, DOI 10.2105/AJPH.84.5.830; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Volland B, 2012, EFFECTS INCOME INEQU; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Wilkinson R., 2003, Social determinants of health: the solid facts; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; World Bank, 2005, WORLD DEV IND; Zhang L, 2012, MULTILEVEL STUDY EFF	40	21	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0178928	10.1371/journal.pone.0178928	http://dx.doi.org/10.1371/journal.pone.0178928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ3JX	28662041	Green Published, gold, Green Submitted			2022-12-26	WOS:000404608300011
J	Wang, LL; Wang, SW; Chen, W; Li, HB; Deng, XP				Wang, Linlin; Wang, Shiwen; Chen, Wei; Li, Hongbing; Deng, Xiping			Physiological mechanisms contributing to increased water-use efficiency in winter wheat under organic fertilization	PLOS ONE			English	Article							GRAIN-YIELD; DRY-MATTER; SOIL-WATER; SPRING WHEAT; DURUM-WHEAT; BIOCHEMICAL RESPONSES; NITROGEN ACCUMULATION; LIPID-PEROXIDATION; OXIDATIVE STRESS; LEAF SENESCENCE	Improving the efficiency of resource utilization has received increasing research attention in recent years. In this study, we explored the potential physiological mechanisms underlying improved grain yield and water-use efficiency of winter wheat (Triticum aestivum L.) following organic fertilizer application. Two wheat cultivars, ChangHan58 (CH58) and XiNong9871 (XN9871), were grown under the same nitrogen (N) fertilizer rate (urea-N, CK; and manure plus urea-N, M) and under two watering regimes (WW, well-watered; and WS, water stress) imposed after anthesis. The M fertilizer treatment had a higher P-n and lower g(s) and T-r than CK under both water conditions, in particular, it significantly increased WRC and psi(w), and decreased EWLR and MDA under WS. Also, the M treatment increased post-anthesis N uptake by 81.4 and 16.4% under WS and WW, thus increasing post-anthesis photosynthetic capacity and delaying leaf senescence. Consequently, the M treatment increased post-anthesis DM accumulation under WS and WW by 51.5 and 29.6%, WUEB by 44.5 and 50.9%, grain number per plant by 11.5 and 12.2% and 1000-grain weight by 7.3 and 3.6%, respectively, compared with CK. The grain yield under M treatment increased by 23 and 15%, and water use efficiency (WUEg) by 25 and 23%, respectively. The increased WUE under organic fertilizer treatment was due to elevated photosynthesis and decreased Tr and gs. Our results suggest that the organic fertilizer treatment enabled plants to use water more efficiently under drought stress.	[Wang, Linlin; Wang, Shiwen; Li, Hongbing; Deng, Xiping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Wang, Linlin] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Wei] Baoji Univ Arts & Sci, Key Lab Disaster Monitoring & Mech Simulating Sha, Baoji, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Baoji University of Arts & Sciences	Deng, XP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	dengxp@ms.iswc.ac.cn	Wang, Shiwen/AAA-9751-2019	Wang, Shiwen/0000-0003-3195-5531; deng, xi ping/0000-0003-4577-9217; Wang, Linlin/0000-0001-5981-8833	National Basic Research Program of China [2015CB150402]; Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China [51479189]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2015CB150402); Ministry of Science and Technology of the People's Republic of China, http://sci-hub.io/http://www.most.gov.cn/eng/, XPD; National Natural Science Foundation of China (No. 51479189), http://sci-hub.io/http://www.nsfc.gov.cn/publish/portal1/, XPD.	Ahmadi A., 2005, International Journal of Agriculture and Biology, V7, P807; Altenbach SB, 2003, J CEREAL SCI, V37, P9, DOI 10.1006/jcrs.2002.0483; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; Bancal MO, 2008, ANN BOT-LONDON, V102, P579, DOI 10.1093/aob/mcn124; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; Chen CC, 2011, AGRON J, V103, P786, DOI 10.2134/agronj2010.0424; Chen D, 2015, INT J BREAST CANC, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0137026; Chen W, 2015, J PLANT NUTR, V38, P13, DOI 10.1080/01904167.2014.892989; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Chen YL, 2015, FIELD CROP RES, V172, P53, DOI 10.1016/j.fcr.2014.11.016; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Dordas CA, 2009, FIELD CROP RES, V110, P35, DOI 10.1016/j.fcr.2008.06.011; Du TS, 2008, AGR WATER MANAGE, V95, P659, DOI 10.1016/j.agwat.2008.01.017; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Abreu ME, 2008, ENVIRON EXP BOT, V64, P105, DOI 10.1016/j.envexpbot.2007.12.016; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Esch A, 1998, CHEMOSPHERE, V36, P645, DOI 10.1016/S0045-6535(97)10101-1; Estrada-Campuzano G, 2012, FIELD CROP RES, V128, P167, DOI 10.1016/j.fcr.2012.01.003; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Fang Y, 2010, CROP PASTURE SCI, V61, P899, DOI 10.1071/CP10125; Ferrante A, 2012, FIELD CROP RES, V136, P52, DOI 10.1016/j.fcr.2012.07.015; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fuertes-Mendizabal T, 2010, J PLANT NUTR SOIL SC, V173, P907, DOI 10.1002/jpln.200900262; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Guan XK, 2015, J AGRON CROP SCI, V201, P253, DOI 10.1111/jac.12103; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guttieri MJ, 2001, CROP SCI, V41, P327, DOI 10.2135/cropsci2001.412327x; He FF, 2009, ENVIRON POLLUT, V157, P1666, DOI 10.1016/j.envpol.2008.12.017; Hu CL, 2015, FIELD CROP RES, V179, P6, DOI 10.1016/j.fcr.2015.03.026; Kato Y, 2011, FIELD CROP RES, V120, P387, DOI 10.1016/j.fcr.2010.11.015; KOBATA T, 1992, CROP SCI, V32, P1238, DOI 10.2135/cropsci1992.0011183X003200050035x; Koutroubas SD, 2012, FIELD CROP RES, V127, P1, DOI 10.1016/j.fcr.2011.10.011; Li FS, 2010, AGR WATER MANAGE, V97, P1156, DOI 10.1016/j.agwat.2010.01.024; Li HB, 2014, PLANT PHYSIOL BIOCH, V85, P31, DOI 10.1016/j.plaphy.2014.10.010; Li Hui, 2013, Fire Control and Command Control, V38, P48; Liu CA, 2013, AGR WATER MANAGE, V117, P123, DOI 10.1016/j.agwat.2012.11.002; Liu P, 2014, J EXPT BOT; Ma SC, 2008, FIELD CROP RES, V105, P56, DOI 10.1016/j.fcr.2007.07.005; Ma SC, 2010, FIELD CROP RES, V115, P158, DOI 10.1016/j.fcr.2009.10.017; Martinez DE, 2008, PLANT J, V56, P196, DOI 10.1111/j.1365-313X.2008.03585.x; Martinez DE, 2007, J EXP BOT, V58, P1099, DOI 10.1093/jxb/erl270; Monneveux P, 2003, J PLANT PHYSIOL, V160, P657, DOI 10.1078/0176-1617-00772; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; PALTA JA, 1994, CROP SCI, V34, P118, DOI 10.2135/cropsci1994.0011183X003400010021x; Puckette MC, 2007, PLANT PHYSIOL BIOCH, V45, P70, DOI 10.1016/j.plaphy.2006.12.004; Qi Wei, 2008, Yingyong Shengtai Xuebao, V19, P306; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rieux CM, 2013, CROP SCI, V53, P1139, DOI 10.2135/cropsci2012.07.0448; Shi CH, 2014, CROP SCI, V54, P2745, DOI 10.2135/cropsci2013.11.0732; Thorup-Kristensen K, 2012, EUR J AGRON, V37, P66, DOI 10.1016/j.eja.2011.11.004; TIESSEN H, 1994, NATURE, V371, P783, DOI 10.1038/371783a0; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Wang J, 2001, ACTA BOT BOREALI-OCC, V22, P285; Wang J, 2013, AGRON J, V105, P143, DOI 10.2134/agronj2012.0067; Wang J, 2011, PLANT SOIL, V347, P41, DOI 10.1007/s11104-011-0764-4; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Xu WZ, 2014, ACTA PHYSIOL PLANT, V36, P1033, DOI 10.1007/s11738-013-1481-9; Xue QW, 2006, J PLANT PHYSIOL, V163, P154, DOI 10.1016/j.jplph.2005.04.026; Yang JC, 2001, FIELD CROP RES, V71, P47, DOI 10.1016/S0378-4290(01)00147-2; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang SL, 2011, SOIL TILL RES, V112, P92, DOI 10.1016/j.still.2010.11.006; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	70	16	17	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2017	12	6							e0180205	10.1371/journal.pone.0180205	http://dx.doi.org/10.1371/journal.pone.0180205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JX	28662113	Green Published, Green Submitted, gold			2022-12-26	WOS:000404608300126
J	Kunzelmann, S; Forstemann, K				Kunzelmann, Stefan; Foerstemann, Klaus			Reversible perturbations of gene regulation after genome editing in Drosophila cells	PLOS ONE			English	Article							ENDO-SIRNAS; RNA PATHWAY; HETEROCHROMATIN	The prokaryotic phage defense CRISPR/cas-system has developed into a versatile toolbox for genome engineering and genetic studies in many organisms. While many efforts were spent on analyzing the consequences of off-target effects, only few studies addressed side-effects that occur due to the targeted manipulation of the genome. Here, we show that the CRISPR/cas9-mediated integration of an epitope tag in combination with a selection cassette can trigger an siRNA-mediated, epigenetic genome surveillance pathway in Drosophila melanogaster cells. After homology-directed insertion of the sequence coding for the epitope tag and the selection marker, a moderate level of siRNAs covering the inserted sequence and extending into the targeted locus was detected. This response affected protein levels less than two-fold and it persisted even after single cell cloning. However, removal of the selection cassette abolished the siRNA generation, demonstrating that this response is reversible. Consistently, marker-free genome engineering did not trigger the same surveillance mechanism. These two observations indicate that the selection cassette we employed induces an aberrant transcriptional arrangement and ultimately sets off the siRNA production. There have been prior concerns about undesirable effects induced by selection markers, but fortunately we were able to show that at least one of the epigenetic changes reverts as the marker gene is excised. Although the effects observed were rather weak (less than twofold de-repression upon ago2 or dcr-2 knock-down), we recommend that when selection markers are used during genome editing, a strategy for their subsequent removal should always be included.	[Kunzelmann, Stefan; Foerstemann, Klaus] Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany	University of Munich	Forstemann, K (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Dept Biochem, Munich, Germany.	foerstemann@lmb.uni-muenchen.de			Sondeforschungsbereich (SFB) of the Deutsche Forschungsgemeinschaft (DFG) [646]	Sondeforschungsbereich (SFB) of the Deutsche Forschungsgemeinschaft (DFG)	The work was supported by the Sondeforschungsbereich (SFB) 646 of the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elmer K, 2014, METHODS MOL BIOL, V1173, P33, DOI 10.1007/978-1-4939-0931-5_4; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kunzelmann S, 2016, G3-GENES GENOM GENET, V6, P1777, DOI 10.1534/g3.116.028241; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Lin CC, 2016, G3 BETHESDA; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2017	12	6							e0180135	10.1371/journal.pone.0180135	http://dx.doi.org/10.1371/journal.pone.0180135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ3JT	28658280	Green Published, gold, Green Submitted			2022-12-26	WOS:000404607900064
J	Berntsson, SG; Landtblom, AM; Flensner, G				Berntsson, Shala Ghaderi; Landtblom, Anne-Marie; Flensner, Gullvi			Cerebellar ataxia and intrathecal baclofen therapy: Focus on patients' experiences	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; FRIEDREICH ATAXIA; CLINICAL-FEATURES; CEREBRAL-PALSY; HEALTH; INDIVIDUALS; DISABILITY; DEPRESSION; RESOURCE; DISEASES	Elucidating patients A experiences of living with chronic progressive hereditary ataxia and the symptomatic treatment with intrathecal baclofen (ITB) is the objective of the current study. A multicenter qualitative study with four patients included due to the rare combination of hereditary ataxia and ITB therapy was designed to elucidate participants' experiences through semi-structured interviews. The transcribed text was analyzed according to content analysis guidelines. Overall we identified living in the present/taking one day at a time as the main theme covering the following categories: 1) Uncertainty about the future as a consequence of living with a hereditary disease; The disease; 2) Impact on life as a whole, 3) Influence on personal life in terms of feeling forced to terminate employment, 4) Limiting daily activities, and 5) ITB therapy, advantages, and disadvantages. Uncertainty about the future was the category that affected participants' personal life, employment, and daily activities. The participants' experience of receiving ITB therapy was expressed in terms of improved quality of life due to better body position and movement as well as better sleep and pain relief.	[Berntsson, Shala Ghaderi; Landtblom, Anne-Marie] Uppsala Univ, Univ Hosp, Dept Neurosci, Neurol, Uppsala, Sweden; [Landtblom, Anne-Marie] Univ Linkoping, Med Fac, Dept Clin & Expt Med, Neurol, Linkoping, Sweden; [Flensner, Gullvi] Univ West, Dept Hlth Sci, Trollhattan, Sweden	Uppsala University; Uppsala University Hospital; Linkoping University; University West - Sweden	Berntsson, SG (corresponding author), Uppsala Univ, Univ Hosp, Dept Neurosci, Neurol, Uppsala, Sweden.	shala.berntsson@neuro.uu.se		Landtblom, Anne-Marie/0000-0001-9567-470X				Albright AL, 1996, J CHILD NEUROL, V11, P77, DOI 10.1177/088307389601100202; Ben Smail D, 2005, MOVEMENT DISORD, V20, P758, DOI 10.1002/mds.20405; Berntsson SG, 2013, CASE REP NEUROL, V5, P201, DOI 10.1159/000356823; Blomqvist P, 1997, SCAND J GASTROENTERO, V32, P1134, DOI 10.3109/00365529709002993; BOUTTE MI, 1987, SOC SCI MED, V24, P209, DOI 10.1016/0277-9536(87)90048-7; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; Daker-White G, 2015, HEALTH EXPECT, V18, P177, DOI 10.1111/hex.12016; Daker-White G, 2013, PHYSIOTHERAPY, V99, P335, DOI 10.1016/j.physio.2013.02.001; Daker-White G, 2011, CHRONIC ILLN, V7, P120, DOI 10.1177/1742395310390532; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Dickson S, 2008, INT J LANG COMM DIS, V43, P135, DOI 10.1080/13682820701862228; Dilorenzo TA, 2008, DISABIL REHABIL, V30, P1088, DOI 10.1080/09638280701464256; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Flensner G, 2003, INT J NURS STUD, V40, P707, DOI 10.1016/S0020-7489(03)00010-5; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Fujioka S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-14; Gauffin H, 2011, EPILEPSY BEHAV, V22, P750, DOI 10.1016/j.yebeh.2011.09.007; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hayashi A, 2008, NEUROREHABILITATION, V23, P159; Jutel A, 2009, SOCIOL HEALTH ILL, V31, P278, DOI 10.1111/j.1467-9566.2008.01152.x; Koopman W, 1999, J Neurosci Nurs, V31, P17; Krach L E, 2006, Pediatr Rehabil, V9, P210, DOI 10.1080/13638490500138678; Kralik D, 2001, J ADV NURS, V33, P594, DOI 10.1046/j.1365-2648.2001.01704.x; Lebre AS, 2003, CYTOGENET GENOME RES, V100, P154, DOI 10.1159/000072850; Maring J, 2013, PEDIATR PHYS THER, V25, P305, DOI 10.1097/PEP.0b013e31828ed7cb; Mathur SN, 2014, PM&R, V6, P506, DOI 10.1016/j.pmrj.2013.12.005; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mozo-Dutton L, 2012, DISABIL REHABIL, V34, P1208, DOI 10.3109/09638288.2011.638032; Natale M, 2016, CLIN NEUROL NEUROSUR, V143, P121, DOI 10.1016/j.clineuro.2016.02.016; Nuttin B, 1999, NEUROMODULATION, V2, P120, DOI 10.1046/j.1525-1403.1999.00120.x; Panourias IG, 2007, ACTA NEUROCHIR SUPPL, V97, P145; Paulson H., 1993, GENEREVIEWS; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P558, DOI 10.1001/archneur.64.4.558; Storey E, 2014, SEMIN NEUROL, V34, P280, DOI 10.1055/s-0034-1386766; Strickland K, 2016, J CLIN NURSING	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0180054	10.1371/journal.pone.0180054	http://dx.doi.org/10.1371/journal.pone.0180054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654671	Green Submitted, gold, Green Published			2022-12-26	WOS:000404541500051
J	Savini, L; Candeloro, L; Conte, A; De Massis, F; Giovannini, A				Savini, L.; Candeloro, L.; Conte, A.; De Massis, F.; Giovannini, A.			Development of a forecasting model for brucellosis spreading in the Italian cattle trade network aimed to prioritise the field interventions	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; SIMULATION-MODEL; TRANSMISSION; ENVIRONMENT; EPIDEMIC; RISK	Brucellosis caused by Brucella abortus is an important zoonosis that constitutes a serious hazard to public health. Prevention of human brucellosis depends on the control of the disease in animals. Livestock movement data represent a valuable source of information to understand the pattern of contacts between holdings, which may determine the inter-herds and intra-herd spread of the disease. The manuscript addresses the use of computational epidemic models rooted in the knowledge of cattle trade network to assess the probabilities of brucellosis spread and to design control strategies. Three different spread network-based models were proposed: the DFC (Disease Flow Centrality) model based only on temporal cattle network structure and unrelated to the epidemiological disease parameters; a deterministic SIR (Susceptible-Infectious-Recovered) model; a stochastic SEIR (SusceptibleExposed- Infectious-Recovered) model in which epidemiological and demographic within-farm aspects were also modelled. Containment strategies based on farms centrality in the cattle network were tested and discussed. All three models started from the identification of the entire sub-network originated from an infected farm, up to the fifth order of contacts. Their performances were based on data collected in Sicily in the framework of the national eradication plan of brucellosis in 2009. Results show that the proposed methods improves the efficacy and efficiency of the tracing activities in comparison to the procedure currently adopted by the veterinary services in the brucellosis control, in Italy. An overall assessment shows that the SIR model is the most suitable for the practical needs of the veterinary services, being the one with the highest sensitivity and the shortest computation time.	[Savini, L.; Candeloro, L.; Conte, A.; De Massis, F.; Giovannini, A.] Ist Zooprofilatt Sperimentale Abruzzo & Molise, Natl & OIE Reference Lab Brucellosis, OIE Collaborating Ctr Vet Training Epidemiol Food, Via Campo Boario, Teramo, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Savini, L (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise, Natl & OIE Reference Lab Brucellosis, OIE Collaborating Ctr Vet Training Epidemiol Food, Via Campo Boario, Teramo, Italy.	l.savini@izs.it	Conte, Annamaria/H-5869-2016; De Massis, Fabrizio/ABG-8949-2021; Giovannini, Armando/B-9828-2013; Savini, Lara LS/C-2851-2018; Candeloro, Luca/ABA-6009-2021; De Massis, Fabrizio/P-9099-2016	Conte, Annamaria/0000-0001-6975-2698; De Massis, Fabrizio/0000-0001-9811-699X; Giovannini, Armando/0000-0001-5006-5564; Savini, Lara LS/0000-0001-6175-7793; Candeloro, Luca/0000-0001-8475-3787; De Massis, Fabrizio/0000-0001-9811-699X				Ainseba Bedr'Eddine, 2010, Journal of Biological Dynamics, V4, P2, DOI 10.1080/17513750903171688; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2015, CYTOSCAPE V 3 2 1; Calistri P, 2013, PREV VET MED, V110, P329, DOI 10.1016/j.prevetmed.2012.12.008; Caporale V., 2009, P 10 C OIE REG COMM, P111; De Massis F, 2005, Clin Microbiol Infect, V11, P632, DOI 10.1111/j.1469-0691.2005.01204.x; Aparicio ED, 2013, REV SCI TECH OIE, V32, P53; Dube C, 2011, REV SCI TECH OIE, V30, P425; Dubie T, 2014, GLOBAL RES J PUBLIC, V1; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Gabor C, 2015, PACKAGE IGRAPH; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Nicoletti P, 2010, Prilozi, V31, P21; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perez-Sancho Marta, 2015, CONTROL ANIMAL BRUCE; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roy S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001259; Saegerman C, 2010, INFECTIOUS PARASITIC; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017	26	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2017	12	6							e0177313	10.1371/journal.pone.0177313	http://dx.doi.org/10.1371/journal.pone.0177313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2LT	28654703	gold, Green Submitted, Green Published			2022-12-26	WOS:000404541500060
J	Chien, CY; Hung, YJ; Shieh, YS; Hsieh, CH; Lu, CH; Lin, FH; Su, SC; Lee, CH				Chien, Chu-Yen; Hung, Yi-Jen; Shieh, Yi-Shing; Hsieh, Chang-Hsun; Lu, Chieh-Hua; Lin, Fu-Huang; Su, Sheng-Chiang; Lee, Chien-Hsing			A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; HEPATIC STEATOSIS; OBESITY; SECRETION; INFLAMMATION; ADIPONECTIN; CHOLESTEROL; PREVALENCE	Background/Objectives Protein disulfide isomerase (PDI) family members are specific endoplasmic reticulum proteins that are involved in the pathogenesis of numerous diseases including neurodegenerative diseases, cancer and obesity. However, the metabolic effects of PDIA4 remain unclear in humans. The aims of this study were to investigate the associations of serum PDIA4 with the metabolic syndrome (MetS) and its components in Chinese adults. Subjects/Methods A total of 669 adults (399 men and 270 women) were recruited. Serum PDIA4 concentrations and biochemical variables were recorded. Insulin sensitivity and beta-cell function were examined by homeostasis model assessment. MetS was defined based on the modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asia Pacific. Results The participants with MetS had significantly higher serum PDIA4 levels than those without MetS (P<0.001). After adjustments, the individuals with the highest PDIA4 tertile were associated with a higher risk of MetS than those with the lowest tertile (OR = 4.83, 95% CI: 2.71-8.60). The concentration of PDIA4 showed a stepwise increase with the components of MetS (P<0.001 for trend). The individuals with the highest PDIA4 tertile were significantly associated with waist circumference (OR = 2.41, 95% CI 1.34-4.32), blood pressure (OR = 2.71, 95% CI 1.57-4.67), fasting glucose concentration (OR = 3.17, 95% CI 1.80-5.57), and serum triglycerides (OR = 4.12, 95% CI 2.30-7.37) than those with the lowest tertile. At cutoff point of 15.24 ng/ml, the diagnostic sensitivity and specificity of PDIA4 for the metabolic syndrome were 67 and 72%, respectively, in male patients and 60 and 78%, respectively, in female patients. Finally, the result showed that PDIA4 had a significantly higher area under the curve compared with blood pressure to detect MetS using receiver operating characteristic analysis. Conclusions Serum PDIA4 concentrations are closely associated to MetS and its components in Chinese adults.	[Chien, Chu-Yen; Su, Sheng-Chiang; Lee, Chien-Hsing] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hung, Yi-Jen; Hsieh, Chang-Hsun; Lu, Chieh-Hua; Su, Sheng-Chiang; Lee, Chien-Hsing] Natl Def Med Ctr, Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan; [Shieh, Yi-Shing] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Shieh, Yi-Shing] Tri Serv Gen Hosp, Dept Oral Diag & Pathol, Taipei, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lee, CH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Lee, CH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan.	doc10383@gmail.com			National Science Council [MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2]; National Defense Medical Center [MAB-104-82]; Tri-Service General Hospital, Taiwan [TSGH-C105-005-503, TSGH-C105-005-S04, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center; Tri-Service General Hospital, Taiwan	This work was supported by research grants from the National Science Council (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2), National Defense Medical Center (MAB-104-82), and Tri-Service General Hospital (TSGH-C105-005-503, TSGH-C105-005-S04, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research grants from the National Science Council (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3, MOST 105-2314-B-016-030-MY2), National Defense Medical Center (MAB-104-82), and Tri-Service General Hospital (TSGH-C105-005-503, TSGH-C105-005-504, TSGH-C106-006-501, TSGH-C106-006-502, TSGH-C106-007-501, TSGH-C105-120, TSGH-C105-183, TSGH-C105-184, TSGH-C105-185), Taiwan.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124285; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lembar S., 2013, INDONESIAN J CLIN PA, V20, P25, DOI [10.24293/ijcpml.v20i1.442, DOI 10.24293/IJCPML.V20I1.442]; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Mojiminiyi OA, 2007, INT J OBESITY, V31, P213, DOI 10.1038/sj.ijo.0803355; Morand JPF, 2005, J BIOL CHEM, V280, P17626, DOI 10.1074/jbc.M413343200; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Organization WH, 2000, AS PAC PERS RED OB I; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pons V, 2011, HUM MUTAT, V32, P751, DOI 10.1002/humu.21494; Prattes S, 2000, J CELL SCI, V113, P2977; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Sun RQ, 2015, BBA-MOL BASIS DIS, V1852, P156, DOI 10.1016/j.bbadis.2014.11.017; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wen-Chin Yang L-TC, 2015, PDIA4 PROTEIN TARGET; Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179963	10.1371/journal.pone.0179963	http://dx.doi.org/10.1371/journal.pone.0179963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650993	Green Published, Green Submitted, gold			2022-12-26	WOS:000404537300033
J	Ma, XY; Pham, VT; Mori, H; MacDougald, OA; Shah, YM; Bodary, PF				Ma, Xiaoya; Pham, Vinh T.; Mori, Hiroyuki; MacDougald, Ormond A.; Shah, Yatrik M.; Bodary, Peter F.			Iron elevation and adipose tissue remodeling in the epididymal depot of a mouse model of polygenic obesity	PLOS ONE			English	Article							ESTROGEN SULFOTRANSFERASE; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; BETA-THALASSEMIA; EXPRESSION; ADIPONECTIN; MACROPHAGES; FERRITIN; MICE	Background Iron dysregulation is a potential contributor to the pathology of obesity-related metabolic complications. KK/HIJ (KK) mice, a polygenic obese mouse model, have elevated serum iron levels. A subset of KK male mice display a bronzing of epididymal adipose tissue (eAT) associated with > 100-fold (p<0.001) higher iron concentration. Methods To further phenotype and characterize the adipose tissue iron overload, 27 male KK mice were evaluated. 14 had bronzing eAT and 13 had normal appearing eAT. Fasting serum and tissues were collected for iron content, qPCR, histology and western blot. Results High iron levels were confirmed in bronzing eAT (High Iron group, HI) versus normal iron level (NI) in normal appearing eAT. Surprisingly, iron levels in subcutaneous and brown adipose depots were not different between the groups (p>0.05). The eAT histology revealed iron retention, macrophage clustering, tissue fibrosis, cell death as well as accumulation of HIF-2 alpha in the high iron eAT. qPCR showed significantly decreased Lep (leptin) and AdipoQ (adiponectin), whereas Tnfa (tumor necrosis factor alpha), and Slc40a1 (ferroportin) were upregulated in HI (p<0.05). Elevated HIF-2 alpha, oxidative stress and local insulin signaling loss was also observed. Significance Our data suggest that deposition of iron in adipose tissue is limited to the epididymal depot in male KK mice. A robust adipose tissue remodeling is concomitant with the high iron concentration, which causes local adipose tissue insulin resistance.	[Ma, Xiaoya; Pham, Vinh T.; Bodary, Peter F.] Univ Michigan, Sch Kinesiol, 1402 Washington Hts, Ann Arbor, MI 48109 USA; [Ma, Xiaoya; Mori, Hiroyuki; MacDougald, Ormond A.; Shah, Yatrik M.] Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [MacDougald, Ormond A.; Shah, Yatrik M.] Univ Michigan, Sch Med, Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bodary, PF (corresponding author), Univ Michigan, Sch Kinesiol, 1402 Washington Hts, Ann Arbor, MI 48109 USA.	pfbodary@umich.edu		MacDougald, Ormond/0000-0001-6907-7960	University of Michigan; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; NIH [CA148828, DK095201];  [DK62876];  [DK092759]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R56DK062876, R01DK095201, R24DK092759, R01DK062876, P30DK089503] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Rackham Graduate Research Grant from University of Michigan. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD28934. YMS work was supported by NIH grants (CA148828 and DK095201). OAM is supported by DK62876 and DK092759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cighetti G, 2002, EUR J CLIN INVEST, V32, P55, DOI 10.1046/j.1365-2362.2002.0320s1055.x; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Farahani P, 2004, OBES RES, V12, P191, DOI 10.1038/oby.2004.26; Fernandez-Real JM, 2002, DIABETES, V51, P1000, DOI 10.2337/diabetes.51.4.1000; Gotardo EMF, 2013, J NUTR SCI VITAMINOL, V59, P454, DOI 10.3177/jnsv.59.454; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Green A, 2006, METABOLISM, V55, P1042, DOI 10.1016/j.metabol.2006.03.015; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khor VK, 2008, ENDOCRINOLOGY, V149, P5440, DOI 10.1210/en.2008-0271; Khor VK, 2010, AM J PHYSIOL-ENDOC M, V299, pE657, DOI 10.1152/ajpendo.00707.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Orr JS, 2014, DIABETES; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	40	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179889	10.1371/journal.pone.0179889	http://dx.doi.org/10.1371/journal.pone.0179889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28651003	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300028
J	Xu, K; Niu, QS; Zhao, HT; Du, YL; Jiang, YS				Xu, Kai; Niu, Qingsheng; Zhao, Huiting; Du, Yali; Jiang, Yusuo			Transcriptomic analysis to uncover genes affecting cold resistance in the Chinese honey bee (Apis cerana cerana)	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; THERMAL ADAPTATION; STRESS; EXPRESSION; TOLERANCE; KINASE; TEMPERATURE; ACCLIMATION; HYMENOPTERA; HARDINESS	The biological activity and geographical distribution of honey bees is strongly temperature-dependent, due to their ectothermic physiology. In China, the endemic Apis cerana cerana exhibits stronger cold hardiness than Western honey bees, making the former species important pollinators of winter-flowering plants. Although studies have examined behavioral and physiological mechanisms underlying cold resistance in bees, data are scarce regarding the exact molecular mechanisms. Here, we investigated gene expression in A. c. cerana under two temperature treatments, using transcriptomic analysis to identify differentially expressed genes (DEGs) and relevant biological processes, respectively. Across the temperature treatments, 501 DEGs were identified. A gene ontology analysis showed that DEGs were enriched in pathways related to sugar and amino acid biosynthesis and metabolism, as well as calcium ion channel activity. Additionally, heat shock proteins, zinc finger proteins, and serine/threonine-protein kinases were differentially expressed between the two treatments. The results of this study provide a general digital expression profile of thermoregulation genes responding to cold hardiness in A. c. cerana. Our data should prove valuable for future research on cold tolerance mechanisms in insects, and may be beneficial in breeding efforts to improve bee hardiness.	[Xu, Kai; Du, Yali; Jiang, Yusuo] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China; [Niu, Qingsheng] Apiculture Sci Inst Jilin Prov, Jilin, Jilin, Peoples R China; [Zhao, Huiting] Shanxi Agr Univ, Coll Life Sci, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Jiang, YS (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China.	jiangys-001@163.com			National Nature Science Foundation of China; foundation is Qingsheng Niu;  [31372382]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation is Qingsheng Niu; 	This work is supported by the National Nature Science Foundation of China. The award number of this foundation is 31372382. The recipient of this foundation is Qingsheng Niu who is the second author of this paper. The funders were undertaken to explore cold tolerance mechanism of honey bee and had an important role in study design, decision to publish, and preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bahar MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073901; Ben Saad R, 2010, PLANT MOL BIOL, V72, P171, DOI 10.1007/s11103-009-9560-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkvens N, 2010, J INSECT PHYSIOL, V56, P438, DOI 10.1016/j.jinsphys.2009.11.019; Blumberg H, 1979, BREAST CANC RES TREA, V139, P163; Carrillo MA, 2005, J INSECT PHYSIOL, V51, P759, DOI 10.1016/j.jinsphys.2005.03.006; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; CHEN CP, 1993, ECOL ENTOMOL, V18, P184, DOI 10.1111/j.1365-2311.1993.tb01088.x; Chen YJ, 2005, SCI SERICULTURE, V31, P111; Cheng WN, 2016, J INSECT PHYSIOL, V95, P66, DOI 10.1016/j.jinsphys.2016.09.005; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; COELHO JR, 1991, ENVIRON ENTOMOL, V20, P1627, DOI 10.1093/ee/20.6.1627; Cohen-Katsenelson K, 2013, J BIOL CHEM, V288, P7294, DOI 10.1074/jbc.M112.422055; Colinet H, 2017, INSECT BIOCHEM MOLEC, V80, P52, DOI 10.1016/j.ibmb.2016.11.007; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Dennis AB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13965; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Faucher SP, 2008, FEMS MICROBIOL LETT, V281, P160, DOI 10.1111/j.1574-6968.2008.01094.x; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Fu L, 2015, ONCOTARGET, V6, P8144, DOI 10.18632/oncotarget.3519; Fu S, 2006, PLANTA, V224, P42, DOI 10.1007/s00425-005-0191-y; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Goto M, 2001, J INSECT PHYSIOL, V47, P157, DOI 10.1016/S0022-1910(00)00099-8; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Heinrich B, 1980, PHYS LETT A, V29, P551; HOLDEN CP, 1994, INSECT BIOCHEM MOLEC, V24, P167, DOI 10.1016/0965-1748(94)90083-3; Huang GY, 1990, J ZHEJIANG FOREST CO, P140; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Lal SV, 2015, CELL STRESS CHAPERON, V20, P545, DOI 10.1007/s12192-014-0563-y; LARSEN KJ, 1994, J INSECT PHYSIOL, V40, P859, DOI 10.1016/0022-1910(94)90019-1; LI ZY, 2006, J BEE, V26, P12; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Liu PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135215; Liu ZH, 2014, GENE, V545, P205, DOI 10.1016/j.gene.2014.05.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nation J. L., 2002, INSECT PHYSL BIOCH, DOI DOI 10.1017/CBO9781107415324.004; Owens CD, 1971, TECHNICAL B; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; PATEL J, 1991, J MOL NEUROSCI, V3, P19, DOI 10.1007/BF02896845; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; RITTER W, 1982, APIDOLOGIE, V13, P169, DOI 10.1051/apido:19820205; Rudrabhatla P, 2002, PLANT PHYSIOL, V130, P380, DOI 10.1104/pp.005173; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Sivan A, 2017, ACTA TROP, V167, P121, DOI 10.1016/j.actatropica.2016.12.017; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Stabentheiner A, 1995, J COMP PHYSIOL B, V165, P433, DOI 10.1007/BF00261297; Stetina T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128976; Sun Y, 2016, INSECT SCI, V23, P37, DOI 10.1111/1744-7917.12193; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waagner D, 2013, J EXP BIOL, V216, P1991, DOI 10.1242/jeb.079814; Wang XH, 2010, J INSECT PHYSIOL, V56, P966, DOI 10.1016/j.jinsphys.2010.04.008; Wanke V, 1997, FEBS LETT, V402, P251, DOI 10.1016/S0014-5793(97)00009-4; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu SH, 2016, INSECT SCI, V23, P430, DOI 10.1111/1744-7917.12320; Zhao YX, 2000, J APPL ENTOMOL, V124, P185, DOI 10.1046/j.1439-0418.2000.00463.x	70	17	21	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2017	12	6							e0179922	10.1371/journal.pone.0179922	http://dx.doi.org/10.1371/journal.pone.0179922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ2KD	28650988	Green Published, gold, Green Submitted			2022-12-26	WOS:000404537300030
J	Cantrell, M; Peers, G				Cantrell, Michael; Peers, Graham			A mutant of Chlamydomonas without LHCSR maintains high rates of photosynthesis, but has reduced cell division rates in sinusoidal light conditions	PLOS ONE			English	Article							CARBON-CONCENTRATING MECHANISM; XANTHOPHYLL-DEFICIENT MUTANT; CYCLIC ELECTRON FLOW; PROTEIN-KINASE STT7; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; STATE TRANSITIONS; GREEN-ALGAE; PHOTOOXIDATIVE STRESS; ENERGY-DISSIPATION	The LHCSR protein belongs to the light harvesting complex family of pigment -binding proteins found in oxygenic photoautotrophs. Previous studies have shown that this complex is required for the rapid induction and relaxation of excess light energy dissipation in a wide range of eukaryotic algae and moss. The ability of cells to rapidly regulate light harvesting between this dissipation state and one favoring photochemistry is believed to be important for reducing oxidative stress and maintaining high photosynthetic efficiency in a rapidly changing light environment. We found that a mutant of Chlamydomonas reinhardtii lacking LHCSR, npq41hcsrl, displays minimal photoinhibition of photosystem II and minimal inhibition of short term oxygen evolution when grown in constant excess light compared to a wild type strain. We also investigated the impact of no LHCSR during growth in a sinusoidal light regime, which mimics daily changes in photosynthetically active radiation. The absence of LHCSR correlated with a slight reduction in the quantum efficiency of photosystem II and a stimulation of the maximal rates of photosynthesis compared to wild type. However, there was no reduction in carbon accumulation during the day. Another novel finding was that npq41hcsrl cultures underwent fewer divisions at night, reducing the overall growth rate compared to the wild type. Our results show that the rapid regulation of light harvesting mediated by LHCSR is required for high growth rates, but it is not required for efficient carbon accumulation during the day in a sinusoidal light environment. This finding has direct implications for engineering strategies directed at increasing photosynthetic productivity in mass cultures.	[Cantrell, Michael; Peers, Graham] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University	Peers, G (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Graham.Peers@colostate.edu		Peers, Graham/0000-0002-3590-7820	Colorado State University	Colorado State University	This work was supported by funds provided by Colorado State University.	Adams WW, 2013, PHOTOSYNTH RES, V117, P31, DOI 10.1007/s11120-013-9849-7; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Berteotti S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21339; Bisova K, 2014, J EXP BOT, V65, P2585, DOI 10.1093/jxb/ert466; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Correa-Galvis V, 2016, J BIOL CHEM, V291, P17478, DOI 10.1074/jbc.M116.737312; CRAIGIE RA, 1982, J CELL SCI, V54, P173; Cross FR, 2015, PLANT J, V82, P370, DOI 10.1111/tpj.12795; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Derks A, 2015, BBA-BIOENERGETICS, V1847, P468, DOI 10.1016/j.bbabio.2015.02.008; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Jallet D, 2016, ALGAL RES, V18, P51, DOI 10.1016/j.algal.2016.05.014; Joliet D, 2016, CHLOROPLASTS CURRENT; Juergens MT, 2016, PLANT PHYSIOL, V171, P2445, DOI 10.1104/pp.16.00761; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Li ZR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.140, 10.1038/nplants.2016.140]; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Lucker BF, 2014, ALGAL RES, V6, P242, DOI 10.1016/j.algal.2013.12.007; Malnoe A, 2014, PLANT CELL, V26, P373, DOI 10.1105/tpc.113.120113; Mathy G, 2010, J PROTEOME RES, V9, P2825, DOI 10.1021/pr900866e; MCDUFF RE, 1982, LIMNOL OCEANOGR, V27, P783, DOI 10.4319/lo.1982.27.4.0783; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Peers G, 2015, US Patent, Patent No. [8,940,508, 8940508]; Peers G, 2014, TRENDS BIOTECHNOL, V32, P551, DOI 10.1016/j.tibtech.2014.09.007; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Perrine Z, 2012, ALGAL RES, V1, P134, DOI 10.1016/j.algal.2012.07.002; PLATT T, 1980, J MAR RES, V38, P687; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Raven J.A, 2013, AQUATIC PHOTOSYNTHES; RAVEN JA, 1989, FUNCT ECOL, V3, P5, DOI 10.2307/2389670; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Shriwastav A, 2015, J APPL PHYCOL, V27, P211, DOI 10.1007/s10811-014-0302-x; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Truong T. B., 2011, INVESTIGATING ROLES; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; Vandenhecke JMR, 2015, PHOTOSYNTH RES, V124, P275, DOI 10.1007/s11120-015-0137-6; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Wobbe L, 2016, TRENDS PLANT SCI, V21, P55, DOI 10.1016/j.tplants.2015.10.004; Wobbe L, 2015, J BIOTECHNOL, V201, P28, DOI 10.1016/j.jbiotec.2014.08.021; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yarnold J, 2016, ALGAL RES, V13, P182, DOI 10.1016/j.algal.2015.11.001; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	83	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179395	10.1371/journal.pone.0179395	http://dx.doi.org/10.1371/journal.pone.0179395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644828	gold, Green Published, Green Submitted			2022-12-26	WOS:000404145100014
J	Kim, HS; Tian, LJ; Kim, H; Moon, WK				Kim, Hoe Suk; Tian, Lianji; Kim, Hyeonjin; Moon, Woo Kyung			Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using H-1-nuclear magnetic resonance spectroscopy	PLOS ONE			English	Article							DRUG-RESISTANCE; GLUTAMINE-METABOLISM; CARCINOMA CELLS; AUTOPHAGY; METABOLOMICS; INHIBITION; PROLIFERATION; MECHANISMS; THERAPY; GLYCINE	Metabolites linked to changes in choline kinase-alpha (CK-alpha) expression and drug resistance, which contribute to survival and autophagy mechanisms, are attractive targets for breast cancer therapies. We previously reported that autophagy played a causative role in driving tamoxifen (TAM) resistance of breast cancer cells (BCCs) and was also promoted by CK-alpha knockdown, resulting in the survival of TAM-resistant BCCs. There is no comparative study yet about the metabolites resulting from BCCs with TAM-resistance and CK-alpha knockdown. Therefore, the aim of this study was to explore the discriminant metabolic biomarkers responsible for TAM resistance as well as CK-alpha expression, which might be linked with autophagy through a protective role. A total of 33 intracellular metabolites, including a range of amino acids, energy metabolism-related molecules and others from cell extracts of the parental cells (MCF-7), TAM-resistant cells (MCF-7/TAM) and CK-alpha knockdown cells (MCF-7/shCK-alpha, MCF-7/TAM/shCK-alpha) were analyzed by proton nuclear magnetic resonance spectroscopy (H-1-NMRS). Principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA) revealed the existence of differences in the intracellular metabolites to separate the 4 groups: MCF-7 cells, MCF-7/TAM cells, MCF-7-shCK-alpha cells, and MCF-7/TAM/shCK-alpha cells. The metabolites with VIP> 1 contributed most to the differentiation of the cell groups, and they included fumarate, UA (unknown A), lactate, myoinositol, glycine, phosphocholine, UE (unknown E), glutamine, formate, and AXP (AMP/ADP/ATP). Our results suggest that these altered metabolites would be promising metabolic biomarkers for a targeted therapeutic strategy in BCCs that exhibit TAM-resistance and aberrant CK-alpha expression, which triggers a survival and drug resistance mechanism.	[Kim, Hoe Suk; Tian, Lianji; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Tian, Lianji; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, H; Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	hyeonjinkim@snu.ac.kr; moonwk@snu.ac.kr	Kim, Hyeonjin/M-3761-2019		SNUH Research Fund to (HSK) [04-2013-1040, 04-2015-0870]; National Research Foundation of Korea (NRF); Korean government (MEST) [2015R1A2A1A05001860]; rain Korea 21 Plus [BK21Plus]	SNUH Research Fund to (HSK); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); rain Korea 21 Plus	This work was supported by grant no.04-2013-1040 and 04-2015-0870 from the SNUH Research Fund to (HSK), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2015R1A2A1A05001860) to (WKM), and (LT)is awardee of graduate student fellowship funded by rain Korea 21 Plus (BK21Plus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Brisson L, 2016, CANCER CELL, V30, P418, DOI 10.1016/j.ccell.2016.08.005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cabot MC, 1997, INT J CANCER, V70, P567, DOI 10.1002/(SICI)1097-0215(19970304)70:5<567::AID-IJC13>3.0.CO;2-A; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Clem BF, 2011, ONCOGENE, V30, P3370, DOI 10.1038/onc.2011.51; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Fanciulli M, 2000, CLIN CANCER RES, V6, P1590; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jia M, 2016, CANCER RES, V76, P5634, DOI 10.1158/0008-5472.CAN-15-2910; Kim HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141110; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Mitsuhashi S, 2011, AUTOPHAGY, V7, P1559, DOI 10.4161/auto.7.12.17925; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mori N, 2015, NMR BIOMED, V28, P1697, DOI 10.1002/nbm.3429; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; NEEMAN M, 1989, CANCER RES, V49, P589; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Raykov Z, 2014, INT J CANCER, V134, P2572, DOI 10.1002/ijc.28597; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rodriguez-Gonzalez A, 2005, INT J ONCOL, V26, P999; Sanchez-Lopez E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.453; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Stewart DA, 2016, J PROTEOME RES, V15, P3225, DOI 10.1021/acs.jproteome.6b00430; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Thewes V, 2015, CANCER RES, V75, P720, DOI 10.1158/0008-5472.CAN-14-0652; Thomas C, 2011, NAT MED, V17, P658, DOI 10.1038/nm0611-658; Thorburn A, 2014, MOL PHARMACOL, V85, P830, DOI 10.1124/mol.114.091850; Tian L, 2013, J PROTEOME RES, V12, P3738, DOI 10.1021/pr400315e; van der Vos KE, 2012, AUTOPHAGY, V8, P1862, DOI 10.4161/auto.22152; Viedma-Rodriguez R, 2014, ONCOL REP, V32, P3, DOI 10.3892/or.2014.3190; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Zarzynska JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/710345; Zhao Z, 2015, CANCER LETT, V358, P17, DOI 10.1016/j.canlet.2014.11.046	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179773	10.1371/journal.pone.0179773	http://dx.doi.org/10.1371/journal.pone.0179773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644842	Green Published, gold, Green Submitted			2022-12-26	WOS:000404145100036
J	Zhu, YR; Reinach, PS; Zhu, HL; Tan, QF; Zheng, QX; Qu, J; Chen, W				Zhu, Yirui; Reinach, Peter S.; Zhu, Hanlei; Tan, Qiufan; Zheng, Qinxiang; Qu, Jia; Chen, Wei			High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea	PLOS ONE			English	Article							IN-VIVO; ENZYMATIC DIGESTION; MOUSE CORNEA; KERATOCONUS; RESISTANCE; IRRADIATION; MICROSCOPY; THICKNESS; KERATITIS; STANDARD	Corneal collagen cross-linking (CXL) halts human corneal ectasias progression by increasing stromal mechanical stiffness. Although some reports describe that this procedure is effective in dealing with some infectious and immunologic corneal thinning diseases, there is a need for more animal models whose corneal thickness more closely resemble those occurring in these patients. To meet this need, we describe here high-intensity protocols that are safe and effective for obtaining CXL in rat corneas. Initially, a range of potentially effective UVA doses were evaluated based on their effectiveness in increasing tissue enzymatic resistance to dissolution. At UVA doses higher than a threshold level of 0.54 J/cm(2), resistance to enzymatic digestion increased relative to that in non-irradiated corneas. Based on the theoretical threshold CXL dose, a CXL regimen was established in which the UVA tissue irradiance was 9 mW/cm(2), which was delivered at doses of either 2.16, 2.7 or 3.24 J/cm(2). Their dose dependent effects were evaluated on ocular surface morphological integrity, keratocyte apoptotic frequency, tissue thickness and endothelial cell layer density. Doses of 2.16 and 2.7 J/cm(2) transiently decreased normal corneal transparency and increased thickness. These effects were fully reversed after 14 days. In contrast, 3.24 J/cm(2) had more irreversible side effects. Three days after treatment, apoptotic frequency in the CXL-2.16 group was lower than that at higher doses. Endothelial cell losses remained evident only in the CXL-3.24 group at 42 days posttreatment. Stromal fiber thickening was evident in all the CXL-treated groups. We determined both the threshold UVA dose using the high-intensity CXL procedure and identified an effective dose range that provides optimal CXL with minimal transient side effects in the rat cornea. These results may help to provide insight into how to improve the CXL outcome in patients afflicted with a severe corneal thinning disease.	[Qu, Jia; Chen, Wei] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Qu, J; Chen, W (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	13806898805@163.com; chenweimd@hotmail.com	Reinach, Peter/AAI-3582-2021		 [81170820];  [81470605]	; 	This study was funded by the research China (81170820 and 81470605 to Wei Chen).The funders had role in study design, decision to publish and preparation of the manuscript.	Aldahlawi NH, 2016, INVEST OPHTH VIS SCI, V57, P1547, DOI 10.1167/iovs.15-18769; Aldahlawi NH, 2015, J CATARACT REFR SURG, V41, P1989, DOI 10.1016/j.jcrs.2015.10.004; Alio JL, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-47; Angunawela RI, 2009, J CATARACT REFR SURG, V35, P606, DOI 10.1016/j.jcrs.2008.11.050; Bawa G, 2013, BIOMED OPT EXPRESS, V4, P2585, DOI 10.1364/BOE.4.002585; Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28145; Dhaliwal JS, 2009, CORNEA, V28, P62, DOI 10.1097/ICO.0b013e31818225c3; Ehlers N, 2009, J REFRACT SURG, V25, pS803, DOI 10.3928/1081597X-20090813-08; Gokhale NS, 2010, CORNEA, V29, P117, DOI 10.1097/ICO.0b013e3181a06c31; Hammer A, 2015, INVEST OPHTH VIS SCI, V56, P6581, DOI 10.1167/iovs.15-17426; Hovakimyan M, 2011, CORNEA, V30, P196, DOI 10.1097/ICO.0b013e3181e16d93; Iseli HP, 2008, CORNEA, V27, P590, DOI 10.1097/ICO.0b013e318169d698; JAKUS MA, 1954, AM J OPHTHALMOL, V38, P40, DOI 10.1016/0002-9394(54)90008-2; Kanellopoulos AJ, 2016, CORNEA, V35, P557, DOI 10.1097/ICO.0000000000000758; Kanellopoulos AJ, 2015, BRIT J OPHTHALMOL, V99, P870, DOI 10.1136/bjophthalmol-2014-306411; Kling S, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.1.7; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Kolozsvari BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076333; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Mazzotta C, 2015, OCUL SURF, V13, P298, DOI 10.1016/j.jtos.2015.04.007; Messmer EM, 2013, CORNEA, V32, P111, DOI 10.1097/ICO.0b013e31824d701b; Rama P, 2009, J CATARACT REFR SURG, V35, P788, DOI 10.1016/j.jcrs.2008.09.035; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Schwartzkopff J, 2010, MOL VIS, V16, P2368; Spadea L, 2010, J REFRACT SURG, V26, P375, DOI 10.3928/1081597X-20100114-03; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Spoerl Eberhard, 2011, Open Ophthalmol J, V5, P14, DOI 10.2174/1874364101105010014; TRESELER PA, 1986, TRANSPLANTATION, V41, P248, DOI 10.1097/00007890-198602000-00022; Wang F, 2008, OPHTHALMOLOGICA, V222, P369, DOI 10.1159/000151247; Wang JH, 2009, EYE CONTACT LENS, V35, P44, DOI 10.1097/ICL.0b013e31819579f2; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1786, DOI 10.1016/S0886-3350(03)00343-2; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Zhang HM, 2013, EXP EYE RES, V115, P255, DOI 10.1016/j.exer.2013.07.025	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2017	12	6							e0179580	10.1371/journal.pone.0179580	http://dx.doi.org/10.1371/journal.pone.0179580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY7CO	28644862	Green Published, Green Submitted, gold			2022-12-26	WOS:000404145100024
J	Alhusban, A; Kozak, A; Pillai, B; Ahmed, H; Sayed, MA; Johnson, MH; Ishrat, T; Ergul, A; Fagan, SC				Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Johnson, Maribeth H.; Ishrat, Tauheed; Ergul, Adviye; Fagan, Susan C.			Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; AT(1) RECEPTOR BLOCKADE; NEUROTROPHIC FACTOR; BRAIN ISCHEMIA; VASCULAR PROTECTION; OXIDATIVE STRESS; DIABETIC STROKE; UP-REGULATION	Stroke is a leading cause of adult disability worldwide. Improving stroke outcome requires an orchestrated interplay that involves up regulation of pro-survival pathways and a concomitant suppression of pro-apoptotic mediators. In this investigation, we assessed the involvement of eNOS in the AT1 blocker-mediated protective and pro-recovery effects in animals with hypertension. We also evaluated the effect of acute eNOS inhibition in hypertensive animals. To achieve these goals, spontaneously hypertensive rats (SHR) were implanted with blood pressure transmitters, and randomized to receive either an eNOS inhibitor (L-NIO) or saline one hour before cerebral ischemia induction. After 3 hours of ischemia, animals were further randomized to receive either candesartan or saline at the time of reperfusion and sacrificed either 24 hours or 7 days later. Candesartan induced an early protective effect that was independent of eNOS inhibition (50% improvement in motor function). However, the protective effect of candesartan was associated with about five fold up regulation of BDNF expression and about three fold reduction in ER stress markers, in an eNOS dependent manner. The early benefit of a single dose of candesartan, present at 24 hours after stroke, was diminished at 7 days, perhaps due to a failure to induce an angiogenic response in these hypertensive animals. In conclusion, our findings demonstrate an early prorecovery effect of candesartan at both functional and molecular levels. Candesartan induced prorecovery signaling was mediated through eNOS. This effect was not maintained at 7 days after experimental ischemia.	[Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Ishrat, Tauheed; Ergul, Adviye] Univ Georgia, Program Clin & Expt Therapeut, Charlie Norwood VA Med Ctr, Augusta, GA USA; [Alhusban, Ahmed; Kozak, Anna; Pillai, Bindu; Ahmed, Heba; Sayed, Mohammed A.; Ishrat, Tauheed; Ergul, Adviye] Univ Georgia, Coll Pharm, Augusta, GA USA; [Alhusban, Ahmed] Jordan Univ Sci & Technol, Coll Pharm, Irbid, Jordan; [Johnson, Maribeth H.; Fagan, Susan C.] Augusta Univ, Dept Biostat, Med Coll Georgia, Augusta, GA 30912 USA; [Ergul, Adviye] Augusta Univ, Dept Physiol, Med Coll Georgia, Augusta, GA USA; [Fagan, Susan C.] Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; University of Georgia; Jordan University of Science & Technology; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fagan, SC (corresponding author), Augusta Univ, Dept Biostat, Med Coll Georgia, Augusta, GA 30912 USA.; Fagan, SC (corresponding author), Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA.	sfagan@uga.edu	Alhusban, Ahmed/AEO-4211-2022	Sayed, Mohammed/0000-0001-5362-9839; Alhusban, Ahmed/0000-0003-1105-0620	NINDS [NS063965, NS054688]; VA Merit Review [BX000891, BX000347]; American Heart Association Established Investigator Award [0740002N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559, R01NS063965, R03NS054688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000891, I01BX000347] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); VA Merit Review(US Department of Veterans Affairs); American Heart Association Established Investigator Award(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Funded by NINDS grants NS063965 (SCF), NS054688 (AE), VA Merit Review: BX000891 (SCF) and BX000347 (AE) and American Heart Association Established Investigator Award 0740002N (AE).; Support: NINDS grants NS063965 (SCF) and NS054688 (AE), VA Merit Review BX000891 (SCF) and BX000347 (AE).	Abdelsaid M, 2015, DIABETES, V64, P1804, DOI 10.2337/db14-1423; Abdelsaid MA, 2012, J CELL SCI, V125, P4751, DOI 10.1242/jcs.103481; Alhusban Ahmed, 2016, Exp Transl Stroke Med, V8, P4, DOI 10.1186/s13231-016-0018-x; Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Alhusban A, 2013, J PHARMACOL EXP THER, V344, P348, DOI 10.1124/jpet.112.197483; Brdon J, 2007, J HYPERTENS, V25, P187, DOI 10.1097/01.hjh.0000254376.80864.d3; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chen G, 2007, J NEUROSCI RES, V85, P1674, DOI 10.1002/jnr.21292; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Elgebaly MM, 2010, J CEREBR BLOOD F MET, V30, P1928, DOI 10.1038/jcbfm.2010.120; Engelhorn T, 2004, J CEREBR BLOOD F MET, V24, P467, DOI 10.1097/00004647-200404000-00012; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Fagan SC, 2006, J HYPERTENS, V24, P535, DOI 10.1097/01.hjh.0000209990.41304.43; Fouda AY, 2017, MOL NEUROBIOL, V54, P661, DOI 10.1007/s12035-015-9675-3; Guan WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024551; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hamai M, 2006, NEUROPHARMACOLOGY, V51, P822, DOI 10.1016/j.neuropharm.2006.05.029; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Iwai M, 2008, HYPERTENS RES, V31, P161, DOI 10.1291/hypres.31.161; Jiang MH, 2002, BRAIN RES, V946, P139, DOI 10.1016/S0006-8993(02)02870-6; Kilic E, 2010, J CEREBR BLOOD F MET, V30, P969, DOI 10.1038/jcbfm.2009.268; Kishi T, 2012, J CARDIOL, V60, P489, DOI 10.1016/j.jjcc.2012.08.004; Klingbeil AU, 2003, AM J HYPERTENS, V16, P123, DOI 10.1016/S0895-7061(02)03154-0; Koh Phil-Ok, 2012, Lab Anim Res, V28, P273, DOI 10.5625/lar.2012.28.4.273; Kozak A, 2009, STROKE, V40, P1870, DOI 10.1161/STROKEAHA.108.537225; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lou M, 2004, J CEREBR BLOOD F MET, V24, P536, DOI 10.1097/00004647-200405000-00008; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Mecca AP, 2009, EXP PHYSIOL, V94, P937, DOI 10.1113/expphysiol.2009.047936; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Qiu B, 2013, BIOCHEM BIOPH RES CO, V436, P655, DOI 10.1016/j.bbrc.2013.05.142; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Sierra C, 2011, CURR HYPERTENS REP, V13, P200, DOI 10.1007/s11906-011-0195-x; Srinivasan K, 2012, LIFE SCI, V90, P154, DOI 10.1016/j.lfs.2011.10.017; Sun YJ, 2005, J CEREBR BLOOD F MET, V25, P485, DOI 10.1038/sj.jcbfm.9600049; Yamakawa H, 2003, J CEREBR BLOOD F MET, V23, P371, DOI 10.1097/01.WCB.0000047369.05600.03; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zhou J, 2006, STROKE, V37, P1271, DOI 10.1161/01.STR.0000217404.64352.d7	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178867	10.1371/journal.pone.0178867	http://dx.doi.org/10.1371/journal.pone.0178867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640888	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800013
